PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Neumann, GA; Cavanaugh, JF; Sun, XL; Mazarico, EM; Smith, DE; Zuber, MT; Mao, DD; Paige, DA; Solomon, SC; Ernst, CM; Barnouin, OS				Neumann, Gregory A.; Cavanaugh, John F.; Sun, Xiaoli; Mazarico, Erwan M.; Smith, David E.; Zuber, Maria T.; Mao, Dandan; Paige, David A.; Solomon, Sean C.; Ernst, Carolyn M.; Barnouin, Olivier S.			Bright and Dark Polar Deposits on Mercury: Evidence for Surface Volatiles	SCIENCE			English	Article							PHASE FUNCTION; NORTH-POLE; ICE; MESSENGER; STABILITY; MISSION; IMAGES; MOON	Measurements of surface reflectance of permanently shadowed areas near Mercury's north pole reveal regions of anomalously dark and bright deposits at 1064-nanometer wavelength. These reflectance anomalies are concentrated on poleward-facing slopes and are spatially collocated with areas of high radar backscatter postulated to be the result of near-surface water ice. Correlation of observed reflectance with modeled temperatures indicates that the optically bright regions are consistent with surface water ice, whereas dark regions are consistent with a surface layer of complex organic material that likely overlies buried ice and provides thermal insulation. Impacts of comets or volatile-rich asteroids could have provided both dark and bright deposits.	[Neumann, Gregory A.; Cavanaugh, John F.; Sun, Xiaoli] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Mazarico, Erwan M.; Smith, David E.; Zuber, Maria T.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Mao, Dandan] Sigma Space Corp, Lanham, MD 20706 USA; [Paige, David A.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Solomon, Sean C.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Solomon, Sean C.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Ernst, Carolyn M.; Barnouin, Olivier S.] Johns Hopkins Appl Phys Lab, Laurel, MD 20723 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Massachusetts Institute of Technology (MIT); University of California System; University of California Los Angeles; Carnegie Institution for Science; Columbia University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Neumann, GA (corresponding author), NASA, Goddard Space Flight Ctr, Code 698, Greenbelt, MD 20771 USA.	gregory.a.neumann@nasa.gov	Sun, Xiaoli/B-5120-2013; Barnouin, Olivier S/I-7475-2015; Ernst, Carolyn M/I-4902-2012; Neumann, Gregory A/I-5591-2013; Mazarico, Erwan/N-6034-2014	Barnouin, Olivier S/0000-0002-3578-7750; Ernst, Carolyn M/0000-0002-9434-7886; Neumann, Gregory A/0000-0003-0644-9944; Mazarico, Erwan/0000-0003-3456-427X	NASA [NAS5-97271, NASW-00002]	NASA(National Aeronautics & Space Administration (NASA))	The MESSENGER project is supported by the NASA Discovery Program under contracts NAS5-97271 to the Johns Hopkins University Applied Physics Laboratory and NASW-00002 to the Carnegie Institution of Washington. We are grateful for the myriad of contributions from the MLA instrument and MESSENGER spacecraft teams and for comments by P. Lucey and two anonymous referees that improved the manuscript.	ARNOLD JR, 1979, J GEOPHYS RES, V84, P5659, DOI 10.1029/JB084iB10p05659; Black GJ, 2010, ICARUS, V209, P224, DOI 10.1016/j.icarus.2009.10.009; Butler BJ, 1997, J GEOPHYS RES-PLANET, V102, P19283, DOI 10.1029/97JE01347; BUTLER BJ, 1993, J GEOPHYS RES-PLANET, V98, P15003, DOI 10.1029/93JE01581; Cavanaugh JF, 2007, SPACE SCI REV, V131, P451, DOI 10.1007/s11214-007-9273-4; GARDNER CS, 1992, IEEE T GEOSCI REMOTE, V30, P1061, DOI 10.1109/36.175341; GEHRELS T, 1956, ASTROPHYS J, V123, P331, DOI 10.1086/146166; Hansen GB, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002149; HARMON JK, 1992, SCIENCE, V258, P640, DOI 10.1126/science.258.5082.640; Harmon JK, 2011, ICARUS, V211, P37, DOI 10.1016/j.icarus.2010.08.007; Hawkins SE, 2007, SPACE SCI REV, V131, P247, DOI 10.1007/sl11214-007-9266-3; Lawrence DJ, 2013, SCIENCE, V339, P292, DOI 10.1126/science.1229953; Mallama A, 2002, ICARUS, V155, P253, DOI 10.1006/icar.2001.6723; Mazarico E, 2011, ICARUS, V211, P1066, DOI 10.1016/j.icarus.2010.10.030; McClintock WE, 2008, SCIENCE, V321, P62, DOI 10.1126/science.1159933; MCCORD TB, 1972, SCIENCE, V178, P745, DOI 10.1126/science.178.4062.745; PAIGE DA, 1992, SCIENCE, V258, P643, DOI 10.1126/science.258.5082.643; Paige DA, 2013, SCIENCE, V339, P300, DOI 10.1126/science.1231106; SLADE MA, 1992, SCIENCE, V258, P635, DOI 10.1126/science.258.5082.635; Solomon SC, 2007, SPACE SCI REV, V131, P3, DOI 10.1007/s11214-007-9247-6; Talpe MJ, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004155; Vasavada AR, 1999, ICARUS, V141, P179, DOI 10.1006/icar.1999.6175; VILAS F, 1985, ICARUS, V64, P133, DOI 10.1016/0019-1035(85)90044-2; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033; Zhang JA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041806; Zhang JA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038614; Zuber MT, 2012, SCIENCE, V336, P217, DOI 10.1126/science.1218805	27	101	103	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2013	339	6117					296	300		10.1126/science.1229764	http://dx.doi.org/10.1126/science.1229764			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23196910	Green Submitted			2022-12-28	WOS:000313622000037
J	Milinkovitch, MC; Manukyan, L; Debry, A; Di-Poi, N; Martin, S; Singh, D; Lambert, D; Zwicker, M				Milinkovitch, Michel C.; Manukyan, Liana; Debry, Adrien; Di-Poi, Nicolas; Martin, Samuel; Singh, Daljit; Lambert, Dominique; Zwicker, Matthias			Crocodile Head Scales Are Not Developmental Units But Emerge from Physical Cracking	SCIENCE			English	Article							SURFACE MECHANICS; PATTERN-FORMATION; ORDER; HAIR	Various lineages of amniotes display keratinized skin appendages (feathers, hairs, and scales) that differentiate in the embryo from genetically controlled developmental units whose spatial organization is patterned by reaction-diffusion mechanisms (RDMs). We show that, contrary to skin appendages in other amniotes (as well as body scales in crocodiles), face and jaws scales of crocodiles are random polygonal domains of highly keratinized skin, rather than genetically controlled elements, and emerge from a physical self-organizing stochastic process distinct from RDMs: cracking of the developing skin in a stress field. We suggest that the rapid growth of the crocodile embryonic facial and jaw skeleton, combined with the development of a very keratinized skin, generates the mechanical stress that causes cracking.	[Milinkovitch, Michel C.; Manukyan, Liana; Debry, Adrien; Di-Poi, Nicolas] Univ Geneva, Lab Artificial & Nat Evolut, Dept Genet & Evolut, CH-1211 Geneva, Switzerland; [Martin, Samuel] La Ferme Crocodiles, Pierrelatte, France; [Singh, Daljit; Zwicker, Matthias] Univ Bern, Comp Graph Grp, CH-3012 Bern, Switzerland; [Lambert, Dominique] Univ Namur, Dept Math, Namur, Belgium; [Lambert, Dominique] Univ Namur, Namur Ctr Complex Syst, Namur, Belgium	University of Geneva; University of Bern; University of Namur; University of Namur	Milinkovitch, MC (corresponding author), Univ Geneva, Lab Artificial & Nat Evolut, Dept Genet & Evolut, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	michel.milinkovitch@unige.ch	Di-Poi, Nicolas/O-6256-2019; Lambert, Dominique Jean-Marie/AAH-6865-2021; Di-Poi, Nicolas/O-2378-2015	Di-Poi, Nicolas/0000-0002-3313-3016; Lambert, Dominique Jean-Marie/0000-0002-6415-3175; Di-Poi, Nicolas/0000-0002-3313-3016; Zwicker, Matthias/0000-0001-8630-5515; Milinkovitch, Michel/0000-0002-2553-0724	University of Geneva; Swiss National Science Foundation; Schmidheiny Foundation	University of Geneva; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Schmidheiny Foundation	This work was supported by the University of Geneva, the Swiss National Science Foundation, and the Schmidheiny Foundation. A. Tzika helped with in situs. H. Li assisted with nonrigid registration. We thank R. Pellet for assistance in mechanics design and A. Roux, M. Gonzalez-Gaitan, B. Chopard, U. Schibler, and anonymous reviewers for useful comments and suggestions.	Alibardi L., 2006, Journal of Submicroscopic Cytology and Pathology, V38, P175; Bohn S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046215; Chang C, 2009, INT J DEV BIOL, V53, P813, DOI 10.1387/ijdb.072556cc; Dhouailly D, 2009, J ANAT, V214, P587, DOI 10.1111/j.1469-7580.2008.01041.x; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Furukawa Y, 2009, INT J COMPUT VISION, V84, P257, DOI 10.1007/s11263-009-0232-2; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Goehring L, 2005, EUROPHYS LETT, V69, P739, DOI 10.1209/epl/i2004-10408-x; Goehring L, 2010, SOFT MATTER, V6, P3562, DOI 10.1039/b922206e; Goehring L, 2009, P NATL ACAD SCI USA, V106, P387, DOI 10.1073/pnas.0805132106; Hayashi T, 2004, NATURE, V431, P647, DOI 10.1038/nature02952; Herrmann HJ., 1990, STAT MODELS FRACTURE; Jagla EA, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.026203; Kazhdan M., 2006, P 4 EUROGRAPHICS S G, P61; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Shorlin KA, 2000, PHYS REV E, V61, P6950, DOI 10.1103/PhysRevE.61.6950; Snavely N, 2006, ACM T GRAPHIC, V25, P835, DOI 10.1145/1141911.1141964; Soares D, 2002, NATURE, V417, P241, DOI 10.1038/417241a; Thompson D.W, 1917, GROWTH FORM; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; WEAIRE D, 1984, CONTEMP PHYS, V25, P59, DOI 10.1080/00107518408210979; Weaire D., 1999, PHYS FOAMS	24	66	65	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					78	81		10.1126/science.1226265	http://dx.doi.org/10.1126/science.1226265			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23196908				2022-12-28	WOS:000312985800055
J	Schiffrin, A; Paasch-Colberg, T; Karpowicz, N; Apalkov, V; Gerster, D; Muhlbrandt, S; Korbman, M; Reichert, J; Schultze, M; Holzner, S; Barth, JV; Kienberger, R; Ernstorfer, R; Yakovlev, VS; Stockman, MI; Krausz, F				Schiffrin, Agustin; Paasch-Colberg, Tim; Karpowicz, Nicholas; Apalkov, Vadym; Gerster, Daniel; Muehlbrandt, Sascha; Korbman, Michael; Reichert, Joachim; Schultze, Martin; Holzner, Simon; Barth, Johannes V.; Kienberger, Reinhard; Ernstorfer, Ralph; Yakovlev, Vladislav S.; Stockman, Mark I.; Krausz, Ferenc			Optical-field-induced current in dielectrics	NATURE			English	Article							ELECTRIC-FIELD; COHERENT CONTROL; THZ; SEMICONDUCTORS; SUPERLATTICES; LOCALIZATION; GENERATION; RADIATION; PULSES	The time it takes to switch on and off electric current determines the rate at which signals can be processed and sampled in modern information technology(1-4). Field-effect transistors(1-3,5,6) are able to control currents at frequencies of the order of or higher than 100 gigahertz, but electric interconnects may hamper progress towards reaching the terahertz (10(12) hertz) range. All-optical injection of currents through interfering photoexcitation pathways(7-10) or photoconductive switching of terahertz transients(11-16) has made it possible to control electric current on a subpicosecond time-scale in semiconductors. Insulators have been deemed unsuitable for both methods, because of the need for either ultraviolet light or strong fields, which induce slow damage or ultrafast break-down(17-20), respectively. Here we report the feasibility of electric signal manipulation in a dielectric. A few-cycle optical waveform reversibly increases-free from breakdown-the a.c. conductivity of amorphous silicon dioxide (fused silica) by more than 18 orders of magnitude within 1 femtosecond, allowing electric currents to be driven, directed and switched by the instantaneous light field. Our work opens the way to extending electronic signal processing and high-speed metrology into the petahertz (10(15) hertz) domain.	[Apalkov, Vadym; Stockman, Mark I.] Georgia State Univ, Dept Phys & Astron, Atlanta, GA 30340 USA; [Gerster, Daniel; Muehlbrandt, Sascha; Reichert, Joachim; Barth, Johannes V.; Kienberger, Reinhard; Ernstorfer, Ralph] Tech Univ Munich, Phys Dept, D-85748 Garching, Germany; [Schultze, Martin; Yakovlev, Vladislav S.; Krausz, Ferenc] Univ Munich, Fak Phys, D-85748 Garching, Germany; [Ernstorfer, Ralph] Fritz Haber Inst Max Planck Gesell, D-14195 Berlin, Germany; [Schiffrin, Agustin; Paasch-Colberg, Tim; Karpowicz, Nicholas; Muehlbrandt, Sascha; Korbman, Michael; Schultze, Martin; Holzner, Simon; Kienberger, Reinhard; Ernstorfer, Ralph; Yakovlev, Vladislav S.; Krausz, Ferenc] Max Planck Inst Quantum Opt, D-85748 Garching, Germany	University System of Georgia; Georgia State University; Technical University of Munich; University of Munich; Max Planck Society; Fritz Haber Institute of the Max Planck Society; Max Planck Society	Schiffrin, A (corresponding author), Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada.	aschiffr@phas.ubc.ca; mstockman@gsu.edu; ferenc.krausz@mpq.mpg.de	Ernstorfer, Ralph/D-1590-2009; Yakovlev, Vladislav/C-4091-2015; BARTH, JV/E-4060-2013	Ernstorfer, Ralph/0000-0001-6665-3520; Kienberger, Reinhard/0000-0001-8781-3685; Yakovlev, Vladislav/0000-0002-0648-9375; Schultze, Martin/0000-0003-0438-9255; BARTH, JV/0000-0002-6270-2150; Schiffrin, Agustin/0000-0003-1140-8485	Munich-Centre for Advanced Photonics; Chemical Sciences, Biosciences and Geosciences Division [DEFG02-01ER15213]; Materials Sciences and Engineering Division of the Office of the Basic Energy Sciences, Office of Science, US Department of Energy [DE-FG02-11ER46789]; ERC	Munich-Centre for Advanced Photonics; Chemical Sciences, Biosciences and Geosciences Division(United States Department of Energy (DOE)); Materials Sciences and Engineering Division of the Office of the Basic Energy Sciences, Office of Science, US Department of Energy(United States Department of Energy (DOE)); ERC(European Research Council (ERC)European Commission)	We thank P. Altpeter and Y. Deng for technical support and discussions, and we thank the Munich-Centre for Advanced Photonics for financial support. A. S. acknowledges the Alexander von Humboldt Foundation and the Swiss National Science Foundation. N.K. acknowledges the Alexander von Humboldt Foundation. The work of M. I. S. and V. A. was supported by the Chemical Sciences, Biosciences and Geosciences Division (grant no. DEFG02-01ER15213) and by the Materials Sciences and Engineering Division (grant no. DE-FG02-11ER46789) of the Office of the Basic Energy Sciences, Office of Science, US Department of Energy. R. K. acknowledges an ERC Starting Grant.	Atanasov R, 1996, PHYS REV LETT, V76, P1703, DOI 10.1103/PhysRevLett.76.1703; AUSTON DH, 1975, APPL PHYS LETT, V26, P101, DOI 10.1063/1.88079; AUSTON DH, 1988, TOP APPL PHYS, V60, P183; BARJOSEPH I, 1989, APPL PHYS LETT, V55, P340, DOI 10.1063/1.101902; BLEUSE J, 1988, PHYS REV LETT, V60, P220, DOI 10.1103/PhysRevLett.60.220; Caulfield HJ, 2010, NAT PHOTONICS, V4, P261, DOI 10.1038/nphoton.2010.94; Deal WR, 2011, IEEE MICROW WIREL CO, V21, P368, DOI 10.1109/LMWC.2011.2143701; Durach M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.086602; Durach M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.086803; Franco I, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.126802; JONES SC, 1989, OPT ENG, V28, P1039, DOI 10.1117/12.7977089; Kahng D., 1963, U.S. Patent, Patent No. [3102230 A, 3102230, 3 102 230 A]; KATZENELLENBOGEN N, 1991, APPL PHYS LETT, V58, P222, DOI 10.1063/1.104695; Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277; Koslowski T, 1997, PHYS REV B, V56, P9469, DOI 10.1103/PhysRevB.56.9469; KURIZKI G, 1989, PHYS REV B, V39, P3435, DOI 10.1103/PhysRevB.39.3435; Lenzner M, 1998, PHYS REV LETT, V80, P4076, DOI 10.1103/PhysRevLett.80.4076; MENDEZ EE, 1988, PHYS REV LETT, V60, P2426, DOI 10.1103/PhysRevLett.60.2426; Nagatsuma T, 2002, MEAS SCI TECHNOL, V13, P1655, DOI 10.1088/0957-0233/13/11/301; Prechtel L, 2011, NANO LETT, V11, P269, DOI 10.1021/nl1036897; Rethfeld B, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.035101; Schwierz F, 2010, NANOMETER CMOS, P1; Schwierz F, 2003, MODERN MICROWAVE TRA; Schwierz F, 2007, SOLID STATE ELECTRON, V51, P1079, DOI 10.1016/j.sse.2007.05.020; Shimosato H, 2007, SPRINGER SER OPT SCI, V132, P317; Taur Y., 2021, FUNDAMENTALS MODERN, DOI 10.1017/9781108847087; Valley GC, 2007, OPT EXPRESS, V15, P1955, DOI 10.1364/OE.15.001955; WANNIER GH, 1960, PHYS REV, V117, P432, DOI 10.1103/PhysRev.117.432; Xu L, 1996, OPT LETT, V21, P2008, DOI 10.1364/OL.21.002008; ZENER C, 1934, P ROYAL SOC, V145, P523, DOI DOI 10.1098/RSPA.1934.0116	30	483	492	13	442	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					70	74		10.1038/nature11567	http://dx.doi.org/10.1038/nature11567			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23222521				2022-12-28	WOS:000312933800032
J	Manchak, M; Holloway, R				Manchak, Mike; Holloway, Robert			Adding clopidogrel to aspirin did not reduce recurrent stroke and increased bleeding in lacunar stroke	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Manchak, Mike; Holloway, Robert] Univ Rochester, Med Ctr, Rochester, NY 14642 USA	University of Rochester	Manchak, M (corresponding author), Univ Rochester, Med Ctr, Rochester, NY 14642 USA.							Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2012	157	12							JC6-2	10.7326/0003-4819-157-12-201212180-02002	http://dx.doi.org/10.7326/0003-4819-157-12-201212180-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057SB	23247951				2022-12-28	WOS:000312583200001
J	Scott, G; Presswood, E				Scott, Gregory; Presswood, Edward			CHRISTMAS 2012: TOMORROW'S WORLD Case report of E.T.-The Extra-Terrestrial	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEN		[Scott, Gregory] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, London W12 0HS, England; [Presswood, Edward] Barnet & Chase Farm Hosp NHS Trust, Chase Farm Hosp, Enfield, Middx, England	Imperial College London; University of London; University College London; Royal Free London NHS Foundation Trust	Scott, G (corresponding author), Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, London W12 0HS, England.	gregory.scott99@imperial.ac.uk		Presswood, Edward/0000-0002-1429-0729; Berger, Marc Moritz/0000-0001-6771-3193; Scott, Gregory/0000-0001-8063-5871				Bierma, 2005, CHICAGO TRIBUNE; Kershner I., 1980, STAR WARS EPISODE 5; McGhee GR, 2011, VIENNA SER THEOR BIO, P1; Nolan JP, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6122; Resuscitation Council, 2010, ADV LIF SUPP RES GUI; Spielberg S, 2005, ET EXTRA TERRESTRIAL; Spielberg Steven, 1982, ET EXTRA TERRESTRIAL; VANPRAAGH R, 1964, AM J CARDIOL, V13, P510, DOI 10.1016/0002-9149(64)90159-6; VanPraagh S, 1996, AM HEART J, V132, P382, DOI 10.1016/S0002-8703(96)90437-8; Wall TL, 1997, ANN INTERN MED, V127, P376, DOI 10.7326/0003-4819-127-5-199709010-00007; Williams SRP, 1997, EUR HEART J, V18, P376; World Health Organization, 2012, CHILD GROWTH STAND W	12	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2012	345								e8127	10.1136/bmj.e8127	http://dx.doi.org/10.1136/bmj.e8127			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IW	23249665				2022-12-28	WOS:000312698900011
J	Gilbertson, SR				Gilbertson, Scott R.			Relay Reactions That Trap Organometallic Intermediates	SCIENCE			English	Editorial Material							ALLYLIC ALCOHOLS; ARYLATION; ALDEHYDES; PALLADIUM; KETONES; HALIDES		Univ Houston, Dept Chem, Houston, TX 77204 USA	University of Houston System; University of Houston	Gilbertson, SR (corresponding author), Univ Houston, Dept Chem, Univ Pk, Houston, TX 77204 USA.	srgilbe2@central.uh.edu						Berthiol F, 2006, TETRAHEDRON, V62, P4372, DOI 10.1016/j.tet.2006.02.061; Bouquillon S, 2001, J ORGANOMET CHEM, V634, P153, DOI 10.1016/S0022-328X(01)01149-4; Harper KC, 2011, SCIENCE, V333, P1875, DOI 10.1126/science.1206997; HECK RF, 1968, J AM CHEM SOC, V90, P5531, DOI 10.1021/ja01022a036; HECK RF, 1968, J AM CHEM SOC, V90, P5535, DOI 10.1021/ja01022a037; HECK RF, 1968, J AM CHEM SOC, V90, P5546, DOI 10.1021/ja01022a040; HECK RF, 1968, J AM CHEM SOC, V90, P5542, DOI 10.1021/ja01022a039; HECK RF, 1968, J AM CHEM SOC, V90, P5538, DOI 10.1021/ja01022a038; HECK RF, 1968, J AM CHEM SOC, V90, P5518, DOI 10.1021/ja01022a034; HECK RF, 1968, J AM CHEM SOC, V90, P5526, DOI 10.1021/ja01022a035; LAROCK RC, 1989, TETRAHEDRON LETT, V30, P6629, DOI 10.1016/S0040-4039(00)70636-8; Werner EW, 2012, SCIENCE, V338, P1455, DOI 10.1126/science.1229208	12	2	2	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1432	1433		10.1126/science.1231509	http://dx.doi.org/10.1126/science.1231509			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239726				2022-12-28	WOS:000312250800037
J	Switzer, JA				Switzer, Jay A.			Atomic Layer Electrodeposition	SCIENCE			English	Editorial Material							UNDERPOTENTIAL DEPOSITION; SURFACES		[Switzer, Jay A.] Missouri Univ Sci & Technol, Dept Chem, Rolla, MO 65409 USA; [Switzer, Jay A.] Missouri Univ Sci & Technol, Mat Res Ctr, Rolla, MO 65409 USA	University of Missouri System; Missouri University of Science & Technology; University of Missouri System; Missouri University of Science & Technology	Switzer, JA (corresponding author), Missouri Univ Sci & Technol, Dept Chem, Rolla, MO 65409 USA.	jswitzer@mst.edu			Direct For Mathematical & Physical Scien [1104801] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Allongue P, 2010, MRS BULL, V35, P761, DOI 10.1557/mrs2010.505; Baker L, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4749819; Brankovic SR, 2001, SURF SCI, V474, pL173, DOI 10.1016/S0039-6028(00)01103-1; Chen MS, 2004, SCIENCE, V306, P252, DOI 10.1126/science.1102420; Debe MK, 2012, NATURE, V486, P43, DOI 10.1038/nature11115; George SM, 2010, CHEM REV, V110, P111, DOI 10.1021/cr900056b; GREGORY BW, 1991, J ELECTROANAL CHEM, V300, P543, DOI 10.1016/0022-0728(91)85415-L; Herrero E, 2001, CHEM REV, V101, P1897, DOI 10.1021/cr9600363; Jayaraju N, 2012, J ELECTROCHEM SOC, V159, pD616, DOI 10.1149/2.053210jes; Jiang XR, 2010, CHEM MATER, V22, P3024, DOI 10.1021/cm902904u; KOLB DM, 1974, J ELECTROANAL CHEM, V54, P25, DOI 10.1016/S0022-0728(74)80377-3; Liu YH, 2012, SCIENCE, V338, P1327, DOI 10.1126/science.1228925; Siegfried MJ, 2005, ANGEW CHEM INT EDIT, V44, P3218, DOI 10.1002/anie.200463018; Switzer JA, 2003, NATURE, V425, P490, DOI 10.1038/nature01990; Switzer JA, 2010, J AM CHEM SOC, V132, P1258, DOI 10.1021/ja909295y	15	28	29	5	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1300	1301		10.1126/science.1231853	http://dx.doi.org/10.1126/science.1231853			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224544				2022-12-28	WOS:000311991200051
J	Reddy, UM; Page, GP; Saade, GR; Silver, RM; Thorsten, VR; Parker, CB; Pinar, H; Willinger, M; Stoll, BJ; Heim-Hall, J; Varner, MW; Goldenberg, RL; Bukowski, R; Wapner, RJ; Drews-Botsch, CD; O'Brien, BM; Dudley, DJ; Levy, B				Reddy, Uma M.; Page, Grier P.; Saade, George R.; Silver, Robert M.; Thorsten, Vanessa R.; Parker, Corette B.; Pinar, Halit; Willinger, Marian; Stoll, Barbara J.; Heim-Hall, Josefine; Varner, Michael W.; Goldenberg, Robert L.; Bukowski, Radek; Wapner, Ronald J.; Drews-Botsch, Carolyn D.; O'Brien, Barbara M.; Dudley, Donald J.; Levy, Brynn		NICHD Stillbirth Collaborative Res	Karyotype versus Microarray Testing for Genetic Abnormalities after Stillbirth	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; COPY-NUMBER VARIANTS; MICRODUPLICATION 22Q11.2; CONGENITAL-ANOMALIES; INDIVIDUALS; DEATHS	BACKGROUND Genetic abnormalities have been associated with 6 to 13% of stillbirths, but the true prevalence may be higher. Unlike karyotype analysis, microarray analysis does not require live cells, and it detects small deletions and duplications called copy-number variants. METHODS The Stillbirth Collaborative Research Network conducted a population-based study of stillbirth in five geographic catchment areas. Standardized postmortem examinations and karyotype analyses were performed. A single-nucleotide polymorphism array was used to detect copy-number variants of at least 500 kb in placental or fetal tissue. Variants that were not identified in any of three databases of apparently unaffected persons were then classified into three groups: probably benign, clinical significance unknown, or pathogenic. We compared the results of karyotype and microarray analyses of samples obtained after delivery. RESULTS In our analysis of samples from 532 stillbirths, microarray analysis yielded results more often than did karyotype analysis (87.4% vs. 70.5%, P<0.001) and provided better detection of genetic abnormalities (aneuploidy or pathogenic copy-number variants, 8.3% vs. 5.8%; P = 0.007). Microarray analysis also identified more genetic abnormalities among 443 antepartum stillbirths (8.8% vs. 6.5%, P = 0.02) and 67 stillbirths with congenital anomalies (29.9% vs. 19.4%, P = 0.008). As compared with karyotype analysis, microarray analysis provided a relative increase in the diagnosis of genetic abnormalities of 41.9% in all stillbirths, 34.5% in antepartum stillbirths, and 53.8% in stillbirths with anomalies. CONCLUSIONS Microarray analysis is more likely than karyotype analysis to provide a genetic diagnosis, primarily because of its success with nonviable tissue, and is especially valuable in analyses of stillbirths with congenital anomalies or in cases in which karyotype results cannot be obtained. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development.)	[Reddy, Uma M.; Willinger, Marian] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pregnancy & Perinatol Branch, NIH, Bethesda, MD USA; [Page, Grier P.; Thorsten, Vanessa R.; Parker, Corette B.] RTI Int, Res Triangle Pk, NC USA; [Saade, George R.; Bukowski, Radek] Univ Texas Med Branch Galveston, Galveston, TX USA; [Silver, Robert M.; Varner, Michael W.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Silver, Robert M.; Varner, Michael W.] Intermt Hlth Care, Salt Lake City, UT USA; [Pinar, Halit; O'Brien, Barbara M.] Brown Univ, Sch Med, Providence, RI 02912 USA; [Stoll, Barbara J.] Emory Univ, Sch Med, Atlanta, GA USA; [Stoll, Barbara J.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Drews-Botsch, Carolyn D.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Heim-Hall, Josefine; Dudley, Donald J.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Goldenberg, Robert L.; Wapner, Ronald J.; Levy, Brynn] Columbia Univ, Med Ctr, New York, NY USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Research Triangle Institute; University of Texas System; University of Texas Medical Branch Galveston; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Brown University; Emory University; Children's Healthcare of Atlanta (CHOA); Emory University; Rollins School Public Health; University of Texas System; University of Texas Health San Antonio; Columbia University	Reddy, UM (corresponding author), NICHD, Pregnancy & Perinatol Branch, 6100 Execut Blvd,Rm 4B03,MSC 7510, Bethesda, MD 20892 USA.	reddyu@mail.nih.gov	Drews-Botsch, Carolyn/M-8560-2016; Varner, Michael/K-9890-2013	Drews-Botsch, Carolyn/0000-0002-8763-7404; Fifer, William P./0000-0002-6936-9303; Parker, Corette/0000-0002-6822-6845; Varner, Michael/0000-0001-9455-3973; Page, Grier/0000-0003-2582-3786; Thorsten, Vanessa/0000-0003-4430-1473; Wapner, Ronald/0000-0003-0727-1244	NICHD [HD45925, HD45944, HD45952, HD45953, HD45954, HD45955]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD045954, U10HD045925, U10HD045944, U10HD045955, U10HD045953, U10HD045952] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by grants (HD45925, HD45944, HD45952, HD45953, HD45954, and HD45955) from the NICHD.; Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development	Benkhalifa M, 2005, PRENATAL DIAG, V25, P894, DOI 10.1002/pd.1230; Bonett DG, 2006, STAT MED, V25, P3039, DOI 10.1002/sim.2440; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; Center for Biomedical Informatics, ALL COP NUMB VAR CHI; Centre for Applied Genomics, ALL COP NUMB VAR DAT; de la Rochebrochard C, 2006, AM J MED GENET A, V140A, P1608, DOI 10.1002/ajmg.a.31227; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Ensenauer RE, 2003, AM J HUM GENET, V73, P1027, DOI 10.1086/378818; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Harris RA, 2011, PRENATAL DIAG, V31, P932, DOI 10.1002/pd.2817; International Standards for Cytogenetic Arrays Consortium, ALL KNOWN BEN COP NU; International Standards for Cytogenetic Arrays Consortium, KNOWN PATH VAR CONS; Kearney HM, 2011, GENET MED, V13, P680, DOI 10.1097/GIM.0b013e3182217a3a; Korteweg FJ, 2008, OBSTET GYNECOL, V111, P865, DOI 10.1097/AOG.0b013e31816a4ee3; MacDorman Marian F, 2009, Natl Vital Stat Rep, V57, P1; McDonald-McGinn DM, 2001, GENET MED, V3, P23, DOI 10.1097/00125817-200101000-00006; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Parker CB, 2011, PAEDIATR PERINAT EP, V25, P425, DOI 10.1111/j.1365-3016.2011.01218.x; PAULI RM, 1994, AM J MED GENET, V50, P116, DOI 10.1002/ajmg.1320500204; Pinar H, 2012, AM J PERINAT, V29, P187, DOI 10.1055/s-0031-1284228; Pinar H, 2011, AM J PERINAT, V28, P781, DOI 10.1055/s-0031-1281509; Portnoi MF, 2009, EUR J MED GENET, V52, P88, DOI 10.1016/j.ejmg.2009.02.008; Raca G, 2009, AM J MED GENET A, V149A, P2437, DOI 10.1002/ajmg.a.33083; Schaeffer AJ, 2004, AM J HUM GENET, V74, P1168, DOI 10.1086/421250; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; Strassberg M, 2011, EXPERT REV MOL DIAGN, V11, P579, DOI [10.1586/erm.11.43, 10.1586/ERM.11.43]; Wapner RJ, 2012, NEW ENGL J MED, V367, P2175, DOI 10.1056/NEJMoa1203382; Warren JE, 2009, OBSTET GYNECOL, V114, P1093, DOI 10.1097/AOG.0b013e3181bc6ab0; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	29	147	162	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2012	367	23					2185	2193		10.1056/NEJMoa1201569	http://dx.doi.org/10.1056/NEJMoa1201569			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048DO	23215556	Green Accepted			2022-12-28	WOS:000311890600005
J	Bhartia, M; Ramachandran, S				Bhartia, Mithun; Ramachandran, Sudarshan			A PATIENT'S JOURNEY Klinefelter's syndrome-a diagnosis mislaid for 46 years	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ramachandran, Sudarshan] Heart England Fdn Trust, Good Hope Hosp, Sutton Coldfield B75 7RR, England; [Bhartia, Mithun] Sandwell Dist Gen Hosp, Dept Endocrinol & Diabet, W Bromwich B71 4HJ, England	Heart of England NHS Foundation Trust; Good Hope Hospital	Ramachandran, S (corresponding author), Heart England Fdn Trust, Good Hope Hosp, Sutton Coldfield B75 7RR, England.	sud.ramachandran@heartofengland.nhs.uk							0	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 3	2012	345								e6938	10.1136/bmj.e6938	http://dx.doi.org/10.1136/bmj.e6938			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HO	23207500	Green Submitted, Bronze			2022-12-28	WOS:000312188700001
J	Eliasmith, C; Stewart, TC; Choo, X; Bekolay, T; DeWolf, T; Tang, C; Rasmussen, D				Eliasmith, Chris; Stewart, Terrence C.; Choo, Xuan; Bekolay, Trevor; DeWolf, Travis; Tang, Charlie; Rasmussen, Daniel			A Large-Scale Model of the Functioning Brain	SCIENCE			English	Article							ITEM; MEMORY	A central challenge for cognitive and systems neuroscience is to relate the incredibly complex behavior of animals to the equally complex activity of their brains. Recently described, large-scale neural models have not bridged this gap between neural activity and biological function. In this work, we present a 2.5-million-neuron model of the brain (called "Spaun") that bridges this gap by exhibiting many different behaviors. The model is presented only with visual image sequences, and it draws all of its responses with a physically modeled arm. Although simplified, the model captures many aspects of neuroanatomy, neurophysiology, and psychological behavior, which we demonstrate via eight diverse tasks.	[Eliasmith, Chris; Stewart, Terrence C.; Choo, Xuan; Bekolay, Trevor; DeWolf, Travis; Tang, Charlie; Rasmussen, Daniel] Univ Waterloo, Ctr Theoret Neurosci, Waterloo, ON N2J 3G1, Canada	University of Waterloo	Eliasmith, C (corresponding author), Univ Waterloo, Ctr Theoret Neurosci, Waterloo, ON N2J 3G1, Canada.	celiasmith@uwaterloo.ca	DeWolf, Travis/AAX-8363-2021	DeWolf, Travis/0000-0002-8780-5631; Bekolay, Trevor/0000-0001-5215-7999	Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs program; Canadian Foundation for Innovation; Ontario Innovation Trust	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs program(Canada Research Chairs); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust	The development of Spaun was supported by the Natural Sciences and Engineering Research Council of Canada, the Canada Research Chairs program, the Canadian Foundation for Innovation, and the Ontario Innovation Trust. We thank M. van der Meer, B. Tripp, M. Laubach, and three anonymous reviewers for insightful comments on previous drafts. All models, scripts, and videos are deposited online at http://nengo.ca/ and http://models.nengo.ca/.	Ananthanarayanan R., 2007, P 2007 ACM IEEE C SU, P1, DOI DOI 10.1145/1362622.1362627; Chaaban I., 2007, TECHNICAL REPORT; de Garis H, 2010, NEUROCOMPUTING, V74, P3, DOI 10.1016/j.neucom.2010.08.004; Dosher BA, 1999, INT J PSYCHOL, V34, P276, DOI 10.1080/002075999399576; FORBES AR, 1964, BRIT J EDUC PSYCHOL, V34, P223, DOI 10.1111/j.2044-8279.1964.tb00632.x; Hadley RF, 2009, NEURAL COMPUT, V21, P510, DOI 10.1162/neco.2008.07-07-572; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; JAHNKE JC, 1968, J EXP PSYCHOL, V76, P618, DOI 10.1037/h0025692; MacNeil D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022885; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; MURDOCK BB, 1993, PSYCHOL REV, V100, P183, DOI 10.1037/0033-295X.100.2.183; Orlov T, 2002, CEREB CORTEX, V12, P306, DOI 10.1093/cercor/12.3.306; Pasternak T., 2003, HDB PSYCHOL, V3, P139; Ranzato M.A., 2007, NIPS P 20 INT C NEUR, V20, P1185; Raven J., 2004, MANUAL RAVENS PROGR; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Stewart TC, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00002; Todorov E, 2009, COGNITIVE NEUROSCIEN, V4; Vasilaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000586	20	475	492	3	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1202	1205		10.1126/science.1225266	http://dx.doi.org/10.1126/science.1225266			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197532				2022-12-28	WOS:000311666200044
J	Brenchley, R; Spannagl, M; Pfeifer, M; Barker, GLA; D'Amore, R; Allen, AM; McKenzie, N; Kramer, M; Kerhornou, A; Bolser, D; Kay, S; Waite, D; Trick, M; Bancroft, I; Gu, Y; Huo, N; Luo, MC; Sehgal, S; Gill, B; Kianian, S; Anderson, O; Kersey, P; Dvorak, J; McCombie, WR; Hall, A; Mayer, KFX; Edwards, KJ; Bevan, MW; Hall, N				Brenchley, Rachel; Spannagl, Manuel; Pfeifer, Matthias; Barker, Gary L. A.; D'Amore, Rosalinda; Allen, Alexandra M.; McKenzie, Neil; Kramer, Melissa; Kerhornou, Arnaud; Bolser, Dan; Kay, Suzanne; Waite, Darren; Trick, Martin; Bancroft, Ian; Gu, Yong; Huo, Naxin; Luo, Ming-Cheng; Sehgal, Sunish; Gill, Bikram; Kianian, Sharyar; Anderson, Olin; Kersey, Paul; Dvorak, Jan; McCombie, W. Richard; Hall, Anthony; Mayer, Klaus F. X.; Edwards, Keith J.; Bevan, Michael W.; Hall, Neil			Analysis of the breadwheat genome using whole-genome shotgun sequencing	NATURE			English	Article							TRANSPOSABLE ELEMENTS; WHEAT GENOME; GENE; EVOLUTION; DIVERSITY; IDENTIFICATION; DUPLICATIONS; INTEGRATION; TRITICEAE; FLOW	Bread wheat (Triticum aestivum) is a globally important crop, accounting for 20 per cent of the calories consumed by humans. Major efforts are underway worldwide to increase wheat production by extending genetic diversity and analysing key traits, and genomic resources can accelerate progress. But so far the very large size and polyploid complexity of the bread wheat genome have been substantial barriers to genome analysis. Here we report the sequencing of its large, 17-gigabase-pair, hexaploid genome using 454 pyrosequencing, and comparison of this with the sequences of diploid ancestral and progenitor genomes. We identified between 94,000 and 96,000 genes, and assigned two-thirds to the three component genomes (A, B and D) of hexaploid wheat. High-resolution synteny maps identified many small disruptions to conserved gene order. We show that the hexaploid genome is highly dynamic, with significant loss of gene family members on polyploidization and domestication, and an abundance of gene fragments. Several classes of genes involved in energy harvesting, metabolism and growth are among expanded gene families that could be associated with crop productivity. Our analyses, coupled with the identification of extensive genetic variation, provide a resource for accelerating gene discovery and improving this major crop.	[McKenzie, Neil; Waite, Darren; Trick, Martin; Bancroft, Ian; Bevan, Michael W.] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Brenchley, Rachel; D'Amore, Rosalinda; Kay, Suzanne; Hall, Anthony; Hall, Neil] Univ Liverpool, Ctr Genome Res, Liverpool L69 7ZB, Merseyside, England; [Spannagl, Manuel; Pfeifer, Matthias; Mayer, Klaus F. X.] Helmholtz Zentrum Munchen, MIPS IBIS, D-85764 Neuherberg, Germany; [Barker, Gary L. A.; Allen, Alexandra M.; Edwards, Keith J.] Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England; [Kramer, Melissa; McCombie, W. Richard] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Kerhornou, Arnaud; Bolser, Dan; Kersey, Paul] European Bioinformat Inst, Cambridge CB10 1SD, England; [Gu, Yong; Huo, Naxin; Anderson, Olin] USDA, Western Reg Lab, Albany, CA 94710 USA; [Luo, Ming-Cheng; Dvorak, Jan] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Sehgal, Sunish; Gill, Bikram] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Kianian, Sharyar] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58018 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Liverpool; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bristol; Cold Spring Harbor Laboratory; European Molecular Biology Laboratory (EMBL); United States Department of Agriculture (USDA); University of California System; University of California Davis; Kansas State University; North Dakota State University Fargo	Bevan, MW (corresponding author), John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England.	Anthony.Hall@liverpool.ac.uk; k.mayer@helmholtz-muenchen.de; k.j.edwards@bristol.ac.uk; michael.bevan@jic.ac.uk; Neil.Hall@liverpool.ac.uk	Luo, Ming-Cheng/C-5600-2011; Bolser, Dan/AAE-3087-2019; Pfeifer, Matthias/GRJ-4579-2022; Hall, Anthony/D-2844-2009; Allen, alexandra/C-7562-2019; Bancroft, Ian/AAH-3831-2020; Mayer, Klaus FX/M-7941-2015; Hall, Neil/A-8717-2013	Luo, Ming-Cheng/0000-0002-9744-5887; Bolser, Dan/0000-0002-3991-0859; Hall, Anthony/0000-0002-1806-020X; Mayer, Klaus FX/0000-0001-6484-1077; Hall, Neil/0000-0002-7995-3810; Kerhornou, Arnaud/0000-0002-2890-295X; Brenchley, Rachel/0000-0003-4062-8217; Kersey, Paul/0000-0002-7054-800X; McCombie, W. Richard/0000-0003-1899-0682; Barker, Gary/0000-0002-9018-9526; Spannagl, Manuel/0000-0003-0701-7035; Hall, Neil/0000-0003-2808-0009; Bancroft, Ian/0000-0001-7707-1171	UK Biological and Biotechnological Sciences Research Council (BBSRC) [BB/G012865, BB/G013985/1, BB/G013004/1]; Wolfson Merit Award from the Royal Society; BBSRC Strategic Programme [B/J004588/1]; EC TriticeaeGenome grant [212019]; TRITEX Project of the Plant20130 Initiative of the German Ministry of Education and Research grant [0315954C]; EC Transplant Grant [283496]; BBSRC Career Development Fellowship [BB/H022333/1]; US NSF [IOS-1032105, DBI-0923128, DBI-0701916, DBI-0822100]; USDA-NIFA [2008-35300-04588]; BBSRC [BB/I02347X/1, BB/G013985/1, BB/G024650/1, BB/H022333/1, BB/E004725/1, BB/G013004/1, BBS/E/T/000PR6193] Funding Source: UKRI; MRC [G0900753] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H022333/1, BBS/E/T/000PR6193, BB/G013004/1, BB/G024650/1, BB/G013985/1, BB/E004725/1, BB/I02347X/1] Funding Source: researchfish; Medical Research Council [G0900753] Funding Source: researchfish; Division Of Integrative Organismal Systems [1032105] Funding Source: National Science Foundation	UK Biological and Biotechnological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wolfson Merit Award from the Royal Society; BBSRC Strategic Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EC TriticeaeGenome grant; TRITEX Project of the Plant20130 Initiative of the German Ministry of Education and Research grant; EC Transplant Grant; BBSRC Career Development Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); US NSF(National Science Foundation (NSF)); USDA-NIFA(United States Department of Agriculture (USDA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	DNA sequence was generated by The University of Liverpool Centre for Genomic Research (United Kingdom), 454 Life Sciences (United States), The Cold Spring Harbor Woodbury Genome Centre (United States) and The Genome Analysis Centre (United Kingdom). This work was supported by UK Biological and Biotechnological Sciences Research Council (BBSRC) grants BB/G012865, BB/G013985/1 and BB/G013004/1, to K.J.E., M.W.B. and N. Hall; a Wolfson Merit Award from the Royal Society, to N. Hall; BBSRC Strategic Programme grant B/J004588/1 (GRO), to M.W.B.; EC TriticeaeGenome grant number 212019, to K.F.X.M. and M.W.B.; The TRITEX Project of the Plant20130 Initiative of the German Ministry of Education and Research grant number 0315954C, to K.F.X.M.; EC Transplant Grant 283496, to K.F.X.M. and P.K., a BBSRC Career Development Fellowship BB/H022333/1, to A.H., US NSF grants IOS-1032105 and DBI-0923128, to W.R.M.; USDA-NIFA grant 2008-35300-04588, to B.G.; and US NSF grants DBI-0701916, to J.D., and DBI-0822100, to S. Kianian.	Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; Buggs RJA, 2012, CURR BIOL, V22, P248, DOI 10.1016/j.cub.2011.12.027; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Dvorak J, 2006, MOL BIOL EVOL, V23, P1386, DOI 10.1093/molbev/msl004; Gill BS, 2004, GENETICS, V168, P1087, DOI 10.1534/genetics.104.034769; Gu YQ, 2004, PLANT PHYSIOL, V135, P459, DOI 10.1104/pp.103.038083; Haudry A, 2007, MOL BIOL EVOL, V24, P1506, DOI 10.1093/molbev/msm077; Hernandez P, 2012, PLANT J, V69, P377, DOI 10.1111/j.1365-313X.2011.04808.x; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; JIN YK, 1994, PLANT CELL, V6, P1177, DOI 10.1105/tpc.6.8.1177; Lee EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002411; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Massa AN, 2011, MOL BIOL EVOL, V28, P2537, DOI 10.1093/molbev/msr080; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mochida K, 2009, PLANT PHYSIOL, V150, P1135, DOI 10.1104/pp.109.138214; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Mun JH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r111; Nesbitt M, 1996, HULLED WHEATS, V4, P41; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Pumphrey M, 2009, GENETICS, V181, P1147, DOI 10.1534/genetics.108.096941; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; RILEY R, 1958, NATURE, V182, P713, DOI 10.1038/182713a0; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Salse J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-555; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sears E. R., 1966, CHROMOSOME MANIPULAT, P22; Shavrukov Y, 2009, BREEDING SCI, V59, P671, DOI 10.1270/jsbbs.59.671; SMITH DB, 1975, CHROMOSOMA, V50, P223, DOI 10.1007/BF00283468; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; United States Department of Agriculture, 2012, WASDE511 USDA; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang SW, 2011, BREEDING SCI, V61, P189, DOI 10.1270/jsbbs.61.189; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629	42	764	828	11	381	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					705	710		10.1038/nature11650	http://dx.doi.org/10.1038/nature11650			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23192148	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000311606000034
J	Skjaerven, R; Wilcox, AJ; Klungsoyr, K; Irgens, LM; Vikse, BE; Vatten, LJ; Lie, RT				Skjaerven, Rolv; Wilcox, Allen J.; Klungsoyr, Kari; Irgens, Lorentz M.; Vikse, Bjorn Egil; Vatten, Lars J.; Lie, Rolv Terje			Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ISCHEMIC-HEART-DISEASE; LONG-TERM MORTALITY; RISK-FACTORS; PREGNANCY COMPLICATIONS; LATER LIFE; RETROSPECTIVE COHORT; MATERNAL RISK; BIRTH-WEIGHT; HYPERTENSION; WOMEN	Objective To assess the association of pre-eclampsia with later cardiovascular death in mothers according to their lifetime number of pregnancies, and particularly after only one child. Design Prospective, population based cohort study. Setting Medical Birth Registry of Norway. Participants We followed 836 147 Norwegian women with a first singleton birth between 1967 and 2002 for cardiovascular mortality through linkage to the national Cause of Death Registry. About 23 000 women died by 2009, of whom 3891 died from cardiovascular causes. Associations between pre-eclampsia and cardiovascular death were assessed by hazard ratios, estimated by Cox regression analyses. Hazard ratios were adjusted for maternal education (three categories), maternal age at first birth, and year of first birth Results The rate of cardiovascular mortality among women with preterm pre-eclampsia was 9.2% after having only one child, falling to 1.1% for those with two or more children. With term pre-eclampsia, the rates were 2.8% and 1.1%, respectively. Women with pre-eclampsia in their first pregnancy had higher rates of cardiovascular death than those who did not have the condition at first birth (adjusted hazard ratio 1.6 (95% confidence interval 1.4 to 2.0) after term pre-eclampsia; 3.7 (2.7 to 4.8) after preterm pre-eclampsia). Among women with only one lifetime pregnancy, the increase in risk of cardiovascular death was higher than for those with two or more children (3.4 (2.6 to 4.6) after term pre-eclampsia; 9.4 (6.5 to 13.7) after preterm pre-eclampsia). The risk of cardiovascular death was only moderately elevated among women with pre-eclamptic first pregnancies who went on to have additional children (1.5 (1.2 to 2.0) after term pre-eclampsia; 2.4 (1.5 to 3.9) after preterm pre-eclampsia). There was little evidence of additional risk after recurrent pre-eclampsia. All cause mortality for women with two or more lifetime births, who had pre-eclampsia in first pregnancy, was not elevated, even with preterm pre-eclampsia in first pregnancy (1.1 (0.87 to 1.14)). Conclusions Cardiovascular death in women with pre-eclampsia in their first pregnancy is concentrated mainly in women with no additional births. This association might be due to health problems that discourage or prevent further pregnancies rather than to pre-eclampsia itself. As a screening criterion for cardiovascular disease risk, pre-eclampsia is a strong predictor primarily among women with only one child-particularly with preterm pre-eclampsia.	[Skjaerven, Rolv; Klungsoyr, Kari; Irgens, Lorentz M.; Lie, Rolv Terje] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Skjaerven, Rolv; Klungsoyr, Kari; Irgens, Lorentz M.; Lie, Rolv Terje] Natl Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway; [Wilcox, Allen J.] NIEHS, NIH, Res Triangle Pk, NC 27709 USA; [Vikse, Bjorn Egil] Univ Bergen, Inst Med, Bergen, Norway; [Vikse, Bjorn Egil] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway; [Vatten, Lars J.] Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7034 Trondheim, Norway	University of Bergen; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Bergen; University of Bergen; Haukeland University Hospital; Norwegian University of Science & Technology (NTNU)	Skjaerven, R (corresponding author), Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway.	rolv.skjaerven@smis.uib.no	Vatten, Lars/AAF-9380-2022; Wilcox, Allen J/C-7723-2019; Klungsøyr, Kari/ABC-6147-2020; Vatten, Lars/AFK-2073-2022	Wilcox, Allen J/0000-0002-3376-1311; Klungsøyr, Kari/0000-0003-2482-1690; 	Norwegian Research Council; National Institute of Environmental Health Sciences, National Institute of Health; National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044003] Funding Source: NIH RePORTER	Norwegian Research Council(Research Council of NorwayEuropean Commission); National Institute of Environmental Health Sciences, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study has been supported by grants from the Norwegian Research Council and by the Intramural Research Program of the National Institute of Environmental Health Sciences, National Institute of Health. The authors' institutions had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: support from the Norwegian Research Council and the National Institute of Environmental Health Sciences; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work	[Anonymous], 1990, AM J OBSTET GYNECOL, V163, P1691; Arnadottir GA, 2005, BJOG-INT J OBSTET GY, V112, P286, DOI 10.1111/j.1471-0528.2004.00396.x; Aronne LJ, 2007, J CLIN LIPIDOL, V1, P575, DOI 10.1016/j.jacl.2007.10.005; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Catov JM, 2010, ANN EPIDEMIOL, V20, P604, DOI 10.1016/j.annepidem.2010.05.007; Catov JM, 2008, ANN EPIDEMIOL, V18, P873, DOI 10.1016/j.annepidem.2008.09.009; Chappell LC, 2008, HYPERTENSION, V51, P1002, DOI 10.1161/HYPERTENSIONAHA.107.107565; Chesley L C, 1976, Perspect Nephrol Hypertens, V5, P31; Chesley LC, 2000, AM J OBSTET GYNECOL, V182, P249, DOI 10.1016/S0002-9378(00)70521-7; Christensen K, 1998, LANCET, V352, P204, DOI 10.1016/S0140-6736(05)77810-7; Funai EF, 2005, EPIDEMIOLOGY, V16, P206, DOI 10.1097/01.ede.0000152912.02042.cd; Glenn David R J, 2003, Hum Fertil (Camb), V6, P174, DOI 10.1080/1464770312331369453; Gordin D, 2013, ACTA DIABETOL, V50, P781, DOI 10.1007/s00592-012-0415-0; Grundy E, 2008, AM J EPIDEMIOL, V167, P271, DOI 10.1093/aje/kwm295; Grundy E, 2010, SOC SCI MED, V70, P1847, DOI 10.1016/j.socscimed.2010.02.004; Hastie CE, 2011, INT J EPIDEMIOL, V40, P914, DOI 10.1093/ije/dyq270; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Jonasson JM, 2007, DIABETES CARE, V30, P2271, DOI 10.2337/dc06-2574; Jonsdottir LS, 1995, ACTA OBSTET GYN SCAN, V74, P772; Karumanchi SA, 2005, KIDNEY INT, V67, P2101, DOI 10.1111/j.1523-1755.2005.00316.x; Klungsoyr K, 2012, PAEDIATR PERINAT EP, V26, P190, DOI 10.1111/j.1365-3016.2012.01260.x; Lawlor DA, 2003, CIRCULATION, V107, P1260, DOI 10.1161/01.CIR.0000053441.43495.1A; Lykke JA, 2009, HYPERTENSION, V53, P944, DOI 10.1161/HYPERTENSIONAHA.109.130765; Marks JB, 2000, J DIABETES COMPLICAT, V14, P108, DOI 10.1016/S1056-8727(00)00065-9; Mosca, 2011, CIRCULATION, V123, pE624, DOI 10.1161/CIR.0b013e318222b330; Mutter WP, 2008, MICROVASC RES, V75, P1, DOI 10.1016/j.mvr.2007.04.009; Oberg S, 2011, CIRCULATION, V123, P2792, DOI 10.1161/CIRCULATIONAHA.110.987339; Parikh NI, 2012, HUM REPROD, V27, P568, DOI 10.1093/humrep/der400; Rich-Edwards JW, 2010, HYPERTENSION, V56, P331, DOI 10.1161/HYPERTENSIONAHA.110.156810; Rich-Edwards JW, 2009, WOMENS HEALTH, V5, P101, DOI 10.2217/17455057.5.2.101; Roberts JL, 2001, BMJ-BRIT MED J, V323, P1217; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; Rodie VA, 2004, ATHEROSCLEROSIS, V175, P189, DOI 10.1016/j.atherosclerosis.2004.01.038; Romundstad PR, 2010, CIRCULATION, V122, P579, DOI 10.1161/CIRCULATIONAHA.110.943407; Sallmen M, 2006, EPIDEMIOLOGY, V17, P520, DOI 10.1097/01.ede.0000229953.76862.e5; Sattar N, 2002, BMJ-BRIT MED J, V325, P157, DOI 10.1136/bmj.325.7356.157; SIBAI BM, 1986, AM J OBSTET GYNECOL, V155, P1011, DOI 10.1016/0002-9378(86)90336-4; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Smith GD, 2007, AM J EPIDEMIOL, V166, P160, DOI 10.1093/aje/kwm054; Solomon CG, 2001, HYPERTENSION, V37, P232, DOI 10.1161/01.HYP.37.2.232; Vestrheim LC, 2010, PREGNANCY HYPERTENS, V1, pS56; Whitworth KW, 2011, DIABETOLOGIA, V54, P516, DOI 10.1007/s00125-010-2003-6; Wikstrom AK, 2005, BJOG-INT J OBSTET GY, V112, P1486, DOI 10.1111/j.1471-0528.2005.00733.x; Wilson BJ, 2003, BRIT MED J, V326, P845, DOI 10.1136/bmj.326.7394.845; Wolf M, 2004, J CLIN ENDOCR METAB, V89, P6239, DOI 10.1210/jc.2004-0548	46	119	121	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2012	345								e7677	10.1136/bmj.e7677	http://dx.doi.org/10.1136/bmj.e7677			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048FM	23186909	Green Published, hybrid			2022-12-28	WOS:000311895700002
J	Riffell, JA; Lei, H; Abrell, L; Hildebrand, JG				Riffell, Jeffrey A.; Lei, Hong; Abrell, Leif; Hildebrand, John G.			Neural Basis of a Pollinator's Buffet: Olfactory Specialization and Learning in Manduca sexta	SCIENCE			English	Article							FLORAL SCENT; MODULATION; HAWKMOTH; MEMORY; EVOLUTION; HONEYBEE; FLOWERS; INSECT; SYSTEM; ODORS	Pollinators exhibit a range of innate and learned behaviors that mediate interactions with flowers, but the olfactory bases of these responses in a naturalistic context remain poorly understood. The hawkmoth Manduca sexta is an important pollinator for many night-blooming flowers but can learn-through olfactory conditioning-to visit other nectar resources. Analysis of the flowers that are innately attractive to moths shows that the scents all have converged on a similar chemical profile that, in turn, is uniquely represented in the moth's antennal (olfactory) lobe. Flexibility in visitation to nonattractive flowers, however, is mediated by octopamine-associated modulation of antennal-lobe neurons during learning. Furthermore, this flexibility does not extinguish the innate preferences. Such processing of stimuli through two olfactory channels, one involving an innate bias and the other a learned association, allows the moths to exist within a dynamic floral environment while maintaining specialized associations.	[Riffell, Jeffrey A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Lei, Hong; Hildebrand, John G.] Univ Arizona, Dept Neurosci, Tucson, AZ 85721 USA; [Abrell, Leif] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA; [Abrell, Leif] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ 85721 USA	University of Washington; University of Washington Seattle; University of Arizona; University of Arizona; University of Arizona	Riffell, JA (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	jriffell@u.washington.edu	Lei, Hong/ABH-1356-2020; Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Lei, Hong/0000-0002-5619-3097; Abrell, Leif/0000-0003-2490-1180	NSF [IOS 0822709, CHE 0216226]; NIH [R01-DC-02751]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002751] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank C. Reisenman, R. Alarcon, A. Dacks, G. Davidowitz, and J. Bronstein for advice and assistance; C. Hedgcock and F. van Breugal for images of flowers and moths; and M. Dickinson and H. Bradshaw for manuscript comments. This work was supported by NSF grants IOS 0822709 to J.A.R. and CHE 0216226 to L. A., and NIH grant R01-DC-02751 to J.G.H.	Alarcon R, 2008, ECOL ENTOMOL, V33, P503, DOI 10.1111/j.1365-2311.2008.00996.x; Arenas A, 2009, EUR J NEUROSCI, V30, P1498, DOI 10.1111/j.1460-9568.2009.06940.x; Cassenaer S, 2012, NATURE, V482, P47, DOI 10.1038/nature10776; Dacks AM, 2006, INSECT BIOCHEM MOLEC, V36, P741, DOI 10.1016/j.ibmb.2006.07.002; Dacks AM, 2012, J NEUROPHYSIOL, V108, P539, DOI 10.1152/jn.00159.2012; Daly KC, 2004, P NATL ACAD SCI USA, V101, P10476, DOI 10.1073/pnas.0401902101; Dobson HEM, 2006, BIOLOGY OF FLORAL SCENT, P147; Dudareva N, 2000, PLANT CELL, V12, P949, DOI 10.1105/tpc.12.6.949; Farooqui T, 2003, J NEUROSCI, V23, P5370; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Knudsen JT, 1998, BRITTONIA, V50, P174, DOI 10.2307/2807848; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; Menzel R., 1985, EXPT BEHAV ECOLOGY, V1, P55; Raguso RA, 2003, INT J PLANT SCI, V164, P877, DOI 10.1086/378539; Raguso RA, 1998, OIKOS, V81, P238, DOI 10.2307/3547045; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; Riffell JA, 2008, P NATL ACAD SCI USA, V105, P3404, DOI 10.1073/pnas.0709811105; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; Schiestl FP, 2003, SCIENCE, V302, P437, DOI 10.1126/science.1087835; Stokl J, 2010, CURR BIOL, V20, P1846, DOI 10.1016/j.cub.2010.09.033; Wright GA, 2009, FUNCT ECOL, V23, P841, DOI 10.1111/j.1365-2435.2009.01627.x; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X	22	102	104	3	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					200	204		10.1126/science.1225483	http://dx.doi.org/10.1126/science.1225483			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23223454				2022-12-28	WOS:000313328200043
J	Knobloch, M; Braun, SMG; Zurkirchen, L; von Schoultz, C; Zamboni, N; Arauzo-Bravo, MJ; Kovacs, WJ; Karalay, O; Suter, U; Machado, RAC; Roccio, M; Lutolf, MP; Semenkovich, CF; Jessberger, S				Knobloch, Marlen; Braun, Simon M. G.; Zurkirchen, Luis; von Schoultz, Carolin; Zamboni, Nicola; Arauzo-Bravo, Marcos J.; Kovacs, Werner J.; Karalay, Oezlem; Suter, Ueli; Machado, Raquel A. C.; Roccio, Marta; Lutolf, Matthias P.; Semenkovich, Clay F.; Jessberger, Sebastian			Metabolic control of adult neural stem cell activity by Fasn-dependent lipogenesis	NATURE			English	Article							FATTY-ACID SYNTHASE; TRANSGENIC MICE; SPOT 14; NEUROGENESIS; HOMEOSTASIS; GLUCOSE	Mechanisms controlling the proliferative activity of neural stem and progenitor cells (NSPCs) have a pivotal role to ensure life-long neurogenesis in the mammalian brain(1). How metabolic programs are coupled with NSPC activity remains unknown. Here we show that fatty acid synthase (Fasn), the key enzyme of de novo lipogenesis(2), is highly active in adult NSPCs and that conditional deletion of Fasn in mouse NSPCs impairs adult neurogenesis. The rate of de novo lipid synthesis and subsequent proliferation of NSPCs is regulated by Spot14, a gene previously implicated in lipid metabolism(3-5), that we found to be selectively expressed in low proliferating adult NSPCs. Spot14 reduces the availability of malonyl-CoA(6), which is an essential substrate for Fasn to fuel lipogenesis. Thus, we identify here a functional coupling between the regulation of lipid metabolism and adult NSPC proliferation.	[Knobloch, Marlen; Braun, Simon M. G.; Machado, Raquel A. C.; Jessberger, Sebastian] Univ Zurich, Fac Med, Brain Res Inst, CH-8057 Zurich, Switzerland; [Knobloch, Marlen; Braun, Simon M. G.; Zurkirchen, Luis; von Schoultz, Carolin; Kovacs, Werner J.; Karalay, Oezlem; Suter, Ueli; Machado, Raquel A. C.; Jessberger, Sebastian] Swiss Fed Inst Technol, Dept Biol, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland; [Zamboni, Nicola] Swiss Fed Inst Technol, Dept Biol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Arauzo-Bravo, Marcos J.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Roccio, Marta; Lutolf, Matthias P.] Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Semenkovich, Clay F.] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA	University of Geneva; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Washington University (WUSTL)	Jessberger, S (corresponding author), Univ Zurich, Fac Med, Brain Res Inst, CH-8057 Zurich, Switzerland.	jessberger@hifo.uzh.ch	Suter, Ueli/A-1624-2010; Zamboni, Nicola/K-3042-2012; Knobloch, Marlen/A-9565-2015; Marcos, Arauzo-Bravo/A-1706-2011; Lutolf, Matthias P/E-5914-2010; Kovacs, Werner/AAD-1107-2019; Jessberger, Sebastian/AAJ-4032-2020	Zamboni, Nicola/0000-0003-1271-1021; Knobloch, Marlen/0000-0002-7490-0285; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Kovacs, Werner/0000-0002-4440-4344; Braun, Simon/0000-0003-2622-9914; Jessberger, Sebastian/0000-0002-0056-8275; Roccio, Marta/0000-0001-7568-9429; Semenkovich, Clay/0000-0003-1163-1871; Martinez Machado, Raquel Arminda/0000-0001-5912-2991	NCCR Neural Plasticity and Repair; Swiss National Science Foundation; TH grant [ETH-01 08-1]; Zurich Neuroscience Center (ZNZ); Novartis Foundation; Theodore Ott Foundation; EMBO Young Investigator program; Janggen-Pohn foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076729, P30DK020579, R01DK088083] Funding Source: NIH RePORTER	NCCR Neural Plasticity and Repair(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); TH grant; Zurich Neuroscience Center (ZNZ); Novartis Foundation(Novartis); Theodore Ott Foundation; EMBO Young Investigator program(European Molecular Biology Organization (EMBO)); Janggen-Pohn foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Aigner, D. C. Lie, F. H. Gage and members of the Jessberger group for conceptual input; S. Kobel, C. Fischer, K. Walter, P. Sidiropoulos, T. Buch, B. Becher, P. Pelczar, P. Lotscher, A. J. Eisch and D. C. Lagace for experimental help or reagents; and the Light Microscopy and Screening Center (LMSC) of the ETH Zurich and the BioImaging and Optics Platform (BIOP) of the EPFL for help with imaging. This study was supported by the NCCR Neural Plasticity and Repair, Swiss National Science Foundation, TH grant (ETH-01 08-1), Zurich Neuroscience Center (ZNZ), Novartis Foundation, Theodore Ott Foundation, and the EMBO Young Investigator program (to S. J.). M. K. was supported by the Janggen-Pohn foundation.	Aipoalani DL, 2010, ENDOCRINOLOGY, V151, P2071, DOI 10.1210/en.2009-1058; Campbell MC, 2003, ENDOCRINOLOGY, V144, P5242, DOI 10.1210/en.2002-0008; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Colbert CL, 2010, P NATL ACAD SCI USA, V107, P18820, DOI 10.1073/pnas.1012736107; Cordey M, 2008, STEM CELLS, V26, P2586, DOI 10.1634/stemcells.2008-0498; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Johansson T, 2010, GENESIS, V48, P264, DOI 10.1002/dvg.20612; Karalay O, 2011, P NATL ACAD SCI USA, V108, P5807, DOI 10.1073/pnas.1013456108; Kim CW, 2010, P NATL ACAD SCI USA, V107, P9626, DOI 10.1073/pnas.1001292107; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Moncur JT, 1998, P NATL ACAD SCI USA, V95, P6989, DOI 10.1073/pnas.95.12.6989; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhu QH, 2001, ENDOCRINOLOGY, V142, P4363, DOI 10.1210/en.142.10.4363	20	316	327	4	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2013	493	7431					226	230		10.1038/nature11689	http://dx.doi.org/10.1038/nature11689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23201681	Green Accepted			2022-12-28	WOS:000313259600040
J	Retallack, GJ				Retallack, Gregory J.			Ediacaran life on land	NATURE			English	Article							COMPACTION; PALEOSOLS; MORAINES; FOSSILS; GROWTH; SOILS	Ediacaran (635-542 million years ago) fossils have been regarded as early animal ancestors of the Cambrian evolutionary explosion of marine invertebrate phyla(1), as giant marine protists(2) and as lichenized fungi(3). Recent documentation of palaeosols in the Ediacara Member of the Rawnsley Quartzite of South Australia(4) confirms past interpretations of lagoonal-aeolian deposition based on synsedimentary ferruginization and loessic texture(5,6). Further evidence for palaeosols comes from non-marine facies, dilation cracks, soil nodules, sand crystals, stable isotopic data and mass balance geochemistry(4). Here I show that the uppermost surfaces of the palaeosols have a variety of fossils in growth position, including Charniodiscus, Dickinsonia, Hallidaya, Parvancorina, Phyllozoon, Praecambridium, Rugoconites, Tribrachidium and 'old-elephant skin' (ichnogenus Rivularites(7)). These fossils were preserved as ferruginous impressions, like plant fossils(8), and biological soil crusts(9,10) of Phanerozoic eon sandy palaeosols. Sand crystals after gypsum(11) and nodules of carbonate(12) are shallow within the palaeosols(4), even after correcting for burial compaction(13). Periglacial involutions and modest geochemical differentiation of the palaeosols are evidence of a dry, cold temperate Ediacaran palaeoclimate in South Australia(4). This new interpretation of some Ediacaran fossils as large sessile organisms of cool, dry soils, is compatible with observations that Ediacaran fossils were similar in appearance and preservation to lichens and other microbial colonies of biological soil crusts(3), rather than marine animals(1), or protists(2).	Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA	University of Oregon	Retallack, GJ (corresponding author), Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA.	gregr@uoregon.edu			PRF fund of the American Chemical Society	PRF fund of the American Chemical Society	K. Lloyd, P. Coulthard, A. Coulthard, K. Anderson and D. Crawford facilitated permission to undertake research in Flinders Ranges National Park. B. Logan and M. Willison aided sampling of drill core at PIRSA, Glenside. T. Palmer and D. Atkins provided mathematical advice. Fieldwork was funded by the PRF fund of the American Chemical Society, and aided by C. Metzger and J. Gehling.	Antcliffe JB, 2008, PALAEONTOLOGY, V51, P11, DOI 10.1111/j.1475-4983.2007.00738.x; Bengtson S, 2007, PALEOBIOLOGY, V33, P351, DOI 10.1666/04040.1; DAN J, 1982, GEODERMA, V28, P173, DOI 10.1016/0016-7061(82)90002-7; DAN J, 1973, ISR J EARTH SCI, V22, P211; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; Ewing SA, 2006, GEOCHIM COSMOCHIM AC, V70, P5293, DOI 10.1016/j.gca.2006.08.020; Food & Agriculture Organization, 1978, SOIL MAP WORLD, VVIII; Gehling JG, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P43; GLAESSNER M, 1961, SCI AM, V204, P72, DOI 10.1038/scientificamerican0361-72; Grazhdankin D, 2007, LETHAIA, V40, P201, DOI 10.1111/j.1502-3931.2007.00025.x; Huldtgren T, 2011, SCIENCE, V334, P1696, DOI 10.1126/science.1209537; Jenkins RJF, 2011, GEOL SOC MEM, V36, P693, DOI 10.1144/M36.68; JENKINS RJF, 1983, J GEOL SOC AUST, V30, P101, DOI 10.1080/00167618308729240; Matthews JA, 2005, HOLOCENE, V15, P1, DOI 10.1191/0959683605hl779rp; Mawson D., 1949, T ROY SOC SOUTH AUST, V72, P276; Retallack G.J., 2012, SOC EC PALEONTOLOGIS, V101, P136; Retallack GJ, 2005, GEOLOGY, V33, P333, DOI 10.1130/G21263.1; Retallack GJ, 2007, ALCHERINGA, V31, P215, DOI 10.1080/03115510701484705; Retallack GJ, 2012, SEDIMENTOLOGY, V59, P1208, DOI 10.1111/j.1365-3091.2011.01302.x; Retallack GJ, 2012, PALAEOGEOGR PALAEOCL, V329, P47, DOI 10.1016/j.palaeo.2012.02.017; Retallack GJ, 2010, GEOLOGY, V38, P403, DOI 10.1130/G30514.1; Retallack GJ, 2009, ALCHERINGA, V33, P355, DOI 10.1080/03115510903271066; Seilacher A, 2005, PALAEOGEOGR PALAEOCL, V227, P323, DOI 10.1016/j.palaeo.2005.06.003; Sheldon ND, 2001, GEOLOGY, V29, P247, DOI 10.1130/0091-7613(2001)029<0247:EFCOPD>2.0.CO;2; Simpson WS, 2010, SEDIMENT GEOL, V230, P139, DOI 10.1016/j.sedgeo.2010.07.004; Solomina O, 2003, ARCT ANTARCT ALP RES, V35, P129, DOI 10.1657/1523-0430(2003)035[0129:LAATMI]2.0.CO;2; Sprigg R. C., 1947, Transactions of the Royal Society of South Australia, V71, P212; Vickers-Rich, 2008, RISE ANIMALS EVOLUTI; Yin Z, 2011, PRECAMBR RES; Yuan XL, 2005, SCIENCE, V308, P1017, DOI 10.1126/science.1111347	30	102	107	1	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					89	92		10.1038/nature11777	http://dx.doi.org/10.1038/nature11777			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23235827				2022-12-28	WOS:000312933800036
J	Azzolin, L; Zanconato, F; Bresolin, S; Forcato, M; Basso, G; Bicciato, S; Cordenonsi, M; Piccolo, S				Azzolin, Luca; Zanconato, Francesca; Bresolin, Silvia; Forcato, Mattia; Basso, Giuseppe; Bicciato, Silvio; Cordenonsi, Michelangelo; Piccolo, Stefano			Role of TAZ as Mediator of Wnt Signaling	CELL			English	Article							PATHWAY; INHIBITION; PROTEIN; YAP; DEGRADATION; COMPONENTS; STABILITY; COMPLEX; TARGETS; LATS	Wnt growth factors are fundamental regulators of cell fate, but how the Wnt signal is translated into biological responses is incompletely understood. Here, we report that TAZ, a biologically potent transcriptional coactivator, serves as a downstream element of the Wnt/beta-catenin cascade. This function of TAZ is independent from its well-established role as mediator of Hippo signaling. In the absence of Wnt activity, the components of the beta-catenin destruction complex-APC, Axin, and GSK3-are also required to keep TAZ at low levels. TAZ degradation depends on phosphorylated beta-catenin that bridges TAZ to its ubiquitin ligase beta-TrCP. Upon Wnt signaling, escape of beta-catenin from the destruction complex impairs TAZ degradation and leads to concomitant accumulation of beta-catenin and TAZ. At the genome-wide level, a substantial portion of Wnt transcriptional responses is mediated by TAZ. TAZ activation is a general feature of Wnt signaling and is functionally relevant to mediate Wnt biological effects.	[Azzolin, Luca; Zanconato, Francesca; Cordenonsi, Michelangelo; Piccolo, Stefano] Univ Padua, Sch Med, Dept Biomed Sci, I-35126 Padua, Italy; [Bresolin, Silvia; Basso, Giuseppe] Univ Padua, Dept Woman & Child Hlth, I-35128 Padua, Italy; [Forcato, Mattia; Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Biomed Sci, Ctr Genome Res, I-41100 Modena, Italy	University of Padua; University of Padua; Universita di Modena e Reggio Emilia	Cordenonsi, M (corresponding author), Univ Padua, Sch Med, Dept Biomed Sci, Viale Colombo 3, I-35126 Padua, Italy.	michelangelo.cordenonsi@unipd.it; piccolo@bio.unipd.it	Forcato, Mattia/B-7733-2015; Bicciato, Silvio/C-9825-2009; BICCIATO, Silvio/J-4466-2019; Bresolin, Silvia/K-6576-2016; Cordenonsi, Michelangelo/K-7692-2016; Azzolin, Luca/K-8012-2016	Forcato, Mattia/0000-0002-7383-6576; Bicciato, Silvio/0000-0002-1944-7078; BICCIATO, Silvio/0000-0002-1944-7078; Bresolin, Silvia/0000-0001-7677-7084; Cordenonsi, Michelangelo/0000-0002-8253-5724; Azzolin, Luca/0000-0002-2425-6153; PICCOLO, STEFANO/0000-0002-2037-0004; BASSO, GIUSEPPE/0000-0002-2634-9302	Italian Welfare Ministry; AIRC-MFAG; Fondazione Citta della Speranza Grant; AIRC; HSFP; Excellence-IIT; Epigenetics Flagship project CNR-Miur grants	Italian Welfare Ministry; AIRC-MFAG(Fondazione AIRC per la ricerca sul cancro); Fondazione Citta della Speranza Grant; AIRC(Fondazione AIRC per la ricerca sul cancro); HSFP; Excellence-IIT; Epigenetics Flagship project CNR-Miur grants	We thank O. Wessely and S. Dupont for comments; S. Zanotti for ST-2 differentiation protocol; G. Martello, M.C. Faux, A.R. Clarke, H. Miyoshi, and L. Naldini for gifts of reagents; and Tito Panciera for helping with RNA preparations. Plasmids purchased from Addgene were kindly deposited by K. Hochedlinger and W. Harper. This work is supported by "Young Italian Researchers" grants from the Italian Welfare Ministry and AIRC-MFAG to M.C.; from Fondazione Citta della Speranza Grant to G.B.; from AIRC Special Program Molecular Clinical Oncology "5 per mille" to S.P. and S.B.; and from HSFP, Excellence-IIT, and Epigenetics Flagship project CNR-Miur grants to S.P.	Barolo S, 2006, ONCOGENE, V25, P7505, DOI 10.1038/sj.onc.1210057; Ben-Ze'Ev A, 1999, ANN NY ACAD SCI, V886, P37, DOI 10.1111/j.1749-6632.1999.tb09398.x; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huang W, 2012, J BIOL CHEM, V287, P26245, DOI 10.1074/jbc.M112.382036; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Kim NG, 2009, P NATL ACAD SCI USA, V106, P5165, DOI 10.1073/pnas.0810185106; Leucht P, 2008, SEMIN CELL DEV BIOL, V19, P434, DOI 10.1016/j.semcdb.2008.09.002; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	32	346	360	2	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1443	1456		10.1016/j.cell.2012.11.027	http://dx.doi.org/10.1016/j.cell.2012.11.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23245942	Bronze			2022-12-28	WOS:000312890300011
J	Ragusa, MJ; Stanley, RE; Hurley, JH				Ragusa, Michael J.; Stanley, Robin E.; Hurley, James H.			Architecture of the Atg17 Complex as a Scaffold for Autophagosome Biogenesis	CELL			English	Article							SMALL-ANGLE SCATTERING; SACCHAROMYCES-CEREVISIAE; MONITORING AUTOPHAGY; MEMBRANE CURVATURE; PROTEIN-KINASE; EARLY STEPS; YEAST; FIP200; MACROMOLECULES; TUMORIGENESIS	Macroautophagy is a bulk clearance mechanism in which the double-membraned phagophore grows and engulfs cytosolic material. In yeast, the phagophore nucleates from a cluster of 20-30 nm diameter Atg9-containing vesicles located at a multiprotein assembly known as the preautophagosomal structure (PAS). The crystal structure of a 2:2:2 complex of the earliest acting PAS proteins, Atg17, Atg29, and Atg31, was solved at 3.05 angstrom resolution. Atg17 is crescent shaped with a 10 nm radius of curvature. Dimerization of the Atg17-Atg31-Atg29 complex is critical for both PAS formation and autophagy, and each dimer contains two separate and complete crescents. Upon induction of autophagy, Atg17-Atg31-Atg29 assembles with Atg1 and Atg13, which in turn initiates the formation of the phagophore. The C-terminal EAT domain of Atg1 was shown to sense membrane curvature, dimerize, and tether lipid vesicles. These data suggest a structural mechanism for the organization of Atg9 vesicles into the early phagophore.	[Ragusa, Michael J.; Stanley, Robin E.; Hurley, James H.] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	james.hurley@nih.gov	Stanley, Robin/M-3008-2019; Stanley, Robin E/C-7128-2019	Stanley, Robin/0000-0002-2106-3102; Stanley, Robin E/0000-0002-2106-3102	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; U.S. DOE [DE-AC02-06CH11357]; NIH, NIDDK; Damon Runyon Cancer Research Fellowship; Ruth Kirschtein NRSA fellowship [GM099319]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM099319] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. DOE(United States Department of Energy (DOE)); NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Damon Runyon Cancer Research Fellowship; Ruth Kirschtein NRSA fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Klionsky and W. Prinz for strains, constructs, and technical advice; X. Zuo for assistance with SAXS; X.-F. Ren and R. Ghirlando for light scattering assistance; B. Canagarajah for assistance with Figure 7; and T.R. Serio for a vector. Crystallographic data were collected at the Southeast Regional Collaborative Access Team 22-ID and 22-BM beamlines at the Advanced Photon Source, Argonne National Laboratory. SAXS data were collected at NCI beamline 12ID-B. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract number W-31-109-Eng-38 and was supported by the U.S. DOE under contract number DE-AC02-06CH11357. This research was supported by the Intramural Program of the NIH, NIDDK (J.H.H.), a Damon Runyon Cancer Research Fellowship (R.E.S.), and a Ruth Kirschtein NRSA fellowship GM099319 (M.J.R.).	Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Cheong H, 2008, MOL BIOL CELL, V19, P668, DOI 10.1091/mbc.E07-08-0826; Choi JD, 2012, ONCOGENE; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan W, 2011, P NATL ACAD SCI USA, V108, P7769, DOI 10.1073/pnas.1016472108; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.E04-08-0669; Kabeya Y, 2007, BIOCHEM BIOPH RES CO, V356, P405, DOI 10.1016/j.bbrc.2007.02.150; Kabeya Y, 2009, BIOCHEM BIOPH RES CO, V389, P612, DOI 10.1016/j.bbrc.2009.09.034; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kawamata T, 2005, BIOCHEM BIOPH RES CO, V338, P1884, DOI 10.1016/j.bbrc.2005.10.163; Kawamata T, 2008, MOL BIOL CELL, V19, P2039, DOI 10.1091/mbc.E07-10-1048; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Klionsky Daniel J., 2007, V390, P363; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liu F, 2010, BLOOD, V116, P4806, DOI 10.1182/blood-2010-06-288589; Lo SY, 2012, NAT STRUCT MOL BIOL, V19, P40, DOI 10.1038/nsmb.2162; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rubinsztein DC, 2012, CURR BIOL, V22, pR29, DOI 10.1016/j.cub.2011.11.034; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Sekito T, 2009, GENES CELLS, V14, P525, DOI 10.1111/j.1365-2443.2009.01299.x; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; Yamamoto H, 2012, J CELL BIOL, V198, P219, DOI 10.1083/jcb.201202061; Yeh YY, 2011, J BIOL CHEM, V286, P28931, DOI 10.1074/jbc.M111.250324; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	50	170	173	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1501	1512		10.1016/j.cell.2012.11.028	http://dx.doi.org/10.1016/j.cell.2012.11.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23219485	Green Accepted, Bronze			2022-12-28	WOS:000312890300015
J	Losos, JB; Hillis, DM; Greene, HW				Losos, Jonathan B.; Hillis, David M.; Greene, Harry W.			Who Speaks with a Forked Tongue?	SCIENCE			English	Editorial Material							PHYLOGENY; MOLECULES; SELECTION; GENES		[Losos, Jonathan B.] Harvard Univ, Harvard Museum Comparat Zool, Cambridge, MA 02138 USA; [Hillis, David M.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Greene, Harry W.] Cornell Univ, Ithaca, NY 14853 USA	Harvard University; University of Texas System; University of Texas Austin; Cornell University	Losos, JB (corresponding author), Harvard Univ, Harvard Museum Comparat Zool, Cambridge, MA 02138 USA.	jlosos@oeb.harvard.edu; dhillis@austin.utexas.edu; hwg5@cornell.edu	Hillis, David/L-5421-2019					Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Blanga-Kanfi S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-71; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Edwards SV, 2009, P NATL ACAD SCI USA, V106, P8799, DOI 10.1073/pnas.0904103106; Gatesy J, 2001, TRENDS ECOL EVOL, V16, P562, DOI 10.1016/S0169-5347(01)02236-4; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; GRAUR D, 1991, NATURE, V351, P649, DOI 10.1038/351649a0; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Messenger SL, 1998, SYST BIOL, V47, P90, DOI 10.1080/106351598261058; Sullivan J, 2005, ANNU REV ECOL EVOL S, V36, P445, DOI 10.1146/annurev.ecolsys.36.102003.152633; Vitt LJ, 2003, AM NAT, V162, P44, DOI 10.1086/375172; Wake DB, 2011, SCIENCE, V331, P1032, DOI 10.1126/science.1188545; Wiens JJ, 2012, BIOL LETTERS, V8, P1043, DOI 10.1098/rsbl.2012.0703	14	57	60	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1428	1429		10.1126/science.1232455	http://dx.doi.org/10.1126/science.1232455			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239723				2022-12-28	WOS:000312250800034
J	Kirby, T				Kirby, Tony			Bongani Mayosi: targeting heart diseases of poverty in Africa	LANCET			English	Biographical-Item																		MAYOSI B, PUBLICATION LIST	1	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 8	2012	380	9858					1985	1985		10.1016/S0140-6736(12)62144-8	http://dx.doi.org/10.1016/S0140-6736(12)62144-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051KI	23217856				2022-12-28	WOS:000312124900013
J	Bhave, PD; Foster, E; Dhaliwal, G				Bhave, Prashant D.; Foster, Elyse; Dhaliwal, Gurpreet			A Missed Connection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ARTERIOVENOUS-FISTULA; COMPLICATION		[Bhave, Prashant D.] Northwestern Univ, Div Cardiol, Chicago, IL 60611 USA; [Foster, Elyse] Univ Calif San Francisco, Div Cardiol, San Francisco, CA USA; [Dhaliwal, Gurpreet] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Dhaliwal, Gurpreet] San Francisco Vet Med Ctr, San Francisco, CA USA	Northwestern University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bhave, PD (corresponding author), Northwestern Univ, Div Cardiol, 251 E Huron St,Feinberg 8-503, Chicago, IL 60611 USA.	pdbhave@gmail.com			Pri-Med; MCE Conferences; Actelion; MAQUET; Evalve/Abbott	Pri-Med; MCE Conferences; Actelion; MAQUET; Evalve/Abbott	Dr. Foster reports receiving lecture fees from Pri-Med and MCE Conferences, consulting fees to her institution from Actelion and MAQUET, grant support to her institution from Evalve/Abbott, and payment to her institution for expert testimony from various law firms regarding cardiac complications of a psychoactive drug and missed endocarditis. No other potential conflict of interest relevant to this article was reported.	Anand Inder S., 2001, Curr Treat Options Cardiovasc Med, V3, P151, DOI 10.1007/s11936-001-0070-1; Fozi K, 2006, Med J Malaysia, V61, P519; KRON J, 1985, AM J CARDIOL, V55, P1445, DOI 10.1016/0002-9149(85)90532-6; Libby P., 2008, BRAUNWALDS HEART DIS; MacRae JM, 2004, AM J KIDNEY DIS, V43, DOI 10.1053/j.ajkd.2004.01.016; Mehta PA, 2009, QJM-INT J MED, V102, P235, DOI 10.1093/qjmed/hcn147; Santos E, 1998, NEURORADIOLOGY, V40, P459, DOI 10.1007/s002340050624; Soukaloun D, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000971; Stern AB, 2011, HEMODIAL INT, P12; Talwar D, 2000, CLIN CHEM, V46, P704; Zenuk Cecli, 2003, Can J Clin Pharmacol, V10, P184	11	1	1	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2012	367	23					2241	2247		10.1056/NEJMcps1115057	http://dx.doi.org/10.1056/NEJMcps1115057			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048DO	23215561				2022-12-28	WOS:000311890600013
J	Arie, S				Arie, Sophie			BRIEFING Is abortion worldwide becoming more restrictive?	BRITISH MEDICAL JOURNAL			English	Editorial Material												mail@sophiearie.com						[Anonymous], 2009, CNN             0730; [Anonymous], 2012, LIFENEWS        0914; Colghan A., 2010, NEW SCI; Department of Health, NUMB TRAV UK AB REP; Gold RB, TROUBLING TREND MORE; Guttmacher Institute, FACTS IND AB WORLDW; Houston M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8165; International Planned Parenthood Federation, AB; Jha P, 2011, LANCET, V377, P1921, DOI 10.1016/S0140-6736(11)60649-1; Kishkovsky Sophia, 2011, NY TIMES; Northern Ireland Health Ministry, STAT TERM PREGN; Smyth L., 2012, BELFAST TELEGRA 1018; WHO, 2005, UNS AB; World Bank, FERT RAT	14	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 4	2012	345								e8161	10.1136/bmj.e8161	http://dx.doi.org/10.1136/bmj.e8161			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	052HY	23212882				2022-12-28	WOS:000312189700005
J	Rostami, K; Hogg-Kollars, S				Rostami, Kamran; Hogg-Kollars, Sabine			Non-coeliac gluten sensitivity	BRITISH MEDICAL JOURNAL			English	Editorial Material							DISEASE; ENTEROPATHY; INTOLERANCE; SYMPTOMS; CEREALS; WHEAT		[Rostami, Kamran] Mid Staffordshire NHS Fdn Trust, Dept Gastroenterol, Stafford, England; [Hogg-Kollars, Sabine] Univ Birmingham, Dept Med & Dent Sci, Sch Canc Sci, Birmingham, W Midlands, England	University of Birmingham	Rostami, K (corresponding author), Mid Staffordshire NHS Fdn Trust, Dept Gastroenterol, Stafford, England.	kamran.rostami@nhs.net						Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; Bizzaro N, 2012, CLIN REV ALLERG IMMU, V42, P279, DOI 10.1007/s12016-010-8223-1; Brottveit M, 2012, SCAND J GASTROENTERO, V47, P770, DOI 10.3109/00365521.2012.679685; Brown AC, 2012, EXPERT REV GASTROENT, V6, P43, DOI [10.1586/EGH.11.79, 10.1586/egh.11.79]; Di Sabatino A, 2012, ANN INTERN MED, V156, P309, DOI 10.7326/0003-4819-156-4-201202210-00010; Ferch Courtney C, 2012, Gastroenterology, V142, P664, DOI 10.1053/j.gastro.2012.01.020; Inomata N, 2009, CURR OPIN ALLERGY CL, V9, P238, DOI 10.1097/ACI.0b013e32832aa5bc; Jackson JR, 2012, PSYCHIAT QUART, V83, P91, DOI 10.1007/s11126-011-9186-y; Kaukinen K, 2000, SCAND J GASTROENTERO, V35, P942, DOI 10.1080/003655200750022995; Ludvigsson JF, 2012, GUT; Ostblom E, 2008, ACTA PAEDIATR, V97, P85, DOI 10.1111/j.1651-2227.2007.00556.x; Pallav K, 2012, ALIMENT PHARM THER, V35, P380, DOI 10.1111/j.1365-2036.2011.04938.x; Rostami Nejad Mohammad, 2011, Gastroenterol Hepatol Bed Bench, V4, P102; Sapone A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-13; Sapone A, 2010, INT ARCH ALLERGY IMM, V152, P75, DOI 10.1159/000260087; Tatham AS, 2008, CLIN EXP ALLERGY, V38, P1712, DOI 10.1111/j.1365-2222.2008.03101.x; Troncone R, 2011, J INTERN MED, V269, P582, DOI 10.1111/j.1365-2796.2011.02385.x; Tucker E, 2012, J GASTROINTEST LIVER, V21, P11; Volta U, 2012, J CLIN GASTROENTEROL, V46, P680, DOI 10.1097/MCG.0b013e3182372541; Volta U, 2012, NAT REV GASTRO HEPAT, V9, P295, DOI 10.1038/nrgastro.2012.15; Wahnschaffe U, 2001, GASTROENTEROLOGY, V121, P1329, DOI 10.1053/gast.2001.29572	21	11	11	0	42	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 30	2012	345								e7982	10.1136/bmj.e7982	http://dx.doi.org/10.1136/bmj.e7982			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048FS	23204003	Bronze			2022-12-28	WOS:000311896500006
J	Ye, JT; Zhang, YJ; Akashi, R; Bahramy, MS; Arita, R; Iwasa, Y				Ye, J. T.; Zhang, Y. J.; Akashi, R.; Bahramy, M. S.; Arita, R.; Iwasa, Y.			Superconducting Dome in a Gate-Tuned Band Insulator	SCIENCE			English	Article							TRANSITION-TEMPERATURE; SEMICONDUCTING SRTIO3; MOLYBDENUM-DISULFIDE; TRANSISTORS; PHYSICS; STATE	A dome-shaped superconducting region appears in the phase diagrams of many unconventional superconductors. In doped band insulators, however, reaching optimal superconductivity by the fine-tuning of carriers has seldom been seen. We report the observation of a superconducting dome in the temperature-carrier density phase diagram of MoS2, an archetypal band insulator. By quasi-continuous electrostatic carrier doping achieved through a combination of liquid and solid gating, we revealed a large enhancement in the transition temperature T-c occurring at optimal doping in the chemically inaccessible low-carrier density regime. This observation indicates that the superconducting dome may arise even in doped band insulators.	[Ye, J. T.; Zhang, Y. J.; Akashi, R.; Arita, R.; Iwasa, Y.] Univ Tokyo, Quantum Phase Elect Ctr, Bunkyo Ku, Tokyo 1138656, Japan; [Ye, J. T.; Zhang, Y. J.; Akashi, R.; Arita, R.; Iwasa, Y.] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; [Bahramy, M. S.; Arita, R.; Iwasa, Y.] RIKEN, Correlated Electron Res Grp, Wako, Saitama 3510198, Japan	University of Tokyo; University of Tokyo; RIKEN	Ye, JT (corresponding author), Univ Tokyo, Quantum Phase Elect Ctr, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	yejianting@ap.t.u-tokyo.ac.jp; iwasa@ap.t.u-tokyo.ac.jp	Zhang, Yijin/T-2403-2019; Ye, Jianting/K-8194-2012; Arita, Ryotaro/D-5965-2012; Bahramy, Mohammad Saeed/B-2865-2013; Iwasa, Yoshihiro/C-1719-2009; Ishida, Mari/AAU-3379-2020	Arita, Ryotaro/0000-0001-5725-072X; Bahramy, Mohammad Saeed/0000-0001-9024-6335; Zhang, Yijin/0000-0003-1127-1124; page, Cassandra/0000-0003-3758-7880	Japan and Strategic International Collaborative Research Program (SICORP), Japan Science and Technology Agency [21224009]; Japan Society for the Promotion of Science through Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)	Japan and Strategic International Collaborative Research Program (SICORP), Japan Science and Technology Agency; Japan Society for the Promotion of Science through Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)	We thank Y. Takada and A. Bianconi for fruitful discussions and M. Nakano and Y. Kasahara for experimental help. This work was supported by a Grant-in-Aid for Scientific Research (S) (no. 21224009) from Japan and Strategic International Collaborative Research Program (SICORP), Japan Science and Technology Agency. M.S.B., R.A., and Y.I. were supported by the Japan Society for the Promotion of Science through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program). Y.I. received additional funding from SICORP, Japan Science and Technology Agency.	Abrahams E, 2001, REV MOD PHYS, V73, P251, DOI 10.1103/RevModPhys.73.251; Ahn CH, 2006, REV MOD PHYS, V78, P1185, DOI 10.1103/RevModPhys.78.1185; Bollinger AT, 2011, NATURE, V472, P458, DOI 10.1038/nature09998; Brivio J, 2011, NANO LETT, V11, P5148, DOI 10.1021/nl2022288; Caviglia AD, 2008, NATURE, V456, P624, DOI 10.1038/nature07576; Caviglia AD, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.126803; Checkelsky JG, 2012, NAT PHYS, V8, P729, DOI [10.1038/nphys2388, 10.1038/NPHYS2388]; FIVAZ R, 1967, PHYS REV, V163, P743, DOI 10.1103/PhysRev.163.743; FRIEND RH, 1987, ADV PHYS, V36, P1, DOI 10.1080/00018738700101951; Klein T, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.165313; KOONCE CS, 1967, PHYS REV, V163, P380, DOI 10.1103/PhysRev.163.380; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Leng X, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.027001; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Reyren N, 2007, SCIENCE, V317, P1196, DOI 10.1126/science.1146006; Schaak RE, 2003, NATURE, V424, P527, DOI 10.1038/nature01877; SCHOOLEY JF, 1965, PHYS REV LETT, V14, P305, DOI 10.1103/PhysRevLett.14.305; SHANKS HR, 1974, SOLID STATE COMMUN, V15, P753, DOI 10.1016/0038-1098(74)90254-3; SOMOANO RB, 1973, J CHEM PHYS, V58, P697, DOI 10.1063/1.1679256; SOMOANO RB, 1975, J CHEM PHYS, V62, P1068, DOI 10.1063/1.430548; Taguchi Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.107001; Takabayashi Y, 2009, SCIENCE, V323, P1585, DOI 10.1126/science.1169163; Taniguchi K, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4740268; Ueno K, 2008, NAT MATER, V7, P855, DOI 10.1038/nmat2298; Ueno K, 2011, NAT NANOTECHNOL, V6, P408, DOI [10.1038/nnano.2011.78, 10.1038/NNANO.2011.78]; WOOLLAM JA, 1977, MATER SCI ENG, V31, P289, DOI 10.1016/0025-5416(77)90048-9; Ye JT, 2010, NAT MATER, V9, P125, DOI [10.1038/NMAT2587, 10.1038/nmat2587]; Ye JT, 2011, P NATL ACAD SCI USA, V108, P13002, DOI 10.1073/pnas.1018388108; Yun WS, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.033305; Zhang YJ, 2012, NANO LETT, V12, P1136, DOI 10.1021/nl2021575	32	790	802	31	708	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2012	338	6111					1193	1196		10.1126/science.1228006	http://dx.doi.org/10.1126/science.1228006			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197529				2022-12-28	WOS:000311666200041
J	Thompson, DWJ; Seidel, DJ; Randel, WJ; Zou, CZ; Butler, AH; Mears, C; Osso, A; Long, C; Lin, R				Thompson, David W. J.; Seidel, Dian J.; Randel, William J.; Zou, Cheng-Zhi; Butler, Amy H.; Mears, Carl; Osso, Albert; Long, Craig; Lin, Roger			The mystery of recent stratospheric temperature trends	NATURE			English	Article							BREWER-DOBSON CIRCULATION; SOUNDING UNIT; CLIMATE; MSU; CONSTRUCTION; EXTENSION; RECORDS	A new data set of middle- and upper-stratospheric temperatures based on reprocessing of satellite radiances provides a view of stratospheric climate change during the period 1979-2005 that is strikingly different from that provided by earlier data sets. The new data call into question our understanding of observed stratospheric temperature trends and our ability to test simulations of the stratospheric response to emissions of greenhouse gases and ozone-depleting substances. Here we highlight the important issues raised by the new data and suggest how the climate science community can resolve them.	[Thompson, David W. J.] Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA; [Seidel, Dian J.] NOAA Air Resources Lab, College Pk, MD 20740 USA; [Randel, William J.] NCAR, Atmospher Chem Div, Boulder, CO 80307 USA; [Zou, Cheng-Zhi] NOAA NESDIS Ctr Satellite Applicat & Res, College Pk, MD 20740 USA; [Butler, Amy H.; Long, Craig; Lin, Roger] NOAA NWS NCEP Climate Predict Ctr, College Pk, MD 20740 USA; [Mears, Carl] Remote Sensing Syst, Santa Rosa, CA 95401 USA; [Osso, Albert] Univ Barcelona, Dept Astron & Meteorol, E-08028 Barcelona, Spain	Colorado State University; National Oceanic Atmospheric Admin (NOAA) - USA; National Center Atmospheric Research (NCAR) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University of Barcelona	Thompson, DWJ (corresponding author), Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA.	davet@atmos.colostate.edu	Ossó, Albert/AAY-2509-2020; Zou, Cheng-Zhi/E-3085-2010; Butler, Amy H/K-6190-2012; Randel, William J/K-3267-2016; Thompson, David W J/F-9627-2012	Ossó, Albert/0000-0001-5653-4886; Butler, Amy H/0000-0002-3632-0925; Randel, William J/0000-0002-5999-7162; Thompson, David W J/0000-0002-5413-4376	National Science Foundation Climate Dynamics Program [AGS-0936255]	National Science Foundation Climate Dynamics Program(National Science Foundation (NSF))	We thank K. Shine, M. Dameris, M. Free and R. Saunders for suggestions and comments on the manuscript. D.W.J.T. is supported by the National Science Foundation Climate Dynamics Program under budget number AGS-0936255. We acknowledge the World Climate Research Programme's (WCRP) Working Group on Coupled Modelling and the WCRP CCM Validation project (CCMVal), which are responsible for archiving the CMIP5 and CCMVal2 output, respectively. We also thank the climate modelling groups for producing and making available their model output as listed in Table 1. For CMIP the US Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals.	Butchart N, 2006, CLIM DYNAM, V27, P727, DOI 10.1007/s00382-006-0162-4; Butchart N., 2010, J CLIM, V23; Christy JR, 2003, J ATMOS OCEAN TECH, V20, P613, DOI 10.1175/1520-0426(2003)20<613:EEOVOM>2.0.CO;2; Deshler T, 2008, ATMOS RES, V90, P223, DOI 10.1016/j.atmosres.2008.03.016; Douglas A., 2011, SCI ASSESSMENT OZONE; Eyring V., 2010, WCRP132 SPARC; Forster P. M., 2011, SCI ASSESSMENT OZONE; Forster PM, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015361; Free M, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006169; Garcia RR, 2008, J ATMOS SCI, V65, P2731, DOI 10.1175/2008JAS2712.1; Garny H, 2011, J ATMOS SCI, V68, P1214, DOI 10.1175/2011JAS3701.1; Hansen J, 1997, J GEOPHYS RES-ATMOS, V102, P25679, DOI 10.1029/97JD01495; Keckhut P, 2004, J ENVIRON MONITOR, V6, P721, DOI 10.1039/b404256e; Lanzante JR, 2003, J CLIMATE, V16, P241, DOI 10.1175/1520-0442(2003)016<0241:THOMRT>2.0.CO;2; McLandress C, 2009, J CLIMATE, V22, P1516, DOI 10.1175/2008JCLI2679.1; Mears CA, 2009, J ATMOS OCEAN TECH, V26, P1040, DOI 10.1175/2008JTECHA1176.1; NASH J, 1988, Q J ROY METEOR SOC, V114, P1153, DOI 10.1002/qj.49711448213; Nash J, 1986, ADV SPACE RES, V6, P37, DOI DOI 10.1016/0273-1177(86)90455-2; Ramaswamy V, 2001, REV GEOPHYS, V39, P71, DOI 10.1029/1999RG000065; Randel WJ, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015195; Randel WJ, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010421; Seidel DJ, 2011, WIRES CLIM CHANGE, V2, P592, DOI 10.1002/wcc.125; Seidel DJ, 2009, B AM METEOROL SOC, V90, P361, DOI 10.1175/2008BAMS2540.1; Shepherd TG, 2011, J ATMOS SCI, V68, P784, DOI 10.1175/2010JAS3608.1; Shine KP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032218; Shine KP, 2003, Q J ROY METEOR SOC, V129, P1565, DOI 10.1256/QJ.02.186; Solomon S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052723; Thompson DWJ, 2005, J CLIMATE, V18, P4785, DOI 10.1175/JCLI3585.1; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Wang L, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017130; Wang LK, 2012, J CLIMATE, V25, P2931, DOI 10.1175/JCLI-D-11-00350.1; Young PJ, 2012, J CLIMATE, V25, P1759, DOI 10.1175/2011JCLI4048.1; Zou CZ, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006798	33	84	90	0	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					692	697		10.1038/nature11579	http://dx.doi.org/10.1038/nature11579			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23192146				2022-12-28	WOS:000311606000032
J	Dill, KA; MacCallum, JL				Dill, Ken A.; MacCallum, Justin L.			The Protein-Folding Problem, 50 Years On	SCIENCE			English	Review							3-DIMENSIONAL FOURIER SYNTHESIS; X-RAY ANALYSIS; STRUCTURE PREDICTION; NONBIOLOGICAL POLYMER; COMPUTATIONAL DESIGN; DYNAMICS; PATHWAYS; RESOLUTION; FUNNELS; CASP	The protein-folding problem was first posed about one half-century ago. The term refers to three broad questions: (i) What is the physical code by which an amino acid sequence dictates a protein's native structure? (ii) How can proteins fold so fast? (iii) Can we devise a computer algorithm to predict protein structures from their sequences? We review progress on these problems. In a few cases, computer simulations of the physical forces in chemically detailed models have now achieved the accurate folding of small proteins. We have learned that proteins fold rapidly because random thermal motions cause conformational changes leading energetically downhill toward the native structure, a principle that is captured in funnel-shaped energy landscapes. And thanks in part to the large Protein Data Bank of known structures, predicting protein structures is now far more successful than was thought possible in the early days. What began as three questions of basic science one half-century ago has now grown into the full-fledged research field of protein physical science.	[Dill, Ken A.; MacCallum, Justin L.] SUNY Stony Brook, Laufer Ctr Phys & Quantitat Biol, Stony Brook, NY 11794 USA; [Dill, Ken A.] SUNY Stony Brook, Dept Phys, Stony Brook, NY 11794 USA; [Dill, Ken A.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Dill, KA (corresponding author), SUNY Stony Brook, Laufer Ctr Phys & Quantitat Biol, Stony Brook, NY 11794 USA.	dill@laufercenter.org			NIH [GM34993]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034993] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the NIH for support from NIH GM34993. We thank D. Baker, H. S. Chan, J. Chodera, W. Englander, D. Farrell, C. Fennell, S. Gellman, L. Gierasch, C. R. Matthews, D. Mobley, J. Moult, G. Rocklin, G. Rollins, and R. Zuckermann for helpful comments.	Allen F, 2001, IBM SYST J, V40, P310, DOI 10.1147/sj.402.0310; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arinaminpathy Y, 2009, DRUG DISCOV TODAY, V14, P1130, DOI 10.1016/j.drudis.2009.08.006; Azoitei ML, 2011, SCIENCE, V334, P373, DOI 10.1126/science.1209368; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonneau R, 2001, PROTEINS, P119; Bowman GR, 2011, CURR OPIN STRUC BIOL, V21, P4, DOI 10.1016/j.sbi.2010.10.006; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; DILL KA, 1985, BIOCHEMISTRY-US, V24, P1501, DOI 10.1021/bi00327a032; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dohm MT, 2011, CURR PHARM DESIGN, V17, P2732; Englander SW, 2007, Q REV BIOPHYS, V40, P287, DOI 10.1017/S0033583508004654; Fersht AR, 2008, NAT REV MOL CELL BIO, V9, P650, DOI 10.1038/nrm2446; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fowler SA, 2009, ORG BIOMOL CHEM, V7, P1508, DOI 10.1039/b817980h; Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r; Guthrie JP, 2009, J PHYS CHEM B, V113, P4501, DOI 10.1021/jp806724u; Hockenmaier J, 2007, PROTEINS, V66, P1, DOI 10.1002/prot.21195; Horne WS, 2008, ACCOUNTS CHEM RES, V41, P1399, DOI 10.1021/ar800009n; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Jones DT, 2003, PROTEINS, V53, P480, DOI 10.1002/prot.10542; Jones DT, 2001, PROTEINS, P127; KAMTEKAR S, 1993, SCIENCE, V262, P1680, DOI 10.1126/science.8259512; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; Kirshenbaum K, 1999, CURR OPIN STRUC BIOL, V9, P530, DOI 10.1016/S0959-440X(99)80075-X; Kryshtafovych A, 2011, PROTEINS, V79, P196, DOI 10.1002/prot.23182; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lee BC, 2005, J AM CHEM SOC, V127, P10999, DOI 10.1021/ja0514904; Lee BC, 2008, J AM CHEM SOC, V130, P8847, DOI 10.1021/ja802125x; LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; MacCallum JL, 2011, TRENDS BIOCHEM SCI, V36, P653, DOI 10.1016/j.tibs.2011.08.003; Mariani V, 2011, PROTEINS, V79, P37, DOI 10.1002/prot.23177; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; MATTHEWS CR, 1993, ANNU REV BIOCHEM, V62, P653, DOI 10.1146/annurev.bi.62.070193.003253; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Moult J, 2005, CURR OPIN STRUC BIOL, V15, P285, DOI 10.1016/j.sbi.2005.05.011; Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nam KT, 2010, NAT MATER, V9, P454, DOI [10.1038/nmat2742, 10.1038/NMAT2742]; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raval A, 2012, PROTEINS, V80, P2071, DOI 10.1002/prot.24098; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Service RF, 2008, SCIENCE, V321, P784, DOI 10.1126/science.321.5890.784; Shah NH, 2008, ORG BIOMOL CHEM, V6, P2516, DOI 10.1039/b804802a; Shaw DE, 2008, COMMUN ACM, V51, P91, DOI 10.1145/1364782.1364802; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Shea JE, 2001, ANNU REV PHYS CHEM, V52, P499, DOI 10.1146/annurev.physchem.52.1.499; Shirts M, 2000, SCIENCE, V290, P1903, DOI 10.1126/science.290.5498.1903; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Simons KT, 1999, PROTEINS, P171; Snow CD, 2002, NATURE, V420, P102, DOI 10.1038/nature01160; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Voelz VA, 2007, PROTEINS, V66, P877, DOI 10.1002/prot.21234; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; ZWANZIG R, 1992, P NATL ACAD SCI USA, V89, P20, DOI 10.1073/pnas.89.1.20	72	909	941	45	788	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1042	1046		10.1126/science.1219021	http://dx.doi.org/10.1126/science.1219021			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23180855				2022-12-28	WOS:000311390600034
J	Krivtsov, AV; Armstrong, SA				Krivtsov, Andrei V.; Armstrong, Scott A.			Can One Cell Influence Cancer Heterogeneity?	SCIENCE			English	Editorial Material							STEM-CELLS; TRANSFORMATION; PROGENITORS; GLIOMA; AML		[Krivtsov, Andrei V.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Krivtsov, AV (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA.	armstros@mskcc.org	Krivtsov, Andrei/AAJ-9966-2021	Krivtsov, Andrei/0000-0002-5511-1686				Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Gibbs KD, 2012, CELL STEM CELL, V10, P210, DOI 10.1016/j.stem.2012.01.004; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lei L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020041; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624	13	3	3	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1035	1036		10.1126/science.1231594	http://dx.doi.org/10.1126/science.1231594			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	041HJ	23180850				2022-12-28	WOS:000311390600029
J	Davies, C; Pan, HC; Godwin, J; Gray, R; Arriagada, R; Raina, V; Abraham, M; Alencar, VHM; Badran, A; Bonfill, X; Bradbury, J; Clarke, M; Collins, R; Davis, SR; Delmestri, A; Forbes, JF; Haddad, P; Hou, MF; Inbar, M; Khaled, H; Kielanowska, J; Kwan, WH; Mathew, BS; Mittra, I; Muller, B; Nicolucci, A; Peralta, O; Pernas, F; Petruzelka, L; Pienkowski, T; Radhika, R; Rajan, B; Rubach, MT; Tort, S; Urrutia, G; Valentini, M; Wang, YC; Peto, R				Davies, Christina; Pan, Hongchao; Godwin, Jon; Gray, Richard; Arriagada, Rodrigo; Raina, Vinod; Abraham, Mirta; Medeiros Alencar, Victor Hugo; Badran, Atef; Bonfill, Xavier; Bradbury, Joan; Clarke, Michael; Collins, Rory; Davis, Susan R.; Delmestri, Antonella; Forbes, John F.; Haddad, Peiman; Hou, Ming-Feng; Inbar, Moshe; Khaled, Hussein; Kielanowska, Joanna; Kwan, Wing-Hong; Mathew, Beela S.; Mittra, Indraneel; Mueller, Bettina; Nicolucci, Antonio; Peralta, Octavio; Pernas, Fany; Petruzelka, Lubos; Pienkowski, Tadeusz; Radhika, Ramachandran; Rajan, Balakrishnan; Rubach, Maryna T.; Tort, Sera; Urrutia, Gerard; Valentini, Miriam; Wang, Yaochen; Peto, Richard		Adjuvant Tamoxifen Longer Against	Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial	LANCET			English	Article							THERAPY	Background For women with oestrogen receptor (ER)-positive early breast cancer, treatment with tamoxifen for 5 years substantially reduces the breast cancer mortality rate throughout the first 15 years after diagnosis. We aimed to assess the further effects of continuing tamoxifen to 10 years instead of stopping at 5 years. Methods In the worldwide Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) trial, 12 894 women with early breast cancer who had completed 5 years of treatment with tamoxifen were randomly allocated to continue tamoxifen to 10 years or stop at 5 years (open control). Allocation (1: 1) was by central computer, using minimisation. After entry (between 1996 and 2005), yearly follow-up forms recorded any recurrence, second cancer, hospital admission, or death. We report effects on breast cancer outcomes among the 6846 women with ER-positive disease, and side-effects among all women (with positive, negative, or unknown ER status). Long-term follow-up still continues. This study is registered, number ISRCTN19652633. Findings Among women with ER-positive disease, allocation to continue tamoxifen reduced the risk of breast cancer recurrence (617 recurrences in 3428 women allocated to continue vs 711 in 3418 controls, p=0.002), reduced breast cancer mortality (331 deaths vs 397 deaths, p=0.01), and reduced overall mortality (639 deaths vs 722 deaths, p=0.01). The reductions in adverse breast cancer outcomes appeared to be less extreme before than after year 10 (recurrence rate ratio [RR] 0.90 [95% CI 0.79-1.02] during years 5-9 and 0.75 [0.62-0.90] in later years; breast cancer mortality RR 0.97 [0.79-1.18] during years 5-9 and 0.71 [0.58-0.88] in later years). The cumulative risk of recurrence during years 5-14 was 21.4% for women allocated to continue versus 25.1% for controls; breast cancer mortality during years 5-14 was 12.2% for women allocated to continue versus 15.0% for controls (absolute mortality reduction 2.8%). Treatment allocation seemed to have no effect on breast cancer outcome among 1248 women with ER-negative disease, and an intermediate effect among 4800 women with unknown ER status. Among all 12 894 women, mortality without recurrence from causes other than breast cancer was little affected (691 deaths without recurrence in 6454 women allocated to continue versus 679 deaths in 6440 controls; RR 0.99 [0.89-1.10]; p=0.84). For the incidence (hospitalisation or death) rates of specific diseases, RRs were as follows: pulmonary embolus 1.87 (95% CI 1.13-3.07, p=0.01 [including 0.2% mortality in both treatment groups]), stroke 1.06 (0.83-1.36), ischaemic heart disease 0.76 (0.60-0.95, p=0.02), and endometrial cancer 1.74 (1.30-2.34, p=0.0002). The cumulative risk of endometrial cancer during years 5-14 was 3.1% (mortality 0.4%) for women allocated to continue versus 1.6% (mortality 0.2%) for controls (absolute mortality increase 0.2%). Interpretation For women with ER-positive disease, continuing tamoxifen to 10 years rather than stopping at 5 years produces a further reduction in recurrence and mortality, particularly after year 10. These results, taken together with results from previous trials of 5 years of tamoxifen treatment versus none, suggest that 10 years of tamoxifen treatment can approximately halve breast cancer mortality during the second decade after diagnosis.	[Davies, Christina; Pan, Hongchao; Gray, Richard; Collins, Rory; Delmestri, Antonella; Wang, Yaochen; Peto, Richard] Univ Oxford, Clin Trial Serv Unit, Oxford OX1 2JD, England; [Davies, Christina; Pan, Hongchao; Gray, Richard; Collins, Rory; Delmestri, Antonella; Wang, Yaochen; Peto, Richard] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford OX1 2JD, England; [Godwin, Jon] Glasgow Caledonian Univ, Glasgow G4 0BA, Lanark, Scotland; [Arriagada, Rodrigo] Inst Gustave Roussy, Villejuif, France; [Raina, Vinod] All India Inst Med Sci, Inst Rotary Canc Hosp, New Delhi, India; [Abraham, Mirta] ICR, Rosario, Santa Fe, Argentina; [Medeiros Alencar, Victor Hugo] ICC, Fortaleza, Ceara, Brazil; [Badran, Atef; Khaled, Hussein] Cairo Univ, Natl Canc Inst, Cairo, Egypt; [Bonfill, Xavier; Tort, Sera; Urrutia, Gerard] St Pau Biomed Res Inst IIB St Pau CIBERESP, Barcelona, Spain; [Bradbury, Joan; Davis, Susan R.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Clarke, Michael] Queens Univ Belfast, Belfast, Antrim, North Ireland; [Forbes, John F.] Univ Newcastle, Australia & New Zealand Breast Canc Trials Grp, Newcastle, NSW 2300, Australia; [Haddad, Peiman] Univ Tehran Med Sci, Inst Canc, Tehran, Iran; [Hou, Ming-Feng] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Inbar, Moshe] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel; [Kielanowska, Joanna; Rubach, Maryna T.] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland; [Kielanowska, Joanna; Rubach, Maryna T.] Inst Oncol, Warsaw, Poland; [Kwan, Wing-Hong] Comprehens Oncol Ctr, Hong Kong, Hong Kong, Peoples R China; [Mathew, Beela S.] Reg Canc Ctr, Trivandrum 695011, Kerala, India; [Mittra, Indraneel] Tata Mem Hosp, Mumbai 400012, Maharashtra, India; [Mueller, Bettina; Peralta, Octavio] Chilean Cooperat Grp Oncol Res GOCCHI, Santiago, Chile; [Nicolucci, Antonio; Valentini, Miriam] Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy; [Pernas, Fany] Inst Invest Clin Rosario, Rosario, Santa Fe, Argentina; [Petruzelka, Lubos] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Pienkowski, Tadeusz] European Hlth Ctr Otwock ECZO, Warsaw, Poland; [Radhika, Ramachandran] Canc Inst WIA, Chennai, Tamil Nadu, India; [Rajan, Balakrishnan] Royal Hosp, Natl Oncol Ctr, Muscat, Oman	University of Oxford; University of Oxford; Glasgow Caledonian University; UNICANCER; Gustave Roussy; All India Institute of Medical Sciences (AIIMS) New Delhi; DR. B.R.A. Institute Rotary Cancer Hospital; Egyptian Knowledge Bank (EKB); Cairo University; National Cancer Institute - Egypt; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Monash University; Queens University Belfast; University of Newcastle; Tehran University of Medical Sciences; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Tata Memorial Centre (TMC); Tata Memorial Hospital; Consorzio Mario Negri Sud; Charles University Prague; The Royal Hospital, Sultanate of Oman	Davies, C (corresponding author), Clin Trial Serv Unit, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.	atlas@ctsu.ox.ac.uk	Barkmanova, Jaroslava/A-1411-2017; Petruzelka, Lubos/A-2750-2017; Colomer, Ramon/C-5142-2008; Zimovjanova, Martina/M-1944-2017; Haddad, Peiman/C-1346-2009; Izquierdo, Mikel/O-8049-2019; Valladares-Ayerbes, Manuel/K-8986-2014; Sedlackova, Eva/B-9959-2017; Tesarova, Petra/A-8718-2017; Zemanova, Milada/M-1921-2017; Collins, Rory/ABA-8487-2020; Izquierdo, Mikel/A-4894-2010; Calvo, Lourdes/M-2352-2014; Kok, Victor C/C-1437-2013; Smakal, Martin/E-4294-2018; Segelov, Eva/Q-7611-2019; Rutgers, Emiel J T/C-5934-2015; IBIS, BIOMARCADORES/P-3515-2015; Davis, Susan D/GZL-2361-2022; Davis, Susan R/A-3111-2009	Barkmanova, Jaroslava/0000-0003-1406-7292; Petruzelka, Lubos/0000-0002-4397-0635; Colomer, Ramon/0000-0002-6393-3444; Zimovjanova, Martina/0000-0001-5261-3501; Haddad, Peiman/0000-0003-0500-5532; Valladares-Ayerbes, Manuel/0000-0002-7950-9584; Sedlackova, Eva/0000-0002-0089-1611; Tesarova, Petra/0000-0003-3607-3474; Zemanova, Milada/0000-0002-1904-1035; Izquierdo, Mikel/0000-0002-1506-4272; Kok, Victor C/0000-0003-3440-8154; Smakal, Martin/0000-0002-5618-5986; Segelov, Eva/0000-0002-4410-6144; Davis, Susan R/0000-0002-2955-0415; Arriagada, Rodrigo/0000-0002-3134-1735; Valentini, Miriam/0000-0002-1421-6975; Ciruelos, Eva/0000-0002-2796-1042; Spry, Nigel/0000-0001-8659-5065; Urrutia, Gerard/0000-0002-8850-0960; Mittra, Indraneel/0000-0002-5768-3821; Gray, Richard/0000-0003-4440-574X; Pienkowski, Tadeusz/0000-0002-0110-5950; Hou, Ming-Feng/0000-0001-6030-9702; Gallardo, Enrique/0000-0002-1375-3488; Evron, Ella/0000-0002-1003-5042; Warzocha, Krzysztof/0000-0002-2396-3905; Caleffi, Maira/0000-0002-9494-9457; Delmestri, Antonella/0000-0003-0388-3403; SEGUI PALMER, MIQUEL ANGEL/0000-0002-5103-6746; Bonfill Cosp, Xavier/0000-0003-1530-3509	Cancer Research UK; UK Medical Research Council; AstraZeneca UK; US Army; EU; MRC [G0901530, MC_U137686850] Funding Source: UKRI; Medical Research Council [G0901530, MC_U137686850] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AstraZeneca UK(AstraZeneca); US Army(United States Department of DefenseUnited States Army); EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding Cancer Research UK, UK Medical Research Council, AstraZeneca UK, US Army, EU-Biomed.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Bulbulia R, 2011, LANCET, V378, P2013, DOI 10.1016/S0140-6736(11)61125-2; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Davies C, 1998, LANCET, V351, P1487, DOI 10.1016/S0140-6736(05)78869-3; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Earl H, 1997, Clin Oncol (R Coll Radiol), V9, P141, DOI 10.1016/S0936-6555(97)80067-2; Early Breast Cancer Trialists' Collaborative Group, 1990, TREATM EARL BREAST C; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Fisher B, 1996, JNCI-J NATL CANCER I, V88, P1529, DOI 10.1093/jnci/88.21.1529; Goss PE, 2006, SEMIN ONCOL, V33, pS8, DOI 10.1053/j.seminoncol.2006.03.025; Gray R, 2000, ANN ONCOL, V11, P505, DOI 10.1023/A:1008323116265; Gray RG, 2008, P AM J CLIN ONCO S10, V26; GUETTA V, 1995, AM J CARDIOL, V76, P1072, DOI 10.1016/S0002-9149(99)80302-6; Li CI, 2002, CANCER EPIDEM BIOMAR, V11, P601; LOVE RR, 1991, ANN INTERN MED, V115, P860, DOI 10.7326/0003-4819-115-11-860; MCDONALD CC, 1991, BRIT MED J, V303, P435, DOI 10.1136/bmj.303.6800.435; Peto R, 1996, J NATL CANCER I, V88, P1791, DOI 10.1093/jnci/88.24.1791; Stewart HJ, 1996, BRIT J CANCER, V74, P297, DOI 10.1038/bjc.1996.356; Swain SM, 1996, J NATL CANCER I, V88, P1510; Tormey DC, 1996, JNCI-J NATL CANCER I, V88, P1828, DOI 10.1093/jnci/88.24.1828; US Food and Drug Administration, NOV TAM CITR; US National Institutes of Health, NIH CONS STAT ADJ TH; World Health Organization, 1992, INT STAT CLASS DIS H	23	1225	1287	8	230	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2013	381	9869					805	816		10.1016/S0140-6736(12)61963-1	http://dx.doi.org/10.1016/S0140-6736(12)61963-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105IL	23219286	Green Submitted, Green Published			2022-12-28	WOS:000316060600030
J	Clement, R				Clement, Rhys			CHRISTMAS 2012: LIVES OF DOCTORS Is it time for an evidence based uniform for doctors?	BRITISH MEDICAL JOURNAL			English	Editorial Material							WHITE COATS; FLORA; BARE; INFECTIONS; FACEMASKS; PHYSICIAN; ATTIRE; ELBOWS		Royal Infirm Edinburgh NHS Trust, Edinburgh EH16 4SA, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Clement, R (corresponding author), Royal Infirm Edinburgh NHS Trust, Edinburgh EH16 4SA, Midlothian, Scotland.	rhysclement@googlemail.com						[Anonymous], 2008, Naked Science Forum, Patent No. 5416929; Ardolino A, 2009, J HOSP INFECT, V71, P291, DOI 10.1016/j.jhin.2008.11.008; BARRETT TG, 1994, BRIT MED J, V309, P1710, DOI 10.1136/bmj.309.6970.1710; Baxter J, 2010, ANN R COLL SURG ENGL, V92, P248; Bianchi MT, 2008, J GEN INTERN MED, V23, P641, DOI 10.1007/s11606-008-0546-8; BLUMHAGEN DW, 1979, ANN INTERN MED, V91, P111, DOI 10.7326/0003-4819-91-1-111; Bond L, 2010, J LARYNGOL OTOL, V124, P963, DOI 10.1017/S0022215110001167; Brandt LJ, 2003, ARCH INTERN MED, V163, P1277, DOI 10.1001/archinte.163.11.1277; Braunstein, 1995, US patent, Patent No. [5 416 929, 7560399]; Brewer TL, 2004, AMBUL PEDIATR, V4, P257, DOI 10.1367/A03-097R1.1; Christoforidis JB, 2011, CURR DRUG TARGETS, V12, P221; Church J, 1986, Nursing (Lond), V3, P140; Davis L, 2008, BRIT DENT J, V204, P112, DOI 10.1038/bdj.2008.63; Department of Health Policy, 2010, UN WORKW GUID UN WOR; Department of Health Policy, 2007, UN WORKW EV BAS DEV; HILL J, 1974, LANCET, V2, P1131; Horwitz MD, 2010, BRIT J HOSP MED, V71, P124, DOI 10.12968/hmed.2010.71.3.46971; Jeans AR, 2010, J HOSP INFECT, V74, P16, DOI 10.1016/j.jhin.2009.06.032; K Ota, 2007, CAN J INFECT CONTROL, V22, P65; Lai ACK, 2012, J R SOC INTERFACE, V9, P938, DOI 10.1098/rsif.2011.0537; Li Y, 2008, J MULTIDISCIP HEALTH, V1, P17; Loh W, 2000, J HOSP INFECT, V45, P65, DOI 10.1053/jhin.1999.0702; Loveday H, 2007, J INFECT PREV, V8, P10; Magos A, 2007, BRIT MED J, V335, P684, DOI 10.1136/bmj.39353.427014.BE; Makary MA, 2007, NEW ENGL J MED, V356, P2693, DOI 10.1056/NEJMoa070378; McGovern B, 2010, J HOSP INFECT, V75, P138, DOI 10.1016/j.jhin.2009.12.008; MONTES LF, 1970, ARCH DERMATOL, V101, P145, DOI 10.1001/archderm.101.2.145; Rehman SU, 2005, AM J MED, V118, P1279, DOI 10.1016/j.amjmed.2005.04.026; Rock, 2009, CAN EV CLOTH STOP GE, Patent No. 7 560 399; Schoeffler L E, 1996, J Okla State Med Assoc, V89, P379; Scott Jude, 2010, Nurs Times, V106, P13; Shaposhnikov OK, 1981, VOEN MED ZH, V4, P58; Song J, 2012, ACS APPL MATER INTER, V4, P460, DOI 10.1021/am201563t; Usher B, 1928, ARCH DERMATOL SYPH, V18, P276, DOI 10.1001/archderm.1928.02380140100009; VALDEZ P, 1994, J EXP PSYCHOL GEN, V123, P394, DOI 10.1037/0096-3445.123.4.394; WIlson JA, 2007, J HOSP INFECT, V66, P301, DOI 10.1016/j.jhin.2007.03.026; WONG D, 1991, BRIT MED J, V303, P1602, DOI 10.1136/bmj.303.6817.1602; Yang L, 2011, ISRN NURS; Yoo HS, 2000, TEXT RES J, V70, P542, DOI 10.1177/004051750007000612	39	5	5	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 18	2012	345								e8286	10.1136/bmj.e8286	http://dx.doi.org/10.1136/bmj.e8286			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IW	23249667				2022-12-28	WOS:000312698900013
J	Besnard, J; Ruda, GF; Setola, V; Abecassis, K; Rodriguiz, RM; Huang, XP; Norval, S; Sassano, MF; Shin, AI; Webster, LA; Simeons, FRC; Stojanovski, L; Prat, A; Seidah, NG; Constam, DB; Bickerton, GR; Read, KD; Wetsel, WC; Gilbert, IH; Roth, BL; Hopkins, AL				Besnard, Jeremy; Ruda, Gian Filippo; Setola, Vincent; Abecassis, Keren; Rodriguiz, Ramona M.; Huang, Xi-Ping; Norval, Suzanne; Sassano, Maria F.; Shin, Antony I.; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Prat, Annik; Seidah, Nabil G.; Constam, Daniel B.; Bickerton, G. Richard; Read, Kevin D.; Wetsel, William C.; Gilbert, Ian H.; Roth, Bryan L.; Hopkins, Andrew L.			Automated design of ligands to polypharmacological profiles	NATURE			English	Article							DE-NOVO DESIGN; DRUG-DISCOVERY; SMALL-MOLECULE; IDENTIFICATION; OPTIMIZATION; PHARMACOLOGY; ANTAGONISTS; INHIBITORS; PREDICTION; PROGRAM	The clinical efficacy and safety of a drug is determined by its activity profile across many proteins in the proteome. However, designing drugs with a specific multi-target profile is both complex and difficult. Therefore methods to design drugs rationally a priori against profiles of several proteins would have immense value in drug discovery. Here we describe a new approach for the automated design of ligands against profiles of multiple drug targets. The method is demonstrated by the evolution of an approved acetylcholinesterase inhibitor drug into brain-penetrable ligands with either specific polypharmacology or exquisite selectivity profiles for G-protein-coupled receptors. Overall, 800 ligand-target predictions of prospectively designed ligands were tested experimentally, of which 75% were confirmed to be correct. We also demonstrate target engagement in vivo. The approach can be a useful source of drug leads when multi-target profiles are required to achieve either selectivity over other drug targets or a desired polypharmacology.	[Besnard, Jeremy; Ruda, Gian Filippo; Abecassis, Keren; Norval, Suzanne; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Bickerton, G. Richard; Read, Kevin D.; Gilbert, Ian H.; Hopkins, Andrew L.] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland; [Setola, Vincent; Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina Chapel Hill, Sch Med, Dept Pharmacol, NIMH Psychoact Drug Screening Program, Chapel Hill, NC 27759 USA; [Rodriguiz, Ramona M.; Shin, Antony I.; Wetsel, William C.] Duke Univ, Sch Med, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC 27710 USA; [Sassano, Maria F.; Roth, Bryan L.] Univ N Carolina Chapel Hill, Sch Med, Div Chem Biol & Med Chem, Chapel Hill, NC 27759 USA; [Prat, Annik; Seidah, Nabil G.] Univ Montreal, Clin Res Inst Montreal IRCM, Lab Biochem Neuroendocrinol, Montreal, PQ H2W 1R7, Canada; [Constam, Daniel B.] Ecole Polytech Fed Lausanne EPFL SV ISREC, CH-1015 Lausanne, Switzerland; [Wetsel, William C.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA	University of Dundee; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Duke University; Duke University; Duke University	Hopkins, AL (corresponding author), Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland.	bryan_roth@med.unc.edu; a.hopkins@dundee.ac.uk	Prat, Annik/S-6757-2018; Roth, Bryan L/F-3928-2010; Seidah, Nabil/I-3596-2013; sassano, maria/G-4941-2013; Roth, Bryan/ABE-7032-2020; Hopkins, Andrew/H-5138-2011	Prat, Annik/0000-0002-8007-5277; Seidah, Nabil/0000-0001-6503-9342; Roth, Bryan/0000-0002-0561-6520; Hopkins, Andrew/0000-0003-1977-018X; Gilbert, Ian/0000-0002-5238-1314; Ruda, Gian Filippo/0000-0001-6150-2715; /0000-0001-6426-0598; Setola, Vincent/0000-0002-9791-2270; Constam, Daniel B./0000-0002-6256-3891; Besnard, Jeremy/0000-0001-5452-8183	SULSA [HR07019]; BBSRC Doctoral Training Programme; BBSRC Pathfinder [BB/FOF/PF/15/09]; BBSRC [BB/J010510/1]; University of Dundee's Pump Priming Fund for Translational Medical Research; National Institutes of Health (NIH) [MH082441]; Wellcome Trust [WT 083481]; North Carolina Biotechnology Center; Michael Hooker Chair of Pharmacology; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061887, U19MH082441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017204] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/J010510/1] Funding Source: researchfish	SULSA; BBSRC Doctoral Training Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Pathfinder(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Dundee's Pump Priming Fund for Translational Medical Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); North Carolina Biotechnology Center; Michael Hooker Chair of Pharmacology; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is supported by SULSA (HR07019), the BBSRC Doctoral Training Programme, the BBSRC Pathfinder (BB/FOF/PF/15/09) and the BBSRC Follow On Fund schemes (BB/J010510/1) (A.L.H.), the University of Dundee's Pump Priming Fund for Translational Medical Research (I.H.G. and A.L.H.) and by grants from the National Institutes of Health (NIH) supporting drug discovery receptor pharmacology (B.L.R.) and the NIH grant MH082441 (W.C.W.). The chemical synthesis and informatics benefits from the infrastructure investments from the Wellcome Trust Strategic Award (WT 083481). We thank J. Overington for StARlite and ChEMBL. We wish to thank D. Murugesan for compound purification and C. Means and T. Rhodes for helping with the open field, hole-board and zero-maze tests. We also wish to thank C. Elms and J. Zhou for their support in the husbandry and generation of the mice used for behavioural testing. We also wish to thank F. Y. Li for customizing the software configuration for the hole-board tests. Some of the equipment used in the behavioural testing was purchased with a grant from the North Carolina Biotechnology Center. B.L.R. also received support from the Michael Hooker Chair of Pharmacology.	Alig L, 2008, J MED CHEM, V51, P2115, DOI 10.1021/jm701487t; Arnsten AFT, 2000, NEUROPSYCHOPHARMACOL, V23, P405, DOI 10.1016/S0893-133X(00)00133-0; Bender A, 2007, COMB CHEM HIGH T SCR, V10, P719, DOI 10.2174/138620707782507313; Brotz-Oesterhelt H, 2008, CURR OPIN PHARMACOL, V8, P564, DOI 10.1016/j.coph.2008.06.008; Brown N, 2004, J COMPUT AID MOL DES, V18, P761, DOI 10.1007/s10822-004-6986-2; Brown N, 2004, J CHEM INF COMP SCI, V44, P1079, DOI 10.1021/ci034290p; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Cannon EO, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-3; Deb K., 2006, INT J COMPUT INTELL, V2, P273, DOI DOI 10.5019/J.IJCIR.2006.67; Dey F, 2008, J CHEM INF MODEL, V48, P679, DOI 10.1021/ci700424b; Ertl P, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-8; Fanelli F., 2008, ANTITARGETS, P155; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; GILLET V, 1993, J COMPUT AID MOL DES, V7, P127, DOI 10.1007/BF00126441; Gillet VJ, 2002, J MOL GRAPH MODEL, V20, P491, DOI 10.1016/S1093-3263(01)00150-4; Glick M, 2006, J CHEM INF MODEL, V46, P193, DOI 10.1021/ci050374h; Heikkila T, 2006, BIOORG MED CHEM LETT, V16, P88, DOI 10.1016/j.bmcl.2005.09.045; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Huang XP, 2010, ASSAY DRUG DEV TECHN, V8, P727, DOI 10.1089/adt.2010.0331; Hughes JD, 2008, BIOORG MED CHEM LETT, V18, P4872, DOI 10.1016/j.bmcl.2008.07.071; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Knowles J. D., 2007, P 9 ANN C GEN EV COM, P773; Kryssanov VV, 2001, ARTIF INTELL ENG, V15, P329, DOI 10.1016/S0954-1810(01)00023-1; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu Q, 2007, J MED CHEM, V50, P5392, DOI 10.1021/jm070750k; Lober S, 2011, TRENDS PHARMACOL SCI, V32, P148, DOI 10.1016/j.tips.2010.12.003; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Martin RE, 2007, J MED CHEM, V50, P6291, DOI 10.1021/jm701143p; Morphy R, 2005, J MED CHEM, V48, P6523, DOI 10.1021/jm058225d; Nicolaou CA, 2007, CURR OPIN DRUG DISC, V10, P316; Nicolaou CA, 2009, J CHEM INF MODEL, V49, P295, DOI 10.1021/ci800308h; Obrezanova O, 2008, J COMPUT AID MOL DES, V22, P431, DOI 10.1007/s10822-008-9193-8; Obrezanova O, 2007, J CHEM INF MODEL, V47, P1847, DOI 10.1021/ci7000633; Ortega R, 2009, BIOORG MED CHEM LETT, V19, P1773, DOI 10.1016/j.bmcl.2009.01.067; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Pogorelov VM, 2005, NEUROPSYCHOPHARMACOL, V30, P1818, DOI 10.1038/sj.npp.1300724; Porton B, 2010, GENES BRAIN BEHAV, V9, P257, DOI 10.1111/j.1601-183X.2009.00555.x; Ribeiz SRI, 2010, CNS DRUGS, V24, P303, DOI 10.2165/11530260-000000000-00000; Roche O, 2007, BIOORG MED CHEM LETT, V17, P3670, DOI 10.1016/j.bmcl.2007.04.056; Rogers D, 2005, J BIOMOL SCREEN, V10, P682, DOI 10.1177/1087057105281365; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Roth BL, 2007, NEW ENGL J MED, V356, P6, DOI 10.1056/NEJMp068265; Ruda GF, 2010, J MED CHEM, V53, P6071, DOI 10.1021/jm1004754; Schneider, 2002, ADAPTIVE SYSTEMS DRU; Schneider G, 2000, J COMPUT AID MOL DES, V14, P487, DOI 10.1023/A:1008184403558; Schneider G, 2011, FUTURE MED CHEM, V3, P415, DOI [10.4155/FMC.11.8, 10.4155/fmc.11.8]; Schneider G, 2009, TRENDS BIOTECHNOL, V27, P18, DOI 10.1016/j.tibtech.2008.09.005; Stahl M, 2002, J COMPUT AID MOL DES, V16, P459, DOI 10.1023/A:1021242018286; Stewart KD, 2006, BIOORGAN MED CHEM, V14, P7011, DOI 10.1016/j.bmc.2006.06.024; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Vidal D, 2010, MOL INFORM, V29, P543, DOI 10.1002/minf.201000055; Vinkers HM, 2003, J MED CHEM, V46, P2765, DOI 10.1021/jm030809x; Wermuth CG, 2006, DRUG DISCOV TODAY, V11, P160, DOI 10.1016/S1359-6446(05)03686-X; Zhao W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-225	58	521	530	6	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					215	+		10.1038/nature11691	http://dx.doi.org/10.1038/nature11691			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23235874	Green Accepted, Green Submitted			2022-12-28	WOS:000312259300034
J	de Lima, M; McNiece, I; Robinson, SN; Munsell, M; Eapen, M; Horowitz, M; Alousi, A; Saliba, R; McMannis, JD; Kaur, I; Kebriaei, P; Parmar, S; Popat, U; Hosing, C; Champlin, R; Bollard, C; Molldrem, JJ; Jones, RB; Nieto, Y; Andersson, BS; Shah, N; Oran, B; Cooper, LJN; Worth, L; Qazilbash, MH; Korbling, M; Rondon, G; Ciurea, S; Bosque, D; Maewal, I; Simmons, PJ; Shpall, EJ				de Lima, Marcos; McNiece, Ian; Robinson, Simon N.; Munsell, Mark; Eapen, Mary; Horowitz, Mary; Alousi, Amin; Saliba, Rima; McMannis, John D.; Kaur, Indreshpal; Kebriaei, Partow; Parmar, Simrit; Popat, Uday; Hosing, Chitra; Champlin, Richard; Bollard, Catherine; Molldrem, Jeffrey J.; Jones, Roy B.; Nieto, Yago; Andersson, Borje S.; Shah, Nina; Oran, Betul; Cooper, Laurence J. N.; Worth, Laura; Qazilbash, Muzaffar H.; Korbling, Martin; Rondon, Gabriela; Ciurea, Stefan; Bosque, Doyle; Maewal, Ila; Simmons, Paul J.; Shpall, Elizabeth J.			Cord-Blood Engraftment with Ex Vivo Mesenchymal-Cell Coculture	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE-LEUKEMIA; BONE-MARROW; UNRELATED DONORS; HEMATOLOGIC MALIGNANCY; PHASE-I/II; STEM-CELLS; TRANSPLANTATION; EXPANSION; ADULTS; PRECURSORS	BACKGROUND Poor engraftment due to low cell doses restricts the usefulness of umbilical-cord-blood transplantation. We hypothesized that engraftment would be improved by transplanting cord blood that was expanded ex vivo with mesenchymal stromal cells. METHODS We studied engraftment results in 31 adults with hematologic cancers who received transplants of 2 cord-blood units, 1 of which contained cord blood that was expanded ex vivo in cocultures with allogeneic mesenchymal stromal cells. The results in these patients were compared with those in 80 historical controls who received 2 units of unmanipulated cord blood. RESULTS Coculture with mesenchymal stromal cells led to an expansion of total nucleated cells by a median factor of 12.2 and of CD34+ cells by a median factor of 30.1. With transplantation of 1 unit each of expanded and unmanipulated cord blood, patients received a median of 8.34x10(7) total nucleated cells per kilogram of body weight and 1.81x10(6) CD34+ cells per kilogram - doses higher than in our previous transplantations of 2 units of unmanipulated cord blood. In patients in whom engraftment occurred, the median time to neutrophil engraftment was 15 days in the recipients of expanded cord blood, as compared with 24 days in controls who received unmanipulated cord blood only (P < 0.001); the median time to platelet engraftment was 42 days and 49 days, respectively (P = 0.03). On day 26, the cumulative incidence of neutrophil engraftment was 88% with expansion versus 53% without expansion (P < 0.001); on day 60, the cumulative incidence of platelet engraftment was 71% and 31%, respectively (P < 0.001). CONCLUSIONS Transplantation of cord-blood cells expanded with mesenchymal stromal cells appeared to be safe and effective. Expanded cord blood in combination with unmanipulated cord blood significantly improved engraftment, as compared with unmanipulated cord blood only. (Funded by the National Cancer Institute and others; ClinicalTrials.gov number, NCT00498316.)	[de Lima, Marcos; McNiece, Ian; Robinson, Simon N.; Alousi, Amin; Saliba, Rima; Kaur, Indreshpal; Kebriaei, Partow; Parmar, Simrit; Popat, Uday; Hosing, Chitra; Champlin, Richard; Molldrem, Jeffrey J.; Jones, Roy B.; Nieto, Yago; Andersson, Borje S.; Shah, Nina; Oran, Betul; Qazilbash, Muzaffar H.; Korbling, Martin; Rondon, Gabriela; Ciurea, Stefan; Bosque, Doyle; Maewal, Ila; Shpall, Elizabeth J.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Munsell, Mark] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Cooper, Laurence J. N.; Worth, Laura] Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA; [Bollard, Catherine] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Eapen, Mary; Horowitz, Mary] Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA; [McMannis, John D.; Simmons, Paul J.] Mesoblast, New York, NY USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Center for International Blood & Marrow Transplant Research; Medical College of Wisconsin	de Lima, M (corresponding author), Case Western Reserve Univ, Div Hematol & Oncol, Univ Hosp Case Med Ctr BMT700, 11100 Euclid Ave,LKS5079, Cleveland, OH 44106 USA.	marcos.delima@uhhospitals.org	horowitz, Mary/ABH-2173-2021	Eapen, Mary/0000-0001-6193-4243; Hosing, Chitra/0000-0003-0409-5556; Bollard, Catherine M./0000-0001-5140-9090	Mesoblast; National Cancer Institute [RO1 CA061508-18, P01 CA148600-02]; Cancer Prevention Research Institute of Texas [RO1 RP100469]; Cancer Center Core Grant [CA016672]; NATIONAL CANCER INSTITUTE [U24CA076518, R01CA061508, P30CA016672, P50CA100632, P01CA148600] Funding Source: NIH RePORTER	Mesoblast; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention Research Institute of Texas; Cancer Center Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported in part by Mesoblast, grants from the National Cancer Institute (RO1 CA061508-18, to Drs. Shpall, Simmons, and Robinson; and P01 CA148600-02, to Drs. Shpall, Simmons, Robinson, Molldrem, Cooper, and Bollard and Mr. Munsell) and the Cancer Prevention Research Institute of Texas (RO1 RP100469, to Drs. Shpall, Simmons, and Robinson and Mr. Munsell), and a Cancer Center Core Grant (CA016672, to the M.D. Anderson Cancer Center investigators).	Barker JN, 2005, BLOOD, V105, P1343, DOI 10.1182/blood-2004-07-2717; Barker JN, 2001, NEW ENGL J MED, V344, P1870, DOI 10.1056/NEJM200106143442417; Barker Juliet N, 2007, Hematology Am Soc Hematol Educ Program, P55; Bashir Qaiser, 2010, Clin Adv Hematol Oncol, V8, P786; Bradstock K, 2009, INTERN MED J, V39, P744, DOI 10.1111/j.1445-5994.2008.01825.x; Briddell RA, 1997, J HEMATOTHER, V6, P145, DOI 10.1089/scd.1.1997.6.145; Brunstein CG, 2010, BLOOD, V116, P4693, DOI 10.1182/blood-2010-05-285304; de Lima M, 2008, BONE MARROW TRANSPL, V41, P771, DOI 10.1038/sj.bmt.1705979; de Lima M, 2002, BRIT J HAEMATOL, V119, P773, DOI 10.1046/j.1365-2141.2002.03893.x; de Lima M, 2007, 49 ANN M AM SOC HEM; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Eapen M, 2010, LANCET ONCOL, V11, P653, DOI 10.1016/S1470-2045(10)70127-3; Fernandez MN, 2003, EXP HEMATOL, V31, P535, DOI 10.1016/S0301-472X(03)00067-5; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Frassoni F, 2008, LANCET ONCOL, V9, P831, DOI 10.1016/S1470-2045(08)70180-3; Gluckman E, 2005, CYTOTHERAPY, V7, P219, DOI 10.1080/14653240510027136; Gluckman E, 2001, NEW ENGL J MED, V344, P1860, DOI 10.1056/NEJM200106143442410; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; Korbling M, 2011, BLOOD, V117, P6411, DOI 10.1182/blood-2010-12-322214; Kraus M, 2007, P INT SOC CELL THER; Laughlin MJ, 2001, NEW ENGL J MED, V344, P1815, DOI 10.1056/NEJM200106143442402; Madlambayan GJ, 2006, EXP HEMATOL, V34, P122, DOI 10.1016/j.exphem.2005.11.005; Majhail NS, 2009, BIOL BLOOD MARROW TR, V15, P564, DOI 10.1016/j.bbmt.2009.01.011; McNiece I, 2004, CYTOTHERAPY, V6, P311, DOI 10.1080/14653240410004871; Miller Cindy L, 2005, Methods Mol Biol, V290, P71; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Robinson SN, 2012, EXP HEMATOL, V40, P445, DOI 10.1016/j.exphem.2012.01.015; Robinson SN, 2006, BONE MARROW TRANSPL, V37, P359, DOI 10.1038/sj.bmt.1705258; Robinson SN, 2007, 49 ANN M AM SOC HEM; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Rocha V, 2007, LANCET, V369, P1906, DOI 10.1016/S0140-6736(07)60892-7; Shpall EJ, 2002, BIOL BLOOD MARROW TR, V8, P368, DOI 10.1053/bbmt.2002.v8.pm12171483; SIMMONS PJ, 1991, BLOOD, V78, P55; SIMMONS PJ, 1991, BLOOD, V78, P2848; Sutherland D R, 1996, J Hematother, V5, P213, DOI 10.1089/scd.1.1996.5.213	36	333	339	2	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24					2305	2315		10.1056/NEJMoa1207285	http://dx.doi.org/10.1056/NEJMoa1207285			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HF	23234514	Green Accepted			2022-12-28	WOS:000312187700004
J	Chinthapalli, K				Chinthapalli, Krishna			Personal health budgets: surplus of cash or deficit of ideas?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Chinthapalli, K (corresponding author), BMJ, London WC1H 9JR, England.	kchinthapalli@bmj.com	Chinthapalli, Krishna/P-8428-2019	Chinthapalli, Krishna/0000-0003-4136-4882				Darzi A., 2009, HIGH QUALITY CARE AL; Davidson J., 2012, PERSONAL HLTH BUDGET, P77; Forder J., 2012, EVALUATION PERSONAL; Health Foundation, 2010, EV SCAN PERS HLTH BU; Jones K., 2011, COST IMPLEMENTING PE; van Ginneken E, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1383	6	2	2	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2012	345								e8329	10.1136/bmj.e8329	http://dx.doi.org/10.1136/bmj.e8329			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056MC	23228864				2022-12-28	WOS:000312493100003
J	Golub, RM				Golub, Robert M.			The Empiricists Strike Back Medical Education 2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OUTCOMES					robert.golub@jamanetwork.org						Arora VM, 2012, JAMA-J AM MED ASSOC, V308, P2195, DOI 10.1001/jama.2012.14584; Baernstein A, 2007, JAMA-J AM MED ASSOC, V298, P1038, DOI 10.1001/jama.298.9.1038; Carney PA, 2004, JAMA-J AM MED ASSOC, V292, P1044, DOI 10.1001/jama.292.9.1044; Dauphinee WD, 2004, ACAD MED, V79, P925, DOI 10.1097/00001888-200410000-00005; Eva KW, 2012, JAMA-J AM MED ASSOC, V308, P2233, DOI 10.1001/jama.2012.36914; Haan CK, 2008, ACAD MED, V83, P574, DOI 10.1097/ACM.0b013e318172318d; Kalet AL, 2010, ACAD MED, V85, P844, DOI 10.1097/ACM.0b013e3181d734a5; Kim A, 2012, JAMA-J AM MED ASSOC, V308, P2187, DOI 10.1001/jama.2012.25315; Kirch DG, 2012, JAMA-J AM MED ASSOC, V308, P2250, DOI 10.1001/jama.2012.74126; Kulier R, 2012, JAMA-J AM MED ASSOC, V308, P2218, DOI 10.1001/jama.2012.33640; Lim JK, 2004, JAMA-J AM MED ASSOC, V292, P2913, DOI 10.1001/jama.292.23.2913; Lucas BP, 2012, JAMA-J AM MED ASSOC, V308, P2199, DOI 10.1001/jama.2012.36522; Prasad K, 2012, JAMA-J AM MED ASSOC, V308, P2248, DOI 10.1001/jama.2012.74124; Rajput V, 2012, JAMA-J AM MED ASSOC, V308, P2197, DOI 10.1001/jama.2012.45065; Reed DA, 2005, JAMA-J AM MED ASSOC, V294, P1052, DOI 10.1001/jama.294.9.1052; Reed DA, 2007, JAMA-J AM MED ASSOC, V298, P1002, DOI 10.1001/jama.298.9.1002; Rothberg MB, 2012, JAMA-J AM MED ASSOC, V308, P2191, DOI 10.1001/jama.2012.14587; Schwartz MD, 2012, JAMA-J AM MED ASSOC, V308, P2252, DOI 10.1001/jama.2012.77034; Traverso G, 2012, JAMA-J AM MED ASSOC, V308, P2193, DOI 10.1001/jama.2012.14681; Volpp KG, 2012, JAMA-J AM MED ASSOC, V308, P2208, DOI 10.1001/jama.2012.34490; Wachter RM, 2012, JAMA-J AM MED ASSOC, V308, P977, DOI 10.1001/2012.jama.10476; West CP, 2012, JAMA-J AM MED ASSOC, V308, P2241, DOI 10.1001/jama.2012.47535; Yeates P, 2012, JAMA-J AM MED ASSOC, V308, P2226, DOI 10.1001/jama.2012.36515	23	6	6	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2012	308	21					2254	2256		10.1001/jama.2012.74128	http://dx.doi.org/10.1001/jama.2012.74128			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047HI	23212506				2022-12-28	WOS:000311829500020
J	Das, P				Das, Pamela			Eric Goosby: US Global AIDS Coordinator and head of PEPFAR	LANCET			English	Biographical-Item																		GOOSBY E, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 1	2012	380	9857					1901	1901		10.1016/S0140-6736(12)62100-X	http://dx.doi.org/10.1016/S0140-6736(12)62100-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	046IK	23200491				2022-12-28	WOS:000311758500015
J	Cote, GM; Sawyer, DB; Chabner, BA				Cote, Gregory M.; Sawyer, Douglas B.; Chabner, Bruce A.			BASIC IMPLICATIONS OF CLINICAL OBSERVATIONS ERBB2 Inhibition and Heart Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							METASTATIC BREAST-CANCER; DILATED CARDIOMYOPATHY; NEUREGULIN RECEPTOR; CARDIAC DEVELOPMENT; TRASTUZUMAB; SURVIVAL; REVEALS; SYSTEMS; PLUS; GENE		[Cote, Gregory M.; Chabner, Bruce A.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Sawyer, Douglas B.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	Harvard University; Massachusetts General Hospital; Vanderbilt University	Cote, GM (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.			Cote, Gregory/0000-0003-0181-886X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL101425, R01HL068144] Funding Source: NIH RePORTER; NHLBI NIH HHS [P20 HL101425, R01 HL068144] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Blackwell KL, 2010, J CLIN ONCOL, V28, P1124, DOI 10.1200/JCO.2008.21.4437; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Crone SA, 2002, ANN NY ACAD SCI, V971, P547, DOI 10.1111/j.1749-6632.2002.tb04525.x; De Keulenaer GW, 2010, CIRC RES, V106, P35, DOI 10.1161/CIRCRESAHA.109.205906; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Garcia-Rivello H, 2005, AM J PHYSIOL-HEART C, V289, pH1153, DOI 10.1152/ajpheart.00048.2005; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Jabbour A, 2011, EUR J HEART FAIL, V13, P83, DOI 10.1093/eurjhf/hfq152; Ky B, 2009, CIRCULATION, V120, P310, DOI 10.1161/CIRCULATIONAHA.109.856310; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Liu FF, 2005, AM J PHYSIOL-HEART C, V289, pH660, DOI 10.1152/ajpheart.00268.2005; Ozcelik C, 2002, P NATL ACAD SCI USA, V99, P8880, DOI 10.1073/pnas.122249299; Pentassuglia L, 2009, EXP CELL RES, V315, P627, DOI 10.1016/j.yexcr.2008.08.015; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261	20	65	67	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2012	367	22					2150	2153		10.1056/NEJMcibr1203156	http://dx.doi.org/10.1056/NEJMcibr1203156			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044MS	23190227				2022-12-28	WOS:000311624400015
J	Prieto, GA				Prieto, German A.			Imaging the Deep Earth	SCIENCE			English	Editorial Material							AMBIENT SEISMIC NOISE		Univ Los Andes, Bogota, Colombia	Universidad de los Andes (Colombia)	Prieto, GA (corresponding author), Univ Los Andes, Bogota, Colombia.	gprieto@mit.edu	Prieto, German/B-8833-2008; Prieto, German/O-3025-2019	Prieto, German/0000-0001-8538-7379; Prieto, German/0000-0001-8538-7379				Aki K., 1957, B EARTHQ RES I TOKYO, V35, P415; Brenguier F, 2008, NAT GEOSCI, V1, P126, DOI 10.1038/ngeo104; CLAERBOUT JF, 1968, GEOPHYSICS, V33, P264, DOI 10.1190/1.1439927; Gerstoft P, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036111; HASSELMANN K, 1963, REV GEOPHYS, V1, P177, DOI 10.1029/RG001i002p00177; Lawrence JF, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007836; LONGUETHIGGINS MS, 1950, PHILOS TR R SOC S-A, V243, P1, DOI 10.1098/rsta.1950.0012; MASTERS G, 2000, GEOPHYS MONOGR SER, V117, P63, DOI DOI 10.1029/GM117P0063; Moschetti MP, 2010, NATURE, V464, P885, DOI 10.1038/nature08951; Poli P, 2012, SCIENCE, V338, P1063, DOI 10.1126/science.1228194; Prieto GA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034428; Shapiro NM, 2005, SCIENCE, V307, P1615, DOI 10.1126/science.1108339; Stixrude L, 2011, GEOPHYS J INT, V184, P1180, DOI 10.1111/j.1365-246X.2010.04890.x; Wang P, 2008, GEOPHYS J INT, V175, P103, DOI 10.1111/j.1365-246X.2008.03861.x; Weaver RL, 2005, SCIENCE, V307, P1568, DOI 10.1126/science.1109834; Zhan ZW, 2010, GEOPHYS J INT, V182, P408, DOI 10.1111/j.1365-246X.2010.04625.x	16	2	3	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1037	1038		10.1126/science.1231290	http://dx.doi.org/10.1126/science.1231290			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23180851				2022-12-28	WOS:000311390600030
J	Tye, KM; Mirzabekov, JJ; Warden, MR; Ferenczi, EA; Tsai, HC; Finkelstein, J; Kim, SY; Adhikari, A; Thompson, KR; Andalman, AS; Gunaydin, LA; Witten, IB; Deisseroth, K				Tye, Kay M.; Mirzabekov, Julie J.; Warden, Melissa R.; Ferenczi, Emily A.; Tsai, Hsing-Chen; Finkelstein, Joel; Kim, Sung-Yon; Adhikari, Avishek; Thompson, Kimberly R.; Andalman, Aaron S.; Gunaydin, Lisa A.; Witten, Ilana B.; Deisseroth, Karl			Dopamine neurons modulate neural encoding and expression of depression-related behaviour	NATURE			English	Article							STRESS-INDUCED ANHEDONIA; VENTRAL TEGMENTAL AREA; SOCIAL DEFEAT; ANIMAL-MODEL; AVERSIVE STIMULI; REWARD CIRCUIT; GABA NEURONS; SUSCEPTIBILITY; MICE; INHIBITION	Major depression is characterized by diverse debilitating symptoms that include hopelessness and anhedonia(1). Dopamine neurons involved in reward and motivation(2-9) are among many neural populations that have been hypothesized to be relevant(10), and certain antidepressant treatments, including medications and brain stimulation therapies, can influence the complex dopamine system. Until now it has not been possible to test this hypothesis directly, even in animal models, as existing therapeutic interventions are unable to specifically target dopamine neurons. Here we investigated directly the causal contributions of defined dopamine neurons to multidimensional depression-like phenotypes induced by chronic mild stress, by integrating behavioural, pharmacological, optogenetic and electrophysiological methods in freely moving rodents. We found that bidirectional control (inhibition or excitation) of specified midbrain dopamine neurons immediately and bidirectionally modulates (induces or relieves) multiple independent depression symptoms caused by chronic stress. By probing the circuit implementation of these effects, we observed that optogenetic recruitment of these dopamine neurons potently alters the neural encoding of depression-related behaviours in the downstream nucleus accumbens of freely moving rodents, suggesting that processes affecting depression symptoms may involve alterations in the neural encoding of action in limbic circuitry.	[Tye, Kay M.] MIT, Picower Inst Learning & Memory Brain & Cognit Sci, Cambridge, MA 02139 USA; [Tye, Kay M.; Mirzabekov, Julie J.; Warden, Melissa R.; Ferenczi, Emily A.; Tsai, Hsing-Chen; Finkelstein, Joel; Kim, Sung-Yon; Adhikari, Avishek; Thompson, Kimberly R.; Andalman, Aaron S.; Gunaydin, Lisa A.; Witten, Ilana B.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Ferenczi, Emily A.; Tsai, Hsing-Chen; Kim, Sung-Yon; Deisseroth, Karl] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA	Massachusetts Institute of Technology (MIT); Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Tye, KM (corresponding author), MIT, Picower Inst Learning & Memory Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	kaytye@mit.edu; deissero@stanford.edu	Kim, Sung-Yon/AAO-8405-2020; Tye, Kay/J-6158-2013; Core, Vector/CAF-4832-2022; Adhikari, Avishek/N-1284-2015; Adhikari, Avishek/A-3339-2012; Adhikari, Avishek/AAF-4444-2021; Warden, Melissa R/M-9300-2016; Andalman, Aaron S/C-7694-2011	Kim, Sung-Yon/0000-0003-0791-7308; Tye, Kay/0000-0002-2435-0182; Adhikari, Avishek/0000-0002-9187-9211; Adhikari, Avishek/0000-0002-9187-9211; Adhikari, Avishek/0000-0002-9187-9211; Warden, Melissa R/0000-0003-2240-3997; 	Helen Hay Whitney Foundation; NRSA [F32 MH880102]; JPB Foundation; NARSAD; Wiegers Family Fund; NIMH; NIDA; DARPA REPAIR Program; Keck Foundation; McKnight Foundation; Gatsby Charitable Foundation; Snyder Foundation; Woo Foundation; Albert Yu and Mary Bechman Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP2DK102256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP2DA035149] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; NARSAD(NARSAD); Wiegers Family Fund; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); DARPA REPAIR Program; Keck Foundation(W.M. Keck Foundation); McKnight Foundation; Gatsby Charitable Foundation; Snyder Foundation; Woo Foundation; Albert Yu and Mary Bechman Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank T. Davidson, S. Pak, C. Ramakrishnan, L. Grosenick, Z. Chen and the members of the Deisseroth Laboratory for support. I. B. W. was supported by the Helen Hay Whitney Foundation; K. M. T was supported by NRSA fellowship F32 MH880102 and the JPB Foundation; K. R. T., M. R. W. and K. D. are NARSAD grant awardees. K. D. was supported by the Wiegers Family Fund and by the NIMH, the NIDA, the DARPA REPAIR Program, the Keck Foundation, the McKnight Foundation, the Gatsby Charitable Foundation, the Snyder Foundation, the Woo Foundation and the Albert Yu and Mary Bechman Foundation. All tools and methods described are distributed and supported freely (http://www.optogenetics.org).	Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; FREEMAN AS, 1987, BRAIN RES, V405, P46, DOI 10.1016/0006-8993(87)90988-7; Friedman A, 2008, J MOL NEUROSCI, V34, P201, DOI 10.1007/s12031-007-9016-8; GRACE AA, 1984, J NEUROSCI, V4, P2877; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Ikemoto S, 2004, NEUROPHARMACOLOGY, V47, P190, DOI 10.1016/j.neuropharm.2004.07.012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P709; Koob GF, 1996, MOL PSYCHIATR, V1, P186; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lammel S., 2012, NATURE; Lemke MR, 2000, J PSYCHIATR RES, V34, P277, DOI 10.1016/S0022-3956(00)00017-0; Lemos J.C., 2012, NATURE          0919; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Roitman MF, 2008, NAT NEUROSCI, V11, P1376, DOI 10.1038/nn.2219; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Tanaka K, 2012, J NEUROSCI, V32, P4319, DOI 10.1523/JNEUROSCI.5952-11.2012; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Valenti O, 2012, EUR J NEUROSCI, V35, P1312, DOI 10.1111/j.1460-9568.2012.08038.x; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Willner P., 1991, EUR NEUROPSYCHOPHARM, V1, P295; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028	34	641	669	14	336	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2013	493	7433					537	+		10.1038/nature11740	http://dx.doi.org/10.1038/nature11740			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23235822	Green Accepted, Green Published			2022-12-28	WOS:000313871400039
J	Schloissnig, S; Arumugam, M; Sunagawa, S; Mitreva, M; Tap, J; Zhu, A; Waller, A; Mende, DR; Kultima, JR; Martin, J; Kota, K; Sunyaev, SR; Weinstock, GM; Bork, P				Schloissnig, Siegfried; Arumugam, Manimozhiyan; Sunagawa, Shinichi; Mitreva, Makedonka; Tap, Julien; Zhu, Ana; Waller, Alison; Mende, Daniel R.; Kultima, Jens Roat; Martin, John; Kota, Karthik; Sunyaev, Shamil R.; Weinstock, George M.; Bork, Peer			Genomic variation landscape of the human gut microbiome	NATURE			English	Article							SALT HYDROLASE ACTIVITY; IV SECRETION SYSTEMS; ESCHERICHIA-COLI; HELICOBACTER-PYLORI; POPULATION-GENETICS; HUMAN FECES; DIVERSITY; BACTERIAL; EVOLUTION; RECONSTRUCTION	Whereas large-scale efforts have rapidly advanced the understanding and practical impact of human genomic variation, the practical impact of variation is largely unexplored in the human microbiome. We therefore developed a framework for metagenomic variation analysis and applied it to 252 faecal metagenomes of 207 individuals from Europe and North America. Using 7.4 billion reads aligned to 101 reference species, we detected 10.3 million single nucleotide polymorphisms (SNPs), 107,991 short insertions/deletions, and 1,051 structural variants. The average ratio of non-synonymous to synonymous polymorphism rates of 0.11 was more variable between gut microbial species than across human hosts. Subjects sampled at varying time intervals exhibited individuality and temporal stability of SNP variation patterns, despite considerable composition changes of their gut microbiota. This indicates that individual-specific strains are not easily replaced and that an individual might have a unique metagenomic genotype, which may be exploitable for personalized diet or drug intake.	[Schloissnig, Siegfried; Arumugam, Manimozhiyan; Sunagawa, Shinichi; Tap, Julien; Zhu, Ana; Waller, Alison; Mende, Daniel R.; Kultima, Jens Roat; Bork, Peer] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Mitreva, Makedonka; Martin, John; Kota, Karthik; Weinstock, George M.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Sunyaev, Shamil R.] Brigham & Womens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; [Sunyaev, Shamil R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	European Molecular Biology Laboratory (EMBL); Washington University (WUSTL); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	gweinsto@genome.wustl.edu; bork@embl.de	Arumugam, Manimozhiyan/E-1211-2011; Mende, Daniel R/I-3662-2019; Sunagawa, Shinichi/Q-5950-2019; Tap, Julien/E-5760-2010; Bork, Peer/F-1813-2013; Powell, Sean/B-2374-2009; ravegnini, gloria/K-1330-2016; Arumugam, Manimozhiyan/AAJ-2394-2020; Weinstock, George M/C-6314-2013	Arumugam, Manimozhiyan/0000-0002-0886-9101; Mende, Daniel R/0000-0001-6831-4557; Sunagawa, Shinichi/0000-0003-3065-0314; Tap, Julien/0000-0001-8998-5413; Bork, Peer/0000-0002-2627-833X; Powell, Sean/0000-0002-0994-5911; ravegnini, gloria/0000-0002-7774-402X; Arumugam, Manimozhiyan/0000-0002-0886-9101; Weinstock, George M/0000-0002-2997-4592; Schloissnig, Siegfried/0000-0003-4574-8330; Mitreva, Makedonka/0000-0001-9572-3436	EMBL; European Community [HEALTH-F4-2007-201052]; IHMS [HEALTH-F4-2010-261376]; National Institutes of Health [U54HG003079, U54HG004968]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, U54HG004968] Funding Source: NIH RePORTER	EMBL; European Community(European Commission); IHMS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors are grateful to J. Korbel and the members of the Bork group at EMBL for discussions and assistance, especially S. Powell for performing some of the computations. We thank the EMBL IT core facility and Y. Yuan for managing the high-performance computing resources. We would like to thank J. I. Gordon for providing three of the samples used. We are also grateful to the European MetaHIT consortium and the NIH Common Fund Human Microbiome Project Consortium for generating and making available the data sets used in this study. The research leading to these results has received funding from EMBL, the European Community's Seventh Framework Programme via the MetaHIT (HEALTH-F4-2007-201052) and IHMS (HEALTH-F4-2010-261376) grants as well as from the National Institutes of Health grants U54HG003079 and U54HG004968.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Allen EE, 2007, P NATL ACAD SCI USA, V104, P1883, DOI 10.1073/pnas.0604851104; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bagel S, 1999, ANTIMICROB AGENTS CH, V43, P868, DOI 10.1128/AAC.43.4.868; Begley M, 2006, APPL ENVIRON MICROB, V72, P1729, DOI 10.1128/AEM.72.3.1729-1738.2006; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P1615, DOI [10.1099/ijs.0.02143-0, 10.1099/00207713-52-5-1615]; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Friedman R, 2004, GENETICS, V167, P1507, DOI 10.1534/genetics.104.026344; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; HOLDEMAN LV, 1974, INT J SYST BACTERIOL, V24, P260, DOI 10.1099/00207713-24-2-260; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Kelly D, 2005, TRENDS IMMUNOL, V26, P326, DOI 10.1016/j.it.2005.04.008; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; KUNZ BA, 1983, GENETICS, V105, P489; Lay C, 2005, APPL ENVIRON MICROB, V71, P4153, DOI 10.1128/AEM.71.7.4153-4155.2005; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Nagai H, 2003, CELL MICROBIOL, V5, P373, DOI 10.1046/j.1462-5822.2003.00285.x; Novichkov PS, 2009, J BACTERIOL, V191, P65, DOI 10.1128/JB.01237-08; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Simmons SL, 2008, PLOS BIOL, V6, P1427, DOI 10.1371/journal.pbio.0060177; Sokurenko EV, 1998, P NATL ACAD SCI USA, V95, P8922, DOI 10.1073/pnas.95.15.8922; Sorek R, 2007, SCIENCE, V318, P1449, DOI 10.1126/science.1147112; Suzuki R, 2012, INFECT GENET EVOL, V12, P203, DOI 10.1016/j.meegid.2011.12.002; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Yamaoka Y, 2009, CLIN MICROBIOL INFEC, V15, P829, DOI 10.1111/j.1469-0691.2009.02967.x; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854	48	523	557	12	378	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					45	50		10.1038/nature11711	http://dx.doi.org/10.1038/nature11711			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23222524	Green Accepted, Green Submitted			2022-12-28	WOS:000312933800027
J	Lader, E				Lader, Ellis			Review: Eplerenone is not more effective for reducing mortality than other aldosterone antagonists	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									NYU, Sch Med, Kingston, NY USA	New York University	Lader, E (corresponding author), NYU, Sch Med, Kingston, NY USA.							Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	4	0	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2012	157	12							JC6-10	10.7326/0003-4819-157-12-201212180-02010	http://dx.doi.org/10.7326/0003-4819-157-12-201212180-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057SB	23247959				2022-12-28	WOS:000312583200009
J	Steinberg, DI				Steinberg, Daniel I.			Novel risk markers improved Framingham Risk Score cardiovascular event prediction in intermediate-risk adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Beth Israel Deaconess Med Ctr, New York, NY 10003 USA	Harvard University; Beth Israel Deaconess Medical Center	Steinberg, DI (corresponding author), Beth Israel Deaconess Med Ctr, New York, NY 10003 USA.							Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c	1	3	3	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2012	157	12							JC6-13	10.7326/0003-4819-157-12-201212180-02013	http://dx.doi.org/10.7326/0003-4819-157-12-201212180-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057SB	23247962				2022-12-28	WOS:000312583200012
J	Lozano, R; Naghavi, M; Foreman, K; Lim, S; Shibuya, K; Aboyans, V; Abraham, J; Adair, T; Aggarwal, R; Ahn, SY; Alvarado, M; Anderson, HR; Anderson, LM; Andrews, KG; Atkinson, C; Baddour, LM; Barker-Collo, S; Bartels, DH; Bell, ML; Benjamin, EJ; Bennett, D; Bhalla, K; Bikbov, B; Bin Abdulhak, A; Birbeck, G; Blyth, F; Bolliger, I; Boufous, SA; Bucello, C; Burch, M; Burney, P; Carapetis, J; Chen, HL; Chou, D; Chugh, SS; Coffeng, LE; Colan, SD; Colquhoun, S; Colson, KE; Condon, J; Connor, MD; Cooper, LT; Corriere, M; Cortinovis, M; de Vaccaro, KC; Couser, W; Cowie, BC; Criqui, MH; Cross, M; Dabhadkar, KC; Dahodwala, N; De Leo, D; Degenhardt, L; Delossantos, A; Denenberg, J; Des Jarlais, DC; Dharmaratne, SD; Dorsey, ER; Driscoll, T; Duber, H; Ebel, B; Erwin, PJ; Espindola, P; Ezzati, M; Feigin, V; Flaxman, AD; Forouzanfar, MH; Fowkes, FGR; Franklin, R; Fransen, M; Freeman, MK; Gabriel, SE; Gakidou, E; Gaspari, F; Gillum, RF; Gonzalez-Medina, D; Halasa, YA; Haring, D; Harrison, JE; Havmoeller, R; Hay, RJ; Hoen, B; Hotez, PJ; Hoy, D; Jacobsen, KH; James, SL; Jasrasaria, R; Jayaraman, S; Johns, N; Karthikeyan, G; Kassebaum, N; Keren, A; Khoo, JP; Knowlton, LM; Kobusingye, O; Koranteng, A; Krishnamurthi, R; Lipnick, M; Lipshultz, SE; Ohno, SL; Mabweijano, J; MacIntyre, MF; Mallinger, L; March, L; Marks, GB; Marks, R; Matsumori, A; Matzopoulos, R; Mayosi, BM; McAnulty, JH; McDermott, MM; McGrath, J; Mensah, GA; Merriman, TR; Michaud, C; Miller, M; Miller, TR; Mock, C; Mocumbi, AO; Mokdad, AA; Moran, A; Mulholland, K; Nair, MN; Naldi, L; Narayan, KMV; Nasseri, K; Norman, P; O'Donnell, M; Omer, SB; Ortblad, K; Osborne, R; Ozgediz, D; Pahari, B; Pandian, JD; Rivero, AP; Padilla, RP; Perez-Ruiz, F; Perico, N; Phillips, D; Pierce, K; Pope, CA; Porrini, E; Pourmalek, F; Raju, M; Ranganathan, D; Rehm, JT; Rein, DB; Remuzzi, G; Rivara, FP; Roberts, T; De Leon, FR; Rosenfeld, LC; Rushton, L; Sacco, RL; Salomon, JA; Sampson, U; Sanman, E; Schwebel, DC; Segui-Gomez, M; Shepard, DS; Singh, D; Singleton, J; Sliwa, K; Smith, E; Steer, A; Taylor, JA; Thomas, B; Tleyjeh, IM; Towbin, JA; Truelsen, T; Undurraga, EA; Venketasubramanian, N; Vijayakumar, L; Vos, T; Wagner, GR; Wang, MR; Wang, WZ; Watt, K; Weinstock, MA; Weintraub, R; Wilkinson, JD; Woolf, AD; Wulf, S; Yeh, PH; Yip, P; Zabetian, A; Zheng, ZJ; Lopez, AD; Murray, CJL				Lozano, Rafael; Naghavi, Mohsen; Foreman, Kyle; Lim, Stephen; Shibuya, Kenji; Aboyans, Victor; Abraham, Jerry; Adair, Timothy; Aggarwal, Rakesh; Ahn, Stephanie Y.; Alvarado, Miriam; Anderson, H. Ross; Anderson, Laurie M.; Andrews, Kathryn G.; Atkinson, Charles; Baddour, Larry M.; Barker-Collo, Suzanne; Bartels, David H.; Bell, Michelle L.; Benjamin, Emelia J.; Bennett, Derrick; Bhalla, Kavi; Bikbov, Boris; Bin Abdulhak, Aref; Birbeck, Gretchen; Blyth, Fiona; Bolliger, Ian; Boufous, Soufi Ane; Bucello, Chiara; Burch, Michael; Burney, Peter; Carapetis, Jonathan; Chen, Honglei; Chou, David; Chugh, Sumeet S.; Coffeng, Luc E.; Colan, Steven D.; Colquhoun, Samantha; Colson, K. Ellicott; Condon, John; Connor, Myles D.; Cooper, Leslie T.; Corriere, Matthew; Cortinovis, Monica; de Vaccaro, Karen Courville; Couser, William; Cowie, Benjamin C.; Criqui, Michael H.; Cross, Marita; Dabhadkar, Kaustubh C.; Dahodwala, Nabila; De Leo, Diego; Degenhardt, Louisa; Delossantos, Allyne; Denenberg, Julie; Des Jarlais, Don C.; Dharmaratne, Samath D.; Dorsey, E. Ray; Driscoll, Tim; Duber, Herbert; Ebel, Beth; Erwin, Patricia J.; Espindola, Patricia; Ezzati, Majid; Feigin, Valery; Flaxman, Abraham D.; Forouzanfar, Mohammad H.; Fowkes, Francis Gerry R.; Franklin, Richard; Fransen, Marlene; Freeman, Michael K.; Gabriel, Sherine E.; Gakidou, Emmanuela; Gaspari, Flavio; Gillum, Richard F.; Gonzalez-Medina, Diego; Halasa, Yara A.; Haring, Diana; Harrison, James E.; Havmoeller, Rasmus; Hay, Roderick J.; Hoen, Bruno; Hotez, Peter J.; Hoy, Damian; Jacobsen, Kathryn H.; James, Spencer L.; Jasrasaria, Rashmi; Jayaraman, Sudha; Johns, Nicole; Karthikeyan, Ganesan; Kassebaum, Nicholas; Keren, Andre; Khoo, Jon-Paul; Knowlton, Lisa Marie; Kobusingye, Olive; Koranteng, Adofo; Krishnamurthi, Rita; Lipnick, Michael; Lipshultz, Steven E.; Ohno, Summer Lockett; Mabweijano, Jacqueline; MacIntyre, Michael F.; Mallinger, Leslie; March, Lyn; Marks, Guy B.; Marks, Robin; Matsumori, Akira; Matzopoulos, Richard; Mayosi, Bongani M.; McAnulty, John H.; McDermott, Mary M.; McGrath, John; Mensah, George A.; Merriman, Tony R.; Michaud, Catherine; Miller, Matthew; Miller, Ted R.; Mock, Charles; Mocumbi, Ana Olga; Mokdad, Ali A.; Moran, Andrew; Mulholland, Kim; Nair, M. Nathan; Naldi, Luigi; Narayan, K. M. Venkat; Nasseri, Kiumarss; Norman, Paul; O'Donnell, Martin; Omer, Saad B.; Ortblad, Katrina; Osborne, Richard; Ozgediz, Doruk; Pahari, Bishnu; Pandian, Jeyaraj Durai; Rivero, Andrea Panozo; Padilla, Rogelio Perez; Perez-Ruiz, Fernando; Perico, Norberto; Phillips, David; Pierce, Kelsey; Pope, C. Arden, III; Porrini, Esteban; Pourmalek, Farshad; Raju, Murugesan; Ranganathan, Dharani; Rehm, Juergen T.; Rein, David B.; Remuzzi, Guiseppe; Rivara, Frederick P.; Roberts, Thomas; De Leon, Felipe Rodriguez; Rosenfeld, Lisa C.; Rushton, Lesley; Sacco, Ralph L.; Salomon, Joshua A.; Sampson, Uchechukwu; Sanman, Ella; Schwebel, David C.; Segui-Gomez, Maria; Shepard, Donald S.; Singh, David; Singleton, Jessica; Sliwa, Karen; Smith, Emma; Steer, Andrew; Taylor, Jennifer A.; Thomas, Bernadette; Tleyjeh, Imad M.; Towbin, Jeffrey A.; Truelsen, Thomas; Undurraga, Eduardo A.; Venketasubramanian, N.; Vijayakumar, Lakshmi; Vos, Theo; Wagner, Gregory R.; Wang, Mengru; Wang, Wenzhi; Watt, Kerrianne; Weinstock, Martin A.; Weintraub, Robert; Wilkinson, James D.; Woolf, Anthony D.; Wulf, Sarah; Yeh, Pon-Hsiu; Yip, Paul; Zabetian, Azadeh; Zheng, Zhi-Jie; Lopez, Alan D.; Murray, Christopher J. L.			Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010	LANCET			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; MILLENNIUM DEVELOPMENT GOALS; RESPIRATORY SYNCYTIAL VIRUS; PUBLIC-HEALTH UTILITY; MATERNAL MORTALITY; CHILD-MORTALITY; NATIONAL CAUSES; 187 COUNTRIES; NONCOMMUNICABLE DISEASE; HOSPITALIZED-PATIENTS	Background Reliable and timely information on the leading causes of death in populations, and how these are changing, is a crucial input into health policy debates. In the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010), we aimed to estimate annual deaths for the world and 21 regions between 1980 and 2010 for 235 causes, with uncertainty intervals (UIs), separately by age and sex. Methods We attempted to identify all available data on causes of death for 187 countries from 1980 to 2010 from vital registration, verbal autopsy, mortality surveillance, censuses, surveys, hospitals, police records, and mortuaries. We assessed data quality for completeness, diagnostic accuracy, missing data, stochastic variations, and probable causes of death. We applied six different modelling strategies to estimate cause-specific mortality trends depending on the strength of the data. For 133 causes and three special aggregates we used the Cause of Death Ensemble model (CODEm) approach, which uses four families of statistical models testing a large set of different models using different permutations of covariates. Model ensembles were developed from these component models. We assessed model performance with rigorous out-of-sample testing of prediction error and the validity of 95% UIs. For 13 causes with low observed numbers of deaths, we developed negative binomial models with plausible covariates. For 27 causes for which death is rare, we modelled the higher level cause in the cause hierarchy of the GBD 2010 and then allocated deaths across component causes proportionately, estimated from all available data in the database. For selected causes (African trypanosomiasis, congenital syphilis, whooping cough, measles, typhoid and parathyroid, leishmaniasis, acute hepatitis E, and HIV/AIDS), we used natural history models based on information on incidence, prevalence, and case-fatality. We separately estimated cause fractions by aetiology for diarrhoea, lower respiratory infections, and meningitis, as well as disaggregations by subcause for chronic kidney disease, maternal disorders, cirrhosis, and liver cancer. For deaths due to collective violence and natural disasters, we used mortality shock regressions. For every cause, we estimated 95% UIs that captured both parameter estimation uncertainty and uncertainty due to model specification where CODEm was used. We constrained cause-specific fractions within every age-sex group to sum to total mortality based on draws from the uncertainty distributions. Findings In 2010, there were 52.8 million deaths globally. At the most aggregate level, communicable, maternal, neonatal, and nutritional causes were 24.9% of deaths worldwide in 2010, down from 15.9 million (34.1%) of 46.5 million in 1990. This decrease was largely due to decreases in mortality from diarrhoeal disease (from 2.5 to 1.4 million), lower respiratory infections (from 3.4 to 2.8 million), neonatal disorders (from 3.1 to 2.2 million), measles (from 0.63 to 0.13 million), and tetanus (from 0.27 to 0.06 million). Deaths from HIV/AIDS increased from 0.30 million in 1990 to 1.5 million in 2010, reaching a peak of 1.7 million in 2006. Malaria mortality also rose by an estimated 19.9% since 1990 to 1.17 million deaths in 2010. Tuberculosis killed 1.2 million people in 2010. Deaths from non-communicable diseases rose by just under 8 million between 1990 and 2010, accounting for two of every three deaths (34.5 million) worldwide by 2010. 8 million people died from cancer in 2010, 38% more than two decades ago; of these, 1.5 million (19%) were from trachea, bronchus, and lung cancer. Ischaemic heart disease and stroke collectively killed 12.9 million people in 2010, or one in four deaths worldwide, compared with one in five in 1990; 1.3 million deaths were due to diabetes, twice as many as in 1990. The fraction of global deaths due to injuries (5.1 million deaths) was marginally higher in 2010 (9.6%) compared with two decades earlier (8.8%). This was driven by a 46% rise in deaths worldwide due to road traffic accidents (1.3 million in 2010) and a rise in deaths from falls. Ischaemic heart disease, stroke, chronic obstructive pulmonary disease (COPD), lower respiratory infections, lung cancer, and HIV/AIDS were the leading causes of death in 2010. Ischaemic heart disease, lower respiratory infections, stroke, diarrhoeal disease, malaria, and HIV/AIDS were the leading causes of years of life lost due to premature mortality (YLLs) in 2010, similar to what was estimated for 1990, except for HIV/AIDS and preterm birth complications. YLLs from lower respiratory infections and diarrhoea decreased by 45-54% since 1990; ischaemic heart disease and stroke YLLs increased by 17-28%. Regional variations in leading causes of death were substantial. Communicable, maternal, neonatal, and nutritional causes still accounted for 76% of premature mortality in sub-Saharan Africa in 2010. Age standardised death rates from some key disorders rose (HIV/AIDS, Alzheimer's disease, diabetes mellitus, and chronic kidney disease in particular), but for most diseases, death rates fell in the past two decades; including major vascular diseases, COPD, most forms of cancer, liver cirrhosis, and maternal disorders. For other conditions, notably malaria, prostate cancer, and injuries, little change was noted. Interpretation Population growth, increased average age of the world's population, and largely decreasing age-specific, sex-specific, and cause-specific death rates combine to drive a broad shift from communicable, maternal, neonatal, and nutritional causes towards non-communicable diseases. Nevertheless, communicable, maternal, neonatal, and nutritional causes remain the dominant causes of YLLs in sub-Saharan Africa. Overlaid on this general pattern of the epidemiological transition, marked regional variation exists in many causes, such as interpersonal violence, suicide, liver cancer, diabetes, cirrhosis, Chagas disease, African trypanosomiasis, melanoma, and others. Regional heterogeneity highlights the importance of sound epidemiological assessments of the causes of death on a regular basis.	[Lozano, Rafael; Naghavi, Mohsen; Lim, Stephen; Ahn, Stephanie Y.; Alvarado, Miriam; Andrews, Kathryn G.; Atkinson, Charles; Bolliger, Ian; Chou, David; Colson, K. Ellicott; Delossantos, Allyne; Dharmaratne, Samath D.; Flaxman, Abraham D.; Forouzanfar, Mohammad H.; Freeman, Michael K.; Gakidou, Emmanuela; Gonzalez-Medina, Diego; Haring, Diana; James, Spencer L.; Jasrasaria, Rashmi; Johns, Nicole; Ohno, Summer Lockett; MacIntyre, Michael F.; Mallinger, Leslie; Mokdad, Ali A.; Nair, M. Nathan; Ortblad, Katrina; Phillips, David; Pierce, Kelsey; Ranganathan, Dharani; Roberts, Thomas; Rosenfeld, Lisa C.; Sanman, Ella; Wang, Mengru; Wulf, Sarah; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Kassebaum, Nicholas] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98121 USA; [Anderson, Laurie M.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98121 USA; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Shibuya, Kenji] Univ Tokyo, Dept Global Hlth, Tokyo, Japan; [Aboyans, Victor] Dupuytren Univ Hosp, Dept Cardiol, Limoges, France; [Abraham, Jerry] Univ Texas San Antonio, Sch Med, San Antonio, TX USA; [Adair, Timothy; Vos, Theo; Lopez, Alan D.] Univ Queensland, Queensland Brain Inst, Sch Populat Hlth, Brisbane, Qld, Australia; [Khoo, Jon-Paul] Univ Queensland, Queensland Brain Inst, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Aggarwal, Rakesh] Sanjay Gandhi Postgrad Inst Med Sci, Lucknow, Uttar Pradesh, India; [Anderson, H. Ross] Univ London, London, England; [Baddour, Larry M.; Erwin, Patricia J.; Gabriel, Sherine E.] Mayo Clin, Rochester, MN USA; [Barker-Collo, Suzanne] Univ Auckland, Auckland 1, New Zealand; [Jayaraman, Sudha] Harvard Univ, Brigham & Womens Hosp, Boston, MA 02115 USA; [Bartels, David H.; Colan, Steven D.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Knowlton, Lisa Marie] Harvard Univ, Harvard Humanitarian Initiat, Boston, MA 02115 USA; [Miller, Matthew; Salomon, Joshua A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Ozgediz, Doruk] Yale Univ, Global Partners Anesthesia & Surg, New Haven, CT USA; [Benjamin, Emelia J.] Boston Univ, Boston, MA 02215 USA; [Bennett, Derrick] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Bennett, Derrick] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Bikbov, Boris] Moscow State Univ Med & Dent, Res Inst Transplantol & Artificial Organs, Moscow, Russia; [Bin Abdulhak, Aref; Tleyjeh, Imad M.] King Fahad Med City, Riyadh, Saudi Arabia; [Birbeck, Gretchen] Michigan State Univ, E Lansing, MI 48824 USA; [Driscoll, Tim] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Fransen, Marlene] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [Smith, Emma] Univ Sydney, Dept Rheumatol, No Clin Sch, Sydney, NSW 2006, Australia; [March, Lyn] Univ Sydney, Inst Bone & Joint Res, Sydney, NSW 2006, Australia; [Degenhardt, Louisa; Singleton, Jessica] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Burch, Michael] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Carapetis, Jonathan] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Chen, Honglei] NIEHS, Res Triangle Pk, NC 27709 USA; [Chugh, Sumeet S.; Havmoeller, Rasmus] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Coffeng, Luc E.] Univ Med Ctr Rotterdam, Erasmus MC, Rotterdam, Netherlands; [Colquhoun, Samantha; Condon, John] Menzies Sch Hlth Res, Darwin, NT, Australia; [Connor, Myles D.] Natl Hlth Serv, Edinburgh, Midlothian, Scotland; [Connor, Myles D.; Fowkes, Francis Gerry R.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Connor, Myles D.] Univ Witwatersrand, Johannesburg, South Africa; [Cooper, Leslie T.] Loyola Univ, Sch Med, Chicago, IL 60611 USA; [Corriere, Matthew] Wake Forest Univ, Sch Publ Hlth Sci, Dept Epidemiol, Winston Salem, NC 27109 USA; [Cortinovis, Monica; Gaspari, Flavio; Perico, Norberto; Remuzzi, Guiseppe] Mario Negri Inst Pharmacol Res, I-24100 Bergamo, Italy; [de Vaccaro, Karen Courville] Hosp Dr Gustavo N Collado, Puerto Chitre, Panama; [Cowie, Benjamin C.] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Criqui, Michael H.] Univ Calif San Diego, San Diego, CA 92103 USA; [Omer, Saad B.] Emory Univ, Sch Publ Hlth, Atlanta, GA USA; [Omer, Saad B.] Emory Univ, Sch Med, Atlanta, GA USA; [Dahodwala, Nabila] Univ Penn, Philadelphia, PA 19104 USA; [De Leo, Diego] Griffith Univ, Brisbane, Qld 4111, Australia; [Des Jarlais, Don C.] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; [Dharmaratne, Samath D.] Univ Peradeniya, Peradeniya, Sri Lanka; [Dorsey, E. Ray] Johns Hopkins Univ, Baltimore, MD USA; [Espindola, Patricia] Hosp Maciel, Montevideo, Uruguay; [Ezzati, Majid] MRC HPA Ctr Environm & Hlth, London, England; [Feigin, Valery; Krishnamurthi, Rita] Auckland Tech Univ, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Franklin, Richard] Royal Life Saving Soc, Sydney, NSW, Australia; [Franklin, Richard; Watt, Kerrianne] James Cook Univ, Townsville, Qld 4811, Australia; [Gillum, Richard F.] Howard Univ, Coll Med, Washington, DC USA; [Halasa, Yara A.; Shepard, Donald S.; Undurraga, Eduardo A.] Brandeis Univ, Waltham, MA USA; [Harrison, James E.] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [Havmoeller, Rasmus] Karolinska Univ Hosp, Stockholm, Sweden; [Hay, Roderick J.] Kings Coll London, Kings Coll Hosp NHS Trust, London, England; [Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, Waco, TX USA; [Hoy, Damian] Monash Univ, Melbourne, Vic 3004, Australia; [Jacobsen, Kathryn H.] George Mason Univ, Fairfax, VA 22030 USA; [Karthikeyan, Ganesan] All India Inst Med Sci, New Delhi, India; [Keren, Andre] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Cardiol, IL-91010 Jerusalem, Israel; [Kobusingye, Olive] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Kobusingye, Olive] Univ S Africa, Johannesburg, South Africa; [Koranteng, Adofo] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Lipnick, Michael] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Lipshultz, Steven E.; Sacco, Ralph L.; Wilkinson, James D.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Mabweijano, Jacqueline] Mulago Hosp, Kampala, Uganda; [Steer, Andrew] Univ Melbourne, Ctr Int Child Hlth, Melbourne, Vic, Australia; [Weintraub, Robert] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic, Australia; [Matsumori, Akira] Asian Pacific Soc Cardiol, Kyoto, Japan; [Matzopoulos, Richard] MRC, Tygerberg, South Africa; [Sliwa, Karen] Univ Cape Town, Hatter Inst, ZA-7925 Cape Town, South Africa; [Mensah, George A.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [McAnulty, John H.] Legacy Hlth Syst, Portland, OR USA; [McDermott, Mary M.] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA; [Merriman, Tony R.] Univ Otago, Dunedin, New Zealand; [Michaud, Catherine] China Med Board, Boston, MA USA; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Mocumbi, Ana Olga] Natl Inst Hlth, Maputo, Mozambique; [Mocumbi, Ana Olga] Univ Eduardo Mondlane, Maputo, Mozambique; [Moran, Andrew] Columbia Univ, New York, NY USA; [Mulholland, Kim] London Sch Hyg & Trop Med, London WC1, England; [Naldi, Luigi] Centro Studi GISED, Bergamo, Italy; [Nasseri, Kiumarss] Univ Liverpool, Sch Publ Hlth, Liverpool L69 3BX, Merseyside, England; [O'Donnell, Martin] Natl Univ Ireland Galway, HRB Clin Res Facil, Galway, Ireland; [Osborne, Richard] Deakin Univ, Melbourne, Vic, Australia; [Pahari, Bishnu] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Pandian, Jeyaraj Durai] Betty Cowan Res & Innovat Ctr, Ludhiana, Punjab, India; [Rivero, Andrea Panozo] Hosp Joan 23, La Paz, Bolivia; [Padilla, Rogelio Perez] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Perez-Ruiz, Fernando] Hosp Univ Cruces, Baracaldo, Spain; [Pope, C. Arden, III] Brigham Young Univ, Provo, UT 84602 USA; [Porrini, Esteban] Hosp Univ Canarias, Tenerife, Spain; [Pourmalek, Farshad] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Raju, Murugesan] Univ Missouri, Mason Eye Inst, Columbia, MO USA; [Rehm, Juergen T.] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Rein, David B.] Univ Chicago, Natl Opin Res Ctr, Chicago, IL 60637 USA; [De Leon, Felipe Rodriguez] Complejo Hosp Caja Seguro Social, Panama City, Panama; [Sampson, Uchechukwu] Vanderbilt Univ, Nashville, TN USA; [Schwebel, David C.] Univ Alabama Birmingham, Birmingham, AL USA; [Segui-Gomez, Maria] Minist Interior, Madrid, Spain; [Singh, David] Queens Med Ctr, Honolulu, HI USA; [Taylor, Jennifer A.] Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA; [Towbin, Jeffrey A.] Cincinnati Childrens Hosp, Cincinnati, OH USA; [Truelsen, Thomas] Copenhagen Univ Hosp, Dept Neurol, Herlev, Denmark; [Venketasubramanian, N.] Natl Univ Singapore, Singapore 117548, Singapore; [Vijayakumar, Lakshmi] Voluntary Hlth Serv, Chennai, Tamil Nadu, India; [Wagner, Gregory R.] NIOSH, Baltimore, MD USA; [Wang, Wenzhi] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [Weinstock, Martin A.] Brown Univ, Providence, RI 02912 USA; [Woolf, Anthony D.] Royal Cornwall Hosp, Truro, England; [Yeh, Pon-Hsiu] London Sch Econ, London WC2A 2AE, England; [Yip, Paul] Univ Hong Kong, Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China; [Zheng, Zhi-Jie] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Imperial College London; University of Tokyo; CHU Limoges; University of Texas System; University of Texas at San Antonio (UTSA); University of Queensland; Queensland Centre for Mental Health Research; University of Queensland; Sanjay Gandhi Postgraduate Institute of Medical Sciences; University of London; Mayo Clinic; University of Auckland; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Yale University; Boston University; University of Oxford; University of Oxford; Moscow State University of Medicine & Dentistry; V.I. Shumakov Federal Research Center of Transplantology & Artificial Organs; Michigan State University; University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of New South Wales Sydney; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Telethon Kids Institute; University of Western Australia; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Cedars Sinai Medical Center; Erasmus University Rotterdam; Erasmus MC; Charles Darwin University; Menzies School of Health Research; NHS Blood & Transplant (NHSBT); University of Edinburgh; University of Witwatersrand; Loyola University Chicago; Wake Forest University; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Victorian Infectious Diseases Reference Laboratory; University of California System; University of California San Diego; Emory University; Emory University; University of Pennsylvania; Griffith University; Harvard University; Beth Israel Deaconess Medical Center; University of Peradeniya; Johns Hopkins University; Imperial College London; James Cook University; Howard University; Brandeis University; Flinders University South Australia; Karolinska Institutet; Karolinska University Hospital; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Baylor College of Medicine; Monash University; George Mason University; All India Institute of Medical Sciences (AIIMS) New Delhi; Hebrew University of Jerusalem; Makerere University; University of South Africa; Kwame Nkrumah University Science & Technology; University of California System; University of California San Francisco; University of Miami; Mulago National Referral Hospital; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; University of Cape Town; University of Cape Town; Legacy Health; Northwestern University; Feinberg School of Medicine; University of Otago; Pacific Institute for Research & Evaluation (PIRE); Eduardo Mondlane University; Columbia University; University of London; London School of Hygiene & Tropical Medicine; University of Liverpool; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway; Deakin University; B.P. Koirala Institute of Health Sciences; Hospital Universitario Cruces; Brigham Young University; Universidad de la Laguna; University of British Columbia; University of Missouri System; University of Missouri Columbia; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Chicago; Caja del Seguro Social (CSS); Complejo Hospitalario Doctor Arnulfo Arias Madrid; Vanderbilt University; University of Alabama System; University of Alabama Birmingham; The Queen's Medical Center; Drexel University; Cincinnati Children's Hospital Medical Center; University of Copenhagen; National University of Singapore; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Beijing Neurosurgical Institute; Capital Medical University; Brown University; Royal Cornwall Hospital; University of London; London School Economics & Political Science; University of Hong Kong; Shanghai Jiao Tong University	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@uw.edu	Perico, Norberto/ABH-3222-2020; Pandian, Jeyaraj Durai/AAV-5591-2020; Venketasubramanian, Narayanaswamy/GPP-5948-2022; Bolliger, Ian W/C-4207-2016; Steer, Andrew C/C-2840-2013; Mokdad, Ali H./AAD-1232-2022; Colan, Steven/ABB-4580-2020; Jayaraman, Sudha/AAH-3059-2019; Bin Abdulhak, Aref/AAK-4348-2020; Karthikeyan, Ganesan/D-5767-2012; Schwebel, David/GXH-9944-2022; Anderson, Hugh R/A-7417-2016; Cowie, Benjamin/HFZ-9941-2022; Narayan, K.M. Venkat/J-9819-2012; Towbin, Jeffrey A./J-5595-2019; Pope, C. Arden/ABD-5522-2021; Courville, Karen/AAW-1462-2021; Aggarwal, Rakesh/D-1583-2009; Jacobsen, Kathryn H./B-5857-2008; Choobkar, Saeed/AAA-3212-2020; PEREZ-RUIZ, FERNANDO/E-4844-2012; Matzopoulos, Richard/AAL-9965-2021; O'Donnell, Martin/ABE-7459-2020; Naldi, Luigi/AFM-8982-2022; Aboyans, Victor/AAN-8308-2020; Osborne, Richard H/A-9447-2010; Krishnamurthi, Rita/AAU-7841-2021; Bikbov, Boris/I-4594-2013; Truelsen, Thomas/AAY-1549-2020; Wagner, Gregory R/B-1014-2009; Lopez, Alan D/F-1487-2010; Bin Abdulhak, Aref/AAM-9492-2020; Carapetis, Jonathan R/H-8933-2014; , Bennett/O-7998-2019; Naldi, Luigi/K-6343-2016; Lopez, Alan/AAA-2734-2022; Pourmalek, Farshad/A-8188-2010; Harding, Richard/G-9729-2012; RUIZ, FERNANDO PEREZ/X-1980-2019; NSABIMANA, Samuel/U-5620-2017; Bennett, Derrick/AAH-1220-2022; Norman, Paul E/C-5485-2013; Franklin, Richard Charles/H-1731-2012; Adair, Tim/O-3494-2019; Harrison, James/B-8958-2009; Bennett, Derrick/AFL-9254-2022; Lozano, Rafael/T-5352-2018; Marks, Guy B./F-5058-2013; Salomon, Joshua/S-1929-2019; Sacco, Ralph/Y-9278-2019; Degenhardt, Louisa J/D-4515-2012; Salomon, Joshua A/D-3898-2009; McGrath, John Joseph/G-5493-2010; Adair, Tim/L-1332-2015; Condon, John R/N-2281-2013; Bell, Michelle/Y-4608-2018; Feigin, Valery/AAF-2313-2019; Ortblad, Katrina/ABF-9070-2020; , Ivan/D-6804-2012; Undurraga, Eduardo A./I-3739-2014; Watt, Kerrianne/G-2520-2010; Remuzzi, Giuseppe/V-9766-2017; Benjamin, Emelia/E-7103-2011	Perico, Norberto/0000-0002-3147-4327; Bolliger, Ian W/0000-0001-8055-297X; Mokdad, Ali H./0000-0002-4994-3339; Jayaraman, Sudha/0000-0003-1094-5836; Karthikeyan, Ganesan/0000-0002-2073-2917; Cowie, Benjamin/0000-0002-7087-5895; Narayan, K.M. Venkat/0000-0001-8621-5405; Towbin, Jeffrey A./0000-0002-6585-714X; Courville, Karen/0000-0002-4182-6736; Aggarwal, Rakesh/0000-0001-9689-494X; Jacobsen, Kathryn H./0000-0002-4198-6246; Matzopoulos, Richard/0000-0001-9063-6210; O'Donnell, Martin/0000-0002-7347-7761; Naldi, Luigi/0000-0002-3160-2835; Osborne, Richard H/0000-0002-9081-2699; Krishnamurthi, Rita/0000-0003-0869-2083; Bikbov, Boris/0000-0002-1925-7506; Lopez, Alan D/0000-0001-5818-6512; Bin Abdulhak, Aref/0000-0001-9988-8609; Carapetis, Jonathan R/0000-0002-1182-9792; Naldi, Luigi/0000-0002-3160-2835; Pourmalek, Farshad/0000-0002-2134-0771; RUIZ, FERNANDO PEREZ/0000-0002-5268-1894; Bennett, Derrick/0000-0002-9170-8447; Norman, Paul E/0000-0003-3406-0506; Franklin, Richard Charles/0000-0003-1864-4552; Adair, Tim/0000-0002-1562-4452; Harrison, James/0000-0001-9893-8491; Bennett, Derrick/0000-0002-9170-8447; Lozano, Rafael/0000-0002-7356-8823; Marks, Guy B./0000-0002-8976-8053; Salomon, Joshua/0000-0003-3929-5515; Degenhardt, Louisa J/0000-0002-8513-2218; Salomon, Joshua A/0000-0003-3929-5515; McGrath, John Joseph/0000-0002-4792-6068; Adair, Tim/0000-0002-1562-4452; Condon, John R/0000-0003-4952-0990; Bell, Michelle/0000-0002-3965-1359; Ortblad, Katrina/0000-0002-5675-8836; Ebel, Beth/0000-0001-9310-8325; Woolf, Anthony/0000-0001-8482-8056; Shibuya, Kenji/0000-0003-2528-7530; Knowlton, Lisa Marie/0000-0001-6046-5035; , Ivan/0000-0002-3108-058X; Miller, Ted/0000-0002-0958-2639; Boufous, Soufiane/0000-0002-5686-1729; Feigin, Valery L./0000-0002-6372-1740; Rein, David/0000-0002-1271-5789; Hotez, Peter/0000-0001-8770-1042; WILKINSON, JAMES/0000-0003-1945-5622; Aboyans, Victor/0000-0002-0322-9818; Phillips, David/0000-0003-2569-1015; Mayosi, Bongani/0000-0001-6641-8950; Kobusingye, Olive/0000-0003-2413-599X; Mocumbi, Ana/0000-0002-9564-2860; Chen, Honglei/0000-0003-3446-7779; Colquhoun, Samantha/0000-0002-6750-1147; Mock, Charles/0000-0002-0564-568X; Merriman, Tony/0000-0003-0844-8726; Cooper, Leslie/0000-0003-1002-3313; Duber, Herbert/0000-0002-5077-3170; Undurraga, Eduardo A./0000-0002-4425-1253; Pandian, Jeyaraj/0000-0003-0028-1968; Watt, Kerrianne/0000-0002-2275-081X; Coffeng, Luc Edgar/0000-0002-4425-2264; Porrini, Esteban/0000-0002-3056-4662; Smith, Emma/0000-0001-6510-2583; Remuzzi, Giuseppe/0000-0002-6194-3446; Burney, Peter/0000-0001-8635-5678; Benjamin, Emelia/0000-0003-4076-2336; Alvarado, Miriam/0000-0003-2864-9410; Mensah, George/0000-0002-0387-5326; Johns, Nicole/0000-0003-4513-4582; Tleyjeh, Imad/0000-0002-5551-0353	Bill & Melinda Gates Foundation; Medtronic; Lundbeck; Prana Biotechnology; Spanish Health Ministry; Hospital de Cruces Rheumatology Association; US NIH; Dana Foundation; Doris Duke Charitable Foundation; WHO; NIH; National Institute of Environmental Health Sciences; African Programme for Onchocerciasis Control (WHO/APOC); NIH [K23 AG034236]; Parkinson Council; Australian NHMRC; Swedish Research Council [2011-1071]; Australian National Health and Medical Research Council; Bill & Melinda Gates Foundation through the Sabin Institute; National Institutes of Health; Dutch Government; Lily and Ernst Hausmann Research Trust; Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; European Center for Injury Prevention, Universidad de Navarra; Department of Health and Ageing; Commonwealth Government of Australia; Institute of Bone and Joint Research (IBJR); University of Sydney (USYD); Department of Rheumatology; Royal North Shore Hospital; St Leonards NSW 2065 Australia; European Chemical Industry Council (CEFIC); CONCAWE (Conservation of Clean Air and Water Europe); General Research Grant at the University of Hong Kong; Medical Research Council [G0901214, G0801056B] Funding Source: researchfish; MRC [G0901214] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG034236] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Medtronic(Medtronic); Lundbeck(Lundbeck Corporation); Prana Biotechnology; Spanish Health Ministry(Instituto de Salud Carlos IIISpanish Government); Hospital de Cruces Rheumatology Association; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); WHO(World Health Organization); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); African Programme for Onchocerciasis Control (WHO/APOC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parkinson Council; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Swedish Research Council(Swedish Research CouncilEuropean Commission); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Bill & Melinda Gates Foundation through the Sabin Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Government; Lily and Ernst Hausmann Research Trust; Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; European Center for Injury Prevention, Universidad de Navarra; Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Commonwealth Government of Australia(Australian Government); Institute of Bone and Joint Research (IBJR); University of Sydney (USYD); Department of Rheumatology; Royal North Shore Hospital; St Leonards NSW 2065 Australia; European Chemical Industry Council (CEFIC); CONCAWE (Conservation of Clean Air and Water Europe); General Research Grant at the University of Hong Kong; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	E R Dorsey has received consulting fees from Medtronic and Lundbeck and research support from Lundbeck and Prana Biotechnology. M Ezzati chaired a session and gave a talk at the World Cardiology Congress (WCC), with travel cost reimbursed by the World Heart Federation. At the WCC, he also gave a talk at a session organised by PepsiCo with no financial or other renumeration. P J Hotez reports holding several positions: Dean, National School of Tropical Medicine, Baylor College of Medicine; Director, Sabin Vaccine Institute Texas Children's Hospital Center for Vaccine Development; and President, Sabin Vaccine Institute. He also is an inventor on several patents: 5,527,937 "Hookworm Anticoagulant"; 5,753,787 "Nucleic Acids for Ancylostoma Secreted Proteins"; 7,303,752 B2 "Hookworm vaccine"; 12/492,734 "Human Hookworm Vaccine"; 61/077,256 "Multivalent Anthelminthic Vaccine"; and PCT-20100701/0.20.5.18 "Malaria Transmission blocking vaccine". G A Mensah is a former employee of PepsiCo. F Perez-Ruiz was an adviser for Ardea, Menarini, Novartis, and Metabolex; was a member of the Speaker's Bureau for Menarini, Novartis; an adviser for educational issues for Savient; led an investigation grants for the Spanish Health Ministry, Hospital de Cruces Rheumatology Association; and was principal investigator in clinical trials for Ardea.; We would like to thank the countless individuals who have contributed to the Global Burden of Disease 2010 Study in various capacities. We would also like to specifically acknowledge the important contribution to this work from multiple staff members of the WHO. We also wish to thank the following organisations that hosted consultations during the final stages of the analytic process, providing valuable feedback about the results and the data to improve the study's findings overall: Pan American Health Organisation; Eastern Mediterranean Regional Office of WHO; UNAIDS; Ministry of Health, Brazil; China Centers for Disease Control; and the University of Zambia. We would like to thank Cynthia Boschi Pinto for her input into the analyses and estimates. Finally, we would like to acknowledge the extensive support from all staff members at the Institute for Health Metrics and Evaluation and specifically thank: James Bullard, Andrew Ernst, and Serkan Yalcin for their tireless support of the computational infrastructure required to produce the results; Linda A Ettinger for her expert administrative support and facilitating communication and coordination among the authors; Peter Speyer, Abigail McLain, Katherine Leach-Kemon, and Eden Stork for their persistent and invaluable work to gain access to and catalogue as much data as possible to inform the estimates; and Erin C Mullany for her systematic efforts in organising drafts of papers, formatting correspondence with expert groups, and preparing the final manuscript. The following individuals would like to acknowledge various forms of institutional support. J P Abraham acknowledges the World Bank Global Road Safety Facility and Department of Global Health & Population, Harvard School of Public Health, and the WHO Violence and Injury Prevention. K Bhalla was supported by the World Bank Global Road Safety Facility for researcher salaries, to pay for many small projects in Africa to digitise secondary data sources, and supporting several gatherings of the injury expert group over the past 6 years. B Bikbov acknowledges the Moscow State University of Medicine and Dentistry, Moscow, Russia; Academician V I Shumakov Federal Research Centre of Transplantology and Artificial Organs, Moscow, Russia; and International Society of Nephrology. G L Birbeck has received research funding from the US NIH, the Dana Foundation, and the Doris Duke Charitable Foundation; she has also received travel grants from the WHO for related work. H Chen acknowledges his participation in this study was in part supported by the intramural research program of the NIH, the National Institute of Environmental Health Sciences. L E Coffeng received financial support from the African Programme for Onchocerciasis Control (WHO/APOC) for work on onchocerciasis. M Cortinovis, F Gaspari, and N Perico acknowledge the International Society of Nephrology (ISN) on the behalf of the entire Genitourinary Expert Group. M Cross and L March acknowledge the University of Sydney (USYD); Institute of Bone and Joint Research, University of Sydney, Department of Rheumatology, Royal North Shore Hospital, St Leonards NSW 2065 Australia. N Dahodwala was supported by NIH grant K23 AG034236 and the Parkinson Council while working on this project. L Degenhardt is supported by an Australian NHMRC Senior Research Fellowship and funding to support work on illicit drug dependence was provided by the Australian National Drug and Alcohol Research Centre of the University of New South Wales, NSW, Australia.; R Havmoeller is supported by a grant from the Swedish Research Council (#2011-1071). D Hoy was supported by the Bill & Melinda Gates Foundation and the Australian National Health and Medical Research Council. P J Hotez acknowledges grant support from several sources: the Bill & Melinda Gates Foundation regarding human hookworm vaccine through the Sabin Institute (Human Hookworm Vaccine Initiative 1 Human Hookworm Vaccine Initiative; Human Hookworm Vaccine Initiative 3 Clinical Development and Evaluation of the Na-GST-1 and Na-APR-1 Hookworm Vaccine Antigen); the National Institutes of Health (Product development of a membrane tetraspanin vaccine against schistosomiasis; RBD Recombinant Protein-based SARS Vaccine for Biodefense); and the Dutch Government (Product Development Support of the Human Hookworm Vaccine). K H Jacobsen was supported by the WHO for her work on Hepatitis A. B M Mayosi was funded by the Lily and Ernst Hausmann Research Trust. T R Merriman acknowledges the Health Research Council of New Zealand. D Ozgediz is grateful for the collaboration colleagues at Mulago Hospital and Makerere University in Kampala, Uganda. B Pahari would like to thank the Mario Negri Institute. U Sampson was funded in part by The Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation and The Vanderbilt Clinical and Translational Scholars Award. M Segui-Gomez's participation was partly supported by funds of the European Center for Injury Prevention, Universidad de Navarra. E Smith acknowledges Department of Health and Ageing, Commonwealth Government of Australia, Institute of Bone and Joint Research (IBJR), University of Sydney (USYD), Department of Rheumatology, Royal North Shore Hospital, St Leonards NSW 2065 Australia. L Rushton was supported by honorarium for board membership of the European Centre for Ecotoxicology and Toxicology of Chemicals; research grants to Imperial College London (as PI) from the European Chemical Industry Council (CEFIC) and CONCAWE (Conservation of Clean Air and Water Europe). P Yip was supported by a General Research Grant at the University of Hong Kong.	AbouZahr C, 2011, REPROD HEALTH MATTER, V19, P117, DOI 10.1016/S0968-8080(11)37550-7; Adair T, 2012, INT J TUBERC LUNG D, V16, P1699, DOI 10.5588/ijtld.12.0251; Ahern RM, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-8; Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Almerie MQ, 2011, INT J GYNECOL OBSTET, V112, P70, DOI 10.1016/j.ijgo.2010.08.007; Almirall J, 2007, RESP MED, V101, P2168, DOI 10.1016/j.rmed.2007.05.007; Anker M, 1997, INT J EPIDEMIOL, V26, P1090, DOI 10.1093/ije/26.5.1090; [Anonymous], 2011, GLOB TUB CONTR 2011; [Anonymous], 2011, POP PROSP W 2010 REV; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Bates M, 2012, LANCET, V380, P560, DOI 10.1016/S0140-6736(12)61323-3; Beaglehole R, 2003, LANCET, V362, P903, DOI 10.1016/S0140-6736(03)14335-8; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Birnbaum JK, 2011, B WORLD HEALTH ORGAN, V89, P278, DOI 10.2471/BLT.11.086280; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Bulatao RA, 1992, GLOBAL ESTIMATES PRO; Centre for Research on the Epidemiology of Disasters (CRED) Office of US Foreign Disaster Assistance (OFDA), EM DAT OFDA CRED INT; Choprapawon C, 2005, Asia Pac J Public Health, V17, P110, DOI 10.1177/101053950501700209; Cooper RS, 1998, LANCET, V351, P208, DOI 10.1016/S0140-6736(97)06512-4; Crowcroft NS, 2002, ARCH DIS CHILD, V86, P336, DOI 10.1136/adc.86.5.336; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Diaz A, 2007, CHEST, V131, P779, DOI 10.1378/chest.06-1800; Elliot AJ, 2008, EXPERT REV VACCINES, V7, P249, DOI 10.1586/14760584.7.2.249; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Flaxman AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-29; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Gakidou E, 2006, DEMOGRAPHY, V43, P569, DOI 10.1353/dem.2006.0024; Ganyaglo GYK, 2012, SEMIN PERINATOL, V36, P79, DOI 10.1053/j.semperi.2011.09.015; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Glaziou P, 2011, B WORLD HEALTH ORGAN, V89, P573, DOI 10.2471/BLT.11.087510; Gleditsch NP, 2002, J PEACE RES, V39, P615, DOI 10.1177/0022343302039005007; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grassly NC, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010637; HAKULINEN T, 1986, INT J EPIDEMIOL, V15, P226, DOI 10.1093/ije/15.2.226; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; James SL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-31; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Koksal I, 2010, TUBERK TORAK, V58, P119; Kulkarni SC, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-16; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Levine OS, 2012, CLIN INFECT DIS, V54, pS93, DOI 10.1093/cid/cir1052; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Logan WPD, 1950, POP STUD-J DEMOG, V4, P132, DOI 10.2307/2172133; Lopez A D, 1982, Popul Bull UN, P66; Lopez AD, 1993, DIS CONTROL PRIORITI, P15; Lozano R, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-32; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Lu TH, 2001, J CLIN EPIDEMIOL, V54, P1086, DOI 10.1016/S0895-4356(01)00383-3; Lynch M, 2012, LANCET, V380, P559, DOI 10.1016/S0140-6736(12)61320-8; Marks G, 1997, HLTH ADULT BRIT 1841; Maruyama T, 2008, RESP MED, V102, P1287, DOI 10.1016/j.rmed.2008.03.027; Maruyama T, 2010, RESP MED, V104, P584, DOI 10.1016/j.rmed.2009.12.008; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Mock C, 2012, WORLD J SURG, V36, P959, DOI 10.1007/s00268-012-1459-6; Murray C, 2012, MORTALITY ESTIMATION; Murray C. J. L., 1996, GLOBAL BURDEN DIS, V1, P117; Murray CJL, 2007, PLOS MED, V4, P1754, DOI 10.1371/journal.pmed.0040326; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Murray CJL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-30; Murray CJL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-27; Murray CJL, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-18; Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000262; Murray CJL, 2006, CIRCULATION, V113, P2071, DOI 10.1161/CIRCULATIONAHA.105.595777; Murray CJL, 2002, BRIT MED J, V324, P346, DOI 10.1136/bmj.324.7333.346; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nugent RA, 2009, LANCET, V374, P784, DOI 10.1016/S0140-6736(09)61589-0; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Porapakkham Y, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-14; Project Description, PROJ DESCR GLOB ENT; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Roulson J, 2005, HISTOPATHOLOGY, V47, P551, DOI 10.1111/j.1365-2559.2005.02243.x; RUZICKA L T, 1990, World Health Statistics Quarterly, V43, P249; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; SCHULZ KF, 1987, GENITOURIN MED, V63, P320; Shah NK, 2012, LANCET, V380, P560, DOI 10.1016/S0140-6736(12)61322-1; Shibli F, 2010, ISR MED ASSOC J, V12, P477; Simons Emily, 2012, Lancet, V379, P2173, DOI 10.1016/S0140-6736(12)60522-4; Sonderegger-Iseli K, 2000, LANCET, V355, P2027, DOI 10.1016/S0140-6736(00)02349-7; Sullivan J., ASSESSMENT IN PRESS; UN Office on Drugs and Crimes, UN SURV CRIM TRENDS; UNAIDS, 2010, GLOB REP UNAIDS REP; UNFPA UNICEF WHO World Bank, 2012, TRENDS MAT MORT 1990; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Waage J, 2010, LANCET, V376, P991, DOI 10.1016/S0140-6736(10)61196-8; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; White NJ, 2012, LANCET, V380, P559, DOI 10.1016/S0140-6736(12)61321-X; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, HLTH METR NETW HMN; WHO, 2001, WORLD HLTH REPORT 20; WHO, DIS INJ REG EST CAUS; WHO, 2012, EST ROT DEATHS CHILD; WHO, 2007, GLOB HLTH OBS DAT RE; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, GLOB EL CONG SYPH RA; World Health Organization, 2009, GLOB STAT REP ROAD S; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Yach D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5097; Zatonski WA, 2010, EUR ADDICT RES, V16, P193, DOI 10.1159/000317248	110	7455	7961	136	904	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2012	380	9859					2095	2128		10.1016/S0140-6736(12)61728-0	http://dx.doi.org/10.1016/S0140-6736(12)61728-0			34	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23245604	Green Published, Green Accepted			2022-12-28	WOS:000312387000012
J	Vos, T; Flaxman, AD; Naghavi, M; Lozano, R; Michaud, C; Ezzati, M; Shibuya, K; Salomon, JA; Abdalla, S; Aboyans, V; Abraham, J; Ackerman, I; Aggarwal, R; Ahn, SY; Ali, MK; Alvarado, M; Anderson, HR; Anderson, LM; Andrews, KG; Atkinson, C; Baddour, LM; Bahalim, AN; Barker-Collo, S; Barrero, LH; Bartels, DH; Basanez, MG; Baxter, A; Bell, ML; Benjamin, EJ; Bennett, D; Bernabe, E; Bhalla, K; Bhandari, B; Bikbov, B; Bin Abdulhak, A; Birbeck, G; Black, JA; Blencowe, H; Blore, JD; Blyth, F; Bolliger, I; Bonaventure, A; Boufous, SA; Bourne, R; Boussinesq, M; Braithwaite, T; Brayne, C; Bridgett, L; Brooker, S; Brooks, P; Brugha, TS; Bryan-Hancock, C; Bucello, C; Buchbinder, R; Buckle, GR; Budke, CM; Burch, M; Burney, P; Burstein, R; Calabria, B; Campbell, B; Canter, CE; Carabin, H; Carapetis, J; Carmona, L; Cella, C; Charlson, F; Chen, HL; Cheng, ATA; Chou, D; Chugh, SS; Coffeng, LE; Colan, SD; Colquhoun, S; Colson, KE; Condon, J; Connor, MD; Cooper, LT; Corriere, M; Cortinovis, M; de Vaccaro, KC; Couser, W; Cowie, BC; Criqui, MH; Cross, M; Dabhadkar, KC; Dahiya, M; Dahodwala, N; Damsere-Derry, J; Danaei, G; Davis, A; De Leo, D; Degenhardt, L; Dellavalle, R; Delossantos, A; Denenberg, J; Derrett, S; Des Jarlais, DC; Dharmaratne, SD; Dherani, M; Diaz-Torne, C; Dolk, H; Dorsey, ER; Driscoll, T; Duber, H; Ebel, B; Edmond, K; Elbaz, A; Ali, SE; Erskine, H; Erwin, PJ; Espindola, P; Ewoigbokhan, SE; Farzadfar, F; Feigin, V; Felson, DT; Ferrari, A; Ferri, CP; Fevre, EM; Finucane, MM; Flaxman, S; Flood, L; Foreman, K; Forouzanfar, MH; Fowkes, FGR; Franklin, R; Fransen, M; Freeman, MK; Gabbe, BJ; Gabriel, SE; Gakidou, E; Ganatra, HA; Garcia, B; Gaspari, F; Gillum, RF; Gmel, G; Gosselin, R; Grainger, R; Groeger, J; Guillemin, F; Gunnell, D; Gupta, R; Haagsma, J; Hagan, H; Halasa, YA; Hall, W; Haring, D; Haro, JM; Harrison, JE; Havmoeller, R; Hay, RJ; Higashi, H; Hill, C; Hoen, B; Hoffman, H; Hotez, PJ; Hoy, D; Huang, JJ; Ibeanusi, SE; Jacobsen, KH; James, SL; Jarvis, D; Jasrasaria, R; Jayaraman, S; Johns, N; Jonas, JB; Karthikeyan, G; Kassebaum, N; Kawakami, N; Keren, A; Khoo, JP; King, CH; Knowlton, LM; Kobusingye, O; Koranteng, A; Krishnamurthi, R; Lalloo, R; Laslett, LL; Lathlean, T; Leasher, JL; Lee, YY; Leigh, J; Lim, SS; Limb, E; Lin, JK; Lipnick, M; Lipshultz, SE; Liu, W; Loane, M; Ohno, SL; Lyons, R; Ma, JX; Mabweijano, J; MacIntyre, MF; Malekzadeh, R; Mallinger, L; Manivannan, S; Marcenes, W; March, L; Margolis, DJ; Marks, GB; Marks, R; Matsumori, A; Matzopoulos, R; Mayosi, BM; McAnulty, JH; McDermott, MM; McGill, N; McGrath, J; Medina-Mora, ME; Meltzer, M; Mensah, GA; Merriman, TR; Meyer, AC; Miglioli, V; Miller, M; Miller, TR; Mitchell, PB; Mocumbi, AO; Moffitt, TE; Mokdad, AA; Monasta, L; Montico, M; Moradi-Lakeh, M; Moran, A; Morawska, L; Mori, R; Murdoch, ME; Mwaniki, MK; Naidoo, K; Nair, MN; Naldi, L; Narayan, KMV; Nelson, PK; Nelson, RG; Nevitt, MC; Newton, CR; Nolte, S; Norman, P; Norman, R; O'Donnell, M; O'Hanlon, S; Olives, C; Omer, SB; Ortblad, K; Osborne, R; Ozgediz, D; Page, A; Pahari, B; Pandian, JD; Rivero, AP; Patten, SB; Pearce, N; Padilla, RP; Perez-Ruiz, F; Perico, N; Pesudovs, K; Phillips, D; Phillips, MR; Pierce, K; Pion, S; Polanczyk, GV; Polinder, S; Pope, CA; Popova, S; Porrini, E; Pourmalek, F; Prince, M; Pullan, RL; Ramaiah, KD; Ranganathan, D; Razavi, H; Regan, M; Rehm, JT; Rein, DB; Remuzzi, G; Richardson, K; Rivara, FP; Roberts, T; Robinson, C; De Leon, FR; Ronfani, L; Room, R; Rosenfeld, LC; Rushton, L; Sacco, RL; Saha, S; Sampson, U; Sanchez-Riera, L; Sanman, E; Schwebel, DC; Scott, JG; Segui-Gomez, M; Shahraz, S; Shepard, DS; Shin, H; Shivakoti, R; Singh, D; Singh, GM; Singh, JA; Singleton, J; Sleet, DA; Sliwa, K; Smith, E; Smith, JL; Stapelberg, NJC; Steer, A; Steiner, T; Stolk, WA; Stovner, LJ; Sudfeld, C; Syed, S; Tamburlini, G; Tavakkoli, M; Taylor, HR; Taylor, JA; Taylor, WJ; Thomas, B; Thomson, WM; Thurston, GD; Tleyjeh, IM; Tonelli, M; Towbin, JRA; Truelsen, T; Tsilimbaris, MK; Ubeda, C; Undurraga, EA; van der Werf, MJ; van Os, J; Vavilala, MS; Venketasubramanian, N; Wang, MR; Wang, WZ; Watt, K; Weatherall, DJ; Weinstock, MA; Weintraub, R; Weisskopf, MG; Weissman, MM; White, RA; Whiteford, H; Wiersma, ST; Wilkinson, JD; Williams, HC; Williams, SRM; Witt, E; Wolfe, F; Woolf, AD; Wulf, S; Yeh, PH; Zaidi, AKM; Zheng, ZJ; Zonies, D; Lopez, AD; Murray, CJL				Vos, Theo; Flaxman, Abraham D.; Naghavi, Mohsen; Lozano, Rafael; Michaud, Catherine; Ezzati, Majid; Shibuya, Kenji; Salomon, Joshua A.; Abdalla, Safa; Aboyans, Victor; Abraham, Jerry; Ackerman, Ilana; Aggarwal, Rakesh; Ahn, Stephanie Y.; Ali, Mohammed K.; Alvarado, Miriam; Anderson, H. Ross; Anderson, Laurie M.; Andrews, Kathryn G.; Atkinson, Charles; Baddour, Larry M.; Bahalim, Adil N.; Barker-Collo, Suzanne; Barrero, Lope H.; Bartels, David H.; Basanez, Maria-Gloria; Baxter, Amanda; Bell, Michelle L.; Benjamin, Emelia J.; Bennett, Derrick; Bernabe, Eduardo; Bhalla, Kavi; Bhandari, Bishal; Bikbov, Boris; Bin Abdulhak, Aref; Birbeck, Gretchen; Black, James A.; Blencowe, Hannah; Blore, Jed D.; Blyth, Fiona; Bolliger, Ian; Bonaventure, Audrey; Boufous, Soufi Ane; Bourne, Rupert; Boussinesq, Michel; Braithwaite, Tasanee; Brayne, Carol; Bridgett, Lisa; Brooker, Simon; Brooks, Peter; Brugha, Traolach S.; Bryan-Hancock, Claire; Bucello, Chiara; Buchbinder, Rachelle; Buckle, Geoff Rey; Budke, Christine M.; Burch, Michael; Burney, Peter; Burstein, Roy; Calabria, Bianca; Campbell, Benjamin; Canter, Charles E.; Carabin, Helene; Carapetis, Jonathan; Carmona, Loreto; Cella, Claudia; Charlson, Fiona; Chen, Honglei; Cheng, Andrew Tai-Ann; Chou, David; Chugh, Sumeet S.; Coffeng, Luc E.; Colan, Steven D.; Colquhoun, Samantha; Colson, K. Ellicott; Condon, John; Connor, Myles D.; Cooper, Leslie T.; Corriere, Matthew; Cortinovis, Monica; de Vaccaro, Karen Courville; Couser, William; Cowie, Benjamin C.; Criqui, Michael H.; Cross, Marita; Dabhadkar, Kaustubh C.; Dahiya, Manu; Dahodwala, Nabila; Damsere-Derry, James; Danaei, Goodarz; Davis, Adrian; De Leo, Diego; Degenhardt, Louisa; Dellavalle, Robert; Delossantos, Allyne; Denenberg, Julie; Derrett, Sarah; Des Jarlais, Don C.; Dharmaratne, Samath D.; Dherani, Mukesh; Diaz-Torne, Cesar; Dolk, Helen; Dorsey, E. Ray; Driscoll, Tim; Duber, Herbert; Ebel, Beth; Edmond, Karen; Elbaz, Alexis; Ali, Suad Eltahir; Erskine, Holly; Erwin, Patricia J.; Espindola, Patricia; Ewoigbokhan, Stalin E.; Farzadfar, Farshad; Feigin, Valery; Felson, David T.; Ferrari, Alize; Ferri, Cleusa P.; Fevre, Eric M.; Finucane, Mariel M.; Flaxman, Seth; Flood, Louise; Foreman, Kyle; Forouzanfar, Mohammad H.; Fowkes, Francis Gerry R.; Franklin, Richard; Fransen, Marlene; Freeman, Michael K.; Gabbe, Belinda J.; Gabriel, Sherine E.; Gakidou, Emmanuela; Ganatra, Hammad A.; Garcia, Bianca; Gaspari, Flavio; Gillum, Richard F.; Gmel, Gerhard; Gosselin, Richard; Grainger, Rebecca; Groeger, Justina; Guillemin, Francis; Gunnell, David; Gupta, Ramyani; Haagsma, Juanita; Hagan, Holly; Halasa, Yara A.; Hall, Wayne; Haring, Diana; Maria Haro, Josep; Harrison, James E.; Havmoeller, Rasmus; Hay, Roderick J.; Higashi, Hideki; Hill, Catherine; Hoen, Bruno; Hoffman, Howard; Hotez, Peter J.; Hoy, Damian; Huang, John J.; Ibeanusi, Sydney E.; Jacobsen, Kathryn H.; James, Spencer L.; Jarvis, Deborah; Jasrasaria, Rashmi; Jayaraman, Sudha; Johns, Nicole; Jonas, Jost B.; Karthikeyan, Ganesan; Kassebaum, Nicholas; Kawakami, Norito; Keren, Andre; Khoo, Jon-Paul; King, Charles H.; Knowlton, Lisa Marie; Kobusingye, Olive; Koranteng, Adofo; Krishnamurthi, Rita; Lalloo, Ratilal; Laslett, Laura L.; Lathlean, Tim; Leasher, Janet L.; Lee, Yong Yi; Leigh, James; Lim, Stephen S.; Limb, Elizabeth; Lin, John Kent; Lipnick, Michael; Lipshultz, Steven E.; Liu, Wei; Loane, Maria; Ohno, Summer Lockett; Lyons, Ronan; Ma, Jixiang; Mabweijano, Jacqueline; MacIntyre, Michael F.; Malekzadeh, Reza; Mallinger, Leslie; Manivannan, Sivabalan; Marcenes, Wagner; March, Lyn; Margolis, David J.; Marks, Guy B.; Marks, Robin; Matsumori, Akira; Matzopoulos, Richard; Mayosi, Bongani M.; McAnulty, John H.; McDermott, Mary M.; McGill, Neil; McGrath, John; Elena Medina-Mora, Maria; Meltzer, Michele; Mensah, George A.; Merriman, Tony R.; Meyer, Ana-Claire; Miglioli, Valeria; Miller, Matthew; Miller, Ted R.; Mitchell, Philip B.; Mocumbi, Ana Olga; Moffitt, Terrie E.; Mokdad, Ali A.; Monasta, Lorenzo; Montico, Marcella; Moradi-Lakeh, Maziar; Moran, Andrew; Morawska, Lidia; Mori, Rintaro; Murdoch, Michele E.; Mwaniki, Michael K.; Naidoo, Kovin; Nair, M. Nathan; Naldi, Luigi; Narayan, K. M. Venkat; Nelson, Paul K.; Nelson, Robert G.; Nevitt, Michael C.; Newton, Charles R.; Nolte, Sandra; Norman, Paul; Norman, Rosana; O'Donnell, Martin; O'Hanlon, Simon; Olives, Casey; Omer, Saad B.; Ortblad, Katrina; Osborne, Richard; Ozgediz, Doruk; Page, Andrew; Pahari, Bishnu; Pandian, Jeyaraj Durai; Rivero, Andrea Panozo; Patten, Scott B.; Pearce, Neil; Perez Padilla, Rogelio; Perez-Ruiz, Fernando; Perico, Norberto; Pesudovs, Konrad; Phillips, David; Phillips, Michael R.; Pierce, Kelsey; Pion, Sebastien; Polanczyk, Guilherme V.; Polinder, Suzanne; Pope, C. Arden, III; Popova, Svetlana; Porrini, Esteban; Pourmalek, Farshad; Prince, Martin; Pullan, Rachel L.; Ramaiah, Kapa D.; Ranganathan, Dharani; Razavi, Homie; Regan, Mathilda; Rehm, Juergen T.; Rein, David B.; Remuzzi, Guiseppe; Richardson, Kathryn; Rivara, Frederick P.; Roberts, Thomas; Robinson, Carolyn; De Leon, Felipe Rodriguez; Ronfani, Luca; Room, Robin; Rosenfeld, Lisa C.; Rushton, Lesley; Sacco, Ralph L.; Saha, Sukanta; Sampson, Uchechukwu; Sanchez-Riera, Lidia; Sanman, Ella; Schwebel, David C.; Scott, James Graham; Segui-Gomez, Maria; Shahraz, Saeid; Shepard, Donald S.; Shin, Hwashin; Shivakoti, Rupak; Singh, David; Singh, Gitanjali M.; Singh, Jasvinder A.; Singleton, Jessica; Sleet, David A.; Sliwa, Karen; Smith, Emma; Smith, Jennifer L.; Stapelberg, Nicolas J. C.; Steer, Andrew; Steiner, Timothy; Stolk, Wilma A.; Stovner, Lars Jacob; Sudfeld, Christopher; Syed, Sana; Tamburlini, Giorgio; Tavakkoli, Mohammad; Taylor, Hugh R.; Taylor, Jennifer A.; Taylor, William J.; Thomas, Bernadette; Thomson, W. Murray; Thurston, George D.; Tleyjeh, Imad M.; Tonelli, Marcello; Towbin, Jeff Rey A.; Truelsen, Thomas; Tsilimbaris, Miltiadis K.; Ubeda, Clotilde; Undurraga, Eduardo A.; van der Werf, Marieke J.; van Os, Jim; Vavilala, Monica S.; Venketasubramanian, N.; Wang, Mengru; Wang, Wenzhi; Watt, Kerrianne; Weatherall, David J.; Weinstock, Martin A.; Weintraub, Robert; Weisskopf, Marc G.; Weissman, Myrna M.; White, Richard A.; Whiteford, Harvey; Wiersma, Steven T.; Wilkinson, James D.; Williams, Hywel C.; Williams, Sean R. M.; Witt, Emma; Wolfe, Frederick; Woolf, Anthony D.; Wulf, Sarah; Yeh, Pon-Hsiu; Zaidi, Anita K. M.; Zheng, Zhi-Jie; Zonies, David; Lopez, Alan D.; Murray, Christopher J. L.			Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010	LANCET			English	Article							IRON-DEFICIENCY ANEMIA; DEPRESSIVE DISORDER; HEARING IMPAIRMENT; COGNITIVE FUNCTION; MENTAL-DISORDERS; LIFE EXPECTANCY; 187 COUNTRIES; PREVALENCE; HEALTH; POPULATION	Background Non-fatal health outcomes from diseases and injuries are a crucial consideration in the promotion and monitoring of individual and population health. The Global Burden of Disease (GBD) studies done in 1990 and 2000 have been the only studies to quantify non-fatal health outcomes across an exhaustive set of disorders at the global and regional level. Neither effort quantified uncertainty in prevalence or years lived with disability (YLDs). Methods Of the 291 diseases and injuries in the GBD cause list, 289 cause disability. For 1160 sequelae of the 289 diseases and injuries, we undertook a systematic analysis of prevalence, incidence, remission, duration, and excess mortality. Sources included published studies, case notification, population-based cancer registries, other disease registries, antenatal clinic serosurveillance, hospital discharge data, ambulatory care data, household surveys, other surveys, and cohort studies. For most sequelae, we used a Bayesian meta-regression method, DisMod-MR, designed to address key limitations in descriptive epidemiological data, including missing data, inconsistency, and large methodological variation between data sources. For some disorders, we used natural history models, geospatial models, back-calculation models (models calculating incidence from population mortality rates and case fatality), or registration completeness models (models adjusting for incomplete registration with health-system access and other covariates). Disability weights for 220 unique health states were used to capture the severity of health loss. YLDs by cause at age, sex, country, and year levels were adjusted for comorbidity with simulation methods. We included uncertainty estimates at all stages of the analysis. Findings Global prevalence for all ages combined in 2010 across the 1160 sequelae ranged from fewer than one case per 1 million people to 350 000 cases per 1 million people. Prevalence and severity of health loss were weakly correlated (correlation coefficient -0.37). In 2010, there were 777 million YLDs from all causes, up from 583 million in 1990. The main contributors to global YLDs were mental and behavioural disorders, musculoskeletal disorders, and diabetes or endocrine diseases. The leading specific causes of YLDs were much the same in 2010 as they were in 1990: low back pain, major depressive disorder, iron-deficiency anaemia, neck pain, chronic obstructive pulmonary disease, anxiety disorders, migraine, diabetes, and falls. Age-specific prevalence of YLDs increased with age in all regions and has decreased slightly from 1990 to 2010. Regional patterns of the leading causes of YLDs were more similar compared with years of life lost due to premature mortality. Neglected tropical diseases, HIV/AIDS, tuberculosis, malaria, and anaemia were important causes of YLDs in sub-Saharan Africa. Interpretation Rates of YLDs per 100 000 people have remained largely constant over time but rise steadily with age. Population growth and ageing have increased YLD numbers and crude rates over the past two decades. Prevalences of the most common causes of YLDs, such as mental and behavioural disorders and musculoskeletal disorders, have not decreased. Health systems will need to address the needs of the rising numbers of individuals with a range of disorders that largely cause disability but not mortality. Quantification of the burden of non-fatal health outcomes will be crucial to understand how well health systems are responding to these challenges. Effective and affordable strategies to deal with this rising burden are an urgent priority for health systems in most parts of the world.	[Baxter, Amanda; Erskine, Holly; Ferrari, Alize; Khoo, Jon-Paul; Saha, Sukanta; Whiteford, Harvey] Univ Queensland, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Vos, Theo; Blore, Jed D.; Charlson, Fiona; Higashi, Hideki; Lee, Yong Yi; Norman, Rosana; Page, Andrew; Lopez, Alan D.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Scott, James Graham] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [McGrath, John] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Flaxman, Abraham D.; Naghavi, Mohsen; Lozano, Rafael; Ahn, Stephanie Y.; Alvarado, Miriam; Andrews, Kathryn G.; Atkinson, Charles; Bolliger, Ian; Burstein, Roy; Campbell, Benjamin; Chou, David; Colson, K. Ellicott; Delossantos, Allyne; Dharmaratne, Samath D.; Forouzanfar, Mohammad H.; Freeman, Michael K.; Gakidou, Emmanuela; Haring, Diana; James, Spencer L.; Jasrasaria, Rashmi; Johns, Nicole; Lim, Stephen S.; Ohno, Summer Lockett; MacIntyre, Michael F.; Mallinger, Leslie; Mokdad, Ali A.; Nair, M. Nathan; Ortblad, Katrina; Phillips, David; Pierce, Kelsey; Ranganathan, Dharani; Roberts, Thomas; Rosenfeld, Lisa C.; Sanman, Ella; Wang, Mengru; Wulf, Sarah; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Anderson, Laurie M.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98121 USA; [Kassebaum, Nicholas] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98121 USA; [Michaud, Catherine] China Med Board, Boston, MA USA; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England; [Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [Finucane, Mariel M.] Harvard Univ, Dept Biostat, Boston, MA 02115 USA; [Salomon, Joshua A.; Danaei, Goodarz; Lin, John Kent; Miller, Matthew; Singh, Gitanjali M.; Sudfeld, Christopher; Tavakkoli, Mohammad; Weisskopf, Marc G.; White, Richard A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Liu, Wei] Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA; [Knowlton, Lisa Marie] Harvard Univ, Harvard Humanitarian Initiat, Boston, MA 02115 USA; [Colan, Steven D.] Harvard Univ, Boston Childrens Hosp, Boston, MA 02115 USA; [Jayaraman, Sudha] Harvard Univ, Brigham & Womens Hosp, Boston, MA 02115 USA; [Bartels, David H.; Bhalla, Kavi] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Aboyans, Victor] Dupuytren Univ Hosp, Dept Cardiol, Limoges, France; [Abraham, Jerry] Univ Texas San Antonio, San Antonio, TX USA; [Steer, Andrew] Univ Melbourne, Ctr Int Child Hlth, Melbourne, Vic, Australia; [Weintraub, Robert] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Degenhardt, Louisa] Univ Melbourne, Ctr Hlth Policy Programs & Econ, Melbourne, Vic, Australia; [Room, Robin] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic, Australia; [Aggarwal, Rakesh] Sanjay Gandhi Postgrad Inst Med Sci, Lucknow, Uttar Pradesh, India; [Omer, Saad B.] Emory Univ, Sch Publ Hlth, Atlanta, GA USA; [Omer, Saad B.] Emory Univ, Sch Med, Atlanta, GA USA; [Anderson, H. Ross; Gupta, Ramyani; Limb, Elizabeth] St Georges Univ London, London, England; [Baddour, Larry M.; Erwin, Patricia J.; Gabriel, Sherine E.] Mayo Clin, Rochester, MN USA; [Barker-Collo, Suzanne] Univ Auckland, Auckland 1, New Zealand; [Barrero, Lope H.] Pontificia Univ Javeriana, Sch Engn, Dept Ind Engn, Bogota, Colombia; [Bell, Michelle L.; Huang, John J.; Ozgediz, Doruk] Yale Univ, New Haven, CT USA; [Felson, David T.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Bennett, Derrick] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Bennett, Derrick] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Bernabe, Eduardo] Kings Coll London, Inst Dent, London WC2R 2LS, England; [Hay, Roderick J.] Kings Coll London, Hosp NHS Trust, London WC2R 2LS, England; [Prince, Martin] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Dahiya, Manu] Queen Mary Univ London, Inst Dent, London, England; [Bikbov, Boris] Moscow State Univ Med & Dent, Res Inst Transplantol & Artificial Organs, Moscow, Russia; [Bin Abdulhak, Aref; Tleyjeh, Imad M.] King Fahad Med City, Riyadh, Saudi Arabia; [Birbeck, Gretchen] Michigan State Univ, E Lansing, MI 48824 USA; [Black, James A.] MRC, Epidemiol Unit, Cambridge, England; [Blencowe, Hannah; Brooker, Simon; Edmond, Karen; Pearce, Neil; Pullan, Rachel L.; Smith, Jennifer L.] London Sch Hyg & Trop Med, London WC1, England; [Smith, Emma] Univ Sydney, No Clin Sch, Dept Rheumatol, Sydney, NSW 2006, Australia; [Fransen, Marlene] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [March, Lyn; Sanchez-Riera, Lidia] Univ Sydney, Inst Bone & Joint Res, Sydney, NSW 2006, Australia; [Driscoll, Tim; Leigh, James] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Bonaventure, Audrey; Elbaz, Alexis] INSERM, Paris, France; [Calabria, Bianca; Degenhardt, Louisa; Nelson, Paul K.; Singleton, Jessica] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Bucello, Chiara; Mitchell, Philip B.] Univ New S Wales, Sydney, NSW, Australia; [Bourne, Rupert] Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, England; [Braithwaite, Tasanee] Moorfields Eye Hosp, London, England; [Brayne, Carol; Richardson, Kathryn] Univ Cambridge, Cambridge, England; [Brugha, Traolach S.] Univ Leicester, Leicester, Leics, England; [Bryan-Hancock, Claire; Flood, Louise; Harrison, James E.; Lathlean, Tim; Pesudovs, Konrad] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [Buchbinder, Rachelle] Cabrini Inst, Malvern, Vic, Australia; [Gabbe, Belinda J.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Buckle, Geoff Rey; Manivannan, Sivabalan] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Budke, Christine M.] Texas A&M Univ, College Stn, TX USA; [Burch, Michael] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Canter, Charles E.] Washington Univ, St Louis, MO USA; [Carabin, Helene] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Carapetis, Jonathan] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Carmona, Loreto] Univ Camilo Jose Cela, Villanueva De La Canada, Spain; [Cella, Claudia; Cortinovis, Monica; Gaspari, Flavio; Miglioli, Valeria; Perico, Norberto; Remuzzi, Guiseppe] Mario Negri Inst Pharmacol Res, I-24100 Bergamo, Italy; [Chen, Honglei] NIEHS, Res Triangle Pk, NC 27709 USA; [Cheng, Andrew Tai-Ann] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Havmoeller, Rasmus] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Polinder, Suzanne] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [Colquhoun, Samantha; Condon, John] Menzies Sch Hlth Res, Darwin, NT, Australia; [Connor, Myles D.] Natl Hlth Serv, Edinburgh, Midlothian, Scotland; [Connor, Myles D.; Fowkes, Francis Gerry R.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Connor, Myles D.] Univ Witwatersrand, Johannesburg, South Africa; [Cooper, Leslie T.] Loyola Univ, Sch Med, Chicago, IL 60611 USA; [Corriere, Matthew] Wake Forest Univ, Sch Publ Hlth Sci, Winston Salem, NC 27109 USA; [de Vaccaro, Karen Courville] Hosp Dr Gustavo N Collado, Puerto Chitre, Panama; [Cowie, Benjamin C.] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Criqui, Michael H.; Denenberg, Julie] Univ Calif San Diego, San Diego, CA 92103 USA; [Dahodwala, Nabila; Margolis, David J.] Univ Penn, Philadelphia, PA 19104 USA; [Damsere-Derry, James] Bldg & Rd Res Inst, Kumasi, Ghana; [Davis, Adrian] MRC Hearing & Commun Grp, Manchester, Lancs, England; [Lalloo, Ratilal] Griffith Univ, Sch Dent & Oral Hlth, Brisbane, Qld 4111, Australia; [Lalloo, Ratilal] Griffith Univ, Populat & Social Hlth Res Program, Brisbane, Qld 4111, Australia; [Dellavalle, Robert] Denver VA Med Ctr, Denver, CO USA; [Derrett, Sarah; Grainger, Rebecca; Merriman, Tony R.; Taylor, William J.; Thomson, W. Murray] Univ Otago, Dunedin, New Zealand; [Des Jarlais, Don C.] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; [Dharmaratne, Samath D.] Univ Peradeniya, Peradeniya, Sri Lanka; [Dherani, Mukesh] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Diaz-Torne, Cesar] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Dolk, Helen; Loane, Maria] Univ Ulster, Ulster, Ireland; [Ali, Suad Eltahir] Fed Minist Hlth, Khartoum, Sudan; [Espindola, Patricia] Hosp Maciel, Montevideo, Uruguay; [Ewoigbokhan, Stalin E.] Emerald Publ Hlth Consulting Serv Ltd, Abuja, Nigeria; [Malekzadeh, Reza] Univ Tehran Med Sci, Digest Dis Res Ctr, Tehran, Iran; [Feigin, Valery] Auckland Tech Univ, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Polanczyk, Guilherme V.] Univ Fed Sao Paulo, Sch Med, Sao Paulo, Brazil; [Flaxman, Seth] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Franklin, Richard] Royal Life Saving Soc, Sydney, NSW, Australia; [Franklin, Richard; Watt, Kerrianne] James Cook Univ, Townsville, Qld 4811, Australia; [Gillum, Richard F.] Howard Univ, Coll Med, Washington, DC USA; [Gmel, Gerhard] Addict Info Switzerland, Lausanne, Switzerland; [Nevitt, Michael C.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Groeger, Justina] Suny Downstate Med Ctr, Coll Med, Brooklyn, NY 11203 USA; [Sleet, David A.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Guillemin, Francis] Univ Lorraine, Nancy, France; [Gunnell, David] Univ Bristol, Bristol, Avon, England; [Hagan, Holly; Thurston, George D.] NYU, New York, NY USA; [Halasa, Yara A.; Shahraz, Saeid; Shepard, Donald S.; Undurraga, Eduardo A.] Brandeis Univ, Waltham, MA USA; [Maria Haro, Josep] Univ Barcelona, CIBERSAM, St Bio De Llobregat, Spain; [Havmoeller, Rasmus] Karolinska Univ Hosp, Stockholm, Sweden; [Hill, Catherine] Queen Elizabeth Hosp, Adelaide, SA, Australia; [Hoen, Bruno] Univ Franche Comte, F-25030 Besancon, France; [Hoen, Bruno] Ctr Hosp Reg Univ Besancon, Besancon, France; [Hoffman, Howard] NIDCD, NIH, Bethesda, MD USA; [Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, Waco, TX USA; [Ibeanusi, Sydney E.] Univ Port Harcourt, Port Harcourt, Nigeria; [Jacobsen, Kathryn H.] George Mason Univ, Fairfax, VA 22030 USA; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany; [Karthikeyan, Ganesan] All India Inst Med Sci, New Delhi, India; [Keren, Andre] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Cardiol, IL-91010 Jerusalem, Israel; [King, Charles H.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Kobusingye, Olive] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Kobusingye, Olive] Univ S Africa, Johannesburg, South Africa; [Koranteng, Adofo] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Laslett, Laura L.] Univ Tasmania, Hobart, Tas 7001, Australia; [Leasher, Janet L.] Nova SE Univ, Ft Lauderdale, FL 33314 USA; [Lipshultz, Steven E.; Sacco, Ralph L.; Wilkinson, James D.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Lyons, Ronan] Swansea Univ, Swansea, W Glam, Wales; [Ma, Jixiang] China Ctr Dis Control, Natl Ctr Noncommunicable Dis Control & Prevent, Beijing, Peoples R China; [Mabweijano, Jacqueline] Mulago Hosp, Kampala, Uganda; [Matsumori, Akira] Asian Pacific Soc Cardiol, Kyoto, Japan; [Matzopoulos, Richard] MRC, Tygerberg, South Africa; [Sliwa, Karen] Univ Cape Town, Hatter Inst, ZA-7925 Cape Town, South Africa; [Mensah, George A.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [McAnulty, John H.] Legacy Hlth Syst, Portland, OR USA; [McDermott, Mary M.] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA; [Elena Medina-Mora, Maria] Natl Inst Psychiat Ramon de la Fuente, Mexico City, DF, Mexico; [Meltzer, Michele] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Mocumbi, Ana Olga] Natl Inst Hlth, Maputo, Mozambique; [Mocumbi, Ana Olga] Univ Eduardo Mondlane, Maputo, Mozambique; [Moffitt, Terrie E.] Duke Univ, Durham, NC USA; [Monasta, Lorenzo; Montico, Marcella; Ronfani, Luca; Tamburlini, Giorgio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Weissman, Myrna M.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Morawska, Lidia] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Tokyo, Japan; [Murdoch, Michele E.] Watford Dist Gen Hosp, Watford, England; [Mwaniki, Michael K.] Kemri Wellcome Trust, Kilifi, Kenya; [Naidoo, Kovin] Univ KwaZulu Natal, AVRI, Durban, South Africa; [Naldi, Luigi] Ctr Studi GISED, Bergamo, Italy; [Nolte, Sandra] Charite, D-13353 Berlin, Germany; [O'Donnell, Martin] Natl Univ Ireland Galway, HRB Clin Res Facil, Galway, Ireland; [Osborne, Richard] Deakin Univ, Melbourne, Vic, Australia; [Pahari, Bishnu] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Pandian, Jeyaraj Durai] Betty Cowan Res & Innovat Ctr, Ludhiana, Punjab, India; [Rivero, Andrea Panozo] Hosp Joan 23, La Paz, Bolivia; [Patten, Scott B.] Univ Calgary, Calgary, AB, Canada; [Perez Padilla, Rogelio] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Perez-Ruiz, Fernando] Hosp Univ Cruces, Baracaldo, Spain; [Phillips, Michael R.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Zheng, Zhi-Jie] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China; [Pope, C. Arden, III] Brigham Young Univ, Provo, UT 84602 USA; [Popova, Svetlana; Rehm, Juergen T.] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Porrini, Esteban] Hosp Univ Canarias, Tenerif, Spain; [Pourmalek, Farshad] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Ramaiah, Kapa D.] Vector Control Res Ctr, Pondicherry, India; [Razavi, Homie] Ctr Dis Anal, Louisville, CO USA; [Regan, Mathilda] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Rein, David B.] Univ Chicago, NORC, Chicago, IL 60637 USA; [De Leon, Felipe Rodriguez] Complejo Hosp Caja Seguro Social, Panama City, Panama; [Room, Robin] Turning Point Alcohol & Drug Ctr, Ctr Alcohol Policy Res, Fitzroy, SA, Australia; [Sampson, Uchechukwu] Vanderbilt Univ, Nashville, TN USA; [Schwebel, David C.; Singh, Jasvinder A.] Univ Alabama Birmingham, Birmingham, AL USA; [Segui-Gomez, Maria] Minist Interior, Madrid, Spain; [Shin, Hwashin] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Singh, David] Queens Med Ctr, Honolulu, HI USA; [Stovner, Lars Jacob] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Syed, Sana; Zaidi, Anita K. M.] Agwa Khan Univ, Karachi, Pakistan; [Taylor, Jennifer A.] Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA; [Tonelli, Marcello] Univ Alberta, Alberta Kidney Dis Network, Edmonton, AB, Canada; [Towbin, Jeff Rey A.] Cincinnati Childrens Hosp, Cincinnati, OH USA; [Truelsen, Thomas] Copenhagen Univ Hosp, Dept Neurol, Herlev, Denmark; [Tsilimbaris, Miltiadis K.] Univ Crete, Sch Med, Iraklion, Greece; [Ubeda, Clotilde] ANLIS, Inst Nacl Epidemiol, Malbran, Argentina; [van der Werf, Marieke J.] KNCV TB Fdn, The Hague, Netherlands; [van Os, Jim] Maastricht Univ Med Ctr, Maastricht, Netherlands; [Venketasubramanian, N.] Natl Univ Singapore, Singapore 117548, Singapore; [Wang, Wenzhi] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [Weinstock, Martin A.] Brown Univ, Providence, RI 02912 USA; [Weintraub, Robert] Royal Childrens Hosp, Melbourne, Vic, Australia; [Weintraub, Robert] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Williams, Hywel C.] Univ Nottingham, Nottingham NG7 2RD, England; [Williams, Sean R. M.] Univ Western Sydney, Campbelltown, NSW, Australia; [Wolfe, Frederick] Arthrit Res, Wichita, KS USA; [Woolf, Anthony D.] Royal Cornwall Hosp, Truro, England; [Yeh, Pon-Hsiu] London Sch Econ, London WC2A 2AE, England; [Zonies, David] Landstuhl Reg Med Ctr, Landstuhl, Germany; [Nelson, Robert G.] NIDDK, NIH, Bethesda, MD USA	Queensland Centre for Mental Health Research; University of Queensland; University of Queensland; University of Queensland; University of Queensland; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Imperial College London; University of Tokyo; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; CHU Limoges; University of Texas System; University of Texas at San Antonio (UTSA); University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Emory University; Emory University; St Georges University London; Mayo Clinic; University of Auckland; Pontificia Universidad Javeriana; Yale University; Boston University; University of Oxford; University of Oxford; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; Queen Mary University London; Moscow State University of Medicine & Dentistry; V.I. Shumakov Federal Research Center of Transplantology & Artificial Organs; Michigan State University; University of London; London School of Hygiene & Tropical Medicine; University of Sydney; University of Sydney; University of Sydney; University of Sydney; Institut National de la Sante et de la Recherche Medicale (Inserm); University of New South Wales Sydney; University of New South Wales Sydney; Anglia Ruskin University; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Cambridge; University of Leicester; Flinders University South Australia; Cabrini Health; Monash University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Texas A&M University System; Texas A&M University College Station; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Washington University (WUSTL); University of Oklahoma System; University of Oklahoma Health Sciences Center; Telethon Kids Institute; University of Western Australia; Camilo Jose Cela University; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Academia Sinica - Taiwan; Cedars Sinai Medical Center; Erasmus University Rotterdam; Erasmus MC; Charles Darwin University; Menzies School of Health Research; NHS Blood & Transplant (NHSBT); University of Edinburgh; University of Witwatersrand; Loyola University Chicago; Wake Forest University; Victorian Infectious Diseases Reference Laboratory; University of California System; University of California San Diego; University of Pennsylvania; Griffith University; Griffith University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Otago; Harvard University; Beth Israel Deaconess Medical Center; University of Peradeniya; University of Liverpool; Hospital of Santa Creu i Sant Pau; Ulster University; Tehran University of Medical Sciences; Universidade Federal de Sao Paulo (UNIFESP); Carnegie Mellon University; James Cook University; Howard University; University of California System; University of California San Francisco; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Centers for Disease Control & Prevention - USA; Universite de Lorraine; University of Bristol; New York University; Brandeis University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Karolinska Institutet; Karolinska University Hospital; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Baylor College of Medicine; University of Port Harcourt; George Mason University; Ruprecht Karls University Heidelberg; All India Institute of Medical Sciences (AIIMS) New Delhi; Hebrew University of Jerusalem; Case Western Reserve University; Makerere University; University of South Africa; Kwame Nkrumah University Science & Technology; University of Tasmania; Nova Southeastern University; University of Miami; Swansea University; Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Mulago National Referral Hospital; University of Cape Town; University of Cape Town; Legacy Health; Northwestern University; Feinberg School of Medicine; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Jefferson University; Pacific Institute for Research & Evaluation (PIRE); Eduardo Mondlane University; Duke University; IRCCS Burlo Garofolo; Columbia University; Queensland University of Technology (QUT); National Center for Child Health & Development - Japan; Watford General Hospital; University of Kwazulu Natal; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway; Deakin University; B.P. Koirala Institute of Health Sciences; University of Calgary; Hospital Universitario Cruces; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Brigham Young University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Universidad de la Laguna; University of British Columbia; Indian Council of Medical Research (ICMR); ICMR - Vector Control Research Center (VCRC); University of California System; University of California Berkeley; University of Chicago; Caja del Seguro Social (CSS); Complejo Hospitalario Doctor Arnulfo Arias Madrid; Turning Point Alcohol & Drug Centre - Australia; Vanderbilt University; University of Alabama System; University of Alabama Birmingham; Health Canada; The Queen's Medical Center; Norwegian University of Science & Technology (NTNU); Drexel University; University of Alberta; Cincinnati Children's Hospital Medical Center; University of Copenhagen; University of Crete; KNCV Tuberculosis Foundation; Maastricht University; Maastricht University Medical Centre (MUMC); National University of Singapore; Beijing Neurosurgical Institute; Capital Medical University; Brown University; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Nottingham; Western Sydney University; National Data Bank for Rheumatic Diseases; Royal Cornwall Hospital; University of London; London School Economics & Political Science; Landstuhl Regional Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@uw.edu	Degenhardt, Louisa J/D-4515-2012; Room, Robin/ABF-7460-2021; Bin Abdulhak, Aref/AAK-4348-2020; Elbaz, Alexis/F-8952-2017; Matzopoulos, Richard/AAL-9965-2021; Franklin, Richard Charles/H-1731-2012; Mokdad, Ali H./AAD-1232-2022; Aggarwal, Rakesh/D-1583-2009; Newton, Charles/V-7872-2019; Erskine, Holly/K-5244-2012; Sacco, Ralph/Y-9278-2019; Hill, Catherine L/AAE-7152-2019; Narayan, K.M. Venkat/J-9819-2012; Naldi, Luigi/AFM-8982-2022; Polanczyk, Guilherme V./AAF-6142-2021; Prince, Martin J/A-9170-2010; Pope, C. Arden/ABD-5522-2021; SHIN, HS/AAE-5381-2022; Choobkar, Saeed/AAA-3212-2020; Bennett, Derrick/AFL-9254-2022; Montico, Marcella/B-5290-2013; RUIZ, FERNANDO PEREZ/X-1980-2019; Room, Robin/ABH-8505-2020; Higashi, Hideki/D-3797-2011; Davis, Adrian C/E-6022-2015; Polanczyk, Guilherme V/C-2345-2012; Patten, Scott/B-4434-2011; Singh, Jasvinder/R-6172-2019; Dellavalle, Robert/L-2020-2013; Braithwaite, Tasanee/AAZ-1118-2020; Phillips, Michael Robert/AAE-7585-2021; Lopez, Alan D/F-1487-2010; Brayne, Carol/AAA-4285-2020; Stovner, Lars Jacob/D-5025-2014; Lathlean, Tim/K-3653-2013; Bennett, Derrick/AAH-1220-2022; Courville, Karen/AAW-1462-2021; Truelsen, Thomas/AAY-1549-2020; Cheng, Andrew/O-1159-2018; Ferrari, Alize J/G-1746-2011; Newton, Charles RJC/B-7578-2014; Naidoo, Kovin Shunmugam/AAF-5914-2020; Cowie, Benjamin/HFZ-9941-2022; Lee, Yong Yi/C-1373-2015; Bell, Michelle/Y-4608-2018; Ganatra, Hammad A/P-8652-2019; , Bennett/O-7998-2019; Jacobsen, Kathryn H./B-5857-2008; Medina-Mora, María Elena I/T-5937-2018; Anderson, Hugh R/A-7417-2016; Bernabe, Eduardo/R-3441-2017; Nolte, Sandra/B-7498-2008; Thomson, William Murray/AAC-8575-2019; Moffitt, Terrie E/D-5295-2011; Naldi, Luigi/K-6343-2016; Harrison, James/B-8958-2009; Lalloo, Ratilal/O-5624-2014; Baxter, Amanda/E-5449-2011; Charlson, Fiona/R-8963-2019; Hall, Wayne D/A-3283-2008; Ebel, Beth/F-4544-2014; Black, James A/A-5917-2010; Carapetis, Jonathan R/H-8933-2014; Osborne, Richard H/A-9447-2010; Ali, Mohammed K/N-9833-2013; Moradi-Lakeh, Maziar/ABC-9793-2021; Tonelli, Marcello/B-3028-2009; O'Donnell, Martin/ABE-7459-2020; Bikbov, Boris/I-4594-2013; Díaz-Torné, César/AAG-2419-2020; PACELLA, ROSANA E./F-2774-2010; Charlson, Fiona J/F-5290-2011; Lopez, Alan/AAA-2734-2022; Grainger, Rebecca/I-1866-2012; Norman, Paul E/C-5485-2013; Schwebel, David/GXH-9944-2022; Monasta, Lorenzo/B-1388-2012; van Os, Jim/V-8884-2019; Salomon, Joshua/S-1929-2019; Salomon, Joshua A/D-3898-2009; Pesudovs, Konrad/T-9403-2019; Pourmalek, Farshad/A-8188-2010; van Os, Jim/C-2113-2014; Zonies, David/B-6497-2011; Bolliger, Ian W/C-4207-2016; Aboyans, Victor/AAN-8308-2020; Oliveira, Claudia DL/G-8618-2011; Karthikeyan, Ganesan/D-5767-2012; Condon, John R/N-2281-2013; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Jayaraman, Sudha/AAH-3059-2019; Perico, Norberto/ABH-3222-2020; Malekzadeh, Reza/U-1382-2017; Whiteford, Harvey A/A-4840-2009; Venketasubramanian, Narayanaswamy/GPP-5948-2022; Boussinesq, Michel/J-7256-2016; Krishnamurthi, Rita/AAU-7841-2021; Marks, Guy B./F-5058-2013; Lozano, Rafael/T-5352-2018; Ortblad, Katrina/ABF-9070-2020; Coffeng, Luc/AAL-6631-2021; Colan, Steven/ABB-4580-2020; Brugha, Traolach/T-9326-2019; Carabin, Helene/B-7600-2016; McGrath, John Joseph/G-5493-2010; Bin Abdulhak, Aref/AAM-9492-2020; Pandian, Jeyaraj Durai/AAV-5591-2020; Feigin, Valery/AAF-2313-2019; Saha, Sukanta/K-3774-2012; Thomson, William Murray/A-4971-2008; Carmona, Loreto/A-2748-2014; Ferri, Cleusa Pinheiro/B-2922-2010; Steer, Andrew C/C-2840-2013; Buchbinder, Rachelle/G-2952-2011; Thurston, George/ABB-1359-2021; Scott, James G/D-5900-2012; Laslett, Laura/G-3973-2011; PEREZ-RUIZ, FERNANDO/E-4844-2012; Haro, Josep Maria/D-1423-2011; Jarvis, Deborah/E-6494-2011; Ronfani, Luca/B-6668-2013; Sudfeld, Christopher/AAW-3856-2021; Gunnell, David/ABE-6653-2020; Leasher, Janet/B-8889-2016; Remuzzi, Giuseppe/V-9766-2017; Blore, Jed/K-6331-2012; Watt, Kerrianne/G-2520-2010; Undurraga, Eduardo A./I-3739-2014; Morawska, Lidia/B-4140-2011; Shivakoti, Rupak/HIU-0448-2022; Benjamin, Emelia/E-7103-2011	Degenhardt, Louisa J/0000-0002-8513-2218; Room, Robin/0000-0002-5618-385X; Elbaz, Alexis/0000-0001-9724-5490; Matzopoulos, Richard/0000-0001-9063-6210; Franklin, Richard Charles/0000-0003-1864-4552; Mokdad, Ali H./0000-0002-4994-3339; Aggarwal, Rakesh/0000-0001-9689-494X; Newton, Charles/0000-0002-6999-5507; Erskine, Holly/0000-0003-3119-9211; Hill, Catherine L/0000-0001-8289-4922; Narayan, K.M. Venkat/0000-0001-8621-5405; Naldi, Luigi/0000-0002-3160-2835; Polanczyk, Guilherme V./0000-0003-2311-3289; Prince, Martin J/0000-0003-1379-7146; SHIN, HS/0000-0002-7263-6257; Bennett, Derrick/0000-0002-9170-8447; Montico, Marcella/0000-0003-0377-8232; RUIZ, FERNANDO PEREZ/0000-0002-5268-1894; Higashi, Hideki/0000-0002-5534-0905; Davis, Adrian C/0000-0001-7134-7528; Polanczyk, Guilherme V/0000-0003-2311-3289; Patten, Scott/0000-0001-9871-4041; Singh, Jasvinder/0000-0003-3485-0006; Dellavalle, Robert/0000-0001-8132-088X; Braithwaite, Tasanee/0000-0002-3025-4066; Phillips, Michael Robert/0000-0002-5973-2439; Lopez, Alan D/0000-0001-5818-6512; Brayne, Carol/0000-0001-5307-663X; Bennett, Derrick/0000-0002-9170-8447; Courville, Karen/0000-0002-4182-6736; Cheng, Andrew/0000-0002-2698-0516; Ferrari, Alize J/0000-0002-7863-9117; Newton, Charles RJC/0000-0002-6999-5507; Cowie, Benjamin/0000-0002-7087-5895; Lee, Yong Yi/0000-0003-2359-6823; Bell, Michelle/0000-0002-3965-1359; Ganatra, Hammad A/0000-0001-9534-2780; Jacobsen, Kathryn H./0000-0002-4198-6246; Medina-Mora, María Elena I/0000-0001-9300-0752; Bernabe, Eduardo/0000-0002-1858-3713; Nolte, Sandra/0000-0001-6185-9423; Moffitt, Terrie E/0000-0002-8589-6760; Naldi, Luigi/0000-0002-3160-2835; Harrison, James/0000-0001-9893-8491; Lalloo, Ratilal/0000-0001-5822-1269; Baxter, Amanda/0000-0001-8198-9022; Charlson, Fiona/0000-0003-2876-5040; Hall, Wayne D/0000-0003-1984-0096; Black, James A/0000-0002-2200-3179; Carapetis, Jonathan R/0000-0002-1182-9792; Osborne, Richard H/0000-0002-9081-2699; Moradi-Lakeh, Maziar/0000-0001-7381-5305; Tonelli, Marcello/0000-0002-0846-3187; O'Donnell, Martin/0000-0002-7347-7761; Bikbov, Boris/0000-0002-1925-7506; Díaz-Torné, César/0000-0001-6275-7699; PACELLA, ROSANA E./0000-0002-9742-1957; Charlson, Fiona J/0000-0003-2876-5040; Grainger, Rebecca/0000-0001-9201-8678; Norman, Paul E/0000-0003-3406-0506; Monasta, Lorenzo/0000-0001-7774-548X; van Os, Jim/0000-0002-7245-1586; Salomon, Joshua/0000-0003-3929-5515; Salomon, Joshua A/0000-0003-3929-5515; Pesudovs, Konrad/0000-0002-6322-9369; Pourmalek, Farshad/0000-0002-2134-0771; Bolliger, Ian W/0000-0001-8055-297X; Karthikeyan, Ganesan/0000-0002-2073-2917; Condon, John R/0000-0003-4952-0990; Jayaraman, Sudha/0000-0003-1094-5836; Perico, Norberto/0000-0002-3147-4327; Malekzadeh, Reza/0000-0002-9820-6335; Whiteford, Harvey A/0000-0003-4667-6623; Boussinesq, Michel/0000-0001-6312-0681; Krishnamurthi, Rita/0000-0003-0869-2083; Marks, Guy B./0000-0002-8976-8053; Lozano, Rafael/0000-0002-7356-8823; Ortblad, Katrina/0000-0002-5675-8836; Coffeng, Luc/0000-0002-4425-2264; Brugha, Traolach/0000-0002-9786-9591; McGrath, John Joseph/0000-0002-4792-6068; Bin Abdulhak, Aref/0000-0001-9988-8609; Thomson, William Murray/0000-0003-0588-6843; Carmona, Loreto/0000-0002-4401-2551; Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Buchbinder, Rachelle/0000-0002-0597-0933; Scott, James G/0000-0002-0744-0688; Laslett, Laura/0000-0002-4336-0095; Haro, Josep Maria/0000-0002-3984-277X; Ronfani, Luca/0000-0001-5710-3914; Sudfeld, Christopher/0000-0002-3203-3638; Gunnell, David/0000-0002-0829-6470; King, Charles/0000-0001-8349-9270; Mori, Rintaro/0000-0001-7656-6156; Mock, Charles/0000-0002-0564-568X; Sanchez Riera, Lidia/0000-0003-0774-2480; Tleyjeh, Imad/0000-0002-5551-0353; Leasher, Janet/0000-0002-8779-5162; Pion, Sebastien/0000-0002-9468-7020; Colquhoun, Samantha/0000-0002-6750-1147; Syed, Sana/0000-0003-0954-0583; Feigin, Valery L./0000-0002-6372-1740; Porrini, Esteban/0000-0002-3056-4662; Johns, Nicole/0000-0003-4513-4582; Razavi, Homie/0000-0002-2658-6930; Woolf, Anthony/0000-0001-8482-8056; Cella, Claudia/0000-0002-9210-0775; Jarvis, Deborah/0000-0002-1753-3896; williams, hywel/0000-0002-5646-3093; Boufous, Soufiane/0000-0002-5686-1729; Cooper, Leslie/0000-0003-1002-3313; Mensah, George/0000-0002-0387-5326; Miller, Ted/0000-0002-0958-2639; Farzadfar, Farshad/0000-0001-8288-4046; Phillips, David/0000-0003-2569-1015; Duber, Herbert/0000-0002-5077-3170; Mocumbi, Ana/0000-0002-9564-2860; Remuzzi, Giuseppe/0000-0002-6194-3446; O'donnell, Colm/0000-0002-8004-450X; Tsilimbaris, Miltiadis/0000-0002-0130-1150; Weissman, Myrna/0000-0003-3490-3075; Loane, Maria/0000-0002-1206-3637; WILKINSON, JAMES/0000-0003-1945-5622; Basanez, Maria-Gloria/0000-0001-5031-3361; Rein, David/0000-0002-1271-5789; Gabbe, Belinda/0000-0001-7096-7688; Blore, Jed/0000-0002-3649-8686; Ebel, Beth/0000-0001-9310-8325; Buckle, Geoffrey/0000-0001-7721-0397; Mitchell, Philip/0000-0002-7954-5235; Ali, Mohammed/0000-0001-7266-2503; Pullan, Rachel/0000-0001-9844-1362; O'Hanlon, Simon/0000-0002-6852-3911; Watt, Kerrianne/0000-0002-2275-081X; Pandian, Jeyaraj/0000-0003-0028-1968; Chen, Honglei/0000-0003-3446-7779; Malekzadeh, Reza/0000-0003-1043-3814; White, Richard Aubrey/0000-0002-6747-1726; Pearce, Neil/0000-0002-9938-7852; Mayosi, Bongani/0000-0001-6641-8950; Undurraga, Eduardo A./0000-0002-4425-1253; Smith, Emma/0000-0001-6510-2583; Lin, John/0000-0003-2490-4453; Taylor, Hugh/0000-0002-9437-784X; Alvarado, Miriam/0000-0003-2864-9410; Groeger, Justina/0000-0003-0324-3385; Morawska, Lidia/0000-0002-0594-9683; Wolfe, Frederick/0000-0002-2801-6413; Ackerman, Ilana/0000-0002-6028-1612; Shivakoti, Rupak/0000-0002-2773-9310; Merriman, Tony/0000-0003-0844-8726; Benjamin, Emelia/0000-0003-4076-2336; Kobusingye, Olive/0000-0003-2413-599X; Stolk, Wilma/0000-0001-9509-1328; Blencowe, Hannah/0000-0003-1556-3159; Calabria, Bianca/0000-0001-6444-4696; Dherani, Mukesh/0000-0002-3055-9636; Budke, Christine/0000-0002-4750-0905; Derrett, Sarah/0000-0003-2867-0498; Shibuya, Kenji/0000-0003-2528-7530; Bonaventure, Audrey/0000-0001-6665-8145; Knowlton, Lisa Marie/0000-0001-6046-5035; Hotez, Peter/0000-0001-8770-1042; Aboyans, Victor/0000-0002-0322-9818; Felson, David/0000-0002-2668-2447; Fevre, Eric/0000-0001-8931-4986; Lathlean, Timothy/0000-0001-7340-1567; Barrero, Lope/0000-0003-1503-0264; Burney, Peter/0000-0001-8635-5678; Gmel, Gerhard/0000-0001-9403-9405	Berlin Heart Honoraria; Lundbeck; Medtronic; Prana Biotechnology; Safework Australia; Assurance-Maladie (CNAMTS) InVS; Inserm; CHU de Nancy; CHU de Nice; Conseil Regional de Lorraine; Societe Francaise de Negma-Lerads; Pfizer; Pierre Fabre Medicaments; Sanofi-Aventis France; Spanish Health Ministry; Hospital de Cruces Rheumatology Association; Novartis; National Council for Scientific and Technological Development (CNPq, Brazil); European Chemical Industry Council (CEFIC); CONCAWE (Conservation of Clean Air and Water Europe); Takeda; Savient; Ardea; Regeneron; Allergan; URL pharmaceuticals; 36 companies; National Institutes of Arthritis, Musculoskeletal and Skin Diseases (NIAMS); National Institute on Aging (NIA); National Cancer Institute (NCI); Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs); Moscow State University of Medicine and Dentistry, Moscow, Russia; Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow, Russia; International Society of Nephrology; Wellcome Trust [098045, 085308]; Department of Health London for the National Health Service Information Centre; University of Leicester; Australian National Health and Medical Research Council (NHMRC); Monash University; Cabrini Health; BUPA Foundation; NIH, the National Institute of Environmental Health Sciences; Africa Programme for Onchocerciasis Control (WHO/APOC); NIH [K23 AG034236]; Parkinson Council; Australian NHMRC; US Department of Veterans Affairs; Health Research Council of New Zealand; University of Otago; National Institute for Stroke and Applied Neurosciences; Swedish Research Council [2011-1071]; Bill and Melinda Gates Foundation; Australian National Health and Medical Research Council; World Health Organization; World Mental Health Japan (WMH-J); Grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Japan Ministry of Health, Labour, and Welfare [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013]; Australian Government; National Health and Medical Research Council of Australia; Arthritis Foundation of Australia; Tasmanian Community Fund; Masonic Centenary Medical Research Foundation; Royal Hobart Hospital Research Foundation; University of Tasmania; Tehran University of Medical Sciences; South African Medical Research Council Burden of Disease Research Unit; University of Cape Town School of Public Health and Family Medicine; Brien Holden Vision Institute; National Drug and Alcohol Research Centre (UNSW, Australia); Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; Biostatistics, Epidemiologic and Bioinformatic Training in Environmental Health Training Grant [ES015459]; Burke Global Health Fellowship; Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; European Center for Injury Prevention, Universidad de Navarra; National Institute of Environmental Health Sciences [ES00260]; Wellcome Trust UK; Medical Research Council UK; Anthony Cerami and Ann Dunne Research Trust; AUT University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES015459, P30ES000260, ZIAES101986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG034236] Funding Source: NIH RePORTER; Medical Research Council [G0901214, G0801056B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish; MRC [G0901214] Funding Source: UKRI	Berlin Heart Honoraria; Lundbeck(Lundbeck Corporation); Medtronic(Medtronic); Prana Biotechnology; Safework Australia; Assurance-Maladie (CNAMTS) InVS; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CHU de Nancy; CHU de Nice; Conseil Regional de Lorraine(Region Grand-Est); Societe Francaise de Negma-Lerads; Pfizer(Pfizer); Pierre Fabre Medicaments; Sanofi-Aventis France(Sanofi-Aventis); Spanish Health Ministry(Instituto de Salud Carlos IIISpanish Government); Hospital de Cruces Rheumatology Association; Novartis(Novartis); National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); European Chemical Industry Council (CEFIC); CONCAWE (Conservation of Clean Air and Water Europe); Takeda(Takeda Pharmaceutical Company Ltd); Savient; Ardea; Regeneron(Regeneron); Allergan(AbbVieAllergan); URL pharmaceuticals; 36 companies; National Institutes of Arthritis, Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs); Moscow State University of Medicine and Dentistry, Moscow, Russia; Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow, Russia; International Society of Nephrology; Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health London for the National Health Service Information Centre; University of Leicester; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); Cabrini Health; BUPA Foundation; NIH, the National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Africa Programme for Onchocerciasis Control (WHO/APOC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parkinson Council; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); US Department of Veterans Affairs(US Department of Veterans Affairs); Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago; National Institute for Stroke and Applied Neurosciences; Swedish Research Council(Swedish Research CouncilEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); World Health Organization(World Health Organization); World Mental Health Japan (WMH-J); Grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Japan Ministry of Health, Labour, and Welfare; Australian Government(Australian GovernmentCGIAR); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Arthritis Foundation of Australia; Tasmanian Community Fund; Masonic Centenary Medical Research Foundation; Royal Hobart Hospital Research Foundation; University of Tasmania; Tehran University of Medical Sciences(Tehran University of Medical Sciences); South African Medical Research Council Burden of Disease Research Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Cape Town School of Public Health and Family Medicine; Brien Holden Vision Institute; National Drug and Alcohol Research Centre (UNSW, Australia); Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Biostatistics, Epidemiologic and Bioinformatic Training in Environmental Health Training Grant; Burke Global Health Fellowship; Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; European Center for Injury Prevention, Universidad de Navarra; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Wellcome Trust UK(Wellcome Trust); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Anthony Cerami and Ann Dunne Research Trust; AUT University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	C E Canter has worked as an Optum Health consultant, Blue Cross Blue Shield consultant, and received Berlin Heart Honoraria and travel fees. E R Dorsey has received payments for consulting services from Lundbeck and Medtronic and research support from Lundbeck and Prana Biotechnology. T Driscoll was supported in part by funding from the National Occupational Health and Safety Commission (now Safework Australia). M Ezzati chaired a session and gave a talk at the World Cardiology Congress (WCC), with travel cost reimbursed by the World Heart Federation. At the WCC, he also gave a talk at a session organised by PepsiCo with no financial or other remuneration. F Guillemin did a study on osteoarthritis epidemiology in an institution that received grants from public sources: Assurance-Maladie (CNAMTS) InVS, Inserm, CHU de Nancy, CHU de Nice, Conseil Regional de Lorraine, Societe Francaise de Negma-Lerads, Pfizer, Pierre Fabre Medicaments, Sanofi-Aventis France. H J Hoffman is a US Federal Government employee of the National Institutes of Health (NIH). P J Hotez reports holding several positions: Dean, National School of Tropical Medicine, Baylor College of Medicine; Director, Sabin Vaccine Institute Texas Children's Hospital Center for Vaccine Development; and President, Sabin Vaccine Institute. He also is an inventor on several patents: 5,527,937 "Hookworm Anticoagulant"; 5,753,787 "Nucleic Acids for Ancylostoma Secreted Proteins"; 7,303,752 B2 "Hookworm vaccine"; 12/492,734 "Human Hookworm Vaccine"; 61/077,256 "Multivalent Anthelminthic Vaccine"; and PCT-20100701/0.20.5.18 "Malaria Transmission blocking vaccine". G A Mensah is a former employee of PepsiCo. F Perez-Ruiz was an advisor for Ardea, Menarini, Novartis, Metabolex; was a member of the Speaker's Bureau for Menarini, Novartis; an advisor for educational issues for Savient; led investigation grants for the Spanish Health Ministry, Hospital de Cruces Rheumatology Association; and was principal investigator in clinical trials for Ardea. G V Polanczyk has served as a speaker or consultant to Eli-Lily, Novartis, Janssen-Cilag, and Shire Pharmaceuticals, developed educational material for Janssen-Cilag, and received an independent investigator grant from Novartis and from the National Council for Scientific and Technological Development (CNPq, Brazil). L Rushton received honorarium for board membership of the European Centre for Ecotoxicology and Toxicology of Chemicals and received research grants to Imperial College London (as PI) from the European Chemical Industry Council (CEFIC) and CONCAWE (Conservation of Clean Air and Water Europe). J A Singh has received research grants from Takeda and Savient and consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals, and Novartis. J A Singh is a member of the executive of OMERACT, an organisation that develops outcome measures in rheumatology and receives arms-length funding from 36 companies; a member of the American College of Rheumatology's Guidelines Subcommittee of the Quality of Care Committee; and a member of the Veterans Affairs Rheumatology Field Advisory Committee. J A Singh is supported by research grants from the National Institutes of Arthritis, Musculoskeletal and Skin Diseases (NIAMS), National Institute on Aging (NIA), National Cancer Institute (NCI) and the Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs) and is also supported by the resources and the use of facilities at the VA Medical Center at Birmingham, Alabama, USA.; We would like to thank the countless individuals who have contributed to the Global Burden of Disease Study 2010 in various capacities. We would also like to specifically acknowledge the important contribution to this work from multiple staff members of the World Health Organization. We also wish to express our gratitude to the following organizations that hosted consultations during the final stages of the analytic process, providing valuable feedback about the results and the data to improve the study's findings overall: Pan American Health Organization; Eastern Mediterranean Regional Office of WHO; UNAIDS; Ministry of Health, Brazil; China Centers for Disease Control; and the University of Zambia. We would like to thank Lori M Newman, Jordis Ott, Poul Erik Petersen, Shekhar Saxena, and Gretchen A Stevens for their collaboration and input into the analyses and estimates. Finally, we would like to acknowledge the extensive support from all staff members at the Institute for Health Metrics and Evaluation and specifically thank: James Bullard, Andrew Ernst, and Serkan Yalcin for their tireless support of the computational infrastructure required to produce the results; Linda A Ettinger for her expert administrative support in order to facilitate communication and coordination amongst the authors; Peter Speyer, Abigail McLain, Katherine Leach-Kemon, and Eden Stork for their persistent and valuable work to gain access to and catalog as much data as possible to inform the estimates; Erin C Mullany for her systematic efforts in organizing drafts of papers, formatting correspondence with expert groups, and preparing the final manuscript; Brad Bell for his review, critiques, and insights about the DisMod-MR software which helped to improve its performance and results; and Jiaji Du for his work developing the user interface for the DisMod-MR software so that multiple expert groups could use it and easily assess the results. The following individuals would like to acknowledge various forms of institutional support. J P Abraham, B Bartels, and P Yeh recognize the support of the World Bank Global Road Safety Facility and Department of Global Health & Population, Harvard School of Public Health, and the World Health Organization Violence and Injury Prevention. B Bikbov acknowledges support from the Moscow State University of Medicine and Dentistry, Moscow, Russia; Academician V.I. Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow, Russia; International Society of Nephrology. R Bourne acknowledges the Vision & Eye Research Unit, Postgraduate Medical Institute, Anglia Ruskin University, Cambridge, UK. S Brooker is supported by a Wellcome Trust Senior Fellowship in Basic Biomedical Science (098045). T S Brugha received funding from the Department of Health London, for the National Health Service Information Centre, by the University of Leicester. R Buchbinder is partially funded by an Australian National Health and Medical Research Council (NHMRC) Practitioner Fellowship, Monash University and Cabrini Health. P Burney and D Jarvis acknowledge that the Chronic Respiratory Disease Group received support from the BUPA Foundation, who had no role in study design, data collection and analysis, interpretation of data, decision to publish, or preparation of the manuscript. C Cella, M Cortinovis, F Gaspari, V Miglioli, and N Perico on behalf of the entire Genitourinary Expert Group acknowledge the International Society of Nephrology (ISN).; H Chen acknowledges that his participation in this study was in part supported by the intramural research program of the NIH, the National Institute of Environmental Health Sciences. L E Coffeng and W A Stolk received financial support from the Africa Programme for Onchocerciasis Control (WHO/APOC) for their work on onchocerciasis. B C Cowie received institutional support from the Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia. M Cross and L March acknowledge the University of Sydney (USYD); Institute of Bone and Joint Research, University of Sydney, Department of Rheumatology, Royal North Shore Hospital, St Leonards NSW 2065 Australia. N Dahodwala was supported by NIH grant K23 AG034236 and the Parkinson Council while working on this project. L Degenhardt is supported by an Australian NHMRC Senior Research Fellowship and funding to support her work for illicit drug dependence was provided by the Australian National Drug and Alcohol Research Centre of the University of New South Wales, Australia. R Dellavalle was supported by the US Department of Veterans Affairs while contributing to this study. S Derrett acknowledges the Health Research Council of New Zealand and the University of Otago for their support. V Feigin and R Krishnamurthi were supported by the National Institute for Stroke and Applied Neurosciences, AUT University. E Fevre acknowledges the Wellcome Trust for grant 085308. W Hall was supported by an NHMRC Australia Fellowship. R Havmoeller was supported by a grant from the Swedish Research Council (#2011-1071). D Hoy was supported by the Bill and Melinda Gates Foundation and the Australian National Health and Medical Research Council. K H Jacobsen was supported by the World Health Organization for her work on hepatitis A. N Kawakami notes that the collection of data ultimately used in this study was supported by the following grants: The World Mental Health Japan (WMH-J) is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013) from the Japan Ministry of Health, Labour, and Welfare. He would like to thank staff members, field coordinators, and interviewers of the WMH Japan 2002-2004 Survey. L L Laslett is supported by an Australian Government Australian Postgraduate Award. She also notes that the TasOAC study, the results of which were used in this research, was supported by the National Health and Medical Research Council of Australia; Arthritis Foundation of Australia; Tasmanian Community Fund; Masonic Centenary Medical Research Foundation, Royal Hobart Hospital Research Foundation, and University of Tasmania Institutional Research Grants Scheme. R Malekzadeh funding from research grant of Tehran University of Medical Sciences to do the related studies. R Matzopoulos acknowledges the two institutions that support his research work: South African Medical Research Council Burden of Disease Research Unit; and the University of Cape Town School of Public Health and Family Medicine. T Merriman acknowledges the Health Research Council of New Zealand. K Naidoo was supported by the Brien Holden Vision Institute. P Nelson was supported by the National Drug and Alcohol Research Centre (UNSW, Australia). R G Nelson acknowledges his research was supported in part by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. C Olives was funded in part by the Biostatistics, Epidemiologic and Bioinformatic Training in Environmental Health Training Grant (ES015459).; D Ozgediz acknowledges the staff and collaborators at the Mulago Hospital and Makerere University in Kampala, Uganda. K Pesudovs received institutional support from Flinders University. R Room's position at the University of Melbourne and Turning Point Alcohol and Drug Centre is funded by the Foundation for Alcohol Research and Education and the Victorian Department of Health. J A Salomon received support from the Burke Global Health Fellowship while working on this study. U Sampson received funding support from the Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation and the Vanderbilt Clinical and Translational Scholars Award. L Sanchez-Riera acknowledges the Spanish Society of Rheumatology (Sociedad Espanola de Reumatologia). M Segui-Gomez's participation was partly supported by funds from the European Center for Injury Prevention, Universidad de Navarra. E Smith acknowledges the Department of Health and Ageing, Commonwealth Government of Australia, Institute of Bone and Joint Research (IBJR), University of Sydney (USYD). G D Thurston was supported in part by Center grant ES00260 from the National Institute of Environmental Health Sciences. D J Weatherall was supported by the Wellcome Trust UK, the Medical Research Council UK and the Anthony Cerami and Ann Dunne Research Trust.	Agency for Healthcare Research and Quality, US MED EXP PAN SURV; ALTER G, 1989, POP STUD-J DEMOG, V43, P25, DOI 10.1080/0032472031000143836; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2021, CANC INCIDENCE 5 CON; Australian Bureau of Statistics A, NAT SURV MENT HLTH W; Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Beaglehole R., 2003, WORLD HLTH REPORT 20; Begg SJ, 2008, MED J AUSTRALIA, V188, P36, DOI 10.5694/j.1326-5377.2008.tb01503.x; Bhidayasiri R, 2011, NEUROEPIDEMIOLOGY, V37, P222, DOI 10.1159/000334440; Brody J A, 1990, Aging (Milano), V2, P283; Brooker S, 2001, TROP MED INT HEALTH, V6, P998, DOI 10.1046/j.1365-3156.2001.00798.x; Brooker S, 2010, INT J PARASITOL, V40, P1137, DOI 10.1016/j.ijpara.2010.04.004; Brooks PM., 2004, APLAR J RHEUMATOL, V7, P272, DOI [10.1111/j.1479-8077.2004.00102.x, DOI 10.1111/J.1479-8077.2004.00102.X]; Canadian Institute of Health Information, 2011, NAT AMB CAR REP SYST; CDC National Center for Health Statistics, 1993, NAT AMB MED CAR SURV; CDC National Center for Health Statistics, 1992, NAT HOSP AMB MED CAR; Chen Wan-qing, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P374; Clements ACA, 2009, B WORLD HEALTH ORGAN, V87, P921, DOI 10.2471/BLT.08.058933; Cohen A., 2002, WORLD MENTAL HLTH CA; Dodhia H, 2008, J PUBLIC HEALTH-UK, V30, P313, DOI 10.1093/pubmed/fdn015; Doll R., 1966, CANC INCIDENCE 5 CON, VI; Doll R, 1970, CANC INCIDENCE 5 CON, VII; Eaton WW, 2007, ACTA PSYCHIAT SCAND, V116, P182, DOI 10.1111/j.1600-0447.2007.01017.x; Eppig C, 2010, P ROY SOC B-BIOL SCI, V277, P3801, DOI 10.1098/rspb.2010.0973; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Friedman C, 2004, J OCCUP ENVIRON MED, V46, P3, DOI 10.1097/01.jom.0000105915.59342.9a; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Gates GA, 2002, J AM GERIATR SOC, V50, P482, DOI 10.1046/j.1532-5415.2002.50114.x; Ghys PD, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010199; Global Initiative for Chronic Obstructive Lung Disease, 2011, GLOB STRAT DIAGN MAN; Goldman LS, 1999, J GEN INTERN MED, V14, P569, DOI 10.1046/j.1525-1497.1999.03478.x; GRUENBERG EM, 1977, MILBANK FUND Q, V55, P3, DOI 10.2307/3349592; Hickman M., 2002, B NARCOTICS, VLIV, P15, DOI DOI 10.1016/J.DRUGOPO.2005.02.05; HOFMAN A, 1991, INT J EPIDEMIOL, V20, P736, DOI 10.1093/ije/20.3.736; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hotez PJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P467; Hsairi M, 2003, Sante Publique, V15, P25; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S20; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S22; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S18; Iwata N, 2002, PSYCHIAT RES, V110, P281, DOI 10.1016/S0165-1781(02)00102-6; Jablensky A, 2000, AUST NZ J PSYCHIAT, V34, P221, DOI 10.1046/j.1440-1614.2000.00728.x; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Johansson S R, 1991, Health Transit Rev, V1, P39; Kapteyn A, 2007, AM ECON REV, V97, P461, DOI 10.1257/aer.97.1.461; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; King CH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000209; King G, 2004, AM POLIT SCI REV, V98, P191, DOI 10.1017/S000305540400108X; Kominski GF, 2002, PUBLIC HEALTH REP, V117, P185, DOI 10.1016/S0033-3549(04)50125-5; KRAMER M, 1980, ACTA PSYCHIAT SCAND, V62, P382, DOI 10.1111/j.1600-0447.1980.tb07714.x; Kristensen N, 2008, LABOUR ECON, V15, P96, DOI 10.1016/j.labeco.2006.11.001; Leonard H, 2003, PAEDIATR PERINAT EP, V17, P58, DOI 10.1046/j.1365-3016.2003.00469.x; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lozoff B, 1996, J PEDIATR-US, V129, P382, DOI 10.1016/S0022-3476(96)70070-7; MacKenzie EJ, 2007, J TRAUMA, V63, pS54, DOI 10.1097/TA.0b013e31815acb09; Manton KG, 2008, J GERONTOL B-PSYCHOL, V63, pS269, DOI 10.1093/geronb/63.5.S269; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Mathers Colin D, 2006, Popul Health Metr, V4, P4, DOI 10.1186/1478-7954-4-4; Mayr WT, 2003, NEUROLOGY, V61, P1373, DOI 10.1212/01.WNL.0000094316.90240.EB; Michaud Catherine M, 2006, Popul Health Metr, V4, P11, DOI 10.1186/1478-7954-4-11; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; MUIR CS, 1987, IARC SCI PUBLICATION, V88; Munos MK, 2010, INT J EPIDEMIOL, V39, P56, DOI 10.1093/ije/dyq022; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJ, GLOBAL BURDEN DIS CO; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Murray CJL., 1996, GLOBAL HLTH STAT COM, V1996; New York Heart Association, 1964, DIS HEART BLOOD VESS; Olshansky S.J., 1991, J AGING HEALTH, V3, P194, DOI DOI 10.1177/089826439100300205; PARKIN DM, 1992, IARC SCI PUBLICATION, V120; PARKIN DM, 1997, IARC SCI PUBLICATION, V143; Parkin DM, 2002, IARC SCI PUBLICATION, VVIII; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; RCGP Research & Surveillance Centre, 2009, WEEKL RET SERV ANN R; RCGP Research & Surveillance Centre, 2005, WEEKL RET SERV ANN R; RCGP Research & Surveillance Centre, 2008, WEEKL RET SERV ANN R; RCGP Research & Surveillance Centre, 2007, WEEKL RET SERV ANN R; RCGP Research & Surveillance Centre, 2010, WEEKL RET SERV ANN R; RCGP Research & Surveillance Centre, 2006, WEEKL RET SERV ANN R; Salomon JA, 2004, BMJ-BRIT MED J, V328, P258, DOI 10.1136/bmj.37963.691632.44; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Schopper D, 2000, INT J EPIDEMIOL, V29, P871, DOI 10.1093/ije/29.5.871; Schur N, 2013, ACTA TROP, V128, P365, DOI 10.1016/j.actatropica.2011.10.006; Simeon DT, 1995, W INDIAN MED J, P27; Soriano JB, 2003, INT J TUBERC LUNG D, V7, P415; Strickland D, 2004, MOVEMENT DISORD, V19, P318, DOI 10.1002/mds.10619; Sugawara N, 2011, ANN GEN PSYCHIATR, V10, DOI 10.1186/1744-859X-10-27; UNAIDS, 2011, SPECTR EPP 2011; US National Institutes of Health National Institute on Alcohol Abuse and Alcoholism, NAT EP SURV ALC REL; van Baal Pieter H M, 2006, Popul Health Metr, V4, P1, DOI 10.1186/1478-7954-4-1; VERBRUGGE LM, 1984, MILBANK FUND Q, V62, P475, DOI 10.2307/3349861; Wallhagen MI, 2008, RES GERONTOL NURS, V1, P80, DOI 10.3928/19404921-20080401-08; WALTER T, 1989, PEDIATRICS, V84, P7; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Waterhouse J., 1976, IARC SCI PUBLICATION, V15; Waterhouse JA, 1982, IARC SCI PUBLICATION, VIV; Watkins WE, 1996, T ROY SOC TROP MED H, V90, P156, DOI 10.1016/S0035-9203(96)90121-2; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2010, WOR HEALT REP, P1; WHO, 2001, WORLD HLTH REPORT 20; Woolf AD, 2000, ANN RHEUM DIS, V59, P81, DOI 10.1136/ard.59.2.81; Woolf AD, 2001, BMJ-BRIT MED J, V322, P1079, DOI 10.1136/bmj.322.7294.1079; World Health Organization, 2004, WORLD HLTH REP 2004; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Zhou SC, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-188	108	4512	4751	52	1436	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2012	380	9859					2163	2196		10.1016/S0140-6736(12)61729-2	http://dx.doi.org/10.1016/S0140-6736(12)61729-2			34	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23245607	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000312387000015
J	Chamberlain, JS				Chamberlain, Jeffrey S.			A Genetic Intervention Stands a Skip Away from Clinical Tests	SCIENCE			English	Editorial Material							DUCHENNE MUSCULAR-DYSTROPHY; MOLECULAR-BASIS; EXPRESSION		[Chamberlain, Jeffrey S.] Univ Washington, Dept Neurol, Sch Med, Seattle, WA 98195 USA; [Chamberlain, Jeffrey S.] Univ Washington, Dept Med, Sch Med, Seattle, WA 98195 USA; [Chamberlain, Jeffrey S.] Univ Washington, Dept Biochem, Sch Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Chamberlain, JS (corresponding author), Univ Washington, Dept Neurol, Sch Med, 1959 NE Pacific St, Seattle, WA 98195 USA.	Jsc5@u.washington.edu		Chamberlain, Jeffrey/0000-0001-5299-0059	NIAMS NIH HHS [R37 AR040864] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR040864] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; BEGGS AH, 1991, AM J HUM GENET, V49, P54; BERTORINI TE, 1991, MUSCLE NERVE, V14, P503, DOI 10.1002/mus.880140603; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Kendall GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3005054; KOENIG M, 1989, AM J HUM GENET, V45, P498; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; Neri M, 2007, NEUROMUSCULAR DISORD, V17, P913, DOI 10.1016/j.nmd.2007.07.005; Nicolas A, 2012, ORPHANET J RARE DIS, V7, DOI [10.1186/1750-1172-7-45, 10.1186/1750-1172-7-42]; PHELPS SF, 1995, HUM MOL GENET, V4, P1251, DOI 10.1093/hmg/4.8.1251; Schmajuk G, 1999, J BIOL CHEM, V274, P21783, DOI 10.1074/jbc.274.31.21783	15	2	2	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1431	1432		10.1126/science.1233074	http://dx.doi.org/10.1126/science.1233074			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239725				2022-12-28	WOS:000312250800036
J	Werner, EW; Mei, TS; Burckle, AJ; Sigman, MS				Werner, Erik W.; Mei, Tian-Sheng; Burckle, Alexander J.; Sigman, Matthew S.			Enantioselective Heck Arylations of Acyclic Alkenyl Alcohols Using a Redox-Relay Strategy	SCIENCE			English	Article							WACKER-TYPE OXIDATION; ALLYLIC ALCOHOLS; ASYMMETRIC HECK; DIAZONIUM SALTS; CATALYST; DIFUNCTIONALIZATION; KETONES; GAMMA	Progress in the development of asymmetric Heck couplings of arenes and acyclic olefins has been limited by a tenuous understanding of the factors that dictate selectivity in migratory insertion and beta-hydride elimination. On the basis of key mechanistic insight recently garnered in the exploration of selective Heck reactions, we report here an enantioselective variant that delivers beta-, gamma-, or delta-aryl carbonyl products from acyclic alkenol substrates. The catalyst system imparts notable regioselectivity during migratory insertion and promotes the migration of the alkene's unsaturation toward the alcohol to ultimately form the ketone product. The reaction uses aryldiazonium salts as the arene source, yields enantiomeric products from opposite starting alkene configurations, and uses a readily accessible ligand. The racemic nature of the alkenol substrate does not bias the enantioselection.	[Werner, Erik W.; Mei, Tian-Sheng; Burckle, Alexander J.; Sigman, Matthew S.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Sigman, MS (corresponding author), Univ Utah, Dept Chem, 315 South 1400 East, Salt Lake City, UT 84112 USA.	sigman@chem.utah.edu	mei, tiansheng/H-5293-2011; Mei, Tian-Sheng/Y-3266-2019	Mei, Tian-Sheng/0000-0002-4985-1071	NIH [R01GM063540]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063540] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grant R01GM063540.	AYYAR KS, 1968, CAN J CHEMISTRY, V46, P1467, DOI 10.1139/v68-242; Beletskaya IP, 2000, CHEM REV, V100, P3009, DOI 10.1021/cr9903048; Berthiol F, 2006, TETRAHEDRON, V62, P4372, DOI 10.1016/j.tet.2006.02.061; Bouquillon S, 2001, J ORGANOMET CHEM, V634, P153, DOI 10.1016/S0022-328X(01)01149-4; Burns NZ, 2009, ANGEW CHEM INT EDIT, V48, P2854, DOI 10.1002/anie.200806086; Calo V, 2007, J ORG CHEM, V72, P2596, DOI 10.1021/jo070005f; Dounay AB, 2003, CHEM REV, V103, P2945, DOI 10.1021/cr020039h; Harper KC, 2012, NAT CHEM, V4, P366, DOI [10.1038/nchem.1297, 10.1038/NCHEM.1297]; Harper KC, 2011, SCIENCE, V333, P1875, DOI 10.1126/science.1206997; Hayashi T, 2003, CHEM REV, V103, P2829, DOI 10.1021/cr020022z; Jensen KH, 2010, J AM CHEM SOC, V132, P17471, DOI 10.1021/ja108106h; Jensen KH, 2009, J AM CHEM SOC, V131, P17074, DOI 10.1021/ja909030c; KIKUKAWA K, 1981, TETRAHEDRON, V37, P31, DOI 10.1016/S0040-4020(01)97711-7; Kikushima K, 2011, J AM CHEM SOC, V133, P6902, DOI 10.1021/ja200664x; LAROCK RC, 1989, TETRAHEDRON LETT, V30, P6629, DOI 10.1016/S0040-4039(00)70636-8; Mc Cartney D, 2011, CHEM SOC REV, V40, P5122, DOI 10.1039/c1cs15101k; McDonald RI, 2011, ORG LETT, V13, P2830, DOI 10.1021/ol200784y; MELPOLDER JB, 1976, J ORG CHEM, V41, P265, DOI 10.1021/jo00864a017; Michel BW, 2011, J AM CHEM SOC, V133, P8317, DOI 10.1021/ja2017043; Michel BW, 2009, J AM CHEM SOC, V131, P6076, DOI 10.1021/ja901212h; Richter JM, 2008, J AM CHEM SOC, V130, P17938, DOI 10.1021/ja806981k; Roglans A, 2006, CHEM REV, V106, P4622, DOI 10.1021/cr0509861; Shibasaki M, 2004, ADV SYNTH CATAL, V346, P1533, DOI 10.1002/adsc.200404203; Sigman MS, 2012, ACCOUNTS CHEM RES, V45, P874, DOI 10.1021/ar200236v; Smith SW, 2009, J AM CHEM SOC, V131, P14231, DOI 10.1021/ja9061823; Tanaka K, 1999, CHEM PHARM BULL, V47, P1053; Taylor JG, 2011, EUR J ORG CHEM, V2011, P1403, DOI 10.1002/ejoc.201001620; Urkalan KB, 2009, ANGEW CHEM INT EDIT, V48, P3146, DOI 10.1002/anie.200900218; Werner EW, 2011, J AM CHEM SOC, V133, P9692, DOI 10.1021/ja203164p; Werner EW, 2010, J AM CHEM SOC, V132, P13981, DOI 10.1021/ja1060998; Yonehara K, 2000, J ORGANOMET CHEM, V603, P40, DOI 10.1016/S0022-328X(00)00069-3; Yoo KS, 2007, ORG LETT, V9, P3933, DOI 10.1021/ol701584f; Yoo KS, 2010, J ORG CHEM, V75, P95, DOI 10.1021/jo901977n; Zultanski SL, 2011, J AM CHEM SOC, V133, P15362, DOI 10.1021/ja2079515	34	334	332	10	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1455	1458		10.1126/science.1229208	http://dx.doi.org/10.1126/science.1229208			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239733	Green Accepted			2022-12-28	WOS:000312250800044
J	Vaux, DL				Vaux, David L.			Know when your numbers are significant	NATURE			English	Editorial Material									[Vaux, David L.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Vaux, David L.] Univ Melbourne, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute; University of Melbourne	Vaux, DL (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.	vaux@wehi.edu.au	Vaux, David/C-7249-2013	Vaux, David/0000-0003-2703-1651				Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Rossner M, 2006, SCIENTIST, V20, P24; Strunk W. Jr., 2009, ELEMENTS STYLE, V4th; Vaux DL, 2012, EMBO REP, V13, P291, DOI 10.1038/embor.2012.36; Vaux DL, 2004, NATURE, V428, P799, DOI 10.1038/428799c; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0	8	89	89	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					180	181		10.1038/492180a	http://dx.doi.org/10.1038/492180a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053GM	23235861	Bronze			2022-12-28	WOS:000312259300015
J	Shaughnessy, AF				Shaughnessy, Allen F.			Monoclonal antibodies: magic bullets with a hefty price tag	BRITISH MEDICAL JOURNAL			English	Editorial Material							CONTROLLED PHASE-3 TRIAL; MULTIPLE-SCLEROSIS; ALEMTUZUMAB		Tufts Univ, Sch Med, Boston, MA 02111 USA	Tufts University	Shaughnessy, AF (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.	Allen.Shaughnessy@Tufts.edu						[Anonymous], 2012, LANCET, V380, P1792; Bourgoin AF, WHAT YOU NEED KNOW F; Cohen JA, 2012, LANCET, V380, P1819, DOI 10.1016/S0140-6736(12)61769-3; Coles AJ, 2012, LANCET, V380, P1829, DOI 10.1016/S0140-6736(12)61768-1; Fanneau de La Horie GC, MAKING BIOL DRUGS MO; Herper M, WORLDS MOST EXPENSIV; Kelley B, 2009, MABS-AUSTIN, V1, P443, DOI 10.4161/mabs.1.5.9448; Staton T, SANOFI PULLS CAMPATH; U.S. Food and Drug Administration, BIOS	9	71	76	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 12	2012	345								e8346	10.1136/bmj.e8346	http://dx.doi.org/10.1136/bmj.e8346			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056MU	23236036				2022-12-28	WOS:000312495100013
J	Bao, W; Melli, M; Caselli, N; Riboli, F; Wiersma, DS; Staffaroni, M; Choo, H; Ogletree, DF; Aloni, S; Bokor, J; Cabrini, S; Intonti, F; Salmeron, MB; Yablonovitch, E; Schuck, PJ; Weber-Bargioni, A				Bao, Wei; Melli, M.; Caselli, N.; Riboli, F.; Wiersma, D. S.; Staffaroni, M.; Choo, H.; Ogletree, D. F.; Aloni, S.; Bokor, J.; Cabrini, S.; Intonti, F.; Salmeron, M. B.; Yablonovitch, E.; Schuck, P. J.; Weber-Bargioni, A.			Mapping Local Charge Recombination Heterogeneity by Multidimensional Nanospectroscopic Imaging	SCIENCE			English	Article							OPTICAL-PROPERTIES; INP NANOWIRES; PHOTOLUMINESCENCE; NANOANTENNAS; TRANSMISSION; MICROSCOPY; TIP	As materials functionality becomes more dependent on local physical and electronic properties, the importance of optically probing matter with true nanoscale spatial resolution has increased. In this work, we mapped the influence of local trap states within individual nanowires on carrier recombination with deeply subwavelength resolution. This is achieved using multidimensional nanospectroscopic imaging based on a nano-optical device. Placed at the end of a scan probe, the device delivers optimal near-field properties, including highly efficient far-field to near-field coupling, ultralarge field enhancement, nearly background-free imaging, independence from sample requirements, and broadband operation. We performed similar to 40-nanometer-resolution hyperspectral imaging of indium phosphide nanowires via excitation and collection through the probes, revealing optoelectronic structure along individual nanowires that is not accessible with other methods.	[Bao, Wei; Melli, M.; Ogletree, D. F.; Aloni, S.; Bokor, J.; Cabrini, S.; Salmeron, M. B.; Schuck, P. J.; Weber-Bargioni, A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA; [Bao, Wei; Salmeron, M. B.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Caselli, N.; Riboli, F.; Wiersma, D. S.; Intonti, F.] European Lab Nonlinear Spect, I-50019 Florence, Italy; [Caselli, N.; Riboli, F.; Intonti, F.] Univ Florence, Dipartimento Fis & Astron, I-50019 Florence, Italy; [Wiersma, D. S.] CNR, Ist Nazl Ott, I-50125 Florence, Italy; [Staffaroni, M.; Bokor, J.; Yablonovitch, E.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Choo, H.] CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); University of California System; University of California Berkeley; California Institute of Technology	Cabrini, S (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA.	scabrini@lbl.gov; pjschuck@lbl.gov; afweber-bargioni@lbl.gov	Bokor, Jeffrey/A-2683-2011; Bao, Wei/B-4520-2014; Cabrini, Stefano/T-6727-2019; Caselli, Niccolò/ABE-6040-2021; wiersma, diederik/ABG-6454-2021; Ogletree, D Frank F/D-9833-2016	Bokor, Jeffrey/0000-0002-4541-0156; Caselli, Niccolò/0000-0003-2609-3834; wiersma, diederik/0000-0001-8150-7425; Ogletree, D Frank F/0000-0002-8159-0182; Intonti, Francesca/0000-0002-8507-3342; Bao, Wei/0000-0003-2974-2625; Riboli, Francesco/0000-0002-5553-9762	U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Scientific User Facilities Division [DE-AC02-05CH11231]; DOE, Office of Basic Energy Sciences, Materials Sciences and Engineering Division [DE-AC02-05CH11231]	U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Scientific User Facilities Division; DOE, Office of Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE))	The authors specifically thank E. Wong for fast and high-quality technical support, as well as our colleagues at the Molecular Foundry for stimulating discussion and assistance. We thank O. Yaghi, D. Milliron, M. Crommie, J. DeYoreo, and Y. D. Suh for valuable advice, discussions and reading of the manuscript. A provisional patent application regarding the fabrication of campanile-like structures on scan probes has been filed. Work at the Molecular Foundry was supported by the U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Scientific User Facilities Division, under contract no. DE-AC02-05CH11231. Campanile tips were prepared by M. Melli, who was supported by the DOE, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, under contract no. DE-AC02-05CH11231.	Balistreri MLM, 2001, SCIENCE, V294, P1080, DOI 10.1126/science.1065163; Bao JM, 2008, NANO LETT, V8, P836, DOI 10.1021/nl072921e; Cho K, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3585138; De Angelis F, 2010, NAT NANOTECHNOL, V5, P67, DOI [10.1038/nnano.2009.348, 10.1038/NNANO.2009.348]; Farahani JN, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.017402; Fischer SA, 2011, CHEM SCI, V2, P400, DOI 10.1039/c0sc00626b; Franceschetti A, 2000, PHYS REV B, V62, pR16287, DOI 10.1103/PhysRevB.62.R16287; Ginzburg P, 2006, OPT LETT, V31, P3288, DOI 10.1364/OL.31.003288; Greffet JJ, 2005, SCIENCE, V308, P1561, DOI 10.1126/science.1113355; Hillenbrand R, 2002, NATURE, V418, P159, DOI 10.1038/nature00899; Kawata S, 2009, NAT PHOTONICS, V3, P388, DOI 10.1038/NPHOTON.2009.111; Kuhn S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.017402; Maas HJ, 2002, J OPT SOC AM B, V19, P1295, DOI 10.1364/JOSAB.19.001295; Neacsu CC, 2010, NANO LETT, V10, P592, DOI 10.1021/nl903574a; Novotny L., 2012, PRINCIPLES NANOOPTIC; Peytavit E, 2007, ELECTRON LETT, V43, P73, DOI 10.1049/el:20073679; Roy D, 2009, J APPL PHYS, V105, DOI 10.1063/1.3056155; Seo M, 2010, NANO LETT, V10, P2064, DOI 10.1021/nl1002153; Shafran E, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.037403; Stadler J, 2012, NANOSCALE, V4, P1856, DOI 10.1039/c1nr11143d; Staffaroni M, 2012, PHOTONIC NANOSTRUCT, V10, P166, DOI 10.1016/j.photonics.2011.12.002; Stockman MI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.137404; van Vugt LK, 2005, J AM CHEM SOC, V127, P12357, DOI 10.1021/ja051860o; Vasa P, 2009, LASER PHOTONICS REV, V3, P483, DOI 10.1002/lpor.200810064; Vedantam S, 2009, NANO LETT, V9, P3447, DOI 10.1021/nl9016368; Wang JF, 2001, SCIENCE, V293, P1455, DOI 10.1126/science.1062340; Wang Y, 2008, NANO LETT, V8, P3041, DOI 10.1021/nl8023824; Weber-Bargioni A, 2011, NANO LETT, V11, P1201, DOI 10.1021/nl104163m; Yamamoto N, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2168043; Yang PD, 2002, ADV FUNCT MATER, V12, P323, DOI 10.1002/1616-3028(20020517)12:5<323::AID-ADFM323>3.0.CO;2-G; Zhang D, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.056601	31	128	130	5	208	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1317	1321		10.1126/science.1227977	http://dx.doi.org/10.1126/science.1227977			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224550				2022-12-28	WOS:000311991200059
J	Kohl, KP; Jones, CD; Sekelsky, J				Kohl, Kathryn P.; Jones, Corbin D.; Sekelsky, Jeff			Evolution of an MCM Complex in Flies That Promotes Meiotic Crossovers by Blocking BLM Helicase	SCIENCE			English	Article							STRAND BREAK REPAIR; GENETIC-ANALYSIS; DROSOPHILA BLM; CROSSING-OVER; MUTS HOMOLOG; RECOMBINATION	Generation of meiotic crossovers in many eukaryotes requires the elimination of anti-crossover activities by using the Msh4-Msh5 heterodimer to block helicases. Msh4 and Msh5 have been lost from the flies Drosophila and Glossina, but we identified a complex of minichromosome maintenance (MCM) proteins that functionally replace Msh4-Msh5. We found that REC, an ortholog of MCM8 that evolved under strong positive selection in flies, interacts with MEI-217 and MEI-218, which arose from a previously undescribed metazoan-specific MCM protein. Meiotic crossovers were reduced in Drosophila rec, mei-217, and mei-218 mutants; however, removal of the Bloom syndrome helicase (BLM) ortholog restored crossovers. Thus, MCMs were co-opted into a novel complex that replaced the meiotic pro-crossover function of Msh4-Msh5 in flies.	[Kohl, Kathryn P.; Sekelsky, Jeff] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Jones, Corbin D.; Sekelsky, Jeff] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Jones, Corbin D.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Sekelsky, Jeff] Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sekelsky, J (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA.	sekelsky@unc.edu	Kang, Hojeong/C-7208-2011; Kim, Bong-Soo/L-4779-2013; Chun, Jongsik/R-8458-2017	Kim, Bong-Soo/0000-0003-1243-8280; Chun, Jongsik/0000-0003-3385-5171; Sekelsky, Jeff/0000-0002-4424-677X	NIH [GM061252, 5T32GM007092]; NSF [MCB-0618691]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092, R01GM061252] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. McKim for helpful discussions and for sharing unpublished results, and N. Crown and other members of the Sekelsky laboratory for helpful comments on the manuscript. Supported by NIH grant GM061252 (J.S.), NSF grant MCB-0618691 (J.S., C.D.J., and G. C. Copenhaver), and NIH grant 5T32GM007092 (K. P. K.). Alignments and trees were submitted to TreeBASE (http://purl.org/phylo/treebase/phylows/study/TB2:S13435).	Adams MD, 2003, SCIENCE, V299, P265, DOI 10.1126/science.1077198; Andersen SL, 2010, BIOESSAYS, V32, P1058, DOI 10.1002/bies.201000087; BAKER BS, 1972, GENETICS, V71, P255; Blanton HL, 2005, PLOS GENET, V1, P343, DOI 10.1371/journal.pgen.0010040; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lake CM, 2007, GENETICS, V176, P2151, DOI 10.1534/genetics.107.073551; Liu H, 2000, GENETICS, V154, P1735; Liu Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-60; Manheim EA, 2002, MOL BIOL CELL, V13, P84, DOI 10.1091/mbc.01-06-0318; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mcvey M, 2007, GENETICS, V176, P1979, DOI 10.1534/genetics.106.070052; Morgan T. H., 1912, Science New York N S, V36; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040	18	44	48	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1363	1365		10.1126/science.1228190	http://dx.doi.org/10.1126/science.1228190			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224558	Green Accepted, Green Submitted			2022-12-28	WOS:000311991200073
J	Abbott, A				Abbott, Alison			COGNITION The brain's decline	NATURE			English	Editorial Material																			0	12	12	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2012	492	7427					S4	S5		10.1038/492S4a	http://dx.doi.org/10.1038/492S4a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048EQ	23222672	Bronze			2022-12-28	WOS:000311893400003
J	Hodges, KV				Hodges, K. V.			Solving Complex Problems	SCIENCE			English	Editorial Material									Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Hodges, KV (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA.	kvhodges@asu.edu	Hodges, Kip/A-7992-2009	Hodges, Kip/0000-0003-2805-8899				Zachary G. Pascal, 1997, ENDLESS FRONTIER VAN	1	3	3	2	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1164	1165		10.1126/science.1215228	http://dx.doi.org/10.1126/science.1215228			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197525				2022-12-28	WOS:000311666200034
J	Rose, J; Parashar, UD				Rose, Johnie; Parashar, Umesh D.			Should India launch a national immunisation programme against rotavirus? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							COST-EFFECTIVENESS; VACCINE; MORTALITY; EFFICACY; DIARRHEA; INFANTS; SAFETY; IMPACT		[Rose, Johnie] Case Western Reserve Univ, Div Res, Dept Family Med & Community Hlth, Cleveland, OH 44106 USA; [Parashar, Umesh D.] Ctr Dis Control & Prevent, Atlanta, GA USA	Case Western Reserve University; Centers for Disease Control & Prevention - USA	Rose, J (corresponding author), Case Western Reserve Univ, Div Res, Dept Family Med & Community Hlth, Cleveland, OH 44106 USA.	johnie.rose@case.edu	/AHA-3700-2022; /AAB-7864-2021	/0000-0001-7458-9303; /0000-0001-7458-9303	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		[Anonymous], 2009, WKLY EPIDEMIOL REC; Babji S, 2012, CURR OPIN VIROL, V2, P443, DOI 10.1016/j.coviro.2012.05.005; Esposito DH, 2011, CLIN INFECT DIS, V52, P171, DOI 10.1093/cid/ciq094; International Institute for Population Sciences Macro International, 2007, NAT FAM HLTH SURV NF, V1, P242; Morris SK, 2012, B WORLD HEALTH ORGAN, V90, P720, DOI 10.2471/BLT.12.101873; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; Patel MM, 2012, LANCET INFECT DIS, V12, P561, DOI 10.1016/S1473-3099(12)70029-4; Richardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211; Rose J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3653; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Steele AD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-213; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Tate JE, 2009, VACCINE, V27, pF18, DOI 10.1016/j.vaccine.2009.08.098; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; WHO - World Health Organization, 2010, STAT ROT ROT VACC IN	15	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 30	2012	345								e7818	10.1136/bmj.e7818	http://dx.doi.org/10.1136/bmj.e7818			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048FS	23203999	Green Accepted			2022-12-28	WOS:000311896500002
J	Hoge, EA; Ivkovic, A; Fricchione, GL				Hoge, Elizabeth A.; Ivkovic, Ana; Fricchione, Gregory L.			Generalized anxiety disorder: diagnosis and treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Review							COGNITIVE-BEHAVIORAL THERAPY; MENTAL-DISORDERS; APPLIED RELAXATION; PRIMARY-CARE; DEPRESSION; METAANALYSIS; PREVALENCE; RECOGNITION; DISABILITY; PLACEBO		[Hoge, Elizabeth A.; Ivkovic, Ana; Fricchione, Gregory L.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Hoge, Elizabeth A.; Fricchione, Gregory L.] Massachusetts Gen Hosp, Benson Henry Inst Mind Body Med, Boston, MA 02114 USA; [Hoge, Elizabeth A.] Massachusetts Gen Hosp, Ctr Anxiety & Traumat Stress Disorders, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Fricchione, GL (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.	gfricchione@partners.org	Hoge, Elizabeth A/H-5879-2012	Hoge, Elizabeth A/0000-0002-5513-2292				Aikins DE, 2001, PSYCHIAT CLIN N AM, V24, P57, DOI 10.1016/S0193-953X(05)70206-9; American Psychiatric Association Task Force on DSM-IV, 1994, DIAGN STAT MAN MENT; Arntz A, 2003, BEHAV RES THER, V41, P633, DOI 10.1016/S0005-7967(02)00045-1; Ballenger JC, 2001, J CLIN PSYCHIAT, V62, P53; Berger A, 2009, EUR J PSYCHIAT, V23, P90, DOI 10.4321/s0213-61632009000200003; Bittner A, 2004, J CLIN PSYCHIAT, V65, P618; Borkovec T. D., 1996, LONG TERM TREATMENTS, P171; Borkovec TD, 2003, CNS SPECTR, V8, P382, DOI 10.1017/S1092852900018642; Culpepper L, 2009, J CLIN PSYCHIAT, V70, P20, DOI 10.4088/JCP.s.7002.04; Goodwin RD, 2002, AM J PSYCHIAT, V159, P1935, DOI 10.1176/appi.ajp.159.11.1935; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Hettema JM, 2008, DEPRESS ANXIETY, V25, P300, DOI 10.1002/da.20491; Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621, DOI 10.4088/jcp.v69n0415; Hoyer J, 2009, PSYCHIAT CLIN N AM, V32, P629, DOI 10.1016/j.psc.2009.05.002; Hunot V, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001848; Kessler RC, 2003, J OCCUP ENVIRON MED, V45, P1257, DOI 10.1097/01.jom.0000100000.70011.bb; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; MATHEWS A, 1989, J ABNORM PSYCHOL, V98, P31, DOI 10.1037/0021-843X.98.1.31; Mennin DS, 2008, DEPRESS ANXIETY, V25, P289, DOI 10.1002/da.20493; Mitte K, 2005, PSYCHOL BULL, V131, P785, DOI 10.1037/0033-2909.131.5.785; Moffitt TE, 2007, PSYCHOL MED, V37, P441, DOI 10.1017/S0033291706009640; Molina E, 2011, PSYCHIAT GENET, V21, P195, DOI 10.1097/YPG.0b013e3283457a48; Nepon J, 2010, DEPRESS ANXIETY, V27, P791, DOI 10.1002/da.20674; Nisenson LG, 1998, GEN HOSP PSYCHIAT, V20, P21, DOI 10.1016/S0163-8343(97)00096-0; Olfson M, 1997, AM J PSYCHIAT, V154, P1734, DOI 10.1176/ajp.154.12.1734; ORMEL J, 1994, JAMA-J AM MED ASSOC, V272, P1741, DOI 10.1001/jama.272.22.1741; ORMEL J, 1991, ARCH GEN PSYCHIAT, V48, P700; Ost LG, 2000, BEHAV RES THER, V38, P777, DOI 10.1016/S0005-7967(99)00095-9; POWER KG, 1990, J ANXIETY DISORD, V4, P267, DOI 10.1016/0887-6185(90)90026-6; Robinson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010942; Schuurmans J, 2006, AM J GERIAT PSYCHIAT, V14, P255, DOI 10.1097/01.JGP.0000196629.19634.00; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Strawn JR, 2012, DEPRESS ANXIETY; Wittchen HU, 2002, J CLIN PSYCHIAT, V63, P24; WITTCHEN HU, 1994, ARCH GEN PSYCHIAT, V51, P355	35	52	54	2	55	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2012	345								e7500	10.1136/bmj.e7500	http://dx.doi.org/10.1136/bmj.e7500			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048FM	23187094				2022-12-28	WOS:000311895700001
J	Eulalio, A; Mano, M; Dal Ferro, M; Zentilin, L; Sinagra, G; Zacchigna, S; Giacca, M				Eulalio, Ana; Mano, Miguel; Dal Ferro, Matteo; Zentilin, Lorena; Sinagra, Gianfranco; Zacchigna, Serena; Giacca, Mauro			Functional screening identifies miRNAs inducing cardiac regeneration	NATURE			English	Article							ZEBRAFISH HEART REGENERATION; DNA-SYNTHESIS; CELL-CYCLE; CARDIOMYOCYTE DEDIFFERENTIATION; MITOTIC DIVISION; GENE-EXPRESSION; HYPERTROPHY; MICRORNAS; PROLIFERATION; RNA	In mammals, enlargement of the heart during embryonic development is primarily dependent on the increase in cardiomyocyte numbers. Shortly after birth, however, cardiomyocytes stop proliferating and further growth of the myocardium occurs through hypertrophic enlargement of the existing myocytes. As a consequence of the minimal renewal of cardiomyocytes during adult life, repair of cardiac damage through myocardial regeneration is very limited. Here we show that the exogenous administration of selected microRNAs (miRNAs) markedly stimulates cardiomyocyte proliferation and promotes cardiac repair. We performed a high-content microscopy, high-throughput functional screening for human miRNAs that promoted neonatal cardiomyocyte proliferation using a whole-genome miRNA library. Forty miRNAs strongly increased both DNA synthesis and cytokinesis in neonatal mouse and rat cardiomyocytes. Two of these miRNAs (hsa-miR-590 and hsa-miR-199a) were further selected for testing and were shown to promote cell cycle re-entry of adult cardiomyocytes ex vivo and to promote cardiomyocyte proliferation in both neonatal and adult animals. After myocardial infarction in mice, these miRNAs stimulated marked cardiac regeneration and almost complete recovery of cardiac functional parameters. The miRNAs identified hold great promise for the treatment of cardiac pathologies consequent to cardiomyocyte loss.	[Eulalio, Ana; Mano, Miguel; Dal Ferro, Matteo; Zentilin, Lorena; Zacchigna, Serena; Giacca, Mauro] ICGEB, Mol Med Lab, I-34149 Trieste, Italy; [Dal Ferro, Matteo; Sinagra, Gianfranco] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Dal Ferro, Matteo; Sinagra, Gianfranco] Azienda Osped Univ Osped Riuniti Trieste, Ctr Translat Cardiol, I-34129 Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Trieste; University of Trieste	Giacca, M (corresponding author), ICGEB, Mol Med Lab, I-34149 Trieste, Italy.	giacca@icgeb.org	sinagra, gianfranco gs/P-7643-2014; Dal Ferro, Matteo/GPP-6060-2022; Giacca, Mauro/J-9287-2016; Mano, Miguel/A-4462-2013; Sinagra, Gianfranco/AAE-3943-2020; Eulalio, Ana/D-3083-2013; ZACCHIGNA, SERENA/E-9496-2017	Dal Ferro, Matteo/0000-0002-2310-0448; Giacca, Mauro/0000-0003-2927-7225; Mano, Miguel/0000-0003-1922-4824; Eulalio, Ana/0000-0002-7355-0674; ZACCHIGNA, SERENA/0000-0001-6705-3076; SINAGRA, GIANFRANCO/0000-0003-2700-8478	FEBS Long Term Fellowship; European Research Council (ERC) [250124]; Project CTC from the Fondazione CRTrieste, Trieste, Italy	FEBS Long Term Fellowship; European Research Council (ERC)(European Research Council (ERC)); Project CTC from the Fondazione CRTrieste, Trieste, Italy	The authors are grateful to M. Dapas and M. Zotti for technical support in AAV production, to M. Sturnega for help in animal experimentation and to S. Kerbavcic for editorial assistance. A. E. is recipient of a FEBS Long Term Fellowship. This work was supported by Advanced Grant 250124 from the European Research Council (ERC) to M. G. and from Project CTC from the Fondazione CRTrieste, Trieste, Italy.	Ahuja P, 2004, J CELL SCI, V117, P3295, DOI 10.1242/jcs.01159; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Arsic N, 2003, MOL THER, V7, P450, DOI 10.1016/S1525-0016(03)00034-0; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bicknell KA, 2007, J MOL CELL CARDIOL, V42, P706, DOI 10.1016/j.yjmcc.2007.01.006; Bird SD, 2003, CARDIOVASC RES, V58, P423, DOI 10.1016/S0008-6363(03)00253-0; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Collesi C, 2008, J CELL BIOL, V183, P117, DOI 10.1083/jcb.200806091; Dorn GW, 2009, CARDIOVASC RES, V81, P465, DOI 10.1093/cvr/cvn243; Fredj S, 2005, J CELL PHYSIOL, V202, P891, DOI 10.1002/jcp.20197; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; KAJSTURA J, 1994, CIRC RES, V74, P383, DOI 10.1161/01.RES.74.3.383; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; Katare R, 2011, CIRC RES, V108, P1238, DOI 10.1161/CIRCRESAHA.110.239111; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NAG AC, 1983, TISSUE CELL, V15, P597, DOI 10.1016/0040-8166(83)90010-1; Nishida Kazuhiko, 2008, Circ J, V72 Suppl A, pA17, DOI 10.1253/circj.CJ-08-0669; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Porrello ER, 2011, CIRC RES, V109, P670, DOI 10.1161/CIRCRESAHA.111.248880; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Pouliquin P, 2009, EUR BIOPHYS J BIOPHY, V39, P91, DOI 10.1007/s00249-009-0494-1; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; REISS K, 1993, EXP CELL RES, V207, P348, DOI 10.1006/excr.1993.1202; ROBLEDO M, 1956, AM J PATHOL, V32, P1215; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Soonpaa MH, 1996, AM J PHYSIOL-HEART C, V271, pH2183; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Trivedi CM, 2010, DEV CELL, V19, P450, DOI 10.1016/j.devcel.2010.08.012; van Amerongen MJ, 2008, J CELL MOL MED, V12, P2233, DOI 10.1111/j.1582-4934.2008.00439.x; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Xiao L, 2001, J MOL CELL CARDIOL, V33, P779, DOI 10.1006/jmcc.2001.1348; Zentilin L, 2010, FASEB J, V24, P1467, DOI 10.1096/fj.09-143180; Zhang Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010498, 10.1371/journal.pone.0015300, 10.1371/journal.pone.0015570, 10.1371/journal.pone.0012559]; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	50	702	739	12	219	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					376	+		10.1038/nature11739	http://dx.doi.org/10.1038/nature11739			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23222520				2022-12-28	WOS:000312488200045
J	Dolan, P; Kavetsos, G				Dolan, Paul; Kavetsos, Georgios			Educational interventions are unlikely to work because obese people aren't unhappy enough to lose weight	BRITISH MEDICAL JOURNAL			English	Editorial Material							VALUING HEALTH; BEHAVIOR		[Dolan, Paul; Kavetsos, Georgios] London Sch Econ, London WC2A 2AE, England	University of London; London School Economics & Political Science	Kavetsos, G (corresponding author), London Sch Econ, London WC2A 2AE, England.	g.kavetsos@lse.ac.uk						Bradford WD, 2010, J HEALTH ECON, V29, P811, DOI 10.1016/j.jhealeco.2010.07.007; Dolan P, 2012, J ECON PSYCHOL, V33, P264, DOI 10.1016/j.joep.2011.10.009; Dolan P, 2008, ECON J, V118, P215, DOI 10.1111/j.1468-0297.2007.02110.x; Dolan P, 2012, MED DECIS MAKING, V32, P578, DOI 10.1177/0272989X11435173; Dolan P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2577; Kahneman D, 2006, J ECON PERSPECT, V20, P3, DOI 10.1257/089533006776526030; Marteau TM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1415; McElroy SL, 2004, J CLIN PSYCHIAT, V65, P634; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; Oswald A., 2007, ECON J, DOI DOI 10.1111/J.1468-0297.2007.02077_1.X; Oswald AJ, 2008, J PUBLIC ECON, V92, P1061; [No title captured], DOI DOI 10.1111/J.1468-0297.2008.02150.X	12	3	3	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2012	345								e8487	10.1136/bmj.e8487	http://dx.doi.org/10.1136/bmj.e8487			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IU	23248082				2022-12-28	WOS:000312698700017
J	Salomon, JA; Vos, T; Hogan, DR; Gagnon, M; Naghavi, M; Mokdad, A; Begum, N; Shah, R; Karyana, M; Kosen, S; Farje, MR; Moncada, G; Dutta, A; Sazawal, S; Dyer, A; Seiler, J; Aboyans, V; Baker, L; Baxter, A; Benjamin, EJ; Bhalla, K; Bin Abdulhak, A; Blyth, F; Bourne, R; Braithwaite, T; Brooks, P; Brugha, TS; Bryan-Hancock, C; Buchbinder, R; Burney, P; Calabria, B; Chen, HL; Chugh, SS; Cooley, R; Criqui, MH; Cross, M; Dabhadkar, KC; Dahodwala, N; Davis, A; Degenhardt, L; Diaz-Torne, C; Dorsey, ER; Driscoll, T; Edmond, K; Elbaz, A; Ezzati, M; Feigin, V; Ferri, CP; Flaxman, AD; Flood, L; Fransen, M; Fuse, K; Gabbe, BJ; Gillum, RF; Haagsma, J; Harrison, JE; Havmoeller, R; Hay, RJ; Hel-Baqui, A; Hoek, HW; Hoffman, H; Hogeland, E; Hoy, D; Jarvis, D; Karthikeyan, G; Knowlton, LM; Lathlean, T; Leasher, JL; Lim, SS; Lipshultz, SE; Lopez, AD; Lozano, R; Lyons, R; Malekzadeh, R; Marcenes, W; March, L; Margolis, DJ; McGill, N; McGrath, J; Mensah, GA; Meyer, AC; Michaud, C; Moran, A; Mori, R; Murdoch, ME; Naldi, L; Newton, CR; Norman, R; Omer, SB; Osborne, R; Pearce, N; Perez-Ruiz, F; Perico, N; Pesudovs, K; Phillips, D; Pourmalek, F; Prince, M; Rehm, JT; Remuzzi, G; Richardson, K; Room, R; Saha, S; Sampson, U; Sanchez-Riera, L; Segui-Gomez, M; Shahraz, S; Shibuya, K; Singh, D; Sliwa, K; Smith, E; Soerjomataram, I; Steiner, T; Stolk, WA; Stovner, LJ; Sudfeld, C; Taylor, HR; Tleyjeh, IM; van der Werf, MJ; Watson, WL; Weatherall, DJ; Weintraub, R; Weisskopf, MG; Whiteford, H; Wilkinson, JD; Woolf, AD; Zheng, ZJ; Murray, CJL				Salomon, Joshua A.; Vos, Theo; Hogan, Daniel R.; Gagnon, Michael; Naghavi, Mohsen; Mokdad, Ali; Begum, Nazma; Shah, Razibuzzaman; Karyana, Muhammad; Kosen, Soewarta; Farje, Mario Reyna; Moncada, Gilberto; Dutta, Arup; Sazawal, Sunil; Dyer, Andrew; Seiler, Jason; Aboyans, Victor; Baker, Lesley; Baxter, Amanda; Benjamin, Emelia J.; Bhalla, Kavi; Bin Abdulhak, Aref; Blyth, Fiona; Bourne, Rupert; Braithwaite, Tasanee; Brooks, Peter; Brugha, Traolach S.; Bryan-Hancock, Claire; Buchbinder, Rachelle; Burney, Peter; Calabria, Bianca; Chen, Honglei; Chugh, Sumeet S.; Cooley, Rebecca; Criqui, Michael H.; Cross, Marita; Dabhadkar, Kaustubh C.; Dahodwala, Nabila; Davis, Adrian; Degenhardt, Louisa; Diaz-Torne, Cesar; Dorsey, E. Ray; Driscoll, Tim; Edmond, Karen; Elbaz, Alexis; Ezzati, Majid; Feigin, Valery; Ferri, Cleusa P.; Flaxman, Abraham D.; Flood, Louise; Fransen, Marlene; Fuse, Kana; Gabbe, Belinda J.; Gillum, Richard F.; Haagsma, Juanita; Harrison, James E.; Havmoeller, Rasmus; Hay, Roderick J.; Hel-Baqui, Abdullah; Hoek, Hans W.; Hoffman, Howard; Hogeland, Emily; Hoy, Damian; Jarvis, Deborah; Karthikeyan, Ganesan; Knowlton, Lisa Marie; Lathlean, Tim; Leasher, Janet L.; Lim, Stephen S.; Lipshultz, Steven E.; Lopez, Alan D.; Lozano, Rafael; Lyons, Ronan; Malekzadeh, Reza; Marcenes, Wagner; March, Lyn; Margolis, David J.; McGill, Neil; McGrath, John; Mensah, George A.; Meyer, Ana-Claire; Michaud, Catherine; Moran, Andrew; Mori, Rintaro; Murdoch, Michele E.; Naldi, Luigi; Newton, Charles R.; Norman, Rosana; Omer, Saad B.; Osborne, Richard; Pearce, Neil; Perez-Ruiz, Fernando; Perico, Norberto; Pesudovs, Konrad; Phillips, David; Pourmalek, Farshad; Prince, Martin; Rehm, Juergen T.; Remuzzi, Guiseppe; Richardson, Kathryn; Room, Robin; Saha, Sukanta; Sampson, Uchechukwu; Sanchez-Riera, Lidia; Segui-Gomez, Maria; Shahraz, Saeid; Shibuya, Kenji; Singh, David; Sliwa, Karen; Smith, Emma; Soerjomataram, Isabelle; Steiner, Timothy; Stolk, Wilma A.; Stovner, Lars Jacob; Sudfeld, Christopher; Taylor, Hugh R.; Tleyjeh, Imad M.; van der Werf, Marieke J.; Watson, Wendy L.; Weatherall, David J.; Weintraub, Robert; Weisskopf, Marc G.; Whiteford, Harvey; Wilkinson, James D.; Woolf, Anthony D.; Zheng, Zhi-Jie; Murray, Christopher J. L.			Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010	LANCET			English	Article							QUALITY-OF-LIFE; PERSON TRADE-OFFS; STATE PREFERENCES; POPULATION; VALUATION; COMMUNITY; US; COMPARABILITY; METHODOLOGY; INFECTION	Background Measurement of the global burden of disease with disability-adjusted life-years (DALYs) requires disability weights that quantify health losses for all non-fatal consequences of disease and injury. There has been extensive debate about a range of conceptual and methodological issues concerning the definition and measurement of these weights. Our primary objective was a comprehensive re-estimation of disability weights for the Global Burden of Disease Study 2010 through a large-scale empirical investigation in which judgments about health losses associated with many causes of disease and injury were elicited from the general public in diverse communities through a new, standardised approach. Methods We surveyed respondents in two ways: household surveys of adults aged 18 years or older (face-to-face interviews in Bangladesh, Indonesia, Peru, and Tanzania; telephone interviews in the USA) between Oct 28, 2009, and June 23, 2010; and an open-access web-based survey between July 26, 2010, and May 16, 2011. The surveys used paired comparison questions, in which respondents considered two hypothetical individuals with different, randomly selected health states and indicated which person they regarded as healthier. The web survey added questions about population health equivalence, which compared the overall health benefits of different life-saving or disease-prevention programmes. We analysed paired comparison responses with probit regression analysis on all 220 unique states in the study. We used results from the population health equivalence responses to anchor the results from the paired comparisons on the disability weight scale from 0 (implying no loss of health) to 1 (implying a health loss equivalent to death). Additionally, we compared new disability weights with those used in WHO's most recent update of the Global Burden of Disease Study for 2004. Findings 13 902 individuals participated in household surveys and 16 328 in the web survey. Analysis of paired comparison responses indicated a high degree of consistency across surveys: correlations between individual survey results and results from analysis of the pooled dataset were 0.9 or higher in all surveys except in Bangladesh (r=0.75). Most of the 220 disability weights were located on the mild end of the severity scale, with 58 (26%) having weights below 0.05. Five (11%) states had weights below 0.01, such as mild anaemia, mild hearing or vision loss, and secondary infertility. The health states with the highest disability weights were acute schizophrenia (0.76) and severe multiple sclerosis (0.71). We identified a broad pattern of agreement between the old and new weights (r=0.70), particularly in the moderate-to-severe range. However, in the mild range below 0.2, many states had significantly lower weights in our study than previously. Interpretation This study represents the most extensive empirical effort as yet to measure disability weights. By contrast with the popular hypothesis that disability assessments vary widely across samples with different cultural environments, we have reported strong evidence of highly consistent results.	[Salomon, Joshua A.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Knowlton, Lisa Marie] Harvard Univ, Harvard Humanitarian Initiat, Boston, MA 02115 USA; [Vos, Theo; Lopez, Alan D.; Norman, Rosana] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Baxter, Amanda; Saha, Sukanta; Whiteford, Harvey] Univ Queensland, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [McGrath, John] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Naghavi, Mohsen; Mokdad, Ali; Baker, Lesley; Cooley, Rebecca; Flaxman, Abraham D.; Lim, Stephen S.; Lozano, Rafael; Phillips, David; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Shah, Razibuzzaman] Projahnmo Shimantik, Dhaka, Bangladesh; [Karyana, Muhammad; Kosen, Soewarta] Minist Hlth, Natl Inst Hlth Res & Dev, Jakarta, Indonesia; [Farje, Mario Reyna; Moncada, Gilberto] Inst Cuanto, Lima, Peru; [Dutta, Arup; Sazawal, Sunil; Hel-Baqui, Abdullah] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Dyer, Andrew; Seiler, Jason] ICF Int, Fairfax, VA USA; [Aboyans, Victor] Dupuytren Univ Hosp, Dept Cardiol, Limoges, France; [Benjamin, Emelia J.] Boston Univ, Boston, MA 02215 USA; [Bin Abdulhak, Aref] King Fahad Med City, Riyadh, Saudi Arabia; [Fransen, Marlene; Smith, Emma] Univ Sydney, Fac Hlth Sci, No Clin Sch, Dept Rheumatol, Sydney, NSW 2006, Australia; [March, Lyn; Sanchez-Riera, Lidia] Univ Sydney, Inst Bone & Joint Res, Sydney, NSW 2006, Australia; [Driscoll, Tim] Univ Sydney, Sch Populat Hlth, Sydney, NSW 2006, Australia; [Bourne, Rupert] Anglia Ruskin Univ, Vision & Eye Res Unit, Cambridge, England; [Braithwaite, Tasanee] Moorfields Eye Hosp, London, England; [Degenhardt, Louisa] Univ Leicester, Ctr Hlth Policy Programs & Econ, Leicester, Leics, England; [Room, Robin] Univ Leicester, Sch Populat Hlth, Leicester, Leics, England; [Weintraub, Robert] Univ Leicester, Royal Childrens Hosp, Dept Pediat, Leicester, Leics, England; [Brugha, Traolach S.] Univ Leicester, Leicester, Leics, England; [Bryan-Hancock, Claire; Flood, Louise; Harrison, James E.; Lathlean, Tim; Pesudovs, Konrad] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [Buchbinder, Rachelle; Hoy, Damian] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Buchbinder, Rachelle] Cabrini Inst, Malvern, Vic, Australia; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Calabria, Bianca; Degenhardt, Louisa; Watson, Wendy L.] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Chen, Honglei] NIEHS, Res Triangle Pk, NC 27709 USA; [Chugh, Sumeet S.; Havmoeller, Rasmus] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Criqui, Michael H.] Univ Calif San Diego, San Diego, CA 92103 USA; [Dabhadkar, Kaustubh C.] Emory Univ, Atlanta, GA 30322 USA; [Dahodwala, Nabila; Margolis, David J.] Univ Penn, Philadelphia, PA 19104 USA; [Davis, Adrian] MRC Hearing & Commun Grp, Manchester, Lancs, England; [Diaz-Torne, Cesar] Hosp Santa Creu & St Pablo, Barcelona, Spain; [Edmond, Karen; Pearce, Neil] London Sch Hyg & Trop Med, London WC1, England; [Elbaz, Alexis] INSERM, Paris, France; [Ezzati, Majid] MRC HPA Ctr Environm & Hlth, London, England; [Feigin, Valery] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Ferri, Cleusa P.] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Fuse, Kana] Natl Inst Populat & Social Secur Res, Dept Populat Struct Res, Tokyo, Japan; [Gillum, Richard F.] Howard Univ, Coll Med, Washington, DC USA; [Soerjomataram, Isabelle] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Hay, Roderick J.] Kings Coll Hosp NHS Fdn Trust, London, England; [Prince, Martin] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Havmoeller, Rasmus] Karolinska Univ Hosp, Stockholm, Sweden; [Hoek, Hans W.] Parnassia Psychiat Inst, The Hague, Netherlands; [Hoffman, Howard] NINCDS, NIH, Bethesda, MD 20892 USA; [Hogeland, Emily; Meyer, Ana-Claire] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Karthikeyan, Ganesan] All India Inst Med Sci, New Delhi, India; [Leasher, Janet L.] Nova SE Univ, Ft Lauderdale, FL 33314 USA; [Lipshultz, Steven E.; Wilkinson, James D.] Univ Miami, Leonard M Miller Sch Med, Miami, FL USA; [Lyons, Ronan] Swansea Univ, Swansea, W Glam, Wales; [Malekzadeh, Reza] Univ Tehran Med Sci, Digest Dis Res Ctr, Tehran, Iran; [Marcenes, Wagner] Queen Mary Univ London, London, England; [Mensah, George A.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Sliwa, Karen] Univ Cape Town, Hatter Inst, ZA-7925 Cape Town, South Africa; [Michaud, Catherine] China Med Board, Boston, MA USA; [Moran, Andrew] Columbia Univ, New York, NY USA; [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Tokyo, Japan; [Murdoch, Michele E.] Watford Dist Gen Hosp, Watford, England; [Naldi, Luigi] Centro Studi GISED, Bergamo, Italy; [Newton, Charles R.; Weatherall, David J.] Univ Oxford, Oxford, England; [Omer, Saad B.] Emory Univ, Sch Publ Hlth & Med, Atlanta, GA 30322 USA; [Osborne, Richard] Deakin Univ, Burwood, NSW, Australia; [Perez-Ruiz, Fernando] Hosp Univ Cruces, Baracaldo, Spain; [Perico, Norberto; Remuzzi, Guiseppe] Mario Negri Inst Pharmacol Res, I-24100 Bergamo, Italy; [Pourmalek, Farshad] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Rehm, Juergen T.] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Room, Robin] Turning Point Alcohol & Drug Ctr, Ctr Alcohol Policy Res, Fitzroy, SA, Australia; [Richardson, Kathryn] Univ Cambridge, Cambridge, England; [Sampson, Uchechukwu] Vanderbilt Univ, Nashville, TN USA; [Sanchez-Riera, Lidia] Inst Invest Biomed Bellvitge, Barcelona, Spain; [Segui-Gomez, Maria] Govt Spain, Minist Interior, Madrid, Spain; [Shahraz, Saeid] Brandeis Univ, Waltham, MA USA; [Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [Singh, David] Queens Med Ctr, Honolulu, HI USA; [Stovner, Lars Jacob] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [van der Werf, Marieke J.] KNCV TB Fdn, The Hague, Netherlands; [Weintraub, Robert] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Woolf, Anthony D.] Royal Cornwall Hosp, Truro, England; [Zheng, Zhi-Jie] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; University of Queensland; Queensland Centre for Mental Health Research; University of Queensland; University of Queensland; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Ministry of Health - Indonesia; National Institute of Health Research & Development - Indonesia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; CHU Limoges; Boston University; University of Sydney; University of Sydney; University of Sydney; Anglia Ruskin University; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Leicester; University of Leicester; University of Leicester; University of Leicester; Flinders University South Australia; Monash University; Cabrini Health; Imperial College London; University of New South Wales Sydney; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Cedars Sinai Medical Center; University of California System; University of California San Diego; Emory University; University of Pennsylvania; University of London; London School of Hygiene & Tropical Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); Imperial College London; Auckland University of Technology; Universidade Federal de Sao Paulo (UNIFESP); Howard University; Erasmus University Rotterdam; Erasmus MC; King's College Hospital NHS Foundation Trust; University of London; King's College London; Karolinska Institutet; Karolinska University Hospital; Parnassia Psychiatric Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of California System; University of California San Francisco; All India Institute of Medical Sciences (AIIMS) New Delhi; Nova Southeastern University; University of Miami; Swansea University; Tehran University of Medical Sciences; University of London; Queen Mary University London; University of Cape Town; University of Cape Town; Columbia University; National Center for Child Health & Development - Japan; Watford General Hospital; University of Oxford; Emory University; Deakin University; Hospital Universitario Cruces; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of British Columbia; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Turning Point Alcohol & Drug Centre - Australia; University of Cambridge; Vanderbilt University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Brandeis University; University of Tokyo; The Queen's Medical Center; Norwegian University of Science & Technology (NTNU); KNCV Tuberculosis Foundation; Murdoch Children's Research Institute; Royal Cornwall Hospital; Shanghai Jiao Tong University	Salomon, JA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.	jsalomon@hsph.harvard.edu	Ferri, Cleusa Pinheiro/B-2922-2010; Braithwaite, Tasanee/AAZ-1118-2020; Harrison, James/B-8958-2009; Naldi, Luigi/AFM-8982-2022; Brugha, Traolach/T-9326-2019; Perico, Norberto/ABH-3222-2020; Karthikeyan, Ganesan/D-5767-2012; Mokdad, Ali H./AAD-1232-2022; Sudfeld, Christopher/AAW-3856-2021; RUIZ, FERNANDO PEREZ/X-1980-2019; Jarvis, Deborah/E-6494-2011; Naldi, Luigi/K-6343-2016; Feigin, Valery/AAF-2313-2019; Buchbinder, Rachelle/G-2952-2011; Prince, Martin J/A-9170-2010; Bin Abdulhak, Aref/AAM-9492-2020; Bin Abdulhak, Aref/AAK-4348-2020; Lozano, Rafael/T-5352-2018; Osborne, Richard H/A-9447-2010; Degenhardt, Louisa J/D-4515-2012; Malekzadeh, Reza/U-1382-2017; Salomon, Joshua A/D-3898-2009; Pourmalek, Farshad/A-8188-2010; Saha, Sukanta/K-3774-2012; PACELLA, ROSANA E./F-2774-2010; Díaz-Torné, César/AAG-2419-2020; PEREZ-RUIZ, FERNANDO/E-4844-2012; Elbaz, Alexis/F-8952-2017; Salomon, Joshua/S-1929-2019; Baxter, Amanda/E-5449-2011; Lopez, Alan D/F-1487-2010; Stovner, Lars Jacob/D-5025-2014; McGrath, John Joseph/G-5493-2010; Pesudovs, Konrad/T-9403-2019; Lathlean, Tim/K-3653-2013; Newton, Charles/V-7872-2019; Room, Robin/ABF-7460-2021; Zhang, Xiao/V-9027-2017; Lopez, Alan/AAA-2734-2022; Whiteford, Harvey A/A-4840-2009; Room, Robin/ABH-8505-2020; Aboyans, Victor/AAN-8308-2020; Davis, Adrian C/E-6022-2015; Newton, Charles RJC/B-7578-2014; Benjamin, Emelia/E-7103-2011; , Ivan/D-6804-2012; Leasher, Janet/B-8889-2016; Remuzzi, Giuseppe/V-9766-2017	Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Braithwaite, Tasanee/0000-0002-3025-4066; Harrison, James/0000-0001-9893-8491; Naldi, Luigi/0000-0002-3160-2835; Brugha, Traolach/0000-0002-9786-9591; Perico, Norberto/0000-0002-3147-4327; Karthikeyan, Ganesan/0000-0002-2073-2917; Mokdad, Ali H./0000-0002-4994-3339; Sudfeld, Christopher/0000-0002-3203-3638; RUIZ, FERNANDO PEREZ/0000-0002-5268-1894; Naldi, Luigi/0000-0002-3160-2835; Buchbinder, Rachelle/0000-0002-0597-0933; Prince, Martin J/0000-0003-1379-7146; Bin Abdulhak, Aref/0000-0001-9988-8609; Lozano, Rafael/0000-0002-7356-8823; Osborne, Richard H/0000-0002-9081-2699; Degenhardt, Louisa J/0000-0002-8513-2218; Malekzadeh, Reza/0000-0002-9820-6335; Salomon, Joshua A/0000-0003-3929-5515; Pourmalek, Farshad/0000-0002-2134-0771; PACELLA, ROSANA E./0000-0002-9742-1957; Díaz-Torné, César/0000-0001-6275-7699; Elbaz, Alexis/0000-0001-9724-5490; Salomon, Joshua/0000-0003-3929-5515; Baxter, Amanda/0000-0001-8198-9022; Lopez, Alan D/0000-0001-5818-6512; McGrath, John Joseph/0000-0002-4792-6068; Pesudovs, Konrad/0000-0002-6322-9369; Newton, Charles/0000-0002-6999-5507; Room, Robin/0000-0002-5618-385X; Zhang, Xiao/0000-0002-2932-5875; Whiteford, Harvey A/0000-0003-4667-6623; Davis, Adrian C/0000-0001-7134-7528; Newton, Charles RJC/0000-0002-6999-5507; Benjamin, Emelia/0000-0003-4076-2336; Tleyjeh, Imad/0000-0002-5551-0353; Aboyans, Victor/0000-0002-0322-9818; Taylor, Hugh/0000-0002-9437-784X; Mensah, George/0000-0002-0387-5326; Shibuya, Kenji/0000-0003-2528-7530; Mori, Rintaro/0000-0001-7656-6156; , Ivan/0000-0002-3108-058X; Malekzadeh, Reza/0000-0003-1043-3814; Chen, Honglei/0000-0003-3446-7779; Woolf, Anthony/0000-0001-8482-8056; WILKINSON, JAMES/0000-0003-1945-5622; KARYANA, MUHAMMAD/0000-0002-7785-5731; Pearce, Neil/0000-0002-9938-7852; O'donnell, Colm/0000-0002-8004-450X; Jarvis, Deborah/0000-0002-1753-3896; Calabria, Bianca/0000-0001-6444-4696; Lathlean, Timothy/0000-0001-7340-1567; Leasher, Janet/0000-0002-8779-5162; Feigin, Valery L./0000-0002-6372-1740; Sanchez Riera, Lidia/0000-0003-0774-2480; Hoek, Hans/0000-0001-6353-5465; Gabbe, Belinda/0000-0001-7096-7688; Stolk, Wilma/0000-0001-9509-1328; Phillips, David/0000-0003-2569-1015; Remuzzi, Giuseppe/0000-0002-6194-3446; Burney, Peter/0000-0001-8635-5678; Smith, Emma/0000-0001-6510-2583	Spanish Health Ministry; Hospital de Cruces Rheumatology Association; Burke Global Health Fellowship Program at the Harvard Global Health Institute; World Bank Global Road Safety Facility; Vision and Eye Research Unit (Postgraduate Medical Institute, Anglia Ruskin University, Cambridge, UK); Department of Health London for the National Health Service Information Centre; University of Leicester for the Estimating the Prevalence of Autism Spectrum Conditions in Adults; Bill & Melinda Gates Foundation; Australian National Health and Medical Research Council (NHMRC); Monash University; Cabrini Health; BUPA Foundation; National Institutes of Health (NIH)-the National Institute of Environmental Health Sciences-USA; Royal North Shore Hospital; Institute of Bone and Joint Research, (University of Sydney); NIH [K23 AG034236]; Parkinson Council; Safework Australia; Swedish Research Council [2011-1071]; Parnassia Psychiatric Institute, The Hague, Netherlands; Department of Psychiatry, University Medical Center Groningen, Netherlands; Department of Epidemiology, Columbia University, New York, NY, USA; Australian National Health and Medical Research Council; Foundation for Alcohol Research and Education; Victorian Department of Health; Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; European Center for Injury Prevention, Universidad de Navarra; Africa Programme for Onchocerciasis Control (WHO/APOC); Wellcome Trust UK; Medical Research Council UK; Anthony Cerami and Ann Dunne Research Trust; MRC [G0901214] Funding Source: UKRI; Medical Research Council [G0901214, G0801056B] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG034236] Funding Source: NIH RePORTER	Spanish Health Ministry(Instituto de Salud Carlos IIISpanish Government); Hospital de Cruces Rheumatology Association; Burke Global Health Fellowship Program at the Harvard Global Health Institute; World Bank Global Road Safety Facility; Vision and Eye Research Unit (Postgraduate Medical Institute, Anglia Ruskin University, Cambridge, UK); Department of Health London for the National Health Service Information Centre; University of Leicester for the Estimating the Prevalence of Autism Spectrum Conditions in Adults; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); Cabrini Health; BUPA Foundation; National Institutes of Health (NIH)-the National Institute of Environmental Health Sciences-USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal North Shore Hospital; Institute of Bone and Joint Research, (University of Sydney); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parkinson Council; Safework Australia; Swedish Research Council(Swedish Research CouncilEuropean Commission); Parnassia Psychiatric Institute, The Hague, Netherlands; Department of Psychiatry, University Medical Center Groningen, Netherlands(Netherlands Government); Department of Epidemiology, Columbia University, New York, NY, USA; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Foundation for Alcohol Research and Education; Victorian Department of Health; Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; European Center for Injury Prevention, Universidad de Navarra; Africa Programme for Onchocerciasis Control (WHO/APOC); Wellcome Trust UK(Wellcome Trust); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Anthony Cerami and Ann Dunne Research Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	A Davis is employed by the UK National Health Service and works for the UK Department of Health as lead adviser on audiology. E R Dorsey has been a consultant to Lundbeck and Medtronic and receives research support from Lundbeck and Prana Biotechnology. M Ezzati chaired a session and gave a talk at the World Cardiology Congress (WCC), with his travel cost reimbursed by the World Heart Federation; he also gave a talk at a session organized by PepsiCo with no financial or other remuneration. H Hoffman is a US Federal Government employee of the National Institutes of Health. G A Mensah is a former employee of PepsiCo. F Perez-Ruiz has been an adviser for Ardea, Menarini, Novartis, Metabolex; has been a member of a speaker's bureau for Menarini and Novartis; has been an adviser on educational issues for Savient; has received investigation grants from the Spanish Health Ministry and Hospital de Cruces Rheumatology Association; and is the principal investigator in clinical trials for Ardea. The other authors declare that they have no conflicts of interest.; We thank all the survey respondents who participated in the study and the survey field staff who did the interviews. We acknowledge institutions that were pivotal in implementation of the survey around the world, providing administrative and logistical support to data collection: Shimantik, Bangladesh; Instituto Cuanto, Peru; the Public Health Laboratory Ivo de Carneri, Pemba Island, Tanzania; ICF International (formerly ICF Macro); and the National Institute of Health Research and Development at the Ministry of Health, Indonesia. We thank the many individuals who have contributed to GBD 2010 in various capacities, and particularly recognise the important contributions to this work from many WHO staff members. We are grateful for guidance and feedback from participants at the Expert Consultation on Disability Weights (Seattle, WA, USA; September, 2008): Laura Damschroder, Dean Jamison, Jennifer Jelsma, Steven Kymes, Donald L Patrick, Michael Schoenbaum, and Michael Wolfson. We give special thanks to Dan Brock, Daniel M Hausman, and Dan Wikler for many enlightening discussions around the topic of disability weights over many years. We thank Colin Mathers and Gretchen Stevens for their particular contributions to many aspects of the study; Farah Chowdhury, Makame H Mohammed, Haidong Wang, Andres I Vecino Ortiz, Rebecca Myerson, and Zhongwei Jia for their assistance in translation of survey instruments; Lebogang Ramma, for insights from adapting the survey in South Africa; Ben Wikler, Jill Oviatt, Corwyn Ellison, and William Heisel for promoting the survey and helping it reach a widespread audience; Emmanuela Gakidou for many helpful suggestions; Erin C Mullany, Kate Muller, and Diana Haring for coordinating, reviewing, and editing the report; and Michael F MacIntyre for his steadfast management of innumerable elements in the overall GBD 2010 enterprise. J A Salomon acknowledges funding from the Burke Global Health Fellowship Program at the Harvard Global Health Institute. K Bhalla's primary source of support was the World Bank Global Road Safety Facility. R Bourne acknowledges support from the Vision and Eye Research Unit (Postgraduate Medical Institute, Anglia Ruskin University, Cambridge, UK). T S Brugha acknowledges funding from the Department of Health London for the National Health Service Information Centre and from the University of Leicester for the Estimating the Prevalence of Autism Spectrum Conditions in Adults: Extending the 2007 Adult Psychiatric Morbidity Survey. C Bryan-Hancock received funding from the Bill & Melinda Gates Foundation to pay for time as a Research Officer on this project. R Buchbinder was partially funded by an Australian National Health and Medical Research Council (NHMRC) Practitioner Fellowship, Monash University, and Cabrini Health. P Burney and D Jarvis acknowledge that the Chronic Respiratory Disease group received funding from the BUPA Foundation; they had no role in study design, data collection, data analysis, data interpretation, decision to submit for publication, or preparation of the report. H Chen acknowledges that his role in the study was partly supported by the intramural research program of the National Institutes of Health (NIH)-the National Institute of Environmental Health Sciences-USA. M Cross and L March acknowledge the support of the Royal North Shore Hospital and the Institute of Bone and Joint Research, (University of Sydney). N Dahodwala was supported by NIH grant K23 AG034236 and the Parkinson Council while working on this project.; L Degenhardt was supported by an Australian National Health and Medical Research Council (NHMRC) Senior Research Fellowship. T Driscoll was supported partly by funding from the National Occupational Health and Safety Commission (now Safework Australia). R Havmoeller was supported by a grant from the Swedish Research Council (#2011-1071). H W Hoek acknowledges support from three institutions: Parnassia Psychiatric Institute, The Hague, Netherlands; the Department of Psychiatry, University Medical Center Groningen, Netherlands; and the Department of Epidemiology, Columbia University, New York, NY, USA. D Hoy was supported by the Bill & Melinda Gates Foundation and the Australian National Health and Medical Research Council. K Pesudovs acknowledges institutional support from Flinders University. R Room's position at the University of Melbourne and Turning Point Alcohol and Drug Centre is funded by the Foundation for Alcohol Research and Education and the Victorian Department of Health. U Sampson was supported by funding by the Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation and the Vanderbilt Clinical and Translational Scholars Award. L Sanchez-Riera acknowledges the Spanish Society of Rheumatology (Sociedad Espanola de Reumatologia). M Segui-Gomez's participation was partly supported by funding from the European Center for Injury Prevention, Universidad de Navarra. E Smith acknowledges the Department of Health and Ageing, Commonwealth Government of Australia, and Institute of Bone and Joint Research (IBJR; University of Sydney). W A Stolk received financial support from the Africa Programme for Onchocerciasis Control (WHO/APOC) for the work on onchocerciasis. D J Weatherall is supported by the Wellcome Trust UK, the Medical Research Council UK, and the Anthony Cerami and Ann Dunne Research Trust.	AbouZahr C, 2000, B WORLD HEALTH ORGAN, V78, P655; Allotey P, 2003, SOC SCI MED, V57, P949, DOI 10.1016/S0277-9536(02)00463-X; [Anonymous], 1999, WORLD HLTH REPORT 19; Arnesen T, 1999, BMJ-BRIT MED J, V319, P1423, DOI 10.1136/bmj.319.7222.1423; Backman G, 2008, LANCET, V372, P2047, DOI 10.1016/S0140-6736(08)61781-X; Baltussen RMPM, 2002, HEALTH ECON, V11, P155, DOI 10.1002/hec.658; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Bastian H, 2000, REPROD HEALTH MATTER, V8, P113, DOI 10.1016/S0968-8080(00)90012-0; Beaglehole R., 2003, WORLD HLTH REPORT 20; BRADLEY RA, 1976, BIOMETRICS, V32, P213, DOI 10.2307/2529494; Brennan DS, 2007, J DENT RES, V86, P713, DOI 10.1177/154405910708600805; Brennan DS, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-96; Brock D., 2003, COST EFFECT RESOUR A, V1, P1, DOI DOI 10.1186/1478-7547-1-112773220; Brock DW, 2002, SUMMARY MEASURES OF POPULATION HEALTH: CONCEPTS, ETHICS, MEASUREMENT AND APPLICATIONS, P115; Broome J, 2002, SUMMARY MEASURES OF POPULATION HEALTH: CONCEPTS, ETHICS, MEASUREMENT AND APPLICATIONS, P91; Brouwer WBF, 2000, J HEALTH ECON, V19, P439, DOI 10.1016/S0167-6296(99)00038-7; Brouwer WBF, 2008, J HEALTH ECON, V27, P325, DOI 10.1016/j.jhealeco.2007.07.003; Bundhamcharoen K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-53; CAMPEAU L, 1976, CIRCULATION, V54, P522, DOI 10.1161/circ.54.3.947585; CHAMIE M, 1995, DISABIL REHABIL, V17, P323, DOI 10.3109/09638289509166718; Chapman G, 2006, TROP MED INT HEALTH, V11, P660, DOI 10.1111/j.1365-3156.2006.01601.x; de Bekker-Grob EW, 2010, VALUE HEALTH, V13, P315, DOI 10.1111/j.1524-4733.2009.00670.x; Doctor JN, 2010, MED DECIS MAKING, V30, P58, DOI 10.1177/0272989X07312478; Dolan P, 2003, HEALTH ECON, V12, P545, DOI 10.1002/hec.760; Dolan P, 1996, J CLIN EPIDEMIOL, V49, P551, DOI 10.1016/0895-4356(95)00532-3; Dolan P, 1999, MED DECIS MAKING, V19, P482, DOI 10.1177/0272989X9901900416; Essink-Bot ML, 2002, B WORLD HEALTH ORGAN, V80, P644; Finkelstein JL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000158; FROBERG DG, 1989, J CLIN EPIDEMIOL, V42, P585, DOI 10.1016/0895-4356(89)90155-8; FROBERG DG, 1989, J CLIN EPIDEMIOL, V42, P459, DOI 10.1016/0895-4356(89)90136-4; Gold MR, 1996, COST EFFECTIVENESS H; Groce NE, 1999, LANCET, V354, P756, DOI 10.1016/S0140-6736(99)06140-1; Grosse SD, 2009, PUBLIC HEALTH REP, V124, P197, DOI 10.1177/003335490912400206; Haagsma JA, 2008, INJURY PREV, V14, P5, DOI 10.1136/ip.2007.017178; Haagsma JA, 2009, QUAL LIFE RES, V18, P657, DOI 10.1007/s11136-009-9484-0; HADORN DC, 1991, SOC SCI MED, V32, P773, DOI 10.1016/0277-9536(91)90303-T; Hausman DM, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-13; Hausman DM, 2010, HEALTH ECON, V19, P280, DOI 10.1002/hec.1474; Hong KS, 2009, STROKE, V40, P3828, DOI 10.1161/STROKEAHA.109.561365; Jankovic S, 2007, EUR J PUBLIC HEALTH, V17, P80, DOI 10.1093/eurpub/ckl072; Jelsma J, 2000, LANCET, V355, P2079, DOI 10.1016/S0140-6736(05)73538-8; Jelsma J, 2002, DISABIL REHABIL, V24, P378, DOI 10.1080/09638280110096269; Jia TW, 2007, B WORLD HEALTH ORGAN, V85, P458, DOI 10.2471/BLT.06.033035; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; King CH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000209; Krabbe PFM, 1997, SOC SCI MED, V45, P1641, DOI 10.1016/S0277-9536(97)00099-3; Kruijshaar ME, 2005, B WORLD HEALTH ORGAN, V83, P443; Kruijshaar ME, 2004, EUR J PUBLIC HEALTH, V14, P141, DOI 10.1093/eurpub/14.2.141; Lai T, 2009, EUR J PUBLIC HEALTH, V19, P541, DOI 10.1093/eurpub/ckp038; Leonardi M, 2006, LANCET, V368, P1219, DOI 10.1016/S0140-6736(06)69498-1; Mahapatra P, 2002, SUMMARY MEASURES OF POPULATION HEALTH: CONCEPTS, ETHICS, MEASUREMENT AND APPLICATIONS, P473; Mansley EC, 2003, HEALTH ECON, V12, P187, DOI 10.1002/hec.707; Mathers CD, 2000, MED J AUSTRALIA, V172, P592, DOI 10.5694/j.1326-5377.2000.tb124125.x; Mathers CD, 2001, B WORLD HEALTH ORGAN, V79, P1076; McIntosh Cameron N, 2007, Chronic Dis Can, V28, P29; McKenna MT, 2005, AM J PREV MED, V28, P415, DOI 10.1016/j.amepre.2005.02.009; Melse JM, 2000, AM J PUBLIC HEALTH, V90, P1241, DOI 10.2105/AJPH.90.8.1241; Menzel P, 2002, SOC SCI MED, V55, P2149, DOI 10.1016/S0277-9536(01)00358-6; Metts RL, 2001, DISABIL SOC, V16, P449, DOI 10.1080/09687590120045996; Mokdad AH, 2009, ANNU REV PUBL HEALTH, V30, P43, DOI 10.1146/annurev.publhealth.031308.100226; Mont D, 2007, LANCET, V369, P1658, DOI 10.1016/S0140-6736(07)60752-1; Murray C.J.L., 1996, HARVARD SCH PUBLIC H; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P981; Naghavi Mohsen, 2009, Popul Health Metr, V7, P9, DOI 10.1186/1478-7954-7-9; NORD E, 1992, SOC SCI MED, V34, P559, DOI 10.1016/0277-9536(92)90211-8; Nyman JA, 2007, MED CARE, V45, P618, DOI 10.1097/MLR.0b013e31803dce05; Osterdal LP, 2009, EUR J HEALTH ECON, V10, P429, DOI 10.1007/s10198-009-0150-9; Perehudoff S, 2008, HLTH ESSENTIAL MED H; Phua HP, 2009, SINGAP MED J, V50, P468; Qian MB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001377; Rehm J, 2010, INT J METH PSYCH RES, V19, P18, DOI 10.1002/mpr.300; Reidpath DD, 2003, HEALTH POLICY PLANN, V18, P351, DOI 10.1093/heapol/czg043; RICHARDSON J, 1994, SOC SCI MED, V39, P7, DOI 10.1016/0277-9536(94)90162-7; Sadana R, 2002, SUMMARY MEASURES OF POPULATION HEALTH: CONCEPTS, ETHICS, MEASUREMENT AND APPLICATIONS, P593; Salomon J.A., 2003, HLTH SYSTEMS PERFORM, P301; Salomon JA, 2002, SUMMARY MEASURES OF POPULATION HEALTH: CONCEPTS, ETHICS, MEASUREMENT AND APPLICATIONS, P619; Salomon JA, 2003, HLTH SYSTEMS PERFORM, P409; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Schwarzinger Michael, 2003, Popul Health Metr, V1, P9, DOI 10.1186/1478-7954-1-9; Stevens G, 2008, PLOS MED, V5, P900, DOI 10.1371/journal.pmed.0050125; Stouthard MEA, 2000, EUR J PUBLIC HEALTH, V10, P24, DOI 10.1093/eurpub/10.1.24; Stouthard MEA, 1997, DISABILITY WEIGHTS D; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; Sullivan PW, 2011, MED DECIS MAKING, V31, P800, DOI 10.1177/0272989X11401031; The Criteria Committee of the New York Heart Association, 1994, NOM CRIT DIAGN DIS H; Thomas C, 2004, DISABIL SOC, V19, P569, DOI 10.1080/0968759042000252506; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; UN General Assembly, 1966, INT CONV EC SOC CULT; Ustun TB, 1999, LANCET, V354, P1306; Ustun TB, 1999, LANCET, V354, P111, DOI 10.1016/S0140-6736(98)07507-2; van Osch SMC, 2004, MED DECIS MAKING, V24, P511, DOI 10.1177/0272989X04268955; van Spijker BAJ, 2011, J AFFECT DISORDERS, V134, P341, DOI 10.1016/j.jad.2011.05.020; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WHO, 2001, WORLD HLTH REPORT 20; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, 2004, WORLD HLTH REP 2004; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Yoon SJ, 2007, J KOREAN MED SCI, V22, P518, DOI 10.3346/jkms.2007.22.3.518	100	832	866	4	262	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2012	380	9859					2129	2143		10.1016/S0140-6736(12)61680-8	http://dx.doi.org/10.1016/S0140-6736(12)61680-8			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23245605				2022-12-28	WOS:000312387000013
J	Dyson, FJ				Dyson, Freeman J.			Is Science Mostly Driven by Ideas or by Tools?	SCIENCE			English	Editorial Material									Inst Adv Study, Princeton, NJ 08540 USA	Institute for Advanced Study - USA	Dyson, FJ (corresponding author), Inst Adv Study, Olden Lane, Princeton, NJ 08540 USA.	dyson@ias.edu							0	50	52	3	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2012	338	6113					1426	1427		10.1126/science.1232773	http://dx.doi.org/10.1126/science.1232773			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053DN	23239721				2022-12-28	WOS:000312250800032
J	Gotzsche, PC				Gotzsche, Peter C.			Big pharma often commits corporate crime, and this must be stopped	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Gotzsche, PC (corresponding author), Rigshosp, Nord Cochrane Ctr, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	pcg@cochrane.dk						ALMASHAT S, 2010, RAPIDLY INCREASING C; Angell M., 2005, TRUTH DRUG CO THEY D; Barboza David, 1999, NY TIMES; Braithwaite John, 1984, CORPORATE CRIME PHAR; Cohen D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4848; Gotzsche PC, 2013, CORPORATE CRIME PHAR; Gotzsche PC, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-249; Kassirer J. P., 2005, TAKE MED COMPLICITY; Kelton Erika, 2012, FORBES; Newman M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5095; Pharmaceutical Research and Manufacturers of America (PhRMA), 2012, PHRMA COD INT HEALTH; Rost P., 2006, WHISTLEBLOWER CONFES; Tanne JH, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3657	13	11	12	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2012	345								e8462	10.1136/bmj.e8462	http://dx.doi.org/10.1136/bmj.e8462			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056NE	23241451				2022-12-28	WOS:000312496200003
J	Cochella, L; Hobert, O				Cochella, Luisa; Hobert, Oliver			Embryonic Priming of a miRNA Locus Predetermines Postmitotic Neuronal Left/Right Asymmetry in C. elegans	CELL			English	Article							GENES	The mechanisms by which functional left/right asymmetry arises in morphologically symmetric nervous systems are poorly understood. Here, we provide a mechanistic framework for how functional asymmetry in a postmitotic neuron pair is specified in C. elegans. A key feature of this mechanism is a temporally separated, two-step activation of the lsy-6 miRNA locus. The lsy-6 locus is first "primed'' by chromatin decompaction in the precursor for the left neuron, but not the right neuron, several divisions before the neurons are born. lsy-6 expression is then "boosted'' to functionally relevant levels several divisions later in the mother of the left neuron, through the activity of a bilaterally expressed transcription factor that can only activate lsy-6 in the primed neuron. This study shows how cells can become committed during early developmental stages to execute a specific fate much later in development and provides a conceptual framework for understanding the generation of neuronal diversity.	[Cochella, Luisa; Hobert, Oliver] Columbia Univ, Howard Hughes Med Inst, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Cochella, L (corresponding author), Columbia Univ, Howard Hughes Med Inst, Med Ctr, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	mlc2155@columbia.edu; or38@columbia.edu	Cochella, Luisa/B-6536-2016; Cochella, Luisa/AHD-8261-2022	Cochella, Luisa/0000-0003-4018-7722; Cochella, Luisa/0000-0003-4018-7722; Hobert, Oliver/0000-0002-7634-2854	Helen Hay Whitney Foundation; National Institutes of Health [R01NS039996-05, R01NS050266-03]; HHMI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050266, R01NS039996] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank I. Greenwald, W. Grueber, R. Mann, and members of the Hobert lab for helpful discussions and comments on the manuscript. We thank P. Meister, S. Gasser, and S. Mango for advice and reagents; I. Topalidou for help with the smFISH; the CGC for strains; Q. Chen for assistance with microinjections; and A. Boyanov for help with obtaining integrated transgenes. L.C. was funded by a postdoctoral fellowship from the Helen Hay Whitney Foundation. This work was funded in part by the National Institutes of Health (R01NS039996-05 and R01NS050266-03) and by the HHMI.	Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Didiano D, 2010, RNA, V16, P349, DOI 10.1261/rna.1931510; Dietzel S, 2004, J CELL SCI, V117, P4603, DOI 10.1242/jcs.01330; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Etchberger JF, 2007, GENE DEV, V21, P1653, DOI 10.1101/gad.1560107; Etchberger JF, 2009, DEVELOPMENT, V136, P147, DOI 10.1242/dev.030064; Fakhouri THI, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001060; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Good K, 2004, DEVELOPMENT, V131, P1967, DOI 10.1242/dev.01088; Hobert O, 2002, NAT REV NEUROSCI, V3, P629, DOI 10.1038/nrn897; Hobert O, 2006, COLD SPRING HARB SYM, V71, P181, DOI 10.1101/sqb.2006.71.006; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Johnston R, 2005, ENVIRON PLANN A, V37, P2, DOI 10.1068/a3811; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Meister P, 2010, GENE DEV, V24, P766, DOI 10.1101/gad.559610; O'Meara MM, 2009, GENETICS, V181, P1679, DOI 10.1534/genetics.108.097832; Ortiz CO, 2009, CURR BIOL, V19, P996, DOI 10.1016/j.cub.2009.05.043; Poole RJ, 2006, CURR BIOL, V16, P2279, DOI 10.1016/j.cub.2006.09.041; Poole RJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002109; Priess J R, 2005, NOTCH SIGNALING C EL; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Sarin S, 2007, GENETICS, V176, P2109, DOI 10.1534/genetics.107.075648; Sarin S, 2009, DEVELOPMENT, V136, P2933, DOI 10.1242/dev.040204; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; Tursun B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004625; Yuzyuk T, 2009, DEV CELL, V16, P699, DOI 10.1016/j.devcel.2009.03.008; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	28	55	55	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1229	1242		10.1016/j.cell.2012.10.049	http://dx.doi.org/10.1016/j.cell.2012.10.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23201143	Green Accepted, Bronze			2022-12-28	WOS:000311999900013
J	Truman, AW; Kristjansdottir, K; Wolfgeher, D; Hasin, N; Polier, S; Zhang, H; Perrett, S; Prodromou, C; Jones, GW; Kron, SJ				Truman, Andrew W.; Kristjansdottir, Kolbrun; Wolfgeher, Donald; Hasin, Naushaba; Polier, Sigrun; Zhang, Hong; Perrett, Sarah; Prodromou, Chrisostomos; Jones, Gary W.; Kron, Stephen J.			CDK-Dependent Hsp70 Phosphorylation Controls G1 Cyclin Abundance and Cell-Cycle Progression	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; CLN3 CYCLIN; GENE-EXPRESSION; CHAPERONE YDJ1; G(1) ARREST; PHO85; DEGRADATION; INHIBITOR; TARGETS	In budding yeast, the essential functions of Hsp70 chaperones Ssa1-4 are regulated through expression level, isoform specificity, and cochaperone activity. Suggesting a novel regulatory paradigm, we find that phosphorylation of Ssa1 T36 within a cyclin-dependent kinase (CDK) consensus site conserved among Hsp70 proteins alters cochaperone and client interactions. T36 phosphorylation triggers displacement of Ydj1, allowing Ssa1 to bind the G1 cyclin Cln3 and promote its degradation. The stress CDK Pho85 phosphorylates T36 upon nitrogen starvation or pheromone stimulation, destabilizing Cln3 to delay onset of S phase. In turn, the mitotic CDK Cdk1 phosphorylates T36 to block Cln3 accumulation in G2/M. Suggesting broad conservation from yeast to human, CDK-dependent phosphorylation of Hsc70 T38 similarly regulates Cyclin D1 binding and stability. These results establish an active role for Hsp70 chaperones as signal transducers mediating growth control of G1 cyclin abundance and activity.	[Truman, Andrew W.; Kristjansdottir, Kolbrun; Wolfgeher, Donald; Kron, Stephen J.] Univ Chicago, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA; [Truman, Andrew W.; Kristjansdottir, Kolbrun; Wolfgeher, Donald; Kron, Stephen J.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Hasin, Naushaba; Jones, Gary W.] Natl Univ Ireland Maynooth, Dept Biol, Maynooth, Kildare, Ireland; [Polier, Sigrun; Prodromou, Chrisostomos] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Zhang, Hong; Perrett, Sarah] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	University of Chicago; University of Chicago; Maynooth University; University of Sussex; Chinese Academy of Sciences; Institute of Biophysics, CAS	Kron, SJ (corresponding author), Univ Chicago, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA.	skron@uchicago.edu	Truman, Andrew/I-8454-2019; Prodromou, Chrisostomos/ABA-9133-2021; Kristjansdottir, Kolla/V-4952-2019; Perrett, Sarah/AAS-9483-2020	Truman, Andrew/0000-0002-6409-3723; Prodromou, Chrisostomos/0000-0003-4320-1147; Kristjansdottir, Kolla/0000-0001-7054-2444; Perrett, Sarah/0000-0003-0137-0997; Jones, Gary/0000-0002-7565-934X; Kron, Stephen/0000-0003-1518-2436	NIGMS [GM60443]; NUI Maynooth John and Pat Hume postgraduate scholarship; Wellcome Trust [095605/Z11/Z]; 973 Program [2012CB911000/2013CB910700]; NATIONAL CANCER INSTITUTE [R01CA164492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060443] Funding Source: NIH RePORTER; Medical Research Council [G0801130B] Funding Source: researchfish	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NUI Maynooth John and Pat Hume postgraduate scholarship; Wellcome Trust(Wellcome TrustEuropean Commission); 973 Program(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank M. Mollapour and S. Takahashi for insightful scientific discussion and A. Amon and P. Nash for helpful comments. We are grateful to E. Craig, M. Aldea, M. Polymenis, C. De Virgilio, D. Levin, P. Piper, B. Zetter, J. Buchner, S. Rospert, D. Klionsky, B. Andrews, and M. Tyers for providing materials used in this study. This work was supported by a generous gift from The Foglia Foundation and Mr. and Mrs. Vincent Foglia (A. W. T., S. J. K.) and NIGMS grant GM60443 (S. J. K.). N.H. was supported by a NUI Maynooth John and Pat Hume postgraduate scholarship. C. P. was funded by a Wellcome Trust Senior Investigator Award (095605/Z11/Z). S. P. and H.Z. were supported by the 973 Program (2012CB911000/2013CB910700).	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Benanti JA, 2012, SEMIN CELL DEV BIOL, V23, P492, DOI 10.1016/j.semcdb.2012.04.005; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; CAPLAN AJ, 1991, J CELL BIOL, V114, P609, DOI 10.1083/jcb.114.4.609; Carroll AS, 2002, TRENDS BIOCHEM SCI, V27, P87, DOI 10.1016/S0968-0004(01)02040-0; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Craig E.A., 2011, HSP70 CHAPERONES ELS; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; DICOMO CJ, 1995, MOL CELL BIOL, V15, P1835; Diehl JA, 2003, MOL CELL BIOL, V23, P1764, DOI 10.1128/MCB.23.5.1764-1774.2003; Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11; Ferrezuelo F, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r67; Ferrezuelo F, 2009, CELL CYCLE, V8, P239, DOI 10.4161/cc.8.2.7543; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Huang D, 2007, MOL MICROBIOL, V66, P303, DOI 10.1111/j.1365-2958.2007.05914.x; Huang DQ, 1998, MOL CELL BIOL, V18, P3289, DOI 10.1128/MCB.18.6.3289; Jaiswal H, 2011, MOL CELL BIOL, V31, P1160, DOI 10.1128/MCB.00986-10; Jones G, 2004, MOL CELL BIOL, V24, P3928, DOI 10.1128/MCB.24.9.3928-3937.2004; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kung C, 2005, P NATL ACAD SCI USA, V102, P3587, DOI 10.1073/pnas.0407170102; Mandal AK, 2008, MOL CELL BIOL, V28, P4434, DOI 10.1128/MCB.00543-08; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mazanka E, 2010, MOL BIOL CELL, V21, P2809, DOI 10.1091/mbc.E10-02-0174; Measday V, 1997, MOL CELL BIOL, V17, P1212, DOI 10.1128/MCB.17.3.1212; Meimaridou E, 2009, J MOL ENDOCRINOL, V42, P1, DOI 10.1677/JME-08-0116; Moffat J, 2000, Prog Cell Cycle Res, V4, P97; Mollapour M, 2010, CELL CYCLE, V9, P2310, DOI 10.4161/cc.9.12.12054; Newcomb LL, 2003, EUKARYOT CELL, V2, P143, DOI 10.1128/EC.2.1.143-149.2003; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Nishizawa M, 1998, MOL BIOL CELL, V9, P2393, DOI 10.1091/mbc.9.9.2393; Sharma D, 2011, P NATL ACAD SCI USA, V108, P13665, DOI 10.1073/pnas.1107421108; Sharma D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006644; SHERLOCK G, 1993, J GEN MICROBIOL, V139, P2531, DOI 10.1099/00221287-139-11-2531; Tan YSH, 2003, J BIOL CHEM, V278, P147, DOI 10.1074/jbc.M208058200; Timblin BK, 1996, GENETICS, V143, P57; Trotter EW, 2001, P NATL ACAD SCI USA, V98, P7313, DOI 10.1073/pnas.121172998; TYERS M, 1992, EMBO J, V11, P1773, DOI 10.1002/j.1460-2075.1992.tb05229.x; Verges E, 2007, MOL CELL, V26, P649, DOI 10.1016/j.molcel.2007.04.023; Wijnen H, 1999, GENETICS, V153, P1131; Wysocki R, 2006, NAT STRUCT MOL BIOL, V13, P908, DOI 10.1038/nsmb1139; YAGLOM J, 1995, MOL CELL BIOL, V15, P731; Yaglom JA, 1996, MOL CELL BIOL, V16, P3679; Yang ZF, 2010, MOL CELL, V38, P250, DOI 10.1016/j.molcel.2010.02.033	47	93	95	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1308	1318		10.1016/j.cell.2012.10.051	http://dx.doi.org/10.1016/j.cell.2012.10.051			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217712	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000311999900019
J	Bourzac, K				Bourzac, Katherine			ANTI-AGEING Live long and prosper	NATURE			English	Editorial Material							CALORIC RESTRICTION											BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Stein PK, 2012, AGING CELL, V11, P644, DOI 10.1111/j.1474-9726.2012.00825.x	6	6	6	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					S18	S20		10.1038/492S18a	http://dx.doi.org/10.1038/492S18a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048EQ	23222670	Bronze			2022-12-28	WOS:000311893400010
J	Perron, JT; Richardson, PW; Ferrier, KL; Lapotre, M				Perron, J. Taylor; Richardson, Paul W.; Ferrier, Ken L.; Lapotre, Mathieu			The root of branching river networks	NATURE			English	Article							TRIPLE JUNCTION REGION; EROSION RATES; MODEL; LANDSCAPE; BE-10; EVOLUTION; HILLSLOPE; BEDROCK; CREEP; AL-26	Branching river networks are one of the most widespread and recognizable features of Earth's landscapes and have also been discovered elsewhere in the Solar System(1,2). But the mechanisms that create these patterns and control their spatial scales are poorly understood. Theories based on probability(3-5) or optimality(3,6-8) have proven useful(9), but do not explain how river networks develop over time through erosion and sediment transport. Here we show that branching at the uppermost reaches of river networks is rooted in two coupled instabilities: first, valleys widen at the expense of their smaller neighbours, and second, side slopes of the widening valleys become susceptible to channel incision. Each instability occurs at a critical ratio of the characteristic timescales for soil transport and channel incision. Measurements from two field sites demonstrate that our theory correctly predicts the size of the smallest valleys with tributaries. We also show that the dominant control on the scale of landscape dissection in these sites is the strength of channel incision, which correlates with aridity and rock weakness, rather than the strength of soil transport. These results imply that the fine-scale structure of branching river networks is an organized signature of erosional mechanics, not a consequence of random topology.	[Perron, J. Taylor; Richardson, Paul W.; Ferrier, Ken L.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Lapotre, Mathieu] Univ Strasbourg, Ecole & Observ Sci Terre, F-67084 Strasbourg, France	Massachusetts Institute of Technology (MIT); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Perron, JT (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	perron@mit.edu	Perron, J. Taylor/D-8983-2012; Lapotre, Mathieu/L-4910-2018	Perron, J. Taylor/0000-0002-0404-8701; Ferrier, Ken/0000-0003-4098-166X; Richardson, Paul/0000-0002-9418-1804; Lapotre, Mathieu/0000-0001-9941-1552	US National Science Foundation Geomorphology and Land Use Dynamics programme [EAR-0951672]; US Department of Defense through a National Defense Science and Engineering Graduate Fellowship; Division Of Earth Sciences [0951672] Funding Source: National Science Foundation	US National Science Foundation Geomorphology and Land Use Dynamics programme; US Department of Defense through a National Defense Science and Engineering Graduate Fellowship; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was supported by the US National Science Foundation Geomorphology and Land Use Dynamics programme through award EAR-0951672 to J.T.P. and by the US Department of Defense through a National Defense Science and Engineering Graduate Fellowship to P. W. R. J.T.P. is a Scholar in the Canadian Institute for Advanced Research (CIFAR). The authors thank T. Clifton and G. Chmiel for assistance with sample preparation, and the Orradre family of San Ardo, California, and numerous landowners in Greene County, Pennsylvania, for granting access to their land.	[Anonymous], 1983, GEOL SOC AM BULL, V94, P1035; Balco G, 2008, QUAT GEOCHRONOL, V3, P174, DOI 10.1016/j.quageo.2007.12.001; Berg T, 1980, GEOLOGIC MAP PENNSYL; Bonnet S, 2009, NAT GEOSCI, V2, P766, DOI 10.1038/NGEO666; CULLING WEH, 1960, J GEOL, V68, P336, DOI 10.1086/626663; CULLING WEH, 1963, J GEOL, V71, P127, DOI 10.1086/626891; Dietrich W.E., 1993, CHANNEL NETWORK HYDR, P175; Ditchburn R.G, 1994, 3 WORKSH S PAC ENV R, P4; Dunne T., 1980, PROG PHYS GEOG, V4, P211, DOI [10.1177/030913338000400204, DOI 10.1177/030913338000400204, DOI 10.1016/S1546-5098(08)60146-6]; Durham D.L, 1974, PROF PAP US GEOL SUR, V819, P1; Fernandes NF, 1997, WATER RESOUR RES, V33, P1307, DOI 10.1029/97WR00534; Gilbert G. K., 1877, REPORT GEOLOGY HENRY, DOI DOI 10.5962/BHL.TITLE.51652; Gonzalez R.C, 2007, DIGITAL IMAGE PROCES, V3rd; Granger DE, 1996, J GEOL, V104, P249, DOI 10.1086/629823; Hack J.T., 1957, 294B US GEOL SURV, V294-B, P1; HANKS TC, 1984, J GEOPHYS RES, V89, P5771, DOI 10.1029/JB089iB07p05771; HORTON RE, 1945, GEOL SOC AM BULL, V56, P275, DOI 10.1130/0016-7606(1945)56[275:edosat]2.0.co;2; Hovius N, 1996, BASIN RES, V8, P29, DOI 10.1111/j.1365-2117.1996.tb00113.x; HOWARD AD, 1983, GEOL SOC AM BULL, V94, P739, DOI 10.1130/0016-7606(1983)94<739:CCIB>2.0.CO;2; HOWARD AD, 1990, WATER RESOUR RES, V26, P2107, DOI 10.1029/WR026i009p02107; HOWARD AD, 1994, WATER RESOUR RES, V30, P2261, DOI 10.1029/94WR00757; HOWARD AD, 1971, GEOGR ANAL, V3, P29; IZUMI N, 1995, J FLUID MECH, V283, P341, DOI 10.1017/S0022112095002357; JENSON SK, 1988, PHOTOGRAMM ENG REM S, V54, P1593; KIRCHNER JW, 1993, GEOLOGY, V21, P591, DOI 10.1130/0091-7613(1993)021<0591:SIOHSL>2.3.CO;2; KOHL CP, 1992, GEOCHIM COSMOCHIM AC, V56, P3583, DOI 10.1016/0016-7037(92)90401-4; Lashermes B, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031140; Leopold L.B., 1962, 500A US GEOL SURV PR, P1; MCKEAN JA, 1993, GEOLOGY, V21, P343, DOI 10.1130/0091-7613(1993)021<0343:QOSPAD>2.3.CO;2; MITASOVA H, 1993, MATH GEOL, V25, P657, DOI 10.1007/BF00893172; MONAGHAN MC, 1992, EARTH PLANET SC LETT, V111, P483, DOI 10.1016/0012-821X(92)90198-5; MONTGOMERY DR, 1992, SCIENCE, V255, P826, DOI 10.1126/science.255.5046.826; NASH DB, 1980, J GEOL, V88, P353, DOI 10.1086/628513; Passalacqua P, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001254; Peckham S. D, 2011, GEOMORPHOMETRY 2011, P27; Perron JT, 2012, EARTH SURF PROC LAND, V37, P52, DOI 10.1002/esp.2205; Perron JT, 2009, NATURE, V460, P502, DOI 10.1038/nature08174; Perron JT, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000977; RIGON R, 1993, WATER RESOUR RES, V29, P1635, DOI 10.1029/92WR02985; Rodriguez-Iturbe I., 2001, FRACTAL RIVER BASINS; ROSENBLOOM NA, 1994, J GEOPHYS RES-SOL EA, V99, P14013, DOI 10.1029/94JB00048; SCHUMM SA, 1956, GEOL SOC AM BULL, V67, P597, DOI 10.1130/0016-7606(1956)67[597:EODSAS]2.0.CO;2; Seidl M.A., 1992, CATENA S, V23, P101, DOI DOI 10.1029/2007WR006219; SEIDL MA, 1994, J GEOL, V102, P457, DOI 10.1086/629686; SHREVE RL, 1967, J GEOL, V75, P178, DOI 10.1086/627245; Small EE, 1999, GEOMORPHOLOGY, V27, P131, DOI 10.1016/S0169-555X(98)00094-4; SMITH TR, 1972, WATER RESOUR RES, V8, P1506, DOI 10.1029/WR008i006p01506; Snyder NP, 2000, GEOL SOC AM BULL, V112, P1250, DOI 10.1130/0016-7606(2000)112<1250:LRTTFD>2.3.CO;2; Snyder NP, 2003, GEOMORPHOLOGY, V53, P97, DOI 10.1016/S0169-555X(02)00349-5; Stock JD, 1999, J GEOPHYS RES-SOL EA, V104, P4983, DOI 10.1029/98JB02139; Strahler A.N., 1957, EOS T AM GEOPHYS UNI, V38, P912, DOI [10.1029/TR038i006p00913, DOI 10.1029/TR038I006P00913]; SUN T, 1994, PHYS REV E, V49, P4865, DOI 10.1103/PhysRevE.49.4865; Tarboton DG, 1997, WATER RESOUR RES, V33, P309, DOI 10.1029/96WR03137; Tomasko MG, 2005, NATURE, V438, P765, DOI 10.1038/nature04126; Tucker GE, 1997, WATER RESOUR RES, V33, P2031, DOI 10.1029/97WR00409; Tucker GE, 1996, BASIN RES, V8, P329, DOI 10.1046/j.1365-2117.1996.00238.x; WILLGOOSE G, 1991, EARTH SURF PROC LAND, V16, P237, DOI 10.1002/esp.3290160305	57	88	92	5	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					100	+		10.1038/nature11672	http://dx.doi.org/10.1038/nature11672			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23222614				2022-12-28	WOS:000311893400053
J	Talkowski, ME; Ordulu, Z; Pillalamarri, V; Benson, CB; Blumenthal, I; Connolly, S; Hanscom, C; Hussain, N; Pereira, S; Picker, J; Rosenfeld, JA; Shaffer, LG; Wilkins-Haug, LE; Gusella, JF; Morton, CC				Talkowski, Michael E.; Ordulu, Zehra; Pillalamarri, Vamsee; Benson, Carol B.; Blumenthal, Ian; Connolly, Susan; Hanscom, Carrie; Hussain, Naveed; Pereira, Shahrin; Picker, Jonathan; Rosenfeld, Jill A.; Shaffer, Lisa G.; Wilkins-Haug, Louise E.; Gusella, James F.; Morton, Cynthia C.			Clinical Diagnosis by Whole-Genome Sequencing of a Prenatal Sample	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BALANCED CHROMOSOME REARRANGEMENTS; CHARGE ASSOCIATION; ROUTINE; UPDATE; CHD7	Conventional cytogenetic testing offers low-resolution detection of balanced karyotypic abnormalities but cannot provide the precise, gene-level knowledge required to predict outcomes. The use of high-resolution whole-genome deep sequencing is currently impractical for the purpose of routine clinical care. We show here that whole-genome "jumping libraries" can offer an immediately applicable, nucleotide-level complement to conventional genetic diagnostics within a time frame that allows for clinical action. We performed large-insert sequencing of DNA extracted from amniotic-fluid cells with a balanced de novo translocation. The amniotic-fluid sample was from a patient in the third trimester of pregnancy who underwent amniocentesis because of severe polyhydramnios after multiple fetal anomalies had been detected on ultrasonography. Using a 13-day sequence and analysis pipeline, we discovered direct disruption of CHD7, a causal locus in the CHARGE syndrome (coloboma of the eye, heart anomaly, atresia of the choanae, retardation, and genital and ear anomalies). Clinical findings at birth were consistent with the CHARGE syndrome, a diagnosis that could not have been reliably inferred from the cytogenetic breakpoint. This case study illustrates the potential power of customized whole-genome jumping libraries when used to augment prenatal karyotyping.	[Talkowski, Michael E.; Gusella, James F.; Morton, Cynthia C.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Talkowski, Michael E.; Pillalamarri, Vamsee; Blumenthal, Ian; Hanscom, Carrie; Gusella, James F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Talkowski, Michael E.; Gusella, James F.; Morton, Cynthia C.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Gusella, James F.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Ordulu, Zehra; Pereira, Shahrin; Wilkins-Haug, Louise E.; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Benson, Carol B.] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Morton, Cynthia C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Connolly, Susan] Childrens Hosp, Dept Radiol, Boston, MA 02115 USA; [Picker, Jonathan] Childrens Hosp, Dept Psychiat, Div Genet, Boston, MA 02115 USA; [Hussain, Naveed] Univ Connecticut, Dept Pediat, Farmington, CT USA; [Rosenfeld, Jill A.; Shaffer, Lisa G.] PerkinElmer, Signature Genom Labs, Spokane, WA USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Connecticut	Morton, CC (corresponding author), Harvard Univ, Sch Med, Dept Neurol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	cmorton@partners.org	Hussain, Naveed/ABD-2342-2021; Ordulu, Zehra/ABI-6638-2020	Ordulu, Zehra/0000-0002-3218-1075; Talkowski, Michael/0000-0003-2889-0992; Hussain, Naveed/0000-0002-1809-5760	National Institutes of Health [GM061354, HD065286, MH087123, MH095867]; Simons Foundation for Autism Research; Nancy Lurie Marks Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH095867, K99MH095867, F32MH087123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation for Autism Research; Nancy Lurie Marks Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by grants from the National Institutes of Health (GM061354, to Drs. Morton and Gusella; HD065286, to Dr. Gusella; and MH087123 and MH095867, to Dr. Talkowski). Drs. Talkowski and Gusella are supported by the Simons Foundation for Autism Research and the Nancy Lurie Marks Family Foundation.	ACOG Committee Opinion, 2009, OBSTET GYNECOL, V114, P1161; Blake KD, 1998, CLIN PEDIATR, V37, P159, DOI 10.1177/000992289803700302; Centers for Disease Control and Prevention (CDC), 2008, MMWR MORB MORTAL WKL, V57, P1; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; Hara Y, 2009, J ANESTH, V23, P630, DOI 10.1007/s00540-009-0791-y; Hochstenbach R, 2009, EUR J MED GENET, V52, P161, DOI 10.1016/j.ejmg.2009.03.015; Janssen N, 2012, HUM MUTAT, V33, P1149, DOI 10.1002/humu.22086; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Long G, 1998, J MED SCREEN, V5, P6, DOI 10.1136/jms.5.1.6; PAGON RA, 1981, J PEDIATR-US, V99, P223, DOI 10.1016/S0022-3476(81)80454-4; Park H, 2010, NAT GENET, V42, P400, DOI 10.1038/ng.555; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; WARBURTON D, 1991, AM J HUM GENET, V49, P995	19	125	134	1	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2012	367	23					2226	2232		10.1056/NEJMoa1208594	http://dx.doi.org/10.1056/NEJMoa1208594			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048DO	23215558	Green Accepted			2022-12-28	WOS:000311890600009
J	Smith, N; Quinton, R				Smith, Neil; Quinton, Richard			A PATIENT'S JOURNEY Kallmann syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Quinton, Richard] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK	Quinton, R (corresponding author), Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	Richard.quinton@ncl.nhs.uk							0	9	9	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 3	2012	345								e6971	10.1136/bmj.e6971	http://dx.doi.org/10.1136/bmj.e6971			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HO	23207501	Bronze			2022-12-28	WOS:000312188700002
J	Janes, CR; Corbett, KK; Jones, JH; Trostle, J				Janes, Craig R.; Corbett, Kitty K.; Jones, James H.; Trostle, James			Emerging infectious diseases: the role of social sciences	LANCET			English	Editorial Material							ECOLOGY; EMERGENCE; RESISTANCE; ZOONOSIS; BEHAVIOR		[Janes, Craig R.; Corbett, Kitty K.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Jones, James H.] Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA; [Jones, James H.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Trostle, James] Trinity Coll, Dept Anthropol, Hartford, CT 06106 USA	Simon Fraser University; Stanford University; Stanford University; Trinity College	Janes, CR (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.	cjanes@sfu.ca		Trostle, James/0000-0002-6045-9521; Jones, James/0000-0003-1680-6757	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050038] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI050038] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aboud FE, 2012, SOC SCI MED, V75, P589, DOI 10.1016/j.socscimed.2012.04.009; Bharti N, 2010, EPIDEMIOL INFECT, V138, P1308, DOI 10.1017/S0950268809991385; Cohen S, 2004, PSYCHOSOM MED, V66, P553, DOI 10.1097/01.psy.0000126200.05189.d3; Dowd JB, 2009, EPIDEMIOLOGY, V20, P902, DOI 10.1097/EDE.0b013e3181bb5302; Eccles M, 2005, J CLIN EPIDEMIOL, V58, P107, DOI 10.1016/j.jclinepi.2004.09.002; Frost LJ, 2008, ACCESS DO GOOD HLTH; Gilchrist MJ, 2007, ENVIRON HEALTH PERSP, V115, P313, DOI 10.1289/ehp.8837; Kapan DD, 2006, ECOHEALTH, V3, P187, DOI 10.1007/s10393-006-0044-6; Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X; Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9; LEVINE MM, 1994, P NATL ACAD SCI USA, V91, P2390, DOI 10.1073/pnas.91.7.2390; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Phillipson J, 2009, J APPL ECOL, V46, P261, DOI 10.1111/j.1365-2664.2009.01625.x; Pulliam JRC, 2012, J R SOC INTERFACE, V9, P89, DOI 10.1098/rsif.2011.0223; Quine CP, 2011, PHILOS T R SOC B, V366, P2010, DOI 10.1098/rstb.2010.0397; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Trostle JA, 2008, EPIDEMIOLOGY, V19, P384, DOI 10.1097/EDE.0b013e31816a9db0; Woolhouse M, 2011, PHILOS T R SOC B, V366, P2045, DOI 10.1098/rstb.2010.0387	19	56	56	2	33	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2012	380	9857					1884	1886		10.1016/S0140-6736(12)61725-5	http://dx.doi.org/10.1016/S0140-6736(12)61725-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	046IK	23200487				2022-12-28	WOS:000311758500005
J	Grubb, M				Grubb, Michael			Cap and trade finds new energy	NATURE			English	Editorial Material									Cambridge Ctr Climate Change Mitigat Res, Cambridge CB3 9EP, England		Grubb, M (corresponding author), Cambridge Ctr Climate Change Mitigat Res, Cambridge CB3 9EP, England.	mjg7@cam.ac.uk		Grubb, Michael/0000-0003-2393-3041				Grubb M., 2012, ANAL EFFECTIVENESS T; Grubb Michael, 2012, STRENGTHENING EU ETS; Kosoy A., 2012, STATE TRENDS CARBON; Lomborg B., 2012, PROJECT SYNDICA 0913; Paterson M, 2012, CLIM POLICY, V12, P82, DOI 10.1080/14693062.2011.579259; Prins G, 2007, NATURE, V449, P973, DOI 10.1038/449973a	6	30	32	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					666	667		10.1038/491666a	http://dx.doi.org/10.1038/491666a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	044FY	23192130	Bronze			2022-12-28	WOS:000311606000017
J	Christini, A; King, E				Christini, Amanda; King, Emmanuel			Neck Mass in a Returning Traveler Soft tissue melioidosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Christini, Amanda; King, Emmanuel] Hosp Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Christini, A (corresponding author), Hosp Univ Penn, Penn Tower,Ste 2009,3400 Spruce St, Philadelphia, PA 19104 USA.	amanda.christini@uphs.upenn.edu						Limmathurotsakul D, 2009, AM J TROP MED HYG, V81, P335, DOI 10.4269/ajtmh.2009.81.335; Pandey V, 2010, INDIAN J ORTHOP, V44, P216, DOI 10.4103/0019-5413.61829; Pattamapaspong N, 2011, SEMIN MUSCULOSKEL R, V15, P480, DOI 10.1055/s-0031-1293494; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0	4	4	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2012	308	20					2142	2143		10.1001/jama.2012.33634	http://dx.doi.org/10.1001/jama.2012.33634			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043IV	23188031				2022-12-28	WOS:000311537200029
J	Lund, LH; Benson, L; Dahlstrom, U; Edner, M				Lund, Lars H.; Benson, Lina; Dahlstrom, Ulf; Edner, Magnus			Association Between Use of Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure and Preserved Ejection Fraction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONVERTING-ENZYME-INHIBITOR; LEFT-VENTRICULAR FUNCTION; PROPENSITY SCORE; CARDIOVASCULAR EVENTS; CANDESARTAN; REDUCTION; MORBIDITY; TRIAL; METAANALYSIS; PERINDOPRIL	Context Heart failure with preserved ejection fraction (HFPEF) may be as common and as lethal as heart failure with reduced ejection fraction (HFREF). Three randomized trials of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ie, renin-angiotensin system [RAS] antagonists) did not reach primary end points but may have had selection bias or been underpowered. Objective To test the hypothesis that use of RAS antagonists is associated with reduced all-cause mortality in an unselected population with HFPEF. Design, Setting, and Patients Prospective study using the Swedish Heart Failure Registry of 41 791 unique patients registered from 64 hospitals and 84 outpatient clinics between 2000 and 2011. Of these, 16 216 patients with HFPEF (ejection fraction >= 40%; mean [SD] age, 75 [11] years; 46% women) were either treated (n=12 543) or not treated (n=3673) with RAS antagonists. Propensity scores for RAS antagonist use were derived from 43 variables. The association between use of RAS antagonists and all-cause mortality was assessed in a cohort matched 1: 1 based on age and propensity score and in the overall cohort with adjustment for propensity score as a continuous covariate. To assess consistency, separate age and propensity score-matched analyses were performed according to RAS antagonist dose in patients with HFPEF and in 20 111 patients with HFREF (ejection fraction <40%) in the same registry. Main Outcome Measure All-cause mortality. Results In the matched HFPEF cohort, 1-year survival was 77% (95% CI, 75%-78%) for treated patients vs 72% (95% CI, 70%-73%) for untreated patients, with a hazard ratio (HR) of 0.91 (95% CI, 0.85-0.98; P=.008). In the overall HFPEF cohort, crude 1-year survival was 86% (95% CI, 86%-87%) for treated patients vs 69% (95% CI, 68%-71%) for untreated patients, with a propensity score-adjusted HR of 0.90 (95% CI, 0.85-0.96; P=.001). In the HFPEF dose analysis, the HR was 0.85 (95% CI, 0.78-0.83) for 50% or greater of target dose vs no treatment (P<.001) and 0.94 (95% CI, 0.87-1.02) for less than 50% of target dose vs no treatment (P=.14). In the age and propensity score-matched HFREF analysis, the HR was 0.80 (95% CI, 0.74-0.86; P<.001). Conclusion Among patients with heart failure and preserved ejection fraction, the use of RAS antagonists was associated with lower all-cause mortality. JAMA. 2012;308(20):2108-2117 www.jama.com	[Lund, Lars H.] Karolinska Univ Hosp, Sect Heart Failure, Dept Cardiol, S-17176 Stockholm, Sweden; [Lund, Lars H.; Edner, Magnus] Karolinska Inst, Dept Med, Unit Cardiol, Stockholm, Sweden; [Benson, Lina] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Dahlstrom, Ulf] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden; [Dahlstrom, Ulf] Linkoping Univ Hosp, Dept Cardiol, Cty Council Ostergotland, S-58185 Linkoping, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Linkoping University; City Council Ostergotland; Linkoping University	Lund, LH (corresponding author), Karolinska Univ Hosp, Sect Heart Failure, Dept Cardiol, N305, S-17176 Stockholm, Sweden.	lars.lund@alumni.duke.edu		Benson, Lina/0000-0002-5393-0055	AstraZeneca; Thoratec; Heart-Ware; Swedish National Board of Health and Welfare; Swedish Association of Local Authorities and Regions; Swedish Society of Cardiology; Swedish Heart-Lung Foundation [20080409, 20100419]; Stockholm County Council [00556-2009, 20110120]	AstraZeneca(AstraZeneca); Thoratec; Heart-Ware; Swedish National Board of Health and Welfare; Swedish Association of Local Authorities and Regions; Swedish Society of Cardiology; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council(Stockholm County Council)	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Lund reported receiving institutional research grants and speaker's and consulting fees from AstraZeneca, Thoratec, and Heart-Ware. No other disclosures were reported.; The Swedish Heart Failure Registry is funded by the Swedish National Board of Health and Welfare, the Swedish Association of Local Authorities and Regions, the Swedish Society of Cardiology, and the Swedish Heart-Lung Foundation. This study received no specific funding. Dr Lund was supported by grants 20080409 and 20100419 from the Swedish Heart-Lung Foundation, grants 00556-2009 and 20110120 from the Stockholm County Council, and an unrestricted research grant from AstraZeneca.	Berry C, 2012, EUR HEART J, V33, P1750, DOI 10.1093/eurheartj/ehr254; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Desai A, 2007, CURR OPIN CARDIOL, V22, P578; Eklind-Cervenka M, 2011, JAMA-J AM MED ASSOC, V305, P175, DOI 10.1001/jama.2010.1949; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Fox KM, 2003, LANCET, V362, P782; Fu MQ, 2012, INT J CARDIOL, V155, P33, DOI 10.1016/j.ijcard.2011.01.081; Guyatt G., 2008, USERS GUIDES MEDICAL; Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290; Henkel DM, 2008, CIRC-HEART FAIL, V1, P91, DOI 10.1161/CIRCHEARTFAILURE.107.743146; Hogg K, 2005, PROG CARDIOVASC DIS, V47, P357, DOI 10.1016/j.pcad.2005.02.001; Jonsson A, 2010, EUR J HEART FAIL, V12, P25, DOI 10.1093/eurjhf/hfp175; Kitzman DW, 2002, JAMA-J AM MED ASSOC, V288, P2144, DOI 10.1001/jama.288.17.2144; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Lenzen MJ, 2004, EUR HEART J, V25, P1214, DOI 10.1016/j.ehj.2004.06.006; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; McMurray J, 2006, EUR HEART J, V27, P2257, DOI 10.1093/eurheartj/ehl249; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Meune C, 2011, J CARDIOVASC PHARM T, V16, P368, DOI 10.1177/1074248410391667; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Packer M, 1999, CIRCULATION, V100, P2312, DOI 10.1161/01.CIR.100.23.2312; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Shah NR, 2000, JAMA-J AM MED ASSOC, V284, P3127, DOI 10.1001/jama.284.24.3127; Solomon SD, 2005, CIRCULATION, V112, P3738, DOI 10.1161/CIRCULATIONAHA.105.561423; Solomon SD, 2004, CIRCULATION, V110, P2180, DOI 10.1161/01.CIR.0000144474.65922.AA; Steinberg BA, 2012, CIRCULATION, V126, P65, DOI 10.1161/CIRCULATIONAHA.111.080770; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; Wright JW, 2008, HEART FAIL REV, V13, P367, DOI 10.1007/s10741-007-9060-z; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zile MR, 2010, CIRCULATION, V121, P1393, DOI 10.1161/CIRCULATIONAHA.109.909614	38	123	125	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2012	308	20					2108	2117		10.1001/jama.2012.14785	http://dx.doi.org/10.1001/jama.2012.14785			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043IV	23188027	Bronze			2022-12-28	WOS:000311537200025
J	Kirste, M; Wang, XA; Schewe, HC; Meijer, G; Liu, KP; van der Avoird, A; Janssen, LMC; Gubbels, KB; Groenenboom, GC; van de Meerakker, SYT				Kirste, Moritz; Wang, Xingan; Schewe, H. Christian; Meijer, Gerard; Liu, Kopin; van der Avoird, Ad; Janssen, Liesbeth M. C.; Gubbels, Koos B.; Groenenboom, Gerrit C.; van de Meerakker, Sebastiaan Y. T.			Quantum-State Resolved Bimolecular Collisions of Velocity-Controlled OH with NO Radicals	SCIENCE			English	Article							DIFFERENTIAL CROSS-SECTIONS; INELASTIC-SCATTERING; MOLECULAR-BEAMS; ENERGY SURFACE; AR	Whereas atom-molecule collisions have been studied with complete quantum-state resolution, interactions between two state-selected molecules have proven much harder to probe. Here, we report the measurement of state-resolved inelastic scattering cross sections for collisions between two open-shell molecules that are both prepared in a single quantum state. Stark-decelerated hydroxyl (OH) radicals were scattered with hexapole-focused nitric oxide (NO) radicals in a crossed-beam configuration. Rotationally and spin-orbit inelastic scattering cross sections were measured on an absolute scale for collision energies between 70 and 300 cm(-1). These cross sections show fair agreement with quantum coupled-channels calculations using a set of coupled model potential energy surfaces based on ab initio calculations for the long-range nonadiabatic interactions and a simplistic short-range interaction. This comparison reveals the crucial role of electrostatic forces in complex molecular collision processes.	[van der Avoird, Ad; Janssen, Liesbeth M. C.; Gubbels, Koos B.; Groenenboom, Gerrit C.; van de Meerakker, Sebastiaan Y. T.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands; [Kirste, Moritz; Wang, Xingan; Schewe, H. Christian; Meijer, Gerard; van de Meerakker, Sebastiaan Y. T.] Max Planck Gesell, Fritz Haber Inst, D-14195 Berlin, Germany; [Liu, Kopin] Acad Sinica, IAMS, Taipei 10617, Taiwan	Radboud University Nijmegen; Max Planck Society; Fritz Haber Institute of the Max Planck Society; Academia Sinica - Taiwan	Groenenboom, GC (corresponding author), Radboud Univ Nijmegen, Inst Mol & Mat, Heijendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands.	gerritg@theochem.ru.nl; basvdm@science.ru.nl	van de Meerakker, Sebastiaan Y.T./D-4581-2012; Meijer, Gerard/D-2141-2009; Groenenboom, Gerrit C/F-9692-2015; Groenenboom, Gerrit/S-8138-2019; Liu, Kopin/F-7929-2012	Meijer, Gerard/0000-0001-9669-8340; Groenenboom, Gerrit/0000-0002-0920-3707; Liu, Kopin/0000-0001-7499-2397; Janssen, Liesbeth/0000-0001-5283-1330	Alexander von Humboldt Foundation (AvHF); AvHF; Netherlands Organisation for Scientific Research (NWO);  [ERC-2009-AdG];  [247142-MolChip]	Alexander von Humboldt Foundation (AvHF); AvHF; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ; 	S.Y.T.v.d.M. acknowledges support from the Netherlands Organisation for Scientific Research (NWO) via a VIDI grant. G. M. and K. B. G. acknowledge support from the ERC-2009-AdG under grant agreement 247142-MolChip. K. L. and A.v.d.A. acknowledge the Alexander von Humboldt Foundation (AvHF) for a Humboldt Research Award. X. W. acknowledges the AvHF for a research fellowship. We thank J. Blokland for her help setting up the narrowband laser system. We thank the referees for valuable and stimulating comments. The authors declare no competing financial interests.	BERNSTEIN RB, 1964, SCIENCE, V144, P141, DOI 10.1126/science.144.3615.141; Berteloite C, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.203201; Chandler D. W., 2010, TUTORIALS MOL REACTI; CLARY DC, 1990, ANNU REV PHYS CHEM, V41, P61; Dagdigian PJ, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3078386; Eyles CJ, 2011, NAT CHEM, V3, P597, DOI [10.1038/nchem.1071, 10.1038/NCHEM.1071]; Gilijamse JJ, 2006, SCIENCE, V313, P1617, DOI 10.1126/science.1131867; Kohguchi H, 2002, ANN RP CH C, V98, P421, DOI 10.1039/B111167C; Kohguchi H, 2001, SCIENCE, V294, P832, DOI 10.1126/science.1063774; LEVINE RD, 1987, MOL REACTION DYNAMIC; Lorenz KT, 2001, SCIENCE, V293, P2063, DOI 10.1126/science.1062754; Nguyen MT, 1998, CHEM PHYS, V230, P1, DOI 10.1016/S0301-0104(97)00383-2; Paterson G, 2012, INT REV PHYS CHEM, V31, P69, DOI 10.1080/0144235X.2012.659046; Sawyer BC, 2011, PHYS CHEM CHEM PHYS, V13, P19059, DOI 10.1039/c1cp21203f; Scharfenberg L, 2011, EUR PHYS J D, V65, P189, DOI 10.1140/epjd/e2011-20009-4; Scharfenberg L, 2010, PHYS CHEM CHEM PHYS, V12, P10660, DOI 10.1039/c004422a; Scharfenberg L, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.023410; SCHIFFMAN A, 1995, INT REV PHYS CHEM, V14, P371, DOI 10.1080/01442359509353315; Schreel K, 1996, J CHEM PHYS, V105, P4522, DOI 10.1063/1.472328; SHARKEY P, 1994, J CHEM SOC FARADAY T, V90, P3609, DOI 10.1039/ft9949003609; Smith IWM, 2011, ANNU REV ASTRON ASTR, V49, P29, DOI 10.1146/annurev-astro-081710-102533; STOLTE S, 1991, NATURE, V353, P391, DOI 10.1038/353391a0; Van De Meerakker SYT, 2008, NAT PHYS, V4, P595, DOI 10.1038/nphys1031; van de Meerakker SYT, 2012, CHEM REV, V112, P4828, DOI 10.1021/cr200349r; Vonk MT, 1997, J CHEM PHYS, V106, P1353, DOI 10.1063/1.473972; Watanabe D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.043201; WEINREB S, 1963, NATURE, V200, P829, DOI 10.1038/200829a0	28	105	105	5	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1060	1063		10.1126/science.1229549	http://dx.doi.org/10.1126/science.1229549			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23180857	Green Submitted			2022-12-28	WOS:000311390600038
J	Andreou, I; Tentolouris, C; Brili, S; Tousoulis, D; Stefanadis, C				Andreou, Ioannis; Tentolouris, Costas; Brili, Stella; Tousoulis, Dimitris; Stefanadis, Christodoulos			Foot-like heart	LANCET			English	Editorial Material									[Andreou, Ioannis; Tentolouris, Costas; Brili, Stella; Tousoulis, Dimitris; Stefanadis, Christodoulos] Univ Athens, Sch Med, Dept Cardiol 1, Hippokrat Hosp, Athens 11528, Greece	Athens Medical School; Hippokration General Hospital; National & Kapodistrian University of Athens	Andreou, I (corresponding author), Univ Athens, Sch Med, Dept Cardiol 1, Vasilissis Sofias 114, Athens 11528, Greece.	yannisand@yahoo.com	Stefanadis, Christodoulos/ABH-2232-2020; Stefanadis, Christodoulos/AAA-4102-2020; Andreou, Ioannis/AAF-6260-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Andreou, Ioannis/0000-0002-2912-1928					0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 25	2013	381	9880					1844	1844		10.1016/S0140-6736(12)61337-3	http://dx.doi.org/10.1016/S0140-6736(12)61337-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151EO	23245994				2022-12-28	WOS:000319443700030
J	Kretz, M; Siprashvili, Z; Chu, C; Webster, DE; Zehnder, A; Qu, K; Lee, CS; Flockhart, RJ; Groff, AF; Chow, J; Johnston, D; Kim, GE; Spitale, RC; Flynn, RA; Zheng, GXY; Aiyer, S; Raj, A; Rinn, JL; Chang, HY; Khavari, PA				Kretz, Markus; Siprashvili, Zurab; Chu, Ci; Webster, Dan E.; Zehnder, Ashley; Qu, Kun; Lee, Carolyn S.; Flockhart, Ross J.; Groff, Abigail F.; Chow, Jennifer; Johnston, Danielle; Kim, Grace E.; Spitale, Robert C.; Flynn, Ryan A.; Zheng, Grace X. Y.; Aiyer, Subhadra; Raj, Arjun; Rinn, John L.; Chang, Howard Y.; Khavari, Paul A.			Control of somatic tissue differentiation by the long non-coding RNA TINCR	NATURE			English	Article							GENE; CHROMATIN; COMPLEXES; REPRESSION; EXPRESSION; MUTATIONS; STAUFEN; SUITE; SHAPE	Several of the thousands of human long non-coding RNAs (lncRNAs) have been functionally characterized(1-4); however, potential roles for lncRNAs in somatic tissue differentiation remain poorly understood. Here we show that a 3.7-kilobase lncRNA, terminal differentiation-induced ncRNA (TINCR), controls human epidermal differentiation by a post-transcriptional mechanism. TINCR is required for high messenger RNA abundance of key differentiation genes, many of which are mutated in human skin diseases, including FLG, LOR, ALOXE3, ALOX12B, ABCA12, CASP14 and ELOVL3. TINCR-deficient epidermis lacked terminal differentiation ultrastructure, including keratohyalin granules and intact lamellar bodies. Genome-scale RNA interactome analysis revealed that TINCR interacts with a range of differentiation mRNAs. TINCR-mRNA interaction occurs through a 25-nucleotide 'TINCR box' motif that is strongly enriched in interacting mRNAs and required for TINCR binding. A high-throughput screen to analyse TINCR binding capacity to approximately 9,400 human recombinant proteins revealed direct binding of TINCR RNA to the staufen1 (STAU1) protein. STAU1-deficient tissue recapitulated the impaired differentiation seen with TINCR depletion. Loss of UPF1 and UPF2, both of which are required for STAU1-mediated RNA decay, however, did not have differentiation effects. Instead, the TINCR-STAU1 complex seems to mediate stabilization of differentiation mRNAs, such as KRT80. These data identify TINCR as a key lncRNA required for somatic tissue differentiation, which occurs through lncRNA binding to differentiation mRNAs to ensure their expression.	[Kretz, Markus; Siprashvili, Zurab; Chu, Ci; Webster, Dan E.; Zehnder, Ashley; Qu, Kun; Lee, Carolyn S.; Flockhart, Ross J.; Groff, Abigail F.; Chow, Jennifer; Johnston, Danielle; Kim, Grace E.; Spitale, Robert C.; Flynn, Ryan A.; Zheng, Grace X. Y.; Chang, Howard Y.; Khavari, Paul A.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Aiyer, Subhadra; Raj, Arjun] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Chang, Howard Y.] Howard Hughes Med Inst, Stanford, CA 94305 USA; [Khavari, Paul A.] Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA	Stanford University; University of Pennsylvania; Harvard University; Howard Hughes Medical Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Chang, HY (corresponding author), Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA.	howchang@stanford.edu; khavari@stanford.edu	Kretz, Markus/ABB-8490-2021; Qu, Kun/G-3359-2012	Flynn, Ryan/0000-0001-5013-0442; Rinn, John/0000-0002-7231-7539; Webster, Dan/0000-0001-6874-8451; Raj, Arjun/0000-0002-2915-6960; Lee, Carolyn/0000-0002-6511-3757	US Veterans Affairs Office of Research and Development; National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases) [AR49737]; NIH [R01-HG004361]; California Institute for Regenerative Medicine; NATIONAL CANCER INSTITUTE [R01CA142635, T32CA009302] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007422, R01AR049737] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008514] Funding Source: NIH RePORTER	US Veterans Affairs Office of Research and Development(US Department of Veterans Affairs); National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by US Veterans Affairs Office of Research and Development funding to P. A. K. and National Institutes of Health (National Institute of Arthritis and Musculoskeletal and Skin Diseases) grant AR49737 to P. A. K., and by NIH R01-HG004361 and California Institute for Regenerative Medicine to H.Y.C. H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bond AM, 2009, NAT NEUROSCI, V12, P1020, DOI 10.1038/nn.2371; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Dugre-Brisson S, 2005, NUCLEIC ACIDS RES, V33, P4797, DOI 10.1093/nar/gki794; Eckl KM, 2009, J INVEST DERMATOL, V129, P1421, DOI 10.1038/jid.2008.409; Elias PM, 2005, J INVEST DERMATOL, V125, P183, DOI 10.1111/j.0022-202X.2005.23668.x; Furic L, 2008, RNA, V14, P324, DOI 10.1261/rna.720308; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; O'Driscoll J, 2002, CLIN EXP DERMATOL, V27, P243, DOI 10.1046/j.1365-2230.2002.01031.x; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sakai K, 2009, J INVEST DERMATOL, V129, P2306, DOI 10.1038/jid.2009.23; Sen GL, 2010, NATURE, V463, P563, DOI 10.1038/nature08683; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Virtanen M, 2003, J INVEST DERMATOL, V121, P1013, DOI 10.1046/j.1523-1747.2003.12534.x; Wan DF, 2004, P NATL ACAD SCI USA, V101, P15724, DOI 10.1073/pnas.0404089101; Westerberg R, 2004, J BIOL CHEM, V279, P5621, DOI 10.1074/jbc.M310529200; Young TL, 2005, CURR BIOL, V15, P501, DOI 10.1016/j.cub.2005.02.027; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	37	661	703	4	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					231	U245		10.1038/nature11661	http://dx.doi.org/10.1038/nature11661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23201690	Green Accepted			2022-12-28	WOS:000313259600041
J	Bagdonaite, J; Jansen, P; Henkel, C; Bethlem, HL; Menten, KM; Ubachs, W				Bagdonaite, Julija; Jansen, Paul; Henkel, Christian; Bethlem, Hendrick L.; Menten, Karl M.; Ubachs, Wim			A Stringent Limit on a Drifting Proton-to-Electron Mass Ratio from Alcohol in the Early Universe	SCIENCE			English	Article							FINE-STRUCTURE CONSTANT; RADIO-SOURCE PKS1830-211; PKS 1830-211; MOLECULAR ABSORPTION; HYPERFINE-STRUCTURE; GRAVITATIONAL LENS; REST FREQUENCIES; METHANOL; REDSHIFT; Z=0.89	The standard model of physics is built on the fundamental constants of nature, but it does not provide an explanation for their values, nor require their constancy over space and time. Here we set a limit on a possible cosmological variation of the proton-to-electron mass ratio m by comparing transitions in methanol observed in the early universe with those measured in the laboratory. From radio-astronomical observations of PKS1830-211, we deduced a constraint of Delta mu/mu = (0.0 +/- 1.0) x 10(-7) at redshift z = 0.89, corresponding to a look-back time of 7 billion years. This is consistent with a null result.	[Bagdonaite, Julija; Jansen, Paul; Bethlem, Hendrick L.; Ubachs, Wim] Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; [Henkel, Christian; Menten, Karl M.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Henkel, Christian] King Abdulaziz Univ, Dept Astron, Jeddah 21413, Saudi Arabia	Vrije Universiteit Amsterdam; Max Planck Society; King Abdulaziz University	Ubachs, W (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, De Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.	w.m.g.ubachs@vu.nl	Bethlem, Hendrick Lucas/B-2831-2008; Ubachs, W./K-3256-2019; Ubachs, Wim/F-5649-2011	Bethlem, Hendrick Lucas/0000-0003-4575-8512; Ubachs, W./0000-0001-7840-3756; Ubachs, Wim/0000-0001-7840-3756	Foundation for Fundamental Research on Matter program "Broken Mirrors & Drifting Constants"; Netherlands Organization for Scientific Research via a VIDI grant; European Research Council via a Starting Grant	Foundation for Fundamental Research on Matter program "Broken Mirrors & Drifting Constants"; Netherlands Organization for Scientific Research via a VIDI grant; European Research Council via a Starting Grant	This work is supported by the Foundation for Fundamental Research on Matter program "Broken Mirrors & Drifting Constants." H. L. B. acknowledges support from the Netherlands Organization for Scientific Research via a VIDI grant and by the European Research Council via a Starting Grant. We thank the staff of the Effelsberg radio telescope for their hospitality and support. The raw data of the radioastronomical observations are available upon request from the Max Planck Institute for Radio Astronomy at Bonn (kmenten@mpifr-bonn.mpg.de).	Barrow JD, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.043521; BRECKENRIDGE SM, 1995, ASTROPHYS J, V438, P504, DOI 10.1086/175095; Chengalur JN, 1999, ASTRON ASTROPHYS, V343, pL79; Ellingsen SP, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/1/L7; Henkel C, 2009, ASTRON ASTROPHYS, V500, P725, DOI 10.1051/0004-6361/200811475; HEUVEL JEM, 1973, J MOL SPECTROSC, V45, P282, DOI 10.1016/0022-2852(73)90159-8; Jansen P, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.062505; Jansen P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.100801; JAUNCEY DL, 1991, NATURE, V352, P132, DOI 10.1038/352132a0; Kanekar N, 2011, ASTROPHYS J LETT, V728, DOI 10.1088/2041-8205/728/1/L12; King JA, 2012, MON NOT R ASTRON SOC, V422, P3370, DOI 10.1111/j.1365-2966.2012.20852.x; Leurini S, 2004, ASTRON ASTROPHYS, V422, P573, DOI 10.1051/0004-6361:20047046; Levshakov SA, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/26; Lidman C, 1999, ASTROPHYS J, V514, pL57, DOI 10.1086/311949; LIN CC, 1959, REV MOD PHYS, V31, P841, DOI 10.1103/RevModPhys.31.841; Lovas FJ, 2004, J PHYS CHEM REF DATA, V33, P177, DOI 10.1063/1.1633275; Malec AL, 2010, MON NOT R ASTRON SOC, V403, P1541, DOI 10.1111/j.1365-2966.2009.16227.x; Menten KM, 2008, ASTRON ASTROPHYS, V492, P725, DOI 10.1051/0004-6361:200810041; Muller HSP, 2004, ASTRON ASTROPHYS, V428, P1019, DOI 10.1051/0004-6361:20041384; Muller S, 2011, ASTRON ASTROPHYS, V535, DOI 10.1051/0004-6361/201117096; Muller S, 2008, ASTRON ASTROPHYS, V491, P739, DOI 10.1051/0004-6361:200810392; Murphy MT, 2008, SCIENCE, V320, P1611, DOI 10.1126/science.1156352; Murphy MT, 2003, MON NOT R ASTRON SOC, V345, P609, DOI 10.1046/j.1365-8711.2003.06970.x; Reinhold E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.151101; Smolin L, 2004, PHYSICA A, V340, P705, DOI 10.1016/j.physa.2004.05.021; van Veldhoven J, 2004, EUR PHYS J D, V31, P337, DOI 10.1140/epjd/e2004-00160-9; van Weerdenburg F, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.180802; Webb JK, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.191101; Webb JK, 1999, PHYS REV LETT, V82, P884, DOI 10.1103/PhysRevLett.82.884; Wiklind T, 1996, NATURE, V379, P139, DOI 10.1038/379139a0	30	98	98	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					46	48		10.1126/science.1224898	http://dx.doi.org/10.1126/science.1224898			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23239626	Green Submitted			2022-12-28	WOS:000312985800046
J	Doerfel, LK; Wohlgemuth, I; Kothe, C; Peske, F; Urlaub, H; Rodnina, MV				Doerfel, Lili K.; Wohlgemuth, Ingo; Kothe, Christina; Peske, Frank; Urlaub, Henning; Rodnina, Marina V.			EF-P Is Essential for Rapid Synthesis of Proteins Containing Consecutive Proline Residues	SCIENCE			English	Article							ELONGATION-FACTOR-P; PEPTIDE-BOND FORMATION; TRANSFER-RNA; TRANSLATION ELONGATION; POSTTRANSLATIONAL MODIFICATION; RIBOSOME-RESCUE; SSRA; TERMINATION; VIRULENCE; HYPUSINE	Elongation factor P (EF-P) is a translation factor of unknown function that has been implicated in a great variety of cellular processes. Here, we show that EF-P prevents ribosome from stalling during synthesis of proteins containing consecutive prolines, such as PPG, PPP, or longer proline strings, in natural and engineered model proteins. EF-P promotes peptide-bond formation and stabilizes the peptidyl-transfer RNA in the catalytic center of the ribosome. EF-P is posttranslationally modified by a hydroxylated beta-lysine attached to a lysine residue. The modification enhances the catalytic proficiency of the factor mainly by increasing its affinity to the ribosome. We propose that EF-P and its eukaryotic homolog, eIF5A, are essential for the synthesis of a subset of proteins containing proline stretches in all cells.	[Doerfel, Lili K.; Wohlgemuth, Ingo; Kothe, Christina; Peske, Frank; Rodnina, Marina V.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany; [Wohlgemuth, Ingo; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Goettingen, Dept Clin Chem, D-37075 Gottingen, Germany	Max Planck Society; Max Planck Society; University of Gottingen	Rodnina, MV (corresponding author), Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany.	rodnina@mpibpc.mpg.de	Rodnina, Marina V./AAD-4667-2019	Rodnina, Marina V./0000-0003-0105-3879; Wohlgemuth, Ingo/0000-0001-9121-7675	Max Planck Society; Deutsche Forschungsgemeinschaft	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank W. Wintermeyer for critically reading the manuscript; W. Holtkamp and J. Mittelstaet for the translation assay and M1 and M2 peptide markers; D. Gorlich and C. Enke for the antibody against EF-P; and O. Geintzer, S. Kappler, T. Wiles, M. Zimmermann, T. Uhlendorf, A. Bursy, and U. Plessmann for expert technical assistance. The work was funded by the Max Planck Society and by grants from the Deutsche Forschungsgemeinschaft.	Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; GLICK BR, 1979, EUR J BIOCHEM, V97, P23, DOI 10.1111/j.1432-1033.1979.tb13081.x; GLICK BR, 1975, P NATL ACAD SCI USA, V72, P4257, DOI 10.1073/pnas.72.11.4257; Gregio APB, 2009, BIOCHEM BIOPH RES CO, V380, P785, DOI 10.1016/j.bbrc.2009.01.148; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Heurgue-Hamard V, 1998, EMBO J, V17, P808, DOI 10.1093/emboj/17.3.808; Holmes A, 2010, INFECT IMMUN, V78, P4445, DOI 10.1128/IAI.00635-10; Johansson M, 2011, P NATL ACAD SCI USA, V108, P79, DOI 10.1073/pnas.1012612107; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Park JH, 2012, J BIOL CHEM, V287, P2579, DOI 10.1074/jbc.M111.309633; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; Peil L, 2012, NAT CHEM BIOL, V8, P695, DOI [10.1038/NCHEMBIO.1001, 10.1038/nchembio.1001]; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Sallee NA, 2008, NATURE, V454, P1005, DOI 10.1038/nature07170; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Sunohara T, 2002, RNA, V8, P1416, DOI 10.1017/S1355838202020198; Tanner DR, 2009, J BIOL CHEM, V284, P34809, DOI 10.1074/jbc.M109.039040; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; Wolff EC, 2007, AMINO ACIDS, V33, P341, DOI 10.1007/s00726-007-0525-0; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Zou SB, 2011, VIRULENCE, V2, P147, DOI 10.4161/viru.2.2.15039	26	304	311	4	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					85	88		10.1126/science.1229017	http://dx.doi.org/10.1126/science.1229017			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23239624				2022-12-28	WOS:000312985800057
J	Ince, C; van Kuijen, AM; Milstein, DMJ; Yuruk, K; Folkow, LP; Fokkens, WJ; Blix, AS				Ince, Can; van Kuijen, Anne-Marije; Milstein, Dan M. J.; Yuruk, Koray; Folkow, Lars P.; Fokkens, Wytske J.; Blix, Arnoldus S.			CHRISTMAS 2012: RESEARCH Why Rudolph's nose is red: observational study	BRITISH MEDICAL JOURNAL			English	Editorial Material							LASER-DOPPLER FLOWMETRY; NASAL HEAT-EXCHANGE; MUCOSAL MICROCIRCULATION; SEPTIC SHOCK; BLOOD-FLOW; REINDEER; RHINOSTEREOMETRY; CONGESTION	Objective To characterise the functional morphology of the nasal microcirculation in humans in comparison with reindeer as a means of testing the hypothesis that the luminous red nose of Rudolph, one of the most well known reindeer pulling Santa Claus's sleigh, is due to the presence of a highly dense and rich nasal microcirculation. Design Observational study. Setting Tromso, Norway (near the North Pole), and Amsterdam, the Netherlands. Participants Five healthy human volunteers, two adult reindeer, and a patient with grade 3 nasal polyposis. Main outcome measures Architecture of the microvasculature of the nasal septal mucosa and head of the inferior turbinates, kinetics of red blood cells, and real time reactivity of the microcirculation to topical medicines. Results Similarities between human and reindeer nasal microcirculation were uncovered. Hairpin-like capillaries in the reindeers' nasal septal mucosa were rich in red blood cells, with a perfused vessel density of 20 (SD 0.7) mm/mm(2). Scattered crypt or gland-like structures surrounded by capillaries containing flowing red blood cells were found in human and reindeer noses. In a healthy volunteer, nasal microvascular reactivity was demonstrated by the application of a local anaesthetic with vasoconstrictor activity, which resulted in direct cessation of capillary blood flow. Abnormal microvasculature was observed in the patient with nasal polyposis. Conclusions The nasal microcirculation of reindeer is richly vascularised, with a vascular density 25% higher than that in humans. These results highlight the intrinsic physiological properties of Rudolph's legendary luminous red nose, which help to protect it from freezing during sleigh rides and to regulate the temperature of the reindeer's brain, factors essential for flying reindeer pulling Santa Claus's sleigh under extreme temperatures.	[Ince, Can] Erasmus Univ, Dept Intens Care Med, Erasmus Med Ctr, NL-3000 CA Rotterdam, Netherlands; [van Kuijen, Anne-Marije; Fokkens, Wytske J.] Univ Amsterdam, Dept Otorhinolaryngol, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands; [Milstein, Dan M. J.; Yuruk, Koray] Univ Amsterdam, Dept Translat Physiol, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands; [Folkow, Lars P.; Blix, Arnoldus S.] Univ Tromso, Dept Arctic & Marine Biol, N-9001 Tromso, Norway	Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; UiT The Arctic University of Tromso	Ince, C (corresponding author), Erasmus Univ, Dept Intens Care Med, Erasmus Med Ctr, S Gravendijkwal 230,POB 2040, NL-3000 CA Rotterdam, Netherlands.	c.ince@erasmusmc.nl	Fokkens, Wytske WJ/ABF-2185-2020; Milstein, Dan M.J./H-2821-2019	Milstein, Dan M.J./0000-0003-1335-5516				Aas-Hansen O, 2000, AM J PHYSIOL-REG I, V279, pR1190; Abrams Don-Carlos, 1997, Rhinology (Utrecht), V35, P22; Bezemer R, 2012, CRIT CARE, V16, DOI 10.1186/cc11236; Blix AS, 2011, J EXP BIOL, V214, P3850, DOI 10.1242/jeb.057455; Blix AS, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-42; BLIX AS, 1983, J PHYSIOL-LONDON, V340, P445, DOI 10.1113/jphysiol.1983.sp014772; Blix AS, 2005, ARCTIC ANIMALS; Boerma EC, 2005, CRIT CARE, V9, pR601, DOI 10.1186/cc3809; Cervin A, 2001, RHINOLOGY, V39, P13; Dobbe JGG, 2008, MED BIOL ENG COMPUT, V46, P659, DOI 10.1007/s11517-008-0349-4; DRUCE HM, 1989, MICROVASC RES, V38, P175, DOI 10.1016/0026-2862(89)90026-5; Goedhart PT, 2007, OPT EXPRESS, V15, P15101, DOI 10.1364/OE.15.015101; Groner W, 1999, NAT MED, V5, P1209, DOI 10.1038/13529; Grudemo H, 1997, ORL-J OTO-RHIN-LARYN, V59, P50, DOI 10.1159/000276905; Grudemo H, 1999, AM J RHINOL, V13, P1, DOI 10.2500/105065899781389911; Ince C, 2005, CRIT CARE, V9, pS13, DOI 10.1186/cc3753; JOHNSEN HK, 1985, AM J PHYSIOL, V249, pR617, DOI 10.1152/ajpregu.1985.249.5.R617; Mathura KR, 2001, LANCET, V358, P1698, DOI 10.1016/S0140-6736(01)06722-8; Meinders AJ, 2009, NEW ENGL J MED, V360, pE9, DOI 10.1056/NEJMicm066261; Milstein DMJ, 2010, ORAL SURG ORAL MED O, V109, P91, DOI 10.1016/j.tripleo.2009.08.041; Philpott CM, 2005, CLIN OTOLARYNGOL, V30, P373, DOI 10.1111/j.1365-2273.2005.00985.x; Sakr Y, 2004, CRIT CARE MED, V32, P1825, DOI 10.1097/01.CCM.0000138558.16257.3F; Spronk PE, 2002, LANCET, V360, P1395, DOI 10.1016/S0140-6736(02)11393-6	23	8	8	0	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2012	345								e8311	10.1136/bmj.e8311	http://dx.doi.org/10.1136/bmj.e8311			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	059IU	23247980	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000312698700003
J	Wang, HD; Dwyer-Lindgren, L; Lofgren, KT; Rajaratnam, JK; Marcus, JR; Levin-Rector, A; Levitz, CE; Lopez, AD; Murray, CJL				Wang, Haidong; Dwyer-Lindgren, Laura; Lofgren, Katherine T.; Rajaratnam, Julie Knoll; Marcus, Jacob R.; Levin-Rector, Alison; Levitz, Carly E.; Lopez, Alan D.; Murray, Christopher J. L.			Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010	LANCET			English	Article							SUB-SAHARAN AFRICA; ADULT MORTALITY; CHILD-MORTALITY; PREMATURE MORTALITY; MATERNAL MORTALITY; UNDER-5 MORTALITY; SCALE-UP; IMPACT; ALCOHOL; RUSSIA	Background Estimation of the number and rate of deaths by age and sex is a key first stage for calculation of the burden of disease in order to constrain estimates of cause-specific mortality and to measure premature mortality in populations. We aimed to estimate life tables and annual numbers of deaths for 187 countries from 1970 to 2010. Methods We estimated trends in under-5 mortality rate (children aged 0-4 years) and probability of adult death (15-59 years) for each country with all available data. Death registration data were available for more than 100 countries and we corrected for undercount with improved death distribution methods. We applied refined methods to survey data on sibling survival that correct for survivor, zero-sibling, and recall bias. We separately estimated mortality from natural disasters and wars. We generated final estimates of under-5 mortality and adult mortality from the data with Gaussian process regression. We used these results as input parameters in a relational model life table system. We developed a model to extrapolate mortality to 110 years of age. All death rates and numbers have been estimated with 95% uncertainty intervals (95% UIs). Findings From 1970 to 2010, global male life expectancy at birth increased from 56.4 years (95% UI 55.5-57.2) to 67.5 years (66.9-68.1) and global female life expectancy at birth increased from 61.2 years (60.2-62.0) to 73.3 years (72.8-73.8). Life expectancy at birth rose by 3-4 years every decade from 1970, apart from during the 1990s (increase in male life expectancy of 1.4 years and in female life expectancy of 1.6 years). Substantial reductions in mortality occurred in eastern and southern sub-Saharan Africa since 2004, coinciding with increased coverage of antiretroviral therapy and preventive measures against malaria. Sex-specifi c changes in life expectancy from 1970 to 2010 ranged from gains of 23-29 years in the Maldives and Bhutan to declines of 1-7 years in Belarus, Lesotho, Ukraine, and Zimbabwe. Globally, 52.8 million (95% UI 51.6-54.1 million) deaths occurred in 2010, which is about 13.5% more than occurred in 1990 (46.5 million [45.7-47.4 million]), and 21.9% more than occurred in 1970 (43.3 million [42.2-44.6 million]). Proportionally more deaths in 2010 occurred at age 70 years and older (42.8% in 2010 vs 33.1% in 1990), and 22.9% occurred at 80 years or older. Deaths in children younger than 5 years declined by almost 60% since 1970 (16.4 million [16.1-16.7 million] in 1970 vs 6.8 million [6.6-7.1 million] in 2010), especially at ages 1-59 months (10.8 million [10.4-11.1 million] in 1970 vs 4.0 million [3.8-4.2 million] in 2010). In all regions, including those most affected by HIV/AIDS, we noted increases in mean ages at death. Interpretation Despite global and regional health crises, global life expectancy has increased continuously and substantially in the past 40 years. Yet substantial heterogeneity exists across age groups, among countries, and over different decades. 179 of 187 countries have had increases in life expectancy after the slowdown in progress in the 1990s. Efforts should be directed to reduce mortality in low-income and middle-income countries. Potential underestimation of achievement of the Millennium Development Goal 4 might result from limitations of demographic data on child mortality for the most recent time period. Improvement of civil registration system worldwide is crucial for better tracking of global mortality.	[Wang, Haidong; Dwyer-Lindgren, Laura; Lofgren, Katherine T.; Rajaratnam, Julie Knoll; Marcus, Jacob R.; Levin-Rector, Alison; Levitz, Carly E.; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Lopez, Alan D.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Queensland	Wang, HD (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	haidong@uw.edu	Levin-Rector, Alison/AAA-6756-2020; Lopez, Alan/AAA-2734-2022; Lopez, Alan D/F-1487-2010	Lopez, Alan D/0000-0001-5818-6512; Levitz, Carly/0000-0003-3094-411X; Dwyer-Lindgren, Laura/0000-0002-3872-6451	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Bill & Melinda Gates Foundation.	Ahmad OB, 2000, B WORLD HEALTH ORGAN, V78, P1175; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Barnes KI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S1-S8; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; BENNETT NG, 1984, DEMOGRAPHY, V21, P217, DOI 10.2307/2061041; BENNETT NG, 1981, POPUL INDEX, V47, P207, DOI 10.2307/2736447; Bhat PNM, 2004, INT J EPIDEMIOL, V33, P717, DOI 10.1093/ije/dyh235; Bicego, 1997, HLTH T REV S2, V7, P7; Blacker J, 2004, AIDS, V18, pS19, DOI 10.1097/00002030-200406002-00003; Bobak M, 2003, EPIDEMIOLOGY, V14, P603, DOI 10.1097/01.ede.0000082000.75818.4d; Boerma JT, 1998, AIDS, V12, pS3; Brass W, 1968, THE DEMOGRAPHY OF TR; Claeson M, 2000, B WORLD HEALTH ORGAN, V78, P1192; Crimmins EM, 2011, EXPLAINING DIVERGENT LEVELS OF LONGEVITY IN HIGH-INCOME COUNTRIES, P1; Franz J, 2006, CENT ASIAN SURV, V25, P481, DOI 10.1080/02634930701210476; Gakidou E, 2004, INT J EPIDEMIOL, V33, P710, DOI 10.1093/ije/dyh099; Gakidou E, 2006, DEMOGRAPHY, V43, P569, DOI 10.1353/dem.2006.0024; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Gleditsch NP, 2002, J PEACE RES, V39, P615, DOI 10.1177/0022343302039005007; Gompertz B., 1871, J I ACTUARIES, V16, P329, DOI DOI 10.1017/S204616740004369X; GRAHAM W, 1989, STUD FAMILY PLANN, V20, P125, DOI 10.2307/1966567; Guillot M, INFANT MORTALITY IN; HILL K, 1977, POP STUD-J DEMOG, V31, P313, DOI 10.1080/00324728.1977.10410432; Hill K, 1987, Asian Pac Popul Forum, V1, P8; James SL, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-12; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; Leon DA, 1997, LANCET, V350, P383, DOI 10.1016/S0140-6736(97)03360-6; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Lopez AD, 2002, WORLD MORTALITY IN 2; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Masquelier B, 2013, DEMOGRAPHY, V50, P207, DOI 10.1007/s13524-012-0149-1; McKee M, 2001, BRIT MED J, V323, P1051, DOI 10.1136/bmj.323.7320.1051; Muheki C, 2004, TROP MED INT HEALTH, V9, P959, DOI 10.1111/j.1365-3156.2004.01292.x; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000262; Murray CJL, 2003, POP STUD-J DEMOG, V57, P165, DOI 10.1080/0032472032000097083; Murray CJL, 1996, THE GLOBAL BURDEN OF; Nicholson A, 2005, B WORLD HEALTH ORGAN, V83, P812; Obermeyer Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000260; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Porter K, 2004, AIDS, V18, pS9, DOI 10.1097/00002030-200406002-00002; PRESTON S, 1980, POPUL INDEX, V46, P179, DOI 10.2307/2736122; PRESTON S, 1980, POP STUD-J DEMOG, V34, P349, DOI 10.1080/00324728.1980.10410395; PRESTON SH, 1970, POP STUD-J DEMOG, V24, P5, DOI 10.1080/00324728.1970.10406109; Quinn TC, 1996, LANCET, V348, P99, DOI 10.1016/S0140-6736(96)01029-X; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rajaratnam JK, 2010, LANCET, V375, P1704, DOI 10.1016/S0140-6736(10)60517-X; Rajaratnam JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000253; Rehm J, 2007, INT J EPIDEMIOL, V36, P458, DOI 10.1093/ije/dyl294; Rowe AK, 2007, AM J TROP MED HYG, V77, P48, DOI 10.4269/ajtmh.2007.77.48; Sewankambo NK, 2000, AIDS, V14, P2391, DOI 10.1097/00002030-200010200-00021; Stanton C, 2000, STUD FAMILY PLANN, V31, P111, DOI 10.1111/j.1728-4465.2000.00111.x; Steketee RW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-299; The International Institute for Strategic Studies, ARMED CONFLICT DATAB; Timaeus I, 1989, MEASURING ADULT MORT; Timaeus IM, 1998, AIDS, V12, pS15; Timaeus IM, 2004, DEMOGRAPHY, V41, P757, DOI 10.1353/dem.2004.0037; TIMAEUS IM, 1991, POPUL INDEX, V57, P552, DOI 10.2307/3644262; UN Inter-agency Group for Child Mortality Estimation, REPORT 2012; United Nations Commission on Information and Accountability for Women's and Children's Health, KEEPING PROMISES MEA; United Nations Department of Economic and Social Affairs Population Division, 1999, WORLD POPULATION PRO; United Nations Department of Economic and Social Affairs Population Division, 1991, WORLD POPULATION PRO; United Nations Department of Economic and Social Affairs Population Division, 1989, WORLD POPULATION PRO; United Nations Department of Economic and Social Affairs Population Division, 1981, WORLD POPULATION PRO; United Nations Department of Economic and Social Affairs Population Division, 1995, WORLD POPULATION PRO; United Nations Department of Economic and Social Affairs Population Division, 2007, WORLD POPULATION PRO; United Nations Department of Economic and Social Affairs Population Division, 1983, WORLD POPULATION PRO; United Nations Department of Economic and Social Affairs Population Division, 2009, WORLD POPULATION PRO; United Nations Department of Economic and Social Affairs Population Division, 2005, WORLD POPULATION PRO; United Nations Department of Economic and Social Affairs Population Division, 1985, WORLD POPULATION PRO; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD POPULATION PRO, V2; United Nations Department of Economic and Social Affairs Population Division, 2003, WORLD POPULATION PRO; United Nations Department of Economic and Social Affairs Population Division, 2001, WORLD POPULATION PRO; United Nations Department of Economic and Social Affairs Population Division, 1997, WORLD POPULATION PRO; United Nations Department of Economic and Social Affairs Population Division, 1993, WORLD POPULATION PRO; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD POPULATION PRO, V1; United Nations ESCAP Statistics Division, TOWARDS A REGIONAL P; Universite Catholique de Louvain Brussels Belgium, EM DAT THE OFDA CRED; Urassa M, 2001, AIDS, V15, P2017, DOI 10.1097/00002030-200110190-00015; USAID, CHILD SURVIVAL CALL; Vapattanawong P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-604; WHO, WHO MORTALITY DATABA; WHO Health Metrics Network, WHO MONITORING OF VI; World Health Organization (WHO), 2006, THE WORLD HEALTH REP; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3; Zaridze D, 2009, INT J EPIDEMIOL, V38, P143, DOI 10.1093/ije/dyn160; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	92	509	541	5	231	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2012	380	9859					2071	2094		10.1016/S0140-6736(12)61719-X	http://dx.doi.org/10.1016/S0140-6736(12)61719-X			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23245603				2022-12-28	WOS:000312387000011
J	Drife, JO				Drife, James Owen			Talented oldsters	BRITISH MEDICAL JOURNAL			English	Editorial Material												J.O.Drife@leeds.ac.uk						Jones BF, 2011, P NATL ACAD SCI USA, V108, P18910, DOI 10.1073/pnas.1102895108	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 14	2012	345								e8459	10.1136/bmj.e8459	http://dx.doi.org/10.1136/bmj.e8459			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056NE	23241509				2022-12-28	WOS:000312496200002
J	McCarthy, M				McCarthy, Michael			Containing the opioid overdose epidemic	BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY		LocalHealthGuide Com, Seattle, WA USA		McCarthy, M (corresponding author), LocalHealthGuide Com, Seattle, WA USA.	mxmc@mac.com						Agency Medical Directors Group, 2010, INT GUID OP DOS CHRO; Franklin GM, 2012, AM J IND MED, V55, P325, DOI 10.1002/ajim.21998; Franklin GM, 2005, AM J IND MED, V48, P91, DOI 10.1002/ajim.20191; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487	4	8	8	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 14	2012	345								e8340	10.1136/bmj.e8340	http://dx.doi.org/10.1136/bmj.e8340			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056NE	23241432				2022-12-28	WOS:000312496200001
J	Sheth, R; Marcon, L; Bastida, MF; Junco, M; Quintana, L; Dahn, R; Kmita, M; Sharpe, J; Ros, MA				Sheth, Rushikesh; Marcon, Luciano; Felix Bastida, M.; Junco, Marisa; Quintana, Laura; Dahn, Randall; Kmita, Marie; Sharpe, James; Ros, Maria A.			Hox Genes Regulate Digit Patterning by Controlling the Wavelength of a Turing-Type Mechanism	SCIENCE			English	Article							REACTION-DIFFUSION MODEL; SONIC-HEDGEHOG; LIMB; GLI3; EXPRESSION; NUMBER; FINS; DOWNSTREAM; REVEALS; HOXD-13	The formation of repetitive structures (such as stripes) in nature is often consistent with a reaction-diffusion mechanism, or Turing model, of self-organizing systems. We used mouse genetics to analyze how digit patterning (an iterative digit/nondigit pattern) is generated. We showed that the progressive reduction in Hoxa13 and Hoxd11-Hoxd13 genes (hereafter referred to as distal Hox genes) from the Gli3-null background results in progressively more severe polydactyly, displaying thinner and densely packed digits. Combined with computer modeling, our results argue for a Turing-type mechanism underlying digit patterning, in which the dose of distal Hox genes modulates the digit period or wavelength. The phenotypic similarity with fish-fin endoskeleton patterns suggests that the pentadactyl state has been achieved through modification of an ancestral Turing-type mechanism.	[Kmita, Marie] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Sharpe, James] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain; [Sheth, Rushikesh; Felix Bastida, M.; Junco, Marisa; Ros, Maria A.] Univ Cantabria, Soc El Desarrollo Reg Cantabria, Consejo Super Invest Cient, Fac Med,Inst Biomed Biotecnol, Santander 39011, Spain; [Marcon, Luciano; Quintana, Laura; Sharpe, James] CRG, EMBL, Syst Biol Res Unit, Barcelona 08003, Spain; [Marcon, Luciano; Quintana, Laura; Sharpe, James] Univ Pompeu Fabra, Barcelona 08003, Spain; [Felix Bastida, M.; Ros, Maria A.] Univ Cantabria, Dept Anat & Biol Celular, Santander 39011, Spain	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; ICREA; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); Pompeu Fabra University; Universidad de Cantabria	Kmita, M (corresponding author), Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.	marie.kmita@ircm.qc.ca; james.sharpe@crg.eu; marian.ros@unican.es	Marcon, Luciano LM/X-9975-2018; Sharpe, James/AAB-7948-2019; kmita, marie/AAU-9620-2020; Sharpe, James/L-1150-2014; Ros, Maria A./K-8160-2014; Marcon, Luciano/AAK-5535-2020	Marcon, Luciano LM/0000-0003-0957-9170; Sharpe, James/0000-0002-1434-9743; Ros, Maria A./0000-0002-1224-7671; Marcon, Luciano/0000-0003-0957-9170; Kmita, Marie/0000-0003-4021-0478	Spanish Ministry of Science and Innovation [BFU2011-24972]; Canadian Institutes of Health Research [MOP-82880]; Formacion Profesorado Universitario fellowship from the Spanish Ministry of Science and Innovation; EMBL-CRG Systems Biology Program; ICREA Funding Source: Custom	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Formacion Profesorado Universitario fellowship from the Spanish Ministry of Science and Innovation; EMBL-CRG Systems Biology Program; ICREA(ICREA)	We thank D. Duboule and P. Chambon for the mutant mice, A. Munteanu for comments on the mathematical analysis, and M. Torres and M. Towers for critical reading of the manuscript. This work was supported by grant BFU2011-24972 from the Spanish Ministry of Science and Innovation to M. A. R. and by grant MOP-82880 from the Canadian Institutes of Health Research to M. K. R. S. was supported by a Formacion Profesorado Universitario fellowship from the Spanish Ministry of Science and Innovation; L. M. was supported by a fellowship from the EMBL-CRG Systems Biology Program.	Bastida MF, 2008, CURR OPIN GENET DEV, V18, P374, DOI 10.1016/j.gde.2008.06.009; Chen YT, 2004, DEVELOPMENT, V131, P2339, DOI 10.1242/dev.01115; Dahn RD, 2007, NATURE, V445, P311, DOI 10.1038/nature05436; Davis AP, 1996, DEVELOPMENT, V122, P1175; Davis MC, 2007, NATURE, V447, P473, DOI 10.1038/nature05838; Freitas R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000754; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Goff DJ, 1997, DEVELOPMENT, V124, P627; Kmita M, 2005, NATURE, V435, P1113, DOI 10.1038/nature03648; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Knezevic V, 1997, DEVELOPMENT, V124, P4523; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Lopez-Rios J, 2012, DEV CELL, V22, P837, DOI 10.1016/j.devcel.2012.01.006; MAINI PK, 1991, INT REV CYTOL, V129, P91; McGlinn E, 2005, MECH DEVELOP, V122, P1218, DOI 10.1016/j.mod.2005.06.012; Miura T, 2004, B MATH BIOL, V66, P627, DOI 10.1016/j.bulm.2003.09.009; Miura T, 2006, J THEOR BIOL, V240, P562, DOI 10.1016/j.jtbi.2005.10.016; NEWMAN SA, 1979, SCIENCE, V205, P662, DOI 10.1126/science.462174; Newman SA, 1996, BIOESSAYS, V18, P171, DOI 10.1002/bies.950180302; Schneider I, 2011, P NATL ACAD SCI USA, V108, P12782, DOI 10.1073/pnas.1109993108; Sheth R, 2007, DEV BIOL, V310, P430, DOI 10.1016/j.ydbio.2007.07.023; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Woltering JM, 2010, DEV CELL, V18, P526, DOI 10.1016/j.devcel.2010.04.002; Zakany J, 1997, P NATL ACAD SCI USA, V94, P13695, DOI 10.1073/pnas.94.25.13695; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681	31	237	239	4	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1476	1480		10.1126/science.1226804	http://dx.doi.org/10.1126/science.1226804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239739	Green Accepted			2022-12-28	WOS:000312250800050
J	Bhaskaran, K; Armstrong, B; Hajat, S; Haines, A; Wilkinson, P; Smeeth, L				Bhaskaran, Krishnan; Armstrong, Ben; Hajat, Shakoor; Haines, Andy; Wilkinson, Paul; Smeeth, Liam			Heat and risk of myocardial infarction: hourly level case-crossover analysis of MINAP database	BRITISH MEDICAL JOURNAL			English	Article							EASTERN UNITED-STATES; AIR-POLLUTION; TIME-SERIES; AMBIENT-TEMPERATURE; 11 CITIES; MORTALITY; ENGLAND; DEATHS; WALES; ADMISSIONS	Objective To quantify the association between exposure to higher temperatures and the risk of myocardial infarction at an hourly temporal resolution. Design Case-crossover study. Setting England and Wales Myocardial Ischaemia National Audit Project (MINAP) database. Participants 24 861 hospital admissions for myocardial infarction occurring in 11 conurbations during the warmest months (June to August) of the years 2003-09. Main outcome measure Odds ratio of myocardial infarction for a 1 degrees C increase in temperature. Results Strong evidence was found for an effect of heat acting 1-6 hours after exposure to temperatures above an estimated threshold of 20 degrees C (95% confidence interval 16 degrees C to 25 degrees C). For each 1 C increase in temperature above this threshold, the risk of myocardial infarction increased by 1.9% (0.5% to 3.3%, P=0.009). Later reductions in risk seemed to offset early increases in risk: the cumulative effect of a 1 degrees C rise in temperature above the threshold was 0.2% (-2.1% to 2.5%) by the end of the third day after exposure. Conclusions Higher ambient temperatures above a threshold of 20 degrees C seem to be associated with a transiently increased risk of myocardial infarction 1-6 hours after exposure. Reductions in risk at longer lags are consistent with heat triggering myocardial infarctions early in highly vulnerable people who would otherwise have had a myocardial infarction some time later ("short term displacement"). Policies aimed at reducing the health effects of hot weather should include consideration of effects operating at sub-daily timescales.	[Bhaskaran, Krishnan; Smeeth, Liam] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Armstrong, Ben; Hajat, Shakoor; Haines, Andy; Wilkinson, Paul] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Bhaskaran, K (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England.	krishnan.bhaskaran@lshtm.ac.uk	; Smeeth, Liam/X-5862-2018	armstrong, benedict/0000-0003-4407-0409; Haines, Andy/0000-0002-8053-4605; Wilkinson, Paul/0000-0001-7456-259X; Bhaskaran, Krishnan/0000-0001-5364-8757; Smeeth, Liam/0000-0002-9168-6022	British Heart Foundation [FS/04/045]; Wellcome Trust [086091/Z/08/Z]; Garfield Weston Foundation; National Institute for Health Research postdoctoral fellowship [NIHR-PDF-2011-04-007]; Wellcome Trust senior research fellowship in clinical science [098504/Z/12/Z]; National Institute for Health Research [PDF-2011-04-007, NF-SI-0510-10090] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Garfield Weston Foundation; National Institute for Health Research postdoctoral fellowship(National Institute for Health Research (NIHR)); Wellcome Trust senior research fellowship in clinical science(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the British Heart Foundation (grant number FS/04/045), the Wellcome Trust (grant number 086091/Z/08/Z), and the Garfield Weston Foundation. KB is supported by a National Institute for Health Research postdoctoral fellowship (grant number NIHR-PDF-2011-04-007). LS is supported by a Wellcome Trust senior research fellowship in clinical science (grant number 098504/Z/12/Z). The British Heart Foundation, the Garfield Weston Foundation, the National Institute for Health Research, and the Wellcome Trust had no role in the design or conduct of this study, or in the preparation, review, approval, or decision to submit the manuscript. All authors carried out this research independently of the funding bodies.	Astrand PO, 2003, TXB WORK PHYSL PHYSL, V4th; Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Bhaskaran K, 2009, HEART, V95, P1760, DOI 10.1136/hrt.2009.175000; Bhaskaran K, 2009, HEART, V95, P1746, DOI 10.1136/hrt.2009.175018; Bhaskaran K, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5531; Bhaskaran K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3823; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Braga ALF, 2001, EPIDEMIOLOGY, V12, P662; Curriero FC, 2003, AM J EPIDEMIOL, V158, P93, DOI 10.1093/aje/kwg105; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Department for Environment Food and Rural Affairs, 2011, UK AIR DAT ARCH; Department of Health, 2011, HEATW PLAN ENGL PROT; Doherty RM, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-S1-S8; Gasparrini A, 2012, OCCUP ENVIRON MED, V69, P56, DOI 10.1136/oem.2010.059782; Goldberg MS, 2011, ENVIRON RES, V111, P853, DOI 10.1016/j.envres.2011.05.022; Hajat S, 2007, OCCUP ENVIRON MED, V64, P93, DOI 10.1136/oem.2006.029017; Hajat S, 2005, EPIDEMIOLOGY, V16, P613, DOI 10.1097/01.ede.0000164559.41092.2a; Halonen JI, 2011, ENVIRON RES, V111, P281, DOI 10.1016/j.envres.2010.12.001; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; KEATINGE WR, 1986, AM J MED, V81, P795, DOI 10.1016/0002-9343(86)90348-7; KUNST AE, 1993, AM J EPIDEMIOL, V137, P331, DOI 10.1093/oxfordjournals.aje.a116680; Loughnan ME, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-41; Lumley T, 2000, ENVIRONMETRICS, V11, P689, DOI 10.1002/1099-095X(200011/12)11:6<689::AID-ENV439>3.0.CO;2-N; Messner Torbjorn, 2002, Int J Circumpolar Health, V61, P201; Met Office, 2012, MET OFF INT DAT ARCH; Mills NL, 2007, NEW ENGL J MED, V357, P1075, DOI 10.1056/NEJMoa066314; Nayha Simo, 2005, Int J Circumpolar Health, V64, P451; Schwartz J, 2004, EPIDEMIOLOGY, V15, P755, DOI 10.1097/01.ede.0000134875.15919.0f; Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stryhn H, 2003, INT S VET EP EC ISVE; Turner LR, 2012, EPIDEMIOLOGY, V23, P594, DOI 10.1097/EDE.0b013e3182572795; Wolf K, 2009, CIRCULATION, V120, P735, DOI 10.1161/CIRCULATIONAHA.108.815860; WOOLHISER DA, 1979, J APPL METEOROL, V18, P34, DOI 10.1175/1520-0450(1979)018<0034:MLEOFC>2.0.CO;2; Yu WW, 2011, HEART, V97, P1089, DOI 10.1136/hrt.2010.217166	36	70	71	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 13	2012	345								e8050	10.1136/bmj.e8050	http://dx.doi.org/10.1136/bmj.e8050			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056MZ	23243290	Green Accepted, Green Submitted, hybrid, Green Published			2022-12-28	WOS:000312495700003
J	Lekomtsev, S; Su, KC; Pye, VE; Blight, K; Sundaramoorthy, S; Takaki, T; Collinson, LM; Cherepanov, P; Divecha, N; Petronczki, M				Lekomtsev, Sergey; Su, Kuan-Chung; Pye, Valerie E.; Blight, Ken; Sundaramoorthy, Sriramkumar; Takaki, Tohru; Collinson, Lucy M.; Cherepanov, Peter; Divecha, Nullin; Petronczki, Mark			Centralspindlin links the mitotic spindle to the plasma membrane during cytokinesis	NATURE			English	Article							CONTRACTILE RING; BINDING DOMAIN; RHOGEF ECT2; PROTEIN; COMPLEX; ABSCISSION; GTPASE; ACTIN; MICROTUBULES; PI(4,5)P-2	At the end of cell division, cytokinesis splits the cytoplasm of nascent daughter cells and partitions segregated sister genomes(1,2). To coordinate cell division with chromosome segregation, the mitotic spindle controls cytokinetic events at the cell envelope. The spindle midzone stimulates the actomyosin-driven contraction of the cleavage furrow, which proceeds until the formation of a microtubule-rich intercellular bridge with the midbody at its centre. The midbody directs the final membrane abscission reaction(1,2) and has been proposed to attach the cleavage furrow to the intercellular bridge(3). How the mitotic spindle is connected to the plasma membrane during cytokinesis is not understood. Here we identify a plasma membrane tethering activity in the centralspindlin protein complex, a conserved component of the spindle midzone and midbody(4). We demonstrate that the C1 domain of the centralspindlin subunit MgcRacGAP associates with the plasma membrane by interacting with polyanionic phosphoinositide lipids. Using X-ray crystallography we determine the structure of this atypical C1 domain. Mutations in the hydrophobic cap and in basic residues of the C1 domain of MgcRacGAP prevent association of the protein with the plasma membrane, and abrogate cytokinesis in human and chicken cells. Artificial membrane tethering of centralspindlin restores cell division in the absence of the C1 domain of MgcRacGAP. Although C1 domain function is dispensable for the formation of the midzone and midbody, it promotes contractility and is required for the attachment of the plasma membrane to the midbody, a long-postulated function of this organelle(3). Our analysis suggests that centralspindlin links the mitotic spindle to the plasma membrane to secure the final cut during cytokinesis in animal cells.	[Lekomtsev, Sergey; Su, Kuan-Chung; Sundaramoorthy, Sriramkumar; Takaki, Tohru; Petronczki, Mark] Canc Res UK London Res Inst, Clare Hall Labs, Cell Div, S Mimms EN6 3LD, Herts, England; [Lekomtsev, Sergey; Su, Kuan-Chung; Sundaramoorthy, Sriramkumar; Takaki, Tohru; Petronczki, Mark] Canc Res UK London Res Inst, Clare Hall Labs, Aneuploidy Lab, S Mimms EN6 3LD, Herts, England; [Pye, Valerie E.; Cherepanov, Peter] Canc Res UK London Res Inst, Clare Hall Labs, Chromatin Struct & Mobile DNA Lab, S Mimms EN6 3LD, Herts, England; [Blight, Ken; Collinson, Lucy M.] Canc Res UK London Res Inst, Electron Microscopy Unit, London WC2A 3PX, England; [Divecha, Nullin] Univ Manchester, Paterson Inst Canc Res, Inositide Lab, Manchester M20 4BX, Lancs, England	Cancer Research UK; Cancer Research UK; Cancer Research UK; Cancer Research UK; Paterson Institute for Cancer Research; University of Manchester	Petronczki, M (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Cell Div, Blanche Lane, S Mimms EN6 3LD, Herts, England.	mark.petronczki@cancer.org.uk	Cherepanov, Peter P/F-6859-2010; Sundaramoorthy, Sriramkumar/AAS-2912-2021	Cherepanov, Peter P/0000-0002-0634-538X; Petronczki, Mark/0000-0003-0139-5692; divecha, nullin/0000-0001-9695-6039; Collinson, Lucy/0000-0003-0260-613X; Pye, Valerie E/0000-0001-9616-2992	Cancer Research UK; EMBO; Cancer Research UK [15272] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); EMBO(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK)	We would like to thank W. Bement, W. Earnshaw, J. Gannon, D. Gerlich, M. Glotzer, G. Hammond, M. Hikida, H. Hochegger, R. Irvine, M. Kurosaki, B. Larijani, P. Parker, A. Piekny, R. Prekeris, E. Sahai, K. Samejima and M. Symons for reagents and advice. Work in the Petronczki laboratory is supported by Cancer Research UK and the EMBO Young Investigator Programme. S.L. acknowledges support from an EMBO Long-Term Fellowship.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; Bastos RN, 2012, J CELL BIOL, V198, P865, DOI 10.1083/jcb.201204107; Brodersen DE, 2000, ACTA CRYSTALLOGR D, V56, P431, DOI 10.1107/S0907444900000834; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Canman JC, 2008, SCIENCE, V322, P1543, DOI 10.1126/science.1163086; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Dambournet D, 2011, NAT CELL BIOL, V13, P981, DOI 10.1038/ncb2279; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hu CK, 2012, MOL BIOL CELL, V23, P1024, DOI 10.1091/mbc.E11-08-0721; Hutterer A, 2009, CURR BIOL, V19, P2043, DOI 10.1016/j.cub.2009.10.050; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kechad A, 2012, CURR BIOL, V22, P197, DOI 10.1016/j.cub.2011.11.062; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Loria A, 2012, CURR BIOL, V22, P213, DOI 10.1016/j.cub.2011.12.019; Miller AL, 2009, NAT CELL BIOL, V11, P71, DOI 10.1038/ncb1814; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Pavicic-Kaltenbrunner V, 2007, MOL BIOL CELL, V18, P4992, DOI 10.1091/mbc.E07-05-0468; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Piekny AJ, 2008, CURR BIOL, V18, P30, DOI 10.1016/j.cub.2007.11.068; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Simon GC, 2008, EMBO J, V27, P1791, DOI 10.1038/emboj.2008.112; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Su KC, 2011, DEV CELL, V21, P1104, DOI 10.1016/j.devcel.2011.11.003; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Yamada T, 2006, EXP CELL RES, V312, P3517, DOI 10.1016/j.yexcr.2006.07.026; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Zavortink M, 2005, J CELL SCI, V118, P5381, DOI 10.1242/jcs.02652; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zhao WM, 2006, MOL BIOL CELL, V17, P3881, DOI 10.1091/mbc.E06-01-0015	44	104	105	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					276	+		10.1038/nature11773	http://dx.doi.org/10.1038/nature11773			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23235882				2022-12-28	WOS:000312259300047
J	Brodsky, JL				Brodsky, Jeffrey L.			Cleaning Up: ER-Associated Degradation to the Rescue	CELL			English	Review							MUTANT ALPHA-1-ANTITRYPSIN; IN-VITRO; PROTEIN; RETROTRANSLOCATION; DISLOCATION; REDUCTASE; DELIVERY; PATHWAY; CYTOSOL; DOMAIN	All cellular proteins are subject to quality control "decisions,'' which help to prevent or delay a myriad of diseases. Quality control within the secretory pathway creates a special challenge, as aberrant polypeptides are recognized and returned to the cytoplasm for proteasomal degradation. This process is termed endoplasmic-reticulum (ER)-associated degradation (ERAD).	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu			National Institutes of Health; Cystic Fibrosis Foundation Therapeutics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I apologize to and thank the many colleagues and authors who helped to shape this field but whose contributions could not be cited due to space limitations. Work in the Brodsky laboratory on ERAD is supported by grants from the National Institutes of Health and Cystic Fibrosis Foundation Therapeutics.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Cormier JH, 2009, MOL CELL, V34, P627, DOI 10.1016/j.molcel.2009.05.018; Garza RM, 2009, J BIOL CHEM, V284, P14710, DOI 10.1074/jbc.M809607200; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Hagiwara M, 2011, MOL CELL, V41, P432, DOI 10.1016/j.molcel.2011.01.021; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Ron E, 2011, MOL BIOL CELL, V22, P3945, DOI 10.1091/mbc.E10-12-0944; Rubenstein EM, 2012, J CELL BIOL, V197, P761, DOI 10.1083/jcb.201203061; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Schafer A, 2009, EMBO J, V28, P2874, DOI 10.1038/emboj.2009.231; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Tirosh B, 2003, J BIOL CHEM, V278, P6664, DOI 10.1074/jbc.M210158200; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Xie W, 2010, SEMIN CELL DEV BIOL, V21, P533, DOI 10.1016/j.semcdb.2010.02.007; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	29	249	251	0	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1163	1167		10.1016/j.cell.2012.11.012	http://dx.doi.org/10.1016/j.cell.2012.11.012			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217703	Bronze, Green Accepted			2022-12-28	WOS:000311999900007
J	Lewis, A; Tomlinson, I				Lewis, Annabelle; Tomlinson, Ian			The Utility of Mouse Models in Post-GWAS Research	SCIENCE			English	Editorial Material							GENOME-WIDE ASSOCIATION; COLORECTAL-CANCER; SNP RS6983267; C-MYC; LOCUS; VARIANT; RANGE; SCAN; MICE		[Lewis, Annabelle; Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Lewis, A (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	iant@well.ox.ac.uk		Lewis, Annabelle/0000-0003-1876-1927	Wellcome Trust [090532] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Jones AM, 2012, J MED GENET, V49, P158, DOI 10.1136/jmedgenet-2011-100586; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Sodir NM, 2011, ONCOTARGET, V2, P1307; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Wokolorczyk D, 2008, CANCER RES, V68, P9982, DOI 10.1158/0008-5472.CAN-08-1838; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yekkala K, 2007, MOL CANCER RES, V5, P1296, DOI 10.1158/1541-7786.MCR-07-0232; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	12	6	6	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1301	1302		10.1126/science.1231733	http://dx.doi.org/10.1126/science.1231733			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224545				2022-12-28	WOS:000311991200052
J	Ruas, JL; White, JP; Rao, RR; Kleiner, S; Brannan, KT; Harrison, BC; Greene, NP; Wu, J; Estall, JL; Irving, BA; Lanza, IR; Rasbach, KA; Okutsu, M; Nair, KS; Yan, Z; Leinwand, LA; Spiegelman, BM				Ruas, Jorge L.; White, James P.; Rao, Rajesh R.; Kleiner, Sandra; Brannan, Kevin T.; Harrison, Brooke C.; Greene, Nicholas P.; Wu, Jun; Estall, Jennifer L.; Irving, Brian A.; Lanza, Ian R.; Rasbach, Kyle A.; Okutsu, Mitsuharu; Nair, K. Sreekumaran; Yan, Zhen; Leinwand, Leslie A.; Spiegelman, Bruce M.			A PGC-1 alpha Isoform Induced by Resistance Training Regulates Skeletal Muscle Hypertrophy	CELL			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; MICE; GROWTH; MASS; HOMEOSTASIS; EXPRESSION; PROTECTS; ATROPHY; FIBERS; DRIVES	PGC-1 alpha is a transcriptional coactivator induced by exercise that gives muscle many of the best known adaptations to endurance-type exercise but has no effects on muscle strength or hypertrophy. We have identified a form of PGC-1 alpha (PGC-1 alpha 4) that results from alternative promoter usage and splicing of the primary transcript. PGC-1 alpha 4 is highly expressed in exercised muscle but does not regulate most known PGC-1 alpha targets such as the mitochondrial OXPHOS genes. Rather, it specifically induces IGF1 and represses myostatin, and expression of PGC-1 alpha 4 in vitro and in vivo induces robust skeletal muscle hypertrophy. Importantly, mice with skeletal muscle-specific transgenic expression of PGC-1 alpha 4 show increased muscle mass and strength and dramatic resistance to the muscle wasting of cancer cachexia. Expression of PGC-1 alpha 4 is preferentially induced in mouse and human muscle during resistance exercise. These studies identify a PGC-1 alpha protein that regulates and coordinates factors involved in skeletal muscle hypertrophy.	[Ruas, Jorge L.; White, James P.; Rao, Rajesh R.; Kleiner, Sandra; Brannan, Kevin T.; Wu, Jun; Estall, Jennifer L.; Rasbach, Kyle A.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Cell Biol, Boston, MA 02115 USA; [Harrison, Brooke C.; Leinwand, Leslie A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Greene, Nicholas P.; Okutsu, Mitsuharu; Yan, Zhen] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Irving, Brian A.; Lanza, Ian R.; Nair, K. Sreekumaran] Mayo Clin, Div Endocrinol, Endocrine Res Unit, Rochester, MN 55905 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Colorado System; University of Colorado Boulder; University of Virginia; Mayo Clinic	Ruas, JL (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.	jorge.ruas@ki.se; bruce_spiegelman@dfci.harvard.edu	Ruas, Jorge/AAE-6094-2019; Irving, Brian/B-9683-2016; Greene, Nicholas/A-6076-2013; Greene, Nicholas/G-7399-2015	Ruas, Jorge/0000-0002-1110-2606; Irving, Brian/0000-0002-4131-9523; Greene, Nicholas/0000-0002-9504-9362; Lanza, Ian/0000-0002-9858-3384; Yan, Zhen/0000-0002-4826-9813; Estall, Jennifer/0000-0002-9838-1440; LEINWAND, LESLIE/0000-0003-1470-4810; Greene, Nicholas/0000-0001-9621-2005	NIH [DK061562, 5K01AR55676-2, T32HL07284, AR050429, GM29090]; Novartis; Wenner-Gren Foundations, Sweden; AHA [09POST2010078, 12SDG8070003]; Novartis, Inc.;  [RR024151];  [AG09531]; Novo Nordisk Fonden [NNF12OC1016062] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024151] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119937, T32HL007284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050429, K01AR055676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061562, K01DK094824, R56DK054477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009531] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis(Novartis); Wenner-Gren Foundations, Sweden; AHA(American Heart Association); Novartis, Inc.; ; ; Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. Srikripa Devarakonda and Sibylle Jager for valuable discussions. ERR alpha and ERR gamma KO myoblasts were a kind gift from Dr. Zhidan Wu (Novartis Institutes for Biomedical Research). The MEF2C/Myogenin promoter cassette was kindly provided by Dr. Eric Olson (University of Texas Southwestern Medical Center). LLC cells were kindly donated by Dr. Jose M. Garcia (Baylor College of Medicine). This project was supported by grants (DK061562) from the NIH and from Novartis to B.M.S. J.L.R. was supported in part by a grant from the Wenner-Gren Foundations, Sweden. This research was supported in part by grants to B. C. H. (NIH, 5K01AR55676-2), N.P.G. (NIH, T32HL07284), J.W. (AHA, 09POST2010078 and 12SDG8070003), B.A.I. (RR024151 and AG09531), Z.Y. (NIH, AR050429), and L. A. L. (NIH, GM29090). B. M. S. is a shareholder and consultant to Ember Therapeutics and has received funding in the form of sponsored research from Novartis, Inc.	Adams GR, 2002, J APPL PHYSIOL, V93, P1159, DOI 10.1152/japplphysiol.01264.2001; Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Axell AM, 2006, AM J PHYSIOL-ENDOC M, V291, pE506, DOI 10.1152/ajpendo.00058.2006; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Busquets S, 2012, J CACHEXIA SARCOPENI, V3, P37, DOI 10.1007/s13539-011-0049-z; Chakkalakal JV, 2010, DEVELOPMENT, V137, P3489, DOI 10.1242/dev.053348; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; Dinchuk JE, 2010, ENDOCRINOLOGY, V151, P4123, DOI 10.1210/en.2010-0032; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; FLORINI JR, 1987, MUSCLE NERVE, V10, P577, DOI 10.1002/mus.880100702; Gentry B, 2011, MUSCLE NERVE, V43, P49, DOI 10.1002/mus.21796; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Iezzi S, 2004, DEV CELL, V6, P673, DOI 10.1016/S1534-5807(04)00107-8; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; MCMILLAN DN, 1992, J ANIM SCI, V70, P3014, DOI 10.2527/1992.70103014x; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Megeney LA, 1996, DEV GENET, V19, P139, DOI 10.1002/(SICI)1520-6408(1996)19:2<139::AID-DVG5>3.0.CO;2-A; Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; Nair KS, 2005, AM J CLIN NUTR, V81, P953; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Short KR, 2003, DIABETES, V52, P1888, DOI 10.2337/diabetes.52.8.1888; Tadaishi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028290; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; White JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024650; Yoshioka T, 2009, J MATER CYCLES WASTE, V11, P1, DOI 10.1007/s10163-008-0223-3; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	40	433	453	3	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1319	1331		10.1016/j.cell.2012.10.050	http://dx.doi.org/10.1016/j.cell.2012.10.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217713	Bronze, Green Accepted			2022-12-28	WOS:000311999900020
J	Sakmar, TP				Sakmar, Thomas P.			Redder Than Red	SCIENCE			English	Editorial Material							HUMAN COLOR-VISION; PIGMENTS; RHODOPSIN; DESIGN; GENES		Rockefeller Univ, Lab Chem Biol & Signal Transduct, New York, NY 10065 USA	Rockefeller University	Sakmar, TP (corresponding author), Rockefeller Univ, Lab Chem Biol & Signal Transduct, New York, NY 10065 USA.	sakmar@rockefeller.edu	Sakmar, Thomas P/D-1833-2015; Aberg, Karina C./A-9954-2018	Sakmar, Thomas P/0000-0002-2836-8953; Aberg, Karina C./0000-0003-1779-2940				Kochendoerfer GG, 1999, TRENDS BIOCHEM SCI, V24, P300, DOI 10.1016/S0968-0004(99)01432-2; Marshall J, 1999, NATURE, V401, P873, DOI 10.1038/44751; MERBS SL, 1992, NATURE, V356, P433, DOI 10.1038/356433a0; NAKANISHI K, 1980, J AM CHEM SOC, V102, P7945, DOI 10.1021/ja00547a028; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; OPRIAN DD, 1991, BIOCHEMISTRY-US, V30, P11367, DOI 10.1021/bi00112a002; Rajamani R, 2011, J COMPUT CHEM, V32, P854, DOI 10.1002/jcc.21663; Tarter M, 2008, PROTEINS, V70, P1626, DOI 10.1002/prot.21848; Vasileiou C, 2007, J AM CHEM SOC, V129, P6140, DOI 10.1021/ja067546r; Wang WJ, 2012, SCIENCE, V338, P1340, DOI 10.1126/science.1226135	10	5	5	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1299	1300		10.1126/science.1231589	http://dx.doi.org/10.1126/science.1231589			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224543				2022-12-28	WOS:000311991200050
J	Stensmyr, MC; Dweck, HKM; Farhan, A; Ibba, I; Strutz, A; Mukunda, L; Linz, J; Grabe, V; Steck, K; Lavista-Llanos, S; Wicher, D; Sachse, S; Knaden, M; Becher, PG; Seki, Y; Hansson, BS				Stensmyr, Marcus C.; Dweck, Hany K. M.; Farhan, Abu; Ibba, Irene; Strutz, Antonia; Mukunda, Latha; Linz, Jeanine; Grabe, Veit; Steck, Kathrin; Lavista-Llanos, Sofia; Wicher, Dieter; Sachse, Silke; Knaden, Markus; Becher, Paul G.; Seki, Yoichi; Hansson, Bill S.			A Conserved Dedicated Olfactory Circuit for Detecting Harmful Microbes in Drosophila	CELL			English	Article							ANTENNAL LOBE; SENSORY INPUT; NEURONS; GEOSMIN; PHEROMONE; BEHAVIOR; SYSTEM; REPRESENTATIONS; INTERNEURONS; ORGANIZATION	Flies, like all animals, need to find suitable and safe food. Because the principal food source for Drosophila melanogaster is yeast growing on fermenting fruit, flies need to distinguish fruit with safe yeast from yeast covered with toxic microbes. We identify a functionally segregated olfactory circuit in flies that is activated exclusively by geosmin. This microbial odorant constitutes an ecologically relevant stimulus that alerts flies to the presence of harmful microbes. Geosmin activates only a single class of sensory neurons expressing the olfactory receptor Or56a. These neurons target the DA2 glomerulus and connect to projection neurons that respond exclusively to geosmin. Activation of DA2 is sufficient and necessary for aversion, overrides input from other olfactory pathways, and inhibits positive chemotaxis, oviposition, and feeding. The geosmin detection system is a conserved feature in the genus Drosophila that provides flies with a sensitive, specific means of identifying unsuitable feeding and breeding sites.	[Stensmyr, Marcus C.; Dweck, Hany K. M.; Farhan, Abu; Ibba, Irene; Strutz, Antonia; Mukunda, Latha; Linz, Jeanine; Grabe, Veit; Steck, Kathrin; Lavista-Llanos, Sofia; Wicher, Dieter; Sachse, Silke; Knaden, Markus; Seki, Yoichi; Hansson, Bill S.] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, D-07745 Jena, Germany; [Becher, Paul G.] Swedish Univ Agr Sci, Div Chem Ecol, S-23053 Alnarp, Sweden	Max Planck Society; Swedish University of Agricultural Sciences	Stensmyr, MC (corresponding author), Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Hans Knoll Str 8, D-07745 Jena, Germany.	mstensmyr@ice.mpg.de; hansson@ice.mpg.de	Abu, Farhan/AAH-8596-2020; Knaden, Markus/E-2151-2015; Hansson, Bill/G-2774-2013; Sachse, Silke/M-8484-2014; Becher, Paul/ABF-4450-2020	Abu, Farhan/0000-0002-7385-5590; Knaden, Markus/0000-0002-6710-1071; Hansson, Bill/0000-0002-4811-1223; Sachse, Silke/0000-0002-9769-8067; Becher, Paul/0000-0001-5058-2668; Seki, Yoichi/0000-0002-3337-4768; Steck, Kathrin/0000-0003-2711-2873; Stensmyr, Marcus/0000-0003-4009-9212; Grabe, Veit/0000-0002-0736-2771	Max Planck Society; German Federal Ministry of Education and Research; Swedish research council Formas	Max Planck Society(Max Planck Society); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Swedish research council Formas(Swedish Research CouncilSwedish Research Council Formas)	This work was supported by the Max Planck Society, the German Federal Ministry of Education and Research (A. S., V. G., and S. S.), and the Swedish research council Formas (P. G. B.). We wish to thank S. Caron and F. Maderspacher for valuable comments on the manuscript, E. Wheeler for editorial assistance, and R. Stieber, K. Weniger, and S. Kaltofen for technical support. We thank I. Urru for assisting with odor collections, S. Koczsan and J. Rybak for morphological analysis, and M. Thoma for providing help with the Flywalk experiments.	Arndt C, 1999, MICROBIOL-SGM, V145, P1989, DOI 10.1099/13500872-145-8-1989; Becher PG, 2010, J CHEM ECOL, V36, P599, DOI 10.1007/s10886-010-9794-2; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Castillo MA, 1999, J AGR FOOD CHEM, V47, P2120, DOI 10.1021/jf981010a; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; GERBER NN, 1965, APPL MICROBIOL, V13, P935, DOI 10.1128/AEM.13.6.935-938.1965; Guo S, 2007, MOL BIOL EVOL, V24, P1198, DOI 10.1093/molbev/msm038; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Juttner F, 2007, APPL ENVIRON MICROB, V73, P4395, DOI 10.1128/AEM.02250-06; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Knaden M, 2012, CELL REPORTS, V1, P392, DOI 10.1016/j.celrep.2012.03.002; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; MATTHEIS JP, 1992, APPL ENVIRON MICROB, V58, P3170, DOI 10.1128/AEM.58.9.3170-3172.1992; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Sargsyan V, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00005; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Seki Y, 2010, J NEUROPHYSIOL, V104, P1007, DOI 10.1152/jn.00249.2010; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Stokl J, 2010, CURR BIOL, V20, P1846, DOI 10.1016/j.cub.2010.09.033; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tinbergen N, 1951, STUDY INSTINCT; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005; Yoshida T., 2000, Drosophila Information Service, V83, P18; Young WF, 1996, WATER RES, V30, P331, DOI 10.1016/0043-1354(95)00173-5	47	360	371	12	176	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1345	1357		10.1016/j.cell.2012.09.046	http://dx.doi.org/10.1016/j.cell.2012.09.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217715	Bronze			2022-12-28	WOS:000311999900022
J	Crida, A; Charnoz, S				Crida, A.; Charnoz, S.			Formation of Regular Satellites from Ancient Massive Rings in the Solar System	SCIENCE			English	Article							SATURNS RINGS; GIANT PLANETS; ACCRETION; ORIGIN; MIGRATION; EVOLUTION; IMPACT; MOONS	When a planetary tidal disk-like Saturn's rings-spreads beyond the Roche radius (inside which planetary tides prevent aggregation), satellites form and migrate away. Here, we show that most regular satellites in the solar system probably formed in this way. According to our analytical model, when the spreading is slow, a retinue of satellites appear with masses increasing with distance to the Roche radius, in excellent agreement with Saturn's, Uranus', and Neptune's satellite systems. This suggests that Uranus and Neptune used to have massive rings that disappeared to give birth to most of their regular satellites. When the spreading is fast, only one large satellite forms, as was the case for Pluto and Earth. This conceptually bridges the gap between terrestrial and giant planet systems.	[Crida, A.] Univ Nice Sophia Antipolis, Observ Cote Azur, Lab Lagrange, CNRS,UMR 7293, F-06304 Nice 4, France; [Charnoz, S.] Univ Paris Diderot, Lab AIM, CEA, Serv Astrophys, F-91191 Gif Sur Yvette, France; [Charnoz, S.] Inst Univ France, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Institut Universitaire de France	Crida, A (corresponding author), Univ Nice Sophia Antipolis, Observ Cote Azur, Lab Lagrange, CNRS,UMR 7293, BP4229, F-06304 Nice 4, France.	crida@oca.eu		CRIDA, Aurelien/0000-0002-1293-9782	French Programme National de Planetologie; "Labex UnivEarths" grant of Univ. Paris Diderot, Paris Sorbonne Cite; CEA-SAp	French Programme National de Planetologie; "Labex UnivEarths" grant of Univ. Paris Diderot, Paris Sorbonne Cite; CEA-SAp	This work was partially funded by the French Programme National de Planetologie. S. Charnoz was supported by a "Labex UnivEarths" grant of Univ. Paris Diderot, Paris Sorbonne Cite, and by CEA-SAp. We thank A. Morbidelli, D. Nesvorny, and N. Murdoch for comments and help in the writing of this manuscript.	[Anonymous], 1849, ACAD MONTPELLIER; Boue G, 2010, ASTROPHYS J LETT, V712, pL44, DOI 10.1088/2041-8205/712/1/L44; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; Canup RM, 2005, SCIENCE, V307, P546, DOI 10.1126/science.1106818; Canup RM, 2002, ASTRON J, V124, P3404, DOI 10.1086/344684; Canup RM, 2006, NATURE, V441, P834, DOI 10.1038/nature04860; Canup RM, 2010, NATURE, V468, P943, DOI 10.1038/nature09661; Charnoz S, 2011, ICARUS, V216, P535, DOI 10.1016/j.icarus.2011.09.017; Charnoz S, 2010, NATURE, V465, P752, DOI 10.1038/nature09096; Charnoz S, 2009, ICARUS, V199, P413, DOI 10.1016/j.icarus.2008.10.019; Crida A, 2010, ASTRON J, V140, P944, DOI 10.1088/0004-6256/140/4/944; Daisaka H, 2001, ICARUS, V154, P296, DOI 10.1006/icar.2001.6716; DONES L, 1991, ICARUS, V92, P194, DOI 10.1016/0019-1035(91)90045-U; ESPOSITO LW, 1989, NATURE, V339, P605, DOI 10.1038/339605a0; Jutzi M, 2011, NATURE, V476, P69, DOI 10.1038/nature10289; Karjalainen R, 2007, ICARUS, V189, P523, DOI 10.1016/j.icarus.2007.02.009; Kokubo E, 2000, ICARUS, V148, P419, DOI 10.1006/icar.2000.6496; Lainey V, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/14; LIN DNC, 1979, MON NOT R ASTRON SOC, V186, P799, DOI 10.1093/mnras/186.4.799; Morbidelli A, 2012, ICARUS, V219, P737, DOI 10.1016/j.icarus.2012.03.025; Mosqueira I, 2003, ICARUS, V163, P198, DOI 10.1016/S0019-1035(03)00076-9; Mosqueira I, 2003, ICARUS, V163, P232, DOI 10.1016/S0019-1035(03)00077-0; Rubincam DP, 2006, ICARUS, V184, P532, DOI 10.1016/j.icarus.2006.05.017; Salmon J, 2010, ICARUS, V209, P771, DOI 10.1016/j.icarus.2010.05.030; Sasaki T, 2010, ASTROPHYS J, V714, P1052, DOI 10.1088/0004-637X/714/2/1052; [No title captured]	27	101	101	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1196	1199		10.1126/science.1226477	http://dx.doi.org/10.1126/science.1226477			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197530	Green Submitted			2022-12-28	WOS:000311666200042
J	Smith, RM; Schaefer, MK; Kainer, MA; Wise, M; Finks, J; Duwve, J; Fontaine, E; Chu, A; Carothers, B; Reilly, A; Fiedler, J; Wiese, AD; Feaster, C; Gibson, L; Griese, S; Purfield, A; Cleveland, AA; Benedict, K; Harris, JR; Brandt, ME; Blau, D; Jernigan, J; Weber, JT; Park, BJ				Smith, Rachel M.; Schaefer, Melissa K.; Kainer, Marion A.; Wise, Matthew; Finks, Jennie; Duwve, Joan; Fontaine, Elizabeth; Chu, Alvina; Carothers, Barbara; Reilly, Amy; Fiedler, Jay; Wiese, Andrew D.; Feaster, Christine; Gibson, Lex; Griese, Stephanie; Purfield, Anne; Cleveland, Angela A.; Benedict, Kaitlin; Harris, Julie R.; Brandt, Mary E.; Blau, Dianna; Jernigan, John; Weber, J. Todd; Park, Benjamin J.		Multistate Fungal Infection	Fungal Infections Associated with Contaminated Methylprednisolone Injections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FACET JOINT INJECTION; LOW-BACK-PAIN; ASPERGILLUS MENINGITIS; CLADOSPORIUM-CLADOSPORIOIDES; CORTICOSTEROID INJECTION; MULTISTATE OUTBREAK; STEROID INJECTIONS; EPIDURAL ABSCESS; UNITED-STATES; SRI-LANKA	BackgroundFungal infections are rare complications of injections for treatment of chronic pain. In September 2012, we initiated an investigation into fungal infections associated with injections of preservative-free methylprednisolone acetate that was purchased from a single compounding pharmacy. MethodsThree lots of methylprednisolone acetate were recalled by the pharmacy; examination of unopened vials later revealed fungus. Notification of all persons potentially exposed to implicated methylprednisolone acetate was conducted by federal, state, and local public health officials and by staff at clinical facilities that administered the drug. We collected clinical data on standardized case-report forms, and we tested for the presence of fungi in isolates and specimens by examining cultures and performing polymerase-chain-reaction assays and histopathological and immunohistochemical testing. ResultsBy October 19, 2012, more than 99% of 13,534 potentially exposed persons had been contacted. As of July 1, 2013, there were 749 reported cases of infection in 20 states, with 61 deaths (8%). Laboratory evidence of Exserohilum rostratum was present in specimens from 153 case patients (20%). Additional data were available for 728 case patients (97%); 229 of these patients (31%) had meningitis with no other documented infection. Case patients had received a median of 1 injection (range, 1 to 6) of implicated methylprednisolone acetate. The median age of the patients was 64 years (range, 15 to 97), and the median incubation period (the number of days from the last injection to the date of the first diagnosis) was 47 days (range, 0 to 249); 40 patients (5%) had a stroke. ConclusionsAnalysis of data from a large, multistate outbreak of fungal infections showed substantial morbidity and mortality. The infections were associated with injection of a contaminated glucocorticoid medication from a single compounding pharmacy. Rapid public health actions included prompt recall of the implicated product, notification of exposed persons, and early outreach to clinicians.	[Smith, Rachel M.; Griese, Stephanie; Purfield, Anne] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Sci Educ & Profess Dev Program Off, Atlanta, GA USA; [Smith, Rachel M.; Purfield, Anne; Cleveland, Angela A.; Benedict, Kaitlin; Harris, Julie R.; Brandt, Mary E.; Park, Benjamin J.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30329 USA; [Schaefer, Melissa K.; Wise, Matthew; Jernigan, John; Weber, J. Todd] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA USA; [Blau, Dianna] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Atlanta, GA USA; [Kainer, Marion A.; Wiese, Andrew D.] Tennessee Dept Hlth, Nashville, TN USA; [Finks, Jennie; Fiedler, Jay] Bur Epidemiol, Michigan Dept Community Hlth, Lansing, MI USA; [Duwve, Joan; Feaster, Christine] Indiana State Dept Hlth, Indianapolis, IN 46202 USA; [Fontaine, Elizabeth; Gibson, Lex] Virginia Dept Hlth, Richmond, VA USA; [Chu, Alvina] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA; [Carothers, Barbara] New Jersey Dept Hlth, Trenton, NJ USA; [Reilly, Amy] Florida Dept Hlth, Tallahassee, FL USA; [Griese, Stephanie] North Carolina Div Publ Hlth, Raleigh, NC USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Tennessee Department Health; MDHHS - Michigan Department of Health & Human Services; Maryland Department of Health & Mental Hygiene; New Jersey Department of Health & Senior Services; Florida Department of Health	Park, BJ (corresponding author), Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30329 USA.	bpark1@cdc.gov	Cleveland, Angela Ahlquist/Q-2778-2019; Wiese, Andrew/D-2200-2019; Wiese, Andrew D/U-9745-2017	Cleveland, Angela Ahlquist/0000-0003-1375-8964; Wiese, Andrew/0000-0002-0699-4224; Wiese, Andrew D/0000-0002-0699-4224; Jernigan, John/0000-0001-8163-925X; Kainer, Marion/0000-0001-7678-8744				ADAM RD, 1986, MEDICINE, V65, P203, DOI 10.1097/00005792-198607000-00001; [Anonymous], 2012, ARCH UPD FUNG MEN; [Anonymous], 2012, CDC FDA JOINT TEL IN; Balajee SA, 2009, J CLIN MICROBIOL, V47, P3138, DOI 10.1128/JCM.01070-09; Centers for Disease Control and Prevention, 2012, MULT FUNG MEN OUTBR; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1109; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P310; Chew FLM, 2009, JPN J OPHTHALMOL, V53, P657, DOI 10.1007/s10384-009-0722-3; Civen R, 2006, CLIN INFECT DIS, V43, P831, DOI 10.1086/507336; Clinical and Laboratory Standards Institute, 2008, MM18A CLSI; Cooper AB, 1996, CAN J ANAESTH, V43, P471, DOI 10.1007/BF03018109; DOUER D, 1987, J MED VET MYCOL, V25, P235; Duquia RP, 2010, MYCOSES, V53, P541, DOI 10.1111/j.1439-0507.2009.01745.x; Gade L, 2013, EUKARYOT CELL, V12, P677, DOI 10.1128/EC.00046-13; Gaul C, 2005, PAIN, V116, P407, DOI 10.1016/j.pain.2005.05.032; GRAY RG, 1981, SEMIN ARTHRITIS RHEU, V10, P231, DOI 10.1016/0049-0172(81)90001-9; Gunaratne PS, 2007, NEW ENGL J MED, V356, P754, DOI 10.1056/NEJMc062547; Hoelzer BC, 2008, EUR J PAIN, V12, P261, DOI 10.1016/j.ejpain.2007.05.005; Hooten WM, 2004, MAYO CLIN PROC, V79, P682, DOI 10.4065/79.5.682; Kabbara Abdallah, 2004, Pain Physician, V7, P269; Kainer MA, 2012, NEW ENGL J MED, V367, P2194, DOI 10.1056/NEJMoa1212972; Kolbe ABL, 2007, ACTA RADIOL, V48, P687, DOI 10.1080/02841850701342153; Lalueza A, 2011, ENDOSCOPY, V43, pE9, DOI 10.1055/s-0030-1255804; Lockhart SR, J CLIN MICR IN PRESS; Main Street Family Pharmacy, 2013, LLC ISS VOL NAT REC; MCGINNIS MR, 1986, J CLIN MICROBIOL, V24, P250, DOI 10.1128/JCM.24.2.250-259.1986; Medprep Consulting Inc, 2013, ANN VOL NAT REC ALL; OSTENSSON A, 1991, BRIT J RHEUMATOL, V30, P35; Park MS, 2007, YONSEI MED J, V48, P711, DOI 10.3349/ymj.2007.48.4.711; Pettit AC, 2012, NEW ENGL J MED, V367, P2119, DOI 10.1056/NEJMoa1212292; Ritter JM, 2013, AM J PATHOL, V183, P881, DOI 10.1016/j.ajpath.2013.05.007; Rodrigo N, 2007, INT J OBSTET ANESTH, V16, P256, DOI 10.1016/j.ijoa.2006.06.010; Saigal G, 2004, AM J NEURORADIOL, V25, P642; Simopoulos Thomas T, 2008, Pain Physician, V11, P693; Smith RM, 2013, NEW ENGL J MED, V368, P2535, DOI 10.1056/NEJMc1306560; Staal JB, 2009, SPINE, V34, P49, DOI 10.1097/BRS.0b013e3181909558; Terr AI, 2001, ANN ALLERG ASTHMA IM, V87, P57, DOI 10.1016/S1081-1206(10)62343-5; Verweij PE, 1999, J CLIN MICROBIOL, V37, P1186, DOI 10.1128/JCM.37.4.1186-1189.1999; Viscoli C, 2002, J CLIN MICROBIOL, V40, P1496, DOI 10.1128/JCM.40.4.1496-1499.2002	39	128	132	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 24	2013	369	17					1598	1609		10.1056/NEJMoa1213978	http://dx.doi.org/10.1056/NEJMoa1213978			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	239MZ	23252499				2022-12-28	WOS:000326031100009
J	Kokkinos, PF; Faselis, C; Myers, J; Panagiotakos, D; Doumas, M				Kokkinos, Peter F.; Faselis, Charles; Myers, Jonathan; Panagiotakos, Demosthenes; Doumas, Michael			Interactive effects of fitness and statin treatment on mortality risk in veterans with dyslipidaemia: a cohort study	LANCET			English	Article							ALL-CAUSE MORTALITY; 20-YEAR FOLLOW-UP; EXERCISE CAPACITY; PHYSICAL-ACTIVITY; PRIMARY PREVENTION; MEN; CHOLESTEROL; PREDICTORS; AMERICAN; EVENTS	Background Statins are commonly prescribed for management of dyslipidaemia and cardiovascular disease. Increased fitness is also associated with low mortality and is recommended as an essential part of promoting health. However, little information exists about the combined effects of fitness and statin treatment on all-cause mortality. We assessed the combined effects of statin treatment and fitness on all-cause mortality risk. Methods In this prospective cohort study, we included dyslipidaemic veterans from Veterans Affairs Medical Centers in Palo Alto, CA, and Washington DC, USA, who had had an exercise tolerance test between 1986, and 2011. We assigned participants to one of four fitness categories based on peak metabolic equivalents (MET) achieved during exercise test and eight categories based on fitness status and statin treatment. The primary endpoint was all-cause mortality adjusted for age, body-mass index, ethnic origin, sex, history of cardiovascular disease, cardiovascular drugs, and cardiovascular risk factors. We assessed mortality from Veteran's Affairs' records on Dec 31, 2011. We compared groups with Cox proportional hazard model. Findings We assessed 10 043 participants (mean age 58.8 years, SD 10.9 years). During a median follow-up of 10.0 years (IQR 6.0-14.2), 2318 patients died, with an average yearly mortality rate of 22 deaths per 1000 person-years. Mortality risk was 18.5% (935/5046) in people taking statins versus 27.7% (1386/4997) in those not taking statins (p<0.0001). In patients who took statins, mortality risk decreased as fitness increased; for highly fit individuals (>9 MET; n=694), the hazard ratio (HR) was 0.30 (95% CI 0.21-0.41; p<0.0001) compared with least fit (<= 5 METs) patients (HR 1; n=1060). For those not treated with statins, the HR for least fit participants (n=1024) was 1.35 (95% CI 1.17-1.54; p<0.0001) and progressively decreased to 0.53 (95% CI 0.44-0.65; p<0.0001) for those in the highest fitness category (n=1498). Interpretation Statin treatment and increased fitness are independently associated with low mortality among dyslipidaemic individuals. The combination of statin treatment and increased fitness resulted in substantially lower mortality risk than either alone, reinforcing the importance of physical activity for individuals with dyslipidaemia.	[Kokkinos, Peter F.; Faselis, Charles; Panagiotakos, Demosthenes; Doumas, Michael] Vet Affairs Med Ctr, Dept Cardiol, Washington, DC 20422 USA; [Kokkinos, Peter F.] Georgetown Univ, Sch Med, Washington, DC USA; [Kokkinos, Peter F.; Faselis, Charles] George Washington Univ, Sch Med, Washington, DC USA; [Myers, Jonathan] Vet Affairs Palo Alto Hlth Care Syst, Div Cardiol, Palo Alto, CA USA; [Myers, Jonathan] Stanford Univ, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Georgetown University; George Washington University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Kokkinos, PF (corresponding author), Vet Affairs Med Ctr, Div Cardiol, 50 Irving St NW, Washington, DC 20422 USA.	peter.kokkinos@va.gov	Panagiotakos, Demosthenes/K-8294-2019; Panagiotakos, Demosthenes/C-9776-2013; Panagiotakos, Demosthenes/M-9167-2019	Panagiotakos, Demosthenes/0000-0001-8583-153X; Panagiotakos, Demosthenes/0000-0001-8583-153X; Faselis, Charles/0000-0001-9895-0327; Doumas, Michael/0000-0002-7269-8044	RRD VA [IK6 RX002477] Funding Source: Medline; Veterans Affairs [IK6RX002477] Funding Source: NIH RePORTER	RRD VA; Veterans Affairs(US Department of Veterans Affairs)		Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; BOYLE CA, 1990, AM J EPIDEMIOL, V131, P160, DOI 10.1093/oxfordjournals.aje.a115470; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; FOSTER C, 1984, AM HEART J, V107, P1229, DOI 10.1016/0002-8703(84)90282-5; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; Kizer KW, 2000, MED CARE, V38, pS7; Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764; Kokkinos P, 2010, CIRCULATION, V122, P1637, DOI 10.1161/CIRCULATIONAHA.110.948349; Kokkinos P, 2010, CIRCULATION, V122, P790, DOI 10.1161/CIRCULATIONAHA.110.938852; Kokkinos P, 2009, HYPERTENSION, V53, P494, DOI 10.1161/HYPERTENSIONAHA.108.127027; Kokkinos P, 2009, DIABETES CARE, V32, P623, DOI 10.2337/dc08-1876; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; Mascitelli L, 2009, INT J CARDIOL, V134, P136, DOI 10.1016/j.ijcard.2007.12.048; McAuley PA, 2007, DIABETES CARE, V30, P1539, DOI 10.2337/dc06-2397; Mora S, 2003, JAMA-J AM MED ASSOC, V290, P1600, DOI 10.1001/jama.290.12.1600; MORRIS CK, 1993, J AM COLL CARDIOL, V22, P175, DOI 10.1016/0735-1097(93)90832-L; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; MYERS J, 1991, J AM COLL CARDIOL, V17, P1334, DOI 10.1016/S0735-1097(10)80144-5; Packard CJ, 1998, CIRCULATION, V97, P1440; Pedersen TR, 1998, CIRCULATION, V97, P1453, DOI 10.1161/01.CIR.97.15.1453; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Sacks FM, 1998, CIRCULATION, V97, P1446; Selim AJ, 2002, MED CARE, V40, P237, DOI 10.1097/00005650-200203000-00007; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Thavendiranathan P, 2006, ARCH INTERN MED, V166, P2307, DOI 10.1001/archinte.166.21.2307; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6	31	132	134	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2013	381	9864					394	399		10.1016/S0140-6736(12)61426-3	http://dx.doi.org/10.1016/S0140-6736(12)61426-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084ZA	23199849				2022-12-28	WOS:000314578900036
J	Chaudhury, D; Walsh, JJ; Friedman, AK; Juarez, B; Ku, SM; Koo, JW; Ferguson, D; Tsai, HC; Pomeranz, L; Christoffel, DJ; Nectow, AR; Ekstrand, M; Domingos, A; Mazei-Robison, MS; Mouzon, E; Lobo, MK; Neve, RL; Friedman, JM; Russo, SJ; Deisseroth, K; Nestler, EJ; Han, MH				Chaudhury, Dipesh; Walsh, Jessica J.; Friedman, Allyson K.; Juarez, Barbara; Ku, Stacy M.; Koo, Ja Wook; Ferguson, Deveroux; Tsai, Hsing-Chen; Pomeranz, Lisa; Christoffel, Daniel J.; Nectow, Alexander R.; Ekstrand, Mats; Domingos, Ana; Mazei-Robison, Michelle S.; Mouzon, Ezekiell; Lobo, Mary Kay; Neve, Rachael L.; Friedman, Jeffrey M.; Russo, Scott J.; Deisseroth, Karl; Nestler, Eric J.; Han, Ming-Hu			Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons	NATURE			English	Article							VENTRAL TEGMENTAL AREA; SOCIAL DEFEAT STRESS; ANTIDEPRESSANT ACTION; REWARD CIRCUIT; IN-VIVO; SUSCEPTIBILITY; STIMULATION; INHIBITION; EXPRESSION; RESPONSES	Ventral tegmental area(VTA) dopamine neurons in the brain's reward circuit have a crucial role in mediating stress responses(1-4), including determining susceptibility versus resilience to social-stress-induced behavioural abnormalities(5). VTA dopamine neurons show two in vivo patterns of firing: low frequency tonic firing and high frequency phasic firing(6-8). Phasic firing of the neurons, which is well known to encode reward signals(6,7,9), is upregulated by repeated social-defeat stress, a highly validated mouse model of depression(5,8,10-13). Surprisingly, this pathophysiological effect is seen in susceptible mice only, with no apparent change in firing rate in resilient individuals(5,8). However, direct evidence-in real time-linking dopamine neuron phasic firing in promoting the susceptible (depression-like) phenotype is lacking. Here we took advantage of the temporal precision and cell-type and projection-pathway specificity of optogenetics to show that enhanced phasic firing of these neurons mediates susceptibility to social-defeat stress in freely behaving mice. We show that optogenetic induction of phasic, but not tonic, firing in VTA dopamine neurons of mice undergoing a subthreshold social-defeat paradigm rapidly induced a susceptible phenotype as measured by social avoidance and decreased sucrose preference. Optogenetic phasic stimulation of these neurons also quickly induced a susceptible phenotype in previously resilient mice that had been subjected to repeated social-defeat stress. Furthermore, we show differences in projection-pathway specificity in promoting stress susceptibility: phasic activation of VTA neurons projecting to the nucleus accumbens (NAc), but not to the medial prefrontal cortex (mPFC), induced susceptibility to social-defeat stress. Conversely, optogenetic inhibition of the VTA-NAc projection induced resilience, whereas inhibition of the VTA-mPFC projection promoted susceptibility. Overall, these studies reveal novel firing-pattern-and neural-circuit-specific mechanisms of depression.	[Chaudhury, Dipesh; Walsh, Jessica J.; Friedman, Allyson K.; Juarez, Barbara; Ku, Stacy M.; Nestler, Eric J.; Han, Ming-Hu] Mt Sinai Sch Med, Friedman Brain Inst, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Walsh, Jessica J.; Juarez, Barbara; Ku, Stacy M.; Koo, Ja Wook; Ferguson, Deveroux; Christoffel, Daniel J.; Mazei-Robison, Michelle S.; Mouzon, Ezekiell; Lobo, Mary Kay; Russo, Scott J.; Nestler, Eric J.; Han, Ming-Hu] Mt Sinai Sch Med, Friedman Brain Inst, Fishberg Dept Neurosci, New York, NY 10029 USA; [Tsai, Hsing-Chen; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Tsai, Hsing-Chen; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Pomeranz, Lisa; Nectow, Alexander R.; Ekstrand, Mats; Domingos, Ana; Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10056 USA; [Neve, Rachael L.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Stanford University; Stanford University; Howard Hughes Medical Institute; Rockefeller University; Massachusetts Institute of Technology (MIT)	Han, MH (corresponding author), Mt Sinai Sch Med, Friedman Brain Inst, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	ming-hu.han@mssm.edu	Russo, Scott/R-7107-2019; Lobo, Mary Kay/K-7734-2015; Mazei-Robison, Michelle/I-4304-2017; Han, Ming-Hu/G-8836-2012; Core, Vector/CAF-4832-2022	Russo, Scott/0000-0002-6470-1805; Lobo, Mary Kay/0000-0002-9419-2079; Mazei-Robison, Michelle/0000-0002-2372-1420; Friedman, Allyson/0000-0002-8190-3011; Walsh, Jessica/0000-0001-8466-8451; Ekstrand, Mats/0000-0003-0019-9462; Domingos, Ana/0000-0002-7938-4814; Juarez, Barbara/0000-0001-7897-8031; Ferguson, Deveroux/0000-0001-9302-5992; Christoffel, Dan/0000-0002-6303-5134; Pomeranz, Lisa/0000-0002-8117-7355	National Institute of Mental Health [R01 MH092306]; Johnson & Johnson IMHRO Rising Star Translational Research Award; National Research Service Awards [F31 MH095425, F32 MH096464]; Mount Sinai PREP [R25 GM064118]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM064118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH096678, F31MH095425, F31MH108326, R01MH092306, T32MH087004, K99MH094405, F32MH096464, T32MH020016, P50MH096890] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Johnson & Johnson IMHRO Rising Star Translational Research Award; National Research Service Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mount Sinai PREP; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health (R01 MH092306 to D. C. and M. H. H.), Johnson & Johnson IMHRO Rising Star Translational Research Award (M. H. H.), the National Research Service Awards (F31 MH095425 to J.J.W. and F32 MH096464 to A. K. F) and the Mount Sinai PREP R25 GM064118 (B.J.). We would like to thank K. Roy for help with some of the schematics in the figures, and we thank R. Cachope and J. Cheer for help with chronic fibre implantation techniques.	Anstrom KK, 2009, NEUROSCIENCE, V161, P3, DOI 10.1016/j.neuroscience.2009.03.023; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Giacobbe P, 2009, EXP NEUROL, V219, P44, DOI 10.1016/j.expneurol.2009.04.028; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Han H. M., 2011, 50 ANN M ACNP; Hemmeter UM, 2010, EXPERT REV NEUROTHER, V10, P1101, DOI [10.1586/ern.10.83, 10.1586/ERN.10.83]; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Iniguez SD, 2010, J NEUROSCI, V30, P7652, DOI 10.1523/JNEUROSCI.0951-10.2010; Inyushin MU, 2010, NEUROSCIENCE, V167, P287, DOI 10.1016/j.neuroscience.2010.01.052; Krishnan V, 2008, AM J PSYCHIAT, V165, P1109, DOI 10.1176/appi.ajp.2008.08071076; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Radulescu AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012695; Razzoli M, 2011, BEHAV BRAIN RES, V218, P253, DOI 10.1016/j.bbr.2010.11.050; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Valenti O, 2012, EUR J NEUROSCI, V35, P1312, DOI 10.1111/j.1460-9568.2012.08038.x; Venzala E., 2012, EUR NEUROPSYCHOPHARM, DOI 10.1016/jeuroneuro.2012.05.010; Willner P, 2005, J AFFECT DISORDERS, V86, P37, DOI 10.1016/j.jad.2004.12.010; Willner P, 1997, INT CLIN PSYCHOPHARM, V12, pS7, DOI 10.1097/00004850-199707003-00002; Yadid G, 2008, PROG BRAIN RES, V172, P265, DOI 10.1016/S0079-6123(08)00913-8	37	696	715	19	421	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2013	493	7433					532	+		10.1038/nature11713	http://dx.doi.org/10.1038/nature11713			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23235832	Green Accepted			2022-12-28	WOS:000313871400038
J	Ruark, E; Snape, K; Humburg, P; Loveday, C; Bajrami, I; Brough, R; Rodrigues, DN; Renwick, A; Seal, S; Ramsay, E; Duarte, SD; Rivas, MA; Warren-Perry, M; Zachariou, A; Campion-Flora, A; Hanks, S; Murray, A; Pour, NA; Douglas, J; Gregory, L; Rimmer, A; Walker, NM; Yang, TP; Adlard, JW; Barwell, J; Berg, J; Brady, AF; Brewer, C; Brice, G; Chapman, C; Cook, J; Davidson, R; Donaldson, A; Douglas, F; Eccles, D; Evans, DG; Greenhalgh, L; Henderson, A; Izatt, L; Kumar, A; Lalloo, F; Miedzybrodzka, Z; Morrison, PJ; Paterson, J; Porteous, M; Rogers, MT; Shanley, S; Walker, L; Gore, M; Houlston, R; Brown, MA; Caufield, MJ; Deloukas, P; McCarthy, MI; Todd, JA; Turnbull, C; Reis, JS; Ashworth, A; Antoniou, AC; Lord, CJ; Donnelly, P; Rahman, N				Ruark, Elise; Snape, Katie; Humburg, Peter; Loveday, Chey; Bajrami, Ilirjana; Brough, Rachel; Rodrigues, Daniel Nava; Renwick, Anthony; Seal, Sheila; Ramsay, Emma; Duarte, Silvana Del Vecchio; Rivas, Manuel A.; Warren-Perry, Margaret; Zachariou, Anna; Campion-Flora, Adriana; Hanks, Sandra; Murray, Anne; Pour, Naser Ansari; Douglas, Jenny; Gregory, Lorna; Rimmer, Andrew; Walker, Neil M.; Yang, Tsun-Po; Adlard, Julian W.; Barwell, Julian; Berg, Jonathan; Brady, Angela F.; Brewer, Carole; Brice, Glen; Chapman, Cyril; Cook, Jackie; Davidson, Rosemarie; Donaldson, Alan; Douglas, Fiona; Eccles, Diana; Evans, D. Gareth; Greenhalgh, Lynn; Henderson, Alex; Izatt, Louise; Kumar, Ajith; Lalloo, Fiona; Miedzybrodzka, Zosia; Morrison, Patrick J.; Paterson, Joan; Porteous, Mary; Rogers, Mark T.; Shanley, Susan; Walker, Lisa; Gore, Martin; Houlston, Richard; Brown, Matthew A.; Caufield, Mark J.; Deloukas, Panagiotis; McCarthy, Mark I.; Todd, John A.; Turnbull, Clare; Reis-Filho, Jorge S.; Ashworth, Alan; Antoniou, Antonis C.; Lord, Christopher J.; Donnelly, Peter; Rahman, Nazneen		Breast Ovarian Canc Susceptibility; Wellcome Trust Case Control Consor	Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer	NATURE			English	Article							DETECTABLE CLONAL MOSAICISM; CONFER SUSCEPTIBILITY; GERMLINE MUTATIONS; TUMOR-SUPPRESSOR; RARE VARIANTS; WIP1; PHOSPHATASE; PROTEIN; AMPLIFICATION; INHIBITOR	Improved sequencing technologies offer unprecedented opportunities for investigating the role of rare genetic variation in common disease. However, there are considerable challenges with respect to study design, data analysis and replication(1). Using pooled next-generation sequencing of 507 genes implicated in the repair of DNA in 1,150 samples, an analytical strategy focused on protein-truncating variants (PTVs) and a large-scale sequencing case-control replication experiment in 13,642 individuals, here we show that rare PTVs in the p53-inducible protein phosphatase PPM1D are associated with predisposition to breast cancer and ovarian cancer. PPM1D PTV mutations were present in 25 out of 7,781 cases versus 1 out of 5,861 controls (P = 1.12 x 10(-5)), including 18 mutations in 6,912 individuals with breast cancer (P = 2.42 x 10(-4)) and 12 mutations in 1,121 individuals with ovarian cancer (P = 3.10 x 10(-9)). Notably, all of the identified PPM1D PTVs were mosaic in lymphocyte DNA and clustered within a 370-base-pair region in the final exon of the gene, carboxy-terminal to the phosphatase catalytic domain. Functional studies demonstrate that the mutations result in enhanced suppression of p53 in response to ionizing radiation exposure, suggesting that the mutant alleles encode hyperactive PPM1D isoforms. Thus, although the mutations cause premature protein truncation, they do not result in the simple loss-of-function effect typically associated with this class of variant, but instead probably have a gain-of-function effect. Our results have implications for the detection and management of breast and ovarian cancer risk. More generally, these data provide new insights into the role of rare and of mosaic genetic variants in common conditions, and the use of sequencing in their identification.	[Ruark, Elise; Snape, Katie; Loveday, Chey; Renwick, Anthony; Seal, Sheila; Ramsay, Emma; Duarte, Silvana Del Vecchio; Warren-Perry, Margaret; Zachariou, Anna; Hanks, Sandra; Murray, Anne; Pour, Naser Ansari; Douglas, Jenny; Houlston, Richard; Turnbull, Clare; Rahman, Nazneen] Inst Canc Res, Div Genet & Epidemiol, Sutton SM2 5NG, Surrey, England; [Humburg, Peter; Rivas, Manuel A.; Gregory, Lorna; Rimmer, Andrew] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Bajrami, Ilirjana; Brough, Rachel; Rodrigues, Daniel Nava; Campion-Flora, Adriana; Reis-Filho, Jorge S.; Ashworth, Alan; Lord, Christopher J.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Brough, Rachel] Inst Canc Res, Canc Res UK Gene Funct Lab, London SW3 6JB, England; [Rivas, Manuel A.] Univ Oxford, Nuffield Dept Clin Med, Oxford OX3 7LD, England; [Walker, Neil M.; Todd, John A.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Juvenile Diabet Res Fdn,Wellcome Trust Diabet & I, Cambridge CB2 0XY, England; [Yang, Tsun-Po] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Adlard, Julian W.] Chapel Allerton Hosp, Yorkshire Reg Genet Serv, Leeds LS7 4SA, W Yorkshire, England; [Barwell, Julian] Univ Hosp Leicester NHS Trust, Leicestershire Genet Ctr, Leicester LE1 5WW, Leics, England; [Berg, Jonathan] Univ Dundee, Div Med Sci, Dundee DD1 9SY, Scotland; [Brady, Angela F.] Kennedy Galton Ctr, NW Thames Reg Genet Serv, London HA1 3UJ, England; [Brewer, Carole] Royal Devon & Exeter Hosp, Peninsula Reg Genet Serv, Exeter EX1 2ED, Devon, England; [Brice, Glen] St George Hosp, SW Thames Reg Genet Serv, London SW17 0RE, England; [Chapman, Cyril] Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; [Cook, Jackie] Sheffield Childrens NHS Fdn Trust, Sheffield Reg Genet Serv, Sheffield S10 2TH, S Yorkshire, England; [Davidson, Rosemarie] So Gen Hosp, Lab Med, W Scotland Reg Genet Serv, Glasgow G51 4TF, Lanark, Scotland; [Donaldson, Alan] Univ Hosp Bristol NHS Fdn Trust, SW Reg Genet Serv, Bristol BS2 8EG, Avon, England; [Douglas, Fiona; Henderson, Alex] Newcastle Upon Tyne Hosp NHS Fdn Trust, No Genet Serv, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Eccles, Diana] Univ Southampton, Southampton Univ Hosp NHS Trust, Fac Med, Southampton SO16 5YA, Hants, England; [Evans, D. Gareth] St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester M13 9WL, Lancs, England; [Greenhalgh, Lynn] Liverpool Womens NHS Fdn Trust, Merseyside & Cheshire Clin Genet Serv, Liverpool L8 7SS, Merseyside, England; [Izatt, Louise] Guys & St Thomas NHS Fdn Trust, SE Thames Reg Genet Serv, London SE1 9RT, England; [Kumar, Ajith] Great Ormond St Hosp Sick Children, NE Thames Reg Genet Serv, London WC1N 3JH, England; [Lalloo, Fiona] St Marys Hosp, Univ Dept Med Genet & Reg Genet Serv, Manchester M13 9WL, Lancs, England; [Miedzybrodzka, Zosia] Aberdeen Royal Infirm, Aberdeen & N Scotland Clin Genet Serv, Aberdeen AB25 2ZA, Scotland; [Morrison, Patrick J.] Queens Univ Belfast, Dept Med Genet, Belfast HSC Trust, No Ireland Reg Genet Serv, Belfast BT9 7AB, Antrim, North Ireland; [Paterson, Joan] Cambridge Univ Hosp NHS Fdn Trust, E Anglian Reg Genet Serv, Cambridge CB2 0QQ, England; [Porteous, Mary] Western Gen Hosp, SE Scotland Clin Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland; [Rogers, Mark T.] Univ Wales Hosp, All Wales Med Genet Serv, Cardiff CF14 4XW, S Glam, Wales; [Shanley, Susan] Royal Marsden NHS Fdn Trust, Dept Canc Genet, Sutton SM2 5PT, Surrey, England; [Walker, Lisa] Oxford Univ Hosp NHS Trust, Oxford Reg Genet Serv, Oxford OX3 7LJ, England; [Gore, Martin] Royal Marsden NHS Fdn, Dept Gynaecol Oncol, London SW3 6JJ, England; [Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld 4102, Australia; [Caufield, Mark J.] Queen Mary Univ London, London Sch Med & Dent, William Harvey Res Inst, Clin Pharmacol & Barts & London Genome Ctr, London EC1M 6BQ, England; [McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Med, Oxford OX3 7LI, England; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LI, England; [Antoniou, Antonis C.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge CB1 8RN, England; [Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of London; Institute of Cancer Research - UK; University of Oxford; Wellcome Centre for Human Genetics; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; Chapel Allerton Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; University of Dundee; University of Exeter; St Georges University London; Birmingham Women's Hospital; Sheffield Children's NHS Foundation Trust; University of Glasgow; University of Bristol; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Manchester; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Manchester; University of Aberdeen; Queens University Belfast; University of Cambridge; University of Edinburgh; Cardiff University; Royal Marsden NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of Queensland; University of London; Queen Mary University London; University of Oxford; University of Cambridge; University of Oxford	Rahman, N (corresponding author), Inst Canc Res, Div Genet & Epidemiol, Sutton SM2 5NG, Surrey, England.	nazneen.rahman@icr.ac.uk	Deloukas, Panos/B-2922-2013; Rivas, Manuel/ABE-8173-2020; Lord, Christopher J/B-3295-2012; Dominiczak, Anna F/P-9390-2017; Breen, Gerome D/A-5540-2010; Humburg, Peter/A-4191-2009; Snape, Katie/AAA-8101-2022; Brown, Matthew A/E-5749-2010; Eccles, Diana/K-6327-2019; eyre, stephen/K-3776-2017; Evans, D Gareth/AAB-4308-2022; Turnbull, Clare/AAA-6596-2019; Lord, Christopher/AAX-7130-2021; Rahman, Nazneen/D-2802-2013; McCarthy, Mark/M-3763-2015; Todd, John/A-3542-2010; Lucassen, Anneke/D-7764-2017; Hemingway, Harry/C-1219-2009	Deloukas, Panos/0000-0001-9251-070X; Rivas, Manuel/0000-0003-1457-9925; Lord, Christopher J/0000-0002-3226-0515; Dominiczak, Anna F/0000-0003-4913-3608; Breen, Gerome D/0000-0003-2053-1792; Humburg, Peter/0000-0002-3331-6496; Brown, Matthew A/0000-0003-0538-8211; Eccles, Diana/0000-0002-9935-3169; eyre, stephen/0000-0002-1251-6974; Evans, D Gareth/0000-0002-8482-5784; Walker, Neil/0000-0001-9796-7688; Yang, Tsun-Po/0000-0002-9077-4434; Harrison, Pille/0000-0003-4117-6910; Ouwehand, Willem/0000-0002-7744-1790; Houlston, Richard/0000-0002-5268-0242; Campbell, James/0000-0001-6756-8766; Rahman, Nazneen/0000-0003-4376-0440; McCarthy, Mark/0000-0002-4393-0510; Newman, William/0000-0002-6382-4678; Todd, John/0000-0003-2740-8148; Mentzer, Alexander/0000-0002-4502-2209; Ansari-Pour, Naser/0000-0003-0908-0484; Forbes, Alastair/0000-0001-7416-9843; Turnbull, Clare/0000-0002-1734-5772; Eeles, Rosalind/0000-0002-3698-6241; Hocking, Lynne J/0000-0002-2414-2826; Weedon, Michael/0000-0002-6174-6135; Lango Allen, Hana/0000-0002-7803-8688; Lucassen, Anneke/0000-0003-3324-4338; Plagnol, Vincent/0000-0002-5597-9215; Hattersley, Andrew/0000-0001-5620-473X; Hemingway, Harry/0000-0003-2279-0624; Donnelly, Peter/0000-0001-9495-3408; Lindgren, Cecilia/0000-0002-4903-9374; Zeggini, Eleftheria/0000-0003-4238-659X; Wain, Louise/0000-0003-4951-1867; Munroe, Patricia/0000-0002-4176-2947; Adlard, Julian/0000-0002-1693-0435	Wellcome Trust [090532/Z/09/Z]; Medical Research Council (MRC) Hub grant [G0900747 91070]; Institute of Cancer Research; Cancer Research UK; RMH-ICR National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Cancer; MRC [G0000934]; Cancer Research UK Senior Cancer Research Fellow [C12292/A11174]; Wolfson-Royal Society Merit Award; Michael and Betty Kadoorie Cancer Genetics Research Programme; MRC [G0800675, G0800759, G9521010, G0700491, G0600329] Funding Source: UKRI; Cancer Research UK [14276, 11174, 15106] Funding Source: researchfish; Medical Research Council [G9521010, MR/K006584/1, G0000934, G0800759, G0600329, G0700491, G0800675] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10219, NF-SI-0508-10275] Funding Source: researchfish; Chief Scientist Office [ETM/137, CZB/4/540, ETM/75] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC) Hub grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute of Cancer Research; Cancer Research UK(Cancer Research UK); RMH-ICR National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Cancer(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK Senior Cancer Research Fellow; Wolfson-Royal Society Merit Award(Royal Society of London); Michael and Betty Kadoorie Cancer Genetics Research Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	We thank all the subjects and families that participated in the research and D. Dudakia, J. Bull and R. Linger for their assistance in recruitment. We are indebted to M. Stratton for discussions of the data and to A. Strydom for editorial assistance. We thank the High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics, Oxford (funded by Wellcome Trust grant reference 090532/Z/09/Z and Medical Research Council (MRC) Hub grant G0900747 91070) for the generation of the phase 1 sequencing data. This work was funded by the Institute of Cancer Research, The Wellcome Trust, Cancer Research UK and Breakthrough Breast Cancer. We acknowledge support by the RMH-ICR National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Cancer. We acknowledge the use of DNA from the British 1958 Birth Cohort collection funded by the MRC grant G0000934 and the Wellcome Trust grant 068545/Z/02. A. C. A. is a Cancer Research UK Senior Cancer Research Fellow (C12292/A11174). P. Do. is supported by a Wolfson-Royal Society Merit Award. K. S. is supported by the Michael and Betty Kadoorie Cancer Genetics Research Programme.	[Anonymous], 2002, IARC Sci Publ, P1; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; Barnes DR, 2012, GENET EPIDEMIOL, V36, P274, DOI 10.1002/gepi.21620; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Caruccio N, 2011, METHODS MOL BIOL, V733, P241, DOI 10.1007/978-1-61779-089-8_17; Chuman Y, 2009, J BIOCHEM, V145, P1, DOI 10.1093/jb/mvn135; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Gayther SA, 2010, CURR OPIN GENET DEV, V20, P231, DOI 10.1016/j.gde.2010.03.001; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hayashi R, 2011, BIOCHEMISTRY-US, V50, P4537, DOI 10.1021/bi101949t; Hernandez L, 2012, J PATHOL, V227, P42, DOI 10.1002/path.3990; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loveday C, 2012, NAT GENET, V44, P475, DOI 10.1038/ng.2224; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Lu XB, 2005, CELL CYCLE, V4, P1060; Lu XB, 2008, CANCER METAST REV, V27, P123, DOI 10.1007/s10555-008-9127-x; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Natrajan R, 2009, CLIN CANCER RES, V15, P2711, DOI 10.1158/1078-0432.CCR-08-1878; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Rayter S, 2008, ONCOGENE, V27, P1036, DOI 10.1038/sj.onc.1210729; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Rimmer A, 2012, PLATYPUS INTEGRATED; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shreeram S, 2006, J EXP MED, V203, P2793, DOI 10.1084/jem.20061563; Silva AL, 2008, RNA, V14, P563, DOI 10.1261/rna.815108; Snape K, 2012, BREAST CANCER RES TR, V134, P429, DOI 10.1007/s10549-012-2057-x; Tan DSP, 2009, CLIN CANCER RES, V15, P2269, DOI 10.1158/1078-0432.CCR-08-2403; Tavassoli FA, 2003, WHO CLASSIFICATION T; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586	40	186	192	0	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					406	U152		10.1038/nature11725	http://dx.doi.org/10.1038/nature11725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23242139	Green Submitted, Green Accepted			2022-12-28	WOS:000313615900052
J	Han, MS; Jung, DY; Morel, C; Lakhani, SA; Kim, JK; Flavell, RA; Davis, RJ				Han, Myoung Sook; Jung, Dae Young; Morel, Caroline; Lakhani, Saquib A.; Kim, Jason K.; Flavell, Richard A.; Davis, Roger J.			JNK Expression by Macrophages Promotes Obesity-Induced Insulin Resistance and Inflammation	SCIENCE			English	Article							ADIPOSE-TISSUE; ACTIVATION; CELLS; POLARIZATION; SENSITIVITY; DIFFERENTIATION	The cJun NH2-terminal kinase (JNK) signaling pathway contributes to inflammation and plays a key role in the metabolic response to obesity, including insulin resistance. Macrophages are implicated in this process. To test the role of JNK, we established mice with selective JNK deficiency in macrophages. We report that feeding a high-fat diet to control and JNK-deficient mice caused similar obesity, but only mice with JNK-deficient macrophages remained insulin-sensitive. The protection of mice with macrophage-specific JNK deficiency against insulin resistance was associated with reduced tissue infiltration by macrophages. Immunophenotyping demonstrated that JNK was required for pro-inflammatory macrophage polarization. These studies demonstrate that JNK in macrophages is required for the establishment of obesity-induced insulin resistance and inflammation.	[Han, Myoung Sook; Morel, Caroline; Davis, Roger J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Han, Myoung Sook; Jung, Dae Young; Morel, Caroline; Kim, Jason K.; Davis, Roger J.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Lakhani, Saquib A.; Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT USA; [Lakhani, Saquib A.; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; Yale University; Yale University; University of Massachusetts System; University of Massachusetts Worcester	Davis, RJ (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA.	roger.davis@umassmed.edu	Lakhani, Sunil R/I-1970-2018	Lakhani, Sunil R/0000-0003-4067-2760; Han, Myoung Sook/0000-0002-7226-2590; Davis, Roger/0000-0002-0130-1652; Lakhani, Saquib/0000-0003-3235-3460; Kim, Jason/0000-0002-7185-042X	National Institutes of Health [DK090963, DK080756, CA065861]; American Diabetes Association [7-10-BETA-02];  [DK093000]; NATIONAL CANCER INSTITUTE [R01CA065861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080756, R24DK090963, P30DK032520, U24DK093000, U2CDK093000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Barrett, V. Benoit, Y. Lee, and J.-H. Liu for technical assistance; S. Vernia for designing Taqman probes; and K. Gemme for administrative assistance. These studies were supported by grants from the National Institutes of Health (DK090963, DK080756, and CA065861). The University of Massachussetts Mouse Metabolic Phenotyping Center is supported by grant DK093000. M. S. H. was supported by a postdoctoral fellowship (7-10-BETA-02) from the American Diabetes Association. R.J.D. and J.K.K. are members of the University of Massachussetts Diabetes and Endocrinology Research Center (DK032520). R.J.D. and R. A. F. are Investigators of the Howard Hughes Medical Institute. Mouse strains described are available to qualified investigators upon completion of a standard institutional materials transfer agreement. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials.	Das M, 2009, CELL, V136, P249, DOI 10.1016/j.cell.2008.11.017; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kitade H, 2012, DIABETES, V61, P1680, DOI 10.2337/db11-1506; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sabio G, 2010, TRENDS BIOCHEM SCI, V35, P490, DOI 10.1016/j.tibs.2010.04.004; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Vallerie SN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003151; WANG J, 1994, CLIN EXP IMMUNOL, V95, P263, DOI 10.1111/j.1440-1681.1994.tb02511.x; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8	24	458	486	5	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					218	222		10.1126/science.1227568	http://dx.doi.org/10.1126/science.1227568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23223452	Green Accepted			2022-12-28	WOS:000313328200048
J	Middleton, MJ; Miller-Jones, JCA; Markoff, S; Fender, R; Henze, M; Hurley-Walker, N; Scaife, AMM; Roberts, TP; Walton, D; Carpenter, J; Macquart, JP; Bower, GC; Gurwell, M; Pietsch, W; Haberl, F; Harris, J; Daniel, M; Miah, J; Done, C; Morgan, JS; Dickinson, H; Charles, P; Burwitz, V; Della Valle, M; Freyberg, M; Greiner, J; Hernanz, M; Hartmann, DH; Hatzidimitriou, D; Riffeser, A; Sala, G; Seitz, S; Reig, P; Rau, A; Orio, M; Titterington, D; Grainge, K				Middleton, Matthew J.; Miller-Jones, James C. A.; Markoff, Sera; Fender, Rob; Henze, Martin; Hurley-Walker, Natasha; Scaife, Anna M. M.; Roberts, Timothy P.; Walton, Dominic; Carpenter, John; Macquart, Jean-Pierre; Bower, Geoffrey C.; Gurwell, Mark; Pietsch, Wolfgang; Haberl, Frank; Harris, Jonathan; Daniel, Michael; Miah, Junayd; Done, Chris; Morgan, John S.; Dickinson, Hugh; Charles, Phil; Burwitz, Vadim; Della Valle, Massimo; Freyberg, Michael; Greiner, Jochen; Hernanz, Margarita; Hartmann, Dieter H.; Hatzidimitriou, Despina; Riffeser, Arno; Sala, Gloria; Seitz, Stella; Reig, Pablo; Rau, Arne; Orio, Marina; Titterington, David; Grainge, Keith			Bright radio emission from an ultraluminous stellar-mass microquasar in M 31	NATURE			English	Article							X-RAY SOURCE; BLACK-HOLE BINARIES; SUPERLUMINAL SOURCE; GRS 1915+105; J1819.3-2525; EVOLUTION; SYSTEMS; CHANDRA; GALAXY; MODEL	A subset of ultraluminous X-ray sources (those with luminosities of less than 10(40) erg s(-1); ref. 1) are thought to be powered by the accretion of gas onto black holes with masses of similar to 5-20M(circle dot), probably by means of an accretion disk(2,3). The X-ray and radio emission are coupled in such Galactic sources; the radio emission originates in a relativistic jet thought to be launched from the innermost regions near the black hole(4,5), with the most powerful emission occurring when the rate of infalling matter approaches a theoretical maximum (the Eddington limit). Only four such maximal sources are known in the Milky Way(6), and the absorption of soft X-rays in the interstellar medium hinders the determination of the causal sequence of events that leads to the ejection of the jet. Here we report radio and X-ray observations of a bright new X-ray source in the nearby galaxy M 31, whose peak luminosity exceeded 10(39) erg s(-1). The radio luminosity is extremely high and shows variability on a timescale of tens of minutes, arguing that the source is highly compact and powered by accretion close to the Eddington limit onto a black hole of stellar mass. Continued radio and X-ray monitoring of such sources should reveal the causal relationship between the accretion flow and the powerful jet emission.	[Middleton, Matthew J.; Roberts, Timothy P.; Harris, Jonathan; Daniel, Michael; Miah, Junayd; Done, Chris] Univ Durham, Dept Phys, Durham DH1 3LE, England; [Middleton, Matthew J.; Markoff, Sera] Astron Inst Anton Pannekoek, NL-1098 XH Amsterdam, Netherlands; [Miller-Jones, James C. A.; Hurley-Walker, Natasha; Macquart, Jean-Pierre; Morgan, John S.] Curtin Univ Technol, Int Ctr Radio Astron Res, Perth, WA 6845, Australia; [Fender, Rob; Scaife, Anna M. M.; Charles, Phil] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Henze, Martin; Pietsch, Wolfgang; Haberl, Frank; Burwitz, Vadim; Freyberg, Michael; Greiner, Jochen; Rau, Arne] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Walton, Dominic] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Walton, Dominic; Carpenter, John] CALTECH, Dept Astron, Pasadena, CA 91125 USA; [Macquart, Jean-Pierre] Curtin Univ Technol, ARC Ctr Excellence All Sky Astrophys CAASTRO, Perth, WA 6845, Australia; [Bower, Geoffrey C.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Gurwell, Mark] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Dickinson, Hugh] Stockholm Univ, Oskar Klein Ctr, AlbaNova, SE-10691 Stockholm, Sweden; [Charles, Phil] Univ Cape Town, Dept Astron, ZA-7701 Rondebosch, South Africa; [Della Valle, Massimo] Osserv Astron Capodimonte, INAF, I-80131 Naples, Italy; [Della Valle, Massimo] Int Ctr Relativist Astrophys, I-65122 Pescara, Italy; [Hernanz, Margarita] Fac Ciencies, Inst Space Sci CSIC IEEC, Barcelona 08193, Spain; [Hartmann, Dieter H.] Clemson Univ, Dept Phys & Astron, Kinard Lab 118, Clemson, SC 29631 USA; [Hatzidimitriou, Despina] Univ Athens, Fac Phys, Dept Astrophys Astron & Mech, Athens 15784, Greece; [Riffeser, Arno; Seitz, Stella] Univ Munich, Univ Observ Munich, D-81679 Munich, Germany; [Sala, Gloria] EUETIB UPC IEEC, Dept Phys & Nucl Engn, Barcelona 08036, Spain; [Reig, Pablo] Fdn Res & Technol Hellas, Iraklion 71110, Crete, Greece; [Orio, Marina] Osserv Astron Padova, I-35122 Padua, Italy; [Titterington, David; Grainge, Keith] Univ Cambridge, Cavendish Lab, Astrophys Grp, Cambridge CB3 0HE, England	Durham University; University of Amsterdam; Curtin University; University of Southampton; Max Planck Society; University of Cambridge; California Institute of Technology; Curtin University; University of California System; University of California Berkeley; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Oskar Klein Centre; Stockholm University; University of Cape Town; Istituto Nazionale Astrofisica (INAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); Clemson University; National & Kapodistrian University of Athens; University of Munich; Institut d'Estudis Espacials de Catalunya (IEEC); Universitat Politecnica de Catalunya; Foundation for Research & Technology - Hellas (FORTH); Istituto Nazionale Astrofisica (INAF); University of Padua; University of Cambridge	Middleton, MJ (corresponding author), Univ Durham, Dept Phys, Durham DH1 3LE, England.	m.j.middleton@durham.ac.uk	Macquart, Jean-Pierre R/B-5306-2013; Daniel, Michael K/A-2903-2010; Miller-Jones, James C. A./B-2411-2013; Della Valle, Massimo/AAE-8884-2021; Hurley-Walker, Natasha/P-6494-2019; Morgan, James/N-8104-2018; Morgan, John S/B-9505-2013; Bower, Geoffrey/ABC-8386-2020; Hatzidimitriou, Despina/AAK-5808-2021; Hatzidimitriou, Despina/A-3732-2015; done, chris/D-4605-2016; Reig, Pablo/A-1198-2014; Hurley-Walker, Natasha/B-9520-2013; Hernanz, Margarita/K-1770-2014	Macquart, Jean-Pierre R/0000-0001-6763-8234; Daniel, Michael K/0000-0002-8053-7910; Miller-Jones, James C. A./0000-0003-3124-2814; Della Valle, Massimo/0000-0003-3142-5020; Hurley-Walker, Natasha/0000-0002-5119-4808; Bower, Geoffrey/0000-0003-4056-9982; done, chris/0000-0002-1065-7239; Reig, Pablo/0000-0002-6446-3050; Hurley-Walker, Natasha/0000-0002-5119-4808; Hernanz, Margarita/0000-0002-8651-7910; Carpenter, John/0000-0003-2251-0602; Gurwell, Mark/0000-0003-0685-3621; Henze, Martin/0000-0001-9985-3406; Haberl, Frank/0000-0002-0107-5237; Roberts, Timothy/0000-0001-8252-6337; Hatzidimitriou, Despina/0000-0002-5415-0464; Morgan, John/0000-0001-9224-5483	Science and Technology Facilities Council (STFC); Netherlands Organization for Scientific Research Vidi Fellowship; European Research Council; Cambridge University; STFC;  [BMWI/DLR];  [FKZ 50 OR 1010]; Science and Technology Facilities Council [ST/G001588/1, ST/J001600/1, ST/F00723X/1] Funding Source: researchfish; STFC [ST/G001588/1, ST/F00723X/1, ST/J001600/1] Funding Source: UKRI	Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)Science and Technology Development Fund (STDF)); Netherlands Organization for Scientific Research Vidi Fellowship(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); Cambridge University(University of Cambridge); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); ; ; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank C. Trott and R. Soria for discussions, and C. Gough for making his code available. This work was supported by a Science and Technology Facilities Council (STFC) standard grant (M.J.M.), Netherlands Organization for Scientific Research Vidi Fellowship (S. M.), European Research Council partial funding (R. F.) and grant number BMWI/DLR, FKZ 50 OR 1010 (M. Henze). The National Radio Astronomy Observatory is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc. We thank the staff of the Mullard Radio Astronomy Observatory for their assistance in the commissioning and operation of AMI, which is supported by Cambridge University and the STFC. This work is based on observations obtained with XMM-Newton, an ESA science mission with instruments and contributions directly funded by ESA Member States and NASA. This research has also made use of data obtained from NASA's Swift and Chandra satellites.	ABRAMOWICZ MA, 1988, ASTROPHYS J, V332, P646, DOI 10.1086/166683; Corbel S, 2012, MON NOT R ASTRON SOC, V421, P2947, DOI 10.1111/j.1365-2966.2012.20517.x; Cseh D, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/17; Dunn RJH, 2010, MON NOT R ASTRON SOC, V403, P61, DOI 10.1111/j.1365-2966.2010.16114.x; Fender R, 2004, ANNU REV ASTRON ASTR, V42, P317, DOI 10.1146/annurev.astro.42.053102.134031; Fender RP, 2004, MON NOT R ASTRON SOC, V355, P1105, DOI 10.1111/j.1365-2966.2004.08384.x; Feng H, 2011, NEW ASTRON REV, V55, P166, DOI 10.1016/j.newar.2011.08.002; Feng H, 2009, ASTROPHYS J, V696, P1712, DOI 10.1088/0004-637X/696/2/1712; Gallo E, 2003, MON NOT R ASTRON SOC, V344, P60, DOI 10.1046/j.1365-8711.2003.06791.x; Grimm HJ, 2002, ASTRON ASTROPHYS, V391, P923, DOI 10.1051/0004-6361:20020826; Henze M, 2012, XMMU J004243 6 41251; Hjellming RM, 2000, ASTROPHYS J, V544, P977, DOI 10.1086/317255; Kaiser CR, 2000, ASTRON ASTROPHYS, V356, P975; King AR, 2009, MON NOT R ASTRON SOC, V393, pL41, DOI 10.1111/j.1745-3933.2008.00594.x; King AR, 2002, MON NOT R ASTRON SOC, V335, pL13, DOI 10.1046/j.1365-8711.2002.05745.x; Kong AKH, 2003, ASTROPHYS J, V585, P298, DOI 10.1086/345947; Merloni A, 2003, MON NOT R ASTRON SOC, V345, P1057, DOI 10.1046/j.1365-2966.2003.07017.x; Middleton MJ, 2012, MON NOT R ASTRON SOC, V420, P2969, DOI 10.1111/j.1365-2966.2011.20145.x; Middleton MJ, 2011, MON NOT R ASTRON SOC, V417, P464, DOI 10.1111/j.1365-2966.2011.19285.x; MIRABEL IF, 1994, NATURE, V371, P46, DOI 10.1038/371046a0; Monachesi A, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/1/55; Orosz JA, 2001, ASTROPHYS J, V555, P489, DOI 10.1086/321442; Plotkin RM, 2012, MON NOT R ASTRON SOC, V419, P267, DOI 10.1111/j.1365-2966.2011.19689.x; Pooley GG, 1997, MON NOT R ASTRON SOC, V292, P925, DOI 10.1093/mnras/292.4.925; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Soria R, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/152; Ueda Y, 2009, ASTROPHYS J, V695, P888, DOI 10.1088/0004-637X/695/2/888; Vilardell F, 2006, ASTRON ASTROPHYS, V459, P321, DOI 10.1051/0004-6361:20065667	30	100	101	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2013	493	7431					187	190		10.1038/nature11697	http://dx.doi.org/10.1038/nature11697			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23235823	Green Accepted, Green Submitted			2022-12-28	WOS:000313259600032
J	Kimball, AB; Kerdel, F; Adams, D; Mrowietz, U; Gelfand, JM; Gniadecki, R; Prens, EP; Schlessinger, J; Zouboulis, CC; van der Zee, HH; Rosenfeld, M; Mulani, P; Gu, YH; Paulson, S; Okun, M; Jemec, GBE				Kimball, Alexa B.; Kerdel, Francisco; Adams, David; Mrowietz, Ulrich; Gelfand, Joel M.; Gniadecki, Robert; Prens, Errol P.; Schlessinger, Joel; Zouboulis, Christos C.; van der Zee, Hessel H.; Rosenfeld, Marie; Mulani, Parvez; Gu, Yihua; Paulson, Susan; Okun, Martin; Jemec, Gregor B. E.			Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa A Parallel Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; CONTROLLED CROSSOVER TRIAL; DOUBLE-BLIND; CLINDAMYCIN; INFLIXIMAB; MORBIDITY; SMOKING; ALPHA	Background: Hidradenitis suppurativa (HS) is a chronic, painful skin disease characterized by abscesses, nodules, and draining fistulas in the axilla and groin of young adults. Objective: To evaluate the efficacy and safety of adalimumab, an anti-tumor necrosis factor-alpha antibody, in patients with moderate to severe HS. Design: Phase 2, parallel, randomized, placebo-controlled trial consisting of a blinded 16-week period (period 1) and an open-label 36-week period (period 2). All study personnel, investigators, and patients remained blinded to treatment group throughout the study. (ClinicalTrials.gov: NCT00918255) Setting: 26 academic and private practice medical centers in the United States and Europe. Patients: 154 adult patients with moderate to severe HS who were unresponsive or intolerant to oral antibiotics. Intervention: Patients were assigned in a 1: 1: 1 ratio to adalimumab, 40 mg/wk; adalimumab, 40 mg every other week (EOW); or placebo. All patients received adalimumab, 40 mg EOW, at the beginning of period 2 but switched to weekly dosing if the response was suboptimal (HS Physician's Global Assessment [PGA] score of moderate or worse) at weeks 28 or 31. Measurements: The primary outcome measure (clinical response) was the proportion of patients achieving an HS-PGA score of clear, minimal, or mild with at least a 2-grade improvement relative to baseline at week 16. Results: At week 16, 3.9% of placebo patients (2 of 51), 9.6% of EOW patients (5 of 52), and 17.6% of weekly patients (9 of 51) achieved clinical response (EOW vs. placebo strata-adjusted difference, 5.6% [95% CI, -4.0% to 15.3%]; P = 0.25; weekly vs. placebo strata-adjusted difference, 13.7% [CI, 1.7% to 25.7%]; P = 0.025). Serious adverse event rates were 3.9%, 5.8%, and 7.8% for placebo, EOW, and weekly patients, respectively (EOW vs. placebo difference, 1.8% [CI, -6.4% to 10.1%]; weekly vs. placebo difference, 3.9% [CI, -5.2% to 13.0%]). Significantly greater improvements in patient-reported outcomes and pain were seen in the weekly dosing group than in the placebo group. A decrease in response was seen after the switch from weekly to EOW dosing in period 2. Limitations: Weeks 16 to 52 of the study were open-label. The study was not powered to assess the risk for known serious adverse effects of adalimumab, such as tuberculosis, other serious infections, and demyelinating disorders. Conclusion: Adalimumab dosed once per week alleviates moderate to severe HS.	[Kimball, Alexa B.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Clin Unit Res Trials & Outcomes Skin, Boston, MA 02114 USA; Florida Acad Dermatol Ctr, Miami, FL USA; Penn State Hershey Med Ctr, Hershey, PA USA; Univ Med Ctr Schleswig Holstein, Kiel, Germany; Univ Penn, Philadelphia, PA 19104 USA; Bispebjerg Hosp, DK-2400 Copenhagen, Denmark; Univ Copenhagen, Copenhagen, Denmark; Erasmus MC, Rotterdam, Netherlands; Skin Specialists PC, Omaha, NE USA; Dessau Med Ctr, Dessau, Germany; Abbott Labs, Abbott Pk, IL 60064 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Kiel; Schleswig Holstein University Hospital; University of Pennsylvania; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Erasmus University Rotterdam; Erasmus MC; Dessau Medical Center; Abbott Laboratories	Kimball, AB (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Clin Unit Res Trials & Outcomes Skin, 50 Staniford St 246, Boston, MA 02114 USA.	harvardskinstudies@partners.org	Zouboulis, Christos C./I-4493-2013; Kimball, Alexandra B./M-6347-2019; Jemec, Gregor/H-6702-2019; Gniadecki, Robert/A-5696-2010	Zouboulis, Christos C./0000-0003-1646-2608; Kimball, Alexandra B./0000-0001-9405-0479; Jemec, Gregor/0000-0002-0712-2540; Gniadecki, Robert/0000-0002-2310-8300; Gelfand, Joel/0000-0003-3480-2661; van der Zee, Hessel H/0000-0002-2874-7726; Prens, Errol/0000-0002-8158-660X	Abbott Laboratories	Abbott Laboratories(Abbott Laboratories)	Abbott Laboratories.	Adams DR, 2010, ARCH DERMATOL, V146, P501, DOI 10.1001/archdermatol.2010.72; Alikhan A, 2009, J AM ACAD DERMATOL, V60, P539, DOI 10.1016/j.jaad.2008.11.911; CLEMMENSEN OJ, 1983, INT J DERMATOL, V22, P325, DOI 10.1111/j.1365-4362.1983.tb02150.x; Esmann S, 2011, ACTA DERM-VENEREOL, V91, P328, DOI 10.2340/00015555-1082; Farrar JT, 2003, J PAIN SYMPTOM MANAG, V25, P406, DOI 10.1016/S0885-3924(03)00162-3; Grant A, 2010, J AM ACAD DERMATOL, V62, P205, DOI 10.1016/j.jaad.2009.06.050; Harde V, 2009, J DTSCH DERMATOL GES, V7, P139, DOI 10.1111/j.1610-0387.2008.06918.x; Haslund P, 2009, ACTA DERM-VENEREOL, V89, P595, DOI 10.2340/00015555-0747; Hurley HJ, 1989, ROENIGK ROENIGKS DER, P729; Jemec GBE, 1998, J AM ACAD DERMATOL, V39, P971, DOI 10.1016/S0190-9622(98)70272-5; Jemec GBE, 2003, J CUTAN MED SURG, V7, P47, DOI 10.1007/s10227-002-2104-z; Konig A, 1999, DERMATOLOGY, V198, P261, DOI 10.1159/000018126; Kurzen H, 2008, EXP DERMATOL, V17, P455, DOI [10.1111/j.1600-0625.2008.00712.x, 10.1111/j.1600-0625.2008.00712_1.x]; MANTON KG, 1987, MILBANK Q, V65, P129, DOI 10.2307/3349954; Martinez F, 2001, INFLAMM BOWEL DIS, V7, P323, DOI 10.1097/00054725-200111000-00008; Matusiak L, 2010, ACTA DERM-VENEREOL, V90, P264, DOI 10.2340/00015555-0866; Miller I, 2011, BRIT J DERMATOL, V165, P391, DOI 10.1111/j.1365-2133.2011.10339.x; MORTIMER PS, 1986, BRIT J DERMATOL, V115, P263, DOI 10.1111/j.1365-2133.1986.tb05740.x; National Research Council, 2010, PREVENTION TREATMENT; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Plewig G, 2009, BRAUN FALCOS DERMATO, P1002; Revuz JE, 2008, J AM ACAD DERMATOL, V59, P596, DOI 10.1016/j.jaad.2008.06.020; Sartorius K, 2009, BRIT J DERMATOL, V161, P831, DOI 10.1111/j.1365-2133.2009.09198.x; Shikiar R, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-71; The MacArthur Initiative on Depression and Primary Care, 2012, US PHQ 9 DIAGN SCOR; van der Zee HH, 2011, BRIT J DERMATOL, V164, P1292, DOI 10.1111/j.1365-2133.2011.10254.x; Von der Werth JM, 2001, BRIT J DERMATOL, V144, P809, DOI 10.1046/j.1365-2133.2001.04137.x; Wolkenstein P, 2007, J AM ACAD DERMATOL, V56, P621, DOI 10.1016/j.jaad.2006.08.061; Zouboulis CC, 2010, FITZPATRICKS DERMATO	29	282	294	2	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2012	157	12					846	U180		10.7326/0003-4819-157-12-201212180-00004	http://dx.doi.org/10.7326/0003-4819-157-12-201212180-00004			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057SB	23247938				2022-12-28	WOS:000312583200014
J	Latos, PA; Pauler, FM; Koerner, MV; Senergin, HB; Hudson, QJ; Stocsits, RR; Allhoff, W; Stricker, SH; Klement, RM; Warczok, KE; Aumayr, K; Pasierbek, P; Barlow, DP				Latos, Paulina A.; Pauler, Florian M.; Koerner, Martha V.; Senergin, H. Basak; Hudson, Quanah J.; Stocsits, Roman R.; Allhoff, Wolfgang; Stricker, Stefan H.; Klement, Ruth M.; Warczok, Katarzyna E.; Aumayr, Karin; Pasierbek, Pawel; Barlow, Denise P.			Airn Transcriptional Overlap, But Not Its lncRNA Products, Induces Imprinted Igf2r Silencing	SCIENCE			English	Article							RNA; EXPRESSION; GROWTH	Mammalian imprinted genes often cluster with long noncoding (lnc) RNAs. Three lncRNAs that induce parental-specific silencing show hallmarks indicating that their transcription is more important than their product. To test whether Airn transcription or product silences the Igf2r gene, we shortened the endogenous lncRNA to different lengths. The results excluded a role for spliced and unspliced Airn lncRNA products and for Airn nuclear size and location in silencing Igf2r. Instead, silencing only required Airn transcriptional overlap of the Igf2r promoter, which interferes with RNA polymerase II recruitment in the absence of repressive chromatin. Such a repressor function for lncRNA transcriptional overlap reveals a gene silencing mechanism that may be widespread in the mammalian genome, given the abundance of lncRNA transcripts.	[Latos, Paulina A.; Pauler, Florian M.; Koerner, Martha V.; Senergin, H. Basak; Hudson, Quanah J.; Allhoff, Wolfgang; Stricker, Stefan H.; Klement, Ruth M.; Warczok, Katarzyna E.; Barlow, Denise P.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Stocsits, Roman R.; Aumayr, Karin] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Pasierbek, Pawel] Inst Mol Biotechnol, A-1030 Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Pauler, FM (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, Lazarettgasse 14, A-1090 Vienna, Austria.	fpauler@cemm.oeaw.ac.at; dbarlow@cemm.oeaw.ac.at	Hudson, Quanah/I-9837-2014; Stricker, Stefan H/A-4930-2015; Stricker, Stefan/A-7410-2013	Hudson, Quanah/0000-0002-3407-4388; Stricker, Stefan H/0000-0002-5488-8530; 	Austrian Science Fund FWF [F4302-B09, W1207-B09]; Genome Research in Austria [GEN-AU 820980]	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Genome Research in Austria	We thank E. F. Wagner and A. Wutz for the R2 Delta and D3 ES cell lines, and G. Superti-Furga, C. Bock, and A. P. Bird for comments on the manuscript. Array data (GSE41444) are available at www.ncbi.nlm.nih.gov/geo. Supported by grants from Austrian Science Fund FWF (F4302-B09 and W1207-B09) and Genome Research in Austria (GEN-AU 820980).	Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Hudson QJ, 2011, DEV BIOL, V353, P420, DOI 10.1016/j.ydbio.2011.02.017; Koerner MV, 2009, DEVELOPMENT, V136, P1771, DOI 10.1242/dev.030403; Kowalczyk MS, 2012, NATURE, V482, P310, DOI 10.1038/482310a; Latos PA, 2009, DEVELOPMENT, V136, P437, DOI 10.1242/dev.032060; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Palmer AC, 2011, TRANSCR-AUSTIN, V2, P9, DOI 10.4161/trns.2.1.13511; Regha K, 2007, MOL CELL, V27, P353, DOI 10.1016/j.molcel.2007.06.024; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sleutels F, 2003, EMBO J, V22, P3696, DOI 10.1093/emboj/cdg341; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; Williamson CM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001347; Wutz A, 2001, DEVELOPMENT, V128, P1881; Yamasaki Y, 2005, HUM MOL GENET, V14, P2511, DOI 10.1093/hmg/ddi255	19	332	344	3	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1469	1472		10.1126/science.1228110	http://dx.doi.org/10.1126/science.1228110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239737				2022-12-28	WOS:000312250800048
J	Grenon, SM; Saary, J; Gray, G; Vanderploeg, JM; Hughes-Fulford, M				Grenon, S. Marlene; Saary, Joan; Gray, Gary; Vanderploeg, James M.; Hughes-Fulford, Millie			Can I take a space flight? Considerations for doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SPACEFLIGHT	Commercial investment is bringing space tourism closer to reality. Marlene Grenon and colleagues outline what doctors will need to know Although perhaps unfamiliar with the specific physiological changes associated with commercial air travel, most physicians will have travelled by plane and many will have attended a passenger in need of medical assistance while on a commercial flight. They are, however, unlikely to have experience of space travel. Numerous commercial enterprises exist that will eventually provide competitively priced access to spaceflight experiences for paying customers. With spaceports construction under way, bookings are already taking place. Physicians can in future expect patients to ask questions and request clearance processes (such as fitness to fly certificates) for space travel as they do for commercial airplane flights today. Here, we provide some background to the field of space medicine for non-experts and point to resources for clinicians when a patient presents with requests related to space travel.	[Grenon, S. Marlene] Univ Calif San Francisco, Div Vasc & Endovasc Surg, San Francisco, CA 94121 USA; [Grenon, S. Marlene] San Francisco VA Med Ctr, Dept Surg, San Francisco, CA USA; [Saary, Joan] Univ Toronto, Dept Occupat Med, Toronto, ON, Canada; [Saary, Joan] Canadian Forces Environm Med Estab, Toronto, ON, Canada; [Gray, Gary] Canadian Space Agcy, Montreal, PQ, Canada; [Vanderploeg, James M.] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Aerosp Med Program, Galveston, TX USA; [Hughes-Fulford, Millie] Vet Affairs Med Ctr, Hughes Fulford Lab, San Francisco, CA 94121 USA; [Hughes-Fulford, Millie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of Toronto; Canadian Space Agency; University of Texas System; University of Texas Medical Branch Galveston; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Grenon, SM (corresponding author), Univ Calif San Francisco, Div Vasc & Endovasc Surg, San Francisco, CA 94121 USA.	marlene.grenon@ucsfmedctr.org		Hughes-Fulford, Millie/0000-0002-0756-068X	NCRR NIH HHS [KL2RR024130] Funding Source: Medline; NIA NIH HHS [UH3 AG037628] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [UH3AG037628] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Antunano MJ, 2001, AVIAT SPACE ENVIR MD, V72, P948; BEZDEK RH, 1992, NATURE, V355, P105, DOI 10.1038/355105a0; Blue RS, 2012, AVIAT SPACE ENVIR MD, V83, P929, DOI 10.3357/ASEM.3351.2012; Bogomolov VV, 2007, AVIAT SPACE ENVIR MD, V78, P1162, DOI 10.3357/ASEM.2175.2007; Center of Excellence for Commercial Space Transportation, FLIGHT CREW MED STAN; FAA Office of Commercial Space Transportation, REG; Federal Aviation Administration, 2006, GUID MED SCREEN COMM; Federal Aviation Administration, FOR SUB REUS VEH 10; Gray G, 2008, PRINCIPLES CLIN MED, P59; Hughes-Fulford M, 2011, FASEB J, V25, P2858, DOI 10.1096/fj.11-0902ufm; International Academy of Astronautics, 2009, MED SAF LIAB ISS SHO; Jennings RT, 2006, AVIAT SPACE ENVIR MD, V77, P475; Launius RD, 2003, SPACE POLICY, V19, P163, DOI 10.1016/S0265-9646(03)00039-0; Mader TH, 2011, OPHTHALMOLOGY, V118, P2058, DOI 10.1016/j.ophtha.2011.06.021; Pandya S, 2009, J NEUROSURG, V111, P1141, DOI 10.3171/2009.2.JNS081334; Rayman RB, 2002, AVIAT SPACE ENVIR MD, V73, P1132; Thirsk R, 2009, CAN MED ASSOC J, V180, P1324, DOI 10.1503/cmaj.090815; Thirsk R, 2009, CAN MED ASSOC J, V180, P1216, DOI 10.1503/cmaj.081125; Vanderploeg J, 2011, AVIAT SPACE ENVIR MD, V82, P475, DOI 10.3357/ASEM.3015.2011; Wilhelm M. J., 2001, Journal of Heart and Lung Transplantation, V20, P201, DOI 10.1016/S1053-2498(00)00427-7; Williams D, 2009, CAN MED ASSOC J, V180, P1317, DOI 10.1503/cmaj.090628; Williams D, 2009, CAN MED ASSOC J, V180, P1292, DOI 10.1503/cmaj.090925	22	22	22	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2012	345								e8124	10.1136/bmj.e8124	http://dx.doi.org/10.1136/bmj.e8124			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056MZ	23241271	Green Published			2022-12-28	WOS:000312495700005
J	Reipurth, B; Mikkola, S				Reipurth, Bo; Mikkola, Seppo			Formation of the widest binary stars from dynamical unfolding of triple systems	NATURE			English	Article							PROPER MOTION; TERTIARY COMPANIONS; HIPPARCOS STARS; EVOLUTION; CATALOG; CLUSTER; DISK	The formation of very wide binary systems(1-3), such as the a Centauri system with Proxima (also known as a Centauri C) separated from a Centauri (which itself is a close binaryA/B) by 15,000 astronomical units(4) (1 AU is the distance from Earth to the Sun), challenges current theories of star formation, because their separation can exceed the typical size of a collapsing cloud core. Various hypotheses have been proposed to overcome this problem, including the suggestion that ultrawide binaries result from the dissolution of a star cluster-when a cluster star gravitationally captures another, distant, cluster star(5-7). Recent observations have shown that very wide binaries are frequently members of triple systems(8,9) and that close binaries often have a distant third companion(10-12). Here we report N-body simulations of the dynamical evolution of newborn triple systems still embedded in their nascent cloud cores that match observations of very wide systems(13-15). We find that although the triple systems are born very compact-and therefore initially are more protected against disruption by passing stars(16,17)-they can develop extreme hierarchical architectures on timescales of millions of years as one component is dynamically scattered into a very distant orbit. The energy of ejection comes from shrinking the orbits of the other two stars, often making them look from a distance like a single star. Such loosely bound triple systems will therefore appear to be very wide binaries.	[Reipurth, Bo] Univ Hawaii Manoa, Inst Astron, Hilo, HI 96720 USA; [Mikkola, Seppo] Univ Turku, Tuorla Observ, FI-21500 Piikkio, Finland	University of Hawaii System; University of Hawaii Manoa; University of Turku	Reipurth, B (corresponding author), Univ Hawaii Manoa, Inst Astron, 640 N Aohoku Pl, Hilo, HI 96720 USA.	reipurth@ifa.hawaii.edu			National Aeronautics and Space Administration through the NASA Astrobiology Institute through the Office of Space Science [NNA09DA77A]	National Aeronautics and Space Administration through the NASA Astrobiology Institute through the Office of Space Science	We thank C. J. Clarke, M. B. N. Kouwenhoven and A. Tokovinin for comments. B. R. thanks the European Southern Observatory and Tuorla Observatory for hospitality during the period when this paper was written, and H.-F. Chiang and C. Aspin for providing additional computer facilities. This work was supported by the National Aeronautics and Space Administration through the NASA Astrobiology Institute under Cooperative Agreement number NNA09DA77A issued through the Office of Space Science. This research has made use of the SIMBAD database, operated at Centre de Donnees astronomiques de Strasbourg, Strasbourg, France, and of NASA's Astrophysics Data System Bibliographic Services.	Allen PR, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/2/62; ANOSOVA JP, 1986, ASTROPHYS SPACE SCI, V124, P217, DOI 10.1007/BF00656037; BAHCALL JN, 1981, ASTROPHYS J, V246, P122, DOI 10.1086/158905; Chaname J, 2004, ASTROPHYS J, V601, P289, DOI 10.1086/380442; Delgado-Donate EJ, 2004, MON NOT R ASTRON SOC, V351, P617, DOI 10.1111/j.1365-2966.2004.07803.x; Dhital S, 2010, ASTRON J, V139, P2566, DOI 10.1088/0004-6256/139/6/2566; DUCHENE G, 2007, PROTOSTARS PLANETS, V5, P379; Faherty JK, 2010, ASTRON J, V139, P176, DOI 10.1088/0004-6256/139/1/176; Goodwin S., 2007, PROTOSTARS PLANETS, P133; Kastner JH, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/2/L23; Korntreff C, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201118019; Kouwenhoven MBN, 2010, MON NOT R ASTRON SOC, V404, P1835, DOI 10.1111/j.1365-2966.2010.16399.x; Law NM, 2010, ASTROPHYS J, V720, P1727, DOI 10.1088/0004-637X/720/2/1727; Lepine S, 2007, ASTRON J, V133, P889, DOI 10.1086/510333; Longhitano M, 2010, ASTRON ASTROPHYS, V509, DOI 10.1051/0004-6361/200913109; Mardling RA, 2008, LECT NOTES PHYS, V760, P59, DOI 10.1007/978-1-4020-8431-7_3; Moeckel N, 2011, MON NOT R ASTRON SOC, V415, P1179, DOI 10.1111/j.1365-2966.2011.18731.x; Moeckel N, 2010, MON NOT R ASTRON SOC, V404, P721, DOI 10.1111/j.1365-2966.2010.16347.x; Reipurth B, 2000, ASTRON J, V120, P3177, DOI 10.1086/316865; Reipurth B, 2010, ASTROPHYS J LETT, V725, pL56, DOI 10.1088/2041-8205/725/1/L56; RETTERER JM, 1982, ASTROPHYS J, V254, P214, DOI 10.1086/159725; Sesar B, 2008, ASTROPHYS J, V689, P1244, DOI 10.1086/592736; Teixeira R, 2008, ASTRON ASTROPHYS, V489, P825, DOI 10.1051/0004-6361:200810133; Tokovinin A, 2006, ASTRON ASTROPHYS, V450, P681, DOI 10.1051/0004-6361:20054427; Tokovinin A., 2008, MULTIPLE STARS H R D, P38; Tokovinin AA, 2002, ASTRON ASTROPHYS, V382, P118, DOI 10.1051/0004-6361:20011586; Tokovinin A, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/4/102; VALTONEN M, 1991, ANNU REV ASTRON ASTR, V29, P9; WEINBERG MD, 1987, ASTROPHYS J, V312, P367, DOI 10.1086/164883; Wertheimer JG, 2006, ASTRON J, V132, P1995, DOI 10.1086/507771	30	132	132	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					221	224		10.1038/nature11662	http://dx.doi.org/10.1038/nature11662			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23222523	Green Submitted			2022-12-28	WOS:000312259300035
J	Ibler, KS; Jemec, GBE; Diepgen, TL; Gluud, C; Hansen, JL; Winkel, P; Thomsen, SF; Agner, T				Ibler, Kristina Sophie; Jemec, Gregor B. E.; Diepgen, Thomas L.; Gluud, Christian; Hansen, Jane Lindschou; Winkel, Per; Thomsen, Simon Francis; Agner, Tove			Skin care education and individual counselling versus treatment as usual in healthcare workers with hand eczema: randomised clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; KITCHEN EMPLOYEES; PREVENTION; INTERVENTION; SEVERITY; INDEX; DISEASES; DERMATITIS; CLASSIFICATION; MULTICENTER	Objective To evaluate the effect of a secondary prevention programme with education on skin care and individual counselling versus treatment as usual in healthcare workers with hand eczema. Design Randomised, observer blinded parallel group superiority clinical trial. Setting Three hospitals in Denmark. Participants 255 healthcare workers with self reported hand eczema within the past year randomised centrally and stratified by profession, severity of eczema, and hospital. 123 were allocated to the intervention group and 132 to the control group. Interventions Education in skin care and individual counselling based on patch and prick testing and assessment of work and domestic related exposures. The control was treatment as usual. Main outcome measures The primary outcome was clinical severity of disease at five month follow-up measured by scores on the hand eczema severity index. The secondary outcomes were scores on the dermatology life quality index, self evaluated severity of hand eczema, skin protective behaviours, and knowledge of hand eczema from onset to follow-up. Results Follow-up data were available for 247 of 255 participants (97%). At follow-up, the mean score on the hand eczema severity index was significantly lower (improved) in the intervention group than control group: difference of means, unadjusted -3.56 (95% confidence interval -4.92 to -2.14); adjusted -3.47 (-4.80 to -2.14), both P<0.001 for difference. The mean score on the dermatology life quality index was also significantly lower (improved) in the intervention group at follow-up: difference of means: unadjusted -0.78, non-parametric test P=0.003; adjusted -0.92, -1.48 to -0.37). Self evaluated severity and skin protective behaviour by hand washings and wearing of protective gloves were also statistically significantly better in the intervention group, whereas this was not the case for knowledge of hand eczema. Conclusion A secondary prevention programme for hand eczema improved severity and quality of life and had a positive effect on self evaluated severity and skin protective behaviour by hand washings and wearing of protective gloves.	[Ibler, Kristina Sophie; Jemec, Gregor B. E.] Roskilde Hosp, Fac Hlth Sci, Dept Dermatol, DK-4000 Roskilde, Denmark; [Ibler, Kristina Sophie; Thomsen, Simon Francis; Agner, Tove] Bispebjerg Hosp, Fac Hlth Sci, Dept Dermatol, DK-2400 Copenhagen, Denmark; [Diepgen, Thomas L.] Heidelberg Univ, Dept Social Med Occupat & Environm Dermatol, D-6900 Heidelberg, Germany; [Gluud, Christian; Hansen, Jane Lindschou; Winkel, Per] Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; Ruprecht Karls University Heidelberg; Rigshospitalet; University of Copenhagen	Ibler, KS (corresponding author), Roskilde Hosp, Fac Hlth Sci, Dept Dermatol, Kogevej 7-13, DK-4000 Roskilde, Denmark.	kristinaibler@hotmail.com	Jemec, Gregor/H-6702-2019; Gluud, Christian/AAY-1027-2021; Gluud, Christian/HGB-3191-2022	Jemec, Gregor/0000-0002-0712-2540; Gluud, Christian/0000-0002-8861-0799; agner, tove/0000-0002-7543-8299; ibler, kristina/0000-0002-5324-1591	Region Zealand's Research Fund; Danish Working Environment Research Fund	Region Zealand's Research Fund; Danish Working Environment Research Fund	This study was funded by Region Zealand's Research Fund and the Danish Working Environment Research Fund.	Agner T, 2002, CONTACT DERMATITIS, V47, P253, DOI 10.1034/j.1600-0536.2002.470501.x; Agner T, 1997, UGESKR LAEGER S6, V159, P1; Agner T, 2008, CONTACT DERMATITIS, V59, P43, DOI 10.1111/j.1600-0536.2008.01362.x; ALK, 2012, ALL DIAGN; [Anonymous], 2001, 24512RET1 DS; Apfelbacher CJ, 2009, CONTACT DERMATITIS, V60, P144, DOI 10.1111/j.1600-0536.2008.01505.x; Basra MKA, 2012, DERMATOL CLIN, V30, P237, DOI 10.1016/j.det.2011.11.002; Coenraads PJ, 2005, BRIT J DERMATOL, V152, P296, DOI 10.1111/J.1365-2133.2004.06270.X; Cvetkovski RS, 2006, ARCH DERMATOL, V142, P305, DOI 10.1001/archderm.142.3.305; DailyMed, 2012, DAILYMED; Dickel H, 2002, BRIT MED J, V324, P1422, DOI 10.1136/bmj.324.7351.1422; Diepgen TL, 2009, BRIT J DERMATOL, V160, P353, DOI 10.1111/j.1365-2133.2008.08907.x; Dulon M, 2009, BRIT J DERMATOL, V161, P337, DOI 10.1111/j.1365-2133.2009.09226.x; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Flyvholm MA, 2005, OCCUP ENVIRON MED, V62, P642, DOI 10.1136/oem.2004.016576; Flyvholm MA, 2007, CONTACT DERMATITIS, V57, P110, DOI 10.1111/j.1600-0536.2007.01134.x; Gluud C, 2006, J HEPATOL, V44, P607, DOI 10.1016/j.jhep.2005.12.006; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; Hald M, 2009, BRIT J DERMATOL, V161, P1294, DOI 10.1111/j.1365-2133.2009.09402.x; Hald M, 2009, BRIT J DERMATOL, V160, P1229, DOI 10.1111/j.1365-2133.2009.09139.x; Hanifin JM, 2001, EXP DERMATOL, V10, P11, DOI 10.1034/j.1600-0625.2001.100102.x; Held E, 2005, BRIT J DERMATOL, V152, P302, DOI 10.1111/J.1365-2133.2004.06305.X; Held E, 2002, OCCUP ENVIRON MED, V59, P556, DOI 10.1136/oem.59.8.556; Held E, 2001, CONTACT DERMATITIS, V44, P297, DOI 10.1034/j.1600-0536.2001.440509.x; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; HOLM S, 1979, SCAND J STAT, V6, P65; Hongbo Y, 2005, J INVEST DERMATOL, V125, P659, DOI 10.1111/j.0022-202X.2005.23621.x; Ibler K, 2011, DERMATOL REP, V3; Ibler KS, 2012, CONTACT DERMATITIS, V66, P247, DOI 10.1111/j.1600-0536.2011.02027.x; Ibler KS, 2011, ACTA DERMATOVENER CR, V19, P161; Ibler KS, 2010, BMC DERMATOL, V10, DOI 10.1186/1471-5945-10-8; Kowalski J, 2007, J AM ACAD DERMATOL, V56, P546; Loffler H, 2006, CONTACT DERMATITIS, V54, P202, DOI 10.1111/j.0105-1873.2006.00825.x; Meding B, 2001, CONTACT DERMATITIS, V45, P99, DOI 10.1034/j.1600-0536.2001.045002099.x; Melilli L, 2006, J AM ACAD DERMATOL, V54, P2894; Schurer N, 2005, INT ARCH OCC ENV HEA, V78, P149, DOI 10.1007/s00420-004-0588-0; Schwanitz HJ, 2003, INT ARCH OCC ENV HEA, V76, P374, DOI 10.1007/s00420-002-0428-z; Sell L, 2005, CONTACT DERMATITIS, V53, P155, DOI 10.1111/j.0105-1873.2005.00674.x; Shikiar Richard, 2005, Health Qual Life Outcomes, V3, P36, DOI 10.1186/1477-7525-3-36; Smedley J, 2012, OCCUP ENVIRON MED, V69, P276, DOI 10.1136/oemed-2011-100315; Soder Stefanie, 2007, J Dtsch Dermatol Ges, V5, P670, DOI 10.1111/j.1610-0387.2007.06419.x; Thomson KF, 2002, BRIT J DERMATOL, V146, P627, DOI 10.1046/j.1365-2133.2002.04692.x; Wallenhammar LM, 2004, J INVEST DERMATOL, V122, P1381, DOI 10.1111/j.0022-202X.2004.22604.x; Weisshaar E, 2007, INT ARCH OCC ENV HEA, V80, P477, DOI 10.1007/s00420-006-0154-z; Weisshaar E, 2006, CONTACT DERMATITIS, V54, P254, DOI 10.1111/j.0105-1873.2006.00811.x; Weisshaar Elke, 2005, J Dtsch Dermatol Ges, V3, P33, DOI 10.1046/j.1439-0353.2005.04798.x; Williams C, 2011, BRIT J DERMATOL, V164, P1311, DOI 10.1111/j.1365-2133.2011.10246.x; Williams C, 2010, BRIT J DERMATOL, V162, P1088, DOI 10.1111/j.1365-2133.2010.09643.x; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	49	84	83	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2012	345								e7822	10.1136/bmj.e7822	http://dx.doi.org/10.1136/bmj.e7822			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056MU	23236031	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000312495100007
J	Haufe, G				Haufe, Guenter			Putting a Greenhouse Gas to Work	SCIENCE			English	Editorial Material							TRIFLUOROMETHYLATIONS; CHEMISTRY		Univ Munster, Inst Organ Chem, D-48149 Munster, Germany	University of Munster	Haufe, G (corresponding author), Univ Munster, Inst Organ Chem, D-48149 Munster, Germany.	haufe@uni-muenster.de						Cormier E, 2009, FLUORINE MED CHEM CH, P525; Han WF, 2012, J FLUORINE CHEM, V140, P7, DOI 10.1016/j.jfluchem.2012.04.012; Hugenberg V, 2012, J FLUORINE CHEM, V143, P238, DOI 10.1016/j.jfluchem.2012.06.015; Langlois B.R., 2005, ACS SYM SER, V911, P57; Ma JA, 2007, J FLUORINE CHEM, V128, P975, DOI 10.1016/j.jfluchem.2007.04.026; Ma JA, 2008, CHEM REV, V108, pPR1, DOI 10.1021/cr800221v; MCCLINTON MA, 1992, TETRAHEDRON, V48, P6555, DOI 10.1016/S0040-4020(01)80011-9; Prakash GKS, 2012, SCIENCE, V338, P1324, DOI 10.1126/science.1227859; Shibata N, 2010, BEILSTEIN J ORG CHEM, V6, DOI 10.3762/bjoc.6.65; Shimizu M, 2005, ANGEW CHEM INT EDIT, V44, P214, DOI 10.1002/anie.200460441; SHONO T, 1991, J ORG CHEM, V56, P2, DOI 10.1021/jo00001a002; Studer A, 2012, ANGEW CHEM INT EDIT, V51, P8950, DOI 10.1002/anie.201202624; Swallow S., 2012, FLUORINE PHARM MED C, P141; Tomashenko OA, 2011, CHEM REV, V111, P4475, DOI 10.1021/cr1004293	14	5	7	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1298	1298		10.1126/science.1231092	http://dx.doi.org/10.1126/science.1231092			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224542				2022-12-28	WOS:000311991200049
J	Fujiwara, Y; Dixon, JA; O'Hara, F; Funder, ED; Dixon, DD; Rodriguez, RA; Baxter, RD; Herle, B; Sach, N; Collins, MR; Ishihara, Y; Baran, PS				Fujiwara, Yuta; Dixon, Janice A.; O'Hara, Fionn; Funder, Erik Daa; Dixon, Darryl D.; Rodriguez, Rodrigo A.; Baxter, Ryan D.; Herle, Bart; Sach, Neal; Collins, Michael R.; Ishihara, Yoshihiro; Baran, Phil S.			Practical and innate carbon-hydrogen functionalization of heterocycles	NATURE			English	Article							AROMATIC-COMPOUNDS; TRIFLUOROMETHYLATION; ARYL; STRATEGIES; CHEMISTRY; FLUORINE; REAGENT; ARENES	Nitrogen-rich heterocyclic compounds have had a profound effect on human health because these chemical motifs are found in a large number of drugs used to combat a broad range of diseases and pathophysiological conditions. Advances in transition-metal-mediated cross-coupling have simplified the synthesis of such molecules; however, C-H functionalization of medicinally important heterocycles that does not rely on pre-functionalized starting materials is an underdeveloped area(1-9). Unfortunately, the innate properties of heterocycles that make them so desirable for biological applications-such as aqueous solubility and their ability to act as ligands-render them challenging substrates for direct chemical functionalization. Here we report that zinc sulphinate salts can be used to transfer alkyl radicals to heterocycles, allowing for the mild (moderate temperature, 50 degrees C or less), direct and operationally simple formation of medicinally relevant C-C bonds while reacting in a complementary fashion to other innate C-H functionalization methods(2-6) (Minisci, borono-Minisci, electrophilic aromatic substitution, transition-metal-mediated C-H insertion and C-H deprotonation). We prepared a toolkit of these reagents and studied their reactivity across a wide range of heterocycles (natural products, drugs and building blocks) without recourse to protecting-group chemistry. The reagents can even be used in tandem fashion in a single pot in the presence of water and air.	[Fujiwara, Yuta; Dixon, Janice A.; O'Hara, Fionn; Funder, Erik Daa; Dixon, Darryl D.; Rodriguez, Rodrigo A.; Baxter, Ryan D.; Herle, Bart; Sach, Neal; Collins, Michael R.; Ishihara, Yoshihiro; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Sach, Neal; Collins, Michael R.] Pfizer Inc, La Jolla Labs, Dept Chem, San Diego, CA 92121 USA	Scripps Research Institute; Pfizer	Baran, PS (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pbaran@scripps.edu		Dixon, Darryl D./0000-0002-3904-9587	US NIH/NIGMS [GM-073949]; Uehara Memorial Foundation; US-UK Fulbright Commission; Aarhus University; OChem Graduate School; CDNA; CFIN; NABIIT; US NIH; Pfizer Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073949] Funding Source: NIH RePORTER	US NIH/NIGMS; Uehara Memorial Foundation(Uehara Memorial Foundation); US-UK Fulbright Commission; Aarhus University; OChem Graduate School; CDNA; CFIN; NABIIT; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Inc.(Pfizer); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D.-H. Huang and L. Pasternack for NMR spectroscopic assistance, A. Schuyler and W. Uritboonthai for mass spectrometry assistance and D. Cayer for the analysis of the beta-lactamase activity. Financial support for this work was provided by the US NIH/NIGMS (GM-073949), the Uehara Memorial Foundation (postdoctoral fellowship for Y.F.), the US-UK Fulbright Commission (postdoctoral fellowship for F.O.), Aarhus University, OChem Graduate School, CDNA, CFIN and NABIIT (fellowship for E. D. F.), the US NIH (graduate fellowship for R. A. R.) and Pfizer Inc. (postdoctoral fellowship for R.D.B.).	Bruckl T, 2012, ACCOUNTS CHEM RES, V45, P826, DOI 10.1021/ar200194b; Cho EJ, 2010, SCIENCE, V328, P1679, DOI 10.1126/science.1190524; Duncton MAJ, 2011, MEDCHEMCOMM, V2, P1135, DOI 10.1039/c1md00134e; Fier PS, 2012, J AM CHEM SOC, V134, P5524, DOI 10.1021/ja301013h; Fujiwara Y, 2012, J AM CHEM SOC, V134, P1494, DOI 10.1021/ja211422g; Fujiwara Y, 2011, J AM CHEM SOC, V133, P3292, DOI 10.1021/ja111152z; Han C, 2009, J AM CHEM SOC, V131, P7532, DOI 10.1021/ja902046m; Hu JB, 2009, CHEM COMMUN, P7465, DOI 10.1039/b916463d; Ji YN, 2011, P NATL ACAD SCI USA, V108, P14411, DOI 10.1073/pnas.1109059108; KAMIGATA N, 1994, J CHEM SOC PERK T 1, P1339, DOI 10.1039/p19940001339; Kino T, 2010, J FLUORINE CHEM, V131, P98, DOI 10.1016/j.jfluchem.2009.09.007; Kirk KL, 2008, ORG PROCESS RES DEV, V12, P305, DOI 10.1021/op700134j; Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; LANGLOIS BR, 1991, TETRAHEDRON LETT, V32, P7525, DOI 10.1016/0040-4039(91)80524-A; Li Y, 2006, ORG LETT, V8, P1693, DOI 10.1021/ol060322t; Ma JA, 2007, J FLUORINE CHEM, V128, P975, DOI 10.1016/j.jfluchem.2007.04.026; Meanwell NA, 2011, J MED CHEM, V54, P2529, DOI 10.1021/jm1013693; MINISCI F, 1989, HETEROCYCLES, V28, P489, DOI 10.3987/REV-88-SR1; Molander GA, 2011, ORG LETT, V13, P1852, DOI 10.1021/ol2003572; Morimoto H, 2011, ANGEW CHEM INT EDIT, V50, P3793, DOI 10.1002/anie.201100633; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Nagib DA, 2011, NATURE, V480, P224, DOI 10.1038/nature10647; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; Qi QQ, 2012, J FLUORINE CHEM, V133, P115, DOI 10.1016/j.jfluchem.2011.07.005; Raymond JI, 1971, J PHYS CHEM-US, V75, P3235; RUSSELL GA, 1985, J ORG CHEM, V50, P3423, DOI 10.1021/jo00218a041; Seiple IB, 2010, J AM CHEM SOC, V132, P13194, DOI 10.1021/ja1066459; Wang XS, 2010, J AM CHEM SOC, V132, P3648, DOI 10.1021/ja909522s; Zhao YC, 2012, ANGEW CHEM INT EDIT, V51, P1033, DOI 10.1002/anie.201106742	30	654	657	4	440	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					95	+		10.1038/nature11680	http://dx.doi.org/10.1038/nature11680			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23201691	Green Accepted			2022-12-28	WOS:000311893400052
J	Hooper, L; Abdelhamid, A; Moore, HJ; Douthwaite, W; Skeaff, CM; Summerbell, CD				Hooper, Lee; Abdelhamid, Asmaa; Moore, Helen J.; Douthwaite, Wayne; Skeaff, C. Murray; Summerbell, Carolyn D.			Effect of reducing total fat intake on body weight: systematic review and meta-analysis of randomised controlled trials and cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HIGH-CARBOHYDRATE DIET; BREAST-CANCER PATIENTS; DISEASE RISK-FACTORS; LIBITUM LOW-FAT; STEP II DIET; LONG-TERM; CARDIOVASCULAR-DISEASE; POSTMENOPAUSAL WOMEN; HDL CHOLESTEROL; BLOOD-PRESSURE	Objective To investigate the relation between total fat intake and body weight in adults and children. Design Systematic review and meta-analysis of randomised controlled trials and cohort studies. Data sources Medline, Embase, CINAHL, and the Cochrane Central Register of Controlled Trials to June 2010. Inclusion criteria Randomised controlled trials and cohort studies of adults or children that compared lower versus usual total fat intake and assessed the effects on measures of body fatness (body weight, body mass index, or waist circumference) after at least six months (randomised controlled trials) or one year (in cohorts). Randomised controlled trials with any intention to reduce weight in participants or confounded by additional medical or lifestyle interventions were excluded. Data extraction Data were extracted and validity was assessed independently and in duplicate. Random effects meta-analyses, subgroups, sensitivity analyses, and metaregression were done. Results 33 randomised controlled trials (73 589 participants) and 10 cohort studies were included, all from developed countries. Meta-analysis of data from the trials suggested that diets lower in total fat were associated with lower relative body weight (by 1.6 kg, 95% confidence interval -2.0 to -1.2 kg, I-2=75%, 57 735 participants). Lower weight gain in the low fat arm compared with the control arm was consistent across trials, but the size of the effect varied. Metaregression suggested that greater reduction in total fat intake and lower baseline fat intake were associated with greater relative weight loss, explaining most of the heterogeneity. The significant effect of a low fat diet on weight was not lost in sensitivity analyses (including removing trials that expended greater time and attention on low fat groups). Lower total fat intake also led to lower body mass index (-0.51 kg/m(2), 95% confidence interval -0.76 to -0.26, nine trials, I-2=77%) and waist circumference (by 0.3 cm, 95% confidence interval -0.58 to -0.02, 15 671 women, one trial). There was no suggestion of negative effects on other cardiovascular risk factors (lipid levels or blood pressure). GRADE assessment suggested high quality evidence for the relation between total fat intake and body weight in adults. Only one randomised controlled trial and three cohort studies were found in children and young people, but these confirmed a positive relation between total fat intake and weight gain. Conclusions There is high quality, consistent evidence that reduction of total fat intake has been achieved in large numbers of both healthy and at risk trial participants over many years. Lower total fat intake leads to small but statistically significant and clinically meaningful, sustained reductions in body weight in adults in studies with baseline fat intakes of 28-43% of energy intake and durations from six months to over eight years. Evidence supports a similar effect in children and young people.	[Hooper, Lee; Abdelhamid, Asmaa] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Moore, Helen J.; Douthwaite, Wayne; Summerbell, Carolyn D.] Univ Durham, Wolfson Res Inst, Sch Med & Hlth, Obes Related Behav Grp, Stockton On Tees, England; [Skeaff, C. Murray] Univ Otago, Dept Human Nutr, Dunedin, New Zealand	University of East Anglia; Durham University; University of Otago	Hooper, L (corresponding author), Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	L.hooper@uea.ac.uk	Hooper, Lee/D-2795-2009; Summerbell, Carolyn D/O-3001-2015; Summerbell, Carolyn/AAC-3159-2019; Summerbell, Carolyn D/O-3759-2015	Hooper, Lee/0000-0002-7904-3331; Summerbell, Carolyn D/0000-0003-1910-9383; Summerbell, Carolyn/0000-0003-1910-9383; Summerbell, Carolyn D/0000-0003-1910-9383; Abdelhamid, Asmaa/0000-0002-9897-5433; Moore, Helen J/0000-0002-0165-7552	WHO; Norwich Medical School, University of East Anglia	WHO(World Health Organization); Norwich Medical School, University of East Anglia	WHO provided funding to Durham University towards the cost of carrying out this systematic review. No funding was received for the searching, analysis, or writing up of the data from randomised controlled trials in adults, but it was supported by the Norwich Medical School, University of East Anglia. The funders did not have any vested interests in the findings of this research.	ANDERSON JW, 1990, ARTERIOSCLEROSIS, V10, pA882; ANDERSON JW, 1992, AM J CLIN NUTR, V56, P887, DOI 10.1093/ajcn/56.5.887; [Anonymous], 1965, LANCET, V2, P501; [Anonymous], 1968, LANCET, V2, P693; Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Astrup A, 2000, BRIT J NUTR, V83, pS25; Azadbakht L, 2007, BRIT J NUTR, V97, P399, DOI 10.1017/S0007114507328602; BAKER BM, 1968, CIRCULATION, V37, P1; BLACK HS, 1994, NEW ENGL J MED, V330, P1272, DOI 10.1056/NEJM199405053301804; BLOEMBERG BPM, 1991, AM J EPIDEMIOL, V134, P39, DOI 10.1093/oxfordjournals.aje.a115991; Boyd NF, 1997, BRIT J CANCER, V76, P127, DOI 10.1038/bjc.1997.348; Boyd NF, 1996, CANCER EPIDEM BIOMAR, V5, P217; BOYD NF, 1988, LANCET, V2, P128, DOI 10.1016/S0140-6736(88)90684-8; Bray GA, 1998, AM J CLIN NUTR, V68, P1157, DOI 10.1093/ajcn/68.6.1157; Bray GA, 2002, AM J CLIN NUTR, V76, P928, DOI 10.1093/ajcn/76.5.928; BURR ML, 1989, LANCET, V2, P757; Butte NF, 2007, AM J CLIN NUTR, V85, P1478, DOI 10.1093/ajcn/85.6.1478; Castagnetta L, 2002, ANN NY ACAD SCI, V963, P282; CHLEBOWSKI RT, 1993, J CLIN ONCOL, V11, P2072, DOI 10.1200/JCO.1993.11.11.2072; CURZIO JL, 1989, J HYPERTENS, V7, pS254, DOI 10.1097/00004872-198900076-00123; Davison KK, 2001, INT J OBESITY, V25, P1834, DOI 10.1038/sj.ijo.0801835; DAYTON S, 1969, CIRCULATION, V40, pIII6; DEBONT AJ, 1981, DIABETOLOGIA, V21, P529, DOI 10.1007/BF00281543; Djuric Z, 2002, NUTR CANCER, V43, P141, DOI 10.1207/S15327914NC432_4; Due A, 2008, AM J CLIN NUTR, V88, P1232, DOI 10.3945/ajcn.2007.25695; DULLAART RPF, 1992, DIABETOLOGIA, V35, P165, DOI 10.1007/BF00402550; EDERER F, 1971, LANCET, V2, P203; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FRANTZ ID, 1989, ARTERIOSCLEROSIS, V9, P129, DOI 10.1161/01.ATV.9.1.129; FRENKIEL PG, 1986, AM J CLIN NUTR, V43, P239, DOI 10.1093/ajcn/43.2.239; Furukawa TA, 2007, JAMA-J AM MED ASSOC, V297, P468, DOI 10.1001/jama.297.5.468-b; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hall WD, 2003, ETHNIC DIS, V13, P337; Hebert JR, 2001, J AM DIET ASSOC, V101, P421, DOI 10.1016/S0002-8223(01)00109-2; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Hjerkinn EM, 2005, AM J CLIN NUTR, V81, P583; HOCKADAY TDR, 1978, BRIT J NUTR, V39, P357, DOI 10.1079/BJN19780045; HOLM LE, 1990, BREAST CANCER RES TR, V16, P103, DOI 10.1007/BF01809294; Hooper L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002137.pub3; HOUTSMULLER AJ, 1980, DOC OPHTHALMOL, V48, P363, DOI 10.1007/BF00141465; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P39, DOI 10.1001/jama.295.1.39; Kelly S, 2006, ASS FOOD NUTR PHYS A; KLESGES RC, 1995, PEDIATRICS, V95, P126; Lanza E, 1996, CANCER EPIDEM BIOMAR, V5, P385; Lean MEJ, 1997, EUR J CLIN NUTR, V51, P243, DOI 10.1038/sj.ejcn.1600391; Leren P, 1966, Acta Med Scand Suppl, V466, P1; Ley SJ, 2004, DIABETES RES CLIN PR, V63, P103, DOI 10.1016/j.diabres.2003.09.001; MANSON JAE, 1990, NEW ENGL J MED, V322, P882, DOI 10.1056/NEJM199003293221303; McAuley KA, 2005, DIABETOLOGIA, V48, P8, DOI 10.1007/s00125-004-1603-4; MCKEOWNEYSSEN GE, 1994, J CLIN EPIDEMIOL, V47, P525, DOI 10.1016/0895-4356(94)90299-2; Mihas C, 2010, PUBLIC HEALTH NUTR, V13, P712, DOI 10.1017/S1368980009991625; Moy T F, 2001, Prev Cardiol, V4, P158, DOI 10.1111/j.1520-037X.2001.00543.x; NORDEVANG E, 1990, EUR J CLIN NUTR, V44, P681; NORDEVANG E, 1992, EUR J CLIN NUTR, V46, P387; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Pierce JP, 2007, JAMA-J AM MED ASSOC, V298, P289, DOI 10.1001/jama.298.3.289; PILKINGTON TRE, 1960, BRIT MED J, V1, P23, DOI 10.1136/bmj.1.5165.23; Poppitt SD, 2002, AM J CLIN NUTR, V75, P11, DOI 10.1093/ajcn/75.1.11; Prospective Studies Collaboration, 2009, LANCET, V373; Retzlaff BM, 1997, J AM COLL NUTR, V16, P52, DOI 10.1080/07315724.1997.10718649; RIVELLESE AA, 1994, BRIT MED J, V308, P227, DOI 10.1136/bmj.308.6923.227; ROSE GA, 1965, BMJ-BRIT MED J, V1, P1531, DOI 10.1136/bmj.1.5449.1531; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Saris WHM, 2000, INT J OBESITY, V24, P1310, DOI 10.1038/sj.ijo.0801451; Sarkkinen E, 1995, THESIS U KUOPIO; Schatzkin A, 1996, CANCER EPIDEM BIOMAR, V5, P375; Seppelt B, 1996, Z ERNAHRUNGSWISS, V35, P369, DOI 10.1007/BF01610555; Simon MS, 1997, NUTR CANCER, V27, P136, DOI 10.1080/01635589709514515; Sondergaard E, 2003, AM HEART J, V145, DOI 10.1016/S0002-8703(03)00078-4; Song YM, 2004, STROKE, V35, P831, DOI 10.1161/01.STR.0000119386.22691.1C; Stefanick ML, 1998, NEW ENGL J MED, V339, P12, DOI 10.1056/NEJM199807023390103; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Strychar I, 2009, DIABETES CARE, V32, P1597, DOI 10.2337/dc08-2322; Summerbell CD, 2009, INT J OBESITY, V33, pS1, DOI 10.1038/ijo.2009.80; Tuttle KR, 2008, AM J CARDIOL, V101, P1523, DOI 10.1016/j.amjcard.2008.01.038; vanhetHof KH, 1997, INT J FOOD SCI NUTR, V48, P19, DOI 10.3109/09637489709006960; Walden CE, 1997, ARTERIOSCL THROM VAS, V17, P375, DOI 10.1161/01.ATV.17.2.375; Walden CE, 2000, ARTERIOSCL THROM VAS, V20, P1580, DOI 10.1161/01.ATV.20.6.1580; WATTS GF, 1992, LANCET, V339, P563, DOI 10.1016/0140-6736(92)90863-X; WHO, 2010, WHO HDB GUID DEV; Willett W C, 2002, Obes Rev, V3, P59, DOI 10.1046/j.1467-789X.2002.00060.x; Woodhill J M, 1978, Adv Exp Med Biol, V109, P317; World Cancer Research Fund/American Institute for Cancer Research, 2009, PREV CANC FOOD NUTR; Yu-Poth S, 1999, AM J CLIN NUTR, V69, P632	85	168	176	0	64	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 6	2012	345								e7666	10.1136/bmj.e7666	http://dx.doi.org/10.1136/bmj.e7666			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052IG	23220130	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000312190500001
J	McConville, JF; Kress, JP				McConville, John F.; Kress, John P.			Weaning Patients from the Ventilator	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PROLONGED MECHANICAL VENTILATION; POSITIVE-PRESSURE VENTILATION; CRITICALLY-ILL PATIENTS; NONINVASIVE VENTILATION; CONTROLLED-TRIAL; RESPIRATORY-DISTRESS; EXTUBATION FAILURE; CARDIAC-SURGERY; TRACHEOSTOMY; TRACHEOTOMY		[McConville, John F.; Kress, John P.] Univ Chicago, Dept Med, Sect Pulm & Crit Care, Chicago, IL 60637 USA	University of Chicago	Kress, JP (corresponding author), Univ Chicago, Dept Med, Sect Pulm & Crit Care, 5841 S Maryland Ave,MC 6026, Chicago, IL 60637 USA.	jkress@medicine.bsd.uchicago.edu			Hospira; France Foundation	Hospira; France Foundation	Dr. Kress reports receiving lecture fees from Hospira and the France Foundation. No other potential conflict of interest relevant to this article was reported.	Arabi Y, 2004, CRIT CARE, V8, pR347, DOI 10.1186/cc2924; Bendixin HH, 1965, RESPIRATORY CARE, P149; Blackwood B, 2010, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; BROCHARD L, 1994, AM J RESP CRIT CARE, V150, P896, DOI 10.1164/ajrccm.150.4.7921460; BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Carson Shannon S, 2006, J Intensive Care Med, V21, P173, DOI 10.1177/0885066605282784; Coplin WM, 2000, AM J RESP CRIT CARE, V161, P1530, DOI 10.1164/ajrccm.161.5.9905102; Cox CE, 2004, CRIT CARE MED, V32, P2219, DOI 10.1097/01.CCM.0000145232.46143.40; Dezfulian C, 2005, AM J MED, V118, P11, DOI 10.1016/j.amjmed.2004.07.051; Epstein SK, 2009, RESP CARE, V54, P198; Epstein SK, 1998, AM J RESP CRIT CARE, V158, P489, DOI 10.1164/ajrccm.158.2.9711045; Epstein SK, 1997, CHEST, V112, P186, DOI 10.1378/chest.112.1.186; Esteban A, 1999, AM J RESP CRIT CARE, V159, P512, DOI 10.1164/ajrccm.159.2.9803106; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Esteban A, 1997, AM J RESP CRIT CARE, V156, P459, DOI 10.1164/ajrccm.156.2.9610109; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Esteban A, 2004, NEW ENGL J MED, V350, P2452, DOI 10.1056/NEJMoa032736; ESTEBAN A, 1994, CHEST, V106, P1188, DOI 10.1378/chest.106.4.1188; Esteban A, 2008, AM J RESP CRIT CARE, V177, P170, DOI 10.1164/rccm.200706-893OC; Ferrer M, 2006, AM J RESP CRIT CARE, V173, P164, DOI 10.1164/rccm.200505-718OC; Frutos-Vivar F, 2006, CHEST, V130, P1664, DOI 10.1378/chest.130.6.1664; Funk GC, 2010, EUR RESPIR J, V35, P88, DOI 10.1183/09031936.00056909; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Silva BNG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007271.pub2; Gray A, 2008, NEW ENGL J MED, V359, P142, DOI 10.1056/NEJMoa0707992; Jubran A, 1997, AM J RESP CRIT CARE, V155, P906, DOI 10.1164/ajrccm.155.3.9117025; Keenan SP, 2002, JAMA-J AM MED ASSOC, V287, P3238, DOI 10.1001/jama.287.24.3238; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Krishnan JA, 2004, AM J RESP CRIT CARE, V169, P673, DOI 10.1164/rccm.200306-761OC; Kurek CJ, 1997, CRIT CARE MED, V25, P983, DOI 10.1097/00003246-199706000-00015; LEMAIRE F, 1988, ANESTHESIOLOGY, V69, P171, DOI 10.1097/00000542-198808000-00004; MacIntyre NR, 2001, CHEST, V120, p375S, DOI 10.1378/chest.120.6_suppl.375S; Masip J, 2005, JAMA-J AM MED ASSOC, V294, P3124, DOI 10.1001/jama.294.24.3124; Namen AM, 2001, AM J RESP CRIT CARE, V163, P658, DOI 10.1164/ajrccm.163.3.2003060; Nava S, 2005, CRIT CARE MED, V33, P2465, DOI 10.1097/01.CCM.0000186416.44752.72; Needham DM, 2005, CRIT CARE MED, V33, P574, DOI [10.1097/01.CCM.0000155992.21174.31, 10.1097/01.ccm.0000155992.21174.31]; Patel SB, 2011, ANN INTERN MED, V154, P434, DOI 10.7326/0003-4819-154-6-201103150-00011; Ram FS., 2004, COCHRANE DB SYST REV, V3, DOI [DOI 10.1002/14651858.CD004104.PUB3, 10.1002/14651858.cd004104.pub3]; Randolph AG, 2002, JAMA-J AM MED ASSOC, V288, P2561, DOI 10.1001/jama.288.20.2561; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rose L, 2008, INTENS CARE MED, V34, P1788, DOI 10.1007/s00134-008-1179-4; Rumbak MJ, 2004, CRIT CARE MED, V32, P1689, DOI 10.1097/01.CCM.0000134835.05161.B6; Salam A, 2004, INTENS CARE MED, V30, P1334, DOI 10.1007/s00134-004-2231-7; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Seneff MG, 1996, CHEST, V110, P469, DOI 10.1378/chest.110.2.469; Strom T, 2010, LANCET, V375, P475, DOI 10.1016/S0140-6736(09)62072-9; Trouillet JL, 2011, ANN INTERN MED, V154, P373, DOI 10.7326/0003-4819-154-6-201103150-00002; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Wunsch H, 2010, CRIT CARE MED, V38, P1947, DOI 10.1097/CCM.0b013e3181ef4460; YANG KL, 1991, NEW ENGL J MED, V324, P1445, DOI 10.1056/NEJM199105233242101	52	130	144	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2012	367	23					2233	2239		10.1056/NEJMra1203367	http://dx.doi.org/10.1056/NEJMra1203367			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048DO	23215559				2022-12-28	WOS:000311890600010
J	Jou, JH; Muir, AJ				Jou, Janice H.; Muir, Andrew J.			Hepatitis C	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																		Alberti A, 2005, J HEPATOL, V42, P266, DOI 10.1016/j.jhep.2004.12.004; Alter MJ, 2004, ANN INTERN MED, V141, P715, DOI 10.7326/0003-4819-141-9-200411020-00013; [Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Benson Gordon D, 2005, Am J Ther, V12, P133, DOI 10.1097/01.mjt.0000140216.40700.95; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Caldwell S, 2009, J GASTROENTEROL, V44, P96, DOI 10.1007/s00535-008-2258-6; CDC, 2001, Morbidity and Mortality Weekly Report, V50, P1; Cheruvattath R, 2007, DIGEST DIS SCI, V52, P732, DOI 10.1007/s10620-006-9457-x; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; de Oliveira AM, 2005, ANN INTERN MED, V142, P898, DOI 10.7326/0003-4819-142-11-200506070-00007; Fabrizi F, 2002, HEPATOLOGY, V36, P3, DOI 10.1053/jhep.2002.34613; Fung J, 2008, J INFECT DIS, V198, P808, DOI 10.1086/591252; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hagan H, 2000, J URBAN HEALTH, V77, P369, DOI 10.1007/BF02386747; Hasan F, 2004, AM J GASTROENTEROL, V99, P1733, DOI 10.1111/j.1572-0241.2004.40077.x; Hawke RL, 2010, J CLIN PHARMACOL, V50, P434, DOI 10.1177/0091270009347475; Hellinger WC, 2012, ANN INTERN MED, V156, P477, DOI 10.7326/0003-4819-156-7-201204030-00002; Hwang LY, 2006, HEPATOLOGY, V44, P341, DOI 10.1002/hep.21252; Innes HA, 2011, HEPATOLOGY, V54, P2281, DOI [10.1002/hep.24776, 10.1002/hep.24561]; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jakiche R, 2007, AM J MED SCI, V333, P26, DOI 10.1097/00000441-200701000-00004; LANPHEAR BP, 1994, INFECT CONT HOSP EP, V15, P745; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Legrand-Abravanel F, 2004, J INFECT DIS, V189, P1397, DOI 10.1086/382544; Litwin AH, 2009, J SUBST ABUSE TREAT, V37, P32, DOI 10.1016/j.jsat.2008.09.009; Lock G, 2006, J VIRAL HEPATITIS, V13, P571, DOI 10.1111/j.1365-2893.2006.00735.x; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Marcellin P, 1999, J HEPATOL, V31, P9, DOI 10.1016/S0168-8278(99)80368-7; McHutchison JG, 2007, NEW ENGL J MED, V357, P2227, DOI 10.1056/NEJMoa073255; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; MEYER SD, 2012, HEPATOLOGY; *MMWR, 2011, MMWR-MORBID MORTAL W, V60, P9452; *MMWR, 2011, MMWR RECOMM REP, V60, P1; Muir AJ, 2004, NEW ENGL J MED, V350, P2265, DOI 10.1056/NEJMoa032502; Murray KF, 2005, HEPATOLOGY, V41, P1407, DOI 10.1002/hep.20704; Nuorti J. P., 2010, Morbidity and Mortality Weekly Report, V59, P1102; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Rambaldi A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003620.pub3; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Roberts EA, 2002, HEPATOLOGY, V36, pS106, DOI 10.1053/jhep.2002.36792; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Sawayama Y, 2000, DIGEST DIS SCI, V45, P351, DOI 10.1023/A:1005472812403; Shaheen AAM, 2007, AM J GASTROENTEROL, V102, P2589, DOI 10.1111/j.1572-0241.2007.01466.x; SHAPIRO CN, 1994, ANN INTERN MED, V120, P82, DOI 10.7326/0003-4819-120-1-199401010-00014; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; Singal AK, 2010, CLIN GASTROENTEROL H, V8, P192, DOI 10.1016/j.cgh.2009.10.026; Smith BD, 2012, ANN INTERN MED, V157, P817, DOI 10.7326/0003-4819-157-9-201211060-00529; Susser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192; Terrault NA, 2002, HEPATOLOGY, V36, pS99, DOI 10.1053/jhep.2002.36797; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Vandelli C, 2004, AM J GASTROENTEROL, V99, P855, DOI 10.1111/j.1572-0241.2004.04150.x; Verma S, 2007, CLIN GASTROENTEROL H, V5, P408, DOI 10.1016/j.cgh.2006.10.014; Vrielink H, 1997, TRANSFUSION, V37, P845, DOI 10.1046/j.1537-2995.1997.37897424409.x; Wiley TE, 1998, HEPATOLOGY, V28, P805, DOI 10.1002/hep.510280330; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	62	2	2	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2012	157	11							ITC6	10.7326/0003-4819-157-11-201212040-01006	http://dx.doi.org/10.7326/0003-4819-157-11-201212040-01006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	049RC	23208180				2022-12-28	WOS:000312000100017
J	Boyce, N				Boyce, Niall			Better care for people with psychotic illness	LANCET			English	Editorial Material							GLOBAL MENTAL-HEALTH		The Lancet, London NW1 7BY, England		Boyce, N (corresponding author), The Lancet, London NW1 7BY, England.	niall.boyce@lancet.com						[Anonymous], 2012, LANCET, V379, P1274; [Anonymous], 2012, NATURE NEWS BLO 1105, V379, P1274; Drew N, 2011, LANCET, V378, P1664, DOI 10.1016/S0140-6736(11)61458-X; Leader D, 2012, GUARDIAN; Patel V, 2011, LANCET, V378, P1441, DOI 10.1016/S0140-6736(11)61385-8; Schizophrenia Commission, 2012, AB ILLN REP SCHIZ CO	6	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 1	2012	380	9857					1893	1893		10.1016/S0140-6736(12)62040-6	http://dx.doi.org/10.1016/S0140-6736(12)62040-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	046IK	23200488				2022-12-28	WOS:000311758500009
J	Macilwain, C				Macilwain, Colin			Science should be ready to jump off 'the cliff'	NATURE			English	Editorial Material												cfmworldview@gmail.com							0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					639	639		10.1038/491639a	http://dx.doi.org/10.1038/491639a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	044FY	23192107	Bronze			2022-12-28	WOS:000311606000005
J	Lichter, AS; McKinney, R				Lichter, Allen S.; McKinney, Ross			Toward a Harmonized and Centralized Conflict of Interest Disclosure Progress From an IOM Initiative	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lichter, Allen S.] Amer Soc Clin Oncol, Alexandria, VA 22314 USA; [McKinney, Ross] Duke Univ, Dept Pediat, Sch Med, Durham, NC 27706 USA; [McKinney, Ross] Duke Univ, Sch Med, Trent Ctr Bioeth Humanities & Hist Med, Durham, NC USA	American Society of Clinical Oncology; Duke University; Duke University	Lichter, AS (corresponding author), Amer Soc Clin Oncol, 2318 Mill Rd,Ste 800, Alexandria, VA 22314 USA.	allen.lichter@asco.org						Lichter A, 2012, HARMONIZING REPORTIN; Lo B, 2009, CONFLICT INTEREST ME	2	13	14	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2012	308	20					2093	2094		10.1001/jama.2012.51172	http://dx.doi.org/10.1001/jama.2012.51172			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043IV	23188024				2022-12-28	WOS:000311537200022
J	Lefaucheur, C; Loupy, A; Vernerey, D; Duong-Van-Huyen, JP; Suberbielle, C; Anglicheau, D; Verine, J; Beuscart, T; Nochy, D; Bruneval, P; Charron, D; Delahousse, M; Empana, JP; Hill, GS; Glotz, D; Legendre, C; Jouven, X				Lefaucheur, Carmen; Loupy, Alexandre; Vernerey, Dewi; Duong-Van-Huyen, Jean-Paul; Suberbielle, Caroline; Anglicheau, Dany; Verine, Jerome; Beuscart, Thibaut; Nochy, Dominique; Bruneval, Patrick; Charron, Dominique; Delahousse, Michel; Empana, Jean-Philippe; Hill, Gary S.; Glotz, Denis; Legendre, Christophe; Jouven, Xavier			Antibody-mediated vascular rejection of kidney allografts: a population-based study	LANCET			English	Article							ACUTE HUMORAL REJECTION; C4D DEPOSITION; TRANSPLANT RECIPIENTS; CLASSIFICATION; SURVIVAL; THERAPY; INJURY; PLASMAPHERESIS; VASCULOPATHY; PATHOLOGY	Background Rejection of allografts has always been the major obstacle to transplantation success. We aimed to improve characterisation of different kidney-allograft rejection phenotypes, identify how each one is associated with anti-HLA antibodies, and investigate their distinct prognoses. Methods Patients who underwent ABO-compatible kidney transplantations in Necker Hospital and Saint-Louis Hospital (Paris, France) between Jan 1, 1998, and Dec 31, 2008, were included in our population-based study. We assessed patients who provided biopsy samples for acute allograft rejection, which was defined as the association of deterioration in function and histopathological lesions. The main outcome was kidney allograft loss-ie, return to dialysis. To investigate distinct rejection patterns, we retrospectively assessed rejection episodes with review of graft histology, C4d in allograft biopsies, and donor-specific anti-HLA antibodies. Findings 2079 patients were included in the main analyses, of whom 302 (15%) had acute biopsy-proven rejection. We identified four distinct patterns of kidney allograft rejection: T cell-mediated vascular rejection (26 patients [9%]), antibody-mediated vascular rejection (64 [21%]), T cell-mediated rejection without vasculitis (139 [46%]), and antibody-mediated rejection without vasculitis (73 [24%]). Risk of graft loss was 9.07 times (95 CI 3.62-19.7) higher in antibody-mediated vascular rejection than in T cell-mediated rejection without vasculitis (p<0.0001), compared with an increase of 2.93 times (1.1-7.9; P=0.0237) in antibody-mediated rejection without vasculitis and no significant rise in T cell-mediated vascular rejection (hazard ratio [HR] 1.5, 95% CI 0.33-7.6; p=0.60). Interpretation We have identified a type of kidney rejection not presently included in classifications: antibody-mediated vascular rejection. Recognition of this distinct phenotype could lead to the development of new treatment strategies that could salvage many kidney allografts.	[Lefaucheur, Carmen; Charron, Dominique] Hop St Louis, AP HP, INSERM, Dept Immunol & Histocompatibil,U940, Paris, France; [Verine, Jerome] Hop St Louis, AP HP, INSERM, Dept Pathol,U940, Paris, France; [Loupy, Alexandre; Anglicheau, Dany; Legendre, Christophe] Hop Necker Enfants Malad, AP HP, Dept Kidney Transplantat, F-75015 Paris, France; [Loupy, Alexandre; Vernerey, Dewi; Beuscart, Thibaut; Empana, Jean-Philippe; Jouven, Xavier] Univ Paris 05, Paris Cardiovasc Res Ctr, Biostat Unit, UMR S970, Paris, France; [Duong-Van-Huyen, Jean-Paul; Beuscart, Thibaut; Nochy, Dominique; Bruneval, Patrick; Hill, Gary S.] Georges Pompidou European Hosp, Dept Pathol, Paris, France; [Jouven, Xavier] Georges Pompidou European Hosp, Dept Cardiol, Paris, France; [Duong-Van-Huyen, Jean-Paul] Hop Foch, Dept Pathol, Suresnes, France; [Delahousse, Michel] Hop Foch, Dept Nephrol & Kidney Transplantat, Suresnes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Foch; Hospital Foch	Loupy, A (corresponding author), Hop Necker Enfants Malad, AP HP, Dept Kidney Transplantat, 149 Rue Sevres, F-75015 Paris, France.	alexandreloupy@gmail.com	lefaucheur, carmen/AAS-7494-2020; Empana, Jean-Philippe/AAF-6923-2021; Loupy, Alexandre/K-8512-2019; lefaucheur, carmen/F-3502-2013	Empana, Jean-Philippe/0000-0002-1469-7772; Glotz, Denis/0000-0001-5258-4237				Ait-Oufella H, 2010, J EXP MED, V207, P1579, DOI 10.1084/jem.20100155; Bohmig GA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341091; de Serrea NPM, 2008, AM J TRANSPLANT, V8, P1290, DOI 10.1111/j.1600-6143.2008.02221.x; Einecke G, 2009, AM J TRANSPLANT, V9, P2520, DOI 10.1111/j.1600-6143.2009.02799.x; EVANS RW, 1985, NEW ENGL J MED, V312, P553, DOI 10.1056/NEJM198502283120905; Everly MJ, 2008, TRANSPLANTATION, V86, P1754, DOI 10.1097/TP.0b013e318190af83; Faguer S, 2007, TRANSPLANTATION, V83, P1277, DOI 10.1097/01.tp.0000261113.30757.d1; Garcia GG, 2012, LANCET, V379, pE36, DOI 10.1016/S0140-6736(12)60202-5; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Herzenberg AM, 2002, J AM SOC NEPHROL, V13, P234, DOI 10.1681/ASN.V131234; Hill GS, 2011, J AM SOC NEPHROL, V22, P975, DOI 10.1681/ASN.2010070777; Hirohashi T, 2010, AM J TRANSPLANT, V10, P510, DOI 10.1111/j.1600-6143.2009.02958.x; Kaufman CL, 2012, AM J TRANSPLANT, V12, P1004, DOI 10.1111/j.1600-6143.2011.03915.x; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Lefaucheur C, 2007, AM J TRANSPLANT, V7, P832, DOI 10.1111/j.1600-6143.2006.01686.x; Lefaucheur C, 2009, AM J TRANSPLANT, V9, P1099, DOI 10.1111/j.1600-6143.2009.02591.x; Lefaucheur C, 2010, J AM SOC NEPHROL, V21, P1398, DOI 10.1681/ASN.2009101065; Loucaidou M, 2003, TRANSPLANTATION, V76, P1120, DOI 10.1097/01.TP.0000076474.76480.A4; Loupy A, 2011, AM J TRANSPLANT, V11, P1478, DOI 10.1111/j.1600-6143.2011.03563.x; Loupy A, 2011, AM J TRANSPLANT, V11, P56, DOI 10.1111/j.1600-6143.2010.03364.x; Loupy A, 2010, TRANSPLANTATION, V89, P1403, DOI 10.1097/TP.0b013e3181da1cc3; Mauiyyedi S, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133779; Montgomery RA, 2000, TRANSPLANTATION, V70, P887, DOI 10.1097/00007890-200009270-00006; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; PORT FK, 1993, JAMA-J AM MED ASSOC, V270, P1339, DOI 10.1001/jama.270.11.1339; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Rocha PN, 2003, TRANSPLANTATION, V75, P1490, DOI 10.1097/01.TP.0000060252.57111.AC; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shimizu T, 2010, CLIN TRANSPLANT, V24, P22, DOI 10.1111/j.1399-0012.2010.01277.x; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Sis B, 2010, AM J TRANSPLANT, V10, P421, DOI 10.1111/j.1600-6143.2009.02938.x; Sis B, 2009, AM J TRANSPLANT, V9, P2312, DOI 10.1111/j.1600-6143.2009.02761.x; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Takemoto SK, 2004, AM J TRANSPLANT, V4, P1033, DOI 10.1111/j.1600-6143.2004.00500.x; Trpkov K, 1996, TRANSPLANTATION, V61, P1586, DOI 10.1097/00007890-199606150-00007	36	240	247	0	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 26	2013	381	9863					313	319		10.1016/S0140-6736(12)61265-3	http://dx.doi.org/10.1016/S0140-6736(12)61265-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077IT	23182298				2022-12-28	WOS:000314021800028
J	Flowers, RM; Farley, KA				Flowers, R. M.; Farley, K. A.			Apatite He-4/He-3 and (U-Th)/He Evidence for an Ancient Grand Canyon	SCIENCE			English	Article							RADIATION-DAMAGE; COLORADO PLATEAU; INCISION; HISTORY; RIVER; CALIFORNIA; EROSION; UPLIFT; MODEL	The Grand Canyon is one of the most dramatic features on Earth, yet when and why it was carved have been controversial topics for more than 150 years. Here, we present apatite He-4/He-3 thermochronometry data from the Grand Canyon basement that tightly constrain the near-surface cooling history associated with canyon incision. He-4/He-3 spectra for eastern Grand Canyon apatites of differing He date, radiation damage, and U-Th zonation yield a self-consistent cooling history that substantially validates the He diffusion kinetic model applied here. Similar data for the western Grand Canyon provide evidence that it was excavated to within a few hundred meters of modern depths by similar to 70 million years ago (Ma), in contrast to the conventional model in which the entire canyon was carved since 5 to 6 Ma.	[Flowers, R. M.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Farley, K. A.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	University of Colorado System; University of Colorado Boulder; California Institute of Technology	Flowers, RM (corresponding author), Univ Colorado, Dept Geol Sci, 2200 Colorado Ave,UCB 399, Boulder, CO 80309 USA.	rebecca.flowers@colorado.edu	Farley, Kenneth/AAE-7735-2020	Farley, Kenneth/0000-0002-7846-7546	NSF [EAR-1019896]; Directorate For Geosciences [1019896] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by NSF grant EAR-1019896 to K.A.F. The data reported in this paper are tabulated in the supplementary materials. We thank B. Wernicke for discussion.	[Anonymous], [No title captured]; BLACKWELDER E, 1934, GEOLOGICAL SOC AM B, V45, P551; DUMITRU TA, 1994, GEOLOGY, V22, P499, DOI 10.1130/0091-7613(1994)022<0499:MCBUAE>2.3.CO;2; ELSTON DP, 1991, J GEOPHYS RES-SOLID, V96, P12389, DOI 10.1029/90JB01978; Farley KA, 2011, GEOCHIM COSMOCHIM AC, V75, P4515, DOI 10.1016/j.gca.2011.05.020; Farley KA, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003243; Flowers RM, 2008, GEOL SOC AM BULL, V120, P571, DOI 10.1130/B26231.1; Flowers RM, 2007, GEOLOGY, V35, P447, DOI 10.1130/G23471A.1; Flowers RM, 2009, GEOCHIM COSMOCHIM AC, V73, P2347, DOI 10.1016/j.gca.2009.01.015; House MA, 1998, NATURE, V396, P66, DOI 10.1038/23926; Karlstrom KE, 2008, GEOLOGY, V36, P835, DOI 10.1130/G25032A.1; Karlstrom KE, 2007, GEOL SOC AM BULL, V119, P1283, DOI 10.1130/0016-7606(2007)119[1283:AAFSOQ]2.0.CO;2; Kelley S. A, 2001, COLORADO RIVER ORIGI, P37; LONGWELL CR, 1946, AM J SCI, V244, P817, DOI 10.2475/ajs.244.12.817; LUCCHITTA I, 1972, GEOL SOC AM BULL, V83, P1933, DOI 10.1130/0016-7606(1972)83[1933:EHOTCR]2.0.CO;2; Lucchitta I, 2000, QUATERNARY RES, V53, P23, DOI 10.1006/qres.1999.2098; Lucchitta I., 2011, GSA TODAY, V21, P4, DOI [10.1130/G119A.1, DOI 10.1130/G119A.1]; Pederson J, 2002, GEOLOGY, V30, P739, DOI 10.1130/0091-7613(2002)030<0739:DIOTGC>2.0.CO;2; Pederson J. L., 2008, GSA TODAY, V18, DOI [10.1130/GSAT01803A.1, DOI 10.1130/GSAT01803A.1]; Pederson J, 2008, SCIENCE, V321, DOI 10.1126/science.1158019; Polyak V, 2008, SCIENCE, V319, P1377, DOI 10.1126/science.1151248; Potochnik A.R., 2001, COLORADO RIVER ORIGI, P17; Shuster DL, 2006, EARTH PLANET SC LETT, V249, P148, DOI 10.1016/j.epsl.2006.07.028; Shuster DL, 2004, EARTH PLANET SC LETT, V217, P1, DOI 10.1016/S0012-821X(03)00595-8; Spencer J.E., 2001, COLOR RIVER ORIG EVO, P215; Wernicke B, 2011, GEOL SOC AM BULL, V123, P1288, DOI 10.1130/B30274.1; Young R. A., 1989, GEOLOGY GRAND CANYON, P166; YOUNG RA, 1979, TECTONOPHYSICS, V61, P25, DOI 10.1016/0040-1951(79)90290-7; Young RA, 2008, GEOL SOC AM SPEC PAP, V439, P319, DOI 10.1130/2008.2439(14)	29	83	85	3	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1616	1619		10.1126/science.1229390	http://dx.doi.org/10.1126/science.1229390			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23196906				2022-12-28	WOS:000312533100052
J	Ashdown, HF; D'Souza, N; Karim, D; Stevens, RJ; Huang, A; Harnden, A				Ashdown, Helen F.; D'Souza, Nigel; Karim, Diallah; Stevens, Richard J.; Huang, Andrew; Harnden, Anthony			CHRISTMAS 2012: RESEARCH Pain over speed bumps in diagnosis of acute appendicitis: diagnostic accuracy study	BRITISH MEDICAL JOURNAL			English	Editorial Material							METAANALYSIS	Objective To assess the diagnostic accuracy of pain on travelling over speed bumps for the diagnosis of acute appendicitis. Design Prospective questionnaire based diagnostic accuracy study. Setting Secondary care surgical assessment unit at a district general hospital in the UK. Participants 101 patients aged 17-76 years referred to the on-call surgical team for assessment of possible appendicitis. Main outcome measures Sensitivity, specificity, positive and negative predictive values, and positive and negative likelihood ratios for pain over speed bumps in diagnosing appendicitis, with histological diagnosis of appendicitis as the reference standard. Results The analysis included 64 participants who had travelled over speed bumps on their journey to hospital. Of these, 34 had a confirmed histological diagnosis of appendicitis, 33 of whom reported increased pain over speed bumps. The sensitivity was 97% (95% confidence interval 85% to 100%), and the specificity was 30% (15% to 49%). The positive predictive value was 61% (47% to 74%), and the negative predictive value was 90% (56% to 100%). The likelihood ratios were 1.4 (1.1 to 1.8) for a positive test result and 0.1 (0.0 to 0.7) for a negative result. Speed bumps had a better sensitivity and negative likelihood ratio than did other clinical features assessed, including migration of pain and rebound tenderness. Conclusions Presence of pain while travelling over speed bumps was associated with an increased likelihood of acute appendicitis. As a diagnostic variable, it compared favourably with other features commonly used in clinical assessment. Asking about speed bumps may contribute to clinical assessment and could be useful in telephone assessment of patients.	[Ashdown, Helen F.; Stevens, Richard J.; Harnden, Anthony] Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [D'Souza, Nigel; Karim, Diallah; Huang, Andrew] Stoke Mandeville Hosp, Dept Surg, Aylesbury HP21 8AL, Bucks, England	University of Oxford	Ashdown, HF (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.	helen.ashdown@phc.ox.ac.uk	D'Souza, Nigel/AAW-8195-2021	Ashdown, Helen/0000-0002-7758-7095; Stevens, Richard/0000-0002-9258-4060	National Institute for Health Research; University of Oxford; National Institute for Health Research [ACF-2010-13-007] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); University of Oxford; National Institute for Health Research(National Institute for Health Research (NIHR))	No formal funding. HFA is an academic clinical fellow, which is a scheme partially funded by the National Institute for Health Research. The University of Oxford acted as study sponsor and had no role in the study design, data collection, analysis or interpretation, writing of the paper, or decision to submit for publication. All authors were independent from funders and sponsors.	Andersson REB, 2004, BRIT J SURG, V91, P28, DOI 10.1002/bjs.4464; Bickell NA, 2006, J AM COLL SURGEONS, V202, P401, DOI 10.1016/j.jamcollsurg.2005.11.016; Bunn F., 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003110, DOI 10.1002/14651858.CD003110]; Department for Transport, 2007, 0107 DEP TRANSP; Golledge J, 1996, ANN ROY COLL SURG, V78, P11; Humes DJ, 2006, BMJ-BRIT MED J, V333, P530, DOI 10.1136/bmj.38940.664363.AE; Lewis SRR, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5976; Towner E, 2001, WHAT WORKS PREVENTIN; Varadhan KK, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2156; WALKER SJ, 1995, ANN ROY COLL SURG, V77, P358	10	16	16	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2012	345								e8012	10.1136/bmj.e8012	http://dx.doi.org/10.1136/bmj.e8012			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	059IU	23247977	Green Published, hybrid			2022-12-28	WOS:000312698700002
J	Galera, C; Orriols, L; M'Bailara, K; Laborey, M; Contrand, B; Ribereau-Gayon, R; Masson, F; Bakiri, S; Gabaude, C; Fort, A; Maury, B; Lemercier, C; Cours, M; Bouvard, MP; Lagarde, E				Galera, Cedric; Orriols, Ludivine; M'Bailara, Katia; Laborey, Magali; Contrand, Benjamin; Ribereau-Gayon, Regis; Masson, Francoise; Bakiri, Sarah; Gabaude, Catherine; Fort, Alexandra; Maury, Bertrand; Lemercier, Celine; Cours, Maurice; Bouvard, Manuel-Pierre; Lagarde, Emmanuel			Mind wandering and driving: responsibility case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DISTRACTION; NETWORK; DRUGS	Objective To assess the association between mind wandering (thinking unrelated to the task at hand) and the risk of being responsible for a motor vehicle crash. Design Responsibility case-control study. Setting Adult emergency department of a university hospital in France, April 2010 to August 2011. Participants 955 drivers injured in a motor vehicle crash. Main outcome measures Responsibility for the crash, mind wandering, external distraction, negative affect, alcohol use, psychotropic drug use, and sleep deprivation. Potential confounders were sociodemographic and crash characteristics. Results Intense mind wandering (highly disrupting/distracting content) was associated with responsibility for a traffic crash (17% (78 of 453 crashes in which the driver was thought to be responsible) v 9% (43 of 502 crashes in which the driver was not thought to be responsible); adjusted odds ratio 2.12, 95% confidence interval 1.37 to 3.28). Conclusions Mind wandering while driving, by decoupling attention from visual and auditory perceptions, can jeopardise the ability of the driver to incorporate information from the environment, thereby threatening safety on the roads.	[Galera, Cedric; Orriols, Ludivine; Laborey, Magali; Contrand, Benjamin; Ribereau-Gayon, Regis; Masson, Francoise; Bakiri, Sarah; Lagarde, Emmanuel] Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, F-33000 Bordeaux, France; [Galera, Cedric; Orriols, Ludivine; Laborey, Magali; Contrand, Benjamin; Ribereau-Gayon, Regis; Masson, Francoise; Bakiri, Sarah; Lagarde, Emmanuel] INSERM, Ctr INSERM Epidemiol Biostat U897, ISPED, Equipe Prevent & Prise Charge Traumatismes, F-33000 Bordeaux, France; [Galera, Cedric; Bouvard, Manuel-Pierre] Univ Bordeaux, Charles Perrens Hosp, Dept Child & Adolescent Psychiat, F-33000 Bordeaux, France; [M'Bailara, Katia] Univ Bordeaux, Charles Perrens Hosp, Dept Psychol, Lab EA4139, F-33000 Bordeaux, France; [Gabaude, Catherine; Fort, Alexandra] Inst Natl Rech Transports & Leur Securite, LESCOT, Bron, France; [Maury, Bertrand] Univ Paris 11, Lab Math Orsay, F-91405 Orsay, France; [Lemercier, Celine] Univ Toulouse 2, CNRS, CLLE LTC, Toulouse, France; [Cours, Maurice] Continental Automot SAS France, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Universite Gustave-Eiffel; Institut National de Recherche sur les Transports et leur Securite (INRETS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite de Toulouse - Jean Jaures	Galera, C (corresponding author), Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, 146 Rue Leo Saignat, F-33000 Bordeaux, France.	cedric.galera@u-bordeaux2.fr	Régis, RIBEREAU-GAYON/U-5423-2019; contrand, benjamin/T-1994-2019; Galera, Cedric/T-4896-2019; Gabaude, Catherine/ABB-2494-2021; Lagarde, Emmanuel/F-7132-2013	Gabaude, Catherine/0000-0002-8175-2233; Maury, Bertrand/0000-0001-5474-4134; Lemercier, Celine/0000-0002-2832-8724; GALERA, CEDRIC/0000-0003-0549-9608; M'bailara, Katia/0000-0003-0211-3298; Lagarde, Emmanuel/0000-0001-8031-7400	ANR (French National Research Agency) [ANR-09-VTT-04]	ANR (French National Research Agency)(French National Research Agency (ANR))	The research was supported by an ANR (French National Research Agency) grant (ANR-09-VTT-04).	Brewer JA, 2011, P NATL ACAD SCI USA, V108, P20254, DOI 10.1073/pnas.1112029108; Christoff K, 2012, BRAIN RES, V1428, P51, DOI 10.1016/j.brainres.2011.09.060; Dingus TA, 2006, DOTHS810593 VIRG TEC; Farmer CM, 2010, TRAFFIC INJ PREV, V11, P466, DOI 10.1080/15389588.2010.494191; He JB, 2011, HUM FACTORS, V53, P13, DOI 10.1177/0018720810391530; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Lang PJ, 1995, INT AFFECTIVE PICTUR; Laumon B, 2005, BRIT MED J, V331, P1371, DOI 10.1136/bmj.38648.617986.1F; Lee JD, 2009, SCIENCE, V324, P344, DOI 10.1126/science.1168085; Liang YL, 2007, IEEE T INTELL TRANSP, V8, P340, DOI 10.1109/TITS.2007.895298; Lowenstein SR, 2001, J TRAUMA, V50, P313, DOI 10.1097/00005373-200102000-00019; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Orriols L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000366; Regan MA, 2011, ACCIDENT ANAL PREV, V43, P1771, DOI 10.1016/j.aap.2011.04.008; ROBERTSON MD, 1994, ACCIDENT ANAL PREV, V26, P243, DOI 10.1016/0001-4575(94)90094-9; Schooler JW, 2011, TRENDS COGN SCI, V15, P319, DOI 10.1016/j.tics.2011.05.006; Smallwood J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018298; Smilek D, 2010, PSYCHOL SCI, V21, P786, DOI 10.1177/0956797610368063; Uzzaman S, 2011, CONSCIOUS COGN, V20, P1882, DOI 10.1016/j.concog.2011.09.010; World Health Organization (WHO), GLOB STAT REP ROAD S	20	96	96	2	43	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2012	345								e8105	10.1136/bmj.e8105	http://dx.doi.org/10.1136/bmj.e8105			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056MZ	23241270	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000312495700004
J	Taubes, G				Taubes, Gary			Treat obesity as physiology, not physics	NATURE			English	Editorial Material									Nutr Sci Initiat, San Diego, CA USA		Taubes, G (corresponding author), Nutr Sci Initiat, San Diego, CA USA.	taubes@gmail.com							0	18	19	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2012	492	7428					155	155		10.1038/492155a	http://dx.doi.org/10.1038/492155a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053GM	23235840	Bronze			2022-12-28	WOS:000312259300004
J	Prakash, GKS; Jog, PV; Batamack, PTD; Olah, GA				Prakash, G. K. Surya; Jog, Parag V.; Batamack, Patrice T. D.; Olah, George A.			Taming of Fluoroform: Direct Nucleophilic Trifluoromethylation of Si, B, S, and C Centers	SCIENCE			English	Article							CARBONYL-COMPOUNDS; ELECTROGENERATED BASE; EFFICIENT PRECURSOR; ALDEHYDES; REAGENTS; TRIFLUOROMETHYLTRIMETHYLSILANE; COMPLEXES; SULFIDES	Fluoroform (CF3H), a large-volume by-product of the manufacture of Teflon, refrigerants, polyvinylidene fluoride (PVDF), fire-extinguishing agents, and foams, is a potent and stable greenhouse gas that has found little practical use despite the growing importance of trifluoromethyl (CF3) functionality in more structurally elaborate pharmaceuticals, agrochemicals, and materials. Direct nucleophilic trifluoromethylation using CF3H has been a challenge. Here, we report on a direct trifluoromethylation protocol using close to stoichiometric amounts of CF3H in common organic solvents such as tetrahydrofuran (THF), diethyl ether, and toluene. The methodology is widely applicable to a variety of silicon, boron, and sulfur-based electrophiles, as well as carbon-based electrophiles.	[Prakash, G. K. Surya; Jog, Parag V.; Batamack, Patrice T. D.; Olah, George A.] Univ So Calif, Dept Chem, Loker Hydrocarbon Res Inst, Los Angeles, CA 90089 USA	University of Southern California	Prakash, GKS (corresponding author), Univ So Calif, Dept Chem, Loker Hydrocarbon Res Inst, Los Angeles, CA 90089 USA.	gprakash@usc.edu	P, G/HGB-5661-2022; Prakash, Surya/AAF-1756-2022; Prakash, Surya/AFC-8224-2022; Jog, Parag/AAJ-3401-2021		Loker Hydrocarbon Research Institute	Loker Hydrocarbon Research Institute	Support of our work by the Loker Hydrocarbon Research Institute is gratefully acknowledged.	Ball ND, 2010, J AM CHEM SOC, V132, P2878, DOI 10.1021/ja100955x; Banks R. E., 1982, PREPARATION PROPERTI; Barhdadi R, 1998, CHEM COMMUN, P1251, DOI 10.1039/a801406j; Billard T, 2001, EUR J ORG CHEM, V2001, P1467; Cho EJ, 2010, SCIENCE, V328, P1679, DOI 10.1126/science.1190524; Dubinina GG, 2008, J AM CHEM SOC, V130, P8600, DOI 10.1021/ja802946s; Folleas B, 1998, TETRAHEDRON LETT, V39, P2973, DOI 10.1016/S0040-4039(98)00391-8; Folleas B, 2000, TETRAHEDRON, V56, P275, DOI 10.1016/S0040-4020(99)00951-5; Forat G., 1996, Eur. Patent, Patent No. [735023, 735023A1]; GROBE J, 1995, SYNLETT, P641; Hagiwara T, 1997, NIPPON KAGAKU KAISHI, P869, DOI 10.1246/nikkashi.1997.869; Han WF, 2012, J FLUORINE CHEM, V140, P7, DOI 10.1016/j.jfluchem.2012.04.012; Hartwig J. F., 2012, [No title captured], Patent No. [US2012/0226041A1, 20120226041]; Khan BA, 2012, CHEM-EUR J, V18, P1577, DOI 10.1002/chem.201102652; Knauber T, 2011, CHEM-EUR J, V17, P2689, DOI 10.1002/chem.201002749; Kolomeitsev AA, 2003, TETRAHEDRON LETT, V44, P8273, DOI 10.1016/j.tetlet.2003.09.072; Langlois B.R., 2005, ACS SYM SER, V911, P57; Langlois BR, 2003, SYNTHESIS-STUTTGART, P185, DOI 10.1055/s-2003-36812; Large S, 2000, J ORG CHEM, V65, P8848, DOI 10.1021/jo000150s; Levin VV, 2011, TETRAHEDRON LETT, V52, P281, DOI 10.1016/j.tetlet.2010.11.025; Molander GA, 2003, ORGANOMETALLICS, V22, P3313, DOI 10.1021/om0302645; Morimoto H, 2011, ANGEW CHEM INT EDIT, V50, P3793, DOI 10.1002/anie.201100633; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Mukhopadhyay S, 2004, ORG PROCESS RES DEV, V8, P660, DOI 10.1021/op040007r; Novak P, 2012, J AM CHEM SOC, V134, P16167, DOI 10.1021/ja307783w; Novak P, 2012, ANGEW CHEM INT EDIT, V51, P7767, DOI 10.1002/anie.201201613; Olah G.A., 2009, SUPERACID CHEM, V2; PAWELKE G, 1989, J FLUORINE CHEM, V42, P429, DOI 10.1016/S0022-1139(00)83934-2; Popov I, 2011, J AM CHEM SOC, V133, P9286, DOI 10.1021/ja2041942; Prakash G. K. S., 2012, PCT Patent Appln., Patent No. [WO 2012/148772 A1, 2012148772, WO 2012/148772]; Prakash G. K. S., 2004, U.S. Patent, Patent No. [6,803,477, 6803477]; Prakash GKS, 1996, SYNLETT, P151; Prakash GKS, 2003, J ORG CHEM, V68, P4457, DOI 10.1021/jo030110z; Prakash GKS, 2001, J FLUORINE CHEM, V112, P123, DOI 10.1016/S0022-1139(01)00477-8; PRAKASH GKS, 1989, J AM CHEM SOC, V111, P393, DOI 10.1021/ja00183a073; Prakash GKS, 1997, CHEM REV, V97, P757, DOI 10.1021/cr9408991; RAMAIAH P, 1995, ORG SYNTH, V72, P232; Rijs NJ, 2012, DALTON T, V41, P3395, DOI 10.1039/c2dt12117d; RUPPERT I, 1984, TETRAHEDRON LETT, V25, P2195, DOI 10.1016/S0040-4039(01)80208-2; SHONO T, 1991, J ORG CHEM, V56, P2, DOI 10.1021/jo00001a002; Stahly G. P., 1989, U.S. Patents, Patent No. [4804774, 4804774A]; STAHLY GP, 1989, J ORG CHEM, V54, P2873, DOI 10.1021/jo00273a020; Wang F, 2011, ANGEW CHEM INT EDIT, V50, P7153, DOI 10.1002/anie.201101691; Ye YD, 2012, J AM CHEM SOC, V134, P9034, DOI 10.1021/ja301553c; Ye YD, 2011, ORG LETT, V13, P5464, DOI 10.1021/ol202174a; Zanardi A, 2011, J AM CHEM SOC, V133, P20901, DOI 10.1021/ja2081026	46	218	221	2	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1324	1327		10.1126/science.1227859	http://dx.doi.org/10.1126/science.1227859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224551				2022-12-28	WOS:000311991200061
J	Wang, WJ; Nossoni, Z; Berbasova, T; Watson, CT; Yapici, I; Lee, KSS; Vasileiou, C; Geiger, JH; Borhan, B				Wang, Wenjing; Nossoni, Zahra; Berbasova, Tetyana; Watson, Camille T.; Yapici, Ipek; Lee, Kin Sing Stephen; Vasileiou, Chrysoula; Geiger, James H.; Borhan, Babak			Tuning the Electronic Absorption of Protein-Embedded All-trans-Retinal	SCIENCE			English	Article							SCHIFF-BASE COUNTERION; BINDING PROTEINS; VISUAL PIGMENTS; RHODOPSIN; COLOR	Protein-chromophore interactions are a central component of a wide variety of critical biological processes such as color vision and photosynthesis. To understand the fundamental elements that contribute to spectral tuning of a chromophore inside the protein cavity, we redesigned human cellular retinol binding protein II (hCRBPII) to fully encapsulate all-trans-retinal and form a covalent bond as a protonated Schiff base. This system, using rational mutagenesis designed to alter the electrostatic environment within the binding pocket of the host protein, enabled regulation of the absorption maximum of the pigment in the range of 425 to 644 nanometers. With only nine point mutations, the hCRBPII mutants induced a systematic shift in the absorption profile of all-trans-retinal of more than 200 nanometers across the visible spectrum.	[Wang, Wenjing; Nossoni, Zahra; Berbasova, Tetyana; Watson, Camille T.; Yapici, Ipek; Lee, Kin Sing Stephen; Vasileiou, Chrysoula; Geiger, James H.; Borhan, Babak] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	Michigan State University	Geiger, JH (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.	geiger@chemistry.msu.edu; babak@chemistry.msu.edu	Lee, Kin Sing Stephen/I-9476-2012; Wang, Wenjing/G-7318-2017	Lee, Kin Sing Stephen/0000-0003-4541-3063; Wang, Wenjing/0000-0001-6025-9848; Geiger, James/0000-0002-9443-4488	NIH [R01-GM54082]; U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division [DE-FG02-06ER15822]; DOE Office of Energy Research [W-31-109-ENG-38]; DOE, Office of Science, Basic Energy Sciences [W-31-109-ENG-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067311, R01GM054082] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division; DOE Office of Energy Research; DOE, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grant R01-GM54082. We thank the U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division (grant DE-FG02-06ER15822 to J.H.G.) and the beamline staff at LS-CAT 21-ID (supported by the DOE Office of Energy Research under contract W-31-109-ENG-38). The Advanced Photon Source is supported by the DOE, Office of Science, Basic Energy Sciences, under contract W-31-109-ENG-38. PDB accession codes for the crystal structures used in this study: 4EXZ (Q108K:K40L); 4EEJ (Q108K:K40L:T51V:T53C:Y19W:R58W:T29L:Q4R); 4GKC (Q108K:K40L:T51V:T53C:Y19W:R58W:T29L:Q4A); 4EFG (Q108K:K40L:T51V:T53C:Y19W:R58W:T29L); 4EDE (Q108K:K40L:T51V:T53C:Y19W:R58W:T29L:A33W). Michigan State University has applied for a patent titled "Colorimetric and Fluorescent Proteins" (U.S. patent pending, serial no. 13/636,499) related to the design methods and materials presented in this work.	BURGI HB, 1983, ACCOUNTS CHEM RES, V16, P153, DOI 10.1021/ar00089a002; Coto PB, 2006, P NATL ACAD SCI USA, V103, P17154, DOI 10.1073/pnas.0604048103; Dwyer JJ, 2000, BIOPHYS J, V79, P1610, DOI 10.1016/S0006-3495(00)76411-3; Gunasekaran K, 2004, PROTEINS, V54, P179, DOI 10.1002/prot.10520; HONIG B, 1976, BIOCHEMISTRY-US, V15, P4593, DOI 10.1021/bi00666a008; Kochendoerfer GG, 1999, TRENDS BIOCHEM SCI, V24, P300, DOI 10.1016/S0968-0004(99)01432-2; Lee KSS, 2012, CHEMPLUSCHEM, V77, P273, DOI 10.1002/cplu.201100082; Li E, 1996, ANNU REV NUTR, V16, P205, DOI 10.1146/annurev.nu.16.070196.001225; Lin SW, 1998, J BIOL CHEM, V273, P24583, DOI 10.1074/jbc.273.38.24583; Nielsen MB, 2009, CHEM SOC REV, V38, P913, DOI 10.1039/b802068j; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Palczewski K, 2012, J BIOL CHEM, V287, P1612, DOI 10.1074/jbc.R111.301150; Rajamani R, 2011, J COMPUT CHEM, V32, P854, DOI 10.1002/jcc.21663; Rajput J, 2010, ANGEW CHEM INT EDIT, V49, P1790, DOI 10.1002/anie.200905061; SAKMAR TP, 1991, P NATL ACAD SCI USA, V88, P3079, DOI 10.1073/pnas.88.8.3079; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Vasileiou C, 2007, J AM CHEM SOC, V129, P6140, DOI 10.1021/ja067546r	18	88	88	1	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1340	1343		10.1126/science.1226135	http://dx.doi.org/10.1126/science.1226135			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224553	Green Accepted			2022-12-28	WOS:000311991200066
J	Nicholson, JM; Ioannidis, JPA				Nicholson, Joshua M.; Ioannidis, John P. A.			Conform and be funded	NATURE			English	Editorial Material									[Nicholson, Joshua M.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA; [Ioannidis, John P. A.] Stanford Prevent Res Ctr, Stanford, CA USA	Virginia Polytechnic Institute & State University; Stanford University	Nicholson, JM (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011; Nicholson, Josh/AAO-6486-2021; Nicholson, Joshua/AAD-8068-2021	Nicholson, Joshua/0000-0002-1111-1828				Couzin ID, 2011, SCIENCE, V334, P1578, DOI 10.1126/science.1210280; Garfield E, 1979, CITATION INDEXING IT; HORROBIN D, 1982, NEW SCI, V94, P842; Horrobin DF, 1996, LANCET, V348, P1293, DOI 10.1016/S0140-6736(96)08029-4; Ioannidis JPA, 2011, NATURE, V477, P529, DOI 10.1038/477529a; Kelly CD, 2006, TRENDS ECOL EVOL, V21, P167, DOI 10.1016/j.tree.2006.01.005; Nicholson JM, 2012, BIOESSAYS, V34, P448, DOI 10.1002/bies.201200001; Tatsioni A, 2010, FASEB J, V24, P1335, DOI 10.1096/fj.09-148239; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201	9	93	95	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					34	36		10.1038/492034a	http://dx.doi.org/10.1038/492034a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048EQ	23222591	Bronze			2022-12-28	WOS:000311893400026
J	Scully, T				Scully, Tony			TO THE LIMIT	NATURE			English	Editorial Material																			0	39	40	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2012	492	7427					S2	S3		10.1038/492S2a	http://dx.doi.org/10.1038/492S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048EQ	23222671	Bronze			2022-12-28	WOS:000311893400002
J	Shmerling, RH				Shmerling, Robert H.			Management of Gout A 57-Year-Old Man With a History of Podagra, Hyperuricemia, and Mild Renal Insufficiency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EVIDENCE BASED RECOMMENDATIONS; RANDOMIZED CONTROLLED-TRIAL; OF-RHEUMATOLOGY GUIDELINES; DOUBLE-BLIND; GENERAL-POPULATION; PARALLEL-GROUP; ACUTE FLARES; SERUM URATE; TASK-FORCE; ALLOPURINOL	Gout is an ancient disease. Despite significant advances in the understanding of its risk factors, etiology, pathogenesis, prevention, and treatment, millions of people with gout experience repeated attacks of acute arthritis and other complications. The incidence of gout is increasing, most likely reflecting increasing rates of obesity and other lifestyle factors, including diet. Comorbid conditions that often accompany gout, including chronic kidney disease and diabetes mellitus, present challenges for the management of gout. Using the case of MrR, a 57-year-old man with a history of podagra, hyperuricemia, and mild renal insufficiency, the diagnosis and treatment of gout are discussed. For those with moderate to severe gout, urate-lowering treatment can eliminate acute attacks of arthritis and prevent complications. In the near future, it is likely that new risk factors for gout will be identified and new ways of preventing and managing this common disease will become available. JAMA. 2012;308(20):2133-2141 www.jama.com	[Shmerling, Robert H.] Beth Israel Deaconess Med Ctr, Div Rheumatol, Boston, MA 02215 USA; [Shmerling, Robert H.] Harvard Univ, Sch Med, Boston, MA USA; [Shmerling, Robert H.] Harvard Hlth Publicat, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Shmerling, RH (corresponding author), Beth Israel Deaconess Med Ctr, Div Rheumatol, 110 Francis St,Ste 4B, Boston, MA 02215 USA.	rshmerli@bidmc.harvard.edu		Shmerling, Robert/0000-0001-7560-1589	UpToDate	UpToDate	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Shmerling reports receiving payments for consulting from Advanced Medical, BCRI, and University of Massachusetts; for expert testimony from Foster and Eldridge, Marshall, Dennehey, Warner, Coleman, and Goggin, Risk Management Foundation, Mednick Associates, and Jarve Kaplan Granato; and for lectures from Harvard Medical School, Harvard Medical Faculty Physicians, and Society of Hospital Medicine. He has received royalties as an author and editor from UpToDate.	AHERN MJ, 1987, AUST NZ J MED, V17, P301, DOI 10.1111/j.1445-5994.1987.tb01232.x; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Becker MA, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2978; BOMALASKI JS, 1984, B RHEUM DIS, V34, P1; Borstad GC, 2004, J RHEUMATOL, V31, P2429; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Caspi D, 2000, ARTHRITIS RHEUM-US, V43, P103, DOI 10.1002/1529-0131(200001)43:1<103::AID-ANR13>3.0.CO;2-C; Cheng TT, 2004, CLIN THER, V26, P399, DOI 10.1016/S0149-2918(04)90035-5; Choi HK, 2004, LANCET, V363, P1277, DOI 10.1016/S0140-6736(04)16000-5; Choi HK, 2005, CURR OPIN RHEUMATOL, V17, P341; Choi HK, 2008, BMJ-BRIT MED J, V336, P309, DOI 10.1136/bmj.39449.819271.BE; Choi HK, 2007, AM J MED, V120, pE5, DOI 10.1016/j.amjmed.2006.09.025; Choi Hyon K., 2010, JAMA (Journal of the American Medical Association), V304, P2270, DOI 10.1001/jama.2010.1638; Choi HK, 2009, ARCH INTERN MED, V169, P502, DOI 10.1001/archinternmed.2008.606; Choi Hyon K, 2005, Curr Rheumatol Rep, V7, P220, DOI 10.1007/s11926-996-0043-1; Dalbeth N, 2006, J RHEUMATOL, V33, P1646; Glazebrook KN, 2011, RADIOLOGY, V261, P516, DOI 10.1148/radiol.11102485; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Hamada T, 2008, AM J HYPERTENS, V21, P1157, DOI 10.1038/ajh.2008.245; Hamburger Max, 2011, Postgrad Med, V123, P3, DOI 10.3810/pgm.2011.11.2511; HANDE KR, 1984, AM J MED, V76, P47, DOI 10.1016/0002-9343(84)90743-5; Hollis-Moffatt JE, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3816; HULTMAN E, 1975, SCAND J CLIN LAB INV, V35, P245, DOI 10.3109/00365517509095736; Janssens HJEM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005521.pub2; Janssens HJEM, 2008, LANCET, V371, P1854, DOI 10.1016/S0140-6736(08)60799-0; Janssens HJEM, 2010, ARCH INTERN MED, V170, P1120, DOI 10.1001/archinternmed.2010.196; Janssens HJEM, 2010, ANN RHEUM DIS, V69, P1255, DOI 10.1136/ard.2009.123687; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Khanna D, 2012, ARTHRIT CARE RES, V64, P1447, DOI 10.1002/acr.21773; Krishnan E, 2012, AM J MED, V125, P499, DOI 10.1016/j.amjmed.2011.11.010; Man CY, 2007, ANN EMERG MED, V49, P670, DOI 10.1016/j.annemergmed.2006.11.014; Mikuls TR, 2005, RHEUMATOLOGY, V44, P1038, DOI 10.1093/rheumatology/keh679; Momeni A, 2010, IRAN J KIDNEY DIS, V4, P128; NOORDZIJ TC, 1991, TRANSPLANTATION, V52, P64, DOI 10.1097/00007890-199107000-00013; Nuki G, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1906; Perez-Ruiz F, 2009, RHEUMATOLOGY, V48, P9, DOI 10.1093/rheumatology/kep087; Pope RM, 2007, ARTHRITIS RHEUM-US, V56, P3183, DOI 10.1002/art.22938; Reinders MK, 2009, ANN RHEUM DIS, V68, P51, DOI 10.1136/ard.2007.083071; Reinders MK, 2007, CLIN RHEUMATOL, V26, P1459, DOI 10.1007/s10067-006-0528-3; Rettenbacher T, 2008, EUR RADIOL, V18, P621, DOI 10.1007/s00330-007-0802-z; Rubin BR, 2004, ARTHRITIS RHEUM-US, V50, P598, DOI 10.1002/art.20007; Sarawate CA, 2006, MAYO CLIN PROC, V81, P925, DOI 10.4065/81.7.925; Schlesinger N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3297; Schlesinger N, 2011, ANN RHEUM DIS, V70, P1264, DOI 10.1136/ard.2010.144063; Schlesinger N, 2009, J RHEUMATOL, V36, P1287, DOI 10.3899/jrheum.080938; Schumacher HR, 2008, ARTHRIT RHEUM-ARTHR, V59, P1540, DOI 10.1002/art.24209; Schumacher HR, 2012, ARTHRITIS RHEUM-US, V64, P876, DOI 10.1002/art.33412; Schumacher HR, 2002, BMJ-BRIT MED J, V324, P1488, DOI 10.1136/bmj.324.7352.1488; Shannon JA, 2012, ANN PHARMACOTHER, V46, P368, DOI 10.1345/aph.1Q593; SHRESTHA M, 1995, ANN EMERG MED, V26, P682, DOI 10.1016/S0196-0644(95)70037-4; Somkrua R, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-118; SORIANO LC, 2011, ARTHRITIS RES THERAP, V0013; Stamp LK, 2012, ARTHRITIS RHEUM-US, V64, P2529, DOI 10.1002/art.34488; Stamp LK, 2012, CURR RHEUMATOL REP, V14, DOI 10.1007/s11926-012-0235-9; Stamp LK, 2011, ARTHRITIS RHEUM-US, V63, P412, DOI 10.1002/art.30119; Stevenson M, 2011, PHARMACOECONOMICS, V29, P133, DOI 10.2165/11535770-000000000-00000; Sundy JS, 2011, JAMA-J AM MED ASSOC, V306, P711, DOI [10.1001/jama.2011.1169, 10.1001/jama.2011.116]; Takahashi S, 2003, ANN RHEUM DIS, V62, P572, DOI 10.1136/ard.62.6.572; Terkeltaub RA, 2010, ARTHRITIS RHEUM-US, V62, P1060, DOI 10.1002/art.27327; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Yamagishi K, 2010, RHEUMATOLOGY, V49, P1461, DOI 10.1093/rheumatology/keq096; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269; Zhang W, 2006, ANN RHEUM DIS, V65, P1301, DOI 10.1136/ard.2006.055251; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	65	9	11	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2012	308	20					2133	2141		10.1001/jama.2012.65028	http://dx.doi.org/10.1001/jama.2012.65028			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043IV	23188030				2022-12-28	WOS:000311537200028
J	Podolsky, SH				Podolsky, Scott H.			Metchnikoff and the microbiome	LANCET			English	Editorial Material							HEALTH		[Podolsky, Scott H.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02114 USA; [Podolsky, Scott H.] Countway Med Lib, Ctr Hist Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Podolsky, SH (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA 02114 USA.	scott_podolsky@hms.harvard.edu						Gilbert SF, 2012, Q REV BIOL IN PRESS, P87; Metchnikoff E., 1908, PROLONGATION LIFE OP; Podolsky S, 1998, B HIST MED, V72, P1, DOI 10.1353/bhm.1998.0056; Relman DA, 2012, NUTR REV, V70, pS2, DOI 10.1111/j.1753-4887.2012.00489.x; Tauber AI, 1991, METCHNIKOFF ORIGINS; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Whorton JamesC., 2000, INNER HYGIENE CONSTI	7	61	66	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 24	2012	380	9856					1810	1811		10.1016/S0140-6736(12)62018-2	http://dx.doi.org/10.1016/S0140-6736(12)62018-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	041XK	23189332				2022-12-28	WOS:000311435000014
J	Snell, WJ				Snell, William J.			Plant Gametes Do Fertilization with a Twist	SCIENCE			English	Editorial Material							SPERM; EGG; BLOCK; GENE		Univ Texas SW Med Sch, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Snell, WJ (corresponding author), Univ Texas SW Med Sch, Dept Cell Biol, Dallas, TX 75390 USA.	william.snell@utsouthwestern.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056778] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056778] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baibakov B, 2012, J CELL BIOL, V197, P897, DOI 10.1083/jcb.201203062; Beale KM, 2012, CURR BIOL, V22, P1090, DOI 10.1016/j.cub.2012.04.041; Ellerman DA, 2009, MOL REPROD DEV, V76, P1188, DOI 10.1002/mrd.21092; Evans JP, 2012, ANNU REV PHYSIOL, V74, P477, DOI 10.1146/annurev-physiol-020911-153339; Hamamura Y, 2011, CURR BIOL, V21, P497, DOI 10.1016/j.cub.2011.02.013; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Kasahara RD, 2012, CURR BIOL, V22, P1084, DOI 10.1016/j.cub.2012.03.069; Liu Y, 2008, ACTA METEOROL SIN, V22, P22; Mori T, 2006, NAT CELL BIOL, V8, P64, DOI 10.1038/ncb1345; Scott RJ, 2008, MOL PLANT, V1, P611, DOI 10.1093/mp/ssn016; Sprunck S, 2012, SCIENCE, V338, P1093, DOI 10.1126/science.1223944; Sprunck S, 2010, BIOCHEM SOC T, V38, P635, DOI 10.1042/BST0380635; Steele RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007680; von Besser K, 2006, DEVELOPMENT, V133, P4761, DOI 10.1242/dev.02683; Wong JL, 2006, CURR TOP DEV BIOL, V72, P1, DOI 10.1016/S0070-2153(05)72001-9; Wong JL, 2010, TRENDS CELL BIOL, V20, P134, DOI 10.1016/j.tcb.2009.12.007	16	2	2	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1038	1039		10.1126/science.1231259	http://dx.doi.org/10.1126/science.1231259			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23180852				2022-12-28	WOS:000311390600031
J	Vermund, SH				Vermund, Sten H.			Treatment as prevention for HIV in China	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY		[Vermund, Sten H.] Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37203 USA; [Vermund, Sten H.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37203 USA	Vanderbilt University; Vanderbilt University	Vermund, SH (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Inst Global Hlth, Nashville, TN 37203 USA.	sten.vermund@vanderbilt.edu	Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698				Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Granich R, 2011, CURR HIV RES, V9, P446, DOI 10.2174/157016211798038597; Hayes R, 2011, CURR HIV RES, V9, P429, DOI 10.2174/157016211798038515; Jia Z, 2012, LANCET; Kerr T, 2010, AM J PUBLIC HEALTH, V100, P1449, DOI 10.2105/AJPH.2009.178467; Kurth Ann E, 2011, Curr HIV/AIDS Rep, V8, P62, DOI 10.1007/s11904-010-0063-3; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Qian HZ, 2006, AIDS, V20, P1429, DOI 10.1097/01.aids.0000233577.33973.fa; Shelton JD, 2011, SCIENCE, V334, P1645, DOI 10.1126/science.1212353; Smith MK, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001260; Tanser F., 2012, 19 C RETR OPP INF SE; Vernazza PL, 1997, AIDS, V11, P1249, DOI 10.1097/00002030-199710000-00008; World Health Organization, 2012, GUID OR PREEXP PROPH	16	5	5	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2013	382	9899					1159	1161		10.1016/S0140-6736(12)62005-4	http://dx.doi.org/10.1016/S0140-6736(12)62005-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	228SL	23206834				2022-12-28	WOS:000325209100008
J	Chou, R; Cottrell, EB; Wasson, N; Rahman, B; Guise, JM				Chou, Roger; Cottrell, Erika Barth; Wasson, Ngoc; Rahman, Basmah; Guise, Jeanne-Marie			Screening for Hepatitis C Virus Infection in Adults: A Systematic Review for the U. S. Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							PERCUTANEOUS LIVER-BIOPSY; QUALITY-OF-LIFE; UNITED-STATES; HUMAN-IMMUNODEFICIENCY; VIRAL-HEPATITIS; NATIONWIDE SURVEY; NATURAL-HISTORY; PRIMARY-CARE; RISK-FACTORS; US VETERANS	Background: Identification of hepatitis C virus (HCV)-infected persons through screening could lead to interventions that improve clinical outcomes. Purpose: To review evidence about potential benefits and harms of HCV screening in asymptomatic adults without known liver enzyme abnormalities. Data Sources: English-language publications identified from MEDLINE (1947 to May 2012), the Cochrane Library Database, clinical trial registries, and reference lists. Study Selection: Randomized trials and cohort, case-control, and cross-sectional studies that assessed yield or clinical outcomes of screening; studies reporting harms from HCV screening; and large series reporting harms of diagnostic liver biopsies. Data Extraction: Multiple investigators abstracted and checked study details and quality by using predefined criteria. Data Synthesis: No study evaluated clinical outcomes associated with screening compared with no screening or of different risk-or prevalence-based strategies. Three cross-sectional studies in higher prevalence populations found that screening strategies that targeted multiple risk factors were associated with sensitivities greater than 90% and numbers needed to screen to identify 1 case of HCV infection of less than 20. Data on direct harms of screening were sparse. A large study of percutaneous liver biopsies (n = 2740) in HCV-infected patients with compensated cirrhosis reported no deaths and a 1.1% rate of serious adverse events (primarily bleeding and severe pain). Limitations: Modeling studies were not examined. High or unreported proportions of potentially eligible patients in the observational studies were not included in calculations of screening yield because of unknown HCV status. Conclusion: Although screening tests can accurately identify adults with chronic HCV infection, targeted screening strategies based on the presence of risk factors misses some patients with HCV infection. Well-designed prospective studies are needed to better understand the effects of different HCV screening strategies on diagnostic yield and clinical outcomes.	[Chou, Roger; Cottrell, Erika Barth; Wasson, Ngoc; Rahman, Basmah; Guise, Jeanne-Marie] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Oregon Health & Science University	Chou, R (corresponding author), 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA.	chour@ohsu.edu		Guise, Jeanne-Marie/0000-0002-8961-488X; Rahman, Basmah/0000-0002-3576-2086; Chou, Roger/0000-0001-9889-8610	AHRQ Rockville, Maryland [290-2007-10057-I]	AHRQ Rockville, Maryland	By AHRQ (contract 290-2007-10057-I, task order 8), Rockville, Maryland.	Agency for Healthcare Research and Quality, 2012, AHRQ PUBL; Alter Harvey, 1999, American Journal of Medicine, V107, p16S; Anderson EM, 2009, SCOT MED J, V54, P3; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Atwell TD, 2010, AM J ROENTGENOL, V194, P784, DOI 10.2214/AJR.08.2122; Austin GE, 2000, AM J MED SCI, V319, P353, DOI 10.1097/00000441-200006000-00002; Bellentani S, 1999, GUT, V44, P874, DOI 10.1136/gut.44.6.874; Berg AO, 2004, ANN INTERN MED, V140, P462, DOI 10.7326/0003-4819-140-6-200403160-00013; Busch MP, 2001, TRANSFUS CLIN BIOL, V8, P200, DOI 10.1016/S1246-7820(01)00125-2; Cadranel JF, 2000, HEPATOLOGY, V32, P477, DOI 10.1053/jhep.2000.16602; Cheung RC, 2000, AM J GASTROENTEROL, V95, P740, DOI 10.1111/j.1572-0241.2000.01854.x; Chou R, 2004, ANN INTERN MED, V140, P465, DOI 10.7326/0003-4819-140-6-200403160-00014; Chou R, 2012, SCREENING HEPATITIS; Chou R, 2013, ANN INTERN MED, V158, P114, DOI 10.7326/0003-4819-158-2-201301150-00576; Conrad S, 2006, CHRONIC ILLN, V2, P121, DOI 10.1179/174592006X110996; Cottrell EB, 2013, ANN INTERN MED, V158, P109, DOI 10.7326/0003-4819-158-2-201301150-00575; Dienstag JL, 2006, GASTROENTEROLOGY, V130, P225, DOI 10.1053/j.gastro.2005.11.011; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; Fabris P, 2006, ALIMENT PHARM THER, V23, P1161, DOI 10.1111/j.1365-2036.2006.02882.x; Farrell RJ, 1999, J HEPATOL, V30, P580, DOI 10.1016/S0168-8278(99)80187-1; Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831; FROEHLICH F, 1993, DIGEST DIS SCI, V38, P1480, DOI 10.1007/BF01308607; Furusyo N, 2000, DIGEST DIS SCI, V45, P2221, DOI 10.1023/A:1026696721059; GARCIATSAO G, 1993, ANN INTERN MED, V118, P150, DOI 10.7326/0003-4819-118-2-199301150-00013; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; GILMORE IT, 1995, GUT, V36, P437, DOI 10.1136/gut.36.3.437; Gunn RA, 2003, SEX TRANSM DIS, V30, P340, DOI 10.1097/00007435-200304000-00013; Hagan H, 2006, PUBLIC HEALTH REP, V121, P710, DOI 10.1177/003335490612100611; Halsey NA, 1998, PEDIATRICS, V101, P481, DOI 10.1542/peds.101.3.481; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Huang JF, 2007, GUT, V56, P736, DOI 10.1136/gut.2006.115410; JANES CH, 1993, ANN INTERN MED, V118, P96, DOI 10.7326/0003-4819-118-2-199301150-00003; Kaur S, 1996, HEPATOLOGY, V24, P979; Kim WR, 2002, HEPATOLOGY, V36, pS30, DOI 10.1053/jhep.2002.36791; Kliem V, 1996, TRANSPLANTATION, V62, P1417, DOI 10.1097/00007890-199611270-00007; Lapane KL, 1998, AM J GASTROENTEROL, V93, P591, DOI 10.1111/j.1572-0241.1998.170_b.x; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; MCGILL DB, 1990, GASTROENTEROLOGY, V99, P1396, DOI 10.1016/0016-5085(90)91167-5; McGinn T, 2008, ARCH INTERN MED, V168, P2009, DOI 10.1001/archinte.168.18.2009; Myers RP, 2008, LIVER INT, V28, P705, DOI 10.1111/j.1478-3231.2008.01691.x; National Center for HIV/AIDS, 2012, DIS BURD VIR HEP A B; Nguyen MT, 2005, ARCH INTERN MED, V165, P2013, DOI 10.1001/archinte.165.17.2013; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Rodger AJ, 1999, HEPATOLOGY, V30, P1299, DOI 10.1002/hep.510300504; Rostaing L, 1996, TRANSPLANT P, V28, P2836; Saadeh S, 2001, HEPATOLOGY, V33, P196, DOI 10.1053/jhep.2001.20534; SanchezQuijano A, 1995, EUR J CLIN MICROBIOL, V14, P949, DOI 10.1007/BF01691375; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; Seeff LB, 2010, CLIN GASTROENTEROL H, V8, P877, DOI 10.1016/j.cgh.2010.03.025; Smith BD, 2012, ANN INTERN MED, V157, P817, DOI 10.7326/0003-4819-157-9-201211060-00529; Soto B, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80001-3; Stewart BJ, 2012, INT J NURS STUD, V49, P560, DOI 10.1016/j.ijnurstu.2011.11.004; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Trepka MJ, 2007, J PUBLIC HEALTH MAN, V13, P263; van der Poorten D, 2006, INTERN MED J, V36, P692, DOI 10.1111/j.1445-5994.2006.01216.x; VAUTIER G, 1994, BRIT MED J, V309, P1455, DOI 10.1136/bmj.309.6967.1455; West J, 2010, GASTROENTEROLOGY, V139, P1230, DOI 10.1053/j.gastro.2010.06.015; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wiese M, 2005, J HEPATOL, V43, P590, DOI 10.1016/j.jhep.2005.04.007; Yawn BP, 2002, AM J MANAG CARE, V8, P253; Zickmund S, 2003, J GEN INTERN MED, V18, P835, DOI 10.1046/j.1525-1497.2003.20826.x; Zuniga IA, 2006, EPIDEMIOL INFECT, V134, P249, DOI 10.1017/S095026880500498X; Zuure F, 2010, EUROSURVEILLANCE, V15, P5	65	60	60	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2013	158	2					101	+		10.7326/0003-4819-158-2-201301150-00574	http://dx.doi.org/10.7326/0003-4819-158-2-201301150-00574			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	077LO	23183613				2022-12-28	WOS:000314029400016
J	Redecke, L; Nass, K; DePonte, DP; White, TA; Rehders, D; Barty, A; Stellato, F; Liang, MN; Barends, TRM; Boutet, S; Williams, GJ; Messerschmidt, M; Seibert, MM; Aquila, A; Arnlund, D; Bajt, S; Barth, T; Bogan, MJ; Caleman, C; Chao, TC; Doak, RB; Fleckenstein, H; Frank, M; Fromme, R; Galli, L; Grotjohann, I; Hunter, MS; Johansson, LC; Kassemeyer, S; Katona, G; Kirian, RA; Koopmann, R; Kupitz, C; Lomb, L; Martin, AV; Mogk, S; Neutze, R; Shoeman, RL; Steinbrener, J; Timneanu, N; Wang, DJ; Weierstall, U; Zatsepin, NA; Spence, JCH; Fromme, P; Schlichting, I; Duszenko, M; Betzel, C; Chapman, HN				Redecke, Lars; Nass, Karol; DePonte, Daniel P.; White, Thomas A.; Rehders, Dirk; Barty, Anton; Stellato, Francesco; Liang, Mengning; Barends, Thomas R. M.; Boutet, Sebastien; Williams, Garth J.; Messerschmidt, Marc; Seibert, M. Marvin; Aquila, Andrew; Arnlund, David; Bajt, Sasa; Barth, Torsten; Bogan, Michael J.; Caleman, Carl; Chao, Tzu-Chiao; Doak, R. Bruce; Fleckenstein, Holger; Frank, Matthias; Fromme, Raimund; Galli, Lorenzo; Grotjohann, Ingo; Hunter, Mark S.; Johansson, Linda C.; Kassemeyer, Stephan; Katona, Gergely; Kirian, Richard A.; Koopmann, Rudolf; Kupitz, Chris; Lomb, Lukas; Martin, Andrew V.; Mogk, Stefan; Neutze, Richard; Shoeman, Robert L.; Steinbrener, Jan; Timneanu, Nicusor; Wang, Dingjie; Weierstall, Uwe; Zatsepin, Nadia A.; Spence, John C. H.; Fromme, Petra; Schlichting, Ilme; Duszenko, Michael; Betzel, Christian; Chapman, Henry N.			Natively Inhibited Trypanosoma brucei Cathepsin B Structure Determined by Using an X-ray Laser	SCIENCE			English	Article							PROTEIN-STRUCTURE DETERMINATION; HUMAN AFRICAN TRYPANOSOMIASIS; CYSTEINE PROTEASES; OCCLUDING LOOP; ACTIVE-SITE; PROPEPTIDE; PAPAIN; NANOCRYSTALLOGRAPHY; CRYSTALLOGRAPHY; DISEASE	The Trypanosoma brucei cysteine protease cathepsin B (TbCatB), which is involved in host protein degradation, is a promising target to develop new treatments against sleeping sickness, a fatal disease caused by this protozoan parasite. The structure of the mature, active form of TbCatB has so far not provided sufficient information for the design of a safe and specific drug against T. brucei. By combining two recent innovations, in vivo crystallization and serial femtosecond crystallography, we obtained the room-temperature 2.1 angstrom resolution structure of the fully glycosylated precursor complex of TbCatB. The structure reveals the mechanism of native TbCatB inhibition and demonstrates that new biomolecular information can be obtained by the "diffraction-before-destruction" approach of x-ray free-electron lasers from hundreds of thousands of individual microcrystals.	[Redecke, Lars; Rehders, Dirk] Univ Hamburg, Inst Biochem & Mol Biol, Joint Lab Struct Biol Infect & Inflammat, D-22607 Hamburg, Germany; [Redecke, Lars; Rehders, Dirk] Deutsch Elekt Synchrotron DESY, Med Univ Lubeck, Inst Biochem, D-22607 Hamburg, Germany; [Redecke, Lars] Med Univ Lubeck, German Ctr Infect Res, D-23538 Lubeck, Germany; [Barends, Thomas R. M.; Kassemeyer, Stephan; Lomb, Lukas; Shoeman, Robert L.; Steinbrener, Jan; Schlichting, Ilme] DESY, Ctr Free Elect Laser Sci CFEL, Max Planck Adv Study Grp, D-22607 Hamburg, Germany; [Nass, Karol; Galli, Lorenzo; Chapman, Henry N.] Univ Hamburg, Dept Phys, D-22761 Hamburg, Germany; [Barends, Thomas R. M.; Kassemeyer, Stephan; Lomb, Lukas; Shoeman, Robert L.; Steinbrener, Jan; Schlichting, Ilme] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Boutet, Sebastien; Williams, Garth J.; Messerschmidt, Marc; Seibert, M. Marvin] Natl Accelerator Lab, Stanford Linear Accelerator Ctr SLAC, Linac Coherent Light Source, Menlo Pk, CA 94025 USA; [Arnlund, David; Johansson, Linda C.; Katona, Gergely; Neutze, Richard] Univ Gothenburg, Dept Chem & Mol Biol, SE-40530 Gothenburg, Sweden; [Barth, Torsten; Koopmann, Rudolf; Mogk, Stefan; Duszenko, Michael] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Bogan, Michael J.] SLAC Natl Accelerator Lab, Photon Ultrafast Laser Sci & Engn PULSE Inst, Menlo Pk, CA 94025 USA; [Chao, Tzu-Chiao; Fromme, Raimund; Grotjohann, Ingo; Hunter, Mark S.; Kupitz, Chris; Fromme, Petra] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Doak, R. Bruce; Kirian, Richard A.; Wang, Dingjie; Weierstall, Uwe; Zatsepin, Nadia A.; Spence, John C. H.] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Frank, Matthias] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Timneanu, Nicusor] Uppsala Univ, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden; [Betzel, Christian] DESY, Univ Hamburg, Inst Biochem & Mol Biol, D-22607 Hamburg, Germany	University of Hamburg; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Lubeck; German Center for Infection Research; University of Lubeck; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; University of Hamburg; Max Planck Society; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Gothenburg; Eberhard Karls University of Tubingen; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Uppsala University; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg	Betzel, C (corresponding author), DESY, Univ Hamburg, Inst Biochem & Mol Biol, Notkestr 85, D-22607 Hamburg, Germany.	christian.betzel@uni-hamburg.de; henry.chapman@desy.de	Fromme, Raimund/C-8885-2012; Neutze, Richard/A-7573-2010; Bajt, Sasa/O-4695-2019; Chao, Tzu-Chiao/A-6400-2013; FRS, Henry N Chapman/G-2153-2010; Zatsepin, Nadia/AAF-2451-2019; Fromme, Raimund/AAG-6578-2019; Messerschmidt, Marc/F-3796-2010; Barty, Anton/K-5137-2014; Johansson, Linda/B-1240-2011; Stellato, Francesco/AAZ-4379-2020; Kirian, Richard/M-3750-2013; Nass, Karol/K-1970-2012; Betzel, Christian/G-8105-2018; Katona, Gergely/B-3491-2008; Bajt, Sasa/G-2228-2010; Timneanu, Nicusor/C-7691-2012; Fromme, Raimund/W-5838-2019; Frank, Matthias/O-9055-2014; Schlichting, Ilme/I-1339-2013; Johansson, Linda/O-6893-2019; Messerschmidt, Marc/Y-8929-2019	Fromme, Raimund/0000-0003-4835-1080; Neutze, Richard/0000-0003-0986-6153; Bajt, Sasa/0000-0002-7163-7602; FRS, Henry N Chapman/0000-0002-4655-1743; Messerschmidt, Marc/0000-0002-8641-3302; Barty, Anton/0000-0003-4751-2727; Johansson, Linda/0000-0003-4776-5142; Nass, Karol/0000-0001-8843-1566; Betzel, Christian/0000-0002-3879-5019; Katona, Gergely/0000-0002-2031-8716; Timneanu, Nicusor/0000-0001-7328-0400; Fromme, Raimund/0000-0003-4835-1080; Johansson, Linda/0000-0003-4776-5142; Messerschmidt, Marc/0000-0002-8641-3302; Johansson, Linda/0000-0002-8931-0683; MARTIN, ANDREW/0000-0003-3704-1829; Kirian, Richard/0000-0001-7197-3086; Zatsepin, Nadia/0000-0003-1757-0205; Aquila, Andrew/0000-0003-0358-2774; Koopmann, Rudolf/0000-0002-7416-6340; Chao, Tzu-Chiao/0000-0001-8781-6958; White, Thomas/0000-0002-8407-0270; Frank, Matthias/0000-0002-5244-0791; Seibert, Mark Marvin/0000-0003-0251-0744	German Federal Ministry for Education and Research [01KX0806, 01KX0807]; Hamburg Ministry of Science and Research; Joachim Herz Stiftung, Hamburg Initiative for Excellence in Research; Hamburg School for Structure and Dynamics in Infection (SDI); Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Inflammation at interfaces" [EXC 306]; DFG; Landesgraduiertenforderung Baden-Wurttemberg; Max Planck Society; Swedish Research Council; Swedish Strategic Research Foundation; Swedish Foundation for International Cooperation in Research and Higher Education; U.S. Department of Energy Office of Basic Energy Sciences through PULSE Institute at SLAC; U.S. Department of Energy through Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; University of California Office of the President Lab Fee Program [118036]; NSF [MCB-1021557, MCB-1120997]; NIH [1R01GM095583]; Div Of Molecular and Cellular Bioscience [1021557] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094599, R01GM095583] Funding Source: NIH RePORTER	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Hamburg Ministry of Science and Research; Joachim Herz Stiftung, Hamburg Initiative for Excellence in Research; Hamburg School for Structure and Dynamics in Infection (SDI); Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Inflammation at interfaces"(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Landesgraduiertenforderung Baden-Wurttemberg; Max Planck Society(Max Planck SocietyFoundation CELLEX); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); Swedish Foundation for International Cooperation in Research and Higher Education; U.S. Department of Energy Office of Basic Energy Sciences through PULSE Institute at SLAC(United States Department of Energy (DOE)); U.S. Department of Energy through Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); University of California Office of the President Lab Fee Program(University of California System); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Experiments were carried out in February 2011 at the LCLS, a national user facility operated by Stanford University on behalf of the U. S. Department of Energy, Office of Basic Energy Sciences. This work was supported by the following agencies: the German Federal Ministry for Education and Research (grants 01KX0806 and 01KX0807), the Hamburg Ministry of Science and Research and Joachim Herz Stiftung as part of the Hamburg Initiative for Excellence in Research and the Hamburg School for Structure and Dynamics in Infection (SDI), the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence "Inflammation at interfaces" (EXC 306), the DFG, the Landesgraduiertenforderung Baden-Wurttemberg, the Max Planck Society, the Swedish Research Council, the Swedish Strategic Research Foundation, the Swedish Foundation for International Cooperation in Research and Higher Education, the U.S. Department of Energy Office of Basic Energy Sciences through PULSE Institute at SLAC, the U.S. Department of Energy through Lawrence Livermore National Laboratory under the contract DE-AC52-07NA27344 and supported by the University of California Office of the President Lab Fee Program (award no. 118036), the NSF (award MCB-1021557 and MCB-1120997), and the NIH (award 1R01GM095583).	Abdulla MH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000298; Alsford S, 2012, NATURE, V482, P232, DOI 10.1038/nature10771; Barrett MP, 2007, BRIT J PHARMACOL, V152, P1155, DOI 10.1038/sj.bjp.0707354; Barty A, 2012, NAT PHOTONICS, V6, P35, DOI [10.1038/nphoton.2011.297, 10.1038/NPHOTON.2011.297]; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Boutet S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/035024; Bryant C, 2009, BIOORG MED CHEM LETT, V19, P6218, DOI 10.1016/j.bmcl.2009.08.098; Chagas JR, 1996, FEBS LETT, V392, P233, DOI 10.1016/0014-5793(96)00822-8; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Chen YM, 1996, FEBS LETT, V393, P24, DOI 10.1016/0014-5793(96)00847-2; Dubin G, 2005, CELL MOL LIFE SCI, V62, P653, DOI 10.1007/s00018-004-4445-9; Fairlamb AH, 2003, TRENDS PARASITOL, V19, P488, DOI 10.1016/j.pt.2003.09.002; Frearson JA, 2010, NATURE, V464, P728, DOI 10.1038/nature08893; Illy C, 1997, J BIOL CHEM, V272, P1197, DOI 10.1074/jbc.272.2.1197; Kerr ID, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000701; Kirian RA, 2010, OPT EXPRESS, V18, P5713, DOI 10.1364/OE.18.005713; Koopmann R, 2012, NAT METHODS, V9, P259, DOI [10.1038/NMETH.1859, 10.1038/nmeth.1859]; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; McGrath ME, 1999, ANNU REV BIOPH BIOM, V28, P181, DOI 10.1146/annurev.biophys.28.1.181; Podobnik M, 1997, J MOL BIOL, V271, P774, DOI 10.1006/jmbi.1997.1218; Quraishi O, 1999, BIOCHEMISTRY-US, V38, P5017, DOI 10.1021/bi981950o; Riekel C, 2004, J SYNCHROTRON RADIAT, V11, P4, DOI 10.1107/S090904950302541X; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Southworth-Davies RJ, 2007, STRUCTURE, V15, P1531, DOI 10.1016/j.str.2007.10.013; Tomoo K, 2010, CURR TOP MED CHEM, V10, P696, DOI 10.2174/156802610791113441; Weierstall U, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3693040; White TA, 2012, J APPL CRYSTALLOGR, V45, P335, DOI 10.1107/S0021889812002312; Yamamoto Y, 2002, CURR PROTEIN PEPT SC, V3, P231, DOI 10.2174/1389203024605331	29	330	341	1	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					227	230		10.1126/science.1229663	http://dx.doi.org/10.1126/science.1229663			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23196907	Green Accepted			2022-12-28	WOS:000313328200050
J	Arranz, R; Coloma, R; Chichon, FJ; Conesa, JJ; Carrascosa, JL; Valpuesta, JM; Ortin, J; Martin-Benito, J				Arranz, Rocio; Coloma, Rocio; Javier Chichon, Francisco; Javier Conesa, Jose; Carrascosa, Jose L.; Valpuesta, Jose M.; Ortin, Juan; Martin-Benito, Jaime			The Structure of Native Influenza Virion Ribonucleoproteins	SCIENCE			English	Article							A VIRUS NUCLEOPROTEIN; RNA; LOCALIZATION; NUCLEAR; REPLICATION; COMPLEXES; OLIGOMERIZATION; RECONSTRUCTION; POLYMERASE; PARTICLES	The influenza viruses cause annual epidemics of respiratory disease and occasional pandemics, which constitute a major public-health issue. The segmented negative-stranded RNAs are associated with the polymerase complex and nucleoprotein (NP), forming ribonucleoproteins (RNPs), which are responsible for virus transcription and replication. We describe the structure of native RNPs derived from virions. They show a double-helical conformation in which two NP strands of opposite polarity are associated with each other along the helix. Both strands are connected by a short loop at one end of the particle and interact with the polymerase complex at the other end. This structure will be relevant for unraveling the mechanisms of nuclear import of parental virus RNPs, their transcription and replication, and the encapsidation of progeny RNPs into virions.	[Coloma, Rocio; Ortin, Juan] Ctr Nacl Biotecnol CSIC, Dept Mol & Cellular Biol, Madrid, Spain; [Arranz, Rocio; Javier Chichon, Francisco; Javier Conesa, Jose; Carrascosa, Jose L.; Valpuesta, Jose M.; Martin-Benito, Jaime] CSIC, Dept Macromol Struct, Ctr Nacl Biotecnol, Madrid, Spain; [Coloma, Rocio; Ortin, Juan] Inst Natl Salud Carlos III, Ctr Invest Biomed Red CIBER Enfermedades Resp, Madrid, Spain; [Valpuesta, Jose M.] Inst Madrileno Estudios Avanzados Nanociencia IMD, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Ortin, J (corresponding author), Ctr Nacl Biotecnol CSIC, Dept Mol & Cellular Biol, Madrid, Spain.	jortin@cnb.csic.es; jmartinb@cnb.csic.es	Conesa, Jose Javier/J-5878-2017; García, Francisco Javier Chichón/R-2167-2019; Ortin, Juan/L-3622-2013; Valpuesta, Jose M/AAA-6002-2019; Chichón García, Francisco Javier/B-6029-2011; Valpuesta, José M/T-1977-2017; Chichón García, Francisco Javier/K-5117-2012	Conesa, Jose Javier/0000-0002-8440-5691; García, Francisco Javier Chichón/0000-0003-2766-0327; Chichón García, Francisco Javier/0000-0003-2766-0327; Valpuesta, José M/0000-0001-7468-8053; Chichón García, Francisco Javier/0000-0003-2766-0327; Arranz, Rocio/0000-0001-5321-0915; Martin-Benito Romero, Jaime/0000-0002-8541-4709; Ortin, Juan/0000-0002-6200-4678	Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion) [BFU2010-17540/BMC, BFU2011-25090/BMC]; FLUPHARM strep project [FP7-259751]; Fundacion Marcelino Botin	Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FLUPHARM strep project; Fundacion Marcelino Botin	The technical assistance of Y. Fernandez and N. Zamarreno is gratefully acknowledged. We thank D. Luque for help with the generation of movies. This work was supported by the Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion) grants BFU2010-17540/BMC (J.O.) and BFU2011-25090/BMC (J.M.-B.), by the FLUPHARM strep project (FP7-259751) (J.O.), and by Fundacion Marcelino Botin (J.O.). J.M.-B. and J.O. designed the experiments. R.A., J.M-B, R.C. F.J.C. and J.J.C. carried out the experiments. J.O. and J.M.-B. wrote the paper with contributions from R.A., R.C., F.J.C., and J.J.C. and discussions with J.L.C. and J.M.V. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. EM maps have been deposited in the EM Data Bank (www.ebi.ac.uk/pdbe/emdb/), accession numbers EMD-2205, 2206, 2207, and 2208. The atomic coordinates of the docking have been deposited in the Protein Data Bank (www.rcsb.org/), accession code 4bbl.	BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; Bullido R, 2000, J GEN VIROL, V81, P135, DOI 10.1099/0022-1317-81-1-135; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; COMPANS RW, 1972, J VIROL, V10, P795, DOI 10.1128/JVI.10.4.795-800.1972; Cros JF, 2005, TRAFFIC, V6, P205, DOI 10.1111/j.1600-0854.2005.00263.x; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; JENNINGS PA, 1983, CELL, V34, P619, DOI 10.1016/0092-8674(83)90394-X; Jorba N, 2008, J GEN VIROL, V89, P520, DOI 10.1099/vir.0.83387-0; Jorba N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000462; Klumpp K, 1997, EMBO J, V16, P1248, DOI 10.1093/emboj/16.6.1248; Martin-Benito J, 2001, EMBO REP, V2, P313, DOI 10.1093/embo-reports/kve063; MURTI KG, 1988, VIROLOGY, V164, P562, DOI 10.1016/0042-6822(88)90574-0; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ng AKL, 2008, FASEB J, V22, P3638, DOI 10.1096/fj.08-112110; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Noda T, 2012, P NATL ACAD SCI USA, V109, P8797, DOI 10.1073/pnas.1206736109; Noda T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1647; Ortega J, 2000, J VIROL, V74, P156, DOI 10.1128/JVI.74.1.156-163.2000; Ozawa M, 2007, J VIROL, V81, P30, DOI 10.1128/JVI.01434-06; PONS MW, 1969, VIROLOGY, V39, P250, DOI 10.1016/0042-6822(69)90045-2; Resa-Infante P, 2011, RNA BIOL, V8, P207, DOI 10.4161/rna.8.2.14513; Ruigrok RWH, 2010, CURR OPIN STRUC BIOL, V20, P104, DOI 10.1016/j.sbi.2009.12.007; RUIGROK RWH, 1995, J GEN VIROL, V76, P1009, DOI 10.1099/0022-1317-76-4-1009; Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004; Wu WWH, 2007, J MOL BIOL, V374, P910, DOI 10.1016/j.jmb.2007.10.022; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379	29	214	219	4	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1634	1637		10.1126/science.1228172	http://dx.doi.org/10.1126/science.1228172			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23180776				2022-12-28	WOS:000312533100057
J	Hastings, G; de Andrade, M; Moodie, C				Hastings, Gerard; de Andrade, Marisa; Moodie, Crawford			Tobacco harm reduction: the devil is in the deployment	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hastings, Gerard; de Andrade, Marisa; Moodie, Crawford] Univ Stirling, Inst Social Mkt, Stirling FK9 4LA, Scotland	University of Stirling	Hastings, G (corresponding author), Univ Stirling, Inst Social Mkt, Stirling FK9 4LA, Scotland.	gerard.hastings@stir.ac.uk		Moodie, Crawford/0000-0002-1805-2509	Cancer Research UK [15192] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		[Anonymous], 2012, PRESCR COST AN ENGL; [Anonymous], 2009, NRT SMOK CESS AIDS U; British American Tobacco, 2011, SUST REP 2011; British American Tobacco, 2011, SUST REP 2011 HARM R; Buck D., 2012, IMPLICATIONS POLICY; Committee on Safety of Medicines, REP WORK GROUP NIC R; Davis RM, 2009, NCI TOBACCO CONTROL; Euromonitor, 2009, TOB UK COUNTR MARK I; Medsafe (Regulatory Information), GUID COD CAT EL CIG; MHRA, DRUG SAF UPD NIC REP; MHRA (Medicines Healthcare products Regulatory Agency), 2009, PUBL ASS REP US NIC; National Institute for Health and Clinical Excellence, 2012, TOB HARM RED APPR SM; Nicoventures, 2012, WHAT IS NIC; O'Reilly D, 2009, TOBACCO HARM REDUCTI; Oxfam, POL PRACT MUGG POV Y; Yeaman A, 1963, IMPLICATIONS BATTELL	16	13	13	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2012	345								e8412	10.1136/bmj.e8412	http://dx.doi.org/10.1136/bmj.e8412			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IU	23248081	Green Submitted			2022-12-28	WOS:000312698700016
J	Prockop, DJ				Prockop, Darwin J.			New Targets for Osteoporosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MESENCHYMAL STEM-CELLS		Scott & White Mem Hosp & Clin, Texas A&M Hlth Sci Ctr, Coll Med, Inst Regenerat Med, Temple, TX USA	Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Prockop, DJ (corresponding author), Scott & White Mem Hosp & Clin, Texas A&M Hlth Sci Ctr, Coll Med, Inst Regenerat Med, Temple, TX USA.							Efimenko A, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-10; Fuchs S, 2012, VITAM HORM, V88, P491, DOI 10.1016/B978-0-12-394622-5.00022-5; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Liu YQ, 2012, J CLIN INVEST, V122, P3101, DOI 10.1172/JCI61209; Wilson A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-229	5	4	5	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24					2353	2354		10.1056/NEJMcibr1210178	http://dx.doi.org/10.1056/NEJMcibr1210178			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HF	23234518				2022-12-28	WOS:000312187700013
J	Rollauer, SE; Tarry, MJ; Graham, JE; Jaaskelainen, M; Jager, F; Johnson, S; Krehenbrink, M; Liu, SM; Lukey, MJ; Marcoux, J; McDowell, MA; Rodriguez, F; Roversi, P; Stansfeld, PJ; Robinson, CV; Sansom, MSP; Palmer, T; Hogbom, M; Berks, BC; Lea, SM				Rollauer, Sarah E.; Tarry, Michael J.; Graham, James E.; Jaaskelainen, Mari; Jaeger, Franziska; Johnson, Steven; Krehenbrink, Martin; Liu, Sai-Man; Lukey, Michael J.; Marcoux, Julien; McDowell, Melanie A.; Rodriguez, Fernanda; Roversi, Pietro; Stansfeld, Phillip J.; Robinson, Carol V.; Sansom, Mark S. P.; Palmer, Tracy; Hogbom, Martin; Berks, Ben C.; Lea, Susan M.			Structure of the TatC core of the twin-arginine protein transport system	NATURE			English	Article							SEC-INDEPENDENT PROTEIN; CYSTEINE SCANNING MUTAGENESIS; SIGNAL PEPTIDE; TRANSLOCASE COMPONENT; PATHWAY; TOPOLOGY; BINDING; FORM; COMPLEXES; EFFICIENT	The twin-arginine translocation (Tat) pathway is one of two general protein transport systems found in the prokaryotic cytoplasmic membrane and is conserved in the thylakoid membrane of plant chloroplasts. The defining, and highly unusual, property of the Tat pathway is that it transports folded proteins, a task that must be achieved without allowing appreciable ion leakage across the membrane. The integral membrane TatC protein is the central component of the Tat pathway. TatC captures substrate proteins by binding their signal peptides. TatC then recruits TatA family proteins to form the active translocation complex. Here we report the crystal structure of TatC from the hyperthermophilic bacterium Aquifex aeolicus. This structure provides a molecular description of the core of the Tat translocation system and a framework for understanding the unique Tat transport mechanism.	[Rollauer, Sarah E.; Graham, James E.; Krehenbrink, Martin; Liu, Sai-Man; Lukey, Michael J.; Rodriguez, Fernanda; Stansfeld, Phillip J.; Sansom, Mark S. P.; Berks, Ben C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Rollauer, Sarah E.; Graham, James E.; Johnson, Steven; Liu, Sai-Man; Lukey, Michael J.; McDowell, Melanie A.; Roversi, Pietro; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Tarry, Michael J.; Jaaskelainen, Mari; Hogbom, Martin] Stockholm Univ, Dept Biochem & Biophys, Stockholm Ctr Biomembrane Res, S-10691 Stockholm, Sweden; [Jaeger, Franziska; Palmer, Tracy] Univ Dundee, Div Mol Microbiol, Coll Life Sci, Dundee DD1 5EH, Scotland; [Marcoux, Julien; Robinson, Carol V.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England	University of Oxford; University of Oxford; Stockholm University; University of Dundee; University of Oxford	Berks, BC (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	ben.berks@bioch.ox.ac.uk; susan.lea@path.ox.ac.uk	Rollauer, Sarah/L-4576-2016; Jaeger, Franziska/I-4764-2017; Stansfeld, Phill/C-6213-2011; Roversi, Pietro/AAK-4241-2021; Stansfeld, Phillip James/AAA-9228-2020; Lea, Susan M/B-7678-2009; Sansom, Mark S.P./C-5157-2009; Johnson, Steven J/F-9182-2016; Jaeger, Franziska/AGY-9260-2022; Marcoux, Julien/I-3908-2012; Roversi, Pietro/F-8925-2011	Rollauer, Sarah/0000-0002-2116-3170; Jaeger, Franziska/0000-0002-6823-4589; Stansfeld, Phill/0000-0001-8800-7669; Roversi, Pietro/0000-0001-9280-9437; Stansfeld, Phillip James/0000-0001-8800-7669; Lea, Susan M/0000-0001-9287-8053; Sansom, Mark S.P./0000-0001-6360-7959; Johnson, Steven J/0000-0002-7877-3543; Jaeger, Franziska/0000-0002-6823-4589; Roversi, Pietro/0000-0001-9280-9437; Palmer, Tracy/0000-0001-9043-2592; robinson, carol/0000-0001-7829-5505; Hogbom, Martin/0000-0001-5574-9383; Graham, James/0000-0002-8639-7592; Lukey, Michael/0000-0003-3608-3883; McDowell, Melanie/0000-0002-5231-8809; Marcoux, Julien/0000-0001-7321-7436; Berks, Ben/0000-0001-9685-4067	Wellcome Trust [083599, 092970MA]; Swedish Foundation for Strategic Research; Swedish Research Council [2010-5061]; E.P. Abrahams Cephalosporin Trust; Biotechnology and Biological Sciences Research Council [BB/E023347/1, BB/1019855/1]; Medical Research Council [G1001640, G0900888]; European Research Council; James Martin 21st Century School Vaccine Design Institute; BBSRC [BB/E023347/1, BB/H000267/1, BB/F02150X/1, BB/I019855/1] Funding Source: UKRI; MRC [G1001640] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/16011, BB/F02150X/1, BB/H000267/1, BB/I019855/1, B19456, BEP17032] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); E.P. Abrahams Cephalosporin Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); James Martin 21st Century School Vaccine Design Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank D. Byrne, G. Orriss and R. Owens for their contributions to the early stages of this project; R. Keller for advice; and J. Willemde Gier, D. Daley and R. Huber for providing strains and reagents. This work was supported by the Wellcome Trust (studentships to S.E.R., J.E.G. and M.A.M.; grant 083599, P.R.; grant 092970MA, M.S.P.S.), the Swedish Foundation for Strategic Research ('Future research leaders 4' to M.H.), the Swedish Research Council (grant 2010-5061 to M.H.), the E.P. Abrahams Cephalosporin Trust (M.K. and F.R.), the Biotechnology and Biological Sciences Research Council (studentship, M.J.L.; grant BB/E023347/1, S-M.L.; grant BB/1019855/1, P.J.S.), the Medical Research Council (grant G1001640, F.J.; grant G0900888, S.J.), and the European Research Council (Advanced Grant IMPRESS, J.M. and C.V.R.). Work in S.M.L.'s group is funded by the James Martin 21st Century School Vaccine Design Institute.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BARKAN A, 1986, EMBO J, V5, P1421, DOI 10.1002/j.1460-2075.1986.tb04378.x; Behrendt J, 2004, FEMS MICROBIOL LETT, V234, P303, DOI 10.1016/j.femsle.2004.03.048; Berks BC, 2003, ADV MICROB PHYSIOL, V47, P187, DOI 10.1016/S0065-2911(03)47004-5; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Bogsch EG, 1998, J BIOL CHEM, V273, P18003, DOI 10.1074/jbc.273.29.18003; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bricogne G.B.E., 2011, BUSTER 2 11 2; Buchanan G, 2002, MOL MICROBIOL, V43, P1457, DOI 10.1046/j.1365-2958.2002.02853.x; Celedon J. M., 2012, BIOCH BIOPHYS ACTA; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2007, EMBO J, V26, P3039, DOI 10.1038/sj.emboj.7601759; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; De Buck E, 2008, TRENDS MICROBIOL, V16, P442, DOI 10.1016/j.tim.2008.06.004; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Drew D, 2002, P NATL ACAD SCI USA, V99, P2690, DOI 10.1073/pnas.052018199; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Fritsch MJ, 2012, MOL MICROBIOL, V84, P1108, DOI 10.1111/j.1365-2958.2012.08080.x; Frobel J, 2012, PHILOS T R SOC B, V367, P1029, DOI 10.1098/rstb.2011.0202; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Gouffi K, 2002, FEBS LETT, V525, P65, DOI 10.1016/S0014-5793(02)03069-7; Greene NP, 2007, J BIOL CHEM, V282, P23937, DOI 10.1074/jbc.M702972200; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Jeong KJ, 2004, J MOL BIOL, V341, P901, DOI 10.1016/j.jmb.2004.05.078; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kneuper H, 2012, MOL MICROBIOL, V85, P945, DOI 10.1111/j.1365-2958.2012.08151.x; Koch S, 2012, J BIOL CHEM, V287, P14420, DOI 10.1074/jbc.M112.354555; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Lausberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039867; Maldonado B, 2011, J MOL MICROB BIOTECH, V20, P168, DOI 10.1159/000329076; Monticelli L, 2008, J COMPUT CHEM, V29, P1740, DOI 10.1002/jcc.20935; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; MOULD RM, 1991, J BIOL CHEM, V266, P12189; Orriss GL, 2007, FEBS LETT, V581, P4091, DOI 10.1016/j.febslet.2007.07.044; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Punginelli C, 2007, J BACTERIOL, V189, P5482, DOI 10.1128/JB.00647-07; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Scott KA, 2008, STRUCTURE, V16, P621, DOI 10.1016/j.str.2008.01.014; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Stansfeld PJ, 2011, J CHEM THEORY COMPUT, V7, P1157, DOI 10.1021/ct100569y; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; Tarry M, 2012, PROTEIN EXPRES PURIF, V82, P373, DOI 10.1016/j.pep.2012.02.003; Tarry MJ, 2009, P NATL ACAD SCI USA, V106, P13284, DOI 10.1073/pnas.0901566106; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Zoufaly S, 2012, J BIOL CHEM, V287, P13430, DOI 10.1074/jbc.M112.343798	63	128	129	2	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					210	+		10.1038/nature11683	http://dx.doi.org/10.1038/nature11683			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23201679	Green Accepted			2022-12-28	WOS:000312259300033
J	Borne, RT; Krantz, MJ				Borne, Ryan T.; Krantz, Mori J.			Lixivaptan for Hyponatremia-The Numbers Game	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TOLVAPTAN		[Borne, Ryan T.; Krantz, Mori J.] Denver Hlth Hosp & Author, Dept Internal Med, Denver, CO USA; [Krantz, Mori J.] Div Cardiol, Denver, CO USA	Denver Health Medical Center	Borne, RT (corresponding author), Denver Hlth Med Ctr, 660 Bannock St,MC 4000, Denver, CO 80204 USA.	ryan.borne@dhha.org						FDA, CARD REN DRUGS ADV C; FDA Ctr Drug Evaluation Res, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-79; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Palmer SC, 2010, ANN INTERN MED, V153, P23, DOI 10.7326/0003-4819-153-1-201007060-00252; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; Wald R, 2010, ARCH INTERN MED, V170, P294, DOI 10.1001/archinternmed.2009.513	6	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2012	308	22					2345	2346		10.1001/jama.2012.54515	http://dx.doi.org/10.1001/jama.2012.54515			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051MW	23232892				2022-12-28	WOS:000312132400023
J	Ellis, O				Ellis, Oliver			Jet packs	BRITISH MEDICAL JOURNAL			English	Editorial Material												oli.ellis@googlemail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 10	2012	345								e8342	10.1136/bmj.e8342	http://dx.doi.org/10.1136/bmj.e8342			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056MC	23230219				2022-12-28	WOS:000312493100004
J	Stella, N				Stella, Nephi			Inflammation to Rebuild a Brain	SCIENCE			English	Editorial Material							NEUROGENESIS; ACTIVATION; MICROGLIA; DISEASE		Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Stella, N (corresponding author), Univ Washington, Dept Pharmacol, 1959 NE Pacific St, Seattle, WA 98195 USA.	nstella@u.washington.edu			NIDA NIH HHS [R01 DA026430, R01 DA014486] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014486, R01DA026430] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Bianchi R, 2011, J BIOL CHEM, V286, P7214, DOI 10.1074/jbc.M110.169342; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Stella N, 2011, SCIENCE, V334, P768, DOI 10.1126/science.1215389; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2	11	10	15	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1303	1304		10.1126/science.1232331	http://dx.doi.org/10.1126/science.1232331			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224546	Green Accepted			2022-12-28	WOS:000311991200053
J	Volpp, KG; Shea, JA; Small, DS; Basner, M; Zhu, JS; Norton, L; Ecker, A; Novak, C; Bellini, LM; Dine, CJ; Mollicone, DJ; Dinges, DF				Volpp, Kevin G.; Shea, Judy A.; Small, Dylan S.; Basner, Mathias; Zhu, Jingsan; Norton, Laurie; Ecker, Adrian; Novak, Cristina; Bellini, Lisa M.; Dine, C. Jessica; Mollicone, Daniel J.; Dinges, David F.			Effect of a Protected Sleep Period on Hours Slept During Extended Overnight In-hospital Duty Hours Among Medical Interns A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VIGILANCE TEST PVT; PSYCHOMOTOR VIGILANCE; DOSE-RESPONSE; WORK; RESTRICTION; ALERTNESS; MORTALITY; RECOVERY; DURATION; REFORM	Context A 2009 Institute of Medicine report recommended protected sleep periods for medicine trainees on extended overnight shifts, a position reinforced by new Accreditation Council for Graduate Medical Education requirements. Objective To evaluate the feasibility and consequences of protected sleep periods during extended duty. Design, Setting, and Participants Randomized controlled trial conducted at the Philadelphia VA Medical Center medical service and Oncology Unit of the Hospital of the University of Pennsylvania (2009-2010). Of the 106 interns and senior medical students who consented, 3 were not scheduled on any study rotations. Among the others, 44 worked at the VA center, 16 at the university hospital, and 43 at both. Intervention Twelve 4-week blocks were randomly assigned to either a standard intern schedule (extended duty overnight shifts of up to 30 hours; equivalent to 1200 overnight intern shifts at each site), or a protected sleep period (protected time from 12: 30 AM to 5: 30 AM with handover of work cell phone; equivalent to 1200 overnight intern shifts at each site). Participants were asked to wear wrist actigraphs and complete sleep diaries. Main Outcome Measures Primary outcome was hours slept during the protected period on extended duty overnight shifts. Secondary outcome measures included hours slept during a 24-hour period (noon to noon) by day of call cycle and Karolinska sleepiness scale. Results For 98.3% of on-call nights, cell phones were signed out as designed. At the VA center, participants with protected sleep had a mean 2.86 hours (95% CI, 2.57-3.10 hours) of sleep vs 1.98 hours (95% CI, 1.68-2.28 hours) among those who did not have protected hours of sleep (P<.001). At the university hospital, participants with protected sleep had a mean 3.04 hours (95% CI, 2.77-3.45 hours) of sleep vs 2.04 hours (95% CI, 1.79-2.24) among those who did not have protected sleep (P<.001). Participants with protected sleep were significantly less likely to have call nights with no sleep: 5.8% (95% CI, 3.0%-8.5%) vs 18.6% (95% CI, 13.9%-23.2%) at the VA center (P<.001) and 5.9% (95% CI, 3.1%-8.7%) vs 14.2% (95% CI, 9.9%-18.4%) at the university hospital (P=.001). Participants felt less sleepy after on-call nights in the intervention group, with Karolinska sleepiness scale scores of 6.65 (95% CI, 6.35-6.97) vs 7.10 (95% CI, 6.85-7.33; P=.01) at the VA center and 5.91 (95% CI, 5.64-6.16) vs 6.79 (95% CI, 6.57-7.04; P<.001) at the university hospital. Conclusions For internal medicine services at 2 hospitals, implementation of a protected sleep period while on call resulted in an increase in overnight sleep duration and improved alertness the next morning.	[Volpp, Kevin G.; Shea, Judy A.; Norton, Laurie; Novak, Cristina] Philadelphia VA Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Shea, Judy A.; Zhu, Jingsan; Norton, Laurie; Novak, Cristina; Bellini, Lisa M.; Dine, C. Jessica] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Basner, Mathias; Ecker, Adrian; Dinges, David F.] Univ Penn, Perelman Sch Med, Dept Psychiat, Div Sleep & Chronobiol, Philadelphia, PA 19104 USA; [Volpp, Kevin G.] Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA; [Small, Dylan S.] Univ Penn, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Shea, Judy A.; Small, Dylan S.; Zhu, Jingsan; Norton, Laurie; Novak, Cristina] Univ Penn, Leonard Davis Inst, Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA; [Mollicone, Daniel J.] Pulsar Informat Inc, Philadelphia, PA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Volpp, KG (corresponding author), Philadelphia VA Med Ctr, Ctr Hlth Equ Res & Promot, 1120 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	volpp70@wharton.upenn.edu	Dinges, David/P-7183-2019	Volpp, Kevin/0000-0003-1423-4599; Dine, Constance/0000-0001-5894-0861	Veterans Affairs Health Services Research and Development Service [08-429]; National Institutes of Health [NR004281]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR004281] Funding Source: NIH RePORTER	Veterans Affairs Health Services Research and Development Service(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was funded by educational grant 08-429 from the Veterans Affairs Health Services Research and Development Service. Dr Dinges was also supported in part by grant NR004281 from the National Institutes of Health.	Agresti A, 2000, AM STAT, V54, P280, DOI 10.2307/2685779; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; [Anonymous], 2003, COMM PROGR REQ DUT H; Arora V, 2006, ANN INTERN MED, V144, P792, DOI 10.7326/0003-4819-144-11-200606060-00005; Ayas NT, 2006, JAMA-J AM MED ASSOC, V296, P1055, DOI 10.1001/jama.296.9.1055; Banks S, 2010, SLEEP, V33, P1013, DOI 10.1093/sleep/33.8.1013; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Basner M, 2011, ACTA ASTRONAUT, V69, P949, DOI 10.1016/j.actaastro.2011.07.015; Basner M, 2011, J OCCUP ENVIRON MED, V53, P1146, DOI 10.1097/JOM.0b013e31822b8356; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Brooks A, 2006, SLEEP, V29, P831, DOI 10.1093/sleep/29.6.831; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; DINGES DF, 1987, SLEEP, V10, P313; DINGES DF, 1988, WORK STRESS, V2, P139, DOI 10.1080/02678378808259158; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Jewett ME, 1999, SLEEP, V22, P171, DOI 10.1093/sleep/22.2.171; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Malmberg B, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-239; Nasca TJ, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMsb1005800; Ramsey F., 2001, STAT SLEUTH COURSE M; Richardson GS, 1996, SLEEP, V19, P718; Rosekind MR, 1997, FATIGUE DUTY LIMITAT, P71; Rosen AK, 2009, MED CARE, V47, P723, DOI 10.1097/MLR.0b013e31819a588f; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Shetty KD, 2007, ANN INTERN MED, V147, P73, DOI 10.7326/0003-4819-147-2-200707170-00161; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Ulmer C, 2009, RESIDENT DUTY HOURS: ENHANCING SLEEP, SUPERVISION, AND SAFETY, P1; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Volpp KG, 2009, J GEN INTERN MED, V24, P1149, DOI 10.1007/s11606-009-1011-z; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307	34	28	28	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2012	308	21					2208	2217		10.1001/jama.2012.34490	http://dx.doi.org/10.1001/jama.2012.34490			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047HI	23212498	Green Accepted, Bronze			2022-12-28	WOS:000311829500012
J	Lloyd-Roberts, S				Lloyd-Roberts, Sue			FEMALE GENITAL MUTILATION UK's shameful record on female genital mutilation	BRITISH MEDICAL JOURNAL			English	Editorial Material									BBC, London, England		Lloyd-Roberts, S (corresponding author), BBC, London, England.	sue.lloyd-roberts@bbc.co.uk						Forward, 2007, STAT STUD EST PREV F	1	3	3	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 3	2012	345								e8121	10.1136/bmj.e8121	http://dx.doi.org/10.1136/bmj.e8121			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HO	23207504				2022-12-28	WOS:000312188700010
J	Williams, D; Sudhanva, M; Clough, C; Brooks, T				Williams, David; Sudhanva, Malur; Clough, Chris; Brooks, Tim			A man who vomited until he couldn't walk	LANCET			English	Editorial Material							WEST-NILE-VIRUS		[Williams, David] Kings Coll Hosp NHS Fdn Trust London, Dept Neurol, Royal Free Hosp, London NW3 2QG, England; [Sudhanva, Malur; Brooks, Tim] Kings Coll Hosp NHS Fdn Trust London, S London Specialist Virol Ctr, London NW3 2QG, England; [Williams, David] Inst Neurol, Sobell Dept, London WC1N 3BG, England; [Sudhanva, Malur; Brooks, Tim] HPA Microbiol Serv Porton, Rare & Imported Pathogens Dept, Salisbury, Wilts, England	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; University College London	Williams, D (corresponding author), Kings Coll Hosp NHS Fdn Trust London, Dept Neurol, Royal Free Hosp, Pond St, London NW3 2QG, England.	dwilliams8@nhs.net		Williams, David/0000-0003-0294-9773; Sudhanva, Malur/0000-0001-8415-4469				Granwehr BP, 2004, LANCET INFECT DIS, V4, P547, DOI 10.1016/S1473-3099(04)01128-4; Komar Nicholas, 2003, Adv Virus Res, V61, P185; Paramasivan R, 2003, INDIAN J MED RES, V118, P101; Petersen LR, 2002, ANN INTERN MED, V137, P173, DOI 10.7326/0003-4819-137-3-200208060-00009; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471	5	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 1	2012	380	9857					1966	1966		10.1016/S0140-6736(12)61952-7	http://dx.doi.org/10.1016/S0140-6736(12)61952-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	046IK	23200505				2022-12-28	WOS:000311758500033
J	Pountain, SJ; Roffe, C				Pountain, S. J.; Roffe, C.			Does routine oxygen supplementation in patients with acute stroke improve outcome?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							THERAPY; SLEEP; HYPOXIA		[Pountain, S. J.; Roffe, C.] N Staffordshire Combined Healthcare NHS Trust, Stoke Stroke Res Grp, Stroke Oxygen Study, Stoke On Trent ST4 7LH, Staffs, England; [Roffe, C.] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England	Keele University	Roffe, C (corresponding author), N Staffordshire Combined Healthcare NHS Trust, Stoke Stroke Res Grp, Stroke Oxygen Study, Stoke On Trent ST4 7LH, Staffs, England.	christine.roffe@northstaffs.nhs.uk	Roffe, Christine/AAT-5611-2020	Roffe, Christine/0000-0002-5259-6649				Ali K, 2005, NEUROCRIT CARE, V3, P24, DOI 10.1385/NCC:3:1:024; Arora A, 2005, BR J CARDIOL, V12, P456; Bassetti CL, 2006, STROKE, V37, P967, DOI 10.1161/01.STR.0000208215.49243.c3; Bennett MH, 2005, COCHRANE DB SYST REV, V3; Bravata DM, 2010, ARCH INTERN MED, V170, P804, DOI 10.1001/archinternmed.2010.92; Chiu EHH, 2006, ARCH NEUROL-CHICAGO, V63, P741, DOI 10.1001/archneur.63.5.741; Cornet AD, 2012, ARCH INTERN MED, V172, P289, DOI 10.1001/archinternmed.2011.624; Indredavik B, 1999, STROKE, V30, P917, DOI 10.1161/01.STR.30.5.917; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Meadows GE, 2004, J APPL PHYSIOL, V97, P1343, DOI 10.1152/japplphysiol.01101.2003; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; Parra O, 2000, AM J RESP CRIT CARE, V161, P375, DOI 10.1164/ajrccm.161.2.9903139; Roffe C, 2003, STROKE, V34, P2641, DOI 10.1161/01.STR.0000095188.65567.4F; Roffe C, 2001, REV CLIN GERONTOL, V11, P323; Roffe C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019113; Ronning OM, 1999, STROKE, V30, P2033, DOI 10.1161/01.STR.30.10.2033; Rowat AM, 2006, CEREBROVASC DIS, V21, P166, DOI 10.1159/000090528; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Singhal AB, 2006, INT J STROKE, V1, P191, DOI 10.1111/j.1747-4949.2006.00058.x	19	13	14	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2012	345								e6976	10.1136/bmj.e6976	http://dx.doi.org/10.1136/bmj.e6976			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048FS	23204040				2022-12-28	WOS:000311896500001
J	Puliyel, JM; Mathew, JL				Puliyel, Jacob M.; Mathew, Joseph L.			Should India launch a national immunisation programme against rotavirus? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COST-EFFECTIVENESS; PUBLIC-HEALTH; VACCINE; INFANTS; PREVENTION; DIARRHEA; DISEASE; IMPACT; GASTROENTERITIS; EPIDEMIOLOGY		[Puliyel, Jacob M.] St Stephens Hosp, Delhi 110054, India; [Mathew, Joseph L.] Postgrad Inst Med Educ & Res, Adv Paediat Ctr, Chandigarh 160012, India	St. Stephen's Hospital; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Puliyel, JM (corresponding author), St Stephens Hosp, Delhi 110054, India.	puliyel@gmail.com						[Anonymous], 2009, Wkly Epidemiol Rec, V84, P220; Bhadoria V, 2012, TRANSFORMING INDIAS; Boom JA, 2010, PEDIATRICS, V125, pE199, DOI 10.1542/peds.2009-1021; Chandran A, 2010, BIOL-TARGETS THER, V4, P213; Esposito DH, 2011, CLIN INFECT DIS, V52, P171, DOI 10.1093/cid/ciq094; GAVI Alliance, ROT VACC SUPP; Gladstone BP, 2011, NEW ENGL J MED, V365, P337, DOI 10.1056/NEJMoa1006261; Government of India, 2007, NAT FAM HLTH SURV NF, V1; Kahn G, 2012, INDIAN PEDIATR, V49, P467, DOI 10.1007/s13312-012-0076-7; Lodha R, 2012, INDIAN PEDIATR, V49, P441; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Parashar UD, 2006, SCIENCE, V312, P851, DOI 10.1126/science.1128827; PATH, ROT QUEST ANSW; Puliyel JM, 2008, BRIT MED J, V336, P974, DOI 10.1136/bmj.39563.529757.BE; Ramani S, 2007, INDIAN J MED RES, V125, P619; Rose J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3653; Sengupta Paramita, 2009, Indian J Community Med, V34, P279, DOI 10.4103/0970-0218.58382; Soares-Weiser K, 2012, COCHRANE DB SYST REV, V2; Steele AD, 2009, J INFECT DIS, V200, pS63, DOI 10.1086/605042; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Tate JE, 2009, VACCINE, V27, pF18, DOI 10.1016/j.vaccine.2009.08.098; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	24	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2012	345								e7832	10.1136/bmj.e7832	http://dx.doi.org/10.1136/bmj.e7832			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048FS	23204000	Bronze			2022-12-28	WOS:000311896500003
J	Davidoff, F				Davidoff, Frank			We need better ways to create new hypotheses and select those to test	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Inst Healthcare Improvement, Wethersfield, CT 06109 USA		Davidoff, F (corresponding author), Inst Healthcare Improvement, 143 Garden St, Wethersfield, CT 06109 USA.	fdavidoff@cox.net						American Bar Association, 2010, FAQS ABOUT THE GRAND; Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Dawkins N., 2010, NEW DIRECTIONS FOR E, V2010, P1; Hobbs L, 2011, PSYCHOLOGY HEALTH SU, V26; Howard Hughes Medical Institute and Burroughs Wellcome Fund, 2006, HOW TO BE A MEMBER O; Ness RB, 2010, ANN EPIDEMIOL, V20, P89, DOI 10.1016/j.annepidem.2009.12.001; Popper K., 2002, LOGIC SCI DISCOVERY; United States Government Accountability Office, 2011, GAO 11 176; US Food and Drug Administration, 2010, SMALL BUSINESS ASSIS; Van de Ven A.H., 2007, ENGAGED SCHOLARSHIP; Vandenbroucke JP, 2008, PLOS MED, V5, P339, DOI 10.1371/journal.pmed.0050067; Vanhaverbeke W., 2008, OPEN INNOVATION RES	12	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2012	345								e7991	10.1136/bmj.e7991	http://dx.doi.org/10.1136/bmj.e7991			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048FM	23187096				2022-12-28	WOS:000311895700005
J	Cavalli, G				Cavalli, Giacomo			EZH2 Goes Solo	SCIENCE			English	Editorial Material							POLYCOMB GROUP PROTEINS; ANDROGEN RECEPTOR; PROSTATE-CANCER; METHYLATION; ESTROGEN; CELLS; PRC2		CNRS, Inst Genet Humaine, F-34396 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Cavalli, G (corresponding author), CNRS, Inst Genet Humaine, 141 Rue Cardonille, F-34396 Montpellier, France.	giacomo.cavalli@igh.cnrs.fr	Cavalli, Giacomo/A-7958-2008; cavalli, giacomo/Z-2754-2019	Cavalli, Giacomo/0000-0003-3709-3469; cavalli, giacomo/0000-0003-3709-3469				Bredfeldt TG, 2010, MOL ENDOCRINOL, V24, P993, DOI 10.1210/me.2009-0438; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chang CJ, 2012, BRIT J CANCER, V106, P243, DOI 10.1038/bjc.2011.551; Culig Z, 1999, BRIT J CANCER, V81, P242, DOI 10.1038/sj.bjc.6690684; Gaughan L, 2011, NUCLEIC ACIDS RES, V39, P1266, DOI 10.1093/nar/gkq861; He AB, 2012, GENE DEV, V26, P37, DOI 10.1101/gad.173930.111; Jacob E, 2008, J BIOL CHEM, V283, P13471, DOI 10.1074/jbc.M709886200; Jacob Eyal, 2011, J Mol Signal, V6, P5, DOI 10.1186/1750-2187-6-5; Ko S, 2011, MOL ENDOCRINOL, V25, P433, DOI 10.1210/me.2010-0482; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Melnick A, 2012, CANCER CELL, V22, P569, DOI 10.1016/j.ccr.2012.10.016; Mousavi K, 2012, MOL CELL, V45, P255, DOI 10.1016/j.molcel.2011.11.019; O'Meara MM, 2012, CHROMOSOMA, V121, P221, DOI 10.1007/s00412-012-0361-1; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604	18	18	21	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1430	1431		10.1126/science.1232332	http://dx.doi.org/10.1126/science.1232332			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239724				2022-12-28	WOS:000312250800035
J	Bomers, MK; van Agtmael, MA; Luik, H; van Veen, MC; Vandenbroucke-Grauls, CMJE; Smulders, YM				Bomers, Marije K.; van Agtmael, Michiel A.; Luik, Hotsche; van Veen, Merk C.; Vandenbroucke-Grauls, Christina M. J. E.; Smulders, Yvo M.			Using a dog's superior olfactory sensitivity to identify Clostridium difficile in stools and patients: proof of principle study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CANINE SCENT DETECTION; LABORATORY DIAGNOSIS; EPIDEMIOLOGY; INFECTION; CANCER; COLONIZATION; ACQUISITION; OUTBREAK; DIARRHEA; DELAYS	Objective To investigate whether a dog's superior olfactory sensitivity can be used to detect Clostridium difficile in stool samples and hospital patients. Design Proof of principle study, using a case-control design. Setting Two large Dutch teaching hospitals. Participants A 2 year old beagle trained to identify the smell of C difficile and tested on 300 patients (30 with C difficile infection and 270 controls). Intervention The dog was guided along the wards by its trainer, who was blinded to the participants' infection status. Each detection round concerned 10 patients (one case and nine controls). The dog was trained to sit or lie down when C difficile was detected. Main outcome measures Sensitivity and specificity for detection of C difficile in stool samples and in patients. Results The dog's sensitivity and specificity for identifying C difficile in stool samples were both 100% (95% confidence interval 91% to 100%). During the detection rounds, the dog correctly identified 25 of the 30 cases (sensitivity 83%, 65% to 94%) and 265 of the 270 controls (specificity 98%, 95% to 99%). Conclusion A trained dog was able to detect C difficile with high estimated sensitivity and specificity, both in stool samples and in hospital patients infected with C difficile.	[Bomers, Marije K.; van Agtmael, Michiel A.; Smulders, Yvo M.] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, NL-1007 MB Amsterdam, Netherlands; [Luik, Hotsche] HL&HONDEN, Edam, Netherlands; [van Veen, Merk C.] St Lucas Andreas Hosp, Dept Internal Med, Amsterdam, Netherlands; [Vandenbroucke-Grauls, Christina M. J. E.] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, NL-1007 MB Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Sint Lucas Andreas Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Bomers, MK (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Internal Med, POB 7057, NL-1007 MB Amsterdam, Netherlands.	m.bomers@vumc.nl	Smulders, YM/AAG-7506-2021; Vandenbroucke-Grauls, Christina/AAO-7953-2020	Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; Bomers, Marije/0000-0003-0399-6926				BARTLETT JG, 1977, J INFECT DIS, V136, P701, DOI 10.1093/infdis/136.5.701; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS12, DOI 10.1086/521863; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Burdette SD, 2007, CLIN INFECT DIS, V44, P1142, DOI 10.1086/513033; CLABOTS CR, 1992, J INFECT DIS, V166, P561, DOI 10.1093/infdis/166.3.561; Cornu JN, 2011, EUR UROL, V59, P197, DOI 10.1016/j.eururo.2010.10.006; Crobach MJT, 2009, CLIN MICROBIOL INFEC, V15, P1053, DOI 10.1111/j.1469-0691.2009.03098.x; Delmee M, 2001, CLIN MICROBIOL INFEC, V7, P411, DOI 10.1046/j.1198-743x.2001.00294.x; Ehmann R, 2012, EUR RESPIR J, V39, P669, DOI 10.1183/09031936.00051711; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Frenz MB, 2003, QJM-INT J MED, V96, P579, DOI 10.1093/qjmed/hcg098; GEORGE RH, 1978, BRIT MED J, V1, P695, DOI 10.1136/bmj.1.6114.695; Hensgens MPM, 2011, EUR J CLIN MICROBIOL, V30, P587, DOI 10.1007/s10096-010-1127-4; Horvath G, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-643; IsselTarver L, 1997, GENETICS, V145, P185; Johansen A, 2002, AGE AGEING, V31; Karre T, 2011, J CLIN MICROBIOL, V49, P725, DOI 10.1128/JCM.01028-10; Kufelnicka AM, 2011, CLIN INFECT DIS, V52, P1451, DOI 10.1093/cid/cir201; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Lefebvre SL, 2008, AM J INFECT CONTROL, V36, P78, DOI 10.1016/j.ajic.2007.09.005; Lit L, 2011, ANIM COGN, V14, P387, DOI 10.1007/s10071-010-0373-2; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; McCulloch M, 2006, INTEGR CANCER THER, V5, P30, DOI 10.1177/1534735405285096; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; Muto CA, 2007, CLIN INFECT DIS, V45, P1266, DOI 10.1086/522654; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; SAMORE MH, 1994, CLIN INFECT DIS, V18, P181, DOI 10.1093/clinids/18.2.181; Samore MH, 1996, AM J MED, V100, P32, DOI 10.1016/S0002-9343(96)90008-X; Scheurer D, 2008, J HOSP MED, V3, P156, DOI 10.1002/jhm.277; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Sonoda H, 2011, GUT, V60, P814, DOI 10.1136/gut.2010.218305; WILLIAMS H, 1989, LANCET, V1, P734; Willis CM, 2004, BMJ-BRIT MED J, V329, P712, DOI 10.1136/bmj.329.7468.712	34	65	69	0	62	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2012	345								e7396	10.1136/bmj.e7396	http://dx.doi.org/10.1136/bmj.e7396			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056MZ	23241268	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000312495700001
J	Stone, JH; Patel, VI; Oliveira, GR; Stone, JR				Stone, John H.; Patel, Virendra I.; Oliveira, George R.; Stone, James R.			Case 38-2012: A 60-Year-Old Man with Abdominal Pain and Aortic Aneurysms	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IGG4-RELATED SYSTEMIC-DISEASE; SURGICAL PATHOLOGY; LYMPHOPLASMACYTIC AORTITIS; RELAPSING POLYCHONDRITIS; ANKYLOSING-SPONDYLITIS; CONSENSUS STATEMENT; INFLAMED CARTILAGE; SCLEROSING DISEASE; ASCENDING AORTA; BEHCETS-DISEASE		[Stone, John H.] Massachusetts Gen Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; [Patel, Virendra I.] Massachusetts Gen Hosp, Dept Surg, Div Vasc & Endovasc Surg, Boston, MA 02114 USA; [Oliveira, George R.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Stone, James R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Stone, John H.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Patel, Virendra I.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Oliveira, George R.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Stone, James R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Stone, JH (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA.				Genentech; GlaxoSmithKline; Merck	Genentech(Roche HoldingGenentech); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company)	Dr. John H. Stone reports receiving grant support from Genentech, and Dr. James R. Stone receiving consulting fees from GlaxoSmithKline and Merck and providing paid expert testimony for GlaxoSmithKline regarding rosiglitazone. No other potential conflict of interest relevant to this article was reported.	BOONTJE AH, 1990, J CARDIOVASC SURG, V31, P611; BULKLEY BH, 1973, CIRCULATION, V48, P1014, DOI 10.1161/01.CIR.48.5.1014; CHIKAMORI T, 1990, EUR HEART J, V11, P572, DOI 10.1093/oxfordjournals.eurheartj.a059752; COCHRANE AD, 1991, ANN THORAC SURG, V52, P1166, DOI 10.1016/0003-4975(91)91304-E; Conrad MF, 2011, J VASC SURG, V53, P1195, DOI 10.1016/j.jvs.2010.11.055; DALTON JC, 1962, NEW ENGL J MED, V266, P719, DOI 10.1056/NEJM196204052661411; Deshpande V, 2012, MODERN PATHOL, V25, P1181, DOI 10.1038/modpathol.2012.72; Dib C, 2006, MAYO CLIN PROC, V81, P772, DOI 10.4065/81.6.772; Dubois M, 2010, EUR J VASC ENDOVASC, V40, P450, DOI 10.1016/j.ejvs.2010.07.017; Ebbo M, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/602809; EVANS JM, 1995, ANN INTERN MED, V122, P502, DOI 10.7326/0003-4819-122-7-199504010-00004; FIRESTEIN GS, 1985, AM J MED, V79, P65, DOI 10.1016/0002-9343(85)90547-9; GRAVALLESE EM, 1989, MEDICINE, V68, P95, DOI 10.1097/00005792-198903000-00003; Guard RW, 1995, PATHOLOGY, V27, P224, DOI 10.1080/00313029500169023; Hsu RB, 2002, J VASC SURG, V36, P746, DOI 10.1067/mva.2002.126557; Ishida M, 2009, PATHOL INT, V59, P269, DOI 10.1111/j.1440-1827.2009.02363.x; Ito H, 2008, PATHOL INT, V58, P421, DOI 10.1111/j.1440-1827.2008.02247.x; Kasashima S, 2008, AM J SURG PATHOL, V32, P197, DOI 10.1097/PAS.0b013e3181342f0d; Kasashima S, 2010, J VASC SURG, V52, P1587, DOI 10.1016/j.jvs.2010.06.072; Khosroshahi A, MEDICINE BA IN PRESS; Khosroshahi A, 2012, ARTHRITIS RHEUM-US, V64, pS1067; Khosroshahi A, 2009, LANCET, V373, P1494, DOI 10.1016/S0140-6736(09)60615-2; Laco J, 2011, CARDIOVASC PATHOL, V20, P352, DOI 10.1016/j.carpath.2010.09.003; Lin MP, 2008, J COMPUT ASSIST TOMO, V32, P616, DOI 10.1097/RCT.0b013e31814db154; LINDBLAD B, 1991, J VASC SURG, V13, P231, DOI 10.1016/0741-5214(91)90215-G; Macedo TA, 2006, RADIOLOGY, V238, P1078; Matsumoto Y, 2008, HUM PATHOL, V39, P975, DOI 10.1016/j.humpath.2007.10.023; Miller DV, 2004, HUM PATHOL, V35, P1112, DOI 10.1016/j.humpath.2004.05.013; Miller DV, 2006, AM J SURG PATHOL, V30, P1150, DOI 10.1097/01.pas.0000213293.04026.ec; Moneta GL, 1998, AM J SURG, V175, P396, DOI 10.1016/S0002-9610(98)00056-7; Ng CS, 2007, JCR-J CLIN RHEUMATOL, V13, P221, DOI 10.1097/RHU.0b013e3181337820; Oderich GS, 2001, J VASC SURG, V34, P900, DOI 10.1067/mva.2001.118084; Osler W, 1885, Br Med J, V1, P577; PENNELL RC, 1985, J VASC SURG, V2, P859, DOI 10.1067/mva.1985.avs0020859; Rojo-Leyva F, 2000, ARTHRITIS RHEUM-US, V43, P901, DOI 10.1002/1529-0131(200004)43:4<901::AID-ANR23>3.0.CO;2-U; ROSE CD, 1990, J RHEUMATOL, V17, P102; Ryu JH, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/232960; Sakata N, 2008, AM J SURG PATHOL, V32, P553, DOI 10.1097/PAS.0b013e31815a04db; Siddiquee Z, 2012, CARDIOVASC PATHOL, V21, P470, DOI 10.1016/j.carpath.2012.02.001; Stone JR, 2012, CARDIOVASC PATHOL, V21, P2, DOI 10.1016/j.carpath.2011.01.001; Stone JR, 2011, CURR OPIN RHEUMATOL, V23, P88, DOI 10.1097/BOR.0b013e3283412f7c; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Stone JH, 2010, ARTHRIT CARE RES, V62, P316, DOI 10.1002/acr.20095; Stone JH, 2009, ARTHRITIS RHEUM-US, V60, P3139, DOI 10.1002/art.24798; TUCKER CR, 1982, AM J CARDIOL, V49, P680, DOI 10.1016/0002-9149(82)91946-4; WALKER DI, 1972, BRIT J SURG, V59, P609, DOI 10.1002/bjs.1800590807; Wang H, 2012, ARTHRITIS RHEUM-US, V64, P317, DOI 10.1002/art.33343; Wang HY, 2012, J CLIN PATHOL, V65, P362, DOI 10.1136/jclinpath-2011-200424; Willett W F 3rd, 1996, J La State Med Soc, V148, P55	49	21	22	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24					2335	2346		10.1056/NEJMcpc1209330	http://dx.doi.org/10.1056/NEJMcpc1209330			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HF	23234517				2022-12-28	WOS:000312187700009
J	Hromas, R; Abkowitz, JL; Keating, A				Hromas, Robert; Abkowitz, Janis L.; Keating, Armand			Facing the NIH Funding Crisis How Professional Societies Can Help	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hromas, Robert] Univ Florida, Coll Med, Dept Med, Gainesville, FL 32610 USA; [Hromas, Robert] Shands Hlth Care Syst, Gainesville, FL USA; [Hromas, Robert; Abkowitz, Janis L.; Keating, Armand] Amer Soc Hematol, Washington, DC USA; [Abkowitz, Janis L.] Univ Washington, Dept Med, Div Hematol, Seattle, WA USA; [Keating, Armand] Princess Margaret Hosp, Cell Therapy Program, Toronto, ON M4X 1K9, Canada	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Hromas, R (corresponding author), Univ Florida, Coll Med, Dept Med, 1600 SW Archer, Gainesville, FL 32610 USA.	robert.hromas@medicine.ufl.edu			NATIONAL CANCER INSTITUTE [R01CA139429] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031823, K12HL087165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085146] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA139429] Funding Source: Medline; NHLBI NIH HHS [K12 HL087165, R01 HL031823] Funding Source: Medline; NIDDK NIH HHS [R01 DK085146] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		American Society of Hematology (ASH, 2012, ASH BRIDG GRANT PROG; Atkinson RD, 2012, LEADERSHIP DECLINE A; DeVol RC., 2011, GLOBAL BIOMEDICAL IN; Ehrlich E., ENGINE STALLED SEQUE; Office of Budget National Institutes of Health (NIH), PRIC IND; Office of Extramural Research National Institutes of Health (NIH), 2011, WHATS 2011 SUCC RAT	6	30	30	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2012	308	22					2343	2344		10.1001/jama.2012.45067	http://dx.doi.org/10.1001/jama.2012.45067			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051MW	23183908	Green Accepted			2022-12-28	WOS:000312132400022
J	Baldi, S; Barral, Y				Baldi, Sandro; Barral, Yves			Bacterial Border Fence	CELL			English	Editorial Material							SEPTINS	Bacteria lack many of the features that eukaryotic cells use to compartmentalize cytoplasm and membranes. In this issue, Schlimpert et al. describe a new mechanism of spatial confinment in the bacterium Caulobacter crescentus that prevents the exchange of soluble and membrane proteins between the stalk and cell body.	[Baldi, Sandro; Barral, Yves] ETH, Inst Biochem, CH-8093 Zurich, Switzerland	ETH Zurich	Barral, Y (corresponding author), ETH, Inst Biochem, CH-8093 Zurich, Switzerland.	yves.barral@bc.biol.ethz.ch		Baldi, Sandro/0000-0002-9689-5317; Barral, Yves/0000-0002-0989-3373				Ackermann M, 2003, SCIENCE, V300, P1920, DOI 10.1126/science.1083532; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Gonin M, 2000, J BACTERIOL, V182, P337, DOI 10.1128/JB.182.2.337-347.2000; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kirkpatrick CL, 2012, FEMS MICROBIOL REV, V36, P193, DOI 10.1111/j.1574-6976.2011.00309.x; Schlimpert S, 2012, CELL, V151, P1270, DOI 10.1016/j.cell.2012.10.046; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; STOVEPOINDEXTER J L, 1964, J Cell Biol, V23, P587, DOI 10.1083/jcb.23.3.587	8	1	1	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1159	1160		10.1016/j.cell.2012.11.035	http://dx.doi.org/10.1016/j.cell.2012.11.035			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217701	Bronze			2022-12-28	WOS:000311999900005
J	Nagano, AJ; Sato, Y; Mihara, M; Antonio, BA; Motoyama, R; Itoh, H; Nagamura, Y; Izawa, T				Nagano, Atsushi J.; Sato, Yutaka; Mihara, Motohiro; Antonio, Baltazar A.; Motoyama, Ritsuko; Itoh, Hironori; Nagamura, Yoshiaki; Izawa, Takeshi			Deciphering and Prediction of Transcriptome Dynamics under Fluctuating Field Conditions	CELL			English	Article							CIRCADIAN CLOCK; GENE-EXPRESSION; ARABIDOPSIS; RICE; PHYTOCHROME; REGULATORS	Determining the drivers of gene expression patterns is more straightforward in laboratory conditions than in the complex fluctuating environments where organisms typically live. We gathered transcriptome data from the leaves of rice plants in a paddy field along with the corresponding meteorological data and used them to develop statistical models for the endogenous and external influences on gene expression. Our results indicate that the transcriptome dynamics are predominantly governed by endogenous diurnal rhythms, ambient temperature, plant age, and solar radiation. The data revealed diurnal gates for environmental stimuli to influence transcription and pointed to relative influences exerted by circadian and environmental factors on different metabolic genes. The model also generated predictions for the influence of changing temperatures on transcriptome dynamics. We anticipate that our models will help translate the knowledge amassed in laboratories to problems in agriculture and that our approach to deciphering the transcriptome fluctuations in complex environments will be applicable to other organisms.	[Nagano, Atsushi J.; Itoh, Hironori; Izawa, Takeshi] Natl Inst Agrobiol Sci, Photosynthesis & Photobiol Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Sato, Yutaka; Antonio, Baltazar A.; Motoyama, Ritsuko; Nagamura, Yoshiaki] Natl Inst Agrobiol Sci, Genome Resource Ctr, Tsukuba, Ibaraki 3058602, Japan; [Mihara, Motohiro; Izawa, Takeshi] Natl Inst Agrobiol Sci, Plant Genom Res Unit, Tsukuba, Ibaraki 3058602, Japan	National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan	Nagamura, Y (corresponding author), Natl Inst Agrobiol Sci, Genome Resource Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	nagamura@affrc.go.jp; tizawa@nias.affrc.go.jp	Nagano, Atsushi J./A-2957-2019	Nagano, Atsushi J./0000-0001-7891-5049; Izawa, Takeshi/0000-0001-5109-0024	Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation) [RTR-0004, GPN0001, RTR-0002]	Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation)(Ministry of Agriculture Forestry & Fisheries - Japan)	We thank M. Ebihara for her experimental assistance; M. Fukata for maintaining the FiT-DB database and registration of some microarray data to GEO; Dr. S. Ishida for useful advice on the annotation enrichment analysis; H. Minami, K. Kamatsuki, N. Namiki for assistance in analysis of microarray data and registration to GEO; and Dr. N. Sakurai for providing the gene lists in KaPPA-View4. This work was supported by grants from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation; RTR-0004 and GPN0001 to T. I. and RTR-0002 to Y.N.).	Doherty CJ, 2010, ANNU REV GENET, V44, P419, DOI 10.1146/annurev-genet-102209-163432; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; IPCC, 2007, CONTRIBUTION WORKING; Itoh H, 2010, NAT GENET, V42, P635, DOI 10.1038/ng.606; Izawa T, 2012, PLANT CELL ENVIRON, V35, P1729, DOI 10.1111/j.1365-3040.2012.02555.x; Izawa T, 2011, PLANT CELL, V23, P1741, DOI 10.1105/tpc.111.083238; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Morita S., 2009, Bulletin of the National Agricultural Research Center for Kyushu Okinawa Region, P1; Richards CL, 2012, PLOS GENET, V8, P482, DOI 10.1371/journal.pgen.1002662; Ronald P, 2011, GENETICS, V188, P11, DOI 10.1534/genetics.111.128553; Salazar JD, 2009, CELL, V139, P1170, DOI 10.1016/j.cell.2009.11.029; Sato Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-10; Shinomura T, 1996, P NATL ACAD SCI USA, V93, P8129, DOI 10.1073/pnas.93.15.8129; Shinomura T, 2000, PLANT PHYSIOL, V122, P147, DOI 10.1104/pp.122.1.147	17	139	143	1	56	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1358	1369		10.1016/j.cell.2012.10.048	http://dx.doi.org/10.1016/j.cell.2012.10.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217716	Bronze			2022-12-28	WOS:000311999900023
J	Stensola, H; Stensola, T; Solstad, T; Froland, K; Moser, MB; Moser, EI				Stensola, Hanne; Stensola, Tor; Solstad, Trygve; Froland, Kristian; Moser, May-Britt; Moser, Edvard I.			The entorhinal grid map is discretized	NATURE			English	Article							SPATIAL REPRESENTATION; FUNCTIONAL ARCHITECTURE; THETA OSCILLATIONS; PATH-INTEGRATION; SINGLE NEURONS; CELLS; INTERFERENCE; DIRECTION; CORTEX; MONKEY	The medial entorhinal cortex (MEC) is part of the brain's circuit for dynamic representation of self-location. The metric of this representation is provided by grid cells, cells with spatial firing fields that tile environments in a periodic hexagonal pattern. Limited anatomical sampling has obscured whether the grid system operates as a unified system or a conglomerate of independent modules. Here we show with recordings from up to 186 grid cells in individual rats that grid cells cluster into a small number of layer-spanning anatomically overlapping modules with distinct scale, orientation, asymmetry and theta-frequency modulation. These modules can respond independently to changes in the geometry of the environment. The discrete topography of the grid-map, and the apparent autonomy of the modules, differ from the graded topography of maps for continuous variables in several sensory systems, raising the possibility that the modularity of the grid map is a product of local self-organizing network dynamics.	[Stensola, Hanne; Stensola, Tor; Solstad, Trygve; Froland, Kristian; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, MTFS, N-7491 Trondheim, Norway; [Stensola, Hanne; Stensola, Tor; Solstad, Trygve; Froland, Kristian; Moser, May-Britt; Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, Ctr Biol Memory, N-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, MTFS, Olav Kyrres Gate 9, N-7491 Trondheim, Norway.	hanne.stensola@ntnu.no; tor.stensola@ntnu.no; edvard.moser@ntnu.no		Stensola, Tor/0000-0002-5485-6141; Stensola, Hanne/0000-0002-5823-944X	European Research Council ('CIRCUIT') [232608]; Kavli Foundation; Centre of Excellence scheme of the Research Council of Norway	European Research Council ('CIRCUIT'); Kavli Foundation; Centre of Excellence scheme of the Research Council of Norway	We thank A. M. Amundgard, K. Haugen, K. Jenssen, E. Krakvik, R. Skjerpeng, and H. Waade for technical assistance, J. Whitlock for implanting an animal in the tangential group, and T. Bonhoeffer, B. Dunn, B. McNaughton, Y. Roudi, A. Treves and A. Witoelar for helpful discussion. The work was supported by an Advanced Investigator Grant from the European Research Council ('CIRCUIT', Grant Agreement no. 232608), the Kavli Foundation and the Centre of Excellence scheme of the Research Council of Norway.	Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Blair HT, 2007, J NEUROSCI, V27, P3211, DOI 10.1523/JNEUROSCI.4724-06.2007; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgalossi A, 2011, NEURON, V70, P773, DOI 10.1016/j.neuron.2011.04.003; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; Couey J.J., 2012, SOC NEC ABSTR, V702.06; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Giocomo LM, 2011, NEURON, V71, P589, DOI 10.1016/j.neuron.2011.07.023; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; HEVNER RF, 1992, J COMP NEUROL, V326, P451, DOI 10.1002/cne.903260310; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; IKEDA J, 1989, BRAIN RES, V505, P176, DOI 10.1016/0006-8993(89)90134-0; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; Kropff E, 2008, HIPPOCAMPUS, V18, P1256, DOI 10.1002/hipo.20520; Krupic J, 2012, SCIENCE, V337, P853, DOI 10.1126/science.1222403; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mhatre H, 2012, HIPPOCAMPUS, V22, P320, DOI 10.1002/hipo.20901; Monaco JD, 2011, J NEUROSCI, V31, P9414, DOI 10.1523/JNEUROSCI.1433-11.2011; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; PAYNE BR, 1981, BRAIN RES, V211, P445, DOI 10.1016/0006-8993(81)90971-9; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Sperry RW, 1943, J COMP NEUROL, V79, P33, DOI 10.1002/cne.900790104; Sreenivasan S, 2011, NAT NEUROSCI, V14, P1330, DOI 10.1038/nn.2901; TOLHURST DJ, 1981, EXP BRAIN RES, V44, P340; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0; Wills TJ, 2010, SCIENCE, V328, P1573, DOI 10.1126/science.1188224; Witter MP, 2006, TRENDS NEUROSCI, V29, P671, DOI 10.1016/j.tins.2006.10.003; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583; Zilli EA, 2010, J NEUROSCI, V30, P13850, DOI 10.1523/JNEUROSCI.0547-10.2010	50	362	368	1	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					72	78		10.1038/nature11649	http://dx.doi.org/10.1038/nature11649			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23222610				2022-12-28	WOS:000311893400047
J	Barzansky, B; Etzel, SI				Barzansky, Barbara; Etzel, Sylvia I.			Medical Schools in the United States, 2011-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Barzansky, Barbara] Amer Med Assoc, Div Undergrad Med Educ, Chicago, IL 60654 USA; Amer Med Assoc, Div Grad Med Educ, Chicago, IL 60654 USA	American Medical Association; American Medical Association	Barzansky, B (corresponding author), Amer Med Assoc, Div Undergrad Med Educ, 515 N State St, Chicago, IL 60654 USA.	barbara.barzansky@ama-assn.org							0	6	6	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2012	308	21					2257	2263		10.1001/jama.2012.13425	http://dx.doi.org/10.1001/jama.2012.13425			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047HI	23212507				2022-12-28	WOS:000311829500021
J	Lucas, BP; Trick, WE; Evans, AT; Mba, B; Smith, J; Das, K; Clarke, P; Varkey, A; Mathew, S; Weinstein, RA				Lucas, Brian P.; Trick, William E.; Evans, Arthur T.; Mba, Benjamin; Smith, Jennifer; Das, Krishna; Clarke, Peter; Varkey, Anita; Mathew, Suja; Weinstein, Robert A.			Effects of 2-vs 4-Week Attending Physician Inpatient Rotations on Unplanned Patient Revisits, Evaluations by Trainees, and Attending Physician Burnout A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICAL-EDUCATION RESEARCH; CARE; OUTCOMES; SATISFACTION; STRESS; READMISSIONS; PERSPECTIVE; WORKLIFE; FACULTY; DESIGN	Context Data are sparse on the effect of varying the durations of internal medicine attending physician ward rotations. Objective To compare the effects of 2- vs 4-week inpatient attending physician rotations on unplanned patient revisits, attending evaluations by trainees, and attending propensity for burnout. Design, Setting, and Participants Cluster randomized crossover noninferiority trial, with attending physicians as the unit of crossover randomization and 4-week rotations as the active control, conducted in a US university-affiliated teaching hospital in academic year 2009. Participants were 62 attending physicians who staffed at least 6 weeks of inpatient service, the 8892 unique patients whom they discharged, and the 147 house staff and 229 medical students who evaluated their performance. Intervention Assignment to random sequences of 2- and 4-week rotations. Main Outcome Measures Primary outcome was 30-day unplanned revisits (visits to the hospital's emergency department or urgent ambulatory clinic, unplanned readmissions, and direct transfers from neighboring hospitals) for patients discharged from 2- vs 4-week within-attending-physician rotations. Noninferiority margin was a 2% increase (odds ratio [OR] of 1.13) in 30-day unplanned patient revisits. Secondary outcomes were length of stay; trainee evaluations of attending physicians; and attending physician reports of burnout, stress, and workplace control. Results Among the 8892 patients, there were 2437 unplanned revisits. The percentage of 30-day unplanned revisits for patients of attending physicians on 2-week rotations was 21.2% compared with 21.5% for 4-week rotations (mean difference, -0.3%; 95% CI, -1.8% to +1.2%). The adjusted OR of a patient having a 30-day unplanned revisit after 2-vs 4-week rotations was 0.97 (1-sided 97.5% upper confidence limit, 1.07; noninferiority P=.007). Average length of stay was not significantly different (geometric means for 2- vs 4-week rotations were 67.2 vs 67.5 hours; difference, -0.9%; 95% CI, -4.7% to +2.9%). Attending physicians were more likely to score lower in their ability to evaluate trainees after 2-vs 4-week rotations by both house staff (41% vs 28% rated less than perfect; adjusted OR, 2.10; 95% CI, 1.50-3.02) and medical students (82% vs 69% rated less than perfect; adjusted OR, 1.41; 95% CI, 1.06-2.10). They were less likely to report higher scores of both burnout severity (16% vs 35%; adjusted OR, 0.39; 95% CI, 0.26-0.58) and emotional exhaustion (19% vs 37%; adjusted OR, 0.45; 95% CI, 0.31 to 0.64) after 2- vs 4-week rotations. Conclusions The use of 2-week inpatient attending physician rotations compared with 4-week rotations did not result in an increase in unplanned patient revisits. It was associated with better self-rated measures of attending physician burnout and emotional exhaustion but worse evaluations by trainees.	[Lucas, Brian P.; Trick, William E.; Mba, Benjamin; Smith, Jennifer; Das, Krishna; Clarke, Peter; Mathew, Suja; Weinstein, Robert A.] Cook Cty Hlth & Hosp Syst, Dept Med, Chicago, IL 60612 USA; [Lucas, Brian P.; Trick, William E.; Mba, Benjamin; Smith, Jennifer; Das, Krishna; Clarke, Peter; Mathew, Suja; Weinstein, Robert A.] Rush Med Coll, Chicago, IL 60612 USA; [Varkey, Anita] Loyola Univ, Med Ctr, Dept Med, Chicago, IL 60611 USA; [Varkey, Anita] Stritch Sch Med, Chicago, IL USA; [Evans, Arthur T.] New York Presbyterian Hosp, Dept Med, New York, NY USA; [Evans, Arthur T.] Weill Cornell Med Coll, New York, NY USA	John H Stroger Junior Hospital Cook County; Rush University; Loyola University Chicago; Loyola University Chicago; NewYork-Presbyterian Hospital; Cornell University	Lucas, BP (corresponding author), Cook Cty Hlth & Hosp Syst, Dept Med, 1900 W Polk St,Room 520, Chicago, IL 60612 USA.	brian_lucas@rush.edu		Trick, William/0000-0002-3243-5098	Agency for Healthcare Research and Quality; Foglia Family Foundation	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Foglia Family Foundation	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Trick reports receiving research support from the Agency for Healthcare Research and Quality, but this support was not used for any portion of the current article. No other disclosures were reported.; Support for this study was provided by a philanthropic gift from the Foglia Family Foundation.	Akl EA, 2004, J GEN INTERN MED, V19, P1133, DOI 10.1111/j.1525-1497.2004.30408.x; Arora VM, 2008, MED CLIN N AM, V92, P315, DOI 10.1016/j.mcna.2007.11.002; Ashforth BE, 1997, J ORGAN BEHAV, V18, P703, DOI 10.1002/(SICI)1099-1379(199711)18:6<703::AID-JOB847>3.0.CO;2-1; Berkowitz SA, 2012, ARCH INTERN MED, V172, P269, DOI 10.1001/archinternmed.2011.606; Carney PA, 2004, JAMA-J AM MED ASSOC, V292, P1044, DOI 10.1001/jama.292.9.1044; Chen FM, 2005, MED EDUC, V39, P350, DOI 10.1111/j.1365-2929.2005.02117.x; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; DIMATTEO MR, 1993, HEALTH PSYCHOL, V12, P93, DOI 10.1037/0278-6133.12.2.93; DONOVAN JL, 1992, SOC SCI MED, V34, P507, DOI 10.1016/0277-9536(92)90206-6; Dyrbye LN, 2011, ARCH INTERN MED, V171, P1207, DOI 10.1001/archinternmed.2011.289; Elnicki DM, 2011, TEACH LEARN MED, V23, P37, DOI 10.1080/10401334.2011.536889; Freeborn DK, 2001, WESTERN J MED, V174, P13, DOI 10.1136/ewjm.174.1.13; Ivancevich JM., 1980, STRESS WORK MANAGERI; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jones B., 2003, DESIGN ANAL CROSS OV, V2nd; Joynt KE, 2012, NEW ENGL J MED, V366, P1366, DOI 10.1056/NEJMp1201598; Kaul S, 2006, ANN INTERN MED, V145, P62, DOI 10.7326/0003-4819-145-1-200607040-00011; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Lazarus RS., 1984, STRESS APPRAISAL COP; Leckie G., 2011, RUNMLWIN STATA MODUL; Linzer M, 2002, STRESS HEALTH, V18, P37, DOI 10.1002/smi.917; Linzer M, 2001, AM J MED, V111, P170, DOI 10.1016/S0002-9343(01)00814-2; LINZER M, 2005, AHRQ PUBLICATION; Lurie SJ, 2003, JAMA-J AM MED ASSOC, V290, P1210, DOI 10.1001/jama.290.9.1210; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; McMahon GT, 2010, NEW ENGL J MED, V362, P1304, DOI 10.1056/NEJMsa0908136; Norris CM, 2006, J CLIN EPIDEMIOL, V59, P448, DOI 10.1016/j.jclinepi.2005.09.007; Nutter D, AAMC PROJECT CLIN ED; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Pocock SJ, 1997, CONTROL CLIN TRIALS, V18, P530, DOI 10.1016/S0197-2456(97)00008-1; Prystowsky JB, 2001, MED EDUC, V35, P331, DOI 10.1046/j.1365-2923.2001.00910.x; Sackett D, 2006, PRINCIPLES TACTICS P; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, V3rd, P22; Schmoldt R A, 1994, HMO Pract, V8, P58; Senn S, 2002, CROSS OVER TRIALS CL; Shanafelt TD, 2009, JAMA-J AM MED ASSOC, V302, P1338, DOI 10.1001/jama.2009.1385; Smith CA, 2004, J GEN INTERN MED, V19, P766, DOI 10.1111/j.1525-1497.2004.30269.x; Smith MEB, 2009, AM J MED, V122, P96, DOI 10.1016/j.amjmed.2008.09.031; Spellberg B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035576; STOUT JK, 1983, PSYCHOL REP, V53, P283, DOI 10.2466/pr0.1983.53.1.283; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Todres M, 2007, BMJ-BRIT MED J, V335, P333, DOI 10.1136/bmj.39253.544688.94; Veninga RL, 1981, WORK STRESS CONNECTI; Williams ES, 2007, HEALTH CARE MANAGE R, V32, P203, DOI 10.1097/01.HMR.0000281626.28363.59; Williams ES, 2002, HEALTH SERV RES, V37, P121; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x	46	40	39	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2012	308	21					2199	2207		10.1001/jama.2012.36522	http://dx.doi.org/10.1001/jama.2012.36522			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	047HI	23212497	Bronze			2022-12-28	WOS:000311829500011
J	McArdle, C				McArdle, Ciarstan			PERSONAL VIEW Patients with melanoma are avoiding follow-up to get insurance	BRITISH MEDICAL JOURNAL			English	Editorial Material							CUTANEOUS MELANOMA		James Cook Univ Hosp, Dept Plast Surg, Middlesbrough TS4 3BW, Cleveland, England	James Cook University Hospital	McArdle, C (corresponding author), James Cook Univ Hosp, Dept Plast Surg, Middlesbrough TS4 3BW, Cleveland, England.	ciarstanmcardle@gmail.com						American Cancer Society, 2012, LEARN CANC MAL SKIN; Cancer Research UK, 2012, SKIN CANC INC STAT T; DiFronzo LA, 1999, ANN SURG ONCOL, V6, P705, DOI 10.1007/s10434-999-0705-0; Marsden JR, 2010, BRIT J DERMATOL, V163, P238, DOI [10.1111/j.1365-2133.2010.09883.x, 10.1016/j.bjps.2010.07.006]	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 3	2012	345								e7803	10.1136/bmj.e7803	http://dx.doi.org/10.1136/bmj.e7803			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HO	23208251				2022-12-28	WOS:000312188700004
J	Cortes, JE; Kantarjian, H; Shah, NP; Bixby, D; Mauro, MJ; Flinn, I; O'Hare, T; Hu, S; Narasimhan, NI; Rivera, VM; Clackson, T; Turner, CD; Haluska, FG; Druker, BJ; Deininger, MWN; Talpaz, M				Cortes, Jorge E.; Kantarjian, Hagop; Shah, Neil P.; Bixby, Dale; Mauro, Michael J.; Flinn, Ian; O'Hare, Thomas; Hu, Simin; Narasimhan, Narayana I.; Rivera, Victor M.; Clackson, Tim; Turner, Christopher D.; Haluska, Frank G.; Druker, Brian J.; Deininger, Michael W. N.; Talpaz, Moshe			Ponatinib in Refractory Philadelphia Chromosome-Positive Leukemias	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOID-LEUKEMIA; KINASE DOMAIN MUTATIONS; CHRONIC MYELOGENOUS LEUKEMIA; INTERNATIONAL-WORKING-GROUP; DIAGNOSED CHRONIC-PHASE; BCR-ABL INHIBITOR; TYROSINE KINASE; RESPONSE CRITERIA; FOLLOW-UP; CLINICAL RESISTANCE	Background Resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Phpositive ALL) is frequently caused by mutations in the BCR-ABL kinase domain. Ponatinib (AP24534) is a potent oral tyrosine kinase inhibitor that blocks native and mutated BCR-ABL, including the gatekeeper mutant T315I, which is uniformly resistant to tyrosine kinase inhibitors. Methods In this phase 1 dose-escalation study, we enrolled 81 patients with resistant hematologic cancers, including 60 with CML and 5 with Ph-positive ALL. Ponatinib was administered once daily at doses ranging from 2 to 60 mg. Median follow-up was 56 weeks (range, 2 to 140). Results Dose-limiting toxic effects included elevated lipase or amylase levels and pancreatitis. Common adverse events were rash, myelosuppression, and constitutional symptoms. Among Ph-positive patients, 91% had received two or more approved tyrosine kinase inhibitors, and 51% had received all three approved tyrosine kinase inhibitors. Of 43 patients with chronic-phase CML, 98% had a complete hematologic response, 72% had a major cytogenetic response, and 44% had a major molecular response. Of 12 patients who had chronic-phase CML with the T315I mutation, 100% had a complete hematologic response and 92% had a major cytogenetic response. Of 13 patients with chronic-phase CML without detectable mutations, 100% had a complete hematologic response and 62% had a major cytogenetic response. Responses among patients with chronic-phase CML were durable. Of 22 patients with accelerated-phase or blast-phase CML or Ph-positive ALL, 36% had a major hematologic response and 32% had a major cytogenetic response. Conclusions Ponatinib was highly active in heavily pretreated patients with Ph-positive leukemias with resistance to tyrosine kinase inhibitors, including patients with the BCR-ABL T315I mutation, other mutations, or no mutations. (Funded by Ariad Pharmaceuticals and others; ClinicalTrials.gov number, NCT00660920.)	[Cortes, Jorge E.] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA; [Shah, Neil P.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Bixby, Dale; Talpaz, Moshe] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Mauro, Michael J.; O'Hare, Thomas; Druker, Brian J.; Deininger, Michael W. N.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Flinn, Ian] Sarah Cannon Res Inst, Nashville, TN USA; [O'Hare, Thomas; Deininger, Michael W. N.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Hu, Simin; Narasimhan, Narayana I.; Rivera, Victor M.; Clackson, Tim; Turner, Christopher D.; Haluska, Frank G.] ARIAD Pharmaceut, Cambridge, MA USA	University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; Oregon Health & Science University; Sarah Cannon Research Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Takeda Pharmaceutical Company Ltd; Takeda Oncology	Cortes, JE (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA.	jcortes@mdanderson.org		Talpaz, Moshe/0000-0003-3361-3981; Druker, Brian/0000-0001-8331-8206; Flinn, Ian/0000-0001-6724-290X; Cortes, Jorge/0000-0002-8636-1071; Rivera, Victor/0000-0002-7258-3001	Ariad Pharmaceuticals; National Institutes of Health [CA016672]; Novartis; Bristol-Myers Squibb; Pfizer; Chemgenex; Deciphera; Incyte; Ambit; Plexxikon; Novartis Oncology; MolecularMD; Blueprint Medicines; Cylene Pharmaceuticals; Gilead Sciences; Millennium Pharmaceuticals; Calistoga; Celgene; Genzyme; NATIONAL CANCER INSTITUTE [P30CA069533, P30CA016672, P01CA049639, R37CA065823] Funding Source: NIH RePORTER	Ariad Pharmaceuticals; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis(Novartis); Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); Chemgenex; Deciphera; Incyte; Ambit; Plexxikon; Novartis Oncology; MolecularMD; Blueprint Medicines; Cylene Pharmaceuticals; Gilead Sciences(Gilead Sciences); Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Calistoga; Celgene(Bristol-Myers SquibbCelgene Corporation); Genzyme(Sanofi-AventisGenzyme Corporation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Ariad Pharmaceuticals and others; Supported by Ariad Pharmaceuticals and by a grant (CA016672) to M.D. Anderson Cancer Center from the National Institutes of Health. Drs. Shah and Deininger are Scholars in Clinical Research of the Leukemia and Lymphoma Society. Dr. Cortes reports receiving consulting fees from Ariad Pharmaceuticals, Novartis, Bristol-Myers Squibb, Pfizer, and Chemgenex and grant support (or grants pending) paid to his institution from Ariad Pharmaceuticals, Novartis, Bristol-Myers Squibb, Pfizer, Chemgenex, Deciphera, and Incyte; Dr. Kantarjian, receiving grant support (or grants pending) paid to his institution from Novartis and Bristol-Myers Squibb; Dr. Shah, receiving consulting fees from Bristol-Myers Squibb and Novartis and grant support (or grants pending) paid to his institution from Bristol-Myers Squibb, Ambit, and Plexxikon; Dr. Mauro, receiving consulting fees and lecture fees from Bristol-Myers Squibb, Novartis Oncology, and Pfizer; Drs. Hu, Narasimhan, Rivera, Clackson, Turner, and Haluska, being employees of and having an equity interest in Ariad Pharmaceuticals; Dr. Druker, serving on advisory boards for MolecularMD, Blueprint Medicines, Ambit Biosciences, Cylene Pharmaceuticals, Gilead Sciences, Hoffmann-La Roche, and Calistoga, receiving consulting fees from MolecularMD, Blueprint Medicines, Cylene Pharmaceuticals, Gilead Sciences, Millennium Pharmaceuticals, and Calistoga and grant support (or grants pending) paid to his institution from Novartis and Bristol-Myers Squibb, receiving royalties on patents (Mutated ABL Kinase Domains #0843 and Detection of Gleevec Resistant Mutations #0996) and from licensing monoclonal antiphosphotyrosine antibody 4G10 to Millipore, and having an equity interest in Blueprint Medicines and MolecularMD (technology used in this study has been licensed to MolecularMD, a potential conflict of interest that has been reviewed and managed by the Conflict of Interest in Research Committee and the Integrity Program Oversight Council at the Oregon Health and Science University); Dr. Deininger, serving as a board member for and receiving consulting fees from Bristol-Myers Squibb, Novartis, and Ariad Pharmaceuticals and receiving grant support (or grants pending) paid to his institution from Bristol-Myers Squibb, Celgene, and Genzyme; and Dr. Talpaz, receiving consulting fees from Ariad Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2011, TASIGNA NILOTINIB CA; [Anonymous], 2011, SPRYCEL DASATINIB TA; Baccarani M, 2009, J CLIN ONCOL, V27, P6041, DOI 10.1200/JCO.2009.25.0779; Branford S, 2003, BLOOD, V102, P276, DOI 10.1182/blood-2002-09-2896; Branford S, 2008, BLOOD, V112, P3330, DOI 10.1182/blood-2008-04-150680; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Cheson BD, 2000, BLOOD, V96, P3671; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Cortes J, 2007, BLOOD, V110, P4005, DOI 10.1182/blood-2007-03-080838; Cortes JE, 2011, BLOOD, V118, P4567, DOI 10.1182/blood-2011-05-355594; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; de Lavallade H, 2008, J CLIN ONCOL, V26, P3358, DOI 10.1200/JCO.2007.15.8154; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Faderl Stefan, 2002, Rev Clin Exp Hematol, V6, P142, DOI 10.1046/j.1468-0734.2002.00066.x; Garg RJ, 2009, BLOOD, V114, P4361, DOI 10.1182/blood-2009-05-221531; Giles FJ, 2010, LEUKEMIA, V24, P1299, DOI 10.1038/leu.2010.110; Gozgit JM, 2012, P AM ASS CANC RES AN; Gozgit JM, 2012, MOL CANCER THER, V11, P690, DOI 10.1158/1535-7163.MCT-11-0450; Gozgit JM, 2011, MOL CANCER THER, V10, P1028, DOI 10.1158/1535-7163.MCT-10-1044; Hughes T, 2006, BLOOD, V108, P28, DOI 10.1182/blood-2006-01-0092; Ibrahim AR, 2010, BLOOD, V116, P5497, DOI 10.1182/blood-2010-06-291922; Jabbour E, 2009, TARGET ONCOL, V4, P3, DOI 10.1007/s11523-008-0100-y; Jabbour E, 2008, BLOOD, V112, P4839, DOI 10.1182/blood-2008-04-149948; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Kantarjian HM, 2012, BLOOD, V119, P1123, DOI 10.1182/blood-2011-08-376087; Kantarjian HM, 2011, LANCET ONCOL, V12, P841, DOI 10.1016/S1470-2045(11)70201-7; Khorashad JS, 2008, J CLIN ONCOL, V26, P4806, DOI 10.1200/JCO.2008.16.9953; Khorashad JS, 2006, LEUKEMIA, V20, P658, DOI 10.1038/sj.leu.2404137; Khoury HJ, 2012, BLOOD, V119, P3403, DOI 10.1182/blood-2011-11-390120; Kummar S, 2006, BRIT J CLIN PHARMACO, V62, P15, DOI 10.1111/j.1365-2125.2006.02713.x; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Nicolini FE, 2006, LEUKEMIA, V20, P1061, DOI 10.1038/sj.leu.2404236; O'Hare T, 2007, BLOOD, V110, P2242, DOI 10.1182/blood-2007-03-066936; O'Hare T, 2009, CANCER CELL, V16, P401, DOI 10.1016/j.ccr.2009.09.028; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Quintes-Cardama A, 2009, CANCER CONTROL, V16, P122, DOI 10.1177/107327480901600204; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Soverini S, 2006, CLIN CANCER RES, V12, P7374, DOI 10.1158/1078-0432.CCR-06-1516; Talpaz M, 2011, ANN M AM SOC CLIN ON; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tefferi A, 2006, BLOOD, V108, P1497, DOI 10.1182/blood-2006-03-009746; Zhou TJ, 2011, CHEM BIOL DRUG DES, V77, P1, DOI 10.1111/j.1747-0285.2010.01054.x	46	536	550	1	60	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2012	367	22					2075	2088		10.1056/NEJMoa1205127	http://dx.doi.org/10.1056/NEJMoa1205127			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044MS	23190221	Green Accepted, Bronze			2022-12-28	WOS:000311624400005
J	Goldstein, JL; Brown, MS				Goldstein, Joseph L.; Brown, Michael S.			A Golden Era of Nobel Laureates	SCIENCE			English	Editorial Material									[Goldstein, Joseph L.; Brown, Michael S.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldstein, JL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	joe.goldstein@utsouthwestern.edu; mike.brown@utsouthwestern.edu							0	22	22	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1033	1034		10.1126/science.1231699	http://dx.doi.org/10.1126/science.1231699			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23180848				2022-12-28	WOS:000311390600027
J	Stern-Ginossar, N; Weisburd, B; Michalski, A; Vu, TKL; Hein, MY; Huang, SX; Ma, M; Shen, B; Qian, SB; Hengel, H; Mann, M; Ingolia, NT; Weissman, JS				Stern-Ginossar, Noam; Weisburd, Ben; Michalski, Annette; Vu Thuy Khanh Le; Hein, Marco Y.; Huang, Sheng-Xiong; Ma, Ming; Shen, Ben; Qian, Shu-Bing; Hengel, Hartmut; Mann, Matthias; Ingolia, Nicholas T.; Weissman, Jonathan S.			Decoding Human Cytomegalovirus	SCIENCE			English	Article							TRANSCRIPTIONAL ACTIVATION; PROTEIN	The human cytomegalovirus (HCMV) genome was sequenced 20 years ago. However, like those of other complex viruses, our understanding of its protein coding potential is far from complete. We used ribosome profiling and transcript analysis to experimentally define the HCMV translation products and follow their temporal expression. We identified hundreds of previously unidentified open reading frames and confirmed a fraction by means of mass spectrometry. We found that regulated use of alternative transcript start sites plays a broad role in enabling tight temporal control of HCMV protein expression and allowing multiple distinct polypeptides to be generated from a single genomic locus. Our results reveal an unanticipated complexity to the HCMV coding capacity and illustrate the role of regulated changes in transcript start sites in generating this complexity.	[Michalski, Annette; Hein, Marco Y.; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Stern-Ginossar, Noam; Weisburd, Ben; Ingolia, Nicholas T.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisico, CA 94158 USA; [Vu Thuy Khanh Le; Hengel, Hartmut] Univ Dusseldorf, Inst Virol, D-40225 Dusseldorf, Germany; [Huang, Sheng-Xiong; Ma, Ming; Shen, Ben] Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Shen, Ben] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Shen, Ben] Scripps Res Inst, Nat Prod Lib Initiat, Jupiter, FL 33458 USA; [Qian, Shu-Bing] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Max Planck Society; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Heinrich Heine University Dusseldorf; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Cornell University	Michalski, A (corresponding author), Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany.	michalsk@biochem.mpg.de; weissman@cmp.ucsf.edu	Hein, Marco/C-2994-2014; Mann, Matthias/A-3454-2013; Le-Trilling, Vu Thuy Khanh/AAW-3600-2020	Hein, Marco/0000-0002-9490-2261; Mann, Matthias/0000-0003-1292-4799; Le-Trilling, Vu Thuy Khanh/0000-0002-2733-3732; Weisburd, Ben/0000-0001-9898-9109; Weissman, Jonathan/0000-0003-2445-670X; Huang, Sheng-Xiong/0000-0002-3616-8556; , Noam/0000-0003-3583-5932	human frontier science program postdoctoral fellowship; Howard Hughes Medical Institute; Max Planck Society; NATIONAL CANCER INSTITUTE [R01CA106150] Funding Source: NIH RePORTER	human frontier science program postdoctoral fellowship(Human Frontier Science Program); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Max Planck Society(Max Planck Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank O. Mandelboim, D. Wolf, M. Trilling, A. Lauring, S. Karniely, and Weissman lab members for critical reading of the manuscript; C. Chu for assistance with sequencing; and J. Pelletier for providing Pateamine A. N.S.-G. is supported by a human frontier science program postdoctoral fellowship. This work was supported by the Howard Hughes Medical Institute (J. S. W.) and the Max Planck Society (M. M.). The Gene Expression Omnibus accession number for the data is GSE41605.	Biegalke BJ, 2004, J VIROL, V78, P9579, DOI 10.1128/JVI.78.17.9579-9583.2004; Bordeleau ME, 2006, CHEM BIOL, V13, P1287, DOI 10.1016/j.chembiol.2006.10.005; Cao JH, 1996, MOL CELL BIOL, V16, P7109; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Davison AJ, 2003, J GEN VIROL, V84, P17, DOI 10.1099/vir.0.18606-0; FIERS W, 1978, NATURE, V273, P113, DOI 10.1038/273113a0; Gatherer D, 2011, P NATL ACAD SCI USA, V108, P19755, DOI 10.1073/pnas.1115861108; Grainger L, 2010, J VIROL, V84, P9472, DOI 10.1128/JVI.00855-10; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Joachim T., 1998, MAKING LARGE SCALE S, P169, DOI DOI 10.17877/DE290R-5098; LEACH FS, 1989, J VIROL, V63, P1783, DOI 10.1128/JVI.63.4.1783-1791.1989; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; LORD PCW, 1989, J GEN VIROL, V70, P2383, DOI 10.1099/0022-1317-70-9-2383; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Murphy E, 2008, CURR TOP MICROBIOL, V325, P1; Murphy E, 2003, P NATL ACAD SCI USA, V100, P13585, DOI 10.1073/pnas.1735466100; Qian ZK, 2008, J VIROL, V82, P3452, DOI 10.1128/JVI.01964-07; Reeves MB, 2007, SCIENCE, V316, P1345, DOI 10.1126/science.1142984; Robert F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005428; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Stamminger T, 2002, J VIROL, V76, P4836, DOI 10.1128/JVI.76.10.4836-4847.2002; Starck SR, 2012, SCIENCE, V336, P1719, DOI 10.1126/science.1220270; Yewdell JW, 2007, CURR OPIN IMMUNOL, V19, P79, DOI 10.1016/j.coi.2006.11.010; Zhang GJ, 2007, J VIROL, V81, P11267, DOI 10.1128/JVI.00007-07	24	409	417	5	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1088	1093		10.1126/science.1227919	http://dx.doi.org/10.1126/science.1227919			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23180859	Green Accepted			2022-12-28	WOS:000311390600046
J	Marcellin, P; Gane, E; Buti, M; Afdhal, N; Sievert, W; Jacobson, IM; Washington, MK; Germanidis, G; Flaherty, JF; Schall, RA; Bornstein, JRD; Kitrinos, KM; Subramanian, GM; McHutchison, JG; Heathcote, EJ				Marcellin, Patrick; Gane, Edward; Buti, Maria; Afdhal, Nezam; Sievert, William; Jacobson, Ira M.; Washington, Mary Kay; Germanidis, George; Flaherty, John F.; Schall, Raul Aguilar; Bornstein, Jeff Rey D.; Kitrinos, Kathryn M.; Subramanian, G. Mani; McHutchison, John G.; Heathcote, E. Jenny			Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study	LANCET			English	Article							ADEFOVIR DIPIVOXIL; LIVER FIBROSIS; HEPATOCELLULAR-CARCINOMA; DNA LEVELS; THERAPY; RISK; REVERSIBILITY; INTERFERON; LAMIVUDINE; LEVEL	Background Whether long-term suppression of replication of hepatitis B virus (HBV) has any beneficial effect on regression of advanced liver fibrosis associated with chronic HBV infection remains unclear. We aimed to assess the effects on fibrosis and cirrhosis of at least 5 years' treatment with tenofovir disoproxil fumarate (DF) in chronic HBV infection. Methods After 48 weeks of randomised double-blind comparison (trials NCT00117676 and NCT00116805) of tenofovir DF with adefovir dipivoxil, participants (positive or negative for HBeAg) were eligible to enter a 7-year study of open-label tenofovir DF treatment, with a pre-specified repeat liver biopsy at week 240. We assessed histological improvement (>= 2 point reduction in Knodell necroinflammatory score with no worsening of fibrosis) and regression of fibrosis (>= 1 unit decrease by Ishak scoring system). Findings Of 641 patients who received randomised treatment, 585 (91%) entered the open-label phase, and 489 (76%) completed 240 weeks. 348 patients (54%) had biopsy results at both baseline and week 240. 304 (87%) of the 348 had histological improvement, and 176 (51%) had regression of fibrosis at week 240 (p<0.0001). Of the 96 (28%) patients with cirrhosis (Ishak score 5 or 6) at baseline, 71 (74%) no longer had cirrhosis (>= 1 unit decrease in score), whereas three of 252 patients without cirrhosis at baseline progressed to cirrhosis at year 5 (p<0.0001). Virological breakthrough occurred infrequently and was not due to resistance to tenofovir DF. The safety profile was favourable: 91 (16%) patients had adverse events but only nine patients had serious events related to the study drug. Interpretation In patients with chronic HBV infection, up to 5 years of treatment with tenofovir DF was safe and effective. Long-term suppression of HBV can lead to regression of fibrosis and cirrhosis.	[Marcellin, Patrick] Hop Beaujon, Serv Hepatol, F-92110 Clichy, France; [Marcellin, Patrick] Hop Beaujon, INSERM, Unit CRB3, Clichy, France; [Gane, Edward] Auckland City Hosp, Auckland, New Zealand; [Buti, Maria] Hosp Gen Univ Vall dHebron, Liver Unit, Barcelona, Spain; [Buti, Maria] CIBERehd, Barcelona, Spain; [Afdhal, Nezam] Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA; [Sievert, William] Monash Univ, Melbourne, Vic 3004, Australia; [Sievert, William] Monash Med Ctr, Melbourne, Vic, Australia; [Jacobson, Ira M.] Weill Cornell Med Coll, New York, NY USA; [Washington, Mary Kay] Vanderbilt Univ, Nashville, TN USA; [Germanidis, George] Aristotle Univ Thessaloniki, Sch Med, AHEPA Univ Hosp, GR-54006 Thessaloniki, Greece; [Flaherty, John F.; Schall, Raul Aguilar; Bornstein, Jeff Rey D.; Kitrinos, Kathryn M.; Subramanian, G. Mani; McHutchison, John G.] Gilead Sci, Foster City, CA USA; [Heathcote, E. Jenny] Univ Toronto, Toronto, ON, Canada	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Auckland City Hospital; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Harvard University; Beth Israel Deaconess Medical Center; Monash University; Monash University; Cornell University; Vanderbilt University; Aristotle University of Thessaloniki; Ahepa University Hospital; Gilead Sciences; University of Toronto	Marcellin, P (corresponding author), Hop Beaujon, Serv Hepatol, 100 Bv Gal Leclerc, F-92110 Clichy, France.	patrick.marcellin@bjn.aphp.fr	GERMANIDIS, GEORGIOS/ABI-3764-2020	Buti Ferret, Maria/0000-0002-0732-3078; Afdhal, Nezam/0000-0002-7342-6593	Chair in Hepatology Research at the University of Toronto; Abbott; Echosens; Gilead; GlaxoSmithKline; Novartis; Pharmasett; Quest; Schering Plough/Merck; Vertex; Achillion; Anadys; Boehringer Ingelheim; Bristol-Myers Squibb; GlobeImmune; Pfizer; Roche/Genentech; Tibotec/Janssen; Zymogenetics	Chair in Hepatology Research at the University of Toronto; Abbott(Abbott Laboratories); Echosens; Gilead(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Pharmasett; Quest; Schering Plough/Merck(Merck & CompanySchering Plough Corporation); Vertex(Vertex Pharmaceuticals); Achillion; Anadys; Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); GlobeImmune; Pfizer(Pfizer); Roche/Genentech(Roche HoldingGenentech); Tibotec/Janssen; Zymogenetics	EJH has been a member of the International Advisory Board for Gilead Sciences. Gilead Sciences has funded a Chair in Hepatology Research at the University of Toronto, a position to which EJH has been named. MB has been a member of the advisory board and a speaker for Gilead and Bristol-Myers Squibb. NA has received research support from Abbott, Echosens, Gilead, GlaxoSmithKline, Novartis, Pharmasett, Quest, Schering Plough/Merck, and Vertex; has been a consultant or member of the Advisory Board for Boehringer Ingelheim, Echosens, Gilead, GlaxoSmithKline, Ligand, Medgenics, Novartis, Springbank, and Vertex; and has stock options in Medgenics and Springbank. GMS, JFF, JB, JGMcH, and KMK are employed by and have stock ownership in Gilead. RAS is a contractor for Gilead. EG has been a member of the regional and international Advisory Boards for Gilead. IMJ has received research support from Achillion, Anadys, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead, GlobeImmune, Novartis, Pfizer, Pharmasett, Roche/Genentech, Schering Plough/Merck, Tibotec/Janssen, Vertex, and Zymogenetics; has been a consultant or Advisory Board Member for Abbott, Achillion, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, GlobeImmune, Inhibitex, Indenix, Kadmon, Novartis, Pharmasett, Presidio, Roche/Genentech, Schering Plough/Merck, Tibotec/Janssen, and Vertex; and has stock options in Springbank and Medgenics; and has been a member of the Speakers' Bureau of Bristol-Myers Squibb, Gilead, Roche/Genentech, Schering Plough/Merck, and Vertex. All other members declare that they have no conflicts of interest.	Bedrossa P, 2003, HEPATOLOGY, V38, P1449; Berhe N, 2008, AM J TROP MED HYG, V78, P228, DOI 10.4269/ajtmh.2008.78.228; Berzigotti A, 2011, HEPATOLOGY, V54, P555, DOI 10.1002/hep.24418; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Chen CJ, 2009, HEPATOLOGY, V49, pS72, DOI 10.1002/hep.22884; Chen ChienJen, 2007, Current Hepatitis Reports, V6, P9, DOI 10.1007/BF02942173; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Dienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013; Dufour JF, 1998, DIGEST DIS SCI, V43, P2573, DOI 10.1023/A:1026601904609; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Falize L, 2006, HEPATOLOGY, V44, P472, DOI 10.1002/hep.21260; Gilead Sciences, 2012, VIR TEN DIS FUM TABL; Hadziyannis SJ, 2003, NEW ENGL J MED, V348, P800, DOI 10.1056/NEJMoa021812; Hadziyannis SJ, 2006, GASTROENTEROLOGY, V131, P1743, DOI 10.1053/j.gastro.2006.09.020; Hammel P, 2001, NEW ENGL J MED, V344, P418, DOI 10.1056/NEJM200102083440604; Heathcote EJ, 2011, GASTROENTEROLOGY, V140, P132, DOI 10.1053/j.gastro.2010.10.011; Iloeje UH, 2007, CLIN GASTROENTEROL H, V5, P921, DOI 10.1016/j.cgh.2007.06.015; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Kallwitz ER, 2010, CLIN GASTROENTEROL H, V8, P72, DOI 10.1016/j.cgh.2009.08.009; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Lok ASF, 2002, NEW ENGL J MED, V346, P1682, DOI 10.1056/NEJM200205303462202; Mallet V, 2008, ANN INTERN MED, V149, P399, DOI 10.7326/0003-4819-149-6-200809160-00006; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Marcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878; Marcellin P, 2008, HEPATOLOGY, V48, P750, DOI 10.1002/hep.22414; Moucari R, 2009, J HEPATOL, V50, P1084, DOI 10.1016/j.jhep.2009.01.016; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Schiff ER, 2011, CLIN GASTROENTEROL H, V9, P274, DOI 10.1016/j.cgh.2010.11.040; Standish RA, 2006, GUT, V55, P569, DOI 10.1136/gut.2005.084475; Yuan HJ, 2005, J VIRAL HEPATITIS, V12, P373, DOI 10.1111/j.1365-2893.2005.00603.x; Zhu YA, 2011, J VIROL METHODS, V173, P340, DOI 10.1016/j.jviromet.2011.03.006	34	1147	1224	7	106	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 9	2013	381	9865					468	475		10.1016/S0140-6736(12)61425-1	http://dx.doi.org/10.1016/S0140-6736(12)61425-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088CH	23234725				2022-12-28	WOS:000314810900032
J	Qin, J; Wu, SP; Creighton, CJ; Dai, FY; Xie, X; Cheng, CM; Frolov, A; Ayala, G; Lin, X; Feng, XH; Ittmann, MM; Tsai, SJ; Tsai, MJ; Tsai, SY				Qin, Jun; Wu, San-Pin; Creighton, Chad J.; Dai, Fangyan; Xie, Xin; Cheng, Chiang-Min; Frolov, Anna; Ayala, Gustavo; Lin, Xia; Feng, Xin-Hua; Ittmann, Michael M.; Tsai, Shaw-Jenq; Tsai, Ming-Jer; Tsai, Sophia Y.			COUP-TFII inhibits TGF-beta-induced growth barrier to promote prostate tumorigenesis	NATURE			English	Article							TRANSCRIPTION FACTOR-II; GENE-EXPRESSION; CANCER; ORPHAN; ANGIOGENESIS; SUPPRESSION; METASTASIS; RECURRENCE; MOUSE	Mutations in phosphatase and tensin homologue (PTEN) or genomic alterations in the phosphatidylinositol-3-OH kinase-signalling pathway are the most common genetic alterations reported in human prostate cancer(1-4). However, the precise mechanism underlying how indolent tumours with PTEN alterations acquire metastatic potential remains poorly understood. Recent studies suggest that upregulation of transforming growth factor (TGF)-beta signalling triggered by PTEN loss will form a growth barrier as a defence mechanism to constrain prostate cancer progression(5), underscoring that TGF-beta signalling might represent a pre-invasive checkpoint to prevent PTEN-mediated prostate tumorigenesis. Here we show that COUP transcription factor II (COUP-TFII, also known as NR2F2)(6-9), a member of the nuclear receptor superfamily, serves as a key regulator to inhibit SMAD4-dependent transcription, and consequently overrides the TGF-beta-dependent checkpoint for PTEN-null indolent tumours. Overexpression of COUP-TFII in the mouse prostate epithelium cooperates with PTEN deletion to augment malignant progression and produce an aggressive metastasis-prone tumour. The functional counteraction between COUP-TFII and SMAD4 is reinforced by genetically engineered mouse models in which conditional loss of SMAD4 diminishes the inhibitory effects elicited by COUP-TFII ablation. The biological significance of COUP-TFII in prostate carcinogenesis is substantiated by patient sample analysis, in which COUP-TFII expression or activity is tightly correlated with tumour recurrence and disease progression, whereas it is inversely associated with TGF-beta signalling. These findings reveal that the destruction of the TGF-beta-dependent barrier by COUP-TFII is crucial for the progression of PTEN-mutant prostate cancer into a life-threatening disease, and supports COUP-TFII as a potential drug target for the intervention of metastatic human prostate cancer.	[Qin, Jun; Wu, San-Pin; Dai, Fangyan; Xie, Xin; Cheng, Chiang-Min; Feng, Xin-Hua; Tsai, Shaw-Jenq; Tsai, Ming-Jer; Tsai, Sophia Y.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Dai, Fangyan; Lin, Xia; Feng, Xin-Hua] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Frolov, Anna; Ayala, Gustavo; Ittmann, Michael M.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Tsai, Shaw-Jenq] Natl Cheng Kung Univ, Dept Physiol, Coll Med, Tainan 701, Taiwan; [Tsai, Ming-Jer; Tsai, Sophia Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; National Cheng Kung University; Baylor College of Medicine	Tsai, MJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	mtsai@bcm.edu; stsai@bcm.edu	Tsai, Shaw-Jenq/AAG-6569-2019; , San Pin Wu/AAF-8371-2020; Dai, Fangyan/J-8927-2016; Ayala, Gustavo/ABC-6625-2020	, San Pin Wu/0000-0001-9626-784X; TSAI, SHAW-JENQ/0000-0002-3569-5813	DERC Center [P30 DK079638]; National Institutes of Health [DK62434, DK59820, DK45641, HL76448]; Dan L. Duncan Cancer Center; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638, R01DK045641, R37DK045641, P01DK059820, U19DK062434] Funding Source: NIH RePORTER	DERC Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dan L. Duncan Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Wu for the Pten<SUP>flox/flox</SUP> mice, F. Wang for ARR2PB-Cre (PB-Cre) transgenic mice and E. J. Robertson for the Smad4<SUP>flox/flox</SUP> mice. We thank H. K. Graves and L.-Y. Yu-Lee for editorial assistance and S. Elledge for comments. We also thank the Baylor Microarray Core supported by the DERC Center (P30 DK079638) for the microarray analysis. This work was supported by grants from the National Institutes of Health DK62434, DK59820 (S.Y.T. and M.-J.T.), DK45641 (M.-J.T.) and HL76448 (S.Y.T.), and the Dan L. Duncan Cancer Center.	Agoulnik IU, 2006, CANCER RES, V66, P10594, DOI 10.1158/0008-5472.CAN-06-1023; Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; Creighton CJ, 2008, J CLIN ONCOL, V26, P4078, DOI 10.1200/JCO.2007.13.4429; Creighton CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034546; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Hodgson MC, 2011, CANCER RES, V71, P572, DOI 10.1158/0008-5472.CAN-10-2314; Jin CL, 2003, PROSTATE, V57, P160, DOI 10.1002/pros.10283; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Li LP, 2009, CELL METAB, V9, P77, DOI 10.1016/j.cmet.2008.12.002; Lin FJ, 2011, ENDOCR REV, V32, P404, DOI 10.1210/er.2010-0021; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Nagasaki S, 2009, CANCER SCI, V100, P639, DOI 10.1111/j.1349-7006.2008.01078.x; Nakagawa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002318; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Park JH, 2002, AM J PATHOL, V161, P727, DOI 10.1016/S0002-9440(10)64228-9; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Qin J, 2010, CANCER RES, V70, P8812, DOI 10.1158/0008-5472.CAN-10-0551; Qin J, 2010, P NATL ACAD SCI USA, V107, P3687, DOI 10.1073/pnas.0914619107; Shin SW, 2009, ONCOL REP, V21, P101, DOI 10.3892/or_00000195; Takamoto N, 2005, DEVELOPMENT, V132, P2179, DOI 10.1242/dev.01808; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wu SP, 2010, MOL ENDOCRINOL, V24, P1297, DOI 10.1210/me.2010-0068; Yeh HY, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-70; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	37	130	138	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					236	U252		10.1038/nature11674	http://dx.doi.org/10.1038/nature11674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23201680	Green Accepted			2022-12-28	WOS:000313259600042
J	De Benedetti, F; Brunner, HI; Ruperto, N; Kenwright, A; Wright, S; Calvo, I; Cuttica, R; Ravelli, A; Schneider, R; Woo, P; Wouters, C; Xavier, R; Zemel, L; Baildam, E; Burgos-Vargas, R; Dolezalova, P; Garay, SM; Merino, R; Joos, R; Grom, A; Wulffraat, N; Zuber, Z; Zulian, F; Lovell, D; Martini, A				De Benedetti, Fabrizio; Brunner, Hermine I.; Ruperto, Nicolino; Kenwright, Andrew; Wright, Stephen; Calvo, Inmaculada; Cuttica, Ruben; Ravelli, Angelo; Schneider, Rayfel; Woo, Patricia; Wouters, Carine; Xavier, Ricardo; Zemel, Lawrence; Baildam, Eileen; Burgos-Vargas, Ruben; Dolezalova, Pavla; Garay, Stella M.; Merino, Rosa; Joos, Rik; Grom, Alexei; Wulffraat, Nico; Zuber, Zbigniew; Zulian, Francesco; Lovell, Daniel; Martini, Alberto		PRINTO; PRCSG	Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECEPTOR ANTAGONIST ANAKINRA; RHEUMATOID-ARTHRITIS; PRELIMINARY DEFINITION; CHRONIC INFLAMMATION; DOUBLE-BLIND; INTERLEUKIN-6; CHILDREN; ETANERCEPT; DISEASE; SAFETY	BACKGROUND Systemic juvenile idiopathic arthritis (JIA) is the most severe subtype of JIA; treatment options are limited. Interleukin-6 plays a pathogenic role in systemic JIA. METHODS We randomly assigned 112 children, 2 to 17 years of age, with active systemic JIA (duration of >= 6 months and inadequate responses to nonsteroidal antiinflammatory drugs and glucocorticoids) to the anti-interleukin-6 receptor antibody tocilizumab (at a dose of 8 mg per kilogram of body weight if the weight was >= 30 kg or 12 mg per kilogram if the weight was <30 kg) or placebo given intravenously every 2 weeks during the 12-week, double-blind phase. Patients meeting the predefined criteria for nonresponse were offered open-label tocilizumab. All patients could enter an open-label extension. RESULTS At week 12, the primary end point (an absence of fever and an improvement of 30% or more on at least three of the six variables in the American College of Rheumatology [ACR] core set for JIA, with no more than one variable worsening by more than 30%) was met in significantly more patients in the tocilizumab group than in the placebo group (64 of 75 [85%] vs. 9 of 37 [24%], P<0.001). At week 52, 80% of the patients who received tocilizumab had at least 70% improvement with no fever, including 59% who had 90% improvement; in addition, 48% of the patients had no joints with active arthritis, and 52% had discontinued oral glucocorticoids. In the double-blind phase, 159 adverse events, including 60 infections (2 serious), occurred in the tocilizumab group, as compared with 38, including 15 infections, in the placebo group. In the double-blind and extension periods combined, 39 serious adverse events (0.25 per patient-year), including 18 serious infections (0.11 per patient-year), occurred in patients who received tocilizumab. Neutropenia developed in 19 patients (17 patients with grade 3 and 2 patients with grade 4), and 21 had aminotransferase levels that were more than 2.5 times the upper limit of the normal range. CONCLUSIONS Tocilizumab was efficacious in severe, persistent systemic JIA. Adverse events were common and included infection, neutropenia, and increased aminotransferase levels. (Funded by Hoffmann-La Roche; ClinicalTrials.gov number, NCT00642460.)	[De Benedetti, Fabrizio] IRCCS Osped Pediat Bambino Gesu, Div Rheumatol, Dept Med, I-00165 Rome, Italy; [Ruperto, Nicolino; Ravelli, Angelo; Martini, Alberto] Pediat II Reumatol Paediat Rheumatol Int Trials O, IRCCS Ist G Gaslini, Genoa, Italy; [Ravelli, Angelo; Martini, Alberto] Univ Genoa, Dipartimento Pediat, Genoa, Italy; [Zulian, Francesco] Univ Padua, Dept Pediat, Unita Reumatol Pediat, Padua, Italy; [Brunner, Hermine I.; Grom, Alexei; Lovell, Daniel] Cincinnati Childrens Hosp, PRCSG Coordinating Ctr, Div Rheumatol, Dept Pediat,Med Ctr, Cincinnati, OH USA; [Kenwright, Andrew; Wright, Stephen] Hoffmann La Roche, Welwyn Garden City, Herts, England; [Woo, Patricia] Great Ormond St Hosp Sick Children, Dept Rheumatol, London, England; [Baildam, Eileen] Alder Hey Childrens Natl Hlth Serv Fdn Trust, Liverpool, Merseyside, England; [Calvo, Inmaculada] Hosp Univ La Fe, Dept Pediat Rheumatol, Valencia, Spain; [Merino, Rosa] Hosp Univ La Paz, Unidad Reumatol Pediat, Madrid, Spain; [Cuttica, Ruben] Hosp Gral Ninos Pedro Elizalde, Rheumatol Sect, Buenos Aires, DF, Argentina; [Garay, Stella M.] Hosp Sor Maria Ludov, Unidad Reumatol, La Plata, Buenos Aires, Argentina; [Schneider, Rayfel] Univ Toronto, Hosp Sick Children, Div Rheumatol, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Wouters, Carine] Univ Hosp Gasthuisberg, Dept Pediat, Div Pediat Rheumatol, B-3000 Louvain, Belgium; [Joos, Rik] Univ Ziekenhuis, Ctr Kinderreumatol, Ghent, Belgium; [Xavier, Ricardo] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Rheumatol Serv, Porto Alegre, RS, Brazil; [Zemel, Lawrence] Connecticut Childrens Med Ctr, Hartford, CT USA; [Burgos-Vargas, Ruben] Univ Nacl Autonoma Mexico, Hosp Gen Mexico, Dept Reumatol, Mexico City 04510, DF, Mexico; [Burgos-Vargas, Ruben] Univ Nacl Autonoma Mexico, Fac Med, Mexico City 04510, DF, Mexico; [Dolezalova, Pavla] Charles Univ Prague, Dept Pediat & Adolescent Med, Prague, Czech Republic; [Dolezalova, Pavla] Gen Univ Hosp, Prague, Czech Republic; [Wulffraat, Nico] Univ Med Ctr, Wilhelmina Kinderziekenhuis, Dept Pediat Immunol & Rheumatol, Utrecht, Netherlands; [Zuber, Zbigniew] Wojewodzki Specjalistyczny Szpital Dzieciecy Sw L, Oddzial Dzieci Starszych, Dept Rheumatol, Krakow, Poland	IRCCS Bambino Gesu; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Padua; Cincinnati Children's Hospital Medical Center; Roche Holding; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Alder Hey Children's NHS Foundation Trust; Hospital Universitari i Politecnic La Fe; Hospital Universitario La Paz; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); KU Leuven; University Hospital Leuven; Ghent University; Universidade Federal do Rio Grande do Sul; Connecticut Children's Medical Center; Hospital General de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Charles University Prague; General University Hospital Prague; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	De Benedetti, F (corresponding author), IRCCS Osped Pediat Bambino Gesu, Div Rheumatol, Dept Med, Piazza S Onofrio 4, I-00165 Rome, Italy.	fabrizio.debenedetti@opbg.net	Ruperto, Nicolino/K-3349-2018; Dolezalova, Pavla/N-6408-2017; RAVELLI, ANGELO/J-8161-2016; de benedetti, fabrizio/J-9577-2018; Burgos-Vargas, Ruben/AAZ-1295-2020; Wulffraat, Nico M/AAE-8929-2020; Zulian, Francesco/AAC-6600-2022; Xavier, Ricardo Machado/G-4426-2012	Ruperto, Nicolino/0000-0001-8407-7782; Dolezalova, Pavla/0000-0001-8375-661X; RAVELLI, ANGELO/0000-0001-9658-0385; de benedetti, fabrizio/0000-0001-8749-8232; Burgos-Vargas, Ruben/0000-0003-1058-8955; Wulffraat, Nico M/0000-0001-9548-5562; Zulian, Francesco/0000-0002-2479-3485; Xavier, Ricardo Machado/0000-0001-6570-4533; Zuber, Zbigniew/0000-0001-9581-0601; MARTINI, Alberto/0000-0001-7642-1459; Wouters, Carine/0000-0002-6426-8845	Hoffmann-La Roche; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; Versus Arthritis [17287] Funding Source: researchfish	Hoffmann-La Roche(Hoffmann-La Roche); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Versus Arthritis(Versus Arthritis)	Funded by Hoffmann-La Roche; ClinicalTrials.gov number, NCT00642460.	Brunner HI, 2002, J RHEUMATOL, V29, P1058; Cazzola M, 1996, BLOOD, V87, P4824, DOI 10.1182/blood.V87.11.4824.bloodjournal87114824; De Benedetti F, 1998, J RHEUMATOL, V25, P203; De Benedetti F, 2006, ARTHRITIS RHEUM, V54, P3551, DOI 10.1002/art.22175; DeBenedetti F, 1997, J RHEUMATOL, V24, P1403; DeBenedetti F, 1997, J CLIN INVEST, V99, P643, DOI 10.1172/JCI119207; DEBENEDETTI F, 1991, ARTHRITIS RHEUM, V34, P1158, DOI 10.1002/art.1780340912; European Medicines Agency, 2009, TOPIC E 2 A CLIN SAF; Gattorno M, 2008, ARTHRITIS RHEUM, V58, P1505, DOI 10.1002/art.23437; Giannini EH, 1997, ARTHRITIS RHEUM, V40, P1202; Hashkes PJ, 2010, ARTHRITIS RHEUM-US, V62, P599, DOI 10.1002/art.27218; Horneff G, 2009, ANN RHEUM DIS, V68, P519, DOI 10.1136/ard.2007.087593; Kimura Y, 2012, ARTHRITIS CARE RES H; Kimura Y, 2012, ARTHRITIS CARE RES H; Lequerre T, 2008, ANN RHEUM DIS, V67, P302, DOI 10.1136/ard.2007.076034; Lomater C, 2000, J RHEUMATOL, V27, P491; Lovell DJ, 2000, NEW ENGL J MED, V342, P763, DOI 10.1056/NEJM200003163421103; McInnes I, 2011, EUR LEAG RHEUM 2011, P25; PADEH S, 1991, ARTHRITIS RHEUM, V34, P1575; Petty RE, 2004, J RHEUMATOL, V31, P390; Prince FHM, 2009, ANN RHEUM DIS, V68, P635, DOI 10.1136/ard.2007.087411; Quartier P, 2011, ANN RHEUM DIS, V70, P747, DOI 10.1136/ard.2010.134254; Ravelli A, 2007, LANCET, V369, P767, DOI 10.1016/S0140-6736(07)60363-8; Ruperto N, 2001, CLIN EXP RHEUMATOL, V19, pS1; Ruperto N, 2001, QUALITY LIFE JUVENIL; Ruperto N, 2011, ARCH DIS CHILD, V96, P596, DOI 10.1136/adc.2010.188946; Russo R, 2011, PEDIAT RHEUMATOL S1, V9, pO18; SINGH G, 1994, ARTHRITIS RHEUM, V37, P1761, DOI 10.1002/art.1780371209; Spiegel LR, 2000, ARTHRITIS RHEUM-US, V43, P2402, DOI 10.1002/1529-0131(200011)43:11<2402::AID-ANR5>3.0.CO;2-C; Strippoli R, 2012, ARTHRITIS RHEUM-US, V64, P1680, DOI 10.1002/art.33496; Wallace CA, 2004, J RHEUMATOL, V31, P2290; Woo P, 2000, ARTHRITIS RHEUM-US, V43, P1849, DOI 10.1002/1529-0131(200008)43:8<1849::AID-ANR22>3.0.CO;2-F; Yokota S, 2008, LANCET, V371, P998, DOI 10.1016/S0140-6736(08)60454-7	33	563	593	1	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2012	367	25					2385	2395		10.1056/NEJMoa1112802	http://dx.doi.org/10.1056/NEJMoa1112802			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056ZP	23252525				2022-12-28	WOS:000312531600006
J	Houle, SKD; McAlister, FA; Jackevicius, CA; Chuck, AW; Tsuyuki, RT				Houle, Sherilyn K. D.; McAlister, Finlay A.; Jackevicius, Cynthia A.; Chuck, Anderson W.; Tsuyuki, Ross T.			Does Performance-Based Remuneration for Individual Health Care Practitioners Affect Patient Care? A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							PAY-FOR-PERFORMANCE; INCENTIVE-BASED CONTRACT; FINANCIAL INCENTIVES; PHYSICIAN REIMBURSEMENT; IMMUNIZATION RATES; SMOKING-CESSATION; QUALITY; UK; MANAGEMENT; PAYMENT	Background: Pay-for-performance (P4P) is increasingly touted as a means to improve health care quality. Purpose: To evaluate the effect of P4P remuneration targeting individual health care providers. Data Sources: MEDLINE, EMBASE, Cochrane Library, OpenSIGLE, Canadian Evaluation Society Unpublished Literature Bank, New York Academy of Medicine Library Grey Literature Collection, and reference lists were searched up until June 2012. Study Selection: Two reviewers independently identified original research papers (randomized, controlled trials; interrupted time series; uncontrolled and controlled before-after studies; and cohort comparisons). Data Extraction: Two reviewers independently extracted the data. Data Synthesis: The literature search identified 4 randomized, controlled trials; 5 interrupted time series; 3 controlled before-after studies; 1 nonrandomized, controlled study; 15 uncontrolled before-after studies; and 2 uncontrolled cohort studies. The variation in study quality, target conditions, and reported outcomes precluded meta-analysis. Uncontrolled studies (15 before-after studies, 2 cohort comparisons) suggested that P4P improves quality of care, but higher-quality studies with contemporaneous controls failed to confirm these findings. Two of the 4 randomized trials were negative, and the 2 statistically significant trials reported small incremental improvements in vaccination rates over usual care (absolute differences, 8.4 and 7.8 percentage points). Of the 5 interrupted time series, 2 did not detect any improvements in processes of care or clinical outcomes after P4P implementation, 1 reported initial statistically significant improvements in guideline adherence that dissipated over time, and 2 reported statistically significant improvements in blood pressure control in patients with diabetes balanced against statistically significant declines in hemoglobin A(1c) control. Limitation: Few methodologically robust studies compare P4P with other payment models for individual practitioners; most are small observational studies of variable quality. Conclusion: The effect of P4P targeting individual practitioners on quality of care and outcomes remains largely uncertain. Implementation of P4P models should be accompanied by robust evaluation plans.	Univ Alberta, Univ Alberta Hosp, Edmonton, AB T6G 2R7, Canada; Inst Hlth Econ, Edmonton, AB, Canada; Western Univ Hlth Sci, Pomona, CA USA	University of Alberta; Western University of Health Sciences	McAlister, FA (corresponding author), Univ Alberta, Univ Alberta Hosp, 2F1-21 WMC,8440 112 St, Edmonton, AB T6G 2R7, Canada.	Finlay.McAlister@ualberta.ca	McAlister, Finlay/C-4151-2013; Tsuyuki, Ross T/E-2462-2016	McAlister, Finlay/0000-0001-7435-3341; Tsuyuki, Ross T/0000-0002-3724-598X	Alberta Innovates Health Solutions; Hypertension Canada; Canadian Institutes for Health Research; Capital Health Chair in Cardiovascular Outcomes Research; Interdisciplinary Chronic Disease Collaboration	Alberta Innovates Health Solutions; Hypertension Canada; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Capital Health Chair in Cardiovascular Outcomes Research; Interdisciplinary Chronic Disease Collaboration	Grant Support: Ms. Houle is supported in her PhD studies through the Interdisciplinary Chronic Disease Collaboration (funded by Alberta Innovates Health Solutions), Hypertension Canada, and the Canadian Institutes for Health Research. Dr. McAlister has career salary support from Alberta Innovates Health Solutions and the Capital Health Chair in Cardiovascular Outcomes Research.	Alshamsan R, 2012, ANN FAM MED, V10, P228, DOI 10.1370/afm.1335; Armour BS, 2004, AM J MANAG CARE, V10, P617; Beaulieu ND, 2005, HEALTH SERV RES, V40, P1318, DOI 10.1111/j.1475-6773.2005.00414.x; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Canadian Medical Association, HLTH CAR TRANSF CAN; Centers for Medicare & Medicaid Services, ROADM IMPL VAL DRIV; Chung Richard S, 2003, J Healthc Qual, V25, P31; Cochrane Effective Practice and Organisation of Care Group, 2012, DAT EXTR; Coleman T, 2007, ADDICTION, V102, P803, DOI 10.1111/j.1360-0443.2007.01766.x; Doran T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3590; Ettner SL, 2006, HEALTH SERV RES, V41, P1221, DOI 10.1111/j.1475-6773.2006.00533.x; Fagan PJ, 2010, HEALTH SERV RES, V45, P1763, DOI 10.1111/j.1475-6773.2010.01166.x; Fairbrother G, 2001, AMBUL PEDIATR, V1, P206, DOI 10.1367/1539-4409(2001)001<0206:IOFIOD>2.0.CO;2; Gavagan TF, 2010, J AM BOARD FAM MED, V23, P622, DOI 10.3122/jabfm.2010.05.070187; Grady KE, 1997, PREV MED, V26, P791, DOI 10.1006/pmed.1997.0219; Greene RA, 2004, AM J MANAG CARE, V10, P670; Guthrie B, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a867; Hamblin R, 2008, J R SOC PROMO HEALTH, V128, P291, DOI 10.1177/1466424008096617; Higgins J., 2009, COCHRANE HDB SYSTEMA; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Kiran T, 2012, DIABETES CARE, V35, P1038, DOI 10.2337/dc11-1402; Kouides RW, 1998, AM J PREV MED, V14, P89, DOI 10.1016/S0749-3797(97)00028-7; Kralewski JE, 2000, HEALTH SERV RES, V35, P591; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; MacBride-Stewart SP, 2008, FAM PRACT, V25, P27, DOI 10.1093/fampra/cmm074; Maisey S, 2008, J HEALTH SERV RES PO, V13, P133, DOI 10.1258/jhsrp.2008.007118; Mannion R, 2008, BMJ-BRIT MED J, V336, P306, DOI 10.1136/bmj.39463.454815.94; McGovern MP, 2008, DIABETIC MED, V25, P1083, DOI 10.1111/j.1464-5491.2008.02544.x; McGovern MP, 2008, FAM PRACT, V25, P33, DOI 10.1093/fampra/cmm073; Millett C, 2007, CAN MED ASSOC J, V176, P1705, DOI 10.1503/cmaj.061556; Morrow R W, 1995, Arch Fam Med, V4, P165, DOI 10.1001/archfami.4.2.165; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; PONTES MC, 1995, HEALTH CARE MANAGE R, V20, P57; Pourat N, 2005, AM J MANAG CARE, V11, P426; Ramsay CR, 2003, INT J TECHNOL ASSESS, V19, P613, DOI 10.1017/S0266462303000576; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Scott A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008451.pub2; Serumaga Brian, 2011, BMJ, V342, pd108, DOI 10.1136/bmj.d108; Simpson CR, 2006, STROKE, V37, P2354, DOI 10.1161/01.STR.0000236067.37267.88; Simpson CR, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X583407; St Jacques PJ, 2004, J CLIN ANESTH, V16, P523, DOI 10.1016/j.jclinane.2004.03.003; Steel N, 2007, BRIT J GEN PRACT, V57, P449; Twardella D, 2007, TOB CONTROL, V16, P15, DOI 10.1136/tc.2006.016253; Vamos EP, 2011, CAN MED ASSOC J, V183, pE809, DOI 10.1503/cmaj.101187; Young GJ, 2007, J GEN INTERN MED, V22, P872, DOI 10.1007/s11606-007-0185-5	45	107	108	0	45	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2012	157	12					889	U240		10.7326/0003-4819-157-12-201212180-00009	http://dx.doi.org/10.7326/0003-4819-157-12-201212180-00009			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	057SB	23247940				2022-12-28	WOS:000312583200018
J	Singh, J				Singh, Jaspal			Review: In asthma controlled with ICSs plus LABAs, stopping LABAs increases asthma impairment	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Carolinas Med Ctr, Charlotte, NC 28203 USA	Carolinas Medical Center	Singh, J (corresponding author), Carolinas Med Ctr, Charlotte, NC 28203 USA.		Singh, Jasvinder/R-6172-2019	Singh, Jasvinder/0000-0003-3485-0006				Bousquet J, 2007, ALLERGY, V62, P102, DOI 10.1111/j.1398-9995.2006.01305.x; Chowdhury BA, 2010, NEW ENGL J MED, V362, P1169, DOI 10.1056/NEJMp1002074	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2012	157	12							JC6-4	10.7326/0003-4819-157-12-201212180-02004	http://dx.doi.org/10.7326/0003-4819-157-12-201212180-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057SB	23247953				2022-12-28	WOS:000312583200003
J	Nemmen, RS; Georganopoulos, M; Guiriec, S; Meyer, ET; Gehrels, N; Sambruna, RM				Nemmen, R. S.; Georganopoulos, M.; Guiriec, S.; Meyer, E. T.; Gehrels, N.; Sambruna, R. M.			A Universal Scaling for the Energetics of Relativistic Jets from Black Hole Systems	SCIENCE			English	Article							ACTIVE GALACTIC NUCLEI; GAMMA-RAY BURSTS; FUNDAMENTAL PLANE; POWER; ACCRETION; FERMI; LUMINOSITIES; AFTERGLOW; BLAZARS; ENERGY	Black holes generate collimated, relativistic jets, which have been observed in gamma-ray bursts (GRBs), microquasars, and at the center of some galaxies [active galactic nuclei (AGN)]. How jet physics scales from stellar black holes in GRBs to the supermassive ones in AGN is still unknown. Here, we show that jets produced by AGN and GRBs exhibit the same correlation between the kinetic power carried by accelerated particles and the gamma-ray luminosity, with AGN and GRBs lying at the low-and high-luminosity ends, respectively, of the correlation. This result implies that the efficiency of energy dissipation in jets produced in black hole systems is similar over 10 orders of magnitude in jet power, establishing a physical analogy between AGN and GRBs.	[Nemmen, R. S.; Georganopoulos, M.; Guiriec, S.; Gehrels, N.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Georganopoulos, M.] Univ Maryland Baltimore Cty, Dept Phys, Baltimore, MD 21250 USA; [Meyer, E. T.] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA; [Sambruna, R. M.] George Mason Univ, Dept Phys & Astron, Fairfax, VA 22030 USA; [Meyer, E. T.] Space Telescope Sci Inst, Baltimore, MD 21218 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore County; Rice University; George Mason University; Space Telescope Science Institute	Nemmen, RS (corresponding author), NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	rodrigo.nemmen@nasa.gov	Nemmen, Rodrigo/O-6841-2014	Nemmen, Rodrigo/0000-0003-3956-0331	NASA Postdoctoral Program at Goddard Space Flight Center; NASA	NASA Postdoctoral Program at Goddard Space Flight Center; NASA(National Aeronautics & Space Administration (NASA))	We thank J. Racusin, M. Lister, C. Dermer, A. Pushkarev, J. McEnery, D. Donato, D. Kazanas, T. Nelson, and F. Tombesi for crucial discussions. R.S.N. and S. G. were supported by an appointment to the NASA Postdoctoral Program at Goddard Space Flight Center, administered by Oak Ridge Associated Universities through a contract with NASA. This research has made use of: (i) StatCodes statistical software hosted by The Pennsylvania State University's Center for Astrostatistics; (ii) data obtained from the HETE science team via the Web site http://space.mit.edu/HETE/Bursts/Data (HETE is an international mission of the NASA Explorer program, run by the Massachusetts Institute of Technology); and (iii) NASA/IPAC Extragalactic Database (NED), which is operated by the Jet Propulsion Laboratory, California Institute of Technology, under contract with NASA.	Ackermann M, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/171; Akritas MG, 1996, ASTROPHYS J, V470, P706, DOI 10.1086/177901; Bloom JS, 2011, SCIENCE, V333, P203, DOI 10.1126/science.1207150; Burrows DN, 2011, NATURE, V476, P421, DOI 10.1038/nature10374; Cavagnolo KW, 2010, ASTROPHYS J, V720, P1066, DOI 10.1088/0004-637X/720/2/1066; CELOTTI A, 1993, MON NOT R ASTRON SOC, V264, P228, DOI 10.1093/mnras/264.1.228; Celotti A, 2008, MON NOT R ASTRON SOC, V385, P283, DOI 10.1111/j.1365-2966.2007.12758.x; Cenko SB, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/77; Falcke H, 2004, ASTRON ASTROPHYS, V414, P895, DOI 10.1051/0004-6361:20031683; Fan YZ, 2006, MON NOT R ASTRON SOC, V369, P197, DOI 10.1111/j.1365-2966.2006.10280.x; Frail DA, 2001, ASTROPHYS J, V562, pL55, DOI 10.1086/338119; Freedman DL, 2001, ASTROPHYS J, V547, P922, DOI 10.1086/318386; Gehrels N, 2009, ANNU REV ASTRON ASTR, V47, P567, DOI 10.1146/annurev.astro.46.060407.145147; Ghisellini G, 2010, MON NOT R ASTRON SOC, V402, P497, DOI 10.1111/j.1365-2966.2009.15898.x; Jorstad SG, 2005, ASTRON J, V130, P1418, DOI 10.1086/444593; Krolik J. H., 1999, ACTIVE GALACTIC NUCL; Marscher AP, 2002, NATURE, V417, P625, DOI 10.1038/nature00772; McNamara BR, 2007, ANNU REV ASTRON ASTR, V45, P117, DOI 10.1146/annurev.astro.45.051806.110625; Meier DL, 2001, SCIENCE, V291, P84, DOI 10.1126/science.291.5501.84; Merloni A, 2003, MON NOT R ASTRON SOC, V345, P1057, DOI 10.1046/j.1365-2966.2003.07017.x; Meyer ET, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/98; Mirabel IF, 1999, ANNU REV ASTRON ASTR, V37, P409, DOI 10.1146/annurev.astro.37.1.409; Narayan R, 2005, SCIENCE, V307, P77, DOI 10.1126/science.1105746; O'Sullivan E, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/1/11; Piran T, 2004, REV MOD PHYS, V76, P1143, DOI 10.1103/RevModPhys.76.1143; Pushkarev AB, 2009, ASTRON ASTROPHYS, V507, pL33, DOI 10.1051/0004-6361/200913422; Racusin JL, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/138; REES MJ, 1984, ANNU REV ASTRON ASTR, V22, P471, DOI 10.1146/annurev.aa.22.090184.002351; Sijacki D, 2007, MON NOT R ASTRON SOC, V380, P877, DOI 10.1111/j.1365-2966.2007.12153.x; Sironi L, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/75; Wang J, 2011, ASTROPHYS J LETT, V726, DOI 10.1088/2041-8205/726/1/L4; Wu QW, 2011, ASTROPHYS J LETT, V740, DOI 10.1088/2041-8205/740/1/L21; Yuan F, 2009, ASTROPHYS J, V703, P1034, DOI 10.1088/0004-637X/703/1/1034; Zhang B, 2007, ASTROPHYS J, V655, P989, DOI 10.1086/510110	35	155	156	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1445	1448		10.1126/science.1227416	http://dx.doi.org/10.1126/science.1227416			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239730	Green Submitted, Green Published			2022-12-28	WOS:000312250800041
J	Oliver-Meseguer, J; Cabrero-Antonino, JR; Dominguez, I; Leyva-Perez, A; Corma, A				Oliver-Meseguer, Judit; Cabrero-Antonino, Jose R.; Dominguez, Irene; Leyva-Perez, Antonio; Corma, Avelino			Small Gold Clusters Formed in Solution Give Reaction Turnover Numbers of 10(7) at Room Temperature	SCIENCE			English	Article							CATALYSIS	Very small gold clusters (3 to 10 atoms) formed from conventional gold salts and complexes can catalyze various organic reactions at room temperature, even when present at concentrations of parts per billion. Absorption and emission ultraviolet-visible spectroscopy and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry revealed that, for example, the ester-assisted hydration of alkynes began only when clusters of three to five gold atoms were formed. The turnover numbers and turnover frequencies associated with these catalyzed reactions can be as high as 10(7) and 10(5) per hour, respectively.	[Oliver-Meseguer, Judit; Cabrero-Antonino, Jose R.; Dominguez, Irene; Leyva-Perez, Antonio; Corma, Avelino] Univ Politecn Valencia, Inst Tecnol Quim, Consejo Super Invest Cient, Valencia 46022, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Tecnologia Quimica (ITQ)	Leyva-Perez, A (corresponding author), Univ Politecn Valencia, Inst Tecnol Quim, Consejo Super Invest Cient, Avda Naranjos S-N, Valencia 46022, Spain.	anleyva@itq.upv.es; acorma@itq.upv.es	Oliver-Meseguer, Judit/K-2288-2015; Domínguez Pérez, Irene/A-4598-2017; Cabrero-Antonino, Jose R./C-4399-2016; Domínguez Pérez, Irene/GMX-3426-2022; Leyva-Pérez, Antonio/B-2301-2016; CANOS, AVELINO CORMA/A-3040-2013	Oliver-Meseguer, Judit/0000-0003-1555-3583; Domínguez Pérez, Irene/0000-0002-5707-3046; Cabrero-Antonino, Jose R./0000-0001-9628-9803; Leyva-Pérez, Antonio/0000-0003-1063-5811; CANOS, AVELINO CORMA/0000-0002-2232-3527	Instituto de Tecnologia Quimica postgraduate scholarship; FPU contract through the Ministerio de Ciencia e Innovacion (MCIINN); Consejo Superior de Investigaciones Cientificas; Consolider-Ingenio (proyecto MULTICAT); MCIINN; Subprograma de Apoyo a Centros y Universidades de Excelencia Severo Ochoa [SEV 2012 0267]	Instituto de Tecnologia Quimica postgraduate scholarship; FPU contract through the Ministerio de Ciencia e Innovacion (MCIINN); Consejo Superior de Investigaciones Cientificas; Consolider-Ingenio (proyecto MULTICAT); MCIINN; Subprograma de Apoyo a Centros y Universidades de Excelencia Severo Ochoa	Supported by an Instituto de Tecnologia Quimica postgraduate scholarship (J.O.-M.); an FPU contract through the Ministerio de Ciencia e Innovacion (MCIINN) (J.R.C.-A.); Consejo Superior de Investigaciones Cientificas (A. L.-P.); Consolider-Ingenio 2010 (proyecto MULTICAT); the MCIINN PLE2009 project; and Subprograma de Apoyo a Centros y Universidades de Excelencia Severo Ochoa (proyecto SEV 2012 0267).	Aguilar D, 2010, CHEM-EUR J, V16, P9287, DOI 10.1002/chem.201000587; Alves L, 2011, J AM CHEM SOC, V133, P10251, DOI 10.1021/ja202862k; Boronat M, 2011, J CATAL, V284, P138, DOI 10.1016/j.jcat.2011.09.010; Chretien S, 2007, CURR OPIN SOLID ST M, V11, P62, DOI 10.1016/j.cossms.2008.07.003; Corma A, 2011, CHEM REV, V111, P1657, DOI 10.1021/cr100414u; Corma A, 2011, CHEM COMMUN, V47, P1446, DOI 10.1039/c0cc04564k; Ghosh N, 2011, J ORG CHEM, V76, P500, DOI 10.1021/jo101995g; Grirrane A, 2011, ACS CATAL, V1, P1647, DOI 10.1021/cs2004278; HARUTA M, 1987, CHEM LETT, P405, DOI 10.1246/cl.1987.405; Hashmi ASK, 2007, CHEM REV, V107, P3180, DOI 10.1021/cr000436x; Hashmi ASK, 2012, ANGEW CHEM INT EDIT, V51, P10633, DOI 10.1002/anie.201204015; Hashmi ASK, 2012, ADV SYNTH CATAL, V354, P555, DOI 10.1002/adsc.201200086; Hashmi ASK, 2012, ORGANOMETALLICS, V31, P644, DOI 10.1021/om200946m; Hashmi ASK, 2010, ANGEW CHEM INT EDIT, V49, P5232, DOI 10.1002/anie.200907078; Hashmi ASK, 2006, EUR J ORG CHEM, V2006, P1387, DOI 10.1002/ejoc.200600009; Herzing AA, 2008, SCIENCE, V321, P1331, DOI 10.1126/science.1159639; HUTCHINGS GJ, 1985, J CATAL, V96, P292, DOI 10.1016/0021-9517(85)90383-5; Lemiere G, 2006, ANGEW CHEM INT EDIT, V45, P7596, DOI 10.1002/anie.200602189; Leyva-Perez A, 2012, ANGEW CHEM INT EDIT, V51, P614, DOI 10.1002/anie.201101726; Lu J., 2012, ANGEW CHEM INT EDIT, V51, P1; Mo FY, 2010, ANGEW CHEM INT EDIT, V49, P2028, DOI 10.1002/anie.200906699; Sakurai H, 2010, PURE APPL CHEM, V82, P2005, DOI 10.1351/PAC-CON-09-12-06; Shichibu Y, 2010, SMALL, V6, P1216, DOI 10.1002/smll.200902398; Walter M, 2008, P NATL ACAD SCI USA, V105, P9157, DOI 10.1073/pnas.0801001105; Wang WB, 2012, J AM CHEM SOC, V134, P5697, DOI 10.1021/ja3011397; Wang WB, 2009, J ORG CHEM, V74, P1640, DOI 10.1021/jo802450n; Yoshida H, 2012, SCIENCE, V335, P317, DOI 10.1126/science.1213194; Zhang Y, 2012, CHEM REV, V112, P2467, DOI 10.1021/cr200260m; Zheng J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.077402	29	337	337	7	413	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1452	1455		10.1126/science.1227813	http://dx.doi.org/10.1126/science.1227813			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239732				2022-12-28	WOS:000312250800043
J	Gayer, G				Gayer, Gabriela			Abdominal Ectopic Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Med Ctr, Palo Alto, CA USA	Stanford University	Gayer, G (corresponding author), Stanford Med Ctr, Palo Alto, CA USA.	ggayer@stanford.edu							0	7	7	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24					2334	2334		10.1056/NEJMicm1111814	http://dx.doi.org/10.1056/NEJMicm1111814			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HF	23234516				2022-12-28	WOS:000312187700007
J	Woolf, RT; Yeghen, T; Menage, HD				Woolf, R. T.; Yeghen, T.; Menage, H. du P.			A rash in a patient with neutropenia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FUSARIUM INFECTION; CANCER CENTER; TRANSPLANTATION; GALACTOMANNAN; MANAGEMENT		[Woolf, R. T.; Menage, H. du P.] Lewisham Healthcare NHS Trust, Univ Hosp Lewisham, Dept Dermatol, London SE13 6LH, England; [Yeghen, T.] Univ Hosp Lewisham, Dept Haematol, London, England	University of London; King's College London; University of London; King's College London	Woolf, RT (corresponding author), Lewisham Healthcare NHS Trust, Univ Hosp Lewisham, Dept Dermatol, London SE13 6LH, England.	richard.woolf@kcl.ac.uk		Woolf, Richard/0000-0003-3200-0075				Agrawal S, 2012, CRIT REV MICROBIOL, V38, P203, DOI 10.3109/1040841X.2011.645521; Boutati EI, 1997, BLOOD, V90, P999, DOI 10.1182/blood.V90.3.999.999_999_1008; Branski LK, 2009, SURG INFECT, V10, P389, DOI 10.1089/sur.2009.024; Campo M, 2010, J INFECTION, V60, P331, DOI 10.1016/j.jinf.2010.01.010; Dignani MC, 2004, CLIN MICROBIOL INFEC, V10, P67, DOI 10.1111/j.1470-9465.2004.00845.x; Halpern AV, 2003, DERMATOLOGY, P1075; Kontoyiannis DP, 2004, LEUKEMIA LYMPHOMA, V45, P139, DOI 10.1080/1042819031000149386; Labois A, 2011, MYCOSES, V54, P8, DOI 10.1111/j.1439-0507.2011.02136.x; Leeflang MM, 2008, COCHRANE DB SYST REV, V4; Maertens J, 2011, BONE MARROW TRANSPL, V46, P709, DOI 10.1038/bmt.2010.175; Martino R, 2002, BRIT J HAEMATOL, V116, P475, DOI 10.1046/j.1365-2141.2002.03259.x; Meersseman W, 2008, AM J RESP CRIT CARE, V177, P27, DOI 10.1164/rccm.200704-606OC; Nucci M, 2003, CANCER, V98, P315, DOI 10.1002/cncr.11510; Nucci M, 2002, CLIN INFECT DIS, V35, P909, DOI 10.1086/342328; Nucci M, 2007, CLIN MICROBIOL REV, V20, P695, DOI 10.1128/CMR.00014-07; Prentice AG, 2008, GUIDELINES MANAGEMEN; Sampathkumar P, 2001, CLIN INFECT DIS, V32, P1237, DOI 10.1086/319753; Slavin MA, 2008, INTERN MED J, V38, P457, DOI [10.1111/j.1445-5994.2008.01649.x, 10.1111/j.1445-5994.2008.01679.x]; Tortorano AM, 2012, J CLIN MICROBIOL, V50, P1051, DOI 10.1128/JCM.05946-11	19	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2012	345								e8296	10.1136/bmj.e8296	http://dx.doi.org/10.1136/bmj.e8296			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056MZ	23243291				2022-12-28	WOS:000312495700006
J	Ko, F; Vitale, S; Chou, CF; Cotch, MF; Saaddine, J; Friedman, DS				Ko, Fang; Vitale, Susan; Chou, Chiu-Fang; Cotch, Mary Frances; Saaddine, Jinan; Friedman, David S.			Prevalence of Nonrefractive Visual Impairment in US Adults and Associated Risk Factors, 1999-2002 and 2005-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TYPE-2 DIABETES-MELLITUS; UNITED-STATES; TEMPORAL TRENDS; RETINOPATHY; CHILDREN; ADOLESCENTS; PERSPECTIVE; HEALTH	Context Over the past decade, chronic illnesses with ophthalmic sequelae such as diabetes and diabetic retinopathy have increased. Objectives To estimate prevalence of nonrefractive visual impairment and to describe its relationship with demographic and systemic risk factors including diagnosed diabetes. Design, Setting, and Participants The National Health and Nutrition Examination Survey (NHANES) examined a representative sample of the US noninstitutionalized population. In 1999-2002 and 2005-2008, 9471 and 10 480 participants aged 20 years or older received questionnaires, laboratory tests, and physical examinations. Visual acuity of less than 20/40 aided by autorefractor was classified as nonrefractive visual impairment. Main Outcome Measure Nonrefractive visual impairment. Results Weighted prevalence of nonrefractive visual impairment increased 21% among US adults aged 20 years and older from 1.4% in 1999-2002 to 1.7% in 2005-2008 (P=.03); and increased 40% among non-Hispanic whites aged 20-39 years from 0.5% to 0.7% (P=.008). In multivariable analyses, statistically significant risk factors for nonrefractive visual impairment in 1999-2002 included age (per year odds ratio [OR], 1.07; 95% CI, 1.05-1.09), poverty (OR, 2.18; 95% CI, 1.31-3.64), lack of insurance (OR, 1.85; 95% CI, 1.16-2.95), and diabetes with 10 or more years since diagnosis (OR, 1.93; 95% CI, 1.15-3.25). In 2005-2008, risk factors included age (OR, 1.05; 95% CI, 1.04-1.07), poverty (OR, 2.23; 95% CI, 1.55-3.22), education less than high school (OR, 2.11; 95% CI, 1.54-2.90), and diabetes with 10 or more years since diagnosis (OR, 2.67; 95% CI, 1.64-4.37). Prevalence of diabetes with 10 or more years since diagnosis increased 22% overall from 2.8% to 3.6% (P=.02); and 133% among non-Hispanic whites aged 20-39 years from 0.3% to 0.7% (P<.001). Conclusion Prevalence of nonrefractive visual impairment was significantly higher in 2005-2008 than in 1999-2002 and may be attributable, in part, to higher prevalence of diabetes, an associated risk factor that increased in prevalence during this time period. JAMA. 2012;308(22):2361-2368 www.jama.com	[Ko, Fang; Friedman, David S.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Dana Ctr Prevent Ophthalmol, Baltimore, MD 21205 USA; [Friedman, David S.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Vitale, Susan; Cotch, Mary Frances] NEI, Div Epidemiol & Clin Applicat, NIH, Bethesda, MD 20892 USA; [Chou, Chiu-Fang; Saaddine, Jinan] Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Centers for Disease Control & Prevention - USA	Friedman, DS (corresponding author), Wilmer 120,600 N Wolfe St, Baltimore, MD 21287 USA.	david.friedman@jhu.edu		Friedman, David/0000-0002-2055-5797; vitale, susan/0000-0002-5972-6848; Cotch, Mary Frances/0000-0002-2046-4350	National Eye Institute (ARVO); Pepose; David Friedman Research Grant Award; Centers for Disease Control and Prevention (CDC) [1U58DP002653-01]; National Center for Health Statistics (NCHS); CDC; National Institutes of Health (NIH) [Z01EY000402]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP002653] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [Z01EY000402, ZIAEY000402] Funding Source: NIH RePORTER	National Eye Institute (ARVO); Pepose; David Friedman Research Grant Award; Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Health Statistics (NCHS); CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Friedman reports having consulted for Alcon, Bausch and Lomb, Merck, Pfizer, Allergan, Nidek, and QLT. Dr Ko reports receipt of support for travel to meetings for the study or other purposes from the National Eye Institute (ARVO travel grant), a Pepose travel grant, and a David Friedman Research Grant Award for provision of writing assistance, medicines, equipment, or administratrive support. The remaining authors report no disclosures.; This study was supported by the Centers for Disease Control and Prevention (CDC) grant 1U58DP002653-01 and the David Friedman Research Grant Award. The National Health and Nutrition Examination Survey (NHANES) is sponsored by the National Center for Health Statistics (NCHS), CDC. Funding for the vision component was provided by the National Eye Institute (NEI), National Institutes of Health (NIH), Intramural Research Program grant Z01EY000402.	Acton KJ, 2002, AM J PUBLIC HEALTH, V92, P1485, DOI 10.2105/AJPH.92.9.1485; Berglund PA., 2009, SAS GLOB FOR 2009 MA, P246; Beydoun MA, 2009, OBESITY, V17, P169, DOI 10.1038/oby.2008.492; Burrows Nilka R., 2011, Morbidity and Mortality Weekly Report, V60, P1549; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Centers for Disease Control and Prevention, 2004, ANTIBIOTIC RESISTANC; Cheung BMY, 2009, AM J MED, V122, P443, DOI 10.1016/j.amjmed.2008.09.047; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Cugati S, 2006, DIABETES RES CLIN PR, V74, P301, DOI 10.1016/j.diabres.2006.04.002; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Fagot-Campagna A, 2000, J PEDIATR-US, V136, P664, DOI 10.1067/mpd.2000.105141; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Frick KD, 2007, ARCH OPHTHALMOL-CHIC, V125, P544, DOI 10.1001/archopht.125.4.544; Hovind P, 2003, DIABETES CARE, V26, P1258, DOI 10.2337/diacare.26.4.1258; Kaufman FR, 2002, J PEDIATR ENDOCR MET, V15, P737; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; KLEIN R, 1991, DIABETES CARE, V14, P914, DOI 10.2337/diacare.14.10.914; Klein R., 1995, DIABETES AM, V2nd ed., P293, DOI DOI 10.1063/1.1522643; Klein R, 2010, DIABETES, V59, P1853, DOI 10.2337/db09-1904; Klein R, 2010, OPHTHALMOLOGY, V117, P63, DOI 10.1016/j.ophtha.2009.06.051; LeCaire T, 2006, AM J EPIDEMIOL, V164, P143, DOI 10.1093/aje/kwj166; Lytle LA, 2012, ABDOM IMAGING, V37, P719, DOI 10.1007/s00261-012-9861-y; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; *NAT HLTH NUTR EX, PUBL US DAT FIL; *NAT HLTH NUTR EX, VIS PROC MAN; National Health and Nutrition Examination Survey, LAB PROC MAN; National Health and Nutrition Examination Survey, HYP TEST; National Health and Nutrition Examination Survey, AN REP GUID; Palaniappan L, 2003, AM J HYPERTENS, V16, P952, DOI 10.1016/S0895-7061(03)01009-4; Pinhas-Hamiel O, 2005, J PEDIATR-US, V146, P693, DOI 10.1016/j.jpeds.2004.12.042; Roberts CB, 2010, ARCH OPHTHALMOL-CHIC, V128, P766, DOI 10.1001/archophthalmol.2010.86; Vitale S, 2006, JAMA-J AM MED ASSOC, V295, P2158, DOI 10.1001/jama.295.18.2158; Yuan YC., 2000, MULTIPLE IMPUTATION; Zambelli-Weiner A, AM J OPHTHALMOL, DOI [10.1016/j.ajo.2012.03 .018, DOI 10.1016/J.AJO.2012.03]; Zhang XZ, 2008, ARCH OPHTHALMOL-CHIC, V126, P1421, DOI 10.1001/archopht.126.10.1421; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111	37	57	58	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2012	308	22					2361	2368		10.1001/jama.2012.85685	http://dx.doi.org/10.1001/jama.2012.85685			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051MW	23232894	Green Accepted			2022-12-28	WOS:000312132400026
J	Liu, YH; Gokcen, D; Bertocci, U; Moffat, TP				Liu, Yihua; Gokcen, Dincer; Bertocci, Ugo; Moffat, Thomas P.			Self-Terminating Growth of Platinum Films by Electrochemical Deposition	SCIENCE			English	Article							SURFACES; AU(111); REPLACEMENT; ADLAYERS; PT(111)	A self-terminating rapid electrodeposition process for controlled growth of platinum (Pt) monolayer films from a K2PtCl4-NaCl electrolyte has been developed that is tantamount to wet atomic layer deposition. Despite the deposition overpotential being in excess of 1 volt, Pt deposition was quenched at potentials just negative of proton reduction by an alteration of the double-layer structure induced by a saturated surface coverage of underpotential deposited H (H-upd). The surface was reactivated for further Pt deposition by stepping the potential to more positive values, where H-upd is oxidized and fresh sites for the adsorption of PtCl42- become available. Periodic pulsing of the potential enables sequential deposition of two-dimensional Pt layers to fabricate films of desired thickness, relevant to a range of advanced technologies.	[Liu, Yihua; Gokcen, Dincer; Bertocci, Ugo; Moffat, Thomas P.] NIST, Mat Measurement Lab, Gaithersburg, MD 20899 USA	National Institute of Standards & Technology (NIST) - USA	Moffat, TP (corresponding author), NIST, Mat Measurement Lab, Gaithersburg, MD 20899 USA.	thomas.moffat@nist.gov	Gokcen, Dincer/H-8723-2016; Gokcen, Dincer/AAR-8632-2020	Gokcen, Dincer/0000-0003-1847-1356; 	NIST-Material Measurement Laboratory programs; NIST-National Research Council Postdoctoral Fellowship Program	NIST-Material Measurement Laboratory programs; NIST-National Research Council Postdoctoral Fellowship Program(National Institute of Standards & Technology (NIST) - USA)	We thank J. J. Mallett for his early observations on the difficulty of electrodepositing Pt films at negative potentials. This work was supported by NIST-Material Measurement Laboratory programs. The x-ray photoelectron spectrometer was provided by NIST-American Recovery and Reinvestment Act funds. Y.L. thanks the NIST-National Research Council Postdoctoral Fellowship Program for support. NIST has filed a provisional patent application (Atomic Layer Deposition of Pt from Aqueous Solutions) based on this work.	Adzic RR, 2007, TOP CATAL, V46, P249, DOI 10.1007/s11244-007-9003-x; Bakos I, 2011, J SOLID STATE ELECTR, V15, P2453, DOI 10.1007/s10008-011-1444-2; Brankovic SR, 2001, SURF SCI, V474, pL173, DOI 10.1016/S0039-6028(00)01103-1; Cumpson PJ, 1997, SURF INTERFACE ANAL, V25, P430, DOI 10.1002/(SICI)1096-9918(199706)25:6<430::AID-SIA254>3.0.CO;2-7; Debe MK, 2012, NATURE, V486, P43, DOI 10.1038/nature11115; Garcia-Araez N, 2005, J ELECTROANAL CHEM, V582, P76, DOI 10.1016/j.jelechem.2005.01.031; Gokcen D, 2011, ELECTROCHIM ACTA, V56, P5545, DOI 10.1016/j.electacta.2011.03.102; Gregory AJ, 1995, J ELECTROANAL CHEM, V399, P105, DOI 10.1016/0022-0728(95)04283-0; GREGORY BW, 1991, J ELECTROANAL CHEM, V300, P543, DOI 10.1016/0022-0728(91)85415-L; Jerkiewicz G, 2011, LANGMUIR, V27, P4220, DOI 10.1021/la200153n; Kondo T, 2010, ELECTROCHIM ACTA, V55, P8302, DOI 10.1016/j.electacta.2010.05.020; Michely T., 2003, SPRINGER SERIES SURF, V42; Nagahara Y, 2004, J PHYS CHEM B, V108, P3224, DOI 10.1021/jp036605+; Pedersen MO, 1999, SURF SCI, V426, P395, DOI 10.1016/S0039-6028(99)00385-4; Roman T, 2013, CATAL TODAY, V202, P183, DOI 10.1016/j.cattod.2012.06.001; Stamenkovic VR, 2007, NAT MATER, V6, P241, DOI 10.1038/nmat1840; Strmcnik D, 2008, ELECTROCHEM COMMUN, V10, P1602, DOI 10.1016/j.elecom.2008.08.019; Wagner FT, 2010, J PHYS CHEM LETT, V1, P2204, DOI 10.1021/jz100553m; Waibel HF, 2002, ELECTROCHIM ACTA, V47, P1461, DOI 10.1016/S0013-4686(01)00861-1; Wieckowski A., 2009, FUEL CELL CATALYSIS	20	180	187	5	338	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1327	1330		10.1126/science.1228925	http://dx.doi.org/10.1126/science.1228925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224552				2022-12-28	WOS:000311991200062
J	Shaheen, NJ; Weinberg, DS; Denberg, TD; Chou, R; Qaseem, A; Shekelle, P				Shaheen, Nicholas J.; Weinberg, David S.; Denberg, Thomas D.; Chou, Roger; Qaseem, Amir; Shekelle, Paul		Amer Coll Phys	Upper Endoscopy for Gastroesophageal Reflux Disease: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							ESOMEPRAZOLE 40 MG; OPEN-ACCESS ENDOSCOPY; QUALITY-OF-LIFE; BARRETTS-ESOPHAGUS; UNITED-STATES; GASTROINTESTINAL ENDOSCOPY; EROSIVE ESOPHAGITIS; TIME TRENDS; SURVEILLANCE; ADENOCARCINOMA	Background: Upper endoscopy is commonly used in the diagnosis and management of gastroesophageal reflux disease (GERD). Evidence demonstrates that it is indicated only in certain situations, and inappropriate use generates unnecessary costs and exposes patients to harms without improving outcomes. Methods: The Clinical Guidelines Committee of the American College of Physicians reviewed evidence regarding the indications for, and yield of, upper endoscopy in the setting of GERD, and to highlight how clinicians can increase the delivery of high-value health care. Best Practice Advice 1: Upper endoscopy is indicated in men and women with heartburn and alarm symptoms (dysphagia, bleeding, anemia, weight loss, and recurrent vomiting). Best Practice Advice 2: Upper endoscopy is indicated in men and women with: Typical GERD symptoms that persist despite a therapeutic trial of 4 to 8 weeks of twice-daily proton-pump inhibitor therapy. Severe erosive esophagitis after a 2-month course of proton-pump inhibitor therapy to assess healing and rule out Barrett esophagus. Recurrent endoscopy after this follow-up examination is not indicated in the absence of Barrett esophagus. History of esophageal stricture who have recurrent symptoms of dysphagia. Best Practice Advice 3: Upper endoscopy may be indicated: In men older than 50 years with chronic GERD symptoms (symptoms for more than 5 years) and additional risk factors (nocturnal reflux symptoms, hiatal hernia, elevated body mass index, tobacco use, and intra-abdominal distribution of fat) to detect esophageal adenocarcinoma and Barrett esophagus. For surveillance evaluation in men and women with a history of Barrett esophagus. In men and women with Barrett esophagus and no dysplasia, surveillance examinations should occur at intervals no more frequently than 3 to 5 years. More frequent intervals are indicated in patients with Barrett esophagus and dysplasia. Ann Intern Med. 2012; 157: 808-816. www.annals.org For author affiliations, see end of text.	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Harvard Vanguard Med Associates, Auburndale, MA 02466 USA; Oregon Hlth & Sci Univ, Portland, OR 97239 USA; W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA	American College of Physicians; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Fox Chase Cancer Center; Harvard Vanguard Medical Associates; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.		Shaheen, Nicholas J/A-1898-2013	Chou, Roger/0000-0001-9889-8610	National Cancer Institute [U54CA163060, U54CA156733]; NATIONAL CANCER INSTITUTE [U54CA163060, U54CA156733] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial support for the development of this best practice advice paper comes exclusively from the ACP's operating budget. Dr. Shaheen is supported by the National Cancer Institute (grant U54CA163060 and U54CA156733).	Ajumobi A, 2010, DIGEST DIS SCI, V55, P1615, DOI 10.1007/s10620-009-0917-y; Alikhan M, 1999, GASTROINTEST ENDOSC, V50, P23, DOI 10.1016/S0016-5107(99)70339-1; [Anonymous], 2000, GASTROINTEST ENDOSC, V52, P831; ARROWSMITH JB, 1991, GASTROINTEST ENDOSC, V37, P421, DOI 10.1016/S0016-5107(91)70773-6; Castell DO, 2002, AM J GASTROENTEROL, V97, P575; Chan M F, 1996, Gastrointest Endosc Clin N Am, V6, P287; Charles RJ, 2003, GASTROINTEST ENDOSC, V57, P183, DOI 10.1067/mge.2003.55; CHOW WH, 1995, JAMA-J AM MED ASSOC, V274, P474, DOI 10.1001/jama.274.6.474; Cook MB, 2009, CANCER EPIDEM BIOMAR, V18, P1174, DOI 10.1158/1055-9965.EPI-08-1118; Corley DA, 2002, GASTROENTEROLOGY, V122, P633, DOI 10.1053/gast.2002.31879; Corley DA, 2009, GASTROINTEST ENDOSC, V69, P1004, DOI 10.1016/j.gie.2008.07.035; Crockett SD, 2012, GASTROINTEST ENDOSC, V75, P23, DOI 10.1016/j.gie.2011.08.042; Dean BB, 2004, CLIN GASTROENTEROL H, V2, P656, DOI 10.1016/S1542-3565(04)00288-5; Dent J, 2005, GUT, V54, P710, DOI 10.1136/gut.2004.051821; Dulai GS, 2002, GASTROENTEROLOGY, V122, P26, DOI 10.1053/gast.2002.30297; Eisen GM, 1999, GASTROINTEST ENDOSC, V50, P814, DOI 10.1016/S0016-5107(99)70164-1; El-Serag HB, 2008, DIGESTION, V78, P6, DOI 10.1159/000151249; El-Serag HB, 1998, GUT, V43, P327, DOI 10.1136/gut.43.3.327; El-Serag HB, 2002, GUT, V50, P368, DOI 10.1136/gut.50.3.368; Eloubeidi MA, 2003, AM J GASTROENTEROL, V98, P1627, DOI 10.1016/S0002-9270(03)00228-4; Eloubeidi MA, 2000, AM J GASTROENTEROL, V95, P1881; Falk GW, 2000, GASTROINTEST ENDOSC, V52, P197, DOI 10.1067/mge.2000.107728; Farrow DC, 2000, CANCER CAUSE CONTROL, V11, P231, DOI 10.1023/A:1008913828105; Gilani N, 2008, WORLD J GASTROENTERO, V14, P3518, DOI 10.3748/wjg.14.3518; Gonvers JJ, 1996, ENDOSCOPY, V28, P661, DOI 10.1055/s-2007-1005573; Hanna S, 2006, AM J GASTROENTEROL, V101, P1416, DOI 10.1111/j.1572-0241.2006.00631.x; Harewood G C, 2008, Ir Med J, V101, P248; Hassan C, 2007, GASTROINTEST ENDOSC, V65, P767, DOI 10.1016/j.gie.2006.12.058; Havelund T, 1999, AM J GASTROENTEROL, V94, P1782; Hirota WK, 2006, GASTROINTEST ENDOSC, V63, P570, DOI 10.1016/j.gie.2006.02.004; Hvid-Jensen F, 2011, NEW ENGL J MED, V365, P1375, DOI 10.1056/NEJMoa1103042; Inadomi JM, 2009, GASTROENTEROLOGY, V136, P2101, DOI 10.1053/j.gastro.2009.02.062; Kahrilas PJ, 2008, GASTROENTEROLOGY, V135, P1392, DOI 10.1053/j.gastro.2008.08.044; Keren D, 2011, CAN J GASTROENTEROL, V25, P83, DOI 10.1155/2011/379014; Khan M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003244.pub2; Krishnamurthy C, 2012, DYSPHAGIA, V27, P101, DOI 10.1007/s00455-011-9346-0; Labenz J, 2005, ALIMENT PHARM THERAP, V21, P739, DOI 10.1111/j.1365-2036.2005.02368.x; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Laine L, 2011, ALIMENT PHARM THER, V33, P203, DOI 10.1111/j.1365-2036.2010.04516.x; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Modiano N, 2009, GASTROINTEST ENDOSC, V69, P1014, DOI 10.1016/j.gie.2008.07.024; Montgomery E, 2001, HUM PATHOL, V32, P368, DOI 10.1053/hupa.2001.23510; NEBEL OT, 1976, AM J DIG DIS, V21, P953, DOI 10.1007/BF01071906; Overholt BF, 2005, GASTROINTEST ENDOSC, V62, P488, DOI 10.1016/j.gie.2005.06.047; Pallarito K., 2009, 4 US NEWS WORLD; PETERS JH, 1994, J THORAC CARDIOV SUR, V108, P813, DOI 10.1016/S0022-5223(94)70178-4; Pharmaceutical Sales 2009, 2009, PHARM SAL 2009; Pohl H, 2010, CANCER EPIDEM BIOMAR, V19, P1468, DOI 10.1158/1055-9965.EPI-10-0012; Rex DK, 2003, GASTROENTEROLOGY, V125, P1670, DOI 10.1053/j.gastro.2003.09.030; Rodriguez S, 2008, AM J GASTROENTEROL, V103, P1892, DOI 10.1111/j.1572-0241.2008.01892.x; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; Rossi A, 2002, GASTROINTEST ENDOSC, V56, P714, DOI 10.1067/mge.2002.129222; Rubenstein JH, 2008, AM J GASTROENTEROL, V103, P842, DOI 10.1111/j.1572-0241.2007.01689.x; Rubenstein JH, 2011, AM J GASTROENTEROL, V106, P254, DOI 10.1038/ajg.2010.470; Rubenstein JH, 2010, GASTROINTEST ENDOSC, V71, P21, DOI 10.1016/j.gie.2009.06.035; Ruigomez A, 2006, AM J GASTROENTEROL, V101, P2685, DOI 10.1111/j.1572-0241.2006.00828.x; Said A, 2003, AM J GASTROENTEROL, V98, P1252, DOI 10.1016/S0002-9270(03)00269-7; Shaheen N, 2002, JAMA-J AM MED ASSOC, V287, P1972, DOI 10.1001/jama.287.15.1972; Shaheen NJ, 2009, NEW ENGL J MED, V360, P2277, DOI 10.1056/NEJMoa0808145; Shaheen NJ, 2005, GASTROENTEROLOGY, V129, P429, DOI 10.1053/j.gastro.2005.05.055; Shaheen NJ, 2002, AM J GASTROENTEROL, V97, P1319, DOI 10.1016/S0002-9270(02)04123-0; Sikkema M, 2010, CLIN GASTROENTEROL H, V8, P235, DOI 10.1016/j.cgh.2009.10.010; Sonnenberg A, 2008, GASTROINTEST ENDOSC, V67, P489, DOI 10.1016/j.gie.2007.08.041; Spechler SJ, 2011, GASTROENTEROLOGY, V140, P1084, DOI 10.1053/j.gastro.2011.01.030; Spechler SJ, 2011, GASTROENTEROLOGY, V140, pE18, DOI 10.1053/j.gastro.2011.01.031; STREITZ JM, 1993, J THORAC CARDIOV SUR, V105, P383; Taylor JB, 2010, AM J GASTROENTEROL, V105, P1730, DOI 10.1038/ajg.2010.194; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; van Sandick JW, 1998, GUT, V43, P216, DOI 10.1136/gut.43.2.216; Vizcaino AP, 2002, INT J CANCER, V99, P860, DOI 10.1002/ijc.10427; Wang KK, 2008, AM J GASTROENTEROL, V103, P788, DOI 10.1111/j.1572-0241.2008.01835.x; Wani S, 2009, AM J GASTROENTEROL, V104, P502, DOI 10.1038/ajg.2008.31	73	108	116	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2012	157	11					808	+		10.7326/0003-4819-157-11-201212040-00008	http://dx.doi.org/10.7326/0003-4819-157-11-201212040-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	049RC	23208168				2022-12-28	WOS:000312000100006
J	Soldner, F; Jaenisch, R				Soldner, Frank; Jaenisch, Rudolf			iPSC Disease Modeling	SCIENCE			English	Editorial Material							PLURIPOTENT; GENERATION		[Soldner, Frank; Jaenisch, Rudolf] Whitehead Inst, Cambridge, MA 02142 USA; [Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Soldner, F (corresponding author), Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu			NATIONAL CANCER INSTITUTE [R01CA084198] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA084198] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Cheng LZ, 2012, CELL STEM CELL, V10, P337, DOI 10.1016/j.stem.2012.01.005; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kim H, 2011, CELL STEM CELL, V8, P695, DOI 10.1016/j.stem.2011.04.002; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Majewski J, 2011, TRENDS GENET, V27, P72, DOI 10.1016/j.tig.2010.10.006; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Onder TT, 2012, CURR OPIN GENET DEV, V22, P500, DOI 10.1016/j.gde.2012.05.005; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424	21	116	121	1	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1155	1156		10.1126/science.1227682	http://dx.doi.org/10.1126/science.1227682			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197518				2022-12-28	WOS:000311666200027
J	Spence, D				Spence, Des			All in it together?	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						[Anonymous], 2012, PULSE           1129; Davies Lizzie, 2012, GUARDIAN; Gov.uk, 2012, NAT MIN WAG RAT; Plunkett J., 2012, GUARDIAN; Revoir P, 2012, MAIL ONLINE     1122	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 30	2012	345								e8168	10.1136/bmj.e8168	http://dx.doi.org/10.1136/bmj.e8168			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048FS	23204008				2022-12-28	WOS:000311896500017
J	Rohling, EJ; Sluijs, A; Dijkstra, HA; Kohler, P; de Wal, RSWV; von der Heydt, AS; Beerling, DJ; Berger, A; Bijl, PK; Crucifix, M; DeConto, R; Drijfhout, SS; Fedorov, A; Foster, GL; Ganopolski, A; Hansen, J; Honisch, B; Hooghiemstra, H; Huber, M; Huybers, P; Knutti, R; Lea, DW; Lourens, LJ; Lunt, D; Masson-Demotte, V; Medina-Elizalde, M; Otto-Bliesner, B; Pagani, M; Palike, H; Renssen, H; Royer, DL; Siddall, M; Valdes, P; Zachos, JC; Zeebe, RE				Rohling, E. J.; Sluijs, A.; Dijkstra, H. A.; Koehler, P.; de Wal, R. S. W. van; von der Heydt, A. S.; Beerling, D. J.; Berger, A.; Bijl, P. K.; Crucifix, M.; DeConto, R.; Drijfhout, S. S.; Fedorov, A.; Foster, G. L.; Ganopolski, A.; Hansen, J.; Hoenisch, B.; Hooghiemstra, H.; Huber, M.; Huybers, P.; Knutti, R.; Lea, D. W.; Lourens, L. J.; Lunt, D.; Masson-Demotte, V.; Medina-Elizalde, M.; Otto-Bliesner, B.; Pagani, M.; Paelike, H.; Renssen, H.; Royer, D. L.; Siddall, M.; Valdes, P.; Zachos, J. C.; Zeebe, R. E.		PALAEOSENS Project Members	Making sense of palaeoclimate sensitivity	NATURE			English	Article							CARBON-DIOXIDE CONCENTRATION; GLOBAL CLIMATE SENSITIVITY; EOCENE ATMOSPHERIC CO2; LAST GLACIAL MAXIMUM; ANTARCTIC TEMPERATURE; EARTHS TEMPERATURE; GEOLOGICAL RECORD; SEA-LEVEL; FUTURE; MODEL	Many palaeoclimate studies have quantified pre-anthropogenic climate change to calculate climate sensitivity (equilibrium temperature change in response to radiative forcing change), but a lack of consistent methodologies produces a wide range of estimates and hinders comparability of results. Here we present a stricter approach, to improve intercomparison of palaeoclimate sensitivity estimates in a manner compatible with equilibrium projections for future climatechange. Over the past 65 million years, this reveals a climate sensitivity (in KW-1 m(2)) of 0.3-1.9 or 0.6-1.3 at 95% or 68% probability, respectively. The latter implies a warming of 2.2-4.8 K per doubling of atmospheric CO2, which agrees with IPCC estimates.	[Rohling, E. J.; Foster, G. L.] Univ Southampton, Sch Ocean & Earth Sci, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; [Rohling, E. J.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Sluijs, A.; Bijl, P. K.; Lourens, L. J.] Univ Utrecht, Dept Earth Sci, Fac Geosci, NL-3584 CD Utrecht, Netherlands; [Dijkstra, H. A.; de Wal, R. S. W. van; von der Heydt, A. S.] Univ Utrecht, Inst Marine & Atmospher Res Utrecht, NL-3584 CC Utrecht, Netherlands; [Koehler, P.] Alfred Wegener Inst Polar & Marine Res AWI, D-27515 Bremerhaven, Germany; [Beerling, D. J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Berger, A.; Crucifix, M.] Catholic Univ Louvain, Georges Lemaitre Ctr Earth & Climate Res, Earth & Life Inst, B-1348 Louvain, Belgium; [DeConto, R.] Univ Massachusetts, Dept Geosci, Morrill Sci Ctr 233, Amherst, MA 01003 USA; [Drijfhout, S. S.] Royal Netherlands Meteorol Inst, NL-3730 AE De Bilt, Netherlands; [Fedorov, A.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Ganopolski, A.] Potsdam Inst Climate Impact Res PIK, D-14412 Potsdam, Germany; [Hansen, J.] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Hoenisch, B.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Hooghiemstra, H.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1098 XH Amsterdam, Netherlands; [Huber, M.] Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA; [Huybers, P.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Knutti, R.] ETH, Inst Atmospher andClimate Sci, CH-8092 Zurich, Switzerland; [Lea, D. W.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; [Lunt, D.; Valdes, P.] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England; [Masson-Demotte, V.] LCEA Saclay, LSCE IPSL CEA CNRS UVSQ, UMR 8212, F-91191 Gif Sur Yvette, France; [Medina-Elizalde, M.] Ctr Invest Cient Yucatan, Unidad Ciencias Agua, Cancun 77500, Quintana Roo, Mexico; [Otto-Bliesner, B.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Paelike, H.] Univ Bremen, MARUM, D-28359 Bremen, Germany; [Renssen, H.] Free Univ Amsterdam, Dept Earth Sci, Fac Earth & Life Sci, NL-1081 HV Amsterdam, Netherlands; [Royer, D. L.] Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT 06459 USA; [Siddall, M.] Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; [Zeebe, R. E.] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA	NERC National Oceanography Centre; University of Southampton; Australian National University; Utrecht University; Utrecht University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Sheffield; Universite Catholique Louvain; University of Massachusetts System; University of Massachusetts Amherst; Royal Netherlands Meteorological Institute; Yale University; Potsdam Institut fur Klimafolgenforschung; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Columbia University; University of Amsterdam; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Harvard University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Santa Barbara; University of Bristol; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centro de Investigacion Cientifica de Yucatan; National Center Atmospheric Research (NCAR) - USA; University of Bremen; Vrije Universiteit Amsterdam; Wesleyan University; University of Bristol; University of Hawaii System; University of Hawaii Manoa	Rohling, EJ (corresponding author), Univ Southampton, Sch Ocean & Earth Sci, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England.	e.rohling@noc.soton.ac.uk	Valdes, Paul/T-2004-2019; Sluijs, Appy/B-3726-2009; Foster, Gavin/CAF-4654-2022; Dijkstra, Henk A./H-2559-2016; von der Heydt, Anna S/B-9250-2008; Pagani, Mark/B-3233-2008; Hoenisch, Baerbel/C-7530-2013; Palike, Heiko/A-6560-2008; Masson-Delmotte, Valerie L/G-1995-2011; Huber, Matthew/A-7677-2008; Ganopolski, Andrey/F-6811-2013; Drijfhout, Sybren/I-4230-2016; Knutti, Reto/B-8763-2008; Beerling, David J/C-2840-2009; Rohling, Eelco J/B-9736-2008; Köhler, Peter/F-7293-2010; van de wal, roderik/D-1705-2011; Valdes, Paul/C-4129-2013; Otto-Bliesner, Bette/AAY-7691-2020; Zachos, James C/A-7674-2008; Foster, Gavin/W-5968-2019; Lunt, Daniel J/G-9451-2011; Hoenisch, Baerbel/ABF-4968-2021	Valdes, Paul/0000-0002-1902-3283; Sluijs, Appy/0000-0003-2382-0215; Foster, Gavin/0000-0003-3688-9668; von der Heydt, Anna S/0000-0002-5557-3282; Hoenisch, Baerbel/0000-0001-5844-3398; Palike, Heiko/0000-0003-3386-0923; Masson-Delmotte, Valerie L/0000-0001-8296-381X; Huber, Matthew/0000-0002-2771-9977; Knutti, Reto/0000-0001-8303-6700; Beerling, David J/0000-0003-1869-4314; Rohling, Eelco J/0000-0001-5349-2158; Köhler, Peter/0000-0003-0904-8484; van de wal, roderik/0000-0003-2543-3892; Zachos, James C/0000-0001-8439-1886; Lunt, Daniel J/0000-0003-3585-6928; Hoenisch, Baerbel/0000-0001-5844-3398; Bijl, Peter/0000-0002-1710-4012; Crucifix, Michel/0000-0002-3437-4911; Royer, Dana/0000-0003-0976-953X; Huybers, Peter/0000-0002-3734-8145	Royal Netherlands Academy of Arts and Sciences (KNAW); UK-NERC consortium iGlass [NE/I009906/1]; Australian Laureate Fellowship [FL120100050]; Royal Society Wolfson Research Merit Awards; European Research Council for ERC [259627]; NSF [0902882]; EU [243908]; NERC [NE/F003641/1, NE/I009906/1, NE/I005595/1] Funding Source: UKRI; Directorate For Geosciences [0902882, 1023724] Funding Source: National Science Foundation	Royal Netherlands Academy of Arts and Sciences (KNAW); UK-NERC consortium iGlass; Australian Laureate Fellowship; Royal Society Wolfson Research Merit Awards(Royal Society of London); European Research Council for ERC(European Research Council (ERC)); NSF(National Science Foundation (NSF)); EU(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This Perspective arose from the first PALAEOSENS workshop in March 2011. We thank the Royal Netherlands Academy of Arts and Sciences (KNAW) for funding and hosting this workshop in Amsterdam, PAGES for their support, and J. Gregory for discussions. This study was supported by the UK-NERC consortium iGlass (NE/I009906/1), and 2012 Australian Laureate Fellowship FL120100050. D.J.B., E.J.R. and P.V. were supported by Royal Society Wolfson Research Merit Awards. A.S. thanks the European Research Council for ERC starting grant 259627, and M.H. acknowledges NSF P2C2 grant 0902882. Some of the work was supported by grant 243908 'Past4Future' of the EU's seventh framework programme; this is Past4Future contribution number 30.	Baker MB, 2009, J CLIMATE, V22, P4574, DOI 10.1175/2009JCLI2647.1; Ballantyne AP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021217; Beerling DJ, 2011, NAT GEOSCI, V4, P418, DOI 10.1038/ngeo1186; Beerling DJ, 2011, P NATL ACAD SCI USA, V108, P9770, DOI 10.1073/pnas.1102409108; Beerling DJ, 2002, ANNU REV EARTH PL SC, V30, P527, DOI 10.1146/annurev.earth.30.091201.141413; BERGER AL, 1977, NATURE, V269, P44, DOI 10.1038/269044a0; BERNER RA, 1991, AM J SCI, V291, P339, DOI 10.2475/ajs.291.4.339; Bijl PK, 2010, SCIENCE, V330, P819, DOI 10.1126/science.1193654; Bintanja R, 2005, NATURE, V437, P125, DOI 10.1038/nature03975; Borzenkova II, 2003, IZV ATMOS OCEAN PHY+, V39, P197; CERLING TE, 1991, AM J SCI, V291, P377, DOI 10.2475/ajs.291.4.377; Charney J., 1979, CARBON DIOXIDE CLIMA; Colman R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036268; Covey C, 1996, CLIMATIC CHANGE, V32, P165, DOI 10.1007/BF00143708; Cramer BS, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007255; Crucifix M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027137; de Boer B, 2012, PALAEOGEOGR PALAEOCL, V335, P4, DOI 10.1016/j.palaeo.2011.02.001; Dickens GR, 1997, GEOLOGY, V25, P259, DOI 10.1130/0091-7613(1997)025<0259:ABOGIT>2.3.CO;2; Dufresne JL, 2008, J CLIMATE, V21, P5135, DOI 10.1175/2008JCLI2239.1; Edwards TL, 2007, PROG PHYS GEOG, V31, P481, DOI 10.1177/0309133307083295; Freeman KH, 1992, GLOBAL BIOGEOCHEM CY, V6, P185, DOI 10.1029/92GB00190; Gasson E, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000358; Gray LJ, 2010, REV GEOPHYS, V48, DOI 10.1029/2009RG000282; Gregory JM, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010405; Gregory JM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018747; Gregory J, 2008, J CLIMATE, V21, P58, DOI 10.1175/2007JCLI1834.1; Hannart A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039640; Hansen J, 2011, ATMOS CHEM PHYS, V11, P13421, DOI 10.5194/acp-11-13421-2011; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; Hansen J., 1984, GEOPHYS MONOGR SER, P130, DOI [10.1029/gm029p0130, 10.1029/GM029p0130, DOI 10.1029/GM029P0130]; Hansen J.E., 2012, PALEOCLIMATE IMPLICA, P21; Hansen J, 2007, PHILOS T R SOC A, V365, P1925, DOI 10.1098/rsta.2007.2052; Hargreaves JC, 2007, CLIM PAST, V3, P77, DOI 10.5194/cp-3-77-2007; Haywood AM, 2011, PHILOS T R SOC A, V369, P933, DOI 10.1098/rsta.2010.0317; Held IM, 2010, J CLIMATE, V23, P2418, DOI 10.1175/2009JCLI3466.1; Honisch B, 2012, SCIENCE, V335, P1058, DOI 10.1126/science.1208277; Honisch B, 2009, SCIENCE, V324, P1551, DOI 10.1126/science.1171477; HOFFERT MI, 1992, NATURE, V360, P573, DOI 10.1038/360573a0; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Huber M, 2011, CLIM PAST, V7, P603, DOI 10.5194/cp-7-603-2011; Huber M, 2011, J CLIMATE, V24, P1034, DOI 10.1175/2010JCLI3403.1; Huybers P, 2008, NAT GEOSCI, V1, P787, DOI 10.1038/ngeo311; Huybers P, 2006, SCIENCE, V313, P508, DOI 10.1126/science.1125249; Huybers P, 2010, J CLIMATE, V23, P3009, DOI 10.1175/2010JCLI3380.1; IMBRIE J, 1980, SCIENCE, V207, P943, DOI 10.1126/science.207.4434.943; Joos F, 2008, P NATL ACAD SCI USA, V105, P1425, DOI 10.1073/pnas.0707386105; Knutti R, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032904; Knutti R, 2008, NAT GEOSCI, V1, P735, DOI 10.1038/ngeo337; Kohler P, 2011, CLIM PAST, V7, P473, DOI 10.5194/cp-7-473-2011; Kohler P, 2010, QUATERNARY SCI REV, V29, P129, DOI 10.1016/j.quascirev.2009.09.026; Kohfeld KE, 2001, EARTH-SCI REV, V54, P81, DOI 10.1016/S0012-8252(01)00042-3; Laine A, 2009, J CLIMATE, V22, P4621, DOI 10.1175/2009JCLI2771.1; Lambert F, 2008, NATURE, V452, P616, DOI 10.1038/nature06763; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lea DW, 2004, J CLIMATE, V17, P2170, DOI 10.1175/1520-0442(2004)017<2170:TYCITS>2.0.CO;2; Lemoine DM, 2010, J CLIMATE, V23, P4395, DOI 10.1175/2010JCLI3503.1; LORIUS C, 1990, NATURE, V347, P139, DOI 10.1038/347139a0; Loulergue L, 2008, NATURE, V453, P383, DOI 10.1038/nature06950; Lourens LJ, 2005, NATURE, V435, P1083, DOI 10.1038/nature03814; Lowenstein TK, 2006, SCIENCE, V313, P1928, DOI 10.1126/science.1129555; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Lunt DJ, 2012, EARTH PLANET SC LETT, V321, P128, DOI 10.1016/j.epsl.2011.12.042; Lunt DJ, 2010, NAT GEOSCI, V3, P60, DOI 10.1038/NGEO706; Mahowald N, 2011, QUATERNARY SCI REV, V30, P832, DOI 10.1016/j.quascirev.2010.09.007; Masson-Delmotte V, 2006, CLIM DYNAM, V26, P513, DOI [10.1007/s00382-005-0081-9, 10.1007/S00382-005-0081-9]; Milankovitch M., 1941, SPECIAL PUBLICATION, V133; Miller KG, 2005, MAR GEOL, V217, P215, DOI 10.1016/j.margeo.2005.02.007; Naafs BDA, 2012, EARTH PLANET SC LETT, V317, P8, DOI 10.1016/j.epsl.2011.11.026; Otto-Bliesner B. L., STATUS CCSM4 PALEO C; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; Panchuk K, 2008, GEOLOGY, V36, P315, DOI 10.1130/G24474A.1; Park J, 2011, AM J SCI, V311, P1, DOI 10.2475/01.2011.01; Roberts AP, 2011, QUATERNARY SCI REV, V30, P3537, DOI 10.1016/j.quascirev.2011.09.007; Roe G, 2009, ANNU REV EARTH PL SC, V37, P93, DOI 10.1146/annurev.earth.061008.134734; Roe GH, 2007, SCIENCE, V318, P629, DOI 10.1126/science.1144735; Rohling EJ, 2012, J CLIMATE, V25, P1635, DOI 10.1175/2011JCLI4078.1; Rohling EJ, 2009, NAT GEOSCI, V2, P500, DOI 10.1038/ngeo557; Rohling EJ, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2007PA001437; Royer DL, 2012, GEOBIOLOGY, V10, P298, DOI 10.1111/j.1472-4669.2012.00320.x; Ruth U, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002376; Schilt A, 2010, QUATERNARY SCI REV, V29, P182, DOI 10.1016/j.quascirev.2009.03.011; Schmidt GA., 2012, PAGES NEWS, V20, P11; Schmittner A, 2011, SCIENCE, V334, P1385, DOI 10.1126/science.1203513; Schneider von Deimling T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026484; SLOAN LC, 1992, PALAEOGEOGR PALAEOCL, V93, P183, DOI 10.1016/0031-0182(92)90096-N; Sluijs A, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001615; Soden BJ, 2006, J CLIMATE, V19, P3354, DOI 10.1175/JCLI3799.1; Solomon S., 2007, PHYS SCI BASIS WORKI; van de Wal RSW, 2011, CLIM PAST, V7, P1459, DOI 10.5194/cp-7-1459-2011; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Waelbroeck C, 2009, NAT GEOSCI, V2, P127, DOI 10.1038/NGEO411; Winckler G, 2008, SCIENCE, V320, P93, DOI 10.1126/science.1150595; Wunsch C, 2008, QUATERNARY SCI REV, V27, P637, DOI 10.1016/j.quascirev.2008.01.006; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266; Zaliapin I, 2010, NONLINEAR PROC GEOPH, V17, P113, DOI 10.5194/npg-17-113-2010; Zeebe RE, 2009, NAT GEOSCI, V2, P576, DOI 10.1038/NGEO578	99	200	202	7	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					683	691		10.1038/nature11574	http://dx.doi.org/10.1038/nature11574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23192145	Green Published			2022-12-28	WOS:000311606000031
J	Patnode, CD; O'Connor, E; Whitlock, EP; Perdue, LA; Soh, C; Hollis, J				Patnode, Carrie D.; O'Connor, Elizabeth; Whitlock, Evelyn P.; Perdue, Leslie A.; Soh, Clara; Hollis, Jack			Primary Care-Relevant Interventions for Tobacco Use Prevention and Cessation in Children and Adolescents: A Systematic Evidence Review for the U.S. Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							SMOKING PREVENTION; RANDOMIZED-TRIAL; BUPROPION; SCHOOL; RESTRICTIONS; OUTCOMES; PARENTS; PROGRAM	Background: Interventions to prevent smoking uptake or encourage cessation among young persons might help prevent tobacco-related illness. Purpose: To review the evidence for the efficacy and harms of primary care-relevant interventions that aim to reduce tobacco use among children and adolescents. Data Sources: Three systematic reviews that collectively covered the relevant literature; MEDLINE, PsycINFO, the Cochrane Central Register of Controlled Trials, and the Database of Abstracts of Reviews of Effects through 14 September 2012; and manual searches of reference lists and gray literature. Study Selection: Two investigators independently reviewed 2453 abstracts and 111 full-text articles. English-language trials of behavior-based or medication interventions that were relevant to primary care and reported tobacco use, health outcomes, or harms were included. Data Extraction: One investigator abstracted data from good- and fair-quality trials into an evidence table, and a second checked these data. Data Synthesis: 19 trials (4 good-quality and 15 fair-quality) that were designed to prevent tobacco use initiation or promote cessation (or both) and reported self-reported smoking status or harms were included. Pooled analyses from a random-effects meta-analysis suggested a 19% relative reduction (risk ratio, 0.81 [95% CI, 0.70 to 0.93]; absolute risk difference, -0.02 [CI, -0.03 to 0.00]) in smoking initiation among participants in behavior-based prevention interventions compared with control participants. Neither behavior-based nor bupropion cessation interventions improved cessation rates. Findings about the harms related to bupropion use were mixed. Limitations: No studies reported health outcomes. Interventions and measures were heterogeneous. Most trials examined only cigarette smoking. The body of evidence was largely published 5 to 15 years ago. Conclusion: Primary care-relevant interventions may prevent smoking initiation over 12 months in children and adolescents.	[Patnode, Carrie D.; O'Connor, Elizabeth; Whitlock, Evelyn P.; Perdue, Leslie A.; Soh, Clara; Hollis, Jack] Oregon Evidence Based Practice Ctr, Portland, OR USA		Patnode, CD (corresponding author), Oregon Evidence Based Practice Ctr, Portland, OR USA.				Agency for Healthcare Research and Quality [HHS-290-2007-10057-I]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By contract HHS-290-2007-10057-I from the Agency for Healthcare Research and Quality.	Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; [Anonymous], 2008, US PREV SERV TASK FO; Arrazola R. A., 2010, Morbidity and Mortality Weekly Report, V59, P1063; Ausems M, 2002, PREV MED, V34, P581, DOI 10.1006/pmed.2002.1021; Bauman K E, 2000, Prev Sci, V1, P227, DOI 10.1023/A:1026503313188; Bauman Karl E, 2002, Prev Sci, V3, P35, DOI 10.1023/A:1014619325968; Bauman KE, 2001, AM J PUBLIC HEALTH, V91, P604, DOI 10.2105/AJPH.91.4.604; Centers for Disease Control and Prevention, 2007, BEST PRACT COMPR TOB; Christakis DA, 2003, AM J PREV MED, V25, P358, DOI 10.1016/S0749-3797(03)00214-9; Colby SM, 2005, ADDICT BEHAV, V30, P865, DOI 10.1016/j.addbeh.2004.10.001; Colby SM, 2012, ADDICT BEHAV, V37, P817, DOI 10.1016/j.addbeh.2012.03.011; Curry SJ, 2003, PREV MED, V37, P617, DOI 10.1016/j.ypmed.2003.09.015; Dolcini MM, 2003, NICOTINE TOB RES, V5, P473, DOI 10.1080/1462220031000118586; Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1; Farkas AJ, 2000, JAMA-J AM MED ASSOC, V284, P717, DOI 10.1001/jama.284.6.717; Fidler W, 2001, TOB CONTROL, V10, P23, DOI 10.1136/tc.10.1.23; Gray KM, 2011, J SUBST ABUSE TREAT, V40, P77, DOI 10.1016/j.jsat.2010.08.010; Grimshaw GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003289.pub4; Haggerty KP, 2007, PREV SCI, V8, P249, DOI 10.1007/s11121-007-0077-2; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hollis JF, 2005, PEDIATRICS, V115, P981, DOI 10.1542/peds.2004-0981; Hovell MF, 1996, AM J PUBLIC HEALTH, V86, P1760, DOI 10.2105/AJPH.86.12.1760; Jackson C, 2006, ARCH PEDIAT ADOL MED, V160, P56, DOI 10.1001/archpedi.160.1.56; Kentala J, 1999, PREV MED, V29, P107, DOI 10.1006/pmed.1999.0512; Killen JD, 2004, J CONSULT CLIN PSYCH, V72, P729, DOI 10.1037/0022-006X.72.4.729; Lando HA, 2007, J SMOK CESS, V2, P23, DOI 10.1375/jsc.2.1.23; Muramoto ML, 2007, ARCH PEDIAT ADOL MED, V161, P1068, DOI 10.1001/archpedi.161.11.1068; Patnode CD, 2012, INTERVENTIONS TOBACC; Pbert L, 2008, PEDIATRICS, V121, pE738, DOI 10.1542/peds.2007-1029; Pbert L, 2011, PEDIATRICS, V128, P926, DOI 10.1542/peds.2011-0520; Prado G, 2007, J CONSULT CLIN PSYCH, V75, P914, DOI 10.1037/0022-006X.75.6.914; Sterne JAC, 2006, PUBLICATION BIAS MET; Stevens MM, 2002, PEDIATRICS, V109, P490, DOI 10.1542/peds.109.3.490; Substance Abuse and Mental Health Services Administration, 2011, NSDUH SER H, VH-41; Thomas RE, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004493.pub2; U.S. Department of Health and Human Services, 2011, FDA ISS FIN RUL REST; U.S. Department of Health and Human Services, 2008, TREATING TOBACCO USE; U.S. Preventive Services Task Force, 2003, COUNS PREV TOB US TO; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO; Wakefield MA, 2000, BRIT MED J, V321, P333, DOI 10.1136/bmj.321.7257.333; Zaza S, 2005, GUID COMM PREV SERV, P3	42	57	58	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 19	2013	158	4					253	260		10.7326/0003-4819-158-4-201302190-00580	http://dx.doi.org/10.7326/0003-4819-158-4-201302190-00580			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	098WR	23229625				2022-12-28	WOS:000315580300016
J	Tana, MM; Hoofnagle, JH				Tana, Michele M.; Hoofnagle, Jay H.			Scar undone: long-term therapy of hepatitis B	LANCET			English	Editorial Material							LAMIVUDINE; IMPROVEMENT; ENTECAVIR; ADEFOVIR		[Tana, Michele M.; Hoofnagle, Jay H.] NIDDKD, Liver Dis Branch, Div Intramural Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hoofnagle, JH (corresponding author), NIDDKD, Liver Dis Branch, Div Intramural Res, NIH, Bethesda, MD 20892 USA.	hoofnaglej@extra.niddk.nih.gov						Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Gara N, 2012, ALIMENT PHARM THER, V35, P1317, DOI 10.1111/j.1365-2036.2012.05093.x; Ghany MG, 2009, HEPATOLOGY, V49, pS174, DOI 10.1002/hep.22900; Gupta SK, 2008, AIDS PATIENT CARE ST, V22, P99, DOI 10.1089/apc.2007.0052; Hadziyannis SJ, 2012, GASTROENTEROLOGY, V143, P629, DOI 10.1053/j.gastro.2012.05.039; Heathcote EJ, 2011, GASTROENTEROLOGY, V140, P132, DOI 10.1053/j.gastro.2010.10.011; Kim WR, 2009, HEPATOLOGY, V49, pS28, DOI 10.1002/hep.22975; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; Lau DTY, 1999, GASTROENTEROLOGY, V117, P1229, DOI 10.1016/S0016-5085(99)70409-9; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Marcellin P, 1997, ANN INTERN MED, V127, P875, DOI 10.7326/0003-4819-127-10-199711150-00003; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Marcellin P, 2012, LANCET; MULLER RS, 1990, SENSOR ACTUAT A-PHYS, V21, P1, DOI 10.1016/0924-4247(90)85001-K; World Health Organisation, 2012, HEP B FACT SHEET 204	16	5	5	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2013	381	9865					433	434		10.1016/S0140-6736(12)61721-8	http://dx.doi.org/10.1016/S0140-6736(12)61721-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088CH	23234726				2022-12-28	WOS:000314810900010
J	Schmidt, E; Zillikens, D				Schmidt, Enno; Zillikens, Detlef			Pemphigoid diseases	LANCET			English	Article							EPIDERMOLYSIS-BULLOSA-ACQUISITA; LINKED-IMMUNOSORBENT-ASSAY; LINEAR IGA DISEASE; DERMAL-EPIDERMAL SEPARATION; GESTATIONIS AUTOANTIBODIES RECOGNIZE; BASEMENT-MEMBRANE SEPARATION; INDUCE SUBEPIDERMAL BLISTERS; AUTOREACTIVE T-CELL; VII-COLLAGEN; PASSIVE TRANSFER	Pemphigoid diseases are a group of well defined autoimmune disorders that are characterised by autoantibodies against structural proteins of the dermal-epidermal junction and, clinically, by tense blisters and erosions on skin or mucous membranes close to the skin surface. The most common of these diseases is bullous pemphigoid, which mainly affects older people and the reported incidence of which in Europe has more than doubled in the past decade. Prognosis and treatments vary substantially between the different disorders and, since clinical criteria are usually not sufficient, direct immunofluorescence microscopy of a perilesional biopsy specimen or serological tests are needed for exact diagnosis. In eight pemphigoid diseases the target antigens have been identified molecularly, which has allowed the development of standard diagnostic assays for detection of serum autoantibodies-some of which are commercially available. In this Seminar we discuss the clinical range, diagnostic criteria, diagnostic assay systems, and treatment options for this group of diseases.	[Schmidt, Enno; Zillikens, Detlef] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Schmidt, Enno] Med Univ Lubeck, Comprehens Ctr Inflammat Med, D-23538 Lubeck, Germany	University of Lubeck; University of Lubeck	Schmidt, E (corresponding author), Med Univ Lubeck, Dept Dermatol, Ratzeburger Allee 160, D-23538 Lubeck, Germany.	enno.schmidt@uk-sh.de	Schmidt, Enno/C-4008-2009; Zillikens, Detlef/C-8572-2011	Schmidt, Enno/0000-0002-1206-8913; 	German Research Foundation Excellence Cluster-Inflammation at Interfaces [EXC 306/1]; Euroimmun; Fresenius Medical Care; Biotest; Novartis	German Research Foundation Excellence Cluster-Inflammation at Interfaces(German Research Foundation (DFG)); Euroimmun; Fresenius Medical Care; Biotest; Novartis(Novartis)	Both authors received honoraria for lectures from Roche and Fresenius Medical Care. We have received funding for research and development projects from Euroimmun (both authors), Fresenius Medical Care (DZ), Biotest (DZ), and Novartis (ES). Neither author has had, within the past 3 years, any stocks, shares, or equity in a relevant company, nor a contract of employment or named position on a company board.; We acknowledge those researchers whose contributions we have not cited directly, but, because of space limitations, through review articles. This work was supported by the German Research Foundation Excellence Cluster-Inflammation at Interfaces (EXC 306/1).	AHMED AR, 1991, J AM ACAD DERMATOL, V24, P987, DOI 10.1016/0190-9622(91)70159-Y; Ambros-Rudolph CM, 2006, J AM ACAD DERMATOL, V54, P395, DOI 10.1016/j.jaad.2005.12.012; Balding SD, 1996, J INVEST DERMATOL, V106, P141, DOI 10.1111/1523-1747.ep12329728; Bastuji-Garin S, 2011, J INVEST DERMATOL, V131, P637, DOI 10.1038/jid.2010.301; BastujiGarin S, 1996, ARCH DERMATOL, V132, P272, DOI 10.1001/archderm.132.3.272; BERNARD P, 1995, ARCH DERMATOL, V131, P48, DOI 10.1001/archderm.131.1.48; Bernard P, 2009, ARCH DERMATOL, V145, P537, DOI 10.1001/archdermatol.2009.53; Bertram F, 2009, J DTSCH DERMATOL GES, V7, P434, DOI 10.1111/j.1610-0387.2008.06976.x; Bieber K, 2009, EXP DERMATOL, V18, P289; Blocker IM, 2012, BRIT J DERMATOL, V166, P964, DOI 10.1111/j.1365-2133.2012.10820.x; Budinger L, 1998, J CLIN INVEST, V102, P2082, DOI 10.1172/JCI3335; Buijsrogge JJA, 2011, BRIT J DERMATOL, V165, P92, DOI 10.1111/j.1365-2133.2011.10346.x; Chan LS, 2002, ARCH DERMATOL, V138, P370, DOI 10.1001/archderm.138.3.370; CHAN LS, 1993, J INVEST DERMATOL, V101, P262, DOI 10.1111/1523-1747.ep12365189; Chan RY, 1999, INVEST OPHTH VIS SCI, V40, P2283; Charneux J, 2011, ARCH DERMATOL, V147, P286, DOI 10.1001/archdermatol.2011.23; Chave TA, 2004, BRIT J DERMATOL, V151, P1107, DOI 10.1111/j.1365-2133.2004.06241.x; Chen M, 1997, J INVEST DERMATOL, V108, P68, DOI 10.1111/1523-1747.ep12285634; Chen M, 2002, J INVEST DERMATOL, V118, P1059, DOI 10.1046/j.1523-1747.2002.01772.x; Chen M, 2012, AUTOIMMUNITY, V45, P91, DOI 10.3109/08916934.2011.606450; Chen YJ, 2011, BRIT J DERMATOL, V165, P593, DOI 10.1111/j.1365-2133.2011.10386.x; Chi CC, 2009, BRIT J DERMATOL, V160, P1222, DOI 10.1111/j.1365-2133.2009.09086.x; Chimanovitch I, 1999, J INVEST DERMATOL, V113, P140, DOI 10.1046/j.1523-1747.1999.00622.x; Christophoridis S, 2000, BRIT J DERMATOL, V143, P349, DOI 10.1046/j.1365-2133.2000.03661.x; Claudepierre T, 2005, J COMP NEUROL, V487, P190, DOI 10.1002/cne.20549; Cortes B, 2011, BRIT J DERMATOL, V165, P368, DOI 10.1111/j.1365-2133.2011.10413.x; Dainichi T, 2010, J DERMATOL, V37, P231, DOI 10.1111/j.1346-8138.2009.00793.x; Dainichi T, 2009, P NATL ACAD SCI USA, V106, P2800, DOI 10.1073/pnas.0809230106; Delaporte E, 1996, J IMMUNOL, V157, P3642; Delgado JC, 1996, P NATL ACAD SCI USA, V93, P8569, DOI 10.1073/pnas.93.16.8569; Di Zenzo G, 2004, J INVEST DERMATOL, V122, P103, DOI 10.1046/j.0022-202X.2003.22126.x; Di Zenzo G, 2008, CLIN IMMUNOL, V128, P415, DOI 10.1016/j.clim.2008.04.012; Di Zenzo G, 2011, J INVEST DERMATOL, V131, P2271, DOI 10.1038/jid.2011.180; DIAZ LA, 1990, J CLIN INVEST, V86, P1088, DOI 10.1172/JCI114812; DOMLOGEHULTSCH N, 1992, J CLIN INVEST, V90, P1628, DOI 10.1172/JCI116033; Dopp R, 2000, J AM ACAD DERMATOL, V42, P577, DOI 10.1067/mjd.2000.103986; Du-Thanh A, 2011, BRIT J DERMATOL, V165, P1337, DOI 10.1111/j.1365-2133.2011.10531.x; Egan CA, 2001, LANCET, V357, P1850, DOI 10.1016/S0140-6736(00)04971-0; Fairley JA, 2007, J INVEST DERMATOL, V127, P2605, DOI 10.1038/sj.jid.5700958; Fairley JA, 2009, J ALLERGY CLIN IMMUN, V123, P704, DOI 10.1016/j.jaci.2008.11.035; Foster C S, 1986, Trans Am Ophthalmol Soc, V84, P527; GAMMON WR, 1982, J INVEST DERMATOL, V78, P285, DOI 10.1111/1523-1747.ep12507222; GAMMON WR, 1984, J INVEST DERMATOL, V82, P139, DOI 10.1111/1523-1747.ep12259692; Ghohestani RF, 2000, J BIOL CHEM, V275, P16002, DOI 10.1074/jbc.275.21.16002; GIUDICE GJ, 1993, J IMMUNOL, V151, P5742; Groth S, 2011, BRIT J DERMATOL, V164, P76, DOI 10.1111/j.1365-2133.2010.10056.x; Gudi VS, 2005, BRIT J DERMATOL, V153, P424, DOI 10.1111/j.1365-2133.2005.06662.x; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; HALL RP, 1993, J INVEST DERMATOL, V101, P9, DOI 10.1111/1523-1747.ep12358276; Herrero-Gonzalez JE, 2006, EUR J IMMUNOL, V36, P1039, DOI 10.1002/eji.200535349; Hirose M, 2012, J AUTOIMMUN, V39, P304, DOI 10.1016/j.jaut.2012.04.002; Hirose M, 2011, J IMMUNOL, V187, P1176, DOI 10.4049/jimmunol.1100596; Hofmann S, 2002, J INVEST DERMATOL, V119, P1065, DOI 10.1046/j.1523-1747.2002.19529.x; Hofmann SC, 2003, BRIT J DERMATOL, V149, P910, DOI 10.1046/j.1365-2133.2003.05603.x; Intong LRA, 2011, DERMATOL CLIN, V29, P447, DOI 10.1016/j.det.2011.03.002; Intong LRA, 2011, J AM ACAD DERMATOL, V64, pAB104; Iwata H, 2009, J INVEST DERMATOL, V129, P919, DOI 10.1038/jid.2008.305; Iwata Y, 2008, ARCH DERMATOL, V144, P41, DOI 10.1001/archdermatol.2007.9; Jenkins RE, 1999, CLIN EXP DERMATOL, V24, P255; Joly P, 2002, NEW ENGL J MED, V346, P321, DOI 10.1056/NEJMoa011592; Joly P, 2012, J INVEST DERMATOL, V132, P1998, DOI 10.1038/jid.2012.35; Joly P, 2009, J INVEST DERMATOL, V129, P1681, DOI 10.1038/jid.2008.412; JORDON RE, 1967, J AMER MED ASSOC, V200, P751, DOI 10.1001/jama.200.9.751; Jung M, 1999, J AM ACAD DERMATOL, V41, P266, DOI 10.1016/S0190-9622(99)70061-7; Kasperkiewicz M, 2012, J PATHOL, V228, P8, DOI 10.1002/path.4023; Kasperkiewicz M, 2012, AUTOIMMUNITY, V45, P55, DOI 10.3109/08916934.2011.606447; KIRTSCHIG G, 1995, J INVEST DERMATOL, V105, P543, DOI 10.1111/1523-1747.ep12323431; Kirtschig G, 2009, COCHRANE DB SYST REV, V4; Kirtschig G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002292.pub3; Kiss M, 2005, J AUTOIMMUN, V24, P1, DOI 10.1016/j.jaut.2004.09.007; Kjellman P, 2008, ARCH DERMATOL, V144, P612, DOI 10.1001/archderm.144.5.612; Kobayashi M, 2002, J DERMATOL SCI, V30, P224, DOI 10.1016/S0923-1811(02)00109-3; Komorowski L, 2012, J AM ACAD DERMATOL; Kromminga A, 2000, J AUTOIMMUN, V15, P293, DOI 10.1006/jaut.2000.0437; LABIB RS, 1986, J IMMUNOL, V136, P1231; Langan SM, 2010, J INVEST DERMATOL, V130, pS60; Langan SM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a180; Lazarova Z, 2004, J AM ACAD DERMATOL, V51, P886, DOI 10.1016/j.jaad.2004.06.004; Lazarova Z, 2000, CLIN IMMUNOL, V95, P26, DOI 10.1006/clim.2000.4845; Lazarova Z, 2000, J INVEST DERMATOL, V114, P178, DOI 10.1046/j.1523-1747.2000.00829.x; Lazarova Z, 1996, J CLIN INVEST, V98, P1509, DOI 10.1172/JCI118942; Le Roux-Villet C, 2011, ARCH DERMATOL, V147, P843, DOI 10.1001/archdermatol.2011.54; Letko E, 2004, CLIN IMMUNOL, V111, P303, DOI 10.1016/j.clim.2003.11.002; LEVER WF, 1953, MEDICINE, V32, P1; Lin L, 2011, J BIOL CHEM, V286, P37358, DOI 10.1074/jbc.M111.272401; LINDELOF B, 1990, ARCH DERMATOL, V126, P66, DOI 10.1001/archderm.126.1.66; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; Liu Z, 2008, J AUTOIMMUN, V31, P331, DOI 10.1016/j.jaut.2008.08.009; Marazza G, 2009, BRIT J DERMATOL, V161, P861, DOI 10.1111/j.1365-2133.2009.09300.x; Marinkovich MP, 1996, J INVEST DERMATOL, V106, P734, DOI 10.1111/1523-1747.ep12345782; Messingham KN, 2011, J IMMUNOL, V187, P553, DOI 10.4049/jimmunol.1001753; MORRISON LH, 1988, J CLIN INVEST, V81, P2023, DOI 10.1172/JCI113554; Nanda A, 2004, INT J DERMATOL, V43, P876, DOI 10.1111/j.1365-4632.2004.02292.x; Ng SY, 2011, DERMATOL CLIN, V29, P629, DOI 10.1016/j.det.2011.06.014; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; OGAWA H, 1995, J DERMATOL SCI, V9, P136, DOI 10.1016/0923-1811(94)00371-K; Olasz EB, 2007, J INVEST DERMATOL, V127, P2807, DOI 10.1038/sj.jid.5700970; Oyama N, 2006, BRIT J DERMATOL, V154, P90, DOI 10.1111/j.1365-2133.2005.06998.x; Perriard J, 1999, J INVEST DERMATOL, V112, P141, DOI 10.1046/j.1523-1747.1999.00497.x; Powell AM, 2005, ARCH DERMATOL, V141, P705, DOI 10.1001/archderm.141.6.705; Rashid KA, 2006, J IMMUNOL, V176, P1968, DOI 10.4049/jimmunol.176.3.1968; Rashid KA, 2006, J INVEST DERMATOL, V126, P2631, DOI 10.1038/sj.jid.5700465; ROENIGK HH, 1971, ARCH DERMATOL, V103, P1, DOI 10.1001/archderm.103.1.1; Rose C, 2007, AM J DERMATOPATH, V29, P119, DOI 10.1097/DAD.0b013e31803326e6; Rose C, 2009, J AM ACAD DERMATOL, V61, P433, DOI 10.1016/j.jaad.2009.02.012; Roussel A, 2011, ARCH DERMATOL, V147, P293, DOI 10.1001/archdermatol.2011.21; Rzany B, 2002, ARCH DERMATOL, V138, P903, DOI 10.1001/archderm.138.7.903; Saleh MA, 2011, J DERMATOL SCI, V62, P169, DOI 10.1016/j.jdermsci.2011.03.003; Saw VPJ, 2008, OCUL SURF, V6, P128, DOI 10.1016/S1542-0124(12)70281-1; Saw VPJ, 2008, OPHTHALMOLOGY, V115, P253, DOI 10.1016/j.ophtha.2007.04.027; Saw VPJ, 2009, AM J PATHOL, V175, P2406, DOI 10.2353/ajpath.2009.090579; Schmidt E, 2000, J INVEST DERMATOL, V115, P842, DOI 10.1046/j.1523-1747.2000.00141.x; Schmidt E, 2005, CUTIS, V76, P205; Schmidt E, 2000, ARCH DERMATOL, V136, P174, DOI 10.1001/archderm.136.2.174; Schmidt E, 2001, BRIT J DERMATOL, V145, P778, DOI 10.1046/j.1365-2133.2001.04471.x; Schmidt E, 2011, DERMATOL CLIN, V29, P427, DOI 10.1016/j.det.2011.03.010; Seppanen A, 2010, NEUROREPORT, V21, P1090, DOI 10.1097/WNR.0b013e3283405352; Setterfield J, 1998, BRIT J DERMATOL, V138, P602; Sitaru C, 2005, J CLIN INVEST, V115, P870, DOI 10.1172/JCI200521386; Sitaru C, 2002, J INVEST DERMATOL, V118, P664, DOI 10.1046/j.1523-1747.2002.01720.x; Sitaru C, 2007, EXP DERMATOL, V16, P770, DOI 10.1111/j.1600-0625.2007.00592.x; Sitaru C, 2006, J IMMUNOL, V177, P3461, DOI 10.4049/jimmunol.177.5.3461; Skaria M, 2000, J INVEST DERMATOL, V114, P998, DOI 10.1046/j.1523-1747.2000.00893.x; STANLEY JR, 1981, CELL, V24, P897, DOI 10.1016/0092-8674(81)90115-X; Foster CS, 2004, CURR OPIN ALLERGY CL, V4, P435, DOI 10.1097/00130832-200410000-00017; Taghipour K, 2010, ARCH DERMATOL, V146, P1251, DOI 10.1001/archdermatol.2010.322; TAYLOR G, 1993, J AM ACAD DERMATOL, V29, P181, DOI 10.1016/0190-9622(93)70164-O; Thoma-Uszynski S, 2006, J IMMUNOL, V176, P2015, DOI 10.4049/jimmunol.176.3.2015; Thorne JE, 2004, OPHTHALMOLOGY, V111, P45, DOI 10.1016/j.ophtha.2003.03.001; Ujiie H, 2012, CLIN IMMUNOL, V142, P167, DOI 10.1016/j.clim.2011.10.002; Ujiie H, 2010, J IMMUNOL, V184, P2166, DOI 10.4049/jimmunol.0903101; VENNING VA, 1995, BRIT J DERMATOL, V132, P831; Venning VA, 2011, DERMATOL CLIN, V29, P453, DOI 10.1016/j.det.2011.03.013; Vodegel RM, 2004, BRIT J DERMATOL, V151, P112, DOI 10.1111/j.1365-2133.2004.06006.x; Waisbourd-Zinman O, 2008, J AM ACAD DERMATOL, V58, P41, DOI 10.1016/j.jaad.2007.08.010; Walmsley N, 2011, J DERMATOL CASE REP, V5, P74, DOI 10.3315/jdcr.2011.1081; Wieland CN, 2010, ARCH DERMATOL, V146, P21, DOI 10.1001/archdermatol.2009.331; WOJNAROWSKA F, 1988, J AM ACAD DERMATOL, V19, P792, DOI 10.1016/S0190-9622(88)70236-4; Wong SN, 2002, BRIT J DERMATOL, V147, P476, DOI 10.1046/j.1365-2133.2002.04919.x; Woodley DT, 2005, J INVEST DERMATOL, V124, P958, DOI 10.1111/j.0022-202X.2005.23702.x; WOODLEY DT, 1984, NEW ENGL J MED, V310, P1007, DOI 10.1056/NEJM198404193101602; WOODLEY DT, 1988, J CLIN INVEST, V81, P683, DOI 10.1172/JCI113373; Yoshida M, 2006, J DERMATOL SCI, V41, P21, DOI 10.1016/j.jdermsci.2005.11.002; Zillikens D, 1999, J INVEST DERMATOL, V113, P947, DOI 10.1046/j.1523-1747.1999.00808.x; Zillikens D, 1999, J INVEST DERMATOL, V113, P117, DOI 10.1046/j.1523-1747.1999.00618.x; Zillikens D, 1996, J INVEST DERMATOL, V106, P1332, DOI 10.1111/1523-1747.ep12349283; Zone JJ, 2004, J INVEST DERM SYMP P, V9, P47, DOI 10.1111/j.1087-0024.2004.00840.x; ZONE JJ, 1990, J CLIN INVEST, V85, P812, DOI 10.1172/JCI114508; Zone JJ, 2007, J INVEST DERMATOL, V127, P1167, DOI 10.1038/sj.jid.5700681; Zumelzu C, 2011, J INVEST DERMATOL, V131, P2386, DOI 10.1038/jid.2011.231	150	601	624	2	44	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 26	2013	381	9863					320	332		10.1016/S0140-6736(12)61140-4	http://dx.doi.org/10.1016/S0140-6736(12)61140-4			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077IT	23237497				2022-12-28	WOS:000314021800029
J	Salque, M; Bogucki, PI; Pyzel, J; Sobkowiak-Tabaka, I; Grygiel, R; Szmyt, M; Evershed, RP				Salque, Melanie; Bogucki, Peter I.; Pyzel, Joanna; Sobkowiak-Tabaka, Iwona; Grygiel, Ryszard; Szmyt, Marzena; Evershed, Richard P.			Earliest evidence for cheese making in the sixth millennium BC in northern Europe	NATURE			English	Article							LIPIDS; MILK; CHEMISTRY; BEESWAX	The introduction of dairying was a critical step in early agriculture, with milk products being rapidly adopted as a major component of the diets of prehistoric farmers and pottery-using late hunter-gatherers(1-5). The processing of milk, particularly the production of cheese, would have been a critical development because it not only allowed the preservation of milk products in a non-perishable and transportable form, but also it made milk a more digestible commodity for early prehistoric farmers(6-10). The finding of abundant milk residues in pottery vessels from seventh millennium sites from north-western Anatolia provided the earliest evidence of milk processing, although the exact practice could not be explicitly defined(1). Notably, the discovery of potsherds pierced with small holes appear at early Neolithic sites in temperate Europe in the sixth millennium BC and have been interpreted typologically as 'cheese-strainers'(10), although a direct association with milk processing has not yet been demonstrated. Organic residues preserved in pottery vessels have provided direct evidence for early milk use in the Neolithic period in the Near East and south-eastern Europe, north Africa, Denmark and the British Isles, based on the delta C-13 and Delta C-13 values of the major fatty acids in milk(1-4). Here we apply the same approach to investigate the function of sieves/strainer vessels, providing direct chemical evidence for their use in milk processing. The presence of abundant milk fat in these specialized vessels, comparable in form to modern cheese strainers(11), provides compelling evidence for the vessels having being used to separate fat-rich milk curds from the lactose-containing whey. This new evidence emphasizes the importance of pottery vessels in processing dairy products, particularly in the manufacture of reduced-lactose milk products among lactose-intolerant prehistoric farming communities(6,7).	[Salque, Melanie; Evershed, Richard P.] Univ Bristol, Sch Chem, Organ Geochem Unit, Bristol BS8 1TS, Avon, England; [Bogucki, Peter I.] Princeton Univ, Sch Engn & Appl Sci, Princeton, NJ 08544 USA; [Pyzel, Joanna] Univ Gdansk, Inst Archaeol, PL-80851 Gdansk, Poland; [Sobkowiak-Tabaka, Iwona] Polish Acad Sci, Inst Archaeol & Ethnol, Ctr Prehist & Medieval Res, PL-61612 Poznan, Poland; [Grygiel, Ryszard] Museum Archaeol & Ethnog Lodz, PL-91415 Lodz, Poland; [Szmyt, Marzena] Poznan Archaeol Museum, PL-61781 Poznan, Poland	University of Bristol; Princeton University; Fahrenheit Universities; University of Gdansk; Polish Academy of Sciences; Institute of Archaeology & Ethnology of the Polish Academy of Sciences	Evershed, RP (corresponding author), Univ Bristol, Sch Chem, Organ Geochem Unit, Cantocks Close, Bristol BS8 1TS, Avon, England.	r.p.evershed@bristol.ac.uk	Sobkowiak-Tabaka, Iwona/AAB-8476-2019	Sobkowiak-Tabaka, Iwona/0000-0001-5913-1177; Pyzel, Joanna/0000-0001-5449-8244; Roffet-Salque, Melanie/0000-0001-9508-788X	7th EU framework Marie Curie Initial Training Networks [FP7-ITN-215362-2]; Biotechnology and Biological Sciences Research Council [1239307] Funding Source: researchfish; Natural Environment Research Council [lsmsf010001] Funding Source: researchfish; NERC [lsmsf010001] Funding Source: UKRI	7th EU framework Marie Curie Initial Training Networks; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the 7th EU framework Marie Curie Initial Training Networks (FP7-ITN-215362-2) for a Ph.D. studentship to M. Sa and the UK Natural Environment Research Council for mass spectrometry facilities.	Bogucki, 1984, OXFORD J ARCHAEOL, V3, P15, DOI [10.1111/j.1468-0092.1984.tb00113.x, DOI 10.1111/J.1468-0092.1984.TB00113.X]; Bourgeois G., 1995, PALEORIENT, V21, P125, DOI [10.3406/paleo.1995.4613, DOI 10.3406/PALEO.1995.4613]; Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; CHARTERS S, 1993, ARCHAEOMETRY, V35, P211, DOI 10.1111/j.1475-4754.1993.tb01036.x; Clark J. G. D., 1942, ANTIQUITY, V16, P208; Clark JGD., 1952, PREHISTORIC EUROPE E; Copley MS, 2003, P NATL ACAD SCI USA, V100, P1524, DOI 10.1073/pnas.0335955100; Craig OE, 2005, ANTIQUITY, V79, P882, DOI 10.1017/S0003598X00115017; Craig OE, 2011, P NATL ACAD SCI USA, V108, P17910, DOI 10.1073/pnas.1107202108; Crane E., 1983, ARCHAEOLOGY BEEKEEPI; Dudd SN, 1998, SCIENCE, V282, P1478, DOI 10.1126/science.282.5393.1478; Dunne J, 2012, NATURE, V486, P390, DOI 10.1038/nature11186; Evershed RP, 2008, NATURE, V455, P528, DOI 10.1038/nature07180; Evershed RP, 2002, ACCOUNTS CHEM RES, V35, P660, DOI 10.1021/ar000200f; Flatz G, 1977, Prog Med Genet, V2, P205; Gouin P., 1997, FOOD FOODWAYS, V7, P157, DOI [DOI 10.1080/07409710.1997.9962063, 10.1080/07409710.1997.9962063]; Grygiel R., 2004, NEOLIT POCZATKI EPOK, P1048; HALLO WW, 1972, J NEAR EASTERN STUD, V31, P87, DOI 10.1086/372151; HERON C, 1994, NATURWISSENSCHAFTEN, V81, P266, DOI 10.1007/BF01131579; Houdet V., 1919, LAITERIE BEURRERIE F; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; KEENEY M, 1962, J AM OIL CHEM SOC, V39, P198, DOI 10.1007/BF02635818; Kindstedt PS., 2012, CHEESE CULTURE HIST; MCCRACKEN RD, 1971, CURR ANTHROPOL, V12, P479, DOI 10.1086/201234; PoPlin Francois, 1980, INITIATION LARCHEOLO, V17, P13; Pyzel J., 2009, CREATING COMMUNITIES, P71; Raven AM, 1997, J ANAL APPL PYROL, V40-1, P267, DOI 10.1016/S0165-2370(97)00036-3; Regert M, 2001, ARCHAEOMETRY, V43, P549, DOI 10.1111/1475-4754.00036; Sherratt A. G., 1981, PATTERN OF THE PAST, P261; Wood J., 2007, FIRE INSTRUMENT ARCH, V1619, P53	30	266	270	7	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2013	493	7433					522	525		10.1038/nature11698	http://dx.doi.org/10.1038/nature11698			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	075GF	23235824				2022-12-28	WOS:000313871400036
J	Roberts, SA; Davidson, AJ; McLean, L; Beynon, RJ; Hurst, JL				Roberts, Sarah A.; Davidson, Amanda J.; McLean, Lynn; Beynon, Robert J.; Hurst, Jane L.			Pheromonal Induction of Spatial Learning in Mice	SCIENCE			English	Article							SEXUAL PHEROMONES; SIGNALS; MOUSE; SCENT; ENVIRONMENT; ATTRACTION; BEHAVIOR; MALES	Many mammals use scent marking for sexual and competitive advertisement, but little is known about the mechanism by which scents are used to locate mates and competitors. We show that darcin, an involatile protein sex pheromone in male mouse urine, can rapidly condition preference for its remembered location among females and competitor males so that animals prefer to spend time in the site even when scent is absent. Learned spatial preference is conditioned through contact with darcin in a single trial and remembered for approximately 14 days. This pheromone-induced learning allows animals to relocate sites of particular social relevance and provides proof that pheromones such as darcin can be highly potent stimuli for social learning.	[Roberts, Sarah A.; Davidson, Amanda J.; Hurst, Jane L.] Univ Liverpool, Mammalian Behav & Evolut Grp, Inst Integrat Biol, Neston CH64 7TE, England; [McLean, Lynn; Beynon, Robert J.] Univ Liverpool, Inst Integrat Biol, Prot Funct Grp, Liverpool L69 7ZB, Merseyside, England	University of Liverpool; University of Liverpool	Hurst, JL (corresponding author), Univ Liverpool, Mammalian Behav & Evolut Grp, Inst Integrat Biol, Leahurst Campus, Neston CH64 7TE, England.	jane.hurst@liv.ac.uk	Beynon, Robert J/K-1408-2014; Hurst, Jane L/G-8793-2015; Roberts, Sarah/E-4936-2013	Beynon, Robert J/0000-0003-0857-495X; Hurst, Jane L/0000-0002-3728-9624; ROBERTS, SARAH/0000-0003-2193-5561	Biotechnology and Biological Science Research Council [BBC503897, BB/J002631/1]; Natural Environment Research Council [NE/G018650]; BBSRC [BB/J002631/1] Funding Source: UKRI; NERC [NE/G018650/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J002631/1] Funding Source: researchfish; Natural Environment Research Council [NE/G018650/1] Funding Source: researchfish	Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank J. Waters, R. Spencer, S. Jopson, and R. Humphries for technical help and members of the Mammalian Behavior & Evolution Group for helpful discussions. The study was funded by research grants to J. L. H. and R. J. B. from the Biotechnology and Biological Science Research Council (BBC503897 and BB/J002631/1) and the Natural Environment Research Council (NE/G018650). The data reported in this study are provided as raw data in the supplementary materials.	[Anonymous], 2014, PHEROMONES ANIMAL BE; Bell MR, 2010, HORM BEHAV, V58, P410, DOI 10.1016/j.yhbeh.2010.05.017; Brown RE., 1985, SOCIAL ODOURS MAMMAL; Cheetham SA, 2009, PHYSIOL BEHAV, V96, P253, DOI 10.1016/j.physbeh.2008.10.005; Coureaud G, 2006, CURR BIOL, V16, P1956, DOI 10.1016/j.cub.2006.08.030; Gosling L. M., 1982, J COMP ETHOL, V60, P89; Gosling LM, 2001, ADV STUD BEHAV, V30, P169, DOI 10.1016/S0065-3454(01)80007-3; HARVEY S, 1989, J CHEM ECOL, V15, P2061, DOI 10.1007/BF01207438; Hurst JL, 2009, BEHAV BRAIN RES, V200, P295, DOI 10.1016/j.bbr.2008.12.020; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Johannesson K, 2008, EVOLUTION, V62, P3178, DOI 10.1111/j.1558-5646.2008.00510.x; LeMaster MP, 2001, ANIM BEHAV, V61, P827, DOI 10.1006/anbe.2000.1658; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Martinez-Ricos J, 2007, CHEM SENSES, V32, P139, DOI 10.1093/chemse/bjl039; Moncho-Bogani J, 2002, PHYSIOL BEHAV, V77, P167, DOI 10.1016/S0031-9384(02)00842-9; Morgan ED, 2009, PHYSIOL ENTOMOL, V34, P1, DOI 10.1111/j.1365-3032.2008.00658.x; Mudge JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r91; Pankevich DE, 2006, PHYSIOL BEHAV, V87, P781, DOI 10.1016/j.physbeh.2006.01.020; Paredes RG, 2009, ILAR J, V50, P15, DOI 10.1093/ilar.50.1.15; Ramm SA, 2008, P ROY SOC B-BIOL SCI, V275, P1727, DOI 10.1098/rspb.2008.0302; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; SCHWENDE FJ, 1986, J CHEM ECOL, V12, P277, DOI 10.1007/BF01045611	22	116	116	0	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2012	338	6113					1462	1465		10.1126/science.1225638	http://dx.doi.org/10.1126/science.1225638			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239735				2022-12-28	WOS:000312250800046
J	Tottrup, AP; Klaassen, RHG; Kristensen, MW; Strandberg, R; Vardanis, Y; Lindstrom, A; Rahbek, C; Alerstam, T; Thorup, K				Tottrup, A. P.; Klaassen, R. H. G.; Kristensen, M. W.; Strandberg, R.; Vardanis, Y.; Lindstrom, A.; Rahbek, C.; Alerstam, T.; Thorup, K.			Drought in Africa Caused Delayed Arrival of European Songbirds	SCIENCE			English	Article							MIGRATORY BIRD		[Tottrup, A. P.; Kristensen, M. W.; Thorup, K.] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Nat Hist Museum, DK-2100 Copenhagen, Denmark; [Klaassen, R. H. G.; Strandberg, R.; Vardanis, Y.; Lindstrom, A.; Alerstam, T.] Lund Univ, Dept Biol, SE-22362 Lund, Sweden; [Klaassen, R. H. G.] Univ Groningen, Montagus Harrier Fdn, NL-9700 CC Groningen, Netherlands; [Klaassen, R. H. G.] Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, NL-9700 CC Groningen, Netherlands	University of Copenhagen; Lund University; University of Groningen; University of Groningen	Tottrup, AP (corresponding author), Univ Copenhagen, Ctr Macroecol Evolut & Climate, Nat Hist Museum, Univ Pk 15, DK-2100 Copenhagen, Denmark.	aptottrup@bio.ku.dk	Thorup, Kasper/A-4835-2013; Rahbek, Carsten/D-9372-2013; Tøttrup, Anders P/N-3836-2013; Klaassen, Raymond/K-3027-2013; Willemoes, Mikkel/J-9391-2012; Rahbek, Carsten/L-1129-2013	Thorup, Kasper/0000-0002-0320-0601; Tøttrup, Anders P/0000-0001-8776-9629; Willemoes, Mikkel/0000-0001-9363-6304; Rahbek, Carsten/0000-0003-4585-0300	Swedish Research Council; Centre for Animal Movement Research; Villum Foundation; Swedish Environmental Protection Agency; Danish National Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Centre for Animal Movement Research; Villum Foundation(Villum Fonden); Swedish Environmental Protection Agency; Danish National Research Foundation(Danmarks Grundforskningsfond)	Danish Nature Agency (J.nr.SN 302-009) and ethical committees in Malmo/Lund (M112-09) approved the studies. Swedish Research Council, Centre for Animal Movement Research, Villum Foundation, Swedish Environmental Protection Agency and Danish National Research Foundation financed this study. Contribution no. 259 from Ottenby Bird Observatory. Tracking data are available at www.movebank.org (digital object identifier: 10.5441/001/1.8jg3h6n7).	GWINNER E, 1978, J COMP PHYSIOL, V125, P267, DOI 10.1007/BF00656605; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Studds CE, 2011, P ROY SOC B-BIOL SCI, V278, P3437, DOI 10.1098/rspb.2011.0332; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; Wikelski M, 2007, J EXP BIOL, V210, P181, DOI 10.1242/jeb.02629; Wilcove D. S., 2008, NO WAY HOME; Wolff C, 2011, SCIENCE, V333, P743, DOI 10.1126/science.1203724	8	120	125	5	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1307	1307		10.1126/science.1227548	http://dx.doi.org/10.1126/science.1227548			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224549				2022-12-28	WOS:000311991200056
J	Savage, N				Savage, Neil			TECHNOLOGY Dancing with robots	NATURE			English	Editorial Material																			0	0	0	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2012	492	7427					S16	S17		10.1038/492S16a	http://dx.doi.org/10.1038/492S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048EQ	23222669	Bronze			2022-12-28	WOS:000311893400009
J	Hitchings, AW; Baker, EH; Khong, TK				Hitchings, Andrew W.; Baker, Emma H.; Khong, Teck K.			Making medicines evergreen	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hitchings, Andrew W.; Baker, Emma H.; Khong, Teck K.] Univ London, Div Biomed Sci, London SW17 0RE, England	University of London	Hitchings, AW (corresponding author), Univ London, Div Biomed Sci, London SW17 0RE, England.	ahitchin@sgul.ac.uk		Hitchings, Andrew/0000-0002-2802-1466; Baker, Emma/0000-0002-0871-3721				[Anonymous], 2010, Drug Ther Bull, V48, P61, DOI 10.1136/dtb.2010.04.0029; [Anonymous], 2006, Drug Ther Bull, V44, P73; [Anonymous], 2003, Drug Ther Bull, V41, P17; General Medical Council, 2011, GOOD PRACT IN PRESS; General Medical Council, 2008, GOOD PRACT PRESCR ME; Greene JA, 2011, NEW ENGL J MED, V365, P83, DOI 10.1056/NEJMhle1101722; Health and Social Care Information Centre, PRESCR DISP COMM ENG; Health and Social Care Information Centre, 1998, PRESCR COST AN ENGL; Joint Formulary Committee, BRIT NAT FORM ONL; National Institute for Health and Clinical Excellence, 2010, NEUR PAIN PHARM MAN, V96; National Prescribing Centre, 2011, MEREC B, V21; Nussbaum A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006369.pub2; Nussbaum AM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008296.pub2; Office of Health Economics, ABPI UK NHS MED BILL; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Pharmaceuticals Janssen, AT ANT MED INV PAL; Rang H. P., 2006, DRUG DISCOVERY DEV; Schwartz LM, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1086; 2002, DRUG THER B, V40, P57	19	22	22	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2012	345								e7941	10.1136/bmj.e7941	http://dx.doi.org/10.1136/bmj.e7941			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048FR	23197598				2022-12-28	WOS:000311896300003
J	Teanby, NA; Irwin, PGJ; Nixon, CA; de Kok, R; Vinatier, S; Coustenis, A; Sefton-Nash, E; Calcutt, SB; Flasar, FM				Teanby, Nicholas A.; Irwin, Patrick G. J.; Nixon, Conor A.; de Kok, Remco; Vinatier, Sandrine; Coustenis, Athena; Sefton-Nash, Elliot; Calcutt, Simon B.; Flasar, F. Michael			Active upper-atmosphere chemistry and dynamics from polar circulation reversal on Titan	NATURE			English	Article							COMPOSITE INFRARED SPECTROMETER; CASSINI/CIRS DATA; TEMPERATURES; MODEL; MESOSPHERE	Saturn's moon Titan has a nitrogen atmosphere comparable to Earth's, with a surface pressure of 1.4 bar. Numerical models reproduce the tropospheric conditions very well but have trouble explaining the observed middle-atmosphere temperatures, composition and winds(1,2). The top of the middle-atmosphere circulation has been thought to lie at an altitude of 450 to 500 kilometres, where there is a layer of haze that appears to be separated from the main haze deck(3). This 'detached' haze was previously explained as being due to the co-location of peak haze production and the limit of dynamical transport by the circulation's upper branch(4). Here we report a build-up of trace gases over the south pole approximately two years after observing the 2009 post-equinox circulation reversal, from which we conclude that middle-atmosphere circulation must extend to an altitude of at least 600 kilometres. The primary drivers of this circulation are summer-hemisphere heating of haze by absorption of solar radiation and winter-hemisphere cooling due to infrared emission by haze and trace gases(5); our results therefore imply that these effects are important well into the thermosphere (altitudes higher than 500 kilometres). This requires both active upper-atmosphere chemistry, consistent with the detection of high-complexity molecules and ions at altitudes greater than 950 kilometres(6,7), and an alternative explanation for the detached haze, such as a transition in haze particle growth from monomers to fractal structures(8).	[Teanby, Nicholas A.; Sefton-Nash, Elliot] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England; [Irwin, Patrick G. J.; Calcutt, Simon B.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Nixon, Conor A.; Flasar, F. Michael] NASA, Planetary Syst Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [de Kok, Remco] SRON, Netherlands Inst Space Res, NL-3584 CA Utrecht, Netherlands; [Vinatier, Sandrine; Coustenis, Athena] Univ Paris Diderot, LESIA Observ Paris, CNRS, Univ Paris 06, F-92195 Meudon, France; [Sefton-Nash, Elliot] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA	University of Bristol; University of Oxford; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; University of California System; University of California Los Angeles	Teanby, NA (corresponding author), Univ Bristol, Sch Earth Sci, Wills Mem Bldg,Queens Rd, Bristol BS8 1RJ, Avon, England.	n.teanby@bristol.ac.uk	Flasar, F Michael/C-8509-2012; Nixon, Conor A/A-8531-2009; Vinatier, Sandrine/AAB-8763-2019; de Kok, Remco/U-5637-2019	Nixon, Conor A/0000-0001-9540-9121; Vinatier, Sandrine/0000-0001-5541-2502; Irwin, Patrick Gerard Joseph/0000-0002-6772-384X; de Kok, Remco/0000-0001-6906-2662; Teanby, Nicholas/0000-0003-3108-5775; Calcutt, Simon/0000-0002-0102-3170	UK Science and Technology Facilities Council; Leverhulme Trust; NASA Cassini mission; STFC [ST/I001948/1, ST/F007957/2, ST/I001018/1, PP/D000866/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D000866/1, ST/I001948/1, ST/F007957/2, ST/I001018/1] Funding Source: researchfish; UK Space Agency [ST/J004545/1] Funding Source: researchfish	UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Leverhulme Trust(Leverhulme Trust); NASA Cassini mission; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	This work was funded by the UK Science and Technology Facilities Council, the Leverhulme Trust and the NASA Cassini mission.	Achterberg RK, 2008, ICARUS, V194, P263, DOI 10.1016/j.icarus.2007.09.029; Achterberg RK, 2011, ICARUS, V211, P686, DOI 10.1016/j.icarus.2010.08.009; Coates AJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030978; Coustenis A, 2010, ICARUS, V207, P461, DOI 10.1016/j.icarus.2009.11.027; Crespin A, 2008, ICARUS, V197, P556, DOI 10.1016/j.icarus.2008.05.010; Flasar FM, 2005, SCIENCE, V308, P975, DOI 10.1126/science.1111150; Flasar FM, 2004, SPACE SCI REV, V115, P169, DOI 10.1007/s11214-004-1454-9; FLASAR FM, 1990, ICARUS, V85, P346, DOI 10.1016/0019-1035(90)90122-P; Hourdin F, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002282; HOURDIN F, 1995, ICARUS, V117, P358, DOI 10.1006/icar.1995.1162; Irwin PGJ, 2008, J QUANT SPECTROSC RA, V109, P1136, DOI 10.1016/j.jqsrt.2007.11.006; Krasnopolsky VA, 2009, ICARUS, V201, P226, DOI 10.1016/j.icarus.2008.12.038; Lavvas PP, 2008, PLANET SPACE SCI, V56, P67, DOI 10.1016/j.pss.2007.05.027; Lavvas P, 2009, ICARUS, V201, P626, DOI 10.1016/j.icarus.2009.01.004; Lebonnois S, 2001, ICARUS, V152, P384, DOI 10.1006/icar.2001.6632; Lebonnois S, 2012, ICARUS, V218, P707, DOI 10.1016/j.icarus.2011.11.032; Liang MC, 2007, ASTROPHYS J, V661, pL199, DOI 10.1086/518785; Newman CE, 2011, ICARUS, V213, P636, DOI 10.1016/j.icarus.2011.03.025; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; Rannou P, 2005, ADV SPACE RES-SERIES, V36, P2194, DOI 10.1016/j.asr.2005.09.041; Rannou P, 2002, NATURE, V418, P853, DOI 10.1038/nature00961; Teanby NA, 2007, ICARUS, V186, P364, DOI 10.1016/j.icarus.2006.09.024; Teanby NA, 2010, FARADAY DISCUSS, V147, P51, DOI 10.1039/c001690j; Teanby NA, 2010, ASTROPHYS J LETT, V724, pL84, DOI 10.1088/2041-8205/724/1/L84; Teanby NA, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003218; Teanby NA, 2009, PHILOS T R SOC A, V367, P697, DOI [10.1098/rsta.2008.0164, 10.1098/rsta.2008.01G4]; Vinatier S, 2010, ICARUS, V205, P559, DOI 10.1016/j.icarus.2009.08.013; Waite JH, 2007, SCIENCE, V316, P870, DOI 10.1126/science.1139727; Waite JH, 2005, SCIENCE, V308, P982, DOI 10.1126/science.1110652; West RA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046843	30	64	64	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					732	735		10.1038/nature11611	http://dx.doi.org/10.1038/nature11611			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23192150	Green Published			2022-12-28	WOS:000311606000039
J	Poli, P; Campillo, M; Pedersen, H				Poli, P.; Campillo, M.; Pedersen, H.		LAPNET Working Grp	Body-Wave Imaging of Earth's Mantle Discontinuities from Ambient Seismic Noise	SCIENCE			English	Article							CROSS-CORRELATION; FREE OSCILLATIONS; TOMOGRAPHY; EXCITATION; TOPOGRAPHY	Ambient seismic noise correlations are widely used for high-resolution surface-wave imaging of Earth's lithosphere. Similar observations of the seismic body waves that propagate through the interior of Earth would provide a window into the deep Earth. We report the observation of the mantle transition zone through noise correlations of P waves as they are reflected by the discontinuities associated with the top [410 kliometers (km)] and the bottom (660 km) of this zone. Our data demonstrate that high-resolution mapping of the mantle transition zone is possible without using earthquake sources.	[Poli, P.; Campillo, M.; Pedersen, H.; LAPNET Working Grp] Univ Grenoble 1, CNRS, Inst Sci Terre ISTerre, F-38041 Grenoble 9, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie	Poli, P (corresponding author), Univ Grenoble 1, CNRS, Inst Sci Terre ISTerre, BP 53, F-38041 Grenoble 9, France.	polip@ujf-grenoble.fr	Pedersen, Helle/AGR-3227-2022; Pedersen, Helle A/E-4927-2017; Shomali, Zaher Hossein/B-3364-2010; Campillo, Michel/AAC-5666-2019; Aleshin, Igor M/L-5906-2017; Campillo, Michel/K-6231-2012	Pedersen, Helle/0000-0003-2936-8047; Pedersen, Helle A/0000-0003-2936-8047; Campillo, Michel/0000-0001-6971-4499; Campillo, Michel/0000-0001-6971-4499; Komminaho, Kari/0000-0003-1297-5748	QUEST Initial Training network within European Union Marie Curie Programme; Agence Nationale de la Recherche BegDy project; Institut Paul Emil Victor; European Research Council advanced grant "Whisper" [227507]; Academy of Finland [122762]; University of Oulu, International Lithosphere Programme task force VIII of the Grant Agency of the Czech Academy of Sciences [IAA300120709]; Russian Academy of Sciences	QUEST Initial Training network within European Union Marie Curie Programme; Agence Nationale de la Recherche BegDy project(French National Research Agency (ANR)); Institut Paul Emil Victor; European Research Council advanced grant "Whisper"(European Research Council (ERC)); Academy of Finland(Academy of Finland); University of Oulu, International Lithosphere Programme task force VIII of the Grant Agency of the Czech Academy of Sciences; Russian Academy of Sciences(Russian Academy of Sciences)	Supported by the QUEST Initial Training network funded within the European Union Marie Curie Programme, the Agence Nationale de la Recherche BegDy project, the Institut Paul Emil Victor, and European Research Council advanced grant "Whisper" 227507. Continuous data from the POLENET-LAPNET seismic experiment are available at the Reseau Sismologique et Geodesique Francais (RESIF) Data Centre (www.resif.fr/portal) under network code XK. The POLENET/LAPNET project is a part of the International Polar Year 2007-2009 and a part of the POLENET consortium, and is supported by the Academy of Finland (grant 122762) and University of Oulu, International Lithosphere Programme task force VIII, grant IAA300120709 of the Grant Agency of the Czech Academy of Sciences, and the Russian Academy of Sciences (Programmes 5 and 9). The equipment for the temporary deployment was provided by RESIF-SisMob (France), EOST-IPG Strasbourg (France), Seismic Pool (MOBNET) of the Geophysical Institute of the Czech Academy of Sciences (Czech Republic), Sodankyla Geophysical Observatory (Finland), Institute of Geosphere Dynamics of RAS (Russia), Institute of Geophysics, ETH Zurich (Switzerland), Institute of Geodesy and Geophysics, Vienna University of Technology (Austria), and University of Leeds (UK). POLENET/LAPNET data were prepared and distributed by the RESIF Data Centre. The POLENET/LAPNET working group consists of E. Kozlovskaya, T. Jamsen, H. Silvennoinen, R. Hurskainen, H. Pedersen, C. Pequegnat, U. Achauer, J. Plomerova, E. Kissling, I. Sanina, R. Bodvarsson, I. Aleshin, E. Bourova, E. Bruckl, T. Eken, R. Guiguet, H. Hausmann, P. Heikkinen, G. Houseman, P. Jedlicka, H. Johnsen, H. Kremenetskaya, K. Komminaho, H. Munzarova, R. Roberts, B. Ruzek, H. Shomali, J. Schweitzer, A. Shaumyan, L. Vecsey, and S. Volosov.	Alinaghi A, 2003, GEOPHYS J INT, V155, P641, DOI 10.1046/j.1365-246X.2003.02075.x; Campillo M, 2003, SCIENCE, V299, P547, DOI 10.1126/science.1078551; Cao Q, 2011, SCIENCE, V332, P1068, DOI 10.1126/science.1202731; Ekstrom G, 2001, J GEOPHYS RES-SOL EA, V106, P26483, DOI 10.1029/2000JB000086; Friedrich A, 1998, J SEISMOL, V2, P47, DOI 10.1023/A:1009788904007; Gerstoft P, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036111; Gouedard P, 2008, GEOPHYS PROSPECT, V56, P375, DOI 10.1111/j.1365-2478.2007.00684.x; Gu Y, 1998, EARTH PLANET SC LETT, V157, P57, DOI 10.1016/S0012-821X(98)00027-2; Hillers G, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003875; Janik T, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004681; KENNETT BLN, 1995, GEOPHYS J INT, V122, P108, DOI 10.1111/j.1365-246X.1995.tb03540.x; Kobayashi N, 1998, NATURE, V395, P357, DOI 10.1038/26427; Kozlovskaya E., 2006, EOS S, V87; Landes M, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006918; Lawrence JF, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001339; Li C., 2008, GEOCHEM GEOPHY GEOSY, V9, P5, DOI [10.1029/2007GC001806, DOI 10.1029/2007GC001806]; Lin FC, 2009, GEOPHYS J INT, V177, P1091, DOI 10.1111/j.1365-246X.2009.04105.x; LONGUETHIGGINS MS, 1950, PHILOS TR R SOC S-A, V243, P1, DOI 10.1098/rsta.1950.0012; Melbourne T, 1998, J GEOPHYS RES-SOL EA, V103, P10091, DOI 10.1029/98JB00164; Ohtani E, 2008, PHYS EARTH PLANET IN, V170, P240, DOI 10.1016/j.pepi.2008.07.024; Poli P, 2012, GEOPHYS J INT, V188, P549, DOI 10.1111/j.1365-246X.2011.05271.x; Poli P., SEISMIC NOISE TOMOGR; Prieto G. A., 2011, CR GEOSCI, V3, P558; Rhie J, 2004, NATURE, V431, P552, DOI 10.1038/nature02942; Roux P, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023803; Ruigrok E, 2011, CR GEOSCI, V343, P512, DOI 10.1016/j.crte.2011.02.006; Sabra KG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023155; Shapiro NM, 2005, SCIENCE, V307, P1615, DOI 10.1126/science.1108339; Shapiro NM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019491; SHEARER PM, 1992, NATURE, V355, P791, DOI 10.1038/355791a0; Stehly L, 2009, GEOPHYS J INT, V178, P338, DOI 10.1111/j.1365-246X.2009.04132.x; Stixrude L, 2011, GEOPHYS J INT, V184, P1180, DOI 10.1111/j.1365-246X.2010.04890.x; Wapenaar K, 2010, GEOPHYSICS, V75, pA195, DOI 10.1190/1.3457445; Yao HJ, 2009, GEOPHYS J INT, V179, P1113, DOI [10.1111/j.1365-246X.2009.04329.x, 10.1111/J.1365-246X.2009.04329.X]; Zhan ZW, 2010, GEOPHYS J INT, V182, P408, DOI 10.1111/j.1365-246X.2010.04625.x; Zhao DP, 2004, PHYS EARTH PLANET IN, V146, P3, DOI 10.1016/j.pepi.2003.07.032	36	120	129	4	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1063	1065		10.1126/science.1228194	http://dx.doi.org/10.1126/science.1228194			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23180858				2022-12-28	WOS:000311390600039
J	Wieczorek, MA; Neumann, GA; Nimmo, F; Kiefer, WS; Taylor, GJ; Melosh, HJ; Phillips, RJ; Solomon, SC; Andrews-Hanna, JC; Asmar, SW; Konopliv, AS; Lemoine, FG; Smith, DE; Watkins, MM; Williams, JG; Zuber, MT				Wieczorek, Mark A.; Neumann, Gregory A.; Nimmo, Francis; Kiefer, Walter S.; Taylor, G. Jeffrey; Melosh, H. Jay; Phillips, Roger J.; Solomon, Sean C.; Andrews-Hanna, Jeffrey C.; Asmar, Sami W.; Konopliv, Alexander S.; Lemoine, Frank G.; Smith, David E.; Watkins, Michael M.; Williams, James G.; Zuber, Maria T.			The Crust of the Moon as Seen by GRAIL	SCIENCE			English	Article							LUNAR COMPOSITION; CONSTITUTION; INVERSION; INTERIOR; DENSITY; SURFACE; EARTH; MODEL	High-resolution gravity data obtained from the dual Gravity Recovery and Interior Laboratory (GRAIL) spacecraft show that the bulk density of the Moon's highlands crust is 2550 kilograms per cubic meter, substantially lower than generally assumed. When combined with remote sensing and sample data, this density implies an average crustal porosity of 12% to depths of at least a few kilometers. Lateral variations in crustal porosity correlate with the largest impact basins, whereas lateral variations in crustal density correlate with crustal composition. The low-bulk crustal density allows construction of a global crustal thickness model that satisfies the Apollo seismic constraints, and with an average crustal thickness between 34 and 43 kilometers, the bulk refractory element composition of the Moon is not required to be enriched with respect to that of Earth.	[Wieczorek, Mark A.] Univ Paris Diderot, Inst Phys Globe Paris, Sorbonne Paris Cite, Case 7071, F-75205 Paris 13, France; [Neumann, Gregory A.; Lemoine, Frank G.] NASA, Solar Syst Explorat Div, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Nimmo, Francis] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Kiefer, Walter S.] Lunar & Planetary Inst, Houston, TX 77058 USA; [Taylor, G. Jeffrey] Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; [Melosh, H. Jay] Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA; [Phillips, Roger J.] SW Res Inst, Planetary Sci Directorate, Boulder, CO 80302 USA; [Solomon, Sean C.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Solomon, Sean C.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Andrews-Hanna, Jeffrey C.] Colorado Sch Mines, Dept Geophys, Golden, CO 80401 USA; [Asmar, Sami W.; Konopliv, Alexander S.; Watkins, Michael M.; Williams, James G.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Smith, David E.; Zuber, Maria T.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	UDICE-French Research Universities; Universite Paris Cite; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of California System; University of California Santa Cruz; University of Hawaii System; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Carnegie Institution for Science; Columbia University; Colorado School of Mines; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Massachusetts Institute of Technology (MIT)	Wieczorek, MA (corresponding author), Univ Paris Diderot, Inst Phys Globe Paris, Sorbonne Paris Cite, Case 7071, 5 Rue Thomas Mann, F-75205 Paris 13, France.	wieczor@ipgp.fr	Kiefer, Walter/F-2759-2016; Wieczorek, Mark A/G-6427-2010; Neumann, Gregory A/I-5591-2013; Lemoine, Frank/D-1215-2013	Kiefer, Walter/0000-0001-6741-5460; Wieczorek, Mark A/0000-0001-7007-4222; Neumann, Gregory A/0000-0003-0644-9944; Lemoine, Frank G./0000-0002-3051-1456	NASA; French Space Agency (CNES); Centre National de la Recherche Scientifique; UnivEarthS LabEx project of Sorbonne Paris Cite	NASA(National Aeronautics & Space Administration (NASA)); French Space Agency (CNES)(Centre National D'etudes Spatiales); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); UnivEarthS LabEx project of Sorbonne Paris Cite	The GRAIL mission is supported by the Discovery Program of NASA and is performed under contract to the Massachusetts Institute of Technology and the Jet Propulsion Laboratory, California Institute of Technology. Additional support for this work was provided by the French Space Agency (CNES), the Centre National de la Recherche Scientifique, and the UnivEarthS LabEx project of Sorbonne Paris Cite. Data products will be made available from the authors upon request.	Bottke WF, 2012, NATURE, V485, P78, DOI 10.1038/nature10967; Cahill JTS, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003282; Canup RM, 2012, SCIENCE, V338, P1052, DOI 10.1126/science.1226073; CLIFFORD SM, 1993, J GEOPHYS RES-PLANET, V98, P10973, DOI 10.1029/93JE00225; Consolmagno GJ, 2008, CHEM ERDE-GEOCHEM, V68, P1, DOI 10.1016/j.chemer.2008.01.003; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Elbra T, 2011, METEORIT PLANET SCI, V46, P1640, DOI 10.1111/j.1945-5100.2011.01253.x; Fassett CI, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003951; Garcia RF, 2011, PHYS EARTH PLANET IN, V188, P96, DOI 10.1016/j.pepi.2011.06.015; Henkel H, 2010, TECTONOPHYSICS, V485, P290, DOI 10.1016/j.tecto.2010.01.008; Ishihara Y, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039708; Khan A, 2007, GEOPHYS J INT, V168, P243, DOI 10.1111/j.1365-246X.2006.03200.x; Khan A, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001658; Kiefer WS, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051319; Konopliv AS, 2001, ICARUS, V150, P1, DOI 10.1006/icar.2000.6573; Kuskov OL, 1998, PHYS EARTH PLANET IN, V107, P285, DOI 10.1016/S0031-9201(98)00082-X; Lognonne P, 2003, EARTH PLANET SC LETT, V211, P27, DOI 10.1016/S0012-821X(03)00172-9; Lucey P, 2006, REV MINERAL GEOCHEM, V60, P83, DOI 10.2138/rmg.2006.60.2; Matsumoto K, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003499; MUELLER S, 1988, J GEOPHYS RES-SOLID, V93, P6338, DOI 10.1029/JB093iB06p06338; Nimmo F, 2003, ICARUS, V166, P21, DOI 10.1016/j.icarus.2003.08.002; Pohl J., 1977, IMPACT EXPLOSION CRA, P343; Prettyman TH, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002656; Schumacher S, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002429.2006; Smith DE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043751; Taylor SR, 2006, GEOCHIM COSMOCHIM AC, V70, P5904, DOI 10.1016/j.gca.2006.06.262; Tong D, 2012, J GEOPHYS RES-ATMOS, V117, DOI [10.1029/2011JD017424, 10.1029/2012JE004062]; Warren PH, 2005, METEORIT PLANET SCI, V40, P477, DOI 10.1111/j.1945-5100.2005.tb00395.x; Wieczorek MA, 1998, J GEOPHYS RES-PLANET, V103, P1715, DOI 10.1029/97JE03136; Wieczorek MA, 2006, REV MINERAL GEOCHEM, V60, P221, DOI 10.2138/rmg.2006.60.3; Yamamoto S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052098; Yamamoto S, 2010, NAT GEOSCI, V3, P533, DOI [10.1038/NGEO897, 10.1038/ngeo897]; Zuber MT, 2013, SPACE SCI REV, V178, P3, DOI 10.1007/s11214-012-9952-7; Zuber MT, 2013, SCIENCE, V339, P668, DOI 10.1126/science.1231507	34	521	541	9	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2013	339	6120					671	675		10.1126/science.1231530	http://dx.doi.org/10.1126/science.1231530			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23223394	Green Accepted			2022-12-28	WOS:000314585600035
J	Xu, K; Zhong, GS; Zhuang, XW				Xu, Ke; Zhong, Guisheng; Zhuang, Xiaowei			Actin, Spectrin, and Associated Proteins Form a Periodic Cytoskeletal Structure in Axons	SCIENCE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; ERYTHROCYTE-MEMBRANE SKELETON; INITIAL SEGMENT; CELLS; DYNAMICS; VISUALIZATION; LOCALIZATION; MICROTUBULES; ORGANIZATION; ANKYRIN(G)	Actin and spectrin play important roles in neurons, but their organization in axons and dendrites remains unclear. We used stochastic optical reconstruction microscopy to study the organization of actin, spectrin, and associated proteins in neurons. Actin formed ringlike structures that wrapped around the circumference of axons and were evenly spaced along axonal shafts with a periodicity of similar to 180 to 190 nanometers. This periodic structure was not observed in dendrites, which instead contained long actin filaments running along dendritic shafts. Adducin, an actin-capping protein, colocalized with the actin rings. Spectrin exhibited periodic structures alternating with those of actin and adducin, and the distance between adjacent actin-adducin rings was comparable to the length of a spectrin tetramer. Sodium channels in axons were distributed in a periodic pattern coordinated with the underlying actin-spectrin-based cytoskeleton.	[Xu, Ke; Zhong, Guisheng; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu	Xu, Ke/A-9476-2011	Xu, Ke/0000-0002-2788-194X	NIH; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096450] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Rasband for providing the beta IV-spectrin and sodium channel antibodies and M. Ericsson, B. Kasthuri, R. Schalek, G. Hao, and C. Speer for help in the preparation of hippocampal tissue slices. This work is supported in part by the NIH and the Collaborative Innovation Award from the HHMI. X.Z. is a HHMI investigator.	Baines AJ, 2010, PROTOPLASMA, V244, P99, DOI 10.1007/s00709-010-0181-1; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1982, NATURE, V299, P126, DOI 10.1038/299126a0; Berghs S, 2000, J CELL BIOL, V151, P985, DOI 10.1083/jcb.151.5.985; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Brachet A, 2010, J CELL BIOL, V191, P383, DOI 10.1083/jcb.201003042; BYERS TJ, 1985, P NATL ACAD SCI USA, V82, P6153, DOI 10.1073/pnas.82.18.6153; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Egner A, 2007, BIOPHYS J, V93, P3285, DOI 10.1529/biophysj.107.112201; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Izeddin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015611; Kapitein LC, 2011, MOL CELL NEUROSCI, V46, P9, DOI 10.1016/j.mcn.2010.08.015; Kole MHP, 2012, NEURON, V73, P235, DOI 10.1016/j.neuron.2012.01.007; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; LEVINE J, 1981, J CELL BIOL, V90, P631, DOI 10.1083/jcb.90.3.631; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; LIU SC, 1987, J CELL BIOL, V104, P527, DOI 10.1083/jcb.104.3.527; Pielage J, 2008, NEURON, V58, P195, DOI 10.1016/j.neuron.2008.02.017; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; SCHNAPP BJ, 1982, J CELL BIOL, V94, P667, DOI 10.1083/jcb.94.3.667; Tatavarty V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007724; Urban NT, 2011, BIOPHYS J, V101, P1277, DOI 10.1016/j.bpj.2011.07.027; Xu K, 2012, NAT METHODS, V9, P185, DOI [10.1038/nmeth.1841, 10.1038/NMETH.1841]; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	36	757	782	9	379	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 25	2013	339	6118					452	456		10.1126/science.1232251	http://dx.doi.org/10.1126/science.1232251			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23239625	Green Accepted			2022-12-28	WOS:000313960700045
J	Strugatsky, D; McNulty, R; Munson, K; Chen, CK; Soltis, SM; Sachs, G; Luecke, H				Strugatsky, David; McNulty, Reginald; Munson, Keith; Chen, Chiung-Kuang; Soltis, S. Michael; Sachs, George; Luecke, Hartmut			Structure of the proton-gated urea channel from the gastric pathogen Helicobacter pylori	NATURE			English	Article							PH; PROTEIN; COMPLEX; SYSTEM	Half the world's population is chronically infected with Helico-bacter pylori(1), causing gastritis, gastric ulcers and an increased incidence of gastric adenocarcinoma(2). Its proton-gated inner-membrane urea channel, HpUreI, is essential for survival in the acidic environment of the stomach(3). The channel is closed at neutral pH and opens at acidic pH to allow the rapid access of urea to cytoplasmic urease(4). Urease produces NH3 and CO2, neutralizing entering protons and thus buffering the periplasm to a pH of roughly 6.1 even in gastric juice at a pH below 2.0. Here we report the structure of HpUreI, revealing six protomers assembled in a hexameric ring surrounding a central bilayer plug of ordered lipids. Each protomer encloses a channel formed by a twisted bundle of six transmembrane helices. The bundle defines a previously unobserved fold comprising a two-helix hairpin motif repeated three times around the central axis of the channel, without the inverted repeat of mammalian-type urea transporters. Both the channel and the protomer interface contain residues conserved in the AmiS/UreI superfamily, suggesting the preservation of channel architecture and oligomeric state in this superfamily. Predominantly aromatic or aliphatic side chains line the entire channel and define two consecutive constriction sites in the middle of the channel. Mutation of Trp 153 in the cytoplasmic constriction site to Ala or Phe decreases the selectivity for urea in comparison with thiourea, suggesting that solute interaction with Trp 153 contributes specificity. The previously unobserved hexameric channel structure described here provides a new model for the permeation of urea and other small amide solutes in prokaryotes and archaea.	[Strugatsky, David; Munson, Keith; Sachs, George] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90073 USA; [Strugatsky, David; Munson, Keith; Sachs, George] Greater W Angeles Hlth Care Syst, Los Angeles, CA 90073 USA; [McNulty, Reginald; Chen, Chiung-Kuang; Luecke, Hartmut] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Soltis, S. Michael] Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Luecke, Hartmut] Univ Calif Irvine, Ctr Biomembrane Syst, Irvine, CA 92697 USA; [Luecke, Hartmut] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Luecke, Hartmut] Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92697 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Sachs, G (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90073 USA.	gsachs@ucla.edu; hudel@uci.edu		McNulty, Reginald/0000-0003-2101-1377	National Institutes of Health (NIH) [R01AI78000, P30CA062203]; National Cancer Institute institutional training grant [5T32CA9054-34]; University of California Irvine Center for Biomembrane Systems; NIH [R01DK53462, R01DK58333]; US Veterans Administration; DOE Office of Biological and Environmental Research; HIN, National Center for Research Resources, Biomedical Technology Program [P41RR001209]; National Institute of General Medical Sciences; NATIONAL CANCER INSTITUTE [T32CA009054, P30CA062203] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058333] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute institutional training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of California Irvine Center for Biomembrane Systems; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Veterans Administration(US Department of Veterans Affairs); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); HIN, National Center for Research Resources, Biomedical Technology Program; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the following for assistance with X-ray data collection at the Stanford Synchrotron Radiation Lightsource (T. Doukov), the Advanced Photon Source (D. Cascio & R. Rajashankar), the Advanced Light Source (J. Nix) and the Swiss Light Source (C. Schulze-Briese). We also thank J. Whitelegge for mass spectrometry characterization of potential heavy atom derivatives; D. R. Scott for the urease assays; B. Hirayama for advice on the oocyte experiments; N. Echols and T. Terwilliger for assistance with the development version of the program Phenix; A. Murzin for fold characterization; T. Silkov for pseudosymmetry analysis; and D. R. Scott, F. Tombola, V. De Souza, K. Luecke, S. Luecke and J. Lanyi for general suggestions. This work was supported by National Institutes of Health (NIH) grants R01AI78000 and P30CA062203, National Cancer Institute institutional training grant 5T32CA9054-34, the University of California Irvine Center for Biomembrane Systems (H. L.), NIH grants R01DK53462 and R01DK58333 (G. S.) and the US Veterans Administration (G. S). Portions of this research were performed at the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the US Department of Energy (DOE) Office of Science by Stanford University. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the HIN, National Center for Research Resources, Biomedical Technology Program (P41RR001209) and the National Institute of General Medical Sciences.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Callenberg KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012722; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Furnham N, 2006, STRUCTURE, V14, P1313, DOI 10.1016/j.str.2006.06.014; Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503; Graham DY, 2010, GUT, V59, P1143, DOI 10.1136/gut.2009.192757; Gray LR, 2011, BIOCHEMISTRY-US, V50, P8656, DOI 10.1021/bi200887a; Hong W, 2003, J MED MICROBIOL, V52, P211, DOI 10.1099/jmm.0.05072-0; Huysmans GHM, 2012, BIOCHEM J, V445, P157, DOI 10.1042/BJ20120169; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-303; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Levin EJ, 2012, P NATL ACAD SCI USA, V109, P11194, DOI 10.1073/pnas.1207362109; Levin EJ, 2009, NATURE, V462, P757, DOI 10.1038/nature08558; Lu W, 2011, SCIENCE, V332, P352, DOI 10.1126/science.1199098; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MeyerRosberg K, 1996, GASTROENTEROLOGY, V111, P886, DOI 10.1016/S0016-5085(96)70056-2; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; ORBACH E, 1980, J GEN PHYSIOL, V75, P427, DOI 10.1085/jgp.75.4.427; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; POUNDER RE, 1995, ALIMENT PHARM THERAP, V9, P33; Scott DR, 2010, J BACTERIOL, V192, P94, DOI 10.1128/JB.00848-09; Scott DR, 2000, INFECT IMMUN, V68, P470, DOI 10.1128/IAI.68.2.470-477.2000; Scott DR, 2002, GASTROENTEROLOGY, V123, P187, DOI 10.1053/gast.2002.34218; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Skouloubris S, 1998, INFECT IMMUN, V66, P4517; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Weeks DL, 2000, SCIENCE, V287, P482, DOI 10.1126/science.287.5452.482; Weeks DL, 2001, MOL MICROBIOL, V40, P1249, DOI 10.1046/j.1365-2958.2001.02466.x; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	33	58	63	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					255	U144		10.1038/nature11684	http://dx.doi.org/10.1038/nature11684			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23222544	Green Accepted, Green Submitted			2022-12-28	WOS:000313259600046
J	Fugger, L; McVean, G; Bell, JI				Fugger, Lars; McVean, Gil; Bell, John I.			Genomewide Association Studies and Common Disease - Realizing Clinical Utility	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fugger, Lars] Univ Oxford, Weatherall Inst Med, Oxford, England; [Fugger, Lars] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [McVean, Gil] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Bell, John I.] Univ Oxford, Off Regius Prof Med, Oxford, England	University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Fugger, L (corresponding author), Univ Oxford, Weatherall Inst Med, Oxford, England.			McVean, Gil/0000-0002-5012-4162	Medical Research Council [MC_UU_12010/3, G1000800I] Funding Source: Medline; Wellcome Trust [090532] Funding Source: Medline; Medical Research Council [G1000800i] Funding Source: researchfish; Rosetrees Trust [M210] Funding Source: researchfish; MRC [MC_UU_12010/3] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Gregory AP, 2012, NATURE, V488, P508, DOI 10.1038/nature11307; Gudjonsson JE, 2012, J AM ACAD DERMATOL, V67, P139, DOI 10.1016/j.jaad.2011.06.037; Rosenblum MD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003504; Travers ME, 2011, HUM GENET, V130, P41, DOI 10.1007/s00439-011-1023-8; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2	5	26	29	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2012	367	25					2370	2371		10.1056/NEJMp1212285	http://dx.doi.org/10.1056/NEJMp1212285			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056ZP	23252523				2022-12-28	WOS:000312531600003
J	Harrington, RA				Harrington, Robert A.			Intraaortic balloon counterpulsation did not reduce mortality in acute MI with cardiogenic shock	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ELEVATION MYOCARDIAL-INFARCTION		Stanford Univ, Stanford, CA 94305 USA	Stanford University	Harrington, RA (corresponding author), Stanford Univ, Stanford, CA 94305 USA.							Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; French JK, 2011, AM HEART J, V162, P89, DOI 10.1016/j.ahj.2011.04.009; Hochman JS, 2001, JAMA-J AM MED ASSOC, V285, P190, DOI 10.1001/jama.285.2.190; Hochman JS, 2003, CIRCULATION, V107, P2998, DOI 10.1161/01.CIR.0000075927.67673.F2; Patel MR, 2011, JAMA-J AM MED ASSOC, V306, P1329, DOI 10.1001/jama.2011.1280; Singh M, 2007, J AM COLL CARDIOL, V50, P1752, DOI 10.1016/j.jacc.2007.04.101	6	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2012	157	12							JC6-11	10.7326/0003-4819-157-12-201212180-02011	http://dx.doi.org/10.7326/0003-4819-157-12-201212180-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057SB	23247960				2022-12-28	WOS:000312583200010
J	Lee, ZE; Modiri, A				Lee, Zone-En; Modiri, Alexandra			Palmoplantar Keratoderma Associated with Esophageal Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lee, Zone-En; Modiri, Alexandra] Washington Hosp Ctr, Washington, DC 20010 USA	MedStar Washington Hospital Center	Lee, ZE (corresponding author), Washington Hosp Ctr, Washington, DC 20010 USA.	zone-en.lee@medstar.net							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24								10.1056/NEJMicm1102375	http://dx.doi.org/10.1056/NEJMicm1102375			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HF	23234534				2022-12-28	WOS:000312187700008
J	Winkelmann, R; Levermann, A; Martin, MA; Frieler, K				Winkelmann, R.; Levermann, A.; Martin, M. A.; Frieler, K.			Increased future ice discharge from Antarctica owing to higher snowfall	NATURE			English	Article							MODEL PISM-PIK; CLIMATE-CHANGE; SHEET; SHELF; BENEATH; FLOW	Anthropogenic climate change is likely to cause continuing global sea level rise(1), but some processes within the Earth system may mitigate the magnitude of the projected effect. Regional and global climate models simulate enhanced snowfall over Antarctica, which would provide a direct offset of the future contribution to global sea level rise from cryospheric mass loss(2,3) and ocean expansion(4). Uncertainties exist in modelled snowfall(5), but even larger uncertainties exist in the potential changes of dynamic ice discharge from Antarctica(1,6) and thus in the ultimate fate of the precipitation-deposited ice mass. Here we show that snowfall and discharge are not independent, but that future ice discharge will increase by up to three times as a result of additional snowfall under global warming. Our results, based on an ice-sheet model(7) forced by climate simulations through to the end of 2500 (ref. 8), show that the enhanced discharge effect exceeds the effect of surface warming as well as that of basal ice-shelf melting, and is due to the difference in surface elevation change caused by snowfall on grounded versus floating ice. Although different underlying forcings drive ice loss from basal melting versus increased snowfall, similar ice dynamical processes are nonetheless at work in both; therefore results are relatively independent of the specific representation of the transition zone. In an ensemble of simulations designed to capture ice-physics uncertainty, the additional dynamic ice loss along the coastline compensates between 30 and 65 per cent of the ice gain due to enhanced snowfall over the entire continent. This results in a dynamic ice loss of up to 1.25 metres in the year 2500 for the strongest warming scenario. The reported effect thus strongly counters a potential negative contribution to global sea level by the Antarctic Ice Sheet.	[Winkelmann, R.; Levermann, A.; Martin, M. A.; Frieler, K.] Potsdam Inst Climate Impact Res PIK, D-14473 Potsdam, Germany; [Winkelmann, R.; Levermann, A.; Martin, M. A.] Univ Potsdam, Inst Phys, D-14476 Potsdam, Germany	Potsdam Institut fur Klimafolgenforschung; University of Potsdam	Winkelmann, R (corresponding author), Potsdam Inst Climate Impact Res PIK, D-14473 Potsdam, Germany.	ricarda.winkelmann@pik-potsdam.de	Levermann, Anders/G-4666-2011	Levermann, Anders/0000-0003-4432-4704; Winkelmann, Ricarda/0000-0003-1248-3217; Frieler, Katja/0000-0003-4869-3013	German Federal Ministry of Education and Research (BMBF) [01LP1171A]; German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU) [11_II_093_Global_A_SIDS, 11_II_093_Global_A_LDCs]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU)	This study was supported by the German Federal Ministry of Education and Research (BMBF, grant 01LP1171A) and the German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU, grant 11_II_093_Global_A_SIDS and LDCs).	Dinniman MS, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004036; Dupont TK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022024; Frieler K, 2012, J CLIMATE, V25, P3117, DOI 10.1175/JCLI-D-11-00199.1; Grosfeld K., 1998, ANTARCT RES SER, V75, P83; Huybrechts P, 1999, J CLIMATE, V12, P2169, DOI 10.1175/1520-0442(1999)012<2169:TDROTG>2.0.CO;2; Huybrechts P, 2011, SURV GEOPHYS, V32, P397, DOI 10.1007/s10712-011-9131-5; Joughin I, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017609; Krinner G, 2007, CLIM DYNAM, V28, P215, DOI 10.1007/s00382-006-0177-x; Larour E, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021693; Le Brocq A. M., 2010, EARTH SYSTEM SCI DAT, V3, P195, DOI [10.5194/essd-2-247-2010, DOI 10.5194/ESSD-2-247-2010, DOI 10.5194/ESSDD-3-195-2010]; Lenaerts JTM, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2010JD015419; Martin MA, 2011, CRYOSPHERE, V5, P727, DOI 10.5194/tc-5-727-2011; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Meinshausen M., 2008, ATMOS CHEM PHYS DISC, V8, P6153, DOI DOI 10.5194/ACPD-8-6153-2008; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Monaghan AJ, 2006, SCIENCE, V313, P827, DOI 10.1126/science.1128243; Olbers D, 2010, OCEAN DYNAM, V60, P141, DOI 10.1007/s10236-009-0252-z; Payne AJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003733; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Schewe J, 2011, EARTH SYST DYNAM, V2, P25, DOI 10.5194/esd-2-25-2011; Schoof C, 2010, Q J MECH APPL MATH, V63, P73, DOI 10.1093/qjmam/hbp025; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Uotila P, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007482; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Vizcaino M, 2010, CLIM DYNAM, V34, P301, DOI 10.1007/s00382-009-0591-y; Walker RT, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034947; Williams MJM, 2001, J GEOPHYS RES-OCEANS, V106, P22383, DOI 10.1029/2000JC000236; Winkelmann R, 2011, CRYOSPHERE, V5, P715, DOI 10.5194/tc-5-715-2011; Winkelmann R., 2012, CRYOSPHERE DISCUSS, V6, P673, DOI [10.5194/tcd-6-673-2012, DOI 10.5194/TCD-6-673-2012]	31	59	60	2	133	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					239	+		10.1038/nature11616	http://dx.doi.org/10.1038/nature11616			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23235878				2022-12-28	WOS:000312259300039
J	Itakura, E; Kishi-Itakura, C; Mizushima, N				Itakura, Eisuke; Kishi-Itakura, Chieko; Mizushima, Noboru			The Hairpin-type Tail-Anchored SNARE Syntaxin 17 Targets to Autophagosomes for Fusion with Endosomes/Lysosomes	CELL			English	Article							ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; MAMMALIAN-CELLS; ATG PROTEINS; HOMOLOG; SYSTEM; TRAFFICKING; BIOGENESIS; STARVATION; TRANSPORT	The lysosome is a degradative organelle, and its fusion with other organelles is strictly regulated. In contrast to fusion with the late endosome, the mechanisms underlying autophagosome-lysosome fusion remain unknown. Here, we identify syntaxin 17 (Stx17) as the autophagosomal SNARE required for fusion with the endosome/lysosome. Stx17 localizes to the outer membrane of completed autophagosomes but not to the isolation membrane (unclosed intermediate structures); for this reason, the lysosome does not fuse with the isolation membrane. Stx17 interacts with SNAP-29 and the endosomal/lysosomal SNARE VAMP8. Depletion of Stx17 causes accumulation of autophagosomes without degradation. Stx17 has a unique C-terminal hairpin structure mediated by two tandem transmembrane domains containing glycine zipper-like motifs, which is essential for its association with the autophagosomal membrane. These findings reveal a mechanism by which the SNARE protein is available to the completed autophagosome.	[Itakura, Eisuke; Kishi-Itakura, Chieko; Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan	Tokyo Medical & Dental University (TMDU)	Mizushima, N (corresponding author), Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Tokyo 1130033, Japan.	nmizu@m.u-tokyo.ac.jp	Mizushima, Noboru/C-3635-2009; Itakura, Eisuke/AAY-7977-2021	Mizushima, Noboru/0000-0002-6258-6444; Itakura, Eisuke/0000-0001-7248-9333	Funding Program for Next Generation World-Leading Researchers; Takeda Science Foundation; Japan Society for the Promotion of Science for Young Scientists	Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Taki Nishimura (Tokyo Medical and Dental University) for help with RNAi experiments, Masaaki Komatsu (Tokyo Metropolitan Institute of Medical Science) for providing Atg3 KO MEFs, and Toshio Kitamura (The University of Tokyo) and Shoji Yamaoka (Tokyo Medical and Dental University) for the retroviral vectors and Plat-E cells, and Atsushi Miyawaki (RIKEN) for providing Venus and SECFP. We also thank Ramanujan S. Hegde and Sichen Shao (MRC Laboratory of Molecular Biology) for critical reading of this manuscript and helpful discussions. This work was supported by the Funding Program for Next Generation World-Leading Researchers, and the Takeda Science Foundation (to N.M.) and grants for a research fellowship of the Japan Society for the Promotion of Science for Young Scientists (to E.I.).	Atlashkin V, 2003, MOL CELL BIOL, V23, P5198, DOI 10.1128/MCB.23.15.5198-5207.2003; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Borgese N, 2003, J CELL BIOL, V161, P1013, DOI 10.1083/jcb.200303069; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Brosig B, 1998, PROTEIN SCI, V7, P1052; Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7; Darsow T, 1997, J CELL BIOL, V138, P517, DOI 10.1083/jcb.138.3.517; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Dilcher M, 2001, J BIOL CHEM, V276, P34537, DOI 10.1074/jbc.M101551200; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Furuta N, 2010, MOL BIOL CELL, V21, P1001, DOI 10.1091/mbc.E09-08-0693; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim S, 2005, P NATL ACAD SCI USA, V102, P14278, DOI 10.1073/pnas.0501234102; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Fader CM, 2009, BBA-MOL CELL RES, V1793, P1901, DOI 10.1016/j.bbamcr.2009.09.011; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Noda T, 2009, CELL DEATH DIFFER, V16, P984, DOI 10.1038/cdd.2009.54; Ohashi Y, 2010, MOL BIOL CELL, V21, P3998, DOI 10.1091/mbc.E10-05-0457; Pedrazzini E, 2000, J CELL BIOL, V148, P899, DOI 10.1083/jcb.148.5.899; Popoff V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005231; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Renna M, 2011, J CELL SCI, V124, P469, DOI 10.1242/jcs.076489; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sato M, 2011, MOL BIOL CELL, V22, P2579, DOI 10.1091/mbc.E11-04-0279; Sato TK, 1998, MOL CELL BIOL, V18, P5308, DOI 10.1128/MCB.18.9.5308; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; von Mollard GF, 1999, MOL BIOL CELL, V10, P1719, DOI 10.1091/mbc.10.6.1719; Weng N, 2007, J BIOL CHEM, V282, P9635, DOI 10.1074/jbc.M611108200; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Yoshimori T, 2000, MOL BIOL CELL, V11, P747, DOI 10.1091/mbc.11.2.747	51	773	795	6	119	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1256	1269		10.1016/j.cell.2012.11.001	http://dx.doi.org/10.1016/j.cell.2012.11.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217709	Bronze			2022-12-28	WOS:000311999900015
J	Sontheimer, EJ				Sontheimer, Erik J.			Small RNAs of Opposite Sign ... but Same Absolute Value	CELL			English	Editorial Material							C. ELEGANS; GENOME-REARRANGEMENT; EPIGENETIC MEMORY; GERMLINE; PIRNAS; TRANSCRIPTS	In ciliates, small RNAs have been shown to target foreign sequences for silencing via elimination from the somatic genome. Fang et al. now reveal a set of Piwi-interacting RNAs (piRNAs) in Oxytricha trifallax that likewise enable genomic self versus nonself discrimination, this time by specifying self sequences for genome retention.	Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Sontheimer, EJ (corresponding author), Northwestern Univ, Dept Mol Biosci, 2205 Tech Dr, Evanston, IL 60208 USA.	erik@northwestern.edu		Sontheimer, Erik/0000-0002-0881-0310				Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Duharcourt S, 2009, TRENDS GENET, V25, P344, DOI 10.1016/j.tig.2009.05.007; Fang WW, 2012, CELL, V151, P1243, DOI 10.1016/j.cell.2012.10.045; Ishizu H, 2012, GENE DEV, V26, P2361, DOI 10.1101/gad.203786.112; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lepere G, 2008, GENE DEV, V22, P1501, DOI 10.1101/gad.473008; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015	10	1	1	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1157	1158		10.1016/j.cell.2012.11.032	http://dx.doi.org/10.1016/j.cell.2012.11.032			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217700	Bronze			2022-12-28	WOS:000311999900004
J	Grayson, M				Grayson, Michelle			Ageing	NATURE			English	Editorial Material																			0	2	2	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2012	492	7427					S1	S1		10.1038/492S1a	http://dx.doi.org/10.1038/492S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048EQ	23222665	Bronze			2022-12-28	WOS:000311893400001
J	Wapner, RJ; Martin, CL; Levy, B; Ballif, BC; Eng, CM; Zachary, JM; Savage, M; Platt, LD; Saltzman, D; Grobman, WA; Klugman, S; Scholl, T; Simpson, JL; McCall, K; Aggarwal, VS; Bunke, B; Nahum, O; Patel, A; Lamb, AN; Thom, EA; Beaudet, AL; Ledbetter, DH; Shaffer, LG; Jackson, L				Wapner, Ronald J.; Martin, Christa Lese; Levy, Brynn; Ballif, Blake C.; Eng, Christine M.; Zachary, Julia M.; Savage, Melissa; Platt, Lawrence D.; Saltzman, Daniel; Grobman, William A.; Klugman, Susan; Scholl, Thomas; Simpson, Joe Leigh; McCall, Kimberly; Aggarwal, Vimla S.; Bunke, Brian; Nahum, Odelia; Patel, Ankita; Lamb, Allen N.; Thom, Elizabeth A.; Beaudet, Arthur L.; Ledbetter, David H.; Shaffer, Lisa G.; Jackson, Laird			Chromosomal Microarray versus Karyotyping for Prenatal Diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COPY-NUMBER VARIANTS; COMPARATIVE GENOMIC HYBRIDIZATION; DEVELOPMENTAL-DISABILITIES; CLINICAL-SIGNIFICANCE; CONGENITAL-ANOMALIES; ARRAY ANALYSIS; DOWN-SYNDROME; SNP ARRAY; IDENTIFICATION; REARRANGEMENTS	BACKGROUND Chromosomal microarray analysis has emerged as a primary diagnostic tool for the evaluation of developmental delay and structural malformations in children. We aimed to evaluate the accuracy, efficacy, and incremental yield of chromosomal microarray analysis as compared with karyotyping for routine prenatal diagnosis. METHODS Samples from women undergoing prenatal diagnosis at 29 centers were sent to a central karyotyping laboratory. Each sample was split in two; standard karyotyping was performed on one portion and the other was sent to one of four laboratories for chromosomal microarray. RESULTS We enrolled a total of 4406 women. Indications for prenatal diagnosis were advanced maternal age (46.6%), abnormal result on Down's syndrome screening (18.8%), structural anomalies on ultrasonography (25.2%), and other indications (9.4%). In 4340 (98.8%) of the fetal samples, microarray analysis was successful; 87.9% of samples could be used without tissue culture. Microarray analysis of the 4282 nonmosaic samples identified all the aneuploidies and unbalanced rearrangements identified on karyotyping but did not identify balanced translocations and fetal triploidy. In samples with a normal karyotype, microarray analysis revealed clinically relevant deletions or duplications in 6.0% with a structural anomaly and in 1.7% of those whose indications were advanced maternal age or positive screening results. CONCLUSIONS In the context of prenatal diagnostic testing, chromosomal microarray analysis identified additional, clinically significant cytogenetic information as compared with karyotyping and was equally efficacious in identifying aneuploidies and unbalanced rearrangements but did not identify balanced translocations and triploidies. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and others; ClinicalTrials.gov number, NCT01279733.)	[Wapner, Ronald J.; Savage, Melissa] Columbia Univ, Med Ctr, Dept Obstet & Gynecol, Carnegie Hill Imaging Women, New York, NY 10032 USA; [Levy, Brynn; Aggarwal, Vimla S.; Nahum, Odelia] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, Carnegie Hill Imaging Women, New York, NY 10032 USA; [Klugman, Susan] Albert Einstein Coll Med, Montefiore Med Ctr, New York, NY USA; [Martin, Christa Lese; Bunke, Brian; Ledbetter, David H.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Ballif, Blake C.; Lamb, Allen N.; Shaffer, Lisa G.] Signature Genom Labs, Spokane, WA USA; [Eng, Christine M.; Patel, Ankita; Beaudet, Arthur L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Zachary, Julia M.; Thom, Elizabeth A.] George Washington Univ, Ctr Biostat, Rockville, MD USA; [Platt, Lawrence D.] Ctr Fetal Med & Womens Ultrasound, Los Angeles, CA USA; [Grobman, William A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Scholl, Thomas] Integrated Genet Inc, Westborough, MA USA; [Simpson, Joe Leigh] Florida Int Univ, Miami, FL 33199 USA; [McCall, Kimberly] Integrated Genet Inc, Santa Fe, NM USA; [Jackson, Laird] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	Columbia University; Columbia University; Montefiore Medical Center; Yeshiva University; Emory University; Baylor College of Medicine; George Washington University; Northwestern University; Feinberg School of Medicine; State University System of Florida; Florida International University; Drexel University	Wapner, RJ (corresponding author), Columbia Univ, Med Ctr, Dept Obstet & Gynecol, Carnegie Hill Imaging Women, 622 W 168th St,PH16-66, New York, NY 10032 USA.	rw2191@mail.cumc.columbia.edu	Patel, Ankita/D-3247-2013	Wapner, Ronald/0000-0003-0727-1244	National Institute of Child Health and Human Development [R01HD05565101, R01HD055651-03S1, RC2HD064525]; Agilent Technologies; Affymetrix; Genzyme; Shire; CombiMatrix; Roche NimbleGen; Celula; Natera; RMA Genetics; Bio Dx; Bayer; Novartis; North American Fetal Therapy Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055651] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [RC2HD064525] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Agilent Technologies; Affymetrix; Genzyme(Sanofi-AventisGenzyme Corporation); Shire; CombiMatrix; Roche NimbleGen(Roche Holding); Celula; Natera; RMA Genetics; Bio Dx; Bayer(Bayer AG); Novartis(Novartis); North American Fetal Therapy Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by grants from the National Institute of Child Health and Human Development (R01HD05565101, R01HD055651-03S1, and RC2HD064525). Agilent Technologies and Affymetrix donated all microarrays and reagents used in the study.; Dr. Aggarwal reports receiving lecture fees from Agilent Technologies and consulting fees from Affymetrix through her institution. Drs. Ballif, Lamb, and Shaffer report being employees of and holding stock in PerkinElmer (Signature Genomics). Dr. Eng reports receiving lecture fees from Genzyme and Shire. Dr. Jackson reports serving as an expert witness in malpractice cases regarding genetic concerns. Dr. Klugman reports serving as an expert witness in a case regarding counseling for a family with a fetus with a rare genetic disorder. Dr. Ledbetter reports receiving consulting fees from and holding stock in CombiMatrix and receiving consulting fees from Roche NimbleGen and Celula. Dr. Levy reports receiving consulting fees from and holding stock in Natera and receiving consulting fees from RMA Genetics and Celula and lecture fees and travel support from Affymetrix and Agilent Technologies. Dr. Scholl reports being an employee of LabCorp (Integrated Genetics). Dr. Simpson reports receiving consulting fees from Bio Dx, Bayer, and Novartis. No other potential conflict of interest relevant to this article was reported.; We thank Deborah A. Driscoll, M. D., Sherman Elias, M. D., Deborah L. Eunpu, M. S., Kurt Hirschhorn, M. D., Charles Lee, Ph.D., Eugene Pergament, M. D., and Dorothy Warburton, Ph. D., for their work as the Clinical Advisory Committee; Maternal Fetal Specialists, Atlanta (Daniel Eller, M. D.), Baylor College of Medicine (Anthony Johnson, D.O.), NJ Perinatal Associates/St. Barnabas Medical Center (Richard Miller, M. D.), Main Line Health and Women's Health Care Group of PA (Alan Donnenfeld, M. D.), Phoenix Perinatal Associates (Rodney Edwards, M. D.), Maternal Fetal Medicine of Central PA (Terry Tressler, D.O.), Thomas Jefferson University (Stuart Weiner, M. D.), Fetal Diagnostic Center (Greggory DeVore, M. D.), Virtua Health System (Ronald Librizzi, D.O.), Valley Health System (Andrei Rebarber, M. D.), Christiana Care Health System (Anthony Sciscione, D.O.), San Francisco Perinatal Associates (James Goldberg, M. D.), University of Medicine and Dentistry, New Jersey-Robert Wood Johnson (Todd Rosen, M. D.), University of California, Irvine (Deborah Wing, M. D.), Vanderbilt Center for Women's Health (William Walsh, M. D.), Children's Hospital of Philadelphia (Mark Johnson, M. D.), Ohio State University Maternal Fetal Medicine (Richard O'Shaughnessy, M. D.), St. Vincent Women's Hospital (Maurice Eggleston, M. D., and James Sumners, M. D.), Englewood Hospital (Ying Chan, M. D.), University of Utah (Robert Silver, M. D.), and Magella Medical Group (Melissa Bush, M. D.) for their role as participating recruitment sites; Nicolasa H. Chavez, Jessica Feinberg, and Andrea M. Murad for their coordinating and recruitment efforts; Lindsay Doherty and Mark McNellis from the George Washington University Data Coordinating Center; the laboratory technologists including Emily Carron from Columbia University, Vanessa Jump from Emory University, Caron Glotzbach from Signature Genomic Laboratories, PerkinElmer, and Patricia Hixson at Baylor College of Medicine; Eliza Sanchez for her work at Integrated Genetics; and the participants and the North American Fetal Therapy Network for their support of the study.	ACOG Committee on Practice Bulletins, 2007, Obstet Gynecol, V109, P217; Baldwin EL, 2008, GENET MED, V10, P415, DOI 10.1097/GIM.0b013e318177015c; Bodurtha J, 2012, NEW ENGL J MED, V366, P64, DOI 10.1056/NEJMra1105043; Caughey AB, 2008, AM J OBSTET GYNECOL, V198; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Faas BHW, 2010, J MED GENET, V47, P586, DOI 10.1136/jmg.2009.075853; Fan HC, 2012, NATURE, V487, P320, DOI 10.1038/nature11251; Gau SSF, 2012, AM J MED GENET B, V159B, P710, DOI 10.1002/ajmg.b.32074; Giardino D, 2009, PRENATAL DIAG, V29, P257, DOI 10.1002/pd.2215; Girirajan S, 2012, NEW ENGL J MED, V367, P1321, DOI 10.1056/NEJMoa1200395; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Grobman WA, 2002, PRENATAL DIAG, V22, P1195, DOI 10.1002/pd.494; Higgins AW, 2008, AM J HUM GENET, V83, P425, DOI 10.1016/j.ajhg.2008.08.011; Hillman SC, 2011, ULTRASOUND OBST GYN, V37, P6, DOI 10.1002/uog.7754; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; Kuppermann M, 2000, OBSTET GYNECOL, V96, P511, DOI 10.1016/S0029-7844(00)00969-8; Manning M, 2010, GENET MED, V12, P742, DOI 10.1097/GIM.0b013e3181f8baad; Maya I, 2010, PRENATAL DIAG, V30, P1131, DOI 10.1002/pd.2626; McGillivray G, 2012, PRENATAL DIAG, V32, P389, DOI 10.1002/pd.3849; Mefford HC, 2012, NEW ENGL J MED, V366, P733, DOI 10.1056/NEJMra1114194; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Park JH, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-102; Reddy UM, 2012, NEW ENGL J MED, V367, P2185, DOI 10.1056/NEJMoa1201569; Rosenberg SA, 2008, PEDIATRICS, V121, pE1503, DOI 10.1542/peds.2007-1680; Sagoo GS, 2009, GENET MED, V11, P139, DOI 10.1097/GIM.0b013e318194ee8f; Shaffer UG, 2006, J PEDIATR-US, V149, P98, DOI 10.1016/j.jpeds.2006.02.006; Srebniak M, 2011, EUR J HUM GENET, V19, P1230, DOI 10.1038/ejhg.2011.119; Tyreman M, 2009, J MED GENET, V46, P531, DOI 10.1136/jmg.2008.065482; WARBURTON D, 1991, AM J HUM GENET, V49, P995; Wolstenholme J, 1996, PRENATAL DIAG, V16, P511, DOI 10.1002/(SICI)1097-0223(199606)16:6<511::AID-PD904>3.0.CO;2-8	32	794	907	5	112	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2012	367	23					2175	2184		10.1056/NEJMoa1203382	http://dx.doi.org/10.1056/NEJMoa1203382			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048DO	23215555	Green Accepted			2022-12-28	WOS:000311890600004
J	Walker, MJ; Beatson, SA				Walker, Mark J.; Beatson, Scott A.			Outsmarting Outbreaks	SCIENCE			English	Editorial Material							TRANSMISSION; EVOLUTION; MRSA		[Walker, Mark J.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia	University of Queensland; University of Queensland	Walker, MJ (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia.	mark.walker@uq.edu.au	Walker, Mark J./F-6940-2011; Beatson, Scott/B-6985-2013	Beatson, Scott/0000-0002-1806-3283; Walker, Mark/0000-0001-7423-2769				Ben Zakour NL, 2012, J CLIN MICROBIOL, V50, P2224, DOI 10.1128/JCM.00675-12; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Maamary PG, 2012, FASEB J, V26, P4675, DOI 10.1096/fj.12-212142; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Pallen MJ, 2010, CURR OPIN MICROBIOL, V13, P625, DOI 10.1016/j.mib.2010.08.003; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Tse H, 2012, J INFECT DIS, V206, P341, DOI 10.1093/infdis/jis362	16	11	12	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1161	1162		10.1126/science.1232327	http://dx.doi.org/10.1126/science.1232327			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	045AL	23197523				2022-12-28	WOS:000311666200032
J	Bischoff, EWMA; Akkermans, R; Bourbeau, J; van Weel, C; Vercoulen, JH; Schermer, TRJ				Bischoff, Erik W. M. A.; Akkermans, Reinier; Bourbeau, Jean; van Weel, Chris; Vercoulen, Jan H.; Schermer, Tjard R. J.			Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COPD; EXACERBATIONS; EFFICACY; MODERATE; SYSTEM; CARE	Objective To assess the long term effects of two different modes of disease management (comprehensive self management and routine monitoring) on quality of life (primary objective), frequency and patients' management of exacerbations, and self efficacy (secondary objectives) in patients with chronic obstructive pulmonary disease (COPD) in general practice. Design 24 month, multicentre, investigator blinded, three arm, pragmatic, randomised controlled trial. Setting 15 general practices in the eastern part of the Netherlands. Participants Patients with COPD confirmed by spirometry and treated in general practice. Patients with very severe COPD or treated by a respiratory physician were excluded. Interventions A comprehensive self management programme as an adjunct to usual care, consisting of four tailored sessions with ongoing telephone support by a practice nurse; routine monitoring as an adjunct to usual care, consisting of 2-4 structured consultations a year with a practice nurse; or usual care alone (contacts with the general practitioner at the patients' own initiative). Outcome measures The primary outcome was the change in COPD specific quality of life at 24 months as measured with the chronic respiratory questionnaire total score. Secondary outcomes were chronic respiratory questionnaire domain scores, frequency and patients' management of exacerbations measured with the Nijmegen telephonic exacerbation assessment system, and self efficacy measured with the COPD self-efficacy scale. Results 165 patients were allocated to self management (n=55), routine monitoring (n=55), or usual care alone (n=55). At 24 months, adjusted treatment differences between the three groups in mean chronic respiratory questionnaire total score were not significant. Secondary outcomes did not differ, except for exacerbation management. Compared with usual care, more exacerbations in the self management group were managed with bronchodilators (odds ratio 2.81, 95% confidence interval 1.16 to 6.82) and with prednisolone, antibiotics, or both (3.98, 1.10 to 15.58). Conclusions Comprehensive self management or routine monitoring did not show long term benefits in terms of quality of life or self efficacy over usual care alone in COPD patients in general practice. Patients in the self management group seemed to be more capable of appropriately managing exacerbations than did those in the usual care group.	[Bischoff, Erik W. M. A.; Akkermans, Reinier; van Weel, Chris; Schermer, Tjard R. J.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6500 HB Nijmegen, Netherlands; [Bourbeau, Jean] McGill Univ, Ctr Hlth, Resp Epidemiol & Clin Res Unit, Montreal Chest Inst, Montreal, PQ, Canada; [Vercoulen, Jan H.] Radboud Univ Nijmegen, Med Ctr, Dept Pulm Dis, NL-6500 HB Nijmegen, Netherlands; [Vercoulen, Jan H.] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; McGill University; Radboud University Nijmegen; Radboud University Nijmegen	Bischoff, EWMA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, POB 9101, NL-6500 HB Nijmegen, Netherlands.	E.Bischoff@elg.umcn.nl	Schermer, Tjard RJ/A-8511-2011; Vercoulen, J.H.M.M./L-4706-2015; van Weel, Chris/D-4375-2009; Bischoff, Erik W.M.A./L-4201-2015	Schermer, Tjard RJ/0000-0002-1391-2995; van Weel, Chris/0000-0003-3653-4701; 	Netherlands Organisation for Health Research and Development (ZonMw); Partners in Care Solutions for COPD (PICASSO)	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Partners in Care Solutions for COPD (PICASSO)	This study was funded by the Netherlands Organisation for Health Research and Development (ZonMw) and Partners in Care Solutions for COPD (PICASSO). The funding sources had no role in the design, conduct, or reporting of the study.	Aaron SD, 2008, THORAX, V63, P122, DOI 10.1136/thx.2007.082636; Adams SG, 2007, ARCH INTERN MED, V167, P551, DOI 10.1001/archinte.167.6.551; BANDURA A, 1982, J BEHAV THER EXP PSY, V13, P195, DOI 10.1016/0005-7916(82)90004-0; Bellamy David, 2006, Prim Care Respir J, V15, P48, DOI 10.1016/j.pcrj.2005.11.003; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Bischoff EWMA, 2012, EUR RESPIR J, V39, P1090, DOI 10.1183/09031936.00057811; Bischoff EWMA, 2011, THORAX, V66, P26, DOI 10.1136/thx.2009.127621; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Bourbeau J, 2004, PATIENT EDUC COUNS, V52, P271, DOI 10.1016/S0738-3991(03)00102-2; Bourbeau J, 2003, ARCH INTERN MED, V163, P585, DOI 10.1001/archinte.163.5.585; Bourbeau J, 2008, INFORMA HEALTHCARE, P357; Bucknall CE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1060; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Cranston JM, 2008, MED J AUSTRALIA, V188, pS50; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Effing T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002990.pub2; Geijer RM, 2001, HUISARTS WET, V44, P207; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Kara M, 2004, PATIENT EDUC COUNS, V55, P114, DOI 10.1016/j.pec.2003.08.006; Lacasse Y, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub2; Langsetmo L, 2008, AM J RESP CRIT CARE, V177, P396, DOI 10.1164/rccm.200708-1290OC; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moody A, 2004, THORAX, V59, P1; Poels PJP, 2006, BRIT MED J, V333, P870, DOI 10.1136/bmj.38987.478727.80; Puhan MA, 2007, RESP MED, V101, P308, DOI 10.1016/j.rmed.2006.04.023; Redelmeier DA, 1996, J CLIN EPIDEMIOL, V49, P1215, DOI 10.1016/S0895-4356(96)00206-5; Rice KL, 2010, AM J RESP CRIT CARE, V182, P890, DOI 10.1164/rccm.200910-1579OC; Schermer T, 2009, RESP MED, V103, P542, DOI 10.1016/j.rmed.2008.11.003; Schunemann HJ, 2005, EUR RESPIR J, V25, P31, DOI 10.1183/09031936.04.00029704; Seemungal TAR, 2000, AM J RESP CRIT CARE, V161, P1608, DOI 10.1164/ajrccm.161.5.9908022; Simpson CR, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X514729; Suissa S, 2006, AM J RESP CRIT CARE, V173, P842, DOI 10.1164/rccm.200508-1338PP; van den Bemt L, 2008, RESP MED, V102, P633, DOI 10.1016/j.rmed.2007.12.014; van den Bemt L, 2009, MED J AUSTRALIA, V191, P249; WIGAL JK, 1991, CHEST, V99, P1193, DOI 10.1378/chest.99.5.1193; Wilkinson TMA, 2004, AM J RESP CRIT CARE, V169, P1298, DOI 10.1164/rccm.200310-1443OC	36	89	94	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 28	2012	345								e7642	10.1136/bmj.e7642	http://dx.doi.org/10.1136/bmj.e7642			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048FO	23190905	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000311895900003
J	Byrne, RA; Neumann, FJ; Mehilli, J; Pinieck, S; Wolff, B; Tiroch, K; Schulz, S; Fusaro, M; Ott, I; Ibrahim, T; Hausleiter, J; Valina, C; Pache, J; Laugwitz, KL; Massberg, S; Kastrati, A				Byrne, Robert A.; Neumann, Franz-Josef; Mehilli, Julinda; Pinieck, Susanne; Wolff, Britta; Tiroch, Klaus; Schulz, Stefanie; Fusaro, Massimiliano; Ott, Ilka; Ibrahim, Tareq; Hausleiter, Joerg; Valina, Christian; Pache, Juergen; Laugwitz, Karl-Ludwig; Massberg, Steffen; Kastrati, Adnan		ISAR-DESIRE 3 Investigators	Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial	LANCET			English	Article							BARE-METAL STENTS; VASCULAR BRACHYTHERAPY; CORONARY RESTENOSIS; END-POINTS; CATHETER; RECURRENCES; PREVENTION	Background The best way to manage restenosis in patients who have previously received a drug-eluting stent is unknown. We investigated the efficacy of paclitaxel-eluting balloons (PEB), paclitaxel-eluting stents (PES), and balloon angioplasty in these patients. Methods In this randomised, open-label trial, we enrolled patients older than 18 years with restenosis of at least 50% after implantation of any limus-eluting stent at three centres in Germany between Aug 3, 2009, and Oct 27, 2011. Patients were randomly assigned (1:1:1; stratified according to centre) to receive PEB, PES, or balloon angioplasty alone by means of sealed, opaque envelopes containing a computer-generated sequence. Patients and investigators were not masked to treatment allocation, but events and angiograms were assessed by individuals who were masked. The primary endpoint was diameter stenosis at follow-up angiography at 6-8 months. Primary analysis was done by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00987324. Findings We enrolled 402 patients, of whom 137 (34%) were assigned to PEB, 131 (33%) to PES, and 134 (33%) to balloon angioplasty. Follow-up angiography at 6-8 months was available for 338 (84%) patients. PEB was non-inferior to PES in terms of diameter stenosis (38.0% [SD 21.5] vs 37.4% [21.8]; difference 0.6%, one-sided 95% CI 4.9%; p(non-inferiority) = 0.007; non-inferiority margin of 7%). Findings were consistent in per-protocol analysis (p(non-inferiority) = 0.011). PEB and PES were superior to balloon angioplasty alone (54.1% [25.0]; p(superiority) < 0.0001 for both comparisons). Frequency of death, myocardial infarction, or target lesion thrombosis did not differ between groups. Interpretation By obviating the need for additional stent implantation, PEB could be a useful treatment for patients with restenosis after implantation of a drug-eluting stent.	[Byrne, Robert A.; Pinieck, Susanne; Wolff, Britta; Schulz, Stefanie; Fusaro, Massimiliano; Ott, Ilka; Kastrati, Adnan] Tech Univ Munich, Deutsch Herzzentrum, D-80636 Munich, Germany; [Ibrahim, Tareq; Laugwitz, Karl-Ludwig] Tech Univ Munich, Klinikum Rechts Isar, Med Klin 1, D-80636 Munich, Germany; [Neumann, Franz-Josef; Valina, Christian] Univ Herzzentrum, Freiburg, Germany; [Mehilli, Julinda; Hausleiter, Joerg; Massberg, Steffen] Klinikum Univ Munchen, Med Klin & Poliklin 1, Munich, Germany; [Tiroch, Klaus] HELIOS Klin, Wuppertal, Germany; [Pache, Juergen] Schon Klin Stamberger See, Berg, Germany	German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; Technical University of Munich; Universitats Herzzentrum Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Helios Kliniken	Byrne, RA (corresponding author), Tech Univ Munich, Deutsch Herzzentrum, D-80636 Munich, Germany.	byrne@dhm.mhn.de	Hausleiter, Jörg/V-4206-2019; , Kastrati/Y-2389-2019; Massberg, Steffen/AAN-6054-2021; Mehilli, Julinda/F-2629-2016; Schupke, Stefanie/G-8382-2016; Byrne, Robert/C-3902-2016	Kufner, Sebastian/0000-0002-8091-4552; Schupke, Stefanie/0000-0002-0294-2283; Byrne, Robert/0000-0001-5224-6393	Deutsches Herzzentrum	Deutsches Herzzentrum	Deutsches Herzzentrum.	Alfonso F, 2006, J AM COLL CARDIOL, V47, P2152, DOI 10.1016/j.jacc.2005.10.078; Alfonso F, 2009, J AM COLL CARDIOL, V54, P1036, DOI 10.1016/j.jacc.2009.04.082; Byrne RA, 2012, MINERVA CARDIOANGIOL, V60, P473; Byrne RA, 2009, EUR HEART J, V30, P2441, DOI 10.1093/eurheartj/ehp352; Byrne RA, 2009, DRUG SAFETY, V32, P749, DOI 10.2165/11316500-000000000-00000; Cassese S, 2012, EUROINTERVENTION, V8, P417, DOI 10.4244/EIJV8I4A65; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028; Gray WA, 2010, CIRCULATION, V121, P2672, DOI 10.1161/CIRCULATIONAHA.110.936922; Habara S, 2011, JACC-CARDIOVASC INTE, V4, P149, DOI 10.1016/j.jcin.2010.10.012; Holmes DR, 2006, JAMA-J AM MED ASSOC, V295, P1264, DOI 10.1001/jama.295.11.1264; Joner M, 2011, THROMB HAEMOSTASIS, V105, P864, DOI 10.1160/TH10-11-0698; Kastrati A, 2005, JAMA-J AM MED ASSOC, V293, P165, DOI 10.1001/jama.293.2.165; Kastrati A, 2011, JACC-CARDIOVASC INTE, V4, P165, DOI 10.1016/j.jcin.2010.11.008; KUNTZ RE, 1992, J AM COLL CARDIOL, V19, P1493, DOI 10.1016/0735-1097(92)90609-Q; Latib A, 2011, JACC-CARDIOVASC INTE, V4, P155, DOI 10.1016/j.jcin.2010.09.027; Marroquin OC, 2008, NEW ENGL J MED, V358, P342, DOI 10.1056/NEJMoa0706258; Mauri L, 2005, CIRCULATION, V111, P321, DOI 10.1161/01.CIR.0000153356.72810.97; Mehilli J, 2010, J AM COLL CARDIOL, V55, P2710, DOI 10.1016/j.jacc.2010.02.009; Mehran R, 1999, CIRCULATION, V100, P1872, DOI 10.1161/01.CIR.100.18.1872; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Pocock SJ, 2008, J AM COLL CARDIOL, V51, P23, DOI 10.1016/j.jacc.2007.07.084; Rittger H, 2012, J AM COLL CARDIOL, V59, P1377, DOI 10.1016/j.jacc.2012.01.015; Scheller B, 2006, NEW ENGL J MED, V355, P2113, DOI 10.1056/NEJMoa061254; Serruys PW, 2006, NEW ENGL J MED, V354, P483, DOI 10.1056/NEJMra051091; Steinberg DH, 2009, AM J CARDIOL, V103, P491, DOI 10.1016/j.amjcard.2008.09.107; Stone GW, 2006, JAMA-J AM MED ASSOC, V295, P1253, DOI 10.1001/jama.295.11.1253; Takagi H, 2011, INT J CARDIOL, V151, P354, DOI 10.1016/j.ijcard.2011.05.086; Uchida T, 2010, JACC-CARDIOVASC INTE, V3, P403, DOI 10.1016/j.jcin.2010.01.010; Unverdorben M, 2009, CIRCULATION, V119, P2986, DOI 10.1161/CIRCULATIONAHA.108.839282; Wohrle J, 2012, J AM COLL CARDIOL, V60, P1733, DOI 10.1016/j.jacc.2012.07.040; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	32	289	304	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 9	2013	381	9865					461	467		10.1016/S0140-6736(12)61964-3	http://dx.doi.org/10.1016/S0140-6736(12)61964-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088CH	23206837				2022-12-28	WOS:000314810900031
J	Bondy-Denomy, J; Pawluk, A; Maxwell, KL; Davidson, AR				Bondy-Denomy, Joe; Pawluk, April; Maxwell, Karen L.; Davidson, Alan R.			Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system	NATURE			English	Article							GENOME SEQUENCE; PSEUDOMONAS; RNA; RESISTANCE; PHAGE; INTERFERENCE; DEFENSE; DNA	A widespread system used by bacteria for protection against potentially dangerous foreign DNA molecules consists of the clustered regularly interspaced short palindromic repeats (CRISPR) coupled with cas (CRISPR-associated) genes(1). Similar to RNA interference in eukaryotes(2), these CRISPR/Cas systems use small RNAs for sequence-specific detection and neutralization of invading genomes(3). Here we describe the first examples of genes that mediate the inhibition of a CRISPR/Cas system. Five distinct 'anti-CRISPR' genes were found in the genomes of bacteriophages infecting Pseudomonas aeruginosa. Mutation of the anti-CRISPR gene of a phage rendered it unable to infect bacteria with a functional CRISPR/Cas system, and the addition of the same gene to the genome of a CRISPR/Cas-targeted phage allowed it to evade the CRISPR/Cas system. Phage-encoded anti-CRISPR genes may represent a widespread mechanism for phages to overcome the highly prevalent CRISPR/Cas systems. The existence of anti-CRISPR genes presents new avenues for the elucidation of CRISPR/Cas functional mechanisms and provides new insight into the co-evolution of phages and bacteria.	[Bondy-Denomy, Joe; Davidson, Alan R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Pawluk, April; Davidson, Alan R.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Maxwell, Karen L.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada	University of Toronto; University of Toronto; University of Toronto	Davidson, AR (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	alan.davidson@utoronto.ca		Maxwell, Karen/0000-0002-0211-5480; Pawluk, April/0000-0002-6136-2086	Canadian Institutes for Health Research [MOP- 6279, XNE86943]; CIHR Canada Graduate Scholarship Doctoral Award	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); CIHR Canada Graduate Scholarship Doctoral Award(Canadian Institutes of Health Research (CIHR))	We thank D. Guttman, Y.-H. Cho, K. Cady and G. O'Toole for providing P. aeruginosa strains and phages. We also thank K. Severinov for providing the M13 phage and E. coli strains required for assaying the type 1-E system. We thank J. Brumell, A. Spence and W. Navarre for reading the manuscript. We also thank D. Bona for technical assistance. This work was supported by an Operating Grant to K. L. M. (fund number MOP- 6279) and an Emerging Team Grant to A. R. D. and K. L. M. (fund number XNE86943), both of which were from the Canadian Institutes for Health Research. J. B. D. was supported by a CIHR Canada Graduate Scholarship Doctoral Award.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Battle SE, 2008, J BACTERIOL, V190, P7130, DOI 10.1128/JB.00785-08; Braid MD, 2004, J BACTERIOL, V186, P6560, DOI 10.1128/JB.186.19.6560-6574.2004; Brouns S. J. J., 2012, COLD SPRING HARB PER, V4; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cady KC, 2011, MICROBIOL-SGM, V157, P430, DOI 10.1099/mic.0.045732-0; Cady KC, 2012, J BACTERIOL, V194, P5728, DOI 10.1128/JB.01184-12; Cady KC, 2011, J BACTERIOL, V193, P3433, DOI 10.1128/JB.01411-10; Chung IY, 2012, J VIROL, V86, P8336, DOI 10.1128/JVI.01127-12; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Heo YJ, 2007, MICROBIOL-SGM, V153, P2885, DOI 10.1099/mic.0.2007/007260-0; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Morgan GJ, 2002, J MOL BIOL, V317, P337, DOI 10.1006/jmbi.2002.5437; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Wang PW, 2004, J BACTERIOL, V186, P400, DOI 10.1128/JB.186.2.400-410.2004; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08	31	471	500	31	418	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					429	U181		10.1038/nature11723	http://dx.doi.org/10.1038/nature11723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23242138	Green Accepted			2022-12-28	WOS:000313615900057
J	Jost, TS				Jost, Timothy Stoltzfus			Religious Freedom and Women's Health - The Litigation on Contraception	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA	Washington & Lee University	Jost, TS (corresponding author), Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA.							Guttmacher Institute, 2012, STATE POLICIES IN BR; Institute of Medicine, 2011, CLINICAL PREVENTIVE; The Becket Fund for Religious Liberty, 2012, THE BECKET FUND FOR	3	9	9	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2013	368	1					4	6		10.1056/NEJMp1214605	http://dx.doi.org/10.1056/NEJMp1214605			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	062PA	23252500				2022-12-28	WOS:000312930600014
J	Brophy, J				Brophy, James			Review: Low-quality evidence fails to show that antihypertensive drugs affect outcomes in mild hypertension	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McGill Univ, Ctr Hlth, Montreal, PQ, Canada	McGill University	Brophy, J (corresponding author), McGill Univ, Ctr Hlth, Montreal, PQ, Canada.		brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875					0	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2012	157	12							JC6-6	10.7326/0003-4819-157-12-201212180-02006	http://dx.doi.org/10.7326/0003-4819-157-12-201212180-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057SB	23247955				2022-12-28	WOS:000312583200005
J	Buckley, NA; Isbister, GK				Buckley, Nicholas A.; Isbister, Geoffrey K.			Review: Application of heat or hot water reduces pain from jellyfish stings	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Buckley, Nicholas A.] Univ New S Wales, Sydney, NSW, Australia; [Isbister, Geoffrey K.] Univ Newcastle, Newcastle, NSW 2300, Australia	University of New South Wales Sydney; University of Newcastle	Buckley, NA (corresponding author), Univ New S Wales, Sydney, NSW, Australia.		Isbister, Geoffrey K/G-8052-2015; Buckley, Nicholas A/D-4030-2012	Isbister, Geoffrey K/0000-0003-1519-7419; Buckley, Nicholas A/0000-0002-6326-4711				Birsa LM, 2010, COMP BIOCHEM PHYS C, V151, P426, DOI 10.1016/j.cbpc.2010.01.007	1	1	1	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2012	157	12							JC6-12	10.7326/0003-4819-157-12-201212180-02012	http://dx.doi.org/10.7326/0003-4819-157-12-201212180-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057SB	23247961				2022-12-28	WOS:000312583200011
J	Smith, DA				Smith, Donald A.			Review: Omega-3 polyunsaturated fatty acid supplements do not reduce major cardiovascular events in adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Mt Sinai Sch Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Smith, DA (corresponding author), Mt Sinai Sch Med, New York, NY 10029 USA.							FAO Fisheries and Agriculture Department, 2007, STAT WORLD FISH AQ 2; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94	2	3	4	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2012	157	12							JC6-5	10.7326/0003-4819-157-12-201212180-02005	http://dx.doi.org/10.7326/0003-4819-157-12-201212180-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057SB	23247954				2022-12-28	WOS:000312583200004
J	Murray, CJL; Vos, T; Lozano, R; Naghavi, M; Flaxman, AD; Michaud, C; Ezzati, M; Shibuya, K; Salomon, JA; Abdalla, S; Aboyans, V; Abraham, J; Ackerman, I; Aggarwal, R; Ahn, SY; Ali, MK; Alvarado, M; Anderson, HR; Anderson, LM; Andrews, KG; Atkinson, C; Baddour, LM; Bahalim, AN; Barker-Collo, S; Barrero, LH; Bartels, DH; Basanez, MG; Baxter, A; Bell, ML; Benjamin, EJ; Bennett, D; Bernabe, E; Bhalla, K; Bhandari, B; Bikbov, B; Bin Abdulhak, A; Birbeck, G; Black, JA; Blencowe, H; Blore, JD; Blyth, F; Bolliger, I; Bonaventure, A; Boufous, SA; Bourne, R; Boussinesq, M; Braithwaite, T; Brayne, C; Bridgett, L; Brooker, S; Brooks, P; Brugha, TS; Bryan-Hancock, C; Bucello, C; Buchbinder, R; Buckle, G; Budke, CM; Burch, M; Burney, P; Burstein, R; Calabria, B; Campbell, B; Canter, CE; Carabin, H; Carapetis, J; Carmona, L; Cella, C; Charlson, F; Chen, HL; Cheng, ATA; Chou, D; Chugh, SS; Coffeng, LE; Colan, SD; Colquhoun, S; Colson, KE; Condon, J; Connor, MD; Cooper, LT; Corriere, M; Cortinovis, M; De Vaccaro, KC; Couser, W; Cowie, BC; Criqui, MH; Cross, M; Dabhadkar, KC; Dahiya, M; Dahodwala, N; Damsere-Derry, J; Danaei, G; Davis, A; De Leo, D; Degenhardt, L; Dellavalle, R; Delossantos, A; Denenberg, J; Derrett, S; Des Jarlais, DC; Dharmaratne, SD; Dherani, M; Diaz-Torne, C; Dolk, H; Dorsey, ER; Driscoll, T; Duber, H; Ebel, B; Edmond, K; Elbaz, A; Ali, SE; Erskine, H; Erwin, PJ; Espindola, P; Ewoigbokhan, SE; Farzadfar, F; Feigin, V; Felson, DT; Ferrari, A; Ferri, CP; Fevre, EM; Finucane, MM; Flaxman, S; Flood, L; Foreman, K; Forouzanfar, MH; Fowkes, FGR; Fransen, M; Freeman, MK; Gabbe, BJ; Gabriel, SE; Gakidou, E; Ganatra, HA; Garcia, B; Gaspari, F; Gillum, RF; Gmel, G; Gonzalez-Medina, D; Gosselin, R; Grainger, R; Grant, B; Groeger, J; Guillemin, F; Gunnell, D; Gupta, R; Haagsma, J; Hagan, H; Halasa, YA; Hall, W; Haring, D; Haro, JM; Harrison, JE; Havmoeller, R; Hay, RJ; Higashi, H; Hill, C; Hoen, B; Hoffman, H; Hotez, PJ; Hoy, D; Huang, JJ; Ibeanusi, SE; Jacobsen, KH; James, SL; Jarvis, D; Jasrasaria, R; Jayaraman, S; Johns, N; Jonas, JB; Karthikeyan, G; Kassebaum, N; Kawakami, N; Keren, A; Khoo, JP; King, CH; Knowlton, LM; Kobusingye, O; Koranteng, A; Krishnamurthi, R; Laden, F; Lalloo, R; Laslett, LL; Lathlean, T; Leasher, JL; Lee, YY; Leigh, J; Levinson, D; Lim, SS; Limb, E; Lin, JK; Lipnick, M; Lipshultz, SE; Liu, W; Loane, M; Ohno, SL; Lyons, R; Mabweijano, J; MacIntyre, MF; Malekzadeh, R; Mallinger, L; Manivannan, S; Marcenes, W; March, L; Margolis, DJ; Marks, GB; Marks, R; Matsumori, A; Matzopoulos, R; Mayosi, BM; McAnulty, JH; McDermott, MM; McGill, N; McGrath, J; Medina-Mora, ME; Meltzer, M; Mensah, GA; Merriman, TR; Meyer, AC; Miglioli, V; Miller, M; Miller, TR; Mitchell, PB; Mock, C; Mocumbi, AO; Moffitt, TE; Mokdad, AA; Monasta, L; Montico, M; Moradi-Lakeh, M; Moran, A; Morawska, L; Mori, R; Murdoch, ME; Mwaniki, MK; Naidoo, K; Nair, MN; Naldi, L; Narayan, KMV; Nelson, PK; Nelson, RG; Nevitt, MC; Newton, CR; Nolte, S; Norman, P; Norman, R; O'Donnell, M; O'Hanlon, S; Olives, C; Omer, SB; Ortblad, K; Osborne, R; Ozgediz, D; Page, A; Pahari, B; Pandian, JD; Rivero, AP; Patten, SB; Pearce, N; Padilla, RP; Perez-Ruiz, F; Perico, N; Pesudovs, K; Phillips, D; Phillips, MR; Pierce, K; Pion, S; Polanczyk, GV; Polinder, S; Pope, CA; Popova, S; Porrini, E; Pourmalek, F; Prince, M; Pullan, RL; Ramaiah, KD; Ranganathan, D; Razavi, H; Regan, M; Rehm, JT; Rein, DB; Remuzzi, G; Richardson, K; Rivara, FP; Roberts, T; Robinson, C; De Leon, FR; Ronfani, L; Room, R; Rosenfeld, LC; Rushton, L; Sacco, RL; Saha, S; Sampson, U; Sanchez-Riera, L; Sanman, E; Schwebel, DC; Scott, JG; Segui-Gomez, M; Shahraz, S; Shepard, DS; Shin, H; Shivakoti, R; Singh, D; Singh, GM; Singh, JA; Singleton, J; Sleet, DA; Sliwa, K; Smith, E; Smith, JL; Stapelberg, NJC; Steer, A; Steiner, T; Stolk, WA; Stovner, LJ; Sudfeld, C; Syed, S; Tamburlini, G; Tavakkoli, M; Taylor, HR; Taylor, JA; Taylor, WJ; Thomas, B; Thomson, WM; Thurston, GD; Tleyjeh, IM; Tonelli, M; Towbin, JRA; Truelsen, T; Tsilimbaris, MK; Ubeda, C; Undurraga, EA; van der Werf, MJ; van Os, J; Vavilala, MS; Venketasubramanian, N; Wang, MR; Wang, WZ; Watt, K; Weatherall, DJ; Weinstock, MA; Weintraub, R; Weisskopf, MG; Weissman, MM; White, RA; Whiteford, H; Wiebe, N; Wiersma, ST; Wilkinson, JD; Williams, HC; Williams, SRM; Witt, E; Wolfe, F; Woolf, AD; Wulf, S; Yeh, PH; Zaidi, AKM; Zheng, ZJ; Zonies, D; Lopez, AD				Murray, Christopher J. L.; Vos, Theo; Lozano, Rafael; Naghavi, Mohsen; Flaxman, Abraham D.; Michaud, Catherine; Ezzati, Majid; Shibuya, Kenji; Salomon, Joshua A.; Abdalla, Safa; Aboyans, Victor; Abraham, Jerry; Ackerman, Ilana; Aggarwal, Rakesh; Ahn, Stephanie Y.; Ali, Mohammed K.; Alvarado, Miriam; Anderson, H. Ross; Anderson, Laurie M.; Andrews, Kathryn G.; Atkinson, Charles; Baddour, Larry M.; Bahalim, Adil N.; Barker-Collo, Suzanne; Barrero, Lope H.; Bartels, David H.; Basanez, Maria-Gloria; Baxter, Amanda; Bell, Michelle L.; Benjamin, Emelia J.; Bennett, Derrick; Bernabe, Eduardo; Bhalla, Kavi; Bhandari, Bishal; Bikbov, Boris; Bin Abdulhak, Aref; Birbeck, Gretchen; Black, James A.; Blencowe, Hannah; Blore, Jed D.; Blyth, Fiona; Bolliger, Ian; Bonaventure, Audrey; Boufous, Soufi Ane; Bourne, Rupert; Boussinesq, Michel; Braithwaite, Tasanee; Brayne, Carol; Bridgett, Lisa; Brooker, Simon; Brooks, Peter; Brugha, Traolach S.; Bryan-Hancock, Claire; Bucello, Chiara; Buchbinder, Rachelle; Buckle, Geoffrey; Budke, Christine M.; Burch, Michael; Burney, Peter; Burstein, Roy; Calabria, Bianca; Campbell, Benjamin; Canter, Charles E.; Carabin, Helene; Carapetis, Jonathan; Carmona, Loreto; Cella, Claudia; Charlson, Fiona; Chen, Honglei; Cheng, Andrew Tai-Ann; Chou, David; Chugh, Sumeet S.; Coffeng, Luc E.; Colan, Steven D.; Colquhoun, Samantha; Colson, K. Ellicott; Condon, John; Connor, Myles D.; Cooper, Leslie T.; Corriere, Matthew; Cortinovis, Monica; De Vaccaro, Karen Courville; Couser, William; Cowie, Benjamin C.; Criqui, Michael H.; Cross, Marita; Dabhadkar, Kaustubh C.; Dahiya, Manu; Dahodwala, Nabila; Damsere-Derry, James; Danaei, Goodarz; Davis, Adrian; De Leo, Diego; Degenhardt, Louisa; Dellavalle, Robert; Delossantos, Allyne; Denenberg, Julie; Derrett, Sarah; Des Jarlais, Don C.; Dharmaratne, Samath D.; Dherani, Mukesh; Diaz-Torne, Cesar; Dolk, Helen; Dorsey, E. Ray; Driscoll, Tim; Duber, Herbert; Ebel, Beth; Edmond, Karen; Elbaz, Alexis; Ali, Suad Eltahir; Erskine, Holly; Erwin, Patricia J.; Espindola, Patricia; Ewoigbokhan, Stalin E.; Farzadfar, Farshad; Feigin, Valery; Felson, David T.; Ferrari, Alize; Ferri, Cleusa P.; Fevre, Eric M.; Finucane, Mariel M.; Flaxman, Seth; Flood, Louise; Foreman, Kyle; Forouzanfar, Mohammad H.; Fowkes, Francis Gerry R.; Fransen, Marlene; Freeman, Michael K.; Gabbe, Belinda J.; Gabriel, Sherine E.; Gakidou, Emmanuela; Ganatra, Hammad A.; Garcia, Bianca; Gaspari, Flavio; Gillum, Richard F.; Gmel, Gerhard; Gonzalez-Medina, Diego; Gosselin, Richard; Grainger, Rebecca; Grant, Bridget; Groeger, Justina; Guillemin, Francis; Gunnell, David; Gupta, Ramyani; Haagsma, Juanita; Hagan, Holly; Halasa, Yara A.; Hall, Wayne; Haring, Diana; Maria Haro, Josep; Harrison, James E.; Havmoeller, Rasmus; Hay, Roderick J.; Higashi, Hideki; Hill, Catherine; Hoen, Bruno; Hoffman, Howard; Hotez, Peter J.; Hoy, Damian; Huang, John J.; Ibeanusi, Sydney E.; Jacobsen, Kathryn H.; James, Spencer L.; Jarvis, Deborah; Jasrasaria, Rashmi; Jayaraman, Sudha; Johns, Nicole; Jonas, Jost B.; Karthikeyan, Ganesan; Kassebaum, Nicholas; Kawakami, Norito; Keren, Andre; Khoo, Jon-Paul; King, Charles H.; Knowlton, Lisa Marie; Kobusingye, Olive; Koranteng, Adofo; Krishnamurthi, Rita; Laden, Francine; Lalloo, Ratilal; Laslett, Laura L.; Lathlean, Tim; Leasher, Janet L.; Lee, Yong Yi; Leigh, James; Levinson, Daphna; Lim, Stephen S.; Limb, Elizabeth; Lin, John Kent; Lipnick, Michael; Lipshultz, Steven E.; Liu, Wei; Loane, Maria; Ohno, Summer Lockett; Lyons, Ronan; Mabweijano, Jacqueline; MacIntyre, Michael F.; Malekzadeh, Reza; Mallinger, Leslie; Manivannan, Sivabalan; Marcenes, Wagner; March, Lyn; Margolis, David J.; Marks, Guy B.; Marks, Robin; Matsumori, Akira; Matzopoulos, Richard; Mayosi, Bongani M.; McAnulty, John H.; McDermott, Mary M.; McGill, Neil; McGrath, John; Elena Medina-Mora, Maria; Meltzer, Michele; Mensah, George A.; Merriman, Tony R.; Meyer, Ana-Claire; Miglioli, Valeria; Miller, Matthew; Miller, Ted R.; Mitchell, Philip B.; Mock, Charles; Mocumbi, Ana Olga; Moffitt, Terrie E.; Mokdad, Ali A.; Monasta, Lorenzo; Montico, Marcella; Moradi-Lakeh, Maziar; Moran, Andrew; Morawska, Lidia; Mori, Rintaro; Murdoch, Michele E.; Mwaniki, Michael K.; Naidoo, Kovin; Nair, M. Nathan; Naldi, Luigi; Narayan, K. M. Venkat; Nelson, Paul K.; Nelson, Robert G.; Nevitt, Michael C.; Newton, Charles R.; Nolte, Sandra; Norman, Paul; Norman, Rosana; O'Donnell, Martin; O'Hanlon, Simon; Olives, Casey; Omer, Saad B.; Ortblad, Katrina; Osborne, Richard; Ozgediz, Doruk; Page, Andrew; Pahari, Bishnu; Pandian, Jeyaraj Durai; Panozo Rivero, Andrea; Patten, Scott B.; Pearce, Neil; Perez Padilla, Rogelio; Perez-Ruiz, Fernando; Perico, Norberto; Pesudovs, Konrad; Phillips, David; Phillips, Michael R.; Pierce, Kelsey; Pion, Sebastien; Polanczyk, Guilherme V.; Polinder, Suzanne; Pope, C. Arden, III; Popova, Svetlana; Porrini, Esteban; Pourmalek, Farshad; Prince, Martin; Pullan, Rachel L.; Ramaiah, Kapa D.; Ranganathan, Dharani; Razavi, Homie; Regan, Mathilda; Rehm, Juergen T.; Rein, David B.; Remuzzi, Guiseppe; Richardson, Kathryn; Rivara, Frederick P.; Roberts, Thomas; Robinson, Carolyn; Rodriguez De Leon, Felipe; Ronfani, Luca; Room, Robin; Rosenfeld, Lisa C.; Rushton, Lesley; Sacco, Ralph L.; Saha, Sukanta; Sampson, Uchechukwu; Sanchez-Riera, Lidia; Sanman, Ella; Schwebel, David C.; Scott, James Graham; Segui-Gomez, Maria; Shahraz, Saeid; Shepard, Donald S.; Shin, Hwashin; Shivakoti, Rupak; Singh, David; Singh, Gitanjali M.; Singh, Jasvinder A.; Singleton, Jessica; Sleet, David A.; Sliwa, Karen; Smith, Emma; Smith, Jennifer L.; Stapelberg, Nicolas J. C.; Steer, Andrew; Steiner, Timothy; Stolk, Wilma A.; Stovner, Lars Jacob; Sudfeld, Christopher; Syed, Sana; Tamburlini, Giorgio; Tavakkoli, Mohammad; Taylor, Hugh R.; Taylor, Jennifer A.; Taylor, William J.; Thomas, Bernadette; Thomson, W. Murray; Thurston, George D.; Tleyjeh, Imad M.; Tonelli, Marcello; Towbin, Jeff Rey A.; Truelsen, Thomas; Tsilimbaris, Miltiadis K.; Ubeda, Clotilde; Undurraga, Eduardo A.; van der Werf, Marieke J.; van Os, Jim; Vavilala, Monica S.; Venketasubramanian, N.; Wang, Mengru; Wang, Wenzhi; Watt, Kerrianne; Weatherall, David J.; Weinstock, Martin A.; Weintraub, Robert; Weisskopf, Marc G.; Weissman, Myrna M.; White, Richard A.; Whiteford, Harvey; Wiebe, Natasha; Wiersma, Steven T.; Wilkinson, James D.; Williams, Hywel C.; Williams, Sean R. M.; Witt, Emma; Wolfe, Frederick; Woolf, Anthony D.; Wulf, Sarah; Yeh, Pon-Hsiu; Zaidi, Anita K. M.; Zheng, Zhi-Jie; Zonies, David; Lopez, Alan D.			Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010	LANCET			English	Article							PUBLIC-HEALTH UTILITY; ECONOMIC COST; RISK-FACTORS; MORTALITY; POPULATION; COUNTRIES; EXPECTANCY; AUSTRALIA; COPD; LOST	Background Measuring disease and injury burden in populations requires a composite metric that captures both premature mortality and the prevalence and severity of ill-health. The 1990 Global Burden of Disease study proposed disability-adjusted life years (DALYs) to measure disease burden. No comprehensive update of disease burden worldwide incorporating a systematic reassessment of disease and injury-specific epidemiology has been done since the 1990 study. We aimed to calculate disease burden worldwide and for 21 regions for 1990, 2005, and 2010 with methods to enable meaningful comparisons over time. Methods We calculated DALYs as the sum of years of life lost (YLLs) and years lived with disability (YLDs). DALYs were calculated for 291 causes, 20 age groups, both sexes, and for 187 countries, and aggregated to regional and global estimates of disease burden for three points in time with strictly comparable definitions and methods. YLLs were calculated from age-sex-country-time-specific estimates of mortality by cause, with death by standardised lost life expectancy at each age. YLDs were calculated as prevalence of 1160 disabling sequelae, by age, sex, and cause, and weighted by new disability weights for each health state. Neither YLLs nor YLDs were age-weighted or discounted. Uncertainty around cause-specific DALYs was calculated incorporating uncertainty in levels of all-cause mortality, cause-specific mortality, prevalence, and disability weights. Findings Global DALYs remained stable from 1990 (2.503 billion) to 2010 (2.490 billion). Crude DALYs per 1000 decreased by 23% (472 per 1000 to 361 per 1000). An important shift has occurred in DALY composition with the contribution of deaths and disability among children (younger than 5 years of age) declining from 41% of global DALYs in 1990 to 25% in 2010. YLLs typically account for about half of disease burden in more developed regions (high-income Asia Pacific, western Europe, high-income North America, and Australasia), rising to over 80% of DALYs in sub-Saharan Africa. In 1990, 47% of DALYs worldwide were from communicable, maternal, neonatal, and nutritional disorders, 43% from non-communicable diseases, and 10% from injuries. By 2010, this had shifted to 35%, 54%, and 11%, respectively. Ischaemic heart disease was the leading cause of DALYs worldwide in 2010 (up from fourth rank in 1990, increasing by 29%), followed by lower respiratory infections (top rank in 1990; 44% decline in DALYs), stroke (fifth in 1990; 19% increase), diarrhoeal diseases (second in 1990; 51% decrease), and HIV/AIDS (33rd in 1990; 351% increase). Major depressive disorder increased from 15th to 11th rank (37% increase) and road injury from 12th to 10th rank (34% increase). Substantial heterogeneity exists in rankings of leading causes of disease burden among regions. Interpretation Global disease burden has continued to shift away from communicable to non-communicable diseases and from premature death to years lived with disability. In sub-Saharan Africa, however, many communicable, maternal, neonatal, and nutritional disorders remain the dominant causes of disease burden. The rising burden from mental and behavioural disorders, musculoskeletal disorders, and diabetes will impose new challenges on health systems. Regional heterogeneity highlights the importance of understanding local burden of disease and setting goals and targets for the post-2015 agenda taking such patterns into account. Because of improved definitions, methods, and data, these results for 1990 and 2010 supersede all previously published Global Burden of Disease results.	[Baxter, Amanda; Erskine, Holly; Ferrari, Alize; Khoo, Jon-Paul; Saha, Sukanta; Whiteford, Harvey] Univ Queensland, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Vos, Theo; Blore, Jed D.; Charlson, Fiona; Higashi, Hideki; Lee, Yong Yi; Norman, Rosana; Page, Andrew; Lopez, Alan D.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Scott, James Graham] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [McGrath, John] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Murray, Christopher J. L.; Lozano, Rafael; Naghavi, Mohsen; Flaxman, Abraham D.; Ahn, Stephanie Y.; Alvarado, Miriam; Andrews, Kathryn G.; Atkinson, Charles; Bolliger, Ian; Burstein, Roy; Campbell, Benjamin; Chou, David; Colson, K. Ellicott; Delossantos, Allyne; Dharmaratne, Samath D.; Forouzanfar, Mohammad H.; Freeman, Michael K.; Gakidou, Emmanuela; Gonzalez-Medina, Diego; Haring, Diana; James, Spencer L.; Jasrasaria, Rashmi; Johns, Nicole; Lim, Stephen S.; Ohno, Summer Lockett; MacIntyre, Michael F.; Mallinger, Leslie; Mokdad, Ali A.; Nair, M. Nathan; Ortblad, Katrina; Phillips, David; Pierce, Kelsey; Ranganathan, Dharani; Roberts, Thomas; Rosenfeld, Lisa C.; Sanman, Ella; Wang, Mengru; Wulf, Sarah] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Anderson, Laurie M.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98121 USA; [Kassebaum, Nicholas] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98121 USA; [Michaud, Catherine] China Med Board, Boston, MA USA; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England; [Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [Finucane, Mariel M.] Harvard Univ, Dept Biostat, Boston, MA 02115 USA; [Salomon, Joshua A.; Danaei, Goodarz; Laden, Francine; Lin, John Kent; Miller, Matthew; Singh, Gitanjali M.; Sudfeld, Christopher; Tavakkoli, Mohammad; Weisskopf, Marc G.; White, Richard A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Liu, Wei] Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA; [Knowlton, Lisa Marie] Harvard Univ, Harvard Humanitarian Initiat, Boston, MA 02115 USA; [Colan, Steven D.] Harvard Univ, Boston Childrens Hosp, Boston, MA 02115 USA; [Jayaraman, Sudha] Harvard Univ, Brigham & Womens Hosp, Boston, MA 02115 USA; [Bartels, David H.; Bhalla, Kavi] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Aboyans, Victor] Dupuytren Univ Hosp, Dept Cardiol, Limoges, France; [Abraham, Jerry] Univ Texas San Antonio, San Antonio, TX USA; [Steer, Andrew] Univ Melbourne, Ctr Int Child Hlth, Melbourne, Vic, Australia; [Weintraub, Robert] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Degenhardt, Louisa] Univ Melbourne, Ctr Hlth Policy Programs & Econ, Melbourne, Vic, Australia; [Room, Robin] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic, Australia; [Aggarwal, Rakesh] Sanjay Gandhi Postgrad Inst Med Sci, Lucknow, Uttar Pradesh, India; [Omer, Saad B.] Emory Univ, Sch Publ Hlth, Atlanta, GA USA; [Omer, Saad B.] Emory Univ, Sch Med, Atlanta, GA USA; [Anderson, H. Ross; Gupta, Ramyani; Limb, Elizabeth] St Georges Univ London, London, England; [Baddour, Larry M.; Erwin, Patricia J.; Gabriel, Sherine E.] Mayo Clin, Rochester, MN USA; [Barker-Collo, Suzanne] Univ Auckland, Auckland 1, New Zealand; [Barrero, Lope H.] Pontificia Univ Javeriana, Sch Engn, Dept Ind Engn, Bogota, Colombia; [Bell, Michelle L.; Huang, John J.; Ozgediz, Doruk] Yale Univ, New Haven, CT USA; [Felson, David T.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Bennett, Derrick] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Bennett, Derrick] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Bernabe, Eduardo] Kings Coll London, Inst Dent, London WC2R 2LS, England; [Hay, Roderick J.] Kings Coll London, Hosp NHS Trust, London WC2R 2LS, England; [Prince, Martin] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Dahiya, Manu] Queen Mary Univ London, Inst Dent, London, England; [Bikbov, Boris] Moscow State Univ Med & Dent, Res Inst Transplantol & Artificial Organs, Moscow, Russia; [Bin Abdulhak, Aref; Tleyjeh, Imad M.] King Fahad Med City, Riyadh, Saudi Arabia; [Birbeck, Gretchen] Michigan State Univ, E Lansing, MI 48824 USA; [Black, James A.] MRC, Epidemiol Unit, Cambridge, England; [Blencowe, Hannah; Brooker, Simon; Edmond, Karen; Pearce, Neil; Pullan, Rachel L.; Smith, Jennifer L.] London Sch Hyg & Trop Med, London WC1, England; [Smith, Emma] Univ Sydney, No Clin Sch, Dept Rheumatol, Sydney, NSW 2006, Australia; [Fransen, Marlene] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [March, Lyn; Sanchez-Riera, Lidia] Univ Sydney, Inst Bone & Joint Res, Sydney, NSW 2006, Australia; [Driscoll, Tim; Leigh, James] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Bonaventure, Audrey; Elbaz, Alexis] INSERM, Paris, France; [Calabria, Bianca; Degenhardt, Louisa; Nelson, Paul K.; Singleton, Jessica] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Bucello, Chiara; Mitchell, Philip B.] Univ New S Wales, Sydney, NSW, Australia; [Bourne, Rupert] Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, England; [Braithwaite, Tasanee] Moorfields Eye Hosp, London, England; [Brayne, Carol; Richardson, Kathryn] Univ Cambridge, Cambridge, England; [Brugha, Traolach S.] Univ Leicester, Leicester, Leics, England; [Bryan-Hancock, Claire; Flood, Louise; Harrison, James E.; Lathlean, Tim; Pesudovs, Konrad] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [Buchbinder, Rachelle] Cabrini Inst, Malvern, Vic, Australia; [Gabbe, Belinda J.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Buckle, Geoffrey; Manivannan, Sivabalan] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Budke, Christine M.] Texas A&M Univ, College Stn, TX USA; [Burch, Michael] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Canter, Charles E.] Washington Univ, St Louis, MO USA; [Carabin, Helene] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Carapetis, Jonathan] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Carmona, Loreto] Univ Camilo Jose Cela, Villanueva De La Canada, Spain; [Cella, Claudia; Cortinovis, Monica; Gaspari, Flavio; Miglioli, Valeria; Perico, Norberto; Remuzzi, Guiseppe] Mario Negri Inst Pharmacol Res, I-24100 Bergamo, Italy; [Chen, Honglei] NIEHS, Res Triangle Pk, NC 27709 USA; [Cheng, Andrew Tai-Ann] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Havmoeller, Rasmus] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Polinder, Suzanne] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Colquhoun, Samantha; Condon, John] Menzies Sch Hlth Res, Darwin, NT, Australia; [Connor, Myles D.] Natl Hlth Serv, Edinburgh, Midlothian, Scotland; [Connor, Myles D.; Fevre, Eric M.; Fowkes, Francis Gerry R.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Connor, Myles D.] Univ Witwatersrand, Johannesburg, South Africa; [Cooper, Leslie T.] Loyola Univ, Sch Med, Chicago, IL 60611 USA; [Corriere, Matthew] Wake Forest Univ, Sch Publ Hlth Sci, Winston Salem, NC 27109 USA; [De Vaccaro, Karen Courville] Hosp Dr Gustavo N Collado, Puerto Chitre, Panama; [Cowie, Benjamin C.] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Criqui, Michael H.; Denenberg, Julie] Univ Calif San Diego, San Diego, CA 92103 USA; [Dahodwala, Nabila; Margolis, David J.] Univ Penn, Philadelphia, PA 19104 USA; [Damsere-Derry, James] Bldg & Rd Res Inst, Kumasi, Ghana; [Davis, Adrian] MRC Hearing & Commun Grp, Manchester, Lancs, England; [Lalloo, Ratilal] Griffith Univ, Sch Dent & Oral Hlth, Brisbane, Qld 4111, Australia; [Lalloo, Ratilal] Griffith Univ, Populat & Social Hlth Res Program, Brisbane, Qld 4111, Australia; [Dellavalle, Robert] Denver VA Med Ctr, Denver, VA USA; [Derrett, Sarah; Grainger, Rebecca; Merriman, Tony R.; Taylor, William J.; Thomson, W. Murray] Univ Otago, Dunedin, New Zealand; [Des Jarlais, Don C.] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; [Dharmaratne, Samath D.] Univ Peradeniya, Peradeniya, Sri Lanka; [Dherani, Mukesh] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Diaz-Torne, Cesar] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Dolk, Helen; Loane, Maria] Univ Ulster, Ulster, Ireland; [Ali, Suad Eltahir] Fed Minist Hlth, Khartoum, Sudan; [Espindola, Patricia] Hosp Maciel, Montevideo, Uruguay; [Ewoigbokhan, Stalin E.] Emerald Publ Hlth Consulting Serv Ltd, Abuja, Nigeria; [Malekzadeh, Reza] Univ Tehran Med Sci, Digest Dis Res Ctr, Tehran, Iran; [Feigin, Valery] Auckland Tech Univ, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Polanczyk, Guilherme V.] Univ Fed Sao Paulo, Sch Med, Sao Paulo, Brazil; [Flaxman, Seth] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Watt, Kerrianne] James Cook Univ, Townsville, Qld 4811, Australia; [Gillum, Richard F.] Howard Univ, Coll Med, Washington, DC USA; [Gmel, Gerhard] Addict Info Switzerland, Lausanne, Switzerland; [Nevitt, Michael C.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Groeger, Justina] Suny Downstate Med Ctr, Coll Med, Brooklyn, NY 11203 USA; [Sleet, David A.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Guillemin, Francis] Univ Lorraine, Nancy, France; [Gunnell, David] Univ Bristol, Bristol, Avon, England; [Hagan, Holly; Thurston, George D.] NYU, New York, NY USA; [Halasa, Yara A.; Shahraz, Saeid; Shepard, Donald S.; Undurraga, Eduardo A.] Brandeis Univ, Waltham, MA USA; [Maria Haro, Josep] Univ Barcelona, CIBERSAM, St Boi De Llobregat, Spain; [Havmoeller, Rasmus] Karolinska Univ Hosp, Stockholm, Sweden; [Hill, Catherine] Queen Elizabeth Hosp, Adelaide, SA, Australia; [Hoen, Bruno] Univ Franche Comte, F-25030 Besancon, France; [Hoen, Bruno] Ctr Hosp Reg Univ Besancon, Besancon, France; [Hoffman, Howard] NIDCD, NIH, Bethesda, MD USA; [Nelson, Robert G.] NIDDK, NIH, Bethesda, MD USA; [Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, Waco, TX USA; [Ibeanusi, Sydney E.] Univ Port Harcourt, Port Harcourt, Nigeria; [Jacobsen, Kathryn H.] George Mason Univ, Fairfax, VA 22030 USA; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany; [Karthikeyan, Ganesan] All India Inst Med Sci, New Delhi, India; [Keren, Andre] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Cardiol, IL-91010 Jerusalem, Israel; [King, Charles H.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Kobusingye, Olive] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Kobusingye, Olive] Univ S Africa, Johannesburg, South Africa; [Koranteng, Adofo] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Laslett, Laura L.] Univ Tasmania, Hobart, Tas 7001, Australia; [Leasher, Janet L.] Nova SE Univ, Ft Lauderdale, FL 33314 USA; [Levinson, Daphna] Minist Hlth, Jerusalem, Israel; [Lipshultz, Steven E.; Sacco, Ralph L.; Wilkinson, James D.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Lyons, Ronan] Swansea Univ, Swansea, W Glam, Wales; [Mabweijano, Jacqueline] Mulago Hosp, Kampala, Uganda; [Matsumori, Akira] Asian Pacific Soc Cardiol, Kyoto, Japan; [Matzopoulos, Richard] MRC, Tygerberg, South Africa; [Sliwa, Karen] Univ Cape Town, Hatter Inst, ZA-7925 Cape Town, South Africa; [Mensah, George A.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [McAnulty, John H.] Legacy Hlth Syst, Portland, OR USA; [McDermott, Mary M.] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA; [Elena Medina-Mora, Maria] Natl Inst Psychiat Ramon de la Fuente, Mexico City, DF, Mexico; [Meltzer, Michele] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Mocumbi, Ana Olga] Natl Inst Hlth, Maputo, Mozambique; [Mocumbi, Ana Olga] Univ Eduardo Mondlane, Maputo, Mozambique; [Moffitt, Terrie E.] Duke Univ, Durham, NC USA; [Monasta, Lorenzo; Montico, Marcella; Ronfani, Luca; Tamburlini, Giorgio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Weissman, Myrna M.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Morawska, Lidia] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Tokyo, Japan; [Murdoch, Michele E.] Watford Dist Gen Hosp, Watford, England; [Mwaniki, Michael K.] Kemri Wellcome Trust, Kilifi, Kenya; [Naidoo, Kovin] Univ KwaZulu Natal, AVRI, Durban, South Africa; [Naldi, Luigi] Ctr Studi GISED, Bergamo, Italy; [Nolte, Sandra] Charite, D-13353 Berlin, Germany; [O'Donnell, Martin] Natl Univ Ireland Galway, HRB Clin Res Facil, Galway, Ireland; [Osborne, Richard] Deakin Univ, Melbourne, Vic, Australia; [Pahari, Bishnu] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Pandian, Jeyaraj Durai] Betty Cowan Res & Innovat Ctr, Ludhiana, Punjab, India; [Panozo Rivero, Andrea] Hosp Joan 23, La Paz, Bolivia; [Patten, Scott B.] Univ Calgary, Calgary, AB, Canada; [Perez Padilla, Rogelio] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Perez-Ruiz, Fernando] Hosp Univ Cruces, Baracaldo, Spain; [Phillips, Michael R.] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Sch Med, Shanghai 200030, Peoples R China; [Zheng, Zhi-Jie] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China; [Pope, C. Arden, III] Brigham Young Univ, Provo, UT 84602 USA; [Popova, Svetlana; Rehm, Juergen T.] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Porrini, Esteban] Hosp Univ Canarias, Tenerif, Spain; [Pourmalek, Farshad] Univ British Columbia, Fac Med, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Ramaiah, Kapa D.] Vector Control Res Ctr, Pondicherry, India; [Razavi, Homie] Ctr Dis Anal, Louisville, CO USA; [Regan, Mathilda] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Rein, David B.] Univ Chicago, NORC, Chicago, IL 60637 USA; [Rodriguez De Leon, Felipe] Complejo Hosp Caja Seguro Social, Panama City, Panama; [Room, Robin] Turning Point Alcohol & Drug Ctr, Ctr Alcohol Policy Res, Fitzroy, SA, Australia; [Sampson, Uchechukwu] Vanderbilt Univ, Nashville, TN USA; [Schwebel, David C.; Singh, Jasvinder A.] Univ Alabama Birmingham, Birmingham, AL USA; [Segui-Gomez, Maria] Minist Interior, Madrid, Spain; [Shin, Hwashin] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Singh, David] Queens Med Ctr, Honolulu, HI USA; [Stovner, Lars Jacob] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Syed, Sana; Zaidi, Anita K. M.] Aga Khan Univ, Karachi, Pakistan; [Taylor, Jennifer A.] Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA; [Tonelli, Marcello] Univ Alberta, Alberta Kidney Dis Network, Edmonton, AB, Canada; [Towbin, Jeff Rey A.] Cincinnati Childrens Hosp, Cincinnati, OH USA; [Truelsen, Thomas] Copenhagen Univ Hosp, Dept Neurol, Herlev, Denmark; [Tsilimbaris, Miltiadis K.] Univ Crete, Sch Med, Iraklion, Greece; [Ubeda, Clotilde] ANLIS, Inst Nacl Epidemiol, Malbran, Argentina; [van der Werf, Marieke J.] KNCV TB Fdn, The Hague, Netherlands; [van Os, Jim] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Venketasubramanian, N.] Natl Univ Singapore, Singapore 117548, Singapore; [Wang, Wenzhi] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [Weinstock, Martin A.] Brown Univ, Providence, RI 02912 USA; [Weintraub, Robert] Royal Childrens Hosp, Melbourne, Vic, Australia; [Weintraub, Robert] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Williams, Hywel C.] Univ Nottingham, Nottingham NG7 2RD, England; [Williams, Sean R. M.] Hollywood Orthopaed Grp, Perth, WA, Australia; [Wolfe, Frederick] Arthrit Res, Wichita, KS USA; [Woolf, Anthony D.] Royal Cornwall Hosp, Truro, England; [Yeh, Pon-Hsiu] London Sch Econ, London WC2A 2AE, England; [Zonies, David] Landstuhl Reg Med Ctr, Landstuhl, Germany	Queensland Centre for Mental Health Research; University of Queensland; University of Queensland; University of Queensland; University of Queensland; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Imperial College London; University of Tokyo; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; CHU Limoges; University of Texas System; University of Texas at San Antonio (UTSA); University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Emory University; Emory University; St Georges University London; Mayo Clinic; University of Auckland; Pontificia Universidad Javeriana; Yale University; Boston University; University of Oxford; University of Oxford; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; Queen Mary University London; Moscow State University of Medicine & Dentistry; V.I. Shumakov Federal Research Center of Transplantology & Artificial Organs; Michigan State University; University of London; London School of Hygiene & Tropical Medicine; University of Sydney; University of Sydney; University of Sydney; University of Sydney; Institut National de la Sante et de la Recherche Medicale (Inserm); University of New South Wales Sydney; University of New South Wales Sydney; Anglia Ruskin University; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Cambridge; University of Leicester; Flinders University South Australia; Cabrini Health; Monash University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Texas A&M University System; Texas A&M University College Station; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Washington University (WUSTL); University of Oklahoma System; University of Oklahoma Health Sciences Center; Telethon Kids Institute; University of Western Australia; Camilo Jose Cela University; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Academia Sinica - Taiwan; Cedars Sinai Medical Center; Erasmus University Rotterdam; Erasmus MC; Charles Darwin University; Menzies School of Health Research; NHS Blood & Transplant (NHSBT); University of Edinburgh; University of Witwatersrand; Loyola University Chicago; Wake Forest University; Victorian Infectious Diseases Reference Laboratory; University of California System; University of California San Diego; University of Pennsylvania; Griffith University; Griffith University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Otago; Harvard University; Beth Israel Deaconess Medical Center; University of Peradeniya; University of Liverpool; Hospital of Santa Creu i Sant Pau; Ulster University; Tehran University of Medical Sciences; Universidade Federal de Sao Paulo (UNIFESP); Carnegie Mellon University; James Cook University; Howard University; University of California System; University of California San Francisco; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Centers for Disease Control & Prevention - USA; Universite de Lorraine; University of Bristol; New York University; Brandeis University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Karolinska Institutet; Karolinska University Hospital; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Baylor College of Medicine; University of Port Harcourt; George Mason University; Ruprecht Karls University Heidelberg; All India Institute of Medical Sciences (AIIMS) New Delhi; Hebrew University of Jerusalem; Case Western Reserve University; Makerere University; University of South Africa; Kwame Nkrumah University Science & Technology; University of Tasmania; Nova Southeastern University; University of Miami; Swansea University; Mulago National Referral Hospital; University of Cape Town; University of Cape Town; Legacy Health; Northwestern University; Feinberg School of Medicine; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Jefferson University; Pacific Institute for Research & Evaluation (PIRE); Eduardo Mondlane University; Duke University; IRCCS Burlo Garofolo; Columbia University; Queensland University of Technology (QUT); National Center for Child Health & Development - Japan; Watford General Hospital; University of Kwazulu Natal; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway; Deakin University; B.P. Koirala Institute of Health Sciences; University of Calgary; Hospital Universitario Cruces; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Brigham Young University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Universidad de la Laguna; University of British Columbia; Indian Council of Medical Research (ICMR); ICMR - Vector Control Research Center (VCRC); University of California System; University of California Berkeley; University of Chicago; Caja del Seguro Social (CSS); Complejo Hospitalario Doctor Arnulfo Arias Madrid; Turning Point Alcohol & Drug Centre - Australia; Vanderbilt University; University of Alabama System; University of Alabama Birmingham; Health Canada; The Queen's Medical Center; Norwegian University of Science & Technology (NTNU); Aga Khan University; Drexel University; University of Alberta; Cincinnati Children's Hospital Medical Center; University of Copenhagen; University of Crete; KNCV Tuberculosis Foundation; Maastricht University; National University of Singapore; Beijing Neurosurgical Institute; Capital Medical University; Brown University; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Nottingham; National Data Bank for Rheumatic Diseases; Royal Cornwall Hospital; University of London; London School Economics & Political Science; Landstuhl Regional Medical Center	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@uw.edu	Moradi-Lakeh, Maziar/ABC-9793-2021; Pourmalek, Farshad/A-8188-2010; Charlson, Fiona J/F-5290-2011; Perico, Norberto/ABH-3222-2020; , Bennett/O-7998-2019; Jarvis, Deborah/E-6494-2011; Erskine, Holly/K-5244-2012; Ali, Mohammed K/N-9833-2013; Schwebel, David/GXH-9944-2022; Carabin, Helene/B-7600-2016; O'Donnell, Martin/ABE-7459-2020; Buchbinder, Rachelle/G-2952-2011; Coffeng, Luc/AAL-6631-2021; Charlson, Fiona/R-8963-2019; PACELLA, ROSANA E./F-2774-2010; Medina-Mora, María Elena I/T-5937-2018; Naldi, Luigi/K-6343-2016; Whiteford, Harvey A/A-4840-2009; Brayne, Carol/AAA-4285-2020; Patten, Scott/B-4434-2011; Ortblad, Katrina/ABF-9070-2020; Stovner, Lars Jacob/D-5025-2014; Room, Robin/ABF-7460-2021; Carmona, Loreto/A-2748-2014; PEREZ-RUIZ, FERNANDO/E-4844-2012; RUIZ, FERNANDO PEREZ/X-1980-2019; Room, Robin/ABH-8505-2020; Nolte, Sandra/B-7498-2008; Newton, Charles/V-7872-2019; Steer, Andrew C/C-2840-2013; Bolliger, Ian W/C-4207-2016; Zonies, David/B-6497-2011; Dellavalle, Robert/L-2020-2013; Salomon, Joshua/S-1929-2019; Mokdad, Ali H./AAD-1232-2022; Phillips, Michael Robert/AAE-7585-2021; Tonelli, Marcello/B-3028-2009; Boussinesq, Michel/J-7256-2016; McGrath, John Joseph/G-5493-2010; Karthikeyan, Ganesan/D-5767-2012; Cowie, Benjamin/HFZ-9941-2022; Bernabe, Eduardo/R-3441-2017; Sacco, Ralph/Y-9278-2019; Malekzadeh, Reza/U-1382-2017; Degenhardt, Louisa J/D-4515-2012; Pesudovs, Konrad/T-9403-2019; Cheng, Andrew/O-1159-2018; Naidoo, Kovin Shunmugam/AAF-5914-2020; Polanczyk, Guilherme V/C-2345-2012; Saha, Sukanta/K-3774-2012; Bell, Michelle/Y-4608-2018; Bikbov, Boris/I-4594-2013; Jacobsen, Kathryn H./B-5857-2008; Condon, John R/N-2281-2013; Thomson, William Murray/AAC-8575-2019; Lalloo, Ratilal/O-5624-2014; Ganatra, Hammad A/P-8652-2019; Thurston, George/ABB-1359-2021; Aboyans, Victor/AAN-8308-2020; Venketasubramanian, Narayanaswamy/GPP-5948-2022; Moffitt, Terrie E/D-5295-2011; Bennett, Derrick/AAH-1220-2022; Lozano, Rafael/T-5352-2018; Haro, Josep Maria/D-1423-2011; Monasta, Lorenzo/B-1388-2012; Lopez, Alan/AAA-2734-2022; Truelsen, Thomas/AAY-1549-2020; Anderson, Hugh R/A-7417-2016; van Os, Jim/V-8884-2019; Higashi, Hideki/D-3797-2011; SHIN, HS/AAE-5381-2022; Colan, Steven/ABB-4580-2020; Grainger, Rebecca/I-1866-2012; Polanczyk, Guilherme V./AAF-6142-2021; Krishnamurthi, Rita/AAU-7841-2021; Brugha, Traolach/T-9326-2019; Wiebe, Natasha/V-7803-2019; Laslett, Laura/G-3973-2011; Lopez, Alan D/F-1487-2010; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Matzopoulos, Richard/AAL-9965-2021; Osborne, Richard H/A-9447-2010; van Os, Jim/C-2113-2014; Bennett, Derrick/AFL-9254-2022; Braithwaite, Tasanee/AAZ-1118-2020; Harrison, James/B-8958-2009; Naldi, Luigi/AFM-8982-2022; Bin Abdulhak, Aref/AAK-4348-2020; Montico, Marcella/B-5290-2013; Salomon, Joshua A/D-3898-2009; Hill, Catherine L/AAE-7152-2019; Courville, Karen/AAW-1462-2021; Norman, Paul E/C-5485-2013; Singh, Jasvinder/R-6172-2019; Newton, Charles RJC/B-7578-2014; Hall, Wayne D/A-3283-2008; Thomson, William Murray/A-4971-2008; Jayaraman, Sudha/AAH-3059-2019; Lathlean, Tim/K-3653-2013; Bin Abdulhak, Aref/AAM-9492-2020; Narayan, K.M. Venkat/J-9819-2012; Ferri, Cleusa Pinheiro/B-2922-2010; Lee, Yong Yi/C-1373-2015; Díaz-Torné, César/AAG-2419-2020; Ronfani, Luca/B-6668-2013; Feigin, Valery/AAF-2313-2019; Black, James A/A-5917-2010; Baxter, Amanda/E-5449-2011; Sudfeld, Christopher/AAW-3856-2021; Elbaz, Alexis/F-8952-2017; Ferrari, Alize J/G-1746-2011; Prince, Martin J/A-9170-2010; Carapetis, Jonathan R/H-8933-2014; Pope, C. Arden/ABD-5522-2021; Scott, James G/D-5900-2012; Aggarwal, Rakesh/D-1583-2009; Davis, Adrian C/E-6022-2015; Pandian, Jeyaraj Durai/AAV-5591-2020; Gunnell, David/ABE-6653-2020; Marks, Guy B./F-5058-2013; Blore, Jed/K-6331-2012; Undurraga, Eduardo A./I-3739-2014; Benjamin, Emelia/E-7103-2011; Shivakoti, Rupak/HIU-0448-2022; Leasher, Janet/B-8889-2016; Watt, Kerrianne/G-2520-2010; Remuzzi, Giuseppe/V-9766-2017; Morawska, Lidia/B-4140-2011	Moradi-Lakeh, Maziar/0000-0001-7381-5305; Pourmalek, Farshad/0000-0002-2134-0771; Charlson, Fiona J/0000-0003-2876-5040; Perico, Norberto/0000-0002-3147-4327; Erskine, Holly/0000-0003-3119-9211; O'Donnell, Martin/0000-0002-7347-7761; Buchbinder, Rachelle/0000-0002-0597-0933; Coffeng, Luc/0000-0002-4425-2264; Charlson, Fiona/0000-0003-2876-5040; PACELLA, ROSANA E./0000-0002-9742-1957; Medina-Mora, María Elena I/0000-0001-9300-0752; Naldi, Luigi/0000-0002-3160-2835; Whiteford, Harvey A/0000-0003-4667-6623; Brayne, Carol/0000-0001-5307-663X; Patten, Scott/0000-0001-9871-4041; Ortblad, Katrina/0000-0002-5675-8836; Room, Robin/0000-0002-5618-385X; Carmona, Loreto/0000-0002-4401-2551; RUIZ, FERNANDO PEREZ/0000-0002-5268-1894; Nolte, Sandra/0000-0001-6185-9423; Newton, Charles/0000-0002-6999-5507; Bolliger, Ian W/0000-0001-8055-297X; Dellavalle, Robert/0000-0001-8132-088X; Salomon, Joshua/0000-0003-3929-5515; Mokdad, Ali H./0000-0002-4994-3339; Phillips, Michael Robert/0000-0002-5973-2439; Tonelli, Marcello/0000-0002-0846-3187; Boussinesq, Michel/0000-0001-6312-0681; McGrath, John Joseph/0000-0002-4792-6068; Karthikeyan, Ganesan/0000-0002-2073-2917; Cowie, Benjamin/0000-0002-7087-5895; Bernabe, Eduardo/0000-0002-1858-3713; Malekzadeh, Reza/0000-0002-9820-6335; Degenhardt, Louisa J/0000-0002-8513-2218; Pesudovs, Konrad/0000-0002-6322-9369; Cheng, Andrew/0000-0002-2698-0516; Polanczyk, Guilherme V/0000-0003-2311-3289; Bell, Michelle/0000-0002-3965-1359; Bikbov, Boris/0000-0002-1925-7506; Jacobsen, Kathryn H./0000-0002-4198-6246; Condon, John R/0000-0003-4952-0990; Lalloo, Ratilal/0000-0001-5822-1269; Ganatra, Hammad A/0000-0001-9534-2780; Moffitt, Terrie E/0000-0002-8589-6760; Bennett, Derrick/0000-0002-9170-8447; Lozano, Rafael/0000-0002-7356-8823; Haro, Josep Maria/0000-0002-3984-277X; Monasta, Lorenzo/0000-0001-7774-548X; van Os, Jim/0000-0002-7245-1586; Higashi, Hideki/0000-0002-5534-0905; SHIN, HS/0000-0002-7263-6257; Grainger, Rebecca/0000-0001-9201-8678; Polanczyk, Guilherme V./0000-0003-2311-3289; Krishnamurthi, Rita/0000-0003-0869-2083; Brugha, Traolach/0000-0002-9786-9591; Wiebe, Natasha/0000-0002-5613-1582; Laslett, Laura/0000-0002-4336-0095; Lopez, Alan D/0000-0001-5818-6512; Matzopoulos, Richard/0000-0001-9063-6210; Osborne, Richard H/0000-0002-9081-2699; Bennett, Derrick/0000-0002-9170-8447; Braithwaite, Tasanee/0000-0002-3025-4066; Harrison, James/0000-0001-9893-8491; Naldi, Luigi/0000-0002-3160-2835; Montico, Marcella/0000-0003-0377-8232; Salomon, Joshua A/0000-0003-3929-5515; Hill, Catherine L/0000-0001-8289-4922; Courville, Karen/0000-0002-4182-6736; Norman, Paul E/0000-0003-3406-0506; Singh, Jasvinder/0000-0003-3485-0006; Newton, Charles RJC/0000-0002-6999-5507; Hall, Wayne D/0000-0003-1984-0096; Thomson, William Murray/0000-0003-0588-6843; Jayaraman, Sudha/0000-0003-1094-5836; Bin Abdulhak, Aref/0000-0001-9988-8609; Narayan, K.M. Venkat/0000-0001-8621-5405; Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Lee, Yong Yi/0000-0003-2359-6823; Díaz-Torné, César/0000-0001-6275-7699; Ronfani, Luca/0000-0001-5710-3914; Black, James A/0000-0002-2200-3179; Baxter, Amanda/0000-0001-8198-9022; Sudfeld, Christopher/0000-0002-3203-3638; Elbaz, Alexis/0000-0001-9724-5490; Ferrari, Alize J/0000-0002-7863-9117; Prince, Martin J/0000-0003-1379-7146; Carapetis, Jonathan R/0000-0002-1182-9792; Scott, James G/0000-0002-0744-0688; Aggarwal, Rakesh/0000-0001-9689-494X; Davis, Adrian C/0000-0001-7134-7528; Gunnell, David/0000-0002-0829-6470; Marks, Guy B./0000-0002-8976-8053; Bonaventure, Audrey/0000-0001-6665-8145; Lathlean, Timothy/0000-0001-7340-1567; Sleet, David/0000-0002-6165-3289; WILKINSON, JAMES/0000-0003-1945-5622; Wolfe, Frederick/0000-0002-2801-6413; Duber, Herbert/0000-0002-5077-3170; Felson, David/0000-0002-2668-2447; Johns, Nicole/0000-0003-4513-4582; Smith, Emma/0000-0001-6510-2583; Cooper, Leslie/0000-0003-1002-3313; Woolf, Anthony/0000-0001-8482-8056; Blore, Jed/0000-0002-3649-8686; Mensah, George/0000-0002-0387-5326; Calabria, Bianca/0000-0001-6444-4696; Gabbe, Belinda/0000-0001-7096-7688; Barrero, Lope/0000-0003-1503-0264; Dherani, Mukesh/0000-0002-3055-9636; Undurraga, Eduardo A./0000-0002-4425-1253; Mayosi, Bongani/0000-0001-6641-8950; Benjamin, Emelia/0000-0003-4076-2336; Budke, Christine/0000-0002-4750-0905; Taylor, Hugh/0000-0002-9437-784X; O'donnell, Colm/0000-0002-8004-450X; Mitchell, Philip/0000-0002-7954-5235; Rein, David/0000-0002-1271-5789; Phillips, David/0000-0003-2569-1015; Malekzadeh, Reza/0000-0003-1043-3814; Shivakoti, Rupak/0000-0002-2773-9310; Pullan, Rachel/0000-0001-9844-1362; Knowlton, Lisa Marie/0000-0001-6046-5035; Farzadfar, Farshad/0000-0001-8288-4046; Boufous, Soufiane/0000-0002-5686-1729; Ali, Mohammed/0000-0001-7266-2503; Kobusingye, Olive/0000-0003-2413-599X; Blencowe, Hannah/0000-0003-1556-3159; Gmel, Gerhard/0000-0001-9403-9405; King, Charles/0000-0001-8349-9270; Buckle, Geoffrey/0000-0001-7721-0397; Miller, Ted/0000-0002-0958-2639; O'Hanlon, Simon/0000-0002-6852-3911; Pandian, Jeyaraj/0000-0003-0028-1968; Mock, Charles/0000-0002-0564-568X; Feigin, Valery L./0000-0002-6372-1740; Chen, Honglei/0000-0003-3446-7779; Leasher, Janet/0000-0002-8779-5162; Weissman, Myrna/0000-0003-3490-3075; Colquhoun, Samantha/0000-0002-6750-1147; Alvarado, Miriam/0000-0003-2864-9410; Pion, Sebastien/0000-0002-9468-7020; williams, hywel/0000-0002-5646-3093; Sanchez Riera, Lidia/0000-0003-0774-2480; Watt, Kerrianne/0000-0002-2275-081X; Merriman, Tony/0000-0003-0844-8726; White, Richard Aubrey/0000-0002-6747-1726; Burney, Peter/0000-0001-8635-5678; Derrett, Sarah/0000-0003-2867-0498; Mori, Rintaro/0000-0001-7656-6156; Remuzzi, Giuseppe/0000-0002-6194-3446; Mocumbi, Ana/0000-0002-9564-2860; Syed, Sana/0000-0003-0954-0583; Hotez, Peter/0000-0001-8770-1042; Jarvis, Deborah/0000-0002-1753-3896; Fevre, Eric/0000-0001-8931-4986; Morawska, Lidia/0000-0002-0594-9683; Tsilimbaris, Miltiadis/0000-0002-0130-1150; Lin, John/0000-0003-2490-4453; Basanez, Maria-Gloria/0000-0001-5031-3361; Cella, Claudia/0000-0002-9210-0775; Stolk, Wilma/0000-0001-9509-1328; Tleyjeh, Imad/0000-0002-5551-0353; Groeger, Justina/0000-0003-0324-3385; Shibuya, Kenji/0000-0003-2528-7530; Loane, Maria/0000-0002-1206-3637; Pearce, Neil/0000-0002-9938-7852; Taylor, William/0000-0001-6075-8479; Ackerman, Ilana/0000-0002-6028-1612; Ebel, Beth/0000-0001-9310-8325; Aboyans, Victor/0000-0002-0322-9818; Razavi, Homie/0000-0002-2658-6930; Porrini, Esteban/0000-0002-3056-4662	Berlin Heart Honoraria; Lundbeck; Medtronic; Prana Biotechnology; Safework Australia; Assurance-Maladie (CNAMTS) InVS; Inserm; CHU de Nancy; CHU de Nice; Conseil Regional de Lorraine; Societe Francaise de Negma-Lerads; Pfizer; Pierre Fabre Medicaments; Sanofi-Afentis France; Spanish Health Ministry; Hospital de Cruces Rheumatology Association; Novartis; National Council for Scientific and Technological Development (CNPq, Brazil); Takeda; Savient; Ardea; Regeneron; Allergan; URL pharmaceuticals; 36 companies; National Institutes of Arthritis, Musculoskeletal and Skin Diseases (NIAMS); National Institutes of Aging (NIA); National Cancer Institute (NCI); Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs); Wellcome Trust [098045, 085308]; Department of Health London for the National Health Service Information Centre; University of Leicester; Australian National Health and Medical Research Council (NHMRC); Monash University; Cabrini Health; BUPA Foundation; NIH; National Institute of Environmental Health Sciences; Africa Programme for Onchocerciasis Control (WHO/APOC); Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia; NIH [K23 AG034236]; Parkinson Council; Australian NHMRC; US Department of Veterans Affairs; Health Research Council of New Zealand; University of Otago; National Institute for Stroke and Applied Neurosciences; AUT University; NHMRC; Swedish Research Council [2011-1071]; Bill and Melinda Gates Foundation; Australian National Health and Medical Research Council; World Health Organization; World Mental Health Japan (WMH-J); Japan Ministry of Health, Labour, and Welfare [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013]; Australian Government; National Health and Medical Research Council of Australia; Arthritis Foundation of Australia; Tasmanian Community Fund; Masonic Centenary Medical Research Foundation; Royal Hobart Hospital Research Foundation; University of Tasmania; Tehran University of Medical Sciences; South African Medical Research Council Burden of Disease Research Unit; University of Cape Town School of Public Health and Family Medicine; Brien Holden Vision Institute; National Drug and Alcohol Research Centre (UNSW, Australia); Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; Biostatistics, Epidemiologic and Bioinformatic Training in Environmental Health Training Grant [ES015459]; Foundation for Alcohol Research and Education; Victorian Department of Health; Burke Global Health Fellowship; Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; Spanish Society of Rheumatology (Sociedad Espanola de Reumatologia); European Center for Injury Prevention, Universidad de Navarra; Department of Health and Ageing; Commonwealth Government of Australia; Institute of Bone and Joint Research (IBJR); University of Sydney (USYD); National Institute of Environmental Health Sciences [ES00260]; Wellcome Trust UK; Medical Research Council UK; Anthony Cerami and Ann Dunne Research Trust; MRC [G0901214] Funding Source: UKRI; Medical Research Council [G0901214, G0801056B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK069062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES015459, ZIAES101986, P30ES000260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG034236] Funding Source: NIH RePORTER	Berlin Heart Honoraria; Lundbeck(Lundbeck Corporation); Medtronic(Medtronic); Prana Biotechnology; Safework Australia; Assurance-Maladie (CNAMTS) InVS; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CHU de Nancy; CHU de Nice; Conseil Regional de Lorraine(Region Grand-Est); Societe Francaise de Negma-Lerads; Pfizer(Pfizer); Pierre Fabre Medicaments; Sanofi-Afentis France; Spanish Health Ministry(Instituto de Salud Carlos IIISpanish Government); Hospital de Cruces Rheumatology Association; Novartis(Novartis); National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Takeda(Takeda Pharmaceutical Company Ltd); Savient; Ardea; Regeneron(Regeneron); Allergan(AbbVieAllergan); URL pharmaceuticals; 36 companies; National Institutes of Arthritis, Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Aging (NIA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs); Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health London for the National Health Service Information Centre; University of Leicester; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); Cabrini Health; BUPA Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Africa Programme for Onchocerciasis Control (WHO/APOC); Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parkinson Council; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); US Department of Veterans Affairs(US Department of Veterans Affairs); Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago; National Institute for Stroke and Applied Neurosciences; AUT University; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Swedish Research Council(Swedish Research CouncilEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); World Health Organization(World Health Organization); World Mental Health Japan (WMH-J); Japan Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Australian Government(Australian GovernmentCGIAR); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Arthritis Foundation of Australia; Tasmanian Community Fund; Masonic Centenary Medical Research Foundation; Royal Hobart Hospital Research Foundation; University of Tasmania; Tehran University of Medical Sciences(Tehran University of Medical Sciences); South African Medical Research Council Burden of Disease Research Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Cape Town School of Public Health and Family Medicine; Brien Holden Vision Institute; National Drug and Alcohol Research Centre (UNSW, Australia); Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Biostatistics, Epidemiologic and Bioinformatic Training in Environmental Health Training Grant; Foundation for Alcohol Research and Education; Victorian Department of Health; Burke Global Health Fellowship; Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; Spanish Society of Rheumatology (Sociedad Espanola de Reumatologia); European Center for Injury Prevention, Universidad de Navarra; Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Commonwealth Government of Australia(Australian Government); Institute of Bone and Joint Research (IBJR); University of Sydney (USYD); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Wellcome Trust UK(Wellcome Trust); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Anthony Cerami and Ann Dunne Research Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	C E Canter has worked as an Optum Health consultant, Blue Cross Blue Shield consultant, and received Berlin Heart Honoraria and travel fees. E R Dorsey has received payments for consulting services from Lundbeck and Medtronic and research support from Lundbeck and Prana Biotechnology. T Driscoll was supported in part by funding from the National Occupational Health and Safety Commission (now Safework Australia). M Ezzati chaired a session and gave a talk at the World Cardiology Congress (WCC), with travel cost reimbursed by the World Heart Federation. At the WCC, he also gave a talk at a session organised by PepsiCo with no financial or other remuneration. F Guillemin conducted a study on osteoarthritis epidemiology in an institution that received grants from public sources: Assurance-Maladie (CNAMTS) InVS, Inserm, CHU de Nancy, CHU de Nice, Conseil Regional de Lorraine, Societe Francaise de Negma-Lerads, Pfizer, Pierre Fabre Medicaments, Sanofi-Afentis France. H J Hoffman is a US Federal Government employee of the National Institutes of Health (NIH). P J Hotez reports holding several positions: Dean, National School of Tropical Medicine, Baylor College of Medicine; Director, Sabin Vaccine Institute Texas Children's Hospital Center for Vaccine Development; and President, Sabin Vaccine Institute. He also is an inventor on several patents: 5,527,937 "Hookworm Anticoagulant"; 5,753,787 "Nucleic Acids for Ancylostoma Secreted Proteins"; 7,303,752 B2 "Hookworm vaccine"; 12/492,734 "Human Hookworm Vaccine"; 61/077,256 "Multivalent Anthelminthic Vaccine"; and PCT-20100701/0.20.5.18 "Malaria Transmission blocking vaccine". G Mensah is a former employee of PepsiCo. F Perez-Ruiz was an advisor for Ardea, Menarini, Novartis, Metabolex; was a member of the Speaker's Bureau for Menarini, Novartis; an advisor for educational issues for Savient; led investigation grants for the Spanish Health Ministry, Hospital de Cruces Rheumatology Association; and was principal investigator in clinical trials for Ardea. G V Polanczyk has served as a speaker and/or consultant to Eli-Lily, Novartis, Janssen-Cilag, and Shire Pharmaceuticals, developed educational material for Janssen-Cilag, and received an independent investigator grant from Novartis and from the National Council for Scientific and Technological Development (CNPq, Brazil). L Rushton received honorarium for board membership of the European Centre for Ecotoxicology and Toxicology of Chemicals and received research grants to Imperial College London (as PI) from the European Chemical Industry Council (CEFIC) and CONCAWE (Conservation of Clean Air and Water Europe). J A Singh has received research grants from Takeda and Savient and consultant fees from Savient, Takeda, Ardea, Regeneron, Allergan, URL pharmaceuticals and Novartis. J A Singh is a member of the executive of OMERACT, an organisation that develops outcome measures in rheumatology and receives arms-length funding from 36 companies; a member of the American College of Rheumatology's Guidelines Subcommittee of the Quality of Care Committee; and a member of the Veterans Affairs Rheumatology Field Advisory Committee. J A Singh is supported by research grants from the National Institutes of Arthritis, Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Aging (NIA), National Cancer Institute (NCI), and the Agency for Health Quality and Research Center for Education and Research on Therapeutics (CERTs) and is also supported by the resources and the use of facilities at the VA Medical Center at Birmingham, AL, USA.; We would like to thank the countless individuals who have contributed to the Global Burden of Disease 2010 study in various capacities. We would like to specifically acknowledge the important contribution to this work from multiple staff members of the World Health Organization. We also wish to express our gratitude to the following organisations that hosted consultations during the final stages of the analytic process, providing valuable feedback about the results and the data to improve the study's findings overall: Pan American Health Organization; Eastern Mediterranean Regional Office of WHO; UNAIDS; Ministry of Health, Brazil; China Centers for Disease Control; and the University of Zambia. We would like to thank Lori M Newman, Jordis Ott, Poul Erik Petersen, Shekhar Saxena, and Gretchen A Stevens for their collaboration and input into the analyses and estimates. Finally, we would like to acknowledge the extensive support from all staff members at the Institute for Health Metrics and Evaluation and specifically thank: James Bullard, Andrew Ernst, and Serkan Yalcin for their tireless support of the computational infrastructure required to produce the results; Linda A Ettinger for her expert administrative support in order to facilitate communication and coordination amongst the authors; Peter Speyer, Abigail McLain, Katherine Leach-Kemon, and Eden Stork for their persistent and valuable work to gain access to and catalog as much data as possible to inform the estimates; and Erin C Mullany for her systematic efforts in organising drafts of papers, formatting correspondence with expert groups, and preparing the final manuscript. The following individuals would like to acknowledge various forms of institutional support. J P Abraham, B Bartels, and P Yeh recognise the support of the World Bank Global Road Safety Facility and Department of Global Health & Population, Harvard School of Public Health, and the World Health Organization Violence and Injury Prevention. B Bikbov acknowledges support from the Moscow State University of Medicine and Dentistry, Moscow, Russia; Academician V I Shumakov Federal Research Center of Transplantology and Artificial Organs, Moscow, Russia; International Society of Nephrology. R Bourne acknowledges the Vision & Eye Research Unit, Postgraduate Medical Institute, Anglia Ruskin University, Cambridge, UK. S Brooker is supported by a Wellcome Trust Senior Fellowship in Basic Biomedical Science (098045). T S Brugha received funding from the Department of Health London, for the National Health Service Information Centre, by the University of Leicester. R Buchbinder is partially funded by an Australian National Health and Medical Research Council (NHMRC) Practitioner Fellowship, Monash University, and Cabrini Health. P Burney and D Jarvis acknowledge the Chronic Respiratory Disease group received funding from the BUPA Foundation. They had no role in study design, data collection and analysis, interpretation of data, decision to publish, or preparation of the manuscript. C Cella, M Cortinovis, F Gaspari, V Miglioli, and N Perico, on behalf of the entire Genitourinary Expert Group, acknowledge the International Society of Nephrology (ISN). H Chen acknowledges that his participation in this study was in part supported by the intramural research program of the NIH, the National Institute of Environmental Health Sciences. L E Coffeng, and W A Stolk received financial support from the Africa Programme for Onchocerciasis Control (WHO/APOC) for their work on onchocerciasis.; B C Cowie received institutional support from the Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia. M Cross and L March acknowledge the University of Sydney (USYD); Institute of Bone and Joint Research, University of Sydney, Department of Rheumatology, Royal North Shore Hospital, St Leonards NSW 2065 Australia. N Dahodwala was supported by NIH grant K23 AG034236 and the Parkinson Council while working on this project. L Degenhardt is supported by an Australian NHMRC Senior Research Fellowship and funding to support her work for illicit drug dependence was provided by the Australian National Drug and Alcohol Research Centre of the University of New South Wales, Australia. R Dellavalle was supported by the US Department of Veterans Affairs while contributing to this study. S Derrett acknowledges the Health Research Council of New Zealand and the University of Otago for their support. V Feigin and R Krishnamurthi were supported by the National Institute for Stroke and Applied Neurosciences, AUT University. E Fevre acknowledges the Wellcome Trust for grant 085308. W Hall was supported by an NHMRC Australia Fellowship. R Havmoeller was supported by a grant from the Swedish Research Council (#2011-1071). D Hoy was supported by the Bill and Melinda Gates Foundation and the Australian National Health and Medical Research Council. K H Jacobsen was supported by the World Health Organization for her work on hepatitis A. N Kawakami notes that the collection of data ultimately used in this study was supported by the following grants: The World Mental Health Japan (WMH-J) is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013) from the Japan Ministry of Health, Labour, and Welfare. He would like to thank staff members, field coordinators, and interviewers of the WMH Japan 2002-2004 Survey. L L Laslett is supported by an Australian Government Australian Postgraduate Award. She also notes that the TasOAC study, the results of which were used in this research, was supported by the National Health and Medical Research Council of Australia; Arthritis Foundation of Australia; Tasmanian Community Fund; Masonic Centenary Medical Research Foundation, Royal Hobart Hospital Research Foundation, and University of Tasmania Institutional Research Grants Scheme. R Malekzadeh received funding from a research grant of Tehran University of Medical Sciences to do the related studies. R Matzopoulos acknowledges the two institutions that support his research work: South African Medical Research Council Burden of Disease Research Unit; and the University of Cape Town School of Public Health and Family Medicine. T Merriman acknowledges the Health Research Council of New Zealand. K Naidoo was supported by the Brien Holden Vision Institute. P Nelson was supported by the National Drug and Alcohol Research Centre (UNSW, Australia). R G Nelson acknowledges his research was supported in part by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. C Olives was funded in part by the Biostatistics, Epidemiologic and Bioinformatic Training in Environmental Health Training Grant (ES015459). D Ozgediz acknowledges the staff and collaborators at the Mulago Hospital and Makerere University in Kampala, Uganda. K Pesudovs received institutional support from Flinders University.; R Room's position at the University of Melbourne and Turning Point Alcohol and Drug Centre is funded by the Foundation for Alcohol Research and Education and the Victorian Department of Health. J A Salomon received support from the Burke Global Health Fellowship while working on this study. U Sampson received funding support from the Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation and the Vanderbilt Clinical and Translational Scholars Award. L Sanchez-Riera acknowledges the Spanish Society of Rheumatology (Sociedad Espanola de Reumatologia). M Segui-Gomez's participation was partly supported by funds from the European Center for Injury Prevention, Universidad de Navarra. E Smith acknowledges the Department of Health and Ageing, Commonwealth Government of Australia, Institute of Bone and Joint Research (IBJR), University of Sydney (USYD). G D Thurston was supported in part by Center grant ES00260 from the National Institute of Environmental Health Sciences. D J Weatherall was supported by the Wellcome Trust UK, the Medical Research Council UK and the Anthony Cerami and Ann Dunne Research Trust.	Adair T, 2012, INT J TUBERC LUNG D, V16, P1699, DOI 10.5588/ijtld.12.0251; Ahern RM, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-8; [Anonymous], 2002, WORLD MORTALITY 2000; [Anonymous], WORLD HLTH REP 2004; [Anonymous], 2006, HIGHL HLTH EST 2005; [Anonymous], 2011, VIET NAM BURD DIS IN; [Anonymous], MALAWI MED J; [Anonymous], 2005, NCMH BACKGR PAP BURD; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Begg SJ, 2008, MED J AUSTRALIA, V188, P36, DOI 10.5694/j.1326-5377.2008.tb01503.x; Bradshaw D, 2003, SAMJ S AFR MED J, V93, P682; Bundhamcharoen K, 2002, THAI WORKING GROUP B; Bundhamcharoen K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-53; Carp FM, 2000, ELDER ABUSE FAMILY I; Lopez FC, 2009, REV ESP SALUD PUBLIC, V83, P137, DOI [10.1590/S1135-57272009000100011, 10.1590/s1135-57272009000100011]; Chalk R, 1998, VIOLENCE FAMILIES AS; CHAMIE M, 1995, DISABIL REHABIL, V17, P323, DOI 10.3109/09638289509166718; Chapman G, 2006, TROP MED INT HEALTH, V11, P660, DOI 10.1111/j.1365-3156.2006.01601.x; Coyte PC, 1998, ARTHRIT CARE RES, V11, P315, DOI 10.1002/art.1790110503; de Salud M, 2004, ESTUDIO CARGA ENFERM; Departamento de Epidemiologia MINSAL, 2007, EST CARG ENF CARG AT; Dgedge M, 2001, B WORLD HEALTH ORGAN, V79, P546; Dodhia H, 2008, J PUBLIC HEALTH-UK, V30, P313, DOI 10.1093/pubmed/fdn015; Escobar M, 1994, CARGA ENFERMEDAD COL; Fouad D, 2007, ECOMOD2007 C; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Friedman C, 2004, J OCCUP ENVIRON MED, V46, P3, DOI 10.1097/01.jom.0000105915.59342.9a; Fukuda Y, 1999, J HLTH WELFARE STAT, V46, P28; Gadelha AMJ, 1998, PROJETO CARGA DOENCA; Genova-Maleras R, 2012, PUBLIC HEALTH, V126, P1024, DOI 10.1016/j.puhe.2012.08.012; Green S, 2007, BURDEN DIS ILLNESS U; Grosse SD, 2009, PUBLIC HEALTH REP, V124, P197, DOI 10.1177/003335490912400206; Heise L L, 1998, Violence Against Women, V4, P262, DOI 10.1177/1077801298004003002; Hsairi M, 2003, Sante Publique, V15, P25; Hu GP, 2010, CHEST, V138, P20, DOI 10.1378/chest.08-2114; Hurley Susan F, 2007, Cost Eff Resour Alloc, V5, P2, DOI 10.1186/1478-7547-5-2; Hyder AA, 1998, AM J PUBLIC HEALTH, V88, P196, DOI 10.2105/AJPH.88.2.196; Hyder AA, 2000, AM J PUBLIC HEALTH, V90, P1235, DOI 10.2105/AJPH.90.8.1235; Hyder AA, 2012, AM J PUBLIC HEALTH, V102, P1061, DOI 10.2105/AJPH.2011.300563; Ikeda S, 1998, J HLTH CARE SOC, V8, P83; Jankovic S, 2007, EUR J PUBLIC HEALTH, V17, P80, DOI 10.1093/eurpub/ckl072; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; Kominski GF, 2002, PUBLIC HEALTH REP, V117, P185, DOI 10.1016/S0033-3549(04)50125-5; Kosen S, 1998, ESTIMATION NATL BURD; Kurmi OP, 2010, THORAX, V65, P221, DOI 10.1136/thx.2009.124644; Lai T, 2009, EUR J PUBLIC HEALTH, V19, P541, DOI 10.1093/eurpub/ckp038; Lapostolle A, 2008, EUR J PUBLIC HEALTH, V18, P195, DOI 10.1093/eurpub/ckm109; Leonardi M, 2006, LANCET, V368, P1219, DOI 10.1016/S0140-6736(06)69498-1; Logan WPD, 1950, POP STUD-J DEMOG, V4, P132, DOI 10.2307/2172133; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lozada P, 1999, PESO ENFERMEDAD ECUA; Lozano R, 2009, CARGA ENFERMEDAD MUN; Lozano R., 1995, J INT DEV, V7, P555, DOI DOI 10.1002/JID.3380070314; Lozano R., 1997, PESO ENFERMEDAD MEXI, P23; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mariotti S, 2003, EUR J EPIDEMIOL, V18, P513, DOI 10.1023/A:1024635401206; Marks G, 1997, HLTH ADULT BRITAIN 1; Mathers CD, 2000, MED J AUSTRALIA, V172, P592, DOI 10.5694/j.1326-5377.2000.tb124125.x; Mathers CD, 2001, LANCET, V357, P1685, DOI 10.1016/S0140-6736(00)04824-8; Mathers CD, 2001, B WORLD HEALTH ORGAN, V79, P1076; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Mathur P., 2011, INDIAN J COMMUNITY M, V36, pS72, DOI [10.4103/0970-0218.94713, DOI 10.4103/0970-0218.94713]; McKenna MT, 2005, AM J PREV MED, V28, P415, DOI 10.1016/j.amepre.2005.02.009; Melse JM, 2000, AM J PUBLIC HEALTH, V90, P1241, DOI 10.2105/AJPH.90.8.1241; Michaud Catherine M, 2006, Popul Health Metr, V4, P11, DOI 10.1186/1478-7954-4-11; Ministerio de Salud de Costa Rica, 2008, MED CARG ENF COST RI; Ministry of Health, 2004, BURD DIS FIN REP; Ministry of Health, 2001, MIN HLTH PUBL HLTH I; Murray, 2002, SUMMARY MEASURES POP, P205; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Murray CJL., 1996, GLOBAL HLTH STAT COM, V1996; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; Norman R., 2006, REVISED BURDEN DIS E; Oh IH, 2011, J KOREAN MED ASSOC, V54, P646, DOI 10.5124/jkma.2011.54.6.646; Peden M., 2004, WORLD REPORT ROAD TR; Peterson S, 1998, SJUKDOMSBORDAN SVERI; Phua HP, 2009, SINGAP MED J, V50, P468; Polinder S, 2012, EPIDEMIOL REV, V34, P17, DOI 10.1093/epirev/mxr022; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Reiss A, 1993, VIOLENCE FAMILIES UN; Rodriguez J, 2008, CARGA ENFERMEDAD COL; Rodriguez J, 2000, CARGA GLOBAL ENFERME; Salas Vergara J, 1996, ESTUDIO PRIORIDADES; Salomon J.A., 2003, HLTH SYSTEMS PERFORM, P301; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Samutharuk B., 1999, MEASUREMENT DIS BURD; Schiamberg LB, 1999, J ELDER ABUSE NEGL, V11, P79, DOI 10.1300/J084v11n01_05; Schopper D, 2000, INT J EPIDEMIOL, V29, P871, DOI 10.1093/ije/29.5.871; Seuc AH, 2010, CAD SAUDE PUBLICA, V26, P615, DOI 10.1590/S0102-311X2010000300018; Stevens G, 2008, PLOS MED, V5, P900, DOI 10.1371/journal.pmed.0050125; The Thai Working Group on Burden of Disease and Injury, 2004, J HEALTH SCI, V13, P239; Thomas C, 2004, DISABIL SOC, V19, P569, DOI 10.1080/0968759042000252506; United Nations, UN ROAD SAF; Velasquez Valdivia A., 2006, ANALISIS ESTUDIO CAR; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; *WHO, WORLD HLTH REP 1999; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, WORLD HLTH REP 2002; World Health Organization, WORLD HLTH REP 2001; World Health Organization, REG BURD DIS EST 200; World Health Organization, 2010, VIOLENCE PREVENTION; World Health Organization, WORLD HLTH REP 2000; YELIN E, 1995, ARTHRITIS RHEUM, V38, P1351, DOI 10.1002/art.1780381002; Yoon SJ, 2007, J KOREAN MED SCI, V22, P518, DOI 10.3346/jkms.2007.22.3.518; Yusoff AF, MALAYSIAN BURDEN DIS; Zhou SC, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-188	112	5513	5743	53	1492	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2012	380	9859					2197	2223		10.1016/S0140-6736(12)61689-4	http://dx.doi.org/10.1016/S0140-6736(12)61689-4			27	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23245608	Green Submitted			2022-12-28	WOS:000312387000016
J	Basset, Y; Cizek, L; Cuenoud, P; Didham, RK; Guilhaumon, F; Missa, O; Novotny, V; Odegaard, F; Roslin, T; Schmidl, J; Tishechkin, AK; Winchester, NN; Roubik, DW; Aberlenc, HP; Bail, J; Barrios, H; Bridle, JR; Castano-Meneses, G; Corbara, B; Curletti, G; da Rocha, WD; de Bakker, D; Delabie, JHC; Dejean, A; Fagan, LL; Floren, A; Kitching, RL; Medianero, E; Miller, SE; de Oliveira, EG; Orivel, J; Pollet, M; Rapp, M; Ribeiro, SP; Roisin, Y; Schmidt, JB; Sorensen, L; Leponce, M				Basset, Yves; Cizek, Lukas; Cuenoud, Philippe; Didham, Raphael K.; Guilhaumon, Francois; Missa, Olivier; Novotny, Vojtech; Odegaard, Frode; Roslin, Tomas; Schmidl, Juergen; Tishechkin, Alexey K.; Winchester, Neville N.; Roubik, David W.; Aberlenc, Henri-Pierre; Bail, Johannes; Barrios, Hector; Bridle, Jon R.; Castano-Meneses, Gabriela; Corbara, Bruno; Curletti, Gianfranco; da Rocha, Wesley Duarte; de Bakker, Domir; Delabie, Jacques H. C.; Dejean, Alain; Fagan, Laura L.; Floren, Andreas; Kitching, Roger L.; Medianero, Enrique; Miller, Scott E.; de Oliveira, Evandro Gama; Orivel, Jerome; Pollet, Marc; Rapp, Mathieu; Ribeiro, Servio P.; Roisin, Yves; Schmidt, Jesper B.; Sorensen, Line; Leponce, Maurice			Arthropod Diversity in a Tropical Forest	SCIENCE			English	Article							HOST-SPECIFICITY; SPECIES RICHNESS; HERBIVOROUS INSECTS; BETA-DIVERSITY; ANT FAUNA; BIODIVERSITY	Most eukaryotic organisms are arthropods. Yet, their diversity in rich terrestrial ecosystems is still unknown. Here we produce tangible estimates of the total species richness of arthropods in a tropical rainforest. Using a comprehensive range of structured protocols, we sampled the phylogenetic breadth of arthropod taxa from the soil to the forest canopy in the San Lorenzo forest, Panama. We collected 6144 arthropod species from 0.48 hectare and extrapolated total species richness to larger areas on the basis of competing models. The whole 6000-hectare forest reserve most likely sustains 25,000 arthropod species. Notably, just 1 hectare of rainforest yields >60% of the arthropod biodiversity held in the wider landscape. Models based on plant diversity fitted the accumulated species richness of both herbivore and nonherbivore taxa exceptionally well. This lends credence to global estimates of arthropod biodiversity developed from plant models.	[Basset, Yves; Roubik, David W.] Smithsonian Trop Res Inst, Panama City, Panama; [Basset, Yves; Cizek, Lukas; Novotny, Vojtech] Univ S Bohemia, Ceske Budejovice 37005, Czech Republic; [Basset, Yves] Univ Panama, Panama City, Panama; [Cizek, Lukas; Novotny, Vojtech] Acad Sci Czech Republ, Ceske Budejovice 37005, Czech Republic; [Cuenoud, Philippe] Museum Hist Nat Ville Geneve, CH-1208 Geneva, Switzerland; [Didham, Raphael K.] Univ Western Australia, Perth, WA 6009, Australia; [Didham, Raphael K.] CSIRO Ecosyst Sci, Perth, WA 6009, Australia; [Guilhaumon, Francois] Univ Evora, Catedra Rui Nabeiro, P-7004516 Evora, Portugal; [Missa, Olivier] Univ York, York YO10 5DD, N Yorkshire, England; [Odegaard, Frode] Norwegian Inst Nat Res, N-7485 Trondheim, Norway; [Roslin, Tomas] Univ Helsinki, FIN-00014 Helsinki, Finland; [Schmidl, Juergen; Bail, Johannes] Univ Erlangen Nurnberg, D-91058 Erlangen, Germany; [Tishechkin, Alexey K.] Santa Barbara Museum Nat Hist, Santa Barbara, CA 93105 USA; [Winchester, Neville N.] Univ Victoria, Victoria, BC V8W 2Y2, Canada; [Aberlenc, Henri-Pierre] Cirad, F-34988 Montferrier Sur Lez, France; [Bridle, Jon R.] Univ Bristol, Bristol BS8 1UD, Avon, England; [Castano-Meneses, Gabriela] Univ Nacl Autonoma Mexico, Mexico City 0510, DF, Mexico; [Corbara, Bruno] Univ Blaise Pascal, F-63000 Clermont Ferrand, France; [Curletti, Gianfranco] Museo Civico Storia Nat, I-10022 Carmagnola, Italy; [da Rocha, Wesley Duarte; Delabie, Jacques H. C.] Ctr Pesquisas Cacau, BR-45600000 Itabuna, Brazil; [da Rocha, Wesley Duarte; Delabie, Jacques H. C.] Univ Estadual Santa Cruz, BR-45662900 Ilheus, Brazil; [de Bakker, Domir] Inst Royal Sci Nat Belgique, B-1000 Brussels, Belgium; [Dejean, Alain] Univ Toulouse 3, F-31062 Toulouse, France; [Floren, Andreas] Univ Wurzburg, D-97070 Wurzburg, Germany; [Kitching, Roger L.] Griffith Univ, Nathan, Qld 4111, Australia; [Miller, Scott E.] Natl Museum Nat Hist, Washington, DC 20008 USA; [de Oliveira, Evandro Gama] Ctr Univ UNA, Belo Horizonte, MG, Brazil; [Orivel, Jerome] CNRS, F-97379 Kourou, France; [Pollet, Marc] Res Inst Nat & Forest, B-1070 Brussels, Belgium; [Rapp, Mathieu] Museum Hist Nat, CH-2000 Neuchatel, Switzerland; [Ribeiro, Servio P.] Univ Fed Ouro Preto, BR-35400000 Ouro Preto, MG, Brazil; [Roisin, Yves] Univ Libre Bruxelles, B-1050 Brussels, Belgium; [Schmidt, Jesper B.; Sorensen, Line] Nat Hist Museum Denmark, DK-2100 Copenhagen, Denmark	Smithsonian Institution; Smithsonian Tropical Research Institute; University of South Bohemia Ceske Budejovice; Universidad de Panama; Czech Academy of Sciences; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Evora; University of York - UK; Norwegian Institute Nature Research; University of Helsinki; University of Erlangen Nuremberg; University of Victoria; CIRAD; University of Bristol; Universidad Nacional Autonoma de Mexico; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Universidade Estadual de Santa Cruz; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Wurzburg; Griffith University; Smithsonian Institution; Smithsonian National Museum of Natural History; Centro Universitario UNA; Centre National de la Recherche Scientifique (CNRS); Research Institute for Nature & Forest; Universidade Federal de Ouro Preto; Universite Libre de Bruxelles	Basset, Y (corresponding author), Smithsonian Trop Res Inst, Panama City, Panama.	bassety@si.edu	Missa, Olivier/G-2687-2012; Delabie, Jacques H C/F-3405-2010; Guilhaumon, francois/GPX-7180-2022; Ribeiro, Sérvio/G-1887-2012; Roslin, Tomas/E-8648-2016; Novotny, Vojtech/G-9434-2014; Basset, Yves F/B-6642-2014; Cizek, Lukas/K-7111-2015; Didham, Raphael K/B-5953-2011; Cizek, Lukas/G-7905-2014; Guilhaumon, François/C-3240-2009; Ribeiro, Sérvio Pontes/AAG-1146-2020	Missa, Olivier/0000-0002-4330-5192; Delabie, Jacques H C/0000-0002-2695-1061; Guilhaumon, francois/0000-0003-4707-8932; Ribeiro, Sérvio/0000-0002-0191-8759; Roslin, Tomas/0000-0002-2957-4791; Novotny, Vojtech/0000-0001-7918-8023; Basset, Yves F/0000-0002-1942-5717; Cizek, Lukas/0000-0002-6447-2002; Cizek, Lukas/0000-0002-6447-2002; Ribeiro, Sérvio Pontes/0000-0002-0191-8759; Miller, Scott/0000-0002-4138-1378; Orivel, Jerome/0000-0002-5636-3228; Roisin, Yves/0000-0001-6635-3552; Dejean, Alain/0000-0002-3561-2248; CORBARA, Bruno/0000-0003-4232-8234; Bridle, Jonathan/0000-0002-5999-0307	STRI; United Nations Environment Programme; Smithsonian Institution (Walcott Fund); European Science Foundation; Global Canopy Programme; SolVin-Solvay SA	STRI(Smithsonian InstitutionSmithsonian Tropical Research Institute); United Nations Environment Programme; Smithsonian Institution (Walcott Fund)(Smithsonian InstitutionSmithsonian National Museum of Natural History); European Science Foundation(European Science Foundation (ESF)European Commission); Global Canopy Programme; SolVin-Solvay SA(Solvay SA)	IBISCA-Panama is an initiative of Pro-Natura International, Ocean Vert, the universities Blaise Pascal and of Panama, and the Smithsonian Tropical Research Institute (STRI), with core funding from SolVin-Solvay SA, STRI, the United Nations Environment Programme, the Smithsonian Institution (Walcott Fund), the European Science Foundation, and the Global Canopy Programme. J. Herrera, E. Andrade, M. Samaniego, S. J. Wright, N. Baiben, S. Bechet, J. Belleguic, T. Aubert, K. Jordan, G. Ebersolt, D. Cleyet-Marrel, L. Pyot, O. Pascal, P. Basset, and E. Bauhaus helped with logistics in the field. A. Barba, R. Cabrera, A. Cornejo, I. Diaz, A. F. R. do Carmo, I. C. do Nascimento, E. A. dos Santos, M. Gonzalez, A. Hernandez, M. Manumbor, M. Mogia, S. Pinzon, B. Perez, L. S. Ramos-Lacau, and O. Valdez helped with initial sorting of the arthropod and plant material. Data (as of 10 May 2012) have been deposited in the Dryad repository: http://dx.doi.org/10.5061/dryad.f3p75.	Basset Y, 2001, PLANT ECOL, V153, P87, DOI 10.1023/A:1017581406101; BASSET Y, 2003, ARTHROPODS TROPICAL; Bonebrake TC, 2010, BIOL CONSERV, V143, P1831, DOI 10.1016/j.biocon.2010.04.044; Coddington JA, 2009, J ANIM ECOL, V78, P573, DOI 10.1111/j.1365-2656.2009.01525.x; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Hamilton AJ, 2011, AM NAT, V177, P544, DOI 10.1086/659643; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Kitching Roger L., 2011, Memoirs of the Queensland Museum, V55, P235; Lewinsohn TM, 2008, ECOL LETT, V11, P398, DOI 10.1111/j.1461-0248.2008.01155.x; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; Longino JT, 1997, ECOL APPL, V7, P1263, DOI 10.1890/1051-0761(1997)007[1263:BAUSIC]2.0.CO;2; May RM, 2004, PHILOS T ROY SOC B, V359, P733, DOI 10.1098/rstb.2003.1455; May RM, 2010, SCIENCE, V329, P41, DOI 10.1126/science.1191058; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Novotny V, 2004, CONSERV BIOL, V18, P227, DOI 10.1111/j.1523-1739.2004.00293.x; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Novotny V, 2007, NATURE, V448, P692, DOI 10.1038/nature06021; Novotny V, 2010, J ANIM ECOL, V79, P1193, DOI 10.1111/j.1365-2656.2010.01728.x; Odegaard F, 2006, BIODIVERS CONSERV, V15, P83, DOI 10.1007/s10531-004-3106-5; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; Strong D., 1984, INSECTS PLANTS COMMU; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	24	321	355	17	579	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1481	1484		10.1126/science.1226727	http://dx.doi.org/10.1126/science.1226727			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239740	Green Submitted			2022-12-28	WOS:000312250800051
J	Mills, E				Mills, Evan			The Greening of Insurance	SCIENCE			English	Editorial Material							CLIMATE; RESPONSES		Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mills, E (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.	emills@lbl.gov						Bordoff J. E., 2008, PAY AS YOU DRIVE AUT; ClimateWise, 2011, CLIMATEWISE PRINC 4; Kron W, 2012, NAT HAZARD EARTH SYS, V12, P535, DOI 10.5194/nhess-12-535-2012; Leggett J., 1993, EUROPEAN ENV, V3, P3; Lloyd's, 2006, CLIM CHANG AD BUST, V360; Lloyd's, 2008, DIR DOCK; Michel-Kerjan E, 2011, SCIENCE, V333, P408, DOI 10.1126/science.1202616; Mills E, 2005, SCIENCE, V309, P1040, DOI 10.1126/science.1112121; Mills E., 1996, J SOC INSUR RES, V1996, P15; Mills E, 2012, B ATOM SCI, V68, P67, DOI 10.1177/0096340212464362; Mills E, 2009, GENEVA PAP R I-ISS P, V34, P323, DOI 10.1057/gpp.2009.14; Munich Reinsurance Co, 1973, FLOOD IN; Patton L., 2008, EUR BUS REV, V2008, P3005; Phelan L, 2011, ENVIRON POLICY GOV, V21, P112, DOI 10.1002/eet.565; Schmidt S, 2009, ENVIRON IMPACT ASSES, V29, P359, DOI 10.1016/j.eiar.2009.03.003; Swiss Reinsurance Co, 2011, HIDD RISK CLIM CHANG; Swiss Reinsurance Co, 2012, WORLD INS 2011; Tran S. M., 2008, J SCI TECHNOL LAW, V14, P73	18	35	35	4	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1424	1425		10.1126/science.1229351	http://dx.doi.org/10.1126/science.1229351			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053DN	23239720				2022-12-28	WOS:000312250800031
J	Uoyama, H; Goushi, K; Shizu, K; Nomura, H; Adachi, C				Uoyama, Hiroki; Goushi, Kenichi; Shizu, Katsuyuki; Nomura, Hiroko; Adachi, Chihaya			Highly efficient organic light-emitting diodes from delayed fluorescence	NATURE			English	Article							EXCITON FORMATION; ELECTROLUMINESCENCE; SINGLET; STATES	The inherent flexibility afforded by molecular design has accelerated the development of a wide variety of organic semiconductors over the past two decades. In particular, great advances have been made in the development of materials for organic light-emitting diodes (OLEDs), from early devices based on fluorescent molecules(1) to those using phosphorescent molecules(2,3). In OLEDs, electrically injected charge carriers recombine to form singlet and triplet excitons in a 1:3 ratio(1); the use of phosphorescent metal-organic complexes exploits the normally non-radiative triplet excitons and so enhances the overall electroluminescence efficiency(2,3). Here we report a class of metal-free organic electroluminescent molecules in which the energy gap between the singlet and triplet excited states is minimized by design(4), thereby promoting highly efficient spin up-conversion from non-radiative triplet states to radiative singlet states while maintaining high radiative decay rates, of more than 10(6) decays per second. In other words, these molecules harness both singlet and triplet excitons for light emission through fluorescence decay channels, leading to an intrinsic fluorescence efficiency in excess of 90 per cent and a very high external electroluminescence efficiency, of more than 19 per cent, which is comparable to that achieved in high-efficiency phosphorescence-based OLEDs(3).	[Uoyama, Hiroki; Goushi, Kenichi; Shizu, Katsuyuki; Nomura, Hiroko; Adachi, Chihaya] Kyushu Univ, Ctr Organ Photon & Elect Res, Nishi Ku, Fukuoka 8190395, Japan; [Goushi, Kenichi; Adachi, Chihaya] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka 8190395, Japan	Kyushu University; Kyushu University	Adachi, C (corresponding author), Kyushu Univ, Ctr Organ Photon & Elect Res, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	adachi@opera.kyushu-u.ac.jp	Adachi, Chihaya/C-2849-2011	Adachi, Chihaya/0000-0001-6117-9604; Goushi, Kenichi/0000-0001-8869-1165; Shizu, Katsuyuki/0000-0002-1835-0418	Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST); International Institute for Carbon Neutral Energy Research (WPI-I2CNER); Japanese Ministry of Education, Culture, Sports, Science and Technology	Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); International Institute for Carbon Neutral Energy Research (WPI-I2CNER); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) and the International Institute for Carbon Neutral Energy Research (WPI-I2CNER), sponsored by the Japanese Ministry of Education, Culture, Sports, Science and Technology. H.U. acknowledges a Grand-in-Aid for JSPS Fellows. We thank H. Nakanotani, J.-i. Nishide, and H. Miyazaki for their assistance with this research. We also thank K. Tokumaru, H. Sasabe, W. Potscavage and M. Gabor for their assistance with preparation of this manuscript.	Adachi C, 2001, J APPL PHYS, V90, P5048, DOI 10.1063/1.1409582; Akai N, 2003, CHEM PHYS LETT, V371, P655, DOI 10.1016/S0009-2614(03)00329-4; [Anonymous], 1978, MODERN MOL PHOTOCHEM; Baldo MA, 1999, APPL PHYS LETT, V75, P4, DOI 10.1063/1.124258; Beljonne D, 2001, J PHYS CHEM A, V105, P3899, DOI 10.1021/jp010187w; BERNANOSE A, 1953, J CHIM PHYS PCB, V50, P64, DOI 10.1051/jcp/1953500064; Cao Y, 1999, NATURE, V397, P414, DOI 10.1038/17087; Endo A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3558906; Endo A, 2009, ADV MATER, V21, P4802, DOI 10.1002/adma.200900983; Frisch M. J, GAUSSIAN 09 REVISION; Goushi K, 2012, NAT PHOTONICS, V6, P253, DOI 10.1038/nphoton.2012.31; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Improta R, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2757168; Improta R, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2222364; KIDO J, 1990, CHEM LETT, P657, DOI 10.1246/cl.1990.657; Martin RL, 2003, J CHEM PHYS, V118, P4775, DOI 10.1063/1.1558471; POPE M, 1963, J CHEM PHYS, V38, P2042, DOI 10.1063/1.1733929; Rothberg LJ, 1996, J MATER RES, V11, P3174, DOI 10.1557/JMR.1996.0403; Segal M, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.075211; Shuai Z, 2000, PHYS REV LETT, V84, P131, DOI 10.1103/PhysRevLett.84.131; Smith LH, 2004, APPL PHYS LETT, V84, P2986, DOI 10.1063/1.1712036; Takase M, 2007, ANGEW CHEM INT EDIT, V46, P5524, DOI 10.1002/anie.200701452; Tanaka D, 2007, JPN J APPL PHYS 2, V46, pL10, DOI 10.1143/JJAP.46.L10; TSUTSUI T, 1991, N-HOLLAND D, P437; Tsutsui T., 1993, ORGANIC MULTILAYER D, P127; Uno H, 2010, HETEROCYCLES, V82, P791, DOI 10.3987/COM-10-S(E)69; Wakamiya A, 2007, ANGEW CHEM INT EDIT, V46, P4273, DOI 10.1002/anie.200604935; Wilson JS, 2001, NATURE, V413, P828, DOI 10.1038/35101565; Wohlgenannt M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.197401; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x	30	4529	4699	220	3427	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					234	+		10.1038/nature11687	http://dx.doi.org/10.1038/nature11687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23235877	Green Published			2022-12-28	WOS:000312259300038
J	Spence, D				Spence, Des			Patient leaflets are worthless	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Hawkes N, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8047	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 12	2012	345								e8336	10.1136/bmj.e8336	http://dx.doi.org/10.1136/bmj.e8336			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056MU	23236035				2022-12-28	WOS:000312495100012
J	Curtis, BA; Tanifuji, G; Burki, F; Gruber, A; Irimia, M; Maruyama, S; Arias, MC; Ball, SG; Gile, GH; Hirakawa, Y; Hopkins, JF; Kuo, A; Rensing, SA; Schmutz, J; Symeonidi, A; Elias, M; Eveleigh, RJM; Herman, EK; Klute, MJ; Nakayama, T; Obornik, M; Reyes-Prieto, A; Armbrust, EV; Aves, SJ; Beiko, RG; Coutinho, P; Dacks, JB; Durnford, DG; Fast, NM; Green, BR; Grisdale, CJ; Hempel, F; Henrissat, B; Hoppner, MP; Ishida, KI; Kim, E; Koreny, LK; Kroth, PG; Liu, Y; Malik, SB; Maier, UG; McRose, D; Mock, T; Neilson, JAD; Onodera, NT; Poole, AM; Pritham, EJ; Richards, TA; Rocap, G; Roy, SW; Sarai, C; Schaack, S; Shirato, S; Slamovits, CH; Spencer, DF; Suzuki, S; Worden, AZ; Zauner, S; Barry, K; Bell, C; Bharti, AK; Crow, JA; Grimwood, J; Kramer, R; Lindquist, E; Lucas, S; Salamov, A; McFadden, GI; Lane, CE; Keeling, PJ; Gray, MW; Grigoriev, IV; Archibald, JM				Curtis, Bruce A.; Tanifuji, Goro; Burki, Fabien; Gruber, Ansgar; Irimia, Manuel; Maruyama, Shinichiro; Arias, Maria C.; Ball, Steven G.; Gile, Gillian H.; Hirakawa, Yoshihisa; Hopkins, Julia F.; Kuo, Alan; Rensing, Stefan A.; Schmutz, Jeremy; Symeonidi, Aikaterini; Elias, Marek; Eveleigh, Robert J. M.; Herman, Emily K.; Klute, Mary J.; Nakayama, Takuro; Obornik, Miroslav; Reyes-Prieto, Adrian; Armbrust, E. Virginia; Aves, Stephen J.; Beiko, Robert G.; Coutinho, Pedro; Dacks, Joel B.; Durnford, Dion G.; Fast, Naomi M.; Green, Beverley R.; Grisdale, Cameron J.; Hempel, Franziska; Henrissat, Bernard; Hoeppner, Marc P.; Ishida, Ken-Ichiro; Kim, Eunsoo; Koreny, Lude. K.; Kroth, Peter G.; Liu, Yuan; Malik, Shehre-Banoo; Maier, Uwe G.; McRose, Darcy; Mock, Thomas; Neilson, Jonathan A. D.; Onodera, Naoko T.; Poole, Anthony M.; Pritham, Ellen J.; Richards, Thomas A.; Rocap, Gabrielle; Roy, Scott W.; Sarai, Chihiro; Schaack, Sarah; Shirato, Shu; Slamovits, Claudio H.; Spencer, David F.; Suzuki, Shigekatsu; Worden, Alexandra Z.; Zauner, Stefan; Barry, Kerrie; Bell, Callum; Bharti, Arvind K.; Crow, John A.; Grimwood, Jane; Kramer, Robin; Lindquist, Erika; Lucas, Susan; Salamov, Asaf; McFadden, Geoffrey I.; Lane, Christopher E.; Keeling, Patrick J.; Gray, Michael W.; Grigoriev, Igor V.; Archibald, John M.			Algal genomes reveal evolutionary mosaicism and the fate of nucleomorphs	NATURE			English	Article							GENE-TRANSFER; NUCLEUS; CHLORARACHNIOPHYTE; PROTEINS; SEQUENCE; GREEN; RED; CRYPTOPHYTES; EUKARYOTES; HISTORY	Cryptophyte and chlorarachniophyte algae are transitional forms in the widespread secondary endosymbiotic acquisition of photosynthesis by engulfment of eukaryotic algae. Unlike most secondary plastid-bearing algae, miniaturized versions of the endosymbiont nuclei (nucleomorphs) persist in cryptophytes and chlorarachniophytes. To determine why, and to address other fundamental questions about eukaryote-eukaryote endosymbiosis, we sequenced the nuclear genomes of the cryptophyte Guillardia theta and the chlorarachniophyte Bigelowiella natans. Both genomes have >21,000 protein genes and are intron rich, and B. natans exhibits unprecedented alternative splicing for a single-celled organism. Phylogenomic analyses and subcellular targeting predictions reveal extensive genetic and biochemical mosaicism, with both host-and endosymbiont-derived genes servicing the mitochondrion, the host cell cytosol, the plastid and the remnant endosymbiont cytosol of both algae. Mitochondrion-to-nucleus gene transfer still occurs in both organisms but plastid-to-nucleus and nucleomorph-to-nucleus transfers do not, which explains why a small residue of essential genes remains locked in each nucleomorph.	[Curtis, Bruce A.; Tanifuji, Goro; Maruyama, Shinichiro; Gile, Gillian H.; Hopkins, Julia F.; Eveleigh, Robert J. M.; Malik, Shehre-Banoo; Onodera, Naoko T.; Slamovits, Claudio H.; Spencer, David F.; Grigoriev, Igor V.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [Curtis, Bruce A.; Tanifuji, Goro; Maruyama, Shinichiro; Nakayama, Takuro; Onodera, Naoko T.; Spencer, David F.] Dalhousie Univ, Ctr Comparat Genom & Evolutionary Bioinformat, Halifax, NS B3H 4R2, Canada; [Curtis, Bruce A.; Tanifuji, Goro; Burki, Fabien; Maruyama, Shinichiro; Nakayama, Takuro; Reyes-Prieto, Adrian] Univ British Columbia, Integrated Microbial Biodivers Program, Canadian Inst Adv Res, Vancouver, BC V6T 1Z4, Canada; [Burki, Fabien; Hirakawa, Yoshihisa] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; [Gruber, Ansgar] Univ Konstanz, Fachbereich Biol, D-78457 Constance, Germany; [Irimia, Manuel] Univ Toronto, Dept Med Res, Toronto, ON M5S 3E1, Canada; [Arias, Maria C.; Ball, Steven G.] Banting & Best Sci & Technol Lille, F-59655 Villeneuve Dascq, France; [Kuo, Alan] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Rensing, Stefan A.; Schmutz, Jeremy] Univ Freiburg, Fac Biol, D-79085 Freiburg, Germany; [Schmutz, Jeremy] HudsonAlpha Genome Sequencing Ctr, Huntsville, AL 35806 USA; [Elias, Marek] Univ Ostrava, Fac Sci, Dept Biol & Ecol, Life Sci Res Ctr, Ostrava 71000, Czech Republic; [Eveleigh, Robert J. M.] Genome Quebec, Montreal, PQ H3A 1A4, Canada; [Herman, Emily K.; Klute, Mary J.] Univ Alberta, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada; [Obornik, Miroslav] Univ S Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Obornik, Miroslav] Univ S Bohemia, Biol Ctr, Ceske Budejovice 37005, Czech Republic; [Obornik, Miroslav] Acad Sci Czech Republ, Inst Microbiol, Trebon 37981, Czech Republic; [Reyes-Prieto, Adrian] Univ New Brunswick, Dept Biol, Fredericton, NB E3B 5A3, Canada; [Armbrust, E. Virginia] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Aves, Stephen J.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4QD, Devon, England; [Beiko, Robert G.] Dalhousie Univ, Fac Comp Sci, Halifax, NS B3H 4R2, Canada; [Coutinho, Pedro] Aix Marseille Univ, CNRS UMR 7257, F-13228 Marseille, France; [Hempel, Franziska] LOEWE Zentrum Synthet Mikrobiol Synmikro, D-35032 Marburg, Germany; [Hoeppner, Marc P.] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Ishida, Ken-Ichiro] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Kim, Eunsoo] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Liu, Yuan] Nat Hist Museum, London SW7 5BD, England; [McRose, Darcy] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Mock, Thomas] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Poole, Anthony M.] Univ Canterbury, Biomol Interact Ctr, Christchurch 8140, New Zealand; [Pritham, Ellen J.] Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; [Roy, Scott W.] San Francisco State Univ, San Francisco, CA 94132 USA; [Schaack, Sarah] Reed Coll, Portland, OR 97202 USA; [Kramer, Robin] Natl Ctr Genome Resources, Santa Fe, NM 87505 USA; [McFadden, Geoffrey I.] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia; [Lane, Christopher E.] Univ Rhode Isl, Kingston, RI 02881 USA	Dalhousie University; Dalhousie University; Canadian Institute for Advanced Research (CIFAR); University of British Columbia; University of British Columbia; University of Konstanz; University of Toronto; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Freiburg; HudsonAlpha Institute for Biotechnology; University of Ostrava; University of Alberta; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of New Brunswick; University of Washington; University of Washington Seattle; University of Exeter; Dalhousie University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Uppsala University; University of Tsukuba; American Museum of Natural History (AMNH); Natural History Museum London; Monterey Bay Aquarium Research Institute; University of East Anglia; University of Canterbury; California State University System; San Francisco State University; Reed College - Oregon; National Center for Genome Resources (NCGR); University of Melbourne; University of Rhode Island	Archibald, JM (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada.	john.archibald@dal.ca	Irimia, Manuel/E-3040-2010; Henrissat, Bernard/J-2475-2012; Grimwood, Jane/ABD-5737-2021; Koreny, Ludek/G-9766-2014; Maruyama, Shinichiro/AAO-4764-2021; NAKAYAMA, Takuro/AAT-9444-2020; Barry, Kerrie Whitelaw/AAA-5500-2020; Slamovits, Claudio/E-2591-2011; Worden, Alexandra Z./AAD-6567-2019; Green, Beverley R./AAJ-5199-2021; Schmutz, Jeremy/N-3173-2013; Mock, Thomas/A-3127-2008; Dacks, Joel/AAE-3308-2021; McFadden, Geoffrey McFadden I/F-7667-2014; Tanifuji, Goro/O-9172-2015; Burki, Fabien/F-4818-2010; Elias, Marek/D-6851-2014; Arias, Maria Cecilia/H-4886-2012; Hirakawa, Yoshihisa/A-6119-2012; Kroth, Peter G/A-9728-2008; Obornik, Miroslav/G-9350-2014; Gruber, Ansgar/B-9587-2008	Irimia, Manuel/0000-0002-2179-2567; Henrissat, Bernard/0000-0002-3434-8588; NAKAYAMA, Takuro/0000-0001-5135-0156; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Slamovits, Claudio/0000-0003-3050-1474; Green, Beverley R./0000-0002-4021-9387; Schmutz, Jeremy/0000-0001-8062-9172; Mock, Thomas/0000-0001-9604-0362; Dacks, Joel/0000-0003-4520-5694; McFadden, Geoffrey McFadden I/0000-0002-5351-1627; Elias, Marek/0000-0003-0066-6542; Kroth, Peter G/0000-0003-4734-8955; Gruber, Ansgar/0000-0002-5876-4391; Grisdale, Cameron/0000-0003-1923-6972; Burki, Fabien/0000-0002-8248-8462; Grigoriev, Igor/0000-0002-3136-8903; Koreny, Ludek/0000-0002-9979-3172; Worden, Alexandra/0000-0002-9888-9324; Malik, Shehre-Banoo/0000-0003-0833-0648; Rocap, Gabrielle/0000-0001-7253-611X; Gray, Michael/0000-0001-7125-2625; Aves, Stephen/0000-0002-5600-900X; McRose, Darcy/0000-0001-9637-7176; Keeling, Patrick/0000-0002-7644-0745; Poole, Anthony/0000-0001-9940-2824; Ball, Steven/0000-0003-1629-1650; Hirakawa, Yoshihisa/0000-0002-3780-354X; Richards, Thomas/0000-0002-9692-0973	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Natural Sciences and Engineering Research Council of Canada; Biotechnology and Biological Sciences Research Council [BB/G00885X/1, BB/G00885X/2] Funding Source: researchfish; Alberta Innovates [201001324] Funding Source: researchfish; BBSRC [BB/G00885X/2, BB/G00885X/1] Funding Source: UKRI	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Alberta Innovates; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under Contract no. DE-AC02-05CH11231. RNA-seq data used in the paper were generated by the National Center for Genome Resources as part of the Gordon and Betty Moore Foundation's Marine Microbial Eukaryote Transcriptome Project. B. A. C. and J.F.H. were supported by a Special Research Opportunities Grant from the Natural Sciences and Engineering Research Council of Canada awarded to J.M.A. and M. W. G. J.M.A., P.J.K., M. W. G. and C. H. S. are members of the Canadian Institute for Advanced Research, Program in Integrated Microbial Biodiversity. G. I. M. is an Australian Research Council Federation Fellow and a Howard Hughes International Scholar. We thank R. A. Andersen (Bigelow Laboratories) for assistance with single-cell isolations, C. X. Chan for a tree-sorting PERL script, H. Gutierrez for help with SM protein family annotation, and B. Read for permission to analyse the Emiliania huxleyi genome sequenced by the JGI.	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Archibald JM, 2003, P NATL ACAD SCI USA, V100, P7678, DOI 10.1073/pnas.1230951100; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Barbrook AC, 2006, TRENDS PLANT SCI, V11, P101, DOI 10.1016/j.tplants.2005.12.004; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bradley RK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001229; Burki F, 2012, GENOME BIOL EVOL, V4, P738, DOI 10.1093/gbe/evs049; Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Curtis BA, 2010, CURR BIOL, V20, pR919, DOI 10.1016/j.cub.2010.09.038; Deschamps P, 2006, EUKARYOT CELL, V5, P954, DOI 10.1128/EC.00380-05; Deschamps P, 2012, GENOME BIOL EVOL, V4, P795, DOI 10.1093/gbe/evs053; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; Douglas SE, 1999, J MOL EVOL, V48, P236, DOI 10.1007/PL00006462; Freitag J, 2012, NATURE, V485, P522, DOI 10.1038/nature11051; Gile GH, 2008, MOL BIOL EVOL, V25, P1967, DOI 10.1093/molbev/msn147; Gilson PR, 2006, P NATL ACAD SCI USA, V103, P9566, DOI 10.1073/pnas.0600707103; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Gould SB, 2006, MOL BIOL EVOL, V23, P2413, DOI 10.1093/molbev/msl113; GRAY MW, 1992, INT REV CYTOL, V141, P233, DOI 10.1016/S0074-7696(08)62068-9; HIBBERD DJ, 1984, J PHYCOL, V20, P310, DOI 10.1111/j.0022-3646.1984.00310.x; HILL DRA, 1986, PHYCOLOGIA, V25, P521, DOI 10.2216/i0031-8884-25-4-521.1; Hirakawa Y, 2011, MOL MICROBIOL, V80, P1439, DOI 10.1111/j.1365-2958.2011.07643.x; Hirakawa Y, 2010, MOL BIOL EVOL, V27, P1538, DOI 10.1093/molbev/msq038; Irimia M, 2008, MOL BIOL EVOL, V25, P375, DOI 10.1093/molbev/msm262; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kugrens Paul, 2003, P715, DOI 10.1016/B978-012741550-5/50022-2; Lane CE, 2007, P NATL ACAD SCI USA, V104, P19908, DOI 10.1073/pnas.0707419104; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; MARTIN W, 1993, P NATL ACAD SCI USA, V90, P8692, DOI 10.1073/pnas.90.18.8692; McFadden G. I., 1997, Phycological Research, V45, P145, DOI 10.1111/j.1440-1835.1997.tb00087.x; Moog D, 2011, GENOME BIOL EVOL, V3, P375, DOI 10.1093/gbe/evr031; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Noutsos C, 2007, TRENDS GENET, V23, P597, DOI 10.1016/j.tig.2007.08.016; Ota S, 2011, PHYCOLOGIA, V50, P317, DOI 10.2216/09-102.1; Palmer JD, 2003, J PHYCOL, V39, P4, DOI 10.1046/j.1529-8817.2003.02185.x; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Ricchetti M, 2004, PLOS BIOL, V2, P1313, DOI 10.1371/journal.pbio.0020273; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Richly E, 2004, MOL BIOL EVOL, V21, P1972, DOI 10.1093/molbev/msh210; Rogers MB, 2007, MOL BIOL EVOL, V24, P54, DOI 10.1093/molbev/msl129; Smith DR, 2011, GENOME BIOL EVOL, V3, P743, DOI [10.1093/gbe/evr001, 10.1093/gbe/evr068]; Sorek R, 2004, TRENDS GENET, V20, P68, DOI 10.1016/j.tig.2003.12.004; Stegemann S, 2006, PLANT CELL, V18, P2869, DOI 10.1105/tpc.106.046466; Stiller JW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-484; Tanifuji G, 2011, GENOME BIOL EVOL, V3, P44, DOI 10.1093/gbe/evq082; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Woehle C, 2011, GENOME BIOL EVOL, V3, P1220, DOI 10.1093/gbe/evr100; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075	50	263	270	1	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					59	65		10.1038/nature11681	http://dx.doi.org/10.1038/nature11681			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23201678	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000311893400045
J	Tobin, JJ; Hartmann, L; Chiang, HF; Wilner, DJ; Looney, LW; Loinard, L; Calvet, N; D'Alessio, P				Tobin, John J.; Hartmann, Lee; Chiang, Hsin-Fang; Wilner, David J.; Looney, Leslie W.; Loinard, Laurent; Calvet, Nuria; D'Alessio, Paola			A similar to 0.2-solar-mass protostar with a Keplerian disk in the very young L1527 IRS system	NATURE			English	Article							COMPLEX STRUCTURE; ENVELOPE; II.; ACCRETION; EVOLUTION; OUTFLOWS; CORE	In their earliest stages, protostars accrete mass from their surrounding envelopes through circumstellar disks. Until now, the smallest observed protostar-to-envelope mass ratio was about 2.1 (ref. 1). The protostar L1527 IRS is thought to be in the earliest stages of star formation(2). Its envelope contains about one solar mass of material within a radius of about 0.05 parsecs (refs 3, 4), and earlier observations suggested the presence of an edge-on disk(5). Here we report observations of dust continuum emission and (CO)-C-13 (rotational quantum number J = 2 -> 1) line emission from the disk around L1527 IRS, from which we determine a protostellar mass of 0.19 +/- 0.04 solar masses and a protostar-to-envelope mass ratio of about 0.2. We conclude that most of the luminosity is generated through the accretion process, with an accretion rate of about 6.6 x 10(-7) solar masses per year. If it has been accreting at that rate through much of its life, its age is approximately 300,000 years, although theory suggests larger accretion rates earlier(6), so it may be younger. The presence of a rotationally supported disk is confirmed, and significantly more mass may be added to its planet-forming region as well as to the protostar itself in the future.	[Tobin, John J.] Natl Radio Astron Observ, Charlottesville, VA 22903 USA; [Hartmann, Lee; Calvet, Nuria] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Chiang, Hsin-Fang; Looney, Leslie W.] Univ Illinois, Dept Astron, Urbana, IL 61801 USA; [Chiang, Hsin-Fang] Univ Hawaii Manoa, Inst Astron, Hilo, HI 96720 USA; [Chiang, Hsin-Fang] Univ Hawaii Manoa, NASA Astrobiol Inst, Hilo, HI 96720 USA; [Wilner, David J.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Loinard, Laurent; D'Alessio, Paola] UNAM, Ctr Radioastron & Astrofis, Morelia 58089, Michoacan, Mexico; [Loinard, Laurent] Max Planck Inst Radioastron, D-53121 Bonn, Germany	National Radio Astronomy Observatory (NRAO); University of Michigan System; University of Michigan; University of Illinois System; University of Illinois Urbana-Champaign; University of Hawaii System; University of Hawaii Manoa; National Aeronautics & Space Administration (NASA); University of Hawaii System; University of Hawaii Manoa; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Universidad Nacional Autonoma de Mexico; Max Planck Society	Tobin, JJ (corresponding author), Natl Radio Astron Observ, Edgemont Rd, Charlottesville, VA 22903 USA.	jtobin@nrao.edu		Loinard, Laurent/0000-0002-5635-3345; Looney, Leslie/0000-0002-4540-6587; Wilner, David/0000-0003-1526-7587	NASA [HSTHF-51300.01-A, NAS 5-26555]; Space Telescope Science Institute; University of Michigan; NASA through the NASA Astrobiology Institute through the Office of Space Science [NNA09DA77A]; Laboratory for Astronomical Imaging at the University of Illinois; NSF [AST-07-09206]; PAPIIT-UNAM; DGAPA; UNAM; CONACyT (Mexico); Alexander von Humboldt Stiftung; Smithsonian Institution; Academia Sinica	NASA(National Aeronautics & Space Administration (NASA)); Space Telescope Science Institute(Space Telescope Science Institute); University of Michigan(University of Michigan System); NASA through the NASA Astrobiology Institute through the Office of Space Science; Laboratory for Astronomical Imaging at the University of Illinois; NSF(National Science Foundation (NSF)); PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); DGAPA; UNAM(Universidad Nacional Autonoma de Mexico); CONACyT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Alexander von Humboldt Stiftung(Alexander von Humboldt Foundation); Smithsonian Institution(Smithsonian Institution); Academia Sinica(Academia Sinica - Taiwan)	We thank E. Bergin for comments on the manuscript and W. Kwon for discussing improvements to the data reduction. J.J.T. was supported by NASA through Hubble Fellowship grant HSTHF-51300.01-A awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., for NASA, under contract NAS 5-26555. L. H. and J.J.T. acknowledge partial support from the University of Michigan. H.-F.C. was supported by NASA through the NASA Astrobiology Institute under cooperative agreement NNA09DA77A issued through the Office of Space Science. L. W. L. and H.-F.C. acknowledge support from the Laboratory for Astronomical Imaging at the University of Illinois and the NSF under grant AST-07-09206. P. D. acknowledges a grant from PAPIIT-UNAM. L. L. was supported by DGAPA, UNAM, CONACyT (Mexico) and the Alexander von Humboldt Stiftung. Support for CARMA construction was derived from the states of Illinois, California and Maryland, the James S. McDonnell Foundation, the Gordon and Betty Moore Foundation, the Kenneth T. and Eileen L. Norris Foundation, the University of Chicago, the Associates of the California Institute of Technology, and the NSF. Continuing CARMA development and operations are supported by the NSF under a cooperative agreement, and by the CARMA partner universities. The Submillimeter Array is a joint project between the Smithsonian Astrophysical Observatory and the Academia Sinica Institute of Astronomy and Astrophysics and is funded by the Smithsonian Institution and the Academia Sinica. The National Radio Astronomy Observatory is a facility of the NSF operated under cooperative agreement by Associated Universities, Inc.	ANDRE P, 1993, ASTROPHYS J, V406, P122, DOI 10.1086/172425; Andrews SM, 2010, ASTROPHYS J, V723, P1241, DOI 10.1088/0004-637X/723/2/1241; Andrews SM, 2005, ASTROPHYS J, V631, P1134, DOI 10.1086/432712; Arce HG, 2006, ASTROPHYS J, V646, P1070, DOI 10.1086/505104; Bell K. R., 2000, PROTOSTARS PLANETS, VIV , P897; Chandler CJ, 2000, ASTROPHYS J, V530, P851, DOI 10.1086/308401; Dapp WB, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/201015700; Dunham MM, 2010, ASTROPHYS J, V710, P470, DOI 10.1088/0004-637X/710/1/470; Evans NJ, 2009, ASTROPHYS J SUPPL S, V181, P321, DOI 10.1088/0067-0049/181/2/321; Hartmann L, 1997, ASTROPHYS J, V475, P770, DOI 10.1086/303547; Hennebelle P, 2008, ASTRON ASTROPHYS, V477, P9, DOI 10.1051/0004-6361:20078309; Joos M, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201118730; Jorgensen JK, 2009, ASTRON ASTROPHYS, V507, P861, DOI 10.1051/0004-6361/200912325; Jorgensen JK, 2007, ASTROPHYS J, V659, P479, DOI 10.1086/512230; Maury AJ, 2010, ASTRON ASTROPHYS, V512, DOI 10.1051/0004-6361/200913492; Narayanan G, 2012, MON NOT R ASTRON SOC, V425, P2641, DOI 10.1111/j.1365-2966.2012.21579.x; Ohashi N, 1997, ASTROPHYS J, V475, P211, DOI 10.1086/303533; Rodriguez LF, 2003, ASTROPHYS J, V583, P330, DOI 10.1086/344833; Simon M, 2000, ASTROPHYS J, V545, P1034, DOI 10.1086/317838; Takakuwa S, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/52; Tobin JJ, 2008, ASTROPHYS J, V679, P1364, DOI 10.1086/587683; Tobin JJ, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/1/45; Tobin JJ, 2010, ASTROPHYS J LETT, V722, pL12, DOI 10.1088/2041-8205/722/1/L12; Tobin JJ, 2010, ASTROPHYS J, V712, P1010, DOI 10.1088/0004-637X/712/2/1010; Vorobyov EI, 2010, ASTROPHYS J, V723, P1294, DOI 10.1088/0004-637X/723/2/1294; Yorke HW, 1999, ASTROPHYS J, V525, P330, DOI 10.1086/307867	27	196	196	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					83	85		10.1038/nature11610	http://dx.doi.org/10.1038/nature11610			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23222612	Green Submitted			2022-12-28	WOS:000311893400049
J	Wehrwein, P				Wehrwein, Peter			STEM CELLS Repeat to fade	NATURE			English	Editorial Material																		Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2011, AGING-US, V3, P555, DOI 10.18632/aging.100333; Garbe JC, 2012, CANCER RES, V72, P3687, DOI 10.1158/0008-5472.CAN-12-0157; Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506; Naito AT, 2012, CELL, V149, P1298, DOI 10.1016/j.cell.2012.03.047; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357	7	3	3	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					S12	S13		10.1038/492S12a	http://dx.doi.org/10.1038/492S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23222667	Bronze			2022-12-28	WOS:000311893400007
J	Eva, KW; Reiter, HI; Rosenfeld, J; Trinh, K; Wood, TJ; Norman, GR				Eva, Kevin W.; Reiter, Harold I.; Rosenfeld, Jack; Trinh, Kien; Wood, Timothy J.; Norman, Geoffrey R.			Association Between a Medical School Admission Process Using the Multiple Mini-interview and National Licensing Examination Scores	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DISCIPLINARY ACTION; CLINICAL SKILLS; STUDENTS; VALIDITY; PERFORMANCE; BEHAVIOR; RELIABILITY; PREDICTORS; SELECTION; MCMASTER	Context There has been difficulty designing medical school admissions processes that provide valid measurement of candidates' nonacademic qualities. Objective To determine whether students deemed acceptable through a revised admissions protocol using a 12-station multiple mini-interview (MMI) outperform others on the 2 parts of the Canadian national licensing examinations (Medical Council of Canada Qualifying Examination [MCCQE]). The MMI process requires candidates to rotate through brief sequential interviews with structured tasks and independent assessment within each interview. Design, Setting, and Participants Cohort study comparing potential medical students who were interviewed at McMaster University using an MMI in 2004 or 2005 and accepted (whether or not they matriculated at McMaster) with those who were interviewed and rejected but gained entry elsewhere. The computer-based MCCQE part I (aimed at assessing medical knowledge and clinical decision making) can be taken on graduation from medical school; MCCQE part II (involving simulated patient interactions testing various aspects of practice) is based on the objective structured clinical examination and typically completed 16 months into postgraduate training. Interviews were granted to 1071 candidates, and those who gained entry could feasibly complete both parts of their licensure examination between May 2007 and March 2011. Scores could be matched on the examinations for 751 (part I) and 623 (part II) interviewees. Intervention Admissions decisions were made by combining z score transformations of scores assigned to autobiographical essays, grade point average, and MMI performance. Academic and nonacademic measures contributed equally to the final ranking. Main Outcome Measures Scores on MCCQE part I (standardized cut-score, 390 [SD, 100]) and part II (standardized mean, 500 [SD, 100]). Results Candidates accepted by the admissions process had higher scores than those who were rejected for part I (mean total score, 531 [95% CI, 524-537] vs 515 [95% CI, 507-522]; P=.003) and for part II (mean total score, 563 [95% CI, 556-570] vs 544 [95% CI, 534-554]; P=.007). Among the accepted group, those who matriculated at McMaster did not outperform those who matriculated elsewhere for part I (mean total score, 524 [95% CI, 515-533] vs 546 [95% CI, 535-557]; P=.004) and for part II (mean total score, 557 [95% CI, 548-566] vs 582 [95% CI, 569-594]; P=.003). Conclusion Compared with students who were rejected by an admission process that used MMI assessment, students who were accepted scored higher on Canadian national licensing examinations. JAMA. 2012;308(21):2233-2240 www.jama.com	[Eva, Kevin W.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Reiter, Harold I.] McMaster Univ, Dept Oncol, Hamilton, ON, Canada; [Rosenfeld, Jack] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Trinh, Kien] McMaster Univ, Dept Family Med, Hamilton, ON L8S 4L8, Canada; [Norman, Geoffrey R.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Wood, Timothy J.] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of British Columbia; McMaster University; McMaster University; McMaster University; McMaster University; University of Ottawa	Eva, KW (corresponding author), Ctr Hlth Educ Scholarship, JPPN 3324,910 W 10th Ave, Vancouver, BC V5Z 4E3, Canada.	kevin.eva@ubc.ca		Wood, Timothy/0000-0001-9177-704X				Albanese MA, 2003, ACAD MED, V78, P313, DOI 10.1097/00001888-200303000-00016; Ambady N, 2000, ADV EXP SOC PSYCHOL, V32, P201, DOI 10.1016/S0065-2601(00)80006-4; [Anonymous], QUAL EX 1; [Anonymous], QUAL EX 2; Axelson RD, 2009, MED EDUC, V43, P1198, DOI 10.1111/j.1365-2923.2009.03537.x; Cadieux G, 2011, MED CARE, V49, P156, DOI 10.1097/MLR.0b013e3182028c1a; Dodson M, 2009, MED EDUC, V43, P168, DOI 10.1111/j.1365-2923.2008.03260.x; Ellis APJ, 2002, J APPL PSYCHOL, V87, P1200, DOI 10.1037//0021-9010.87.6.1200; Eva KW, 2011, ACAD MED, V86, pS51, DOI 10.1097/ACM.0b013e31822a6cce; Eva KW, 2009, MED EDUC, V43, P767, DOI 10.1111/j.1365-2923.2009.03407.x; Eva KW, 2004, MED EDUC, V38, P314, DOI 10.1046/j.1365-2923.2004.01776.x; Hofmeister M, 2009, MED EDUC, V43, P573, DOI 10.1111/j.1365-2923.2009.03380.x; Jones P Eugene, 2011, J Physician Assist Educ, V22, P36; Julian ER, 2005, ACAD MED, V80, P910, DOI 10.1097/00001888-200510000-00010; Kulatunga-Moruzi C, 2002, TEACH LEARN MED, V14, P43, DOI 10.1207/S15328015TLM1401_10; Lukis K, PREPARE YOUR DENT SC; Neville AJ, 2007, ACAD MED, V82, P370, DOI 10.1097/ACM.0b013e318033385d; Norman G, 2004, ADV HEALTH SCI EDUC, V9, P79, DOI 10.1023/B:AHSE.0000027553.28703.cf; O'Neill L, 2011, MED EDUC, V45, P1111, DOI 10.1111/j.1365-2923.2011.04057.x; Papadakis MA, 2004, ACAD MED, V79, P244, DOI 10.1097/00001888-200403000-00011; Papadakis MA, 2005, NEW ENGL J MED, V353, P2673, DOI 10.1056/NEJMsa052596; PURYEAR JB, 1981, J MED EDUC, V56, P881; Reibnegger G, 2010, MED EDUC, V44, P205, DOI 10.1111/j.1365-2923.2009.03576.x; Reiter HI, 2007, MED EDUC, V41, P378, DOI 10.1111/j.1365-2929.2007.02709.x; Reiter HI, 2005, TEACH LEARN MED, V17, P4, DOI 10.1207/s15328015tlm1701_2; Rosenfeld JM, 2008, ADV HEALTH SCI EDUC, V13, P43, DOI 10.1007/s10459-006-9029-z; Salvatori P, 2001, ADV HEALTH SCI EDUC, V6, P159, DOI 10.1023/A:1011489618208; Swing Susan R, 2009, J Grad Med Educ, V1, P278, DOI 10.4300/JGME-D-09-00010.1; Tamblyn R, 2007, JAMA-J AM MED ASSOC, V298, P993, DOI 10.1001/jama.298.9.993; Urlings-Strop LC, 2011, MED EDUC, V45, P1032, DOI 10.1111/j.1365-2923.2011.04031.x; Wenghofer E, 2009, MED EDUC, V43, P1166, DOI 10.1111/j.1365-2923.2009.03534.x; Wood TJ, 2006, ADV HEALTH SCI EDUC, V11, P115, DOI 10.1007/s10459-005-7853-1	32	76	76	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2012	308	21					2233	2240		10.1001/jama.2012.36914	http://dx.doi.org/10.1001/jama.2012.36914			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047HI	23212501				2022-12-28	WOS:000311829500015
J	Lane, R				Lane, Richard			Andrew Dobson: taking a macroscopic view of zoonoses	LANCET			English	Biographical-Item														Dobson, Andy/0000-0002-9678-1694				DOBSON A, PUBLICATION LIST	1	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 1	2012	380	9857					1899	1899		10.1016/S0140-6736(12)62098-4	http://dx.doi.org/10.1016/S0140-6736(12)62098-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	046IK	23200490				2022-12-28	WOS:000311758500014
J	Shepherd, A; Ivins, ER; Geruo, A; Barletta, VR; Bentley, MJ; Bettadpur, S; Briggs, KH; Bromwich, DH; Forsberg, R; Galin, N; Horwath, M; Jacobs, S; Joughin, I; King, MA; Lenaerts, JTM; Li, JL; Ligtenberg, SRM; Luckman, A; Luthcke, SB; McMillan, M; Meister, R; Milne, G; Mouginot, J; Muir, A; Nicolas, JP; Paden, J; Payne, AJ; Pritchard, H; Rignot, E; Rott, H; Sorensen, LS; Scambos, TA; Scheuchl, B; Schrama, EJO; Smith, B; Sundal, AV; van Angelen, JH; van de Berg, WJ; van den Broeke, MR; Vaughan, DG; Velicogna, I; Wahr, J; Whitehouse, PL; Wingham, DJ; Yi, DH; Young, D; Zwally, HJ				Shepherd, Andrew; Ivins, Erik R.; Geruo, A.; Barletta, Valentina R.; Bentley, Mike J.; Bettadpur, Srinivas; Briggs, Kate H.; Bromwich, David H.; Forsberg, Rene; Galin, Natalia; Horwath, Martin; Jacobs, Stan; Joughin, Ian; King, Matt A.; Lenaerts, Jan T. M.; Li, Jilu; Ligtenberg, Stefan R. M.; Luckman, Adrian; Luthcke, Scott B.; McMillan, Malcolm; Meister, Rakia; Milne, Glenn; Mouginot, Jeremie; Muir, Alan; Nicolas, Julien P.; Paden, John; Payne, Antony J.; Pritchard, Hamish; Rignot, Eric; Rott, Helmut; Sorensen, Louise Sandberg; Scambos, Ted A.; Scheuchl, Bernd; Schrama, Ernst J. O.; Smith, Ben; Sundal, Aud V.; van Angelen, Jan H.; van de Berg, Willem J.; van den Broeke, Michiel R.; Vaughan, David G.; Velicogna, Isabella; Wahr, John; Whitehouse, Pippa L.; Wingham, Duncan J.; Yi, Donghui; Young, Duncan; Zwally, H. Jay			A Reconciled Estimate of Ice-Sheet Mass Balance	SCIENCE			English	Article							PINE ISLAND GLACIER; RELATIVE SEA-LEVEL; ISOSTATIC-ADJUSTMENT; ANTARCTIC PENINSULA; WEST ANTARCTICA; GREENLAND; MODEL; CLIMATE; SURFACE; SHELF	We combined an ensemble of satellite altimetry, interferometry, and gravimetry data sets using common geographical regions, time intervals, and models of surface mass balance and glacial isostatic adjustment to estimate the mass balance of Earth's polar ice sheets. We find that there is good agreement between different satellite methods-especially in Greenland and West Antarctica-and that combining satellite data sets leads to greater certainty. Between 1992 and 2011, the ice sheets of Greenland, East Antarctica, West Antarctica, and the Antarctic Peninsula changed in mass by -142 +/- 49, +14 +/- 43, -65 +/- 26, and -20 +/- 14 gigatonnes year(-1), respectively. Since 1992, the polar ice sheets have contributed, on average, 0.59 +/- 0.20 millimeter year(-1) to the rate of global sea-level rise.	[Shepherd, Andrew; Briggs, Kate H.; Sundal, Aud V.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Ivins, Erik R.; Velicogna, Isabella] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Geruo, A.; Wahr, John] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Barletta, Valentina R.; Forsberg, Rene; Sorensen, Louise Sandberg] Tech Univ Denmark, DTU SPACE, Geodynam Dept, Natl Space Inst, DK-2880 Lyngby, Denmark; [Bentley, Mike J.; Whitehouse, Pippa L.] Univ Durham, Dept Geog, Durham DH1 3LE, England; [Bettadpur, Srinivas] Univ Texas Austin, Ctr Space Res, Austin, TX 78759 USA; [Bromwich, David H.; Nicolas, Julien P.] Ohio State Univ, Byrd Polar Res Ctr, Polar Meteorol Grp, Columbus, OH 43210 USA; [Bromwich, David H.; Nicolas, Julien P.] Ohio State Univ, Dept Geog, Atmospher Sci Program, Columbus, OH 43210 USA; [Galin, Natalia; Meister, Rakia; Muir, Alan; Wingham, Duncan J.] UCL, Dept Earth Sci, Ctr Polar Observat & Modelling, London WC1E 6BT, England; [Horwath, Martin] Tech Univ Munich, Inst Astron & Phys Geodasie, D-80333 Munich, Germany; [Jacobs, Stan] Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Joughin, Ian; Smith, Ben] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA; [King, Matt A.] Newcastle Univ, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Lenaerts, Jan T. M.; Ligtenberg, Stefan R. M.; van Angelen, Jan H.; van de Berg, Willem J.; van den Broeke, Michiel R.] Univ Utrecht, Inst Marine & Atmospher Res, Utrecht, Netherlands; [Li, Jilu; Paden, John] Univ Kansas, Ctr Remote Sensing Ice Sheets, Lawrence, KS 66045 USA; [Luckman, Adrian] Swansea Univ, Coll Sci, Dept Geog, Swansea SA2 8PP, W Glam, Wales; [Luthcke, Scott B.] NASA, Goddard Space Flight Ctr, Planetary Geodynam Lab, Greenbelt, MD 20771 USA; [Milne, Glenn] Univ Ottawa, Dept Earth Sci, Ottawa, ON K1N 6N5, Canada; [Mouginot, Jeremie; Rignot, Eric; Velicogna, Isabella] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Payne, Antony J.] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England; [Pritchard, Hamish; Vaughan, David G.] British Antarctic Survey, Cambridge CB3 0ET, England; [Rott, Helmut] Univ Innsbruck, Inst Meteorol & Geophys, A-6020 Innsbruck, Austria; [Scambos, Ted A.] Univ Colorado, Natl Snow & Ice Data Ctr, Boulder, CO 80309 USA; [Schrama, Ernst J. O.] Delft Univ Technol, Fac Aerosp Engn, NL-2629 HS Delft, Netherlands; [Yi, Donghui] NASA, Goddard Space Flight Ctr, Cryospher Sci Lab, SGT Inc, Greenbelt, MD 20771 USA; [Young, Duncan] Univ Texas Austin, Inst Geophys, Austin, TX 78759 USA; [Zwally, H. Jay] NASA, Goddard Space Flight Ctr, Cryospher Sci Lab, Greenbelt, MD 20771 USA; [King, Matt A.] Univ Tasmania, Sch Geog & Environm Studies, Hobart, Tas 7001, Australia	University of Leeds; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Colorado System; University of Colorado Boulder; Technical University of Denmark; Durham University; University of Texas System; University of Texas Austin; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of London; University College London; Technical University of Munich; Columbia University; University of Washington; University of Washington Seattle; Newcastle University - UK; Utrecht University; University of Kansas; Swansea University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Ottawa; University of California System; University of California Irvine; University of Bristol; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Innsbruck; University of Colorado System; University of Colorado Boulder; Delft University of Technology; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Stinger Ghaffarian Technologies, Inc. (SGT); University of Texas System; University of Texas Austin; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Tasmania	Shepherd, A (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.	ashepherd@leeds.ac.uk; erik.r.ivins@jpl.nasa.gov	McMillan, Malcolm/K-7712-2014; Bettadpur, Srinivas/M-3744-2014; Luthcke, Scott B/D-6283-2012; Pritchard, Hamish Daniel/AAU-4696-2021; Rignot, Eric/A-4560-2014; Horwath, Martin/ABH-4320-2020; Vaughan, David/C-8348-2011; payne, antony/A-8916-2008; Joughin, Ian/AAR-7778-2021; Bromwich, David/C-9225-2016; Joughin, Ian R/A-2998-2008; Sørensen, Louise Sandberg/E-5282-2014; Ligtenberg, Stefan/AAF-8290-2020; A, Geruo/AAP-3565-2020; Lenaerts, Jan/D-9423-2012; Young, Duncan A./G-6256-2010; Luckman, Adrian/GVS-1716-2022; Bentley, Michael J/F-7386-2011; Velicogna, Isabella/R-5561-2018; van de Berg, Willem Jan/H-4385-2011; Van den Broeke, Michiel R./F-7867-2011; King, Matt/B-4622-2008; Mouginot, Jeremie/G-7045-2015; Horwath, Martin/F-9239-2011	Rignot, Eric/0000-0002-3366-0481; payne, antony/0000-0001-8825-8425; Joughin, Ian/0000-0001-6229-679X; Joughin, Ian R/0000-0001-6229-679X; Sørensen, Louise Sandberg/0000-0002-3771-4061; A, Geruo/0000-0001-5714-402X; Lenaerts, Jan/0000-0003-4309-4011; Young, Duncan A./0000-0002-6866-8176; Bentley, Michael J/0000-0002-2048-0019; Velicogna, Isabella/0000-0002-9020-1898; van de Berg, Willem Jan/0000-0002-8232-2040; Van den Broeke, Michiel R./0000-0003-4662-7565; King, Matt/0000-0001-5611-9498; Mouginot, Jeremie/0000-0001-9155-5455; Horwath, Martin/0000-0001-5797-244X; Muir, Alan/0000-0001-7754-088X; Forsberg, Rene/0000-0002-7288-9545; Shepherd, Andrew/0000-0002-4914-1299; Bettadpur, Srinivas/0000-0003-3885-2228; Yi, Donghui/0000-0001-6363-5538; Vaughan, David/0000-0002-9065-0570; Luckman, Adrian/0000-0002-9618-5905; SCHRAMA, ERNST/0000-0002-9654-4082; McMillan, Malcolm/0000-0002-5113-0177; Barletta, Valentina Roberta/0000-0003-4427-0830; Whitehouse, Pippa/0000-0002-9092-3444	Phillip Leverhulme Prize award; European Union [125]; NASA [NNX09AE47G, NNX08AD64G]; Netherlands Organization for Scientific Research; Netherlands Polar Program; UK Natural Environment Research Council; NSF; Lamont Doherty Earth Observatory; NERC [cpom20001, NE/E004806/1, NE/E007023/1, NE/I010874/1, NE/F014260/1, NE/E014089/1] Funding Source: UKRI; Natural Environment Research Council [cpom20001, NE/F014260/1, earth010006, NE/E007023/1, NE/E004806/1, NE/E014089/1, bas0100027, NE/I010874/1] Funding Source: researchfish	Phillip Leverhulme Prize award; European Union(European Commission); NASA(National Aeronautics & Space Administration (NASA)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Polar Program; UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NSF(National Science Foundation (NSF)); Lamont Doherty Earth Observatory; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This Ice Sheet Mass Balance Exercise (IMBIE) was facilitated by the European Space Agency and NASA and by a Phillip Leverhulme Prize awarded to A. S. The work was additionally supported by the European Union Framework Programme 7 ice2sea program (ice2sea publication 125), the Lamont Doherty Earth Observatory, NASA (grants NNX09AE47G and NNX08AD64G), the Netherlands Organization for Scientific Research, the Netherlands Polar Program, the UK Natural Environment Research Council, and the NSF. Antarctic glacier ice thickness data used in the IOM calculations were acquired by NASA IceBridge and the Centro de Estudios Cientifico Chile, and additional estimates were provided by J. Bamber and J. Griggs. E. van Meijgaard provided assistance with the RACMO model.	Ackert RP, 2011, EARTH PLANET SC LETT, V307, P83, DOI 10.1016/j.epsl.2011.04.015; Berthier E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051755; Bevis M, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002642; Bindoff NL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P385; Boening C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053316; Bracegirdle TJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008933; Chen JL, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007789; Church JA, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P639; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Davis CH, 2005, SCIENCE, V308, P1898, DOI 10.1126/science.1110662; De Angelis H, 2003, SCIENCE, V299, P1560, DOI 10.1126/science.1077987; Ettema J, 2010, CRYOSPHERE, V4, P511, DOI 10.5194/tc-4-511-2010; Ettema J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038110; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fettweis X, 2011, CRYOSPHERE, V5, P359, DOI 10.5194/tc-5-359-2011; Fleming K, 2004, QUATERNARY SCI REV, V23, P1053, DOI 10.1016/j.quascirev.2003.11.001; Giovinetto MB, 2000, ANN GLACIOL-SER, V31, P171, DOI 10.3189/172756400781820200; Gogineni S, 2001, J GEOPHYS RES-ATMOS, V106, P33761, DOI 10.1029/2001JD900183; Goodwin I., 2003, J GEOPHYS RES, V108, P16; Gunter B, 2009, J GEODESY, V83, P1051, DOI 10.1007/s00190-009-0323-4; Hein AS, 2011, EARTH PLANET SC LETT, V307, P211, DOI 10.1016/j.epsl.2011.04.037; Hock R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037020; Holland DM, 2008, NAT GEOSCI, V1, P659, DOI 10.1038/ngeo316; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; Ivins ER, 2005, ANTARCT SCI, V17, P541, DOI 10.1017/S0954102005002968; Ivins ER, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007607; Jacobs SS, 2011, NAT GEOSCI, V4, P519, DOI [10.1038/NGEO1188, 10.1038/ngeo1188]; Jenkins A, 2010, NAT GEOSCI, V3, P468, DOI 10.1038/NGEO890; Johannessen OM, 2005, SCIENCE, V310, P1013, DOI 10.1126/science.1115356; Joughin I, 2004, NATURE, V432, P608, DOI 10.1038/nature03130; Joughin I, 2008, SCIENCE, V320, P781, DOI 10.1126/science.1153288; Joughin I, 2010, J GLACIOL, V56, P415, DOI 10.3189/002214310792447734; Krabill W, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021533; Krinner G, 2007, CLIM DYNAM, V28, P215, DOI 10.1007/s00382-006-0177-x; Lemke P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P337; Lenaerts JTM, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016145; Lenaerts JTM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050713; Li J, 2011, ANN GLACIOL, V52, P1, DOI 10.3189/172756411799096321; Ligtenberg SRM, 2011, CRYOSPHERE, V5, P809, DOI 10.5194/tc-5-809-2011; Luthcke SB, 2006, SCIENCE, V314, P1286, DOI 10.1126/science.1130776; Luthcke SB, 2008, J GLACIOL, V54, P767, DOI 10.3189/002214308787779933; Mackintosh A, 2011, NAT GEOSCI, V4, P195, DOI 10.1038/NGEO1061; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Monaghan AJ, 2006, SCIENCE, V313, P827, DOI 10.1126/science.1128243; Moon T, 2012, SCIENCE, V336, P576, DOI 10.1126/science.1219985; Munneke PK, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015113; OHMURA A, 1991, J GLACIOL, V37, P140; Payne AJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021284; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Rignot E, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020697; Rignot E, 2002, SCIENCE, V297, P1502, DOI 10.1126/science.1073888; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Rignot E, 2011, SCIENCE, V333, P1427, DOI 10.1126/science.1208336; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Rignot E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035417; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Riva REM, 2009, EARTH PLANET SC LETT, V288, P516, DOI 10.1016/j.epsl.2009.10.013; Rott H, 2011, CRYOSPHERE, V5, P125, DOI 10.5194/tc-5-125-2011; Rott H, 1996, SCIENCE, V271, P788, DOI 10.1126/science.271.5250.788; Schrama EJO, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2009JB006847; Shepherd A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014183; Shepherd A, 2001, SCIENCE, V291, P862, DOI 10.1126/science.291.5505.862; Shepherd A, 2007, SCIENCE, V315, P1529, DOI 10.1126/science.1136776; Shepherd A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042496; Shuman CA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025227; Simpson MJR, 2009, QUATERNARY SCI REV, V28, P1631, DOI 10.1016/j.quascirev.2009.03.004; Tapley BD, 2004, SCIENCE, V305, P503, DOI 10.1126/science.1099192; Tarasov L, 2002, GEOPHYS J INT, V150, P198, DOI 10.1046/j.1365-246X.2002.01702.x; Tedesco M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/1/014005; Thomas ID, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049277; Todd C, 2010, QUATERNARY SCI REV, V29, P1328, DOI 10.1016/j.quascirev.2010.02.001; Turner J., 2009, ANTARCTIC CLIMATE CH; Uotila P, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007482; van de Berg W. J., 2008, THESIS UTRECHT U UTR; van den Broeke M, 2009, SCIENCE, V326, P984, DOI 10.1126/science.1178176; van Meijgaard E., 2008, KNMI REGIONAL ATMOSP; Vaughan DG, 1999, J CLIMATE, V12, P933, DOI 10.1175/1520-0442(1999)012<0933:RONSMB>2.0.CO;2; Velicogna I, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023955; Velicogna I, 2006, SCIENCE, V311, P1754, DOI 10.1126/science.1123785; Velicogna I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040222; Velicogna I, 2006, NATURE, V443, P329, DOI 10.1038/nature05168; Wahr J, 2000, J GEOPHYS RES-SOL EA, V105, P16279, DOI 10.1029/2000JB900113; Whitehouse PL, 2012, GEOPHYS J INT, V190, P1464, DOI 10.1111/j.1365-246X.2012.05557.x; Whitehouse PL, 2012, QUATERNARY SCI REV, V32, P1, DOI 10.1016/j.quascirev.2011.11.016; Wingham DJ, 2006, PHILOS T R SOC A, V364, P1627, DOI 10.1098/rsta.2006.1792; Wingham DJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039126; Wingham DJ, 1998, SCIENCE, V282, P456, DOI 10.1126/science.282.5388.456; Zwally HJ, 2005, J GLACIOL, V51, P509, DOI 10.3189/172756505781829007; Zwally HJ, 2011, SURV GEOPHYS, V32, P351, DOI 10.1007/s10712-011-9123-5; Zwally HJ, 2011, J GLACIOL, V57, P88, DOI 10.3189/002214311795306682; ZWALLY HJ, 1989, SCIENCE, V246, P1587, DOI 10.1126/science.246.4937.1587; [No title captured]	93	993	1011	15	589	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1183	1189		10.1126/science.1228102	http://dx.doi.org/10.1126/science.1228102			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197528	Green Submitted			2022-12-28	WOS:000311666200039
J	Leinonen, MK; Nieminen, P; Lonnberg, S; Malila, N; Hakama, M; Pokhrel, A; Laurila, P; Tarkkanen, J; Anttila, A				Leinonen, Maarit K.; Nieminen, Pekka; Lonnberg, Stefan; Malila, Nea; Hakama, Matti; Pokhrel, Arun; Laurila, Pekka; Tarkkanen, Jussi; Anttila, Ahti			Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland	BRITISH MEDICAL JOURNAL			English	Article							INTRAEPITHELIAL NEOPLASIA; CYTOLOGY; WOMEN; ADENOCARCINOMA; COHORT	Objective To compare the detection rates of precancerous and cancerous cervical lesions by human papillomavirus (HPV) DNA testing and by conventional cytology screening. Design Prospective randomised trial. Two cohorts were followed over one screening round of five years, screened initially by primary HPV DNA testing or by primary Pap test. Setting Population based programme for cervical cancer screening in Finland. Participants Women aged 25-65 years invited for screening in 2003-07 (101 678 in HPV arm; 101 747 in conventional cytology arm). Intervention Women were randomly allocated (1: 1) to primary HPV DNA screening followed by cytology triage if they had positive results, or to primary cytology screening. Screening method was disclosed at the screening visit. Trial personnel involved were aware of all test results. Main outcome measures Cumulative detection rates of cervical intraepithelial neoplasia (CIN), adenocarcinoma in situ (AIS), and invasive cervical cancer before the second screening (after five years) or before 31 December 2008. Lesions detected at screening and during the five year interval were included. Results 1010 and 701 precancerous or cancerous lesions were detected during an average follow-up of 3.6 years in the HPV and cytology arms, respectively. Among invited women, the hazard ratio was 1.53 (95% confidence interval l. 28 to 1.84) for CIN grade 1, 1.54 (1.33 to 1.78) for CIN 2, 1.32 (1.09 to 1.59) for CIN 3 or AIS, and 0.81 (0.48 to 1.37) for cervical cancer. In 25-34 year old participants, the cumulative hazard (or cumulative detection rate) was 0.0057 (0.0045 to 0.0072) for HPV screening versus 0.0046 (0.0035 to 0.0059) for conventional screening; corresponding data for women aged 35 years and older were 0.0022 (0.0019 to 0.0026) and 0.0017 (0.0014 to 0.0021), respectively. Conclusions Primary HPV DNA screening detects more cervical lesions than primary cytology within one screening round of five years. Even if the detection rate of CIN 3 or AIS increased in the HPV arm in both age groups, the absolute difference in cumulative rates in women aged 35 years or older was small. By carefully selecting age groups and screening intervals, HPV screening could increase the overall detection rate of cervical precancerous lesions only slightly. However, these findings should be interpreted in the context of the high level of opportunistic screening that occurs in Finland.	[Leinonen, Maarit K.; Lonnberg, Stefan; Malila, Nea; Hakama, Matti; Anttila, Ahti] Finnish Canc Registry, Mass Screening Registry, FI-00130 Helsinki, Finland; [Nieminen, Pekka] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, Espoo, Finland; [Malila, Nea; Hakama, Matti] Univ Tampere, Tampere Sch Hlth Sci, FIN-33101 Tampere, Finland; [Laurila, Pekka; Tarkkanen, Jussi] Univ Helsinki, Cent Hosp, Dept Pathol, HUSLAB, Helsinki, Finland	Finnish Cancer Registry; University of Helsinki; Helsinki University Central Hospital; Tampere University; University of Helsinki; Helsinki University Central Hospital	Leinonen, MK (corresponding author), Finnish Canc Registry, Mass Screening Registry, FI-00130 Helsinki, Finland.	maarit.leinonen@cancer.fi	Leinonen, Maarit/AAP-7165-2020; Leinonen, Maarit/AAX-3832-2020; Nieminen, Pekka/W-8570-2019	Leinonen, Maarit/0000-0002-7631-4749; Lonnberg, Stefan/0000-0002-5561-9041	Academy of Finland; European Union through the action programme Europe Against Cancer; Finnish Cancer Organisations; Finnish Medical Society Duodecim	Academy of Finland(Academy of Finland); European Union through the action programme Europe Against Cancer; Finnish Cancer Organisations; Finnish Medical Society Duodecim	This study was supported by research grants from the Academy of Finland, the European Union through the action programme Europe Against Cancer, the Finnish Cancer Organisations, and the Finnish Medical Society Duodecim. The funders had no role in study design, data collection, data analysis, data interpretation, writing of the report or the decision to submit it for publication.	[Anonymous], 282011 NIH WELF WORK; Anttila A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-252; Arbyn M, 2008, EUROPEAN GUIDELINES; Arbyn M, 2009, EUR J CANCER, V45, P2640, DOI 10.1016/j.ejca.2009.07.018; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754; *INT AG RES CANC, 2007, IARC MON EV CARC RIS; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Leinonen M, 2009, JNCI-J NATL CANCER I, V101, P1612, DOI 10.1093/jnci/djp367; Lonnberg S, 2012, ACTA ONCOL, V51, P37, DOI 10.3109/0284186X.2011.593547; Lynge E, 2009, EUR J CANCER, V45, P2714, DOI 10.1016/j.ejca.2009.07.024; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Meijer CJLM, 2009, INT J CANCER, V124, P516, DOI 10.1002/ijc.24010; Moscicki AB, 2004, LANCET, V364, P1678, DOI 10.1016/S0140-6736(04)17354-6; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Naucler P, 2009, JNCI-J NATL CANCER I, V101, P88, DOI 10.1093/jnci/djn444; NIEMINEN P, 1995, OBSTET GYNECOL, V85, P1017, DOI 10.1016/0029-7844(95)00063-W; Rijkaart DC, 2012, LANCET ONCOL, V13, P78, DOI 10.1016/S1470-2045(11)70296-0; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sasieni P, 2009, BRIT MED J, V339, pb2968, DOI DOI 10.1136/BMJ.B2968; Sasieni P, 2009, INT J CANCER, V125, P525, DOI 10.1002/ijc.24410	23	65	68	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 29	2012	345								e7789	10.1136/bmj.e7789	http://dx.doi.org/10.1136/bmj.e7789			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048FR	23197596	hybrid, Green Published			2022-12-28	WOS:000311896300002
J	Monterroso, J; Chandana, S				Monterroso, Joanne; Chandana, Sreenivasa			Massive Splenomegaly in Hairy-Cell Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Monterroso, Joanne] Western Michigan Univ, Sch Med, Kalamazoo, MI 49008 USA; [Chandana, Sreenivasa] W Michigan Canc Ctr, Kalamazoo, MI USA	Western Michigan University	Monterroso, J (corresponding author), Western Michigan Univ, Sch Med, Kalamazoo, MI 49008 USA.								0	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2012	367	22					2133	2133		10.1056/NEJMicm1013222	http://dx.doi.org/10.1056/NEJMicm1013222			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044MS	23190224				2022-12-28	WOS:000311624400011
J	Hernandez, AF; Mi, XJ; Hammill, BG; Hammill, SC; Heidenreich, PA; Masoudi, FA; Qualls, LG; Peterson, ED; Fonarow, GC; Curtis, LH				Hernandez, Adrian F.; Mi, Xiaojuan; Hammill, Bradley G.; Hammill, Stephen C.; Heidenreich, Paul A.; Masoudi, Frederick A.; Qualls, Laura G.; Peterson, Eric D.; Fonarow, Gregg C.; Curtis, Lesley H.			Associations Between Aldosterone Antagonist Therapy and Risks of Mortality and Readmission Among Patients With Heart Failure and Reduced Ejection Fraction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR DYSFUNCTION; CLINICAL-TRIALS; OLDER PATIENTS; SPIRONOLACTONE; HYPERKALEMIA; STATES; RATES; CARE	Context Aldosterone antagonist therapy for heart failure and reduced ejection fraction has been highly efficacious in randomized trials. However, questions remain regarding the effectiveness and safety of the therapy in clinical practice. Objective To examine the clinical effectiveness of newly initiated aldosterone antagonist therapy among older patients hospitalized with heart failure and reduced ejection fraction. Design, Setting, and Participants Using clinical registry data linked to Medicare claims from 2005 through 2010, we examined outcomes of eligible patients hospitalized with heart failure and reduced ejection fraction. We used Cox proportional hazards models and inverse-weighted estimates of the probability of treatment to adjust for treatment selection bias. Main Outcome Measures All-cause mortality, cardiovascular readmission, and heart failure readmission at 3 years, and hyperkalemia readmission at 30 days and 1 year. Results Among 5887 patients who met the inclusion criteria, the mean age was 77.6 years; of those 1070 (18.2%) started aldosterone antagonist therapy at discharge. Cumulative incidence rates among treated and untreated patients were 49.9% vs 51.2% (P=.62) for mortality; 63.8% vs 63.9% (P=.65) for cardiovascular readmission; and 38.7% vs 44.9% (P<.001) for heart failure readmission at 3 years; and 2.9% vs 1.2% (P<.001) for hyperkalemia readmission within 30 days and 8.9% vs 6.3% (P=.002) within 1 year. After inverse weighting for the probability of treatment, there were no significant differences in mortality (hazard ratio [HR], 1.04; 95% CI, 0.96-1.14; P=.32) and cardiovascular readmission (HR, 1.00; 95% CI, 0.91-1.09; P=.94). Heart failure readmission was lower among treated patients at 3 years (HR, 0.87; 95% CI, 0.77-0.98; P=.02). Readmission associated with hyperkalemia was higher with aldosterone antagonist therapy at 30 days (HR, 2.54; 95% CI, 1.51-4.29; P<.001) and 1 year (HR, 1.50; 95% CI, 1.23-1.84; P<.001). Conclusions Initiation of aldosterone antagonist therapy at hospital discharge was not independently associated with improved mortality or cardiovascular readmission but was associated with improved heart failure readmission among eligible older patients with heart failure and reduced ejection fraction. There was a significant increase in the risk of readmission with hyperkalemia, predominantly within 30 days after discharge. JAMA. 2012;308(20):2097-2107 www.jama.com	[Hernandez, Adrian F.; Mi, Xiaojuan; Qualls, Laura G.; Peterson, Eric D.; Curtis, Lesley H.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27715 USA; [Hernandez, Adrian F.; Peterson, Eric D.; Curtis, Lesley H.] Duke Univ, Sch Med, Dept Med, Durham, NC 27715 USA; Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Heidenreich, Paul A.] VA Palo Alto Healthcare Syst, Palo Alto, CA USA; [Masoudi, Frederick A.] Univ Colorado Anschutz Med Campus, Aurora, CO USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA	Duke University; Duke University; Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Los Angeles	Hernandez, AF (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	adrian.hernandez@duke.edu	Peterson, Eric David/ABF-5033-2021; Masoudi, Frederick/Q-7467-2019; Fonarow, Gregg C/D-5988-2014; Heidenreich, Paul/AAU-6864-2021; Hernandez, Adrian F/A-7818-2016	Fonarow, Gregg C/0000-0002-3192-8093; Heidenreich, Paul/0000-0001-7730-8490; Hernandez, Adrian F/0000-0003-3387-9616	Amylin Pharmaceutical; Johnson Johnson; American College of Cardiology; Oklahoma Foundation for Medical Quality; American Heart Association; Massachusetts Medical Society; Eli Lilly Co; GlaxoSmithKline; Ahmanson Foundation; National Heart, Lung, and Blood Institute; (Duke University DEcIDE Center) from the Agency for Healthcare Research and Quality, US Department of Health and Human Services [HHSA29020050032I]; Agency for Healthcare Research and Quality [U19HS021092]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U19HS021092] Funding Source: NIH RePORTER	Amylin Pharmaceutical(Bristol-Myers Squibb); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); American College of Cardiology(General Electric); Oklahoma Foundation for Medical Quality; American Heart Association(American Heart Association); Massachusetts Medical Society; Eli Lilly Co(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Ahmanson Foundation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); (Duke University DEcIDE Center) from the Agency for Healthcare Research and Quality, US Department of Health and Human Services; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Hernandez reported receiving grant funding from Amylin Pharmaceutical and Johnson & Johnson; and receiving honoraria from AstraZeneca, Corthera, and sanofi-aventis. Dr Masoudi reported receiving salary support through his institution from the American College of Cardiology and the Oklahoma Foundation for Medical Quality; and receiving payment for editorial board service from the American Heart Association and the Massachusetts Medical Society. Dr Peterson reported receiving grant funding from Eli Lilly& Co and Johnson & Johnson. Dr Fonarow reported receiving grant funding and other research support from GlaxoSmithKline; receiving honoraria from Boston Scientific/Guidant, GlaxoSmithKline, Medtronic, Merck, Novartis, Pfizer, and St Jude Medical; and serving as a consultant for Amgen, Gambro, GlaxoSmithKline, Medtronic, Merck, Novartis, Pfizer, Relypsa, Scios, and St Jude Medical. Dr Fonarow holds the Eliot Corday Chair of Cardiovascular Medicine at UCLA and is also supported by the Ahmanson Foundation. Dr Curtis reported receiving grant funding from GlaxoSmithKline, Johnson & Johnson, and the National Heart, Lung, and Blood Institute. Drs Hernandez, Setoguchi, Peterson, and Curtis have made available online detailed listings of financial disclosures (https://www.dcri.org/about-us/conflict-of-interest).; This study was funded under contract number HHSA29020050032I (Duke University DEcIDE Center) from the Agency for Healthcare Research and Quality, US Department of Health and Human Services, as part of the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) program. Dr Peterson was supported in part by grant number U19HS021092 from the Agency for Healthcare Research and Quality. Get With the Guidelines-Heart Failure is provided by the American Heart Association; is currently supported in part by Medtronic, Ortho-McNeil, and the American Heart Association Pharmaceutical Roundtable; and had been funded through support from GlaxoSmithKline.	Albert NM, 2009, JAMA-J AM MED ASSOC, V302, P1658, DOI 10.1001/jama.2009.1493; Austin PC, 2006, STAT MED, V25, P2084, DOI 10.1002/sim.2328; Cherubini A, 2011, ARCH INTERN MED, V171, P550, DOI 10.1001/archinternmed.2011.31; Curtis LH, 2007, MED CARE, V45, pS103, DOI 10.1097/MLR.0b013e31806518ac; Curtis LH, 2012, AM HEART J, V163, P946, DOI 10.1016/j.ahj.2012.03.007; Dreyer NA, 2010, AM J MANAG CARE, V16, P467; Ezekowitz JA, 2009, EUR HEART J, V30, P469, DOI 10.1093/eurheartj/ehn543; Fonarow GC, 2004, AM HEART J, V148, P43, DOI 10.1016/j.ahj.2004.03.004; Fonarow GC, 2012, J AM HEART ASSOC, V1, P16, DOI 10.1161/JAHA.111.000018; Fonarow GC, 2011, AM HEART J, V161, P1024, DOI 10.1016/j.ahj.2011.01.027; Fonarow GC, 2011, CIRCULATION, V123, P1601, DOI 10.1161/CIRCULATIONAHA.110.989632; Ghali JK, 2010, J AM COLL CARDIOL, V56, P2077, DOI 10.1016/j.jacc.2010.07.013; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hamaguchi S, 2010, AM HEART J, V160, P1156, DOI 10.1016/j.ahj.2010.08.036; Hammill BG, 2009, AM HEART J, V157, P995, DOI 10.1016/j.ahj.2009.04.002; Heiat A, 2002, ARCH INTERN MED, V162, P1682, DOI 10.1001/archinte.162.15.1682; Hernandez AF, 2010, AM HEART J, V159, P406, DOI 10.1016/j.ahj.2009.12.024; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jessup M, 2009, J AM COLL CARDIOL, V53, P1343, DOI 10.1016/j.jacc.2008.11.009; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Levine M, 2008, USERS GUIDES MED LIT, P363; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; MANTEL N, 1974, J AM STAT ASSOC, V69, P81, DOI 10.2307/2285503; Masoudi FA, 2005, CIRCULATION, V112, P39, DOI 10.1161/CIRCULATIONAHA.104.527549; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Sox HC, 2009, ANN INTERN MED, V151, P203, DOI 10.7326/0003-4819-151-3-200908040-00125; Tamirisa KP, 2004, AM HEART J, V148, P971, DOI 10.1016/j.ahj.2004.10.005; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	32	99	101	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2012	308	20					2097	2107		10.1001/jama.2012.14795	http://dx.doi.org/10.1001/jama.2012.14795			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043IV	23188026	Bronze			2022-12-28	WOS:000311537200024
J	Senyo, SE; Steinhauser, ML; Pizzimenti, CL; Yang, VK; Cai, L; Wang, M; Wu, TD; Guerquin-Kern, JL; Lechene, CP; Lee, RT				Senyo, Samuel E.; Steinhauser, Matthew L.; Pizzimenti, Christie L.; Yang, Vicky K.; Cai, Lei; Wang, Mei; Wu, Ting-Di; Guerquin-Kern, Jean-Luc; Lechene, Claude P.; Lee, Richard T.			Mammalian heart renewal by pre-existing cardiomyocytes	NATURE			English	Article							STEM-CELLS; MOUSE; REGENERATION; TURNOVER	Although recent studies have revealed that heart cells are generated in adult mammals, the frequency of generation and the source of new heart cells are not yet known. Some studies suggest a high rate of stem cell activity with differentiation of progenitors to cardiomyocytes(1). Other studies suggest that new cardiomyocytes are born at a very low rate(2-4), and that they may be derived from the division of pre-existing cardiomyocytes. Here we show, by combining two different pulse-chase approaches-genetic fate-mapping with stable isotope labelling, and multi-isotope imaging mass spectrometry-that the genesis of cardiomyocytes occurs at a low rate by the division of pre-existing cardiomyocytes during normal ageing, a process that increases adjacent to areas of myocardial injury. We found that cell cycle activity during normal ageing and after injury led to polyploidy and multinucleation, but also to new diploid, mononucleate cardiomyocytes. These data reveal pre-existing cardiomyocytes as the dominant source of cardiomyocyte replacement in normal mammalian myocardial homeostasis as well as after myocardial injury.	[Senyo, Samuel E.; Steinhauser, Matthew L.; Pizzimenti, Christie L.; Yang, Vicky K.; Cai, Lei; Lee, Richard T.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Cambridge, MA 02139 USA; [Senyo, Samuel E.; Steinhauser, Matthew L.; Pizzimenti, Christie L.; Yang, Vicky K.; Cai, Lei; Wang, Mei; Lechene, Claude P.; Lee, Richard T.] Harvard Univ, Sch Med, Cambridge, MA 02139 USA; [Wu, Ting-Di; Guerquin-Kern, Jean-Luc] INSERM, U759, F-91405 Orsay, France; [Wu, Ting-Di; Guerquin-Kern, Jean-Luc] Inst Curie, Lab Microscopie Ion, F-91405 Orsay, France; [Wang, Mei; Lechene, Claude P.] Natl Resource Imaging Mass Spectrometry, Cambridge, MA 02139 USA; [Wang, Mei; Lechene, Claude P.] Brigham & Womens Hosp, Dept Med, Div Genet, Cambridge, MA 02139 USA; [Lee, Richard T.] Harvard Stem Cell Inst, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Harvard University; Brigham & Women's Hospital; Harvard University	Lee, RT (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Cambridge, MA 02139 USA.	rlee@partners.org	Guerquin-Kern, Jean-Luc/M-5000-2018; Steinhauser, Matthew L./GVT-6393-2022	Guerquin-Kern, Jean-Luc/0000-0002-8610-0146; Steinhauser, Matthew L./0000-0001-5287-9246; Senyo, Samuel/0000-0002-9206-6845; WU, Ting-Di/0000-0002-6398-0363; Lee, Richard/0000-0003-4687-1381	National Institutes of Health (NIH) [F32 HL108570, K08 DK090147, EB001974, AG034641, AG032977, AG040019]; American Heart Association (AHA FTF); Future Leaders in Cardiovascular Medicine; Watkins Cardiovascular Leadership Award; Ellison Medical Foundation [AG-SS-2215-08]; Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL108570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P20EB001974, P41EB001974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040019, R21AG034641, R01AG032977] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA FTF)(American Heart Association); Future Leaders in Cardiovascular Medicine; Watkins Cardiovascular Leadership Award; Ellison Medical Foundation(Lawrence Ellison Foundation); Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Gannon for surgical assistance; J. Lammerding and P. Isserman for assistance with microscopy and IP Lab software; and C. MacGillivray for histology; and J. C. Poczatek and Z. Kaufman for assistance with OpenMIMS Data Analysis and image data processing. S. E. S. is funded by the National Institutes of Health (NIH; F32 HL108570). M. L. S. is funded by the American Heart Association (AHA FTF), Future Leaders in Cardiovascular Medicine, Watkins Cardiovascular Leadership Award and the NIH (K08 DK090147). C. P. L. is funded by the NIH (EB001974 and AG034641) and the Ellison Medical Foundation (AG-SS-2215-08). R. T. L. is funded by the NIH (AG032977 and AG040019) and the Harvard Stem Cell Institute.	ADLER CP, 1986, J MOL CELL CARDIOL, V18, P39, DOI 10.1016/S0022-2828(86)80981-6; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2011, EXP CELL RES, V317, P188, DOI 10.1016/j.yexcr.2010.08.017; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Dong F, 2012, CIRCULATION, V126, P314, DOI 10.1161/CIRCULATIONAHA.111.082453; Hosoda T, 2011, J THROMB HAEMOST, V9, P151, DOI 10.1111/j.1538-7836.2011.04363.x; Hosoda T, 2009, P NATL ACAD SCI USA, V106, P17169, DOI 10.1073/pnas.0903089106; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Hu VW, 2002, FASEB J, V16, P1456, DOI 10.1096/fj.02-0142fje; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498; KATZBERG AA, 1977, AM J ANAT, V149, P489, DOI 10.1002/aja.1001490406; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; KLEIN PD, 1986, J CLIN PHARMACOL, V26, P378, DOI 10.1002/j.1552-4604.1986.tb03544.x; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Soonpaa MH, 1997, AM J PHYSIOL-HEART C, V272, pH220, DOI 10.1152/ajpheart.1997.272.1.H220; Steinhauser ML, 2012, NATURE, V481, P516, DOI 10.1038/nature10734; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhang DS, 2012, NATURE, V481, P520, DOI 10.1038/nature10745	27	862	904	7	203	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					433	U186		10.1038/nature11682	http://dx.doi.org/10.1038/nature11682			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23222518	Green Accepted, Green Submitted			2022-12-28	WOS:000313615900058
J	Marchioli, R; Finazzi, G; Specchia, G; Cacciola, R; Cavazzina, R; Cilloni, D; De Stefano, V; Elli, E; Iurlo, A; Latagliata, R; Lunghi, F; Lunghi, M; Marfisi, RM; Musto, P; Masciulli, A; Musolino, C; Cascavilla, N; Quarta, G; Randi, ML; Rapezzi, D; Ruggeri, M; Rumi, E; Scortechini, AR; Santini, S; Scarano, M; Siragusa, S; Spadea, A; Tieghi, A; Angelucci, E; Visani, G; Vannucchi, AM; Barbui, T				Marchioli, Roberto; Finazzi, Guido; Specchia, Giorgina; Cacciola, Rossella; Cavazzina, Riccardo; Cilloni, Daniela; De Stefano, Valerio; Elli, Elena; Iurlo, Alessandra; Latagliata, Roberto; Lunghi, Francesca; Lunghi, Monia; Marfisi, Rosa Maria; Musto, Pellegrino; Masciulli, Arianna; Musolino, Caterina; Cascavilla, Nicola; Quarta, Giovanni; Randi, Maria Luigia; Rapezzi, Davide; Ruggeri, Marco; Rumi, Elisa; Scortechini, Anna Rita; Santini, Simone; Scarano, Marco; Siragusa, Sergio; Spadea, Antonio; Tieghi, Alessia; Angelucci, Emanuele; Visani, Giuseppe; Vannucchi, Alessandro Maria; Barbui, Tiziano		CYTO-PV Collaborative Grp	Cardiovascular Events and Intensity of Treatment in Polycythemia Vera	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ESSENTIAL THROMBOCYTHEMIA; RECURRENT THROMBOSIS; RISK-FACTOR; HEMATOCRIT; LEUKOCYTOSIS; PREVENTION; DIAGNOSIS; EFFICACY; WARFARIN; SAFETY	BACKGROUND Current treatment recommendations for patients with polycythemia vera call for maintaining a hematocrit of less than 45%, but this therapeutic strategy has not been tested in a randomized clinical trial. METHODS We randomly assigned 365 adults with JAK2-positive polycythemia vera who were being treated with phlebotomy, hydroxyurea, or both to receive either more intensive treatment (target hematocrit, <45%) (low-hematocrit group) or less intensive treatment (target hematocrit, 45 to 50%) (high-hematocrit group). The primary composite end point was the time until death from cardiovascular causes or major thrombotic events. The secondary end points were cardiovascular events, cardiovascular hospitalizations, incidence of cancer, progression to myelofibrosis, myelodysplasia or leukemic transformation, and hemorrhage. An intention-to-treat analysis was performed. RESULTS After a median follow-up of 31 months, the primary end point was recorded in 5 of 182 patients in the low-hematocrit group (2.7%) and 18 of 183 patients in the high-hematocrit group (9.8%) (hazard ratio in the high-hematocrit group, 3.91; 95% confidence interval [CI], 1.45 to 10.53; P = 0.007). The primary end point plus superficial-vein thrombosis occurred in 4.4% of patients in the low-hematocrit group, as compared with 10.9% in the high-hematocrit group (hazard ratio, 2.69; 95% CI, 1.19 to 6.12; P = 0.02). Progression to myelofibrosis, myelodysplasia or leukemic transformation, and bleeding were observed in 6, 2, and 2 patients, respectively, in the low-hematocrit group, as compared with 2, 1, and 5 patients, respectively, in the high-hematocrit group. There was no significant between-group difference in the rate of adverse events. CONCLUSIONS In patients with polycythemia vera, those with a hematocrit target of less than 45% had a significantly lower rate of cardiovascular death and major thrombosis than did those with a hematocrit target of 45 to 50%. (Funded by the Italian Medicines Agency and others; ClinicalTrials.gov number, NCT01645124, and EudraCT number, 2007-006694-91.)	[Marchioli, Roberto; Cavazzina, Riccardo; Marfisi, Rosa Maria; Masciulli, Arianna; Scarano, Marco] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, I-66030 Santa Maria Imbaro, Italy; [Finazzi, Guido; Barbui, Tiziano] Osped Riuniti Bergamo, Unit Hematol & Transplant, I-24100 Bergamo, Italy; [Specchia, Giorgina] Azienda Osped Univ Osped Consorziale Policlin Bar, Div Hematol, Bari, Italy; [Cacciola, Rossella] Osped Ferrarotto Alessi Catania, Unit Hematol & Bone Marrow Transplant, Catania, Italy; [Cilloni, Daniela] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Cilloni, Daniela] San Luigi Gonzaga Hosp, Orbassano, Italy; [De Stefano, Valerio] Univ Cattolica Sacro Cuore, Hematol Unit, Rome, Italy; [Latagliata, Roberto] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy; [Spadea, Antonio] Regina Elena Inst Canc Res, Hematol Unit, Rome, Italy; [Elli, Elena] Azienda Osped San Gerardo Monza, Hematol Unit, Monza, Italy; [Iurlo, Alessandra] Fdn Ist Recovero & Cura Carrattere Sci IRCCS Ca G, Unita Operat Ematol, Milan, Italy; [Iurlo, Alessandra] Fdn Ist Recovero & Cura Carrattere Sci IRCCS Ca G, Ctr Trapianti Midollo Osseo, Milan, Italy; [Iurlo, Alessandra] Univ Milan, Milan, Italy; [Lunghi, Francesca] IRCCS Osped San Raffaele, Unit Hematol & Bone Marrow Transplant, Milan, Italy; [Lunghi, Monia] Amedeo Avogadro Univ Eastern Piedmont, Dept Translat Med, Div Hematol, Novara, Italy; [Musto, Pellegrino] IRCCS Ctr Riferimento Oncol Basilicata, Hematol Unit, Rionero In Vulture, Italy; [Musolino, Caterina] Azienda Osped Univ Policlin Martino, Hematol Unit, Messina, Italy; [Cascavilla, Nicola] IRCCS Casa Sollievo Sofferenza, Hematol Unit, San Giovanni Rotondo, Italy; [Quarta, Giovanni] Osped Summa Perrino, Hematol Unit, Brindisi, Italy; [Randi, Maria Luigia] Univ Padua, Dipartimento Sci Med & Chirurg, Padua, Italy; [Rapezzi, Davide] Azienda Osped S Croce & Carle, Div Hematol, Cuneo, Italy; [Ruggeri, Marco] Osped San Bortolo, Dept Cell Therapy & Hematol, Vicenza, Italy; [Rumi, Elisa] IRCCS Policlin S Matteo, Div Hematol, Pavia, Italy; [Scortechini, Anna Rita] Osped Riuniti Ancona, Ancona, Italy; [Santini, Simone] Osped Misericordia & Dolce, Div Med Oncol, Prato, Italy; [Siragusa, Sergio] Azienda Osped Univ Policlin P Giaccone, Unita Operat Ematol Con Trapianto, Palermo, Italy; [Tieghi, Alessia] Azienda Osped Arcispedale Santa Maria Nuova IRCCS, Dept Oncol, Reggio Emilia, Italy; [Angelucci, Emanuele] Osped Armando Businco, Div Hematol, Cagliari, Italy; [Visani, Giuseppe] Marche Nord Hosp, Hematol & Hematopoiet Stem Cells Transplant Ctr, Pesaro, Italy; [Vannucchi, Alessandro Maria] Univ Florence, Azienda Osped Univ Careggi, Sect Hematol, Florence, Italy	Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Ospedali Riuniti di Bergamo; University of Turin; Azienda Ospedaliero-Universitaria San Luigi Gonzaga; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Eastern Piedmont Amedeo Avogadro; IRCCS CROB; AOU Policlinico Gaetano Martino; IRCCS Casa Sollievo Della Sofferenza; University of Padua; ULSS 8 Berica; Ospedale San Bortolo di Vicenza; IRCCS Fondazione San Matteo; University of Palermo; Policlinico Paolo Giaccone; IRCCS Arcispedale S. Maria Nuova; University of Florence; Azienda Ospedaliero Universitaria Careggi	Marchioli, R (corresponding author), Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Via Nazl 8-A, I-66030 Santa Maria Imbaro, Italy.	marchioli@negrisud.it	Rubagotti, Sara/J-9342-2018; elli, elena maria/AAE-4006-2020; Breccia, Massimo/G-6026-2018; Angelucci, Emanuele/AAC-1855-2021; Pisani, Francesco/ABH-8545-2020; Vannucchi, Alessandro M./K-7499-2016; Cazzola, Mario/AAQ-8854-2021; Pieri, Lisa/K-1762-2016; Rumi, Elisa/J-7424-2016; Guglielmelli, Paola/K-7509-2016; Rambaldi, Alessandro/P-2603-2018; Gaidano, Gianluca/AAW-2773-2021; De Stefano, Valerio/J-3650-2018; Tieghi, Alessia/AAC-2897-2020; Specchia, Giorgina/K-3084-2016	elli, elena maria/0000-0001-5576-5412; Breccia, Massimo/0000-0003-1163-6162; Pisani, Francesco/0000-0002-6853-5605; Vannucchi, Alessandro M./0000-0001-5755-0730; Cazzola, Mario/0000-0001-6984-8817; Pieri, Lisa/0000-0003-1812-8072; Rumi, Elisa/0000-0002-7572-9504; Guglielmelli, Paola/0000-0003-1809-284X; Rambaldi, Alessandro/0000-0002-3739-7502; Gaidano, Gianluca/0000-0002-4681-0151; De Stefano, Valerio/0000-0002-5178-5827; Tieghi, Alessia/0000-0002-6911-4095; CORTELEZZI, AGOSTINO/0000-0001-9283-4800; Bartalucci, Niccolo/0000-0002-9328-3948; SPADEA, ANTONIO/0000-0002-3651-2951; Tezza, Fabiana/0000-0002-3897-5140; Angelucci, Emanuele/0000-0002-6512-6080; Cascavilla, Nicola/0000-0002-8901-2379; Musto, Pellegrino/0000-0003-3277-6594; Specchia, Giorgina/0000-0002-2479-9529	Italian Medicines Agency (AIFA) [FARM6YNXAN]; Special Program Molecular Clinical Oncology 5x1000 of Associazione Italiana per la Ricerca sul Cancro-Gruppo Italiano Malattie Mieloproliferative [1005]; Sigma-Tau; Societa Prodotti Antibiotici; GlaxoSmithKline; Novartis; Amgen; Pronova BioPharma; Pierre Fabre Italia; Genzyme; Menarini; General Electric; Ferrer; Pronova Biocare; Bristol-Myers Squibb; Shire	Italian Medicines Agency (AIFA); Special Program Molecular Clinical Oncology 5x1000 of Associazione Italiana per la Ricerca sul Cancro-Gruppo Italiano Malattie Mieloproliferative(Fondazione AIRC per la ricerca sul cancro); Sigma-Tau; Societa Prodotti Antibiotici; GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Amgen(Amgen); Pronova BioPharma; Pierre Fabre Italia; Genzyme(Sanofi-AventisGenzyme Corporation); Menarini(Menarini Group); General Electric(General Electric); Ferrer; Pronova Biocare; Bristol-Myers Squibb(Bristol-Myers Squibb); Shire	Supported by grants from the Italian Medicines Agency (AIFA) (Project FARM6YNXAN) and Special Program Molecular Clinical Oncology 5x1000 of Associazione Italiana per la Ricerca sul Cancro-Gruppo Italiano Malattie Mieloproliferative (Project 1005).; Dr. Marchioli reports receiving grant support to his institution from Sigma-Tau, Societa Prodotti Antibiotici, GlaxoSmithKline, Novartis, Amgen, Pronova BioPharma, Pierre Fabre Italia, Genzyme, Menarini, and General Electric and receiving lecture fees from Ferrer, Pronova Biocare, and Sigma-Tau; Dr. Latagliata, serving on the advisory board for and receiving consulting fees from Novartis and Bristol-Myers Squibb and receiving consulting fees from Shire; Dr. Lunghi, receiving lecture fees from Bristol-Myers Squibb, Novartis, and Amgen; Drs. Cavazzina, Masciulli, and Scarano, receiving grant support to their institutions from Sigma-Tau, Societa Prodotti Antibiotici, GlaxoSmithKline, Novartis, Amgen, Pronova BioPharma, Pierre Fabre Italia, and Genzyme; and Dr. Vannucchi, serving on the advisory board for Novartis. No other potential conflict of interest relevant to this article was reported.	Barbui T, 2011, J CLIN ONCOL, V29, P761, DOI 10.1200/JCO.2010.31.8436; BERK PD, 1986, SEMIN HEMATOL, V23, P132; Campbell PJ, 2012, BLOOD, V120, P1409, DOI 10.1182/blood-2012-04-424911; Carobbio A, 2007, BLOOD, V109, P2310, DOI 10.1182/blood-2006-09-046342; Crowther MA, 2003, NEW ENGL J MED, V349, P1133, DOI 10.1056/NEJMoa035241; Crowther MA, 2003, NEW ENGL J MED, V349, P2577; Crowther MA, 2004, NEW ENGL J MED, V351, P200; Di Nisio M, 2007, BRIT J HAEMATOL, V136, P249, DOI 10.1111/j.1365-2141.2006.06430.x; Finazzi G, 2005, BLOOD, V105, P2664, DOI 10.1182/blood-2004-09-3426; Finazzi G, 2005, J THROMB HAEMOST, V3, P848, DOI 10.1111/j.1538-7836.2005.01340.x; Fruchtman SM, 1997, SEMIN HEMATOL, V34, P17; Landolfi R, 2004, NEW ENGL J MED, V350, P114, DOI 10.1056/NEJMoa035572; Landolfi R, 2007, BLOOD, V109, P2446, DOI 10.1182/blood-2006-08-042515; Marchioli R, 2005, SEMIN HEMATOL, V42, P259, DOI 10.1053/j.seminhematol.2005.05.021; Marchioli R, 2005, J CLIN ONCOL, V23, P2224, DOI 10.1200/JCO.2005.07.062; Marchioli R, 2011, THROMBOSIS, V2011; PEARSON TC, 1978, LANCET, V2, P1219; Prchal JT, 2003, BLOOD, V101, P4229; Prchal JT, 2005, WILLIAMS HEMATOLOGY, P779; Schafer AI, 2006, BLOOD, V107, P4214, DOI 10.1182/blood-2005-08-3526; Spivak Jerry L, 2003, Hematology Am Soc Hematol Educ Program, P200; Spivak JL, 2002, BLOOD, V100, P4272, DOI 10.1182/blood-2001-12-0349; Tefferi A, 2012, AM J HEMATOL, V87, P285, DOI 10.1002/ajh.23135; Vannucchi AM, 2009, CA-CANCER J CLIN, V59, P171, DOI 10.3322/caac.20009	24	478	500	3	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2013	368	1					22	33		10.1056/NEJMoa1208500	http://dx.doi.org/10.1056/NEJMoa1208500			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062PA	23216616	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000312930600002
J	Blendon, RJ; Benson, JM; Brule, A				Blendon, Robert J.; Benson, John M.; Brule, Amanda			Implications of the 2012 Election for Health Care - The Voters' Perspective	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[Blendon, Robert J.; Benson, John M.; Brule, Amanda] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Blendon, Robert J.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Blendon, RJ (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							Blendon RJ, 2012, NEW ENGL J MED, V367, P1658, DOI 10.1056/NEJMsr1211472	1	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2012	367	25					2443	2447		10.1056/NEJMsr1213905	http://dx.doi.org/10.1056/NEJMsr1213905			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056ZP	23190187				2022-12-28	WOS:000312531600017
J	van der Harst, P; Zhang, WH; Leach, IM; Rendon, A; Verweij, N; Sehmi, J; Paul, DS; Elling, U; Allayee, H; Li, XZ; Radhakrishnan, A; Tan, ST; Voss, K; Weichenberger, CX; Albers, CA; Al-Hussani, A; Asselbergs, FW; Ciullo, M; Danjou, F; Dina, C; Esko, T; Evans, DM; Franke, L; Goegele, M; Hartiala, J; Hersch, M; Holm, H; Hottenga, JJ; Kanoni, S; Kleber, ME; Lagou, V; Langenberg, C; Lopez, LM; Lyytikainen, LP; Melander, O; Murgia, F; Nolte, IM; O'Reilly, PF; Padmanabhan, S; Parsa, A; Pirastu, N; Porcu, E; Portas, L; Prokopenko, I; Ried, JS; Shin, SY; Tang, CS; Teumer, A; Traglia, M; Ulivi, S; Westra, HJ; Yang, J; Zhao, JH; Anni, F; Abdellaoui, A; Attwood, A; Balkau, B; Bandinelli, S; Bastardot, F; Benyamin, B; Boehm, BO; Cookson, WO; Das, D; de Bakker, PIW; de Boer, RA; de Geus, EJC; de Moor, MH; Dimitriou, M; Domingues, FS; Doring, A; Engstrom, G; Eyjolfsson, GI; Ferrucci, L; Fischer, K; Galanello, R; Garner, SF; Genser, B; Gibson, QD; Girotto, G; Gudbjartsson, DF; Harris, SE; Hartikainen, AL; Hastie, CE; Hedblad, B; Illig, T; Jolley, J; Kahonen, M; Kema, IP; Kemp, JP; Liang, LM; Lloyd-Jones, H; Loos, RJF; Meacham, S; Medland, SE; Meisinger, C; Memari, Y; Mihailov, E; Miller, K; Moffatt, MF; Nauck, M; Novatchkova, M; Nutile, T; Olafsson, I; Onundarson, PT; Parracciani, D; Penninx, BW; Perseu, L; Piga, A; Pistis, G; Pouta, A; Puc, U; Raitakari, O; Ring, SM; Robino, A; Ruggiero, D; Ruokonen, A; Saint-Pierre, A; Sala, C; Salumets, A; Sambrook, J; Schepers, H; Schmidt, CO; Sillje, HHW; Sladek, R; Smit, JH; Starr, JM; Stephens, J; Sulem, P; Tanaka, T; Thorsteinsdottir, U; Tragante, V; van Gilst, WH; van Pelt, LJ; van Veldhuisen, DJ; Volker, U; Whitfield, JB; Willemsen, G; Winkelmann, BR; Wirnsberger, G; Algra, A; Cucca, F; d'Adamo, AP; Danesh, J; Deary, IJ; Dominiczak, AF; Elliott, P; Fortina, P; Froguel, P; Gasparini, P; Greinacher, A; Hazen, SL; Jarvelin, MR; Khaw, KT; Lehtimaki, T; Maerz, W; Martin, NG; Metspalu, A; Mitchell, BD; Montgomery, GW; Moore, C; Navis, G; Pirastu, M; Pramstaller, PP; Ramirez-Solis, R; Schadt, E; Scott, J; Shuldiner, AR; Smith, GD; Smith, JG; Snieder, H; Sorice, R; Spector, TD; Stefansson, K; Stumvoll, M; Tang, WHW; Toniolo, D; Tonjes, A; Visscher, PM; Vollenweider, P; Wareham, NJ; Wolffenbuttel, BHR; Boomsma, DI; Beckmann, JS; Dedoussis, GV; Deloukas, P; Ferreira, MA; Sanna, S; Uda, M; Hicks, AA; Penninger, JM; Gieger, C; Kooner, JS; Ouwehand, WH; Soranzo, N; Chambers, JC				van der Harst, Pim; Zhang, Weihua; Leach, Irene Mateo; Rendon, Augusto; Verweij, Niek; Sehmi, Joban; Paul, Dirk S.; Elling, Ulrich; Allayee, Hooman; Li, Xinzhong; Radhakrishnan, Aparna; Tan, Sian-Tsung; Voss, Katrin; Weichenberger, Christian X.; Albers, Cornelis A.; Al-Hussani, Abtehale; Asselbergs, Folkert W.; Ciullo, Marina; Danjou, Fabrice; Dina, Christian; Esko, Tonu; Evans, David M.; Franke, Lude; Goegele, Martin; Hartiala, Jaana; Hersch, Micha; Holm, Hilma; Hottenga, Jouke-Jan; Kanoni, Stavroula; Kleber, Marcus E.; Lagou, Vasiliki; Langenberg, Claudia; Lopez, Lorna M.; Lyytikainen, Leo-Pekka; Melander, Olle; Murgia, Federico; Nolte, Ilja M.; O'Reilly, Paul F.; Padmanabhan, Sandosh; Parsa, Afshin; Pirastu, Nicola; Porcu, Eleonora; Portas, Laura; Prokopenko, Inga; Ried, Janina S.; Shin, So-Youn; Tang, Clara S.; Teumer, Alexander; Traglia, Michela; Ulivi, Sheila; Westra, Harm-Jan; Yang, Jian; Zhao, Jing Hua; Anni, Franco; Abdellaoui, Abdel; Attwood, Antony; Balkau, Beverley; Bandinelli, Stefania; Bastardot, Francois; Benyamin, Beben; Boehm, Bernhard O.; Cookson, William O.; Das, Debashish; de Bakker, Paul I. W.; de Boer, Rudolf A.; de Geus, Eco J. C.; de Moor, Marleen H.; Dimitriou, Maria; Domingues, Francisco S.; Doering, Angela; Engstrom, Gunnar; Eyjolfsson, Gudmundur Ingi; Ferrucci, Luigi; Fischer, Krista; Galanello, Renzo; Garner, Stephen F.; Genser, Bernd; Gibson, Quince D.; Girotto, Giorgia; Gudbjartsson, Daniel Fannar; Harris, Sarah E.; Hartikainen, Anna-Liisa; Hastie, Claire E.; Hedblad, Bo; Illig, Thomas; Jolley, Jennifer; Kahonen, Mika; Kema, Ido P.; Kemp, John P.; Liang, Liming; Lloyd-Jones, Heather; Loos, Ruth J. F.; Meacham, Stuart; Medland, Sarah E.; Meisinger, Christa; Memari, Yasin; Mihailov, Evelin; Miller, Kathy; Moffatt, Miriam F.; Nauck, Matthias; Novatchkova, Maria; Nutile, Teresa; Olafsson, Isleifur; Onundarson, Pall T.; Parracciani, Debora; Penninx, Brenda W.; Perseu, Lucia; Piga, Antonio; Pistis, Giorgio; Pouta, Anneli; Puc, Ursula; Raitakari, Olli; Ring, Susan M.; Robino, Antonietta; Ruggiero, Daniela; Ruokonen, Aimo; Saint-Pierre, Aude; Sala, Cinzia; Salumets, Andres; Sambrook, Jennifer; Schepers, Hein; Schmidt, Carsten Oliver; Sillje, Herman H. W.; Sladek, Rob; Smit, Johannes H.; Starr, John M.; Stephens, Jonathan; Sulem, Patrick; Tanaka, Toshiko; Thorsteinsdottir, Unnur; Tragante, Vinicius; van Gilst, Wiek H.; van Pelt, L. Joost; van Veldhuisen, Dirk J.; Voelker, Uwe; Whitfield, John B.; Willemsen, Gonneke; Winkelmann, Bernhard R.; Wirnsberger, Gerald; Algra, Ale; Cucca, Francesco; d'Adamo, Adamo Pio; Danesh, John; Deary, Ian J.; Dominiczak, Anna F.; Elliott, Paul; Fortina, Paolo; Froguel, Philippe; Gasparini, Paolo; Greinacher, Andreas; Hazen, Stanley L.; Jarvelin, Marjo-Riitta; Khaw, Kay Tee; Lehtimaki, Terho; Maerz, Winfried; Martin, Nicholas G.; Metspalu, Andres; Mitchell, Braxton D.; Montgomery, Grant W.; Moore, Carmel; Navis, Gerjan; Pirastu, Mario; Pramstaller, Peter P.; Ramirez-Solis, Ramiro; Schadt, Eric; Scott, James; Shuldiner, Alan R.; Smith, George Davey; Smith, J. Gustav; Snieder, Harold; Sorice, Rossella; Spector, Tim D.; Stefansson, Kari; Stumvoll, Michael; Tang, W. H. Wilson; Toniolo, Daniela; Toenjes, Anke; Visscher, Peter M.; Vollenweider, Peter; Wareham, Nicholas J.; Wolffenbuttel, Bruce H. R.; Boomsma, Dorret I.; Beckmann, Jacques S.; Dedoussis, George V.; Deloukas, Panos; Ferreira, Manuel A.; Sanna, Serena; Uda, Manuela; Hicks, Andrew A.; Penninger, Josef Martin; Gieger, Christian; Kooner, Jaspal S.; Ouwehand, Willem H.; Soranzo, Nicole; Chambers, John C.			Seventy-five genetic loci influencing the human red blood cell	NATURE			English	Article							GENOME-WIDE ASSOCIATION; HEMOGLOBIN LEVELS; VARIANTS; EXPRESSION; PROTEIN; COHORT; DOMAIN; LEVEL; MOUSE; STEM	Anaemia is a chief determinant of global ill health, contributing to cognitive impairment, growth retardation and impaired physical capacity. To understand further the genetic factors influencing red blood cells, we carried out a genome-wide association study of haemoglobin concentration and related parameters in up to 135,367 individuals. Here we identify 75 independent genetic loci associated with one or more red blood cell phenotypes at P < 10(-8), which together explain 4-9% of the phenotypic variance per trait. Using expression quantitative trait loci and bioinformatic strategies, we identify 121 candidate genes enriched in functions relevant to red blood cell biology. The candidate genes are expressed preferentially in red blood cell precursors, and 43 have haematopoietic phenotypes in Mus musculus or Drosophila melanogaster. Through open-chromatin and coding-variant analyses we identify potential causal genetic variants at 41 loci. Our findings provide extensive new insights into genetic mechanisms and biological pathways controlling red blood cell formation and function.	[Zhang, Weihua; Al-Hussani, Abtehale; O'Reilly, Paul F.; Elliott, Paul; Jarvelin, Marjo-Riitta; Chambers, John C.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London W2 1PG, England; [van der Harst, Pim; Leach, Irene Mateo; Verweij, Niek; de Boer, Rudolf A.; Sillje, Herman H. W.; van Gilst, Wiek H.; van Veldhuisen, Dirk J.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9700 RB Groningen, Netherlands; [van der Harst, Pim; Franke, Lude; Westra, Harm-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Zhang, Weihua; Sehmi, Joban; Tan, Sian-Tsung; Miller, Kathy; Kooner, Jaspal S.; Chambers, John C.] Ealing Hosp NHS Trust, Uxbridge UB1 3HW, Middx, England; [Rendon, Augusto; Radhakrishnan, Aparna; Voss, Katrin; Albers, Cornelis A.; Attwood, Antony; Garner, Stephen F.; Jolley, Jennifer; Lloyd-Jones, Heather; Meacham, Stuart; Sambrook, Jennifer; Stephens, Jonathan; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge CB2 0XY, England; [Rendon, Augusto; Radhakrishnan, Aparna; Voss, Katrin; Albers, Cornelis A.; Attwood, Antony; Garner, Stephen F.; Jolley, Jennifer; Lloyd-Jones, Heather; Meacham, Stuart; Sambrook, Jennifer; Stephens, Jonathan; Ouwehand, Willem H.] NHS Blood & Transplant, Cambridge CB2 0PT, England; [Rendon, Augusto] Inst Publ Hlth, MRC Biostat Unit, Cambridge CB2 2SR, England; [Rendon, Augusto; Radhakrishnan, Aparna; Voss, Katrin; Attwood, Antony; Garner, Stephen F.; Jolley, Jennifer; Lloyd-Jones, Heather; Meacham, Stuart; Sambrook, Jennifer; Stephens, Jonathan; Ouwehand, Willem H.] NIHR Cambridge Biomed Res Ctr, Cambridge CB2 0QQ, England; [Sehmi, Joban; Tan, Sian-Tsung; Cookson, William O.; Moffatt, Miriam F.; Scott, James; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London W12 0NN, England; [Paul, Dirk S.; Radhakrishnan, Aparna; Albers, Cornelis A.; Kanoni, Stavroula; Shin, So-Youn; Attwood, Antony; Meacham, Stuart; Memari, Yasin; Ramirez-Solis, Ramiro; Deloukas, Panos; Ouwehand, Willem H.; Soranzo, Nicole] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Elling, Ulrich; Novatchkova, Maria; Puc, Ursula; Wirnsberger, Gerald; Penninger, Josef Martin] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Allayee, Hooman; Hartiala, Jaana] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Li, Xinzhong] Univ London Imperial Coll Sci Technol & Med, Inst Clin Sci, London W12 0NN, England; [Li, Xinzhong; Chambers, John C.] Royal Brompton & Harefield NHS Fdn Trust, NIHR Cardiovasc Biomed Res Unit, London SW3 6NP, England; [Li, Xinzhong; Chambers, John C.] Univ London Imperial Coll Sci Technol & Med, London SW3 6NP, England; [Weichenberger, Christian X.; Goegele, Martin; Domingues, Francisco S.; Saint-Pierre, Aude; Pramstaller, Peter P.; Hicks, Andrew A.] European Acad Bozen Bolzano EURAC, Ctr Biomed, I-39100 Bolzano, Italy; [Asselbergs, Folkert W.; Tragante, Vinicius] Univ Med Ctr Utrecht, Dept Cardiol, Div Heart & Lungs, NL-3508 Utrecht, Netherlands; [Asselbergs, Folkert W.; de Bakker, Paul I. W.; Algra, Ale] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 Utrecht, Netherlands; [Asselbergs, Folkert W.; de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3508 Utrecht, Netherlands; [Ciullo, Marina; Mihailov, Evelin; Nutile, Teresa; Ruggiero, Daniela; Sorice, Rossella] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, I-80131 Naples, Italy; [Danjou, Fabrice; Anni, Franco; Galanello, Renzo] Univ Cagliari, Osped Reg Microcitemie ASL8, Dipartimento Sci Biomed & Biotecnol, I-09121 Cagliari, Italy; [Dina, Christian] INSERM, UMR 1087, F-44007 Nantes 1, France; [Dina, Christian] CNRS, UMR 6291, F-44007 Nantes 1, France; [Dina, Christian] Univ Nantes, Sch Med, F-44000 Nantes, France; [Esko, Tonu; Fischer, Krista; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Evans, David M.; Kemp, John P.; Smith, George Davey] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol BS8 2BN, Avon, England; [Hersch, Micha; Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Hersch, Micha] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Holm, Hilma; Gudbjartsson, Daniel Fannar; Sulem, Patrick; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Hottenga, Jouke-Jan; Abdellaoui, Abdel; de Geus, Eco J. C.; de Moor, Marleen H.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Kleber, Marcus E.; Genser, Bernd; Maerz, Winfried] Heidelberg Univ, Med Fac Mannheim, Mannheim Inst Publ Hlth Social & Prevent Med, D-68167 Mannheim, Germany; [Kleber, Marcus E.] LURIC Study Nonprofit LLC, D-79098 Freiburg, Germany; [Lagou, Vasiliki; Prokopenko, Inga] Univ Oxford, Radcliffe Dept Med, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Lagou, Vasiliki; Prokopenko, Inga] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Langenberg, Claudia; Zhao, Jing Hua; Loos, Ruth J. F.; Wareham, Nicholas J.] Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Lopez, Lorna M.; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Lopez, Lorna M.; Harris, Sarah E.; Starr, John M.; Deary, Ian J.; Visscher, Peter M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Lyytikainen, Leo-Pekka; Lehtimaki, Terho] Tampere Univ Hosp, Fimlab Labs, Dept Clin Chem, FIN-33521 Tampere, Finland; [Lyytikainen, Leo-Pekka; Lehtimaki, Terho] Univ Tampere, Sch Med, Dept Clin Chem, FIN-33521 Tampere, Finland; [Melander, Olle; Engstrom, Gunnar; Hedblad, Bo; Smith, J. Gustav] Lund Univ, Dept Clin Sci, SE-20502 Malmo, Sweden; [Murgia, Federico; Portas, Laura; Pirastu, Mario] Natl Res Council Italy, Inst Populat Genet, I-07100 Sassari, Italy; [Nolte, Ilja M.; Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 RB Groningen, Netherlands; [Padmanabhan, Sandosh; Hastie, Claire E.; Dominiczak, Anna F.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland; [Parsa, Afshin; Gibson, Quince D.; Mitchell, Braxton D.; Shuldiner, Alan R.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Pirastu, Nicola; Girotto, Giorgia; Robino, Antonietta; d'Adamo, Adamo Pio; Gasparini, Paolo] Univ Trieste, IRCCS Burlo Garofolo Trieste, Inst Maternal & Child Hlth, I-34137 Trieste, Italy; [Porcu, Eleonora; Perseu, Lucia; Cucca, Francesco; Sanna, Serena; Uda, Manuela] Cittadella Univ Monserrato, CNR, Ist Ric Genet & Biomed, I-09042 Cagliari, Italy; [Ried, Janina S.; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, D-85764 Neuherberg, Germany; [Tang, Clara S.; Benyamin, Beben; Medland, Sarah E.; Whitfield, John B.; Martin, Nicholas G.; Montgomery, Grant W.; Visscher, Peter M.; Ferreira, Manuel A.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Teumer, Alexander; Voelker, Uwe] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, D-17487 Greifswald, Germany; [Traglia, Michela; Pistis, Giorgio; Sala, Cinzia; Toniolo, Daniela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Yang, Jian; Visscher, Peter M.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld 4102, Australia; [Balkau, Beverley] INSERM, U1018, CESP Ctr Res Epidemiol & Populat Hlth, F-94807 Villejuif, France; [Balkau, Beverley] Univ Paris 11, UMRS 1018, F-94807 Villejuif, France; [Bandinelli, Stefania] Azienda Sanit Firenze, Geriatr Unit, I-50125 Florence, Italy; [Bastardot, Francois; Vollenweider, Peter] Univ Lausanne, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Benyamin, Beben; Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Boehm, Bernhard O.] Univ Hosp, Dept Med, Div Endocrinol & Diabet, D-89075 Ulm, Germany; [Das, Debashish] UCL, Hatter Cardiovasc Inst, London WC1E 6HX, England; [de Bakker, Paul I. W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [de Bakker, Paul I. W.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Dimitriou, Maria; Dedoussis, George V.] Harokopio Univ, Athens 17671, Greece; [Doering, Angela] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, D-85764 Neuherberg, Germany; [Doering, Angela; Meisinger, Christa] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Eyjolfsson, Gudmundur Ingi] Lab Mjodd, IS-108 Reykjavik, Iceland; [Ferrucci, Luigi; Tanaka, Toshiko] NIA, Clin Res Branch, Baltimore, MD 21250 USA; [Gibson, Quince D.] Univ Fed Bahia, Inst Saude Colet, BR-40110040 Salvador, BA, Brazil; [Harris, Sarah E.] Univ Edinburgh, Med Genet Sect, Edinburgh EH4 2XU, Midlothian, Scotland; [Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Sci Obstet & Gynecol, FIN-90220 Oulu, Finland; [Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, D-85764 Neuherberg, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, D-30625 Hannover, Germany; [Kahonen, Mika] Tampere Univ Hosp, Dept Clin Physiol, FIN-33521 Tampere, Finland; [Kahonen, Mika] Univ Tampere, Sch Med, Dept Clin Physiol, FIN-33521 Tampere, Finland; [Kema, Ido P.; van Pelt, L. Joost] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, NL-9700 RB Groningen, Netherlands; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Biostat, Dept Epidemiol, Boston, MA 02115 USA; [Memari, Yasin] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Nauck, Matthias] Univ Med Greifswald, Inst Clin Chem & Lab Med, D-17475 Greifswald, Germany; [Olafsson, Isleifur] Landspitali Univ Hosp, Dept Clin Biochem, IS-101 Reykjavik, Iceland; [Onundarson, Pall T.; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Onundarson, Pall T.] Landspitali Univ Hosp, Hematol Lab, IS-101 Reykjavik, Iceland; [Onundarson, Pall T.] Landspitali Univ Hosp, Coagulat Disorder Ctr, IS-101 Reykjavik, Iceland; [Parracciani, Debora] Genet Pk Ogliastra, Perdasdefogu, Sardinia, Italy; [Penninx, Brenda W.; Smit, Johannes H.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Psychiat, NL-1081 BT Amsterdam, Netherlands; [Penninx, Brenda W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9700 RB Groningen, Netherlands; [Penninx, Brenda W.] Leiden Univ, Med Ctr, Dept Psychiat, NL-2333 Leiden, Netherlands; [Piga, Antonio] Univ Turin, Dept Clin & Biol Sci, Div Pediat, I-10043 Turin, Italy; [Piga, Antonio] Univ Turin, Dept Clin & Biol Sci, Thalassemia Ctr, I-10043 Turin, Italy; [Pouta, Anneli; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, FIN-90220 Oulu, Finland; [Pouta, Anneli] Natl Inst Hlth & Welf, FIN-90101 Oulu, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20521 Turku, Finland; [Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, FIN-20521 Turku, Finland; [Ring, Susan M.] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England; [Ruokonen, Aimo] Univ Oulu, Inst Diagnost, FIN-90014 Oulu, Finland; [Salumets, Andres] Competence Ctr Reprod Med & Biol, EE-50410 Tartu, Estonia; [Salumets, Andres] Univ Tartu, Inst Gen & Mol Pathol, EE-51014 Tartu, Estonia; [Schepers, Hein] Univ Groningen, Univ Med Ctr Groningen, Dept Expt Hematol, NL-9700 RB Groningen, Netherlands; [Schepers, Hein] Univ Groningen, Univ Med Ctr Groningen, Dept Stem Cell Biol, NL-9700 RB Groningen, Netherlands; [Schmidt, Carsten Oliver] Univ Med Greifswald, Inst Community Med, D-17475 Greifswald, Germany; [Sladek, Rob] McGill Univ, Fac Med, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Sladek, Rob] McGill Univ, Fac Med, Dept Med, Montreal, PQ H3A 1B1, Canada; [Starr, John M.] Univ Edinburgh, Western Gen Hosp, Geriatr Med Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Winkelmann, Bernhard R.] ClinPhen Study Ctr, D-60594 Frankfurt, Germany; [Algra, Ale] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol & Neurosurg, Utrecht Stroke Ctr, NL-3584 CG Utrecht, Netherlands; [Cucca, Francesco] Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy; [Danesh, John; Moore, Carmel] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Elliott, Paul; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, MRC HPA Ctr Environm & Hlth, London W2 1PG, England; [Fortina, Paolo] Thomas Jefferson Univ, Coll Med, Dept Canc Biol, Philadelphia, PA 19107 USA; [Fortina, Paolo] Univ Roma La Sapienza, Dipartimento Med Mol, I-00161 Rome, Italy; [Froguel, Philippe] Lille Pasteur Inst, CNRS, UMR 8199, F-59100 Lille, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London W2 1PG, England; [Greinacher, Andreas] Univ Med Greifswald, Inst Immunol & Transfus Med, D-17487 Greifswald, Germany; [Hazen, Stanley L.; Tang, W. H. Wilson] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Lifecourse snd Serv, FIN-90101 Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, FIN-90220 Oulu, Finland; [Khaw, Kay Tee] Addenbrookes Hosp, Clin Gerontol Unit, Cambridge CB2 2QQ, England; [Maerz, Winfried] Synlab Acad, D-68165 Mannheim, Germany; [Navis, Gerjan] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9700 RB Groningen, Netherlands; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, I-39100 Bolzano, Italy; [Pramstaller, Peter P.] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Schadt, Eric] Mt Sinai Sch Med, Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Shuldiner, Alan R.] Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Baltimore, MD 21201 USA; [Smith, J. Gustav] Lund Univ, Dept Cardiol, S-22185 Lund, Sweden; [Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Stumvoll, Michael; Toenjes, Anke] Univ Leipzig, Dept Med, D-04103 Leipzig, Germany; [Stumvoll, Michael; Toenjes, Anke] Univ Leipzig, IFB Adipos Dis, D-04103 Leipzig, Germany; [Toniolo, Daniela] CNR, Inst Mol Genet, I-27100 Pavia, Italy; [Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, NL-9700 RB Groningen, Netherlands; [Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Kooner, Jaspal S.; Chambers, John C.] Imperial Coll Healthcare NHS Trust, London W12 0HS, England	Imperial College London; University of Groningen; University of Groningen; University of Cambridge; MRC Biostatistics Unit; University of Cambridge; University of Cambridge; Imperial College London; Wellcome Trust Sanger Institute; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Southern California; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; European Academy of Bozen-Bolzano; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Cagliari; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Nantes Universite; Universite de Franche-Comte; University of Tartu; University of Tartu; University of Bristol; University of Lausanne; Swiss Institute of Bioinformatics; Vrije Universiteit Amsterdam; Ruprecht Karls University Heidelberg; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Edinburgh; University of Edinburgh; Tampere University; Tampere University Hospital; Tampere University; Lund University; Consiglio Nazionale delle Ricerche (CNR); University of Groningen; University of Glasgow; University System of Maryland; University of Maryland Baltimore; IRCCS Burlo Garofolo; University of Trieste; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Cagliari; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; QIMR Berghofer Medical Research Institute; Greifswald Medical School; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Queensland; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Azienda Sanitaria di Firenze; University of Lausanne; University of Queensland; Ulm University; University of London; University College London; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harokopio University Athens; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Universidade Federal da Bahia; University of Edinburgh; University of Oulu; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; Tampere University; Tampere University Hospital; Tampere University; University of Groningen; Harvard University; Harvard T.H. Chan School of Public Health; University of London; King's College London; Greifswald Medical School; Landspitali National University Hospital; University of Iceland; Landspitali National University Hospital; Landspitali National University Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Turin; University of Turin; University of Oulu; Finland National Institute for Health & Welfare; University of Turku; University of Turku; University of Bristol; University of Oulu; University of Tartu; University of Groningen; University of Groningen; Greifswald Medical School; McGill University; McGill University; University of Edinburgh; Utrecht University; Utrecht University Medical Center; University of Sassari; University of Cambridge; Imperial College London; Jefferson University; Sapienza University Rome; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Imperial College London; Greifswald Medical School; Cleveland Clinic Foundation; Finland National Institute for Health & Welfare; University of Oulu; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; SYNLAB Group; University of Groningen; Krankenhaus Bozen; University of Lubeck; Icahn School of Medicine at Mount Sinai; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lund University; University of London; King's College London; Leipzig University; Leipzig University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Groningen; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Imperial College London	Chambers, JC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London W2 1PG, England.	p.van.der.harst@umcg.nl; christian.gieger@helmholtz-muenchen.de; j.kooner@ic.ac.uk; who1000@cam.ac.uk; ns6@sanger.ac.uk; john.chambers@ic.ac.uk	Onundarson, Pall T./AAJ-1037-2020; Colaus, PsyColaus/K-6607-2013; Asselbergs, Folkert W./ABD-6752-2021; van Gilst, Wiek/R-1806-2019; van Veldhuisen, Dirk Jan/E-8967-2014; Montgomery, Grant W/B-7148-2008; Sala, Cinzia Felicita/AAN-1900-2020; bandinelli, stefania/AAL-4570-2020; Dominiczak, Anna F/P-9390-2017; Prokopenko, Inga/AAU-9895-2020; Albers, Kees/A-4170-2015; sanna, serena/H-3009-2019; Dedoussis, George/AAN-7252-2021; Pirastu, Nicola/AHB-6226-2022; Danjou, Fabrice/D-1563-2014; Raitakari, Olli/AAQ-7389-2021; de Moor, Marleen/J-7434-2019; Verweij, Niek/A-4499-2017; Verweij, Niek/ABC-6249-2021; Lopez, Lorna/AAR-4912-2020; Martin, Nicholas/R-9235-2019; Ferreira, Manuel A R/D-3609-2013; Evans, David M/H-6325-2013; Yang, Jian/A-5852-2010; Gasparini, Paolo/B-6173-2014; Deary, Ian J/C-6297-2009; Sladek, Robert/R-2391-2019; de Boer, Rudolf/ABE-9879-2020; Bastardot, Francois/J-4013-2017; Lagou, Vasiliki/N-8451-2013; Medland, Sarah/AAT-7595-2020; Loos, Ruth/GON-5877-2022; zhang, weihua/GXV-1334-2022; d'Adamo, Adamo Pio/G-4064-2011; Boehm, Bernhard Otto/F-8750-2015; Ulivi, Sheila/H-3700-2013; de Bakker, Paul IW/B-8730-2009; Benyamin, Beben/D-9195-2012; Penninx, Brenda WJH/S-7627-2017; Boomsma, Dorret I/AAX-4470-2020; Bastardot, François/P-7809-2019; li, xin/HHS-9461-2022; Dina, Christian R/D-3535-2015; Uda, Manuela/AAC-2645-2019; Paul, Dirk S./H-3469-2019; Tang, Wai Hong Wilson/I-1238-2013; ruggiero, daniela/K-5638-2016; FROGUEL, Philippe/O-6799-2017; Kanoni, Stavroula/AAN-7161-2021; Wolffenbuttel, Bruce/A-8419-2011; Prokopenko, Inga/H-3241-2014; Teumer, Alexander/S-7438-2019; Padmanabhan, Sandosh/S-3963-2016; Mitchell, Braxton/CAF-0876-2022; Toniolo, Daniela/AAE-2969-2019; Franke, Lude/P-7036-2016; Lehtimäki, Terho/AAD-1094-2022; Hartiala, Jaana A/GLR-1825-2022; Visscher, Peter/ABB-6151-2020; Salumets, Andres/J-2278-2015; Penninger, Josef M/I-6860-2013; Beckmann, Jacques S/A-9772-2008; Davey Smith, George/A-7407-2013; Hazen, Stanley L/ABD-5845-2021; Stefansson, Kari/AAE-7187-2019; Loos, Ruth J F/Q-2862-2016; Langenberg, Claudia/ABG-9067-2021; Ciullo, Marina/AAE-3041-2020; Schmidt, Carsten Oliver/AAH-2778-2019; de Geus, Eco J.C./M-9318-2015; Deloukas, Panos/B-2922-2013; Lyytikäinen, Leo-Pekka/C-8544-2016; Medland, Sarah E/C-7630-2013; Hicks, Andrew Anthony/E-9518-2017; Fortina, Paolo/ABE-8350-2020; Traglia, Michela/AAX-5816-2020; Cookson, William/HHC-1790-2022; Kemp, John P./R-3091-2018; Khaw, Kay-Tee/AAZ-3209-2021; Meisinger, Christine/B-5358-2014; Pirastu, Nicola/G-4358-2011; Austin, Eric Douglas/A-6070-2013; Stumvoll, Michael/ABE-1121-2021; Pramstaller, Peter P/C-2357-2008; Robino, Antonietta/K-9398-2016; Girotto, Giorgia/I-9452-2018	Asselbergs, Folkert W./0000-0002-1692-8669; van Gilst, Wiek/0000-0003-2968-8585; Montgomery, Grant W/0000-0002-4140-8139; Dominiczak, Anna F/0000-0003-4913-3608; Albers, Kees/0000-0003-4115-3727; sanna, serena/0000-0002-3768-1749; Dedoussis, George/0000-0002-7798-6221; Danjou, Fabrice/0000-0002-4976-2327; de Moor, Marleen/0000-0001-7177-5637; Verweij, Niek/0000-0002-4303-7685; Lopez, Lorna/0000-0002-0241-9783; Martin, Nicholas/0000-0003-4069-8020; Ferreira, Manuel A R/0000-0001-9059-1825; Evans, David M/0000-0003-0663-4621; Yang, Jian/0000-0003-2001-2474; Deary, Ian J/0000-0002-1733-263X; Sladek, Robert/0000-0002-2730-1204; Bastardot, Francois/0000-0003-4060-0353; Medland, Sarah/0000-0003-1382-380X; d'Adamo, Adamo Pio/0000-0001-9367-4909; Ulivi, Sheila/0000-0003-3606-835X; de Bakker, Paul IW/0000-0001-7735-7858; Benyamin, Beben/0000-0001-5608-2293; Penninx, Brenda WJH/0000-0001-7779-9672; Bastardot, François/0000-0003-4060-0353; Dina, Christian R/0000-0002-7722-7348; Uda, Manuela/0000-0002-4890-6456; Paul, Dirk S./0000-0002-8230-0116; ruggiero, daniela/0000-0003-3898-7827; FROGUEL, Philippe/0000-0003-2972-0784; Kanoni, Stavroula/0000-0002-1691-9615; Wolffenbuttel, Bruce/0000-0001-9262-6921; Prokopenko, Inga/0000-0003-1624-7457; Teumer, Alexander/0000-0002-8309-094X; Toniolo, Daniela/0000-0001-9545-6032; Franke, Lude/0000-0002-5159-8802; Lehtimäki, Terho/0000-0002-2555-4427; Hartiala, Jaana A/0000-0003-4883-9318; Visscher, Peter/0000-0002-2143-8760; Salumets, Andres/0000-0002-1251-8160; Penninger, Josef M/0000-0002-8194-3777; Beckmann, Jacques S/0000-0002-9741-1900; Davey Smith, George/0000-0002-1407-8314; Loos, Ruth J F/0000-0002-8532-5087; Langenberg, Claudia/0000-0002-5017-7344; Ciullo, Marina/0000-0002-9621-9984; Schmidt, Carsten Oliver/0000-0001-5266-9396; de Geus, Eco J.C./0000-0001-6022-2666; Deloukas, Panos/0000-0001-9251-070X; Lyytikäinen, Leo-Pekka/0000-0002-7200-5455; Medland, Sarah E/0000-0003-1382-380X; Hicks, Andrew Anthony/0000-0001-6320-0411; Kemp, John P./0000-0002-9105-2249; Austin, Eric Douglas/0000-0002-1709-9022; Stumvoll, Michael/0000-0001-6225-8240; Radhakrishnan, Aparna/0000-0002-8153-9037; Padmanabhan, Sandosh/0000-0003-3869-5808; Gogele, Martin/0000-0003-4785-4348; s, hema/0000-0002-3440-9475; Kahonen, Mika/0000-0002-4510-7341; Pirastu, Nicola/0000-0002-5363-3886; Tang, W. H. Wilson/0000-0002-8335-735X; Schepers, Hein/0000-0002-7731-3318; Murgia, Federico/0000-0002-3608-845X; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Willemsen, Gonneke/0000-0003-3755-0236; Memari, Yasin/0000-0002-1747-542X; Soranzo, Nicole/0000-0003-1095-3852; Lagou, Vasiliki/0000-0003-3165-8940; Mitchell, Braxton/0000-0003-4920-4744; Robino, Antonietta/0000-0003-2152-2353; CUCCA, Francesco/0000-0002-7414-1995; Esko, Tonu/0000-0003-1982-6569; Melander, Olle/0000-0002-2581-484X; Gieger, Christian/0000-0001-6986-9554; Whitfield, John/0000-0002-1103-0876; Stephens, Jonathan/0000-0003-2020-9330; Tang, Clara/0000-0003-0265-2638; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Fortina, Paolo/0000-0002-5898-2081; Kleber, Marcus/0000-0003-0663-7275; Gasparini, Paolo/0000-0002-0859-0856; Girotto, Giorgia/0000-0003-4507-6589; Ouwehand, Willem/0000-0002-7744-1790; Shuldiner, Alan/0000-0001-9921-4305; van Pelt, Joost/0000-0001-5538-1806; Meisinger, Christa/0000-0002-9026-6544; Portas, Laura/0000-0003-1789-1893; Engstrom, Gunnar/0000-0002-8618-9152; Pramstaller, Peter P/0000-0002-9831-8302; Meacham, Stuart/0000-0002-3667-6059; Volker, Uwe/0000-0002-5689-3448; Rendon, Augusto/0000-0001-8994-0039; Gudbjartsson, Daniel/0000-0002-5222-9857; Genser, Bernd/0000-0001-5787-0902; O'Reilly, Paul/0000-0001-7515-0845; Ramirez-Solis, Ramiro/0000-0003-4182-173X; Weichenberger, Christian X./0000-0002-2176-0274; Domingues, Francisco/0000-0003-4567-4562; NUTILE, TERESA/0000-0001-7062-8352	Austrian Science Fund FWF [I 434] Funding Source: Medline; British Heart Foundation [RG/08/014/24067, RG/09/012/28096] Funding Source: Medline; Cancer Research UK [14136] Funding Source: Medline; Medical Research Council [G9815508, MC_U106188470, MC_U106179471, G0700704, G0600705, G0401527, G0801056, G1000143, G1002084] Funding Source: Medline; NCATS NIH HHS [UL1 TR000439] Funding Source: Medline; NCI NIH HHS [R01 CA165001] Funding Source: Medline; NCRR NIH HHS [U54 RR020278, UL1 RR025005, K12 RR023250] Funding Source: Medline; NHGRI NIH HHS [U01 HG004402] Funding Source: Medline; NHLBI NIH HHS [P01 HL076491, HHSN268201100006C, U01 HL072515, HHSN268201100009C, HHSN268201100005C, R01 HL087641, R01 HL059367, P20 HL113452, U01 HL084756, P01 HL098055, R01 HL088119, HHSN268201100012C, R01 HL103931, HHSN268201100010C, HHSN268201100008C, R01 HL087679, HHSN268201100007C, R01 HL103866, HHSN268201100011C, R01 HL086694] Funding Source: Medline; NIA NIH HHS [N01AG12109, R01 AG018728] Funding Source: Medline; NICHD NIH HHS [R01 HD042157] Funding Source: Medline; NIDA NIH HHS [HHSN271201100005C] Funding Source: Medline; NIDDK NIH HHS [P30 DK072488] Funding Source: Medline; NIGMS NIH HHS [R01 GM053275, U01 GM074518] Funding Source: Medline; NIMH NIH HHS [RL1 MH083268, U24 MH068457, R01 MH081802] Funding Source: Medline; NLM NIH HHS [R01 LM010098] Funding Source: Medline; Wellcome Trust [097117, 092731] Funding Source: Medline; Department of Health [RP-PG-0310-1002] Funding Source: Medline; Chief Scientist Office [CZB/4/505, ETM/55] Funding Source: Medline; MRC [G0700704, G1002084, G0801056, MC_U106188470, G0600705] Funding Source: UKRI; Austrian Science Fund (FWF) [I 434] Funding Source: researchfish; Medical Research Council [G0801056B, G0700704B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10136, RP-PG-0310-1002, NF-SI-0611-10275] Funding Source: researchfish; Wellcome Trust [096964/Z/11/Z] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042157] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA165001] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278, UL1RR025005, K12RR023250] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086694, R01HL103866, R01HL087641, U01HL084756, P01HL076491, R01HL059367, R01HL088119, R01HL103931, R01HL087679, P01HL098055, P20HL113452, U01HL072515] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074518, R01GM053275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH068457, R01MH081802, RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018728] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010098] Funding Source: NIH RePORTER	Austrian Science Fund FWF(Austrian Science Fund (FWF)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Wellcome Trust(Wellcome Trust); Department of Health; Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		An XU, 2008, BRIT J HAEMATOL, V141, P367, DOI 10.1111/j.1365-2141.2008.07091.x; ANDERSON RJ, 1990, J TRAUMA, V30, P1059, DOI 10.1097/00005373-199009000-00001; Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Berhane S, 2011, VIROLOGY, V421, P149, DOI 10.1016/j.virol.2011.09.025; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Camaschella C, 2011, CURR OPIN PEDIATR, V23, P14, DOI 10.1097/MOP.0b013e3283425591; Chambers JC, 2009, NAT GENET, V41, P1170, DOI 10.1038/ng.462; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; Das S, 2001, J BIOL CHEM, V276, P6720, DOI 10.1074/jbc.M008863200; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Ding KY, 2012, MAYO CLIN PROC, V87, P461, DOI 10.1016/j.mayocp.2012.01.016; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Galanello R, 2009, BLOOD, V114, P3935, DOI 10.1182/blood-2009-04-217901; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Giresi PG, 2009, METHODS, V48, P233, DOI 10.1016/j.ymeth.2009.03.003; Goto A, 2001, BIOCHEM J, V359, P99, DOI 10.1042/0264-6021:3590099; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Paul DS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002139; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pickrell JK, 2011, BIOINFORMATICS, V27, P2144, DOI 10.1093/bioinformatics/btr354; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Scanlon KS, 2000, OBSTET GYNECOL, V96, P741, DOI 10.1016/S0029-7844(00)00982-0; Shah RC, 2011, NEUROLOGY, V77, P219, DOI 10.1212/WNL.0b013e318225aaa9; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Tiwari S, 2001, J BIOL CHEM, V276, P16193, DOI 10.1074/jbc.M007640200; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; van Wijk R, 2003, BLOOD, V101, P345, DOI 10.1182/blood-2002-06-1851; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	47	236	237	0	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					369	+		10.1038/nature11677	http://dx.doi.org/10.1038/nature11677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23222517	Green Accepted, Green Published			2022-12-28	WOS:000312488200044
J	Sidibe, M; Piot, P; Dybul, M				Sidibe, Michel; Piot, Peter; Dybul, Mark			AIDS is not over	LANCET			English	Editorial Material							SYSTEMATIC ANALYSIS; GLOBAL BURDEN; 21 REGIONS; DISEASE		[Sidibe, Michel] UNAIDS, CH-1211 Geneva, Switzerland; [Piot, Peter] London Sch Hyg & Trop Med, London WC1, England; [Dybul, Mark] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland	UNAIDS; University of London; London School of Hygiene & Tropical Medicine	Sidibe, M (corresponding author), UNAIDS, CH-1211 Geneva, Switzerland.	executivedirector@unaids.org						[Anonymous], 5 IAS C HIV PATH TRE; [Anonymous], 19 SUMM AFR UN ADD A; [Anonymous], PCB311219 UNAIDS; [Anonymous], INV RES RES PEOPL PE; [Anonymous], 2012, UNAIDS REP GLOB AIDS; [Anonymous], INT J TUBERC LUNG S1; [Anonymous], B WHO; [Anonymous], UN END AIDS ACH TARG; [Anonymous], INT J TUBERC LUNG S1; [Anonymous], LANCET; [Anonymous], INTEGRATION TUBERCUL; Kasenga F, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1883; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Melaku Z, 2011, 6 IAS C HIV PATH TRE; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Pfaendler KS, 2008, GYNECOL ONCOL, V110, P402, DOI 10.1016/j.ygyno.2008.04.031; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; van't Hoog AH, 2005, JAIDS-J ACQ IMM DEF, V40, P344, DOI 10.1097/01.qai.0000160712.86580.ff; World Health Organization, 2008, The global burden of disease: 2004 update	19	12	12	0	45	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2012	380	9859					2058	2060		10.1016/S0140-6736(12)62088-1	http://dx.doi.org/10.1016/S0140-6736(12)62088-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23245599				2022-12-28	WOS:000312387000006
J	Xu, KX; Wu, ZJ; Groner, AC; He, HSHS; Cai, CM; Lis, RT; Wu, XQ; Stack, EC; Loda, M; Liu, T; Xu, H; Cato, L; Thornton, JE; Gregory, RI; Morrissey, C; Vessella, RL; Montironi, R; Magi-Galluzzi, C; Kantoff, PW; Balk, SP; Liu, XS; Brown, M				Xu, Kexin; Wu, Zhenhua Jeremy; Groner, Anna C.; He, Housheng Hansen; Cai, Changmeng; Lis, Rosina T.; Wu, Xiaoqiu; Stack, Edward C.; Loda, Massimo; Liu, Tao; Xu, Han; Cato, Laura; Thornton, James E.; Gregory, Richard I.; Morrissey, Colm; Vessella, Robert L.; Montironi, Rodolfo; Magi-Galluzzi, Cristina; Kantoff, Philip W.; Balk, Steven P.; Liu, X. Shirley; Brown, Myles			EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent	SCIENCE			English	Article							GENE-EXPRESSION; HISTONE METHYLTRANSFERASE; SUPPRESSES METHYLATION; PHOSPHORYLATION; LYSINE-27; COMPLEX; PROGRESSION; PROTEIN; AKT	Epigenetic regulators represent a promising new class of therapeutic targets for cancer. Enhancer of zeste homolog 2 (EZH2), a subunit of Polycomb repressive complex 2 (PRC2), silences gene expression via its histone methyltransferase activity. We found that the oncogenic function of EZH2 in cells of castration-resistant prostate cancer is independent of its role as a transcriptional repressor. Instead, it involves the ability of EZH2 to act as a coactivator for critical transcription factors including the androgen receptor. This functional switch is dependent on phosphorylation of EZH2 and requires an intact methyltransferase domain. Hence, targeting the non-PRC2 function of EZH2 may have therapeutic efficacy for treating metastatic, hormone-refractory prostate cancer.	[Xu, Kexin; Wu, Zhenhua Jeremy; Groner, Anna C.; He, Housheng Hansen; Liu, Tao; Xu, Han; Cato, Laura; Liu, X. Shirley; Brown, Myles] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA; [Xu, Kexin; Groner, Anna C.; He, Housheng Hansen; Lis, Rosina T.; Wu, Xiaoqiu; Stack, Edward C.; Loda, Massimo; Cato, Laura; Kantoff, Philip W.; Brown, Myles] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Xu, Kexin; Groner, Anna C.; He, Housheng Hansen; Cai, Changmeng; Lis, Rosina T.; Wu, Xiaoqiu; Stack, Edward C.; Loda, Massimo; Cato, Laura; Kantoff, Philip W.; Balk, Steven P.; Brown, Myles] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Wu, Zhenhua Jeremy; He, Housheng Hansen; Liu, Tao; Xu, Han; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Wu, Zhenhua Jeremy; He, Housheng Hansen; Liu, Tao; Xu, Han; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Cai, Changmeng; Balk, Steven P.] Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA; [Lis, Rosina T.; Wu, Xiaoqiu; Stack, Edward C.; Loda, Massimo] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Lis, Rosina T.; Stack, Edward C.; Loda, Massimo] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Loda, Massimo] Kings Coll London, Div Canc Studies, London SE1 8UB, England; [Thornton, James E.; Gregory, Richard I.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Thornton, James E.; Gregory, Richard I.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Morrissey, Colm; Vessella, Robert L.] Univ Washington, Med Ctr, Dept Urol, Seattle, WA 98195 USA; [Vessella, Robert L.] Puget Sound VA Hlth Care Syst, Seattle, WA 98108 USA; [Montironi, Rodolfo] Polytech Univ Marche Reg, United Hosp, Sect Pathol Anat, I-60126 Ancona, Italy; [Magi-Galluzzi, Cristina] Cleveland Clin, Pathol & Lab Med Inst, Glickman Urol & Kidney Inst, Dept Canc Biol,Taussig Canc Inst, Cleveland, OH 44195 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of London; King's College London; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Washington; University of Washington Seattle; Marche Polytechnic University; Cleveland Clinic Foundation	Liu, XS (corresponding author), Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA.	xsliu@jimmy.harvard.edu; myles_brown@dfci.harvard.edu	Liu, Tao/AAO-6310-2021; Brown, Myles/B-6906-2008; He, Hansen/ABD-8439-2020; Cai, Changmeng/AAE-6835-2020; Liu, Tao/G-3585-2010; Magi-Galluzzi, Cristina/AAW-6484-2020; Brown, Myles/AAX-5332-2021	Liu, Tao/0000-0002-8818-8313; He, Hansen/0000-0003-2898-3363; Liu, Tao/0000-0002-8818-8313; Brown, Myles/0000-0002-8213-1658; Kantoff, Philip/0000-0001-7275-0597; Liu, Tao/0000-0003-0446-9001; Cai, Changmeng/0000-0002-8701-2586	Prostate Cancer Foundation (PCF); Swiss National Science Foundation; NSF; A. David Mazzone Project Development Award; PCF Challenge Awards; U.S. Department of Defense Idea Development Award [PC100950]; National Cancer Institute [CA131945, CA89021, CA90381]; NIH [CA166507, CA111803, CA090381, GM99409, CA85859, CA097186]; NATIONAL CANCER INSTITUTE [R01CA131945, P50CA097186, P01CA085859, P50CA090381, P01CA089021, K99CA166507, R00CA166507, R01CA111803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099409] Funding Source: NIH RePORTER	Prostate Cancer Foundation (PCF); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NSF(National Science Foundation (NSF)); A. David Mazzone Project Development Award; PCF Challenge Awards; U.S. Department of Defense Idea Development Award(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Huang, A. Chinnaiyan, Y. Shang, and D. Reinberg for sharing their reagents, and Y. Qiu, X. Yang, J. Xu, and M. Ni for technical support and advice. Supported by a Prostate Cancer Foundation (PCF) Young Investigator Award (K. X.); a Swiss National Science Foundation prospective researcher fellowship (A. C. G.); a NSF graduate research fellowship (J. E. T.); an A. David Mazzone Project Development Award (M. B.); PCF Challenge Awards (S. P. B. and M. B.); U.S. Department of Defense Idea Development Award PC100950 (S. P. B.); National Cancer Institute grants CA131945, CA89021, and CA90381 (M. L.); and NIH grants CA166507 (C. C.), CA111803 (S. P. B.), CA090381 (M. B., S. P. B., P. W. K.), GM99409 (X. S. L.), and CA85859 and CA097186 (C. M., R. L. V.). All data sets have been deposited in the Gene Expression Omnibus database (GSE39461). M. B. serves as a consultant to Novartis Pharmaceuticals.	Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Culig Z, 1999, BRIT J CANCER, V81, P242, DOI 10.1038/sj.bjc.6690684; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Joshi P, 2008, J BIOL CHEM, V283, P27757, DOI 10.1074/jbc.M804442200; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; LaJeunesse D, 1996, DEVELOPMENT, V122, P2189; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	22	571	591	3	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1465	1469		10.1126/science.1227604	http://dx.doi.org/10.1126/science.1227604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239736	Green Accepted			2022-12-28	WOS:000312250800047
J	Yardimci, H; Wang, XD; Loveland, AB; Tappin, I; Rudner, DZ; Hurwitz, J; van Oijen, AM; Walter, JC				Yardimci, Hasan; Wang, Xindan; Loveland, Anna B.; Tappin, Inger; Rudner, David Z.; Hurwitz, Jerard; van Oijen, Antoine M.; Walter, Johannes C.			Bypass of a protein barrier by a replicative DNA helicase	NATURE			English	Article							SIMIAN-VIRUS-40 T-ANTIGEN; LARGE-TUMOR-ANTIGEN; SINGLE-STRANDED-DNA; HEXAMERIC HELICASE; VIRAL ORIGIN; SV40 ORIGIN; IN-VITRO; MECHANISM; FORK; TRANSLOCATION	Replicative DNA helicases generally unwind DNA as a single hexamer that encircles and translocates along one strand of the duplex while excluding the complementary strand (known as steric exclusion). By contrast, large T antigen, the replicative DNA helicase of the simian virus 40 (SV40), is reported to function as a pair of stacked hexamers that pumps double-stranded DNA through its central channel while laterally extruding single-stranded DNA. Here we use single-molecule and ensemble assays to show that large T antigen assembled on the SV40 origin unwinds DNA efficiently as a single hexamer that translocates on single-stranded DNA in the 3'-to-5' direction. Unexpectedly, large T antigen unwinds DNA past a DNA-protein crosslink on the translocation strand, suggesting that the large T antigen ring can open to bypass bulky adducts. Together, our data underscore the profound conservation among replicative helicase mechanisms, and reveal a new level of plasticity in the interactions of replicative helicases with DNA damage.	[van Oijen, Antoine M.] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; [Yardimci, Hasan; Loveland, Anna B.; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Wang, Xindan; Rudner, David Z.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Tappin, Inger; Hurwitz, Jerard] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	University of Groningen; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center	van Oijen, AM (corresponding author), Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands.	a.m.van.oijen@rug.nl; johannes_walter@hms.harvard.edu	Institute, Zernike/W-7033-2019; van Oijen, Antoine/I-3167-2014; Wang, Xindan/P-3967-2014; Wang, Xindan/Q-6600-2019	van Oijen, Antoine/0000-0002-1794-5161; Wang, Xindan/0000-0001-6458-180X; Yardimci, Hasan/0000-0001-5009-1391; Walter, Johannes/0000-0002-4186-7570; Loveland, Anna B./0000-0001-9172-7747	National Institutes of Health (NIH) [GM62267, HL098316, GM077248, GM5 R01 GM034559, GM086466]; American Cancer Society (ACS) [RSG0823401GMC]; Netherlands Organization for Scientific Research (NWO) [Vici 680-47-607]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098316] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077248, R01GM062267, R01GM034559, R01GM086466] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society (ACS)(American Cancer Society); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Richardson for critical reading of the manuscript, and C. Etson for help in the preparation of lambda ori DNA. J.C.W. was supported by grants from the National Institutes of Health (NIH) (GM62267 and HL098316) and American Cancer Society (ACS) (RSG0823401GMC). A.M.v.O. was supported by grants from the NIH (GM077248), ACS (RSG0823401GMC), and the Netherlands Organization for Scientific Research (NWO; Vici 680-47-607). J.H. was funded by NIH grant GM5 R01 GM034559. X.W. was a long-term postdoctoral fellow of the Human Frontier Science Program; D.Z.R. was supported by NIH grant GM086466.	Alexandrov AI, 2002, J BIOL CHEM, V277, P44886, DOI 10.1074/jbc.M207022200; Anand RP, 2012, NUCLEIC ACIDS RES, V40, P1091, DOI 10.1093/nar/gkr836; Barbaro BA, 2000, J VIROL, V74, P8601, DOI 10.1128/JVI.74.18.8601-8613.2000; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; BOROWIEC JA, 1988, P NATL ACAD SCI USA, V85, P64, DOI 10.1073/pnas.85.1.64; BULLOCK PA, 1991, MOL CELL BIOL, V11, P2350, DOI 10.1128/MCB.11.5.2350; CHEN L, 1991, BIOCHEMISTRY-US, V30, P11018, DOI 10.1021/bi00110a002; Cuesta I, 2010, J MOL BIOL, V397, P1276, DOI 10.1016/j.jmb.2010.02.042; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; EKI T, 1992, J BIOL CHEM, V267, P7284; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Fanning E, 2009, VIROLOGY, V384, P352, DOI 10.1016/j.virol.2008.11.038; Fanning Ellen, 2009, P1, DOI 10.1007/978-0-387-68945-6_1; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; GOETZ GS, 1988, J BIOL CHEM, V263, P383; Gomez-Lorenzo MG, 2003, EMBO J, V22, P6205, DOI 10.1093/emboj/cdg612; ISHIMI Y, 1988, J BIOL CHEM, V263, P19723; Kaplan DL, 2004, MOL CELL, V15, P453, DOI 10.1016/j.molcel.2004.06.039; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Kuhn H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn107; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Loparo JJ, 2011, P NATL ACAD SCI USA, V108, P3584, DOI 10.1073/pnas.1018824108; MACMILLAN AM, 1992, J ORG CHEM, V57, P2989, DOI 10.1021/jo00037a006; Morris PD, 2002, BIOCHEMISTRY-US, V41, P2372, DOI 10.1021/bi012058b; MURAKAMI Y, 1993, J BIOL CHEM, V268, P11008; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Sclafani RA, 2004, GENE DEV, V18, P2039, DOI 10.1101/gad.1240604; Seinsoth S, 2003, EMBO REP, V4, P263, DOI 10.1038/sj.embor.embor770; SENGUPTA DJ, 1992, SCIENCE, V256, P1656, DOI 10.1126/science.256.5064.1656; Smelkova NV, 1997, J VIROL, V71, P8766, DOI 10.1128/JVI.71.11.8766-8773.1997; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Tanner NA, 2010, SINGLE MOL TOOLS B, P259; Thomason Lynn C., 2009, V501, P239, DOI 10.1007/978-1-60327-164-6_21; Wang IN, 2006, GENETICS, V172, P17, DOI 10.1534/genetics.105.045922; Weisshart K, 1999, J VIROL, V73, P2201, DOI 10.1128/JVI.73.3.2201-2211.1999; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; WOBBE CR, 1985, P NATL ACAD SCI USA, V82, P5710, DOI 10.1073/pnas.82.17.5710; WOLD MS, 1987, P NATL ACAD SCI USA, V84, P3643, DOI 10.1073/pnas.84.11.3643; Wu CX, 2001, J VIROL, V75, P2839, DOI 10.1128/JVI.75.6.2839-2847.2001; Yardimci H, 2012, METHODS, V57, P179, DOI 10.1016/j.ymeth.2012.03.033; Yardimci H, 2010, MOL CELL, V40, P834, DOI 10.1016/j.molcel.2010.11.027	46	69	69	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					205	+		10.1038/nature11730	http://dx.doi.org/10.1038/nature11730			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23201686	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000312259300032
J	Campbell-Thompson, M; Wasserfall, C; Montgomery, EL; Atkinson, MA; Kaddis, JS				Campbell-Thompson, Martha; Wasserfall, Clive; Montgomery, Emily L.; Atkinson, Mark A.; Kaddis, John S.			Pancreas Organ Weight in Individuals With Disease-Associated Autoantibodies at Risk for Type 1 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MELLITUS		[Campbell-Thompson, Martha; Wasserfall, Clive; Montgomery, Emily L.; Atkinson, Mark A.] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA; [Kaddis, John S.] City Hope Natl Med Ctr, Dept Informat Sci, Duarte, CA USA	State University System of Florida; University of Florida; City of Hope	Campbell-Thompson, M (corresponding author), Univ Florida, Dept Pathol, Gainesville, FL 32611 USA.	jkaddis@coh.org	wasserfall, clive/J-9078-2012; Wasserfall, Clive/ABF-9385-2020; Campbell-Thompson, Martha/A-7584-2010	wasserfall, clive/0000-0002-3522-8932; Wasserfall, Clive/0000-0002-3522-8932; Kaddis, John/0000-0002-6752-7670; Campbell-Thompson, Martha/0000-0001-6878-1235	NIDDK NIH HHS [DP3 DK101120] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Campbell-Thompson M, 2012, DIABETES-METAB RES, V28, P608, DOI 10.1002/dmrr.2316; FONSECA V, 1985, BRIT MED J, V291, P1240, DOI 10.1136/bmj.291.6504.1240; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Loftin LB, 1991, ADV ED RES SUBSTANTI, V1, P133; MANSFIELD ER, 1982, AM STAT, V36, P158, DOI 10.2307/2683167; Yu LP, 2012, DIABETES CARE, V35, P1213, DOI 10.2337/dc11-2081	6	96	96	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2012	308	22					2337	2339		10.1001/jama.2012.15008	http://dx.doi.org/10.1001/jama.2012.15008			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051MW	23232891	Bronze			2022-12-28	WOS:000312132400020
J	Bar-Peled, L; Sabatini, DM				Bar-Peled, Liron; Sabatini, David M.			SnapShot: mTORC1 Signaling at the Lysosomal Surface	CELL			English	Editorial Material							GROWTH-CONTROL; UPSTREAM; TOR		[Bar-Peled, Liron; Sabatini, David M.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Bar-Peled, L (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.			/0000-0002-1446-7256				Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Russell RC, 2011, DEVELOPMENT, V138, P3343, DOI 10.1242/dev.058230	10	30	30	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1390	+	1390.e1	10.1016/j.cell.2012.11.038	http://dx.doi.org/10.1016/j.cell.2012.11.038			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217718	Bronze			2022-12-28	WOS:000311999900027
J	Matsumura, M; Hara, S				Matsumura, Masami; Hara, Satoshi			Crowned Dens Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Matsumura, Masami; Hara, Satoshi] Kanazawa Univ, Kanazawa, Ishikawa, Japan	Kanazawa University	Matsumura, M (corresponding author), Kanazawa Univ, Kanazawa, Ishikawa, Japan.		hara, satoshi/AAA-3930-2020						0	16	19	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2012	367	23					E34	E34		10.1056/NEJMicm1100764	http://dx.doi.org/10.1056/NEJMicm1100764			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048DO	23215579				2022-12-28	WOS:000311890600012
J	Martin, W; Freyenhagen, F; Hall, E; O'Shea, T; Szerletics, A; Ashley, V				Martin, Wayne; Freyenhagen, Fabian; Hall, Elizabeth; O'Shea, Tom; Szerletics, Antal; Ashley, Vivienne			An unblinkered view of best interests	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Martin, Wayne; Freyenhagen, Fabian; Hall, Elizabeth; O'Shea, Tom; Szerletics, Antal; Ashley, Vivienne] Univ Essex, Sch Philosophy & Art Hist, Essex Auton Project, Colchester CO4 3SQ, Essex, England	University of Essex	Ashley, V (corresponding author), Univ Essex, Sch Philosophy & Art Hist, Essex Auton Project, Colchester CO4 3SQ, Essex, England.	vlashl@essex.ac.uk	Antal, Szerletics/AFE-8036-2022; Antal, Szerletics/AAE-9630-2022	Antal, Szerletics/0000-0002-2530-2254; Antal, Szerletics/0000-0002-2530-2254	AHRC [AH/H001301/1] Funding Source: UKRI; Arts and Humanities Research Council [AH/H001301/1] Funding Source: researchfish	AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))		BERGER B, 1983, WAR FAMILY CAPTURING; Essex Autonomy Project, 2011, BEST INT DEC MAK LEG; Herring J, 2012, LEGAL STUDIES; Holman A., 2007, MAKING DECISIONS EAS; Mental Health Foundation, 2008, BANK GOOD DEC CAN ME; U. Department of Health, 2009, LEG ISS REL NON HEAR	6	6	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 5	2012	345								e8007	10.1136/bmj.e8007	http://dx.doi.org/10.1136/bmj.e8007			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052ID	23223685	Green Accepted			2022-12-28	WOS:000312190200001
J	Rothberg, MB				Rothberg, Michael B.			Overcoming the Obstacles to Research During Residency What Does It Take?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRAINING-PROGRAMS		[Rothberg, Michael B.] Baystate Med Ctr, Internal Med Residency Program, Springfield, MA USA; [Rothberg, Michael B.] Baystate Med Ctr, Div Gen Med, Springfield, MA USA; [Rothberg, Michael B.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Baystate Medical Center; Baystate Medical Center; Tufts University	Rothberg, MB (corresponding author), Cleveland Clin, Inst Med, Dept Internal Med, 9500 Euclid Ave,G10, Cleveland, OH 44195 USA.	rothbem@ccf.org						Accreditation Council for Graduate Medical Education, 2011, ACGME PROGR REQ GRAD; Alguire PC, 1996, ANN INTERN MED, V124, P321, DOI 10.7326/0003-4819-124-3-199602010-00007; Byrnes AB, 2007, J CANCER EDUC, V22, P47, DOI 10.1007/BF03174375; Levine RB, 2005, J GEN INTERN MED, V20, P155, DOI 10.1111/j.1525-1497.2005.40270.x; National Institutes of Health, 2008, CLIN RES TRAIN ON LI; Nevin J, UPDATES RESIDENCY RE; Rivera JA, 2005, J GEN INTERN MED, V20, P366, DOI 10.1111/j.1525-1497.2005.04157.x; Takahashi O, 2009, J GEN INTERN MED, V24, P716, DOI 10.1007/s11606-009-0970-4; Vinci RJ, 2009, PEDIATRICS, V124, P1126, DOI 10.1542/peds.2008-3700	9	61	63	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2012	308	21					2191	2192		10.1001/jama.2012.14587	http://dx.doi.org/10.1001/jama.2012.14587			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047HI	23212493				2022-12-28	WOS:000311829500007
J	Ahmad, SS; Duke, S; Jena, R; Williams, MV; Burnet, NG				Ahmad, Saif S.; Duke, Simon; Jena, Rajesh; Williams, Michael V.; Burnet, Neil G.			Advances in radiotherapy	BRITISH MEDICAL JOURNAL			English	Review							INTENSITY-MODULATED RADIOTHERAPY; 2ND MALIGNANT NEOPLASMS; RADIATION-THERAPY; PROSTATE-CANCER; BREAST-CANCER; PROTON; COMPLICATIONS; RADIOSURGERY; MANAGEMENT; DISEASE		[Ahmad, Saif S.; Duke, Simon; Jena, Rajesh; Williams, Michael V.] Cambridge Univ Hosp NHS Fdn Trust, Cambridge CB2 0QQ, England; [Burnet, Neil G.] Univ Cambridge, Cambridge CB2 1TN, England	University of Cambridge; University of Cambridge	Ahmad, SS (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Cambridge CB2 0QQ, England.	saif.ahmad@nhs.net	Duke, Simon/AAB-7351-2019; Burnet, Neil/L-1025-2019	Ahmad, Saif/0000-0003-1020-2346				AlDuhaiby EZ, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-18; Allen AM, 2012, RADIOTHER ONCOL, V103, P8, DOI 10.1016/j.radonc.2012.02.001; Andreyev J, 2007, LANCET ONCOL, V8, P1007, DOI 10.1016/S1470-2045(07)70341-8; Brodin NP, 2012, CANCER-AM CANCER SOC, V118, P5432, DOI 10.1002/cncr.27536; Burnet NG, 2012, CLIN ONCOL R COLL RA; Button MR, 2010, CLIN ONCOL-UK, V22, P698, DOI 10.1016/j.clon.2010.06.020; Chi A, 2010, RADIOTHER ONCOL, V94, P1, DOI 10.1016/j.radonc.2009.12.008; Chow E, 2012, CLIN ONCOL-UK, V24, P112, DOI 10.1016/j.clon.2011.11.004; de Gonzalez AB, 2010, BRIT J CANCER, V102, P220, DOI 10.1038/sj.bjc.6605435; Dearnaley DP, 1999, LANCET, V353, P267, DOI 10.1016/S0140-6736(98)05180-0; Delaney G, 2005, CANCER-AM CANCER SOC, V104, P1129, DOI 10.1002/cncr.21324; DeLaney TF, 2011, FRONT RADIAT THER ON, V43, P465, DOI 10.1159/000322511; Department of Health, 2011, RAD DAT ANN REP 2009; Hall EJ, 2003, INT J RADIAT ONCOL, V56, P83, DOI 10.1016/S0360-3016(03)00073-7; HANCOCK SL, 1993, JAMA-J AM MED ASSOC, V270, P1949, DOI 10.1001/jama.270.16.1949; Hopwood P, 2010, LANCET ONCOL, V11, P231, DOI 10.1016/S1470-2045(09)70382-1; Hummel S, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14470; Jefferies S, 2009, CLIN ONCOL-UK, V21, P204, DOI 10.1016/j.clon.2008.11.017; Jereczek-Fossa BA, 2002, CRIT REV ONCOL HEMAT, V41, P317, DOI 10.1016/S1040-8428(01)00143-3; Marks LB, 2011, INT J RADIAT ONCOL, V79, P1287, DOI 10.1016/j.ijrobp.2010.12.004; Marks LB, 2010, INT J RADIAT ONCOL, V76, pS10, DOI 10.1016/j.ijrobp.2009.07.1754; Martin A, 2010, CLIN ONCOL-UK, V22, P157, DOI 10.1016/j.clon.2009.12.003; Maughan TS, 2010, CLIN ONCOL-UK, V22, P707, DOI 10.1016/j.clon.2010.03.006; Mayles WPM, 2012, CLIN ONCOL-UK, V24, P543, DOI 10.1016/j.clon.2012.06.005; Miller MC, 2009, CURR OPIN OTOLARYNGO, V17, P111, DOI 10.1097/MOO.0b013e328325a538; Nutting CM, 2011, LANCET ONCOL, V12, P127, DOI 10.1016/S1470-2045(10)70290-4; Ruben JD, 2008, INT J RADIAT ONCOL, V70, P1530, DOI 10.1016/j.ijrobp.2007.08.046; Schulz-Ertner D, 2007, J CLIN ONCOL, V25, P953, DOI 10.1200/JCO.2006.09.7816; Short S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3247; Staffurth J, 2010, CLIN ONCOL-UK, V22, P643, DOI 10.1016/j.clon.2010.06.013; Swerdlow AJ, 2012, J CLIN ONCOL, V30, P2745, DOI 10.1200/JCO.2011.38.8835; Travis LB, 1997, JNCI-J NATL CANCER I, V89, P1429, DOI 10.1093/jnci/89.19.1429; Travis LB, 2012, JNCI-J NATL CANCER I, V104, P357, DOI 10.1093/jnci/djr533; TUBIANA M, 1992, EUR J CANCER, V28A, P2061, DOI 10.1016/0959-8049(92)90256-2; Verellen D, 2007, NAT REV CANCER, V7, P949, DOI 10.1038/nrc2288; Williams MV, 2010, CLIN ONCOL-UK, V22, P623, DOI 10.1016/j.clon.2010.06.015; Williams MV, 2011, INT J RADIAT ONCOL, V79, P1601, DOI 10.1016/j.ijrobp.2010.10.055	37	69	69	0	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 4	2012	345								e7765	10.1136/bmj.e7765	http://dx.doi.org/10.1136/bmj.e7765			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HY	23212681				2022-12-28	WOS:000312189700001
J	Ke, YG; Ong, LL; Shih, WM; Yin, P				Ke, Yonggang; Ong, Luvena L.; Shih, William M.; Yin, Peng			Three-Dimensional Structures Self-Assembled from DNA Bricks	SCIENCE			English	Article							NANOSCALE SHAPES; FOLDING DNA; ORIGAMI; RNA; LATTICES; NANOTECHNOLOGY; CRYSTAL; DESIGN; MOTOR	We describe a simple and robust method to construct complex three-dimensional (3D) structures by using short synthetic DNA strands that we call "DNA bricks." In one-step annealing reactions, bricks with hundreds of distinct sequences self-assemble into prescribed 3D shapes. Each 32-nucleotide brick is a modular component; it binds to four local neighbors and can be removed or added independently. Each 8-base pair interaction between bricks defines a voxel with dimensions of 2.5 by 2.5 by 2.7 nanometers, and a master brick collection defines a "molecular canvas" with dimensions of 10 by 10 by 10 voxels. By selecting subsets of bricks from this canvas, we constructed a panel of 102 distinct shapes exhibiting sophisticated surface features, as well as intricate interior cavities and tunnels.	[Ke, Yonggang; Ong, Luvena L.; Shih, William M.; Yin, Peng] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Ke, Yonggang; Shih, William M.] Harvard Univ, Harvard Med Sch, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Ke, Yonggang; Shih, William M.] Harvard Univ, Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ong, Luvena L.] MIT, Harvard Massachusetts Inst Technol MIT Div Hlth S, Cambridge, MA 02139 USA; [Yin, Peng] Harvard Univ, Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Yin, P (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	py@hms.harvard.edu		/0000-0001-5317-3018	Office of Naval Research (ONR) Young Investigator Program award [N000141110914]; ONR grant [N000141010827, N000014091118, N000141010241]; Army Research Office [W911NF1210238]; NSF [CCF1054898]; NIH [1DP2OD007292, 1DP2OD004641]; Wyss Institute Faculty Startup Fund; Wyss Institute Faculty Grant; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004641, DP2OD007292] Funding Source: NIH RePORTER; Division of Computing and Communication Foundations [1054898] Funding Source: National Science Foundation	Office of Naval Research (ONR) Young Investigator Program award(Office of Naval Research); ONR grant; Army Research Office; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wyss Institute Faculty Startup Fund; Wyss Institute Faculty Grant; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The authors thank M. Dai for technical assistance; E. Winfree, B. Wei, and S. Woo for discussions; and D. Pastuszak for assistance in draft preparation. This work is supported by an Office of Naval Research (ONR) Young Investigator Program award N000141110914, an ONR grant N000141010827, an Army Research Office grant W911NF1210238, an NSF CAREER award CCF1054898, an NIH Director's New Innovator award 1DP2OD007292, and a Wyss Institute Faculty Startup Fund to P.Y., and by a Wyss Institute Faculty Grant, ONR grants N000014091118 and N000141010241, and an NIH Director's New Innovator award 1DP2OD004641 to W.M.S.. L.L.O. is supported by an NSF graduate research fellowship. Y.K. conceived the project, designed and performed the experiments, analyzed the data, and wrote the paper; L.L.O. designed and performed the experiments, analyzed the data, and wrote the paper; W.M.S. conceived the project, discussed the results, and wrote the paper; P.Y. conceived, designed, and supervised the study, interpreted the data, and wrote the paper. The DNA sequences for the nanostructures can be found in the supplementary materials. A provisional patent has been filed based on this work.	Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Choi HMT, 2010, NAT BIOTECHNOL, V28, P1208, DOI 10.1038/nbt.1692; Chworos A, 2004, SCIENCE, V306, P2068, DOI 10.1126/science.1104686; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; Derr ND, 2012, SCIENCE, V338, P662, DOI 10.1126/science.1226734; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Ke YG, 2012, J AM CHEM SOC, V134, P1770, DOI 10.1021/ja209719k; Ke YG, 2009, J AM CHEM SOC, V131, P15903, DOI 10.1021/ja906381y; Ke YG, 2009, NANO LETT, V9, P2445, DOI 10.1021/nl901165f; Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889; Leontis NB, 2006, CURR OPIN STRUC BIOL, V16, P279, DOI 10.1016/j.sbi.2006.05.009; Lin CX, 2006, CHEMPHYSCHEM, V7, P1641, DOI 10.1002/cphc.200600260; Lin CX, 2012, NAT CHEM, V4, P832, DOI 10.1038/NCHEM.1451; Omabegho T, 2009, SCIENCE, V324, P67, DOI 10.1126/science.1170336; Park SH, 2006, ANGEW CHEM INT EDIT, V45, P735, DOI 10.1002/anie.200503797; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Rothemund PWK, 2012, NATURE, V485, P584, DOI 10.1038/485584a; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; Schulman R, 2012, P NATL ACAD SCI USA, V109, P6405, DOI 10.1073/pnas.1117813109; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Severcan I, 2010, NAT CHEM, V2, P772, DOI [10.1038/nchem.733, 10.1038/NCHEM.733]; Sherman WB, 2004, NANO LETT, V4, P1203, DOI 10.1021/nl049527q; Shih WM, 2010, CURR OPIN STRUC BIOL, V20, P276, DOI 10.1016/j.sbi.2010.03.009; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zhang DY, 2011, NAT CHEM, V3, P103, DOI 10.1038/NCHEM.957; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274	43	825	853	15	707	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2012	338	6111					1177	1183		10.1126/science.1227268	http://dx.doi.org/10.1126/science.1227268			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197527	Green Accepted			2022-12-28	WOS:000311666200038
J	Manosas, M; Perumal, SK; Croquette, V; Benkovic, SJ				Manosas, Maria; Perumal, Senthil K.; Croquette, Vincent; Benkovic, Stephen J.			Direct Observation of Stalled Fork Restart via Fork Regression in the T4 Replication System	SCIENCE			English	Article							MAMMALIAN-CELLS; DNA-REPLICATION; UVSW PROTEIN; BACTERIOPHAGE-T4; REPAIR; MODEL; HELICASE; RECOMBINATION; REPLISOME; REVERSAL	The restart of a stalled replication fork is a major challenge for DNA replication. Depending on the nature of the damage, different repair processes might be triggered; one is template switching, which is a bypass of a leading-strand lesion via fork regression. Using magnetic tweezers to study the T4 bacteriophage enzymes, we have reproduced in vitro the complete process of template switching. We show that the UvsW DNA helicase in cooperation with the T4 holoenzyme can overcome leading-strand lesion damage by a pseudostochastic process, periodically forming and migrating a four-way Holliday junction. The initiation of the repair process requires partial replisome disassembly via the departure of the replicative helicase. The results support the role of fork regression pathways in DNA repair.	[Manosas, Maria; Croquette, Vincent] Univ Paris Diderot, Univ Paris 06, Ecole Normale Super, Lab Phys Stat,CNRS, F-75005 Paris, France; [Manosas, Maria] Univ Barcelona, Fac Fis, Dept Fis Fonamental, E-08028 Barcelona, Spain; [Croquette, Vincent] Ecole Normale Super, Dept Biol, F-75005 Paris, France; [Perumal, Senthil K.; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Manosas, Maria] Inst Sanidad Carlos III, CIBER BBN Bioingn Biomat & Nanomed, Madrid, Spain	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; University of Barcelona; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Croquette, V (corresponding author), Univ Paris Diderot, Univ Paris 06, Ecole Normale Super, Lab Phys Stat,CNRS, 24 Rue Lhomond, F-75005 Paris, France.	vincent.croquette@lps.ens.fr; sjb1@psu.edu		Manosas Castejon, Maria/0000-0001-8001-4055; Croquette, Vincent/0000-0003-1400-0039	Human Frontier Science Program; U.S. National Institutes of Health [GM013306]; ERC [Magreps 267 862]; Juan de la Cierva Program MICINN-JDC; Engineering and Physical Sciences Research Council [EP/H006702/1] Funding Source: researchfish; EPSRC [EP/H006702/1] Funding Source: UKRI	Human Frontier Science Program(Human Frontier Science Program); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); Juan de la Cierva Program MICINN-JDC; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank B. Michel and D. Bensimon for useful comments on the manuscript and M. M. Spiering for DNA substrates. This work was supported by a Human Frontier Science Program grant (to V.C. and S.J.B.), U.S. National Institutes of Health grant GM013306 (to S.J.B.), ERC grant Magreps 267 862 (to V.C.), and Juan de la Cierva Program MICINN-JDC (to M.M). M.M. conducted single-molecule assays and performed the analysis. S.K.P. conducted ensemble assays, analyzed data, and prepared DNA and proteins. V.C. built the magnetic tweezers. M.M., S.K.P., V.C., and S.J.B. wrote the paper. Materials and methods are available as supplementary materials.	Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; CarlesKinch K, 1997, EMBO J, V16, P4142, DOI 10.1093/emboj/16.13.4142; CHASE JW, 1986, ANNU REV BIOCHEM, V55, P103, DOI 10.1146/annurev.biochem.55.1.103; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; FUJIWARA Y, 1976, MUTAT RES, V37, P91, DOI 10.1016/0027-5107(76)90058-0; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; HACKER KJ, 1994, J BIOL CHEM, V269, P24221; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; Long DT, 2009, EMBO REP, V10, P394, DOI 10.1038/embor.2009.13; Machwe A, 2006, BIOCHEMISTRY-US, V45, P13939, DOI 10.1021/bi0615487; Manosas M, 2012, NUCLEIC ACIDS RES, V40, P6174, DOI 10.1093/nar/gks253; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; Nelson SW, 2007, J BIOL CHEM, V282, P407, DOI 10.1074/jbc.M608153200; Nelson SW, 2010, J MOL BIOL, V401, P743, DOI 10.1016/j.jmb.2010.06.027; VENKATESAN M, 1982, J BIOL CHEM, V257, P2426; Webb MR, 2007, J BIOL CHEM, V282, P34401, DOI 10.1074/jbc.M705913200; Yeeles JTP, 2011, SCIENCE, V334, P235, DOI 10.1126/science.1209111	19	63	64	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1217	1220		10.1126/science.1225437	http://dx.doi.org/10.1126/science.1225437			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197534	Green Accepted			2022-12-28	WOS:000311666200048
J	Liebschutz, JM; Rothman, EF				Liebschutz, Jane M.; Rothman, Emily F.			Intimate-Partner Violence - What Physicians Can Do	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Liebschutz, Jane M.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Rothman, Emily F.] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA	Boston University; Boston University	Liebschutz, JM (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.		Rothman, Emily/K-4753-2014	Rothman, Emily/0000-0003-0113-2577; Liebschutz, Jane/0000-0003-3492-1521				Black M.C., 2011, NATL INTIMATE PARTNE; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; James L, 2012, INTERPERSONAL DOMEST; Nelson HD, 2012, ANN INTERN MED, V156, P796, DOI 10.7326/0003-4819-156-11-201206050-00447; Sherin K M, 1998, Fam Med, V30, P508	5	28	28	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2012	367	22					2071	2073		10.1056/NEJMp1204278	http://dx.doi.org/10.1056/NEJMp1204278			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	044MS	23190220				2022-12-28	WOS:000311624400003
J	Alfonso, F; Perez-Vizcayno, MJ				Alfonso, Fernando; Perez-Vizcayno, Maria J.			Drug-eluting balloons for restenosis after stent implantation	LANCET			English	Editorial Material							COATED BALLOONS; PACLITAXEL; ANGIOPLASTY; CATHETER; TRIAL; MULTICENTER; PREVENTION		[Alfonso, Fernando; Perez-Vizcayno, Maria J.] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Clin San Carlos Univ Hosp, Cardiovasc Inst, Madrid 28040, Spain	Hospital Clinico San Carlos	Alfonso, F (corresponding author), Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Clin San Carlos Univ Hosp, Cardiovasc Inst, Madrid 28040, Spain.	falf@hotmail.com						Alfonso F, 2004, EUR HEART J, V25, P1829, DOI 10.1016/j.ehj.2004.07.019; Alfonso F, 2005, AM HEART J, V149, DOI 10.1016/j.ahj.2004.06.022; Alfonso F, 2012, JACC-CARDIOVASC INTE, V5, P728, DOI 10.1016/j.jcin.2012.03.017; Alfonso F, 2010, J AM COLL CARDIOL, V55, P2717, DOI 10.1016/j.jacc.2010.03.026; Byrne RA, 2012, LANCET; Diaz JF, 2011, REV ESP CARDIOL, V64, P1012, DOI [10.1016/j.rec.2011.09.001, 10.1016/j.recesp.2011.08.001]; Gray WA, 2010, CIRCULATION, V121, P2672, DOI 10.1161/CIRCULATIONAHA.110.936922; Habara S, 2011, JACC-CARDIOVASC INTE, V4, P149, DOI 10.1016/j.jcin.2010.10.012; Kastrati A, 2005, JAMA-J AM MED ASSOC, V293, P165, DOI 10.1001/jama.293.2.165; Loh JP, 2012, JACC-CARDIOVASC INTE, V5, P1001, DOI 10.1016/j.jcin.2012.08.005; Mehilli J, 2010, J AM COLL CARDIOL, V55, P2710, DOI 10.1016/j.jacc.2010.02.009; Rittger H, 2012, J AM COLL CARDIOL, V59, P1377, DOI 10.1016/j.jacc.2012.01.015; Scheller B, 2006, NEW ENGL J MED, V355, P2113, DOI 10.1056/NEJMoa061254; Unverdorben M, 2009, CIRCULATION, V119, P2986, DOI 10.1161/CIRCULATIONAHA.108.839282; Wohrle J, 2012, J AM COLL CARDIOL, V60, P1733, DOI 10.1016/j.jacc.2012.07.040	15	5	5	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2013	381	9865					431	433		10.1016/S0140-6736(12)62120-5	http://dx.doi.org/10.1016/S0140-6736(12)62120-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088CH	23206833				2022-12-28	WOS:000314810900009
J	Kreso, A; O'Brien, CA; van Galen, P; Gan, OI; Notta, F; Brown, AMK; Ng, K; Ma, J; Wienholds, E; Dunant, C; Pollett, A; Gallinger, S; McPherson, J; Mullighan, CG; Shibata, D; Dick, JE				Kreso, Antonija; O'Brien, Catherine A.; van Galen, Peter; Gan, Olga I.; Notta, Faiyaz; Brown, Andrew M. K.; Ng, Karen; Ma, Jing; Wienholds, Erno; Dunant, Cyrille; Pollett, Aaron; Gallinger, Steven; McPherson, John; Mullighan, Charles G.; Shibata, Darryl; Dick, John E.			Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer	SCIENCE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GENE-EXPRESSION; INITIATING CELLS; TUMOR-GROWTH; STEM-CELLS; EVOLUTION; ORIGINS; STOCHASTICITY; HETEROGENEITY; BIODIVERSITY	Intratumoral heterogeneity arises through the evolution of genetically diverse subclones during tumor progression. However, it remains unknown whether cells within single genetic clones are functionally equivalent. By combining DNA copy number alteration (CNA) profiling, sequencing, and lentiviral lineage tracking, we followed the repopulation dynamics of 150 single lentivirus-marked lineages from 10 human colorectal cancers through serial xenograft passages in mice. CNA and mutational analysis distinguished individual clones and showed that clones remained stable upon serial transplantation. Despite this stability, the proliferation, persistence, and chemotherapy tolerance of lentivirally marked lineages were variable within each clone. Chemotherapy promoted the dominance of previously minor or dormant lineages. Thus, apart from genetic diversity, tumor cells display inherent functional variability in tumor propagation potential, which contributes to both cancer growth and therapy tolerance.	[Kreso, Antonija; O'Brien, Catherine A.; van Galen, Peter; Gan, Olga I.; Notta, Faiyaz; Wienholds, Erno; Dick, John E.] Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Campbell Family Inst, Toronto, ON M5G 1L7, Canada; [Kreso, Antonija; Notta, Faiyaz; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada; [O'Brien, Catherine A.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5L 1F4, Canada; [O'Brien, Catherine A.] Univ Toronto, Dept Surg, Toronto, ON M5L 1F4, Canada; [Brown, Andrew M. K.; Ng, Karen; McPherson, John] Ontario Inst Canc Res, Toronto, ON M5G 1L7, Canada; [Ma, Jing; Mullighan, Charles G.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Dunant, Cyrille] Univ Toronto, Dept Civil Engn, Toronto, ON M5S 1A4, Canada; [Pollett, Aaron] Mt Sinai Hosp, Dept Pathol, Toronto, ON M5G 1X5, Canada; [Gallinger, Steven] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Fred Litwin Ctr Canc Genet, Toronto, ON M7H 2B9, Canada; [Shibata, Darryl] Univ So Calif, Keck Sch Med, Los Angeles, CA 90089 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; St Jude Children's Research Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Southern California	Dick, JE (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Campbell Family Inst, Toronto, ON M5G 1L7, Canada.	jdick@uhnres.utoronto.ca	Mullighan, Charles/H-3253-2011; McPherson, John D/D-2633-2017; Pollett, Aaron/AAQ-2540-2021; Pollett, Aaron/J-2308-2016; Gallinger, Steven/E-4575-2013	Mullighan, Charles/0000-0002-1871-1850; McPherson, John D/0000-0001-8049-9347; Pollett, Aaron/0000-0001-5121-8788; Pollett, Aaron/0000-0001-5121-8788; van Galen, Peter/0000-0002-0735-1570; Dunant, Cyrille/0000-0001-5176-4439; Dick, John/0000-0002-9527-8317; O'Brien, Catherine/0000-0003-0682-3879	Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research; Summit Award; Canadian Institutes for Health Research; Netherlands Organisation for Scientific Research; NIH [R21 CA149990-01]; Canada Research Chair; Princess Margaret Hospital Foundation; Ontario Ministry of Health and Long Term Care (OMOHLTC); province of Ontario; NATIONAL CANCER INSTITUTE [R21CA149990] Funding Source: NIH RePORTER	Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Institute for Cancer Research; Summit Award; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Princess Margaret Hospital Foundation; Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario); province of Ontario; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. Gibson, A. Khandani, and P. Penttila for experimental support and members of the Dick lab, especially M. Doedens, J. Wang, M. Milyavsky, and E. Laurenti for technical support and critical assessment of this work, as well as UHN biobank for specimens, the Clinical Applications of Core Technology (Affymetrix) Laboratory of the Hartwell Center for Bioinformatics and Biotechnology of St. Jude Children's Research Hospital, and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital. Supported by Genome Canada through the Ontario Genomics Institute, Ontario Institute for Cancer Research and a Summit Award with funds from the province of Ontario, the Canadian Institutes for Health Research, the Netherlands Organisation for Scientific Research, NIH grant R21 CA149990-01, a Canada Research Chair, the Princess Margaret Hospital Foundation, and the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC.	ABULAFI AM, 1994, BRIT J SURG, V81, P7, DOI 10.1002/bjs.1800810106; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Roche-Lestienne C, 2003, NEW ENGL J MED, V348, P2265, DOI 10.1056/NEJMc035089; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825	30	518	544	1	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					543	548		10.1126/science.1227670	http://dx.doi.org/10.1126/science.1227670			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23239622	Green Accepted			2022-12-28	WOS:000314270000050
J	Granger, AJ; Shi, Y; Lu, W; Cerpas, M; Nicoll, RA				Granger, Adam J.; Shi, Yun; Lu, Wei; Cerpas, Manuel; Nicoll, Roger A.			LTP requires a reserve pool of glutamate receptors independent of subunit type	NATURE			English	Article							AMPA RECEPTOR; SYNAPTIC PLASTICITY; LONG-TERM; SURFACE EXPRESSION; GLUR1 SUBUNIT; TRAFFICKING; PHOSPHORYLATION; CAMKII; SYNAPSES; NEURONS	Long-term potentiation (LTP) of synaptic transmission is thought to be an important cellular mechanism underlying memory formation. A widely accepted model posits that LTP requires the cytoplasmic carboxyl tail (C-tail) of the AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptor subunit GluA1. To find the minimum necessary requirement of the GluA1 C-tail for LTP in mouse CA1 hippocampal pyramidal neurons, we used a single-cell molecular replacement strategy to replace all endogenous AMPA receptors with transfected subunits. In contrast to the prevailing model, we found no requirement of the GluA1 C-tail for LTP. In fact, replacement with the GluA2 subunit showed normal LTP, as did an artificially expressed kainate receptor not normally found at these synapses. The only conditions under which LTP was impaired were those with markedly decreased AMPA receptor surface expression, indicating a requirement for a reserve pool of receptors. These results demonstrate the synapse's remarkable flexibility to potentiate with a variety of glutamate receptor subtypes, requiring a fundamental change in our thinking with regard to the core molecular events underlying synaptic plasticity.	[Granger, Adam J.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA; [Shi, Yun; Lu, Wei; Cerpas, Manuel; Nicoll, Roger A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	nicoll@cmp.uscf.edu	Shi, Yun/B-5623-2009; Lu, Wei/S-5617-2018; Shi, Yun S/T-8845-2018	Shi, Yun/0000-0002-8842-9818; Lu, Wei/0000-0001-6668-8432; Granger, Adam/0000-0002-3953-6764	National Science Foundation; National Institute of Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070957] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Jackson, J. Levy, S. Fischbach, K. Lovero, N. Sheng, S. Shipman and M. Younger for critical discussions and reading of the manuscript; K. Bjorgen for technical help with organotypic slice cultures; and L. Subramanian from the Kriegstein laboratory for technical help with in utero electroporations. We thank P. Seeburg and R. Sprengel for the Gria1-3<SUP>fl/fl</SUP> mice. A. J. G. was supported by the National Science Foundation Graduate Research Fellowship. R. A. N. is supported by the National Institute of Health.	Andrasfalvy BK, 2003, J PHYSIOL-LONDON, V552, P35, DOI 10.1113/jphysiol.2003.045575; Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Coleman SK, 2003, J NEUROSCI, V23, P798; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Contractor A, 2011, TRENDS NEUROSCI, V34, P154, DOI 10.1016/j.tins.2010.12.002; Copits BA, 2011, J NEUROSCI, V31, P7334, DOI 10.1523/JNEUROSCI.0100-11.2011; Dargan SL, 2009, NEUROPHARMACOLOGY, V56, P121, DOI 10.1016/j.neuropharm.2008.08.016; Elias GM, 2008, P NATL ACAD SCI USA, V105, P20953, DOI 10.1073/pnas.0811025106; Granger AJ, 2011, J PHYSIOL-LONDON, V589, P4095, DOI 10.1113/jphysiol.2011.213033; Greger IH, 2007, TRENDS NEUROSCI, V30, P407, DOI 10.1016/j.tins.2007.06.005; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lu W, 2010, P NATL ACAD SCI USA, V107, P22266, DOI 10.1073/pnas.1016289107; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Makino Y, 2011, P NATL ACAD SCI USA, V108, P8450, DOI 10.1073/pnas.1105261108; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Murakoshi H, 2012, TRENDS NEUROSCI, V35, P135, DOI 10.1016/j.tins.2011.12.002; Navarro-Quiroga I, 2007, J NEUROSCI, V27, P5007, DOI 10.1523/JNEUROSCI.0867-07.2007; Opazo P, 2011, MOL CELL NEUROSCI, V46, P1, DOI 10.1016/j.mcn.2010.08.014; Panicker S, 2008, P NATL ACAD SCI USA, V105, P1032, DOI 10.1073/pnas.0711313105; Patterson M, 2011, BRIT J PHARMACOL, V163, P1626, DOI 10.1111/j.1476-5381.2011.01328.x; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Shen L, 2000, J NEUROSCI, V20, P7932; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wisden W, 1993, Curr Opin Neurobiol, V3, P291, DOI 10.1016/0959-4388(93)90120-N; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhang W, 2009, NEURON, V61, P385, DOI 10.1016/j.neuron.2008.12.014	42	221	224	0	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2013	493	7433					495	+		10.1038/nature11775	http://dx.doi.org/10.1038/nature11775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23235828	Green Accepted, Green Submitted			2022-12-28	WOS:000313871400030
J	Clark, AM; Briffa, TG; Thirsk, L; Neubeck, L; Redfern, J				Clark, Alexander M.; Briffa, Thomas G.; Thirsk, Lorraine; Neubeck, Lis; Redfern, Julie			CHRISTMAS 2012: SPORT What football teaches us about researching complex health interventions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIALS		Univ Alberta, Clin Sci Build, Fac Nurs, Edmonton, AB T6G1C9, Canada; Univ Western Australia, Sch Popul Hlth, Crawley, WA, Australia; Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia	University of Alberta; University of Western Australia; George Institute for Global Health; University of Sydney	Clark, AM (corresponding author), Univ Alberta, Clin Sci Build, Fac Nurs, Edmonton, AB T6G1C9, Canada.	alex.clark@ualberta.ca	Neubeck, Lis/AAL-2192-2020; Redfern, Julie/AAM-8617-2020; Thirsk, Lorraine Marie/AAW-4593-2021	Neubeck, Lis/0000-0001-5852-1034; Redfern, Julie/0000-0001-8707-5563; Clark, Alexander/0000-0002-2860-0492; Thirsk, Lorraine/0000-0001-5459-9491				Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Glasziou P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3852; Koenigstorfer J, 2010, J SPORT MANAGE, V24, P649, DOI 10.1123/jsm.24.6.649; Lawson T, 2009, CAMB J ECON, V33, P759, DOI 10.1093/cje/bep035; Lewin S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3496; Shiell A, 2008, BMJ-BRIT MED J, V336, P1281, DOI 10.1136/bmj.39569.510521.AD; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Wolfson S, 2005, J SPORT SCI, V23, P365, DOI 10.1080/02640410400021567	10	19	19	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2012	345								e8316	10.1136/bmj.e8316	http://dx.doi.org/10.1136/bmj.e8316			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056NE	23241365	Green Published			2022-12-28	WOS:000312496200010
J	Shen, YD; Wollam, J; Magner, D; Karalay, O; Antebi, A				Shen, Yidong; Wollam, Joshua; Magner, Daniel; Karalay, Oezlem; Antebi, Adam			A Steroid Receptor-MicroRNA Switch Regulates Life Span in Response to Signals from the Gonad	SCIENCE			English	Article							STEM-CELLS; LONGEVITY; DAF-16	Although the gonad primarily functions in procreation, it also affects animal life span. Here, we show that removal of the Caenorhabditis elegans germ line triggers a switch in the regulatory state of the organism to promote longevity, co-opting components involved in larval developmental timing circuits. These components include the DAF-12 steroid receptor, which is involved in the larval stage two-to-stage three (L2-L3) transition and up-regulates members of the let-7 microRNA (miRNA) family. The miRNAs target an early larval nuclear factor lin-14 and akt-1/kinase, thereby stimulating DAF-16/FOXO signaling to extend life. Our studies suggest that metazoan life span is coupled to the gonad through elements of a developmental timer.	[Shen, Yidong; Wollam, Joshua; Magner, Daniel; Karalay, Oezlem; Antebi, Adam] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Shen, Yidong; Wollam, Joshua; Magner, Daniel; Antebi, Adam] Baylor Coll Med, Huffington Ctr Aging, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Antebi, Adam] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany	Max Planck Society; Baylor College of Medicine; University of Cologne	Antebi, A (corresponding author), Max Planck Inst Biol Ageing, Joseph Stelzmann Str 9B, D-50931 Cologne, Germany.	antebi@age.mpg.de	Shen, Yi/GRS-3602-2022		European Molecular Biology Organization; National Institute on Aging/NIH; Ellison Medical Foundation; Max Planck Society; Sybacol/Bundesministerium fur Bildung und Forschung; CECAD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027498] Funding Source: NIH RePORTER	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); National Institute on Aging/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); Max Planck Society(Max Planck Society); Sybacol/Bundesministerium fur Bildung und Forschung; CECAD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Montino for technical help; M. Denzel for manuscript comments; S. Lo (Chang-Qung University) for plasmids; and I. Greenwald (Columbia University), H. Aguilaniu (ENS de Lyon), C. Kenyon (University of California San Francisco), and the Caenorhabditis Genetics Center for strains. This work was supported by an European Molecular Biology Organization fellowship (Y.S.) and the National Institute on Aging/NIH, the Ellison Medical Foundation, the Max Planck Society, Sybacol/Bundesministerium fur Bildung und Forschung, and CECAD (A. A.). Strain pha-1(e2123);arEx1273(lin-14::gfp) is available from Iva Greenwald (Columbia University) subject to a materials transfer agreement with the Howard Hughes Medical Institute.	Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Bethke A, 2009, SCIENCE, V324, P95, DOI 10.1126/science.1164899; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Boulias K, 2012, CELL METAB, V15, P439, DOI 10.1016/j.cmet.2012.02.014; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; Gerisch B, 2007, P NATL ACAD SCI USA, V104, P5014, DOI 10.1073/pnas.0700847104; Goudeau J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000599; Hammell CM, 2009, P NATL ACAD SCI USA, V106, P18668, DOI 10.1073/pnas.0908131106; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lapierre LR, 2011, CURR BIOL, V21, P1507, DOI 10.1016/j.cub.2011.07.042; McCormick M, 2012, AGING CELL, V11, P192, DOI 10.1111/j.1474-9726.2011.00768.x; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Resnick TD, 2010, DEV DYNAM, V239, P1477, DOI 10.1002/dvdy.22260; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wollam J, 2011, AGING CELL, V10, P879, DOI 10.1111/j.1474-9726.2011.00733.x; Yamawaki TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000468; Yoshiyama-Yanagawa T, 2011, J BIOL CHEM, V286, P25756, DOI 10.1074/jbc.M111.244384; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	21	73	77	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1472	1476		10.1126/science.1228967	http://dx.doi.org/10.1126/science.1228967			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239738	Green Accepted			2022-12-28	WOS:000312250800049
J	Jan, S; Lurie, N				Jan, Sophia; Lurie, Nicole			Disaster Resilience and People with Functional Needs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jan, Sophia] Univ Penn, Dept Med, Perelman Sch Med, Robert Wood Johnson Fdn,Clin Scholars Program, Philadelphia, PA 19104 USA; [Jan, Sophia] Univ Penn, Dept Pediat, Perelman Sch Med, Robert Wood Johnson Fdn,Clin Scholars Program, Philadelphia, PA 19104 USA; [Jan, Sophia] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Jan, Sophia] Childrens Hosp Philadelphia, PolicyLab, Philadelphia, PA 19104 USA; [Lurie, Nicole] US Dept HHS, Washington, DC 20201 USA	Robert Wood Johnson Foundation (RWJF); University of Pennsylvania; Pennsylvania Medicine; Robert Wood Johnson Foundation (RWJF); University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Jan, S (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Robert Wood Johnson Fdn,Clin Scholars Program, Philadelphia, PA 19104 USA.		Jan, Sophia/AAP-3625-2020	Jan, Sophia/0000-0002-1796-6464				Chandra A., 2011, BUILDING COMMUNITY R, DOI 10.7249/TR915; Chandra A, 2010, JAMA-J AM MED ASSOC, V304, P1608, DOI 10.1001/jama.2010.1456; Rendall MS, 2011, HOUSEHOLD STRUCTURE; Schoch-Spana M, 2008, BIOSECUR BIOTERROR, V6, P129, DOI 10.1089/bsp.2008.0520	4	22	22	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24					2272	2273		10.1056/NEJMp1213492	http://dx.doi.org/10.1056/NEJMp1213492			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	052HF	23234513				2022-12-28	WOS:000312187700017
J	Narayan, N; Lee, IH; Borenstein, R; Sun, JH; Wong, R; Tong, G; Fergusson, MM; Liu, J; Rovira, II; Cheng, HL; Wang, GH; Gucek, M; Lombard, D; Alt, FW; Sack, MN; Murphy, E; Cao, L; Finkel, T				Narayan, Nisha; Lee, In Hye; Borenstein, Ronen; Sun, Junhui; Wong, Renee; Tong, Guang; Fergusson, Maria M.; Liu, Jie; Rovira, Ilsa I.; Cheng, Hwei-Ling; Wang, Guanghui; Gucek, Marjan; Lombard, David; Alt, Fredrick W.; Sack, Michael N.; Murphy, Elizabeth; Cao, Liu; Finkel, Toren			RETRACTED: The NAD-dependent deacetylase SIRT2 is required for programmed necrosis (Retracted article. See vol. 506, pg. 516, 2014)	NATURE			English	Article; Retracted Publication							INDUCED CELL-DEATH; APOPTOSIS; RIP1; PHOSPHORYLATION; IDENTIFICATION; NECROPTOSIS; MECHANISMS; REGULATOR; AUTOPHAGY; KINASE	Although initially viewed as unregulated, increasing evidence suggests that cellular necrosis often proceeds through a specific molecular program. In particular, death ligands such as tumour necrosis factor (TNF)-alpha activate necrosis by stimulating the formation of a complex containing receptor-interacting protein 1 (RIP1) and receptor-interacting protein 3 (RIP3). Relatively little is known regarding how this complex formation is regulated. Here, we show that the NAD-dependent deacetylase SIRT2 binds constitutively to RIP3 and that deletion or knockdown of SIRT2 prevents formation of the RIP1-RIP3 complex in mice. Furthermore, genetic or pharmacological inhibition of SIRT2 blocks cellular necrosis induced by TNF-alpha. We further demonstrate that RIP1 is a critical target of SIRT2-dependent deacetylation. Using gain- and loss-of-function mutants, we demonstrate that acetylation of RIP1 lysine 530 modulates RIP1-RIP3 complex formation and TNF-alpha-stimulated necrosis. In the setting of ischaemia-reperfusion injury, RIP1 is deacetylated in a SIRT2-dependent fashion. Furthermore, the hearts of Sirt2(-/-) mice, or wild-type mice treated with a specific pharmacological inhibitor of SIRT2, show marked protection from ischaemic injury. Taken together, these results implicate SIRT2 as an important regulator of programmed necrosis and indicate that inhibitors of this deacetylase may constitute a novel approach to protect against necrotic injuries, including ischaemic stroke and myocardial infarction.	[Narayan, Nisha; Lee, In Hye; Borenstein, Ronen; Fergusson, Maria M.; Liu, Jie; Rovira, Ilsa I.; Sack, Michael N.; Finkel, Toren] NHLBI, Ctr Mol Med, NIH, Bethesda, MD 20892 USA; [Sun, Junhui; Wong, Renee; Tong, Guang; Murphy, Elizabeth] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Tong, Guang] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian 710032, Peoples R China; [Cheng, Hwei-Ling; Alt, Fredrick W.] Childrens Hosp, Howard Hughes Med Inst, Program Cellular & Mol Med, Boston, MA 02115 USA; [Cheng, Hwei-Ling; Alt, Fredrick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Cheng, Hwei-Ling; Alt, Fredrick W.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Wang, Guanghui; Gucek, Marjan] NHLBI, Prote Core, NIH, Bethesda, MD 20892 USA; [Lombard, David] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Lombard, David] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; [Cao, Liu] China Med Univ, Key Lab Med Cell Biol, Shenyang 110001, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Air Force Military Medical University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; China Medical University	Finkel, T (corresponding author), NHLBI, Ctr Mol Med, NIH, Bldg 10, Bethesda, MD 20892 USA.	finkelt@nih.gov		Lombard, David/0000-0002-4292-0185	NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005102, ZIGHL006020, ZIAHL006038, ZIAHL002066] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to M. Lenardo for providing the RIP1-deficient Jurkat cell line, X. Wang for the Flag-tagged RIP3 plasmid and Y. Zhao for helpful discussions. This work was supported by NIH Intramural funds. F.W.A. is an Investigator of the Howard Hughes Medical Institute.	Beirowski B, 2011, P NATL ACAD SCI USA, V108, pE952, DOI 10.1073/pnas.1104969108; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Csonka C, 2010, J PHARMACOL TOX MET, V61, P163, DOI 10.1016/j.vascn.2010.02.014; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Fearns C, 2006, J BIOL CHEM, V281, P34592, DOI 10.1074/jbc.M604019200; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200; Li A, 2006, BIOCHEM BIOPH RES CO, V350, P818, DOI 10.1016/j.bbrc.2006.08.199; Lim SY, 2007, CARDIOVASC DRUG THER, V21, P467, DOI 10.1007/s10557-007-6067-6; Mahul-Mellier AL, 2012, BBA-MOL CELL RES, V1823, P1353, DOI 10.1016/j.bbamcr.2012.05.022; McComb S, 2012, CELL DEATH DIFFER, V19, P1791, DOI 10.1038/cdd.2012.59; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Thomas M, 1996, ONCOGENE, V13, P471; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Yuan JY, 2010, GENE DEV, V24, P2592, DOI 10.1101/gad.1984410; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006	32	112	118	3	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					199	+		10.1038/nature11700	http://dx.doi.org/10.1038/nature11700			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23201684				2022-12-28	WOS:000312259300031
J	Boyce, N				Boyce, Niall			The Wakley Prize 2012: Good night, and good luck	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Boyce, N (corresponding author), The Lancet, London NW1 7BY, England.	niall.boyce@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 8	2012	380	9858					1977	1977		10.1016/S0140-6736(12)62132-1	http://dx.doi.org/10.1016/S0140-6736(12)62132-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051KI	23217854				2022-12-28	WOS:000312124900009
J	Nauck, MA; Meier, JJ				Nauck, Michael A.; Meier, Juris J.			Diagnostic Accuracy of an "Amended" Insulin-Glucose Ratio for the Biochemical Diagnosis of Insulinomas	ANNALS OF INTERNAL MEDICINE			English	Article							C-PEPTIDE; ENDOSCOPIC ULTRASONOGRAPHY; HYPOGLYCEMIC DISORDERS; ENDOCRINE TUMORS; PROINSULIN; SECRETION; LOCALIZATION; SUPPRESSION	Background: Recent biochemical diagnostic guidelines for insulinomas require demonstration of hypoglycemia with inappropriately elevated (nonsuppressed) insulin, C-peptide, or proinsulin, but these criteria may overlap with those in patients without insulinomas. Use of an "amended" insulin-glucose ratio that accounts for the normal variation in insulin secretion according to prevailing glycemia may improve diagnostic accuracy. Objective: To compare the diagnostic accuracy of current diagnostic guideline criteria with the amended insulin-glucose ratio in patients with a suspected insulinoma. Design: Retrospective cohort study. Setting: 2 specialized university departments in Germany. Patients: 114 patients with suspected hypoglycemia over 10 years having diagnostic prolonged fasts. Measurements: Glucose, insulin, C-peptide, and the amended insulin-glucose ratio were measured during and at discontinuation of prolonged fasts. Results: Of 114 patients who were evaluated, 49 had surgical resection of histologically confirmed insulinomas. Insulinoma was excluded in 65 patients; follow-up for a mean of 10 years (range, 0 to 16 years) showed no progressively severe hypoglycemic events or diagnoses of insulinoma. Patients with insulinoma had lower glucose levels and higher insulin and C-peptide levels overall than did control patients at the end of prolonged fasts, but there was considerable overlap. The amended insulin-glucose ratio correctly identified 48 of 49 patients with insulinoma and excluded the diagnosis in 64 of 65 control patients, resulting in positive and negative predictive values of 0.98 (95% CI, 0.89 to 1.00) and 0.99 (CI, 0.92 to 1.00), respectively, compared with 0.75 (CI, 0.63 to 0.85) and 0.98 (CI, 0.89 to 1.00), respectively, for glucose, insulin, and C-peptide concentration criteria. Limitation: The study had a retrospective design, no proinsulin concentrations were available, and a nonspecific insulin immunoassay (crossreactive with proinsulin) was used. Conclusion: The amended insulin-glucose ratio showed improved diagnostic accuracy over established criteria that use glucose, insulin, and C-peptide concentrations.	Diabet Zentrum Bad Lauterberg, Harz, Germany; Ruhr Univ Bochum, Bochum, Germany	Ruhr University Bochum	Nauck, MA (corresponding author), Diabet Zentrum Bad Lauterberg, Kirchberg 21, D-37431 Bad Lauterberg im Harz, Germany.	nauck@diabeteszentrum.de	Nauck, Michael Albrecht/ABA-9752-2021	Nauck, Michael Albrecht/0000-0002-5749-6954				Chammas NK, 2003, ANN CLIN BIOCHEM, V40, P689, DOI 10.1258/000456303770367315; Christ E, 2009, J CLIN ENDOCR METAB, V94, P4398, DOI 10.1210/jc.2009-1082; CREUTZFELDT W, 1973, DIABETOLOGIA, V9, P217, DOI 10.1007/BF01219786; Cryer PE, 2009, J CLIN ENDOCR METAB, V94, P709, DOI 10.1210/jc.2008-1410; ELAHI D, 1982, NEW ENGL J MED, V306, P1196, DOI 10.1056/NEJM198205203062002; GIVEN BD, 1985, J CLIN INVEST, V76, P1398, DOI 10.1172/JCI112116; GORDEN P, 1995, J CLIN ENDOCR METAB, V80, P2884, DOI 10.1210/jc.80.10.2884; Heise T, 2004, DIABETES, V53, P1614, DOI 10.2337/diabetes.53.6.1614; HUTTER R, 1988, DEUT MED WOCHENSCHR, V113, P1146, DOI 10.1055/s-2008-1067784; KAO PC, 1994, J CLIN ENDOCR METAB, V78, P1048, DOI 10.1210/jc.78.5.1048; KIMURA W, 1991, DIGEST DIS SCI, V36, P933, DOI 10.1007/BF01297144; MARKS V, 1974, CLIN GASTROENTEROL, V3, P559; MELANI F, 1970, NEW ENGL J MED, V283, P713, DOI 10.1056/NEJM197010012831401; MERIMEE TJ, 1974, NEW ENGL J MED, V291, P1275, DOI 10.1056/NEJM197412122912404; MERIMEE TJ, 1977, DIABETES, V26, P161, DOI 10.2337/diabetes.26.3.161; MITRAKOU A, 1993, NEW ENGL J MED, V329, P834, DOI 10.1056/NEJM199309163291203; Mohan V., 1997, Diabetologia, V40, pA96; Nauck MA, 1997, EUR J CLIN INVEST, V27, P109, DOI 10.1046/j.1365-2362.1997.630621.x; Nauck MA., 1991, ENDOCR PATHOL, P195; POLONSKY KS, 1986, J CLIN INVEST, V77, P98, DOI 10.1172/JCI112308; RIZZA RA, 1981, DIABETES, V30, P377, DOI 10.2337/diabetes.30.5.377; ROSCH T, 1992, NEW ENGL J MED, V326, P1721, DOI 10.1056/NEJM199206253262601; SERVICE FJ, 1992, J CLIN ENDOCR METAB, V74, P204, DOI 10.1210/jc.74.1.204; SERVICE FJ, 1995, NEW ENGL J MED, V332, P1144, DOI 10.1056/NEJM199504273321707; SERVICE FJ, 1976, MAYO CLIN PROC, V51, P417; SERVICE FJ, 1993, J CLIN ENDOCR METAB, V76, P655, DOI 10.1210/jc.76.3.655; TURNER RC, 1971, BRIT MED J, V2, P132, DOI 10.1136/bmj.2.5754.132; Vezzosi D, 2007, EUR J ENDOCRINOL, V157, P75, DOI 10.1530/EJE-07-0109; Wild D, 2008, NEW ENGL J MED, V359, P766, DOI 10.1056/NEJMc0802045; Zimmer T, 1996, GUT, V39, P562, DOI 10.1136/gut.39.4.562	30	25	27	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2012	157	11					767	+		10.7326/0003-4819-157-11-201212040-00004	http://dx.doi.org/10.7326/0003-4819-157-11-201212040-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	049RC	23208166				2022-12-28	WOS:000312000100002
J	Blevins, CH; Wilson, ME				Blevins, Christopher H.; Wilson, Michael E.			EASILY MISSED? Klinefelter's syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material							PREVALENCE; 47,XXY		[Blevins, Christopher H.; Wilson, Michael E.] Mayo Clin, Dept Med, Rochester, MN 55905 USA	Mayo Clinic	Wilson, ME (corresponding author), Mayo Clin, Dept Med, 200 1st St SW, Rochester, MN 55905 USA.	wilson.michael1@mayo.edu						Achermann JC, 2011, WILLIAMS TXB ENDOCRI, V12th, P868; Bojesen A, 2003, J CLIN ENDOCR METAB, V88, P622, DOI 10.1210/jc.2002-021491; Bojesen A, 2007, NAT CLIN PRACT UROL, V4, P192, DOI 10.1038/ncpuro0775; Bojesen A, 2006, DIABETES CARE, V29, P1591, DOI 10.2337/dc06-0145; CAMPBELL WA, 1981, CLIN GENET, V19, P275; Damani MN, 2001, FERTIL STERIL, V76, P1054, DOI 10.1016/S0015-0282(01)02837-0; GORDON DL, 1972, ARCH INTERN MED, V130, P726, DOI 10.1001/archinte.130.5.726; Jiang-Feng M, 2012, FERTIL STERIL, V98, P1331, DOI 10.1016/j.fertnstert.2012.07.1122; Lanfranco F, 2004, LANCET, V364, P273, DOI 10.1016/S0140-6736(04)16678-6; LEONARD J M, 1975, Birth Defects Original Article Series, V11, P17; Manning Melanie A, 2002, Adolesc Med, V13, P367; Radicioni AF, 2010, J ENDOCRINOL INVEST, V33, P839, DOI 10.1007/BF03350351; Ratcliffe S, 1999, ARCH DIS CHILD, V80, P192, DOI 10.1136/adc.80.2.192; SALBENBLATT JA, 1985, PEDIATR RES, V19, P82, DOI 10.1203/00006450-198501000-00022; SASCO AJ, 1993, INT J CANCER, V53, P538, DOI 10.1002/ijc.2910530403; Smyth CM, 1998, ARCH INTERN MED, V158, P1309, DOI 10.1001/archinte.158.12.1309; Swerdlow AJ, 2005, J CLIN ENDOCR METAB, V90, P6516, DOI 10.1210/jc.2005-1077; van den Bergh JPW, 2001, OSTEOPOROSIS INT, V12, P55, DOI 10.1007/s001980170158; Verri A, 2010, MOL HUM REPROD, V16, P425, DOI 10.1093/molehr/gaq018	19	7	7	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 3	2012	345								e7558	10.1136/bmj.e7558	http://dx.doi.org/10.1136/bmj.e7558			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HO	23207502				2022-12-28	WOS:000312188700003
J	Baumgardner, JR; Bilheimer, LT; Booth, MB; Carrington, WJ; Duchovny, NJ; Werble, EC				Baumgardner, James R.; Bilheimer, Linda T.; Booth, Mark B.; Carrington, William J.; Duchovny, Noelia J.; Werble, Ellen C.			Cigarette Taxes and the Federal Budget - Report from the CBO	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Baumgardner, James R.; Bilheimer, Linda T.; Booth, Mark B.; Carrington, William J.; Duchovny, Noelia J.; Werble, Ellen C.] Congress Budget Off, Washington, DC USA	Congressional Budget Office	Baumgardner, JR (corresponding author), Congress Budget Off, Washington, DC USA.							[Anonymous], 2012, 2012 LONG TERM BUDGE; [Anonymous], 2012, RAISING EXCISE TAX C; Goldman DP, 2006, FORUM HLTH EC POLICY, P9; Kahn R, 2008, CIRCULATION, V118, P576, DOI 10.1161/CIRCULATIONAHA.108.190186; Neckerman KM, 2011, TOBACCO WHAT WOULD H, P256	5	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2012	367	22					2068	2070		10.1056/NEJMp1210319	http://dx.doi.org/10.1056/NEJMp1210319			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	044MS	23190219				2022-12-28	WOS:000311624400002
J	Melott, AL; Thomas, BC				Melott, Adrian L.; Thomas, Brian C.			Causes of an AD 774-775 C-14 increase	NATURE			English	Letter							SUPERFLARES		[Melott, Adrian L.] Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; [Thomas, Brian C.] Washburn Univ, Dept Phys & Astron, Topeka, KS 66621 USA	University of Kansas; Washburn University	Melott, AL (corresponding author), Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA.	melott@ku.edu	Thomas, Brian C./I-6931-2019	Thomas, Brian C./0000-0001-9091-0830				Calisto M, 2012, ATMOS CHEM PHYS, V12, P8679, DOI 10.5194/acp-12-8679-2012; Ejzak LM, 2007, ASTROPHYS J, V654, P373, DOI 10.1086/509106; Hapgood M, 2012, NATURE, V484, P311, DOI 10.1038/484311a; Love JJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051431; Maehara H, 2012, NATURE, V485, P478, DOI 10.1038/nature11063; Melott AL, 2011, ASTROBIOLOGY, V11, P343, DOI 10.1089/ast.2010.0603; Miyake F, 2012, NATURE, V486, P240, DOI 10.1038/nature11123; National Research Council Space Studies Board, 2008, SEV SPAC WEATH EV UN; Reedy R. C., 1996, ASP C SER, VCS-94, P429; Schaefer BE, 2000, ASTROPHYS J, V529, P1026, DOI 10.1086/308325; Schrijver CJ, 2012, J GEOPHYS RES-SPACE, V117, DOI 10.1029/2012JA017706; Schrijver CJ, 2010, ASTROPHYS J, V710, P1480, DOI 10.1088/0004-637X/710/2/1480; Siscoe G, 2006, ADV SPACE RES-SERIES, V38, P173, DOI 10.1016/j.asr.2005.02.102; Thomas BC, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029174	14	62	62	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					E1	E2		10.1038/nature11695	http://dx.doi.org/10.1038/nature11695			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23192153	Green Submitted			2022-12-28	WOS:000311606000001
J	O'Neill, HS; Jenner, FE				O'Neill, Hugh St C.; Jenner, Frances E.			The global pattern of trace-element distributions in ocean floor basalts	NATURE			English	Article							MIDOCEAN RIDGE BASALTS; GEOCHEMICAL EVOLUTION; PHASE-EQUILIBRIA; CRYSTALLIZATION; BENEATH; CONSTRAINTS; MELT; PLAGIOCLASE; EARTH; SYSTEMATICS	The magmatic layers of the oceanic crust are created at constructive plate margins by partial melting of the mantle as it wells up. The chemistry of ocean floor basalts, the most accessible product of this magmatism, is studied for the insights it yields into the compositional heterogeneity of the mantle and its thermal structure. However, before eruption, parental magma compositions are modified at crustal pressures by a process that has usually been assumed to be fractional crystallization. Here we show that the global distributions of trace elements in ocean floor basalts describe a systematic pattern that cannot be explained by simple fractional crystallization alone, but is due to cycling of magma through the global ensemble of magma chambers. Variability in both major and incompatible trace-element contents about the average global pattern is due to fluctuations in the magma fluxes into and out of the chambers, and their depth, as well as to differences in the composition of the parental magmas.	[O'Neill, Hugh St C.; Jenner, Frances E.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2600, Australia; [Jenner, Frances E.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	Australian National University; Carnegie Institution for Science	O'Neill, HS (corresponding author), Australian Natl Univ, Res Sch Earth Sci, GPO Box 4, Canberra, ACT 2600, Australia.	hugh.oneill@anu.edu.au	O'Neill, Hugh S/G-2302-2011	O'Neill, Hugh S/0000-0001-7018-9783; Jenner, Frances/0000-0003-2189-6478	Australian National University	Australian National University(Australian National University)	This work was funded by the Australian National University. I. Campbell, R. Arculus, S. Turner, R. Carlson and E. Hauri are thanked for comments on earlier versions of this manuscript, and the final presentation has benefited from reviews by A. Hofmann and W. McDonough.	Aigner-Torres M, 2007, CONTRIB MINERAL PETR, V153, P647, DOI 10.1007/s00410-006-0168-2; ALBAREDE F, 1985, NATURE, V318, P356, DOI 10.1038/318356a0; Arevalo R, 2010, CHEM GEOL, V271, P70, DOI 10.1016/j.chemgeo.2009.12.013; BEATTIE P, 1991, CONTRIB MINERAL PETR, V109, P212, DOI 10.1007/BF00306480; Bindeman IN, 1998, GEOCHIM COSMOCHIM AC, V62, P1175, DOI 10.1016/S0016-7037(98)00047-7; Cordier C, 2012, MINER PETROL, V104, P1, DOI 10.1007/s00710-011-0159-5; Cottrell E, 2011, EARTH PLANET SC LETT, V305, P270, DOI 10.1016/j.epsl.2011.03.014; Danyushevsky LV, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003516; Danyushevsky LV, 2001, J VOLCANOL GEOTH RES, V110, P265, DOI 10.1016/S0377-0273(01)00213-X; DICK HJB, 1984, CONTRIB MINERAL PETR, V86, P54, DOI 10.1007/BF00373711; DUNGAN MA, 1978, CONTRIB MINERAL PETR, V67, P417, DOI 10.1007/BF00383301; Elliott T., 2003, TREATISE GEOCHEMISTR, V2, P465; Falloon TJ, 2008, J PETROL, V49, P591, DOI 10.1093/petrology/egn009; Falloon TJ, 2007, CHEM GEOL, V241, P207, DOI 10.1016/j.chemgeo.2007.01.015; Goss AR, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002977; Hart SR, 2006, CONTRIB MINERAL PETR, V152, P295, DOI 10.1007/s00410-006-0108-1; Herzberg C, 2004, J PETROL, V45, P2389, DOI 10.1093/petrology/egh040; HESS PC, 1992, GEOPH MONOG SERIES, V71, P67; Hofmann A.W., 2003, TREAT GEOCHEM, V2, P61, DOI DOI 10.1016/B0-08-043751-6/02123-X; HOFMANN AW, 1988, EARTH PLANET SC LETT, V90, P297, DOI 10.1016/0012-821X(88)90132-X; Jenner FE, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003890; Jenner FE, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC004009; Jenner FE, 2010, J PETROL, V51, P2445, DOI 10.1093/petrology/egq063; Kamenetsky VS, 2012, CHEM GEOL, V302, P76, DOI 10.1016/j.chemgeo.2011.04.008; Kendrick MA, 2012, GEOCHIM COSMOCHIM AC, V81, P82, DOI 10.1016/j.gca.2011.12.004; Klein E. M., 2008, J GEOPHYS RES, V92, P8089; Klein E.M., 2004, TREATISE GEOCHEMISTR, V3, P433, DOI [DOI 10.1016/B0-08-043751-6/03030-9, 10.1016/B0-08-043751-6/03030-9]; LANGMUIR CH, 1992, GEOPH MONOG SERIES, V71, P183; LEEMAN WP, 1979, GEOCHIM COSMOCHIM AC, V43, P171, DOI 10.1016/0016-7037(79)90056-5; MCKENZIE D, 1988, J PETROL, V29, P625, DOI 10.1093/petrology/29.3.625; Melson WG, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000249; Michael PJ, 1998, J GEOPHYS RES-SOL EA, V103, P18325, DOI 10.1029/98JB00791; OHARA MJ, 1977, NATURE, V266, P503, DOI 10.1038/266503a0; OHARA MJ, 1981, J GEOL SOC LONDON, V138, P237, DOI 10.1144/gsjgs.138.3.0237; OHARA MJ, 1968, NATURE, V220, P683, DOI 10.1038/220683a0; Palme H., 2003, TREATISE GEOCHEMISTR, V2, P1, DOI DOI 10.1016/B978-0-08-095975-7.00201-1; RannoU E, 2006, GEOCHIM COSMOCHIM AC, V70, P4783, DOI 10.1016/j.gca.2006.07.007; Rubin KH, 2007, EARTH PLANET SC LETT, V260, P257, DOI 10.1016/j.epsl.2007.05.035; SCHIANO P, 1993, EARTH PLANET SC LETT, V119, P37, DOI 10.1016/0012-821X(93)90005-T; SHEN Y, 1995, J GEOPHYS RES-SOL EA, V100, P2211, DOI 10.1029/94JB02768; Sims KWW, 2002, GEOCHIM COSMOCHIM AC, V66, P3481, DOI 10.1016/S0016-7037(02)00909-2; WALKER D, 1979, CONTRIB MINERAL PETR, V70, P111, DOI 10.1007/BF00374440; WHITE WM, 1977, GEOL SOC AM BULL, V88, P571, DOI 10.1130/0016-7606(1977)88<571:SKRCSB>2.0.CO;2; Wood B. J., 2003, TREATISE GEOCHEMISTR, V2, P395; Wood BJ, 1997, CONTRIB MINERAL PETR, V129, P166, DOI 10.1007/s004100050330	45	121	121	1	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					698	+		10.1038/nature11678	http://dx.doi.org/10.1038/nature11678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23192147				2022-12-28	WOS:000311606000033
J	van den Bosch, RCE; Gebhardt, K; Gueltekin, K; van de Ven, G; van der Wel, A; Walsh, JL				van den Bosch, Remco C. E.; Gebhardt, Karl; Gueltekin, Kayhan; van de Ven, Glenn; van der Wel, Arjen; Walsh, Jonelle L.			An over-massive black hole in the compact lenticular galaxy NGC 1277	NATURE			English	Article							ACTIVE GALACTIC NUCLEI; ELLIPTIC GALAXIES; SCALING RELATIONS; MASSES; LUMINOSITIES; CENTERS; MODEL; DISKS	Most massive galaxies have supermassive black holes at their centres, and the masses of the black holes are believed to correlate with properties of the host-galaxy bulge component(1). Several explanations have been proposed for the existence of these locally established empirical relationships, including the non-causal, statistical process of galaxy-galaxy merging(2), direct feedback between the black hole and its host galaxy(3), and galaxy-galaxy merging and the subsequent violent relaxation and dissipation(4). The empirical scaling relations are therefore important for distinguishing between various theoretical models of galaxy evolution(5,6), and they furthermore form the basis for all black-hole mass measurements at large distances. Observations have shown that the mass of the black hole is typically 0.1 per cent of the mass of the stellar bulge of the galaxy(7,8). Until now, the galaxy with the largest known fraction of its mass in its central black hole (11 per cent) was the small galaxy NGC 4486B(1,9). Here we report observations of the stellar kinematics of NGC 1277, which is a compact, lenticular galaxy with a mass of 1.2 x 10(11) solar masses. From the data, we determine that the mass of the central black hole is 1.7 x 10(10) solar masses, or 59 per cent of its bulge mass. We also show observations of five other compact galaxies that have properties similar to NGC 1277 and therefore may also contain over-massive black holes. It is not yet known if these galaxies represent a tail of a distribution, or if disk-dominated galaxies fail to follow the usual black-hole mass scaling relations(4,10).	[van den Bosch, Remco C. E.; van de Ven, Glenn; van der Wel, Arjen] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [van den Bosch, Remco C. E.; Gebhardt, Karl; Walsh, Jonelle L.] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA; [Gueltekin, Kayhan] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA	Max Planck Society; University of Texas System; University of Texas Austin; University of Michigan System; University of Michigan	van den Bosch, RCE (corresponding author), Max Planck Inst Astron, Konigstuhl 17, D-69117 Heidelberg, Germany.	bosch@mpia.de	van der Wel, Arjen/G-8365-2011; van de Ven, Glenn/R-5189-2019	van der Wel, Arjen/0000-0002-5027-0135; van de Ven, Glenn/0000-0003-4546-7731; Gultekin, Kayhan/0000-0002-1146-0198; Gebhardt, Karl/0000-0002-8433-8185; van den Bosch, Remco/0000-0002-0420-6159	US National Science Foundation [NSF-0908639, AST-1102845]; US National Aeronautics Space Administration [GO0-11151X, G02-13111X]; Space Telescope Science Institute [HST-GO-12557.01-A]	US National Science Foundation(National Science Foundation (NSF)); US National Aeronautics Space Administration; Space Telescope Science Institute(Space Telescope Science Institute)	K. Gebhardt and J.L.W. are supported by the US National Science Foundation (NSF-0908639, AST-1102845). K. Gultekin acknowledges support provided by the US National Aeronautics Space Administration (GO0-11151X, G02-13111X) and the Space Telescope Science Institute (HST-GO-12557.01-A). The Hobby-Eberly Telescope is a joint project of the University of Texas at Austin, the Pennsylvania State University, Ludwig-Maximilians-Universitat Munchen and Georg-August-Universitat Gottingen. The Hobby-Eberly Telescope is named in honour of its principal benefactors, William P. Hobby and Robert E. Eberly.	Cappellari M, 2004, PUBL ASTRON SOC PAC, V116, P138, DOI 10.1086/381875; Croton DJ, 2006, MON NOT R ASTRON SOC, V365, P11, DOI 10.1111/j.1365-2966.2005.09675.x; Fabian AC, 1999, MON NOT R ASTRON SOC, V308, pL39, DOI 10.1046/j.1365-8711.1999.03017.x; Fernandes RC, 2005, MON NOT R ASTRON SOC, V358, P363, DOI 10.1111/j.1365-2966.2005.08752.x; Greene JE, 2010, ASTROPHYS J, V721, P26, DOI 10.1088/0004-637X/721/1/26; Gultekin K, 2009, ASTROPHYS J, V698, P198, DOI 10.1088/0004-637X/698/1/198; Haring N, 2004, ASTROPHYS J, V604, pL89, DOI 10.1086/383567; Hill GJ, 1998, P SOC PHOTO-OPT INS, V3355, P375, DOI 10.1117/12.316773; Jahnke K, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/2/92; Jarrett TH, 2000, ASTRON J, V119, P2498, DOI 10.1086/301330; Kormendy J, 2011, NATURE, V469, P374, DOI 10.1038/nature09694; Magorrian J, 1998, ASTRON J, V115, P2285, DOI 10.1086/300353; McConnell NJ, 2011, NATURE, V480, P215, DOI 10.1038/nature10636; Merritt D, 2001, SCIENCE, V293, P1116, DOI 10.1126/science.1063896; Navarro JF, 1996, ASTROPHYS J, V462, P563, DOI 10.1086/177173; Nowak N, 2010, MON NOT R ASTRON SOC, V403, P646, DOI 10.1111/j.1365-2966.2009.16167.x; Pahre MA, 1998, ASTRON J, V116, P1591, DOI 10.1086/300544; Peng CY, 2002, ASTRON J, V124, P266, DOI 10.1086/340952; Reines AE, 2011, NATURE, V470, P66, DOI 10.1038/nature09724; Sani E, 2011, MON NOT R ASTRON SOC, V413, P1479, DOI 10.1111/j.1365-2966.2011.18229.x; SCHWARZSCHILD M, 1979, ASTROPHYS J, V232, P236, DOI 10.1086/157282; Somerville RS, 2008, MON NOT R ASTRON SOC, V391, P481, DOI 10.1111/j.1365-2966.2008.13805.x; van den Bosch RCE, 2008, MON NOT R ASTRON SOC, V385, P647, DOI 10.1111/j.1365-2966.2008.12874.x; van den Bosch RCE, 2010, MON NOT R ASTRON SOC, V401, P1770, DOI 10.1111/j.1365-2966.2009.15832.x; Van der Wel A, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/1/38; van Dokkum PG, 2008, ASTROPHYS J LETT, V677, pL5, DOI 10.1086/587874; van Dokkum PG, 2009, NATURE, V460, P717, DOI 10.1038/nature08220; VANDERMAREL RP, 1993, ASTROPHYS J, V407, P525, DOI 10.1086/172534	28	154	154	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					729	731		10.1038/nature11592	http://dx.doi.org/10.1038/nature11592			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23192149	Green Published, Green Submitted			2022-12-28	WOS:000311606000038
J	Wang, CJ				Wang, C. Jason			Medical Documentation in the Electronic Era	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VISION; CARE		[Wang, C. Jason] Stanford Univ, CHP PCOR, Stanford, CA 94305 USA; [Wang, C. Jason] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	Stanford University; Stanford University	Wang, CJ (corresponding author), Stanford Univ, CHP PCOR, 117 Encina Commons, Stanford, CA 94305 USA.	cjwang1@stanford.edu			NIH HHS [DP2 OD008647] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008647] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Davis K, 2005, J GEN INTERN MED, V20, P953, DOI 10.1111/j.1525-1497.2005.0178.x; Krist AH, 2011, JAMA-J AM MED ASSOC, V305, P300, DOI 10.1001/jama.2010.2011; Longhurst CA., 2011, J PARTICIP MED, V3, pE30; Lown BA, 2012, ACAD MED, V87, P392, DOI 10.1097/ACM.0b013e318248e5ae; Schenarts PJ, 2012, J SURG EDUC, V69, P105, DOI 10.1016/j.jsurg.2011.10.008; Wang CJ, 2012, JAMA-J AM MED ASSOC, V307, P569, DOI 10.1001/jama.2012.102	6	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2012	308	20					2091	2092		10.1001/jama.2012.14849	http://dx.doi.org/10.1001/jama.2012.14849			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043IV	23188023				2022-12-28	WOS:000311537200021
J	Shi, XS; Bi, YC; Yang, W; Guo, XD; Jiang, Y; Wan, CJ; Li, LY; Bai, YB; Guo, J; Wang, YJ; Chen, XJ; Wu, B; Sun, HB; Liu, WL; Wang, JF; Xu, CQ				Shi, Xiaoshan; Bi, Yunchen; Yang, Wei; Guo, Xingdong; Jiang, Yan; Wan, Chanjuan; Li, Lunyi; Bai, Yibing; Guo, Jun; Wang, Yujuan; Chen, Xiangjun; Wu, Bo; Sun, Hongbin; Liu, Wanli; Wang, Junfeng; Xu, Chenqi			Ca2+ regulates T-cell receptor activation by modulating the charge property of lipids	NATURE			English	Article							IMMUNOLOGICAL SYNAPSE; PLASMA-MEMBRANE; CRAC CHANNEL; K+ CHANNEL; PROTEINS; BINDING; ORAI; PHOSPHORYLATION; RECOGNITION; SIGNALS	Ionic protein-lipid interactions are critical for the structure and function of membrane receptors, ion channels, integrins and many other proteins(1-7). However, the regulatory mechanism of these interactions is largely unknown. Here we show that Ca2+ can bind directly to anionic phospholipids and thus modulate membrane protein function. The activation of T-cell antigen receptor-CD3 complex (TCR), a key membrane receptor for adaptive immunity, is regulated by ionic interactions between positively charged CD3 epsilon/zeta cytoplasmic domains (CD3(CD)) and negatively charged phospholipids in the plasma membrane(1,8-10). Crucial tyrosines are buried in the membrane and are largely protected from phosphorylation in resting T cells. It is not clear how CD3CD dissociates from the membrane in antigen-stimulated T cells. The antigen engagement of even a single TCR triggers a Ca2+ influx(11) and TCR-proximal Ca2+ concentration is higher than the average cytosolic Ca2+ concentration(12). Our biochemical, live-cell fluorescence resonance energy transfer and NMR experiments showed that an increase in Ca2+ concentration induced the dissociation of CD3CD from the membrane and the solvent exposure of tyrosine residues. As a consequence, CD3 tyrosine phosphorylation was significantly enhanced by Ca2+ influx. Moreover, when compared with wild-type cells, Ca2+ channel-deficient T cells had substantially lower levels of CD3 phosphorylation after stimulation. The effect of Ca2+ on facilitating CD3 phosphorylation is primarily due to the charge of this ion, as demonstrated by the fact that replacing Ca2+ with the non-physiological ion Sr2+ resulted in the same feedback effect. Finally, P-31 NMR spectroscopy showed that Ca2+ bound to the phosphate group in anionic phospholipids at physiological concentrations, thus neutralizing the negative charge of phospholipids. Rather than initiating CD3 phosphorylation, this regulatory pathway of Ca2+ has a positive feedback effect on amplifying and sustaining CD3 phosphorylation and should enhance T-cell sensitivity to foreign antigens. Our study thus provides a new regulatory mechanism of Ca2+ to T-cell activation involving direct lipid manipulation.	[Bi, Yunchen; Wan, Chanjuan; Wang, Yujuan; Wu, Bo; Sun, Hongbin; Wang, Junfeng] Chinese Acad Sci, High Magnet Field Lab, Hefei Inst Phys Sci, Hefei 230031, Anhui, Peoples R China; [Shi, Xiaoshan; Yang, Wei; Guo, Xingdong; Jiang, Yan; Li, Lunyi; Bai, Yibing; Guo, Jun; Xu, Chenqi] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Shi, Xiaoshan; Yang, Wei; Guo, Xingdong; Jiang, Yan; Li, Lunyi; Bai, Yibing; Guo, Jun; Xu, Chenqi] Chinese Acad Sci, Natl Ctr Prot Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai 201203, Peoples R China; [Chen, Xiangjun; Liu, Wanli] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tsinghua University	Wang, JF (corresponding author), Chinese Acad Sci, High Magnet Field Lab, Hefei Inst Phys Sci, 350 Shushanhu Rd, Hefei 230031, Anhui, Peoples R China.	junfeng@hmfl.ac.cn; cqxu@sibcb.ac.cn	liu, wanli/H-5690-2011; Sun, Hongbin/C-9721-2015; Shi, Xiaoshan/AAH-7734-2021	liu, wanli/0000-0003-2624-6802; Sun, Hongbin/0000-0002-7712-0655; Shi, Xiaoshan/0000-0001-7931-8684; Bai, Yibing/0000-0002-2944-5367; Xu, Chenqi/0000-0002-4968-6782; Wu, Bo/0000-0003-4556-0477; Yang, Wei/0000-0001-9438-7215; Liu, Wanli/0000-0003-0395-2800	National Basic Research Program of China (973 Program) [2011CB910901, 2012CB910804, 2012CB917202]; National Science Foundation of China [31070738]; Chinese Academy of Sciences [KSCX2-EW-J-11]; Shanghai Municipal Commission for Science and Technology [10PJ1411500]; Young Talent Program of Shanghai Institutes for Biological Sciences, CAS [2010KIP101]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Municipal Commission for Science and Technology; Young Talent Program of Shanghai Institutes for Biological Sciences, CAS	We would like to thank R. Lewis for his gift of CJ-1 Jurkat cell line; S.-c. Sun, A. Lin, D. Li, J. J. Chou, H. Gu and M. Lei for discussions. C. X. is funded by the National Basic Research Program of China (973 Program, no. 2011CB910901 and no. 2012CB910804), the National Science Foundation of China (no. 31070738), the Chinese Academy of Sciences (Hundred Talents Program and no. KSCX2-EW-J-11), the Shanghai Municipal Commission for Science and Technology (10PJ1411500) and the Young Talent Program of Shanghai Institutes for Biological Sciences, CAS (no. 2010KIP101). J. W. is funded by the National Basic Research Program of China (973 Program, no. 2012CB917202) and the Chinese Academy of Sciences (Hundred Talents Program).	Aivazian D, 2000, NAT STRUCT BIOL, V7, P1023; DeFord-Watts LM, 2011, J IMMUNOL, V186, P6839, DOI 10.4049/jimmunol.1002721; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; FANGER CM, 1995, J CELL BIOL, V131, P655, DOI 10.1083/jcb.131.3.655; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Huse M, 2007, IMMUNITY, V27, P76, DOI 10.1016/j.immuni.2007.05.017; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kim C, 2012, NATURE, V481, P209, DOI 10.1038/nature10697; Kuhns MS, 2008, CELL, V135, P594, DOI 10.1016/j.cell.2008.10.033; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lioudyno MI, 2008, P NATL ACAD SCI USA, V105, P2011, DOI 10.1073/pnas.0706122105; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Paddock C, 2011, BLOOD, V117, P6012, DOI 10.1182/blood-2010-11-317867; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Park CY, 2010, SCIENCE, V330, P101, DOI 10.1126/science.1191027; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Quintana A, 2011, EMBO J, V30, P3895, DOI 10.1038/emboj.2011.289; Sigalov AB, 2006, BIOCHEMISTRY-US, V45, P15731, DOI 10.1021/bi061108f; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zilly FE, 2011, EMBO J, V30, P1209, DOI 10.1038/emboj.2011.53	31	156	168	13	274	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					111	+		10.1038/nature11699	http://dx.doi.org/10.1038/nature11699			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23201688				2022-12-28	WOS:000312933800041
J	Greenstone, M				Greenstone, Michael			Tiotropium improved lung function and delayed exacerbations in poorly controlled asthma	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE		Castle Hill Hosp, Cottingham, England	University of Hull	Greenstone, M (corresponding author), Castle Hill Hosp, Cottingham, England.							Global Initiative for Asthma (GINA), GLOB STRAT ASTHM MAN; Singh S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3215; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Vogelmeier C, 2011, NEW ENGL J MED, V364, P1093, DOI 10.1056/NEJMoa1008378	4	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2012	157	12							JC6-3	10.7326/0003-4819-157-12-201212180-02003	http://dx.doi.org/10.7326/0003-4819-157-12-201212180-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057SB	23247952				2022-12-28	WOS:000312583200002
J	Howard, S; Adams, J; White, M				Howard, Simon; Adams, Jean; White, Martin			CHRISTMAS 2012: RESEARCH Nutritional content of supermarket ready meals and recipes by television chefs in the United Kingdom: cross sectional study	BRITISH MEDICAL JOURNAL			English	Editorial Material							UK	Objectives To compare the energy and macronutrient content of main meals created by television chefs with ready meals sold by supermarkets, and to compare both with nutritional guidelines published by the World Health Organization and UK Food Standards Agency. Design Cross sectional study. Setting Three supermarkets with the largest share of the grocery market in the United Kingdom, 2010. Samples 100 main meal recipes from five bestselling cookery books by UK television chefs and 100 own brand ready meals from the three leading UK supermarkets. Main outcome measures Number of meals for which the nutritional content complied with WHO recommendations, and the proportion of nutrients classified as red, amber, or green using the UK FSA's "traffic light" system for labelling food. Results No recipe or ready meal fully complied with the WHO recommendations. The ready meals were more likely to comply with the recommended proportions of energy derived from carbohydrate (18% v 6%, P = 0.01) and sugars (83% v 81%, P = 0.05) and fibre density (56% v 14% P < 0.01). The recipes were more likely to comply with the recommended sodium density (36% v 4%, P < 0.01), although salt used for seasoning was not assessed. The distributions of traffic light colours under the FSA's food labelling recommendations differed: the modal traffic light was red for the recipes (47%) and green for ready meals (42%). Overall, the recipes contained significantly more energy (2530 kJ v 2067 kJ), protein (37.5 g v 27.9 g), fat (27.1 g v 17.2 g), and saturated fat (9.2 g v 6.8 g; P < 0.01 for all) and significantly less fibre (3.3 g v 6.5 g, P < 0.01) per portion than the ready meals. Conclusions Neither recipes created by television chefs nor ready meals sold by three of the leading UK supermarkets complied with WHO recommendations. Recipes were less healthy than ready meals, containing significantly more energy, protein, fat, and saturated fat, and less fibre per portion than the ready meals.	[Howard, Simon] NHS Tees, Stockton On Tees TS17 6SG, England; [Adams, Jean; White, Martin] Newcastle Univ, UKCRC Ctr Translat Res Publ Hlth, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Howard, S (corresponding author), NHS Tees, Stockton On Tees TS17 6SG, England.	simonhoward@nhs.net	Howard, Simon/I-4976-2015; Adams, Jean/G-2402-2010	Howard, Simon/0000-0002-6317-0942; Adams, Jean/0000-0002-5733-7830; White, Martin/0000-0002-1861-6757	Fuse, the Centre for Translational Research in Public Health, a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence; British Heart Foundation; Cancer Research UK; Economic and Social Research Council [RES-590-38-0003]; Medical Research Council; National Institute for Health Research under the UKCRC; ESRC [ES/G007470/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007470/1] Funding Source: researchfish	Fuse, the Centre for Translational Research in Public Health, a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research under the UKCRC; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	At the time this research was done, MW was partly and JA fully supported by Fuse, the Centre for Translational Research in Public Health, a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence. Fuse receives funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council (No RES-590-38-0003), Medical Research Council, and the National Institute for Health Research, under the auspices of UKCRC. Views expressed do not necessarily represent those of the funders.	Adams J, 2011, BRIT J NUTR, V105, P810, DOI 10.1017/S0007114510004435; Adams J, 2009, EUR J PUBLIC HEALTH, V19, P144, DOI 10.1093/eurpub/ckn132; Alexy U, 2011, EUR J CLIN NUTR, V65, P160, DOI 10.1038/ejcn.2010.254; [Anonymous], EATW PLAT; [Anonymous], BBC NEWS ONLINE; [Anonymous], 2010, GUARDIAN; Bittman M., 2012, NY TIMES; British Heart Foundation, 2012, POL STAT UNH FOOD DR; Broadcasters' Audience Research Board, WEEKL TOP 30 PROGR; Caraher M., 2000, J STUDY FOOD SOC, V4, P27, DOI 10.2752/152897900786690805; Chilled Food Association, 2010, HIST UK CHILL FOODS; Consensus Action on Salt and Health, 2012, FOOD IND PROGR; Corrigan T., 2010, IS AM READY BRIT REA; Department of Health, 2009, CHANGE4LIFE MARK STR; DUBBERT PM, 1984, J APPL BEHAV ANAL, V17, P85, DOI 10.1901/jaba.1984.17-85; Fearnley-Whittingstall H., 2009, RIVER COTTAGE EVERYD; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Food Standards Agency, 2007, FRONT OF PACK TRAFF; Food Standards Agency, 2003, SALT READ MEALS SURV; Food Standards Agency, 2003, READ MEALS MARK; Garner E., 2009, TESCO SHARE TURNAROU; Harrison K, 2005, AM J PUBLIC HEALTH, V95, P1568, DOI 10.2105/AJPH.2004.048058; Hopkins J., 2008, Journal of Human Nutrition and Dietetics, V21, P389, DOI 10.1111/j.1365-277X.2008.00881_23.x; JOHNSON WG, 1990, ADDICT BEHAV, V15, P285, DOI 10.1016/0306-4603(90)90071-5; LACORS, 2010, UPD NUTR LAB TOL; Lawson N., 2010, KITCHEN RECIPES HEAR; Mintel Oxygen, 2010, CHILL FORZ READ MEAL; Morrisons, 2010, MARK OV ANN REP FIN; NHS Choices, 2010, QUICK HLTH MEALS; NHS Choices, 2011, 5 DAY RUN; Ofcom, 2010, HFSS ADV RESTR FIN R; Oliver J, 2010, JAMIES 30 MINUTE MEA; Oliver J., 2008, JAMIES MINISTRY FOOD; Oxford English Dictionary, 2008, TV DINN; Pascale L., 2011, BAKING MADE EASY; Reilly J, 2006, FRONT NUTR SCI, P201, DOI 10.1079/9780851990323.0201; RTS Resources, 2010, W EUR READ MEALS 201; Short F., 2003, Food Service Technology, V3, P177, DOI 10.1111/j.1471-5740.2003.00080.x; Sweney M., 2009, GUARDIAN; Triggle N., 2012, BBC NEWS ONLINE; UK Heart, 2012, CEL CHEFS TEA PART R; USDA, 2011, COOK MOR OFT HOM; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Windiets, 2012, WINDIETS DIET AN; World Health Organization, 2003, POP NUTR INT GOALS P, P54	45	61	62	0	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2012	345								e7607	10.1136/bmj.e7607	http://dx.doi.org/10.1136/bmj.e7607			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IU	23247976	Green Published, hybrid			2022-12-28	WOS:000312698700001
J	Watts, C; Cairncross, S				Watts, Charlotte; Cairncross, Sandy			Should the GBD risk factor rankings be used to guide policy?	LANCET			English	Editorial Material									[Watts, Charlotte; Cairncross, Sandy] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Watts, C (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1H 9SH, England.	charlotte.watts@lshtm.ac.uk						Ezzati M, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P241; Laxminarayan R, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P35; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; Vos T, 2006, B WORLD HEALTH ORGAN, V84, P739, DOI 10.2471/BLT.06.030411	6	22	22	0	35	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2012	380	9859					2060	2061		10.1016/S0140-6736(12)62121-7	http://dx.doi.org/10.1016/S0140-6736(12)62121-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23245600				2022-12-28	WOS:000312387000007
J	George, DR; Whitehouse, PJ; D'Alton, S; Ballenger, J				George, Daniel R.; Whitehouse, Peter J.; D'Alton, Simon; Ballenger, Jesse			Through the amyloid gateway	LANCET			English	Editorial Material									[George, Daniel R.] Penn State Coll Med, Penn State Milton S Hershey Med Ctr, Dept Humanities, Hershey, PA 17033 USA; [Whitehouse, Peter J.] Case Western Reserve Univ, Fairhill Ctr, Cleveland, OH 44106 USA; [D'Alton, Simon] Univ Florida, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL USA; [Ballenger, Jesse] Penn State Univ, Program Sci Technol & Soc, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Case Western Reserve University; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	George, DR (corresponding author), Penn State Coll Med, Penn State Milton S Hershey Med Ctr, Dept Humanities, Hershey, PA 17033 USA.	Drg21@psu.edu						Ackeknecht EH, 1953, RUDOLF VIRCHOW DOCTO; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Engstrom EJ, 2007, CULT MED PSYCHIAT, V31, P405, DOI 10.1007/s11013-007-9060-4; Stein J., 2008, ENVIRONMENTAL THREAT; Whitehouse P. J., 2008, THE MYTH OF ALZHEIME; World Health Organization Alzheimer's Disease International, 2012, ALZHEIMERS DISEASE I	6	8	8	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 8	2012	380	9858					1986	1987		10.1016/S0140-6736(12)62145-X	http://dx.doi.org/10.1016/S0140-6736(12)62145-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051KI	23236607				2022-12-28	WOS:000312124900014
J	Al Mamun, AM; Lombardo, MJ; Shee, C; Lisewski, AM; Gonzalez, C; Lin, DX; Nehring, RB; Saint-Ruf, C; Gibson, JL; Frisch, RL; Lichtarge, O; Hastings, PJ; Rosenberg, SM				Al Mamun, Abu Amar M.; Lombardo, Mary-Jane; Shee, Chandan; Lisewski, Andreas M.; Gonzalez, Caleb; Lin, Dongxu; Nehring, Ralf B.; Saint-Ruf, Claude; Gibson, Janet L.; Frisch, Ryan L.; Lichtarge, Olivier; Hastings, P. J.; Rosenberg, Susan M.			Identity and Function of a Large Gene Network Underlying Mutagenic Repair of DNA Breaks	SCIENCE			English	Article							STRESS-INDUCED MUTATION; ESCHERICHIA-COLI; SIGMA-FACTOR; EXPRESSION; DATABASE; CANCERS; SWITCH; CELLS	Mechanisms of DNA repair and mutagenesis are defined on the basis of relatively few proteins acting on DNA, yet the identities and functions of all proteins required are unknown. Here, we identify the network that underlies mutagenic repair of DNA breaks in stressed Escherichia coli and define functions for much of it. Using a comprehensive screen, we identified a network of >= 93 genes that function in mutation. Most operate upstream of activation of three required stress responses (RpoS, RpoE, and SOS, key network hubs), apparently sensing stress. The results reveal how a network integrates mutagenic repair into the biology of the cell, show specific pathways of environmental sensing, demonstrate the centrality of stress responses, and imply that these responses are attractive as potential drug targets for blocking the evolution of pathogens.	[Al Mamun, Abu Amar M.; Lombardo, Mary-Jane; Shee, Chandan; Lisewski, Andreas M.; Gonzalez, Caleb; Lin, Dongxu; Nehring, Ralf B.; Gibson, Janet L.; Frisch, Ryan L.; Lichtarge, Olivier; Hastings, P. J.; Rosenberg, Susan M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Saint-Ruf, Claude] Univ Paris, INSERM, U1001, F-75730 Paris 15, France; [Lichtarge, Olivier; Rosenberg, Susan M.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Rosenberg, SM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	smr@bcm.edu		Rosenberg, Susan M./0000-0003-1444-473X	NSF [0905536, 1062455]; NIH [GM79656, GM66099, DP1-CA174424, R01-GM64022, R01-GM53158, F32-GM095267, F32-GM19909]; Direct For Computer & Info Scie & Enginr [0905536] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [DP1CA174424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053158, R01GM079656, R25GM056929, R01GM066099, F32GM095267, F32GM019909, R01GM064022] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Nichols and C. A. Gross for earlier bioinformatic analysis and discussion; S. Gottesman, C. Herman, J. D. Wang, and J. Weissman for discussions; J. Casadesus, S. Gottesman, C. Herman, G. Ira, X. Pan, E. Rogers, T. Silhavy, and J. D. Wang for comments on the manuscript; and D. Satory for help with strains. Bioinformatics supported by NSF 0905536, 1062455, and NIH GM79656 and GM66099 grants (O.L., A. M. L.). R.B.N. was supported by NIH Director's Pioneer Award DP1-CA174424 (S. M. R.). Supported by NIH grants R01-GM64022 (P. J. H.), R01-GM53158 (S. M. R.) and fellowships F32-GM095267 (R. L. F.) and F32-GM19909 (M.-J.L.). The genes of mutagenic repair of DNA breaks are accessible at http://wiki.porteco.org/tools/simnetwork.	Ades SE, 2003, J BACTERIOL, V185, P2512, DOI 10.1128/JB.185.8.2512-2519.2003; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Bindra RS, 2007, CANCER METAST REV, V26, P249, DOI 10.1007/s10555-007-9061-3; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Friedrich T, 1998, BBA-BIOENERGETICS, V1364, P134, DOI 10.1016/S0005-2728(98)00024-3; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Gennis R. B., 1996, CELLULAR MOL BIOL, V1, P217; Gibson JL, 2010, MOL MICROBIOL, V77, P415, DOI 10.1111/j.1365-2958.2010.07213.x; Hernandez SB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002459; KLECKNER N, 1991, METHOD ENZYMOL, V204, P139; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5; Mittelman D, 2010, CELL STRESS CHAPERON, V15, P463, DOI 10.1007/s12192-010-0205-y; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; Prieto AI, 2006, GENETICS, V174, P575, DOI 10.1534/genetics.106.060889; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Rosenberg SM, 2012, BIOESSAYS, V34, P885, DOI 10.1002/bies.201200050; Roth JR, 2006, ANNU REV MICROBIOL, V60, P477, DOI 10.1146/annurev.micro.60.080805.142045; ROUVIERE PE, 1995, EMBO J, V14, P1032, DOI 10.1002/j.1460-2075.1995.tb07084.x; Shee C, 2012, CELL REP, V2, P714, DOI 10.1016/j.celrep.2012.08.033; Shee C, 2011, P NATL ACAD SCI USA, V108, P13659, DOI 10.1073/pnas.1104681108; STRATHERN JN, 1995, GENETICS, V140, P965; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973	28	139	141	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1344	1348		10.1126/science.1226683	http://dx.doi.org/10.1126/science.1226683			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224554	Green Accepted			2022-12-28	WOS:000311991200067
J	Lindenmayer, DB; Laurance, WF; Franklin, JF				Lindenmayer, David B.; Laurance, William F.; Franklin, Jerry F.			Global Decline in Large Old Trees	SCIENCE			English	Editorial Material							LANDSCAPE; FUTURE; FIRE		[Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT 0200, Australia; [Laurance, William F.] James Cook Univ, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld 4878, Australia; [Laurance, William F.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld 4878, Australia; [Franklin, Jerry F.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA	Australian National University; James Cook University; James Cook University; University of Washington; University of Washington Seattle	Lindenmayer, DB (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, GPO Box 4, Canberra, ACT 0200, Australia.	david.lindenmayer@anu.edu.au	Laurance, William F/B-2709-2012; Lindenmayer, David B/P-7183-2017	Laurance, William F/0000-0003-4430-9408; Lindenmayer, David B/0000-0002-4766-4088				Anderegg WRL, 2013, NAT CLIM CHANGE, V3, P30, DOI 10.1038/nclimate1635; Asner GP, 2012, ECOL LETT, V15, P1211, DOI 10.1111/j.1461-0248.2012.01842.x; Fischer J, 2010, P NATL ACAD SCI USA, V107, P19597, DOI 10.1073/pnas.1008476107; Gibbons P, 2008, CONSERV BIOL, V22, P1309, DOI 10.1111/j.1523-1739.2008.00997.x; Jonsson MT, 2009, J VEG SCI, V20, P91, DOI 10.1111/j.1654-1103.2009.05394.x; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Laurance W, 2012, NEW SCI, V213, P39, DOI 10.1016/S0262-4079(12)60248-6; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lindenmayer D, 2009, FOREST PATTERN AND ECOLOGICAL PROCESS: A SYNTHESIS OF 25 YEARS OF RESEARCH, P1; Lutz JA, 2009, FOREST ECOL MANAG, V257, P2296, DOI 10.1016/j.foreco.2009.03.009; Mackey B, 2012, ECOL APPL, V22, P1852, DOI 10.1890/11-1479.1; Palik BJ, 2011, FOREST ECOL MANAG, V261, P128, DOI 10.1016/j.foreco.2010.09.041; Remm J, 2011, FOREST ECOL MANAG, V262, P579, DOI 10.1016/j.foreco.2011.04.028; Vanak AT, 2012, ECOGRAPHY, V35, P315, DOI 10.1111/j.1600-0587.2011.07213.x; VANPELT R, 2007, IDENTIFYING MATURE O	15	352	376	16	270	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1305	1306		10.1126/science.1231070	http://dx.doi.org/10.1126/science.1231070			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224548	Green Published			2022-12-28	WOS:000311991200055
J	Schlimpert, S; Klein, EA; Briegel, A; Hughes, V; Kahnt, J; Bolte, K; Maier, UG; Brun, YV; Jensen, GJ; Gitai, Z; Thanbichler, M				Schlimpert, Susan; Klein, Eric A.; Briegel, Ariane; Hughes, Velocity; Kahnt, Joerg; Bolte, Kathrin; Maier, Uwe G.; Brun, Yves V.; Jensen, Grant J.; Gitai, Zemer; Thanbichler, Martin			General Protein Diffusion Barriers Create Compartments within Bacterial Cells	CELL			English	Article							CAULOBACTER-CRESCENTUS; NUTRIENT-UPTAKE; CROSSBANDS; STALKS; MEMBRANE; PEPTIDOGLYCAN; MORPHOGENESIS; LOCALIZATION; INDICATORS; DIVISION	In eukaryotes, the differentiation of cellular extensions such as cilia or neuronal axons depends on the partitioning of proteins to distinct plasma membrane domains by specialized diffusion barriers. However, examples of this compartmentalization strategy are still missing for prokaryotes, although complex cellular architectures are also widespread among this group of organisms. This study reveals the existence of a protein-mediated membrane diffusion barrier in the stalked bacterium Caulobacter crescentus. We show that the Caulobacter cell envelope is compartmentalized by macromolecular complexes that prevent the exchange of both membrane and soluble proteins between the polar stalk extension and the cell body. The barrier structures span the cross-sectional area of the stalk and comprise at least four proteins that assemble in a cell-cycle-dependent manner. Their presence is critical for cellular fitness because they minimize the effective cell volume, allowing faster adaptation to environmental changes that require de novo synthesis of envelope proteins.	[Schlimpert, Susan; Thanbichler, Martin] Max Planck Inst Terr Microbiol, Max Planck Res Grp Prokaryot Cell Biol, D-35043 Marburg, Germany; [Kahnt, Joerg] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany; [Schlimpert, Susan; Thanbichler, Martin] Univ Marburg, Dept Biol, Microbiol Lab, D-35043 Marburg, Germany; [Bolte, Kathrin; Maier, Uwe G.] Univ Marburg, Dept Biol, Cell Biol Lab, D-35043 Marburg, Germany; [Klein, Eric A.; Gitai, Zemer] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Jensen, Grant J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Hughes, Velocity; Brun, Yves V.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Briegel, Ariane; Jensen, Grant J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Maier, Uwe G.; Thanbichler, Martin] LOEWE Ctr Synthet Microbiol, D-35043 Marburg, Germany	Max Planck Society; Max Planck Society; Philipps University Marburg; Philipps University Marburg; Princeton University; California Institute of Technology; Howard Hughes Medical Institute; Indiana University System; Indiana University Bloomington; California Institute of Technology	Thanbichler, M (corresponding author), Max Planck Inst Terr Microbiol, Max Planck Res Grp Prokaryot Cell Biol, Karl von Frisch Str 10, D-35043 Marburg, Germany.	thanbichler@mpi-marburg.mpg.de	Gitai, Zemer/AAI-6989-2021; Briegel, Ariane/AAC-1085-2021	Briegel, Ariane/0000-0003-3733-3725; Hughes, Velocity/0000-0002-3869-7726; Klein, Eric/0000-0003-3941-6233; Brun, Yves/0000-0002-9289-1909; Schlimpert, Susan/0000-0001-6364-8056	Max Planck Society; Human Frontier Science Program [RGY0069/2008-C]; National Institutes of Health (NIH) [DP2OD004389]; NRSA postdoctoral fellowship from National Institute of General Medical Sciences [F32GM906842]; NIH [GM51986, RO1 GM094800B]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM090684, R01GM051986, R01GM094800] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004389] Funding Source: NIH RePORTER	Max Planck Society(Max Planck Society); Human Frontier Science Program(Human Frontier Science Program); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA postdoctoral fellowship from National Institute of General Medical Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Stephanie Wick for excellent technical assistance; Nikolay Ouzounov for helpful discussions; Juliane Kuhn, Patrick Viollier, and Grant Bowman for providing plasmids and strains; and Sarah Cheng for help with image segmentation. This work was supported by funds from the Max Planck Society to M. T., a Young Investigator Grant (RGY0069/2008-C) from the Human Frontier Science Program to Z.G. and M.T., a National Institutes of Health (NIH) Director's New Innovator Award (DP2OD004389) to Z.G., an NRSA postdoctoral fellowship (F32GM906842) from the National Institute of General Medical Sciences to E. A. K., NIH grant GM51986 to Y.V.B, and NIH grant RO1 GM094800B to G.J.J.	Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Divakaruni AV, 2007, MOL MICROBIOL, V66, P174, DOI 10.1111/j.1365-2958.2007.05910.x; Gan L, 2008, P NATL ACAD SCI USA, V105, P18953, DOI 10.1073/pnas.0808035105; Gonin M, 2000, J BACTERIOL, V182, P337, DOI 10.1128/JB.182.2.337-347.2000; Hughes HV, 2010, P NATL ACAD SCI USA, V107, P5599, DOI 10.1073/pnas.0909119107; Ingerson-Mahar M, 2010, NAT CELL BIOL, V12, P739, DOI 10.1038/ncb2087; Ireland MME, 2002, MOL MICROBIOL, V45, P1029, DOI 10.1046/j.1365-2958.2002.03071.x; JONES HC, 1973, J BACTERIOL, V116, P466, DOI 10.1128/JB.116.1.466-470.1973; Lang GI, 2009, P NATL ACAD SCI USA, V106, P5755, DOI 10.1073/pnas.0901620106; Le Blastier S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014198; Marks ME, 2010, J BACTERIOL, V192, P3678, DOI 10.1128/JB.00255-10; McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294; Moll A, 2010, MOL MICROBIOL, V77, P90, DOI 10.1111/j.1365-2958.2010.07224.x; Murat D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000422; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; Neugebauer H, 2005, J BACTERIOL, V187, P8300, DOI 10.1128/JB.187.24.8300-8311.2005; PAERL HW, 1982, ADV MICROB ECOL, V6, P75; POINDEXTER JLS, 1964, J CELL BIOL, V23, P587; POINDEXTER JS, 1978, J BACTERIOL, V135, P1141, DOI 10.1128/JB.135.3.1141-1145.1978; Poindexter JS, 1996, J BACTERIOL, V178, P3939, DOI 10.1128/jb.178.13.3939-3948.1996; POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; SCHMIDT JM, 1966, J CELL BIOL, V28, P423, DOI 10.1083/jcb.28.3.423; SCHMIDT JM, 1973, ARCH MIKROBIOL, V89, P33, DOI 10.1007/BF00409397; SCHMIDT JM, 1975, J BACTERIOL, V124, P1601, DOI 10.1128/JB.124.3.1601-1603.1975; Seitz LC, 1998, J BACTERIOL, V180, P5235, DOI 10.1128/JB.180.19.5235-5239.1998; SMIT J, 1982, J CELL BIOL, V95, P41, DOI 10.1083/jcb.95.1.41; STALEY JT, 1973, NATURE, V246, P155, DOI 10.1038/246155a0; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Wagner JK, 2006, P NATL ACAD SCI USA, V103, P11772, DOI 10.1073/pnas.0602047103; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420	33	51	51	1	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1270	1282		10.1016/j.cell.2012.10.046	http://dx.doi.org/10.1016/j.cell.2012.10.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23201141	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000311999900016
J	Shivkumar, S				Shivkumar, Soumya			PRIMARY CARE More health professionals for rural India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												soumya.shivkumar@gmail.com						Chaudhuri M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8206; Garg S, 2012, NATL MED J INDIA, V25, P111; Government of India. Ministry of Health and Family Welfare, 2011, RUR HLTH STAT IND HI; Nabi Azad Ghulam, 2012, TIMES INDIA     0520; Rao KD, 2010, WHICH DOCTOR PRIMARY	5	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2012	345								e8339	10.1136/bmj.e8339	http://dx.doi.org/10.1136/bmj.e8339			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052II	23220734				2022-12-28	WOS:000312190800005
J	Moreau, A; Ciraci, C; Mock, JJ; Hill, RT; Wang, Q; Wiley, BJ; Chilkoti, A; Smith, DR				Moreau, Antoine; Ciraci, Cristian; Mock, Jack J.; Hill, Ryan T.; Wang, Qiang; Wiley, Benjamin J.; Chilkoti, Ashutosh; Smith, David R.			Controlled-reflectance surfaces with film-coupled colloidal nanoantennas	NATURE			English	Article							PERFECT ABSORBER; NEGATIVE-INDEX; GOLD; SILVER	Efficient and tunable absorption is essential for a variety of applications, such as designing controlled-emissivity surfaces for thermophotovoltaic devices(1), tailoring an infrared spectrum for controlled thermal dissipation(2) and producing detector elements for imaging(3). Metamaterials based on metallic elements are particularly efficient as absorbing media, because both the electrical and the magnetic properties of a metamaterial can be tuned by structured design(4). So far, metamaterial absorbers in the infrared or visible range have been fabricated using lithographically patterned metallic structures(2,5-9), making them inherently difficult to produce over large areas and hence reducing their applicability. Here we demonstrate a simple method to create a metamaterial absorber by randomly adsorbing chemically synthesized silver nanocubes onto a nanoscale-thick polymer spacer layer on a gold film, making no effort to control the spatial arrangement of the cubes on the film. We show that the film-coupled nanocubes provide a reflectance spectrum that can be tailored by varying the geometry (the size of the cubes and/or the thickness of the spacer). Each nanocube is the optical analogue of a grounded patch antenna, with a nearly identical local field structure that is modified by the plasmonic response of the metal's dielectric function, and with an anomalously large absorption efficiency that can be partly attributed to an interferometric effect(10). The absorptivity of large surface areas can be controlled using this method, at scales out of reach of lithographic approaches (such as electron-beam lithography) that are otherwise required to manipulate matter on the nanoscale.	[Moreau, Antoine; Ciraci, Cristian; Mock, Jack J.; Smith, David R.] Duke Univ, Ctr Metamat & Integrated Plasmon, Durham, NC 27708 USA; [Moreau, Antoine] Univ Blaise Pascal, Clermont Univ, F-63000 Clermont Ferrand, France; [Moreau, Antoine] CNRS, IP, UMR 6602, F-63171 Aubiere, France; [Hill, Ryan T.; Chilkoti, Ashutosh] Duke Univ, Ctr Biol Inspired Mat & Mat Syst, Durham, NC 27708 USA; [Wang, Qiang; Wiley, Benjamin J.] Duke Univ, Dept Chem, Durham, NC 27708 USA; [Wang, Qiang] Capital Normal Univ, Lab Microsized Funct Mat, Beijing 100048, Peoples R China; [Wang, Qiang] Capital Normal Univ, Coll Elementary Educ, Beijing 100048, Peoples R China; [Chilkoti, Ashutosh] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA	Duke University; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite Clermont Auvergne (UCA); Duke University; Duke University; Capital Normal University; Capital Normal University; Duke University	Smith, DR (corresponding author), Duke Univ, Ctr Metamat & Integrated Plasmon, Durham, NC 27708 USA.	drsmith@ee.duke.edu	Moreau, Antoine/C-5790-2009; Ciracì, Cristian/K-3602-2017; Wiley, Benjamin/A-7003-2008; Smith, David R/E-4710-2012	Moreau, Antoine/0000-0003-1293-1219; Ciracì, Cristian/0000-0003-3349-8389; Wiley, Benjamin/0000-0002-1314-6223; 	US Air Force Office of Scientific Research [FA9550-09-1-0562]; US Army Research Office through a Multidisciplinary University Research Initiative [W911NF-09-1-0539]; US NIH [R21EB009862, F32EB009299]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [F32EB009299, R21EB009862] Funding Source: NIH RePORTER	US Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); US Army Research Office through a Multidisciplinary University Research Initiative; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the US Air Force Office of Scientific Research (grant no. FA9550-09-1-0562) and by the US Army Research Office through a Multidisciplinary University Research Initiative (grant no. W911NF-09-1-0539). Additional support includes US NIH grant R21EB009862, to A. C., and US NIH F32 award (F32EB009299), to R.T.H.	Albooyeh M., 2012, MAXIMAL ABSORPTION L; Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; Avitzour Y, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.045131; Bermel P, 2010, OPT EXPRESS, V18, pA314, DOI 10.1364/OE.18.00A314; Bozhevolnyi SI, 2007, OPT EXPRESS, V15, P10869, DOI 10.1364/OE.15.010869; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Dolling G, 2005, OPT LETT, V30, P3198, DOI 10.1364/OL.30.003198; Granet G, 2002, J OPT A-PURE APPL OP, V4, pS145, DOI 10.1088/1464-4258/4/5/362; Hanauer M, 2007, NANO LETT, V7, P2881, DOI 10.1021/nl071615y; Hao JM, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3442904; Im SH, 2005, ANGEW CHEM INT EDIT, V44, P2154, DOI 10.1002/anie.200462208; Koechlin C, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3670051; Landy NI, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.207402; Le Perchec J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.066408; Liu N, 2010, NANO LETT, V10, P2342, DOI 10.1021/nl9041033; Liu XL, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.045901; Marinakos SM, 2007, ANAL CHEM, V79, P5278, DOI 10.1021/ac0706527; Michota A, 2002, SURF SCI, V502, P214, DOI 10.1016/S0039-6028(01)01948-3; Mock JJ, 2008, NANO LETT, V8, P2245, DOI 10.1021/nl080872f; Moreau A, 2007, J OPT A-PURE APPL OP, V9, P165, DOI 10.1088/1464-4258/9/2/008; Niesler FBP, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4714741; Shadrivov IV, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.083902; Shalaev VM, 2007, NAT PHOTONICS, V1, P41, DOI 10.1038/nphoton.2006.49; Shalaev VM, 2005, OPT LETT, V30, P3356, DOI 10.1364/OL.30.003356; Sun YG, 2002, SCIENCE, V298, P2176, DOI 10.1126/science.1077229; Tittl A, 2011, NANO LETT, V11, P4366, DOI 10.1021/nl202489g; Wallwork ML, 2001, LANGMUIR, V17, P1126, DOI 10.1021/la000870u; Wan WJ, 2011, SCIENCE, V331, P889, DOI 10.1126/science.1200735; Wu CH, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.075102; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713	30	565	575	24	1026	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					86	+		10.1038/nature11615	http://dx.doi.org/10.1038/nature11615			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23222613	Green Accepted			2022-12-28	WOS:000311893400050
J	Sandora, TJ; Goldmann, DA				Sandora, Thomas J.; Goldmann, Donald A.			Preventing Lethal Hospital Outbreaks of Antibiotic-Resistant Bacteria	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sandora, Thomas J.; Goldmann, Donald A.] Boston Childrens Hosp, Div Infect Dis, Boston, MA USA; [Sandora, Thomas J.; Goldmann, Donald A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Goldmann, Donald A.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Goldmann, Donald A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Goldmann, Donald A.] Inst Healthcare Improvement, Cambridge, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Institute for Healthcare Improvement	Sandora, TJ (corresponding author), Boston Childrens Hosp, Div Infect Dis, Boston, MA USA.							Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Goldmann DA, 1996, JAMA-J AM MED ASSOC, V275, P234, DOI 10.1001/jama.275.3.234; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Ursprung R, 2005, QUAL SAF HEALTH CARE, V14, P284, DOI 10.1136/qshc.2004.012542; Zawacki A, 2004, INFECT CONT HOSP EP, V25, P1083, DOI 10.1086/502348	5	36	36	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2012	367	23					2168	2170		10.1056/NEJMp1212370	http://dx.doi.org/10.1056/NEJMp1212370			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048DO	23215553	Bronze			2022-12-28	WOS:000311890600002
J	Shubin, N				Shubin, Neil			Farish A. Jenkins Jr (1940-2012) OBITUARY	NATURE			English	Biographical-Item									Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Shubin, N (corresponding author), Univ Chicago, Chicago, IL 60637 USA.	nshubin@uchicago.edu						JENKINS FA, PUBLICATION LIST	1	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2012	492	7427					42	42		10.1038/492042a	http://dx.doi.org/10.1038/492042a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23222601	Bronze			2022-12-28	WOS:000311893400035
J	Arora, VM; Farnan, JM; Humphrey, HJ				Arora, Vineet M.; Farnan, Jeanne M.; Humphrey, Holly J.			Professionalism in the Era of Duty Hours Time for a Shift Change?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HOURS RESTRICTIONS; WORK; PRESENTEEISM		[Arora, Vineet M.] Univ Chicago, Dept Med, Gen Internal Med Sect, Chicago, IL 60637 USA; [Farnan, Jeanne M.] Univ Chicago, Sect Hosp Med, Chicago, IL 60637 USA; [Arora, Vineet M.; Farnan, Jeanne M.; Humphrey, Holly J.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Arora, VM (corresponding author), Univ Chicago, Dept Med, Gen Internal Med Sect, 5841 S Maryland Ave,MC 2007,AMB W216, Chicago, IL 60637 USA.	varora@uchicago.edu		Arora, Vineet/0000-0002-4745-7599	NIA NIH HHS [K23 AG033763, K23AG033763] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K23AG033763] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arora V, 2006, ANN INTERN MED, V144, P792, DOI 10.7326/0003-4819-144-11-200606060-00005; Arora VM, 2008, JAMA-J AM MED ASSOC, V300, P1132, DOI 10.1001/jama.300.10.1132; Carpenter Robert O, 2006, Curr Surg, V63, P448, DOI 10.1016/j.cursur.2006.06.003; Coverdill JE, 2010, ACAD MED, V85, pS72, DOI 10.1097/ACM.0b013e3181ed455b; Dew K, 2005, SOC SCI MED, V60, P2273, DOI 10.1016/j.socscimed.2004.10.022; Hafferty FW, 2008, PERSPECT BIOL MED, V51, P599, DOI 10.1353/pbm.0.0044; Hafferty FW, 2009, MED EDUC, V43, P826, DOI 10.1111/j.1365-2923.2009.03445.x; Jena AB, 2010, JAMA-J AM MED ASSOC, V304, P1166, DOI 10.1001/jama.2010.1315; Mourad M, 2011, ACAD MED, V86, P586, DOI 10.1097/ACM.0b013e318212e1cb; Szymczak JE, 2010, MILBANK Q, V88, P350, DOI 10.1111/j.1468-0009.2010.00603.x	10	27	27	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2012	308	21					2195	2196		10.1001/jama.2012.14584	http://dx.doi.org/10.1001/jama.2012.14584			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	047HI	23212495				2022-12-28	WOS:000311829500009
J	Brotherton, SE; Etzel, SI				Brotherton, Sarah E.; Etzel, Sylvia I.			Graduate Medical Education, 2011-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brotherton, Sarah E.; Etzel, Sylvia I.] Amer Med Assoc, Div Grad Med Educ, Chicago, IL 60654 USA	American Medical Association	Brotherton, SE (corresponding author), Amer Med Assoc, Div Grad Med Educ, 515 N State St, Chicago, IL 60654 USA.	sarah.brotherton@ama-assn.org							0	57	58	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2012	308	21					2264	2279		10.1001/jama.2012.7913	http://dx.doi.org/10.1001/jama.2012.7913			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047HI	23212508				2022-12-28	WOS:000311829500022
J	Morse, SS; Mazet, JAK; Woolhouse, M; Parrish, CR; Carroll, D; Karesh, WB; Zambrana-Torrelio, C; Lipkin, WI; Daszak, P				Morse, Stephen S.; Mazet, Jonna A. K.; Woolhouse, Mark; Parrish, Colin R.; Carroll, Dennis; Karesh, William B.; Zambrana-Torrelio, Carlos; Lipkin, W. Ian; Daszak, Peter			Zoonoses 3 Prediction and prevention of the next pandemic zoonosis	LANCET			English	Article							EMERGING INFECTIOUS-DISEASES; INFLUENZA-VIRUS; RISK-FACTORS; HOST-RANGE; TRANSMISSION; EMERGENCE; SURVEILLANCE; DYNAMICS; CORONAVIRUS; BIODIVERSITY	Most pandemics-eg, HIV/AIDS, severe acute respiratory syndrome, pandemic influenza-originate in animals, are caused by viruses, and are driven to emerge by ecological, behavioural, or socioeconomic changes. Despite their substantial effects on global public health and growing understanding of the process by which they emerge, no pandemic has been predicted before infecting human beings. We review what is known about the pathogens that emerge, the hosts that they originate in, and the factors that drive their emergence. We discuss challenges to their control and new efforts to predict pandemics, target surveillance to the most crucial interfaces, and identify prevention strategies. New mathematical modelling, diagnostic, communications, and informatics technologies can identify and report hitherto unknown microbes in other species, and thus new risk assessment approaches are needed to identify microbes most likely to cause human disease. We lay out a series of research and surveillance opportunities and goals that could help to overcome these challenges and move the global pandemic strategy from response to pre-emption.	[Karesh, William B.; Zambrana-Torrelio, Carlos; Daszak, Peter] EcoHealth Alliance, New York, NY 10001 USA; [Morse, Stephen S.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, New York, NY USA; [Morse, Stephen S.; Mazet, Jonna A. K.] Univ Calif Davis, Hlth Inst 1, Sch Vet Med, Davis, CA 95616 USA; [Woolhouse, Mark] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Parrish, Colin R.] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; [Carroll, Dennis] US Agcy Int Dev, Washington, DC 20523 USA; [Karesh, William B.] IUCN Species Survival Commiss, Wildlife Hlth Specialist Grp, Gland, Switzerland	Columbia University; Columbia University; University of California System; University of California Davis; University of Edinburgh; Cornell University; United States Agency for International Development (USAID)	Daszak, P (corresponding author), EcoHealth Alliance, 460 W 34th St, New York, NY 10001 USA.	daszak@ecohealthalliance.org	daszak, peter/U-4588-2017; Zambrana-Torrelio, Carlos/AAH-3911-2020; Lipkin, W. Ian/ABE-6216-2020; Karesh, William/AAU-9084-2020	daszak, peter/0000-0002-2046-5695; Zambrana-Torrelio, Carlos/0000-0002-5614-7496; Lipkin, W. Ian/0000-0002-8768-9386; Karesh, William/0000-0001-6042-2860	US Agency for International Development (USAID) Emerging Pandemic Threats PREDICT project (USAID) [GHN-A-009-00010-00]; National Institutes of Health [AI079231, AI57158]; Defense Threat Reduction Agency; Ecology and Evolution of Infectious Diseases award from the Fogarty International Center of the National Institutes of Health [2R01-TW005869]; National Science Foundation Human and Social Dynamics programme [BCS-0826779]; Wellcome-Trust-funded VIZIONS project; Arts and Letters Foundation; FOGARTY INTERNATIONAL CENTER [R01TW005869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092571, R01AI079231, U54AI057158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100471] Funding Source: NIH RePORTER	US Agency for International Development (USAID) Emerging Pandemic Threats PREDICT project (USAID)(United States Agency for International Development (USAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Ecology and Evolution of Infectious Diseases award from the Fogarty International Center of the National Institutes of Health; National Science Foundation Human and Social Dynamics programme; Wellcome-Trust-funded VIZIONS project; Arts and Letters Foundation; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by the US Agency for International Development (USAID) Emerging Pandemic Threats PREDICT project (USAID cooperative agreement GHN-A-009-00010-00). WIL is supported by grants from the National Institutes of Health (AI079231, AI57158), and the Defense Threat Reduction Agency. PD is supported by an Ecology and Evolution of Infectious Diseases award from the Fogarty International Center of the National Institutes of Health (2R01-TW005869) and the National Science Foundation Human and Social Dynamics programme (BCS-0826779). MW receives support from the Wellcome-Trust-funded VIZIONS project, and SSM is supported by the Arts and Letters Foundation. We thank Murray Trostle for his invaluable insights and Aleksei A Chmura (EcoHealth Alliance) for figure 2. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. This paper is dedicated to the memory of Prof Joshua Lederberg (1925-2008).	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; [Anonymous], 2009, SUSTAINING GLOBAL SU; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Barber MRW, 2011, INFLUENZA OTHER RESP, V5, P8; Baric RS, 2005, P NATL ACAD SCI USA, V102, P8073, DOI 10.1073/pnas.0503091102; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bull J, 2003, NATURE, V426, P609, DOI 10.1038/426609a; BURKE DS, 1998, PATHOLOGY EMERGING I, P00001; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chan EH, 2010, P NATL ACAD SCI USA, V107, P21701, DOI 10.1073/pnas.1006219107; Chan J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001005; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Cui J, 2007, EMERG INFECT DIS, V13, P1526, DOI 10.3201/eid1310.070448; Damon IK, 2011, VACCINE, V29, pD54, DOI 10.1016/j.vaccine.2011.04.014; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davies TJ, 2008, P ROY SOC B-BIOL SCI, V275, P1695, DOI 10.1098/rspb.2008.0284; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; DOWNS WG, 1982, ANNU REV MED, V33, P1, DOI 10.1146/annurev.me.33.020182.000245; Ewald P, 1996, EVOLUTION INFECT DIS; Fenner Frank, 1993, P176; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Goldberg TL, 2008, EMERG INFECT DIS, V14, P1375, DOI [10.3201/eid14.9.071196, 10.3201/eid1409.071196]; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Holmes E., 2009, EVOLUTION EMERGENCE; Hosseini P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012763; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Janes CR, 2012, LANCET, V380, P1884, DOI 10.1016/S0140-6736(12)61725-5; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kalscheuer H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003481; Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X; Karesh WB, 2009, CLIN MED, V9, P259, DOI 10.7861/clinmedicine.9-3-259; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9; Kimball AM, 2008, MED CLIN N AM, V92, P1459, DOI 10.1016/j.mcna.2008.06.001; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Lederberg J., 1992, I MED US COMMITTEE; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Lipkin WI, 2010, MICROBIOL MOL BIOL R, V74, P363, DOI 10.1128/MMBR.00007-10; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Long WJ, 2011, PANDEMICS AND PEACE: PUBLIC HEALTH COOPERATION IN ZONES OF CONFLICT, P1; Mackenzie JS, 1999, EMERG INFECT DIS, V5, P1, DOI 10.3201/eid0501.990101; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Moresco EMY, 2011, CURR OPIN VIROL, V1, P513, DOI 10.1016/j.coviro.2011.10.005; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; Morse SS, 1996, HEALTH POLICY, V38, P135, DOI 10.1016/0168-8510(96)00863-9; MORSE SS, 1990, ISSUES SCI TECHNOL, V7, P81; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Morse SS, 2012, BIOSECUR BIOTERROR, V10, P6, DOI 10.1089/bsp.2011.0088; Morse Stephen S., 1994, P1; Murphy FA, 1998, EMERG INFECT DIS, V4, P429, DOI 10.3201/eid0403.980324; National Biosurveillance Advisory Subcommittee, IMPR NAT AB DET RESP; Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08; Peiris JSM, 2012, SCIENCE, V335, P1173, DOI 10.1126/science.1219936; Pepin KM, 2010, NAT REV MICROBIOL, V8, P802, DOI 10.1038/nrmicro2440; Pulliam JRC, 2008, ECOHEALTH, V5, P80, DOI 10.1007/s10393-007-0149-6; Pulliam JRC, 2012, J R SOC INTERFACE, V9, P89, DOI 10.1098/rsif.2011.0223; Pulliam JRC, 2009, J INFECT DIS, V199, P565, DOI 10.1086/596510; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Relman DA, 2011, NEW ENGL J MED, V365, P347, DOI 10.1056/NEJMra1003071; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Smolinsky M.S., 2003, MICROBIAL THREATS HL; Ssematimba A, 2013, PREV VET MED, V109, P106, DOI 10.1016/j.prevetmed.2012.09.001; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Vidal Jean-Marc, 2010, Cytokine, V51, P213, DOI 10.1016/j.cyto.2010.04.008; Webby R, 2004, NAT MED, V10, pS77, DOI 10.1038/nm1151; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; Wolf B, 2012, CYTOKINE, V60, P828, DOI 10.1016/j.cyto.2012.08.018; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5; Woolhouse M, 2012, PHILOS T R SOC B, V367, P2864, DOI 10.1098/rstb.2011.0354; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; World Health Organization, 2008, INT HLTH REG 2005, V2nd; World Health Organization, GLOB OUTBR AL RESP N; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	90	515	539	16	292	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2012	380	9857					1956	1965		10.1016/S0140-6736(12)61684-5	http://dx.doi.org/10.1016/S0140-6736(12)61684-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	046IK	23200504	Bronze, Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000311758500032
J	Bertelsen, M; Linneberg, A; Rosenberg, T; Christoffersen, N; Vorum, H; Gade, E; Larsen, M				Bertelsen, Mette; Linneberg, Allan; Rosenberg, Thomas; Christoffersen, Nynne; Vorum, Henrik; Gade, Else; Larsen, Michael			Comorbidity in patients with branch retinal vein occlusion: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; FOLLOW-UP; PLASMA HOMOCYSTEINE; POOLED DATA; POPULATION; PREVALENCE; MORTALITY; METAANALYSIS; MORBIDITY; COHORT	Objectives To evaluate comorbidity before and after the diagnosis of branch retinal vein occlusion to determine whether it is a consequence of arterial thickening and therefore could serve as a diagnostic marker for other comorbidities and to evaluate the risk factors for the development of such occlusion. Design Case-control study with prospective follow-up data from Danish national registries. Setting Four secondary referral centres covering about 80% of the Danish population (4.4 million). Participants 1168 patients with photographically verified branch retinal vein occlusion and 116 800 controls alive and aged >= 40 when the occlusion was diagnosed in the corresponding case. Main outcome measures The risk of comorbidity 10 years and 1 year before the diagnosis of branch retinal vein occlusion and the incident comorbidity in a mean period of seven years after the diagnosis, with odds ratios and incidence rate ratios adjusted for age, sex, and year of diagnosis. Results Risk factors present 10 years and 1 year before the diagnosis of branch retinal vein occlusion included peripheral artery disease (odds ratio 1.83, 95% confidence interval 1.14 to 2.95), diabetes (1.74, 1.40 to 2.17) and arterial hypertension (2.16, 1.86 to 2.51). After the diagnosis, patients had an increased risk of developing arterial hypertension (incidence rate ratio 1.37, 95% confidence interval 1.15 to 1.57), diabetes (1.51, 1.17 to 2.04), congestive heart failure (1.41, 1.12 to 1.68), and cerebrovascular disease (1.49, 1.27 to 1.76). Conclusion Diabetes, hypertension, and peripheral artery disease are associated with an increased risk of developing branch retinal vein occlusion up to a decade later. Branch retinal vein occlusion was associated with an increased risk of subsequently developing hypertension, diabetes, congestive heart failure, and cerebrovascular disease, emphasising the importance of preventive initiatives. These results fit the assumption that branch retinal vein occlusion is a consequence of arterial thickening and that the arteriovenous crossing signs that precede it are hallmarks of arterial disease.	[Bertelsen, Mette; Larsen, Michael] Glostrup Cty Hosp, Dept Ophthalmol, DK-2600 Glostrup, Denmark; [Bertelsen, Mette; Rosenberg, Thomas; Christoffersen, Nynne; Larsen, Michael] Kennedy Ctr, Natl Eye Clin Visually Impaired, DK-2600 Glostrup, Denmark; [Bertelsen, Mette; Rosenberg, Thomas; Larsen, Michael] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Linneberg, Allan] Glostrup Cty Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Vorum, Henrik] Aalborg Univ Hosp, Dept Ophthalmol, Aalborg, Denmark; [Gade, Else] Odense Univ Hosp, Dept Ophthalmol, DK-5000 Odense, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Aalborg University; Aalborg University Hospital; University of Southern Denmark; Odense University Hospital	Bertelsen, M (corresponding author), Glostrup Cty Hosp, Dept Ophthalmol, Nordre Ringvej 57, DK-2600 Glostrup, Denmark.	mettebertelsen12@gmail.com	Bertelsen, Mette/AFO-7185-2022; Larsen, Michael/E-9620-2010	Larsen, Michael/0000-0002-5172-5891; Linneberg, Allan/0000-0002-0994-0184	Dag Lenards Foundation; Danish Diabetes Academy	Dag Lenards Foundation; Danish Diabetes Academy	We acknowledge the support of the Danish Diabetes Academy.; This study was funded by the Dag Lenards Foundation. The foundation had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the reports; or in the decision to submit the article for publication.	Andersen TF, 1999, DAN MED BULL, V46, P263; APPIAH AP, 1989, ANN OPHTHALMOL, V21, P153; Ariturk N, 1996, BRIT J OPHTHALMOL, V80, P633, DOI 10.1136/bjo.80.7.633; Cahill M, 2000, BRIT J OPHTHALMOL, V84, P154, DOI 10.1136/bjo.84.2.154; Cahill MT, 2003, AM J OPHTHALMOL, V136, P1136, DOI 10.1016/S0002-9394(03)00571-3; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheung N, 2008, INVEST OPHTH VIS SCI, V49, P4297, DOI 10.1167/iovs.08-1826; Christoffersen N, 2007, OPHTHALMOLOGY, V114, P1186, DOI 10.1016/j.ophtha.2007.01.031; Chua B, 2005, AM J OPHTHALMOL, V139, P181, DOI 10.1016/j.ajo.2004.06.084; Cugati S, 2007, OPHTHALMOLOGY, V114, P520, DOI 10.1016/j.ophtha.2006.06.061; Eve Disease Case-Control Study Group, 1993, AM J OPHTHALMOL, V116, P286; FRUCHT J, 1984, BRIT J OPHTHALMOL, V68, P26, DOI 10.1136/bjo.68.1.26; Greiner K, 1999, AM J OPHTHALMOL, V128, P69, DOI 10.1016/S0002-9394(99)00074-4; Greiner Kathrin, 1999, International Ophthalmology, V23, P155, DOI 10.1023/A:1010639332737; Hayreh SS, 2001, AM J OPHTHALMOL, V131, P61, DOI 10.1016/S0002-9394(00)00709-1; Ho JD, 2009, AM J OPHTHALMOL, V147, P283, DOI 10.1016/j.ajo.2008.08.006; Hu CC, 2009, BRIT J OPHTHALMOL, V93, P717, DOI 10.1136/bjo.2008.151605; Janssen MCH, 2005, THROMB HAEMOSTASIS, V93, P1021, DOI 10.1160/TH04-11-0768; JOHNSTON RL, 1985, ARCH OPHTHALMOL-CHIC, V103, P1831; Kadayifcilar S, 2001, BRIT J OPHTHALMOL, V85, P1174, DOI 10.1136/bjo.85.10.1174; Kiire CA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e499; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kirwan JF, 1997, EYE, V11, P53, DOI 10.1038/eye.1997.11; Klein R, 2000, Trans Am Ophthalmol Soc, V98, P133; Klein R, 2008, ARCH OPHTHALMOL-CHIC, V126, P513, DOI 10.1001/archopht.126.4.513; Kuhli C, 2004, AM J OPHTHALMOL, V137, P459, DOI 10.1016/j.ajo.2003.10.024; Kuo RN, 2011, MED CARE, V49, P1031, DOI 10.1097/MLR.0b013e31822ebe11; Lidegaard O, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6423; Lim LL, 2008, BRIT J OPHTHALMOL, V92, P1316, DOI 10.1136/bjo.2008.140640; Majji AB, 1997, RETINA-J RET VIT DIS, V17, P200, DOI 10.1097/00006982-199705000-00005; Martin SC, 2002, BRIT J OPHTHALMOL, V86, P774, DOI 10.1136/bjo.86.7.774; Munch IC, 2012, ACTA OPHTHALMOL, V90, P613, DOI 10.1111/j.1755-3768.2011.2148.x; Pedersen CB, 2006, DAN MED BULL, V53, P441; RATH EZ, 1992, OPHTHALMOLOGY, V99, P509; Rehak J, 2008, CURR EYE RES, V33, P111, DOI 10.1080/02713680701851902; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; RUBINSTEIN K, 1976, BRIT J OPHTHALMOL, V60, P148, DOI 10.1136/bjo.60.2.148; Singer Donald R.J., 2002, Eur J Intern Med, V13, P160, DOI 10.1016/S0953-6205(02)00024-9; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Tsaloumas MD, 2000, EYE, V14, P821, DOI 10.1038/eye.2000.230; Weger M, 2005, OPHTHALMOLOGY, V112, P1910, DOI 10.1016/j.ophtha.2005.05.019; Werther W, 2011, ARCH OPHTHALMOL-CHIC, V129, P326, DOI 10.1001/archophthalmol.2011.2; Williamson TH, 1996, BRIT J OPHTHALMOL, V80, P203, DOI 10.1136/bjo.80.3.203; Wong TY, 2010, NEW ENGL J MED, V363, P2135, DOI 10.1056/NEJMcp1003934; Yasuda M, 2010, INVEST OPHTH VIS SCI, V51, P3205, DOI 10.1167/iovs.09-4453	45	57	58	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2012	345								e7885	10.1136/bmj.e7885	http://dx.doi.org/10.1136/bmj.e7885			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048FS	23204001	hybrid, Green Published			2022-12-28	WOS:000311896500004
J	Yamamoto, S; Charng, WL; Rana, NA; Kakuda, S; Jaiswal, M; Bayat, V; Xiong, B; Zhang, K; Sandoval, H; David, G; Wang, H; Haltiwanger, RS; Bellen, HJ				Yamamoto, Shinya; Charng, Wu-Lin; Rana, Nadia A.; Kakuda, Shinako; Jaiswal, Manish; Bayat, Vafa; Xiong, Bo; Zhang, Ke; Sandoval, Hector; David, Gabriela; Wang, Hao; Haltiwanger, Robert S.; Bellen, Hugo J.			A Mutation in EGF Repeat-8 of Notch Discriminates Between Serrate/Jagged and Delta Family Ligands	SCIENCE			English	Article							DORSAL-VENTRAL BOUNDARY; FRINGE; ACTIVATION; BINDING; GLYCOSYLTRANSFERASE; MODULATION; DOMAIN; HEAD	Notch signaling affects many developmental and cellular processes and has been implicated in congenital disorders, stroke, and numerous cancers. The Notch receptor binds its ligands Delta and Serrate and is able to discriminate between them in different contexts. However, the specific domains in Notch responsible for this selectivity are poorly defined. Through genetic screens in Drosophila, we isolated a mutation, Notch(jigsaw), that affects Serrate-but not Delta-dependent signaling. Notch(jigsaw) carries a missense mutation in epidermal growth factor repeat-8 (EGFr-8) and is defective in Serrate binding. A homologous point mutation in mammalian Notch2 also exhibits defects in signaling of a mammalian Serrate homolog, Jagged1. Hence, an evolutionarily conserved valine in EGFr-8 is essential for ligand selectivity and provides a molecular handle to study numerous Notch-dependent signaling events.	[Yamamoto, Shinya; Charng, Wu-Lin; Bayat, Vafa; Xiong, Bo; David, Gabriela; Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Rana, Nadia A.; Kakuda, Shinako; Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Jaiswal, Manish; Sandoval, Hector; Wang, Hao; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Jaiswal, Manish; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Bayat, Vafa] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Zhang, Ke; Bellen, Hugo J.] Baylor Coll Med, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA	Baylor College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Bellen, HJ (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	hbellen@bcm.edu	Zhang, Ke/B-8598-2018; Xiong, Bo/M-3605-2014; Bayat, Vafa/ABG-2774-2021; Yamamoto, Shinya/ABB-2837-2021	Zhang, Ke/0000-0002-4794-8355; Yamamoto, Shinya/0000-0003-2172-8036; Bayat, Vafa/0000-0002-1524-0520; Jaiswal, Manish/0000-0001-8360-8289; Xiong, Bo/0000-0002-2695-9100; Bellen, Hugo/0000-0001-5992-5989; Sandoval, Hector/0000-0002-9186-7384	NIH [1RC4GM096355-01, 5R01GM061126-12, 5T32-HD055200, 5R01GM067858]; Intellectual and Developmental Disabilities Research Center [NIH 5P30HD024064]; Nakajima Foundation; Taiwan Merit Scholarships Program; National Science Council [NSC-095-SAF-I-564-015-TMS]; Edward and Josephine Hudson Scholarship Fund; Houston Laboratory and Population Science Training Program in Gene-Environment Interaction from the Burroughs Wellcome Fund [1008200]; Research Education and Career Horizon Institutional Research and Academic Career Development Award Fellowship [5K12GM084897]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD055200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC4GM096355, R01GM061126, R01GM067858, K12GM084897] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intellectual and Developmental Disabilities Research Center; Nakajima Foundation; Taiwan Merit Scholarships Program; National Science Council(Ministry of Science and Technology, Taiwan); Edward and Josephine Hudson Scholarship Fund; Houston Laboratory and Population Science Training Program in Gene-Environment Interaction from the Burroughs Wellcome Fund; Research Education and Career Horizon Institutional Research and Academic Career Development Award Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Bloomington Drosophila Stock Center, the Vienna Drosophila RNAi Center, and the Developmental Studies Hybridoma Bank for distribution of flies and antibodies. We are grateful to S. Artavanis-Tsakonas, G. Bornkamm, S. Bray, S. Chiba, P. Heitzler, H. Hiral, K. Irvine, H. Jafar-Nejad, A. Martinez-Arias, M. Milan, L. Strobl, G. Weinmaster, and C. Wesley for flies and reagents. We thank K. Schulze for critical reading and editing of the manuscript. We acknowledge S. Gibbs, A. Jawaid, Y. Chen, C. Benitez, B. McNulty, A. Lin-Moore, D. Bei, L. Wang, Y. Kawagishi, and T. Busby for technical assistance. We thank R. Kopan, S. Blacklow, M. Milan, K. Cook, N. Giagtzoglou, K. Venken, H. Tsuda, C. Yao, and H. Takeuchi for helpful comments and discussion. This research was supported in part by the NIH (1RC4GM096355-01 to H.J.B. and 5R01GM061126-12 to R. S. H). Confocal microscopy at Baylor College of Medicine is supported by the Intellectual and Developmental Disabilities Research Center (NIH 5P30HD024064). S. Y. was supported by a fellowship from the Nakajima Foundation. W.-L. C. was supported by Taiwan Merit Scholarships Program sponsored by the National Science Council (NSC-095-SAF-I-564-015-TMS). V. B. received support from the NIH (5T32-HD055200) and the Edward and Josephine Hudson Scholarship Fund. B. X. was supported by the Houston Laboratory and Population Science Training Program in Gene-Environment Interaction from the Burroughs Wellcome Fund (grant 1008200). H. S. received support from a supplement to NIH 5R01GM067858 and the Research Education and Career Horizon Institutional Research and Academic Career Development Award Fellowship 5K12GM084897. H.J.B. is a Howard Hughes Medical Institute Investigator.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Becam I, 2010, CURR BIOL, V20, P554, DOI 10.1016/j.cub.2010.01.058; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; DECELIS JF, 1993, P NATL ACAD SCI USA, V90, P4037, DOI 10.1073/pnas.90.9.4037; deCelis JF, 1996, DEVELOPMENT, V122, P359; Haberman AS, 2003, DEV BIOL, V258, P443, DOI 10.1016/S0012-1606(03)00140-4; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; Klein T, 1998, DEVELOPMENT, V125, P2951; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; McBride KL, 2008, HUM MOL GENET, V17, P2886, DOI 10.1093/hmg/ddn187; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; McKellar SH, 2007, J THORAC CARDIOV SUR, V134, P290, DOI 10.1016/j.jtcvs.2007.02.041; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Mohamed SA, 2006, BIOCHEM BIOPH RES CO, V345, P1460, DOI 10.1016/j.bbrc.2006.05.046; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Pei ZF, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-4; Rana NA, 2011, J BIOL CHEM, V286, P31623, DOI 10.1074/jbc.M111.268243; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200; Zeng CY, 1998, GENE DEV, V12, P1086, DOI 10.1101/gad.12.8.1086	28	70	72	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1229	1232		10.1126/science.1228745	http://dx.doi.org/10.1126/science.1228745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197537	Green Accepted			2022-12-28	WOS:000311666200051
J	Halliday, AN				Halliday, Alex N.			The Origin of the Moon	SCIENCE			English	Editorial Material							FORMING GIANT IMPACT; ACCRETION; ISOTOPES; DIFFERENTIATION; EARTH		Univ Oxford, Dept Earth Sci, Oxford OX1 3AN, England	University of Oxford	Halliday, AN (corresponding author), Univ Oxford, Dept Earth Sci, S Parks Rd, Oxford OX1 3AN, England.	alexh@earth.ox.ac.uk			Science and Technology Facilities Council [ST/G00272X/1, PP/D001250/1, ST/F001940/1] Funding Source: researchfish; STFC [ST/G00272X/1, ST/F001940/1, PP/D001250/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Armytage RMG, 2012, GEOCHIM COSMOCHIM AC, V77, P504, DOI 10.1016/j.gca.2011.10.032; CAMERON AGW, 1991, ICARUS, V92, P204, DOI 10.1016/0019-1035(91)90046-V; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; Canup RM, 2012, SCIENCE, V338, P1052, DOI 10.1126/science.1226073; Chambers JE, 2004, EARTH PLANET SC LETT, V223, P241, DOI 10.1016/j.epsl.2004.04.031; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Dahl TW, 2010, EARTH PLANET SC LETT, V295, P177, DOI 10.1016/j.epsl.2010.03.038; Halliday AN, 2004, NATURE, V427, P505, DOI 10.1038/nature02275; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; Pahlevan K, 2011, EARTH PLANET SC LETT, V301, P433, DOI 10.1016/j.epsl.2010.10.036; Reufer A, 2012, ICARUS, V221, P296, DOI 10.1016/j.icarus.2012.07.021; Taylor GJ, 2009, ELEMENTS, V5, P17, DOI 10.2113/gselements.5.1.17; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037; Zhang JJ, 2012, NAT GEOSCI, V5, P251, DOI [10.1038/NGEO1429, 10.1038/ngeo1429]; [No title captured]	17	9	9	0	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1040	1041		10.1126/science.1229954	http://dx.doi.org/10.1126/science.1229954			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23180854				2022-12-28	WOS:000311390600033
J	Jia, ZW; Mao, YR; Zhang, FJ; Ruan, YH; Ma, Y; Li, J; Guo, W; Liu, EW; Dou, ZH; Zhao, Y; Wang, L; Li, QQ; Xie, PY; Tang, HL; Han, J; Jin, X; Xu, J; Xiong, R; Zhao, DC; Li, P; Wang, X; Wang, LY; Qing, QQ; Ding, ZW; Chen, RY; Liu, ZF; Shao, YM				Jia, Zhongwei; Mao, Yurong; Zhang, Fujie; Ruan, Yuhua; Ma, Ye; Li, Jian; Guo, Wei; Liu, Enwu; Dou, Zhihui; Zhao, Yan; Wang, Lu; Li, Qianqian; Xie, Peiyan; Tang, Houlin; Han, Jing; Jin, Xia; Xu, Juan; Xiong, Ran; Zhao, Decai; Li, Ping; Wang, Xia; Wang, Liyan; Qing, Qianqian; Ding, Zhengwei; Chen, Ray Y.; Liu, Zhongfu; Shao, Yiming			Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HETEROSEXUAL TRANSMISSION; SEXUAL TRANSMISSION; DISCORDANT COUPLES; DRUG-RESISTANCE; VIRAL LOAD; MORTALITY; PREVALENCE; INFECTION; FEMALE	Background On the basis of the results of the randomised clinical trial HPTN 052 and observational studies, WHO has recommended that antiretroviral therapy be off ered to all HIV-infected individuals with uninfected partners of the opposite sex (serodiscordant couples) to reduce the risk of transmission. Whether or not such a public health approach is feasible and the outcomes are sustainable at a large scale and in a developing country setting has not previously been assessed. Methods In this retrospective observational cohort study, we included treated and treatment-naive HIV-positive individuals with HIV-negative partners of the opposite sex who had been added to the national HIV epidemiology and treatment databases between Jan 1, 2003 and Dec 31, 2011. We analysed the annual rate of HIV infection in HIVnegative partners during follow-up, stratifi ed by treatment status of the index partner. Cox proportional hazards analyses were done to examine factors related to HIV transmission. Findings Based on data from 38 862 serodiscordant couples, with 101 295.1 person-years of follow-up for the seronegative partners, rates of HIV infection were 2.6 per 100 person-years (95% CI 2.4-2.8) among the 14 805 couples in the treatment-naive cohort (median baseline CD4 count for HIV-positive partners 441 cells per mu l [IQR 314-590]) and 1.3 per 100 person-years (1.2-1.3) among the 24 057 couples in the treated cohort (median baseline CD4 count for HIV-positive partners 168 cells per mu l [62-269]). We calculated a 26% relative reduction in HIV transmission (adjusted hazard ratio 0.74, 95% CI 0.65-0.84) in the treated cohort. The reduction in transmission was seen across almost all demographic subgroups and was signifi cant in the fi rst year (0.64, 0.54-0.76), and among couples in which the HIV-positive partner had been infected by blood or plasma transfusion (0.76, 0.59-0.99) or heterosexual intercourse (0.69, 0.56-0.84), but not among couples in which the HIV-positive partner was infected by injecting drugs (0.98, 0.71-1.36). Interpretation Antiretroviral therapy for HIV-positive individuals in serodiscordant couples reduced HIV transmission across China, which suggests that the treatment-as-prevention approach is a feasible public health prevention strategy on a national scale in a developing country context. The durability and generalisability of such protection, however, needs to be further studied.	[Jia, Zhongwei] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China; [Mao, Yurong; Zhang, Fujie; Ruan, Yuhua; Ma, Ye; Li, Jian; Guo, Wei; Liu, Enwu; Dou, Zhihui; Zhao, Yan; Wang, Lu; Xie, Peiyan; Tang, Houlin; Han, Jing; Jin, Xia; Xu, Juan; Xiong, Ran; Zhao, Decai; Li, Ping; Wang, Xia; Qing, Qianqian; Ding, Zhengwei; Liu, Zhongfu; Shao, Yiming] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing 102206, Peoples R China; [Ruan, Yuhua; Xie, Peiyan; Li, Ping; Wang, Xia; Shao, Yiming] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China; [Ruan, Yuhua; Wang, Xia; Shao, Yiming] Collaborat Innovat Ctr Infect Dis, Hangzhou, Zhejiang, Peoples R China; [Jia, Zhongwei] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Takemi Program Int Hlth, Boston, MA 02115 USA; [Li, Qianqian] China Ocean Univ, Coll Math Sci, Qingdao, Peoples R China; [Xie, Peiyan; Li, Ping] Guangxi Med Univ, Sch Publ Hlth, Nanning, Peoples R China; [Chen, Ray Y.] NIAID, NIH, Bethesda, MD 20892 USA	Peking University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Harvard University; Harvard T.H. Chan School of Public Health; Ocean University of China; Guangxi Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shao, YM (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.	zhongfuliu@163.com; yshao08@gmail.com	tang, houlin/HGA-1502-2022; Chen, Ray/GRJ-6736-2022; Wang, Xia/C-3298-2018; Chen, Ray/T-5102-2019; Liu, Enwu/AGC-4748-2022	Wang, Xia/0000-0002-1684-7076; Liu, Enwu/0000-0003-2580-3523; Chen, Ray/0000-0001-6344-1442	Chinese Government's 12th Five-Year Plan; National Natural Science Foundation of China,; Canadian International Development Research Centre	Chinese Government's 12th Five-Year Plan; National Natural Science Foundation of China,(National Natural Science Foundation of China (NSFC)); Canadian International Development Research Centre	Chinese Government's 12th Five-Year Plan, the National Natural Science Foundation of China, and the Canadian International Development Research Centre.	Anglemyer A, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009153, 10.1002/14651858.CD009153.pub2]; [Anonymous], HIV TRANSM RISK; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Coburn BJ, 2011, LANCET INFECT DIS, V11, P263, DOI 10.1016/S1473-3099(11)70080-9; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; DEVINCENZI I, 1992, BRIT MED J, V304, P809; Dou ZH, 2010, INT J EPIDEMIOL, V39, pII56, DOI 10.1093/ije/dyq215; Dou ZH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013737; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Leynaert B, 1998, AM J EPIDEMIOL, V148, P88, DOI 10.1093/oxfordjournals.aje.a009564; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Liu J, 2011, AIDS RES HUM RETROV, V27, P925, DOI [10.1089/aid.2010.0328, 10.1089/AID.2010.0328]; Ma Y, 2010, INT J EPIDEMIOL, V39, P973, DOI 10.1093/ije/dyp233; Ma Y, 2010, CLIN INFECT DIS, V50, P264, DOI 10.1086/649215; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Montaner JSG, 2010, JAIDS-J ACQ IMM DEF, V55, pS5, DOI 10.1097/QAI.0b013e3181f9c1f0; NICOLOSI A, 1994, EPIDEMIOLOGY, V5, P570, DOI 10.1097/00001648-199411000-00003; PADIAN NS, 1991, JAMA-J AM MED ASSOC, V266, P1664; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; State Council AIDS Working Committee Office & UN Theme Group on AIDS in China, 2011, JOINT ASS HIV AIDS P; Varghese B, 2002, SEX TRANSM DIS, V29, P38, DOI 10.1097/00007435-200201000-00007; Wang L, 2012, AIDS CARE, V24, P1059, DOI 10.1080/09540121.2012.661837; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; World Health Organization, 2012, GUID OR PREEXP PROPH; Zhang FJ, 2008, CLIN INFECT DIS, V47, P825, DOI 10.1086/590945; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006	31	100	120	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 5	2013	382	9899					1195	1203		10.1016/S0140-6736(12)61898-4	http://dx.doi.org/10.1016/S0140-6736(12)61898-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	228SL	23206835				2022-12-28	WOS:000325209100024
J	Al Ghazal, P; Korber, A; Klode, J; Dissemond, J				Al Ghazal, Philipp; Koerber, Andreas; Klode, Joachim; Dissemond, Joachim			Leser-Trelat sign and breast cancer	LANCET			English	Editorial Material									[Al Ghazal, Philipp; Koerber, Andreas; Klode, Joachim; Dissemond, Joachim] Univ Sch Med Essen Duisburg, Dept Dermatol Venereol & Allergol, D-45122 Essen, Germany	University of Duisburg Essen	Dissemond, J (corresponding author), Univ Sch Med Essen Duisburg, Dept Dermatol Venereol & Allergol, Hufelandstr 55, D-45122 Essen, Germany.	joachim.dissemond@uk-essen.de	Dissemond, Joachim/AFG-0691-2022						0	4	6	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 11	2013	381	9878					1653	1653		10.1016/S0140-6736(12)61257-4	http://dx.doi.org/10.1016/S0140-6736(12)61257-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146SX	23201213				2022-12-28	WOS:000319112400032
J	Powles, TJ				Powles, Trevor J.			Extended adjuvant tamoxifen for breast cancer-a new era?	LANCET			English	Editorial Material							RANDOMIZED-TRIAL; THERAPY; LETROZOLE		Canc Ctr London, London SW19 4NB, England		Powles, TJ (corresponding author), Canc Ctr London, London SW19 4NB, England.	trevorpowles@aol.com						Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Earl H, 1997, Clin Oncol (R Coll Radiol), V9, P141, DOI 10.1016/S0936-6555(97)80067-2; Fisher B, 1996, JNCI-J NATL CANCER I, V88, P1529, DOI 10.1093/jnci/88.21.1529; Goss PE, 2005, JNCI-J NATL CANCER I, V97, P1262, DOI 10.1093/jnci/dji250; Regan MM, 2011, LANCET ONCOL, V12, P1101, DOI 10.1016/S1470-2045(11)70270-4; Stewart HJ, 1996, BRIT J CANCER, V74, P297, DOI 10.1038/bjc.1996.356; Tormey DC, 1996, JNCI-J NATL CANCER I, V88, P1828, DOI 10.1093/jnci/88.24.1828	9	6	6	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2013	381	9869					782	783		10.1016/S0140-6736(12)62038-8	http://dx.doi.org/10.1016/S0140-6736(12)62038-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105IL	23219287				2022-12-28	WOS:000316060600006
J	Agnelli, G; Buller, HR; Cohen, A; Curto, M; Gallus, AS; Johnson, M; Porcari, A; Raskob, GE; Weitz, JI				Agnelli, Giancarlo; Buller, Harry R.; Cohen, Alexander; Curto, Madelyn; Gallus, Alexander S.; Johnson, Margot; Porcari, Anthony; Raskob, Gary E.; Weitz, Jeffrey I.		AMPLIFY-EXT Investigators	Apixaban for Extended Treatment of Venous Thromboembolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ARTERIAL CARDIOVASCULAR EVENTS; INTENSITY WARFARIN THERAPY; PULMONARY-EMBOLISM; LONG-TERM; PREVENTION	BACKGROUND Apixaban, an oral factor Xa inhibitor that can be administered in a simple, fixed-dose regimen, may be an option for the extended treatment of venous thromboembolism. METHODS In this randomized, double-blind study, we compared two doses of apixaban (2.5 mg and 5 mg, twice daily) with placebo in patients with venous thromboembolism who had completed 6 to 12 months of anticoagulation therapy and for whom there was clinical equipoise regarding the continuation or cessation of anticoagulation therapy. The study drugs were administered for 12 months. RESULTS A total of 2486 patients underwent randomization, of whom 2482 were included in the intention-to-treat analyses. Symptomatic recurrent venous thromboembolism or death from venous thromboembolism occurred in 73 of the 829 patients (8.8%) who were receiving placebo, as compared with 14 of the 840 patients (1.7%) who were receiving 2.5 mg of apixaban (a difference of 7.2 percentage points; 95% confidence interval [CI], 5.0 to 9.3) and 14 of the 813 patients (1.7%) who were receiving 5 mg of apixaban (a difference of 7.0 percentage points; 95% CI, 4.9 to 9.1) (P<0.001 for both comparisons). The rates of major bleeding were 0.5% in the placebo group, 0.2% in the 2.5-mg apixaban group, and 0.1% in the 5-mg apixaban group. The rates of clinically relevant nonmajor bleeding were 2.3% in the placebo group, 3.0% in the 2.5-mg apixaban group, and 4.2% in the 5-mg apixaban group. The rate of death from any cause was 1.7% in the placebo group, as compared with 0.8% in the 2.5-mg apixaban group and 0.5% in the 5-mg apixaban group. CONCLUSIONS Extended anticoagulation with apixaban at either a treatment dose (5 mg) or a thromboprophylactic dose (2.5 mg) reduced the risk of recurrent venous thromboembolism without increasing the rate of major bleeding. (Funded by Bristol-Myers Squibb and Pfizer; AMPLIFY-EXT ClinicalTrials.gov number, NCT00633893.)	[Agnelli, Giancarlo] Univ Perugia, Dept Internal & Cardiovasc Med, Stroke Unit, I-06100 Perugia, Italy; [Buller, Harry R.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Cohen, Alexander] Kings Coll Hosp London, London, England; [Curto, Madelyn; Johnson, Margot; Porcari, Anthony] Pfizer Inc, Groton, CT 06340 USA; [Gallus, Alexander S.] Flinders Med Ctr, Adelaide, SA, Australia; [Gallus, Alexander S.] Flinders Univ S Australia, Dept Haematol, Adelaide, SA 5001, Australia; [Raskob, Gary E.] Univ Oklahoma, Coll Publ Hlth, Hlth Sci Ctr, Oklahoma City, OK USA; [Weitz, Jeffrey I.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Weitz, Jeffrey I.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Weitz, Jeffrey I.] Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada	University of Perugia; University of Amsterdam; Academic Medical Center Amsterdam; King's College Hospital NHS Foundation Trust; King's College Hospital; Pfizer; Flinders Medical Centre; Flinders University South Australia; University of Oklahoma System; University of Oklahoma Health Sciences Center; McMaster University; McMaster University; McMaster University	Agnelli, G (corresponding author), Univ Perugia, Piazzale Menghini 1, I-06100 Perugia, Italy.	agnellig@unipg.it	Weitz, Jeffrey/AAD-1929-2019; Beyer-Westendorf, Jan/K-7569-2019; Holaj, Robert/D-4241-2017; Lodigiani, Corrado/AAW-1964-2020; Khalafallah, Alhossain/H-9762-2019; Nishinari, Kenji/J-1655-2014; Fijalkowska, Anna/V-3994-2018; Szopiński, Piotr/X-6579-2018; Kvasnicka, Tomas/K-7262-2017; Paramo, Jose A/D-6552-2017	Weitz, Jeffrey/0000-0002-1092-7550; Beyer-Westendorf, Jan/0000-0002-6983-9993; Holaj, Robert/0000-0002-9488-9706; Lodigiani, Corrado/0000-0002-9152-9385; Khalafallah, Alhossain/0000-0002-2399-3311; Nishinari, Kenji/0000-0002-8952-7874; Fijalkowska, Anna/0000-0002-2225-9684; Szopiński, Piotr/0000-0001-6001-0823; Kvasnicka, Tomas/0000-0001-9546-3750; Harenberg, Job/0000-0003-4590-4225; Gallus, Alexander/0000-0001-7347-9989; chetter, ian/0000-0002-2566-6859; Lanas, Fernando/0000-0003-3595-9759; Albino, Jose/0000-0002-2112-3689; Ritchie, Bruce/0000-0003-4754-1050; Marschang, Peter/0000-0002-8239-3447; Paramo, Jose A/0000-0003-1497-6242	Bristol-Myers Squibb; Pfizer; Bayer; Boehringer Ingelheim; Daiichi Sankyo; Bayer Healthcare; Sanofi-Aventis; Johnson Johnson; Pfizer, Portola; Portola; Janssen; Takeda; Quintiles	Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Daiichi Sankyo(Daiichi Sankyo Company Limited); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Sanofi-Aventis(Sanofi-Aventis); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Pfizer, Portola; Portola; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Takeda(Takeda Pharmaceutical Company Ltd); Quintiles	Dr. Agnelli reports receiving consulting fees from Bayer, Boehringer Ingelheim, and Daiichi Sankyo and lecture fees from Bayer Healthcare, Bristol-Myers Squibb, and Sanofi-Aventis; Dr. Buller, receiving payment for board membership and for manuscript preparation and consulting fees through his institution from Bayer and Daiichi Sankyo; Dr. Cohen, receiving payment for board membership from Bayer, Bristol-Myers Squibb, Daiichi Sankyo, Johnson & Johnson, Pfizer, Portola, and Sanofi-Aventis and consulting fees, lecture fees, travel support, and payment for the development of educational presentations from Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, GlaxoSmithKline, Johnson & Johnson, Mitsubishi Pharma, Pfizer, Portola, Sanofi-Aventis, Schering-Plough, and Takeda; Drs. Curto, Johnson, and Porcari, being employed by and having an equity interest in Pfizer; Dr. Gallus, receiving consulting fees from Bristol-Myers Squibb, Bayer, Daiichi Sankyo, Boehringer Ingelheim, and Pfizer; Dr. Raskob, receiving consulting fees, directly and through his institution, from Daiichi Sankyo, Bayer, Johnson & Johnson, Janssen, Takeda, Quintiles, and Sanofi-Aventis, receiving lecture fees, directly and through his institution, from Pfizer, Bayer, and Janssen, and receiving payment for manuscript preparation, directly and through his institution, from Bristol-Meyers Squibb, Daiichi Sankyo, Sanofi-Aventis, and Bayer; and Dr. Weitz, receiving consulting fees from Boehringer Ingelheim, Bayer, Bristol-Myers Squibb, Merck, Daiichi Sankyo, Janssen, and Pfizer. No other potential conflict of interest relevant to this article was reported.	Anand SS, 2003, J AM COLL CARDIOL, V41, p62S, DOI 10.1016/S0735-1097(02)02776-6; [Anonymous], 1999, CPMPEWP56398 EUR AG; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Becattini C, 2010, J THROMB HAEMOST, V8, P891, DOI 10.1111/j.1538-7836.2010.03777.x; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; Buller HR, 2007, NEW ENGL J MED, V357, P1105; Buller HR, 2007, NEW ENGL J MED, V357, P1094; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Goldhaber SZ, 2012, LANCET, V379, P1835, DOI 10.1016/S0140-6736(11)61904-1; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kearon Clive, 2012, Chest, V141, pe419S, DOI 10.1378/chest.11-2301; Middeldorp Saskia, 2011, BMJ, V342, pd2758, DOI 10.1136/bmj.d2758; Raskob GE, 2012, J BONE JOINT SURG BR, V94B, P257, DOI 10.1302/0301-620X.94B2.27850; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Schulman S, 2011, J THROMB HAEMOST, V9, P22; Schulman S, 2003, NEW ENGL J MED, V349, P1713, DOI 10.1056/NEJMoa030104; Sorensen HT, 2007, LANCET, V370, P1773, DOI 10.1016/S0140-6736(07)61745-0; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310	20	858	912	3	100	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 21	2013	368	8					699	708		10.1056/NEJMoa1207541	http://dx.doi.org/10.1056/NEJMoa1207541			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	092CG	23216615	Green Submitted, Green Published			2022-12-28	WOS:000315095800004
J	Graves, JA				Graves, John A.			Medicaid Expansion Opt-Outs and Uncompensated Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Vanderbilt Univ, Sch Med, Dept Prevent Med, Inst Med & Publ Hlth, Nashville, TN 37212 USA	Vanderbilt University	Graves, JA (corresponding author), Vanderbilt Univ, Sch Med, Dept Prevent Med, Inst Med & Publ Hlth, Nashville, TN 37212 USA.							Kaiser Commission on Medicaid and the Uninsured, AR STAT TOD MED CHIP; Medicare Payment Advisory Committee, 2012, JUN 2012 DATA BOOK H; The Advisory Board Company, 2012, WHICH STATES WOULD S	3	25	25	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2012	367	25					2365	2367		10.1056/NEJMp1209450	http://dx.doi.org/10.1056/NEJMp1209450			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056ZP	23252522				2022-12-28	WOS:000312531600001
J	Litvinov, IV; Jafarian, F				Litvinov, Ivan V.; Jafarian, Fatemeh			Lichen Striatus and Lines of Blaschko	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Litvinov, Ivan V.; Jafarian, Fatemeh] McGill Univ, Montreal, PQ, Canada	McGill University	Litvinov, IV (corresponding author), McGill Univ, Montreal, PQ, Canada.	fatemeh.jafarian@mcgill.ca		Litvinov, Ivan/0000-0003-0562-4675					0	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2012	367	25					2427	2427		10.1056/NEJMicm1200973	http://dx.doi.org/10.1056/NEJMicm1200973			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056ZP	23252528				2022-12-28	WOS:000312531600010
J	Zhang, C; Srinivasan, Y; Arlow, DH; Fung, JJ; Palmer, D; Zheng, YW; Green, HF; Pandey, A; Dror, RO; Shaw, DE; Weis, WI; Coughlin, SR; Kobilka, BK				Zhang, Cheng; Srinivasan, Yoga; Arlow, Daniel H.; Fung, Juan Jose; Palmer, Daniel; Zheng, Yaowu; Green, Hillary F.; Pandey, Anjali; Dror, Ron O.; Shaw, David E.; Weis, William I.; Coughlin, Shaun R.; Kobilka, Brian K.			High-resolution crystal structure of human protease-activated receptor 1	NATURE			English	Article							THROMBIN-RECEPTOR; AGONIST RECOGNITION; FORCE-FIELD; MEMBRANE-PROTEINS; OPIOID RECEPTOR; MECHANISM; BINDING; SODIUM; SPECIFICITY; TRAFFICKING	Protease-activated receptor 1 (PAR1) is the prototypical member of a family of G-protein-coupled receptors that mediate cellular responses to thrombin and related proteases. Thrombin irreversibly activates PAR1 by cleaving the amino-terminal exodomain of the receptor, which exposes a tethered peptide ligand that binds the heptahelical bundle of the receptor to affect G-protein activation. Here we report the 2.2 angstrom resolution crystal structure of human PAR1 bound to vorapaxar, a PAR1 antagonist. The structure reveals an unusual mode of drug binding that explains how a small molecule binds virtually irreversibly to inhibit receptor activation by the tethered ligand of PAR1. In contrast to deep, solvent-exposed binding pockets observed in other peptide-activated G-protein-coupled receptors, the vorapaxar-binding pocket is superficial but has little surface exposed to the aqueous solvent. Protease-activated receptors are important targets for drug development. The structure reported here will aid the development of improved PAR1 antagonists and the discovery of antagonists to other members of this receptor family.	[Srinivasan, Yoga; Palmer, Daniel; Zheng, Yaowu; Coughlin, Shaun R.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Zhang, Cheng; Fung, Juan Jose; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Arlow, Daniel H.; Green, Hillary F.; Dror, Ron O.; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Pandey, Anjali] Portola Pharmaceut, San Francisco, CA 94080 USA; [Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University; D. E. Shaw Research; Stanford University	Coughlin, SR (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, 555 Mission Bay Blvd S,S452P, San Francisco, CA 94158 USA.	shaun.coughlin@ucsf.edu; kobilka@stanford.edu	Weis, William I/G-1437-2011; Zhang, Cheng/O-4372-2015; Palmer, Daniel/J-2967-2014; Palmer, Daniel/Q-7595-2016	Weis, William I/0000-0002-5583-6150; Zhang, Cheng/0000-0001-9042-4007; Palmer, Daniel/0000-0002-7954-9332; Palmer, Daniel/0000-0002-7954-9332; Dror, Ron/0000-0002-6418-2793; Kobilka, Brian/0000-0001-5958-3990	National Institutes of Health [NS028471, HL44907, HL65590]; Mathers Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065590, R01HL065185, R01HL044907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge support from the National Institutes of Health, grants NS028471 (B. K. K.), and HL44907 and HL65590 (S. R. C.), and from the Mathers Foundation (B.K.K. and W.I.W.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAHOU WF, 1994, BLOOD, V84, P4195, DOI 10.1182/blood.V84.12.4195.bloodjournal84124195; Blackhart BD, 2000, MOL PHARMACOL, V58, P1178, DOI 10.1124/mol.58.6.1178; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Caffrey M, 2009, ANNU REV BIOPHYS, V38, P29, DOI 10.1146/annurev.biophys.050708.133655; Chackalamannil S, 2005, J MED CHEM, V48, P5884, DOI 10.1021/jm0502236; CHEN J, 1994, J BIOL CHEM, V269, P16041; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cornelissen I, 2010, P NATL ACAD SCI USA, V107, P18605, DOI 10.1073/pnas.1013309107; COSTA T, 1990, MOL PHARMACOL, V37, P383; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P669, DOI 10.1016/S0006-2952(00)00360-9; Garcia-Lopez MT, 2010, CURR MED CHEM, V17, P109, DOI 10.2174/092986710790112639; GERSZTEN RE, 1994, NATURE, V368, P648, DOI 10.1038/368648a0; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; HEIN L, 1994, J BIOL CHEM, V269, P27719; HORSTMAN DA, 1990, J BIOL CHEM, V265, P21590; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ISHII K, 1995, J BIOL CHEM, V270, P16435, DOI 10.1074/jbc.270.27.16435; ISHII K, 1993, J BIOL CHEM, V268, P9780; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kosoglou T, 2012, EUR J CLIN PHARMACOL, V68, P249, DOI 10.1007/s00228-011-1120-6; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Lerner DJ, 1996, J BIOL CHEM, V271, P13943, DOI 10.1074/jbc.271.24.13943; LIU LW, 1991, J BIOL CHEM, V266, P16977; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; MATHEWS II, 1994, BIOCHEMISTRY-US, V33, P3266, DOI 10.1021/bi00177a018; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; NANEVICZ T, 1995, J BIOL CHEM, V270, P21619, DOI 10.1074/jbc.270.37.21619; Nanevicz T, 1996, J BIOL CHEM, V271, P702, DOI 10.1074/jbc.271.2.702; Neve KA, 2001, MOL PHARMACOL, V60, P373, DOI 10.1124/mol.60.2.373; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Selent J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000884; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; Shapiro MJ, 1998, J BIOL CHEM, V273, P29009, DOI 10.1074/jbc.273.44.29009; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Shaw D.E., 2009, P C HIGH PERF COMP N, P1, DOI DOI 10.1145/1654059.1654126; Smit MJ, 2007, ANNU REV PHARMACOL, V47, P53, DOI 10.1146/annurev.pharmtox.47.120505.105126; Soto AG, 2010, J BIOL CHEM, V285, P18781, DOI 10.1074/jbc.M110.111088; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Wilson MH, 2001, MOL PHARMACOL, V59, P929, DOI 10.1124/mol.59.4.929; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939	70	336	350	3	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					387	+		10.1038/nature11701	http://dx.doi.org/10.1038/nature11701			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23222541	Green Accepted, Green Submitted			2022-12-28	WOS:000312488200047
J	Jones, MM				Jones, Melvyn M.			Apixaban reduced stroke or systemic embolism more than warfarin in AF regardless of renal function	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ATRIAL-FIBRILLATION		UCL, Sch Med, London W1N 8AA, England	University of London; University College London; UCL Medical School	Jones, MM (corresponding author), UCL, Sch Med, Mortimer St, London W1N 8AA, England.		Jones, Melvyn/C-2300-2008	Jones, Melvyn/0000-0002-8766-7443				Marinigh R, 2011, J AM COLL CARDIOL, V57, P1339, DOI 10.1016/j.jacc.2010.12.013; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Steffel J, 2012, EUR HEART J, V33, P2766, DOI 10.1093/eurheartj/ehs267	3	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2012	157	12							JC6-7	10.7326/0003-4819-157-12-201212180-02007	http://dx.doi.org/10.7326/0003-4819-157-12-201212180-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057SB	23247956				2022-12-28	WOS:000312583200006
J	Kaboli, PJ; Go, JT; Hockenberry, J; Glasgow, JM; Johnson, SR; Rosenthal, GE; Jones, MP; Vaughan-Sarrazin, M				Kaboli, Peter J.; Go, Jorge T.; Hockenberry, Jason; Glasgow, Justin M.; Johnson, Skyler R.; Rosenthal, Gary E.; Jones, Michael P.; Vaughan-Sarrazin, Mary			Associations Between Reduced Hospital Length of Stay and 30-Day Readmission Rate and Mortality: 14-Year Experience in 129 Veterans Affairs Hospitals	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; HEALTH-CARE-SYSTEM; TRIAL; PROGRAM; TRENDS; RISK; VA	Background: Reducing length of stay (LOS) has been a priority for hospitals and health care systems. However, there is concern that this reduction may result in increased hospital readmissions. Objective: To determine trends in hospital LOS and 30-day readmission rates for all medical diagnoses combined and 5 specific common diagnoses in the Veterans Health Administration. Design: Observational study from 1997 to 2010. Setting: All 129 acute care Veterans Affairs hospitals in the United States. Patients: 4 124 907 medical admissions with subsamples of 2 chronic diagnoses (heart failure and chronic obstructive pulmonary disease) and 3 acute diagnoses (acute myocardial infarction, community-acquired pneumonia, and gastrointestinal hemorrhage). Measurements: Unadjusted LOS and 30-day readmission rates with multivariable regression analyses to adjust for patient demographic characteristics, comorbid conditions, and admitting hospitals. Results: For all medical diagnoses combined, risk-adjusted mean hospital LOS decreased by 1.46 days from 5.44 to 3.98 days, or 2% annually (P < 0.001). Reductions in LOS were also observed for the 5 specific common diagnoses, with greatest reductions for acute myocardial infarction (2.85 days) and community-acquired pneumonia (2.22 days). Over the 14 years, risk-adjusted 30-day readmission rates for all medical diagnoses combined decreased from 16.5% to 13.8% (P < 0.001). Reductions in readmissions were also observed for the 5 specific common diagnoses, with greatest reductions for acute myocardial infarction (22.6% to 19.8%) and chronic obstructive pulmonary disease (17.9% to 14.6%). All-cause mortality 90 days after admission was reduced by 3% annually. Of note, hospitals with mean risk-adjusted LOS that was lower than expected had a higher readmission rate, suggesting a modest tradeoff between hospital LOS and readmission (6% increase for each day lower than expected). Limitations: This study is limited to the Veterans Health Administration system; non-Veterans Affairs admissions were not available. No measure of readmission preventability was used. Conclusion: Veterans Affairs hospitals demonstrated simultaneous improvements in hospital LOS and readmissions over 14 years, suggesting that as LOS improved, hospital readmission did not increase. This is important because hospital readmission is being used as a quality indicator and may result in payment incentives. Future work should explore these relationships to see whether a tipping point exists for LOS reduction and hospital readmission.	[Kaboli, Peter J.] Univ Iowa, Vet Rural Hlth Resource Ctr Cent Reg,Carver Coll, Comprehens Access & Delivery Res & Evaluat Ctr, Iowa City Vet Affairs Med Ctr,Iowa City Veterans, Iowa City, IA 52246 USA; Univ Iowa, Coll Publ Hlth, Iowa City, IA 52246 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Kaboli, PJ (corresponding author), Univ Iowa, Vet Rural Hlth Resource Ctr Cent Reg,Carver Coll, Comprehens Access & Delivery Res & Evaluat Ctr, Iowa City Vet Affairs Med Ctr,Iowa City Veterans, Mailstop 152,601 Highway 6 W, Iowa City, IA 52246 USA.	peter.kaboli@va.gov	Glasgow, Justin/AAG-2728-2020	Glasgow, Justin/0000-0003-1449-2643; Kaboli, Peter/0000-0003-0993-0952; Vaughan Sarrazin, Mary/0000-0001-8717-1061	Office of Rural Health and the Health Services Research & Development Service, Veterans Health Administration, U.S. Department of Veterans Affairs, Veterans Rural Health Resource Center-Central Region; Center for Comprehensive Access & Delivery Research and Evaluation at the Iowa City Veterans Affairs Healthcare System [HFP 04-149]; Veterans Affairs Quality Scholars Fellowship Program, Veterans Affairs Office of Academic Affiliations; Office of Rural Health and the Health Services Research & Development Service, Veterans Health Administration, U.S. Department of Veterans Affairs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	Office of Rural Health and the Health Services Research & Development Service, Veterans Health Administration, U.S. Department of Veterans Affairs, Veterans Rural Health Resource Center-Central Region; Center for Comprehensive Access & Delivery Research and Evaluation at the Iowa City Veterans Affairs Healthcare System; Veterans Affairs Quality Scholars Fellowship Program, Veterans Affairs Office of Academic Affiliations; Office of Rural Health and the Health Services Research & Development Service, Veterans Health Administration, U.S. Department of Veterans Affairs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Grant Support: By the Office of Rural Health and the Health Services Research & Development Service, Veterans Health Administration, U.S. Department of Veterans Affairs, Veterans Rural Health Resource Center-Central Region, and the Center for Comprehensive Access & Delivery Research and Evaluation at the Iowa City Veterans Affairs Healthcare System (HFP 04-149). Dr. Go was supported by the Veterans Affairs Quality Scholars Fellowship Program, Veterans Affairs Office of Academic Affiliations.; Office of Rural Health and the Health Services Research & Development Service, Veterans Health Administration, U.S. Department of Veterans Affairs.	[Anonymous], 2008, FED REG; Baker DW, 2004, ARCH INTERN MED, V164, P538, DOI 10.1001/archinte.164.5.538; Bernheim SM, 2010, CIRC-CARDIOVASC QUAL, V3, P459, DOI 10.1161/CIRCOUTCOMES.110.957613; Centers for Medicare & Medicaid Services, 2009, MED AC CAR EP DEM OR; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; DAVIES M, 2007, CHALLENGES INPATIENT, P1; Desai MM, 2009, CIRC-CARDIOVASC QUAL, V2, P500, DOI 10.1161/CIRCOUTCOMES.108.832949; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; FRANKL SE, 1991, AM J MED, V90, P667; Glasgow JM, 2010, J GEN INTERN MED, V25, P926, DOI 10.1007/s11606-010-1371-4; Goldfield NI, 2008, HEALTH CARE FINANC R, V30, P75; Hasan O, 2010, J GEN INTERN MED, V25, P211, DOI 10.1007/s11606-009-1196-1; Healthcare Cost and Utilization Project Clinical Classifications Software, 2010, CLIN CLASS SOFTW CCS; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Jha AK, 2009, NEW ENGL J MED, V361, P2637, DOI 10.1056/NEJMsa0904859; Kaboli PJ, 2006, J GEN INTERN MED, V21, P62; Luft H.S., 2008, TOTAL CURE ANTIDOTE; National Quality Forum, NAT PRIOR PARTN READ; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Rosenthal GE, 2003, MED CARE, V41, P882, DOI 10.1097/00005650-200308000-00003; Ross JS, 2010, CIRC-HEART FAIL, V3, P97, DOI 10.1161/CIRCHEARTFAILURE.109.885210; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; Society of Hospital Medicine, 2008, BOOSTING CAR T; The Joint Commission, NAT PAT SAF GOALS; U.S. General Accounting Office, 1985, BETT PAT MAN PRACT C; van Walraven C, 2011, J EVAL CLIN PRACT; van Walraven C, 2011, CAN MED ASSOC J, V183, pE391, DOI 10.1503/cmaj.101860; Wachter RM, 2002, JAMA-J AM MED ASSOC, V287, P487, DOI 10.1001/jama.287.4.487; Weeks WB, 2009, J RURAL HEALTH, V25, P62, DOI 10.1111/j.1748-0361.2009.00200.x; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206; Worzala C, 2003, HEALTH AFFAIR, V22, P175, DOI 10.1377/hlthaff.22.6.175	33	232	233	0	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2012	157	12					837	U161		10.7326/0003-4819-157-12-201212180-00003	http://dx.doi.org/10.7326/0003-4819-157-12-201212180-00003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057SB	23247937				2022-12-28	WOS:000312583200013
J	Hugi, A; Villares, G; Blaser, S; Liu, HC; Faist, J				Hugi, Andreas; Villares, Gustavo; Blaser, Stephane; Liu, H. C.; Faist, Jerome			Mid-infrared frequency comb based on a quantum cascade laser	NATURE			English	Article							SEMICONDUCTOR-LASERS; PULSE GENERATION; MU-M; MICRORESONATOR; OSCILLATOR	Optical frequency combs(1) act as rulers in the frequency domain and have opened new avenues in many fields such as fundamental time metrology, spectroscopy and frequency synthesis. In particular, spectroscopy by means of optical frequency combs has surpassed the precision and speed of Fourier spectrometers. Such a spectroscopy technique is especially relevant for the mid-infrared range, where the fundamental rotational-vibrational bands of most light molecules are found(2). Most mid-infrared comb sources are based on down-conversion of near-infrared, mode-locked, ultrafast lasers using nonlinear crystals(3). Their use in frequency comb spectroscopy applications has resulted in an unequalled combination of spectral coverage, resolution and sensitivity(4-7). Another means of comb generation is pumping an ultrahigh-quality factor microresonator with a continuous-wave laser(8-10). However, these combs depend on a chain of optical components, which limits their use. Therefore, to widen the spectroscopic applications of such mid-infrared combs, a more direct and compact generation scheme, using electrical injection, is preferable. Here we present a compact, broadband, semiconductor frequency comb generator that operates in the mid-infrared. We demonstrate that the modes of a continuous-wave, free-running, broadband quantum cascade laser(11) are phase-locked. Combining mode proliferation based on four-wave mixing with gain provided by the quantum cascade laser leads to a phase relation similar to that of a frequency-modulated laser. The comb centre carrier wavelength is 7 micrometres. We identify a narrow drive current range with intermode beat linewidths narrower than 10 hertz. We find comb bandwidths of 4.4 per cent with an intermode stability of less than or equal to 200 hertz. The intermode beat can be varied over a frequency range of 65 kilohertz by radio-frequency injection. The large gain bandwidth and independent control over the carrier frequency offset and the mode spacing open the way to broadband, compact, all-solid-state mid-infrared spectrometers.	[Hugi, Andreas; Villares, Gustavo; Faist, Jerome] ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland; [Blaser, Stephane] Alpes Lasers SA, CH-2001 Neuchatel, Switzerland; [Liu, H. C.] Shanghai Jiao Tong Univ, Dept Phys, Key Lab Artificial Struct & Quantum Control, Shanghai 200240, Peoples R China	Swiss Federal Institutes of Technology Domain; ETH Zurich; Shanghai Jiao Tong University	Faist, J (corresponding author), ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	h.c.liu@sjtu.edu.cn; jfaist@ethz.ch	Faist, Jerome/A-7339-2013	Faist, Jerome/0000-0003-4429-7988	Quantum Photonics National Center of Competence in Research of the Swiss National Science Foundation; National Major Basic Research Projects [2011CB925603]; Shanghai Municipal Major Basic Research Project [09DJ1400102]	Quantum Photonics National Center of Competence in Research of the Swiss National Science Foundation; National Major Basic Research Projects; Shanghai Municipal Major Basic Research Project	We thank M. Quack and E. Miloglyadov for their help with the high-resolution Fourier transform infrared spectrometer measurements, U. Keller and V. Wittwer for providing scientific equipment, and J. Khurgin for discussions. This work was financially supported by the Quantum Photonics National Center of Competence in Research of the Swiss National Science Foundation. H.C.L. acknowledges support from the National Major Basic Research Projects (2011CB925603) and the Shanghai Municipal Major Basic Research Project (09DJ1400102).	Adler F, 2010, ANNU REV ANAL CHEM, V3, P175, DOI 10.1146/annurev-anchem-060908-155248; Adler F, 2009, OPT LETT, V34, P1330, DOI 10.1364/OL.34.001330; Aellen T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2345035; Banerjee S, 2003, SEMICOND SCI TECH, V18, P655, DOI 10.1088/0268-1242/18/7/309; Barbieri S, 2011, NAT PHOTONICS, V5, P306, DOI [10.1038/nphoton.2011.49, 10.1038/NPHOTON.2011.49]; Braje D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.193902; Del'Haye P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.053903; Del'Haye P, 2007, NATURE, V450, P1214, DOI 10.1038/nature06401; DERICKSON DJ, 1992, IEEE J QUANTUM ELECT, V28, P2186, DOI 10.1109/3.159527; Faist J, 1997, NATURE, V387, P777, DOI 10.1038/42872; FAIST J, 1994, SCIENCE, V264, P553, DOI 10.1126/science.264.5158.553; Ferdous F, 2011, NAT PHOTONICS, V5, P770, DOI 10.1038/nphoton.2011.255; Foltynowicz A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.233002; Gordon A, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.053804; Grant PD, 2006, IEEE PHOTONIC TECH L, V18, P2218, DOI 10.1109/LPT.2006.884267; Herr T, 2012, NAT PHOTONICS, V6, P480, DOI [10.1038/nphoton.2012.127, 10.1038/NPHOTON.2012.127]; Johnson TA, 2012, APPL PHYS B-LASERS O, V107, P31, DOI 10.1007/s00340-011-4748-0; Keilmann F, 2004, OPT LETT, V29, P1542, DOI 10.1364/OL.29.001542; Kippenberg TJ, 2011, SCIENCE, V332, P555, DOI 10.1126/science.1193968; Parz W, 2009, OPT LETT, V34, P208, DOI 10.1364/OL.34.000208; Rosencher E, 1996, SCIENCE, V271, P168, DOI 10.1126/science.271.5246.168; Soibel A, 2004, IEEE J QUANTUM ELECT, V40, P844, DOI 10.1109/JQE.2004.830186; Telle HR, 1999, APPL PHYS B-LASERS O, V69, P327, DOI 10.1007/s003400050813; Terazzi R, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/033045; Udem T, 2002, NATURE, V416, P233, DOI 10.1038/416233a; Vodopyanov KL, 2011, OPT LETT, V36, P2275, DOI 10.1364/OL.36.002275; WALROD D, 1991, APPL PHYS LETT, V59, P2932, DOI 10.1063/1.105827; Wang C. Y., 2011, MIDINFRARED OPTICAL; Wang CY, 2009, OPT EXPRESS, V17, P12929, DOI 10.1364/OE.17.012929; YAMADA M, 1989, J APPL PHYS, V66, P81, DOI 10.1063/1.343860	30	493	498	22	370	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2012	492	7428					229	233		10.1038/nature11620	http://dx.doi.org/10.1038/nature11620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23235876				2022-12-28	WOS:000312259300037
J	Liu, SM; Kandoth, PK; Warren, SD; Yeckel, G; Heinz, R; Alden, J; Yang, CL; Jamai, A; El-Mellouki, T; Juvale, PS; Hill, J; Baum, TJ; Cianzio, S; Whitham, SA; Korkin, D; Mitchum, MG; Meksem, K				Liu, Shiming; Kandoth, Pramod K.; Warren, Samantha D.; Yeckel, Greg; Heinz, Robert; Alden, John; Yang, Chunling; Jamai, Aziz; El-Mellouki, Tarik; Juvale, Parijat S.; Hill, John; Baum, Thomas J.; Cianzio, Silvia; Whitham, Steven A.; Korkin, Dmitry; Mitchum, Melissa G.; Meksem, Khalid			A soybean cyst nematode resistance gene points to a new mechanism of plant resistance to pathogens	NATURE			English	Article							SERINE HYDROXYMETHYLTRANSFERASE; HETERODERA-GLYCINES; RHG1 LOCUS; EXPRESSION; POLYMORPHISMS; REGISTRATION; RESPONSES; DENSITY; STRESS; VECTOR	Soybean (Glycine max (L.) Merr.) is an important crop that provides a sustainable source of protein and oil worldwide. Soybean cyst nematode (Heterodera glycines Ichinohe) is a microscopic roundworm that feeds on the roots of soybean and is a major constraint to soybean production. This nematode causes more than US$1 billion in yield losses annually in the United States alone(1), making it the most economically important pathogen on soybean. Although planting of resistant cultivars forms the core management strategy for this pathogen, nothing is known about the nature of resistance. Moreover, the increase in virulent populations of this parasite on most known resistance sources necessitates the development of novel approaches for control. Here we report the map-based cloning of a gene at the Rhg4 (for resistance to Heterodera glycines 4) locus, a major quantitative trait locus contributing to resistance to this pathogen. Mutation analysis, gene silencing and transgenic complementation confirm that the gene confers resistance. The gene encodes a serine hydroxymethyltransferase, an enzyme that is ubiquitous in nature and structurally conserved across kingdoms. The enzyme is responsible for interconversion of serine and glycine and is essential for cellular one-carbon metabolism. Alleles of Rhg4 conferring resistance or susceptibility differ by two genetic polymorphisms that alter a key regulatory property of the enzyme. Our discovery reveals an unprecedented plant resistance mechanism against a pathogen. The mechanistic knowledge of the resistance gene can be readily exploited to improve nematode resistance of soybean, an increasingly important global crop.	[Liu, Shiming; Jamai, Aziz; El-Mellouki, Tarik; Meksem, Khalid] So Illinois Univ, Dept Plant Soil & Agr Syst, Carbondale, IL 62901 USA; [Kandoth, Pramod K.; Yeckel, Greg; Heinz, Robert; Alden, John; Mitchum, Melissa G.] Univ Missouri, Christopher S Bond Life Sci Ctr, Div Plant Sci, Columbia, MO 65211 USA; [Kandoth, Pramod K.; Yeckel, Greg; Heinz, Robert; Alden, John; Mitchum, Melissa G.] Univ Missouri, Interdisciplinary Plant Grp, Columbia, MO 65211 USA; [Warren, Samantha D.; Korkin, Dmitry] Univ Missouri, Christopher S Bond Life Sci Ctr, Dept Comp Sci, Columbia, MO 65211 USA; [Warren, Samantha D.; Korkin, Dmitry] Univ Missouri, Inst Informat, Columbia, MO 65211 USA; [Yang, Chunling; Juvale, Parijat S.; Hill, John; Baum, Thomas J.; Whitham, Steven A.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA 50011 USA; [Cianzio, Silvia] Iowa State Univ, Dept Agron, Ames, IA 50011 USA	Southern Illinois University System; Southern Illinois University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Iowa State University; Iowa State University	Meksem, K (corresponding author), So Illinois Univ, Dept Plant Soil & Agr Syst, Carbondale, IL 62901 USA.	goellnerm@missouri.edu; meksemk@siu.edu	Meksem, Khalid/AAD-3101-2022; Liu, Shiming/AAG-9495-2020	Meksem, Khalid/0000-0002-9469-9718; /0000-0002-4613-8422	Illinois-Missouri Biotechnology Alliance [2005-3]; United Soybean Board [0253, 3253, 2268, 1251]; USDA-NIFA [2006-35300-17195]; National Science Foundation Plant Genome Research Program [0820642]; Illinois Soybean Association; North Central Soybean Research Program; Iowa Soybean Association; Department of Education Graduate Assistance in Areas of National Need (GAANN) Fellowship; Div Of Biological Infrastructure [0845196] Funding Source: National Science Foundation	Illinois-Missouri Biotechnology Alliance; United Soybean Board; USDA-NIFA(United States Department of Agriculture (USDA)); National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Illinois Soybean Association; North Central Soybean Research Program; Iowa Soybean Association; Department of Education Graduate Assistance in Areas of National Need (GAANN) Fellowship; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank X. Yang for technical assistance with soybean hairy root propagation and M. Kroll for proofreading the manuscript. We thank R. Hussey, W. Gassmann, P. Gresshoff, A. Bendahmane, D. Xu and B. McClure for critical reading of the manuscript. We thank K. Sharma and S. Puthur for use of the HPLC facility and technical help. This work was supported by the Illinois-Missouri Biotechnology Alliance (project 2005-3 to M.G.M. and K.M.), United Soybean Board (project 0253 to K.M., S.C. and M.G.M.; project 3253 to K.M. and S.C.; project 2268 to K.M. and M.G.M; project 1251 to J.H. and S.A.W.), USDA-NIFA (grant 2006-35300-17195 to K.M.), the National Science Foundation Plant Genome Research Program (grant 0820642 to S.A.W., J.H., M. G. M. and T.J.B.), the National Science Foundation CAREER Program (DBI-0845196 to D.K.), Missouri Soybean Merchandising Council (project 258 to M.G.M.), Illinois Soybean Association, North Central Soybean Research Program, Iowa Soybean Association, and a Department of Education Graduate Assistance in Areas of National Need (GAANN) Fellowship (to S.D.W.).	Alfadhli S, 2000, MOL BIOCHEM PARASIT, V110, P283, DOI 10.1016/S0166-6851(00)00282-6; Bagnyukova TV, 2008, BRAIN RES, V1237, P44, DOI 10.1016/j.brainres.2008.07.073; BERNARD RL, 1988, CROP SCI, V28, P1027; Brown S, 2010, J NEMATOL, V42, P201; CALDWELL B. E., 1960, AGRON JOUR, V52, P635; Concibido VC, 2004, CROP SCI, V44, P1121, DOI 10.2135/cropsci2004.1121; Cooper JL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-9; Dong K, 1997, GENETICS, V146, P1311; ENDO BY, 1965, PHYTOPATHOLOGY, V55, P375; HARTWIG EE, 1973, CROP SCI, V13, P287, DOI 10.2135/cropsci1973.0011183X001300020047x; Heil SG, 2001, MOL GENET METAB, V73, P164, DOI 10.1006/mgme.2001.3175; Hofmann J, 2010, PLANT J, V62, P1058, DOI 10.1111/j.1365-313X.2010.04217.x; Hwang TY, 2009, DNA RES, V16, P213, DOI 10.1093/dnares/dsp010; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Ithal N, 2007, MOL PLANT MICROBE IN, V20, P510, DOI 10.1094/MPMI-20-5-0510; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Kandoth PK, 2011, PLANT PHYSIOL, V155, P1960, DOI 10.1104/pp.110.167536; Kim YI, 2003, J NUTR, V133, p3731S, DOI 10.1093/jn/133.11.3731S; Koenning S. R., 2010, PLANT HLTH PROG; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lim U, 2005, J NUTR, V135, P1989, DOI 10.1093/jn/135.8.1989; Liu XH, 2011, FUNCT INTEGR GENOMIC, V11, P539, DOI 10.1007/s10142-011-0225-4; MATSON ARNOLD L., 1965, CROP SCI, V5, P477, DOI 10.2135/cropsci1965.0011183X000500050032x; Meksem, 2008, HDB PLANT FUNCTIONAL, P251, DOI DOI 10.1002/9783527622542.CH12; Meksem K, 2000, THEOR APPL GENET, V101, P747, DOI 10.1007/s001220051540; Meksem K, 2001, THEOR APPL GENET, V103, P710, DOI 10.1007/s001220100597; Melito S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-104; Niblack T. L., 2008, PLANT HLTH PROG; NIBLACK TL, 1993, J NEMATOL, V25, P880; Novakovic P, 2006, CARCINOGENESIS, V27, P916, DOI 10.1093/carcin/bgi312; Reed MC, 2010, BIOESSAYS, V32, P422, DOI 10.1002/bies.200900167; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Skibola CF, 2002, BLOOD, V99, P3786, DOI 10.1182/blood.V99.10.3786; SMITH TJ, 1973, CROP SCI, V13, P495, DOI 10.2135/cropsci1973.0011183X001300040033x; STAUFFER GV, 1981, GENE, V14, P63, DOI 10.1016/0378-1119(81)90148-7; Wang JY, 2010, NEW PHYTOL, V187, P1003, DOI 10.1111/j.1469-8137.2010.03300.x; Xiao YL, 2005, PLANT PHYSIOL, V139, P1323, DOI 10.1104/pp.105.063479; Zhang CQ, 2010, PLANT PHYSIOL, V153, P52, DOI 10.1104/pp.109.151639; Zhang Y, 2008, ANAL BIOCHEM, V375, P367, DOI 10.1016/j.ab.2007.12.015	39	247	298	19	311	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					256	+		10.1038/nature11651	http://dx.doi.org/10.1038/nature11651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23235880				2022-12-28	WOS:000312259300043
J	Robbins, GK; Lester, W; Johnson, KL; Chang, YC; Estey, G; Surrao, D; Zachary, K; Lammert, SM; Chueh, HC; Meigs, JB; Freedberg, KA				Robbins, Gregory K.; Lester, William; Johnson, Kristin L.; Chang, Yuchiao; Estey, Gregory; Surrao, Dominic; Zachary, Kimon; Lammert, Sara M.; Chueh, Henry C.; Meigs, James B.; Freedberg, Kenneth A.			Efficacy of a Clinical Decision-Support System in an HIV Practice A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							ELECTRONIC HEALTH RECORD; PHYSICIAN ORDER ENTRY; AMBULATORY-CARE; ANTIRETROVIRAL THERAPY; FOLLOW-UP; INFECTED PATIENTS; DELIVERY-SYSTEM; PATIENT SAFETY; ALERTS; INFORMATICS	Background: Data to support improved patient outcomes from clinical decision-support systems (CDSSs) are lacking in HIV care. Objective: To test the efficacy of a CDSS in improving HIV outcomes in an outpatient clinic. Design: Randomized, controlled trial. (ClinicalTrials.gov registration number: NCT00678600) Setting: Massachusetts General Hospital HIV Clinic. Participants: HIV care providers and their patients. Intervention: Computer alerts were generated for virologic failure (HIV RNA level >400 copies/mL after a previous HIV RNA level <= 400 copies/mL), evidence of suboptimal follow-up, and 11 abnormal laboratory test results. Providers received interactive computer alerts, facilitating appointment rescheduling and repeated laboratory testing, for half of their patients and static alerts for the other half. Measurements: The primary end point was change in CD4 cell count. Other end points included time to clinical event, 6-month suboptimal follow-up, and severe laboratory toxicity. Results: Thirty-three HIV care providers followed 1011 patients with HIV. In the intervention group, the mean increase in CD4 cell count was greater (0.0053 vs. 0.0032 x 10(9) cells/L per month; difference, 0.0021 x 10(9) cells/L per month [95% CI, 0.0001 to 0.004]; P = 0.040) and the rate of 6-month suboptimal follow-up was lower (20.6 vs. 30.1 events per 100 patient-years; P = 0.022) than those in the control group. Median time to next scheduled appointment was shorter in the intervention group than in the control group after a suboptimal follow-up alert (1.71 vs. 3.48 months; P < 0.001) and after a toxicity alert (2.79 vs. >6 months; P = 0.072). More than 90% of providers supported adopting the CDSS as part of standard care. Limitation: This was a 1-year informatics study conducted at a single hospital subspecialty clinic. Conclusion: A CDSS using interactive provider alerts improved CD4 cell counts and clinic follow-up for patients with HIV. Wider implementation of such systems can provide important clinical benefits.	[Robbins, Gregory K.] Harvard Univ, Massachusetts Gen Hosp, Div Infect Dis, Ctr AIDS Res, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Robbins, GK (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Div Infect Dis, Ctr AIDS Res, 55 Fruit St,Cox 5, Boston, MA 02114 USA.	grobbins@partners.org	Meigs, James/P-3927-2019	Meigs, James/0000-0002-2439-2657; Robbins, Gregory/0000-0001-7545-5817; Lester, William/0000-0003-4086-9280; Estey, Greg/0000-0002-9869-7971	National Institute of Allergy and Infectious Diseases [K01AI062435, K24AI062476, P30AI42851, K24DK080140, R37AI42006]; Massachusetts General Hospital; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042006, K24AI062476, K01AI062435, P30AI042851, R37AI042006, P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK080140] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Massachusetts General Hospital(General Electric); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By the National Institute of Allergy and Infectious Diseases (K01AI062435, K24AI062476, P30AI42851, K24DK080140, and R37AI42006) and the Massachusetts General Hospital Clinical Research Program.; National Institute of Allergy and Infectious Diseases.	[Anonymous], 2004, CLARIFICATION    AUG; Arnedo-Valero M, 2005, CLIN INFECT DIS, V41, P883, DOI 10.1086/432881; Baker JV, 2008, JAIDS-J ACQ IMM DEF, V48, P541, DOI 10.1097/QAI.0b013e31817bebb3; Bakken S, 2004, MED CARE, V42, P49, DOI 10.1097/01.mlr.0000109125.00113.f4; Bakken S, 2001, J AM MED INFORM ASSN, V8, P199, DOI 10.1136/jamia.2001.0080199; Bakken S, 2007, STUD HEALTH TECHNOL, V129, P1447; Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847; Bindoff IK, 2007, J CLIN PHARM THER, V32, P81, DOI 10.1111/j.1365-2710.2007.00801.x; Chueh H, 2012, ONCALL CLIN WEB PORT; Cowen ME, 2008, J HEALTHC MANAG, V53, P407, DOI 10.1097/00115514-200811000-00010; Crosson FJ, 2005, HEALTH AFFAIR, V24, P1543, DOI 10.1377/hlthaff.24.6.1543; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; de Lusignan Simon, 2007, Inform Prim Care, V15, P255; Deeks SG, 2009, CLIN INFECT DIS, V49, P1582, DOI 10.1086/644768; Department of Health and Human Services, 2009, FED REG, V74, P62785; Dickey J, 2004, MED TEACH, V26, P428, DOI 10.1080/01421590410001730967; Doebbeling BN, 2006, J GEN INTERN MED, V21, pS50, DOI 10.1111/j.1525-1497.2006.00363.x; Feldbaum James, 2008, Healthc Inform, V25, P95; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Grant RW, 2006, DIABETES TECHNOL THE, V8, P576, DOI 10.1089/dia.2006.8.576; Gurwitz JH, 2008, J AM GERIATR SOC, V56, P2225, DOI 10.1111/j.1532-5415.2008.02004.x; Hsieh TC, 2004, J AM MED INFORM ASSN, V11, P482, DOI 10.1197/jamia.M1556; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2000, ERR IS HUMAN BUILDIN; Isaac T, 2009, ARCH INTERN MED, V169, P305, DOI 10.1001/archinternmed.2008.551; Jenders Robert A, 2007, AMIA Annu Symp Proc, P359; Judge J, 2006, J AM MED INFORM ASSN, V13, P385, DOI 10.1197/jamia.M1945; Kucher N, 2009, J THROMB HAEMOST, V7, P1291, DOI 10.1111/j.1538-7836.2009.03509.x; Le Tiec C, 2005, CLIN PHARMACOKINET, V44, P1035, DOI 10.2165/00003088-200544100-00003; Lester WT, 2009, J AM MED INFORM ASSN, V16, P187, DOI 10.1197/jamia.M2813; Lester WT, 2006, J GEN INTERN MED, V21, P22, DOI 10.1111/j.1525-1497.2005.00268.x; Lester WT, 2004, STUD HEALTH TECHNOL, V107, P232; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lo HG, 2009, J AM MED INFORM ASSN, V16, P66, DOI 10.1197/jamia.M2687; Lok JJ, 2010, AIDS, V24, P1867, DOI 10.1097/QAD.0b013e32833adbcf; McGowan JJ, 2008, J AM MED INFORM ASSN, V15, P297, DOI 10.1197/jamia.M2584; Middleton B, 2005, J AM MED INFORM ASSN, V12, P13, DOI 10.1197/jamia.M1669; Mocroft A, 2008, HIV MED, V9, P261, DOI 10.1111/j.1468-1293.2008.00557.x; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Ndiaye B, 2009, AIDS, V23, P1786, DOI 10.1097/QAD.0b013e32832e3469; Partners HealthCare System, 2012, RES PAT DAT REG RPDR; Patel V, 2011, INT J MED INFORM, V80, P171, DOI 10.1016/j.ijmedinf.2010.11.008; Payne TH, 2000, CHEST, V118, p47S, DOI 10.1378/chest.118.2_suppl.47S; Piketty C, 2001, J INFECT DIS, V183, P1328, DOI 10.1086/319861; Poon Eric G, 2003, AMIA Annu Symp Proc, P1072; Poon EG, 2010, MED CARE, V48, P203, DOI 10.1097/MLR.0b013e3181c16203; RIND DM, 1994, ARCH INTERN MED, V154, P1511, DOI 10.1001/archinte.154.13.1511; Robbins GK, 2007, JAIDS-J ACQ IMM DEF, V44, P30, DOI 10.1097/01.qai.0000248351.10383.b7; Robbins GK, 2010, CLIN INFECT DIS, V50, P779, DOI 10.1086/650537; Ruland CM, 2002, J BIOMED INFORM, V35, P313, DOI 10.1016/S1532-0464(03)00037-6; SAFRAN C, 1995, LANCET, V346, P341, DOI 10.1016/S0140-6736(95)92226-1; Schulman J, 2007, J AM MED INFORM ASSN, V14, P537, DOI 10.1197/jamia.M2436; Shah NR, 2006, J AM MED INFORM ASSN, V13, P5, DOI 10.1197/jamia.M1868; Van der Sijs H, 2006, J AM MED INFORM ASSN, V13, P138, DOI 10.1197/jamia.M1809; Weingart SN, 2003, ARCH INTERN MED, V163, P2625, DOI 10.1001/archinte.163.21.2625	56	25	25	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2012	157	11					757	+		10.7326/0003-4819-157-11-201212040-00003	http://dx.doi.org/10.7326/0003-4819-157-11-201212040-00003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	049RC	23208165	Green Accepted			2022-12-28	WOS:000312000100001
J	Redford, KH; Jensen, DB; Breheny, JJ				Redford, Kent H.; Jensen, Deborah B.; Breheny, James J.			Integrating the Captive and the Wild	SCIENCE			English	Editorial Material									[Redford, Kent H.] Archipelago Consulting, Irvington, NY 10533 USA; [Jensen, Deborah B.] Woodland Pk Zoo, Seattle, WA 98130 USA; [Breheny, James J.] Wildlife Conservat Soc, Bronx, NY 10460 USA	Wildlife Conservation Society	Redford, KH (corresponding author), Archipelago Consulting, Irvington, NY 10533 USA.							Finkelstein ME, 2012, P NATL ACAD SCI USA, V109, P11449, DOI 10.1073/pnas.1203141109; Hamede R, 2012, CONSERV BIOL, V26, P124, DOI 10.1111/j.1523-1739.2011.01747.x; Lacy R., 2010, P 65 WAZA ANN C TECH; Lacy RC, 2013, ZOO BIOL, V32, P19, DOI 10.1002/zoo.21029; Miller KA, 2012, CONSERV BIOL, V26, P790, DOI 10.1111/j.1523-1739.2012.01902.x; Pritchard DJ, 2012, ORYX, V46, P18, DOI 10.1017/S0030605310001766; Randall DA, 2004, EMERG INFECT DIS, V10, P2214, DOI 10.3201/eid1012.040080; Redford KH, 2011, BIOSCIENCE, V61, P39, DOI 10.1525/bio.2011.61.1.9; Roman Joe, 2011, LISTED DISPATCHES AM; Scott JM, 2010, CONSERV LETT, V3, P91, DOI 10.1111/j.1755-263X.2010.00096.x; Shepherdson D., 2004, P SPEC RISK 2004 PAT; SOULE M, 1986, ZOO BIOL, V5, P101, DOI 10.1002/zoo.1430050205; Valladares-Padua Claudio B., 2002, P301; Vander Haegen WM, 2009, J WILDLIFE MANAGE, V73, P1402, DOI 10.2193/2008-484; Volis S, 2010, BIODIVERS CONSERV, V19, P2441, DOI 10.1007/s10531-010-9849-2	15	43	52	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1157	1158		10.1126/science.1228899	http://dx.doi.org/10.1126/science.1228899			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197520				2022-12-28	WOS:000311666200029
J	Ding, SY; Liu, YS; Zeng, YN; Himmel, ME; Baker, JO; Bayer, EA				Ding, Shi-You; Liu, Yu-San; Zeng, Yining; Himmel, Michael E.; Baker, John O.; Bayer, Edward A.			How Does Plant Cell Wall Nanoscale Architecture Correlate with Enzymatic Digestibility?	SCIENCE			English	Article							TRICHODERMA-REESEI; CORN STOVER; CRYSTAL-STRUCTURE; BINDING MODULES; CELLULOSE; SYSTEM; RECALCITRANCE; CELLULASES; MICROSCOPY; BIOFUELS	Greater understanding of the mechanisms contributing to chemical and enzymatic solubilization of plant cell walls is critical for enabling cost-effective industrial conversion of cellulosic biomass to biofuels. Here, we report the use of correlative imaging in real time to assess the impact of pretreatment, as well as the resulting nanometer-scale changes in cell wall structure, upon subsequent digestion by two commercially relevant cellulase systems. We demonstrate that the small, noncomplexed fungal cellulases deconstruct cell walls using mechanisms that differ considerably from those of the larger, multienzyme complexes (cellulosomes). Furthermore, high-resolution measurement of the microfibrillar architecture of cell walls suggests that digestion is primarily facilitated by enabling enzyme access to the hydrophobic cellulose face. The data support the conclusion that ideal pretreatments should maximize lignin removal and minimize polysaccharide modification, thereby retaining the essentially native microfibrillar structure.	[Ding, Shi-You; Liu, Yu-San; Zeng, Yining; Himmel, Michael E.; Baker, John O.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Weizmann Institute of Science	Ding, SY (corresponding author), Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA.	shi.you.ding@nrel.gov	Ding, Shi-You/O-1209-2013; DING, SHIYOU/ABD-8519-2021	DING, SHIYOU/0000-0002-1102-1507; Zeng, Yining/0000-0002-0202-2479	U.S. Department of Energy (DOE) [DE-AC36-08-GO28308]; National Renewable Energy Laboratory; BioEnergy Science Center; DOE Bioenergy Research Center; Genomic Science Program [ER65258]; Office of Biological and Environmental Research in the DOE Office of Science	U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); National Renewable Energy Laboratory(United States Department of Energy (DOE)); BioEnergy Science Center; DOE Bioenergy Research Center(United States Department of Energy (DOE)); Genomic Science Program; Office of Biological and Environmental Research in the DOE Office of Science(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank M. P. Tucker for the fungal cellulases; S. Xie for guidance regarding SRS microscopy; K. Ruckman for manuscript editing; and A. J. Ragauskas, C. E. Wyman, M. F. Davis, D. J. Johnson, and R. H. Atalla for valuable discussion. This work was supported by the U.S. Department of Energy (DOE) under contract no. DE-AC36-08-GO28308 with the National Renewable Energy Laboratory. We acknowledge research support from the BioEnergy Science Center, a DOE Bioenergy Research Center, and the Genomic Science Program (ER65258), both supported by the Office of Biological and Environmental Research in the DOE Office of Science. S.-Y.D. conceptualized the project, conducted AFM, analyzed the data, and wrote the manuscript. Y.-S.L. conducted enzyme labeling, bright-field light microscopy, and CLSM. Y.Z. conducted SRS microscopy. E. A. B. purified the cellulosomes. S.-Y.D., M. E. H., J.O.B., and E. A. B. revised the manuscript. We declare no competing financial interests.	ATALLA RH, 1986, J RAMAN SPECTROSC, V17, P229, DOI 10.1002/jrs.1250170213; BERGHEM ER, 1973, EUR J BIOCHEM, V37, P21, DOI 10.1111/j.1432-1033.1973.tb02952.x; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chen F, 2012, P NATL ACAD SCI USA, V109, P1772, DOI 10.1073/pnas.1120992109; Dagel DJ, 2011, J PHYS CHEM B, V115, P635, DOI 10.1021/jp109798p; Ding SY, 2006, BIOTECHNIQUES, V41, P435, DOI 10.2144/000112244; Ding SY, 2006, J AGR FOOD CHEM, V54, P597, DOI 10.1021/jf051851z; Donohoe BS, 2009, BIOTECHNOL BIOENG, V103, P480, DOI 10.1002/bit.22281; Fernandes AN, 2011, P NATL ACAD SCI USA, V108, pE1195, DOI 10.1073/pnas.1108942108; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; GILKES NR, 1988, J BIOL CHEM, V263, P10401; Gritsch CS, 2005, ANN BOT-LONDON, V95, P619, DOI 10.1093/aob/mci068; Harris D, 2010, PLANT PHYSIOL, V153, P420, DOI 10.1104/pp.110.154203; HENRISSAT B, 1985, BIO-TECHNOL, V3, P722, DOI 10.1038/nbt0885-722; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Ishizawa CI, 2009, CELLULOSE, V16, P677, DOI 10.1007/s10570-009-9313-1; Jansen S, 1998, IAWA J, V19, P347, DOI 10.1163/22941932-90000658; JOHNSON EA, 1982, APPL ENVIRON MICROB, V43, P1125, DOI 10.1128/AEM.43.5.1125-1132.1982; Jung HG, 2006, CROP SCI, V46, P1801, DOI 10.2135/cropsci2006.02-0086; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Kumar R, 2009, BIOTECHNOL BIOENG, V102, P1544, DOI 10.1002/bit.22203; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Liu YS, 2011, J BIOL CHEM, V286, P11195, DOI 10.1074/jbc.M110.216556; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; MORAG E, 1992, Enzyme and Microbial Technology, V14, P289, DOI 10.1016/0141-0229(92)90153-F; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; OOSHIMA H, 1990, BIOTECHNOL BIOENG, V36, P446, DOI 10.1002/bit.260360503; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Saar BG, 2010, ANGEW CHEM INT EDIT, V49, P5476, DOI 10.1002/anie.201000900; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Wise L. E., 1946, Paper Trade Journal, V122, P35; Yang B, 2011, BIOFUELS-UK, V2, P421, DOI 10.4155/BFS.11.116; Zeng YN, 2010, BIOENERG RES, V3, P272, DOI 10.1007/s12155-010-9079-1	35	550	577	17	564	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1055	1060		10.1126/science.1227491	http://dx.doi.org/10.1126/science.1227491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23180856				2022-12-28	WOS:000311390600037
J	Boumil, MM				Boumil, Marcia M.			Off-Label Marketing and the First Amendment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA	Massachusetts Department of Public Health; Tufts University	Boumil, MM (corresponding author), Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA.								0	9	9	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2013	368	2					103	105		10.1056/NEJMp1214926	http://dx.doi.org/10.1056/NEJMp1214926			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	066RO	23234470				2022-12-28	WOS:000313238100014
J	Tao, YJ; Zheng, WJ				Tao, Yitzhi Jane; Zheng, Wenjie			Visualizing the Influenza Genome	SCIENCE			English	Editorial Material							RNA		[Tao, Yitzhi Jane; Zheng, Wenjie] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA	Rice University	Tao, YJ (corresponding author), Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA.	ytao@rice.edu						Arranz R, 2012, SCIENCE, V338, P1634, DOI 10.1126/science.1228172; Egelman EH, 2007, CURR OPIN STRUC BIOL, V17, P556, DOI 10.1016/j.sbi.2007.07.006; Moeller A, 2012, SCIENCE, V338, P1631, DOI 10.1126/science.1227270; Resa-Infante P, 2011, RNA BIOL, V8, P207, DOI 10.4161/rna.8.2.14513; RUIGROK RWH, 1995, J GEN VIROL, V76, P1009, DOI 10.1099/0022-1317-76-4-1009; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379	6	0	0	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1545	1546		10.1126/science.1231588	http://dx.doi.org/10.1126/science.1231588			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23180772				2022-12-28	WOS:000312533100033
J	Rosenbaum, S				Rosenbaum, Sara			Threading the Needle - Medicaid and the 113th Congress	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		George Washington Univ, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC USA	George Washington University	Rosenbaum, S (corresponding author), George Washington Univ, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC USA.							Adashi EY, 2010, NEW ENGL J MED, V362, P2047, DOI 10.1056/NEJMp1003729; Congressional Budget Office, 2012, EST INS COV PROV AFF; Congressional Budget Office, 2012, CHOIC DEF RED; Holahan J, 2012, NEW ENGL J MED, V367, P393, DOI 10.1056/NEJMp1204899; Sommers BD, 2012, NEW ENGL J MED, V367, P1025, DOI 10.1056/NEJMsa1202099	5	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2012	367	25					2368	2369		10.1056/NEJMp1213901	http://dx.doi.org/10.1056/NEJMp1213901			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056ZP	23216548				2022-12-28	WOS:000312531600002
J	Spiegelhalter, D				Spiegelhalter, David			CHRISTMAS 2012: THOUGHTS FOR TODAY Using speed of ageing and "microlives" to communicate the effects of lifetime habits and environment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY; HEALTH; TIME		Univ Cambridge, Stat Lab, Cambridge CB3 0WB, England	University of Cambridge	Spiegelhalter, D (corresponding author), Univ Cambridge, Stat Lab, Cambridge CB3 0WB, England.	d.spiegelhalter@statslab.cam.ac.uk						Chapman GB, 1996, J EXP PSYCHOL LEARN, V22, P771, DOI 10.1037/0278-7393.22.3.771; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Haybittle JL, 1998, INT J EPIDEMIOL, V27, P885, DOI 10.1093/ije/27.5.885; Katzmarzyk PT, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000828; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Nichols M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000957; Office of National Statistics, 2011, INT LIF TABL 2008 20; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Parkes G, 2008, BMJ-BRIT MED J, V336, P598, DOI 10.1136/bmj.39503.582396.25; Shaw M, 2000, BRIT MED J, V320, P53, DOI 10.1136/bmj.320.7226.53; Swindell WR, 2009, EXP GERONTOL, V44, P190, DOI 10.1016/j.exger.2008.10.005; Wells S, 2010, HEART, V96, P708, DOI 10.1136/hrt.2009.191320	12	10	10	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2012	345								e8223	10.1136/bmj.e8223	http://dx.doi.org/10.1136/bmj.e8223			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IU	23247978	Green Submitted			2022-12-28	WOS:000312698700018
J	Engwerda, CR; Good, MF				Engwerda, Christian R.; Good, Michael F.			Platelets Kill the Parasite Within	SCIENCE			English	Editorial Material							FALCIPARUM-INFECTED ERYTHROCYTES; PLASMODIUM-FALCIPARUM; DUFFY ANTIGEN; CHEMOKINE RECEPTOR; MALARIA; VIVAX; GENES		[Engwerda, Christian R.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Good, Michael F.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia	QIMR Berghofer Medical Research Institute; Griffith University	Engwerda, CR (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	michael.good@griffith.edu.au	Engwerda, Christian/I-3072-2015	Engwerda, Christian/0000-0003-2813-4804				Allen SJ, 1996, QJM-INT J MED, V89, P779, DOI 10.1093/qjmed/89.10.779; Baruch DI, 1997, BLOOD, V90, P3766, DOI 10.1182/blood.V90.9.3766; CHAUDHURI A, 1994, J BIOL CHEM, V269, P7835; Culleton R, 2012, INT J PARASITOL, V42, P1091, DOI 10.1016/j.ijpara.2012.08.005; EISMAN R, 1990, BLOOD, V76, P336; ESCALANTE AA, 1995, P NATL ACAD SCI USA, V92, P5793, DOI 10.1073/pnas.92.13.5793; HAYNES JD, 1988, J EXP MED, V167, P1873, DOI 10.1084/jem.167.6.1873; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; McMorran BJ, 2012, SCIENCE, V338, P1348, DOI 10.1126/science.1228892; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Prugnolle F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001283; Wassmer SC, 2008, J INFECT DIS, V197, P72, DOI 10.1086/523761; WHO, 2011, WORLD MALARIA REPORT 2011, P1	15	3	3	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1304	1305		10.1126/science.1232439	http://dx.doi.org/10.1126/science.1232439			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224547				2022-12-28	WOS:000311991200054
J	Zhuravleva, A; Clerico, EM; Gierasch, LM				Zhuravleva, Anastasia; Clerico, Eugenia M.; Gierasch, Lila M.			An Interdomain Energetic Tug-of-War Creates the Allosterically Active State in Hsp70 Molecular Chaperones	CELL			English	Article							SUBSTRATE-BINDING DOMAIN; CONFORMATIONAL-CHANGES; STRUCTURAL BASIS; WEIGHT PROTEINS; METHYL-GROUPS; DNAK; ATPASE; MUTATIONS; MECHANISM; INSIGHTS	The allosteric mechanism of Hsp70 molecular chaperones enables ATP binding to the N-terminal nucleotide-binding domain (NBD) to alter substrate affinity to the C-terminal substrate-binding domain (SBD) and substrate binding to enhance ATP hydrolysis. Cycling between ATP-bound and ADP/substrate-bound states requires Hsp70s to visit a state with high ATPase activity and fast on/off kinetics of substrate binding. We have trapped this "allosterically active'' state for the E. coli Hsp70, DnaK, and identified how interactions among the NBD, the beta subdomain of the SBD, the SBD alpha-helical lid, and the conserved hydrophobic interdomain linker enable allosteric signal transmission between ligand-binding sites. Allostery in Hsp70s results from an energetic tug-of-war between domain conformations and formation of two orthogonal interfaces: between the NBD and SBD, and between the helical lid and the beta subdomain of the SBD. The resulting energetic tension underlies Hsp70 functional properties and enables them to be modulated by ligands and cochaperones and "tuned'' through evolution.	[Zhuravleva, Anastasia; Clerico, Eugenia M.; Gierasch, Lila M.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Gierasch, Lila M.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Gierasch, LM (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.	gierasch@biochem.umass.edu		Zhuravleva, Anastasia/0000-0001-6165-8509	NIH [GM027616]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027616] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM027616. We thank Fabian Romano and Alejandro Heuck for assistance with the time-resolved fluorescence measurements.	Ahmad A, 2011, P NATL ACAD SCI USA, V108, P18966, DOI 10.1073/pnas.1111220108; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bhattacharya A, 2009, J MOL BIOL, V388, P475, DOI 10.1016/j.jmb.2009.01.062; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; BUKAU B, 1990, EMBO J, V9, P4027, DOI 10.1002/j.1460-2075.1990.tb07624.x; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Chang L, 2011, CHEM BIOL, V18, P210, DOI 10.1016/j.chembiol.2010.12.010; Clerico EM, 2010, BIOPOLYMERS, V94, P742, DOI 10.1002/bip.21426; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fernandez-Saiz V, 2006, J BIOL CHEM, V281, P7479, DOI 10.1074/jbc.M512744200; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Keller R, 2004, THESIS ETH ZURICH; Kumar DP, 2011, J MOL BIOL, V411, P1099, DOI 10.1016/j.jmb.2011.07.001; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Manley G, 2012, ARCH BIOCHEM BIOPHYS, V519, P223, DOI 10.1016/j.abb.2011.10.023; Mapa K, 2010, MOL CELL, V38, P89, DOI 10.1016/j.molcel.2010.03.010; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1; MCCARTY JS, 1991, P NATL ACAD SCI USA, V88, P9513, DOI 10.1073/pnas.88.21.9513; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; Moro F, 2003, FEBS LETT, V533, P119, DOI 10.1016/S0014-5793(02)03752-3; Revington M, 2004, J BIOL CHEM, V279, P33958, DOI 10.1074/jbc.M313967200; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; Ruschak AM, 2010, J BIOMOL NMR, V46, P75, DOI 10.1007/s10858-009-9376-1; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; Sharma D, 2011, P NATL ACAD SCI USA, V108, P13665, DOI 10.1073/pnas.1107421108; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Swain JF, 2006, J BIOL CHEM, V281, P1605, DOI 10.1074/jbc.M509356200; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; Tugarinov V, 2005, CHEMBIOCHEM, V6, P1567, DOI 10.1002/cbic.200500110; Tugarinov V, 2003, J AM CHEM SOC, V125, P13868, DOI 10.1021/ja030345s; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Tzeng SR, 2011, CURR OPIN STRUC BIOL, V21, P62, DOI 10.1016/j.sbi.2010.10.007; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Weigelt J, 1998, J AM CHEM SOC, V120, P10778, DOI 10.1021/ja982649y; WILBANKS SM, 1995, BIOCHEMISTRY-US, V34, P12095, DOI 10.1021/bi00038a002; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zhuravleva A, 2011, P NATL ACAD SCI USA, V108, P6987, DOI 10.1073/pnas.1014448108	52	186	187	0	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1296	1307		10.1016/j.cell.2012.11.002	http://dx.doi.org/10.1016/j.cell.2012.11.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217711	Green Accepted, Bronze			2022-12-28	WOS:000311999900018
J	Kilpatrick, AM; Randolph, SE				Kilpatrick, A. Marm; Randolph, Sarah E.			Drivers, dynamics, and control of emerging vector-borne zoonotic diseases	LANCET			English	Article							WEST-NILE-VIRUS; CONGO HEMORRHAGIC-FEVER; CLIMATE-CHANGE; LYME-DISEASE; CHIKUNGUNYA VIRUS; YELLOW-FEVER; DENGUE-FEVER; TRANSMISSION; MALARIA; ENCEPHALITIS	Emerging vector-borne diseases are an important issue in global health. Many vector-borne pathogens have appeared in new regions in the past two decades, while many endemic diseases have increased in incidence. Although introductions and emergence of endemic pathogens are often considered to be distinct processes, many endemic pathogens are actually spreading at a local scale coincident with habitat change. We draw attention to key differences between dynamics and disease burden that result from increased pathogen transmission after habitat change and after introduction into new regions. Local emergence is commonly driven by changes in human factors as much as by enhanced enzootic cycles, whereas pathogen invasion results from anthropogenic trade and travel where and when conditions (eg, hosts, vectors, and climate) are suitable for a pathogen. Once a pathogen is established, ecological factors related to vector characteristics can shape the evolutionary selective pressure and result in increased use of people as transmission hosts. We describe challenges inherent in the control of vector-borne zoonotic diseases and some emerging non-traditional strategies that could be effective in the long term.	[Kilpatrick, A. Marm] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Randolph, Sarah E.] Univ Oxford, Dept Zool, Oxford Tick Res Grp, Oxford OX1 3PS, England	University of California System; University of California Santa Cruz; University of Oxford	Kilpatrick, AM (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	akilpatr@ucsc.edu	Randolph, Sarah/AAR-9346-2021		National Science Foundation; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090159] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AMK acknowledges funding from the National Science Foundation and the National Institutes of Health.	BARBOUR AG, 1993, SCIENCE, V260, P1610, DOI 10.1126/science.8503006; Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454; Beyrer C, 2007, LANCET, V370, P619, DOI 10.1016/S0140-6736(07)61301-4; Bogich TL, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001354; Bowden SE, 2011, AM J TROP MED HYG, V84, P234, DOI 10.4269/ajtmh.2011.10-0134; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586; Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075; (CDC) Centers for Disease Control and Prevention, 2012, REP LYM DIS CAS STAT; Centers for Disease Control and Prevention, 2012, W NIL VIR; Chaves LF, 2012, PARASITOLOGY, V139, P14, DOI 10.1017/S0031182011001685; Chaves LF, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000176; Cohen JE, 2001, SCIENCE, V293, P694, DOI 10.1126/science.1060638; D'Ortenzio E, 2011, EMERG INFECT DIS, V17, P309, DOI 10.3201/eid1702.101056; Davis CT, 2005, VIROLOGY, V342, P252, DOI 10.1016/j.virol.2005.07.022; de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Duplantier JM, 2005, VET RES, V36, P437, DOI 10.1051/vetres:2005007; Effler PV, 2005, EMERG INFECT DIS, V11, P742; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fonseca DM, 2006, AM J TROP MED HYG, V74, P284, DOI 10.4269/ajtmh.2006.74.284; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Gerstl S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-28; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; Godfrey ER, 2011, PARASITE VECTOR, V4, pe35; Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025; Gray J S, 2009, Interdiscip Perspect Infect Dis, V2009, P593232, DOI 10.1155/2009/593232; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; HESS AD, 1970, AM J TROP MED HYG, V19, P327, DOI 10.4269/ajtmh.1970.19.327; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Holmes EC, 2003, TRENDS MICROBIOL, V11, P543, DOI 10.1016/j.tim.2003.10.006; HOOGSTRAAL H, 1979, J MED ENTOMOL, V15, P307, DOI 10.1093/jmedent/15.4.307; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Killeen GF, 2003, LANCET INFECT DIS, V3, P663, DOI 10.1016/S1473-3099(03)00776-X; Kilpatrick AM, 2007, AM J TROP MED HYG, V77, P667, DOI 10.4269/ajtmh.2007.77.667; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2006, CONSERV BIOL, V20, P1224, DOI 10.1111/j.1523-1739.2006.00423.x; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; Kilpatrick AM, 2010, VECTOR-BORNE ZOONOT, V10, P377, DOI 10.1089/vbz.2009.0029; Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; Levi T, 2012, P NATL ACAD SCI USA, V109, P10942, DOI 10.1073/pnas.1204536109; Linard C, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-15; Lipkin WI, 2010, MICROBIOL MOL BIOL R, V74, P363, DOI 10.1128/MMBR.00007-10; Lloyd-Smith JO, 2003, P ROY SOC B-BIOL SCI, V270, P1979, DOI 10.1098/rspb.2003.2481; Logiudice K, 2008, ECOLOGY, V89, P2841, DOI 10.1890/07-1047.1; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; Lukan M, 2010, EMERG INFECT DIS, V16, P524, DOI 10.3201/eid1603.081364; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Ogden NH, 2009, CAN MED ASSOC J, V180, P1221, DOI 10.1503/cmaj.080148; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Randolph SE, 2012, PARASITOLOGY, V139, P847, DOI 10.1017/S0031182012000200; Randolph SE, 2010, EUROSURVEILLANCE, V15, P24; Randolph SE, 2000, P ROY SOC B-BIOL SCI, V267, P1741, DOI 10.1098/rspb.2000.1204; Reiter P, 2008, REV SCI TECH OIE, V27, P383, DOI 10.20506/rst.27.2.1804; Reiter P, 2003, EMERG INFECT DIS, V9, P86; Reiter P, 2010, REV SCI TECH OIE, V29, P57, DOI 10.20506/rst.29.1.1960; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rogers DJ, 2006, ADV PARASIT, V62, P345, DOI 10.1016/S0065-308X(05)62010-6; Rohr JR, 2011, TRENDS ECOL EVOL, V26, P270, DOI 10.1016/j.tree.2011.03.002; Russell RC, 2009, MED J AUSTRALIA, V190, P265, DOI 10.5694/j.1326-5377.2009.tb02393.x; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Sumilo D, 2008, VACCINE, V26, P2580, DOI 10.1016/j.vaccine.2008.03.029; Sumilo D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000500; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Tsao JI, 2004, P NATL ACAD SCI USA, V101, P18159, DOI 10.1073/pnas.0405763102; Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Wonham MJ, 2004, P ROY SOC B-BIOL SCI, V271, P501, DOI 10.1098/rspb.2003.2608; Yamamoto SS, 2009, MAL J, V8, P5; Yasuoka J, 2007, AM J TROP MED HYG, V76, P450, DOI 10.4269/ajtmh.2007.76.450; Yergolkar PN, 2006, EMERG INFECT DIS, V12, P1580, DOI 10.3201/eid1210.060529; Yozwiak NL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001485	83	373	385	16	272	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2012	380	9857					1946	1955		10.1016/S0140-6736(12)61151-9	http://dx.doi.org/10.1016/S0140-6736(12)61151-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	046IK	23200503	Green Accepted			2022-12-28	WOS:000311758500031
J	Gothelf, KV				Gothelf, Kurt V.			LEGO-like DNA Structures	SCIENCE			English	Editorial Material							SHAPES		[Gothelf, Kurt V.] Aarhus Univ, Dept Chem, Ctr DNA Nanotechnol CDNA, DK-8000 Aarhus C, Denmark; [Gothelf, Kurt V.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Gothelf, KV (corresponding author), Aarhus Univ, Dept Chem, Ctr DNA Nanotechnol CDNA, Langelandsgade 140, DK-8000 Aarhus C, Denmark.	kvg@chem.au.dk						Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; ROBINSON BH, 1987, PROTEIN ENG, V1, P295, DOI 10.1093/protein/1.4.295; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312	11	23	25	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2012	338	6111					1159	1160		10.1126/science.1229960	http://dx.doi.org/10.1126/science.1229960			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197521				2022-12-28	WOS:000311666200030
J	Rao, V				Rao, Veena			Law on infant foods inhibits the marketing of complementary foods for infants, furthering undernutrition in India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Govt Karnataka, Dept Hlth & Family Welf, Karnataka Nutr Mission, Bangalore 560009, Karnataka, India		Rao, V (corresponding author), Govt Karnataka, Dept Hlth & Family Welf, Karnataka Nutr Mission, Bangalore 560009, Karnataka, India.	nobel_6@hotmail.com						Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Government of India Ministry of Health and Family Welfare, 2005, NAT FAM HLTH SURV 3, V3; Unicef, IND CHILDR; World Health Organization, 2001, COMPL FEED REP GLOB; World Health Organization, 1981, INT COD MARK BREAST; World Health Organization (WHO), 2001, GLOB STRAT INF YOUNG; Zeigler J, 2006, CHILDRENS RIGHTS UN	7	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 30	2012	345								e8131	10.1136/bmj.e8131	http://dx.doi.org/10.1136/bmj.e8131			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048FS	23204041	Green Submitted			2022-12-28	WOS:000311896500008
J	Misegades, LK; Winter, K; Harriman, K; Talarico, J; Messonnier, NE; Clark, TA; Martin, SW				Misegades, Lara K.; Winter, Kathleen; Harriman, Kathleen; Talarico, John; Messonnier, Nancy E.; Clark, Thomas A.; Martin, Stacey W.			Association of Childhood Pertussis With Receipt of 5 Doses of Pertussis Vaccine by Time Since Last Vaccine Dose, California, 2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EFFICACY; DIPHTHERIA; TETANUS	Context In 2010, California experienced its largest pertussis epidemic in more than 60 years; a substantial burden of disease was noted in the 7- to 10-year-old age group despite high diphtheria, tetanus, and acellular pertussis vaccine (DTaP) coverage, indicating the possibility of waning protection. Objective To evaluate the association between pertussis and receipt of 5 DTaP doses by time since fifth DTaP dose. Design, Setting, and Participants Case-control evaluation conducted in 15 California counties. Cases (n=682) were all suspected, probable, and confirmed pertussis cases among children aged 4 to 10 years reported from January through December 14, 2010; controls (n=2016) were children in the same age group who received care from the clinicians reporting the cases. Three controls were selected per case. Vaccination histories were obtained from medical records and immunization registries. Main Outcome Measures Primary outcomes were (1) odds ratios (ORs) for the association between pertussis and receipt of the 5-dose DTaP series and (2) ORs for the association between pertussis and time since completion (<12, 12-23, 24-35, 36-47, 48-59, or >= 60 months) of the 5-dose DTaP series. Logistic regression was used to calculate ORs, accounting for clustering by county and clinician, and vaccine effectiveness (VE) was estimated as (1-OR) x 100%. Results Among cases and controls, 53 (7.8%) and 19 (0.9%) had not received any pertussis-containing vaccines, respectively. Compared with controls, children with pertussis had a lower odds of having received all 5 doses of DTaP (OR, 0.11; 95% CI, 0.06-0.21 [estimated VE, 88.7%; 95% CI, 79.4%-93.8%]). When children were categorized by time since completion of the DTaP series, using an unvaccinated reference group, children with pertussis compared with controls were less likely to have received their fifth dose within the prior 12 months (19 [2.8%] vs 354 [17.6%], respectively; OR, 0.02; 95% CI, 0.01-0.04 [estimated VE, 98.1%; 95% CI, 96.1%-99.1%]). This association was evident with longer time since vaccination, with ORs increasing with time since the fifth dose. At 60 months or longer (n=231 cases [33.9%] and n=288 controls [14.3%]), the OR was 0.29 (95% CI, 0.15-0.54 [estimated VE, 71.2%; 95% CI, 45.8%-84.8%]). Accordingly, the estimated VE declined each year after receipt of the fifth dose of DTaP. Conclusion Among children in 15 California counties, children with pertussis, compared with controls, had lower odds of having received the 5-dose DTaP series; as time since last DTaP dose increased, the odds increased, which is consistent with a progressive decrease in estimated vaccine effectiveness each year after the final dose of pertussis vaccine. JAMA. 2012;308(20):2126-2132 www.jama.com	[Misegades, Lara K.; Messonnier, Nancy E.; Clark, Thomas A.; Martin, Stacey W.] US Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30329 USA; [Misegades, Lara K.] US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30329 USA; [Winter, Kathleen; Harriman, Kathleen; Talarico, John] Calif Dept Publ Hlth, Immunizat Branch, Richmond, VA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Misegades, LK (corresponding author), US Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd NE,MS C25, Atlanta, GA 30329 USA.	lmisegades@cdc.gov						[Anonymous], 1996, MMWR Recomm Rep, V45, P1; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; Bisgard KM, 2005, PEDIATRICS, V116, pE285, DOI 10.1542/peds.2004-2759; Black Carla L., 2011, Morbidity and Mortality Weekly Report, V60, P1157; BORTOLUSSI R, 1995, PEDIATR INFECT DIS J, V14, P870, DOI 10.1097/00006454-199510000-00010; Broder Karen R., 2006, Morbidity and Mortality Weekly Report, V55, P1; California Department of Health Services Immunization Branch, 2011, PERT REP; California Department of Public Health, 2010, PERT CDPH CAS DEF; Centers for Disease Control and Prevention, 2010, COV IND VACC VACC SE; Cherry JD, 2012, PEDIATRICS, V129, P968, DOI 10.1542/peds.2011-2594; Clark T, 2011, NAT IMM C MARCH 30 W; CODY CL, 1981, PEDIATRICS, V68, P650; DeBolt Chas, 2012, Morbidity and Mortality Weekly Report, V61, P517; Division of Integrated Surveillance Systems and Services National Center for Public Health Informatics Coordinating Center for Health Information and Service Centers for Disease Control and Prevention US Department of Health and Human Services, NAT NOT DIS SURV SYS; EDWARDS KM, 2004, VACCINES, P471; FINE PEM, 1987, REV INFECT DIS, V9, P866; Fitzmaurice G, 2000, NUTRITION, V16, P1114, DOI 10.1016/S0899-9007(00)00437-8; Friedrich MJ, 2011, JAMA-J AM MED ASSOC, V306, P27, DOI 10.1001/jama.2011.888; GROB PR, 1981, BRIT MED J, V282, P1925, DOI 10.1136/bmj.282.6280.1925; JENKINSON D, 1988, BRIT MED J, V296, P612, DOI 10.1136/bmj.296.6622.612; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; LAMBERT HJ, 1965, PUBLIC HEALTH REP, V80, P365, DOI 10.2307/4592424; LONG SS, 1990, PEDIATRICS, V85, P294; Mieszkowski Katharine, 2010, NY TIMES; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Preziosi MP, 2003, CLIN INFECT DIS, V37, P772, DOI 10.1086/377270; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rodrigues LC, 1999, EPIDEMIOL REV, V21, P56, DOI 10.1093/oxfordjournals.epirev.a017988; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; Winter K, 2012, J PEDIAT, V2012, P20; Witt MA, 2012, CLIN INFECT DIS, V54, P1730, DOI 10.1093/cid/cis287	31	181	182	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2012	308	20					2126	2132		10.1001/jama.2012.14939	http://dx.doi.org/10.1001/jama.2012.14939			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043IV	23188029	Bronze			2022-12-28	WOS:000311537200027
J	Fuglie, K; Heisey, P; King, J; Pray, CE; Schimmelpfennig, D				Fuglie, Keith; Heisey, Paul; King, John; Pray, Carl E.; Schimmelpfennig, David			The Contribution of Private Industry to Agricultural Innovation	SCIENCE			English	Editorial Material							PRODUCTIVITY; WILL		[Fuglie, Keith; Heisey, Paul; Schimmelpfennig, David] Econ Res Serv, USDA, Washington, DC 20472 USA; [King, John] USDA, Off Chief Scientist, Washington, DC 20250 USA; [Pray, Carl E.] Rutgers State Univ, New Brunswick, NJ 08901 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Rutgers State University New Brunswick	Schimmelpfennig, D (corresponding author), Econ Res Serv, USDA, Washington, DC 20472 USA.	des@ers.usda.gov		Fuglie, Keith/0000-0002-7601-0542; King, John/0000-0003-4947-0241				Alston J. M., 2004, California Agriculture, V58, P80, DOI 10.3733/ca.v058n02p80; Alston JM, 2010, NAT RES MANAG POLICY, V34, P1, DOI 10.1007/978-1-4419-0658-8; Alston JM, 2009, SCIENCE, V325, P1209, DOI 10.1126/science.1170451; [Anonymous], 2011, COST TIME INVOLVED D; Cohen JI, 2005, NAT BIOTECHNOL, V23, P27, DOI 10.1038/nbt0105-27; DASGUPTA P, 1980, ECON J, V90, P266, DOI 10.2307/2231788; Fuglie K., 2011, EC RES REP USDA; Fuglie K.O., 2001, J AGR APPL EC, V33, P459; Huffman W.E., 2006, SCI AGR LONG TERM PE, V2nd ed.; Klotz C., 1995, AGES9525 USDA EC RES; McDougall P., 2010, COST NEW AGROCHEMICA; Pardey P. G., 2006, Agricultural research: a growing global divide?; Piesse J, 2010, PHILOS T R SOC B, V365, P3035, DOI 10.1098/rstb.2010.0140; Pingali PL, 2002, FOOD POLICY, V27, P223, DOI 10.1016/S0306-9192(02)00012-X; Pray C. E, 2007, HDB AGR EC, V3; Pray CE, 1998, WORLD DEV, V26, P1127, DOI 10.1016/S0305-750X(98)00040-0; Rubenstein KD, 2006, CROP SCI, V46, P1021, DOI 10.2135/cropsci2005.0129; SCHILDOW DV, 2004, CLIN RESP MED, P19; Wang CG, 2009, AM J AGR ECON, V91, P374, DOI 10.1111/j.1467-8276.2008.01246.x; *WORLD BANK, 2007, WORLD DEV REP 2008 A	20	29	29	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1031	1032		10.1126/science.1226294	http://dx.doi.org/10.1126/science.1226294			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	041HJ	23180847				2022-12-28	WOS:000311390600026
J	Sprunck, S; Rademacher, S; Vogler, F; Gheyselinck, J; Grossniklaus, U; Dresselhaus, T				Sprunck, Stefanie; Rademacher, Svenja; Vogler, Frank; Gheyselinck, Jacqueline; Grossniklaus, Ueli; Dresselhaus, Thomas			Egg Cell-Secreted EC1 Triggers Sperm Cell Activation During Double Fertilization	SCIENCE			English	Article							SIGNAL-TRANSDUCTION; ARABIDOPSIS; PLANTS; FUSION	Double fertilization is the defining characteristic of flowering plants. However, the molecular mechanisms regulating the fusion of one sperm with the egg and the second sperm with the central cell are largely unknown. We show that gamete interactions in Arabidopsis depend on small cysteine-rich EC1 (EGG CELL 1) proteins accumulating in storage vesicles of the egg cell. Upon sperm arrival, EC1-containing vesicles are exocytosed. The sperm endomembrane system responds to exogenously applied EC1 peptides by redistributing the potential gamete fusogen HAP2/GCS1 (HAPLESS 2/GENERATIVE CELL SPECIFIC 1) to the cell surface. Furthermore, fertilization studies with ec1 quintuple mutants show that successful male-female gamete interactions are necessary to prevent multiple-sperm cell delivery. Our findings provide evidence that mutual gamete activation, regulated exocytosis, and sperm plasma membrane modifications govern flowering plant gamete interactions.	[Sprunck, Stefanie; Rademacher, Svenja; Vogler, Frank; Dresselhaus, Thomas] Univ Regensburg, Biochem Zentrum Regensburg, D-93053 Regensburg, Germany; [Gheyselinck, Jacqueline; Grossniklaus, Ueli] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Gheyselinck, Jacqueline; Grossniklaus, Ueli] Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland	University of Regensburg; University of Zurich; University of Zurich	Sprunck, S (corresponding author), Univ Regensburg, Biochem Zentrum Regensburg, Univ Str 31, D-93053 Regensburg, Germany.	stefanie.sprunck@biologie.uni-regensburg.de	Grossniklaus, Ueli/E-9995-2016	Grossniklaus, Ueli/0000-0002-0522-8974	Deutsche Forschungsgemeinschaft [SP 686/1-2, SFB924, DR 334/5]; Universitat Bayern e.V.; Australian Grains Research Development Corporation; Swiss National Science Foundation [3100AO-112489]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Universitat Bayern e.V.; Australian Grains Research Development Corporation(Grains R&D Corp); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Seeds were kindly provided by M. Johnson (HAP2p:HAP2-YFP) and F. Berger (HTR10p:HTR10-mRFP1). We thank M. Gebert for her help in in situ hybridization, M. Gahrtz for providing plasmids, M. Kammerer and B. Bellmann for technical assistance, and F. Sprenger for his support in spinning disc microscopy. This work was supported by the Deutsche Forschungsgemeinschaft (grants SP 686/1-2 and SFB924 to S. S. and DR 334/5 to T. D.), by a graduate scholarship of Universitat Bayern e.V. (to S. R.), and, in part, by the Australian Grains Research Development Corporation (to T. D.) and the Swiss National Science Foundation (grant 3100AO-112489 to U. G.). S. S. and T. D. are inventors on a patent (WO 2007/092992) related to the EC1 promoter sequences. Accession numbers and author contributions are listed in the supplementary materials.	Beale KM, 2012, CURR BIOL, V22, P1090, DOI 10.1016/j.cub.2012.04.041; Berger F, 2008, TRENDS PLANT SCI, V13, P437, DOI 10.1016/j.tplants.2008.05.011; Faure JE, 2002, PLANT J, V30, P481, DOI 10.1046/j.1365-313X.2002.01305.x; Gebert M, 2008, PLANT CELL, V20, P2798, DOI 10.1105/tpc.108.061028; Grote E, 2010, J CELL SCI, V123, P1902, DOI 10.1242/jcs.066662; Guignard M.L., 1899, REV G N BOT, V11, P129; Hamamura Y, 2011, CURR BIOL, V21, P497, DOI 10.1016/j.cub.2011.02.013; Hirohashi N, 2008, DEV GROWTH DIFFER, V50, pS221, DOI 10.1111/j.1440-169X.2008.01017.x; Ingouff M, 2007, CURR BIOL, V17, P1032, DOI 10.1016/j.cub.2007.05.019; Inoue N, 2011, ASIAN J ANDROL, V13, P81, DOI 10.1038/aja.2010.70; Kasahara RD, 2012, CURR BIOL, V22, P1084, DOI 10.1016/j.cub.2012.03.069; Liu Y, 2008, ACTA METEOROL SIN, V22, P22; McCue AD, 2011, J EXP BOT, V62, P1621, DOI 10.1093/jxb/err032; Mori T, 2006, NAT CELL BIOL, V8, P64, DOI 10.1038/ncb1345; Nawaschin S., 1898, B IMP ACAD SCI, V9, P377; Neill AT, 2004, REPRODUCTION, V127, P141, DOI 10.1530/rep.1.00085; Pan JM, 2000, CURR OPIN MICROBIOL, V3, P596, DOI 10.1016/S1369-5274(00)00146-6; Parrington J, 2007, DEV DYNAM, V236, P2027, DOI 10.1002/dvdy.21255; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Sprunck S, 2005, PLANT J, V41, P660, DOI 10.1111/j.1365-313X.2005.02332.x; Sprunck S, 2010, BIOCHEM SOC T, V38, P635, DOI 10.1042/BST0380635; von Besser K, 2006, DEVELOPMENT, V133, P4761, DOI 10.1242/dev.02683; Wong JL, 2010, TRENDS CELL BIOL, V20, P134, DOI 10.1016/j.tcb.2009.12.007	23	204	221	9	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2012	338	6110					1093	1097		10.1126/science.1223944	http://dx.doi.org/10.1126/science.1223944			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23180860				2022-12-28	WOS:000311390600047
J	Andrews-Hanna, JC; Asmar, SW; Head, JW; Kiefer, WS; Konopliv, AS; Lemoine, FG; Matsuyama, I; Mazarico, E; McGovern, PJ; Melosh, HJ; Neumann, GA; Nimmo, F; Phillips, RJ; Smith, DE; Solomon, SC; Taylor, GJ; Wieczorek, MA; Williams, JG; Zuber, MT				Andrews-Hanna, Jeffrey C.; Asmar, Sami W.; Head, James W., III; Kiefer, Walter S.; Konopliv, Alexander S.; Lemoine, Frank G.; Matsuyama, Isamu; Mazarico, Erwan; McGovern, Patrick J.; Melosh, H. Jay; Neumann, Gregory A.; Nimmo, Francis; Phillips, Roger J.; Smith, David E.; Solomon, Sean C.; Taylor, G. Jeffrey; Wieczorek, Mark A.; Williams, James G.; Zuber, Maria T.			Ancient Igneous Intrusions and Early Expansion of the Moon Revealed by GRAIL Gravity Gradiometry	SCIENCE			English	Article							EVOLUTION; ROCKS; EARTH	The earliest history of the Moon is poorly preserved in the surface geologic record due to the high flux of impactors, but aspects of that history may be preserved in subsurface structures. Application of gravity gradiometry to observations by the Gravity Recovery and Interior Laboratory (GRAIL) mission results in the identification of a population of linear gravity anomalies with lengths of hundreds of kilometers. Inversion of the gravity anomalies indicates elongated positive-density anomalies that are interpreted to be ancient vertical tabular intrusions or dikes formed by magmatism in combination with extension of the lithosphere. Crosscutting relationships support a pre-Nectarian to Nectarian age, preceding the end of the heavy bombardment of the Moon. The distribution, orientation, and dimensions of the intrusions indicate a globally isotropic extensional stress state arising from an increase in the Moon's radius by 0.6 to 4.9 kilometers early in lunar history, consistent with predictions of thermal models.	[Andrews-Hanna, Jeffrey C.] Colorado Sch Mines, Dept Geophys, Golden, CO 80401 USA; [Andrews-Hanna, Jeffrey C.] Colorado Sch Mines, Ctr Space Resources, Golden, CO 80401 USA; [Asmar, Sami W.; Konopliv, Alexander S.; Williams, James G.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Head, James W., III] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Kiefer, Walter S.; McGovern, Patrick J.] Lunar & Planetary Inst, Houston, TX 77058 USA; [Lemoine, Frank G.; Mazarico, Erwan; Neumann, Gregory A.] NASA, Solar Syst Explorat Div, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Matsuyama, Isamu] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Mazarico, Erwan; Smith, David E.; Zuber, Maria T.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Melosh, H. Jay] Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA; [Nimmo, Francis] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Phillips, Roger J.] SW Res Inst, Planetary Sci Directorate, Boulder, CO 80302 USA; [Solomon, Sean C.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Solomon, Sean C.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Taylor, G. Jeffrey] Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; [Wieczorek, Mark A.] Univ Paris Diderot, Inst Phys Globe Paris, Sorbonne Paris Cite, Case 7071, F-75205 Paris 13, France	Colorado School of Mines; Colorado School of Mines; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Brown University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Arizona; Massachusetts Institute of Technology (MIT); Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California Santa Cruz; Carnegie Institution for Science; Columbia University; University of Hawaii System; UDICE-French Research Universities; Universite Paris Cite	Andrews-Hanna, JC (corresponding author), Colorado Sch Mines, Dept Geophys, Golden, CO 80401 USA.	jcahanna@mines.edu	Wieczorek, Mark A/G-6427-2010; Mazarico, Erwan/N-6034-2014; Kiefer, Walter/F-2759-2016; Lemoine, Frank/D-1215-2013; Neumann, Gregory A/I-5591-2013	Wieczorek, Mark A/0000-0001-7007-4222; Mazarico, Erwan/0000-0003-3456-427X; Kiefer, Walter/0000-0001-6741-5460; Neumann, Gregory A/0000-0003-0644-9944; McGovern, Patrick/0000-0001-9647-3096; Lemoine, Frank G./0000-0002-3051-1456; Matsuyama, Isamu/0000-0002-2917-8633	NASA GRAIL Guest Scientist Program	NASA GRAIL Guest Scientist Program	The GRAIL mission is a component of the NASA Discovery Program and is performed under contract to the Massachusetts Institute of Technology and the Jet Propulsion Laboratory. J.C.A.-H., J.W.H., W. S. K., I. M., P.J.M., F.N., and G.J.T. were supported by grants from the NASA GRAIL Guest Scientist Program. The data used in this study will have been archived in the Geosciences Node of the NASA Planetary Data System by the time of publication.	Anderson E. M., 1951, DYNAMICS FAULTING DY; Andrews-Hanna JC, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003954; Andrews-Hanna JC, 2013, ICARUS, V222, P159, DOI 10.1016/j.icarus.2012.10.031; Ernst RE, 2001, ANNU REV EARTH PL SC, V29, P489, DOI 10.1146/annurev.earth.29.1.489; GUDMUNDSSON A, 1995, J VOLCANOL GEOTH RES, V64, P1, DOI 10.1016/0377-0273(95)92782-Q; Hartmann WK, 1997, METEORIT PLANET SCI, V32, P109, DOI 10.1111/j.1945-5100.1997.tb01246.x; HEAD JW, 1993, PLANET SPACE SCI, V41, P719, DOI 10.1016/0032-0633(93)90114-H; HEAD JW, 1991, GEOPHYS RES LETT, V18, P2121, DOI 10.1029/91GL02536; Jekeli C, 2006, SURV GEOPHYS, V27, P257, DOI 10.1007/s10712-005-3826-4; KAULA WM, 1979, J GEOPHYS RES, V84, P999, DOI 10.1029/JB084iB03p00999; Kiefer WS, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051319; Mege D, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001852; MELOSH HJ, 1980, ICARUS, V43, P334, DOI 10.1016/0019-1035(80)90178-5; Podmore F., 1985, GEOL ASSOC CAN SPEC, V33, P317; Purucker ME, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003922; Purucker ME, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2010JE003650; RUBIN AM, 1993, EARTH PLANET SC LETT, V119, P641, DOI 10.1016/0012-821X(93)90069-L; RUBIN AM, 1992, J GEOPHYS RES-SOL EA, V97, P1839, DOI 10.1029/91JB02170; Rummel R, 2011, J GEODESY, V85, P777, DOI 10.1007/s00190-011-0500-0; Smith DE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043751; SNYDER GA, 1995, J GEOPHYS RES-PLANET, V100, P9365, DOI 10.1029/95JE00575; SOLOMON SC, 1977, PHYS EARTH PLANET IN, V15, P135, DOI 10.1016/0031-9201(77)90026-7; Stoffler D, 2001, SPACE SCI REV, V96, P9, DOI 10.1023/A:1011937020193; Wieczorek MA, 2013, SCIENCE, V339, P671, DOI 10.1126/science.1231530; Wieczorek MA, 2012, SCIENCE, V335, P1212, DOI 10.1126/science.1214773; WILSON AH, 1982, J PETROL, V23, P240, DOI 10.1093/petrology/23.2.240; Wilson L., 2009, LUNAR PLANET SCI, V40; Zuber MT, 2013, SPACE SCI REV, V178, P3, DOI 10.1007/s11214-012-9952-7; Zuber MT, 2013, SCIENCE, V339, P668, DOI 10.1126/science.1231507	29	106	113	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2013	339	6120					675	678		10.1126/science.1231753	http://dx.doi.org/10.1126/science.1231753			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23223393				2022-12-28	WOS:000314585600036
J	Woodcock, J; Khan, M; Yu, LX				Woodcock, Janet; Khan, Mansoor; Yu, Lawrence X.			Withdrawal of Generic Budeprion for Nonbioequivalence	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Woodcock, Janet; Khan, Mansoor; Yu, Lawrence X.] US FDA, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Woodcock, J (corresponding author), US FDA, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA.		/AAE-3713-2022; Yu, Lawrence/L-6280-2016	Khan, Mansoor/0000-0003-3649-3874				*FOOD DRUG ADM, 2003, GUIDANCE FOR INDUSTR, P77671	1	40	42	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2012	367	26					2463	2465		10.1056/NEJMp1212969	http://dx.doi.org/10.1056/NEJMp1212969			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059OG	23216549				2022-12-28	WOS:000312714200002
J	Martinez, ME; Thompson, P; Messer, K; Ashbeck, EL; Lieberman, DA; Baron, JA; Ahnen, DJ; Robertson, DJ; Jacobs, ET; Greenberg, ER; Cross, AJ; Atkin, W				Martinez, Maria Elena; Thompson, Patricia; Messer, Karen; Ashbeck, Erin L.; Lieberman, David A.; Baron, John A.; Ahnen, Dennis J.; Robertson, Douglas J.; Jacobs, Elizabeth T.; Greenberg, E. Robert; Cross, Amanda J.; Atkin, Wendy			One-Year Risk for Advanced Colorectal Neoplasia: US Versus UK Risk-Stratification Guidelines	ANNALS OF INTERNAL MEDICINE			English	Article							SOCIETY TASK-FORCE; NATIONAL-SURVEY; COLONOSCOPY SURVEILLANCE; ADENOMA DETECTION; CONSENSUS UPDATE; CANCER; POLYPECTOMY; RECOMMENDATIONS; PHYSICIANS; RECURRENCE	Background: Guidelines from the United Kingdom and the United States on risk stratification after polypectomy differ, as do recommended surveillance intervals. Objective: To compare risk for advanced colorectal neoplasia at 1-year colonoscopy among patients cross-classified by U. S. and U. K. surveillance guidelines. Design: Pooled analysis of 4 prospective studies between 1984 and 1998. Setting: Academic and private clinics in the United States. Patients: 3226 postpolypectomy patients with 6- to 18-month follow-up colonoscopy. Measurements: Rates of advanced neoplasia (an adenoma >= 1 cm, high-grade dysplasia, >25% villous architecture, or invasive cancer) at 1 year, compared across U. S. and U. K. risk categories. Results: Advanced neoplasia was detected 1 year after polypectomy in 3.8% (95% CI, 2.7% to 4.9%) of lower-risk patients and 11.2% (CI, 9.8% to 12.6%) of higher-risk patients by U. S. criteria. According to U. K. criteria, 4.4% (CI, 3.3% to 5.4%) of low-risk patients, 9.9% (CI, 8.3% to 11.5%) of intermediate-risk patients, and 18.7% (CI, 14.8% to 22.5%) of high-risk patients presented with advanced neoplasia; U. K. high-risk patients comprised 12.1% of all patients. All U. S. lower-risk patients were low-risk by U. K. criteria; however, more patients were classified as low-risk, because the U. K. guidelines do not consider histologic features. Higher-risk U. S. patients were distributed across the 3 U. K. categories. Among all patients with advanced neoplasia, 26.3% were reclassified by the U. K. criteria to a higher-risk category and 7.0% to a lower-risk category, with a net 19.0% benefiting from detection 2 years earlier. Overall, substitution of U. K. for U. S. guidelines resulted in an estimated 0.03 additional colonoscopy every 5 years per patient. Limitations: Patients were enrolled 15 to 20 years ago, and quality measures for colonoscopy were unavailable. Patients lacking follow-up colonoscopy or with surveillance colonoscopy after 6 to 18 months and those with cancer or insufficient baseline adenoma characteristics were excluded (2076 of 5302). Conclusion: Application of the U. K. guidelines in the United States could identify a subset of high-risk patients who may warrant a 1-year clearing colonoscopy without substantially increasing rates of colonoscopy.	[Martinez, Maria Elena] Univ Calif San Diego, Moores Canc Ctr, Sch Med, La Jolla, CA 92093 USA; Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA; Univ Arizona, Coll Med, Tucson, AZ USA; Univ Arizona, Mel & Enid Zuckerman Arizona Coll Publ Hlth, Tucson, AZ USA; Portland VA Med Ctr, Portland, OR USA; Univ N Carolina, Sch Med, Chapel Hill, NC USA; Denver Vet Affairs Med Ctr, Denver, CO USA; Univ Colorado, Sch Med, Denver, CO USA; White River Junct Vet Affairs Med Ctr, White River Jct, VT USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; NCI, Rockville, MD USA; Univ London Imperial Coll Sci Technol & Med, London, England	University of California System; University of California San Diego; Arizona Center Cancer Care; University of Arizona; University of Arizona; University of Arizona; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Imperial College London	Martinez, ME (corresponding author), Univ Calif San Diego, Moores Canc Ctr, Sch Med, 3855 Hlth Sci Dr 0901, La Jolla, CA 92093 USA.	e8martinez@ucsd.edu			European Union Health Programme [2005317]; International Agency for Research on Cancer; National Cancer Institute [CA-41108, CA-23074, CA95060, CA37287, CA104869, CA23108, CA59005, CA26852]; European Union Public Health Programme; National Institute for Health Research [04/33/01] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U01CA037287, P30CA023108, R01CA026852, R01CA059005, U01CA046927, P30CA023074, P01CA041108, P50CA095060, R01CA104869, ZIACP010198] Funding Source: NIH RePORTER	European Union Health Programme; International Agency for Research on Cancer; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Union Public Health Programme; National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support: By the European Union Health Programme (Development of European Guidelines for Quality Assurance of Colorectal Cancer Screening; grant agreement 2005317); the International Agency for Research on Cancer; and the U.S. Public Health Service grants CA-41108, CA-23074, CA95060, CA37287, CA104869, CA23108, CA59005, and CA26852 from the National Cancer Institute.; European Union Public Health Programme.	Ahnen DJ, 2011, AM J GASTROENTEROL, V106, P190, DOI 10.1038/ajg.2010.423; Alberts DS, 2000, NEW ENGL J MED, V342, P1156, DOI 10.1056/NEJM200004203421602; Atkin WS, 2012, ENDOSCOPY, V44, pSE151, DOI 10.1055/s-0032-1309821; Atkin WS, 2002, GUT, V51, pV6, DOI 10.1136/gut.51.suppl_5.v6; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Boolchand V, 2006, ANN INTERN MED, V145, P654, DOI 10.7326/0003-4819-145-9-200611070-00007; Brenner H, 2012, ANN INTERN MED, V157, P225, DOI 10.7326/0003-4819-157-4-201208210-00002; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chen SC, 2007, AM J GASTROENTEROL, V102, P856, DOI 10.1111/j.1572-0241.2006.01054.x; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; Costantini M, 2003, J CLIN EPIDEMIOL, V56, P209, DOI 10.1016/S0895-4356(02)00587-5; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; GREENBERG ER, 1994, NEW ENGL J MED, V331, P141, DOI 10.1056/NEJM199407213310301; Kahi CJ, 2011, CLIN GASTROENTEROL H, V9, P42, DOI 10.1016/j.cgh.2010.09.013; Kahi CJ, 2010, AM J GASTROENTEROL, V105, P1301, DOI 10.1038/ajg.2010.51; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Klabunde CN, 2003, PREV MED, V36, P352, DOI 10.1016/S0091-7435(02)00066-X; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Martinez ME, 2009, GASTROENTEROLOGY, V136, P832, DOI 10.1053/j.gastro.2008.12.007; Mysliwiec PA, 2004, ANN INTERN MED, V141, P264, DOI 10.7326/0003-4819-141-4-200408170-00006; National Health Service, 2009, 1 NAT HLTH SERV CANC; Nodora JN, 2011, CANCER CAUSE CONTROL, V22, P1277, DOI 10.1007/s10552-011-9801-0; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Ransohoff DF, 2011, DIGEST DIS SCI, V56, P2623, DOI 10.1007/s10620-011-1791-y; Rex DK, 2006, AM J GASTROENTEROL, V101, P2866, DOI 10.1111/j.1572-0241.2006.00905.x; Rex Douglas K, 2010, Gastroenterol Hepatol (N Y), V6, P428; Rex DK, 2010, GASTROINTEST ENDOSC, V71, P142, DOI 10.1016/j.gie.2009.09.011; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; Terry MB, 2002, CANCER EPIDEM BIOMAR, V11, P660; Winawer SJ, 2006, CA-CANCER J CLIN, V56, P143, DOI 10.3322/canjclin.56.3.143; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301; Yabroff KR, 2011, J GEN INTERN MED, V26, P177, DOI 10.1007/s11606-010-1516-5	36	35	35	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2012	157	12					856	U192		10.7326/0003-4819-157-12-201212180-00005	http://dx.doi.org/10.7326/0003-4819-157-12-201212180-00005			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057SB	23247939	Green Accepted, Green Submitted			2022-12-28	WOS:000312583200015
J	Raicek, JE; Stone, BH; Kaptchuk, TJ				Raicek, Jacqueline E.; Stone, Bradley H.; Kaptchuk, Ted J.			CHRISTMAS 2012: YESTERDAY'S WORLD Placebos in 19th century medicine: a quantitative analysis of the BMJ	BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To provide the first quantitative data on the use of the term "placebo" in the 19th century. Design Computer search of BMJ's archival database from January 1840 (the first issue) through December 1899 for uses of the words "placebo(s)." Grounded theory was used to categorise the implications of uses of the term. Results 71 citations contained the term "placebo(s)." Of these, 22 (31%) used the term to mean "no effect" or as a general pejorative term, 18 (25%) portrayed placebo treatment as permitting the unfolding of the natural history (the normal waxing and waning of illness), 14 (20%) described placebo as important to satisfy patients, 7 (10%) described it as fulfilling a physician's performance role, 3 (4%) described its use to buy time, 3 (4%) described its use for financial gain, 2 (3%) used it in a manner similar to a placebo control, and only one implied that placebo could have a clinical effect. Only one citation mentioned telling the patient about his placebo treatment. Conclusion Nineteenth century physicians had diverse a priori assumptions about placebos. These findings remind us that contemporary medicine needs to use rigorous science to separate fact from its own beliefs concerning the "provision of care." As in previous generations, ethical issues concerning placebos continue to challenge medicine.	[Raicek, Jacqueline E.; Stone, Bradley H.; Kaptchuk, Ted J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Program Placebo Studies & Therapeut Encounter, Boston, MA 02215 USA; [Raicek, Jacqueline E.] Univ New England, Coll Osteopath Med, Biddeford, ME 04005 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of New England - Maine	Kaptchuk, TJ (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Program Placebo Studies & Therapeut Encounter, Boston, MA 02215 USA.	ted_kaptchuk@hms.harvard.edu			NIH NCCAM [K24 AT004095, R01 AT004662, R01AT005280, R01 AT006364, P01 AT006663]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT004662, R01AT005280] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [P01AT006663, R01AT006364, K24AT004095] Funding Source: NIH RePORTER	NIH NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The paper is supported in part from NIH NCCAM grants K24 AT004095, R01 AT004662, R01AT005280, R01 AT006364, and P01 AT006663.	[Anonymous], 1871, BMJ, V2, P744; [Anonymous], 1897, BMJ, V1, P1543; [Anonymous], 1889, BMJ, V1, P1051; [Anonymous], 1889, BMJ, V1, P130; [Anonymous], 1869, BMJ, V2, P7; [Anonymous], 1851, BMJ, V0, P956; [Anonymous], 1853, BMJ, V0, P1047; [Anonymous], 1889, BMJ, V2, P844; Bostick NA, 2008, J CLIN ETHIC, V19, P58; Cargill J, 1891, BRIT MED J, V1, P87; Cormack JR, 1851, BRIT MED J, V0, P444; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Glaser B.G., 1965, AWARENESS DYING; Hartridge G, 1886, Br Med J, V1, P200; Kaptchuk TJ, 1998, LANCET, V351, P1722, DOI 10.1016/S0140-6736(97)10111-8; Kaptchuk TJ, 1998, B HIST MED, V72, P389, DOI 10.1353/bhm.1998.0159; McKeown W A, 1879, Br Med J, V2, P1013; Miller FM, PLACEBO READER; Pepper O., 1945, AM J PHARM, V117, P409; Shears C, 1884, Br Med J, V1, P1199; Sloane J, 1857, BRIT MED J, V0, P363; Symonds, 1842, BRIT MED J, V0, P63; Symonds C J, 1899, Br Med J, V1, P517; Tilburt JC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1938; Tracey I, 2010, NAT MED, V16, P1277, DOI 10.1038/nm.2229; Ward OT, 1848, BRIT MED J, V0, P5; West RU, 1849, BRIT MED J, V0, P391; Wills C J, 1879, Br Med J, V1, P623; WOLF S, 1950, J CLIN INVEST, V29, P100, DOI 10.1172/JCI102225	29	9	9	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 18	2012	345								e8326	10.1136/bmj.e8326	http://dx.doi.org/10.1136/bmj.e8326			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	059IW	23249668	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000312698900001
J	Charlier, P; Brun, L; Pretre, C; Huynh-Charlier, I				Charlier, Philippe; Brun, Luc; Pretre, Clarisse; Huynh-Charlier, Isabelle			CHRISTMAS 2012: Toilet hygiene in the classical era	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Charlier, Philippe] Univ Hosp, Dept Forens Med & Pathol, F-92380 Garches, France; [Charlier, Philippe] Fac Med, Lab Med Eth, Paris, France; [Brun, Luc] Univ Hosp, Dept Pathol, Parakou, Benin; [Pretre, Clarisse] Univ Lille 3, HALMA IPEL, Villeneuve Dascq, France; [Huynh-Charlier, Isabelle] Univ Hosp Pitie Salpetriere, Dept Radiol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Universite de Lille - ISITE; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Charlier, P (corresponding author), Univ Hosp, Dept Forens Med & Pathol, 104 R Poincare Blvd, F-92380 Garches, France.	ph_charlier@yahoo.fr		Brun, luc Valere C./0000-0002-6024-3982				Aristophanes, 1998, BIRDS OTHER PLAYS; Charlier P., 2011, FEUILLETS BIOL, V52, P61; Colozier E., 1952, MEFRA, V64, P67; Janicke David M., 1996, Emergency Medicine Clinics of North America, V14, P757, DOI 10.1016/S0733-8627(05)70278-9; Needham J., 1986, SCI CIVILIZATION CHI, V5, P122; Papadopoulos JK, 2002, HESPERIA, V71, P149, DOI 10.2307/3182005; Rabelais F., GARGANTUA PANTAGRUEL, V1, P13; Seneca, COMMUNICATION, V70, P20	8	6	6	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2012	345								e8287	10.1136/bmj.e8287	http://dx.doi.org/10.1136/bmj.e8287			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	059IU	23247990	Bronze			2022-12-28	WOS:000312698700023
J	Otsuka, K; Karato, S				Otsuka, Kazuhiko; Karato, Shun-ichiro			Deep penetration of molten iron into the mantle caused by a morphological instability	NATURE			English	Article							FE-MG INTERDIFFUSION; HIGH-PRESSURES; EARTHS CORE; CONSTRAINTS; CONDUCTIVITY; TEMPERATURES; ENTRAINMENT; MECHANISMS; DIFFUSION; BOUNDARY	The core-mantle boundary of Earth is a region where iron-rich liquids interact with oxides and silicates in the mantle(1). Iron enrichment may occur at the bottom of the mantle, leading to low seismic-wave velocities and high electrical conductivity(2-5), but plausible physical processes of iron enrichment have not been suggested. Diffusion-controlled iron enrichment is inefficient because it is too slow(6), although the diffusion can be fast enough along grain boundaries for some elements(7). More fundamentally, experimental studies and geophysical observations show that the core is under-saturated with oxygen, implying that the mantle next to the core should be depleted in FeO. Here we show that (Mg,Fe)O in contact with iron-rich liquids leads to a morphological instability, causing blobs of iron-rich liquid to penetrate the oxide. This morphological instability is generated by the chemical potential gradient between two materials when they are not in bulk chemical equilibrium, and should be a common process in Earth's interior. Iron-rich melt could be transported 50 to 100 kilometres away from the core-mantle boundary by this mechanism, providing an explanation for the iron-rich regions in the mantle.	[Otsuka, Kazuhiko; Karato, Shun-ichiro] Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA	Yale University	Karato, S (corresponding author), Yale Univ, Dept Geol & Geophys, 210 Whitney Ave, New Haven, CT 06511 USA.	shun-ichiro.karato@yale.edu			National Science Foundation [EAR-0809330]	National Science Foundation(National Science Foundation (NSF))	We are grateful to Z. Du, T. Hiraga, T. Kawazoe, K. Tsuno and T. Yoshino for discussions and J. Eckert, G. Amulele, Z. Du, D. Wang and R. Farla for technical support. We thank M. Zuber, J. Schubert and S. Peale for a discussion on Mercury. B. Buffett provided a useful comment on the magnetic coupling between the core and the mantle. B. Watson provided constructive criticism. This research was financially supported by the National Science Foundation under grant number EAR-0809330.	Anderson OL, 2002, PHYS EARTH PLANET IN, V131, P19, DOI 10.1016/S0031-9201(02)00017-1; BOEHLER R, 1993, NATURE, V363, P534, DOI 10.1038/363534a0; Brandon AD, 2005, EARTH PLANET SC LETT, V232, P211, DOI 10.1016/j.epsl.2005.01.034; BUFFETT BA, 1992, J GEOPHYS RES-SOL EA, V97, P19581, DOI 10.1029/92JB00977; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Frost DJ, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006302; Garnero EJ, 2004, SCIENCE, V304, P834, DOI 10.1126/science.1097849; Hayden LA, 2007, NATURE, V450, P709, DOI 10.1038/nature06380; Holme R, 1998, GEOPHYS J INT, V132, P167, DOI 10.1046/j.1365-246x.1998.00424.x; Holzapfel C, 2005, SCIENCE, V309, P1707, DOI 10.1126/science.1111895; Ishii M, 1999, SCIENCE, V285, P1231, DOI 10.1126/science.285.5431.1231; Kanda RVS, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025009; Labrosse S, 2007, NATURE, V450, P866, DOI 10.1038/nature06356; Lay T, 1998, NATURE, V392, P461, DOI 10.1038/33083; LEIGHTON D, 1987, J FLUID MECH, V181, P415, DOI 10.1017/S0022112087002155; Masters G., 2000, EARTHS DEEP INTERIOR, V117, P63, DOI DOI 10.1029/GM117P0063; McNamara AK, 2010, EARTH PLANET SC LETT, V299, P1, DOI 10.1016/j.epsl.2010.07.042; MULLINS WW, 1964, J APPL PHYS, V35, P444, DOI 10.1063/1.1713333; Nagao H, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001786; Nakada M, 2012, PHYS EARTH PLANET IN, V192, P68, DOI 10.1016/j.pepi.2011.10.001; Ohta K, 2010, EARTH PLANET SC LETT, V289, P497, DOI 10.1016/j.epsl.2009.11.042; Otsuka K, 2011, PHYS EARTH PLANET IN, V189, P27, DOI 10.1016/j.pepi.2011.09.007; Otsuka K, 2010, PHYS EARTH PLANET IN, V180, P179, DOI 10.1016/j.pepi.2009.10.005; POIRIER JP, 1992, PHYS EARTH PLANET IN, V73, P29, DOI 10.1016/0031-9201(92)90105-5; RINGWOOD AE, 1990, PHYS CHEM MINER, V17, P313; Seagle CT, 2008, EARTH PLANET SC LETT, V265, P655, DOI 10.1016/j.epsl.2007.11.004; Shannon MC, 1998, SCIENCE, V280, P1059, DOI 10.1126/science.280.5366.1059; SLEEP NH, 1988, GEOPHYS J INT, V95, P437, DOI 10.1111/j.1365-246X.1988.tb06695.x; Smith DE, 2012, SCIENCE, V336, P214, DOI 10.1126/science.1218809; Stauffer D., 1992, INTRO PERCOLATION TH; STEVENSON DJ, 1981, SCIENCE, V214, P611, DOI 10.1126/science.214.4521.611; Trampert J, 2004, SCIENCE, V306, P853, DOI 10.1126/science.1101996; Van Orman JA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016343; Yamazaki D, 2003, EARTH PLANET SC LETT, V216, P301, DOI 10.1016/S0012-821X(03)00534-X	34	54	54	2	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					243	+		10.1038/nature11663	http://dx.doi.org/10.1038/nature11663			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23235879				2022-12-28	WOS:000312259300040
J	Hou, XW; Pedi, L; Diver, MM; Long, SB				Hou, Xiaowei; Pedi, Leanne; Diver, Melinda M.; Long, Stephen B.			Crystal Structure of the Calcium Release-Activated Calcium Channel Orai	SCIENCE			English	Article							CRAC CHANNEL; PLASMA-MEMBRANE; SUBUNIT STOICHIOMETRY; ION SELECTIVITY; MOLECULAR-BASIS; CA2+ SENSOR; I-CRAC; STIM1; STORE; CELLS	The plasma membrane protein Orai forms the pore of the calcium release-activated calcium (CRAC) channel and generates sustained cytosolic calcium signals when triggered by depletion of calcium from the endoplasmic reticulum. The crystal structure of Orai from Drosophila melanogaster, determined at 3.35 angstrom resolution, reveals that the calcium channel is composed of a hexameric assembly of Orai subunits arranged around a central ion pore. The pore traverses the membrane and extends into the cytosol. A ring of glutamate residues on its extracellular side forms the selectivity filter. A basic region near the intracellular side can bind anions that may stabilize the closed state. The architecture of the channel differs markedly from other ion channels and gives insight into the principles of selective calcium permeation and gating.	[Hou, Xiaowei; Pedi, Leanne; Diver, Melinda M.; Long, Stephen B.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Long, SB (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10065 USA.	longs@mskcc.org		Long, Stephen/0000-0002-8144-1398; Hou, Xiaowei/0000-0002-6668-1115; Diver, Melinda/0000-0001-5037-7322	NIH [GM094273]; Burroughs Wellcome Career Award; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094273] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career Award(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Goldberg, M. B. Long, R. MacKinnon, and N. P. Pavletich for discussions and comments on the manuscript; C. D. Lima and members of the laboratory for discussions; E. Gouaux for green fluorescent protein fusion vectors; the staff of beamlines X25 and X29 (National Synchrotron Light Source, Brookhaven National Laboratory); the staff of the monoclonal antibody and proteomics and microchemistry facilities at MSKCC; the Keck Biophysics Resource at Yale University; and the Center for Applied Isotope Studies at the University of Georgia for protein analysis. This work was supported by the NIH (grant GM094273) and by a Burroughs Wellcome Career Award (to S. B. L). Atomic coordinates and structure factors have been deposited in the Protein Data Bank with accession numbers 4HKR (wild type) and 4HKS (K163W mutant).	Aussel C, 1996, BIOCHEM J, V313, P909, DOI 10.1042/bj3130909; Bakowski D, 2002, PFLUG ARCH EUR J PHY, V443, P892, DOI 10.1007/s00424-001-0775-8; Carrasco S, 2011, ANNU REV BIOCHEM, V80, P973, DOI 10.1146/annurev-biochem-061609-165311; Demuro A, 2011, P NATL ACAD SCI USA, V108, P17832, DOI 10.1073/pnas.1114814108; Derler I, 2009, J BIOL CHEM, V284, P15903, DOI 10.1074/jbc.M808312200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; HILLE B, 1992, IONIC CHANNELS EXCIT, pR13; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; HOTH M, 1995, PFLUG ARCH EUR J PHY, V430, P315, DOI 10.1007/BF00373905; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; James BD, 1996, INORG CHIM ACTA, V247, P169, DOI 10.1016/0020-1693(95)04955-X; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; KAWASAKI H, 1995, PROTEIN PROFILE, V2, P297; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; LeppleWienhues A, 1996, BIOPHYS J, V71, P787, DOI 10.1016/S0006-3495(96)79278-0; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2010, J GEN PHYSIOL, V136, P673, DOI 10.1085/jgp.201010484; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; McNally BA, 2009, P NATL ACAD SCI USA, V106, P22516, DOI 10.1073/pnas.0909574106; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prakriya M, 2006, J GEN PHYSIOL, V128, P373, DOI 10.1085/jgp.200609588; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2011, P NATL ACAD SCI USA, V108, P17838, DOI 10.1073/pnas.1114821108; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	43	422	430	5	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1308	1313		10.1126/science.1228757	http://dx.doi.org/10.1126/science.1228757			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23180775	Green Accepted			2022-12-28	WOS:000311991200057
J	McWilliams, RS; Spaulding, DK; Eggert, JH; Celliers, PM; Hicks, DG; Smith, RF; Collins, GW; Jeanloz, R				McWilliams, R. Stewart; Spaulding, Dylan K.; Eggert, Jon H.; Celliers, Peter M.; Hicks, Damien G.; Smith, Raymond F.; Collins, Gilbert W.; Jeanloz, Raymond			Phase Transformations and Metallization of Magnesium Oxide at High Pressure and Temperature	SCIENCE			English	Article							LOWER MANTLE; MGO; EQUATION; STATE; EXOPLANETS; PERICLASE; PLANETS; MGSIO3; EARTH; CORE	Magnesium oxide (MgO) is representative of the rocky materials comprising the mantles of terrestrial planets, such that its properties at high temperatures and pressures reflect the nature of planetary interiors. Shock-compression experiments on MgO to pressures of 1.4 terapascals (TPa) reveal a sequence of two phase transformations: from B1 (sodium chloride) to B2 (cesium chloride) crystal structures above 0.36 TPa, and from electrically insulating solid to metallic liquid above 0.60 TPa. The transitions exhibit large latent heats that are likely to affect the structure and evolution of super-Earths. Together with data on other oxide liquids, we conclude that magmas deep inside terrestrial planets can be electrically conductive, enabling magnetic field-producing dynamo action within oxide-rich regions and blurring the distinction between planetary mantles and cores.	[McWilliams, R. Stewart] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [McWilliams, R. Stewart] Howard Univ, Washington, DC 20059 USA; [Spaulding, Dylan K.; Jeanloz, Raymond] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94707 USA; [Eggert, Jon H.; Celliers, Peter M.; Hicks, Damien G.; Smith, Raymond F.; Collins, Gilbert W.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Div Phys, Livermore, CA 94550 USA; [Jeanloz, Raymond] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Jeanloz, Raymond] Univ Calif Berkeley, Miller Inst Basic Res Sci, Berkeley, CA 94720 USA	Carnegie Institution for Science; Howard University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	McWilliams, RS (corresponding author), Univ Los Andes, Dept Fis, Grp Geociencias, Bogota, Colombia.	stewartmcwilliams@gmail.com	Hicks, Damien G/B-5042-2015; Collins, Gilbert/ABH-2158-2020; McWilliams, R./J-4358-2016	Hicks, Damien G/0000-0001-8322-9983; Celliers, Peter/0000-0001-7600-1227; McWilliams, Stewart/0000-0002-3730-8661; Eggert, Jon/0000-0001-5730-7108	U.S. Department of Energy by Lawrence Livermore National Laboratory [W-7405-Eng-48, DE-AC52-07NA27344]; U.S. Army Research Office [56122-CH-H]; Krell Institute Department of Energy (DOE) National Nuclear Security Administration (NNSA) [DE-FC52-08NA28752]; DOE/NNSA National Laser User Facility Program; Miller Institute for Basic Research in Science; University of California	U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); U.S. Army Research Office; Krell Institute Department of Energy (DOE) National Nuclear Security Administration (NNSA); DOE/NNSA National Laser User Facility Program; Miller Institute for Basic Research in Science; University of California(University of California System)	We thank N. Gomez-Perez, R. J. Hemley, D. C. Swift, R. E. Cohen, D. A. Dalton, and W. Unites for helpful discussions. This work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory in part under contract W-7405-Eng-48 and in part under contract DE-AC52-07NA27344. We also acknowledge financial support from the U.S. Army Research Office (grant 56122-CH-H), a Krell Institute Department of Energy (DOE) National Nuclear Security Administration (NNSA) graduate fellowship (contract DE-FC52-08NA28752), the DOE/NNSA National Laser User Facility Program, the Miller Institute for Basic Research in Science, and the University of California. Data are available in this manuscript and in the supplementary materials.	Aguado A, 2005, PHYS REV LETT, V94, DOI [10.1103/PhysRevLett.94.068501, 10.1103/PhysRevLett.94.233401]; Ahrens T. J., 1995, AGU HDB PHYS CONSTAN, VII, P45; Alfe D, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.220101; Alfe D, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.235701; Baraffe I, 2008, ASTRON ASTROPHYS, V482, P315, DOI 10.1051/0004-6361:20079321; Belonoshko AB, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.054110; de Koker N, 2009, GEOPHYS J INT, V178, P162, DOI 10.1111/j.1365-246X.2009.04142.x; DUFFY TS, 1995, J GEOPHYS RES-SOL EA, V100, P529, DOI 10.1029/94JB02065; Eggert JH, 2010, NAT PHYS, V6, P40, DOI 10.1038/NPHYS1438; Gaillard F, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003282; Guillot T, 2005, ANNU REV EARTH PL SC, V33, P493, DOI 10.1146/annurev.earth.32.101802.120325; Hicks DG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.025502; Hicks DG, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.174102; JEANLOZ R, 1989, J GEOPHYS RES-SOLID, V94, P5873, DOI 10.1029/JB094iB05p05873; Karato SI, 2011, ICARUS, V212, P14, DOI 10.1016/j.icarus.2010.12.005; Karki BB, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.174208; KNITTLE E, 1986, GEOPHYS RES LETT, V13, P1541, DOI 10.1029/GL013i013p01541; Knudson MD, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.225501; Marsh S. P., 1980, LASL SHOCK HUGONIOT; McQueen R.G., 1970, HIGH VELOCITY IMPACT, P293; Oganov AR, 2003, J CHEM PHYS, V118, P10174, DOI 10.1063/1.1570394; Solomatov V.S., 2000, ORIGIN EARTH MOON, P323; Spaulding DK, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.065701; Stevens GD, 2006, AIP CONF PROC, V845, P1353, DOI 10.1063/1.2263575; Stevenson DJ, 2010, SPACE SCI REV, V152, P651, DOI 10.1007/s11214-009-9572-z; SVENDSEN B, 1987, GEOPHYS J INT, V91, P667, DOI 10.1111/j.1365-246X.1987.tb01664.x; Tateno S, 2010, SCIENCE, V330, P359, DOI 10.1126/science.1194662; Umemoto K, 2006, SCIENCE, V311, P983, DOI 10.1126/science.1120865; Valencia D, 2006, ICARUS, V181, P545, DOI 10.1016/j.icarus.2005.11.021; VASSILIOU MS, 1981, GEOPHYS RES LETT, V8, P729, DOI 10.1029/GL008i007p00729; Wood BJ, 2000, EARTH PLANET SC LETT, V174, P341, DOI 10.1016/S0012-821X(99)00273-3; Young DA, 1991, PHASE DIAGRAMS ELEME; Zeldovich YB, 2002, DOVER BOOKS PHYS; ZERR A, 1994, NATURE, V371, P506, DOI 10.1038/371506a0; Zhang L, 2008, J PHYS CHEM SOLIDS, V69, P2344, DOI 10.1016/j.jpcs.2008.04.006; Zhang L, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034585	36	131	133	2	217	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1330	1333		10.1126/science.1229450	http://dx.doi.org/10.1126/science.1229450			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23180773				2022-12-28	WOS:000311991200063
J	Fanfair, RN; Benedict, K; Bos, J; Bennett, SD; Lo, YC; Adebanjo, T; Etienne, K; Deak, E; Derado, G; Shieh, WJ; Drew, C; Zaki, S; Sugerman, D; Gade, L; Thompson, EH; Sutton, DA; Engelthaler, DM; Schupp, JM; Brandt, ME; Harris, JR; Lockhart, SR; Turabelidze, G; Park, BJ				Fanfair, Robyn Neblett; Benedict, Kaitlin; Bos, John; Bennett, Sarah D.; Lo, Yi-Chun; Adebanjo, Tolu; Etienne, Kizee; Deak, Eszter; Derado, Gordana; Shieh, Wun-Ju; Drew, Clifton; Zaki, Sherif; Sugerman, David; Gade, Lalitha; Thompson, Elizabeth H.; Sutton, Deanna A.; Engelthaler, David M.; Schupp, James M.; Brandt, Mary E.; Harris, Julie R.; Lockhart, Shawn R.; Turabelidze, George; Park, Benjamin J.			Necrotizing Cutaneous Mucormycosis after a Tornado in Joplin, Missouri, in 2011	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							APOPHYSOMYCES-ELEGANS; SOFT-TISSUE; TSUNAMI SURVIVOR; ZYGOMYCOSIS; OUTBREAK; INFECTIONS; EPIDEMIOLOGY; MANAGEMENT; FASCIITIS; RHIZOPUS	BACKGROUND Mucormycosis is a fungal infection caused by environmentally acquired molds. We investigated a cluster of cases of cutaneous mucormycosis among persons injured during the May 22, 2011, tornado in Joplin, Missouri. METHODS We defined a case as a soft-tissue infection in a person injured during the tornado, with evidence of a mucormycete on culture or immunohistochemical testing plus DNA sequencing. We conducted a case-control study by reviewing medical records and conducting interviews with case patients and hospitalized controls. DNA sequencing and whole-genome sequencing were performed on clinical specimens to identify species and assess strain-level differences, respectively. RESULTS A total of 13 case patients were identified, 5 of whom (38%) died. The patients had a median of 5 wounds (range, 1 to 7); 11 patients (85%) had at least one fracture, 9 (69%) had blunt trauma, and 5 (38%) had penetrating trauma. All case patients had been located in the zone that sustained the most severe damage during the tornado. On multivariate analysis, infection was associated with penetrating trauma (adjusted odds ratio for case patients vs. controls, 8.8; 95% confidence interval [CI], 1.1 to 69.2) and an increased number of wounds (adjusted odds ratio, 2.0 for each additional wound; 95% CI, 1.2 to 3.2). Sequencing of the D1-D2 region of the 28S ribosomal DNA yielded Apophysomyces trapeziformis in all 13 case patients. Whole-genome sequencing showed that the apophysomyces isolates were four separate strains. CONCLUSIONS We report a cluster of cases of cutaneous mucormycosis among Joplin tornado survivors that were associated with substantial morbidity and mortality. Increased awareness of fungi as a cause of necrotizing soft-tissue infections after a natural disaster is warranted.	[Fanfair, Robyn Neblett; Benedict, Kaitlin; Bennett, Sarah D.; Adebanjo, Tolu; Etienne, Kizee; Deak, Eszter; Gade, Lalitha; Brandt, Mary E.; Harris, Julie R.; Lockhart, Shawn R.; Park, Benjamin J.] Ctr Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA USA; [Derado, Gordana] Ctr Dis Control & Prevent, Biostat Off, Atlanta, GA USA; [Fanfair, Robyn Neblett; Bennett, Sarah D.; Lo, Yi-Chun] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA USA; [Shieh, Wun-Ju; Drew, Clifton; Zaki, Sherif] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA USA; [Sugerman, David] Ctr Dis Control & Prevent, Div Injury Response, Atlanta, GA USA; [Bos, John; Lo, Yi-Chun; Turabelidze, George] Missouri Dept Hlth & Senior Serv, Jefferson, AR USA; [Thompson, Elizabeth H.; Sutton, Deanna A.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Engelthaler, David M.; Schupp, James M.] Translat Genom Res Inst, Flagstaff, AZ USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Texas System; University of Texas Health San Antonio; Translational Genomics Research Institute	Park, BJ (corresponding author), 1600 Clifton Rd,MS C-09, Atlanta, GA 30333 USA.	bpark1@cdc.gov						Alexander BD, 2010, AM J TRANSPLANT, V10, P2161, DOI 10.1111/j.1600-6143.2010.03216.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andresen D, 2005, LANCET, V365, P876, DOI 10.1016/S0140-6736(05)71046-1; [Anonymous], 2011, MMWR MORB MORTAL WKL, V60, P992; [Anonymous], 2005, EM WOUND MAN HEALTHC; [Anonymous], 2003, TORN BEING PREP; Antoniadou A, 2009, CLIN MICROBIOL INFEC, V15, P55, DOI 10.1111/j.1469-0691.2009.02982.x; Balajee SA, 2008, J MICROBIOL METH, V73, P252, DOI 10.1016/j.mimet.2008.02.011; Chamilos G, 2008, CLIN INFECT DIS, V47, P503, DOI 10.1086/590004; Christiaens G, 2005, J HOSP INFECT, V61, P88, DOI 10.1016/j.jhin.2004.12.011; Daley WR, 2005, AM J EPIDEMIOL, V161, P1144, DOI 10.1093/aje/kwi142; Etienne K, 2011, PLOS ONE IN PRESS; Gomes MZR, 2011, CLIN MICROBIOL REV, V24, P411, DOI 10.1128/CMR.00056-10; Guarner J, 2011, CLIN MICROBIOL REV, V24, P247, DOI 10.1128/CMR.00053-10; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; HUFFNAGLE KE, 1992, J MED VET MYCOL, V30, P83; Ibrahim AS, 2008, CURR OPIN INFECT DIS, V21, P620, DOI 10.1097/QCO.0b013e3283165fd1; Ivers LC, 2006, CURR OPIN INFECT DIS, V19, P408, DOI 10.1097/01.qco.0000244044.85393.9e; Jain D, 2006, MODERN PATHOL, V19, P1221, DOI 10.1038/modpathol.3800639; Kimura M, 1999, ARCH PATHOL LAB MED, V123, P386; Kindo A J, 2007, Indian J Med Microbiol, V25, P285; Kontoyiannis DP, 2011, BLOOD, V118, P1216, DOI 10.1182/blood-2011-03-316430; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; LeMaile-Williams M, 2006, CLIN INFECT DIS, V43, pE83, DOI 10.1086/508277; Maravi-Poma E, 2004, INTENS CARE MED, V30, P724, DOI 10.1007/s00134-003-2132-1; Meis JF, 2009, CLIN MICROBIOL INFEC, V15, P10, DOI 10.1111/j.1469-0691.2009.02973.x; Munoz-Cadavid C, 2010, J CLIN MICROBIOL, V48, P2147, DOI 10.1128/JCM.00459-10; National Weather Service. Springfield MO, 2011, JOPL TORN EV SUMM; Oklahoma State Department of Health, 2006, TORN MORT QUEST MED; PATINO JF, 1991, WORLD J SURG, V15, P240, DOI 10.1007/BF01659059; Roden MM, 2005, CLIN INFECT DIS, V41, P634, DOI 10.1086/432579; Skiada A, 2009, CLIN MICROBIOL INFEC, V15, P41, DOI 10.1111/j.1469-0691.2009.02979.x; Snell BJ, 2007, PLAST RECONSTR SURG, V119, P448, DOI 10.1097/01.prs.0000233624.34950.f8; Spellberg B, 2005, CLIN MICROBIOL REV, V18, P556, DOI 10.1128/CMR.18.3.556-569.2005; Sun HY, 2011, LANCET INFECT DIS, V11, P301, DOI 10.1016/S1473-3099(10)70316-9; U.S. Army Corps of Engineers, JOPL MISS TORN PATH; Wang Jue, 2002, Surg Infect (Larchmt), V3, P283, DOI 10.1089/109629602761624243; Weddle G, 2011, 49 ANN M INF DIS SOC; White T. J, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1	39	212	213	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2012	367	23					2214	2225		10.1056/NEJMoa1204781	http://dx.doi.org/10.1056/NEJMoa1204781			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048DO	23215557				2022-12-28	WOS:000311890600008
J	Kessler, S				Kessler, Sarah			BMJ CHRISTMAS APPEAL 2012 Lifebox: Make it zero	BRITISH MEDICAL JOURNAL			English	Editorial Material									Lifebox Fdn, London, England		Kessler, S (corresponding author), Lifebox Fdn, London, England.	sarah@lifebox.org						Feinmann J, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e807; Feinmann J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d8085; Feinmann J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7773; Funk LM, 2010, LANCET, V376, P1055, DOI 10.1016/S0140-6736(10)60392-3; Lifebox, SAF SURG BLOG; Walker IA, 2012, BRIT J ANAESTH, V109, P47, DOI 10.1093/bja/aes175	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 4	2012	345								e8241	10.1136/bmj.e8241	http://dx.doi.org/10.1136/bmj.e8241			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	052HY	23212685				2022-12-28	WOS:000312189700009
J	Bok, K; Green, KY				Bok, Karin; Green, Kim Y.			Norovirus Gastroenteritis in Immunocompromised Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HEMATOPOIETIC STEM-CELL; TRANSPLANT RECIPIENTS; NOSOCOMIAL TRANSMISSION; VIRAL GASTROENTERITIS; MOLECULAR EVOLUTION; GII.4 NOROVIRUS; IN-VIVO; INFECTION; DIARRHEA; IMMUNOSUPPRESSION		[Bok, Karin; Green, Kim Y.] NIAID, Caliciviruses Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Green, KY (corresponding author), NIAID, Caliciviruses Sect, Infect Dis Lab, NIH, 50 S Dr,Bldg 50,Rm 6318, Bethesda, MD 20892 USA.	kgreen@niaid.nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000897] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alkhouri N, 2011, PEDIATR TRANSPLANT, V15, P671, DOI 10.1111/j.1399-3046.2011.01522.x; Armbrust Sven, 2009, BMC Res Notes, V2, P96, DOI 10.1186/1756-0500-2-96; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Blanco NB, 2011, TRANSPL INFECT DIS, V13, P213, DOI 10.1111/j.1399-3062.2010.00565.x; Bok K, 2011, P NATL ACAD SCI USA, V108, P325, DOI 10.1073/pnas.1014577107; Boon D, 2011, J VIROL, V85, P8656, DOI 10.1128/JVI.00472-11; Bresee JS, 2012, J INFECT DIS, V205, P1374, DOI 10.1093/infdis/jis206; Bull RA, 2012, J VIROL, V86, P3219, DOI 10.1128/JVI.06712-11; Capizzi T, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-131; Carlsson B, 2009, J GEN VIROL, V90, P432, DOI 10.1099/vir.0.005082-0; Chachu KA, 2008, J VIROL, V82, P6610, DOI 10.1128/JVI.00141-08; Chachu KA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000236; Cogbill CH, 2011, MODERN PATHOL, V24, P117, DOI 10.1038/modpathol.2010.163; Ebdrup L, 2011, J CLIN VIROL, V50, P263, DOI 10.1016/j.jcv.2010.11.007; Engelen MA, 2011, TRANSPL INT, V24, pE102, DOI 10.1111/j.1432-2277.2011.01330.x; Fields B.N., 2007, FIELDS VIROLOGY, V1; Fishman JA, 2011, LIVER TRANSPLANT, V17, pS34, DOI 10.1002/lt.22378; Florescu DF, 2011, PEDIATR TRANSPLANT, V15, P718, DOI 10.1111/j.1399-3046.2011.01556.x; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hoffmann D, 2012, INFECT GENET EVOL, V12, P461, DOI 10.1016/j.meegid.2012.01.020; Kaufman SS, 2005, J PEDIATR GASTR NUTR, V40, P328, DOI 10.1097/01.MPG.0000155182.54001.48; Kirby A, 2012, EXPERT REV ANTI-INFE, V10, P423, DOI [10.1586/ERI.12.21, 10.1586/eri.12.21]; Koo HL, 2009, CLIN INFECT DIS, V49, P1069, DOI 10.1086/605558; KOZICKI M, 1985, INT J EPIDEMIOL, V14, P169, DOI 10.1093/ije/14.1.169; Krones E, 2012, GASTROENTEROL CLIN N, V41, P677, DOI 10.1016/j.gtc.2012.06.009; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Ludwig A, 2008, J MED VIROL, V80, P1461, DOI 10.1002/jmv.21217; Nilsson M, 2003, J VIROL, V77, P13117, DOI 10.1128/JVI.77.24.13117-13124.2003; Noel JS, 1999, J INFECT DIS, V179, P1334, DOI 10.1086/314783; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Roddie C, 2009, CLIN INFECT DIS, V49, P1061, DOI 10.1086/605557; Roos-Weil D, 2011, TRANSPLANTATION, V92, P61, DOI 10.1097/TP.0b013e31821c9392; Rossignol JF, 2006, ALIMENT PHARM THERAP, V24, P1423, DOI 10.1111/j.1365-2036.2006.03128.x; Saif MA, 2011, PEDIATR TRANSPLANT, V15, P505, DOI 10.1111/j.1399-3046.2011.01500.x; Schorn R, 2010, CLIN INFECT DIS, V51, P307, DOI 10.1086/653939; Schwartz S, 2011, BLOOD, V117, P5850, DOI 10.1182/blood-2010-12-325886; Siddiq DM, 2011, J INFECTION, V63, P394, DOI 10.1016/j.jinf.2011.08.002; Siebenga JJ, 2008, J INFECT DIS, V198, P994, DOI 10.1086/591627; Sukhrie FHA, 2012, CLIN INFECT DIS, V54, P931, DOI 10.1093/cid/cir971; Sukhrie FHA, 2010, J CLIN MICROBIOL, V48, P4303, DOI 10.1128/JCM.01308-10; Tajiri H, 2008, PEDIATR EMERG CARE, V24, P601, DOI 10.1097/PEC.0b013e3181850cc8; Tan M, 2011, TRENDS MICROBIOL, V19, P382, DOI 10.1016/j.tim.2011.05.007; Tomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019; van de Ven AAJM, 2011, ANTIVIR THER, V16, P611, DOI 10.3851/IMP1792; Webster AC, 2006, TRANSPLANTATION, V81, P1234, DOI 10.1097/01.tp.0000219703.39149.85; Wingfield T, 2010, J CLIN VIROL, V49, P219, DOI 10.1016/j.jcv.2010.07.025; Xerry J, 2010, J CLIN MICROBIOL, V48, P2552, DOI 10.1128/JCM.00066-10; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	48	249	258	1	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2012	367	22					2126	2132		10.1056/NEJMra1207742	http://dx.doi.org/10.1056/NEJMra1207742			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044MS	23190223	Green Accepted			2022-12-28	WOS:000311624400010
J	Kerkering, TM; Grifasi, ML; Baffoe-Bonnie, AW; Bansal, E; Garner, DC; Smith, JA; Demicco, DD; Schleupner, CJ; Aldoghaither, RA; Savaliya, VA				Kerkering, Thomas M.; Grifasi, Marissa L.; Baffoe-Bonnie, Anthony W.; Bansal, Ekta; Garner, Dorothy C.; Smith, Jean A.; Demicco, Deborah D.; Schleupner, Charles J.; Aldoghaither, Rabia A.; Savaliya, Vipul A.			Early Clinical Observations in Prospectively Followed Patients With Fungal Meningitis Related to Contaminated Epidural Steroid Injections	ANNALS OF INTERNAL MEDICINE			English	Article							CENTRAL-NERVOUS-SYSTEM; CEREBRAL PHEOHYPHOMYCOSIS; MELANIZED FUNGI; AMPHOTERICIN-B; EXSEROHILUM	Background: Administration of epidural steroid injections (ESIs) with contaminated methylprednisolone resulted in an outbreak of fungal meningitis in many locations in the United States. Objective: To characterize early clinical findings and initial response to treatment. Design: Case series with standardized observation studied from 4 October to 31 October 2012. Setting: An 800-bed hospital in Virginia. Patients: 172 patients who presented to the hospital with exposure to contaminated ESI. Intervention: Standardized approach to screening, case definition, treatment, and data collection. Measurements: Clinical findings, cerebrospinal fluid (CSF) values, magnetic resonance imaging (MRI), serum and CSF voriconazole concentrations, and clinician assessment of response to therapy. Results: Of 172 patients presenting to the hospital who had had ESI, 131 had lumbar puncture because of symptoms or signs consistent with central nervous system disease. Twenty-five (19%) had neutrophilic meningitis. All were started on voriconazole therapy alone. Three patients developed stroke during treatment. Ten patients had arachnoiditis, another had an epidural abscess, and 9 had urine retention. Fifteen continued to receive voriconazole, and 10 were switched to amphotericin B. Cerebrospinal fluid leukocyte counts began to decrease by day 13 of treatment. Findings on MRI included ventriculitis, leptomeningeal enhancement, infarction, hemorrhage, and arachnoiditis. Serum voriconazole levels varied, and CSF concentrations of voriconazole were approximately 50% those of serum. Exserohilum rostratum and Cladosporium species have been cultured. Limitations: This is an observational study of an evolving outbreak. Not all exposed patients presented for evaluation. Follow-up is too short to determine final outcomes. Conclusion: Meningitis after receipt of contaminated ESI has been diagnosed in many exposed patients presenting to 1 hospital. Most patients have improved on receipt of empirical voriconazole therapy. The full natural history and long-term sequelae of this infection are currently unknown. Primary Funding Source: None. Ann Intern Med. 2013;158:154-161.	[Kerkering, Thomas M.; Grifasi, Marissa L.; Baffoe-Bonnie, Anthony W.; Bansal, Ekta; Garner, Dorothy C.; Smith, Jean A.; Demicco, Deborah D.; Schleupner, Charles J.; Aldoghaither, Rabia A.; Savaliya, Vipul A.] Virginia Tech Caril Sch Med, Roanoke, VA 24014 USA		Kerkering, TM (corresponding author), Virginia Tech Caril Sch Med, 1906 Belleview Ave, Roanoke, VA 24014 USA.			SAVALIYA, Vipul/0000-0002-3221-4500				ADAM RD, 1986, MEDICINE, V65, P203, DOI 10.1097/00005792-198607000-00001; Adler A, 2006, EUR J CLIN MICROBIOL, V25, P247, DOI 10.1007/s10096-006-0093-3; BENNETT JE, 1979, NEW ENGL J MED, V301, P126, DOI 10.1056/NEJM197907193010303; Carter E, 2004, J CLIN MICROBIOL, V42, P5419, DOI 10.1128/JCM.42.11.5419-5423.2004; Centers for Disease Control and Prevention Health Alert Network, 2012, MEN STROK ASS POT CO; da Cunha KC, 2012, ANTIMICROB AGENTS CH, V56, P4951, DOI 10.1128/AAC.00488-12; Doshi SM, 2012, AM J KIDNEY DIS, V59, P222, DOI 10.1053/j.ajkd.2011.08.029; Filizzola Marcelo J., 2003, International Journal of Infectious Diseases, V7, P282, DOI 10.1016/S1201-9712(03)90108-1; Kainer Marion, 2012, Morbidity and Mortality Weekly Report, V61, P839; Kantarcioglu AS, 2004, MYCOSES, V47, P4, DOI 10.1046/j.1439-0507.2003.00956.x; Li DM, 2009, LANCET INFECT DIS, V9, P376, DOI 10.1016/S1473-3099(09)70131-8; Lyons JL, 2012, ANN INTERN MED, V157, P835, DOI 10.7326/0003-4819-158-1-201212040-00557; Moja M, 2000, NEURORADIOLOGY, V42, P261, DOI 10.1007/s002340050882; Pai MP, 2011, ANTIMICROB AGENTS CH, V55, P2601, DOI 10.1128/AAC.01765-10; Pettit AC, 2012, N ENGL J MED; Revankar SG, 2010, CLIN MICROBIOL REV, V23, P884, DOI 10.1128/CMR.00019-10; Revankar SG, 2004, CLIN INFECT DIS, V38, P206, DOI 10.1086/380635; SAAG MS, 1992, NEW ENGL J MED, V326, P83, DOI 10.1056/NEJM199201093260202; Theuretzbacher U, 2006, CLIN PHARMACOKINET, V45, P649, DOI 10.2165/00003088-200645070-00002; vanderHorst CM, 1997, NEW ENGL J MED, V337, P15, DOI 10.1056/NEJM199707033370103; Virginia Department of Health, 2012, EP UPD FUNG INF ASS	21	41	41	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2013	158	3					154	+		10.7326/0003-4819-158-3-201302050-00568	http://dx.doi.org/10.7326/0003-4819-158-3-201302050-00568			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087JP	23183583				2022-12-28	WOS:000314757900002
J	Ude, S; Lassak, J; Starosta, AL; Kraxenberger, T; Wilson, DN; Jung, K				Ude, Susanne; Lassak, Juergen; Starosta, Agata L.; Kraxenberger, Tobias; Wilson, Daniel N.; Jung, Kirsten			Translation Elongation Factor EF-P Alleviates Ribosome Stalling at Polyproline Stretches	SCIENCE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; PEPTIDE-BOND FORMATION; COLI CAD OPERON; SALMONELLA-ENTERICA; ESCHERICHIA-COLI; TRANSFER-RNA; POSTTRANSLATIONAL MODIFICATION; PROTEIN-SYNTHESIS; POXA; IDENTIFICATION	Translation elongation factor P (EF-P) is critical for virulence in bacteria. EF-P is present in all bacteria and orthologous to archaeal and eukaryotic initiation factor 5A, yet the biological function has so far remained enigmatic. Here, we demonstrate that EF-P is an elongation factor that enhances translation of polyproline-containing proteins: In the absence of EF-P, ribosomes stall at polyproline stretches, whereas the presence of EF-P alleviates the translational stalling. Moreover, we demonstrate the physiological relevance of EF-P to fine-tune the expression of the polyproline-containing pH receptor CadC to levels necessary for an appropriate stress response. Bacterial, archaeal, and eukaryotic cells have hundreds to thousands of polyproline-containing proteins of diverse function, suggesting that EF-P and a/eIF-5A are critical for copy-number adjustment of multiple pathways across all kingdoms of life.	[Ude, Susanne; Lassak, Juergen; Starosta, Agata L.; Kraxenberger, Tobias; Wilson, Daniel N.; Jung, Kirsten] Univ Munich, Ctr Integrated Prot Sci Munich CiPSM, Munich, Germany; [Ude, Susanne; Lassak, Juergen; Kraxenberger, Tobias; Jung, Kirsten] Univ Munich, Dept Biol 1, D-82152 Martinsried, Germany; [Starosta, Agata L.; Wilson, Daniel N.] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Starosta, Agata L.; Wilson, Daniel N.] Univ Munich, Dept Biochem, D-81377 Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Wilson, DN (corresponding author), Univ Munich, Ctr Integrated Prot Sci Munich CiPSM, Munich, Germany.	wilson@genzentrum.de; jung@lmu.de	Starosta, Agata/D-9535-2017; Wilson, Daniel/AAE-8504-2019; Lassak, Jürgen Michael/Q-2128-2019	Starosta, Agata/0000-0003-3915-5723; Wilson, Daniel/0000-0003-3816-3828; Lassak, Jürgen Michael/0000-0003-3936-3389	Excellence Cluster "Center for integrated Protein Science" Munich [Exc114/1]; European Molecular Biology Organization; Deutsche Forschungsgemeinschaft [JU270/5-3, WI3285/1-1]; AXA Postdoctoral fellowship	Excellence Cluster "Center for integrated Protein Science" Munich; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); AXA Postdoctoral fellowship(AXA Research Fund)	This work was supported by the Excellence Cluster "Center for integrated Protein Science" Munich (Exc114/1), the European Molecular Biology Organization young investigator program (to D.N.W.) and grants JU270/5-3 (K.J.) and WI3285/1-1 (D.N.W.) from the Deutsche Forschungsgemeinschaft. A.L.S. is funded by an AXA Postdoctoral fellowship.	Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Bearson SMD, 2011, FOODBORNE PATHOG DIS, V8, P725, DOI 10.1089/fpd.2010.0796; Bearson SMD, 2006, APPL ENVIRON MICROB, V72, P2829, DOI 10.1128/AEM.72.4.2829-2836.2006; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; de Crecy E, 2007, APPL MICROBIOL BIOT, V77, P489, DOI 10.1007/s00253-007-1168-5; Fritz G, 2009, J MOL BIOL, V393, P272, DOI 10.1016/j.jmb.2009.08.037; Garmendia J, 2003, MICROBIOL-SGM, V149, P2385, DOI 10.1099/mic.0.26397-0; GLICK BR, 1979, EUR J BIOCHEM, V97, P23, DOI 10.1111/j.1432-1033.1979.tb13081.x; GLICK BR, 1975, P NATL ACAD SCI USA, V72, P4257, DOI 10.1073/pnas.72.11.4257; Kaniga K, 1998, INFECT IMMUN, V66, P5599, DOI 10.1128/IAI.66.12.5599-5606.1998; Kyrpides NC, 1998, P NATL ACAD SCI USA, V95, P224, DOI 10.1073/pnas.95.1.224; Lucas RL, 2000, J BACTERIOL, V182, P1872, DOI 10.1128/JB.182.7.1872-1882.2000; MENG SY, 1992, J BACTERIOL, V174, P2670, DOI 10.1128/jb.174.8.2670-2678.1992; Muto H, 2008, BIOCHEM BIOPH RES CO, V366, P1043, DOI 10.1016/j.bbrc.2007.12.072; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Neely MN, 1996, J BACTERIOL, V178, P5522, DOI 10.1128/jb.178.18.5522-5528.1996; Park JH, 2012, J BIOL CHEM, V287, P2579, DOI 10.1074/jbc.M111.309633; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; Peil L, 2012, NAT CHEM BIOL, V8, P695, DOI [10.1038/NCHEMBIO.1001, 10.1038/nchembio.1001]; Peng WT, 2001, J BACTERIOL, V183, P36, DOI 10.1128/JB.183.1.36-45.2001; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Zou SB, 2012, J BACTERIOL, V194, P413, DOI 10.1128/JB.05864-11	25	286	295	6	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					82	85		10.1126/science.1228985	http://dx.doi.org/10.1126/science.1228985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23239623				2022-12-28	WOS:000312985800056
J	Eltzschig, HK; Sitkovsky, MV; Robson, SC				Eltzschig, Holger K.; Sitkovsky, Michail V.; Robson, Simon C.			MECHANISMS OF DISEASE Purinergic Signaling during Inflammation	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							A2B ADENOSINE RECEPTOR; INDUCIBLE FACTOR-I; ECTO-5'-NUCLEOTIDASE CD73; ATP RELEASE; EXTRACELLULAR ADENOSINE; PULMONARY INFLAMMATION; DEPENDENT INDUCTION; CUTTING EDGE; HYPOXIA; PROTECTION		[Robson, Simon C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Sch Med, Boston, MA 02215 USA; [Eltzschig, Holger K.] Univ Colorado, Dept Anesthesiol, Sch Med, Mucosal Inflammat Program, Aurora, CO 80045 USA; [Sitkovsky, Michail V.] Northeastern Univ, New England Inflammat & Tissue Protect Inst, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; Northeastern University	Robson, SC (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Sch Med, 330 Brookline Ave,CLS 612, Boston, MA 02215 USA.	holger.eltzschig@ucdenver.edu; srobson@bidmc.harvard.edu	Robson, Simon C./AAA-8537-2021		NATIONAL CANCER INSTITUTE [R21CA164970, R01CA111985] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045897, U19AI090959, T32AI074490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097320] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA164970, R01 CA111985] Funding Source: Medline; NHLBI NIH HHS [R01 HL098294] Funding Source: Medline; NIAID NIH HHS [U19 AI090959, T32 AI074490, P01 AI045897] Funding Source: Medline; NIGMS NIH HHS [R01 GM097320] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aherne CM, 2012, GUT, V61, P695, DOI 10.1136/gutjnl-2011-300012; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Avni I, 2010, OPHTHALMOLOGY, V117, P1287, DOI 10.1016/j.ophtha.2009.11.029; Blackburn MR, 2000, J EXP MED, V192, P159, DOI 10.1084/jem.192.2.159; Boison D, 2010, CELL DEATH DIFFER, V17, P1071, DOI 10.1038/cdd.2009.131; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Chalmin F, 2012, IMMUNITY, V36, P362, DOI 10.1016/j.immuni.2011.12.019; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Chiao CW, 2008, J PHARMACOL EXP THER, V326, P864, DOI 10.1124/jpet.107.135350; Colgan SP, 2012, ANNU REV PHYSIOL, V74, P153, DOI 10.1146/annurev-physiol-020911-153230; Cronstein BN, 1999, P NATL ACAD SCI USA, V96, P6377, DOI 10.1073/pnas.96.11.6377; CRONSTEIN BN, 1990, J CLIN INVEST, V85, P1150, DOI 10.1172/JCI114547; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Dixon BS, 2009, NEW ENGL J MED, V360, P2191, DOI 10.1056/NEJMoa0805840; Drury AN, 1929, J PHYSIOL-LONDON, V68, P213, DOI 10.1113/jphysiol.1929.sp002608; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eckle T, 2012, NAT MED, V18, P774, DOI 10.1038/nm.2728; Eckle T, 2009, PHYSIOLOGY, V24, P298, DOI 10.1152/physiol.00022.2009; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Eltzschig HK, 2004, BRIT MED BULL, V70, P71, DOI 10.1093/bmb/ldh025; Eltzschig HK, 2005, BR MED B, V73, P139; Eltzschig HK, 2008, TRENDS CARDIOVAS MED, V18, P103, DOI 10.1016/j.tcm.2008.01.006; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Eltzschig HK, 2006, BLOOD, V108, P1602, DOI 10.1182/blood-2006-02-001016; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Eltzschig HK, 2009, ANESTHESIOLOGY, V111, P904, DOI 10.1097/ALN.0b013e3181b060f2; Eltzschig HK, 2009, BLOOD, V113, P224, DOI 10.1182/blood-2008-06-165746; Faigle M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002801; Fernando SL, 2007, AM J RESP CRIT CARE, V175, P360, DOI 10.1164/rccm.200607-970OC; Fletcher JM, 2009, J IMMUNOL, V183, P7602, DOI 10.4049/jimmunol.0901881; Fontana P, 2003, CIRCULATION, V108, P2971, DOI 10.1161/01.CIR.0000106904.80795.35; Fontana P, 2003, CIRCULATION, V108, P989, DOI 10.1161/01.CIR.0000085073.69189.88; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Frick JS, 2009, J IMMUNOL, V182, P4957, DOI 10.4049/jimmunol.0801324; Friedman DJ, 2009, P NATL ACAD SCI USA, V106, P16788, DOI 10.1073/pnas.0902869106; Goto S, 2006, J AM COLL CARDIOL, V47, P155, DOI 10.1016/j.jacc.2005.08.055; Grenegard M, 2008, J BIOL CHEM, V283, P18493, DOI 10.1074/jbc.M800358200; Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137; Grenz A, 2007, J AM SOC NEPHROL, V18, P833, DOI 10.1681/ASN.2006101141; Grenz A, 2007, FASEB J, V21, P2863, DOI 10.1096/fj.06-7947com; Grenz A, 2012, J CLIN INVEST, V122, P693, DOI 10.1172/JCI60214; Grenz A, 2011, ANTIOXID REDOX SIGN, V15, P2221, DOI 10.1089/ars.2010.3665; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Hart ML, 2008, GASTROENTEROLOGY, V135, P1739, DOI 10.1053/j.gastro.2008.07.064; Hart ML, 2008, FASEB J, V22, P2784, DOI 10.1096/fj.07-103911; Hart ML, 2008, ARTERIOSCL THROM VAS, V28, P1477, DOI 10.1161/ATVBAHA.108.169219; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; Hart ML, 2010, J IMMUNOL, V184, P4017, DOI 10.4049/jimmunol.0901851; Hart ML, 2009, J IMMUNOL, V182, P3965, DOI 10.4049/jimmunol.0802193; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Kohler, 2007, CIRCULATION, V116, pE514, DOI 10.1161/CIRCULATIONAHA.107.187466; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Koeppen M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006784; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Kornum BR, 2011, NAT GENET, V43, P66, DOI 10.1038/ng.734; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Loffler M, 2007, ARTERIOSCL THROM VAS, V27, P1004, DOI 10.1161/ATVBAHA.106.126714; Louis NA, 2008, J IMMUNOL, V180, P4246, DOI 10.4049/jimmunol.180.6.4246; McDonald B, 2011, SCIENCE, V331, P1517; MILLER SL, 1959, SCIENCE, V130, P245, DOI 10.1126/science.130.3370.245; Mitchell CH, 1999, AM J PHYSIOL-CELL PH, V276, pC659, DOI 10.1152/ajpcell.1999.276.3.C659; Morabito L, 1998, J CLIN INVEST, V101, P295, DOI 10.1172/JCI1554; Morote-Garcia JC, 2008, BLOOD, V111, P5571, DOI 10.1182/blood-2007-11-126763; Morote-Garcia JC, 2009, GASTROENTEROLOGY, V136, P607, DOI 10.1053/j.gastro.2008.10.037; Naganuma M, 2006, J IMMUNOL, V177, P2765, DOI 10.4049/jimmunol.177.5.2765; NURDEN P, 1995, J CLIN INVEST, V95, P1612, DOI 10.1172/JCI117835; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Pinsky DJ, 2002, J CLIN INVEST, V109, P1031, DOI 10.1172/JCI200210649; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701; Riegel AK, 2011, BLOOD, V117, P2548, DOI 10.1182/blood-2010-10-313957; Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Spychala J, 2002, J LAB CLIN MED, V140, P84, DOI 10.1067/mlc.2002.125798; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]; Sun XF, 2010, GASTROENTEROLOGY, V139, P1030, DOI 10.1053/j.gastro.2010.05.007; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Thunberg U, 2002, LANCET, V360, P1935, DOI 10.1016/S0140-6736(02)11917-9; van Giezen JJJ, 2012, J CARDIOVASC PHARM T, V17, P164, DOI 10.1177/1074248411410883; Wallace KL, 2010, BLOOD, V116, P5010, DOI 10.1182/blood-2010-06-290643; White N, 2006, TRENDS PHARMACOL SCI, V27, P211, DOI 10.1016/j.tips.2006.02.004; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Woulfe D, 2001, J CLIN INVEST, V107, P1503, DOI 10.1172/JCI13361; Yang D, 2010, J THROMB HAEMOST, V8, P817, DOI 10.1111/j.1538-7836.2010.03769.x; Yang ZQ, 2005, CIRCULATION, V111, P2190, DOI 10.1161/01.CIR.0000163586.62253.A5	103	470	485	5	74	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 13	2012	367	24					2322	2333		10.1056/NEJMra1205750	http://dx.doi.org/10.1056/NEJMra1205750			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HF	23234515	Green Accepted			2022-12-28	WOS:000312187700006
J	Kale, J; Liu, Q; Leber, B; Andrews, DW				Kale, Justin; Liu, Qian; Leber, Brian; Andrews, David W.			Shedding Light on Apoptosis at Subcellular Membranes	CELL			English	Review							ENDOPLASMIC-RETICULUM; BCL-XL; BAX; CELLS; ACTIVATION; PROTEINS; BINDING; FAMILY; PERMEABILIZATION; AUTOPHAGY	Regulation of apoptosis by Bcl-2 family proteins is a paradigm for complex protein-protein and protein-membrane systems. Elucidating the molecular mechanisms of these interactions in vitro in live cells and in animal studies has been significantly enhanced by using fluorescence techniques.	[Kale, Justin; Liu, Qian; Leber, Brian; Andrews, David W.] McMaster Univ, Dept Biochem, Hamilton, ON L8S 4L8, Canada; [Kale, Justin; Liu, Qian; Leber, Brian; Andrews, David W.] McMaster Univ, Dept Biomed Sci, Hamilton, ON L8S 4L8, Canada; [Leber, Brian] McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada	McMaster University; McMaster University; McMaster University	Andrews, DW (corresponding author), Univ Toronto, Sunnybrook Res Inst, 100 Coll St, Toronto, ON M5S 1A8, Canada.	david.andrews@sri.utoronto.ca	Kale, Justin/AAO-6023-2020	Kale, Justin/0000-0002-4915-0806; Andrews, David/0000-0002-9266-7157; Leber, Brian/0000-0001-5502-1480	Canadian Institute of Health Research (CIHR) [FRN12517]; Tier I Canada Research Chair in Membrane Biogenesis; Canadian Breast Cancer Foundation, Ontario Division	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Tier I Canada Research Chair in Membrane Biogenesis(Canada Research Chairs); Canadian Breast Cancer Foundation, Ontario Division	The work in the authors' laboratory is supported by grant FRN12517 from the Canadian Institute of Health Research (CIHR) to D.W.A. and B.L. and by a Tier I Canada Research Chair in Membrane Biogenesis to D.W.A. J.K. and Q.L. are recipients of a doctoral and a postdoctoral fellowship, respectively, from the Canadian Breast Cancer Foundation, Ontario Division.	Aranovich A, 2012, MOL CELL, V45, P754, DOI 10.1016/j.molcel.2012.01.030; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Chonghaile TN, 2008, ONCOGENE, V27, pS149, DOI 10.1038/onc.2009.52; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Dumitru R, 2012, MOL CELL, V46, P573, DOI 10.1016/j.molcel.2012.04.002; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Ehrhardt H, 2011, BLOOD, V118, P6123, DOI 10.1182/blood-2010-02-269811; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gavathiotis E, 2012, NAT CHEM BIOL, V8, P639, DOI [10.1038/NCHEMBIO.995, 10.1038/nchembio.995]; He HL, 1997, J CELL BIOL, V138, P1219, DOI 10.1083/jcb.138.6.1219; Heath-Engel HM, 2008, ONCOGENE, V27, P6419, DOI 10.1038/onc.2008.309; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kutuk O, 2008, CURR MOL MED, V8, P102; Leber B, 2010, ONCOGENE, V29, P5221, DOI 10.1038/onc.2010.283; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Merino D, 2012, BLOOD, V119, P5807, DOI 10.1182/blood-2011-12-400929; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Zhou FF, 2010, MOL IMAGING BIOL, V12, P63, DOI 10.1007/s11307-009-0235-y	20	60	64	2	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1179	1184		10.1016/j.cell.2012.11.013	http://dx.doi.org/10.1016/j.cell.2012.11.013			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217705	Bronze			2022-12-28	WOS:000311999900009
J	Ashley, SF; Parks, GT; Nuttall, WJ; Boxall, C; Grimes, RW				Ashley, Stephen F.; Parks, Geoffrey T.; Nuttall, William J.; Boxall, Colin; Grimes, Robin W.			Thorium fuel has risks	NATURE			English	Editorial Material									[Ashley, Stephen F.; Parks, Geoffrey T.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Nuttall, William J.] Open Univ, Dept Design,Dev Environm & Mat, Milton Keynes MK7 6AA, Bucks, England; [Boxall, Colin] Univ Lancaster, Dept Engn, Lancaster, England; [Grimes, Robin W.] Univ London Imperial Coll Sci Technol & Med, Ctr Nucl Engn, London, England	University of Cambridge; Open University - UK; Lancaster University; Imperial College London	Ashley, SF (corresponding author), Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England.	sfa24@cam.ac.uk		boxall, colin/0000-0003-1521-3968; Ashley, Stephen/0000-0001-5139-2209				Alvarez R., 2012, MANAGING URANIUM 233; [Anonymous], 2002, IAEA SAF GLOSS, P19; Codding J. W., 1964, 17007 IDO AT EN COMM; Delpech S, 2009, J FLUORINE CHEM, V130, P11, DOI 10.1016/j.jfluchem.2008.07.009; International Atomic Energy Agency, 1997, INFCIRC540CORR IAEA; KATZIN LI, 1956, J INORG NUCL CHEM, V3, P229, DOI 10.1016/0022-1902(56)80023-7; Moulton D. M., 1970, US Patent, Patent No. [3,495,975, 3495975]; Nicholson E. L., 1972, CONF7205223 OAK RIDG; Shaffer J.H., 1971, USA, Patent, Patent No. 3577225; WHATLEY ME, 1970, NUCL APPL TECHNOL, V8, P170, DOI 10.13182/NT70-A28623	10	57	61	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					31	33		10.1038/492031a	http://dx.doi.org/10.1038/492031a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23222590	Bronze			2022-12-28	WOS:000311893400025
J	Kulier, R; Gulmezoglu, AM; Zamora, J; Plana, MN; Carroli, G; Cecatti, JG; Germar, MJ; Pisake, L; Mittal, S; Pattinson, R; Wolomby-Molondo, JJ; Bergh, AM; May, W; Souza, JP; Koppenhoefer, S; Khan, KS				Kulier, Regina; Guelmezoglu, Ahmet Metin; Zamora, Javier; Nieves Plana, M.; Carroli, Guillermo; Cecatti, Jose G.; Germar, Maria J.; Pisake, Lumbiganon; Mittal, Sunneeta; Pattinson, Robert; Wolomby-Molondo, Jean-Jose; Bergh, Anne-Marie; May, Win; Souza, Joao Paulo; Koppenhoefer, Shawn; Khan, Khalid S.			Effectiveness of a Clinically Integrated e-Learning Course in Evidence-Based Medicine for Reproductive Health Training A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EDUCATIONAL ENVIRONMENT; VALIDATION; QUESTIONNAIRE; PROFESSIONS; EVALUATE	Context For evidence-based practice to embed culturally in the workplace, teaching of evidence-based medicine(EBM) should be clinically integrated. In low-middle-in come countries (LMICs) there is a scarcity of EBM-trained clinical tutors, lack of protected time for teaching EBM, and poor access to relevant databases in languages other than English. Objective To evaluate the effects of a clinically integrated e-learning EBM course incorporating the World Health Organization( WHO) Reproductive Health Library(RHL) on knowledge, skills, and educational environment compared with traditional EBM teaching. Design, Setting, and Participants International cluster randomized trial conducted between April 2009 and November 2010 among postgraduate trainees in obstetrics-gynecology in 7 LMICs (Argentina, Brazil, Democratic Republic of the Congo, India, Philippines, South Africa, Thailand). Each training unit was randomized to an experimental clinically integrated course consisting of e-modules using the RHL for learning activities and trainee assessments (31 clusters, 123 participants) or to a control self-directed EBM course incorporating the RHL (29 clusters, 81 participants). A facilitator with EBM teaching experience was available at all teaching units. Courses were administered for 8 weeks, with assessments at baseline and 4 weeks after course completion. The study was completed in 24 experimental clusters (98 participants) and 22 control clusters (68 participants). Main Outcome Measures Primary outcomes were change in EBM knowledge (score range, 0-62) and skills (score range, 0-14). Secondary outcome was educational environment (5-point Likert scale anchored between 1 [strongly agree] and 5 [strongly disagree]). Results At baseline, the study groups were similar in age, year of training, and EBM-related attitudes and knowledge. After the trial, the experimental group had higher mean scores in knowledge (38.1 [95% CI, 36.7 to 39.4] in the control group vs 43.1 [95% CI, 42.0 to 44.1] in the experimental group; adjusted difference, 4.9 [95% CI, 2.9 to 6.8]; P<.001) and skills (8.3 [95% CI, 7.9 to 8.7] vs 9.1 [95% CI, 8.7 to 9.4]; adjusted difference, 0.7 [95% CI, 0.1 to 1.3]; P=.02). Although there was no difference in improvement for the overall score for educational environment (6.0 [95% CI, -0.1 to 12.0] vs 13.6 [95% CI, 8.0 to 19.2]; adjusted difference, 9.6 [95% CI, -6.8 to 26.1]; P=.25), there was an associated mean improvement in the domains of general relationships and support (-0.5 [95% CI, -1.5 to 0.4] vs 0.3 [95% CI, -0.6 to 1.1]; adjusted difference, 2.3 [95% CI, 0.2 to 4.3]; P=.03) and EBM application opportunities (0.5[95% CI, -0.7 to 1.8] vs 2.9 [95%, CI, 1.8 to 4.1]; adjusted difference, 3.3 [95% CI, 0.1 to 6.5]; P=.04). Conclusion In a group of LMICs, a clinically integrated e-learning EBM curriculum in reproductive health compared with a self-directed EBM course resulted in higher knowledge and skill scores and improved educational environment.	[Khan, Khalid S.] Queen Mary Univ London, Barts & London Sch Med & Dent, Womens Hlth Res Unit, London E1 2AD, England; [Kulier, Regina] WHO, Dept Res Policy & Cooperat, CH-1211 Geneva, Switzerland; [Guelmezoglu, Ahmet Metin; Souza, Joao Paulo] WHO, UNDP UNFPA WHO World Bank Special Programme Res D, CH-1211 Geneva, Switzerland; [Zamora, Javier; Nieves Plana, M.] Hosp Ramon y Cajal IRYCIS, Clin Biostat Unit, Madrid, Spain; [Zamora, Javier; Nieves Plana, M.] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Carroli, Guillermo] CREP, Rosario, Santa Fe, Argentina; [Cecatti, Jose G.] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil; [Germar, Maria J.] Univ Philippines, Coll Med, Dept Obstet & Gynecol, Philippine Gen Hosp, Manila, Philippines; [Pisake, Lumbiganon] Khon Kaen Univ, Fac Med, Dept Obstet & Gynecol, Khon Kaen, Thailand; [Mittal, Sunneeta] All India Inst Med Sci, Dept Obstet & Gynecol, New Delhi, India; [Pattinson, Robert; Bergh, Anne-Marie] Univ Pretoria, MRC, Maternal & Infant Hlth Care Res Unit, ZA-0002 Pretoria, South Africa; [Wolomby-Molondo, Jean-Jose] Clin Univ Kinshasa, Dept Gynecol & Obstet, Kinshasa, DEM REP CONGO; [May, Win] Univ So Calif, Keck Sch Med, Dept Med Educ, Los Angeles, CA 90033 USA; [Koppenhoefer, Shawn] Ecole Polytech Fed Lausanne, Lausanne, Switzerland	University of London; Queen Mary University London; World Health Organization; United Nations Population Fund; World Health Organization; Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidade Estadual de Campinas; University of the Philippines System; University of the Philippines Manila; Khon Kaen University; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Pretoria; Universite de Kinshasa; University of Southern California; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Khan, KS (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Womens Hlth Res Unit, Tumer St, London E1 2AD, England.	k.s.khan@qmul.ac.uk	May, Win/W-4981-2017; Zamora, Javier/AEO-0608-2022; Plana, Maria Nieves/AAQ-8897-2020; Souza, João Paulo/G-1982-2010; Zamora, Javier/B-1722-2009; Cecatti, Jose Guilherme/M-5945-2013; Khan, Khalid S/AAT-8824-2020	May, Win/0000-0002-7040-3484; Zamora, Javier/0000-0003-4901-588X; Souza, João Paulo/0000-0002-2288-4244; Zamora, Javier/0000-0003-4901-588X; Cecatti, Jose Guilherme/0000-0003-1285-8445; Khan, Khalid S/0000-0001-5084-7312; Plana, Maria Nieves/0000-0003-0921-7954	UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, World Health Organization; European Union Leonardo da Vinci Vocational Training Action Programme [UK/05/B/F/PP-162_349]; European Union [101377, 247613]; Canadian Institutes of Health Research	UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, World Health Organization; European Union Leonardo da Vinci Vocational Training Action Programme; European Union(European Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This trial was funded by the UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research, World Health Organization. The initial development and piloting of the e-learning course was funded by the European Union Leonardo da Vinci Vocational Training Action Programme (project grant UK/05/B/F/PP-162_349). Drs Zamora and Khan used funding from European Union made available to the EBM-CONNECT Collaboration through its Seventh Framework Programme, Marie Curie Actions, International Staff Exchange Scheme (proposal 101377; grant agreement 247613) for data analysis and drafting the manuscript. The EBM-CONNECT (Evidence-Based Medicine COllaboratioN: NEtwork for systematic reviews and guideline development researCh and disseminaTion) Collaboration (in alphabetical order by country): L. Mignini, Centro Rosarino de Estudios Perinatales, Argentina; P. von Dadelszen, L. Magee, D. Sawchuck, University of British Columbia, Canada; E. Gao, Shanghai Institute of Planned Parenthood Research, China; B. W. Mol, K. Oude Rengerink, Academic Medical Centre, the Netherlands; J. Zamora, Ramon y Cajal, Spain; C. Fox, J. Daniels, University of Birmingham; and K. S. Khan, S. Thangaratinam, C. Meads, Barts and the London School of Medicine, Queen Mary University of London, United Kingdom. The EBM-CONNECT Canadian Collaborators receive funding from the Canadian Institutes of Health Research.	Belfield C, 2001, MED TEACH, V23, P164, DOI 10.1080/0142150020031084; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Cohen J., 1988, STAT POWER ANAL BEHA, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; Cook TD, 2002, EDUC EVAL POLICY AN, V24, P175, DOI 10.3102/01623737024003175; Coppus Sjors F P J, 2007, BMC Med Educ, V7, P46, DOI 10.1186/1472-6920-7-46; Davis James, 2007, BMC Med Educ, V7, P23, DOI 10.1186/1472-6920-7-23; Davis J, 2008, ARCHIT DIGEST, V65, P30; Fritsche L, 2002, BMJ-BRIT MED J, V325, P1338, DOI 10.1136/bmj.325.7376.1338; Gulmezoglu AM, 2007, BJOG-INT J OBSTET GY, V114, P16, DOI 10.1111/j.1471-0528.2006.01091.x; Hadley J, 2010, J ROY SOC MED, V103, P288, DOI 10.1258/jrsm.2010.100036; Hatala R, 2006, J GEN INTERN MED, V21, P538, DOI 10.1111/j.1525-1497.2006.00445.x; Holt MC, 2004, MED TEACH, V26, P553, DOI 10.1080/01421590410001711599; Hutchinson L, 2003, BRIT MED J, V326, P810, DOI 10.1136/bmj.326.7393.810; Keogh-Brown M R, 2007, Health Technol Assess, V11, pix; Khan Khalid S, 2006, BMC Med Educ, V6, P59, DOI 10.1186/1472-6920-6-59; Kulier R, 2008, BJOG-INT J OBSTET GY, V115, P1197, DOI 10.1111/j.1471-0528.2008.01821.x; Kulier R, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-8; Kulier R, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-21; Kulier R, 2008, BMC MED EDUC, V8, DOI 10.1186/1472-6920-8-27; Kunz R, 2009, J EVAL CLIN PRACT, V15, P1196, DOI 10.1111/j.1365-2753.2009.01268.x; Malick SM, 2010, J ROY SOC MED, V103, P231, DOI 10.1258/jrsm.2010.100105; Pell G, 2005, MED EDUC, V39, P970, DOI 10.1111/j.1365-2929.2005.02237.x; Ramos KD, 2003, BRIT MED J, V326, P319, DOI 10.1136/bmj.326.7384.319; Rengerink KO, 2011, MED TEACH, V33, pe125, DOI 10.3109/0142159X.2011.542520; Richardson W Scott, 2005, ACP J Club, V143, pA10; Roff S, 2005, MED TEACH, V27, P322, DOI 10.1080/01421590500151054; Soemantri D, 2010, MED TEACH, V32, P947, DOI 10.3109/01421591003686229; Straus SE, 2004, BRIT MED J, V329, P1029, DOI 10.1136/bmj.329.7473.1029; Taylor R, 2001, MED EDUC, V35, P544, DOI 10.1046/j.1365-2923.2001.00916.x; Torgerson CJ, 2002, MED EDUC, V36, P1002, DOI 10.1046/j.1365-2923.2002.01335.x; Vieira JE, 2008, CLINICS, V63, P741, DOI 10.1590/S1807-59322008000600006; Weberschock Tobias, 2013, Evid Based Med, V18, P170, DOI 10.1136/eb-2012-100801; World Health Organization (WHO), RHL WHO REPR HLTH LI	33	41	44	0	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2012	308	21					2218	2225		10.1001/jama.2012.33640	http://dx.doi.org/10.1001/jama.2012.33640			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047HI	23212499	Bronze			2022-12-28	WOS:000311829500013
J	Yeates, P; O'Neill, P; Mann, K; Eva, KW				Yeates, Peter; O'Neill, Paul; Mann, Karen; Eva, Kevin W.			Effect of Exposure to Good vs Poor Medical Trainee Performance on Attending Physician Ratings of Subsequent Performances	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WORKPLACE-BASED ASSESSMENT; CLINICAL COMPETENCE; CONTROLLED-TRIAL; JUDGMENT; CONSEQUENCES; ACTIVATION; VALUES; SCORES	Context Competency-based models of education require assessments to be based on individuals' capacity to perform, yet the nature of human judgment may fundamentally limit the extent to which such assessment is accurately possible. Objective To determine whether recent observations of the Mini Clinical Evaluation Exercise (Mini-CEX) performance of postgraduate year 1 physicians influence raters' scores of subsequent performances, consistent with either anchoring bias (scores biased similar to previous experience) or contrast bias (scores biased away from previous experience). Design, Setting, and Participants Internet-based randomized, blinded experiment using videos of Mini-CEX assessments of postgraduate year 1 trainees interviewing new internal medicine patients. Participants were 41 attending physicians from England and Wales experienced with the Mini-CEX, with 20 watching and scoring 3 good trainee performances and 21 watching and scoring 3 poor performances. All then watched and scored the same 3 borderline video performances. The study was completed between July and November 2011. Main Outcome Measures The primary outcome was scores assigned to the borderline videos, using a 6-point Likert scale (anchors included: 1, well below expectations; 3, borderline; 6, well above expectations). Associations were tested in a multi-variable analysis that included participants' sex, years of practice, and the stringency index (within-group z score of initial 3 ratings). Results The mean rating scores assigned by physicians who viewed borderline video performances following exposure to good performances was 2.7 (95% CI, 2.4-3.0) vs 3.4 (95% CI, 3.1-3.7) following exposure to poor performances (difference of 0.67 [95% CI, 0.28-1.07]; P=.001). Borderline videos were categorized as consistent with failing scores in 33 of 60 assessments (55%) in those exposed to good performances and in 15 of 63 assessments (24%) in those exposed to poor performances (P<.001). They were categorized as consistent with passing scores in 5 of 60 assessments (8.3%) in those exposed to good performances compared with 25 of 63 assessments (39.5%) in those exposed to poor performances (P<.001). Sex and years of attending practice were not associated with scores. The priming condition (good vs poor performances) and the stringency index jointly accounted for 45% of the observed variation in raters' scores for the borderline videos (P<.001). Conclusion In an experimental setting, attending physicians exposed to videos of good medical trainee performances rated subsequent borderline performances lower than those who had been exposed to poor performances, consistent with a contrast bias. JAMA. 2012;308(21):2226-2232 www.jama.com	[Yeates, Peter; O'Neill, Paul] Univ S Manchester Hosp, Manchester M23 9LT, Lancs, England; [Yeates, Peter] Univ Manchester, Sch Translat Med, Manchester, Lancs, England; [O'Neill, Paul; Mann, Karen] Univ Manchester, Sch Med, Manchester, Lancs, England; [Mann, Karen] Dalhousie Univ, Div Med Educ, Halifax, NS, Canada; [Eva, Kevin W.] Univ British Columbia, Dept Med, Ctr Hlth Educ Scholarship, Vancouver, BC, Canada	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; University of Manchester; Dalhousie University; University of British Columbia	Yeates, P (corresponding author), Univ S Manchester Hosp, Southmoor Rd, Manchester M23 9LT, Lancs, England.	peter.yeates@manchester.ac.uk		Yeates, Peter/0000-0001-6316-4051	Medtronic Inc; Social Sciences and Research Council of Canada; Association for the Study of Medical Education; National Institute for Health Research [ACF-2006-06-008] Funding Source: researchfish	Medtronic Inc(Medtronic); Social Sciences and Research Council of Canada; Association for the Study of Medical Education; National Institute for Health Research(National Institute for Health Research (NIHR))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Yeates reported receiving reimbursement for travel costs from Medtronic Inc to attend a meeting to discuss future collaboration on an unrelated research project. Dr Mann reported receiving honoraria for her role as chair of the objectives committee for the Medical Council of Canada; receiving grant income from the Social Sciences and Research Council of Canada (coinvestigator) for a project on technology in a new curriculum and from the Society for Academic CME for a project on a study of facilitated reflection; and receiving reimbursement for travel costs (without additional honoraria) for invited guest speaker engagements at Durham University, UK, in July 2012, Utrecht Medical Centre in March 2012, and at University College London, UK, in June 2012. No other authors reported conflicts of interest.; Dr Yeates received a traveling fellowship award from the Association for the Study of Medical Education that was used in support of this study.	Carifio J, 2008, MED EDUC, V42, P1150, DOI 10.1111/j.1365-2923.2008.03172.x; Chapman GB, 1999, ORGAN BEHAV HUM DEC, V79, P115, DOI 10.1006/obhd.1999.2841; Cook DA, 2009, J GEN INTERN MED, V24, P74, DOI 10.1007/s11606-008-0842-3; Crowley RS, 2013, ADV HEALTH SCI EDUC, V18, P343, DOI 10.1007/s10459-012-9374-z; Donato AA, 2008, MED EDUC, V42, P1234, DOI 10.1111/j.1365-2923.2008.03230.x; Eva KW, 2005, MED EDUC, V39, P98, DOI 10.1111/j.1365-2929.2004.01972.x; General Medical Council, LIST REG MED PRACT S; GLASS GV, 1972, REV EDUC RES, V42, P237, DOI 10.2307/1169991; Govaerts MJB, 2011, ADV HEALTH SCI EDUC, V16, P151, DOI 10.1007/s10459-010-9250-7; Greifeneder R, 2010, BRIT J SOC PSYCHOL, V49, P405, DOI 10.1348/014466609X479699; Hawkins RE, 2010, ACAD MED, V85, P1453, DOI 10.1097/ACM.0b013e3181eac3e6; Ilgen JS, 2011, ACAD EMERG MED, V18, pS79, DOI 10.1111/j.1553-2712.2011.01182.x; Kogan JR, 2011, MED EDUC, V45, P1048, DOI 10.1111/j.1365-2923.2011.04025.x; McManus I C, 2006, BMC Med Educ, V6, P42, DOI 10.1186/1472-6920-6-42; Mitchell C, 2011, MED EDUC, V45, P1190, DOI 10.1111/j.1365-2923.2011.04056.x; Mussweiler T, 2003, PSYCHOL REV, V110, P472, DOI 10.1037/0033-295X.110.3.472; National Health Service, SPEC TRAIN; Newble D, 2004, MED EDUC, V38, P199, DOI 10.1111/j.1365-2923.2004.01755.x; Norcini JJ, 2005, CLIN TEACH, V2, P25, DOI 10.1111/j.1743-498X.2005.00060.x; Ramineni C, 2007, ACAD MED, V82, pS101, DOI 10.1097/ACM.0b013e3181405bbf; Riva P, 2011, J PAIN SYMPTOM MANAG, V42, P265, DOI 10.1016/j.jpainsymman.2010.10.264; Schwarz N, 1999, AM PSYCHOL, V54, P93, DOI 10.1037/0003-066X.54.2.93; STEVENS SS, 1946, SCIENCE, V103, P677, DOI 10.1126/science.103.2684.677; Stewart N, 2005, PSYCHOL REV, V112, P881, DOI 10.1037/0033-295X.112.4.881; Wass V, 2001, LANCET, V357, P945, DOI 10.1016/S0140-6736(00)04221-5; Wilkinson JR, 2008, MED EDUC, V42, P364, DOI 10.1111/j.1365-2923.2008.03010.x; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; Yeates P, 2013, ADV HEALTH SCI EDUC, V18, P325, DOI 10.1007/s10459-012-9372-1	28	33	33	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2012	308	21					2226	2232		10.1001/jama.2012.36515	http://dx.doi.org/10.1001/jama.2012.36515			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	047HI	23212500	Green Published, Bronze			2022-12-28	WOS:000311829500014
J	Kay, M				Kay, Meera			TOBACCO CONTROL Gutkha wars: India toughens up on oral tobacco use	BRITISH MEDICAL JOURNAL			English	Editorial Material												meerakay@ymail.com						Daily Bhaskar, 2012, DAILY BHASKAR; Daily News and Analysis, 2012, DAILY NEWS ANAL CANC; Ghosh Abantika, 2012, INDIAN EXPRESS; Gupta PC, 2003, RESPIROLOGY, V8, P419, DOI 10.1046/j.1440-1843.2003.00507.x; John RM., 2010, EC TOBACCO TOBACCO T; Ministry of Health and Family Welfare, 2009, GLOBAL ADULT TOBACCO; Sinha D. N, 2004, REPORT ORAL TOBACCO, P3	7	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 4	2012	345								e8238	10.1136/bmj.e8238	http://dx.doi.org/10.1136/bmj.e8238			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	052HY	23212964				2022-12-28	WOS:000312189700007
J	Daszak, P				Daszak, Peter			Anatomy of a pandemic	LANCET			English	Editorial Material							INFECTIOUS-DISEASES; ZOONOSIS; ORIGIN; VIRUS		EcoHlth Alliance, New York, NY 10001 USA	EcoHealth Alliance	Daszak, P (corresponding author), EcoHlth Alliance, New York, NY 10001 USA.	daszak@ecohealthalliance.org	daszak, peter/U-4588-2017	daszak, peter/0000-0002-2046-5695	NIGMS NIH HHS [R01 GM100471] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100471] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Davis S, 2004, SCIENCE, V304, P736, DOI 10.1126/science.1095854; Dobson AP, 1996, BIOSCIENCE, V46, P115, DOI 10.2307/1312814; Furuse Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-52; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X; Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9; Li Y, 2007, P NATL ACAD SCI USA, V104, P15787, DOI 10.1073/pnas.0609268104; Morse SS, 2012, PREDICT BUILDING GLO, V380, P1956; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Pulliam JRC, 2012, J R SOC INTERFACE, V9, P89, DOI 10.1098/rsif.2011.0223; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997	14	20	21	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2012	380	9857					1883	1884		10.1016/S0140-6736(12)61887-X	http://dx.doi.org/10.1016/S0140-6736(12)61887-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	046IK	23200486	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000311758500004
J	Williams, C; Hoppe, HJ; Rezgui, D; Strickland, M; Forbes, BE; Grutzner, F; Frago, S; Ellis, RZ; Wattana-Amorn, P; Prince, SN; Zaccheo, OJ; Nolan, CM; Mungall, AJ; Jones, EY; Crump, MP; Hassan, AB				Williams, Christopher; Hoppe, Hans-Juergen; Rezgui, Dellel; Strickland, Madeleine; Forbes, Briony E.; Grutzner, Frank; Frago, Susana; Ellis, Rosamund Z.; Wattana-Amorn, Pakorn; Prince, Stuart N.; Zaccheo, Oliver J.; Nolan, Catherine M.; Mungall, Andrew J.; Jones, E. Yvonne; Crump, Matthew P.; Hassan, A. Bassim			An Exon Splice Enhancer Primes IGF2:IGF2R Binding Site Structure and Function Evolution	SCIENCE			English	Article							GROWTH-FACTOR-II; 6-PHOSPHATE RECEPTOR; INSIGHTS; ORIGIN	Placental development and genomic imprinting coevolved with parental conflict over resource distribution to mammalian offspring. The imprinted genes IGF2 and IGF2R code for the growth promoter insulin-like growth factor 2 (IGF2) and its inhibitor, mannose 6-phosphate (M6P)/IGF2 receptor (IGF2R), respectively. M6P/IGF2R of birds and fish do not recognize IGF2. In monotremes, which lack imprinting, IGF2 specifically bound M6P/IGF2R via a hydrophobic CD loop. We show that the DNA coding the CD loop in monotremes functions as an exon splice enhancer (ESE) and that structural evolution of binding site loops (AB, HI, FG) improved therian IGF2 affinity. We propose that ESE evolution led to the fortuitous acquisition of IGF2 binding by M6P/IGF2R that drew IGF2R into parental conflict; subsequent imprinting may then have accelerated affinity maturation.	[Hoppe, Hans-Juergen; Rezgui, Dellel; Frago, Susana; Prince, Stuart N.; Zaccheo, Oliver J.; Hassan, A. Bassim] Univ Oxford, Sir William Dunn Sch Pathol, Oxford Mol Pathol Inst, Canc Res UK Tumour Growth Control Grp, Oxford OX1 3RE, England; [Williams, Christopher; Strickland, Madeleine; Ellis, Rosamund Z.; Wattana-Amorn, Pakorn; Crump, Matthew P.] Univ Bristol, Sch Chem, Dept Organ & Biol Chem, Bristol BS8 1TS, Avon, England; [Forbes, Briony E.; Grutzner, Frank] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Nolan, Catherine M.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Mungall, Andrew J.] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Jones, E. Yvonne] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Canc Res UK Receptor Struct Res Grp, Oxford OX3 7BN, England	University of Oxford; University of Bristol; University of Adelaide; University College Dublin; British Columbia Cancer Agency; Cancer Research UK; University of Oxford; Wellcome Centre for Human Genetics	Hassan, AB (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Oxford Mol Pathol Inst, Canc Res UK Tumour Growth Control Grp, S Parks Rd, Oxford OX1 3RE, England.	matt.crump@bristol.ac.uk; bass.hassan@path.ox.ac.uk	Mungall, Andrew J./U-7067-2018; Wiliams, Christopher/P-4904-2015; Grutzner, Frank/ABB-2820-2021; Frago, Susana/L-1477-2017; Strickland, Madeleine/L-8425-2019; Jones, Yvonne/J-2293-2016; Wattana-Amorn, Pakorn/GPK-6717-2022; Jones, Yvonne/N-8111-2019; Forbes, Briony/R-1838-2019; Grutzner, Frank/AAD-5834-2020	Mungall, Andrew J./0000-0002-0905-2742; Wiliams, Christopher/0000-0001-5806-9842; Grutzner, Frank/0000-0002-3088-7314; Frago, Susana/0000-0002-1369-1328; Strickland, Madeleine/0000-0001-8160-070X; Jones, Yvonne/0000-0002-3834-1893; Wattana-Amorn, Pakorn/0000-0002-4780-7122; Jones, Yvonne/0000-0002-3834-1893; Forbes, Briony/0000-0003-4360-9927; Crump, Matthew/0000-0002-7868-5818; Hassan, Andrew/0000-0002-2517-6681; Hoppe, Hans/0000-0002-5107-876X	Cancer Research UK [C429, C375]; Wellcome Trust; Science Foundation Ireland; Algerian Government; National Health and Medical Research Council; Australian Research Council (ARC, Australia);  [EP1945663B];  [US20090304651A]; Cancer Research UK [9891] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Algerian Government; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC, Australia)(Australian Research Council); ; ; Cancer Research UK(Cancer Research UK)	We thank C. Graham, J. Crosby, N. Barclay, C. Ponting, E. Tsend-Ayush, S.-C. Ong, S. Murphy, and N. Proudfoot. Work supported by Cancer Research UK (A.B.H., M.P.C., and E.Y.J., C429, C375), Wellcome Trust (M.P.C. NMR facility), Science Foundation Ireland (C.M.N.), Algerian Government (D.R.), National Health and Medical Research Council and Australian Research Council (ARC, Australia; B.E.F. and F.G. are ARC Research Fellows). The research described in this manuscript is the subject of a worldwide patent application on improved affinity mutants of IGF2R domain 11 IGF2WO2007020402A, granted in Europe as EP1945663B and pending in the United States as US20090304651A. The ensembles of NMR structures and associated NMR chemical shifts have been deposited with the protein database and BioMagResBank with the following accession codes: chicken, 2L21/17110; echidna, 2L5W/17287; opossum, 2L2G/17134; domain 11<SUP>E4</SUP>, 2L2A/17128; domain 11<SUP>E4</SUP>/IGF2 complex, 2L29/17127. The authors declare that there are no competing financial interests.	Brown J, 2002, EMBO J, V21, P1054, DOI 10.1093/emboj/21.5.1054; Brown J, 2008, EMBO J, V27, P265, DOI 10.1038/sj.emboj.7601938; CANFIELD WM, 1989, J BIOL CHEM, V264, P7100; Chess A, 2012, NAT REV GENET, V13, P421, DOI 10.1038/nrg3239; Delaine C, 2007, J BIOL CHEM, V282, P18886, DOI 10.1074/jbc.M700531200; Dewey CN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-311; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; HAIG D, 1991, CELL, V64, P1045; Hore TA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000169; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; Killian JK, 2001, J EXP ZOOL, V291, P205, DOI 10.1002/jez.1070; Killian JK, 2001, HUM MOL GENET, V10, P1721, DOI 10.1093/hmg/10.17.1721; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; LAU MMH, 1994, GENE DEV, V8, P2953, DOI 10.1101/gad.8.24.2953; Pask AJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r1; Renfree MB, 2009, ANNU REV GENOM HUM G, V10, P241, DOI 10.1146/annurev-genom-082908-150026; TRIVERS RL, 1974, AM ZOOL, V14, P249; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; Warnecke T, 2009, BIOCHEM SOC T, V37, P756, DOI 10.1042/BST0370756; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Williams C, 2007, STRUCTURE, V15, P1065, DOI 10.1016/j.str.2007.07.007; Xiao XS, 2007, P NATL ACAD SCI USA, V104, P18583, DOI 10.1073/pnas.0707349104; Yandell CA, 1999, J BIOL CHEM, V274, P27076, DOI 10.1074/jbc.274.38.27076; Zaccheo OJ, 2006, J MOL BIOL, V359, P403, DOI 10.1016/j.jmb.2006.03.046	24	30	31	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1209	1213		10.1126/science.1228633	http://dx.doi.org/10.1126/science.1228633			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197533	Green Accepted			2022-12-28	WOS:000311666200046
J	Messerli, FH; Bangalore, S				Messerli, Franz H.; Bangalore, Sripal			Diuretic-based regimens for obese patients?	LANCET			English	Editorial Material							HEART-FAILURE; HYPERTENSION; RISK; METAANALYSIS		[Messerli, Franz H.] Columbia Univ Coll Phys & Surg, St Lukes Roosevelt Hosp, Div Cardiol, New York, NY 10019 USA; [Bangalore, Sripal] NYU, Sch Med, New York, NY USA	Columbia University; Mount Sinai St. Luke's; Mount Sinai West; New York University	Messerli, FH (corresponding author), Columbia Univ Coll Phys & Surg, St Lukes Roosevelt Hosp, Div Cardiol, New York, NY 10019 USA.	messerli.f@gmail.com	Messerli, Franz/AAR-4783-2021	Bangalore, Sripal/0000-0001-9485-0652				Bakris G, 2006, DIABETES CARE, V29, P2592, DOI 10.2337/dc06-1373; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; FREIS ED, 1960, PHYSIOL REV, V40, P27, DOI 10.1152/physrev.1960.40.1.27; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; McGavock JM, 2006, ANN INTERN MED, V144, P517, DOI 10.7326/0003-4819-144-7-200604040-00011; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; MESSERLI FH, 1982, LANCET, V1, P1165; MESSERLI FH, 1987, ANN INTERN MED, V107, P158, DOI 10.7326/0003-4819-107-2-158; Messerli FH, 2008, CIRCULATION, V117, P2706, DOI 10.1161/CIRCULATIONAHA.107.695007; National Institute for Health and Clinical Excellence, 2011, CLIN MAN PRIM HYP AD; Weber MA, 2012, LANCET	16	3	3	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2013	381	9866					512	513		10.1016/S0140-6736(12)61819-4	http://dx.doi.org/10.1016/S0140-6736(12)61819-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089RK	23219285				2022-12-28	WOS:000314927500006
J	Vincent, JL; Preiser, JC				Vincent, Jean-Louis; Preiser, Jean-Charles			When should we add parenteral to enteral nutrition?	LANCET			English	Editorial Material							CRITICALLY-ILL PATIENTS; ENERGY-BALANCE; PROVISION; PROTEIN; GUIDELINES; SUPPORT		[Vincent, Jean-Louis; Preiser, Jean-Charles] Univ Libre Brussels, Dept Intens Care, Erasme Univ Hosp, B-1070 Brussels, Belgium	Universite Libre de Bruxelles	Vincent, JL (corresponding author), Univ Libre Brussels, Dept Intens Care, Erasme Univ Hosp, B-1070 Brussels, Belgium.	jlvincen@ulb.ac.be	Preiser, Jean-Charles/AAL-2355-2021	Preiser, Jean-Charles/0000-0003-3163-0390; Vincent, Jean-Louis/0000-0001-6011-6951				Allingstrup MJ, 2012, CLIN NUTR, V31, P462, DOI 10.1016/j.clnu.2011.12.006; Barr J, 2004, CHEST, V125, P1446, DOI 10.1378/chest.125.4.1446; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Dvir D, 2006, CLIN NUTR, V25, P37, DOI 10.1016/j.clnu.2005.10.010; Heidegger CP, 2012, LANCET; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; Hoffer LJ, 2012, AM J CLIN NUTR, V96, P591, DOI 10.3945/ajcn.111.032078; Martindale RG, 2009, CRIT CARE MED, V37, P1757, DOI 10.1097/CCM.0b013e3181a40116; Singer P, 2009, CLIN NUTR, V28, P387, DOI 10.1016/j.clnu.2009.04.024; Villet S, 2005, CLIN NUTR, V24, P502, DOI 10.1016/j.clnu.2005.03.006; Weijs PJM, 2012, JPEN-PARENTER ENTER, V36, P60, DOI 10.1177/0148607111415109; Wolfe RR, 1999, EUR J CLIN NUTR, V53, pS136, DOI 10.1038/sj.ejcn.1600754	12	26	30	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 2	2013	381	9864					354	355		10.1016/S0140-6736(12)61893-5	http://dx.doi.org/10.1016/S0140-6736(12)61893-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084ZA	23218814				2022-12-28	WOS:000314578900010
J	Ascano, M; Mukherjee, N; Bandaru, P; Miller, JB; Nusbaum, JD; Corcoran, DL; Langlois, C; Munschauer, M; Dewell, S; Hafner, M; Williams, Z; Ohler, U; Tuschl, T				Ascano, Manuel, Jr.; Mukherjee, Neelanjan; Bandaru, Pradeep; Miller, Jason B.; Nusbaum, Jeffrey D.; Corcoran, David L.; Langlois, Christine; Munschauer, Mathias; Dewell, Scott; Hafner, Markus; Williams, Zev; Ohler, Uwe; Tuschl, Thomas			FMRP targets distinct mRNA sequence elements to regulate protein expression	NATURE			English	Article							FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; PAR-CLIP; SYNAPTIC FUNCTION; BINDING PROTEIN; CGG-REPEAT; GENE; IDENTIFICATION; MUTATION; AUTISM	Fragile X syndrome (FXS) is a multi-organ disease that leads to mental retardation, macro-orchidism in males and premature ovarian insufficiency in female carriers. FXS is also a prominent monogenic disease associated with autism spectrum disorders (ASDs). FXS is typically caused by the loss of fragile X mental retardation 1 (FMR1) expression, which codes for the RNA-binding protein FMRP. Here we report the discovery of distinct RNA-recognition elements that correspond to the two independent RNA-binding domains of FMRP, in addition to the binding sites within the messenger RNA targets for wild-type and I304N mutant FMRP isoforms and the FMRP paralogues FXR1P and FXR2P (also known as FXR1 and FXR2). RNA-recognition-element frequency, ratio and distribution determine target mRNA association with FMRP. Among highly enriched targets, we identify many genes involved in ASD and show that FMRP affects their protein levels in human cell culture, mouse ovaries and human brain. Notably, we discovered that these targets are also dysregulated in Fmr1(-/-) mouse ovaries showing signs of premature follicular overdevelopment. These results indicate that FMRP targets share signalling pathways across different cellular contexts. As the importance of signalling pathways in both FXS and ASD is becoming increasingly apparent, our results provide a ranked list of genes as basis for the pursuit of new therapeutic targets for these neurological disorders.	[Ascano, Manuel, Jr.; Bandaru, Pradeep; Miller, Jason B.; Nusbaum, Jeffrey D.; Munschauer, Mathias; Hafner, Markus; Williams, Zev; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA; [Mukherjee, Neelanjan; Corcoran, David L.; Ohler, Uwe] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Langlois, Christine; Williams, Zev] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Program Early & Recurrent Pregnancy Loss, Bronx, NY 10461 USA; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Duke University; Yeshiva University; Albert Einstein College of Medicine; Rockefeller University	Tuschl, T (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA.	uwe.ohler@duke.edu; ttuschl@rockefeller.edu	Hafner, Markus/O-7100-2018; Ascano, Manuel/ABA-3586-2020; Munschauer, Mathias/AAK-2789-2020	Hafner, Markus/0000-0002-4336-6518; Ascano, Manuel/0000-0002-9370-5493; Munschauer, Mathias/0000-0001-6143-4548; Corcoran, David/0000-0001-7460-9247; Mukherjee, Neelanjan/0000-0003-0017-1400; Nusbaum, Jeffrey/0000-0001-5024-8256	NIH/NCRR/RU CCTS [UL1RR024143]; NSF [MCB-0822033]; Simons Foundation Autism Research Initiative [CEN5300891]; NIH [R01 MH080442, K08 HD068546]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD068546] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080442] Funding Source: NIH RePORTER	NIH/NCRR/RU CCTS; NSF(National Science Foundation (NSF)); Simons Foundation Autism Research Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Human tissue was obtained from the NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore. We would like to thank the following members of the Tuschl laboratory for their support and assistance: G. Wardle, N. Renwick and I. Ben-Dov. We would like to thank J. Keene for his advice throughout the project. We would like to acknowledge M. Khorshid, L. Burger and M. Zavolan for analysing PAR-CLIP data at the initial stages of the project and discussions. We would like to thank the Memorial Sloan-Kettering Cancer Center in-situ core for their assistance with the mouse histology. Finally, we would like to express our appreciation to all members of the Tuschl laboratory for their assistance and collegiality. This work was supported, in part, by the following agencies: NIH/NCRR/RU CCTS (M. A., UL1RR024143), NSF (U.O., MCB-0822033), Simons Foundation Autism Research Initiative (T. T., CEN5300891) and NIH (T. T., R01 MH080442; Z.W., K08 HD068546).	Ascano M, 2012, WIRES RNA, V3, P159, DOI 10.1002/wrna.1103; ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; BAKKER CE, 1994, CELL, V78, P23; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bateup HS, 2011, J NEUROSCI, V31, P8862, DOI 10.1523/JNEUROSCI.1617-11.2011; Belmonte MK, 2006, NAT NEUROSCI, V9, P1221, DOI 10.1038/nn1765; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Brown V, 1998, J BIOL CHEM, V273, P15521, DOI 10.1074/jbc.273.25.15521; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Ceman S, 1999, MOL CELL BIOL, V19, P7925; Chevere-Torres I, 2012, NEUROBIOL DIS, V45, P1101, DOI 10.1016/j.nbd.2011.12.028; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Davidovic L, 2007, HUM MOL GENET, V16, P3047, DOI 10.1093/hmg/ddm263; De Rubeis S, 2012, ADV EXP MED BIOL, V970, P517, DOI 10.1007/978-3-7091-0932-8_23; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Fridell RA, 1996, EMBO J, V15, P5408, DOI 10.1002/j.1460-2075.1996.tb00924.x; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Georgiev S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r19; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Gross C, 2012, NEUROPSYCHOPHARMACOL, V37, P178, DOI 10.1038/npp.2011.137; Gross C, 2010, J NEUROSCI, V30, P10624, DOI 10.1523/JNEUROSCI.0402-10.2010; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hagerman R, 2012, RESULTS PROBL CELL D, V54, P297, DOI 10.1007/978-3-642-21649-7_17; Hoell J., 2013, HDB RNA BIOCH, V1; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; Krueger DD, 2011, ANNU REV MED, V62, P411, DOI 10.1146/annurev-med-061109-134644; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Ling SC, 2004, P NATL ACAD SCI USA, V101, P17428, DOI 10.1073/pnas.0408114101; Mahony S, 2007, PLOS COMPUT BIOL, V3, P578, DOI 10.1371/journal.pcbi.0030061; Oostra BA, 2009, BBA-GEN SUBJECTS, V1790, P467, DOI 10.1016/j.bbagen.2009.02.007; Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; VERKERK AJMH, 1993, HUM MOL GENET, V2, P399, DOI 10.1093/hmg/2.4.399; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VINCENT A, 1991, NATURE, V349, P624, DOI 10.1038/349624a0; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052	50	466	474	0	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					382	+		10.1038/nature11737	http://dx.doi.org/10.1038/nature11737			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23235829	Green Accepted			2022-12-28	WOS:000312488200046
J	Schriger, DL; Savage, DF; Altman, DG				Schriger, David L.; Savage, Dan F.; Altman, Douglas G.			Presentation of continuous outcomes in randomised trials: an observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EMPIRICAL-EVIDENCE; CONSORT STATEMENT; PUBLICATION BIAS; RAW DATA; QUALITY; FIGURES; ANYWAY; TABLES	Objective To characterise the percentage of available outcome data being presented in reports of randomised clinical trials with continuous outcome measures, thereby determining the potential for incomplete reporting bias. Design Descriptive cross sectional study. Data sources A random sample of 200 randomised trials from issues of 20 medical journals in a variety of specialties during 2007-09. Main outcome measures For each paper's best reported primary outcome, we calculated the fraction of data reported using explicit scoring rules. For example, a two arm trial with 100 patients per limb that reported 2 sample sizes, 2 means, and 2 standard deviations reported 6/200 data elements (1.5%), but if that paper included a scatterplot with 200 points it would score 200/200 (100%). We also assessed compliance with 2001 CONSORT items about the reporting of results. Results The median percentage of data reported for the best reported continuous outcome was 9% (interquartile range 3-26%) but only 3.5% (3-7%) when we adjusted studies to 100 patients per arm to control for varying study size; 17% of articles showed 100% of the data. Tables were the predominant means of presenting the most data (59% of articles), but papers that used figures reported a higher proportion of data. There was substantial heterogeneity among journals with respect to our primary outcome and CONSORT compliance. Limitations We studied continuous outcomes of randomised trials in higher impact journals. Results may not apply to categorical outcomes, other study designs, or other journals. Conclusions Trialists present only a small fraction of available data. This paucity of data may increase the potential for incomplete reporting bias, a failure to present all relevant information about a study's findings.	[Schriger, David L.; Savage, Dan F.] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA; [Schriger, David L.] Univ Calif Los Angeles, Ctr Emergency Med, Los Angeles, CA 90024 USA; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of Oxford	Schriger, DL (corresponding author), Univ Calif Los Angeles, Sch Med, 924 Westwood Blvd, Los Angeles, CA 90024 USA.	schriger@ucla.edu		Schriger, David/0000-0003-0242-1127	Korein Foundation; Cancer Research UK [C5529]; MRC [MR/J004871/1] Funding Source: UKRI; Medical Research Council [MR/J004871/1] Funding Source: researchfish	Korein Foundation; Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DLS has an unrestricted grant from the Korein Foundation, which has no involvement in the selection or conduct of research projects. DGA receives general support from Cancer Research UK programme grant C5529.	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Broad W., 1982, BETRAYERS TRUTH; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Cooper RJ, 2002, ANN EMERG MED, V40, P317, DOI 10.1067/mem.2002.127327; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Delamothe T, 1996, BRIT MED J, V312, P1241, DOI 10.1136/bmj.312.7041.1241; DICKERSIN K, 1993, ANN NY ACAD SCI, V703, P135, DOI 10.1111/j.1749-6632.1993.tb26343.x; Drummond GB, 2011, J PHYSIOL-LONDON, V589, P1861, DOI 10.1113/jphysiol.2011.205062; Dwan Kerry, 2011, Cochrane Database Syst Rev, pMR000031, DOI 10.1002/14651858.MR000031.pub2; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Gelman A, 2002, AM STAT, V56, P121, DOI 10.1198/000313002317572790; Gotzsche PC, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-249; Groves T, 2010, BIOSTATISTICS, V11, P391, DOI 10.1093/biostatistics/kxq031; Groves T, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1252; Groves T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a3123; Hrynaszkiewicz Iain, 2010, BMJ, V340, pc181, DOI [10.1186/1745-6215-11-9, 10.1136/bmj.c181]; Hutton JL, 2000, J ROY STAT SOC C-APP, V49, P359, DOI 10.1111/1467-9876.00197; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Laine C, 2007, ANN INTERN MED, V146, P450, DOI 10.7326/0003-4819-146-6-200703200-00154; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Pocock SJ, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-36; Royal Society, 2012, SCI OP ENT; Schriger DL, 2006, ANN EMERG MED, V48, P750, DOI 10.1016/j.annemergmed.2006.06.017; Schriger DL, 2011, ANN EMERG MED, V57, P153, DOI 10.1016/j.annemergmed.2010.10.008; Schriger DL, 2010, INT J EPIDEMIOL, V39, P421, DOI 10.1093/ije/dyp370; Schriger DL, 2001, ANN EMERG MED, V37, P75, DOI 10.1067/mem.2001.111570; Schriger DL, 2006, ANN EMERG MED, V48, pe1; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Smyth RMD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7153; Tufte ER, 1990, ENVISIONING INFORM, P51; Vickers AJ, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-15; Wendler D, 2008, ARCH INTERN MED, V168, P1294, DOI 10.1001/archinte.168.12.1294; World Medical Association, 2008, WMA DECL HELS ETH PR; Ziman J. M., 1978, RELIABLE KNOWLEDGE E, P6	37	10	10	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2012	345								e8486	10.1136/bmj.e8486	http://dx.doi.org/10.1136/bmj.e8486			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	059IW	23249670	hybrid, Green Published			2022-12-28	WOS:000312698900002
J	Hawass, Z; Ismail, S; Selim, A; Saleem, SN; Fathalla, D; Wasef, S; Gad, AZ; Saad, R; Fares, S; Amer, H; Gostner, P; Gad, YZ; Pusch, CM; Zink, AR				Hawass, Zahi; Ismail, Somaia; Selim, Ashraf; Saleem, Sahar N.; Fathalla, Dina; Wasef, Sally; Gad, Ahmed Z.; Saad, Rama; Fares, Suzan; Amer, Hany; Gostner, Paul; Gad, Yehia Z.; Pusch, Carsten M.; Zink, Albert R.			CHRISTMAS 2012: YESTERDAY'S WORLD Revisiting the harem conspiracy and death of Ramesses III: anthropological, forensic, radiological, and genetic study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANCIENT DNA	Objective To investigate the true character of the harem conspiracy described in the Judicial Papyrus of Turin and determine whether Ramesses III was indeed killed. Design Anthropological, forensic, radiological, and genetic study of the mummies of Ramesses III and unknown man E, found together and taken from the 20th dynasty of ancient Egypt (circa 1190-1070 BC). Results Computed tomography scans revealed a deep cut in Ramesses III's throat, probably made by a sharp knife. During the mummification process, a Horus eye amulet was inserted in the wound for healing purposes, and the neck was covered by a collar of thick linen layers. Forensic examination of unknown man E showed compressed skin folds around his neck and a thoracic inflation. Unknown man E also had an unusual mummification procedure. According to genetic analyses, both mummies had identical haplotypes of the Y chromosome and a common male lineage. Conclusions This study suggests that Ramesses III was murdered during the harem conspiracy by the cutting of his throat. Unknown man E is a possible candidate as Ramesses III's son Pentawere.	[Zink, Albert R.] European Acad, Inst Mummies & Iceman, I-39100 Bolzano, Italy; [Hawass, Zahi] Supreme Council Antiqu, Cairo, Egypt; [Ismail, Somaia; Gad, Yehia Z.] Natl Res Ctr, Dept Med Mol Genet, Cairo, Egypt; [Ismail, Somaia; Fathalla, Dina; Gad, Ahmed Z.; Saad, Rama; Fares, Suzan] Egyptian Museum, Ancient DNA Lab, Cairo, Egypt; [Selim, Ashraf; Saleem, Sahar N.] Cairo Univ, Dept Radiol, Kasr Al Ainy Fac Med, Cairo, Egypt; [Wasef, Sally] Cairo Univ, Learning Resource Ctr, Kasr Al Ainy Fac Med, Cairo, Egypt; [Gostner, Paul] Cent Hosp Bolzano, Dept Radiodiagnost, Bolzano, Italy; [Pusch, Carsten M.] Univ Tubingen, Inst Human Genet, Div Mol Genet, Tubingen, Germany	European Academy of Bozen-Bolzano; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Krankenhaus Bozen; Eberhard Karls University of Tubingen	Zink, AR (corresponding author), European Acad, Inst Mummies & Iceman, I-39100 Bolzano, Italy.	albert.zink@eurac.edu	Wasef, Sally/L-2853-2016; Zink, Albert/P-4024-2015; Saleem, Sahar N/A-3651-2008; gad, yehia/A-6833-2008	Wasef, Sally/0000-0002-7207-7395; Zink, Albert/0000-0002-1461-747X; Saleem, Sahar N/0000-0001-6713-9099; Amer, Hany/0000-0003-3101-6235; Gad, Ahmed/0000-0002-6149-3414; ismail, somaia/0000-0002-0695-7941; Fathalla, Dina/0000-0003-3845-529X; Ali, Rama/0000-0002-7001-3750; gad, yehia/0000-0002-8432-4541				Aghayev E, 2005, FORENSIC SCI INT, V152, P65, DOI 10.1016/j.forsciint.2005.02.034; Athey TW., 2006, J GENET GENEAL, V2, P34; Breasted JH., 1906, ANCIENT RECORDS EGYT; Brier B, 2006, ARCHAEOLOGY, V59, P36; Forbes R. J., 1964, STUDIES ANCIENT TECH; Hawass Z, 2010, JAMA-J AM MED ASSOC, V303, P638, DOI 10.1001/jama.2010.121; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Iskander Z., 1980, XRAY ATLAS ROYAL MUM; Maspero G., 1889, MISSION ARCHEOLOGIQU, P511; Maspero G., 1886, CR HEBD ACAD SCI, P294; Nerlich AG, 2000, LANCET, V356, P2176, DOI 10.1016/S0140-6736(00)03507-8; Redford S., 2002, HAREM CONSPIRACY MUR; Roberts C, 2008, INT J OSTEOARCHAEOL, V18, P600, DOI 10.1002/oa.966; Shaw I., 1995, BRIT DICT ANCIENT EG, V1995, P133; Smith GE., 1912, ROYAL MUMMIES CATALO; Suarez-Penaranda JM, 2008, J FORENSIC SCI, V53, P720, DOI 10.1111/j.1556-4029.2008.00700.x; Waterfield R, 2008, HISTORIES	17	24	24	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2012	345								e8268	10.1136/bmj.e8268	http://dx.doi.org/10.1136/bmj.e8268			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IU	23247979	Green Published			2022-12-28	WOS:000312698700019
J	Murray, CJL; Ezzati, M; Flaxman, AD; Lim, S; Lozano, R; Michaud, C; Naghavi, M; Salomon, JA; Shibuya, K; Vos, T; Wikler, D; Lopez, AD				Murray, Christopher J. L.; Ezzati, Majid; Flaxman, Abraham D.; Lim, Stephen; Lozano, Rafael; Michaud, Catherine; Naghavi, Mohsen; Salomon, Joshua A.; Shibuya, Kenji; Vos, Theo; Wikler, Daniel; Lopez, Alan D.			GBD 2010: design, definitions, and metrics	LANCET			English	Editorial Material							ADJUSTED LIFE YEARS; GLOBAL BURDEN; SYSTEMATIC ANALYSIS; 187 COUNTRIES; RISK-FACTORS; 21 REGIONS; DISABILITY; DISEASE; MORTALITY; HEALTH		[Murray, Christopher J. L.; Flaxman, Abraham D.; Lim, Stephen; Lozano, Rafael; Naghavi, Mohsen] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England; [Michaud, Catherine] China Med Board, Boston, MA USA; [Salomon, Joshua A.; Wikler, Daniel] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Vos, Theo; Lopez, Alan D.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health; University of Queensland; University of Tokyo	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	cjlm@uw.edu	Salomon, Joshua/S-1929-2019; Lopez, Alan D/F-1487-2010; Lozano, Rafael/T-5352-2018; Salomon, Joshua A/D-3898-2009; Lopez, Alan/AAA-2734-2022	Salomon, Joshua/0000-0003-3929-5515; Lopez, Alan D/0000-0001-5818-6512; Lozano, Rafael/0000-0002-7356-8823; Salomon, Joshua A/0000-0003-3929-5515; Shibuya, Kenji/0000-0003-2528-7530	Medical Research Council [G0801056B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Airoldi M, 2009, HEALTH ECON, V18, P1237, DOI 10.1002/hec.1424; Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2; [Anonymous], 184 U YORK CTR HLTH; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Arnesen T, 2004, HEALTH POLICY, V70, P137, DOI 10.1016/j.healthpol.2003.08.004; Bognar G, 2008, ECON PHILOS, V24, P167, DOI 10.1017/S026626710800179X; Brouwer WBF, 2005, BRIT MED J, V331, P446, DOI 10.1136/bmj.331.7514.446; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Murray, 2002, SUMMARY MEASURES POP, P205; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 1997, J HEALTH ECON, V16, P703, DOI 10.1016/S0167-6296(97)00004-0; Murray CJL, 2003, POP STUD-J DEMOG, V57, P165, DOI 10.1080/0032472032000097083; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Parsonage M, 1992, Health Econ, V1, P71, DOI 10.1002/hec.4730010110; Salomon JA, 2004, BMJ-BRIT MED J, V328, P258, DOI 10.1136/bmj.37963.691632.44; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, 2000, WORLD HLTH REP 2000	26	726	771	3	144	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2012	380	9859					2063	2066		10.1016/S0140-6736(12)61899-6	http://dx.doi.org/10.1016/S0140-6736(12)61899-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23245602				2022-12-28	WOS:000312387000009
J	Zwiers, R; Zantvoord, FWA; Engelaer, FM; van Bodegom, D; van der Ouderaa, FJG; Westendorp, RGJ				Zwiers, R.; Zantvoord, F. W. A.; Engelaer, F. M.; van Bodegom, D.; van der Ouderaa, F. J. G.; Westendorp, R. G. J.			Mortality in former Olympic athletes: retrospective cohort analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALL-CAUSE MORTALITY; PHYSICAL-ACTIVITY; LIFE EXPECTANCY; HEALTH-BENEFITS; SOCCER PLAYERS; LONGEVITY; SPORTS; DISEASE; EXERCISE; INJURIES	Objective To assess the mortality risk in subsequent years (adjusted for year of birth, nationality, and sex) of former Olympic athletes from disciplines with different levels of exercise intensity. Design Retrospective cohort study. Setting Former Olympic athletes. Participants 9889 athletes (with a known age at death) who participated in the Olympic Games between 1896 and 1936, representing 43 types of disciplines with different levels of cardiovascular, static, and dynamic intensity exercise; high or low risk of bodily collision; and different levels of physical contact. Main outcome measure All cause mortality. Results Hazard ratios for mortality among athletes from disciplines with moderate cardiovascular intensity (1.01, 95% confidence interval 0.96 to 1.07) or high cardiovascular intensity (0.98, 0.92 to 1.04) were similar to those in athletes from disciplines with low cardiovascular intensity. The underlying static and dynamic components in exercise intensity showed similar non-significant results. Increased mortality was seen among athletes from disciplines with a high risk of bodily collision (hazard ratio 1.11, 1.06 to 1.15) and with high levels of physical contact (1.16, 1.11 to 1.22). In a multivariate analysis, the effect of high cardiovascular intensity remained similar (hazard ratio 1.05, 0.89 to 1.25); the increased mortality associated with high physical contact persisted (hazard ratio 1.13, 1.06 to 1.21), but that for bodily collision became non-significant (1.03, 0.98 to 1.09) as a consequence of its close relation with physical contact. Conclusions Among former Olympic athletes, engagement in disciplines with high intensity exercise did not bring a survival benefit compared with disciplines with low intensity exercise. Those who engaged in disciplines with high levels of physical contact had higher mortality than other Olympians later in life.	[Zwiers, R.; Zantvoord, F. W. A.; Engelaer, F. M.; van Bodegom, D.; van der Ouderaa, F. J. G.; Westendorp, R. G. J.] Leyden Acad Vital & Ageing, NL-2333 AA Leiden, Netherlands; [Engelaer, F. M.; van Bodegom, D.; Westendorp, R. G. J.] Leiden Univ, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Engelaer, FM (corresponding author), Leyden Acad Vital & Ageing, Rijnsburgerweg 10, NL-2333 AA Leiden, Netherlands.	Engelaer@leydenacademy.nl	Van Der Ouderaa, Frans/AAA-8580-2020	van Bodegom, David/0000-0002-5691-8342				BACKX FJG, 1991, AM J SPORT MED, V19, P124, DOI 10.1177/036354659101900206; Bauman A E, 2004, J Sci Med Sport, V7, P6, DOI 10.1016/S1440-2440(04)80273-1; BEAGLEHOLE R, 1983, NEW ZEAL MED J, V96, P513; Belli S, 2005, EUR J EPIDEMIOL, V20, P237, DOI 10.1007/s10654-004-6879-7; Bianco M, 2007, INT J SPORTS MED, V28, P697, DOI 10.1055/s-2007-964863; BLAIR SN, 1992, ANNU REV PUBL HEALTH, V13, P99, DOI 10.1146/annurev.pu.13.050192.000531; Blair SN, 1996, RES Q EXERCISE SPORT, V67, P193, DOI 10.1080/02701367.1996.10607943; Erlichman J, 2002, Obes Rev, V3, P257, DOI 10.1046/j.1467-789X.2002.00077.x; Gajewski AK, 2008, EUR J EPIDEMIOL, V23, P335, DOI 10.1007/s10654-008-9237-3; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hootman JM, 2007, J ATHL TRAINING, V42, P311; KARVONEN MJ, 1974, MED SCI SPORT EXER, V6, P49; Kokkinos P, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/924945; KUJALA UM, 1994, METABOLISM, V43, P1255, DOI 10.1016/0026-0495(94)90219-4; Kujala UM, 2001, JAMA-J AM MED ASSOC, V285, P44, DOI 10.1001/jama.285.1.44; Kuss O, 2011, SCAND J MED SCI SPOR, V21, pE260, DOI 10.1111/j.1600-0838.2010.01269.x; LEE IM, 1995, JAMA-J AM MED ASSOC, V273, P1179, DOI 10.1001/jama.273.15.1179; Lee IM, 2001, MED SCI SPORT EXER, V33, pS459, DOI 10.1097/00005768-200106001-00016; Lippi G, 2006, CLIN CHEM LAB MED, V44, P322, DOI 10.1515/CCLM.2006.056; Melzer K, 2004, CURR OPIN CLIN NUTR, V7, P641, DOI 10.1097/00075197-200411000-00009; MENOTTI A, 1990, EUR J EPIDEMIOL, V6, P257, DOI 10.1007/BF00150429; Mitchell JH, 2005, J AM COLL CARDIOL, V45, P1364, DOI 10.1016/j.jacc.2005.02.015; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; SARNA S, 1993, MED SCI SPORT EXER, V25, P237; SCHNOHR P, 1971, LANCET, V2, P1364; Sports Reference, 2011, OL STAT HIST; Taioli E, 2007, EUR J PUBLIC HEALTH, V17, P600, DOI 10.1093/eurpub/ckm035; Teramoto M, 2010, J SCI MED SPORT, V13, P410, DOI 10.1016/j.jsams.2009.04.010; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Waterbor J, 1998, NEW ENGL J MED, V318, P1278; Williams MA, 2007, CIRCULATION, V116, P572, DOI 10.1161/CIRCULATIONAHA.107.185214; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; Xie J, 2008, BMJ-BRIT MED J, V336, P258, DOI 10.1136/bmj.39433.616678.25; YAMAJI K, 1977, Journal of Human Ergology, V6, P15	35	30	30	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2012	345								e7456	10.1136/bmj.e7456	http://dx.doi.org/10.1136/bmj.e7456			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056MZ	23241269	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000312495700002
J	Kagan, JC				Kagan, Jonathan C.			Signaling Organelles of the Innate Immune System	CELL			English	Review							TOLL-LIKE RECEPTORS; INTERFERON REGULATORY FACTOR-3; NF-KAPPA-B; RIG-I; PATHOGEN RECOGNITION; ANTIVIRAL RESPONSES; PATTERN-RECOGNITION; ACCESSORY PROTEIN; ADAPTER MOLECULE; DROSOPHILA MYD88	There are at least five families of microbe-detection receptors that function to detect and eradicate potentially infectious microorganisms that enter multicellular eukaryotes. While a multitude of proteins regulating innate immune signal transduction have already been defined, continuous genetic screening for regulators of innate immunity may not yield as significant insight into the operation of these pathways as was obtained in the past. This diminished return on experimental investment suggests that we are approaching the asymptote of genetics-only approaches to study innate immunity. In contrast, it remains unclear how known regulators of innate immunity interact within the infrastructure of mammalian cells to execute their signaling functions. In this Perspective, I first highlight the locations within mammalian cells that permit innate immune signal transduction and then offer a model whereby structurally distinct proteins can be grouped functionally through their ability to assemble platforms of regulators on the signaling organelles of the innate immune system.	[Kagan, Jonathan C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kagan, Jonathan C.] Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Kagan, JC (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	jonathan.kagan@childrens.harvard.edu			National Institutes of Health [AI093589, AI072955]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI072955, R01AI093589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This Perspective was not designed to comprehensively cover all aspects of innate immunity. As such, several important areas of host defense are not discussed or cited. The views expressed reflect my personal opinion and should not be considered a consensus in the field. I would like to thank members of my lab for helpful discussions during preparation of this manuscript. The National Institutes of Health grants AI093589 and AI072955 support the work performed in the laboratory of J.C.K. J.C.K. holds an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Blanco AM, 2008, J NEUROCHEM, V106, P625, DOI 10.1111/j.1471-4159.2008.05425.x; Brikos C, 2007, MOL CELL PROTEOMICS, V6, P1551, DOI 10.1074/mcp.M600455-MCP200; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cambronne ED, 2006, TRAFFIC, V7, P929, DOI 10.1111/j.1600-0854.2006.00446.x; Chiang CY, 2012, J BIOL CHEM, V287, P3704, DOI 10.1074/jbc.C111.328559; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Doyle SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1706; Du X, 1999, BLOOD CELL MOL DIS, V25, P328, DOI 10.1006/bcmd.1999.0262; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gioannini TL, 2007, IMMUNOL RES, V39, P249, DOI 10.1007/s12026-007-0069-0; Gioannini TL, 2005, J ENDOTOXIN RES, V11, P117, DOI 10.1179/096805105X35198; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Goodridge HS, 2012, TRAFFIC, V13, P1062, DOI 10.1111/j.1600-0854.2012.01382.x; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hidmark A, 2012, J IMMUNOL, V189, P2717, DOI 10.4049/jimmunol.1200898; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Horng T, 2001, P NATL ACAD SCI USA, V98, P12654, DOI 10.1073/pnas.231471798; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Korherr C, 1997, EUR J IMMUNOL, V27, P262, DOI 10.1002/eji.1830270139; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Li T, 2012, P NATL ACAD SCI USA, V109, P10558, DOI 10.1073/pnas.1203447109; Liu HM, 2012, CELL HOST MICROBE, V11, P528, DOI 10.1016/j.chom.2012.04.006; LIU PS, 1995, J BIOL CHEM, V270, P27179, DOI 10.1074/jbc.270.45.27179; Marek LR, 2012, IMMUNITY, V36, P612, DOI 10.1016/j.immuni.2012.01.019; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 2009, IMMUNITY, V30, P766, DOI 10.1016/j.immuni.2009.06.004; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Ohnishi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038423; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Radons J, 2002, J BIOL CHEM, V277, P16456, DOI 10.1074/jbc.M201000200; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rhee I, 2012, NAT IMMUNOL, V13, P439, DOI 10.1038/ni.2246; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sun HY, 2002, P NATL ACAD SCI USA, V99, P12871, DOI 10.1073/pnas.202396399; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Tissieres P, 2008, BLOOD, V111, P2122, DOI 10.1182/blood-2007-06-097782; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Triantafilou M, 2002, J CELL SCI, V115, P2603; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	105	75	77	1	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1168	1178		10.1016/j.cell.2012.11.011	http://dx.doi.org/10.1016/j.cell.2012.11.011			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217704	Green Accepted, Bronze			2022-12-28	WOS:000311999900008
J	Xu, YF; Xu, C; Kato, A; Tempel, W; Abreu, JG; Bian, CB; Hu, YG; Hu, D; Zhao, B; Cerovina, T; Diao, JB; Wu, FZ; He, HH; Cui, QY; Clark, E; Ma, C; Barbara, A; Veenstra, GJC; Xu, GL; Kaiser, UB; Liu, XS; Sugrue, SP; He, X; Min, JR; Kato, Y; Shi, YG				Xu, Yufei; Xu, Chao; Kato, Akiko; Tempel, Wolfram; Abreu, Jose Garcia; Bian, Chuanbing; Hu, Yeguang; Hu, Di; Zhao, Bin; Cerovina, Tanja; Diao, Jianbo; Wu, Feizhen; He, Housheng Hansen; Cui, Qingyan; Clark, Erin; Ma, Chun; Barbara, Andrew; Veenstra, Gert Jan C.; Xu, Guoliang; Kaiser, Ursula B.; Liu, X. Shirley; Sugrue, Stephen P.; He, Xi; Min, Jinrong; Kato, Yoichi; Shi, Yujiang Geno			Tet3 CXXC Domain and Dioxygenase Activity Cooperatively Regulate Key Genes for Xenopus Eye and Neural Development	CELL			English	Article							EMBRYONIC STEM-CELLS; DNA METHYLATION; MAMMALIAN DNA; SELF-RENEWAL; 5-HYDROXYMETHYLCYTOSINE; MOUSE; 5-METHYLCYTOSINE; PROTEINS; GENOME; 5-CARBOXYLCYTOSINE	Ten-Eleven Translocation (Tet) family of dioxygenases dynamically regulates DNA methylation and has been implicated in cell lineage differentiation and oncogenesis. Yet their functions and mechanisms of action in gene regulation and embryonic development are largely unknown. Here, we report that Xenopus Tet3 plays an essential role in early eye and neural development by directly regulating a set of key developmental genes. Tet3 is an active 5mC hydroxylase regulating the 5mC/5hmC status at target gene promoters. Biochemical and structural studies further demonstrate that the Tet3 CXXC domain is critical for specific Tet3 targeting. Finally, we show that the enzymatic activity and CXXC domain are both crucial for Tet3's biological function. Together, these findings define Tet3 as a transcription regulator and reveal a molecular mechanism by which the 5mC hydroxylase and DNA binding activities of Tet3 cooperate to control target gene expression and embryonic development.	[Xu, Chao; Tempel, Wolfram; Bian, Chuanbing; Cerovina, Tanja; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Xu, Yufei; Hu, Yeguang; Hu, Di; Clark, Erin; Ma, Chun; Barbara, Andrew; Kaiser, Ursula B.; Shi, Yujiang Geno] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens,Dept Med, Boston, MA 02115 USA; [Xu, Chao; Tempel, Wolfram; Bian, Chuanbing; Cerovina, Tanja; Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada; [Kato, Akiko; Kato, Yoichi] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Abreu, Jose Garcia; He, Xi] Harvard Univ, Sch Med, Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Hu, Di; Zhao, Bin; Diao, Jianbo; Wu, Feizhen; Ma, Chun] Fudan Univ, Inst Biomed Sci, Lab Epigenet, Shanghai 200032, Peoples R China; [He, Housheng Hansen; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [He, Housheng Hansen; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Cui, Qingyan; Xu, Guoliang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Veenstra, Gert Jan C.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Liu, X. Shirley] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA; [Sugrue, Stephen P.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA	University of Toronto; Structural Genomics Consortium; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Toronto; State University System of Florida; Florida State University; Harvard University; Boston Children's Hospital; Harvard Medical School; Fudan University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Radboud University Nijmegen; Harvard University; Dana-Farber Cancer Institute; State University System of Florida; University of Florida	Min, JR (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada.	jr.min@utoronto.ca; yoichi.kato@med.fsu.edu; yujiang_shi@hms.harvard.edu	Min, Jinrong/G-3449-2011; Xu, Chao/G-3885-2010; Wu, Feizhen/AGR-5215-2022; Wu, Feizhen/R-6415-2019; Abreu, Jose G/G-6159-2010; Abreu, Jose G/ABB-1199-2021; He, Hansen/ABD-8439-2020; Veenstra, Gert Jan C./D-4963-2012; Neurociencia, Inct/I-1011-2013	Min, Jinrong/0000-0001-5210-3130; Xu, Chao/0000-0003-0444-7080; Wu, Feizhen/0000-0002-1265-9887; Abreu, Jose G/0000-0002-9875-7786; Abreu, Jose G/0000-0002-1363-1755; He, Hansen/0000-0003-2898-3363; Veenstra, Gert Jan C./0000-0002-7787-4940; Cui, Qingyan/0000-0002-5029-4436	NIH [GM078458, GM087641, GM074241]; Brigham and Women's Hospital Biomedical Research Institute; Chinese Ministry of Education Project 985; CNPq (Brazil); Boston Children's Hospital Intellectual and Developmental Disabilities Research Center [P30 HD-18655]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through Ontario Genomics Institute; GlaxoSmithKline; Eli Lilly; Pfizer; Novartis Research Foundation; Life Technologies; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Wellcome Trust; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL EYE INSTITUTE [P30EY021721, R01EY007883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078458, R01GM074241, R15GM087641] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brigham and Women's Hospital Biomedical Research Institute; Chinese Ministry of Education Project 985; CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Boston Children's Hospital Intellectual and Developmental Disabilities Research Center; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Eli Lilly(Eli Lilly); Pfizer(Pfizer); Novartis Research Foundation; Life Technologies; Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Wellcome Trust(Wellcome TrustEuropean Commission); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Harland for helpful discussions, A Khorasani for critical reading of the manuscript and Q. Xu and L. Jiang for statistical analyses. We also thank R. Moon, W. Harris, J. Yang, X. Wang, M. Vetter and J.-P. Saint-Jeannet for valuable discussions and technical help. This work was supported by NIH grants GM078458 to Y.G.S., GM087641 to Y.K., and GM074241 to X.H., Brigham and Women's Hospital Biomedical Research Institute fund to sustain research excellence to Y.G.S., and Chinese Ministry of Education Project 985 to Biomedical Core Facility, Fudan University. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. J. G. A. was funded partially by CNPq (Brazil). Y.G.S. is a Pew Scholar. X. H. acknowledges support by Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (P30 HD-18655). The Structural Genomics Consortium is a registered charity (No. 1097737) that receives funds from Canadian Institutes for Health Research, Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Eli Lilly, Pfizer, Novartis Research Foundation, Life Technologies, Ontario Innovation Trust, Ontario Ministry for Research and Innovation and Wellcome Trust (JM). Argonne National Laboratory is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357.	Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; BESTOR TH, 1993, CURR BIOL, V3, P384, DOI 10.1016/0960-9822(93)90209-7; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hsu CH, 2012, CELL REP, V2, P568, DOI 10.1016/j.celrep.2012.08.030; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Matarese F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.95; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Pradhan M, 2008, BIOCHEMISTRY-US, V47, P10000, DOI 10.1021/bi8011725; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Sakano D, 2010, DEV CELL, V18, P450, DOI 10.1016/j.devcel.2009.12.023; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	30	184	204	0	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1200	1213		10.1016/j.cell.2012.11.014	http://dx.doi.org/10.1016/j.cell.2012.11.014			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217707	Bronze, Green Accepted			2022-12-28	WOS:000311999900011
J	Simcoe, RA; Sullivan, PW; Cooksey, KL; Kao, MM; Matejek, MS; Burgasser, AJ				Simcoe, Robert A.; Sullivan, Peter W.; Cooksey, Kathy L.; Kao, Melodie M.; Matejek, Michael S.; Burgasser, Adam J.			Extremely metal-poor gas at a redshift of 7	NATURE			English	Article							INTERGALACTIC MEDIUM; QUASAR; ABUNDANCES; EVOLUTION	In typical astrophysical environments, the abundance of heavy elements ranges from 0.001 to 2 times the solar value. Lower abundances have been seen in selected stars in the Milky Way's halo(1-3) and in two quasar absorption systems at redshift z = 3 (ref. 4). These are widely interpreted as relics from the early Universe, when all gas possessed a primordial chemistry. Before now there have been no direct abundance measurements from the first billion years after the Big Bang, when the earliest stars began synthesizing elements. Here we report observations of hydrogen and heavy-element absorption in a spectrum of a quasar at z = 7.04, when the Universe was just 772 million years old (5.6 per cent of its present age). We detect a large column of neutral hydrogen but no corresponding metals (defined as elements heavier than helium), limiting the chemical abundance to less than 1/10,000 times the solar level if the gas is in a gravitationally bound proto-galaxy, or to less than 1/1,000 times the solar value if it is diffuse and unbound. If the absorption is truly intergalactic(5,6), it would imply that the Universe was neither ionized by starlight nor chemically enriched in this neighbourhood at z approximate to 7. If it is gravitationally bound, the inferred abundance is too low to promote efficient cooling(7,8), and the system would be a viable site to form the predicted but as yet unobserved massive population III stars.	[Simcoe, Robert A.; Sullivan, Peter W.; Cooksey, Kathy L.; Kao, Melodie M.; Matejek, Michael S.] MIT Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Kao, Melodie M.] CALTECH, Dept Astron, Pasadena, CA 91125 USA; [Burgasser, Adam J.] Univ Calif San Diego, Ctr Astrophys & Space Sci, La Jolla, CA 92093 USA	Massachusetts Institute of Technology (MIT); California Institute of Technology; University of California System; University of California San Diego	Simcoe, RA (corresponding author), MIT Kavli Inst Astrophys & Space Res, 77 Massachusetts Ave,Bldg 37,Room 664L, Cambridge, MA 02139 USA.	simcoe@space.mit.edu		Cooksey, Kathy/0000-0001-5810-5225; Burgasser, Adam J./0000-0002-6523-9536	NSF [AST-0908920, AST-1109115]; Direct For Mathematical & Physical Scien [1003139] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1109115] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank J. O'Meara and A. Frebel for comments during the preparation of this Letter. M. Haehnelt also provided advice on methods for modelling the quasar near-zone, and G. Richards shared his composite QSO spectra in electronic form. This work includes data gathered with the 6.5-m Magellan Telescopes located at Las Campanas Observatory, Chile. R. A. S. acknowledges support from the NSF under awards AST-0908920 and AST-1109115. K. L. C. is supported by the NSF Astronomy and Astrophysics Postdoctoral Fellowship programme.	Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Bromm V, 2001, MON NOT R ASTRON SOC, V328, P969, DOI 10.1046/j.1365-8711.2001.04915.x; Cooke R, 2011, MON NOT R ASTRON SOC, V417, P1534, DOI 10.1111/j.1365-2966.2011.19365.x; Ellison SL, 2011, MON NOT R ASTRON SOC, V412, P448, DOI 10.1111/j.1365-2966.2010.17911.x; Ellison SL, 2010, MON NOT R ASTRON SOC, V406, P1435, DOI 10.1111/j.1365-2966.2010.16780.x; Frebel A, 2005, NATURE, V434, P871, DOI 10.1038/nature03455; Frebel A, 2007, MON NOT R ASTRON SOC, V380, pL40, DOI 10.1111/j.1745-3933.2007.00344.x; Fumagalli M, 2011, SCIENCE, V334, P1245, DOI 10.1126/science.1213581; Hewett PC, 2010, MON NOT R ASTRON SOC, V405, P2302, DOI 10.1111/j.1365-2966.2010.16648.x; Miralda-Escude J, 1998, ASTROPHYS J, V501, P15, DOI 10.1086/305799; Mortlock DJ, 2011, NATURE, V474, P616, DOI 10.1038/nature10159; Prochaska JX, 2007, ASTROPHYS J SUPPL S, V171, P29, DOI 10.1086/513714; Prochaska JX, 1996, ASTROPHYS J, V470, P403, DOI 10.1086/177875; Richards GT, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/5/167; Schaye J, 2003, ASTROPHYS J, V596, P768, DOI 10.1086/378044; Simcoe R. A., 2008, P SOC PHOTO-OPT INS, V7014, P27; Simcoe RA, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/159; Vanden Berk DE, 2001, ASTRON J, V122, P549, DOI 10.1086/321167; Venemans BP, 2012, ASTROPHYS J LETT, V751, DOI 10.1088/2041-8205/751/2/L25; Vladilo G, 2001, ASTROPHYS J, V557, P1007, DOI 10.1086/321650; Yip CW, 2004, ASTRON J, V128, P2603, DOI 10.1086/425626; Zheng W, 1997, ASTROPHYS J, V475, P469, DOI 10.1086/303560	25	74	74	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					79	82		10.1038/nature11612	http://dx.doi.org/10.1038/nature11612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23222611	Green Accepted, Green Submitted			2022-12-28	WOS:000311893400048
J	Machens, CK				Machens, Christian K.			Building the Human Brain	SCIENCE			English	Editorial Material							REPRESENTATIONS; NETWORKS		Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, P-1400038 Lisbon, Portugal	Fundacao Champalimaud	Machens, CK (corresponding author), Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Av Brasilia, P-1400038 Lisbon, Portugal.	christian.machens@neuro.fchampalimaud.org		Machens, Christian/0000-0003-1717-1562				Brody CD, 2003, CURR OPIN NEUROBIOL, V13, P204, DOI 10.1016/S0959-4388(03)00050-3; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; Eliasmith C, 2005, NEURAL COMPUT, V17, P1276, DOI 10.1162/0899766053630332; Eliasmith C, 2012, SCIENCE, V338, P1202, DOI 10.1126/science.1225266; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; PLATE TA, 1995, IEEE T NEURAL NETWOR, V6, P623, DOI 10.1109/72.377968; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309	9	61	64	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2012	338	6111					1156	1157		10.1126/science.1231865	http://dx.doi.org/10.1126/science.1231865			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	045AL	23197519				2022-12-28	WOS:000311666200028
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA Is Movember misleading men?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], NHS ABD AORT AN SCRE; Cancer Research UK, WHY ISNT THER UK PSA; Cancer Research UK, UK BOW CANC SCREEN; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Movember, MENS HLTH CHECKL; Movember UK, PROST CANC; Movember UK, SOM SUPP OUR MAL CAN; Movember UK, ANN REP 2011; Prosdex, WELC PROSD; Prostate Cancer UK, 2011, ACC; *WHO, 2004, SHOULD MASS SCREEN P; Wilson and Junger, 1968, PRINCIPLES PRACTICE	12	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 28	2012	345								e8046	10.1136/bmj.e8046	http://dx.doi.org/10.1136/bmj.e8046			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048FO	23190912	Bronze			2022-12-28	WOS:000311895900009
J	Juncadella, IJ; Kadl, A; Sharma, AK; Shim, YM; Hochreiter-Hufford, A; Borish, L; Ravichandran, KS				Juncadella, Ignacio J.; Kadl, Alexandra; Sharma, Ashish K.; Shim, Yun M.; Hochreiter-Hufford, Amelia; Borish, Larry; Ravichandran, Kodi S.			Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation	NATURE			English	Article							DUST MITE ALLERGEN; ASTHMA; RESPONSES; FAMILY; ENGULFMENT; MECHANISM; MIMICRY; PROTEIN; INNATE; MOUSE	Lung epithelial cells can influence immune responses to airway allergens(1,2). Airway epithelial cells also undergo apoptosis after encountering environmental allergens(3); yet, relatively little is known about how these are cleared, and their effect on airway inflammation. Here we show that airway epithelial cells efficiently engulf apoptotic epithelial cells and secrete anti-inflammatory cytokines, dependent upon intracellular signalling by the small GTPase Rac1. Inducible deletion of Rac1 expression specifically in airway epithelial cells in a mouse model resulted in defective engulfment by epithelial cells and aberrant anti-inflammatory cytokine production. Intranasal priming and challenge of these mice with house dust mite extract or ovalbumin as allergens led to exacerbated inflammation, augmented Th2 cytokines and airway hyper-responsiveness, with decreased interleukin (IL)-10 in bronchial lavages. Rac1-deficient epithelial cells produced much higher IL-33 upon allergen or apoptotic cell encounter, with increased numbers of nuocyte-like cells(1,4,5). Administration of exogenous IL-10 'rescued' the airway inflammation phenotype in Rac1-deficient mice, with decreased IL-33. Collectively, these genetic and functional studies suggest a new role for Rac1-dependent engulfment by airway epithelial cells and in establishing the anti-inflammatory environment, and that defects in cell clearance in the airways could contribute to inflammatory responses towards common allergens.	[Juncadella, Ignacio J.; Hochreiter-Hufford, Amelia; Borish, Larry; Ravichandran, Kodi S.] Univ Virginia, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Juncadella, Ignacio J.; Hochreiter-Hufford, Amelia; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Juncadella, Ignacio J.; Hochreiter-Hufford, Amelia; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Kadl, Alexandra; Shim, Yun M.; Borish, Larry] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Sharma, Ashish K.] Univ Virginia, Dept Surg, Charlottesville, VA 22908 USA; [Borish, Larry] Univ Virginia, Ctr Asthma & Allerg Dis, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA.	Ravi@virginia.edu	Kadl, Alexandra/AAV-3395-2021; Shim, Yun Michael/N-2049-2017	Shim, Yun Michael/0000-0002-3780-3371; Ravichandran, Kodi/0000-0001-9049-1410; Sharma, Ashish/0000-0002-1234-6039	Immunology Training Grant; NHLBI; American Asthma Foundation; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI100799, T32AI007496, R01AI057438] Funding Source: NIH RePORTER	Immunology Training Grant; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Asthma Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the members of the Ravichandran laboratory for their suggestions, especially J. Kinchen and P. Trampont. We thank J. Whitsett for the rtTA-CCSP/Cre mice, X. Liu for the TGF-beta responsive cell line PE25, and J. Steinke and J. Kennedy for providing human nasal epithelial cells. This work was supported by an Immunology Training Grant (I. J. J.), a F32 postdoctoral fellowship from the NHLBI (I. J. J.), and grants from the American Asthma Foundation and the National Institutes of Health (K. S. R.). K. S. R. has been a William Benter Senior Fellow of the American Asthma Foundation.	Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Borish L, 1996, J ALLERGY CLIN IMMUN, V97, P1288, DOI 10.1016/S0091-6749(96)70197-5; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; Daidoji T, 2008, J VIROL, V82, P11294, DOI 10.1128/JVI.01192-08; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Elliott MR, 2010, ANN NY ACAD SCI, V1209, P30, DOI 10.1111/j.1749-6632.2010.05764.x; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fahy JV, 2011, AM J RESP CRIT CARE, V184, P390, DOI 10.1164/rccm.201107-1258ED; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Jyonouchi H, 1999, APOPTOSIS, V4, P407, DOI 10.1023/A:1009607607603; Kirsch T, 2007, BLOOD, V109, P2854, DOI 10.1182/blood-2006-06-026187; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lloyd CM, 2010, CURR OPIN IMMUNOL, V22, P800, DOI 10.1016/j.coi.2010.10.006; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; NAYLOR BERNARD, 1962, THORAX, V17, P69, DOI 10.1136/thx.17.1.69; Park D, 2011, NATURE, V477, P220, DOI 10.1038/nature10340; Park D, 2009, CURR BIOL, V19, P346, DOI 10.1016/j.cub.2009.01.042; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Thomas WR, 2010, TRENDS MOL MED, V16, P321, DOI 10.1016/j.molmed.2010.04.008; Thomas WR, 2009, EXPERT REV CLIN IMMU, V5, P233, DOI [10.1586/eci.09.5, 10.1586/ECI.09.5]; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; White Steven R, 2011, J Allergy (Cairo), V2011, P948406, DOI 10.1155/2011/948406; Yamada Y, 2004, PEDIAT ALLERG IMM-UK, V15, P159, DOI 10.1111/j.1399-3038.2004.00155.x	30	195	205	4	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2013	493	7433					547	+		10.1038/nature11714	http://dx.doi.org/10.1038/nature11714			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23235830	Green Accepted			2022-12-28	WOS:000313871400041
J	Alonzo, F; Kozhaya, L; Rawlings, SA; Reyes-Robles, T; DuMont, AL; Myszka, DG; Landau, NR; Unutmaz, D; Torres, VJ				Alonzo, Francis, III; Kozhaya, Lina; Rawlings, Stephen A.; Reyes-Robles, Tamara; DuMont, Ashley L.; Myszka, David G.; Landau, Nathaniel R.; Unutmaz, Derya; Torres, Victor J.			CCR5 is a receptor for Staphylococcus aureus leukotoxin ED	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN-COUPLED RECEPTORS; CHEMOKINE RECEPTORS; HIV-1 INFECTION; BIOSENSOR TECHNOLOGY; SMALL-MOLECULE; CORECEPTOR; RESISTANT; CELLS; IDENTIFICATION	Pore-forming toxins are critical virulence factors for many bacterial pathogens and are central to Staphylococcus aureus-mediated killing of host cells. S. aureus encodes pore-forming bi-component leukotoxins that are toxic towards neutrophils, but also specifically target other immune cells. Despite decades since the first description of staphylococcal leukocidal activity, the host factors responsible for the selectivity of leukotoxins towards different immune cells remain unknown. Here we identify the human immunodeficiency virus (HIV) co-receptor CCR5 as a cellular determinant required for cytotoxic targeting of subsets of myeloid cells and T lymphocytes by the S. aureus leukotoxin ED (LukED). We further demonstrate that LukED-dependent cell killing is blocked by CCR5 receptor antagonists, including the HIV drug maraviroc. Remarkably, CCR5-deficient mice are largely resistant to lethal S. aureus infection, highlighting the importance of CCR5 targeting in S. aureus pathogenesis. Thus, depletion of CCR5(+) leukocytes by LukED suggests a new immune evasion mechanism of S. aureus that can be therapeutically targeted.	[Alonzo, Francis, III; Kozhaya, Lina; Rawlings, Stephen A.; Reyes-Robles, Tamara; DuMont, Ashley L.; Landau, Nathaniel R.; Unutmaz, Derya; Torres, Victor J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Unutmaz, Derya] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Unutmaz, Derya] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Myszka, David G.] Biosensor Tools LLC, Salt Lake City, UT 84103 USA	New York University; New York University; New York University	Torres, VJ (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	derya.unutmaz@nyumc.org; victor.torres@nyumc.org	Rawlings, Stephen/ABA-6797-2020	Rawlings, Stephen/0000-0003-3637-1447; Torres, Victor/0000-0002-7126-0489; Unutmaz, Derya/0000-0001-8898-6633	New York University School of Medicine Development Funds; American Heart Association Scientist Development Grant [09SDG2060036]; National Institutes of Health (NIH) [R56-AI091856-01A1]; NIH [T32-AI007180, R42-MH084372-02A1, R21-AI087973, R01-AI065303]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087973, T32AI007180, R01AI065303, R56AI091856, F32AI098395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R42MH084372] Funding Source: NIH RePORTER	New York University School of Medicine Development Funds; American Heart Association Scientist Development Grant(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the Torres laboratory, D. R. Littman, M. Lu, and A. Darwin for reading this manuscript. We also thank V. KewalRamani for providing reagents, and S. Polsky for assistance with purification of PBMCs. This research was supported by New York University School of Medicine Development Funds, an American Heart Association Scientist Development Grant (09SDG2060036) to V.J.T. and National Institutes of Health (NIH) grants R56-AI091856-01A1 to V.J.T., NIH training grant T32-AI007180 to F. A., A. L. D. and S. A. R., NIH R42-MH084372-02A1 to D. G. M., and NIH R21-AI087973 and R01-AI065303 grants to D.U.	Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Alonzo F, 2012, MOL MICROBIOL, V83, P423, DOI 10.1111/j.1365-2958.2011.07942.x; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Berro R, 2011, J VIROL, V85, P8227, DOI 10.1128/JVI.00767-11; Bischofberger M, 2012, CELL HOST MICROBE, V12, P266, DOI 10.1016/j.chom.2012.08.005; Caccuri F, 2012, P NATL ACAD SCI USA, V109, P14580, DOI 10.1073/pnas.1206605109; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; DeLeo FR, 2011, P NATL ACAD SCI USA, V108, P18091, DOI 10.1073/pnas.1111084108; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Didigu CA, 2012, VIRUSES-BASEL, V4, P309, DOI 10.3390/v4020309; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; DuMont AL, 2011, MOL MICROBIOL, V79, P814, DOI 10.1111/j.1365-2958.2010.07490.x; El Hed A, 2010, J INFECT DIS, V201, P843, DOI 10.1086/651021; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Giagulli C, 2012, BLOOD, V119, P2274, DOI 10.1182/blood-2011-06-364083; Golding H, 2003, BLOOD, V102, P3280, DOI 10.1182/blood-2003-04-1096; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; Hedrick PW, 2006, TRENDS GENET, V22, P293, DOI 10.1016/j.tig.2006.04.007; Hummel S, 2005, GENES IMMUN, V6, P371, DOI 10.1038/sj.gene.6364172; Lalani AS, 1999, SCIENCE, V286, P1968, DOI 10.1126/science.286.5446.1968; Lee B, 1999, J BIOL CHEM, V274, P9617, DOI 10.1074/jbc.274.14.9617; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Lucotte G, 2002, INFECT GENET EVOL, V1, P201, DOI 10.1016/S1567-1348(02)00027-8; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Menestrina G, 2003, FEBS LETT, V552, P54, DOI 10.1016/S0014-5793(03)00850-0; Moore PCL, 2002, J MED MICROBIOL, V51, P516, DOI 10.1099/0022-1317-51-6-516; Morner A, 1999, J VIROL, V73, P2343; Navratilova I, 2005, ANAL BIOCHEM, V339, P271, DOI 10.1016/j.ab.2004.12.017; Navratilova I, 2006, ANAL BIOCHEM, V355, P132, DOI 10.1016/j.ab.2006.04.021; Navratilova I, 2006, ANAL BIOCHEM, V353, P278, DOI 10.1016/j.ab.2006.03.049; Oswald-Richter K, 2007, PLOS PATHOG, V3, P553, DOI 10.1371/journal.ppat.0030058; Panton PN, 1932, LANCET, V1, P506; Rahbar R, 2009, J VIROL, V83, P2226, DOI 10.1128/JVI.01655-08; Rich RL, 2009, ANAL BIOCHEM, V386, P98, DOI 10.1016/j.ab.2008.12.011; Saita Y, 2007, INT IMMUNOPHARMACOL, V7, P1528, DOI 10.1016/j.intimp.2007.07.019; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Stenlund P, 2003, ANAL BIOCHEM, V316, P243, DOI 10.1016/S0003-2697(03)00046-0; Strizki JM, 2005, ANTIMICROB AGENTS CH, V49, P4911, DOI 10.1128/AAC.49.12.4911-4919.2005; Van de Velde H., 1894, CELLULE, V10, P403; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; von Eiff C, 2004, DIAGN MICR INFEC DIS, V49, P157, DOI 10.1016/j.diagmicrobio.2004.03.009; Wan Q, 2011, J EXP MED, V208, P1875, DOI 10.1084/jem.20102516; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	44	205	212	4	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					51	+		10.1038/nature11724	http://dx.doi.org/10.1038/nature11724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23235831	Green Accepted			2022-12-28	WOS:000312933800028
J	Cooper, DKC				Cooper, David K. C.			CHRISTMAS 2012: YESTERDAY'S WORLD John Collins Warren (1778-1856): An American surgeon in London	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Pittsburgh, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cooper, DKC (corresponding author), Univ Pittsburgh, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15261 USA.	cooperdk@upmc.edu						WARREN JR, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2012	345								e8251	10.1136/bmj.e8251	http://dx.doi.org/10.1136/bmj.e8251			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	059IU	23248078				2022-12-28	WOS:000312698700020
J	Salomon, JA; Wang, HD; Freeman, MK; Vos, T; Flaxman, AD; Lopez, AD; Murray, CJL				Salomon, Joshua A.; Wang, Haidong; Freeman, Michael K.; Vos, Theo; Flaxman, Abraham D.; Lopez, Alan D.; Murray, Christopher J. L.			Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010	LANCET			English	Article							MILLENNIUM DEVELOPMENT GOALS; SOCIOECONOMIC INEQUALITIES; MENTAL-DISORDERS; EUROPEAN-UNION; UNITED-STATES; MORTALITY; TRENDS; POPULATION; COMPRESSION; DISABILITY	Background Healthy life expectancy (HALE) summarises mortality and non-fatal outcomes in a single measure of average population health. It has been used to compare health between countries, or to measure changes over time. These comparisons can inform policy questions that depend on how morbidity changes as mortality decreases. We characterise current HALE and changes over the past two decades in 187 countries. Methods Using inputs from the Global Burden of Disease Study (GBD) 2010, we assessed HALE for 1990 and 2010. We calculated HALE with life table methods, incorporating estimates of average health over each age interval. Inputs from GBD 2010 included age-specific information for mortality rates and prevalence of 1160 sequelae, and disability weights associated with 220 distinct health states relating to these sequelae. We computed estimates of average overall health for each age group, adjusting for comorbidity with a Monte Carlo simulation method to capture how multiple morbidities can combine in an individual. We incorporated these estimates in the life table by the Sullivan method to produce HALE estimates for each population defined by sex, country, and year. We estimated the contributions of changes in child mortality, adult mortality, and disability to overall change in population health between 1990 and 2010. Findings In 2010, global male HALE at birth was 58.3 years (uncertainty interval 56.7-59.8) and global female HALE at birth was 61.8 years (60.1-63.4). HALE increased more slowly than did life expectancy over the past 20 years, with each 1-year increase in life expectancy at birth associated with a 0.8-year increase in HALE. Across countries in 2010, male HALE at birth ranged from 27.9 years (17.3-36.5) in Haiti, to 68.8 years (67.0-70.4) in Japan. Female HALE at birth ranged from 37.1 years (26.9-43.7) in Haiti, to 71.7 years (69.7-73.4) in Japan. Between 1990 and 2010, male HALE increased by 5 years or more in 42 countries compared with 37 countries for female HALE, while male HALE decreased in 21 countries and 11 for female HALE. Between countries and over time, life expectancy was strongly and positively related to number of years lost to disability. This relation was consistent between sexes, in cross-sectional and longitudinal analysis, and when assessed at birth, or at age 50 years. Changes in disability had small effects on changes in HALE compared with changes in mortality. Interpretation HALE differs substantially between countries. As life expectancy has increased, the number of healthy years lost to disability has also increased in most countries, consistent with the expansion of morbidity hypothesis, which has implications for health planning and health-care expenditure. Compared with substantial progress in reduction of mortality over the past two decades, relatively little progress has been made in reduction of the overall effect of non-fatal disease and injury on population health. HALE is an attractive indicator for monitoring health post-2015.	[Salomon, Joshua A.] Harvard Univ, Harvard Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Wang, Haidong; Freeman, Michael K.; Flaxman, Abraham D.; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Vos, Theo; Flaxman, Abraham D.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	Harvard University; Harvard T.H. Chan School of Public Health; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Queensland	Salomon, JA (corresponding author), Harvard Univ, Harvard Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.	jsalomon@hsph.harvard.edu	Salomon, Joshua/S-1929-2019; Lopez, Alan D/F-1487-2010; Salomon, Joshua A/D-3898-2009; Lopez, Alan/AAA-2734-2022	Salomon, Joshua/0000-0003-3929-5515; Lopez, Alan D/0000-0001-5818-6512; Salomon, Joshua A/0000-0003-3929-5515; 	Burke Global Health Fellowship; Bill & Melinda Gates Foundation	Burke Global Health Fellowship; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The Bill & Melinda Gates Foundation; We thank the countless individuals who have contributed to the Global Burden of Disease Study 2010 in various capacities. We are especially grateful to multiple staff members of WHO for their important contribution. We also thank all staff members at the Institute for Health Metrics and Evaluation for their support, and specifically: James Bullard, Andrew Ernst, and Serkan Yalcin for their tireless support of the computational infrastructure required to produce the results; Linda A Ettinger for her expert administrative support and facilitating communication and coordination between the authors; Peter Speyer, Abigail McLain, Katherine Leach-Kemon, and Eden Stork for their persistent and invaluable work to gain access to and catalogue as much data as possible to inform the estimates; and Erin C Mullany, Diana Haring, and Summer Lockett Ohno for coordinating, reviewing, and editing the manuscript. J A Salomon received support from the Burke Global Health Fellowship while working on this study.	ALTER G, 1989, POP STUD-J DEMOG, V43, P25, DOI 10.1080/0032472031000143836; Andreev EM, 2003, B WORLD HEALTH ORGAN, V81, P778; [Anonymous], 2012, LANCET, V379, P1274, DOI 10.1016/S0140-6736(12)60518-2; [Anonymous], 1999, WORLD HLTH REPORT 19; Bajekal Madhavi, 2005, Health Stat Q, P18; Banham D, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-13; Beaglehole R., 2003, WORLD HLTH REPORT 20; Breakwell Claudia, 2005, Health Stat Q, P17; Brito L, 2012, SCIENCE, V336, P1396, DOI [10.1126/science.1224531, 10.1126/science.1224006]; Brody J A, 1990, Aging (Milano), V2, P283; Bronnum-Hansen H, 2005, EUR J PUBLIC HEALTH, V15, P20, DOI 10.1093/eurpub/cki106; Bronnum-Hansen H, 2008, SCAND J PUBLIC HEALT, V36, P44, DOI 10.1177/1403494807085193; Cai LM, 2007, DEMOGRAPHY, V44, P479, DOI 10.1353/dem.2007.0022; Chang CF, 2005, SOUTH MED J, V98, P977, DOI 10.1097/01.smj.0000182512.68037.0c; Cheung KSL, 2010, EUR J AGEING, V7, P257, DOI 10.1007/s10433-010-0171-3; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P75, DOI 10.1093/geronb/gbq088; Crimmins EM, 1997, POPUL DEV REV, V23, P555, DOI 10.2307/2137572; CRIMMINS EM, 1994, DEMOGRAPHY, V31, P159, DOI 10.2307/2061913; Crimmins EM, 2001, SOC SCI MED, V52, P1629, DOI 10.1016/S0277-9536(00)00273-2; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Doblhammer G, 2001, SOC SCI MED, V52, P385, DOI 10.1016/S0277-9536(00)00141-6; Ekholm O, 2009, SCAND J PUBLIC HEALT, V37, P661, DOI 10.1177/1403494809341098; European Union Task Force on Health Expectancies, 2008, HLTH LIF YEARS EUR U; Fries James F, 2011, J Aging Res, V2011, P261702, DOI 10.4061/2011/261702; FRIES JF, 1983, MILBANK FUND Q, V61, P397, DOI 10.2307/3349864; Fries JF, 2003, ANN INTERN MED, V139, P455, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00015; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Fukuda Y, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-65; Graham P, 2004, J EPIDEMIOL COMMUN H, V58, P659, DOI 10.1136/jech.2003.014910; Groenewegen PP, 2003, PUBLIC HEALTH, V117, P424, DOI 10.1016/S0033-3506(03)00100-8; GRUENBERG EM, 1977, MILBANK FUND Q, V55, P3, DOI 10.2307/3349592; Gu D, 2009, SOC SCI MED, V68, P2170, DOI 10.1016/j.socscimed.2009.03.031; Haines A, 2012, LANCET, V379, P2189, DOI 10.1016/S0140-6736(12)60779-X; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Imai K, 2007, J AM STAT ASSOC, V102, P1199, DOI 10.1198/016214507000000040; Jagger C, 2003, J PUBLIC HEALTH MED, V25, P42, DOI 10.1093/pubmed/fdg009; Jagger C, 2008, LANCET, V372, P2124, DOI 10.1016/S0140-6736(08)61594-9; Jagger C, 2011, J EPIDEMIOL COMMUN H, V65, P1030, DOI 10.1136/jech.2010.117705; Jiang Yongwen, 2005, Med Health R I, V88, P282; KATZ S, 1983, NEW ENGL J MED, V309, P1218, DOI 10.1056/NEJM198311173092005; KRAMER M, 1980, ACTA PSYCHIAT SCAND, V62, P382, DOI 10.1111/j.1600-0447.1980.tb07714.x; Lau RS, 2012, ASIA-PAC J PUBLIC HE, V24, P195, DOI 10.1177/1010539510376663; Lloyd-Sherlock P, 2012, LANCET, V379, P1295, DOI 10.1016/S0140-6736(12)60519-4; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Majer IM, 2011, J EPIDEMIOL COMMUN H, V65, P972, DOI 10.1136/jech.2010.111492; MANTON KG, 1982, MILBANK FUND Q, V60, P183, DOI 10.2307/3349767; Mathers CD, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-66; Mathers CD, 2001, LANCET, V357, P1685, DOI 10.1016/S0140-6736(00)04824-8; Mathers CD, 2002, SUMMARY MEASURES OF POPULATION HEALTH: CONCEPTS, ETHICS, MEASUREMENT AND APPLICATIONS, P177; Mathers Colin D, 2006, Popul Health Metr, V4, P4, DOI 10.1186/1478-7954-4-4; McMichael AJ, 2004, LANCET, V363, P1155, DOI 10.1016/S0140-6736(04)15902-3; Moser K, 2005, B WORLD HEALTH ORGAN, V83, P202; Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000262; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P981; Murray CJL, 2003, POP STUD-J DEMOG, V57, P165, DOI 10.1080/0032472032000097083; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; Nusselder WJ, 1996, AM J PUBLIC HEALTH, V86, P187, DOI 10.2105/AJPH.86.2.187; Parker MG, 2007, GERONTOLOGIST, V47, P150, DOI 10.1093/geront/47.2.150; Parker MG, 2005, J GERONTOL A-BIOL, V60, P1351, DOI 10.1093/gerona/60.10.1351; Perenboom RJM, 1996, SOC SCI MED, V43, P1703, DOI 10.1016/S0277-9536(96)00058-5; Preston SH., 1976, MORT PATT NAT POP SP; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rajaratnam JK, 2010, LANCET, V375, P1704, DOI 10.1016/S0140-6736(10)60517-X; RILEY JC, 1990, POPUL DEV REV, V16, P403, DOI 10.2307/1972830; RITCHIE K, 1994, AM J PUBLIC HEALTH, V84, P232, DOI 10.2105/AJPH.84.2.232; Robine JM, 2009, QUAL AGEING OLDER AD, V10, P5, DOI 10.1108/14717794200900012; Robine JM, 2004, J GERONTOL A-BIOL, V59, P590, DOI 10.1093/gerona/59.6.M590; ROBINE JM, 1991, BMJ-BRIT MED J, V302, P457, DOI 10.1136/bmj.302.6774.457; Sachs JD, 2012, LANCET, V379, P2206, DOI 10.1016/S0140-6736(12)60685-0; Salomon JA, 2004, BMJ-BRIT MED J, V328, P258, DOI 10.1136/bmj.37963.691632.44; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Salomon JA, 2009, AM J EPIDEMIOL, V170, P343, DOI 10.1093/aje/kwp144; SANDERS BS, 1964, AM J PUBLIC HEALTH N, V54, P1063, DOI 10.2105/AJPH.54.7.1063; Sihvonen AP, 1998, SOC SCI MED, V47, P303, DOI 10.1016/S0277-9536(98)00020-3; Stiefel MC, 2010, MILBANK Q, V88, P30, DOI 10.1111/j.1468-0009.2010.00588.x; SULLIVAN DF, 1971, HSMHA HEALTH REP, V86, P347, DOI 10.2307/4594169; Szwarcwald CL, 2011, AM J PUBLIC HEALTH, V101, P517, DOI 10.2105/AJPH.2010.195453; United Nations Development Programme, 1990, HUM DEV REP 1990; Van de Water HPA, 1997, PHILOS T R SOC B, V352, P1819, DOI 10.1098/rstb.1997.0167; Van Oyen H, 2013, INT J PUBLIC HEALTH, V58, P143, DOI 10.1007/s00038-012-0361-1; VERBRUGGE LM, 1984, MILBANK FUND Q, V62, P475, DOI 10.2307/3349861; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; White Chris, 2010, Health Stat Q, P28, DOI 10.1057/hsq.2010.3; WHO, 2001, WORLD HLTH REPORT 20; WILKINS R, 1983, AM J PUBLIC HEALTH, V73, P1073, DOI 10.2105/AJPH.73.9.1073; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	90	594	624	2	198	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2012	380	9859					2144	2162		10.1016/S0140-6736(12)61690-0	http://dx.doi.org/10.1016/S0140-6736(12)61690-0			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23245606				2022-12-28	WOS:000312387000014
J	Brenner, S				Brenner, Sydney			The Revolution in the Life Sciences	SCIENCE			English	Editorial Material									Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Brenner, S (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	sydney.brenner@hotmail.com			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)			0	19	23	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 14	2012	338	6113					1427	1428		10.1126/science.1232919	http://dx.doi.org/10.1126/science.1232919			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053DN	23239722				2022-12-28	WOS:000312250800033
J	Sobczak, JPJ; Martin, TG; Gerling, T; Dietz, H				Sobczak, Jean-Philippe J.; Martin, Thomas G.; Gerling, Thomas; Dietz, Hendrik			Rapid Folding of DNA into Nanoscale Shapes at Constant Temperature	SCIENCE			English	Article							SINGLE-STRANDED-DNA; ORIGAMI; PROTEINS; STATE	We demonstrate that, at constant temperature, hundreds of DNA strands can cooperatively fold a long template DNA strand within minutes into complex nanoscale objects. Folding occurred out of equilibrium along nucleation-driven pathways at temperatures that could be influenced by the choice of sequences, strand lengths, and chain topology. Unfolding occurred in apparent equilibrium at higher temperatures than those for folding. Folding at optimized constant temperatures enabled the rapid production of three-dimensional DNA objects with yields that approached 100%. The results point to similarities with protein folding in spite of chemical and structural differences. The possibility for rapid and high-yield assembly will enable DNA nanotechnology for practical applications.	[Sobczak, Jean-Philippe J.; Martin, Thomas G.; Gerling, Thomas; Dietz, Hendrik] Tech Univ Munich, Dept Phys, Walter Schottky Inst, D-85748 Garching, Germany	Technical University of Munich	Dietz, H (corresponding author), Tech Univ Munich, Dept Phys, Walter Schottky Inst, Coulombwall 4A, D-85748 Garching, Germany.	dietz@tum.de		Dietz, Hendrik/0000-0003-1270-3662	Deutsche Forschungsgemeinschaft through the Excellence Cluster CIPSM; Deutsche Forschungsgemeinschaft [SFB863]; Technische Universitat Munchen Institute for Advanced Study; European Research Council [256270]	Deutsche Forschungsgemeinschaft through the Excellence Cluster CIPSM; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Technische Universitat Munchen Institute for Advanced Study; European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft through the Excellence Cluster CIPSM and the SFB863, the Technische Universitat Munchen Institute for Advanced Study, and a European Research Council Starting Grant to H. D. (GA no. 256270). We thank E. Lin Shiao for preliminary experiments, M. Schickinger for the design of the gearlike object, C. Castro for the design of the hinged-bar object, F. Praetorius for preparing scaffold DNA, and B. Wei and P. Yin for supplying DNA strands for tile-based DNA objects. Additional data described in this work can be found in the online supplementary materials.	Alberts B., 2008, MOL BIOL CEL, V5th ed.; Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Jungmann R, 2008, J AM CHEM SOC, V130, P10062, DOI 10.1021/ja8030196; Ke YG, 2012, J AM CHEM SOC, V134, P1770, DOI 10.1021/ja209719k; Ke YG, 2009, J AM CHEM SOC, V131, P15903, DOI 10.1021/ja906381y; Ke YG, 2009, NANO LETT, V9, P2445, DOI 10.1021/nl901165f; Kim DN, 2012, NUCLEIC ACIDS RES, V40, P2862, DOI 10.1093/nar/gkr1173; Liedl T, 2010, NAT NANOTECHNOL, V5, P520, DOI [10.1038/nnano.2010.107, 10.1038/NNANO.2010.107]; Liu WY, 2011, ANGEW CHEM INT EDIT, V50, P264, DOI 10.1002/anie.201005911; Martin TG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2095; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; Pinheiro AV, 2011, NAT NANOTECHNOL, V6, P763, DOI [10.1038/NNANO.2011.187, 10.1038/nnano.2011.187]; Porter LL, 2012, P NATL ACAD SCI USA, V109, P9420, DOI 10.1073/pnas.1202604109; PRIVALOV PL, 1989, ANNU REV BIOPHYS BIO, V18, P47, DOI 10.1146/annurev.biophys.18.1.47; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Wei RS, 2012, ANGEW CHEM INT EDIT, V51, P4864, DOI 10.1002/anie.201200688; Woo S, 2011, NAT CHEM, V3, P620, DOI [10.1038/NCHEM.1070, 10.1038/nchem.1070]; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274; Zipper H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh101	30	193	195	2	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1458	1461		10.1126/science.1229919	http://dx.doi.org/10.1126/science.1229919			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239734				2022-12-28	WOS:000312250800045
J	Shen, K; Arslan, S; Akopian, D; Ha, T; Shan, SO				Shen, Kuang; Arslan, Sinan; Akopian, David; Ha, Taekjip; Shan, Shu-ou			Activated GTPase movement on an RNA scaffold drives co-translational protein targeting	NATURE			English	Article							SIGNAL RECOGNITION PARTICLE; SINGLE-MOLECULE FRET; SRP RNA; CRYSTAL-STRUCTURE; RECEPTOR; RIBOSOME; COMPLEX; MECHANISM; TRANSLOCATION; COMPONENTS	Approximately one-third of the proteome is initially destined for the eukaryotic endoplasmic reticulum or the bacterial plasma membrane(1). The proper localization of these proteins is mediated by a universally conserved protein-targeting machinery, the signal recognition particle (SRP), which recognizes ribosomes carrying signal sequences(2-4) and, through interactions with the SRP receptor(5,6), delivers them to the protein-translocation machinery on the target membrane(7). The SRP is an ancient ribonucleoprotein particle containing an essential, elongated SRP RNA for which precise functions have remained elusive. Here we used single-molecule fluorescence microscopy to show that the Escherichia coli SRP-SRP receptor GTPase complex, after initial assembly at the tetra-loop end of SRP RNA, travels over 100 angstrom to the distal end of this RNA, where rapid GTP hydrolysis occurs. This movement is negatively regulated by the translating ribosome and, at a later stage, positively regulated by the SecYEG translocon, providing an attractive mechanism for ensuring the productive exchange of the targeting and translocation machineries at the ribosome exit site with high spatial and temporal accuracy. Our results show that large RNAs can act as molecular scaffolds that enable the easy exchange of distinct factors and precise timing of molecular events in a complex cellular process; this concept may be extended to similar phenomena in other ribonucleoprotein complexes.	[Shen, Kuang; Akopian, David; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Arslan, Sinan; Ha, Taekjip] Univ Illinois, Dept Phys, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA	California Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	sshan@caltech.edu	Shen, Kuang/H-9441-2016; Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Arslan, Sinan/0000-0001-7270-8372	National Institutes of Health (NIH) [GM078024, GM45162, GM065367]; Caltech [350270]; Beckman Young Investigator award; David and Lucile Packard Fellowship in Science and Engineering; Henry Dreyfus Teacher-Scholar award; National Science Foundation Physics Frontiers Centers program [08222613]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367, R37GM045162, R01GM078024, R01GM045162] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech; Beckman Young Investigator award; David and Lucile Packard Fellowship in Science and Engineering(The David & Lucile Packard Foundation); Henry Dreyfus Teacher-Scholar award; National Science Foundation Physics Frontiers Centers program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Ban and members of the Shan group for comments on the manuscript, C. Richards, L. Cai, T. Zhiyentayev, K. Lee and R. Zhou for help with RNClabelling and the instrument and software setup, and C.L. Guo, S. Kouand H. Lester for discussions. This work is supported by National Institutes of Health (NIH) grant GM078024 to S.-o.S., an NIH instrument supplement to grant GM45162 to D.C. Rees, and Caltech matching fund 350270 for the single-molecule instruments. S.-o.S. was supported by the Beckman Young Investigator award, the David and Lucile Packard Fellowship in Science and Engineering, and the Henry Dreyfus Teacher-Scholar award. T.H. was supported by National Science Foundation Physics Frontiers Centers program (08222613) and NIH grant GM065367.	ALTHOFF S, 1994, NUCLEIC ACIDS RES, V22, P1933, DOI 10.1093/nar/22.11.1933; Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Dalal K, 2010, METHODS MOL BIOL, V619, P145, DOI 10.1007/978-1-60327-412-8_9; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Estrozi LF, 2011, NAT STRUCT MOL BIOL, V18, P88, DOI 10.1038/nsmb.1952; FerreDAmare AR, 1996, NUCLEIC ACIDS RES, V24, P977, DOI 10.1093/nar/24.5.977; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Hoskins AA, 2011, CURR OPIN CHEM BIOL, V15, P864, DOI 10.1016/j.cbpa.2011.10.010; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Mothes W, 1998, J CELL BIOL, V142, P355, DOI 10.1083/jcb.142.2.355; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; Peluso P, 2001, BIOCHEMISTRY-US, V40, P15224, DOI 10.1021/bi011639y; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Schaffitzel C, 2007, J STRUCT BIOL, V158, P463, DOI 10.1016/j.jsb.2007.01.005; Schaffitzel C, 2006, NATURE, V444, P503, DOI 10.1038/nature05182; Shan SO, 2007, J CELL BIOL, V178, P611, DOI 10.1083/jcb.200702018; Shan SO, 2004, PLOS BIOL, V2, P1572, DOI 10.1371/journal.pbio.0020320; Shen K, 2011, RNA, V17, P892, DOI 10.1261/rna.2610411; Shen K, 2010, P NATL ACAD SCI USA, V107, P7698, DOI 10.1073/pnas.1002968107; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Sluis EO, 2002, FEBS LETT, V527, P159, DOI 10.1016/S0014-5793(02)03202-7; Yodh JG, 2010, Q REV BIOPHYS, V43, P185, DOI 10.1017/S0033583510000107; YUAN R, 1981, ANNU REV BIOCHEM, V50, P285, DOI 10.1146/annurev.bi.50.070181.001441; Zhang X, 2008, J MOL BIOL, V381, P581, DOI 10.1016/j.jmb.2008.05.049; Zhang X, 2011, P NATL ACAD SCI USA, V108, P6450, DOI 10.1073/pnas.1019051108; Zhang X, 2010, SCIENCE, V328, P757, DOI 10.1126/science.1186743; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106	38	62	63	1	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2012	492	7428					271	+		10.1038/nature11726	http://dx.doi.org/10.1038/nature11726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23235881	Green Accepted			2022-12-28	WOS:000312259300046
J	Arasawa, S; Nakase, H; Ozaki, Y; Uza, N; Matsuura, M; Chiba, T				Arasawa, Soichi; Nakase, Hiroshi; Ozaki, Yoshinao; Uza, Norimitsu; Matsuura, Minoru; Chiba, Tsutomu			Mediterranean mimicker	LANCET			English	Editorial Material							MEFV GENE-MUTATIONS; ULCERATIVE-COLITIS; FEVER		[Nakase, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University	Nakase, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto 6068507, Japan.	hiropy_n@kuhp.kyoto-u.ac.jp	Nakase, Hiroshi/AAZ-4425-2020	Uza, Norimitsu/0000-0002-1334-5740				Berdeli A, 2011, GENET TEST MOL BIOMA, V15, P475, DOI 10.1089/gtmb.2010.0146; Centola M, 2000, BLOOD, V95, P3223, DOI 10.1182/blood.V95.10.3223; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Villani AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007154; Yildirim B, 2011, RHEUMATOL INT, V31, P859, DOI 10.1007/s00296-010-1380-y	5	12	12	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 8	2012	380	9858					2052	2052		10.1016/S0140-6736(12)61377-4	http://dx.doi.org/10.1016/S0140-6736(12)61377-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051KI	23217869				2022-12-28	WOS:000312124900037
J	Nikfardjam, M				Nikfardjam, Mariam			Omega-3 fatty acids and cardioprotection-IIb or not IIb?	LANCET			English	Editorial Material									Med Univ Vienna, A-1090 Vienna, Austria	Medical University of Vienna	Nikfardjam, M (corresponding author), Med Univ Vienna, A-1090 Vienna, Austria.	mariam.nikfardjam@meduniwien.ac.at						Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; ClinicalTrials.gov, RISK PREV STUD EV EF; ClinicalTrials.gov, VIT D OM 3 TRIAL VIT; ClinicalTrials.gov, STUD CARD EV IN DIAB; Kwak SM, 2012, ARCH INTERN MED, V172, P686, DOI 10.1001/archinternmed.2012.262; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d	7	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	2012	380	9858					1976	1977		10.1016/S0140-6736(12)62039-X	http://dx.doi.org/10.1016/S0140-6736(12)62039-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051KI	23217853				2022-12-28	WOS:000312124900008
J	Benovic, JL				Benovic, Jeffrey L.			G-Protein-Coupled Receptors Signal Victory	CELL			English	Editorial Material							BETA-ADRENERGIC-RECEPTOR; CRYSTAL-STRUCTURE; BINDING-SITES; RHODOPSIN; KINASE	The 2012 Nobel Prize in Chemistry has been awarded to Brian K. Kobilka and Robert J. Lefkowitz for their studies of G-protein-coupled receptors. Their pioneering work over the past 40 years has provided detailed molecular insight into the structure and function of this fundamentally important family of receptors.	Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Jefferson University	Benovic, JL (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	jeffrey.benovic@jefferson.edu			NIGMS NIH HHS [R01 GM047417] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047417] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; CARON MG, 1979, J BIOL CHEM, V254, P2923; CARON MG, 1976, J BIOL CHEM, V251, P2374; Chezerov V., 2007, SCIENCE, V318, P1258; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; LEFKOWITZ RJ, 1974, BIOCHEM BIOPH RES CO, V60, P703, DOI 10.1016/0006-291X(74)90297-6; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004	14	16	17	0	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1148	1150		10.1016/j.cell.2012.11.015	http://dx.doi.org/10.1016/j.cell.2012.11.015			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23201142	Bronze			2022-12-28	WOS:000311999900001
J	McMorran, BJ; Wieczorski, L; Drysdale, KE; Chan, JA; Huang, HM; Smith, C; Mitiku, C; Beeson, JG; Burgio, G; Foote, SJ				McMorran, Brendan J.; Wieczorski, Laura; Drysdale, Karen E.; Chan, Jo-Anne; Huang, Hong Ming; Smith, Clare; Mitiku, Chalachew; Beeson, James G.; Burgio, Gaetan; Foote, Simon J.			Platelet Factor 4 and Duffy Antigen Required for Platelet Killing of Plasmodium falciparum	SCIENCE			English	Article							ERYTHROCYTE CHEMOKINE RECEPTOR; SEVERE MALARIA; MICROBICIDAL PROTEINS; STAPHYLOCOCCUS-AUREUS; AFRICAN CHILDREN; BLOOD-CELLS; THROMBOCYTOPENIA; INFECTION; CHOLESTEROL; INHIBITION	Platelets restrict the growth of intraerythrocytic malaria parasites by binding to parasitized cells and killing the parasite within. Here, we show that the platelet molecule platelet factor 4 (PF4 or CXCL4) and the erythrocyte Duffy-antigen receptor (Fy) are necessary for platelet-mediated killing of Plasmodium falciparum parasites. PF4 is released by platelets on contact with parasitized red cells, and the protein directly kills intraerythrocytic parasites. This function for PF4 is critically dependent on Fy, which binds PF4. Genetic disruption of Fy expression inhibits binding of PF4 to parasitized cells and concomitantly prevents parasite killing by both human platelets and recombinant human PF4. The protective function afforded by platelets during a malarial infection may therefore be compromised in Duffy-negative individuals, who do not express Fy.	[McMorran, Brendan J.; Huang, Hong Ming; Burgio, Gaetan; Foote, Simon J.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [McMorran, Brendan J.; Wieczorski, Laura; Drysdale, Karen E.; Smith, Clare; Mitiku, Chalachew; Burgio, Gaetan; Foote, Simon J.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas 7000, Australia; [Chan, Jo-Anne; Beeson, James G.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3004, Australia	Macquarie University; University of Tasmania; Burnet Institute	McMorran, BJ (corresponding author), Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia.	brendan.mcmorran@mq.edu.au	Foote, Simon J/F-2802-2013; Burgio, Gaetan/B-6722-2015	Burgio, Gaetan/0000-0002-7434-926X; Smith, Clare M./0000-0003-2601-0955; McMorran, Brendan/0000-0003-1845-8872; Foote, Simon/0000-0002-9142-2107	National Health and Medical Research Council of Australia [605524, 490037]; Australian Cancer Research Foundation; National Collaborative Research Infrastructure Strategy of Australia; Bill and Melinda Gates Foundation Grand Challenges Explorations; Howard Hughes Medical Institute; Australian Research Council [DP120100061]; Victorian State Government Operational Infrastructure Support Scheme	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation; National Collaborative Research Infrastructure Strategy of Australia(Australian GovernmentDepartment of Industry, Innovation and Science); Bill and Melinda Gates Foundation Grand Challenges Explorations(Bill & Melinda Gates Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Australian Research Council(Australian Research Council); Victorian State Government Operational Infrastructure Support Scheme	We thank the Australian Red Cross Blood Services in Hobart and Brisbane for providing red blood cells and antibodies, the platelet donors, and C. Flowers and R. McWhirter for phlebotomy. We also acknowledge funding support from the National Health and Medical Research Council of Australia (grants 605524 and 490037), the Australian Cancer Research Foundation, the National Collaborative Research Infrastructure Strategy of Australia, The Bill and Melinda Gates Foundation Grand Challenges Explorations, The Howard Hughes Medical Institute, Australian Research Council (grant DP120100061 and Future Fellowship to J.G.B.), and the Victorian State Government Operational Infrastructure Support Scheme. Ethics approval for the platelet donations was received from the Human Research Ethics Committee (Tasmania) Network (H0009004). Data are deposited in the Dryad Repository: http://dx.doi.org/10.5061/dryad.8sb5h	Adedapo Aduragbenro D., 2007, Journal of Vector Borne Diseases, V44, P266; Akimitsu N, 2004, PARASITOL RES, V93, P499, DOI 10.1007/s00436-004-1165-x; Allen SJ, 1996, QJM-INT J MED, V89, P779, DOI 10.1093/qjmed/89.10.779; CHAUDHURI A, 1994, J BIOL CHEM, V269, P7835; Chotivanich K, 2004, J INFECT DIS, V189, P1052, DOI 10.1086/381900; Erhart LM, 2004, AM J TROP MED HYG, V70, P8, DOI 10.4269/ajtmh.2004.70.8; Gerardin P, 2002, AM J TROP MED HYG, V66, P686, DOI 10.4269/ajtmh.2002.66.686; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; HORSTMANN RD, 1981, BLUT, V42, P157, DOI 10.1007/BF01026385; Howes RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1265; Kashiwazaki M, 2003, INT IMMUNOL, V15, P1219, DOI 10.1093/intimm/dxg121; Ladhani S, 2002, BRIT J HAEMATOL, V119, P839, DOI 10.1046/j.1365-2141.2002.03904.x; Lauer S, 2000, EMBO J, V19, P3556, DOI 10.1093/emboj/19.14.3556; LU ZH, 1995, J BIOL CHEM, V270, P26239; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; OCKENHOUSE CF, 1989, SCIENCE, V243, P1469, DOI 10.1126/science.2467377; Pain A, 2001, P NATL ACAD SCI USA, V98, P1805, DOI 10.1073/pnas.98.4.1805; Peterson JE, 2010, AM J HEMATOL, V85, P487, DOI 10.1002/ajh.21732; PEYRON F, 1989, PARASITOLOGY, V99, P317, DOI 10.1017/S0031182000059011; Polack B, 1997, HAEMOSTASIS, V27, P278; Samuel BU, 2001, J BIOL CHEM, V276, P29319, DOI 10.1074/jbc.M101268200; Srivastava Kalyan, 2008, Cell Host Microbe, V4, P179, DOI 10.1016/j.chom.2008.07.003; SZABO MC, 1995, J BIOL CHEM, V270, P25348, DOI 10.1074/jbc.270.43.25348; Tang YQ, 2002, INFECT IMMUN, V70, P6524, DOI 10.1128/IAI.70.12.6524-6533.2002; Tripathy R, 2007, PEDIATRICS, V120, pE454, DOI 10.1542/peds.2006-3171; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Xiong YQ, 2002, J INFECT DIS, V185, P348, DOI 10.1086/338514; Yeaman MR, 2007, BBA-BIOMEMBRANES, V1768, P609, DOI 10.1016/j.bbamem.2006.11.010; Yeaman MR, 1998, J CLIN INVEST, V101, P178, DOI 10.1172/JCI562; ZUCKER MB, 1991, P SOC EXP BIOL MED, V198, P693	32	111	111	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1348	1351		10.1126/science.1228892	http://dx.doi.org/10.1126/science.1228892			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224555	Green Published			2022-12-28	WOS:000311991200068
J	Sebastian, C; Zwaans, BMM; Silberman, DM; Gymrek, M; Goren, A; Zhong, L; Ram, O; Truelove, J; Guimaraes, AR; Toiber, D; Cosentino, C; Greenson, JK; MacDonald, AI; McGlynn, L; Maxwell, F; Edwards, J; Giacosa, S; Guccione, E; Weissleder, R; Bernstein, BE; Regev, A; Shiels, PG; Lombard, DB; Mostoslavsky, R				Sebastian, Carlos; Zwaans, Bernadette M. M.; Silberman, Dafne M.; Gymrek, Melissa; Goren, Alon; Zhong, Lei; Ram, Oren; Truelove, Jessica; Guimaraes, Alexander R.; Toiber, Debra; Cosentino, Claudia; Greenson, Joel K.; MacDonald, Alasdair I.; McGlynn, Liane; Maxwell, Fraser; Edwards, Joanne; Giacosa, Sofia; Guccione, Ernesto; Weissleder, Ralph; Bernstein, Bradley E.; Regev, Aviv; Shiels, Paul G.; Lombard, David B.; Mostoslavsky, Raul			The Histone Deacetylase SIRT6 Is a Tumor Suppressor that Controls Cancer Metabolism	CELL			English	Article							MULTIPLE INTESTINAL NEOPLASIA; C-MYC; GENE-EXPRESSION; RIBOSOMAL DNA; TUMORIGENESIS; TRANSCRIPTION; GLYCOLYSIS; PHYSIOLOGY; INTEGRITY; MUTATION	Reprogramming of cellular metabolism is a key event during tumorigenesis. Despite being known for decades (Warburg effect), the molecular mechanisms regulating this switch remained unexplored. Here, we identify SIRT6 as a tumor suppressor that regulates aerobic glycolysis in cancer cells. Importantly, loss of SIRT6 leads to tumor formation without activation of known oncogenes, whereas transformed SIRT6-deficient cells display increased glycolysis and tumor growth, suggesting that SIRT6 plays a role in both establishment and maintenance of cancer. By using a conditional SIRT6 allele, we show that SIRT6 deletion in vivo increases the number, size, and aggressiveness of tumors. SIRT6 also functions as a regulator of ribosome metabolism by corepressing MYC transcriptional activity. Lastly, Sirt6 is selectively downregulated in several human cancers, and expression levels of SIRT6 predict prognosis and tumor-free survival rates, highlighting SIRT6 as a critical modulator of cancer metabolism. Our studies reveal SIRT6 to be a potent tumor suppressor acting to suppress cancer metabolism.	[Zwaans, Bernadette M. M.; Greenson, Joel K.; Lombard, David B.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Lombard, David B.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; [Sebastian, Carlos; Silberman, Dafne M.; Goren, Alon; Zhong, Lei; Ram, Oren; Toiber, Debra; Cosentino, Claudia; Giacosa, Sofia; Bernstein, Bradley E.; Mostoslavsky, Raul] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Goren, Alon; Ram, Oren; Bernstein, Bradley E.; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Gymrek, Melissa; Bernstein, Bradley E.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Gymrek, Melissa] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Goren, Alon; Ram, Oren; Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Goren, Alon; Ram, Oren; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Goren, Alon; Ram, Oren; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Goren, Alon; Ram, Oren; Truelove, Jessica; Guimaraes, Alexander R.; Weissleder, Ralph; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02140 USA; [MacDonald, Alasdair I.; McGlynn, Liane; Maxwell, Fraser; Edwards, Joanne; Shiels, Paul G.] Univ Glasgow, MVLS, Inst Canc Sci, Glasgow G12 8QQ, Lanark, Scotland; [Guccione, Ernesto] Inst Mol & Cell Biol, Proteos 138673, Singapore; [Silberman, Dafne M.] CEFyBO UBA CONICET, Sch Med, Dept Human Biochem, Buenos Aires, DF, Argentina	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); University of Glasgow; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Lombard, DB (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	davidlom@umich.edu; rmostoslavsky@mgh.harvard.edu	Sebastian, Carlos/CAG-6271-2022; Edwards, Joanne/J-1903-2015; Sebastian, Carlos/H-8014-2018; Cosentino, Claudia/AAF-1100-2019	Edwards, Joanne/0000-0002-7192-6906; Sebastian, Carlos/0000-0001-6623-8028; Gymrek, Melissa/0000-0002-6086-3903; /0000-0003-0828-4143; Shiels, Paul/0000-0002-7577-9843; Lombard, David/0000-0002-4292-0185; Goren, Alon/0000-0001-5669-9357	NIH [GM093072-01, DK088190-01A1, GM101171]; Sidney Kimmel Cancer Research Foundation; Richard D. and Katherine M. O'Connor Research Fund of the University of Michigan Comprehensive Cancer Center; Nathan Shock Center [AG013283]; Pardee Foundation; Beatriu de Pinos Postdoctoral Fellowship (Generalitat de Catalunya); National Defense Science and Engineering Graduate Fellowship; Brain Power for Israel Foundation; Fondazione Umberto Veronesi; NHGRI Center of Excellence in Genome Science [P50HG006193]; NATIONAL CANCER INSTITUTE [R01CA175727] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K08EB012859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093072, R01GM101171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013283] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sidney Kimmel Cancer Research Foundation; Richard D. and Katherine M. O'Connor Research Fund of the University of Michigan Comprehensive Cancer Center; Nathan Shock Center; Pardee Foundation; Beatriu de Pinos Postdoctoral Fellowship (Generalitat de Catalunya)(Generalitat de Catalunya); National Defense Science and Engineering Graduate Fellowship; Brain Power for Israel Foundation; Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); NHGRI Center of Excellence in Genome Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH awards GM093072-01 and DK088190-01A1 (R.M.) and GM101171 (D.B.L.), the Sidney Kimmel Cancer Research Foundation (R.M.), the Richard D. and Katherine M. O'Connor Research Fund of the University of Michigan Comprehensive Cancer Center (D.B.L.), the Nathan Shock Center (AG013283; D.B.L.), and the Pardee Foundation (D.B.L.). R.M. is a Howard Goodman Scholar and an MGH Research Scholar. D.B.L. is a New Scholar in Aging of the Ellison Medical Foundation. C.S. is the recipient of a Beatriu de Pinos Postdoctoral Fellowship (Generalitat de Catalunya). M.G. is supported by a National Defense Science and Engineering Graduate Fellowship. D.T. is the recipient of the Brain Power for Israel Foundation. C.C. is supported by a Fellowship from the Fondazione Umberto Veronesi. A.R. is supported by a P50HG006193 from the NHGRI Center of Excellence in Genome Science. D.B.L. would like to thank Dr. Chuxia Deng (NIDDK/NIH) for the floxed SIRT6 mouse strain. We thank Nabeel Bardeesy, Eric Fearon, Alexandros Tzatsos, Polina Paskaleva, Kevin Haigis, Agustina D'Urso, Marco Bezzi, and the Mostoslavsky and Lombard labs for technical advice, reagents, and helpful discussions. We thank the ENCODE Chromatin Project at the Broad Institute for data sharing. R.M. is a member of Sirtris scientific advisory board.	Anders M., 2011, MOL CARCINOG; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Fang YJ, 2011, CANCER LETT, V306, P10, DOI 10.1016/j.canlet.2011.02.019; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Martinez-Pastor B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00022; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; YAMAMOTO T, 1990, BIOCHEM BIOPH RES CO, V170, P223, DOI 10.1016/0006-291X(90)91263-R; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Younes M, 1996, CANCER RES, V56, P1164; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	44	483	504	0	151	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1185	1199		10.1016/j.cell.2012.10.047	http://dx.doi.org/10.1016/j.cell.2012.10.047			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217706	Green Accepted, Bronze			2022-12-28	WOS:000311999900010
J	Eisenstein, M				Eisenstein, Michael			CENTENARIANS Great expectations	NATURE			English	Editorial Material							GENOME-WIDE ASSOCIATION											Andersen SL, 2012, J GERONTOL A-BIOL, V67, P395, DOI 10.1093/gerona/glr223; Beekman M, 2010, P NATL ACAD SCI USA, V107, P18046, DOI 10.1073/pnas.1003540107; Bergman A, 2007, PLOS COMPUT BIOL, V3, P1648, DOI 10.1371/journal.pcbi.0030170; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Nebel A, 2011, MECH AGEING DEV, V132, P324, DOI 10.1016/j.mad.2011.06.008; Sebastiani P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029848	7	8	8	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					S6	S8		10.1038/492S6a	http://dx.doi.org/10.1038/492S6a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048EQ	23222673				2022-12-28	WOS:000311893400004
J	Kim, A; Mumm, LA; Korenstein, D				Kim, Azalea; Mumm, Lawrence A.; Korenstein, Deborah			Routine Conflict of Interest Disclosure by Preclinical Lecturers and Medical Students' Attitudes Toward the Pharmaceutical and Device Industries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Kim, Azalea; Mumm, Lawrence A.] Mt Sinai Sch Med, Dept Med Educ, New York, NY 10029 USA; [Korenstein, Deborah] Mt Sinai Sch Med, Dept Med, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Kim, A (corresponding author), Mt Sinai Sch Med, Dept Med Educ, New York, NY 10029 USA.	deborah.korenstein@mssm.edu						Hebert PC, 2010, CAN MED ASSOC J, V182, P1279, DOI 10.1503/cmaj.100605; Institute of Medicine, 2009, CONFL INT RES ED PRA; Korenstein D, 2010, ARCH SURG-CHICAGO, V145, P570, DOI 10.1001/archsurg.2010.75; Sierles FS, 2005, JAMA-J AM MED ASSOC, V294, P1034, DOI 10.1001/jama.294.9.1034; Vagelos RC, REPORT AAMC TASK FOR; Weinfurt KP, 2009, CONFLICTS INTEREST M	6	9	9	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2012	308	21					2187	2189		10.1001/jama.2012.25315	http://dx.doi.org/10.1001/jama.2012.25315			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047HI	23212492	Bronze			2022-12-28	WOS:000311829500006
J	Traverso, G; McMahon, GT				Traverso, Giovanni; McMahon, Graham T.			Residency Training and International Medical Graduates Coming to America No More	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							EDUCATION		[McMahon, Graham T.] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Traverso, Giovanni] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Traverso, Giovanni; McMahon, Graham T.] Harvard Univ, Sch Med, Boston, MA USA; [Traverso, Giovanni] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Traverso, Giovanni] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	McMahon, GT (corresponding author), Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, 221 Longwood Ave, Boston, MA 02115 USA.	gmcmahon@partners.org	Traverso, Carlo Giovanni/ABC-9065-2020; McMahon, Graham/D-3740-2009	Traverso, Carlo Giovanni/0000-0001-7851-4077; McMahon, Graham/0000-0003-4288-6535	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007191] Funding Source: NIH RePORTER; NIDDK NIH HHS [T32 DK007191] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMA- IMG Section Governing Council, 2010, INT MED GRAD AM MED; Boulet JR, 2009, HEALTH AFFAIR, V28, P226, DOI 10.1377/hlthaff.28.1.226; Center for Workforce Studies, 2012, RES 2011 MED SCH ENR; Cooper-Patrick L, 1999, JAMA-J AM MED ASSOC, V282, P583, DOI 10.1001/jama.282.6.583; Educational Commission for Foreign Medical Graduates, 2012, ED COMM FOR MED GRA; Foundation for Advancement of International Medical Education and Research, 2012, INT MED ED DIR; Iglehart JK, 2011, NEW ENGL J MED, V365, P1340, DOI 10.1056/NEJMhpr1107519; Mick SS, 2000, SOC SCI MED, V50, P185, DOI 10.1016/S0277-9536(99)00183-5; Norcini JJ, 2008, J HEALTH CARE POOR U, V19, P493, DOI 10.1353/hpu.0.0015; Sondheimer HM, 2010, JAMA-J AM MED ASSOC, V304, P1168, DOI 10.1001/jama.2010.1316	10	19	19	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2012	308	21					2193	2194		10.1001/jama.2012.14681	http://dx.doi.org/10.1001/jama.2012.14681			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	047HI	23212494	Green Accepted			2022-12-28	WOS:000311829500008
J	Black, ME				Black, Mary E.			Lest we forget	BRITISH MEDICAL JOURNAL			English	Editorial Material												drmaryblack@gmail.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 30	2012	345								e8158	10.1136/bmj.e8158	http://dx.doi.org/10.1136/bmj.e8158			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048FS	23204007				2022-12-28	WOS:000311896500014
J	Seabury, SA; Jena, AB; Chandra, A				Seabury, Seth A.; Jena, Anupam B.; Chandra, Amitabh			Trends in the Earnings of Health Care Professionals in the United States, 1987-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Seabury, Seth A.] RAND Corp, Santa Monica, CA USA; [Jena, Anupam B.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Chandra, Amitabh] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	RAND Corporation; Harvard University; Harvard Medical School; Harvard University	Seabury, SA (corresponding author), RAND Corp, Santa Monica, CA USA.	amitabh_chandra@harvard.edu			NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG19783-02] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alhassani A, 2012, NEW ENGL J MED, V366, P289, DOI 10.1056/NEJMp1113059; Medical Group Management Association, PHYS COMP PROD SURV; POPE GC, 1992, HEALTH AFFAIR, V11, P181, DOI 10.1377/hlthaff.11.1.181; Staiger DO, 2010, JAMA-J AM MED ASSOC, V303, P747, DOI 10.1001/jama.2010.168; Tu HT, 2006, ISSUE BRIEF CTR STUD; US Census Bureau, 66 US CENS BUR	6	18	18	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2012	308	20					2083	2085		10.1001/jama.2012.14552	http://dx.doi.org/10.1001/jama.2012.14552			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043IV	23188021	Bronze			2022-12-28	WOS:000311537200017
J	Zuber, MT; Smith, DE; Watkins, MM; Asmar, SW; Konopliv, AS; Lemoine, FG; Melosh, HJ; Neumann, GA; Phillips, RJ; Solomon, SC; Wieczorek, MA; Williams, JG; Goossens, SJ; Kruizinga, G; Mazarico, E; Park, RS; Yuan, DN				Zuber, Maria T.; Smith, David E.; Watkins, Michael M.; Asmar, Sami W.; Konopliv, Alexander S.; Lemoine, Frank G.; Melosh, H. Jay; Neumann, Gregory A.; Phillips, Roger J.; Solomon, Sean C.; Wieczorek, Mark A.; Williams, James G.; Goossens, Sander J.; Kruizinga, Gerhard; Mazarico, Erwan; Park, Ryan S.; Yuan, Dah-Ning			Gravity Field of the Moon from the Gravity Recovery and Interior Laboratory (GRAIL) Mission	SCIENCE			English	Article							LUNAR PROSPECTOR; INTERNAL STRUCTURE; MARE VOLCANISM; EVOLUTION; TOPOGRAPHY	Spacecraft-to-spacecraft tracking observations from the Gravity Recovery and Interior Laboratory (GRAIL) have been used to construct a gravitational field of the Moon to spherical harmonic degree and order 420. The GRAIL field reveals features not previously resolved, including tectonic structures, volcanic landforms, basin rings, crater central peaks, and numerous simple craters. From degrees 80 through 300, over 98% of the gravitational signature is associated with topography, a result that reflects the preservation of crater relief in highly fractured crust. The remaining 2% represents fine details of subsurface structure not previously resolved. GRAIL elucidates the role of impact bombardment in homogenizing the distribution of shallow density anomalies on terrestrial planetary bodies.	[Zuber, Maria T.; Smith, David E.; Mazarico, Erwan] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Watkins, Michael M.; Asmar, Sami W.; Konopliv, Alexander S.; Williams, James G.; Kruizinga, Gerhard; Park, Ryan S.; Yuan, Dah-Ning] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Lemoine, Frank G.; Neumann, Gregory A.] NASA, Solar Syst Explorat Div, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Melosh, H. Jay] Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA; [Phillips, Roger J.] SW Res Inst, Boulder, CO 80302 USA; [Solomon, Sean C.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Solomon, Sean C.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Wieczorek, Mark A.] Univ Paris Diderot, Inst Phys Globe Paris, Sorbonne Paris Cite, Case 7071, F-75205 Paris 13, France; [Goossens, Sander J.] Univ Maryland Baltimore Cty, Baltimore, MD 21250 USA	Massachusetts Institute of Technology (MIT); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Carnegie Institution for Science; Columbia University; UDICE-French Research Universities; Universite Paris Cite; University System of Maryland; University of Maryland Baltimore County	Zuber, MT (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	zuber@mit.edu	Neumann, Gregory A/I-5591-2013; Wieczorek, Mark A/G-6427-2010; Goossens, Sander J/K-2526-2015; Lemoine, Frank/D-1215-2013; Mazarico, Erwan/N-6034-2014	Neumann, Gregory A/0000-0003-0644-9944; Wieczorek, Mark A/0000-0001-7007-4222; Goossens, Sander J/0000-0002-7707-1128; Mazarico, Erwan/0000-0003-3456-427X; Lemoine, Frank G./0000-0002-3051-1456	NASA	NASA(National Aeronautics & Space Administration (NASA))	The GRAIL mission is supported by NASA's Discovery Program and is performed under contract to the Massachusetts Institute of Technology and the Jet Propulsion Laboratory, California Institute of Technology. We are grateful to the GRAIL spacecraft, instrument, and operations teams for outstanding support. We thank J. Andrews-Hanna, J. Head, W. Kiefer, P. McGovern, F. Nimmo, J. Soderblom, and M. Sori for helpful comments on the manuscript. The data used in this study have been submitted to the Geosciences Node of the NASA Planetary Data System.	Andrews-Hanna JC, 2013, SCIENCE, V339, P675, DOI 10.1126/science.1231753; CADOGAN PH, 1974, NATURE, V250, P315, DOI 10.1038/250315a0; Han SC, 2011, ICARUS, V215, P455, DOI 10.1016/j.icarus.2011.07.020; Hatch S. J., 2010, AIAA ASTR C TOR ONT; HEAD JW, 1992, GEOCHIM COSMOCHIM AC, V56, P2155, DOI 10.1016/0016-7037(92)90183-J; Jolliff BL, 2000, J GEOPHYS RES-PLANET, V105, P4197, DOI 10.1029/1999JE001103; Konopliv AS, 1998, SCIENCE, V281, P1476, DOI 10.1126/science.281.5382.1476; Konopliv AS, 2001, ICARUS, V150, P1, DOI 10.1006/icar.2000.6573; Mazarico E, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003472; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; MULLER PM, 1968, SCIENCE, V161, P680, DOI 10.1126/science.161.3842.680; Namiki N, 2009, SCIENCE, V323, P900, DOI 10.1126/science.1168029; Ohtake M, 2009, NATURE, V461, P236, DOI 10.1038/nature08317; PHILLIPS RJ, 1992, J GEOPHYS RES-PLANET, V97, P15923, DOI 10.1029/92JE01696; Roncoli R., 2010, AIAA GUID NAV CONTR; Shearer CK, 2006, REV MINERAL GEOCHEM, V60, P365, DOI 10.2138/rmg.2006.60.4; Smith D.E., 2012, SCIENCE, V335; Smith DE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043751; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; Tapley BD, 2004, SCIENCE, V305, P503, DOI 10.1126/science.1099192; Wieczorek MA, 2000, J GEOPHYS RES-PLANET, V105, P20417, DOI 10.1029/1999JE001092; Wieczorek MA, 2013, SCIENCE, V339, P671, DOI 10.1126/science.1231530; Zuber M. T., 2012, INT ASTRONAUT C, V12, pB4; Zuber MT, 2012, SCIENCE, V336, P217, DOI 10.1126/science.1218805; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788; ZUBER MT, 1994, SCIENCE, V266, P1839, DOI 10.1126/science.266.5192.1839	26	286	311	1	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					668	671		10.1126/science.1231507	http://dx.doi.org/10.1126/science.1231507			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23223395				2022-12-28	WOS:000314585600034
J	Shao, W; Zhang, SZ; Tang, M; Zhang, XH; Zhou, Z; Yin, YQ; Zhou, QB; Huang, YY; Liu, YJ; Wawrousek, E; Chen, T; Li, SB; Xu, M; Zhou, JN; Hu, G; Zhou, JW				Shao, Wei; Zhang, Shu-zhen; Tang, Mi; Zhang, Xin-hua; Zhou, Zheng; Yin, Yan-qing; Zhou, Qin-bo; Huang, Yuan-yuan; Liu, Ying-jun; Wawrousek, Eric; Chen, Teng; Li, Sheng-bin; Xu, Ming; Zhou, Jiang-ning; Hu, Gang; Zhou, Jia-wei			Suppression of neuroinflammation by astrocytic dopamine D2 receptors via alpha B-crystallin	NATURE			English	Article							HUMAN-BRAIN; INFLAMMATION; MICROGLIA; PATHWAY; INNATE; MICE	Chronic neuroinflammation is a common feature of the ageing brain and some neurodegenerative disorders. However, the molecular and cellular mechanisms underlying the regulation of innate immunity in the central nervous system remain elusive. Here we show that the astrocytic dopamine D2 receptor (DRD2) modulates innate immunity through alpha B-crystallin (CRYAB), which is known to suppress neuroinflammation(1,2). We demonstrate that knockout mice lacking Drd2 showed remarkable inflammatory response in multiple central nervous system regions and increased the vulnerability of nigral dopaminergic neurons to neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity(3). Astrocytes null for Drd2 became hyper-responsive to immune stimuli with a marked reduction in the level of CRYAB. Preferential ablation of Drd2 in astrocytes robustly activated astrocytes in the substantia nigra. Gain- or loss-of-function studies showed that CRYAB is critical for DRD2-mediated modulation of innate immune response in astrocytes. Furthermore, treatment of wildtype mice with the selective DRD2 agonist quinpirole increased resistance of the nigral dopaminergic neurons to MPTP through partial suppression of inflammation. Our study indicates that astrocytic DRD2 activation normally suppresses neuroinflammation in the central nervous system through a CRYAB-dependent mechanism, and provides a new strategy for targeting the astrocyte-mediated innate immune response in the central nervous system during ageing and disease.	[Shao, Wei; Zhang, Shu-zhen; Tang, Mi; Zhang, Xin-hua; Zhou, Zheng; Yin, Yan-qing; Zhou, Qin-bo; Huang, Yuan-yuan; Liu, Ying-jun; Zhou, Jia-wei] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Tang, Mi; Hu, Gang] Nanjing Med Univ, Dept Pharmacol, Jiangsu Key Lab Neurodegenerat, Nanjing 210029, Jiangsu, Peoples R China; [Wawrousek, Eric] NEI, NIH, Bethesda, MD 20892 USA; [Chen, Teng; Li, Sheng-bin] Xi An Jiao Tong Univ, Sch Med, Dept Forens Sci, Xian 710061, Shanxi, Peoples R China; [Xu, Ming] Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA; [Zhou, Jiang-ning] Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Brain Funct & Dis, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing Medical University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Xi'an Jiaotong University; University of Chicago; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhou, JW (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai 200031, Peoples R China.	jwzhou@ion.ac.cn	Liu, Yingjun/AAW-5353-2020; Zhou, JiangNing/N-3374-2013; Shao, Wei/GNW-5579-2022; Wawrousek, Eric/A-4547-2008; Zhou, Zheng/AAA-8079-2020	Liu, Yingjun/0000-0003-1543-1965; Shao, Wei/0000-0002-8782-4904; Zhou, Jiawei/0000-0002-1844-9178; Zhang, Xin-hua/0000-0002-5702-6733; Zhou, Qinbo/0000-0002-7967-2138	Chinese Academy of Sciences; National Basic Research Program of China [2011CBA00408, 2011CB504102]; Natural Science Foundation of China [31021063, 31123002]; Shanghai Metropolitan Fund for Research and Development; NATIONAL EYE INSTITUTE [ZICEY000458] Funding Source: NIH RePORTER	Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Metropolitan Fund for Research and Development; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank B. Zhang and Y.J. Yan for technical assistance; L. Zhu for technical support in DNA microarray analysis; the Optical Imaging Center of ION and the Cell Biology Analysis Center of IBCB for technical support in confocal microscopy; T. L. Hagemann for providing the CRYAB construct; R. Quinlan for anti-CRYAB antibodies, Y. Q. Ding for providing the Drd1 and Drd2 gene null mice; we also thank Shanghai Research Center for Model Organisms for creating Drd2-floxed mice. This work was supported by grants from the Chinese Academy of Sciences, National Basic Research Program of China (nos 2011CBA00408 and 2011CB504102), Natural Science Foundation of China (nos 31021063 and 31123002), and Shanghai Metropolitan Fund for Research and Development.	ANTONINI A, 1993, ANN NY ACAD SCI, V695, P81, DOI 10.1111/j.1749-6632.1993.tb23033.x; Bal A, 1994, Brain Res Mol Brain Res, V23, P204; Bhat R, 2009, NEURON, V64, P123, DOI 10.1016/j.neuron.2009.09.015; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Cai L, 2011, NEUROSCIENCE, V181, P196, DOI 10.1016/j.neuroscience.2011.02.059; Casper KB, 2007, GENESIS, V45, P292, DOI 10.1002/dvg.20287; Hagemann TL, 2009, HUM MOL GENET, V18, P1190, DOI 10.1093/hmg/ddp013; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Kaasinen V, 2000, NEUROBIOL AGING, V21, P683, DOI 10.1016/S0197-4580(00)00149-4; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Luo XY, 2009, J NEUROCHEM, V108, P952, DOI 10.1111/j.1471-4159.2008.05845.x; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; Saijo K, 2010, ADV IMMUNOL, V106, P21, DOI 10.1016/S0065-2776(10)06002-5; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; SEEMAN P, 1987, SYNAPSE, V1, P399, DOI 10.1002/syn.890010503; Xu M, 1997, NEURON, V19, P837, DOI 10.1016/S0896-6273(00)80965-4; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	22	270	289	6	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					90	94		10.1038/nature11748	http://dx.doi.org/10.1038/nature11748			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23242137				2022-12-28	WOS:000314741200040
J	Heidegger, CP; Berger, MM; Graf, S; Zingg, W; Darmon, P; Costanza, MC; Thibault, R; Pichard, C				Heidegger, Claudia Paula; Berger, Mette M.; Graf, Severine; Zingg, Walter; Darmon, Patrice; Costanza, Michael C.; Thibault, Ronan; Pichard, Claude			Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: a randomised controlled clinical trial	LANCET			English	Article							INTENSIVE INSULIN THERAPY; EARLY ENTERAL NUTRITION; CARE; METAANALYSIS; INFECTIONS; GUIDELINES; SUPPORT; BALANCE; IMPACT; INJURY	Background Enteral nutrition (EN) is recommended for patients in the intensive-care unit (ICU), but it does not consistently achieve nutritional goals. We assessed whether delivery of 100% of the energy target from days 4 to 8 in the ICU with EN plus supplemental parenteral nutrition (SPN) could optimise clinical outcome. Methods This randomised controlled trial was undertaken in two centres in Switzerland. We enrolled patients on day 3 of admission to the ICU who had received less than 60% of their energy target from EN, were expected to stay for longer than 5 days, and to survive for longer than 7 days. We calculated energy targets with indirect calorimetry on day 3, or if not possible, set targets as 25 and 30 kcal per kg of ideal bodyweight a day for women and men, respectively. Patients were randomly assigned (1: 1) by a computer-generated randomisation sequence to receive EN or SPN. The primary outcome was occurrence of nosocomial infection after cessation of intervention (day 8), measured until end of follow-up (day 28), analysed by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00802503. Findings We randomly assigned 153 patients to SPN and 152 to EN. 30 patients discontinued before the study end. Mean energy delivery between day 4 and 8 was 28 kcal/kg per day (SD 5) for the SPN group (103% [SD 18%] of energy target), compared with 20 kcal/kg per day (7) for the EN group (77% [27%]). Between days 9 and 28, 41 (27%) of 153 patients in the SPN group had a nosocomial infection compared with 58 (38%) of 152 patients in the EN group (hazard ratio 0.65, 95% CI 0.43-0.97; p=0.0338), and the SPN group had a lower mean number of nosocomial infections per patient (-0.42 [-0.79 to -0.05]; p=0.0248). Interpretation Individually optimised energy supplementation with SPN starting 4 days after ICU admission could reduce nosocomial infections and should be considered as a strategy to improve clinical outcome in patients in the ICU for whom EN is insufficient.	[Heidegger, Claudia Paula; Graf, Severine] Univ Hosp Geneva, Serv Intens Care, CH-1211 Geneva 14, Switzerland; [Graf, Severine; Darmon, Patrice; Thibault, Ronan; Pichard, Claude] Univ Hosp Geneva, Nutr Unit, CH-1211 Geneva 14, Switzerland; [Zingg, Walter] Univ Hosp Geneva, Infect Control Programme, CH-1211 Geneva 14, Switzerland; [Berger, Mette M.] Univ Lausanne Hosp, Serv Adult Intens Care, Lausanne, Switzerland; [Costanza, Michael C.] Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA	University of Geneva; University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Vermont	Pichard, C (corresponding author), Univ Hosp Geneva, Nutr Unit, CH-1211 Geneva 14, Switzerland.	claude.pichard@unige.ch		Thibault, Ronan/0000-0002-6038-5649; Darmon, Patrice/0000-0003-1726-2296	Foundation Nutrition 2000Plus; ICU Quality Funds; Baxter; Fresenius Kabi; Laboratoire Aguettant; B Braun; Nestle Medical Nutrition; Novartis; Novo Nordisk France; Nutricia; Abbott; Cosmed; Nutricia-Numico; Pfizer; Solvay; APSI-ICU quality funds of the Geneva University Hospital; Internal Service Resources of the Lausanne University Hospital; academic Societe Nationale Francaise de Gastroenterologie	Foundation Nutrition 2000Plus; ICU Quality Funds; Baxter; Fresenius Kabi; Laboratoire Aguettant; B Braun; Nestle Medical Nutrition(Nestle SA); Novartis(Novartis); Novo Nordisk France(Novo Nordisk); Nutricia(Danone Nutricia); Abbott(Abbott Laboratories); Cosmed; Nutricia-Numico(Danone Nutricia); Pfizer(Pfizer); Solvay(Solvay SA); APSI-ICU quality funds of the Geneva University Hospital; Internal Service Resources of the Lausanne University Hospital; academic Societe Nationale Francaise de Gastroenterologie	Funding Foundation Nutrition 2000Plus, ICU Quality Funds, Baxter, and Fresenius Kabi.; MMB has received research grants and consulting fees from Laboratoire Aguettant, Baxter, B Braun, Fresenius Kabi, Nestle Medical Nutrition, and Novartis. PD was supported by an unrestricted academic research fellowship from Novo Nordisk France. RT has received consultancy fees from Baxter, B Braun, Nestle Medical Nutrition, and Nutricia. CP has received research grants and consulting fees from Abbott, Baxter, B Braun, Cosmed, Fresenius Kabi, Nestle Medical Nutrition, Novartis, Nutricia-Numico, Pfizer, and Solvay. CPH, SG, WZ, and MCC declare that they have no conflicts of interest.; The trial was investigator driven. Financial support came from the public Foundation Nutrition 2000Plus, APSI-ICU quality funds of the Geneva University Hospital, Internal Service Resources of the Lausanne University Hospital, and from unconditional and non-restrictive research grants from Baxter and Fresenius Kabi, representing less than 25% of the global expenses. RT has received a research award from the academic Societe Nationale Francaise de Gastroenterologie. The sponsors did not place any restrictions on the study design. We thank the entire team (physicians, nurses, physiotherapists, laboratory technicians) of both intensive care units; Aurelie Clerc, statistician, for her data processing work; and Vanessa Brancato and Marcos Coronado Lujan for helping to obtain the data.	Alberda C, 2009, INTENS CARE MED, V35, P1728, DOI 10.1007/s00134-009-1567-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bregeon F, 2008, CRIT CARE MED, V36, P3205, DOI 10.1097/CCM.0b013e31818f0e20; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Desachy A, 2008, INTENS CARE MED, V34, P1054, DOI 10.1007/s00134-007-0983-6; Dhaliwal R, 2004, INTENS CARE MED, V30, P1666, DOI 10.1007/s00134-004-2345-y; Doig GS, 2009, INTENS CARE MED, V35, P2018, DOI 10.1007/s00134-009-1664-4; Dvir D, 2006, CLIN NUTR, V25, P37, DOI 10.1016/j.clnu.2005.10.010; Genton L, 2004, CLIN NUTR, V23, P307, DOI 10.1016/j.clnu.2003.07.006; Gramlich L, 2004, NUTRITION, V20, P843, DOI 10.1016/j.nut.2004.06.003; Heidegger CP, 2007, INTENS CARE MED, V33, P963, DOI 10.1007/s00134-007-0654-7; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Krinsley J, 2010, CRIT CARE, V14, DOI 10.1186/cc9275; LARCA L, 1982, CRIT CARE MED, V10, P297, DOI 10.1097/00003246-198205000-00001; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Martin CM, 2004, CAN MED ASSOC J, V170, P197, DOI 10.1503/cmaj.1040621; Martindale RG, 2009, CRIT CARE MED, V37, P1757, DOI 10.1097/CCM.0b013e3181a40116; Peter JV, 2005, CRIT CARE MED, V33, P213, DOI 10.1097/01.CCM.0000150960.36228.C0; Rubinson L, 2004, CRIT CARE MED, V32, P350, DOI 10.1097/01.CCM.0000089641.06306.68; Simpson F, 2005, INTENS CARE MED, V31, P12, DOI 10.1007/s00134-004-2511-2; Singer P, 2011, INTENS CARE MED, V37, P601, DOI 10.1007/s00134-011-2146-z; Singer P, 2009, CLIN NUTR, V28, P387, DOI 10.1016/j.clnu.2009.04.024; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Villet S, 2005, CLIN NUTR, V24, P502, DOI 10.1016/j.clnu.2005.03.006; WILLIFORD WO, 1991, NEW ENGL J MED, V325, P525; Zingg W, 2011, J HOSP INFECT, V77, P304, DOI 10.1016/j.jhin.2010.11.011; Zingg W, 2009, CRIT CARE MED, V37, P2167, DOI 10.1097/CCM.0b013e3181a02d8f	30	478	501	0	59	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2013	381	9864					385	393		10.1016/S0140-6736(12)61351-8	http://dx.doi.org/10.1016/S0140-6736(12)61351-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	084ZA	23218813				2022-12-28	WOS:000314578900035
J	Wiles, N; Thomas, L; Abel, A; Ridgway, N; Turner, N; Campbell, J; Garland, A; Hollinghurst, S; Jerrom, B; Kessler, D; Kuyken, W; Morrison, J; Turner, K; Williams, C; Peters, T; Lewis, G				Wiles, Nicola; Thomas, Laura; Abel, Anna; Ridgway, Nicola; Turner, Nicholas; Campbell, John; Garland, Anne; Hollinghurst, Sandra; Jerrom, Bill; Kessler, David; Kuyken, Willem; Morrison, Jill; Turner, Katrina; Williams, Chris; Peters, Tim; Lewis, Glyn			Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial	LANCET			English	Article							STAR-ASTERISK-D; CLINICAL-TRIALS; ANALYSIS SYSTEM; MEDICATION; TRENDS; PSYCHOTHERAPY; AUGMENTATION; COMBINATION; PREVENTION; STRATEGIES	Background Only a third of patients with depression respond fully to antidepressant medication but little evidence exists regarding the best next-step treatment for those whose symptoms are treatment resistant. The CoBalT trial aimed to examine the effectiveness of cognitive behavioural therapy (CBT) as an adjunct to usual care (including pharmacotherapy) for primary care patients with treatment resistant depression compared with usual care alone. Methods This two parallel-group multicentre randomised controlled trial recruited 469 patients aged 18-75 years with treatment resistant depression (on antidepressants for >= 6 weeks, Beck depression inventory [BDI] score >= 14 and international classification of diseases [ICD]-10 criteria for depression) from 73 UK general practices. Participants were randomised, with a computer generated code (stratified by centre and minimised according to baseline BDI score, whether the general practice had a counsellor, previous treatment with antidepressants, and duration of present episode of depression) to one of two groups: usual care or CBT in addition to usual care, and were followed up for 12 months. Because of the nature of the intervention it was not possible to mask participants, general practitioners, CBT therapists, or researchers to the treatment allocation. Analyses were by intention to treat. The primary outcome was response, defined as at least 50% reduction in depressive symptoms (BDI score) at 6 months compared with baseline. This trial is registered, ISRCTN38231611. Findings Between Nov 4, 2008, and Sept 30, 2010, we assigned 235 patients to usual care, and 234 to CBT plus usual care. 422 participants (90%) were followed up at 6 months and 396 (84%) at 12 months, finishing on Oct 31, 2011. 95 participants (46%) in the intervention group met criteria for response at 6 months compared with 46 (22%) in the usual care group (odds ratio 3.26, 95% CI 2.10-5.06, p<0.001). Interpretation Before this study, no evidence from large-scale randomised controlled trials was available for the effectiveness of augmentation of antidepressant medication with CBT as a next-step for patients whose depression has not responded to pharmacotherapy. Our study has provided robust evidence that CBT as an adjunct to usual care that includes antidepressants is an effective treatment, reducing depressive symptoms in this population.	[Wiles, Nicola; Thomas, Laura; Turner, Nicholas; Lewis, Glyn] Univ Bristol, Ctr Mental Hlth Addict & Suicide Res, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Peters, Tim] Univ Bristol, Sch Clin Sci, Bristol BS8 2BN, Avon, England; [Abel, Anna; Kuyken, Willem] Univ Exeter, Mood Disorders Ctr, Exeter, Devon, England; [Ridgway, Nicola; Williams, Chris] Univ Glasgow, Acad Unit Mental Hlth & Wellbeing, Inst Hlth & Wellbeing, Gartnavel Royal Hosp, Glasgow, Lanark, Scotland; [Campbell, John] Univ Exeter, Primary Care Res Grp, Sch Med, Exeter, Devon, England; [Garland, Anne] Nottinghamshire Healthcare NHS Trust, Nottingham Psychotherapy Unit, Nottingham, England; [Hollinghurst, Sandra; Kessler, David; Turner, Katrina] Univ Bristol, Ctr Acad Primary Care, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Jerrom, Bill] Avon & Wiltshire Mental Hlth Partnership NHS Trus, Chippenham, England; [Morrison, Jill] Univ Glasgow, Inst Hlth & Wellbeing, Gen Practice & Primary Care Grp, Glasgow, Lanark, Scotland	University of Bristol; University of Bristol; University of Exeter; Gartnavel Royal Hospital; University of Glasgow; University of Exeter; University of Nottingham; University of Bristol; University of Glasgow	Wiles, N (corresponding author), Univ Bristol, Ctr Mental Hlth Addict & Suicide Res, Sch Social & Community Med, Oakfield House, Bristol BS8 2BN, Avon, England.	nicola.wiles@bristol.ac.uk	Kuyken, Willem/ABC-5152-2021; Lewis, Glyn/E-9944-2012; Campbell, John/A-5792-2011; Kessler, david/ABB-6489-2021	Lewis, Glyn/0000-0001-5205-8245; Campbell, John/0000-0002-6752-3493; Wiles, Nicola/0000-0002-5250-3553; Turner, Nicholas/0000-0003-1591-6997; Peters, Tim/0000-0003-2881-4180; Turner, Katrina/0000-0002-6375-2918; Kuyken, Willem/0000-0002-8596-5252; Ridgway, Nicola/0000-0003-4801-2679	National Institute for Health Research Health Technology Assessment; CLAHRC-NDL; National Institute for Health Research Health Technology Assessment (NIHR HTA) [06/404/02]; Mental Health Research Network; Scottish Mental Health Research Network; Primary Care Research Network; Scottish Primary Care Research Network; Department of Health and local Primary Care Trusts (PCTs); MRC [G0800800] Funding Source: UKRI; Medical Research Council [G0800800] Funding Source: researchfish; National Institute for Health Research [06/404/501] Funding Source: researchfish	National Institute for Health Research Health Technology Assessment; CLAHRC-NDL; National Institute for Health Research Health Technology Assessment (NIHR HTA); Mental Health Research Network; Scottish Mental Health Research Network; Primary Care Research Network; Scottish Primary Care Research Network; Department of Health and local Primary Care Trusts (PCTs); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding National Institute for Health Research Health Technology Assessment.; CW has been a past president of the British Association for Behavioural and Cognitive Psychotherapies (BABCP), a workshop leader, and author of texts on depression and self-help resources. WK is cofounder of the Mood Disorders Centre, teaches nationally, and internationally on CBT and coauthored a cognitive therapy book (Collaborative Case Conceptualization, Guilford Press). AG is clinical lead for the Nottingham Specialised Depression Service, Principal Investigator to the CLAHRC-NDL funded Depression Study, a past president of the BABCP, a CBT workshop leader both nationally and internationally, and author of texts on depression. The other authors declare that they have no conflicts of interest.; This research was funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme (project number 06/404/02). The views expressed in this publication are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS, or the Department of Health. We thank all the patients, practitioners, and general practice surgery staff who took part in this research. We thank the members of our Trial Steering Committee and Data Monitoring Committee for their valuable advice and support during the project. We acknowledge the additional support that has been provided by the Mental Health Research Network, Scottish Mental Health Research Network, Primary Care Research Network, and Scottish Primary Care Research Network. We also acknowledge the support provided by the Department of Health and local Primary Care Trusts (PCTs) and Health Boards in meeting the excess treatment and service support costs associated with the trial. We thank the following colleagues who have contributed to the CoBalT study, through recruitment and retention of patients, provision of administrative support, or delivery of therapy: Joy Farrimond, Mary Yarwood, Katrina Crook, Caroline Baker, Nathan Filer, Alex Burrage, Samantha Green, Meyrem Musa, Emma Riggs, Ros Fortune, and Kate Chapman in Bristol; Rachel Winder, Caroline Jenkinson, Alice Garood, Holly Sugg, Miriam Cassell, Rob Kidney, and Clare Bootle in Exeter; and Monica Cairns, Seonaid Cleare, Janice Reid, June Anderson, Jacqueline McTaggart, Katy Park and Eileen Riddoch in Glasgow. We thank Catriona Kent who was the main clinical supervisor for the Glasgow therapists. Finally, we thank Debbie Sharp who was a coapplicant on the original grant application.	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Beck AT, 1996, PSYCHOL ASSESS; Beck AT, 1987, COGNITIVE THERAPY DE; Beck J.S., 2011, COGNITIVE BEHAV THER, V(2nd); Berlim MT, 2007, EUR NEUROPSYCHOPHARM, V17, P696, DOI 10.1016/j.euroneuro.2007.03.009; Blackburn IM., 2001, COGNITIVE THERAPY SC, VIn.; Blackburn IM, 2001, BEHAV COGN PSYCHOTH, V29, P431, DOI 10.1017/S1352465801004040; Brown S, 2005, STAT MED, V24, P3715, DOI 10.1002/sim.2391; Churchill R, 2001, Health Technol Assess, V5, P1; Department of Health, 2011, TALK THER 4 YEAR PLA; Dunn G, 2005, STAT METHODS MED RES, V14, P369, DOI 10.1191/0962280205sm403oa; George CF, 2000, BRIT J CLIN PHARMACO, V50, P166, DOI 10.1046/j.1365-2125.2000.00244.x; Hepner KA, 2010, ADM POLICY MENT HLTH, V37, P270, DOI 10.1007/s10488-009-0247-6; Hollon SD, 2005, ARCH GEN PSYCHIAT, V62, P417, DOI 10.1001/archpsyc.62.4.417; Keller MB, 2000, NEW ENGL J MED, V342, P1462, DOI 10.1056/NEJM200005183422001; Kennedy SH, 2003, J CLIN PSYCHIAT, V64, P439, DOI 10.4088/JCP.v64n0414; Kocsis JH, 2009, ARCH GEN PSYCHIAT, V66, P1178, DOI 10.1001/archgenpsychiatry.2009.144; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LEWIS G, 1994, J EPIDEMIOL COMMUN H, V48, P207, DOI 10.1136/jech.48.2.207; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McManus P, 2000, MED J AUSTRALIA, V173, P458, DOI 10.5694/j.1326-5377.2000.tb139294.x; McPherson S, 2005, ACTA PSYCHIAT SCAND, V111, P331, DOI 10.1111/j.1600-0447.2004.00498.x; Middleton N, 2001, J PUBLIC HEALTH MED, V23, P262, DOI 10.1093/pubmed/23.4.262; Moore R. G., 2003, COGNITIVE THERAPY CH; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; National Institute for Clinical Excellence, 2009, NAT PRACT CLIN GUID, P90; Olfson M, 2002, AM J PSYCHIAT, V159, P1914, DOI 10.1176/appi.ajp.159.11.1914; Paykel ES, 1999, ARCH GEN PSYCHIAT, V56, P829, DOI 10.1001/archpsyc.56.9.829; Roberts C, 2005, CLIN TRIALS, V2, P152, DOI 10.1191/1740774505cn076oa; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stimpson N, 2002, BRIT J PSYCHIAT, V181, P284, DOI 10.1192/bjp.181.4.284; Strauss WH, 2002, YOK JAP 12 WORLD C P; Thase ME, 2007, AM J PSYCHIAT, V164, P739, DOI 10.1176/appi.ajp.164.5.739; Thomas LJ, 2012, CONTEMP CLIN TRIALS, V33, P312, DOI 10.1016/j.cct.2011.10.016; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wiles NJ, 2008, BEHAV COGN PSYCHOTH, V36, P21, DOI 10.1017/S135246580700389X; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	41	216	220	0	85	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2013	381	9864					375	384		10.1016/S0140-6736(12)61552-9	http://dx.doi.org/10.1016/S0140-6736(12)61552-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084ZA	23219570	Green Submitted			2022-12-28	WOS:000314578900034
J	Rosenbluh, J; Nijhawan, D; Cox, AG; Li, XN; Neal, JT; Schafer, EJ; Zack, TI; Wang, XX; Tsherniak, A; Schinzel, AC; Shao, DD; Schumacher, SE; Weir, BA; Vazquez, F; Cowley, GS; Root, DE; Mesirov, JP; Beroukhim, R; Kuo, CJ; Goessling, W; Hahn, WC				Rosenbluh, Joseph; Nijhawan, Deepak; Cox, Andrew G.; Li, Xingnan; Neal, James T.; Schafer, Eric J.; Zack, Travis I.; Wang, Xiaoxing; Tsherniak, Aviad; Schinzel, Anna C.; Shao, Diane D.; Schumacher, Steven E.; Weir, Barbara A.; Vazquez, Francisca; Cowley, Glenn S.; Root, David E.; Mesirov, Jill P.; Beroukhim, Rameen; Kuo, Calvin J.; Goessling, Wolfram; Hahn, William C.			beta-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis	CELL			English	Article							YES-ASSOCIATED PROTEIN; HIPPO PATHWAY; CELL-PROLIFERATION; SIGNALING PATHWAY; ZEBRAFISH EMBRYOS; GROWTH-CONTROL; COLON-CANCER; ORGAN SIZE; PHOSPHORYLATION; ACTIVATION	Wnt/beta-catenin signaling plays a key role in the pathogenesis of colon and other cancers; emerging evidence indicates that oncogenic beta-catenin regulates several biological processes essential for cancer initiation and progression. To decipher the role of beta-catenin in transformation, we classified beta-catenin activity in 85 cancer cell lines in which we performed genome-scale loss-of-function screens and found that beta-catenin active cancers are dependent on a signaling pathway involving the transcriptional regulator YAP1. Specifically, we found that YAP1 and the transcription factor TBX5 form a complex with beta-catenin. Phosphorylation of YAP1 by the tyrosine kinase YES1 leads to localization of this complex to the promoters of antiapoptotic genes, including BCL2L1 and BIRC5. A small-molecule inhibitor of YES1 impeded the proliferation of beta-catenin-dependent cancers in both cell lines and animal models. These observations define a beta-catenin-YAP1-TBX5 complex essential to the transformation and survival of beta-catenin-driven cancers.	[Rosenbluh, Joseph; Nijhawan, Deepak; Schafer, Eric J.; Wang, Xiaoxing; Schinzel, Anna C.; Shao, Diane D.; Weir, Barbara A.; Vazquez, Francisca; Goessling, Wolfram; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Zack, Travis I.; Schumacher, Steven E.; Beroukhim, Rameen; Hahn, William C.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Rosenbluh, Joseph; Nijhawan, Deepak; Cox, Andrew G.; Schafer, Eric J.; Wang, Xiaoxing; Schinzel, Anna C.; Shao, Diane D.; Beroukhim, Rameen; Goessling, Wolfram; Hahn, William C.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Cox, Andrew G.; Goessling, Wolfram] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; [Rosenbluh, Joseph; Nijhawan, Deepak; Schafer, Eric J.; Zack, Travis I.; Wang, Xiaoxing; Tsherniak, Aviad; Schinzel, Anna C.; Shao, Diane D.; Schumacher, Steven E.; Weir, Barbara A.; Vazquez, Francisca; Cowley, Glenn S.; Root, David E.; Mesirov, Jill P.; Beroukhim, Rameen; Hahn, William C.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Cox, Andrew G.; Goessling, Wolfram] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Li, Xingnan; Neal, James T.; Kuo, Calvin J.] Stanford Univ, Sch Med, Div Hematol, Dept Med, Stanford, CA 94305 USA; [Zack, Travis I.] Harvard Univ, Program Biophys, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Stanford University; Harvard University	Hahn, WC (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02215 USA.	william_hahn@dfci.harvard.edu	Schumacher, Steven/E-9821-2013; Shao, Diane/GRO-3470-2022; Vazquez, Francisca/AAA-3751-2020; Mesirov, Jill/AGF-7626-2022; Vazquez, Francisca/ABC-4620-2020	Schumacher, Steven/0000-0002-6819-5647; Vazquez, Francisca/0000-0002-2857-4685; Cox, Andrew/0000-0003-4189-9422; Tsherniak, Aviad/0000-0002-3797-1877; Neal, James/0000-0002-3962-8570; Rosenbluh, Joseph/0000-0001-9815-8049; Kuo, Calvin/0000-0002-7427-5985; Shao, Diane/0000-0003-2087-4082; Goessling, Wolfram/0000-0001-9972-1569	NIH/NCI [R01 CA140545, RC2 CA148268, U54 CA143798, U01 DK085527, U01 CA151920, R01 DK085720, U54 CA112962, R01 DK090311]; Pew Charitable Trust; Fidelity Foundation; Stanford University; DoD [W81XWH-10-1-0062]; Conquer Cancer Foundation; Sass Foundation; SPORE career development award [P50 CA127003]; NIH [F32 GM090437]; NATIONAL CANCER INSTITUTE [U54CA143798, R01CA140545, U01CA151920, R01CA109467, P50CA127003, RC2CA148268, U54CA112962, F32CA124082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090311, R01DK085720, U01DK085527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074024, T32GM007753, F32GM090437] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pew Charitable Trust; Fidelity Foundation; Stanford University(Stanford University); DoD(United States Department of Defense); Conquer Cancer Foundation; Sass Foundation; SPORE career development award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Hahn lab for helpful discussions and L. Gafney and L. Solomon for assistance with graphic arts. This work was supported in part by NIH/NCI grants R01 CA140545 (W.C.H.), RC2 CA148268 (W.C.H.), U54 CA143798 (R.B.), U01 DK085527 (C.J.K.), U01 CA151920 (C.J.K.), R01 DK085720 (C.J.K.), U54 CA112962 (A.T., J.P.M., and W.C.H.), R01 DK090311 (W.G.), the Pew Charitable Trust (W.G.), a Fidelity Foundation grant (C.J.K.), a Stanford University Dean's Fellowship (J.T.N.), a DoD breast cancer postdoctoral fellowship W81XWH-10-1-0062 (X.W.), Conquer Cancer Foundation Young Investigator Award and Sass Foundation Fellowship (D.N.), a SPORE career development award P50 CA127003 (J.R.), and an NIH F32 postdoctoral fellowship F32 GM090437 (J.R.). J.R. is a John Svenson postdoctoral fellow. W.C.H. and R.B. are consultants for Novartis Pharmaceuticals.	Angus-Hill ML, 2011, P NATL ACAD SCI USA, V108, P4914, DOI 10.1073/pnas.1102300108; Badouel C, 2009, CURR OPIN CELL BIOL, V21, P837, DOI 10.1016/j.ceb.2009.09.010; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cheesman SE, 2011, P NATL ACAD SCI USA, V108, P4570, DOI 10.1073/pnas.1000072107; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Du JY, 2009, NAT BIOTECHNOL, V27, P77, DOI 10.1038/nbt.1513; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Jiang Q, 2009, BIOCHEM BIOPH RES CO, V384, P114, DOI 10.1016/j.bbrc.2009.04.070; Jopling C, 2007, MECH DEVELOP, V124, P129, DOI 10.1016/j.mod.2006.10.003; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Mori AD, 2004, CURR OPIN CARDIOL, V19, P211, DOI 10.1097/00001573-200405000-00004; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mudumana SP, 2004, DEV DYNAM, V230, P165, DOI 10.1002/dvdy.20032; Mulholland DJ, 2002, J BIOL CHEM, V277, P17933, DOI 10.1074/jbc.M200135200; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nautiyal J, 2011, INT J CANCER, V128, P951, DOI 10.1002/ijc.25410; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; PENA SV, 1995, GASTROENTEROLOGY, V108, P117, DOI 10.1016/0016-5085(95)90015-2; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Sullivan-Brown J, 2011, NAT PROTOC, V6, P46, DOI 10.1038/nprot.2010.165; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Tang W, 2008, P NATL ACAD SCI USA, V105, P9697, DOI 10.1073/pnas.0804709105; Tsai WB, 2005, DEV BIOL, V277, P129, DOI 10.1016/j.ydbio.2004.08.052; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang M, 2012, DEVELOPMENT, V139, P2009, DOI 10.1242/dev.074435; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	58	530	549	6	90	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1457	1473		10.1016/j.cell.2012.11.026	http://dx.doi.org/10.1016/j.cell.2012.11.026			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23245941	Bronze, Green Accepted			2022-12-28	WOS:000312890300012
J	Altman, DG				Altman, Douglas G.			CHRISTMAS 2012: A RESEARCH Building a metaphor: Another brick in the wall?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Oxford, Ctr Stat Med, Wolfson Coll Annexe, Oxford OX2 6UD, England	University of Oxford	Altman, DG (corresponding author), Univ Oxford, Ctr Stat Med, Wolfson Coll Annexe, Oxford OX2 6UD, England.	doug.altman@csm.ox.ac.uk						Cooper H, 2009, HDB RES SYNTHESIS ME, P4; FORSCHER BK, 1963, SCIENCE, V142, P339, DOI 10.1126/science.142.3590.339; LIPSEY MW, 1997, NEW DIRECTIONS EVALU, V76, P7, DOI DOI 10.1002/EV.1084; PLATT JR, 1964, SCIENCE, V146, P347, DOI 10.1126/science.146.3642.347; POINCARE H, 2002, SCI HYPOTHESE; Rayleigh The Lord., 1884, 54 M BRIT ASS ADV SC; Tobin MJ, 2001, AM J RESP CRIT CARE, V164, P1333, DOI 10.1164/ajrccm.164.8.2109028a; Tobin MJ, 2000, AM J RESP CRIT CARE, V162, P773, DOI 10.1164/ajrccm.162.3.ed08-00; Weed M., 2005, EUR SPORT MANAG Q, V5, P77, DOI [https://doi.org/10.1080/16184740500089763, DOI 10.1080/16184740500089763]; Ziman J, 2001, SCI ENG ETHICS, V7, P165, DOI 10.1007/s11948-001-0038-2; Ziman J., 1968, PUBLIC KNOWLEDGE ESS, P109	11	3	3	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2012	345								e8302	10.1136/bmj.e8302	http://dx.doi.org/10.1136/bmj.e8302			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IU	23248079	Green Published			2022-12-28	WOS:000312698700021
J	Huedo-Medina, TB; Kirsch, I; Middlemass, J; Klonizakis, M; Siriwardena, AN				Huedo-Medina, Tania B.; Kirsch, Irving; Middlemass, Jo; Klonizakis, Markos; Siriwardena, A. Niroshan			Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SHORT-TERM MANAGEMENT; INITIAL SEVERITY; SLEEP CHANGES; BENZODIAZEPINE; PUBLICATION; TRIALS; HETEROGENEITY; EFFICACY; QUALITY; POWER	Objectives To investigate the effectiveness of non-benzodiazepine hypnotics (Z drugs) and associated placebo responses in adults and to evaluate potential moderators of effectiveness in a dataset used to approve these drugs. Design Systematic review and meta-analysis. Data source US Food and Drug Administration (FDA). Study selection Randomised double blind parallel placebo controlled trials of currently approved Z drugs (eszopiclone, zaleplon, and zolpidem). Data extraction Change score from baseline to post-test for drug and placebo groups; drug efficacy analysed as the difference of both change scores. Weighted raw and standardised mean differences with their confidence intervals under random effects assumptions for polysomnographic and subjective sleep latency, as primary outcomes. Secondary outcomes included waking after sleep onset, number of awakenings, total sleep time, sleep efficiency, and subjective sleep quality. Weighted least square regression analysis was used to explain heterogeneity of drug effects. Data synthesis 13 studies containing 65 separate drug-placebo comparisons by type of outcome, type of drug, and dose were included. Studies included 4378 participants from different countries and varying drug doses, lengths of treatment, and study years. Z drugs showed significant, albeit small, improvements (reductions) in our primary outcomes: polysomnographic sleep latency (weighted standardised mean difference, 95% confidence interval -0.57 to -0.16) and subjective sleep latency (-0.33, -0.62 to -0.04) compared with placebo. Analyses of weighted mean raw differences showed that Z drugs decreased polysomnographic sleep latency by 22 minutes (-33 to -11 minutes) compared with placebo. Although no significant effects were found in secondary outcomes, there were insufficient studies reporting these outcomes to allow firm conclusions. Moderator analyses indicated that sleep latency was more likely to be reduced in studies published earlier, with larger drug doses, with longer duration of treatment, with a greater proportion of younger and/or female patients, and with zolpidem. Conclusion Compared with placebo, Z drugs produce slight improvements in subjective and polysomnographic sleep latency, especially with larger doses and regardless of type of drug. Although the drug effect and the placebo response were rather small and of questionable clinical importance, the two together produced to a reasonably large clinical response.	[Middlemass, Jo; Klonizakis, Markos; Siriwardena, A. Niroshan] Lincoln Univ, Commun & Hlth Res Unit, Lincoln Sch Hlth & Social Care, Lincoln LN6 7TS, England; [Huedo-Medina, Tania B.] Univ Connecticut, Dept Allied Hlth Sci, Storrs, CT 06269 USA; [Kirsch, Irving] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Cambridge, MA 02138 USA; [Kirsch, Irving] Univ Plymouth, Sch Psychol, Plymouth PL4 8AA, Devon, England	University of Lincoln; University of Connecticut; Harvard University; Beth Israel Deaconess Medical Center; University of Plymouth	Siriwardena, AN (corresponding author), Lincoln Univ, Commun & Hlth Res Unit, Lincoln Sch Hlth & Social Care, Lincoln LN6 7TS, England.	nsiriwardena@lincoln.ac.uk	Klonizakis, Markos/A-3680-2009; Kirsch, Irving/P-9316-2019; Siriwardena, A Niroshan/M-3805-2017	Siriwardena, A Niroshan/0000-0003-2484-8201; Klonizakis, Markos/0000-0002-8864-4403	College of Social Science Research Fund at the University of Lincoln	College of Social Science Research Fund at the University of Lincoln	This study was funded by the College of Social Science Research Fund at the University of Lincoln. This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.	BECKER BJ, 1988, BRIT J MATH STAT PSY, V41, P257, DOI 10.1111/j.2044-8317.1988.tb00901.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Belanger L, 2007, J SLEEP RES, V16, P77, DOI 10.1111/j.1365-2869.2007.00566.x; Buscemi N, 2007, J GEN INTERN MED, V22, P1335, DOI 10.1007/s11606-007-0251-z; Chilcott LA, 1996, PHARMACOECONOMICS, V10, P1, DOI 10.2165/00019053-199600101-00003; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cooper H. M., 2009, HDB RES SYNTHESIS ME; Dundar Y, 2004, HEALTH TECHNOL ASSES, V8, P1; Dundar Y, 2004, HUM PSYCHOPHARM CLIN, V19, P305, DOI 10.1002/hup.594; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FISHER S, 1965, PSYCHOPHARMACOLOGIA, V7, P57, DOI 10.1007/BF00404165; Food and Drug Administration Center for Drug Evaluation and Research, 1987, GUID IND GUID FORM C; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Gleser L.J., 1994, HDB RES SYNTHESIS, P339, DOI DOI 10.7758/9781610448864.16; Godlee F, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5641; Hedges LV, 2004, PSYCHOL METHODS, V9, P426, DOI 10.1037/1082-989X.9.4.426; Hedges LV, 1981, J EDUC STAT, V6, P107, DOI [10.2307/1164588, DOI 10.2307/1164588, 10.3102/10769986006002107]; HEMMINKI E, 1980, BRIT MED J, V280, P833, DOI 10.1136/bmj.280.6217.833; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holbrook AM, 2000, CAN MED ASSOC J, V162, P225; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kirsch I., 1998, PREVENTION TREATMENT, V1, DOI 10.1037/1522-3736.1.1.12a; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Kripke DF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000850; Lipsey M. W., 2001, PRACTICAL METAANALYS, DOI DOI 10.1016/J.AUTNEU.2007.06.087; MacLean CH, 2003, J CLIN EPIDEMIOL, V56, P44, DOI 10.1016/S0895-4356(02)00520-6; Mattila Taina, 2011, Eur Neuropsychopharmacol, V21, P500, DOI 10.1016/j.euroneuro.2010.10.005; McCall WV, 2003, SLEEP MED, V4, P57, DOI 10.1016/S1389-9457(02)00242-3; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Miller W.R., 1995, HDB ALCOHOLISM TREAT, V2nd ed., P12; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; National Institute for Health and Clinical Excellence, 2004, TECHN APPR GUID; National Institute for Health and Clinical Excellence, 2004, DEPR MAN DEPR PRIM S; Nowell PD, 1997, JAMA-J AM MED ASSOC, V278, P2170; Olivo SA, 2008, PHYS THER, V88, P156, DOI 10.2522/ptj.20070147; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373; Schmidt FL, 2009, BRIT J MATH STAT PSY, V62, P97, DOI 10.1348/000711007X255327; Service National Framework., 2000, NAT SERV FRAM MENT H; Siriwardena AN, 2008, BRIT J GEN PRACT, V58, P417, DOI 10.3399/bjgp08X299290; Siriwardena AN, 2006, BRIT J GEN PRACT, V56, P964; Siriwardena AN, 2010, J EVAL CLIN PRACT, V16, P731, DOI 10.1111/j.1365-2753.2009.01186.x; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779	45	132	139	2	48	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2012	345								e8343	10.1136/bmj.e8343	http://dx.doi.org/10.1136/bmj.e8343			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IU	23248080	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000312698700004
J	Chen, B; Lutker, K; Raju, SV; Yan, JY; Kanitpanyacharoen, W; Lei, JL; Yang, SZ; Wenk, HR; Mao, HK; Williams, Q				Chen, Bin; Lutker, Katie; Raju, Selva Vennila; Yan, Jinyuan; Kanitpanyacharoen, Waruntorn; Lei, Jialin; Yang, Shizhong; Wenk, Hans-Rudolf; Mao, Ho-kwang; Williams, Quentin			Texture of Nanocrystalline Nickel: Probing the Lower Size Limit of Dislocation Activity	SCIENCE			English	Article							MAXIMUM STRENGTH; DEFORMATION; PRESSURE; METALS; ALUMINUM; COPPER	The size of nanocrystals provides a limitation on dislocation activity and associated stress-induced deformation. Dislocation-mediated plastic deformation is expected to become inactive below a critical particle size, which has been proposed to be between 10 and 30 nanometers according to computer simulations and transmission electron microscopy analysis. However, deformation experiments at high pressure on polycrystalline nickel suggest that dislocation activity is still operative in 3-nanometer crystals. Substantial texturing is observed at pressures above 3.0 gigapascals for 500-nanometer nickel and at greater than 11.0 gigapascals for 20-nanometer nickel. Surprisingly, texturing is also seen in 3-nanometer nickel when compressed above 18.5 gigapascals. The observations of pressure-promoted texturing indicate that under high external pressures, dislocation activity can be extended down to a few-nanometers-length scale.	[Chen, Bin; Raju, Selva Vennila; Yan, Jinyuan] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Chen, Bin; Raju, Selva Vennila; Yan, Jinyuan; Williams, Quentin] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Lutker, Katie] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Raju, Selva Vennila] Univ Nevada, Dept Phys, Las Vegas, NV 89119 USA; [Kanitpanyacharoen, Waruntorn; Wenk, Hans-Rudolf] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Lei, Jialin; Yang, Shizhong] So Univ, Louisiana Opt Network Initiat LONI Inst, Baton Rouge, LA 70813 USA; [Mao, Ho-kwang] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Mao, Ho-kwang] Ctr High Pressure Sci & Technol Adv Res, Shanghai 201203, Peoples R China	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Santa Cruz; University of California System; University of California Berkeley; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of California System; University of California Berkeley; Southern University System; Southern University & A&M College; Carnegie Institution for Science	Chen, B (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA.	bchen@lbl.gov	Mao, Hokwang/K-8013-2013		NSF; Consortium for Materials Properties Research in Earth Sciences (COMPRES) under NSF [EAR 10-43050]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE) [DE-AC02-05CH11231]; NSF-Louisiana Alliance for Simulation-Guided Materials Applications (LA-SiGMA) [EPS-1003897]; NASA/Louisiana Education Quality Support Fund (LEQSF); DOE [DE-FE0007220, DE-FE0003693, DE-FE0004734]; Department of Computer Science; Physical Chemistry of Semiconductor Nanocrystals Program [KC3105]; Office of Basic Energy Science of the DOE [DE-AC02-05CH11231]; Carnegie/Department of Energy Alliance Center (CDAC); National Science Foundation [EAR-0836402]; Energy Frontier Research in Extreme Environments Center (EFree), an Energy Frontier Research Center; DOE Office of Science, Office of Basic Energy Sciences [DE-SG0001057]; EPSCoR [1003897] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Consortium for Materials Properties Research in Earth Sciences (COMPRES) under NSF; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); NSF-Louisiana Alliance for Simulation-Guided Materials Applications (LA-SiGMA); NASA/Louisiana Education Quality Support Fund (LEQSF); DOE(United States Department of Energy (DOE)); Department of Computer Science; Physical Chemistry of Semiconductor Nanocrystals Program; Office of Basic Energy Science of the DOE(United States Department of Energy (DOE)); Carnegie/Department of Energy Alliance Center (CDAC)(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Energy Frontier Research in Extreme Environments Center (EFree), an Energy Frontier Research Center; DOE Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	B.C. and K. L. thank A. P. Alivisatos for discussions. The authors thank J. Knight, A. MacDowell, S. Clark, and A. Gleason for technical help. Financial support for this work was provided by NSF, including from the Consortium for Materials Properties Research in Earth Sciences (COMPRES) under NSF Cooperative Agreement EAR 10-43050. ALS is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE) under contract DE-AC02-05CH11231. J. L. and S.Y. are supported by NSF-Louisiana Alliance for Simulation-Guided Materials Applications (LA-SiGMA) program (#EPS-1003897), NASA/Louisiana Education Quality Support Fund (LEQSF) (2009-2012)-Phase3-03; DOE awards DE-FE0007220, DE-FE0003693, DE-FE0004734; and the Department of Computer Science. K. L. is supported by the Physical Chemistry of Semiconductor Nanocrystals Program, KC3105, Office of Basic Energy Science of the DOE under contract DE-AC02-05CH11231. W. K. and H. R. W. thank the Carnegie/Department of Energy Alliance Center (CDAC) and the National Science Foundation (EAR-0836402) for financial support. H.-k.M. was supported as part of Energy Frontier Research in Extreme Environments Center (EFree), an Energy Frontier Research Center funded by the DOE Office of Science, Office of Basic Energy Sciences under award DE-SG0001057. The authors thank the anonymous reviewers and M. Lavine for their helpful comments and suggestions.	Budrovic Z, 2004, SCIENCE, V304, P273, DOI 10.1126/science.1095071; CAGIN T, 1989, PHYS REV B, V39, P12484, DOI 10.1103/PhysRevB.39.12484; CARTER CB, 1977, PHILOS MAG, V35, P1161, DOI 10.1080/14786437708232942; Chen MW, 2003, SCIENCE, V300, P1275, DOI 10.1126/science.1083727; Chung HY, 2007, SCIENCE, V316, P436, DOI 10.1126/science.1139322; Groma I, 2004, DIFFRACTION ANALYSIS OF THE MICROSTRUCTURE OF MATERIALS, P287; Hirth IP, 1992, THEORY DISLOCATIONS; Honda K., 1937, J I METALS JAPAN, V1, P217; Kocks U. F., 2000, TEXTURE ANISOTROPY P, P10; Kumar KS, 2003, ACTA MATER, V51, P5743, DOI 10.1016/j.actamat.2003.08.032; Li XY, 2010, NATURE, V464, P877, DOI 10.1038/nature08929; Lu L, 2009, SCIENCE, V323, P607, DOI 10.1126/science.1167641; Lutterotti L, 1997, J APPL PHYS, V81, P594, DOI 10.1063/1.364220; Miyagi L, 2010, SCIENCE, V329, P1639, DOI 10.1126/science.1192465; Murayama M, 2002, SCIENCE, V295, P2433, DOI 10.1126/science.1067430; Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969; Pizzagalli L, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.045203; Qadri SB, 2001, J APPL PHYS, V89, P115, DOI 10.1063/1.1328066; Schiotz J, 2003, SCIENCE, V301, P1357, DOI 10.1126/science.1086636; Schiotz J, 1998, NATURE, V391, P561, DOI 10.1038/35328; Shan ZW, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.095502; Shan ZW, 2004, SCIENCE, V305, P654, DOI 10.1126/science.1098741; Wang LH, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.135501; Weissmuller J, 2005, ADV ENG MATER, V7, P202, DOI 10.1002/adem.200400211; Wickham JN, 2000, PHYS REV LETT, V84, P923, DOI 10.1103/PhysRevLett.84.923; Yamakov V, 2002, NAT MATER, V1, P45, DOI 10.1038/nmat700	26	89	90	8	219	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1448	1451		10.1126/science.1228211	http://dx.doi.org/10.1126/science.1228211			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239731				2022-12-28	WOS:000312250800042
J	Lee, JT				Lee, Jeannie T.			Epigenetic Regulation by Long Noncoding RNAs	SCIENCE			English	Review							X-CHROMOSOME INACTIVATION; XIST RNA; TRANSCRIPTION; CHROMATIN; GENE; ANTISENSE; PLURIPOTENCY; REVEALS; BINDING; TSIX	Recent studies show that transcription of the mammalian genome is not only pervasive but also enormously complex. It is estimated that an average of 10 transcription units, the vast majority of which make long noncoding RNAs (lncRNAs), may overlap each traditional coding gene. These lncRNAs include not only antisense, intronic, and intergenic transcripts but also pseudogenes and retrotransposons. Do they universally have function, or are they merely transcriptional by-products of conventional coding genes? A glimpse into the molecular biology of multiple emerging lncRNA systems reveals the "Wild West" landscape of their functions and mechanisms and the key problems to solve in the years ahead toward understanding these intriguing macromolecules.	[Lee, Jeannie T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst HHMI,Dept Mol Biol, Boston, MA 02138 USA; [Lee, Jeannie T.] Harvard Univ, Dept Genet, Sch Med, Boston, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Lee, JT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst HHMI,Dept Mol Biol, Boston, MA 02138 USA.	lee@molbio.mgh.harvard.edu	Hang, Chen/H-5336-2011; Felli, Mario/D-8940-2017	Felli, Mario/0000-0002-5154-1646	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R37 GM058839, R01 GM058839] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058839, R37GM058839] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amrein H, 1997, CELL, V88, P459, DOI 10.1016/S0092-8674(00)81886-3; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hawkins PG, 2010, TRANSCR-AUSTIN, V1, P165, DOI 10.4161/trns.1.3.13332; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Hirotsune S, 2003, NATURE, V423, P91, DOI 10.1038/nature01535; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2010, RNA BIOL, V7, P582, DOI 10.4161/rna.7.5.13216; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Jones BK, 1998, GENE DEV, V12, P2200, DOI 10.1101/gad.12.14.2200; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Latos PA, 2012, SCIENCE, V338, P1469, DOI 10.1126/science.1228110; Lee JT, 2011, NAT REV MOL CELL BIO, V12, P815, DOI 10.1038/nrm3231; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lunyak VV, 2007, SCIENCE, V317, P248, DOI 10.1126/science.1140871; Magistri M, 2012, TRENDS GENET, V28, P389, DOI 10.1016/j.tig.2012.03.013; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Mariner PD, 2008, MOL CELL, V29, P499, DOI 10.1016/j.molcel.2007.12.013; Meller VH, 1997, CELL, V88, P445, DOI 10.1016/S0092-8674(00)81885-1; Modarresi F, 2012, NAT BIOTECHNOL, V30, P453, DOI 10.1038/nbt.2158; Mohamed JS, 2010, RNA, V16, P324, DOI 10.1261/rna.1441510; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pauler FM, 2007, TRENDS GENET, V23, P284, DOI 10.1016/j.tig.2007.03.018; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sado T, 2005, DEV CELL, V9, P159, DOI 10.1016/j.devcel.2005.05.015; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Schorderet P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002071; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Tian D, 2010, CELL, V143, P390, DOI 10.1016/j.cell.2010.09.049; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wan LB, 2008, ADV GENET, V61, P207, DOI 10.1016/S0065-2660(07)00007-7; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011	79	960	1028	12	582	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1435	1439		10.1126/science.1231776	http://dx.doi.org/10.1126/science.1231776			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239728				2022-12-28	WOS:000312250800039
J	Whinnett, ZI; Sohaib, SMA; Davies, DW				Whinnett, Zachary I.; Sohaib, S. M. Afzal; Davies, D. Wyn			Diagnosis and management of supraventricular tachycardia	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RADIOFREQUENCY CATHETER ABLATION; NODAL REENTRANT TACHYCARDIA; LEFT ATRIAL TACHYCARDIAS; SLOW PATHWAY ABLATION; QUALITY-OF-LIFE; FLECAINIDE ACETATE; THERAPY; FIBRILLATION; ARRHYTHMIAS; MECHANISM		[Whinnett, Zachary I.; Sohaib, S. M. Afzal; Davies, D. Wyn] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Waller Dept Cardiol, London W2 1NY, England	Imperial College London	Davies, DW (corresponding author), Imperial Coll Healthcare NHS Trust, St Marys Hosp, Waller Dept Cardiol, London W2 1NY, England.	dwyndavies@aol.com			British Heart Foundation; British Heart Foundation [FS/10/38/28268, FS/11/92/29122, SP/10/002/28189] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: SMAS is funded by the British Heart Foundation; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Aagaard M., 2012, ROPE JUMPING FITNESS; [Anonymous], 1989, NEW ENGL J MED, V321, P406; Bathina MN, 1998, AM J CARDIOL, V82, P589, DOI 10.1016/S0002-9149(98)00416-0; BENDITT DG, 1991, CIRCULATION, V83, P345, DOI 10.1161/01.CIR.83.1.345; Biviano AB, 2012, PACE, V35, P17, DOI 10.1111/j.1540-8159.2011.03227.x; Blomstrom-Lundqvist Carina, 2003, Journal of the American College of Cardiology, V42, P1493, DOI 10.1016/j.jacc.2003.08.013; Calkins H, 1999, CIRCULATION, V99, P262, DOI 10.1161/01.CIR.99.2.262; Delacretaz E, 2006, NEW ENGL J MED, V354, P1039, DOI 10.1056/NEJMcp051145; Delaney B, 2011, EUR J EMERG MED, V18, P148, DOI 10.1097/MEJ.0b013e3283400ba2; DIMARCO JP, 1990, ANN INTERN MED, V113, P104, DOI 10.7326/0003-4819-113-2-104; Feldman A, 2011, PACE, V34, P927, DOI 10.1111/j.1540-8159.2011.03092.x; Friedman PL, 2004, HEART RHYTHM, V1, P129, DOI 10.1016/j.hrthm.2004.02.022; Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013; GANZ LI, 1995, NEW ENGL J MED, V332, P162, DOI 10.1056/NEJM199501193320307; Goldberg AS, 2002, AM J CARDIOL, V89, P1120, DOI 10.1016/S0002-9149(02)02285-3; GURSOY S, 1992, NEW ENGL J MED, V327, P772, DOI 10.1056/NEJM199209103271105; HENTHORN RW, 1991, CIRCULATION, V83, P119, DOI 10.1161/01.CIR.83.1.119; Ho SY, 2000, HEART, V83, P444, DOI 10.1136/heart.83.4.444; HOHNLOSER SH, 1992, AM J CARDIOL, V70, pA3, DOI 10.1016/0002-9149(92)91071-B; HOLT P, 1985, INT J CARDIOL, V8, P67, DOI 10.1016/0167-5273(85)90264-5; KASTOR JA, 1990, NEW ENGL J MED, V322, P1713; KAY GN, 1993, J CARDIOVASC ELECTR, V4, P371, DOI 10.1111/j.1540-8167.1993.tb01277.x; KLEIN GJ, 1979, NEW ENGL J MED, V301, P1080, DOI 10.1056/NEJM197911153012003; KUNZE KP, 1987, CIRCULATION, V75, P1050, DOI 10.1161/01.CIR.75.5.1050; Lafuente-Lafuente C, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5216; LESH MD, 1994, CIRCULATION, V89, P1074, DOI 10.1161/01.CIR.89.3.1074; MCGUIRE MA, 1993, CIRCULATION, V88, P2315, DOI 10.1161/01.CIR.88.5.2315; MYERBURG RJ, 1993, ANN INTERN MED, V119, P1187, DOI 10.7326/0003-4819-119-12-199312150-00006; Natale A, 2000, J AM COLL CARDIOL, V35, P1898, DOI 10.1016/S0735-1097(00)00635-5; Obeyesekere MN, 2012, CIRCULATION, V125, P2308, DOI 10.1161/CIRCULATIONAHA.111.055350; Orejarena LA, 1998, J AM COLL CARDIOL, V31, P150, DOI 10.1016/S0735-1097(97)00422-1; Porter MJ, 2004, HEART RHYTHM, V1, P393, DOI 10.1016/j.hrthm.2004.05.007; Scheinman MM, 2000, PACE, V23, P1020, DOI 10.1111/j.1540-8159.2000.tb00891.x; Stern JD, 2011, PACE, V34, P269, DOI 10.1111/j.1540-8159.2010.02948.x; SUNG R, 1986, AM HEART J, V111, P42; Tada H, 2002, AM J CARDIOL, V89, P470, DOI 10.1016/S0002-9149(01)02274-3; Walfridsson U, 2009, PACE, V32, P1299, DOI 10.1111/j.1540-8159.2009.02476.x; Walsh Edward P, 2002, Card Electrophysiol Rev, V6, P422, DOI 10.1023/A:1021192526642; Wasmer K, 2012, HEART RHYTHM, V9, P1660, DOI 10.1016/j.hrthm.2012.06.007; WINNIFORD MD, 1984, AM J CARDIOL, V54, P1138, DOI 10.1016/S0002-9149(84)80162-9; Wood KA, 1997, AM J CARDIOL, V79, P145, DOI 10.1016/S0002-9149(96)00701-1	41	22	23	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2012	345								e7769	10.1136/bmj.e7769	http://dx.doi.org/10.1136/bmj.e7769			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056MO	23233691				2022-12-28	WOS:000312494500001
J	Hughes, V				Hughes, Virginia			MICROBIOME Cultural differences	NATURE			English	Editorial Material																		Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Poulain M, 2004, EXP GERONTOL, V39, P1423, DOI 10.1016/j.exger.2004.06.016; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344	5	12	13	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					S14	S15		10.1038/492S14a	http://dx.doi.org/10.1038/492S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048EQ	23222668	Bronze			2022-12-28	WOS:000311893400008
J	Rajput, V				Rajput, Vijay			Not Born in the USA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											Rajput, V (corresponding author), Rowan Univ, Cooper Med Sch, Cooper Univ Hosp, Camden, NJ 08102 USA.	rajput-vj@cooperhealth.edu							0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2012	308	21					2197	2198		10.1001/jama.2012.45065	http://dx.doi.org/10.1001/jama.2012.45065			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047HI	23212496				2022-12-28	WOS:000311829500010
J	Appelbaum, FR				Appelbaum, Frederick R.			E. Donnall Thomas (1920-2012)	SCIENCE			English	Biographical-Item									Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Appelbaum, FR (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N, Seattle, WA 98109 USA.	fappelba@fhcrc.org						THOMAS ED, PUBLICATION LIST, P51246	1	2	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2012	338	6111					1163	1163		10.1126/science.1232395	http://dx.doi.org/10.1126/science.1232395			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197524				2022-12-28	WOS:000311666200033
J	Joughin, I; Alley, RB; Holland, DM				Joughin, Ian; Alley, Richard B.; Holland, David M.			Ice-Sheet Response to Oceanic Forcing	SCIENCE			English	Review							GROUNDING-LINE RETREAT; PINE ISLAND GLACIER; EAST GREENLAND; SHELF COLLAPSE; RAPID RETREAT; ROSS SEA; FJORD; ACCELERATION; CIRCULATION; ANTARCTICA	The ice sheets of Greenland and Antarctica are losing ice at accelerating rates, much of which is a response to oceanic forcing, especially of the floating ice shelves. Recent observations establish a clear correspondence between the increased delivery of oceanic heat to the ice-sheet margin and increased ice loss. In Antarctica, most of these processes are reasonably well understood but have not been rigorously quantified. In Greenland, an understanding of the processes by which warmer ocean temperatures drive the observed retreat remains elusive. Experiments designed to identify the relevant processes are confounded by the logistical difficulties of instrumenting ice-choked fjords with actively calving glaciers. For both ice sheets, multiple challenges remain before the fully coupled ice-ocean-atmosphere models needed for rigorous sea-level projection are available.	[Joughin, Ian] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA; [Alley, Richard B.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Holland, David M.] NYU, Dept Math, Ctr Atmosphere Ocean Sci, New York, NY 10012 USA; [Holland, David M.] NYU, Courant Inst Math Sci, New York, NY 10012 USA	University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; New York University; New York University	Joughin, I (corresponding author), Univ Washington, Appl Phys Lab, Polar Sci Ctr, 1013 NE 40th, Seattle, WA 98105 USA.	ian@apl.washington.edu	Joughin, Ian R/A-2998-2008; Joughin, Ian/AAR-7778-2021	Joughin, Ian R/0000-0001-6229-679X; Joughin, Ian/0000-0001-6229-679X	U.S. NSF [ANT-0424589, ANT-1043528, ANT-0944286, ANT-0909335, ARC-080639, ANT-073286]; NASA [NNX06A103G, NNX08AD64G, NNX10AI04G, NNX08AN52]; Office of Polar Programs (OPP) [0806393] Funding Source: National Science Foundation	U.S. NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We acknowledge the contributions from the papers cited in this manuscript and, just as important, the immense body of research that could not be cited because of space constraints. Comments by M. Maki and the anonymous reviewers improved the manuscript. The U.S. NSF supported I.J.'s (ANT-0424589), R.B.A's (ANT-0424589, ANT-1043528, ANT-0944286, and ANT-0909335), and D.M.H.'s (ARC-080639 and ANT-073286) effort. Additional support was provided by NASA for I.J. (NNX06A103G and NNX08AD64G), R.B.A. (NNX10AI04G), and D.M.H. (NNX08AN52).	Alley RB, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001086; Alley RB, 2008, SCIENCE, V322, P1344, DOI 10.1126/science.1162543; Alley RB, 2007, SCIENCE, V315, P1838, DOI 10.1126/science.1138396; Amundson JM, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001405; Briner JP, 2010, QUATERNARY SCI REV, V29, P3861, DOI 10.1016/j.quascirev.2010.09.005; Christoffersen P, 2011, CRYOSPHERE, V5, P701, DOI 10.5194/tc-5-701-2011; Conway H, 1999, SCIENCE, V286, P280, DOI 10.1126/science.286.5438.280; Cuffey K., 2010, PHYS GLACIERS; Ding QH, 2011, NAT GEOSCI, V4, P398, DOI [10.1038/ngeo1129, 10.1038/NGEO1129]; Docquier D, 2011, SURV GEOPHYS, V32, P417, DOI 10.1007/s10712-011-9133-3; Dowdeswell JA, 2008, GEOLOGY, V36, P819, DOI 10.1130/G24808A.1; Ekstrom G, 2006, SCIENCE, V311, P1756, DOI 10.1126/science.1122112; Funder S.V., 1989, QUATERNARY GEOLOGY C, P763; Gomez N, 2010, NAT GEOSCI, V3, P850, DOI 10.1038/NGEO1012; Hellmer HH, 2012, NATURE, V485, P225, DOI 10.1038/nature11064; Holland DM, 2008, NAT GEOSCI, V1, P659, DOI 10.1038/ngeo316; Howat IM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024737; Huybrechts P, 2004, GLOBAL PLANET CHANGE, V42, P83, DOI 10.1016/j.gloplacha.2003.11.011; JACOBS SS, 1992, J GLACIOL, V38, P375, DOI 10.3189/S0022143000002252; Jacobs SS, 2011, NAT GEOSCI, V4, P519, DOI [10.1038/NGEO1188, 10.1038/ngeo1188]; Jakobsson M, 2011, GEOLOGY, V39, P691, DOI 10.1130/G32153.1; Jenkins A, 2011, J PHYS OCEANOGR, V41, P2279, DOI 10.1175/JPO-D-11-03.1; Jenkins A, 2010, NAT GEOSCI, V3, P468, DOI 10.1038/NGEO890; Joughin I, 2004, NATURE, V432, P608, DOI 10.1038/nature03130; Joughin I, 2011, NAT GEOSCI, V4, P506, DOI [10.1038/ngeo1194, 10.1038/NGEO1194]; Joughin I, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044819; Joughin I, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2008JF001023; Luckman A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025428; Marcott SA, 2011, P NATL ACAD SCI USA, V108, P13415, DOI 10.1073/pnas.1104772108; Moon T, 2012, SCIENCE, V336, P576, DOI 10.1126/science.1219985; Mosola AB, 2006, QUATERNARY SCI REV, V25, P2177, DOI 10.1016/j.quascirev.2005.12.013; Motyka RJ, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2009JF001632; Murray T, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001522; Nick FM, 2010, J GLACIOL, V56, P781, DOI 10.3189/002214310794457344; Nick FM, 2009, NAT GEOSCI, V2, P110, DOI 10.1038/NGEO394; Parizek BR, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001325; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Rignot E, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020697; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Rignot E, 2010, NAT GEOSCI, V3, P187, DOI 10.1038/NGEO765; Sanderson T. J. O., 1979, J GLACIOL, V22, P435, DOI DOI 10.1017/S0022143000014453; Scambos TA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020670; Schoof C, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000664; Schumann K, 2012, QUATERNARY SCI REV, V40, P78, DOI 10.1016/j.quascirev.2012.02.016; Shepherd A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021106; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Shepherd A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042496; Shipp S, 1999, GEOL SOC AM BULL, V111, P1486, DOI 10.1130/0016-7606(1999)111<1486:LPHROT>2.3.CO;2; Simpson MJR, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007776; Solomon S., 2007, CLIMATE CHANGE 2007, V4; Straneo F, 2011, NAT GEOSCI, V4, P322, DOI [10.1038/ngeo1109, 10.1038/NGEO1109]; Straneo F, 2010, NAT GEOSCI, V3, P182, DOI 10.1038/NGEO764; Thoma M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034939; THOMAS RH, 1979, NATURE, V277, P355, DOI 10.1038/277355a0; Vieli A, 2011, SURV GEOPHYS, V32, P437, DOI 10.1007/s10712-011-9132-4; Weertman J., 1974, J GLACIOL, V13, P3, DOI [DOI 10.3189/S0022143000023327, 10.3189/S0022143000023327]	58	157	160	3	181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1172	1176		10.1126/science.1226481	http://dx.doi.org/10.1126/science.1226481			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197526				2022-12-28	WOS:000311666200037
J	Paley, MA; Kroy, DC; Odorizzi, PM; Johnnidis, JB; Dolfi, DV; Barnett, BE; Bikoff, EK; Robertson, EJ; Lauer, GM; Reiner, SL; Wherry, EJ				Paley, Michael A.; Kroy, Daniela C.; Odorizzi, Pamela M.; Johnnidis, Jonathan B.; Dolfi, Douglas V.; Barnett, Burton E.; Bikoff, Elizabeth K.; Robertson, Elizabeth J.; Lauer, Georg M.; Reiner, Steven L.; Wherry, E. John			Progenitor and Terminal Subsets of CD8(+) T Cells Cooperate to Contain Chronic Viral Infection	SCIENCE			English	Article							TRANSCRIPTION FACTOR; PD-1 EXPRESSION; HIV-1 INFECTION; CUTTING EDGE; EXHAUSTION; BET; RESPONSES; ANTIGEN; CD4(+); DIFFERENTIATION	Chronic infections strain the regenerative capacity of antiviral T lymphocyte populations, leading to failure in long-term immunity. The cellular and molecular events controlling this regenerative capacity, however, are unknown. We found that two distinct states of virus-specific CD8(+) T cells exist in chronically infected mice and humans. Differential expression of the T-box transcription factors T-bet and Eomesodermin (Eomes) facilitated the cooperative maintenance of the pool of antiviral CD8(+) T cells during chronic viral infection. T-bet(hi) cells displayed low intrinsic turnover but proliferated in response to persisting antigen, giving rise to Eomes(hi) terminal progeny. Genetic elimination of either subset resulted in failure to control chronic infection, which suggests that an imbalance in differentiation and renewal could underlie the collapse of immunity in humans with chronic infections.	[Paley, Michael A.; Odorizzi, Pamela M.; Johnnidis, Jonathan B.; Dolfi, Douglas V.; Barnett, Burton E.; Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Paley, Michael A.; Odorizzi, Pamela M.; Johnnidis, Jonathan B.; Dolfi, Douglas V.; Barnett, Burton E.; Wherry, E. John] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Kroy, Daniela C.; Lauer, Georg M.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02115 USA; [Bikoff, Elizabeth K.; Robertson, Elizabeth J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Reiner, Steven L.] Univ Penn, Abramson Family Canc Res Inst, Dept Med, Philadelphia, PA 19104 USA; [Reiner, Steven L.] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Oxford; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Wherry, EJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	wherry@mail.med.upenn.edu	Wherry, John/ABI-1280-2020; Lauer, Georg/J-1467-2018	Lauer, Georg/0000-0002-9792-4271; Paley, Michael/0000-0001-8724-3176	Deutsche Forschungsgemeinschaft [r3839/1-1]; NIH [T32-AI-07324, AI0663445, AI061699, AI076458, AI083022, AI078897, HHSN266200500030C, AI082630]; Dana Foundation; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061699, R01AI076458, P01AI078897, R56AI076458, U19AI082630, T32AI007632, R01AI042370, T32AI007324, U19AI083022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Wherry, Reiner, and Artis labs for helpful comments and the UPenn Flow Cytometry Core for cell sorting. We thank E. Crosby for isolation of skin lymphocytes. Supported by Deutsche Forschungsgemeinschaft grant r3839/1-1 (D.C.K.); NIH grants T32-AI-07324 (M.A.P.), AI0663445 (G.M.L.), AI061699 and AI076458 (S.L.R.), AI083022, AI078897, and HHSN266200500030C (E.J.W.), and AI082630 (E.J.W. and G.M.L.); and the Dana Foundation (E.J.W. and G.M.L.). E.J.W. has a patent licensing agreement on therapeutic targeting of the PD-1 pathway (U.S. patent application no. 20070122378).	Arnold SJ, 2009, GENESIS, V47, P775, DOI 10.1002/dvg.20562; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2010, J VIROL, V84, P2078, DOI 10.1128/JVI.01579-09; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Casazza JP, 2001, J VIROL, V75, P6508, DOI 10.1128/JVI.75.14.6508-6516.2001; Ciocca ML, 2012, J IMMUNOL, V188, P4145, DOI 10.4049/jimmunol.1200176; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Hellerstein M, 1999, NAT MED, V5, P83, DOI 10.1038/4772; Hellerstein MK, 2003, J CLIN INVEST, V112, P956, DOI 10.1172/JCI200317533; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Kasprowicz V, 2008, J VIROL, V82, P3154, DOI 10.1128/JVI.02474-07; Lechner F, 2000, EUR J IMMUNOL, V30, P2479, DOI 10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; McCune JM, 2000, J CLIN INVEST, V105, pR1, DOI 10.1172/JCI8647; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Nakamoto N, 2008, GASTROENTEROLOGY, V134, P1927, DOI 10.1053/j.gastro.2008.02.033; Ribeiro-dos-Santos P, 2012, BLOOD, V119, P4928, DOI 10.1182/blood-2011-12-395186; Sachsenberg N, 1998, J EXP MED, V187, P1295, DOI 10.1084/jem.187.8.1295; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101	31	570	584	4	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2012	338	6111					1220	1225		10.1126/science.1229620	http://dx.doi.org/10.1126/science.1229620			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197535	Green Accepted			2022-12-28	WOS:000311666200049
J	Merie, C; Kober, L; Olsen, PS; Andersson, C; Gislason, G; Jensen, JS; Torp-Pedersen, C				Merie, Charlotte; Kober, Lars; Olsen, Peter Skov; Andersson, Charlotte; Gislason, Gunnar; Jensen, Jan Skov; Torp-Pedersen, Christian			Association of Warfarin Therapy Duration After Bioprosthetic Aortic Valve Replacement With Risk of Mortality, Thromboembolic Complications, and Bleeding	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VALVULAR HEART-DISEASE; ANTITHROMBOTIC THERAPY; TASK-FORCE; ANTICOAGULATION; MANAGEMENT; OCTOGENARIANS; GUIDELINES; CARDIOLOGY; VALIDITY; REGISTRY	Context The need for anticoagulation after surgical aortic valve replacement (AVR) with biological prostheses is not well examined. Objective To perform a nationwide study of the association of warfarin treatment with the risk of thromboembolic complications, bleeding incidents, and cardiovascular deaths after bioprosthetic AVR surgery. Design, Setting, and Participants Through a search in the Danish National Patient Registry, 4075 patients were identified who had bioprosthetic AVR surgery performed between January 1, 1997, and December 31, 2009. Concomitant comorbidity and medication were retrieved. Poisson regression models were used to determine risk. Main Outcome Measures Incidence rate ratios (IRRs) of strokes, thromboembolic events, cardiovascular deaths, and bleeding incidents by discontinuing warfarin as opposed to continued treatment 30 to 89 days, 90 to 179 days, 180 to 364 days, 365 to 729 days, and at least 730 days after surgery. Results The median duration of follow-up was 6.57 person-years. Estimated rates of events per 100 person-years in patients not treated with warfarin compared with those treated with warfarin with comparative absolute risk were 7.00 (95% CI, 4.07-12.06) vs 2.69 (95% CI, 1.49-4.87; adjusted IRR, 2.46; 95% CI, 1.09-5.55) for strokes; 13.07 (95% CI, 8.76-19.50) vs 3.97 (95% CI, 2.43-6.48; adjusted IRR, 2.93; 95% CI, 1.54-5.55) for thromboembolic events; 11.86 (95% CI, 7.81-18.01) vs 5.37 (95% CI, 3.54-8.16; adjusted IRR, 2.32; 95% CI, 1.28-4.22) for bleeding incidents; and 31.74 (95% CI, 24.69-40.79) vs 3.83 (95% CI, 2.35-6.25; adjusted IRR, 7.61; 95% CI, 4.37-13.26) for cardiovascular deaths within 30 to 89 days after surgery; and 6.50 (95% CI, 4.67-9.06) vs 2.08 (95% CI, 0.99-4.36; adjusted IRR, 3.51; 95% CI, 1.54-8.03) for cardiovascular deaths within 90 to 179 days after surgery. Conclusion Discontinuation of warfarin treatment within 6 months after bioprosthetic AVR surgery was associated with increased cardiovascular death. JAMA. 2012;308(20):2118-2125 www.jama.com	[Merie, Charlotte; Andersson, Charlotte; Gislason, Gunnar; Jensen, Jan Skov; Torp-Pedersen, Christian] Copenhagen Univ Hosp Gentofte, Dept Cardiol, Copenhagen, Denmark; [Kober, Lars] Rigshosp, Dept Cardiol, Copenhagen Univ Hosp, Copenhagen, Denmark; [Olsen, Peter Skov] Rigshosp, Dept Cardiothorac Surg, Copenhagen Univ Hosp, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Merie, C (corresponding author), Copenhagen Univ Hosp Gentofte, Dept Cardiol, Niels Andersens Vej 65, DK-2900 Hellerup, Denmark.	c.merie@mail.dk	Torp-Pedersen, Christian/E-5931-2013; Andersson, Charlotte/P-4849-2014; Gislason, Gunnar/B-7561-2009	Gislason, Gunnar/0000-0002-0548-402X; Kober, Lars/0000-0002-6635-1466	Research Fund of the Department of Cardiology at Copenhagen-University Hospital Gentofte, Gentofte, Denmark; Danish Agency for Science, Technology, and Innovation [FSS-11-120873]; Cardiome; sanofi-aventis; Merck; Bristol-Meyers Squibb	Research Fund of the Department of Cardiology at Copenhagen-University Hospital Gentofte, Gentofte, Denmark; Danish Agency for Science, Technology, and Innovation; Cardiome; sanofi-aventis(Sanofi-Aventis); Merck(Merck & Company); Bristol-Meyers Squibb(Bristol-Myers Squibb)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Kober reported receiving payment for giving lectures on unrelated issues from Servier as well as unrelated consultancy for Bayer. Dr Andersson reported receiving an independent research grant FSS-11-120873 unrelated to current study with 30 months salary and meeting expenses from the Danish Agency for Science, Technology, and Innovation. Dr Torp-Pedersen reported receiving consultancy fees for antiarrhythmic drugs from Cardiome, sanofi-aventis, Merck, and Bristol-Meyers Squibb. No other authors reported any financial disclosures.; This work was supported by the Research Fund of the Department of Cardiology at Copenhagen-University Hospital Gentofte, Gentofte, Denmark.	Aramendi JL, 1998, J HEART VALVE DIS, V7, P610; Brennan JM, 2012, J HEART VALVE DIS, V21, P78; Brown ML, 2008, J THORAC CARDIOV SUR, V135, P878, DOI 10.1016/j.jtcvs.2007.10.065; Bucerius J, 2003, ANN THORAC SURG, V75, P472, DOI 10.1016/S0003-4975(02)04370-9; Colli A, 2008, EUR J CARDIO-THORAC, V33, P531, DOI 10.1016/j.ejcts.2007.12.019; ElBardissi AW, 2010, J THORAC CARDIOV SUR, V139, P1137, DOI 10.1016/j.jtcvs.2009.10.064; Gaist D, 1997, DAN MED BULL, V44, P445; Gherli T, 2004, CIRCULATION, V110, P496, DOI 10.1161/01.CIR.0000137122.95108.52; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; HERAS M, 1995, J AM COLL CARDIOL, V25, P1111, DOI 10.1016/0735-1097(94)00563-6; Higgins J, 2011, J THORAC CARDIOV SUR, V142, P595, DOI 10.1016/j.jtcvs.2010.05.056; Kolh P, 2007, EUR J CARDIO-THORAC, V31, P600, DOI 10.1016/j.ejcts.2007.01.003; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Melby SJ, 2007, ANN THORAC SURG, V83, P1651, DOI 10.1016/j.athoracsur.2006.09.068; Mistiaen W, 2004, J THORAC CARDIOV SUR, V127, P1166, DOI 10.1016/j.jtcvs.2003.11.010; Nowell J, 2007, EUR J CARDIO-THORAC, V31, P578, DOI 10.1016/j.ejcts.2006.12.017; ORSZULAK TA, 1995, ANN THORAC SURG, V59, P462, DOI 10.1016/0003-4975(94)00862-2; Salem DN, 2008, CHEST, V133, p593S, DOI 10.1378/chest.08-0724; Salem DN, 2004, CHEST, V126, p457S, DOI 10.1378/chest.126.3_suppl.457S; Sundt TM, 2005, J THORAC CARDIOV SUR, V129, P1024, DOI 10.1016/j.jtcvs.2004.11.028; Thourani VH, 2011, ANN THORAC SURG, V91, P1798, DOI 10.1016/j.athoracsur.2011.02.015; Tiede DJ, 1998, MAYO CLIN PROC, V73, P665; Tjang YS, 2007, EUR J CARDIO-THORAC, V32, P469, DOI 10.1016/j.ejcts.2007.06.012; Vahanian A, 2007, EUR HEART J, V28, P230, DOI 10.1093/eurheartj/ehl428; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Whitley WS, 2008, SEMIN CARDIOTHORAC V, V12, P290, DOI 10.1177/1089253208328583	27	155	157	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2012	308	20					2118	2125		10.1001/jama.2012.54506	http://dx.doi.org/10.1001/jama.2012.54506			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043IV	23188028	Bronze			2022-12-28	WOS:000311537200026
J	Weber, MA; Jamerson, K; Bakris, GL; Weir, MR; Zappe, D; Zhang, Y; Dahlof, B; Velazquez, EJ; Pitt, B				Weber, Michael A.; Jamerson, Kenneth; Bakris, George L.; Weir, Matthew R.; Zappe, Dion; Zhang, Ying; Dahlof, Bjorn; Velazquez, Eric J.; Pitt, Bertram			Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial	LANCET			English	Article							PERCUTANEOUS CORONARY INTERVENTION; MASS INDEX; SYSTOLIC HYPERTENSION; OBESITY PARADOX; COMBINATION THERAPY; PROSPECTIVE COHORT; ARTERY-DISEASE; HEART-DISEASE; MORTALITY; RISK	Background In previous clinical trials in high-risk hypertensive patients, paradoxically higher cardiovascular event rates have been reported in patients of normal weight compared with obese individuals. As a prespecified analysis of the Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial, we aimed to investigate whether the type of hypertension treatment affects patients' cardiovascular outcomes according to their body size. Methods On the basis of body-mass index (BMI), we divided the full ACCOMPLISH cohort into obese (BMI >= 30, n=5709), overweight (>= 25 to <30, n=4157), or normal weight (<25, n=1616) categories. The ACCOMPLISH cohort had already been randomised to treatment with single-pill combinations of either benazepril and hydrochlorothiazide or benazepril and amlodipine. We compared event rates (adjusted for age, sex, diabetes, previous cardiovascular events, stroke, or chronic kidney disease) for the primary endpoint of cardiovascular death or non-fatal myocardial infarction or stroke. The analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00170950. Findings In patients allocated benazepril and hydrochlorothiazide, the primary endpoint (per 1000 patient-years) was 30.7 in normal weight, 21.9 in overweight, and 18.2 in obese patients (overall p=0.0034). However, in those allocated benazepril and amlodipine, the primary endpoint did not differ between the three BMI groups (18.2, 16.9, and 16.5, respectively; overall p=0.9721). In obese individuals, primary event rates were similar with both benazepril and hydrochlorothiazide and benazepril and amlodipine, but rates were significantly lower with benazepril and amlodipine in overweight patients (hazard ratio 0.76, 95% CI 0.59-0.94; p=0.0369) and those of normal weight (0.57, 0.39-0.84; p=0.0037). Interpretation Hypertension in normal weight and obese patients might be mediated by different mechanisms. Thiazide-based treatment gives less cardiovascular protection in normal weight than obese patients, but amlodipine-based therapy is equally effective across BMI subgroups and thus offers superior cardiovascular protection in non-obese hypertension.	[Weber, Michael A.] SUNY, Downstate Coll Med, Brooklyn, NY 11203 USA; [Jamerson, Kenneth; Pitt, Bertram] Univ Michigan, Ann Arbor, MI 48109 USA; [Bakris, George L.] Univ Chicago Med, Chicago, IL USA; [Weir, Matthew R.] Univ Maryland, Baltimore, MD 21201 USA; [Zappe, Dion; Zhang, Ying] Novartis Pharmaceut, E Hanover, NJ USA; [Dahlof, Bjorn] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Velazquez, Eric J.] Duke Univ, Sch Med, Durham, NC USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; SUNY Maritime College; University of Michigan System; University of Michigan; University System of Maryland; University of Maryland Baltimore; Novartis; Sahlgrenska University Hospital; Duke University	Weber, MA (corresponding author), SUNY, Downstate Coll Med, Brooklyn, NY 11203 USA.	michaelwebermd@cs.com	Weir, Matthew R/ABC-3654-2021	Weir, Matthew R/0000-0001-8820-5702	Novartis Pharmaceuticals; NHLBI; NIH; NIDDK; Novartis; Forest; Takeda	Novartis Pharmaceuticals(Novartis); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Novartis(Novartis); Forest; Takeda(Takeda Pharmaceutical Company Ltd)	Novartis Pharmaceuticals.; MAW is a consultant for Boehringer Ingelheim, Daiichi Sankyo, Forest, and Takeda, and provides speaking services for Daiichi Sankyo, Forest, Novartis, and Takeda. KJ is a consultant for Boehringer Ingelheim, Forest, Novartis, XOMA Pharmaceuticals, Pfizer, and InVasc Therapeutics, provides speaking services for Daiichi Sankyo, and receives research support from NHLBI, NIH, NIDDK, and Novartis. GLB consults for Takeda, Abbott, Relpsya, Medtronic, Daichi-Sankyo, Novartis, and Fibrogen, and has investigator-initiated grants from Forest and Takeda. MRW is a scientific adviser for Amgen, Novartis, Pfizer, Daiichi Sankyo, and MSD. DZ and YZ are employees of Novartis. BD is a consultant for Novartis, Boehringer Ingelheim, Bayer, and Vicore Pharma, owns stock in Mintage Scientific AB, and provides speaking services for Novartis, MSD, Boehringer Ingelheim, Pfizer, Krka, Bayer, and Vicore Pharma. EJV and BP are consultants to Novartis.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; BARRETTCONNOR E, 1985, CIRCULATION, V72, P53, DOI 10.1161/01.CIR.72.1.53; Bombelli M, 2011, HYPERTENSION, V58, P1029, DOI 10.1161/HYPERTENSIONAHA.111.175125; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; CARMAN WJ, 1994, CIRCULATION, V89, P703, DOI 10.1161/01.CIR.89.2.703; Curtis JP, 2005, ARCH INTERN MED, V165, P55, DOI 10.1001/archinte.165.1.55; de Simone G, 2005, CIRCULATION, V111, P1924, DOI 10.1161/01.CIR.0000161799.91577.0A; DeSchutter A, 2010, CIRCULATION, V122; DeSchutter A, 2011, J AM COLL CARDIOL, V57, pE570, DOI 10.1016/S0735-1097(11)60570-6; FERNANDEZ PG, 1987, CLIN INVEST MED, V10, P513; GALLETTI F, 1989, CARDIOVASC DRUG THER, V3, P135, DOI 10.1007/BF01883856; GOLDBOURT U, 1987, HYPERTENSION, V10, P22, DOI 10.1161/01.HYP.10.1.22; Gruberg L, 2002, J AM COLL CARDIOL, V39, P578, DOI 10.1016/S0735-1097(01)01802-2; Gurm HS, 2002, AM J CARDIOL, V90, P42, DOI 10.1016/S0002-9149(02)02384-6; HALL JE, 1994, HYPERTENSION, V23, P381, DOI 10.1161/01.HYP.23.3.381; HALL JE, 1993, HYPERTENSION, V22, P292, DOI 10.1161/01.HYP.22.3.292; Jamerson KA, 2004, AM J HYPERTENS, V17, P793, DOI 10.1016/j.amjhyper.2004.05.004; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Jamerson KA, 2011, HYPERTENSION, V57, P174, DOI 10.1161/HYPERTENSIONAHA.110.159939; Jousilahti P, 1996, CIRCULATION, V93, P1372, DOI 10.1161/01.CIR.93.7.1372; Kang XP, 2006, J AM COLL CARDIOL, V47, P1418, DOI 10.1016/j.jacc.2005.11.062; KOENIG W, 1991, J CARDIOVASC PHARM, V18, P349, DOI 10.1097/00005344-199109000-00007; MESSERLI FH, 1983, AM J MED, V74, P808, DOI 10.1016/0002-9343(83)91071-9; Parra D, 2009, NEW ENGL J MED, V360, P1147, DOI 10.1056/NEJMc082725; REISIN E, 1999, HYPERTENSION, P206; Rubinshtein R, 2006, AM J CARDIOL, V97, P1277, DOI 10.1016/j.amjcard.2005.11.061; Rumantir MS, 1999, J HYPERTENS, V17, P1125, DOI 10.1097/00004872-199917080-00012; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Wassertheil-Smoller S, 2000, ARCH INTERN MED, V160, P494, DOI 10.1001/archinte.160.4.494; Weber MA, 2001, J AM COLL CARDIOL, V37, P169, DOI 10.1016/S0735-1097(00)01103-7; Weber MA, 2007, BLOOD PRESSURE, V16, P13, DOI 10.1080/08037050701217643; Weir MR, 2012, KIDNEY INT, V81, P568, DOI 10.1038/ki.2011.417; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867	33	81	85	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2013	381	9866					537	545		10.1016/S0140-6736(12)61343-9	http://dx.doi.org/10.1016/S0140-6736(12)61343-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089RK	23219284				2022-12-28	WOS:000314927500028
J	Otto, MW; Wisniewski, SR				Otto, Michael W.; Wisniewski, Stephen R.			CBT for treatment resistant depression	LANCET			English	Editorial Material							STAR-ASTERISK-D; PSYCHOTHERAPY; EFFICACY; MODERATE; THERAPY		[Otto, Michael W.] Boston Univ, Dept Psychol, Boston, MA 02138 USA; [Wisniewski, Stephen R.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA	Boston University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Otto, MW (corresponding author), Boston Univ, Dept Psychol, Boston, MA 02138 USA.	mwotto@bu.edu		Wisniewski, Stephen/0000-0002-3877-9860; Otto, Michael/0000-0002-8915-7578				Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; DeRubeis RJ, 2005, ARCH GEN PSYCHIAT, V62, P409, DOI 10.1001/archpsyc.62.4.409; Fava M, 2003, PSYCHIAT CLIN N AM, V26, P457, DOI 10.1016/S0193-953X(02)00107-7; Gaynes BN, 2009, PSYCHIAT SERV, V60, P1439, DOI 10.1176/ps.2009.60.11.1439; Guidi J, 2011, PSYCHOL MED, V41, P321, DOI 10.1017/S0033291710000826; McHugh RK, 2012, 32 ANN C ANX DIS ASS; Richards DA, 2011, J AFFECT DISORDERS, V133, P51, DOI 10.1016/j.jad.2011.03.024; Stein MB, 2011, J CLIN PSYCHIAT, V72, P970, DOI 10.4088/JCP.09m05626blu; Trivedi RB, 2011, J GEN INTERN MED, V26, P643, DOI 10.1007/s11606-010-1608-2; van der Lem R, 2012, PSYCHOTHER PSYCHOSOM, V81, P226, DOI 10.1159/000330890; Weissman MM, 2006, ARCH GEN PSYCHIAT, V63, P925, DOI 10.1001/archpsyc.63.8.925; Wiles N., 2012, LANCET	12	5	5	0	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 2	2013	381	9864					352	353		10.1016/S0140-6736(12)61844-3	http://dx.doi.org/10.1016/S0140-6736(12)61844-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084ZA	23219571				2022-12-28	WOS:000314578900009
J	Shimazu, T; Hirschey, MD; Newman, J; He, WJ; Shirakawa, K; Le Moan, N; Grueter, CA; Lim, H; Saunders, LR; Stevens, RD; Newgard, CB; Farese, RV; de Cabo, R; Ulrich, S; Akassoglou, K; Verdin, E				Shimazu, Tadahiro; Hirschey, Matthew D.; Newman, John; He, Wenjuan; Shirakawa, Kotaro; Le Moan, Natacha; Grueter, Carrie A.; Lim, Hyungwook; Saunders, Laura R.; Stevens, Robert D.; Newgard, Christopher B.; Farese, Robert V., Jr.; de Cabo, Rafael; Ulrich, Scott; Akassoglou, Katerina; Verdin, Eric			Suppression of Oxidative Stress by beta-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor	SCIENCE			English	Article							KETONE-BODIES; METABOLISM; EXPRESSION; CELLS	Concentrations of acetyl-coenzyme A and nicotinamide adenine dinucleotide (NAD(+)) affect histone acetylation and thereby couple cellular metabolic status and transcriptional regulation. We report that the ketone body D-beta-hydroxybutyrate (beta OHB) is an endogenous and specific inhibitor of class I histone deacetylases (HDACs). Administration of exogenous beta OHB, or fasting or calorie restriction, two conditions associated with increased beta OHB abundance, all increased global histone acetylation in mouse tissues. Inhibition of HDAC by beta OHB was correlated with global changes in transcription, including that of the genes encoding oxidative stress resistance factors FOXO3A and MT2. Treatment of cells with beta OHB increased histone acetylation at the Foxo3a and Mt2 promoters, and both genes were activated by selective depletion of HDAC1 and HDAC2. Consistent with increased FOXO3A and MT2 activity, treatment of mice with beta OHB conferred substantial protection against oxidative stress.	[Shimazu, Tadahiro; Hirschey, Matthew D.; Newman, John; He, Wenjuan; Shirakawa, Kotaro; Lim, Hyungwook; Saunders, Laura R.; Verdin, Eric] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Shimazu, Tadahiro; Hirschey, Matthew D.; Newman, John; He, Wenjuan; Shirakawa, Kotaro; Lim, Hyungwook; Saunders, Laura R.; Farese, Robert V., Jr.; Verdin, Eric] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Le Moan, Natacha; Akassoglou, Katerina] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Grueter, Carrie A.; Farese, Robert V., Jr.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Grueter, Carrie A.; Farese, Robert V., Jr.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Stevens, Robert D.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA; [Stevens, Robert D.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27704 USA; [Stevens, Robert D.; Newgard, Christopher B.] Duke Univ, Med Ctr, Dept Canc Biol & Med, Durham, NC 27704 USA; [de Cabo, Rafael] NIA, Lab Expt Gerontol, NIH, Baltimore, MD 21224 USA; [Ulrich, Scott] Ithaca Coll, Dept Chem, Ithaca, NY 14850 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Duke University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Verdin, E (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA.	everdin@gladstone.ucsf.edu	de Cabo, Rafael/E-7996-2010; Verdin, Eric/AAB-7999-2019; Newman, John C/L-8112-2013; SHIMAZU, Tadahiro/ABC-3950-2020; de Cabo, Rafael Carlos/J-5230-2016; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael/0000-0003-2830-5693; de Cabo, Rafael Carlos/0000-0003-2830-5693; Grueter, Carrie/0000-0002-1913-2527; Hirschey, Matthew/0000-0003-4541-5376; de Cabo, Rafael/0000-0002-3354-2442; Akassoglou, Katerina/0000-0002-2632-1465; Verdin, Eric/0000-0003-3703-3183	Gladstone Institutes; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, R01DK056084, P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000363, ZIAAG000361, ZIAAG000368, T32AG000212] Funding Source: NIH RePORTER	Gladstone Institutes(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Carroll for graphics, G. Howard and S. Ordway for editorial assistance, V. Fonseca for administrative assistance, and A. Brunet (Stanford University) for reagents. Supported by funds from the Gladstone Institutes.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; CAHILL GF, 1966, J CLIN INVEST, V45, P1751, DOI 10.1172/JCI105481; CANDIDO EPM, 1978, CELL, V14, P105, DOI 10.1016/0092-8674(78)90305-7; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; Kawai K, 2000, CHEM RES TOXICOL, V13, P1275, DOI 10.1021/tx000119l; Kim DY, 2007, J NEUROCHEM, V101, P1316, DOI 10.1111/j.1471-4159.2007.04483.x; KOESLAG JH, 1980, J PHYSIOL-LONDON, V301, P79, DOI 10.1113/jphysiol.1980.sp013190; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Ladurner AG, 2006, MOL CELL, V24, P1, DOI 10.1016/j.molcel.2006.09.002; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; North BJ, 2005, METHODS, V36, P338, DOI 10.1016/j.ymeth.2005.03.004; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; OWEN OE, 1973, J CLIN INVEST, V52, P2606, DOI 10.1172/JCI107453; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; VanLint C, 1996, GENE EXPRESSION, V5, P245; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097	22	929	962	12	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2013	339	6116					211	214		10.1126/science.1227166	http://dx.doi.org/10.1126/science.1227166			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23223453	Green Accepted			2022-12-28	WOS:000313328200046
J	Ryan, CJ; Smith, MR; de Bono, JS; Molina, A; Logothetis, CJ; de Souza, P; Fizazi, K; Mainwaring, P; Piulats, JM; Ng, S; Carles, J; Mulders, PFA; Basch, E; Small, EJ; Saad, F; Schrijvers, D; Van Poppel, H; Mukherjee, SD; Suttmann, H; Gerritsen, WR; Flaig, TW; George, DJ; Yu, EY; Efstathiou, E; Pantuck, A; Winquist, E; Higano, CS; Taplin, ME; Park, Y; Kheoh, T; Griffin, T; Scher, HI; Rathkopf, DE				Ryan, Charles J.; Smith, Matthew R.; de Bono, Johann S.; Molina, Arturo; Logothetis, Christopher J.; de Souza, Paul; Fizazi, Karim; Mainwaring, Paul; Piulats, Josep M.; Ng, Siobhan; Carles, Joan; Mulders, Peter F. A.; Basch, Ethan; Small, Eric J.; Saad, Fred; Schrijvers, Dirk; Van Poppel, Hendrik; Mukherjee, Som D.; Suttmann, Henrik; Gerritsen, Winald R.; Flaig, Thomas W.; George, Daniel J.; Yu, Evan Y.; Efstathiou, Eleni; Pantuck, Allan; Winquist, Eric; Higano, Celestia S.; Taplin, Mary-Ellen; Park, Youn; Kheoh, Thian; Griffin, Thomas; Scher, Howard I.; Rathkopf, Dana E.		COU-AA-302 Investigators	Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN CYTOCHROME P450(17-ALPHA); HORMONAL-THERAPY; CONTROLLED-TRIAL; END-POINTS; ACETATE; MITOXANTRONE; INHIBITION; PREDNISONE; DOCETAXEL; CYP17	BACKGROUND Abiraterone acetate, an androgen biosynthesis inhibitor, improves overall survival in patients with metastatic castration-resistant prostate cancer after chemotherapy. We evaluated this agent in patients who had not received previous chemotherapy. METHODS In this double-blind study, we randomly assigned 1088 patients to receive abiraterone acetate (1000 mg) plus prednisone (5 mg twice daily) or placebo plus prednisone. The coprimary end points were radiographic progression-free survival and overall survival. RESULTS The study was unblinded after a planned interim analysis that was performed after 43% of the expected deaths had occurred. The median radiographic progression-free survival was 16.5 months with abiraterone-prednisone and 8.3 months with prednisone alone (hazard ratio for abiraterone-prednisone vs. prednisone alone, 0.53; 95% confidence interval [CI], 0.45 to 0.62; P<0.001). Over a median follow-up period of 22.2 months, overall survival was improved with abiraterone-prednisone (median not reached, vs. 27.2 months for prednisone alone; hazard ratio, 0.75; 95% CI, 0.61 to 0.93; P = 0.01) but did not cross the efficacy boundary. Abiraterone-prednisone showed superiority over prednisone alone with respect to time to initiation of cytotoxic chemotherapy, opiate use for cancer-related pain, prostate-specific antigen progression, and decline in performance status. Grade 3 or 4 mineralocorticoid- related adverse events and abnormalities on liver-function testing were more common with abiraterone-prednisone. CONCLUSIONS Abiraterone improved radiographic progression-free survival, showed a trend toward improved overall survival, and significantly delayed clinical decline and initiation of chemotherapy in patients with metastatic castration-resistant prostate cancer. (Funded by Janssen Research and Development, formerly Cougar Biotechnology; ClinicalTrials.gov number, NCT00887198.)	[Ryan, Charles J.; Small, Eric J.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Smith, Matthew R.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Taplin, Mary-Ellen] Dana Farber Canc Inst, Boston, MA 02115 USA; [de Bono, Johann S.] Inst Canc Res, Sutton, Surrey, England; [de Bono, Johann S.] Royal Marsden Hosp, Sutton, Surrey, England; [Molina, Arturo; Park, Youn; Kheoh, Thian; Griffin, Thomas] Janssen Res & Dev, Los Angeles, CA USA; [Pantuck, Allan] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Logothetis, Christopher J.; Efstathiou, Eleni] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [de Souza, Paul] St George Private Hosp, Kogarah, NSW, Australia; [Mainwaring, Paul] Haematol & Oncol Clin Australia, Brisbane, Qld, Australia; [Ng, Siobhan] St John God Hosp, Subiaco, WA, Australia; [Fizazi, Karim] Univ Paris 11, Inst Gustave Roussy, Villejuif, France; [Piulats, Josep M.] Inst Catala Oncol Hosp, Barcelona, Spain; [Carles, Joan] Univ Vall dHebron, Barcelona, Spain; [Mulders, Peter F. A.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Gerritsen, Winald R.] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Basch, Ethan; Scher, Howard I.; Rathkopf, Dana E.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Saad, Fred] Univ Montreal, Montreal, PQ, Canada; [Mukherjee, Som D.] Juravinski Canc Ctr, Hamilton Hlth Serv, Hamilton, ON, Canada; [Winquist, Eric] London Hlth Sci Ctr, London, ON, Canada; [Schrijvers, Dirk] Hosp Network Antwerp ZNA Middelheim, Antwerp, Belgium; [Van Poppel, Hendrik] Katholieke Univ Leuven Hosp, Louvain, Belgium; [Suttmann, Henrik] Urologikum Hamburg, Hamburg, Germany; [Flaig, Thomas W.] Univ Colorado, Ctr Canc, Aurora, CO USA; [George, Daniel J.] Duke Univ Hosp, Med Ctr, Durham, NC USA; [Yu, Evan Y.; Higano, Celestia S.] Univ Washington, Seattle, WA 98195 USA; [Efstathiou, Eleni] Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, GR-10679 Athens, Greece	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Johnson & Johnson; Janssen Pharmaceuticals; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Texas System; UTMD Anderson Cancer Center; St John of God Health Care; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Radboud University Nijmegen; Vrije Universiteit Amsterdam; Memorial Sloan Kettering Cancer Center; Universite de Montreal; McMaster University; London Health Sciences Centre; ZNA Middelheim Hospital; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; University of Colorado System; University of Colorado Anschutz Medical Campus; Duke University; University of Washington; University of Washington Seattle; Alexandra Hospital; Athens Medical School; National & Kapodistrian University of Athens	Ryan, CJ (corresponding author), UCSF Helen Diller Family Comprehens Canc Ctr, Genitourinary Med Oncol Program, 1600 Divisadero St, San Francisco, CA 94115 USA.	ryanc@medicine.ucsf.edu	Mulders, Peter F.A./H-8076-2014; gerritsen, Winald/H-8031-2014; de Souza, Paul/P-5069-2019; Piulats, Josep M/F-2862-2019	Piulats, Josep M/0000-0002-3606-1724; Rathkopf, Dana/0000-0002-4503-7582; Horvath, Lisa/0000-0001-6842-9223; Carles, Joan/0000-0002-9983-5934; Joshua, Anthony/0000-0001-5159-4580; colombel, marc/0000-0002-0152-8021; joly, florence/0000-0001-6168-4942; de Bono, Johann S/0000-0002-2034-595X; Fradet, Yves/0000-0002-7581-2500; OUDARD, Stephane/0000-0003-0893-285X	Janssen Research and Development; NATIONAL CANCER INSTITUTE [P30CA008748, K24CA121990, P30CA016672] Funding Source: NIH RePORTER	Janssen Research and Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Ortho Biotech Oncology Research and Development, a unit of Cougar Biotechnology (now Janssen Research and Development).	Attard G, 2005, BJU INT, V96, P1241, DOI 10.1111/j.1464-410X.2005.05821.x; Attard G, 2009, J CLIN ONCOL, V27, P3742, DOI 10.1200/JCO.2008.20.0642; Barrie SE, 1997, J STEROID BIOCHEM, V60, P347, DOI 10.1016/S0960-0760(96)00225-7; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Efstathiou E, 2012, J CLIN ONCOL, V30, P637, DOI 10.1200/JCO.2010.33.7675; Engel-Nitz Nicole M, 2011, Cancer Manag Res, V3, P233, DOI 10.2147/CMR.S21033; Garcia JA, 2012, CANCER-AM CANCER SOC, V118, P2583, DOI 10.1002/cncr.26582; Harris V, 2011, CLIN ONCOL-UK, V23, P706, DOI 10.1016/j.clon.2011.04.014; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Jarman M, 1998, J MED CHEM, V41, P5375, DOI 10.1021/jm981017j; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Molenberghs G, 2004, STAT METHODS MED RES, V13, P177, DOI 10.1191/0962280204sm362ra; Molina A, 2011, J UROLOGY, V185, P787, DOI 10.1016/j.juro.2010.10.042; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; POTTER GA, 1995, J MED CHEM, V38, P2463, DOI 10.1021/jm00013a022; Ryan CJ, 2011, CLIN CANCER RES, V17, P4854, DOI 10.1158/1078-0432.CCR-11-0815; Ryan CJ, 2010, J CLIN ONCOL, V28, P1481, DOI 10.1200/JCO.2009.24.1281; Saad F, 2002, JNCI-J NATL CANCER I, V94, P1458, DOI 10.1093/jnci/94.19.1458; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Small EJ, 1997, J CLIN ONCOL, V15, P382, DOI 10.1200/JCO.1997.15.1.382; Sternberg CN, 2009, J CLIN ONCOL, V27, P5431, DOI 10.1200/JCO.2008.20.1228; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720	26	2006	2070	3	178	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2013	368	2					138	148		10.1056/NEJMoa1209096	http://dx.doi.org/10.1056/NEJMoa1209096			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066RO	23228172	Green Published, Green Accepted			2022-12-28	WOS:000313238100004
J	Schultze, M; Bothschafter, EM; Sommer, A; Holzner, S; Schweinberger, W; Fiess, M; Hofstetter, M; Kienberger, R; Apalkov, V; Yakovlev, VS; Stockman, MI; Krausz, F				Schultze, Martin; Bothschafter, Elisabeth M.; Sommer, Annkatrin; Holzner, Simon; Schweinberger, Wolfgang; Fiess, Markus; Hofstetter, Michael; Kienberger, Reinhard; Apalkov, Vadym; Yakovlev, Vladislav S.; Stockman, Mark I.; Krausz, Ferenc			Controlling dielectrics with the electric field of light	NATURE			English	Article							SUPERLATTICES; LOCALIZATION	The control of the electric and optical properties of semiconductors with microwave fields forms the basis of modern electronics, information processing and optical communications. The extension of such control to optical frequencies calls for wideband materials such as dielectrics, which require strong electric fields to alter their physical properties(1-5). Few-cycle laser pulses permit damage-free exposure of dielectrics to electric fields of several volts per angstrom(6) and significant modifications in their electronic system(6-13). Fields of such strength and temporal confinement can turn a dielectric from an insulating state to a conducting state within the optical period(14). However, to extend electric signal control and processing to light frequencies depends on the feasibility of reversing these effects approximately as fast as they can be induced. Here we study the underlying electron processes with sub-femtosecond solid-state spectroscopy, which reveals the feasibility of manipulating the electronic structure and electric polarizability of a dielectric reversibly with the electric field of light. We irradiate a dielectric (fused silica) with a waveform-controlled near-infrared few-cycle light field of several volts per angstrom and probe changes in extreme-ultraviolet absorptivity and near-infrared reflectivity on a timescale of approximately a hundred attoseconds to a few femtoseconds. The field-induced changes follow, in a highly nonlinear fashion, the turn-on and turn-off behaviour of the driving field, in agreement with the predictions of a quantum mechanical model. The ultrafast reversibility of the effects implies that the physical properties of a dielectric can be controlled with the electric field of light, offering the potential for petahertz-bandwidth signal manipulation.	[Schultze, Martin; Bothschafter, Elisabeth M.; Sommer, Annkatrin; Holzner, Simon; Schweinberger, Wolfgang; Fiess, Markus; Kienberger, Reinhard; Krausz, Ferenc] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Schultze, Martin; Hofstetter, Michael; Yakovlev, Vladislav S.; Krausz, Ferenc] Univ Munich, Fak Phys, D-80539 Munich, Germany; [Bothschafter, Elisabeth M.; Kienberger, Reinhard] Tech Univ Munich, Phys Dept, D-85748 Garching, Germany; [Apalkov, Vadym; Stockman, Mark I.] Georgia State Univ, Dept Phys, Atlanta, GA 30340 USA	Max Planck Society; University of Munich; Technical University of Munich; University System of Georgia; Georgia State University	Schultze, M (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	martin.schultze@mpq.mpg.de; mstockman@gsu.edu; krausz@lmu.de	Bothschafter, Elisabeth/D-4021-2016; Yakovlev, Vladislav S/C-4091-2015	Yakovlev, Vladislav S/0000-0002-0648-9375; Kienberger, Reinhard/0000-0001-8781-3685; Schultze, Martin/0000-0003-0438-9255	Max Planck Society; Deutsche Forschungsgemeinschaft Cluster of Excellence: Munich Centre for Advanced Photonics; Chemical Sciences, Biosciences and Geosciences Division [DEFG02-01ER15213]; Materials Sciences and Engineering Division of the Office of the Basic Energy Sciences, Office of Science, US Department of Energy [DE-FG02-11ER46789]	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft Cluster of Excellence: Munich Centre for Advanced Photonics(German Research Foundation (DFG)); Chemical Sciences, Biosciences and Geosciences Division(United States Department of Energy (DOE)); Materials Sciences and Engineering Division of the Office of the Basic Energy Sciences, Office of Science, US Department of Energy(United States Department of Energy (DOE))	This work was supported by the Max Planck Society and the Deutsche Forschungsgemeinschaft Cluster of Excellence: Munich Centre for Advanced Photonics (www.munich-photonics.de). The work of M. I. S. and V. A. was supported by grant number DEFG02-01ER15213 from the Chemical Sciences, Biosciences and Geosciences Division and by grant number DE-FG02-11ER46789 from the Materials Sciences and Engineering Division of the Office of the Basic Energy Sciences, Office of Science, US Department of Energy. We thank K. Yabana, R. Ernstorfer and N. Karpowicz for discussions.	BLEUSE J, 1988, PHYS REV LETT, V60, P220, DOI 10.1103/PhysRevLett.60.220; Bloch F, 1929, Z PHYS, V52, P555, DOI 10.1007/BF01339455; Durach M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.086602; Durach M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.086803; Fiess M, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3475689; FRANZ W, 1958, Z NATURFORSCH PT A, V13, P484; Gertsvolf M, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/13/131002; Ghimire S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.167407; Ghimire S, 2011, NAT PHYS, V7, P138, DOI 10.1038/NPHYS1847; Goulielmakis E, 2010, NATURE, V466, P739, DOI 10.1038/nature09212; Keldysh LV, 1958, J EXP THEOR PHYS SOV, V6, P763; Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277; Lenzner M, 1998, PHYS REV LETT, V80, P4076, DOI 10.1103/PhysRevLett.80.4076; LI D, 1994, AM MINERAL, V79, P622; MENDEZ EE, 1993, PHYS TODAY, V46, P34, DOI 10.1063/1.881353; MENDEZ EE, 1988, PHYS REV LETT, V60, P2426, DOI 10.1103/PhysRevLett.60.2426; Mitrofanov AV, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.147401; Mizumoto Y, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.045216; Schultze M, 2011, J ELECTRON SPECTROSC, V184, P68, DOI 10.1016/j.elspec.2011.01.003; Shih T, 2009, APPL PHYS A-MATER, V96, P363, DOI 10.1007/s00339-009-5196-0; Wannier G. H., 1959, ELEMENTS SOLID STATE, P173; WANNIER GH, 1960, PHYS REV, V117, P432, DOI 10.1103/PhysRev.117.432; ZENER C, 1934, P ROYAL SOC, V145, P523, DOI DOI 10.1098/RSPA.1934.0116	23	384	389	9	355	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					75	78		10.1038/nature11720	http://dx.doi.org/10.1038/nature11720			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23222519				2022-12-28	WOS:000312933800033
J	DeWalt, DA				DeWalt, Darren A.			Extended follow-up in an HF clinic did not reduce death or hospital admission in stable systolic HF	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEART-FAILURE; MANAGEMENT		Univ N Carolina, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	DeWalt, DA (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.							DeWalt DA, 2012, CIRCULATION, V125, P2854, DOI 10.1161/CIRCULATIONAHA.111.081745; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; Powell LH, 2010, JAMA-J AM MED ASSOC, V304, P1331, DOI 10.1001/jama.2010.1362	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2012	157	12							JC6-9	10.7326/0003-4819-157-12-201212180-02009	http://dx.doi.org/10.7326/0003-4819-157-12-201212180-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057SB	23247958				2022-12-28	WOS:000312583200008
J	Bernitt, S; Brown, GV; Rudolph, JK; Steinbrugge, R; Graf, A; Leutenegger, M; Epp, SW; Eberle, S; Kubicek, K; Mackel, V; Simon, MC; Trabert, E; Magee, EW; Beilmann, C; Hell, N; Schippers, S; Muller, A; Kahn, SM; Surzhykov, A; Harman, Z; Keitel, CH; Clementson, J; Porter, FS; Schlotter, W; Turner, JJ; Ullrich, J; Beiersdorfer, P; Lopez-Urrutia, JRC				Bernitt, S.; Brown, G. V.; Rudolph, J. K.; Steinbruegge, R.; Graf, A.; Leutenegger, M.; Epp, S. W.; Eberle, S.; Kubicek, K.; Maeckel, V.; Simon, M. C.; Traebert, E.; Magee, E. W.; Beilmann, C.; Hell, N.; Schippers, S.; Mueller, A.; Kahn, S. M.; Surzhykov, A.; Harman, Z.; Keitel, C. H.; Clementson, J.; Porter, F. S.; Schlotter, W.; Turner, J. J.; Ullrich, J.; Beiersdorfer, P.; Lopez-Urrutia, J. R. Crespo			An unexpectedly low oscillator strength as the origin of the Fe XVII emission problem	NATURE			English	Article							SPECTRAL-LINE INTENSITIES; ATOMIC DATA; LABORATORY MEASUREMENTS; CHANDRA; SOLAR; DENSITY	Highly charged iron (Fe16+, here referred to as Fe XVII) produces some of the brightest X-ray emission lines from hot astrophysical objects(1), including galaxy clusters and stellar coronae, and it dominates the emission of the Sun at wavelengths near 15 angstroms. The Fe XVII spectrum is, however, poorly fitted by even the best astrophysical models. A particular problem has been that the intensity of the strongest Fe XVII line is generally weaker than predicted(2,3). This has affected the interpretation of observations by the Chandra and XMM-Newton orbiting X-ray missions(1), fuelling a continuing controversy over whether this discrepancy is caused by incomplete modelling of the plasma environment in these objects or by shortcomings in the treatment of the underlying atomic physics. Here we report the results of an experiment in which a target of iron ions was induced to fluoresce by subjecting it to femtosecond X-ray pulses from a free-electron laser(4); our aim was to isolate a key aspect of the quantum mechanical description of the line emission. Surprisingly, we find a relative oscillator strength that is unexpectedly low, differing by 3.6 sigma from the best quantum mechanical calculations. Our measurements suggest that the poor agreement is rooted in the quality of the underlying atomic wavefunctions rather than in insufficient modelling of collisional processes.	[Bernitt, S.; Rudolph, J. K.; Steinbruegge, R.; Epp, S. W.; Eberle, S.; Kubicek, K.; Maeckel, V.; Beilmann, C.; Harman, Z.; Keitel, C. H.; Ullrich, J.; Lopez-Urrutia, J. R. Crespo] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Brown, G. V.; Graf, A.; Traebert, E.; Magee, E. W.; Hell, N.; Clementson, J.; Beiersdorfer, P.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Rudolph, J. K.; Schippers, S.; Mueller, A.] Univ Giessen, Inst Atom & Mol Phys, D-35392 Giessen, Germany; [Leutenegger, M.; Porter, F. S.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Leutenegger, M.] Univ Maryland, Dept Phys, Baltimore, MD 21250 USA; [Epp, S. W.] Ctr Free Electron Laser Sci, Max Planck Adv Study Grp, D-22607 Hamburg, Germany; [Simon, M. C.] TRIUMF, Vancouver, BC V6T 2A3, Canada; [Hell, N.] Univ Erlangen Nurnberg, Dr Karl Remeis Sternwarte Bamberg, D-96049 Bamberg, Germany; [Hell, N.] Univ Erlangen Nurnberg, Erlangen Ctr Astroparticle Phys, D-96049 Bamberg, Germany; [Kahn, S. M.] SLAC Natl Accelerator Lab, Kavli Inst Particle Astrophys & Cosmol, Menlo Pk, CA 94025 USA; [Surzhykov, A.] Heidelberg Univ, Inst Phys, D-69120 Heidelberg, Germany; [Surzhykov, A.] GSI Helmholtzzentrum Schwerionenforsch GmbH, D-64291 Darmstadt, Germany; [Harman, Z.] ExtreMe Matter Inst EMMI, D-64291 Darmstadt, Germany; [Schlotter, W.; Turner, J. J.] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA 94025 USA	Max Planck Society; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Justus Liebig University Giessen; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore; Max Planck Society; University of British Columbia; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Ruprecht Karls University Heidelberg; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Bernitt, S (corresponding author), Max Planck Inst Kernphys, D-69117 Heidelberg, Germany.	sven.bernitt@mpi-hd.mpg.de	Hell, Natalie/ABF-4728-2021; Schippers, Stefan/GWZ-8616-2022; Turner, Joshua/GXF-3437-2022; Muller, Alfred/A-3548-2009; Traebert, Elmar/I-2706-2019; Kubicek, Katharina/AAE-5683-2019; López-Urrutia, José R. Crespo/F-7069-2011; Surzhykov, Andrey/AAF-7390-2019; Schippers, Stefan/AAY-3754-2021; Schippers, Stefan/A-7786-2008; Porter, Frederick S/D-3501-2012	Hell, Natalie/0000-0003-3057-1536; Schippers, Stefan/0000-0002-6166-7138; Muller, Alfred/0000-0002-0030-6929; Traebert, Elmar/0000-0002-3949-0372; Kubicek, Katharina/0000-0001-8481-2249; López-Urrutia, José R. Crespo/0000-0002-2937-8037; Surzhykov, Andrey/0000-0002-6441-0864; Schippers, Stefan/0000-0002-6166-7138; Schippers, Stefan/0000-0002-6166-7138; Porter, Frederick S/0000-0002-6374-1119; Brown, Gregory/0000-0001-6338-9445; Leutenegger, Maurice/0000-0002-3331-7595; Magee, Edward/0000-0002-1491-0983; Epp, Sascha/0000-0001-6366-9113; Steinbrugge, Rene/0000-0001-7442-1260; Simon, Martin/0000-0003-3098-914X	LCLS; Stanford University through the Stanford Institute for Materials Energy Sciences; Stanford University through Lawrence Berkeley National Laboratory; University of Hamburg through the BMBF; Center for Free Electron Laser Science; US Department of Energy; Helmholtz Alliance.; Helmholtz association; EMMI; BMBF; Deutsche Forschungsgemeinschaft	LCLS; Stanford University through the Stanford Institute for Materials Energy Sciences; Stanford University through Lawrence Berkeley National Laboratory; University of Hamburg through the BMBF; Center for Free Electron Laser Science; US Department of Energy(United States Department of Energy (DOE)); Helmholtz Alliance.; Helmholtz association(Helmholtz Association); EMMI; BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank the staff at MPIK, LLNL and SLAC, especially D. Layne (LLNL) who provided technical support. Portions of this research were carried out on the SXR instrument at the LCLS, a division of SLAC National Accelerator Laboratory and an Office of Science user facility operated by Stanford University for the US Department of Energy. The SXR instrument is funded by a consortium whose membership includes the LCLS, Stanford University through the Stanford Institute for Materials Energy Sciences, Lawrence Berkeley National Laboratory, University of Hamburg through the BMBF priority programme, and the Center for Free Electron Laser Science. The present work was performed in part at LLNL under the auspices of the US Department of Energy and supported in part by the Helmholtz Alliance. P. B. performed part of the work reported here while at the Department of Chemistry and the Chemical Physics Program, University of Puerto Rico. A.S. was supported by the Helmholtz association and Z.H. was supported by EMMI. N.H. acknowledges support from BMBF, and E. T., A.M., J.K.R. and S.S. acknowledge support from the Deutsche Forschungsgemeinschaft.	Behar E, 2001, ASTROPHYS J, V548, P966, DOI 10.1086/318999; Beiersdorfer P, 2004, ASTROPHYS J, V610, P616, DOI 10.1086/421512; Beiersdorfer P, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.032705; BHATIA AK, 1992, ATOM DATA NUCL DATA, V52, P1, DOI 10.1016/0092-640X(92)90007-5; BHATIA AK, 1985, ATOM DATA NUCL DATA, V32, P435, DOI 10.1016/0092-640X(85)90020-8; BLAKE RL, 1965, ASTROPHYS J, V142, P1, DOI 10.1086/148258; Brown GV, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.253201; Brown GV, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.139302; Brown GV, 1998, ASTROPHYS J, V502, P1015, DOI 10.1086/305941; Brown GV, 2001, ASTROPHYS J, V557, pL75, DOI 10.1086/323004; Chen GX, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.062708; CORNILLE M, 1994, ATOM DATA NUCL DATA, V58, P1, DOI 10.1006/adnd.1994.1022; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; Epp SW, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.183001; Epp SW, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/19/194008; Fournier KB, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.012717; Gu M. F., 2009, NEW BENCHMARK XRAY L; Huenemoerder DP, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/4/129; MARRS RE, 1994, PHYS TODAY, V47, P27, DOI 10.1063/1.881419; MCKENZIE DL, 1980, ASTROPHYS J, V241, P409, DOI 10.1086/158354; Mewe R, 2001, ASTRON ASTROPHYS, V368, P888, DOI 10.1051/0004-6361:20010026; Nikulin VK, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.139301; Paerels FBS, 2003, ANNU REV ASTRON ASTR, V41, P291, DOI 10.1146/annurev.astro.41.071601.165952; PARKINSON JH, 1973, ASTRON ASTROPHYS, V24, P215; RALCHENKO Y, NIST ATOMIC SPECTRA; Safronova UI, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.012507; Schlotter WF, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3698294; SCHMELZ JT, 1992, ASTROPHYS J, V398, pL115, DOI 10.1086/186590; WALJESKI K, 1994, ASTROPHYS J, V429, P909, DOI 10.1086/174375; Xu H, 2002, ASTROPHYS J, V579, P600, DOI 10.1086/342828	30	114	116	5	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					225	228		10.1038/nature11627	http://dx.doi.org/10.1038/nature11627			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23235875	Green Published			2022-12-28	WOS:000312259300036
J	Ye, Y; Blaser, G; Horrocks, MH; Ruedas-Rama, MJ; Ibrahim, S; Zhukov, AA; Orte, A; Klenerman, D; Jackson, SE; Komander, D				Ye, Yu; Blaser, Georg; Horrocks, Mathew H.; Ruedas-Rama, Maria J.; Ibrahim, Shehu; Zhukov, Alexander A.; Orte, Angel; Klenerman, David; Jackson, Sophie E.; Komander, David			Ubiquitin chain conformation regulates recognition and activity of interacting proteins	NATURE			English	Article							FLUORESCENCE COINCIDENCE SPECTROSCOPY; LINEAR POLYUBIQUITIN CHAINS; KAPPA-B ACTIVATION; SINGLE-MOLECULE; STRUCTURAL BASIS; DIUBIQUITIN; BINDING; NMR; E2	Mechanisms of protein recognition have been extensively studied for single-domain proteins(1), but are less well characterized for dynamic multidomain systems. Ubiquitin chains represent a biologically important multidomain system that requires recognition by structurally diverse ubiquitin-interacting proteins(2,3). Ubiquitin chain conformations in isolation are often different from conformations observed in ubiquitin-interacting protein complexes, indicating either great dynamic flexibility or extensive chain remodelling upon binding. Using single-molecule fluorescence resonance energy transfer, we show that Lys 63-, Lys 48- and Met 1-linked diubiquitin exist in several distinct conformational states in solution. Lys 63- and Met 1-linked diubiquitin adopt extended 'open' and more compact 'closed' conformations, and ubiquitin-binding domains and deubiquitinases (DUBs) select pre-existing conformations. By contrast, Lys 48-linked diubiquitin adopts predominantly compact conformations. DUBs directly recognize existing conformations, but may also remodel ubiquitin chains to hydrolyse the isopeptide bond. Disruption of the Lys 48-diubiquitin interface changes conformational dynamics and affects DUB activity. Hence, conformational equilibria in ubiquitin chains provide an additional layer of regulation in the ubiquitin system, and distinct conformations observed in differently linked polyubiquitin may contribute to the specificity of ubiquitin-interacting proteins.	[Ye, Yu; Komander, David] MRC, Mol Biol Lab, Div Prot & Nucle Acids Chem, Cambridge CB2 0QH, England; [Blaser, Georg; Horrocks, Mathew H.; Ibrahim, Shehu; Zhukov, Alexander A.; Klenerman, David; Jackson, Sophie E.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Ruedas-Rama, Maria J.; Orte, Angel] Univ Granada, Fac Pharm, Dept Phys Chem, E-18071 Granada, Spain	MRC Laboratory Molecular Biology; University of Cambridge; University of Granada	Komander, D (corresponding author), MRC, Mol Biol Lab, Div Prot & Nucle Acids Chem, Cambridge CB2 0QH, England.	dk10012@cam.ac.uk; sej13@cam.ac.uk; dk@mrc-lmb.cam.ac.uk	Orte, Angel/J-4810-2012; Ye, Yu/D-5727-2019; Ruedas-Rama, Maria Jose/L-2277-2014; Ye, Yu/ABE-7107-2021	Orte, Angel/0000-0003-1905-4183; Ye, Yu/0000-0003-0441-6399; Ruedas-Rama, Maria Jose/0000-0003-0853-187X; Ye, Yu/0000-0003-0441-6399; Klenerman, David/0000-0001-7116-6954; Horrocks, Mathew/0000-0001-5495-5492; Jackson, Sophie/0000-0002-7470-9800	Medical Research Council [U105192732]; EMBO Young Investigator Program; BBSRC; Newton Trust; EMBO YIP small grant; EPSRC; Biotechnology and Biological Sciences Research Council [BB/F00219X/1] Funding Source: researchfish; Medical Research Council [MC_U105192732] Funding Source: researchfish; BBSRC [BB/F00219X/1] Funding Source: UKRI; MRC [MC_U105192732] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newton Trust; EMBO YIP small grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank members of the Komander, Jackson and Klenerman laboratories, R. Williams, S. Freund, C. Johnson, S. McLaughlin and A. Fersht for discussions. Work in the Komander laboratory is supported by the Medical Research Council (U105192732) and the EMBO Young Investigator Program. G. B. and S. I. were supported by the BBSRC, the Newton Trust and an EMBO YIP small grant to D.Ko. Work in the Klenerman laboratory is supported by EPSRC.	Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Clarke RW, 2007, ANAL CHEM, V79, P2771, DOI 10.1021/ac062188w; COOK WJ, 1992, J BIOL CHEM, V267, P16467; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirano T, 2011, J BIOL CHEM, V286, P37496, DOI 10.1074/jbc.M111.256354; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Iwai K, 2011, CELL CYCLE, V10, P3095, DOI 10.4161/cc.10.18.17437; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Lo Conte L, 1999, J MOL BIOL, V285, P2177; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Orte A, 2008, ANAL CHEM, V80, P8389, DOI 10.1021/ac8009092; Orte A, 2006, ANAL CHEM, V78, P7707, DOI 10.1021/ac061122y; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rohaim A, 2012, ACTA CRYSTALLOGR D, V68, P102, DOI 10.1107/S0907444911051195; Ryabov Y, 2006, PROTEINS, V63, P787, DOI 10.1002/prot.20917; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Schaefer JB, 2011, J BIOL CHEM, V286, P45186, DOI 10.1074/jbc.M111.310094; Tenno T, 2004, GENES CELLS, V9, P865, DOI 10.1111/j.1365-2443.2004.00780.x; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Ye Y, 2011, EMBO REP, V12, P350, DOI 10.1038/embor.2011.17	29	129	131	0	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 13	2012	492	7428					266	270		10.1038/nature11722	http://dx.doi.org/10.1038/nature11722			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23201676	Green Accepted, Green Submitted			2022-12-28	WOS:000312259300045
J	Munoz, J; Kuriakose, P				Munoz, Javier; Kuriakose, Philip			Antibiotic-Refractory Sinusitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NON-HODGKIN-LYMPHOMA; B-CELL LYMPHOMA; RHINOSINUSITIS		[Munoz, Javier; Kuriakose, Philip] Henry Ford Hosp, Dept Hematol & Oncol, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Munoz, J (corresponding author), Henry Ford Hosp, Dept Hematol & Oncol, 2799 W Grand Blvd, Detroit, MI 48202 USA.	javier.munoz@me.com						Abramson JS, 2005, BLOOD, V106, P1164, DOI 10.1182/blood-2005-02-0687; Ansell SM, 2005, MAYO CLIN PROC, V80, P1087, DOI 10.4065/80.8.1087; Garbutt JM, 2012, JAMA-J AM MED ASSOC, V307, P685, DOI 10.1001/jama.2012.138; Hung CC, 2009, NEW ENGL J MED, V360, P2340, DOI 10.1056/NEJMicm0800492; Oprea C, 2005, BRIT J HAEMATOL, V131, P468, DOI 10.1111/j.1365-2141.2005.05787.x; Pileri SA, 2011, SEMIN DIAGN PATHOL, V28, P113, DOI 10.1053/j.semdp.2011.02.001; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tichenor WS, 2008, J ALLERGY CLIN IMMUN, V121, P917, DOI 10.1016/j.jaci.2007.08.065	8	2	2	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2012	308	22					2399	2400		10.1001/jama.2012.91077	http://dx.doi.org/10.1001/jama.2012.91077			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051MW	23232896				2022-12-28	WOS:000312132400030
J	Newbatt, E; Beckles, Z; Ullman, R; Lumsden, MA				Newbatt, Emma; Beckles, Zosia; Ullman, Roz; Lumsden, Mary Ann		Guideline Dev Grp	Ectopic pregnancy and miscarriage: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Newbatt, Emma; Beckles, Zosia; Ullman, Roz] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England; [Lumsden, Mary Ann] Univ Glasgow, Glasgow G4 0SF, Lanark, Scotland	University of Glasgow	Ullman, R (corresponding author), Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England.	rullman@ncc-wch.org.uk	Ramlakhan, Shammi/ABD-5794-2020; Riggs, Elisha/K-4267-2019; Beckles, Zosia/R-9630-2019	Ramlakhan, Shammi/0000-0003-1792-0842; Riggs, Elisha/0000-0003-0799-7467; Beckles, Zosia/0000-0003-4352-2266	NICE	NICE	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: EN, ZB, and RU have support from NICE for the submitted work; MAL receives travel, accommodation, and meetings expenses from the Royal College of Obstetricians and Gynaecologists for sitting on multiple committees, including the Guideline Development Group; MAL's institution receives consultancy fees from Abbott Pharmaceuticals (for drugs in heavy menstrual bleeding); no other financial relationships with any organisation that might have an interest in the submitted work; no other relationships or activities that could appear to have influenced the submitted work	HESonline Hospital Episode Statistics, 2010, NHS MAT STAT 2010 11; National Institute for Health and Clinical Excellence, 2012, MANAGEMENT OUTCOME E; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Poddar A, 2011, J OBSTET GYNAECOL, V31, P640, DOI 10.3109/01443615.2011.593650	4	28	29	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2012	345								e8136	10.1136/bmj.e8136	http://dx.doi.org/10.1136/bmj.e8136			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056MU	23236034				2022-12-28	WOS:000312495100011
J	Xiong, W; Grillet, N; Elledge, HM; Wagner, TFJ; Zhao, B; Johnson, KR; Kazmierczak, P; Muller, U				Xiong, Wei; Grillet, Nicolas; Elledge, Heather M.; Wagner, Thomas F. J.; Zhao, Bo; Johnson, Kenneth R.; Kazmierczak, Piotr; Mueller, Ulrich			TMHS Is an Integral Component of the Mechanotransduction Machinery of Cochlear Hair Cells	CELL			English	Article							USHER-SYNDROME PROTEINS; HEARING-LOSS; TIP-LINK; MYOSIN VIIA; FAST ADAPTATION; GAMMA-SUBUNIT; ION CHANNELS; WALTZER MICE; MOUSE MODEL; CADHERIN-23	Hair cells are mechanosensors for the perception of sound, acceleration, and fluid motion. Mechanotransduction channels in hair cells are gated by tip links, which connect the stereocilia of a hair cell in the direction of their mechanical sensitivity. The molecular constituents of the mechanotransduction channels of hair cells are not known. Here, we show that mechanotransduction is impaired in mice lacking the tetraspan TMHS. TMHS binds to the tip-link component PCDH15 and regulates tip-link assembly, a process that is disrupted by deafness-causing Tmhs mutations. TMHS also regulates transducer channel conductance and is required for fast channel adaptation. TMHS therefore resembles other ion channel regulatory subunits such as the transmembrane alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor regulatory proteins (TARPs) of AMPA receptors that facilitate channel transport and regulate the properties of pore-forming channel subunits. We conclude that TMHS is an integral component of the hair cell's mechanotransduction machinery that functionally couples PCDH15 to the transduction channel.	[Xiong, Wei; Grillet, Nicolas; Elledge, Heather M.; Wagner, Thomas F. J.; Zhao, Bo; Kazmierczak, Piotr; Mueller, Ulrich] Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Johnson, Kenneth R.] Jackson Lab, Bar Harbor, ME 04609 USA	Scripps Research Institute; Jackson Laboratory	Muller, U (corresponding author), Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	umueller@scripps.edu	Zhao, Bo/S-6404-2019; Xiong, Wei/AAY-5944-2020; Kaźmierczak, Piotr/AAD-7059-2021	Xiong, Wei/0000-0002-2784-7696; Kaźmierczak, Piotr/0000-0002-4060-3055; Zhao, Bo/0000-0003-2881-5714; Grillet, Nicolas/0000-0001-8007-9246	NIH [DC005965, DC007704]; Dorris Neuroscience Center; Skaggs Institute for Chemical Biology; Bundy Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005965, R01DC004301, R01DC007704] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dorris Neuroscience Center; Skaggs Institute for Chemical Biology; Bundy Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	W.X. carried out the electrophysiological recordings, calcium imaging experiments, and the analysis of protein localization in transfected cells. W. X. and T.F.J.W. developed the electroporation technique. N.G. carried out in situ hybridizations and the analysis of hair cell morphology and tip links by SEM. W.X., N.G., T.F.J.W., and P.K. carried out immunolocalization experiments in hair cells. H. M. E. and B.Z. generated plasmid constructs and carried out co-immunoprecipitation experiments. K.R.J. provided TMHS mutant mice and generated the TMHS antibody. W. X., N.G., T.F.J.W., P. K., and U. M. contributed to the planning of the work. U. M. wrote the manuscript with help from W. X. and N.G. We thank S. W. Webb and S. R. Harkins-Perry for cloning constructs. This work was supported by the NIH (DC005965 and DC007704 to U. M.), the Dorris Neuroscience Center, the Skaggs Institute for Chemical Biology, and the Bundy Foundation (to W.X. and U.M.).	Adato A, 2005, HUM MOL GENET, V14, P347, DOI 10.1093/hmg/ddi031; Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; Bahloul A, 2010, HUM MOL GENET, V19, P3557, DOI 10.1093/hmg/ddq271; Beurg M, 2006, J NEUROSCI, V26, P10992, DOI 10.1523/JNEUROSCI.2188-06.2006; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Caberlotto E, 2011, P NATL ACAD SCI USA, V108, P5825, DOI 10.1073/pnas.1017114108; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; Grillet N, 2009, AM J HUM GENET, V85, P328, DOI 10.1016/j.ajhg.2009.07.017; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; JAY SD, 1990, SCIENCE, V248, P490, DOI 10.1126/science.2158672; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kennedy HJ, 2003, NAT NEUROSCI, V6, P832, DOI 10.1038/nn1089; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Lagziel A, 2005, DEV BIOL, V280, P295, DOI 10.1016/j.ydbio.2005.01.015; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Longo-Guess CM, 2007, MAMM GENOME, V18, P646, DOI 10.1007/s00335-007-9049-x; Longo-Guess CM, 2005, P NATL ACAD SCI USA, V102, P7894, DOI 10.1073/pnas.0500760102; Mchugh RK, 2006, ANAT REC PART A, V288A, P370, DOI 10.1002/ar.a.20297; Michalski N, 2009, PFLUG ARCH EUR J PHY, V459, P115, DOI 10.1007/s00424-009-0711-x; Michel V, 2005, DEV BIOL, V280, P281, DOI 10.1016/j.ydbio.2005.01.014; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Ricci AJ, 2005, J NEUROSCI, V25, P7831, DOI 10.1523/JNEUROSCI.1127-05.2005; Ricci AJ, 2003, NEURON, V40, P983, DOI 10.1016/S0896-6273(03)00721-9; Sakaguchi H, 2009, CURR OPIN OTOLARYNGO, V17, P388, DOI 10.1097/MOO.0b013e3283303472; Schwander M, 2007, J NEUROSCI, V27, P2163, DOI 10.1523/JNEUROSCI.4975-06.2007; Schwander M, 2009, P NATL ACAD SCI USA, V106, P5252, DOI 10.1073/pnas.0900691106; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Shabbir MI, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039834; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; Sollner C, 2004, NATURE, V428, P955, DOI 10.1038/nature02484; Stauffer EA, 2005, NEURON, V47, P541, DOI 10.1016/j.neuron.2005.07.024; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Waguespack J, 2007, J NEUROSCI, V27, P13890, DOI 10.1523/JNEUROSCI.2159-07.2007; Webb SW, 2011, DEVELOPMENT, V138, P1607, DOI 10.1242/dev.060061; Wilson SM, 2001, GENOMICS, V74, P228, DOI 10.1006/geno.2001.6554; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004	51	160	164	2	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1283	1295		10.1016/j.cell.2012.10.041	http://dx.doi.org/10.1016/j.cell.2012.10.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217710	Bronze, Green Accepted			2022-12-28	WOS:000311999900017
J	Chang, CY; Furlong, LA				Chang, Christina Y.; Furlong, Lesley-Anne			Microbial Stowaways in Topical Antiseptic Products	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chang, Christina Y.; Furlong, Lesley-Anne] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Chang, CY (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							[Anonymous], 2011, Morbidity and Mortality Weekly Report, V60, P347; [Anonymous], 2009, ALLERGY INFECT ASS M; FDA, ARCH REC MARK WITHDR; Weber DJ, 2007, ANTIMICROB AGENTS CH, V51, P4217, DOI 10.1128/AAC.00138-07	4	12	12	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2012	367	23					2170	2173		10.1056/NEJMp1212680	http://dx.doi.org/10.1056/NEJMp1212680			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048DO	23215554				2022-12-28	WOS:000311890600003
J	von der Heyden, BP; Roychoudhury, AN; Mtshali, TN; Tyliszczak, T; Myneni, SCB				von der Heyden, B. P.; Roychoudhury, A. N.; Mtshali, T. N.; Tyliszczak, T.; Myneni, S. C. B.			Chemically and Geographically Distinct Solid-Phase Iron Pools in the Southern Ocean	SCIENCE			English	Article							SPECTROSCOPY	Iron is a limiting nutrient in many parts of the oceans, including the unproductive regions of the Southern Ocean. Although the dominant fraction of the marine iron pool occurs in the form of solid-phase particles, its chemical speciation and mineralogy are challenging to characterize on a regional scale. We describe a diverse array of iron particles, ranging from 20 to 700 nanometers in diameter, in the waters of the Southern Ocean euphotic zone. Distinct variations in the oxidation state and composition of these iron particles exist between the coasts of South Africa and Antarctica, with different iron pools occurring in different frontal zones. These speciation variations can result in solubility differences that may affect the production of bioavailable dissolved iron.	[von der Heyden, B. P.; Roychoudhury, A. N.; Mtshali, T. N.] Univ Stellenbosch, Dept Earth Sci, ZA-7602 Matieland, South Africa; [von der Heyden, B. P.; Myneni, S. C. B.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Mtshali, T. N.] CSIR, ZA-7600 Stellenbosch, South Africa; [Tyliszczak, T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA	Stellenbosch University; Princeton University; Council for Scientific & Industrial Research (CSIR) - South Africa; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Roychoudhury, AN (corresponding author), Univ Stellenbosch, Dept Earth Sci, Private Bag X1, ZA-7602 Matieland, South Africa.	roy@sun.ac.za		von der Heyden, Bjorn/0000-0002-4006-9278; Roychoudhury, Alakendra/0000-0002-5627-8891	National Research Foundation, South Africa (Blue Skies Program and SANAP); Stellenbosch University VR(R) fund; NSF (chemical sciences); U.S. Department of Energy (Office of Basic Energy Sciences and Subsurface Biogeochemical Research program); Princeton in Africa program	National Research Foundation, South Africa (Blue Skies Program and SANAP); Stellenbosch University VR(R) fund; NSF (chemical sciences); U.S. Department of Energy (Office of Basic Energy Sciences and Subsurface Biogeochemical Research program); Princeton in Africa program	Supported by grants from National Research Foundation, South Africa (Blue Skies Program and SANAP), Stellenbosch University VR(R) fund, NSF (chemical sciences), the U.S. Department of Energy (Office of Basic Energy Sciences and Subsurface Biogeochemical Research program), and the Princeton in Africa program. We thank the support staff at the Advanced Light Source for helping with data collection and sample preparation. This work benefited from discussions with F. Morel, D. Sigman, and four anonymous reviewers.	Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; BALISTRIERI LS, 1983, GEOCHIM COSMOCHIM AC, V47, P1091, DOI 10.1016/0016-7037(83)90239-9; Bluhm H, 2006, J ELECTRON SPECTROSC, V150, P86, DOI 10.1016/j.elspec.2005.07.005; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/NGEO964, 10.1038/ngeo964]; Cassar N, 2007, SCIENCE, V317, P1067, DOI 10.1126/science.1144602; Chever F, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005880; Cornell RM, 2003, IRON OXIDES STRUCTUR, DOI [10.1002/3527602097.ins, DOI 10.1002/]; de Groot FMF, 2009, J PHYS CONF SER, V190, DOI 10.1088/1742-6596/190/1/012004; FITZPATRICK RW, 1982, GEODERMA, V27, P335, DOI 10.1016/0016-7061(82)90022-2; Kraemer SM, 2004, AQUAT SCI, V66, P3, DOI 10.1007/s00027-003-0690-5; Lam PJ, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002557; Nishioka J, 2005, MAR CHEM, V95, P51, DOI 10.1016/j.marchem.2004.06.040; Oakes M, 2012, ATMOS CHEM PHYS, V12, P745, DOI 10.5194/acp-12-745-2012; Pollard RT, 2002, DEEP-SEA RES PT II, V49, P3289, DOI 10.1016/S0967-0645(02)00084-X; Sunda W. G., 2001, BIOGEOCHEMISTRY IRON, P41; VANDERLAAN G, 1992, J PHYS-CONDENS MAT, V4, P4189, DOI 10.1088/0953-8984/4/16/019	16	68	69	3	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1199	1201		10.1126/science.1227504	http://dx.doi.org/10.1126/science.1227504			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197531				2022-12-28	WOS:000311666200043
J	Savage, PE				Savage, Phillip E.			Algae Under Pressure and in Hot Water	SCIENCE			English	Editorial Material							BIO-OIL; EXTRACTION; BIOMASS		Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Savage, PE (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	psavage@umich.edu	Savage, Phillip/ABC-8765-2021	Savage, Phillip/0000-0002-7902-3744				Akiya N, 2002, CHEM REV, V102, P2725, DOI 10.1021/cr000668w; Berl E, 1944, SCIENCE, V99, P309, DOI 10.1126/science.99.2573.309; Biller P, 2012, BIOFUELS-UK, V3, P603, DOI 10.4155/BFS.12.42; Chakraborty M, 2012, FUEL, V95, P63, DOI 10.1016/j.fuel.2011.10.055; Duan PG, 2011, BIORESOURCE TECHNOL, V102, P1899, DOI 10.1016/j.biortech.2010.08.013; Guan QQ, 2012, ENERG FUEL, V26, P4575, DOI 10.1021/ef3007992; Heilmann SM, 2010, BIOMASS BIOENERG, V34, P875, DOI 10.1016/j.biombioe.2010.01.032; Khan MY, 2012, ENERG FUEL, V26, P6137, DOI 10.1021/ef300935z; Levine RB, 2010, ENERG FUEL, V24, P5235, DOI 10.1021/ef1008314; Patil PD, 2011, BIORESOURCE TECHNOL, V102, P118, DOI 10.1016/j.biortech.2010.06.031; Roussis SG, 2012, ENERG FUEL, V26, P5294, DOI 10.1021/ef300798b; Savage PE, 2010, RSC ENERGY ENVIRON S, P192; Soh L, 2011, GREEN CHEM, V13, P1422, DOI 10.1039/c1gc15068e; Stucki S, 2009, ENERG ENVIRON SCI, V2, P535, DOI 10.1039/b819874h; U.S. Department of Energy, 2010, NAT ALG BIOF TECHN R; Valdez PJ, 2012, BIOMASS BIOENERG, V46, P317, DOI 10.1016/j.biombioe.2012.08.009	16	77	78	1	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1039	1040		10.1126/science.1224310	http://dx.doi.org/10.1126/science.1224310			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041HJ	23180853				2022-12-28	WOS:000311390600032
J	Stocker, TF				Stocker, Thomas F.			The Closing Door of Climate Targets	SCIENCE			English	Editorial Material							CUMULATIVE CARBON EMISSIONS		[Stocker, Thomas F.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Stocker, Thomas F.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland	University of Bern; University of Bern	Stocker, TF (corresponding author), Univ Bern, Inst Phys, CH-3012 Bern, Switzerland.	stocker@climate.unibe.ch	Stocker, Thomas/B-1273-2013					Allen MR, 2009, NATURE, V458, P1163, DOI 10.1038/nature08019; Andres RJ, 2012, BIOGEOSCIENCES, V9, P1845, DOI 10.5194/bg-9-1845-2012; Bowerman NHA, 2011, PHILOS T R SOC A, V369, P45, DOI 10.1098/rsta.2010.0288; den Elzen M, 2007, GLOBAL ENVIRON CHANG, V17, P260, DOI 10.1016/j.gloenvcha.2006.10.003; Friedlingstein P, 2010, NAT GEOSCI, V3, P811, DOI 10.1038/ngeo1022; Matthews HD, 2009, NATURE, V459, P829, DOI 10.1038/nature08047; UNFCCC, 2009, COP ACC; UNFCCC, 2010, CANC AGR	8	85	88	2	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2013	339	6117					280	282		10.1126/science.1232468	http://dx.doi.org/10.1126/science.1232468			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23196911				2022-12-28	WOS:000313622000031
J	Moeller, A; Kirchdoerfer, RN; Potter, CS; Carragher, B; Wilson, IA				Moeller, Arne; Kirchdoerfer, Robert N.; Potter, Clinton S.; Carragher, Bridget; Wilson, Ian A.			Organization of the Influenza Virus Replication Machinery	SCIENCE			English	Article							A VIRUS; ELECTRON-MICROSCOPY; RIBONUCLEOPROTEIN COMPLEXES; CRYSTAL-STRUCTURE; VIRAL POLYMERASE; HUMAN-CELLS; NUCLEOPROTEIN; RNA; GENERATION; BINDING	Influenza virus ribonucleoprotein complexes (RNPs) are central to the viral life cycle and in adaptation to new host species. RNPs are composed of the viral genome, viral polymerase, and many copies of the viral nucleoprotein. In vitro cell expression of all RNP protein components with four of the eight influenza virus gene segments enabled structural determination of native influenza virus RNPs by means of cryogenic electron microscopy (cryo-EM). The cryo-EM structure reveals the architecture and organization of the native RNP, defining the attributes of its largely helical structure and how polymerase interacts with nucleoprotein and the viral genome. Observations of branched-RNP structures in negative-stain electron microscopy and their putative identification as replication intermediates suggest a mechanism for viral replication by a second polymerase on the RNP template.	[Moeller, Arne; Potter, Clinton S.; Carragher, Bridget] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Kirchdoerfer, Robert N.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Carragher, B (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	bcarr@scripps.edu; wilson@scripps.edu		Carragher, Bridget/0000-0002-0624-5020; Moeller, Arne/0000-0003-1101-5366	National Institutes of Health [AI058113, GM095573]; National Center for Research Resources [2P41RR017573-11]; National Institute of General Medical Sciences Biomedical Technology Resource Centers [9 P41 GM103310-11]; Joint Center for Innovation in Membrane Protein Production for Structure Determination [P50GM073197]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI058113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103310, R01GM095573, P50GM073197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences Biomedical Technology Resource Centers; Joint Center for Innovation in Membrane Protein Production for Structure Determination; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Webster (St. Jude Children's Research Hospital) for providing the eight plasmid system (pHW2000, the cloning vector: pHW191-PB2, pHW192-PB1, pHW193-PA, and pHW195-NP, under a material transfer agreement from St. Jude) used for recombinant RNP expression; M. Brimble and P. Harris (Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland) for synthesizing the FLAG peptide; J. Quispe for help in EM grid specimen preparation; and A. Su for helpful advice on statistical analyses. We also thank J. Martin-Benito and J. Ortin (Consejo Superior de Investigaciones Cientificas, Spain) for sending us the previously reconstructed mini-RNP map. This project has been funded in part by the National Institutes of Health AI058113 to I. A. W. and GM095573 to C. S. P and B. C. The project was also supported by grants from the National Center for Research Resources (2P41RR017573-11) and the National Institute of General Medical Sciences Biomedical Technology Resource Centers (9 P41 GM103310-11) and by the Joint Center for Innovation in Membrane Protein Production for Structure Determination (P50GM073197). This is publication 21687 from The Scripps Research Institute. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Reconstructions of the free polymerase, RNP-bound polymerase, central filament, and loop regions have been deposited in the EM Data Bank (EMDB entry numbers 2209, 2211, 2212, and 2213). Coordinates of NP protomers docked into the central filament map have been deposited in the Protein Data Bank (PDB code 2YMN) The authors report no conflicts of interest.	BAUDIN F, 1994, EMBO J, V13, P3158, DOI 10.1002/j.1460-2075.1994.tb06614.x; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; COMPANS RW, 1972, J VIROL, V10, P795, DOI 10.1128/JVI.10.4.795-800.1972; Fields B. N., 2007, FIELDS VIROLOGY; Fournier E, 2012, NUCLEIC ACIDS RES, V40, P2197, DOI 10.1093/nar/gkr985; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; Jorba N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000462; Kranzusch PJ, 2010, P NATL ACAD SCI USA, V107, P20069, DOI 10.1073/pnas.1007152107; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Li Z, 2009, J VIROL, V83, P4153, DOI 10.1128/JVI.02642-08; LUO GX, 1991, J VIROL, V65, P2861, DOI 10.1128/JVI.65.6.2861-2867.1991; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; NAEVE CW, 1980, J VIROL, V34, P764, DOI 10.1128/JVI.34.3.764-771.1980; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ng AKL, 2008, FASEB J, V22, P3638, DOI 10.1096/fj.08-112110; Noda T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1647; Ortega J, 2000, J VIROL, V74, P156, DOI 10.1128/JVI.74.1.156-163.2000; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rameix-Welti MA, 2009, J VIROL, V83, P1320, DOI 10.1128/JVI.00977-08; Resa-Infante P, 2010, J VIROL, V84, P10477, DOI 10.1128/JVI.01115-10; Ruigrok RWH, 2010, CURR OPIN STRUC BIOL, V20, P104, DOI 10.1016/j.sbi.2009.12.007; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Shen YF, 2011, P NATL ACAD SCI USA, V108, P16515, DOI 10.1073/pnas.1113107108; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Torreira E, 2007, NUCLEIC ACIDS RES, V35, P3774, DOI 10.1093/nar/gkm336; Wu WWH, 2007, J MOL BIOL, V374, P910, DOI 10.1016/j.jmb.2007.10.022; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	35	175	179	4	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1631	1634		10.1126/science.1227270	http://dx.doi.org/10.1126/science.1227270			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23180774	Green Accepted			2022-12-28	WOS:000312533100056
J	Fasano, A; Catassi, C				Fasano, Alessio; Catassi, Carlo			Celiac Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PEDIATRIC GASTROENTEROLOGY; TISSUE TRANSGLUTAMINASE; NATURAL-HISTORY; UNITED-STATES; AT-RISK; DIAGNOSIS; PREVALENCE; ANTIBODIES; CHILDREN; POPULATION	A 22-year-old woman fractures her wrist while playing volleyball. She reports a history of fatigue and intermittent oral ulcerations but no other symptoms. Radiography of her wrist shows osteopenia. Laboratory testing is notable for a hematocrit of 32% and low levels of ferritin and 25-hydroxyvitamin D. Although she reports no gastrointestinal symptoms, celiac disease is suspected. How should she be further evaluated and, if testing indicates celiac disease, how should her case be managed?	[Fasano, Alessio] Univ Maryland, Sch Med, Ctr Celiac Res, Hlth Sci Facil 2, Baltimore, MD 21201 USA; [Fasano, Alessio; Catassi, Carlo] Univ Maryland, Sch Med, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA; [Catassi, Carlo] Univ Politecn Marche, Dept Pediat, Ancona, Italy	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Marche Polytechnic University	Fasano, A (corresponding author), Univ Maryland, Sch Med, Ctr Celiac Res, Hlth Sci Facil 2, Rm S345,20 Penn St, Baltimore, MD 21201 USA.	afasano@mbrc.umaryland.edu	Fasano, Alessio/K-5486-2016	Fasano, Alessio/0000-0002-2134-0261	Glaxo-SmithKline; Menarini Diagnostics; Dr. Schar, Inc.; Heinz	Glaxo-SmithKline(GlaxoSmithKline); Menarini Diagnostics(Menarini Group); Dr. Schar, Inc.; Heinz	Dr. Fasano reports receiving consulting fees from Glaxo-SmithKline and owning stock in Alba Therapeutics. Dr. Catassi reports receiving consulting fees from Menarini Diagnostics, Dr. Schar, Inc., and Heinz. No other potential conflict of interest relevant to this article was reported. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.	Alarida K, 2011, DIGEST LIVER DIS, V43, P688, DOI 10.1016/j.dld.2011.01.002; [Anonymous], 2001, Gastroenterology, V120, P1522; [Anonymous], 2004, NIH Consens State Sci Statements, V21, P1; Biagi F, 2010, ANN MED, V42, P557, DOI 10.3109/07853890.2010.523229; Canavan C, 2011, ALIMENT PHARM THER, V34, P1012, DOI 10.1111/j.1365-2036.2011.04811.x; Caproni M, 2009, J EUR ACAD DERMATOL, V23, P633, DOI 10.1111/j.1468-3083.2009.03188.x; Catassi C, 2007, AM J CLIN NUTR, V85, P160, DOI 10.1093/ajcn/85.1.160; Catassi C, 2007, AM J GASTROENTEROL, V102, P1454, DOI 10.1111/j.1572-0241.2007.01173.x; Catassi C, 2010, ANN MED, V42, P530, DOI 10.3109/07853890.2010.514285; Codex Alimentarius IFS, 2008, 1181979 COD COMM NUT, P118; Dalgic B, 2011, AM J GASTROENTEROL, V106, P1512, DOI 10.1038/ajg.2011.183; Daum S, 2005, BEST PRACT RES CL GA, V19, P413, DOI 10.1016/j.bpg.2005.02.001; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; Frost AR, 2009, EUR J ENDOCRINOL, V160, P675, DOI 10.1530/EJE-08-0846; Giersiepen K, 2012, J PEDIATR GASTR NUTR, V54, P229, DOI 10.1097/MPG.0b013e318216f2e5; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Gupta R, 2009, WORLD J GASTROENTERO, V15, P6028, DOI 10.3748/wjg.15.6028; Hadjivassiliou M, 2008, CEREBELLUM, V7, P494, DOI 10.1007/s12311-008-0052-x; Hill ID, 2005, J PEDIATR GASTR NUTR, V40, P1, DOI 10.1097/00005176-200501000-00001; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Lanzini A, 2009, ALIMENT PHARM THER, V29, P1299, DOI 10.1111/j.1365-2036.2009.03992.x; Lenhardt A, 2004, DIGEST LIVER DIS, V36, P730, DOI 10.1016/j.dld.2004.06.017; Matysiak-Budnik T, 2007, GUT, V56, P1379, DOI 10.1136/gut.2006.100511; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; Raivio T, 2006, ALIMENT PHARM THER, V24, P147, DOI 10.1111/j.1365-2036.2006.02957.x; Rashid M, 2007, CAN J GASTROENTEROL, V21, P649, DOI 10.1155/2007/340591; Rubio-Tapia A, 2008, CLIN GASTROENTEROL H, V6, P983, DOI 10.1016/j.cgh.2008.04.008; Salmi TT, 2006, GUT, V55, P1746, DOI 10.1136/gut.2005.071514; Sapone A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-13; Sapone A, 2010, INT ARCH ALLERGY IMM, V152, P75, DOI 10.1159/000260087; Sattar N, 2011, J PEDIATR-US, V158, P272, DOI 10.1016/j.jpeds.2010.08.050; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Sellitto M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033387; Sharaiha RZ, 2012, CANCER-AM CANCER SOC, V118, P3786, DOI 10.1002/cncr.26700; Simell S, 2007, AM J GASTROENTEROL, V102, P2026, DOI 10.1111/j.1572-0241.2007.01360.x; Sverker A, 2005, J HUM NUTR DIET, V18, P171, DOI 10.1111/j.1365-277X.2005.00591.x; Szajewska H, 2012, ALIMENT PHARM THER, V36, P607, DOI 10.1111/apt.12023; Tonutti E, 2009, J CLIN LAB ANAL, V23, P165, DOI 10.1002/jcla.20313; Tosco A, 2011, CLIN GASTROENTEROL H, V9, P320, DOI 10.1016/j.cgh.2010.09.006; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Volta U, 2011, EXPERT REV GASTROENT, V5, P479, DOI [10.1586/EGH.11.38, 10.1586/egh.11.38]; Wang XQ, 2011, J PEDIATR GASTR NUTR, V53, P368, DOI 10.1097/MPG.0b013e31822a0128; Wouters J, 2009, J PEDIATR-US, V154, P239, DOI 10.1016/j.jpeds.2008.08.007; Zanoni G, 2006, PLOS MED, V3, P1637, DOI 10.1371/journal.pmed.0030358; Zintzaras E, 2006, CLIN VACCINE IMMUNOL, V13, P187, DOI 10.1128/CVI.13.2.187-192.2006	48	413	430	2	123	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2012	367	25					2419	2426		10.1056/NEJMcp1113994	http://dx.doi.org/10.1056/NEJMcp1113994			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056ZP	23252527				2022-12-28	WOS:000312531600009
J	Ruperto, N; Brunner, HI; Quartier, P; Constantin, T; Wulffraat, N; Horneff, G; Brik, R; McCann, L; Kasapcopur, O; Rutkowska-Sak, L; Schneider, R; Berkun, Y; Calvo, I; Erguven, M; Goffin, L; Hofer, M; Kallinich, T; Oliveira, SK; Uziel, Y; Viola, S; Nistala, K; Wouters, C; Cimaz, R; Ferrandiz, MA; Flato, B; Gamir, ML; Kone-Paut, I; Grom, A; Magnusson, B; Ozen, S; Sztajnbok, F; Lheritier, K; Abrams, K; Kim, D; Martini, A; Lovell, DJ				Ruperto, Nicolino; Brunner, Hermine I.; Quartier, Pierre; Constantin, Tamas; Wulffraat, Nico; Horneff, Gerd; Brik, Riva; McCann, Liza; Kasapcopur, Ozgur; Rutkowska-Sak, Lidia; Schneider, Rayfel; Berkun, Yackov; Calvo, Inmaculada; Erguven, Muferet; Goffin, Laurence; Hofer, Michael; Kallinich, Tilmann; Oliveira, Sheila K.; Uziel, Yosef; Viola, Stefania; Nistala, Kiran; Wouters, Carine; Cimaz, Rolando; Ferrandiz, Manuel A.; Flato, Berit; Gamir, Maria Luz; Kone-Paut, Isabelle; Grom, Alexei; Magnusson, Bo; Ozen, Seza; Sztajnbok, Flavio; Lheritier, Karine; Abrams, Ken; Kim, Dennis; Martini, Alberto; Lovell, Daniel J.		PRINTO; PRCSG	Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECEPTOR ANTAGONIST ANAKINRA; DOUBLE-BLIND; PRELIMINARY DEFINITION; RHEUMATOID-ARTHRITIS; SELECT CATEGORIES; FOLLOW-UP; CHILDREN; CLASSIFICATION; EFFICACY; CRITERIA	BACKGROUND Interleukin-1 is pivotal in the pathogenesis of systemic juvenile idiopathic arthritis (JIA). We assessed the efficacy and safety of canakinumab, a selective, fully human, anti-interleukin-1 beta monoclonal antibody, in two trials. METHODS In trial 1, we randomly assigned patients, 2 to 19 years of age, with systemic JIA and active systemic features (fever; >= 2 active joints; C-reactive protein, >30 mg per liter; and glucocorticoid dose, <= 1.0 mg per kilogram of body weight per day), in a double-blind fashion, to a single subcutaneous dose of canakinumab (4 mg per kilogram) or placebo. The primary outcome, termed adapted JIA ACR 30 response, was defined as improvement of 30% or more in at least three of the six core criteria for JIA, worsening of more than 30% in no more than one of the criteria, and resolution of fever. In trial 2, after 32 weeks of open-label treatment with canakinumab, patients who had a response and underwent glucocorticoid tapering were randomly assigned to continued treatment with canakinumab or to placebo. The primary outcome was time to flare of systemic JIA. RESULTS At day 15 in trial 1, more patients in the canakinumab group had an adapted JIA ACR 30 response (36 of 43 [84%], vs. 4 of 41 [10%] in the placebo group; P<0.001). In trial 2, among the 100 patients (of 177 in the open-label phase) who underwent randomization in the withdrawal phase, the risk of flare was lower among patients who continued to receive canakinumab than among those who were switched to placebo (74% of patients in the canakinumab group had no flare, vs. 25% in the placebo group, according to Kaplan-Meier estimates; hazard ratio, 0.36; P = 0.003). The average glucocorticoid dose was reduced from 0.34 to 0.05 mg per kilogram per day, and glucocorticoids were discontinued in 42 of 128 patients (33%). The macrophage activation syndrome occurred in 7 patients; infections were more frequent with canakinumab than with placebo. CONCLUSIONS These two phase 3 studies show the efficacy of canakinumab in systemic JIA with active systemic features. (Funded by Novartis Pharma; ClinicalTrials.gov numbers, NCT00889863 and NCT00886769.)	[Ruperto, Nicolino; Viola, Stefania; Martini, Alberto] Univ Genoa, Ist Giannina Gaslini, Paediat Reumatol Paediat Rheumatol Int Tials Org, Coordinating Ctr, Genoa, Italy; [Martini, Alberto] Univ Genoa, Dipartimento Pediat, Genoa, Italy; [Cimaz, Rolando] Azienda Osped Univ Meyer, Florence, Italy; [Brunner, Hermine I.; Grom, Alexei; Lovell, Daniel J.] Cincinnati Childrens Hosp Med Ctr, PRCSG Coordinating Ctr, Div Rheumatol, Dept Pediat, Cincinnati, OH USA; [Quartier, Pierre] Univ Paris 05, Unite Immunol Hematol & Rhumatol Pediat, Hop Necker Enfants Malad, Paris, France; [Kone-Paut, Isabelle] Univ Paris Sud, Ctr Reference Natl Malad Autoinflammatoires, Ctr Hosp Univ Le Kremlin Bicetre, F-94275 Le Kremlin Bicetre, France; [Constantin, Tamas] Semmelweis Univ, Unit Pediat Rheumatol, H-1085 Budapest, Hungary; [Wulffraat, Nico] Wilhelmina Childrens Hosp, Dept Pediat Immunol & Rheumatol, Utrecht, Netherlands; [Horneff, Gerd] Charite, Zentrum Allgemeine Paediat & Neonatol, Berlin, Germany; [Brik, Riva] Rambam Med Ctr, Dept Pediat, Haifa, Israel; [Berkun, Yackov] Hadassah Univ Hosp Mt Scopus, Hadassah Med Ctr, Dept Pediat, Jerusalem, Israel; [Uziel, Yosef] Meir Med Ctr, Dept Pediat, Kefar Sava, Israel; [McCann, Liza] Alder Hey Childrens Natl Hlth Serv Fdn Trust, Liverpool, Merseyside, England; [Nistala, Kiran] UCL, Great Ormond St Hosp, Ctr Paediat & Adolescent Rheumatol, London, England; [Kasapcopur, Ozgur] Istanbul Univ, Cerrahpasa Med Fac, Istanbul, Turkey; [Erguven, Muferet] Goztepe Educ & Res Hosp, Clin Pediat Hlth & Dis, Istanbul, Turkey; [Oliveira, Sheila K.] Hacettepe Univ, Dept Pediat Nephrol & Rheumatol, Childrens Hosp, Ankara, Turkey; [Rutkowska-Sak, Lidia] Inst Rheumatol, Pediat Clin, Warsaw, Poland; [Schneider, Rayfel] Univ Toronto, Hosp Sick Children, Div Rheumatol, Toronto, ON M5G 1X8, Canada; [Calvo, Inmaculada] Hosp Univ La Fe, Dept Pediat Rheumatol, Valencia, Spain; [Gamir, Maria Luz] Hosp Ramon & Cajal, Unidad Reumatol Pediat, E-28034 Madrid, Spain; [Goffin, Laurence] Univ Libre Bruxelles, Hop Univ Enfants Reine Fabiola, Serv Pediat, Brussels, Belgium; [Wouters, Carine] Univ Hosp Gasthuisberg, Div Pediat Rheumatol, Dept Pediat, B-3000 Louvain, Belgium; Univ Lausanne, Unite Romande Rhumatol Pediat, Ctr Hosp Univ Vaudois, Lausanne, Switzerland; [Hofer, Michael] Hop Cantonal Univ Geneva, Geneva, Switzerland; [Lheritier, Karine] Novartis Pharmaceut, Basel, Switzerland; [Oliveira, Sheila K.] Univ Fed Rio de Janeiro, Inst Puericultura & Pediat Martagao Gesteira, Rio De Janeiro, Brazil; [Sztajnbok, Flavio] Hosp Univ Pedro Ernesto, Nucleo Estudos Saude Adolescente, Rio De Janeiro, Brazil; [Ferrandiz, Manuel A.] Inst Nacl Salud Nino, Lima, Peru; [Flato, Berit] Univ Hosp, Rikshosp, Dept Rheumatol, Oslo, Norway; [Magnusson, Bo] Karolinska Univ Hosp, Pediat Rheumatol Unit, Stockholm, Sweden; [Abrams, Ken; Kim, Dennis] Nova Pharmaceut Corp, E Hanover, NJ USA	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; Cincinnati Children's Hospital Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Semmelweis University; Wilhelmina Kinderziekenhuis; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Rambam Health Care Campus; Technion Israel Institute of Technology; Hebrew University of Jerusalem; Hadassah University Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Alder Hey Children's NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Istanbul University; Istanbul University - Cerrahpasa; Istanbul Goztepe Training and Research Hospital; Hacettepe University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Hospital Universitari i Politecnic La Fe; Hospital Universitario Ramon y Cajal; Universite Libre de Bruxelles; KU Leuven; University Hospital Leuven; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; Novartis; Universidade Federal do Rio de Janeiro; University of Oslo; National Hospital Norway; Karolinska Institutet; Karolinska University Hospital; Novartis	Ruperto, N (corresponding author), PRINTO, Ist Giannina Gaslini, Via Gaslini 5, I-16147 Genoa, Italy.	nicolaruperto@ospedale-gaslini.ge.it	Ruperto, Nicolino/K-3349-2018; Anton, Jordi/A-9848-2017; Berkun, Yackov/A-1694-2009; Ramanan, Athimalaipet V/J-3280-2014; Sztajnbok, Flavio/AAK-1469-2020; OZEN, SEZA/I-9096-2013; Kasapcopur, Ozgur/A-8888-2018; CIMAZ, Rolando/AAA-9058-2019; Kone-paut, Isabelle/AAF-6296-2019; McCann, Liza/AAA-8311-2021; Berner, Reinhard/P-7351-2017; Oliveira, Sheila/F-5213-2016; Frosch, Michael/AAZ-1318-2020; Wulffraat, Nico M/AAE-8929-2020	Ruperto, Nicolino/0000-0001-8407-7782; Anton, Jordi/0000-0002-8792-4219; Berkun, Yackov/0000-0001-9823-4750; Kasapcopur, Ozgur/0000-0002-1125-7720; CIMAZ, Rolando/0000-0002-3260-4226; Berner, Reinhard/0000-0002-6216-9173; Oliveira, Sheila/0000-0002-2426-716X; Wulffraat, Nico M/0000-0001-9548-5562; bader-meunier, brigitte/0000-0001-8476-8196; Quartier, Pierre/0000-0002-1769-549X; Wouters, Carine/0000-0002-6426-8845; MARTINI, Alberto/0000-0001-7642-1459; McCann, Liza/0000-0002-0372-5758	Novartis Pharma; Versus Arthritis [17287] Funding Source: researchfish	Novartis Pharma; Versus Arthritis(Versus Arthritis)	Supported by Novartis Pharma.	Brunner HI, 2002, J RHEUMATOL, V29, P1058; Cassidy J.T., 2010, TXB PEDIAT RHEUMATOL, V6th ed.; CASSIDY JT, 1986, ARTHRITIS RHEUM, V29, P274, DOI 10.1002/art.1780290216; De Benedetti F, 1998, J RHEUMATOL, V25, P203; De Benedetti F, 2012, NEW ENGL J MED, V367, P2385, DOI 10.1056/NEJMoa1112802; de Vries MK, 2008, NEW ENGL J MED, V359, P2496; DeBenedetti F, 1997, J CLIN INVEST, V99, P643, DOI 10.1172/JCI119207; Gattorno M, 2008, ARTHRITIS RHEUM, V58, P1516, DOI 10.1002/art.23475; Gattorno M, 2008, ARTHRITIS RHEUM, V58, P1505, DOI 10.1002/art.23437; Giannini EH, 1996, J RHEUMATOL, V23, P919; Giannini EH, 1997, ARTHRITIS RHEUM, V40, P1202; Griffin TA, 2009, ARTHRITIS RHEUM-US, V60, P2113, DOI 10.1002/art.24534; Hashkes PJ, 2010, ARTHRITIS RHEUM-US, V62, P599, DOI 10.1002/art.27218; Kimura Y, 2012, ARTHRITIS CARE RES H; Kuemmerle-Deschner JB, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3266; Lachmann HJ, 2011, ARTHRITIS RHEUM-US, V63, P314, DOI 10.1002/art.30105; Lachmann HJ, 2009, NEW ENGL J MED, V360, P2416, DOI 10.1056/NEJMoa0810787; Lepore L, 2010, J PEDIATR-US, V157, P310, DOI 10.1016/j.jpeds.2010.02.040; MARTINI A, 1994, LANCET, V344, P1052, DOI 10.1016/S0140-6736(94)91710-8; Nigrovic PA, 2011, ARTHRITIS RHEUM-US, V63, P545, DOI 10.1002/art.30128; Packham JC, 2002, RHEUMATOLOGY, V41, P1428, DOI 10.1093/rheumatology/41.12.1428; PADEH S, 1991, ARTHRITIS RHEUM, V34, P1575; Pascual V, 2005, J EXP MED, V201, P1479, DOI 10.1084/jem.20050473; Petty RE, 2004, J RHEUMATOL, V31, P390; Petty Ross E., 1998, Journal of Rheumatology, V25, P1991; Picco P, 2009, ARTHRITIS RHEUM-US, V60, P264, DOI 10.1002/art.24174; Prakken B, 2011, LANCET, V377, P2138, DOI 10.1016/S0140-6736(11)60244-4; Quartier P, 2011, ANN RHEUM DIS, V70, P747, DOI 10.1136/ard.2010.134254; Ravelli A, 2005, J PEDIATR-US, V146, P598, DOI 10.1016/j.jpeds.2004.12.016; Ravelli A, 2007, LANCET, V369, P767, DOI 10.1016/S0140-6736(07)60363-8; Ruperto N, 2001, CLIN EXP RHEUMATOL, V19, pS1; Ruperto N, 2001, CLIN EXP RHEUMATOL, V19, pI; Ruperto N, 2008, LANCET, V372, P383, DOI 10.1016/S0140-6736(08)60998-8; Ruperto N, 2012, ARTHRITIS RHEUM-US, V64, P557, DOI 10.1002/art.33342; Ruperto N, 2011, ARCH DIS CHILD, V96, P596, DOI 10.1136/adc.2010.188946; Ruperto N, 2010, ARTHRITIS RHEUM-US, V62, P3131, DOI 10.1002/art.27670; Schulz KF, 2010, LANCET, V375, P1144, DOI 10.1016/S0140-6736(10)60413-8; Sfriso P, 2008, NEW ENGL J MED, V359, P2495, DOI 10.1056/NEJMc081987; SINGH G, 1994, ARTHRITIS RHEUM, V37, P1761, DOI 10.1002/art.1780371209; Wallace CA, 2004, J RHEUMATOL, V31, P2290; Wallace CA, 2011, ARTHRIT CARE RES, V63, P929, DOI 10.1002/acr.20497; Yokota S, 2008, LANCET, V371, P998, DOI 10.1016/S0140-6736(08)60454-7	42	487	524	3	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2012	367	25					2396	2406		10.1056/NEJMoa1205099	http://dx.doi.org/10.1056/NEJMoa1205099			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056ZP	23252526	Green Published			2022-12-28	WOS:000312531600007
J	Bloomfield, HE				Bloomfield, Hanna E.			Review: Statins reduce pancreatitis in adults with normal or mildly elevated triglyceride levels	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Bloomfield, Hanna E.] Minneapolis VA Hlth Care Syst, Minneapolis, MN 55417 USA; [Bloomfield, Hanna E.] Univ Minnesota, Minneapolis, MN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Bloomfield, HE (corresponding author), Minneapolis VA Hlth Care Syst, Minneapolis, MN 55417 USA.			bloomfield, hanna/0000-0002-0756-7064				Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Lederle FA, 2012, ANN INTERN MED, V157, P662, DOI 10.7326/0003-4819-157-9-201211060-00011	3	1	1	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 18	2012	157	12							JC6-8	10.7326/0003-4819-157-12-201212180-02008	http://dx.doi.org/10.7326/0003-4819-157-12-201212180-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057SB	23247957				2022-12-28	WOS:000312583200007
J	Rose, J				Rose, James			CHRISTMAS 2012: EVOLUTION OF PRACTICE Gastroscopic painting	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rose, James] Ayr Hosp, Ayr, Scotland		Rose, J (corresponding author), 13 Racecourse Rd, Ayr KA7 2DQ, Scotland.	jamesdrrose@googlemail.com						Arafa MA, 1935, P ROY SOC MED, V28, P777; Brown L, 1883, BRIT MED J, V2, P811; DAVIDSON SW, 1941, BRIT J RADIOL, V14, P307; EDWARDS HC, 1984, BRIT MED J, V289, P1784, DOI 10.1136/bmj.289.6460.1784; Ehrentheil OF, 1932, ARCH VERDAUUNGSKRANK, V52, P206; ELSNER H, 1911, GASTROSKOPIE; Freeman H, 1945, BRIT J SURG, V32, P303; GIBSON US, 1988, GASTROINTEST ENDOSC, V34, P383; GUTZEIT K, 1937, GASTROSKOPIE; Henning N, 1935, LEHRBUCH GASTROSCOPI; Henning N, 1934, ENLZUNDUNG MAGENS; Hubner A, 1928, GASTROSKOPIE; Hughes JH, 1938, BRIT J SURG, V26, P35, DOI 10.1002/bjs.18002610106; Moutier Francois, 1935, TRAITE GASTROSCOPIE; NELSON RS, 1958, GASTROENTEROLOGY, V35, P74; Rodgers H, 1937, TXB GASTROSCOPY; Rodgers H, 1948, BR SURG PRACT, V3, P419; Rose JD, 1937, NEWCASTLE MED J, V17, P52; Rose JD, 1941, MED PRESS CIRCULAR, V206, P1; Schindler R, 1937, GASTROSCOPY ENDOSCOP, P9; SCHINDLER R, 1937, GASTROSCOPY, P292; Schindler Rudolf, 1923, LEHRBUCH ATLAS GASTR; Taylor H, 1937, BRIT J SURG, V24, P469, DOI 10.1002/bjs.1800249508	23	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 18	2012	345								e8323	10.1136/bmj.e8323	http://dx.doi.org/10.1136/bmj.e8323			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IW	23251015				2022-12-28	WOS:000312698900010
J	Kim, JY				Kim, Jim Yong			Data for better health-and to help end poverty	LANCET			English	Editorial Material									World Bank, Washington, DC 20433 USA	The World Bank	Kim, JY (corresponding author), World Bank, 1818 H St NW, Washington, DC 20433 USA.	president@worldbank.org							0	9	9	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 15	2012	380	9859					2055	2055		10.1016/S0140-6736(12)62162-X	http://dx.doi.org/10.1016/S0140-6736(12)62162-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23245597				2022-12-28	WOS:000312387000004
J	Smith, C				Smith, Caitlin			TWO MICROSCOPES ARE BETTER THAN ONE	NATURE			English	Editorial Material																		Bertazzo S, 2012, NANOSCALE, V4, P2851, DOI 10.1039/c2nr30431g; Caplan J, 2011, CURR OPIN STRUC BIOL, V21, P686, DOI 10.1016/j.sbi.2011.06.010; Harke B., 2012, OPT NANOSCOPY, V1, P3, DOI DOI 10.1186/2192-2853-1-3; MARANTO AR, 1982, SCIENCE, V217, P953, DOI 10.1126/science.7112109; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; Ou HD, 2012, CELL, V151, P304, DOI 10.1016/j.cell.2012.08.035; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041	7	46	46	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					293	297		10.1038/492293a	http://dx.doi.org/10.1038/492293a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053GM	23235883	Bronze			2022-12-28	WOS:000312259300051
J	Stringer, C				Stringer, Chris			The 100-year mystery of Piltdown Man	NATURE			English	Editorial Material									Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	Natural History Museum London	Stringer, C (corresponding author), Nat Hist Museum, Dept Earth Sci, Cromwell Rd, London SW7 5BD, England.	c.stringer@nhm.ac.uk						Dawson C., 1913, Quarterly Journal of the Geological Society of London, V69; Gardiner BG, 2003, ZOOL J LINN SOC-LOND, V139, P315, DOI 10.1046/j.1096-3642.2003.00079.x; McNabb J, 2006, ARCHAEOL J, V163, P1; Russell Miles, 2003, PILTDOWN MAN SECRET; Stringer C., 2007, HOMOBRITANNICUS; Thackeray J. Francis, 2011, Transactions of the Royal Society of South Africa, V66, P9, DOI 10.1080/0035919X.2011.564435; Weiner J, 2003, PILTDOWN FORGERY; WEINER J. S., 1953, BULL BRIT MUS [NAT HIST] GEOL, V2, P139; WEINER J. S., 1955, BULL BRIT MUS [NAT HIST] GEOL, V2, P225	9	7	7	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 13	2012	492	7428					177	179		10.1038/492177a	http://dx.doi.org/10.1038/492177a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053GM	23235860	Bronze			2022-12-28	WOS:000312259300014
J	Latshang, TD; Nussbaumer-Ochsner, Y; Henn, RM; Ulrich, S; Lo Cascio, CM; Ledergerber, B; Kohler, M; Bloch, KE				Latshang, Tsogyal D.; Nussbaumer-Ochsner, Yvonne; Henn, Rahel M.; Ulrich, Silvia; Lo Cascio, Christian M.; Ledergerber, Bruno; Kohler, Malcolm; Bloch, Konrad E.			Effect of Acetazolamide and AutoCPAP Therapy on Breathing Disturbances Among Patients With Obstructive Sleep Apnea Syndrome Who Travel to Altitude A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITIVE AIRWAY PRESSURE; ACUTE MOUNTAIN-SICKNESS; DOUBLE-BLIND; PERFORMANCE; STANDARDIZATION; SOJOURN; SCALE; LUNG	Context Many patients with obstructive sleep apnea syndrome (OSA) living near sea level travel to altitude, but this may expose them to hypoxemia and exacerbation of sleep apnea. The treatment in this setting is not established. Objective To evaluate whether acetazolamide and autoadjusted continuous positive airway pressure (autoCPAP) control breathing disturbances in OSA patients at altitude. Design, Setting, and Participants Randomized, placebo-controlled, double-blind, crossover trial involving 51 patients with OSA living below an altitude of 800 m and receiving CPAP therapy who underwent studies at a university hospital at 490 m and resorts in Swiss mountain villages at 1630 m and 2590 m in summer 2009. Interventions Patients were studied during 2 sojourns of 3 days each in mountain villages, 2 days at 1630 m, 1 day at 2590 m, separated by a 2-week washout period at less than 800 m. At altitude, patients either took acetazolamide (750 mg/d) or placebo in addition to autoCPAP. Main Outcome Measures Primary outcomes were nocturnal oxygen saturation and the apnea/hypopnea index; secondary outcomes were sleep structure, vigilance, symptoms, adverse effects, and exercise performance. Results Acetazolamide and autoCPAP treatment was associated with higher nocturnal oxygen saturation at 1630 m and 2590 m than placebo and autoCPAP: medians, 94% (interquartile range [IQR], 93%-95%) and 91% (IQR, 90%-92%) vs 93% (IQR, 92%-94%) and 89% (IQR, 87%-91%), respectively. Median increases were 1.0% (95% CI, 0.3%-1.0%) and 2.0% (95% CI, 2.0%-2.0). Median night-time spent with oxygen saturation less than 90% at 2590 m was 13% (IQR, 2%-38%) vs 57% (IQR, 28%-82%; P<.001). Acetazolamide and autoCPAP resulted in better control of sleep apnea at 1630 m and 2590 m than placebo and autoCPAP: median apnea/hypopnea index was 5.8 events per hour (5.8/h) (IQR, 3.0/h-10.1/h) and 6.8/h (IQR, 3.5/h-10.1/h) vs 10.7/h (IQR, 5.1/h-17.7/h) and 19.3/h (IQR, 9.3/h-29.0/h), respectively; median reduction was 3.2/h (95% CI, 1.3/h-7.5/h) and 9.2 (95% CI, 5.1/h-14.6/h). Conclusion Among patients with OSA spending 3 days at moderately elevated altitude, a combination of acetazolamide and autoCPAP therapy, compared with autoCPAP alone, resulted in improvement in nocturnal oxygen saturation and apnea/hypopnea index.	[Latshang, Tsogyal D.; Nussbaumer-Ochsner, Yvonne; Henn, Rahel M.; Ulrich, Silvia; Lo Cascio, Christian M.; Kohler, Malcolm; Bloch, Konrad E.] Univ Zurich Hosp, Div Pulm, Sleep Disorders Ctr, CH-8091 Zurich, Switzerland; [Latshang, Tsogyal D.; Nussbaumer-Ochsner, Yvonne; Henn, Rahel M.; Ulrich, Silvia; Lo Cascio, Christian M.; Kohler, Malcolm; Bloch, Konrad E.] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland; [Ledergerber, Bruno] Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital	Bloch, KE (corresponding author), Univ Zurich Hosp, Div Pulm, Sleep Disorders Ctr, Raemistr 100, CH-8091 Zurich, Switzerland.	konrad.bloch@usz.ch	Ledergerber, Bruno/B-5656-2009	Ledergerber, Bruno/0000-0002-6881-4401; Ulrich, Silvia/0000-0002-5250-5022	Philips Respironics; ResMed; Swiss National Science Foundation; Lung Leagues of Zurich and Schaffhausen; Center for Clinical Research, University of Zurich; University Hospital Zurich; Philips Respironics, Switzerland	Philips Respironics; ResMed; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Lung Leagues of Zurich and Schaffhausen; Center for Clinical Research, University of Zurich; University Hospital Zurich; Philips Respironics, Switzerland	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Bloch reported having received unconditional institutional grants from Philips Respironics and ResMed and served as a consultant for imtmedical. No other disclosures were reported.; This study was supported by grants from the Swiss National Science Foundation, Lung Leagues of Zurich and Schaffhausen, Center for Clinical Research, University of Zurich, and University Hospital Zurich and by an unconditional grant from Philips Respironics, Switzerland.	Basner RC, 2007, NEW ENGL J MED, V356, P1751, DOI 10.1056/NEJMct066953; Basnyat B, 2003, HIGH ALT MED BIOL, V4, P45, DOI 10.1089/152702903321488979; Bloch K E, 1997, Technol Health Care, V5, P285; Bloch KE, 1999, RESPIRATION, V66, P440, DOI 10.1159/000029408; Bloch KE, 1997, EUR RESPIR J, V10, P576; Bradley TD, 2005, NEW ENGL J MED, V353, P2025, DOI 10.1056/NEJMoa051001; Burgess KR, 2006, RESPIROLOGY, V11, P62, DOI 10.1111/j.1440-1843.2006.00785.x; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Cremona G, 2002, LANCET, V359, P303, DOI 10.1016/S0140-6736(02)07496-2; Dai YMN, 2010, CIRCULATION, V121, P1598, DOI 10.1161/CIRCULATIONAHA.109.902452; Dinges DF, 1997, SLEEP, V20, P267; Fischer R, 2004, EUR RESPIR J, V23, P47, DOI 10.1183/09031936.03.00113102; Juniper M, 2000, EUR RESPIR J, V15, P590, DOI 10.1034/j.1399-3003.2000.15.27.x; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Kohler M, 2011, AM J RESP CRIT CARE, V184, P1192, DOI 10.1164/rccm.201106-0964OC; Kohler M, 2010, NAT REV CARDIOL, V7, P677, DOI 10.1038/nrcardio.2010.145; Latshang TD, 2011, HIGH ALT MED BIOL, V12, P303, DOI 10.1089/ham.2011.1055; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Morgenthaler TI, 2006, SLEEP, V29, P1203, DOI 10.1093/sleep/29.9.1203; Nussbaumer-Ochsner Y, 2012, CHEST, V141, P131, DOI 10.1378/chest.11-0375; Nussbaumer-Ochsner Y, 2010, THORAX, V65, P429, DOI 10.1136/thx.2009.125849; Patz DS, 2010, SLEEP, V33, P715, DOI 10.1093/sleep/33.5.715; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; SAMPSON JB, 1983, AVIAT SPACE ENVIR MD, V54, P1063; Senn O, 2005, CHEST, V128, P1291, DOI 10.1378/chest.128.3.1291; Senn O, 2003, AM J RESP CRIT CARE, V168, P1506, DOI 10.1164/rccm.200304-542OC; Senn O, 2006, MED SCI SPORT EXER, V38, P1565, DOI 10.1249/01.mss.0000229102.37359.af; Smith I, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003531.pub3; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Ulrich S, 2010, EUR RESPIR J, V36, p980s; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	34	58	62	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2012	308	22					2390	2398		10.1001/jama.2012.94847	http://dx.doi.org/10.1001/jama.2012.94847			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051MW	23232895	Bronze			2022-12-28	WOS:000312132400029
J	Stewart, CMW; Schoeman, SA; Booth, RA; Smith, SD; Wilcox, MH; Wilson, JD				Stewart, Catherine M. W.; Schoeman, Sarah A.; Booth, Russell A.; Smith, Susan D.; Wilcox, Mark H.; Wilson, Janet D.			Assessment of self taken swabs versus clinician taken swab cultures for diagnosing gonorrhoea in women: single centre, diagnostic accuracy study	BRITISH MEDICAL JOURNAL			English	Article							DETECT CHLAMYDIA-TRACHOMATIS; ACID AMPLIFICATION TEST; NEISSERIA-GONORRHOEAE; VAGINAL SWABS; SPECIMENS; URINE; INFECTIONS; PERFORMANCE; ASSAYS; NAATS	Objective To compare gonorrhoea detection by self taken vulvovaginal swabs (tested with nucleic acid amplification tests) with the culture of urethral and endocervical samples taken by clinicians. Design Prospective study of diagnostic accuracy. Setting 1 sexual health clinic in an urban setting (Leeds Centre for Sexual Health, United Kingdom), between March 2009 and January 2010. Participants Women aged 16 years or older, attending the clinic for sexually transmitted infection (STI) testing and consenting to perform a vulvovaginal swab themselves before routine examination. During examination, clinicians took urethral and endocervical samples for culture and an endocervical swab for nucleic acid amplification testing. Interventions Urethra and endocervix samples were analysed by gonococcal culture. Vulvovaginal swabs and endocervical swabs were analysed by the Aptima Combo 2 (AC2) assay; positive results from this assay were confirmed with a second nucleic acid amplification test. Main outcome measures Positive confirmation of gonorrhoea. Results Of 3859 women with complete data and test results, 96 (2.5%) were infected with gonorrhoea (overall test sensitivities: culture 81%, endocervical swabs with AC2 96%, vulvovaginal swabs with AC2 99%). The AC2 assays were more sensitive than culture (P<0.001), but the endocervical and vulvovaginal assays did not differ significantly (P=0.375). Specificity of all Aptima Combo 2 tests was 100%. Of 1625 women who had symptoms suggestive of a bacterial STI, 56 (3.4%) had gonorrhoea (culture 84%, endocervical AC2 100%, vulvovaginal AC2 100%). The AC2 assays were more sensitive than culture (P=0.004), and the endocervical and vulvovaginal assays were equivalent to each other. Of 2234 women who did not have symptoms suggesting a bacterial STI, 40 (1.8%) had gonorrhoea (culture 78%, endocervical AC2 90%, vulvovaginal AC2 98%). The vulvovaginal swab was more sensitive than culture (P=0.008), but there was no difference between the endocervical and vulvovaginal AC2 assays (P=0.375) or between the endocervical AC2 assay and culture (P=0.125). The endocervical swab assay performed less well in women without symptoms of a bacterial STI than in those with symptoms (90% v 100%, P=0.028), whereas the vulvovaginal swab assay performed similarly (98% v 100%, P=0.42). Conclusion Self taken vulvovaginal swabs analysed by nucleic acid amplification tests are significantly more sensitive at detecting gonorrhoea than culture of clinician taken urethral and endocervical samples, and are equivalent to endocervical swabs analysed by nucleic acid amplification tests. Self taken vulvovaginal swabs are the sample of choice in women without symptoms and have the advantage of being non-invasive. In women who need a clinical examination, either a clinician taken or self taken vulvovaginal swab is recommended.	[Stewart, Catherine M. W.; Schoeman, Sarah A.; Wilson, Janet D.] Leeds Gen Infirm, Dept Genitourinary Med, Leeds LS1 3EX, W Yorkshire, England; [Booth, Russell A.; Smith, Susan D.; Wilcox, Mark H.] Leeds Gen Infirm, Dept Clin Microbiol, Leeds LS1 3EX, W Yorkshire, England	Leeds General Infirmary; University of Leeds; Leeds General Infirmary; University of Leeds	Wilson, JD (corresponding author), Leeds Gen Infirm, Dept Genitourinary Med, Leeds LS1 3EX, W Yorkshire, England.	janet_d.wilson@leedsth.nhs.uk		Wilson, Janet/0000-0001-9865-0834	Gen-Probe	Gen-Probe	Funding, in the form of the extra diagnostic reagents and equipment needed for the study, was provided by Gen-Probe. The funders had no role in the initiation or design of the study, collection of samples, analysis, interpretation of data, writing of the paper, or the submission for publication. The study and researchers are independent of the funders, Gen-Probe.	Benzie A, 2010, INT J STD AIDS, V21, P246, DOI 10.1258/ijsa.2010.010004; Bignell C, 2006, SEX TRANSM INFECT, V82, P6, DOI 10.1136/sti.2006.023036; Bignell C, 2011, INT J STD AIDS, V22, P541, DOI 10.1258/ijsa.2011.011267; Brown L, 2010, SEX TRANSM INFECT, V86, P525, DOI 10.1136/sti.2009.039479; Buimer M, 1996, J CLIN MICROBIOL, V34, P2395, DOI 10.1128/JCM.34.10.2395-2400.1996; Carne CA, 2010, INT J STD AIDS, V21, P512, DOI 10.1258/ijsa.2010.009573; Chernesky MA, 2005, SEX TRANSM DIS, V32, P729, DOI 10.1097/01.olq.0000190057.61633.8d; Chisholm SA, 2010, J ANTIMICROB CHEMOTH, V65, P2141, DOI 10.1093/jac/dkq289; Cook RL, 2005, ANN INTERN MED, V142, P914, DOI 10.7326/0003-4819-142-11-200506070-00010; CSSG, 2006, NEW FRONT ANN REP NA; Fang JY, 2008, J PEDIATR ADOL GYNEC, V21, P355, DOI 10.1016/j.jpag.2008.03.010; Gaydos CA, 2010, J CLIN MICROBIOL, V48, P3236, DOI 10.1128/JCM.01019-10; Gaydos CA, 2003, J CLIN MICROBIOL, V41, P304, DOI 10.1128/JCM.41.1.304-309.2003; Health Protection Agency, 2011, SEX TRANSM INF ENGL; Health Protection Agency, 2011, GRASP 2010 REP GON R; Ison C, 2006, SEX TRANSM INFECT, V82, P515, DOI 10.1136/sti.2006.022731; Katz AR, 2004, CLIN INFECT DIS, V38, P814, DOI 10.1086/381895; KELLOGG JA, 1992, J CLIN MICROBIOL, V30, P2988, DOI 10.1128/JCM.30.11.2988-2990.1992; Moss S, 2007, INT J STD AIDS, V18, P551, DOI 10.1258/095646207781439784; Schachter J, 2003, J CLIN MICROBIOL, V41, P3784, DOI 10.1128/JCM.41.8.3784-3789.2003; Schachter J, 2005, SEX TRANSM DIS, V32, P725, DOI 10.1097/01.olq.0000190092.59482.96; Schoeman SA, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8013; Shafer MA, 2003, J CLIN MICROBIOL, V41, P4395, DOI 10.1128/JCM.41.9.4395-4399.2003; Skidmore S, 2006, J CLIN MICROBIOL, V44, P4389, DOI 10.1128/JCM.01060-06; Van Dyck E, 2001, J CLIN MICROBIOL, V39, P1751, DOI 10.1128/JCM.39.5.1751-1756.2001; Whiley DM, 2008, SEX HEALTH, V5, P17, DOI 10.1071/SH07050	26	23	23	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 12	2012	345								e8107	10.1136/bmj.e8107	http://dx.doi.org/10.1136/bmj.e8107			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056MU	23236033	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000312495100010
J	Stillman, MD				Stillman, Michael D.			Enough, Already	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Louisville, Sch Med, Dept Internal Med, Louisville, KY 40292 USA	University of Louisville	Stillman, MD (corresponding author), Univ Louisville, Sch Med, Dept Internal Med, Louisville, KY 40292 USA.	michael.stillman1972@gmail.com						Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P2597, DOI 10.1001/jama.2012.6911	1	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2012	308	22					2347	2348		10.1001/jama.2012.14475	http://dx.doi.org/10.1001/jama.2012.14475			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051MW	23232893				2022-12-28	WOS:000312132400024
J	Nielsen, J				Nielsen, James			"Thank you for seeing my beautiful daughter Kate ... "	LANCET			English	Editorial Material									Concord Hosp, Dept Anaesthet, Concord, NSW 2137, Australia	Concord Repatriation General Hospital	Nielsen, J (corresponding author), Concord Hosp, Dept Anaesthet, Hosp Rd, Concord, NSW 2137, Australia.	jamesrnielsen@gmail.com							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 8	2012	380	9858					2050	2051		10.1016/S0140-6736(12)62003-0	http://dx.doi.org/10.1016/S0140-6736(12)62003-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051KI	23217868				2022-12-28	WOS:000312124900036
J	Kolev, NG; Ramey-Butler, K; Cross, GAM; Ullu, E; Tschudi, C				Kolev, Nikolay G.; Ramey-Butler, Kiantra; Cross, George A. M.; Ullu, Elisabetta; Tschudi, Christian			Developmental Progression to Infectivity in Trypanosoma brucei Triggered by an RNA-Binding Protein	SCIENCE			English	Article							TSETSE-FLY	Unraveling the intricate interactions between Trypanosoma brucei, the protozoan parasite causing African trypanosomiasis, and the tsetse (Glossina) vector remains a challenge. Metacyclic trypanosomes, which inhabit the tsetse salivary glands, transmit the disease and are produced through a complex differentiation and unknown program. By overexpressing a single RNA-binding protein, TbRBP6, in cultured noninfectious trypanosomes, we recapitulated the developmental stages that have been observed in tsetse, including the generation of infective metacyclic forms expressing the variant surface glycoprotein. Thus, events leading to acquisition of infectivity in the insect vector are now accessible to laboratory investigation, providing an opening for new intervention strategies.	[Ramey-Butler, Kiantra; Ullu, Elisabetta] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06536 USA; [Kolev, Nikolay G.; Tschudi, Christian] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06536 USA; [Cross, George A. M.] Rockefeller Univ, Mol Parasitol Lab, New York, NY 10065 USA; [Ullu, Elisabetta] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06536 USA	Yale University; Yale University; Rockefeller University; Yale University	Ullu, E (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06536 USA.	elisabetta.ullu@yale.edu; christian.tschudi@yale.edu	Cross, George A M/B-7444-2011	Cross, George A M/0000-0003-1374-6955; Butler, Kiantra/0000-0001-6635-8601	National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) [AI028798, AI043594, AI021729, AI076879]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028798, R37AI021729, R37AI028798, R01AI021729, R21AI076879, R01AI043594] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Savage and S. Aksoy for assistance with the infectivity assays, J. Bangs for providing the immunofluorescence protocol and advice, D. Engman for the antibody against calflagin, and M. Chaudhuri for the antibody against alternative oxidase. Supported by grants AI028798 (E. U.), AI043594 (C. T.), AI021729 (G. A. M. C.), and AI076879 (S. Aksoy) from the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or the NIH. The sequence data from this study have been submitted to the National Center for Biotechnology Information Sequence Read Archive under accession nos. SRP002243 and SRA059559.	Bruce D, 1909, P R SOC LOND B-CONTA, V81, P405, DOI 10.1098/rspb.1909.0041; Ginger ML, 2002, EUKARYOT CELL, V1, P1000, DOI 10.1128/EC.1.6.1000-1009.2002; Rotureau B, 2012, DEVELOPMENT, V139, P1842, DOI 10.1242/dev.072611; Sharma R, 2009, TRENDS PARASITOL, V25, P517, DOI 10.1016/j.pt.2009.08.001; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Wurst M, 2012, MOL MICROBIOL, V83, P1048, DOI 10.1111/j.1365-2958.2012.07988.x	6	127	127	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2012	338	6112					1352	1353		10.1126/science.1229641	http://dx.doi.org/10.1126/science.1229641			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224556	Green Accepted			2022-12-28	WOS:000311991200069
J	Lyssiotis, CA; Cantley, LC				Lyssiotis, Costas A.; Cantley, Lewis C.			SIRT6 Puts Cancer Metabolism in the Driver's Seat	CELL			English	Editorial Material							HISTONE DEACETYLASE SIRT6; MYC	The rewiring of metabolism in cancer is thought to result from hyperactivation of signaling pathways that instruct cells to grow. Sebastian et al. show that loss of the tumor suppressor SIRT6 transforms cells by activating tumor metabolism. This occurs independently of mutations in canonical growth signaling pathways and reveals a tumorigenic role for cancer metabolism.	[Lyssiotis, Costas A.; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Med, Dept Signal Transduct, Boston, MA 02115 USA; [Lyssiotis, Costas A.; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Lyssiotis, Costas A.; Cantley, Lewis C.] Cornell Weill Med Coll, Dept Med, New York, NY 10065 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Cornell University	Lyssiotis, CA (corresponding author), Beth Israel Deaconess Med Ctr, Div Med, Dept Signal Transduct, Boston, MA 02115 USA.	clyssiot@bidmc.harvard.edu; lewis_cantley@hms.harvard.edu	Lyssiotis, Costas A/AAI-1923-2019; Cantley, Lewis C/D-1800-2014	Lyssiotis, Costas A/0000-0001-9309-6141; Cantley, Lewis C/0000-0002-1298-7653	NIGMS NIH HHS [R01 GM056203] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	10	24	27	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 7	2012	151	6					1155	1156		10.1016/j.cell.2012.11.020	http://dx.doi.org/10.1016/j.cell.2012.11.020			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217699	Green Accepted, Bronze			2022-12-28	WOS:000311999900003
J	Barr, B; Taylor-Robinson, D; Whitehead, M				Barr, Ben; Taylor-Robinson, David; Whitehead, Margaret			Impact on health inequalities of rising prosperity in England 1998-2007, and implications for performance incentives: longitudinal ecological study	BRITISH MEDICAL JOURNAL			English	Article							MORTALITY; UNEMPLOYMENT; DEPRIVATION; MECHANISMS; CHALLENGES; RECESSION; MIGRATION; CRISES	Objective To investigate whether the uneven rise in prosperity between 1999 and 2008 accounted for differential increases in life expectancy in English local authorities. Design Longitudinal ecological study. Setting 324 local authorities in England, classified by their baseline level of deprivation. Main outcome measures Multivariable regression was used to investigate the association between trends in prosperity between 1998 and 2007 and trends in life expectancy. Trends in health inequalities were assessed by comparing the experience of Spearhead local authorities (the 70 most deprived in 1998) with the average for all English local authorities. Results Those local authorities that experienced the greatest improvement in prosperity experienced greater increases in life expectancy. With each 1% absolute decline in unemployment, life expectancy increased by 2.2 (95% confidence interval 0.5 to 3.8) months in men and by 1.7 (0.4 to 3.1) months in women. With each 1000 pound increase in average household income in a local authority, life expectancy increased by 1.4 (0.3 to 2.5) months in men and by 1.1 (0.2 to 1.9) months in women. The more deprived a local authority was in 1998, the lower the rate at which life expectancy improved. Conclusion Decreases in unemployment and increases in average income in an area explained, to a large extent, why some local authorities "performed" better than others. Health inequalities between Spearhead and all local authorities widened during the period of rising prosperity, but they would have widened to an even greater extent had unemployment not fallen at a faster rate in more deprived areas. With worsening economic trends over the next 10 years, this research suggests that increases in life expectancy are likely to be smaller and health inequalities may widen at a faster rate than in the previous decade. Allocating resources to local authorities on the basis of their "performance" at increasing life expectancy is likely to reward more affluent areas rather than disadvantaged areas with greater needs, exacerbating the problem.	[Barr, Ben; Taylor-Robinson, David; Whitehead, Margaret] Univ Liverpool, Inst Psychol Hlth & Soc, Dept Publ Hlth & Policy, Liverpool L69 3GB, Merseyside, England; [Barr, Ben] NIH, Bethesda, MD USA; [Taylor-Robinson, David] MRC, London W1N 4AL, England	University of Liverpool; National Institutes of Health (NIH) - USA	Barr, B (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Dept Publ Hlth & Policy, Liverpool L69 3GB, Merseyside, England.	benbarr@liverpool.ac.uk	Barr, Ben R/W-9989-2018	Barr, Ben R/0000-0002-4208-9475	NIHR [DRF-2009-02-12]; MRC [G0802448]; Medical Research Council [G0802448] Funding Source: researchfish; National Institute for Health Research [DRF-2009-02-12] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	BB is supported by an NIHR doctoral research fellowship (DRF-2009-02-12). DT-R is supported by an MRC population health scientist fellowship (G0802448). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barnes M., 2009, SOCIAL IMPACTS RECES; Barr B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5142; Ben-Shlomo Y, 2005, INT J EPIDEMIOL, V34, P1181, DOI 10.1093/ije/dyi242; Blackman T, 2011, SOC SCI MED, V72, P1965, DOI 10.1016/j.socscimed.2011.04.003; Boyle P, 2004, PROG HUM GEOG, V28, P767, DOI 10.1191/0309132504ph518pr; Boyle P, 2004, SOC SCI MED, V58, P2459, DOI 10.1016/j.socscimed.2003.09.011; Brenner H.M., 1979, LANCET, V314, P568; Brenner MH, 2005, INT J EPIDEMIOL, V34, P1214, DOI 10.1093/ije/dyi146; Brewer M., 2011, CHILD WORKING AGE PO; Chandola T, 2001, HEALTH PLACE, V7, P105, DOI 10.1016/S1353-8292(01)00002-8; Department of Health, 2003, TACKL HLTH IN PROGR; Department of the Environment Transport and the Regions, IND DEPR 2000; EuroStat, 2008, NOM TERR UN STAT; EYER J, 1977, INT J HEALTH SERV, V7, P125, DOI 10.2190/9WA2-RVL3-MT9D-EL9D; Gerdtham UG, 2006, ECON HUM BIOL, V4, P298, DOI 10.1016/j.ehb.2006.04.001; Granados JAT, 2005, INT J EPIDEMIOL, V34, P1194, DOI 10.1093/ije/dyi141; Hertzman C, 2001, SOC SCI MED, V53, P1575, DOI 10.1016/S0277-9536(00)00437-8; Kawachi I, 1999, HEALTH SERV RES, V34, P215; Kawachi I, 2010, ANN NY ACAD SCI, V1186, P56, DOI 10.1111/j.1749-6632.2009.05340.x; Levell, 2010, DISTRIBUTIONAL EFFEC; lives Healthy, 2012, HLTH LIV HLTH PEOPL; Marmot M, 2010, FAIR SOC HLTH LIVES; McKee M, 2005, INT J EPIDEMIOL, V34, P1203, DOI 10.1093/ije/dyi144; MOSER KA, 1987, BRIT MED J, V294, P86, DOI 10.1136/bmj.294.6564.86; National Audit Office, 2010, TACKL IN LIF EXP AR; National Institute for Health and Clinical Excellence, 2007, BEH CHANG POP COMM I; NHS Information Centre, 2011, NHSIC IND PORT; Norman P, 2005, SOC SCI MED, V60, P2755, DOI 10.1016/j.socscimed.2004.11.008; Office for National Statistics, 2011, NOMIS OFF LAB MARK S; Office for National Statistics, 2010, REG ACC METH GUID; Organisation for Economic Co-operation and Development, 2011, DIV WE STAND WHY IN; Rutter M, 2000, DEV PSYCHOPATHOL, V12, P265, DOI 10.1017/S0954579400003023; Siegrist J, 2004, SOC SCI MED, V58, P1463, DOI 10.1016/S0277-9536(03)00349-6; STEFANSSON CG, 1991, SOC SCI MED, V32, P419, DOI 10.1016/0277-9536(91)90343-B; Stuckler D, 2012, J EPIDEMIOL COMMUN H, V66, P410, DOI 10.1136/jech.2010.121376; Stuckler D, 2011, LANCET, V378, P124, DOI 10.1016/S0140-6736(11)61079-9; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Taylor-Robinson D, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1487; Voss M, 2004, AM J PUBLIC HEALTH, V94, P2155, DOI 10.2105/AJPH.94.12.2155	40	12	12	1	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 4	2012	345								e7831	10.1136/bmj.e7831	http://dx.doi.org/10.1136/bmj.e7831			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	052HY	23212879	hybrid, Green Published			2022-12-28	WOS:000312189700002
J	Reis, S; Grennfelt, P; Klimont, Z; Amann, M; ApSimon, H; Hettelingh, JP; Holland, M; LeGall, AC; Maas, R; Posch, M; Spranger, T; Sutton, MA; Williams, M				Reis, S.; Grennfelt, P.; Klimont, Z.; Amann, M.; ApSimon, H.; Hettelingh, J. -P.; Holland, M.; LeGall, A. -C.; Maas, R.; Posch, M.; Spranger, T.; Sutton, M. A.; Williams, M.			From Acid Rain to Climate Change	SCIENCE			English	Editorial Material									[Reis, S.; Sutton, M. A.] Ctr Ecol & Hydrol, Penicuik EH26 0QB, Midlothian, Scotland; [Grennfelt, P.] Swedish Environm Res Inst, SE-40014 Gothenburg, Sweden; [Klimont, Z.; Amann, M.] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [ApSimon, H.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Hettelingh, J. -P.; Maas, R.; Posch, M.] Natl Inst Publ Hlth & Environm, NL-3721 MA Bilthoven, Netherlands; [Holland, M.] Ecometr Res & Consulting, Reading RG8 7PW, Berks, England; [LeGall, A. -C.] Natl Inst Ind Environm & Risks, F-60550 Verneuil En Halatte, France; [Spranger, T.] Fed Minist Environm Nat Conservat & Nucl Safety, D-11055 Berlin, Germany; [Williams, M.] Kings Coll London, Environm Res Grp, London SE1 9NH, England	UK Centre for Ecology & Hydrology (UKCEH); IVL Swedish Environmental Research Institute; International Institute for Applied Systems Analysis (IIASA); Imperial College London; Netherlands National Institute for Public Health & the Environment; Institut National de l'Environnement Industriel et des Risques (INERIS); University of London; King's College London	Reis, S (corresponding author), Ctr Ecol & Hydrol, Penicuik EH26 0QB, Midlothian, Scotland.	srei@ceh.ac.uk	Klimont, Zbigniew/P-7641-2015; Sutton, Mark/K-2700-2012; Reis, Stefan/E-4713-2011; Klimont, Zbigniew/O-6683-2019	Klimont, Zbigniew/0000-0003-2630-198X; Sutton, Mark/0000-0002-1342-2072; Reis, Stefan/0000-0003-2428-8320; Klimont, Zbigniew/0000-0003-2630-198X; Williams, Martin/0000-0002-4677-6491	Natural Environment Research Council [ceh010023] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Amann M, 2011, ENVIRON MODELL SOFTW, V26, P1489, DOI 10.1016/j.envsoft.2011.07.012; [Anonymous], 2011, NEAR TERM CLIMATE PR; Dentener F., 2010, AIR POLLUTION STUDIE; Hettelingh JP, 2007, WATER AIR SOIL POLL, V7, P379; Holland M., 2011, COST BENEFIT ANAL RE; Howard C. M., 2011, EUROPEAN NITROGEN AS, DOI [10.1017/CBO9780511976988, DOI 10.1017/CBO9780511976988]; Mills G., 2011, OZONE POLLUTION HIDD; Posch M, 2011, ENVIRON POLLUT, V159, P2223, DOI 10.1016/j.envpol.2010.11.001; Raes F, 2007, SCIENCE, V318, P1386, DOI 10.1126/science.1147873; Rafaj P., 2012, ENVC3SER20110009 IIA; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Sundqvist G, 2011, POLIT SCI ENVIRON, P195; UNECE, 2009, CLEAR AIR; UNECE, 2012, PART UNECE AIR POLL	15	103	107	5	222	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1153	1154		10.1126/science.1226514	http://dx.doi.org/10.1126/science.1226514			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197517				2022-12-28	WOS:000311666200026
J	Stadler, D; Krinner, S; Meineke, J; Brantut, JP; Esslinger, T				Stadler, David; Krinner, Sebastian; Meineke, Jakob; Brantut, Jean-Philippe; Esslinger, Tilman			Observing the drop of resistance in the flow of a superfluid Fermi gas	NATURE			English	Article							BOSE-EINSTEIN CONDENSATE; THERMODYNAMICS; VORTICES	The ability of particles to flow with very low resistance is characteristic of superfluid and superconducting states, leading to their discovery in the past century(1,2). Although measuring the particle flow in liquid helium or superconducting materials is essential to identify superfluidity or superconductivity, no analogous measurement has been performed for superfluids based on ultracold Fermi gases. Here we report direct measurements of the conduction properties of strongly interacting fermions, observing the well-known drop in resistance that is associated with the onset of superfluidity. By varying the depth of the trapping potential in a narrow channel connecting two atomic reservoirs, we observed variations of the atomic current over several orders of magnitude. We related the intrinsic conduction properties to the thermodynamic functions in a model-independent way, by making use of high-resolution in situ imaging in combination with current measurements. Our results show that, as in solid-state systems, current and resistance measurements in quantum gases provide a sensitive probe with which to explore many-body physics. Our method is closely analogous to the operation of a solid-state field-effect transistor and could be applied as a probe for optical lattices and disordered systems, paving the way for modelling complex superconducting devices.	[Stadler, David; Krinner, Sebastian; Meineke, Jakob; Brantut, Jean-Philippe; Esslinger, Tilman] ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Brantut, JP (corresponding author), ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	brantutj@phys.ethz.ch; esslinger@phys.ethz.ch	Esslinger, Tilman/M-9022-2016; Brantut, Jean-Philippe/G-2793-2013; Gernaey, Krist V./J-1759-2018	Esslinger, Tilman/0000-0002-8333-107X; Gernaey, Krist V./0000-0002-0364-1773; Brantut, Jean-Philippe/0000-0002-4610-6682	NCCR MaNEP and QSIT; ERC	NCCR MaNEP and QSIT; ERC(European Research Council (ERC)European Commission)	We acknowledge discussions with W. Zwerger, A. Georges, C. Kollath, C. Grenier, M. Sigrist, G. Blatter and G. Bruun. We thank L. Tarruell, T. Donner and H. Moritz for their careful reading of the manuscript. We acknowledge financing from NCCR MaNEP and QSIT, ERC project SQMS, FP7 project NAME-QUAM and ETHZ. J.-P.B. acknowledges support from EU through a Marie Curie Fellowship.	Albiez M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010402; Amo A, 2009, NAT PHYS, V5, P805, DOI 10.1038/NPHYS1364; Bartenstein M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120401; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Brantut JP, 2012, SCIENCE, V337, P1069, DOI 10.1126/science.1223175; Burger S, 2001, PHYS REV LETT, V86, P4447, DOI 10.1103/PhysRevLett.86.4447; Cao C, 2011, SCIENCE, V331, P58, DOI 10.1126/science.1195219; Dyke P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.105304; Enss T, 2011, ANN PHYS-NEW YORK, V326, P770, DOI 10.1016/j.aop.2010.10.002; Giorgini S, 2008, REV MOD PHYS, V80, P1215, DOI 10.1103/RevModPhys.80.1215; Horikoshi M, 2010, SCIENCE, V327, P442, DOI 10.1126/science.1183012; Ku MJH, 2012, SCIENCE, V335, P563, DOI 10.1126/science.1214987; LeBlanc LJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.025302; Leggett A. J, 2006, QUANTUM LIQUIDS B EI; Luo L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.080402; Madison KW, 2000, PHYS REV LETT, V84, P806, DOI 10.1103/PhysRevLett.84.806; Matthews MR, 1999, PHYS REV LETT, V83, P2498, DOI 10.1103/PhysRevLett.83.2498; Miller DE, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.070402; Nascimbene S, 2010, NATURE, V463, P1057, DOI 10.1038/nature08814; O'Hara KM, 2002, SCIENCE, V298, P2179, DOI 10.1126/science.1079107; Orel AA, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/11/113032; Petrov DS, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.012706; Raman C, 1999, PHYS REV LETT, V83, P2502, DOI 10.1103/PhysRevLett.83.2502; Ramanathan A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.130401; Schunck CH, 2008, NATURE, V454, P739, DOI 10.1038/nature07176; Seaman BT, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.023615; Sommer A, 2011, NATURE, V472, P201, DOI 10.1038/nature09989; van Delft D, 2010, PHYS TODAY, V63, P38, DOI 10.1063/1.3490499; Zimmermann B, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/043007; Zwierlein MW, 2005, NATURE, V435, P1047, DOI 10.1038/nature03858	31	80	80	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					736	+		10.1038/nature11613	http://dx.doi.org/10.1038/nature11613			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	044FY	23192151	Green Submitted			2022-12-28	WOS:000311606000040
J	Wu, D				Wu, David			Virtual Grief	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Washington, Palliat Med Fellowship Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Wu, D (corresponding author), Univ Washington, Palliat Med Fellowship Program, Seattle, WA 98195 USA.	djwu@comcast.net		Wu, David/0000-0003-1973-7777					0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2012	308	20					2095	2096		10.1001/jama.2012.14169	http://dx.doi.org/10.1001/jama.2012.14169			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043IV	23188025				2022-12-28	WOS:000311537200023
J	Chen, Q; Chen, YB; Bian, CJ; Fujiki, R; Yu, XC				Chen, Qiang; Chen, Yibin; Bian, Chunjing; Fujiki, Ryoji; Yu, Xiaochun			TET2 promotes histone O-GlcNAcylation during gene transcription	NATURE			English	Article							EMBRYONIC STEM-CELLS; GLCNAC TRANSFERASE; TETRATRICOPEPTIDE REPEATS; 5-HYDROXYMETHYLCYTOSINE; GENOME; 5-METHYLCYTOSINE; PROTEINS; NUCLEAR; DNA; DIFFERENTIATION	Ten eleven translocation (TET) enzymes, including TET1, TET2 and TET3, convert 5-methylcytosine to 5-hydroxymethylcytosine(1) and regulate gene transcription(2-5). However, the molecular mechanism by which TET family enzymes regulate gene transcription remains elusive(5,6). Using protein affinity purification, here we search for functional partners of TET proteins, and find that TET2 and TET3 associate with O-linked beta-N-acetylglucosamine (O-GlcNAc) transferase (OGT), an enzyme that by itself catalyses the addition of O-GlcNAc onto serine and threonine residues (O-GlcNAcylation) in vivo(7,8). TET2 directly interacts with OGT, which is important for the chromatin association of OGT in vivo. Although this specific interaction does not regulate the enzymatic activity of TET2, it facilitates OGT-dependent histone O-GlcNAcylation. Moreover, OGT associates with TET2 at transcription start sites. Downregulation of TET2 reduces the amount of histone 2B Ser 112 GlcNAc marks in vivo, which are associated with gene transcription regulation. Taken together, these results reveal a TET2-dependent O-GlcNAcylation of chromatin. The double epigenetic modifications on both DNA and histones by TET2 and OGT coordinate together for the regulation of gene transcription.	[Chen, Qiang; Chen, Yibin; Bian, Chunjing; Yu, Xiaochun] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Fujiki, Ryoji] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; [Fujiki, Ryoji] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Michigan System; University of Michigan; University of Tokyo; Japan Science & Technology Agency (JST)	Yu, XC (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, 1150 W Med Ctr Dr,5560A MSRBII, Ann Arbor, MI 48109 USA.	xiayu@med.umich.edu	chen, qiang/G-5031-2016; Chen, Yibin/L-3533-2014; Chen, Yibin/A-3019-2015	Chen, Yibin/0000-0003-1060-9373	National Institutes of Health [CA132755, CA130899]; University of Michigan Cancer Center; GI Peptide Research Center; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA132755, R01CA130899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Cancer Center(University of Michigan System); GI Peptide Research Center; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank H. Kuang for proofreading the manuscript and J. Hutchins for research support. This work was supported by the National Institutes of Health (CA132755 and CA130899 to X.Y.), the University of Michigan Cancer Center and GI Peptide Research Center. X.Y. is a recipient of the Era of Hope Scholar Award from the Department of Defense.	Borst P, 2008, ANNU REV MICROBIOL, V62, P235, DOI 10.1146/annurev.micro.62.081307.162750; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Robinson KA, 2007, AM J PHYSIOL-ENDOC M, V292, pE884, DOI 10.1152/ajpendo.00569.2006; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Vosseller K, 2002, CURR OPIN CHEM BIOL, V6, P851, DOI 10.1016/S1367-5931(02)00384-8; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang Z, 2011, STEM CELLS DEV, V20, P259, DOI 10.1089/scd.2010.0072; Zhang SS, 2011, J BIOL CHEM, V286, P37483, DOI 10.1074/jbc.M111.284885	35	366	383	2	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2013	493	7433					561	+		10.1038/nature11742	http://dx.doi.org/10.1038/nature11742			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23222540	Green Accepted			2022-12-28	WOS:000313871400044
J	Paige, DA; Siegler, MA; Harmon, JK; Neumann, GA; Mazarico, EM; Smith, DE; Zuber, MT; Harju, E; Delitsky, ML; Solomon, SC				Paige, David A.; Siegler, Matthew A.; Harmon, John K.; Neumann, Gregory A.; Mazarico, Erwan M.; Smith, David E.; Zuber, Maria T.; Harju, Ellen; Delitsky, Mona L.; Solomon, Sean C.			Thermal Stability of Volatiles in the North Polar Region of Mercury	SCIENCE			English	Article							COMET HALLEY; POLES; ICE; DEPOSITS; WATER; MOON	Thermal models for the north polar region of Mercury, calculated from topographic measurements made by the MErcury Surface, Space ENvironment, GEochemistry, and Ranging (MESSENGER) spacecraft, show that the spatial distribution of regions of high radar backscatter is well matched by the predicted distribution of thermally stable water ice. MESSENGER measurements of near-infrared surface reflectance indicate bright surfaces in the coldest areas where water ice is predicted to be stable at the surface, and dark surfaces within and surrounding warmer areas where water ice is predicted to be stable only in the near subsurface. We propose that the dark surface layer is a sublimation lag deposit that may be rich in impact-derived organic material.	[Paige, David A.; Siegler, Matthew A.; Harju, Ellen] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Siegler, Matthew A.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Harmon, John K.] Natl Astron & Ionosphere Ctr, Arecibo, PR 00612 USA; [Neumann, Gregory A.; Mazarico, Erwan M.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Smith, David E.; Zuber, Maria T.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Delitsky, Mona L.] Calif Specialty Engn, Flintridge, CA 91012 USA; [Solomon, Sean C.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Solomon, Sean C.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	University of California System; University of California Los Angeles; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Massachusetts Institute of Technology (MIT); Carnegie Institution for Science; Columbia University	Paige, DA (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA.	dap@moon.ucla.edu	Mazarico, Erwan/N-6034-2014; Neumann, Gregory A/I-5591-2013	Mazarico, Erwan/0000-0003-3456-427X; Neumann, Gregory A/0000-0003-0644-9944	NASA [NNX07AR64G, NAS5-97271, NASW-00002]	NASA(National Aeronautics & Space Administration (NASA))	Supported by NASA grant NNX07AR64G. We thank L. Carter, A. McEwen, D. Schriver, and M. Slade for assistance with this research. The MESSENGER project is supported by the NASA Discovery Program under contract NAS5-97271 to The Johns Hopkins University Applied Physics Laboratory and NASW-00002 to the Carnegie Institution of Washington. MESSENGER data used in this study are available through the NASA Planetary Data System Geosciences Node. Arecibo radar data used in this study are available at www.naic.edu/~radarusr/Mercpole.	Bell J.F., 1989, ASTEROIDS, P921; Colaprete A, 2010, SCIENCE, V330, P463, DOI 10.1126/science.1186986; Crider D, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022689; Cruikshank DP, 1998, ICARUS, V135, P389, DOI 10.1006/icar.1998.5997; Cruikshank DP, 2003, EARTH MOON PLANETS, V92, P315, DOI 10.1023/B:MOON.0000031948.39136.7d; GRADIE J, 1980, NATURE, V283, P840, DOI 10.1038/283840a0; Harmon JK, 2007, SPACE SCI REV, V132, P307, DOI 10.1007/s11214-007-9234-y; Harmon JK, 2011, ICARUS, V211, P37, DOI 10.1016/j.icarus.2010.08.007; Johnson R. E., 1991, ENRICO FERMI SERIES, P129; JOHNSON RE, 1991, J GEOPHYS RES-PLANET, V96, P17553, DOI 10.1029/91JE01743; JOHNSON RE, 1987, ASTRON ASTROPHYS, V187, P889; Keller H.U., 2001, CENTURY SPACE SCI, V2, P1235; LANZEROTTI LJ, 1987, J GEOPHYS RES, V92, P14949, DOI 10.1029/JA092iA13p14949; Lawrence DJ, 2013, SCIENCE, V339, P292, DOI 10.1126/science.1229953; Lucey PG, 2000, P SOC PHOTO-OPT INS, V4137, P84, DOI 10.1117/12.411612; Margot JL, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004161; MITCHELL DL, 1992, ICARUS, V98, P125, DOI 10.1016/0019-1035(92)90213-Q; MORGAN TH, 1991, J GEOPHYS RES-SPACE, V96, P1351, DOI 10.1029/90JA02127; Mouawad N, 2011, ICARUS, V211, P21, DOI 10.1016/j.icarus.2010.10.019; Neumann GA, 2013, SCIENCE, V339, P296, DOI 10.1126/science.1229764; PAIGE DA, 1992, SCIENCE, V258, P643, DOI 10.1126/science.258.5082.643; Paige DA, 2010, SCIENCE, V330, P479, DOI 10.1126/science.1187726; Paillou P, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035216; PEALE SJ, 1974, ASTRON J, V79, P722, DOI 10.1086/111604; SAGDEEV RZ, 1986, NATURE, V321, P262, DOI 10.1038/321262a0; Schorghofer N, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002779; Siegler MA, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003652; SLADE MA, 1992, SCIENCE, V258, P635, DOI 10.1126/science.258.5082.635; Slavin JA, 2009, SCIENCE, V324, P606, DOI 10.1126/science.1172011; SOTER S, 1967, NATURE, V214, P1315, DOI 10.1038/2141315a0; SPRAGUE AL, 1995, ICARUS, V118, P211, DOI 10.1006/icar.1995.1186; TEDESCO EF, 1989, ASTRON J, V97, P580, DOI 10.1086/115007; Vasavada AR, 1999, ICARUS, V141, P179, DOI 10.1006/icar.1999.6175; Zhang JA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041806; Zhang JA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038614; Zuber MT, 2012, SCIENCE, V336, P217, DOI 10.1126/science.1218805	36	80	82	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2013	339	6117					300	303		10.1126/science.1231106	http://dx.doi.org/10.1126/science.1231106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23196905				2022-12-28	WOS:000313622000038
J	Nejad, SH; Schaefer, PW; Bajwa, EK; Smith, FA				Nejad, Shamim H.; Schaefer, Pamela W.; Bajwa, Ednan K.; Smith, Felicia A.			Case 39-2012: A 55-Year-Old Man with Alcoholism, Recurrent Seizures, and Agitation Delirium (alcohol withdrawal delirium and multifactorial delirium).	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYNDROME PRACTICE GUIDELINE		[Nejad, Shamim H.; Smith, Felicia A.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Schaefer, Pamela W.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Bajwa, Ednan K.] Massachusetts Gen Hosp, Dept Pulm & Crit Care, Boston, MA 02114 USA; [Nejad, Shamim H.; Smith, Felicia A.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Schaefer, Pamela W.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Bajwa, Ednan K.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Nejad, SH (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.		Schaefer, Pamela/AAA-1323-2019	Bajwa, Ednan/0000-0001-9026-1009				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BALLENGER JC, 1978, BRIT J PSYCHIAT, V133, P1, DOI 10.1192/bjp.133.1.1; Becker HC, 1996, ALCOHOL CLIN EXP RES, V20, pA121, DOI 10.1111/j.1530-0277.1996.tb01760.x; Beghi E, 2010, EPILEPSIA, V51, P671, DOI 10.1111/j.1528-1167.2009.02285.x; Gold JA, 2007, CRIT CARE MED, V35, P724, DOI 10.1097/01.CCM.0000256841.28351.80; Hughes JR, 2009, EPILEPSY BEHAV, V15, P92, DOI 10.1016/j.yebeh.2009.02.037; McKeon A, 2008, J NEUROL NEUROSUR PS, V79, P854, DOI 10.1136/jnnp.2007.128322; NTAIS C, 2005, COCHRANE DB SYST REV, V3; Stanley KM, 2005, PHARMACOTHERAPY, V25, P1073, DOI 10.1592/phco.2005.25.8.1073; Stanley KM, 2003, PHARMACOTHERAPY, V23, P843, DOI 10.1592/phco.23.7.843.32719; Trzepacz PT., 2011, TXB PSYCHOSOMATIC ME	11	0	0	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2012	367	25					2428	2434		10.1056/NEJMcpc1114035	http://dx.doi.org/10.1056/NEJMcpc1114035			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056ZP	23252529				2022-12-28	WOS:000312531600012
J	Kneebone, R; Woods, A				Kneebone, Roger; Woods, Abigail			CHRISTMAS 2012: EVOLUTION OF PRACTICE Bringing surgical history to life	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISTRIBUTED-SIMULATION		[Kneebone, Roger; Woods, Abigail] Univ London Imperial Coll Sci Technol & Med, London W2 1NY, England	Imperial College London	Kneebone, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, London W2 1NY, England.	r.kneebone@imperial.ac.uk			Wellcome Trust [095998] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Hartley LP., 1953, GO; Kassab E, 2012, SIMUL HEALTHC, V7, P155, DOI 10.1097/SIH.0b013e31824a86db; Kassab E, 2011, ANN SURG, V254, P1059, DOI 10.1097/SLA.0b013e318228944a; Kneebone R, 2010, QUAL SAF HEALTH CARE, V19, pI47, DOI 10.1136/qshc.2010.042424; Kneebone R, 2010, MED TEACH, V32, P65, DOI 10.3109/01421590903419749; MAINGOT R, 1980, ABDOMINAL OPERATIONS	6	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 18	2012	345								e8135	10.1136/bmj.e8135	http://dx.doi.org/10.1136/bmj.e8135			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IW	23249666	Green Accepted			2022-12-28	WOS:000312698900012
J	Chan, M				Chan, Margaret			From new estimates to better data	LANCET			English	Editorial Material									WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	Chan, M (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	porria@who.int						Chan M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000223	1	40	41	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2012	380	9859					2054	2054		10.1016/S0140-6736(12)62135-7	http://dx.doi.org/10.1016/S0140-6736(12)62135-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23245596				2022-12-28	WOS:000312387000003
J	Horton, R				Horton, Richard			GBD 2010: understanding disease, injury, and risk	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Rodin J, 2012, LANCET, V380, P861, DOI 10.1016/S0140-6736(12)61340-3	1	174	184	0	54	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 15	2012	380	9859					2053	2054		10.1016/S0140-6736(12)62133-3	http://dx.doi.org/10.1016/S0140-6736(12)62133-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23245595				2022-12-28	WOS:000312387000002
J	O'Connor, TJ; Boyd, D; Dorer, MS; Isberg, RR				O'Connor, Tamara J.; Boyd, Dana; Dorer, Marion S.; Isberg, Ralph R.			Aggravating Genetic Interactions Allow a Solution to Redundancy in a Bacterial Pathogen	SCIENCE			English	Article							LEGIONELLA-PNEUMOPHILA GENOME; RAB GTPASE FUNCTION; ENDOPLASMIC-RETICULUM; IDENTIFICATION; MACROPHAGES; SYSTEM	Interactions between hosts and pathogens are complex, so understanding the events that govern these interactions requires the analysis of molecular mechanisms operating in both organisms. Many pathogens use multiple strategies to target a single event in the disease process, confounding the identification of the important determinants of virulence. We developed a genetic screening strategy called insertional mutagenesis and depletion (iMAD) that combines bacterial mutagenesis and RNA interference, to systematically dissect the interplay between a pathogen and its host. We used this technique to resolve the network of proteins secreted by the bacterium Legionella pneumophila to promote intracellular growth, a critical determinant of pathogenicity of this organism. This strategy is broadly applicable, allowing the dissection of any interface between two organisms involving numerous interactions.	[O'Connor, Tamara J.; Dorer, Marion S.; Isberg, Ralph R.] Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02111 USA; [O'Connor, Tamara J.; Dorer, Marion S.; Isberg, Ralph R.] Tufts Univ, Sch Med, Dept Mol Microbiol & Microbiol, Boston, MA 02111 USA; [Boyd, Dana] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Tufts University; Tufts University; Harvard University; Harvard Medical School	Isberg, RR (corresponding author), Tufts Univ, Sch Med, Howard Hughes Med Inst, 150 Harrison Ave, Boston, MA 02111 USA.	ralph.isberg@tufts.edu			Howard Hughes Medical Institute; Natalie V. Zucker Fellowship; NIH [GMO41883]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041883] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Natalie V. Zucker Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Rubin and C. Sassetti for helpful advice regarding the TraSH protocol, plasmids, and equipment use; J. Vogel for plasmids; K. Bodi, TUCF genomics core facility, and A. Ensminger for scientific advice with genome sequencing protocols and analyses; and A. Camilli for equipment use. We thank D. Daigle, K. Davis, E. Haenssler, A. Hempstead, D. DeJesus, S. Mohammadi, and E. Creasey for reviewing the manuscript. This work was supported by the Howard Hughes Medical Institute (T.J.O. and M. S. D.), a Natalie V. Zucker Fellowship (T.J.O.), and NIH grant GMO41883 (D. B.). R. R. I. is an investigator of the Howard Hughes Medical Institute.	Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; BRAND BC, 1994, MOL MICROBIOL, V14, P797, DOI 10.1111/j.1365-2958.1994.tb01316.x; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Creasey EA, 2012, P NATL ACAD SCI USA, V109, P3481, DOI 10.1073/pnas.1121286109; Dorer MS, 2006, PLOS PATHOG, V2, P315, DOI 10.1371/journal.ppat.0020034; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Kvitko BH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000388; Laguna RK, 2006, P NATL ACAD SCI USA, V103, P18745, DOI 10.1073/pnas.0609012103; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Monnat J, 2000, MOL BIOL CELL, V11, P3469, DOI 10.1091/mbc.11.10.3469; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Nguyen TMN, 2006, J INFECT DIS, V193, P102, DOI 10.1086/498575; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Paz I, 2010, CELL MICROBIOL, V12, P530, DOI 10.1111/j.1462-5822.2009.01415.x; Robinson CG, 2006, CELL MICROBIOL, V8, P793, DOI 10.1111/j.1462-5822.2005.00666.x; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Swanson MS, 1996, INFECT IMMUN, V64, P2585, DOI 10.1128/IAI.64.7.2585-2594.1996; Tilney LG, 2001, J CELL SCI, V114, P4637; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	27	86	86	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1440	1444		10.1126/science.1229556	http://dx.doi.org/10.1126/science.1229556			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239729	Green Accepted			2022-12-28	WOS:000312250800040
J	Moses, H; Dorsey, ER				Moses, Hamilton; Dorsey, E. Ray			Biomedical Research in an Age of Austerity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Moses, Hamilton] Alerion Inst, N Garden, VA 22959 USA; [Moses, Hamilton; Dorsey, E. Ray] Johns Hopkins Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Moses, H (corresponding author), Alerion Inst, N Garden, VA 22959 USA.	hm@alerion.us						2012 Pharmaceutical Industry Profile, 2012, 2012 PHARM IND PROF; Dorsey ER, 2010, JAMA-J AM MED ASSOC, V303, P137, DOI 10.1001/jama.2009.1987; Federal Obligations for Research and Development, FED OBL RES DEV CHAR; Fineberg HV, 2012, NEW ENGL J MED, V366, P1020, DOI 10.1056/NEJMsa1114777; Ledford H, 2010, NATURE, V464, P1258, DOI 10.1038/4641258a; Moses H, 2001, JAMA-J AM MED ASSOC, V285, P933, DOI 10.1001/jama.285.7.933; Moses H, 2011, NEW ENGL J MED, V364, P567, DOI 10.1056/NEJMsb1007634; Orszag PR, 2010, NEW ENGL J MED, V363, P601, DOI 10.1056/NEJMp1006571	8	26	27	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 12	2012	308	22					2341	2342		10.1001/jama.2012.14846	http://dx.doi.org/10.1001/jama.2012.14846			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051MW	23240142				2022-12-28	WOS:000312132400021
J	Daley, GQ				Daley, George Q.			Cellular Alchemy and the Golden Age of Reprogramming	CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; NUCLEAR TRANSPLANTATION; PARKINSONIAN MICE; DEFINED FACTORS; SOMATIC-CELLS; FIBROBLASTS	The 2012 Nobel Prize in Medicine or Physiology recognizes the architects of two of the great paradigm-shifting discoveries of the last half-century of biology. In experiments performed nearly 50 years apart, Gurdon and Yamanaka made feasible the reawakening of pluripotency inherent in all cells and challenged forever our notions of cellular identity.	[Daley, George Q.] Childrens Hosp, Howard Hughes Med Inst, Manton Ctr Orphan Dis Res, Div Pediat Hematol Oncol,Stem Cell Transplantat P, Boston, MA 02115 USA; [Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Daley, George Q.] Broad Inst, Boston, MA 02115 USA; [Daley, George Q.] Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Daley, GQ (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Manton Ctr Orphan Dis Res, Div Pediat Hematol Oncol,Stem Cell Transplantat P, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P8048, DOI 10.1073/pnas.1337135100; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; GURDON JB, 1966, NATURE, V210, P1240, DOI 10.1038/2101240a0; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hyun I, 2007, CELL STEM CELL, V1, P367, DOI 10.1016/j.stem.2007.09.006; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Tabar V, 2008, NAT MED, V14, P379, DOI 10.1038/nm1732; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	20	15	16	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1151	1154		10.1016/j.cell.2012.11.016	http://dx.doi.org/10.1016/j.cell.2012.11.016			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217698	Bronze			2022-12-28	WOS:000311999900002
J	Gao, L; Shao, L; Higgins, CD; Poulton, JS; Peifer, M; Davidson, MW; Wu, XF; Goldstein, B; Betzig, E				Gao, Liang; Shao, Lin; Higgins, Christopher D.; Poulton, John S.; Peifer, Mark; Davidson, Michael W.; Wu, Xufeng; Goldstein, Bob; Betzig, Eric			Noninvasive Imaging beyond the Diffraction Limit of 3D Dynamics in Thickly Fluorescent Specimens	CELL			English	Article							STRUCTURED ILLUMINATION MICROSCOPY; PLANE ILLUMINATION; ADAPTIVE OPTICS; MOUSE-BRAIN; C. ELEGANS; RESOLUTION; CELLS; LIVE; BIOLOGY; LIGHT	Optical imaging of the dynamics of living specimens involves tradeoffs between spatial resolution, temporal resolution, and phototoxicity, made more difficult in three dimensions. Here, however, we report that rapid three-dimensional (3D) dynamics can be studied beyond the diffraction limit in thick or densely fluorescent living specimens over many time points by combining ultrathin planar illumination produced by scanned Bessel beams with super-resolution structured illumination microscopy. We demonstrate in vivo karyotyping of chromosomes during mitosis and identify different dynamics for the actin cytoskeleton at the dorsal and ventral surfaces of fibroblasts. Compared to spinning disk confocal microscopy, we demonstrate substantially reduced photodamage when imaging rapid morphological changes in D. discoideum cells, as well as improved contrast and resolution at depth within developing C. elegans embryos. Bessel beam structured plane illumination thus promises new insights into complex biological phenomena that require 4D subcellular spatiotemporal detail in either a single or multicellular context.	[Gao, Liang; Shao, Lin; Betzig, Eric] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Higgins, Christopher D.; Poulton, John S.; Peifer, Mark; Goldstein, Bob] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Wu, Xufeng] NHLBI, NIH, Bethesda, MD 20892 USA; [Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32310 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); State University System of Florida; Florida State University; State University System of Florida; Florida State University	Betzig, E (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	betzige@janelia.hhmi.org		Peifer, Mark/0000-0003-1412-3987; Goldstein, Bob/0000-0001-6961-675X	NIH [R01-GM083071, R01-GM67236]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083071, R01GM067236] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the following Janelia Farm researchers: Thomas Planchon and Bi-Chang Chen for their help with the instrument; Helen White and Sarah Winfrey for cell culture and transfection; Aliosha Nern and Phuson Hulamm for the D. melanogaster brain sample; and Hanchuan Peng for the C. elegans L1 larva. We also thank Dan Milkie of Coleman Technologies, Chadds Ford, PA for custom instrument control software; Goeh Jung of the NHLBI/NIH for the D. discoideum specimen; and Jennifer Lippincott-Schwartz and John Hammer of the NIH for valuable suggestions. B.G. acknowledges the support of NIH R01-GM083071. J.S.P. and M.P. acknowledge the support of NIH R01-GM67236.	Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Booth MJ, 2007, PHILOS T R SOC A, V365, P2829, DOI 10.1098/rsta.2007.0013; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Fiolka R, 2012, P NATL ACAD SCI USA, V109, P5311, DOI 10.1073/pnas.1119262109; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Huisken J, 2009, DEVELOPMENT, V136, P1963, DOI 10.1242/dev.022426; Ji N, 2010, NAT METHODS, V7, P141, DOI 10.1038/NMETH.1411; Khodjakov A, 2006, METHODS, V38, P2, DOI 10.1016/j.ymeth.2005.07.007; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; Long FH, 2009, NAT METHODS, V6, P667, DOI [10.1038/NMETH.1366, 10.1038/nmeth.1366]; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Murray JI, 2008, NAT METHODS, V5, P703, DOI 10.1038/nmeth.1228; Neil MAA, 1997, OPT LETT, V22, P1905, DOI 10.1364/OL.22.001905; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Pohl C, 2010, DEV CELL, V19, P402, DOI 10.1016/j.devcel.2010.08.014; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Schroeder T, 2011, NAT METHODS, V8, pS30, DOI [10.1038/NMETH.1577, 10.1038/nmeth.1577]; Scott EK, 2002, J COMP NEUROL, V454, P470, DOI 10.1002/cne.10467; Shao L, 2011, NAT METHODS, V8, P1044, DOI [10.1038/NMETH.1734, 10.1038/nmeth.1734]; Stephens DJ, 2003, SCIENCE, V300, P82, DOI 10.1126/science.1082160; York AG, 2012, NAT METHODS, V9, P749, DOI [10.1038/NMETH.2025, 10.1038/nmeth.2025]; Zanacchi FC, 2011, NAT METHODS, V8, P1047, DOI [10.1038/NMETH.1744, 10.1038/nmeth.1744]	28	235	244	7	197	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1370	1385		10.1016/j.cell.2012.10.008	http://dx.doi.org/10.1016/j.cell.2012.10.008			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217717	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000311999900024
J	Jaeger, PA; Doherty, C; Ideker, T				Jaeger, Philipp A.; Doherty, Colleen; Ideker, Trey			Modeling Transcriptome Dynamics in a Complex World	CELL			English	Editorial Material							ARABIDOPSIS; LANDSCAPE; PHENOTYPE; NETWORKS; YEAST	An accurate prediction of how extrinsic stimuli influence changes in gene expression has been challenging. In this issue, Nagano and colleagues successfully model genome-wide mRNA expression changes under variable environmental conditions in rice, raising hopes that scientists will soon be able to predict genome-wide transcriptional responses in a variety of organisms in uncontrolled real-world settings.	[Jaeger, Philipp A.; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Jaeger, Philipp A.; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Doherty, Colleen] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Ideker, T (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	trey.ideker@gmail.com	Jaeger, Philipp/H-8377-2012	Jaeger, Philipp/0000-0002-3624-0802; Ideker, Trey/0000-0002-1708-8454				Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Ferrier T, 2011, CURR OPIN BIOTECH, V22, P260, DOI 10.1016/j.copbio.2010.11.010; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nagano AJ, 2012, CELL, V151, P1358, DOI 10.1016/j.cell.2012.10.048; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Walley JW, 2010, J INTEGR PLANT BIOL, V52, P354, DOI 10.1111/j.1744-7909.2010.00940.x	14	10	11	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1161	1162		10.1016/j.cell.2012.11.031	http://dx.doi.org/10.1016/j.cell.2012.11.031			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217702	Bronze			2022-12-28	WOS:000311999900006
J	Karesh, WB; Dobson, A; Lloyd-Smith, JO; Lubroth, J; Dixon, MA; Bennett, M; Aldrich, S; Harrington, T; Formenty, P; Loh, EH; Machalaba, CC; Thomas, MJ; Heymann, DL				Karesh, William B.; Dobson, Andy; Lloyd-Smith, James O.; Lubroth, Juan; Dixon, Matthew A.; Bennett, Malcolm; Aldrich, Stephen; Harrington, Todd; Formenty, Pierre; Loh, Elizabeth H.; Machalaba, Catherine C.; Thomas, Mathew Jason; Heymann, David L.			Zoonoses 1 Ecology of zoonoses: natural and unnatural histories	LANCET			English	Article							EMERGING INFECTIOUS-DISEASES; ANTIBIOTIC-RESISTANCE; HUMAN HEALTH; COMPETITIVE-EXCLUSION; ESCHERICHIA-COLI; GLOBAL TRENDS; EMERGENCE; DYNAMICS; POPULATIONS; WILDLIFE	More than 60% of human infectious diseases are caused by pathogens shared with wild or domestic animals. Zoonotic disease organisms include those that are endemic in human populations or enzootic in animal populations with frequent cross-species transmission to people. Some of these diseases have only emerged recently. Together, these organisms are responsible for a substantial burden of disease, with endemic and enzootic zoonoses causing about a billion cases of illness in people and millions of deaths every year. Emerging zoonoses are a growing threat to global health and have caused hundreds of billions of US dollars of economic damage in the past 20 years. We aimed to review how zoonotic diseases result from natural pathogen ecology, and how other circumstances, such as animal production, extraction of natural resources, and antimicrobial application change the dynamics of disease exposure to human beings. In view of present anthropogenic trends, a more effective approach to zoonotic disease prevention and control will require a broad view of medicine that emphasises evidence-based decision making and integrates ecological and evolutionary principles of animal, human, and environmental factors. This broad view is essential for the successful development of policies and practices that reduce probability of future zoonotic emergence, targeted surveillance and strategic prevention, and engagement of partners outside the medical community to help improve health outcomes and reduce disease threats.	[Karesh, William B.; Loh, Elizabeth H.; Machalaba, Catherine C.] EcoHlth Alliance, New York, NY 10001 USA; [Karesh, William B.] IUCN Species Survival Commiss, Wildlife Hlth Specialist Grp, Gland, Switzerland; [Karesh, William B.] World Org Anim Hlth Working Grp Wildlife Dis, Paris, France; [Dobson, Andy] Princeton Univ, Princeton, NJ 08544 USA; [Dobson, Andy] Santa Fe Inst, Santa Fe, NM 87501 USA; [Lloyd-Smith, James O.] Univ Calif Los Angeles, Los Angeles, CA USA; [Lloyd-Smith, James O.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Lubroth, Juan] Food & Agr Org UN, Anim Hlth Serv, Rome, Italy; [Dixon, Matthew A.; Heymann, David L.] Chatham House Ctr Global Hlth Secur, London, England; [Bennett, Malcolm] Univ Liverpool, Inst Infect & Global Hlth, Sch Vet Sci, Leahurst, Neston, England; [Aldrich, Stephen; Harrington, Todd] Bioecon Res Associates Bioera, Stockbridge, VT USA; [Formenty, Pierre] WHO, Strategies Epidem & Emerging Dis Pandem & Epidem, CH-1211 Geneva, Switzerland; [Thomas, Mathew Jason] US Dept HHS, Int Influenza Unit, Off Global Affairs, Washington, DC 20201 USA; [Heymann, David L.] London Sch Hyg & Trop Med, London WC1, England	EcoHealth Alliance; Princeton University; The Santa Fe Institute; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Food & Agriculture Organization of the United Nations (FAO); University of Liverpool; World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Karesh, WB (corresponding author), EcoHlth Alliance, 460 W 34th St, New York, NY 10001 USA.	karesh@ecohealthalliance.org	/K-4080-2012; Lloyd-Smith, James/AAG-4463-2021; Dixon, Matthew A/ABE-9187-2021; Karesh, William/AAU-9084-2020; Bennett, Malcolm/G-4004-2010	/0000-0001-7941-502X; Dixon, Matthew A/0000-0002-1710-6237; Karesh, William/0000-0001-6042-2860; Bennett, Malcolm/0000-0003-0475-390X; Bennett, Malcolm/0000-0002-5490-2910	US Agency for International Development (USAID) Emerging Pandemic Threats programme PREDICT; US National Science Foundation [EF-0928690]; De Logi Chair in Biological Sciences; Research and Policy for Infectious Disease Dynamics programme of the Science and Technology Directorate; Department of Homeland Security; Fogarty International Center, National Institutes of Health	US Agency for International Development (USAID) Emerging Pandemic Threats programme PREDICT(United States Agency for International Development (USAID)); US National Science Foundation(National Science Foundation (NSF)); De Logi Chair in Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Research and Policy for Infectious Disease Dynamics programme of the Science and Technology Directorate; Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	WBK, EL, and CM were funded by the US Agency for International Development (USAID) Emerging Pandemic Threats programme PREDICT. Support for economic assessments provided by SA and TH was provided by the Public Health Agency of Canada and the Canadian Ministry of Health. JOL-S is supported by US National Science Foundation grant EF-0928690, the De Logi Chair in Biological Sciences, and the Research and Policy for Infectious Disease Dynamics programme of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. We thank James Newcomb, Robert Carlson, and Alex Thiermann for their input, and the anonymous reviewers for their detailed critiques and valuable suggestions. The contents are the responsibility of the authors and do not necessarily reflect the views of the governments of the USA, UK, or Canada.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Andersson DI, 2011, FEMS MICROBIOL REV, V35, P901, DOI 10.1111/j.1574-6976.2011.00289.x; [Anonymous], 1999, LIVESTOCK 2020 NEXT; [Anonymous], [No title captured]; Anyamba A, 2009, P NATL ACAD SCI USA, V106, P955, DOI 10.1073/pnas.0806490106; Bal AM, 2011, CURR OPIN INFECT DIS, V24, P357, DOI 10.1097/QCO.0b013e3283483262; Barton MD, 2000, NUTR RES REV, V13, P279, DOI 10.1079/095442200108729106; Callaway T. R., 2008, Animal Health Research Reviews, V9, P217, DOI 10.1017/S1466252308001540; Callaway TR, 2009, CURR ISSUES MOL BIOL, V11, P67; Cobey S, 2012, SCIENCE, V335, P1376, DOI 10.1126/science.1215947; Coker R, 2011, LANCET INFECT DIS, V11, P326, DOI 10.1016/S1473-3099(10)70312-1; Craig PS, 2006, PARASITOL INT, V55, pS221, DOI 10.1016/j.parint.2005.11.034; Crhanova M, 2011, INFECT IMMUN, V79, P2755, DOI 10.1128/IAI.01375-10; D'Costa VM, 2007, CURR OPIN MICROBIOL, V10, P481, DOI 10.1016/j.mib.2007.08.009; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davis MF, 2011, CURR OPIN MICROBIOL, V14, P244, DOI 10.1016/j.mib.2011.04.003; Dobson A, 2003, SCIENCE, V301, P1488, DOI 10.1126/science.1090481; Dobson AP, 1996, BIOSCIENCE, V46, P115, DOI 10.2307/1312814; Fisher RA, 1930, NATURE, V126, P805, DOI 10.1038/126805a0; Ford J, 1971, ROLE TYPANOSOMIASIS; Gilchrist MJ, 2007, ENVIRON HEALTH PERSP, V115, P313, DOI 10.1289/ehp.8837; Gilliver MA, 1999, NATURE, V401, P233, DOI 10.1038/45724; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Gustafson RH, 1997, J APPL MICROBIOL, V83, P531, DOI 10.1046/j.1365-2672.1997.00280.x; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hawley DM, 2010, J EVOLUTION BIOL, V23, P1680, DOI 10.1111/j.1420-9101.2010.02035.x; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Hjelle B, 2000, J INFECT DIS, V181, P1569, DOI 10.1086/315467; International Livestock Research Institute, 2012, MAPP POV LIK ZOON HO; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Karesh WB, 2005, EMERG INFECT DIS, V11, P1000; Karesh WB, 2005, FOREIGN AFF, V84, P38, DOI 10.2307/20034419; Keiser J, 2009, CLIN MICROBIOL REV, V22, P466, DOI 10.1128/CMR.00012-09; Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Mallon DJP, 2002, EMERG INFECT DIS, V8, P636, DOI 10.3201/eid0806.010247; Manges AR, 2010, J INFECT DIS, V202, P1877, DOI 10.1086/657319; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Mather AE, 2012, P ROY SOC B-BIOL SCI, V279, P1630, DOI 10.1098/rspb.2011.1975; McNeill WilliamH., 1998, PLAGUES PEOPLES; Metcalf CJE, 2011, SCIENCE, V333, P984, DOI 10.1126/science.1204588; Molyneux D, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-106; Molyneux DH, 2006, ADV PARASIT, V61, P1, DOI 10.1016/S0065-308X(05)61001-9; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5; Murdoch W.W., 2013, CONSUMER RESOURCE DY; Newcomb J, 2011, EC IMPACT SELECTED I; Newell DG, 2010, INT J FOOD MICROBIOL, V139, pS3, DOI 10.1016/j.ijfoodmicro.2010.01.021; Parisien A, 2008, J APPL MICROBIOL, V104, P1, DOI 10.1111/j.1365-2672.2007.03498.x; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Poulsen JR, 2009, CONSERV BIOL, V23, P1597, DOI 10.1111/j.1523-1739.2009.01251.x; Pramodh N, 2003, J RURAL REMOTE ENV H, V2, P23; Pulliam JRC, 2012, J R SOC INTERFACE, V9, P89, DOI 10.1098/rsif.2011.0223; Rabinowitz P, 2009, VET ITAL, V45, P23; Relman DA, 2011, NEW ENGL J MED, V365, P347, DOI 10.1056/NEJMra1003071; Rouquet P, 2005, EMERG INFECT DIS, V11, P283, DOI 10.3201/eid1102.040533; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; Rwego IB, 2008, CONSERV BIOL, V22, P1600, DOI 10.1111/j.1523-1739.2008.01018.x; Schneitz C, 2005, FOOD CONTROL, V16, P657, DOI 10.1016/j.foodcont.2004.06.002; Sims LD, 2005, VET REC, V157, P159, DOI 10.1136/vr.157.6.159; Sjolund M, 2008, EMERG INFECT DIS, V14, P70, DOI 10.3201/eid1401.070704; Smith KF, 2005, FRONT ECOL ENVIRON, V3, P29, DOI 10.1890/1540-9295(2005)003[0029:ETTEID]2.0.CO;2; Smolinski M.S., 2003, COMMITTEE EMERGING M; Souza V, 1999, APPL ENVIRON MICROB, V65, P3373; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Torgerson PR, 2011, VET PARASITOL, V182, P79, DOI 10.1016/j.vetpar.2011.07.017; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; WALSH JF, 1993, PARASITOLOGY, V106, pS55, DOI 10.1017/S0031182000086121; Weiss RA, 2004, PHILOS T R SOC B, V359, P1137, DOI 10.1098/rstb.2004.1487; Wilcox B. A., 2006, Unasylva (English ed.), V57, P11; Williams NJ, 2011, J APPL MICROBIOL, DOI 10.1111/j.1365-2672.2011.04952.x; Winkler MS, 2010, ENVIRON IMPACT ASSES, V30, P52, DOI 10.1016/j.eiar.2009.05.005; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Woolhouse MEJ, 2006, MICROBE, V1, P511, DOI 10.1128/microbe.1.511.1; World Health Organization, 2006, WHO CONS DEV STRAT E	77	421	435	12	257	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 1	2012	380	9857					1936	1945		10.1016/S0140-6736(12)61678-X	http://dx.doi.org/10.1016/S0140-6736(12)61678-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	046IK	23200502	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000311758500030
J	Bromm, V				Bromm, Volker			Embers of the Distant Past	SCIENCE			English	Editorial Material							1ST STARS; GALAXIES; UNIVERSE		Univ Texas Austin, Dept Astron, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Bromm, V (corresponding author), Univ Texas Austin, Dept Astron, 2511 Speedway, Austin, TX 78712 USA.	vbromm@astro.as.utexas.edu						Ackermann M, 2012, SCIENCE, V338, P1190, DOI 10.1126/science.1227160; Bromm V, 2006, ASTROPHYS J, V642, P382, DOI 10.1086/500799; Bromm V, 2009, NATURE, V459, P49, DOI 10.1038/nature07990; Campisi MA, 2011, MON NOT R ASTRON SOC, V416, P2760, DOI 10.1111/j.1365-2966.2011.19238.x; Fumagalli M, 2011, SCIENCE, V334, P1245, DOI 10.1126/science.1213581; Hummel JA, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/1/72; Kashlinsky A, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/63; Komatsu E, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/2/18; Mirabel IF, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201016357; Robertson BE, 2010, NATURE, V468, P49, DOI 10.1038/nature09527; Salvaterra R, 2003, MON NOT R ASTRON SOC, V339, P973, DOI 10.1046/j.1365-8711.2003.06244.x; Santos MR, 2002, MON NOT R ASTRON SOC, V336, P1082, DOI 10.1046/j.1365-8711.2002.05895.x; Springel V, 2006, NATURE, V440, P1137, DOI 10.1038/nature04805	14	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 30	2012	338	6111					1160	1161		10.1126/science.1231128	http://dx.doi.org/10.1126/science.1231128			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197522				2022-12-28	WOS:000311666200031
J	Helm, D				Helm, Dieter			The Kyoto approach has failed	NATURE			English	Editorial Material									Univ Oxford, New Coll, Oxford OX1 2JD, England	University of Oxford	Helm, D (corresponding author), Univ Oxford, New Coll, Oxford OX1 2JD, England.	dieter.helm@new.ox.ac.uk						[Anonymous], 2011, MED TERM COAL MARK R; BP, 2021, BPS STAT REV WORLD E; European Commission, 2008, 20 20 2020 EUR CLIM; European Parliament and the Council of the European Union, 2003, OFF J EUR UNION, VL275, P32; Helm D., 2007, TOO GOOD BE TRUE UKS; Helm D., 2012, 80 GRANTH RES I CLIM; Helm D., 2012, CARBON CRUNCH WERE G, P40; MacKay D., 2008, SUSTAINABLE ENERGY H; US Energy Information Administration, 2012, MONTHLY ENERGY R OCT	9	25	26	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 29	2012	491	7426					663	665		10.1038/491663a	http://dx.doi.org/10.1038/491663a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	044FY	23192129	Bronze			2022-12-28	WOS:000311606000016
J	Lawrence, DJ; Feldman, WC; Goldsten, JO; Maurice, S; Peplowski, PN; Anderson, BJ; Bazell, D; McNutt, RL; Nittler, LR; Prettyman, TH; Rodgers, DJ; Solomon, SC; Weider, SZ				Lawrence, David J.; Feldman, William C.; Goldsten, John O.; Maurice, Sylvestre; Peplowski, Patrick N.; Anderson, Brian J.; Bazell, David; McNutt, Ralph L., Jr.; Nittler, Larry R.; Prettyman, Thomas H.; Rodgers, Douglas J.; Solomon, Sean C.; Weider, Shoshana Z.			Evidence for Water Ice Near Mercury's North Pole from MESSENGER Neutron Spectrometer Measurements	SCIENCE			English	Article							LUNAR PROSPECTOR; MOON; SURFACE; REGOLITH; HYDROGEN; DEPOSITS; ELEMENTS; RAY	Measurements by the Neutron Spectrometer on the MErcury Surface, Space ENvironment, GEochemistry, and Ranging (MESSENGER) spacecraft show decreases in the flux of epithermal and fast neutrons from Mercury's north polar region that are consistent with the presence of water ice in permanently shadowed regions. The neutron data indicate that Mercury's radar-bright polar deposits contain, on average, a hydrogen-rich layer more than tens of centimeters thick beneath a surficial layer 10 to 30 cm thick that is less rich in hydrogen. Combined neutron and radar data are best matched if the buried layer consists of nearly pure water ice. The upper layer contains less than 25 weight % water-equivalent hydrogen. The total mass of water at Mercury's poles is inferred to be 2 x 10(16) to 10(18) grams and is consistent with delivery by comets or volatile-rich asteroids.	[Lawrence, David J.; Goldsten, John O.; Peplowski, Patrick N.; Anderson, Brian J.; Bazell, David; McNutt, Ralph L., Jr.; Rodgers, Douglas J.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Feldman, William C.; Prettyman, Thomas H.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Maurice, Sylvestre] Univ Toulouse 3, CNRS, Observ Midi Pyrenees, Inst Rech Astrophys & Planetol, F-31062 Toulouse, France; [Nittler, Larry R.; Solomon, Sean C.; Weider, Shoshana Z.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Solomon, Sean C.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Carnegie Institution for Science; Columbia University	Lawrence, DJ (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	david.j.lawrence@jhuapl.edu	Lawrence, David J/E-7463-2015; McNutt, Ralph L/E-8006-2010; Peplowski, Patrick N/I-7254-2012	Lawrence, David J/0000-0002-7696-6667; McNutt, Ralph L/0000-0002-4722-9166; Peplowski, Patrick N/0000-0001-7154-8143; Weider, Shoshana/0000-0003-1034-909X; Prettyman, Thomas/0000-0003-0072-2831	NASA [NAS5-97271, NASW-00002]; NASA's MESSENGER Participating Scientist Program	NASA(National Aeronautics & Space Administration (NASA)); NASA's MESSENGER Participating Scientist Program	We thank the MESSENGER team for their contributions to the development and operation of the spacecraft, P. G. Lucey and two anonymous reviewers for comments that improved the manuscript, D. Delapp and D. Seagraves of Los Alamos National Laboratory for early help in the data reduction and calibration, respectively, and D. Hurley for discussions regarding surface modification models. This work was supported by the NASA Discovery Program, with funding for MESSENGER provided under contract NAS5-97271 to The Johns Hopkins University Applied Physics Laboratory and NASW-00002 to the Carnegie Institution of Washington. Several authors are supported by NASA's MESSENGER Participating Scientist Program. All original data reported in this paper are archived by the NASA Planetary Data System.	Butler BJ, 1997, J GEOPHYS RES-PLANET, V102, P19283, DOI 10.1029/97JE01347; BUTLER BJ, 1993, J GEOPHYS RES-PLANET, V98, P15003, DOI 10.1029/93JE01581; Carrier I., 1991, LUNAR SOURCEBOOK USE, P475; Chabot NL, 2013, J GEOPHYS RES-PLANET, V118, DOI 10.1029/2012JE004172; Chabot NL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051526; Crider D, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022689; Evans LG, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004178; Feldman WC, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028936; FELDMAN WC, 1986, NUCL INSTRUM METH A, V245, P182, DOI 10.1016/0168-9002(86)90274-3; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Gasnault O, 2001, GEOPHYS RES LETT, V28, P3797, DOI 10.1029/2001GL013072; Glotch TD, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049548; Goldsten JO, 2007, SPACE SCI REV, V131, P339, DOI 10.1007/s11214-007-9262-7; Hagerty JJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002592; Harmon JK, 2011, ICARUS, V211, P37, DOI 10.1016/j.icarus.2010.08.007; Head JW, 2011, SCIENCE, V333, P1853, DOI 10.1126/science.1211997; Ho GC, 2011, SCIENCE, V333, P1865, DOI 10.1126/science.1211141; Lawrence DJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002637; Lawrence DJ, 2011, PLANET SPACE SCI, V59, P1665, DOI 10.1016/j.pss.2011.07.001; Lawrence DJ, 2010, ICARUS, V209, P195, DOI 10.1016/j.icarus.2010.04.005; Lawrence DJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022022; Little RC, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2001JE001497; Maurice S, 2000, J GEOPHYS RES-PLANET, V105, P20365, DOI 10.1029/1999JE001151; Maurice S, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2011JE003810; Moses JI, 1999, ICARUS, V137, P197, DOI 10.1006/icar.1998.6036; Neumann GA, 2013, SCIENCE, V339, P296, DOI 10.1126/science.1229764; Nittler LR, 2011, SCIENCE, V333, P1847, DOI 10.1126/science.1211567; Paige DA, 2013, SCIENCE, V339, P300, DOI 10.1126/science.1231106; Peplowski PN, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004141; Peplowski PN, 2011, SCIENCE, V333, P1850, DOI 10.1126/science.1211576; Prettyman T. H., 2007, ENCY SOLAR SYSTEM, P765; Prettyman TH, 2012, SCIENCE, V338, P242, DOI 10.1126/science.1225354; SLADE MA, 1992, SCIENCE, V258, P635, DOI 10.1126/science.258.5082.635; SPRAGUE AL, 1995, ICARUS, V118, P211, DOI 10.1006/icar.1995.1186; Starukhina LV, 2000, ICARUS, V147, P585, DOI 10.1006/icar.2000.6476; Weider SZ, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004153	36	130	133	1	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2013	339	6117					292	296		10.1126/science.1229953	http://dx.doi.org/10.1126/science.1229953			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23196909				2022-12-28	WOS:000313622000036
J	Fu, WQ; O'Connor, TD; Jun, G; Kang, HM; Abecasis, G; Leal, SM; Gabriel, S; Altshuler, D; Shendure, J; Nickerson, DA; Bamshad, MJ; Akey, JM				Fu, Wenqing; O'Connor, Timothy D.; Jun, Goo; Kang, Hyun Min; Abecasis, Goncalo; Leal, Suzanne M.; Gabriel, Stacey; Altshuler, David; Shendure, Jay; Nickerson, Deborah A.; Bamshad, Michael J.; Akey, Joshua M.		NHLBI Exome Sequencing Project	Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants	NATURE			English	Article							POPULATION-GROWTH; RARE; MUTATIONS; DISEASE; GENE; EVOLUTION; HISTORY; EXCESS; AGE	Establishing the age of each mutation segregating in contemporary human populations is important to fully understand our evolutionary history(1,2) and will help to facilitate the development of new approaches for disease-gene discovery(3). Large-scale surveys of human genetic variation have reported signatures of recent explosive population growth(4-6), notable for an excess of rare genetic variants, suggesting that many mutations arose recently. To more quantitatively assess the distribution of mutation ages, we resequenced 15,336 genes in 6,515 individuals of European American and African American ancestry and inferred the age of 1,146,401 autosomal single nucleotide variants (SNVs). We estimate that approximately 73% of all protein-coding SNVs and approximately 86% of SNVs predicted to be deleterious arose in the past 5,000-10,000 years. The average age of deleterious SNVs varied significantly across molecular pathways, and disease genes contained a significantly higher proportion of recently arisen deleterious SNVs than other genes. Furthermore, European Americans had an excess of deleterious variants in essential and Mendelian disease genes compared to African Americans, consistent with weaker purifying selection due to the Out-of-Africa dispersal. Our results better delimit the historical details of human protein-coding variation, show the profound effect of recent human history on the burden of deleterious SNVs segregating in contemporary populations, and provide important practical information that can be used to prioritize variants in disease-gene discovery.	[Fu, Wenqing; O'Connor, Timothy D.; Shendure, Jay; Nickerson, Deborah A.; Bamshad, Michael J.; Akey, Joshua M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Jun, Goo; Kang, Hyun Min; Abecasis, Goncalo] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gabriel, Stacey; Altshuler, David] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Baylor College of Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Washington; University of Washington Seattle	Fu, WQ (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	wqfu@u.washington.edu; akeyj@u.washington.edu	Singleton, Andrew B/C-3010-2009; de Bakker, Paul IW/B-8730-2009; Jun, Goo/F-1941-2017; Jun, Goo/M-5235-2016; Abecasis, Goncalo R/B-7840-2010; Altshuler, David M/A-4476-2009; Shendure, Jay/AAU-3684-2021	de Bakker, Paul IW/0000-0001-7735-7858; Jun, Goo/0000-0003-0891-0204; Jun, Goo/0000-0003-0891-0204; Altshuler, David M/0000-0002-7250-4107; Shendure, Jay/0000-0002-1516-1865; Bustamante, Carlos D./0000-0002-4187-7920; Quinlan, Aaron/0000-0003-1756-0859; Ballantyne, Christie/0000-0002-6432-1730; Turner, Emily/0000-0001-9040-9229; Abecasis, Goncalo/0000-0003-1509-1825; Akey, Joshua/0000-0002-4411-1330; Seshadri, Sudha/0000-0001-6135-2622; Caan, Bette/0000-0002-5803-310X; O'Connor, Timothy/0000-0002-0276-1896	National Heart, Lung and Blood Institute (NHLBI); NHLBI [RC2 HL-103010, RC2 HL-102923, RC2 HL-102924, RC2 HL-102925, RC2 HL-102926]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102923, RC2HL102926, RC2HL102924, RC2HL102925, RC2HL103010] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006513] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We acknowledge the support of the National Heart, Lung and Blood Institute (NHLBI), the contributions of the research institutions that participated in this study, the study investigators, field staff and study participants who created this resource for biomedical research, and the Population Genetics Project Team of the NHLBI. We thank J. Wilson and R. Do for critical feedback on the manuscript. Funding for the GO (Grand Opportunity) Exome Sequencing Project was provided by NHLBI grants RC2 HL-103010 (Heart GO), RC2 HL-102923 (Lung GO) and RC2 HL-102924 (WHISP). The exome sequencing was was supported by NHLBI grants RC2 HL-102925 (Broad GO) and RC2 HL-102926 (Seattle GO).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Griffiths R., 1998, COMMUN STAT STOCH MO, V14, P273, DOI [10.1080/15326349808807471, DOI 10.1080/15326349808807471]; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hawks J, 2007, P NATL ACAD SCI USA, V104, P20753, DOI 10.1073/pnas.0707650104; Jia EZ, 2009, MOL BIOL REP, V36, P245, DOI 10.1007/s11033-007-9173-4; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; KIMURA M, 1973, GENETICS, V75, P199; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Liao BY, 2006, MOL BIOL EVOL, V23, P2072, DOI 10.1093/molbev/msl076; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pyun JA, 2012, MATURITAS, V71, P402, DOI 10.1016/j.maturitas.2012.01.011; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Valdmanis PN, 2007, AM J HUM GENET, V80, P152, DOI 10.1086/510782	27	650	658	3	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2013	493	7431					216	220		10.1038/nature11690	http://dx.doi.org/10.1038/nature11690			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23201682	Green Submitted, Green Accepted			2022-12-28	WOS:000313259600038
J	Chesnut, RM; Temkin, N; Carney, N; Dikmen, S; Rondina, C; Videtta, W; Petroni, G; Lujan, S; Pridgeon, J; Barber, J; Machamer, J; Chaddock, K; Celix, JM; Cherner, M; Hendrix, T				Chesnut, Randall M.; Temkin, Nancy; Carney, Nancy; Dikmen, Sureyya; Rondina, Carlos; Videtta, Walter; Petroni, Gustavo; Lujan, Silvia; Pridgeon, Jim; Barber, Jason; Machamer, Joan; Chaddock, Kelley; Celix, Juanita M.; Cherner, Marianna; Hendrix, Terence			A Trial of Intracranial-Pressure Monitoring in Traumatic Brain Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE-CARE; HEAD-INJURY; MANAGEMENT	Background Intracranial-pressure monitoring is considered the standard of care for severe traumatic brain injury and is used frequently, but the efficacy of treatment based on monitoring in improving the outcome has not been rigorously assessed. Methods We conducted a multicenter, controlled trial in which 324 patients 13 years of age or older who had severe traumatic brain injury and were being treated in intensive care units (ICUs) in Bolivia or Ecuador were randomly assigned to one of two specific protocols: guidelines-based management in which a protocol for monitoring intra-parenchymal intracranial pressure was used (pressure-monitoring group) or a protocol in which treatment was based on imaging and clinical examination (imaging-clinical examination group). The primary outcome was a composite of survival time, impaired consciousness, and functional status at 3 months and 6 months and neuropsychological status at 6 months; neuropsychological status was assessed by an examiner who was unaware of protocol assignment. This composite measure was based on performance across 21 measures of functional and cognitive status and calculated as a percentile (with 0 indicating the worst performance, and 100 the best performance). Results There was no significant between-group difference in the primary outcome, a composite measure based on percentile performance across 21 measures of functional and cognitive status (score, 56 in the pressure-monitoring group vs. 53 in the imaging-clinical examination group; P = 0.49). Six-month mortality was 39% in the pressure-monitoring group and 41% in the imaging-clinical examination group (P = 0.60). The median length of stay in the ICU was similar in the two groups (12 days in the pressure-monitoring group and 9 days in the imaging-clinical examination group; P = 0.25), although the number of days of brain-specific treatments (e.g., administration of hyperosmolar fluids and the use of hyperventilation) in the ICU was higher in the imaging-clinical examination group than in the pressure-monitoring group (4.8 vs. 3.4, P = 0.002). The distribution of serious adverse events was similar in the two groups. Conclusions For patients with severe traumatic brain injury, care focused on maintaining monitored intracranial pressure at 20 mm Hg or less was not shown to be superior to care based on imaging and clinical examination. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT01068522.)	[Chesnut, Randall M.; Temkin, Nancy; Dikmen, Sureyya; Pridgeon, Jim; Barber, Jason; Chaddock, Kelley; Celix, Juanita M.] Univ Washington, Harborview Med Ctr, Dept Neurol Surg, Seattle, WA 98104 USA; [Chesnut, Randall M.] Univ Washington, Harborview Med Ctr, Dept Orthopaed & Sports Med, Seattle, WA 98104 USA; [Temkin, Nancy] Univ Washington, Harborview Med Ctr, Dept Biostat, Seattle, WA 98104 USA; [Dikmen, Sureyya; Machamer, Joan] Univ Washington, Harborview Med Ctr, Dept Rehabil Med, Seattle, WA 98104 USA; [Carney, Nancy] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Rondina, Carlos; Petroni, Gustavo; Lujan, Silvia] Hosp Emergencias Dr Clemente Alvarez, Santa Fe, Argentina; [Videtta, Walter] Hosp Nacl Prof Alejandro Posadas, Buenos Aires, DF, Argentina; [Hendrix, Terence] Univ Calif San Diego, HIV Neurobehav Res Programs, La Jolla, CA 92093 USA; [Cherner, Marianna] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; Oregon Health & Science University; University of California System; University of California San Diego; University of California System; University of California San Diego	Chesnut, RM (corresponding author), Univ Washington, Harborview Med Ctr, Dept Neurol Surg, 325 9th Ave,Box 359766, Seattle, WA 98104 USA.	chesnutr@uw.edu		Chesnut, Randall/0000-0001-6377-3666	National Institutes of Health and the Fogarty International Center; National Institute of Neurological Disorders and Stroke [ROINS058302]; Integra Life Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058302, R01NS080648] Funding Source: NIH RePORTER	National Institutes of Health and the Fogarty International Center; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Integra Life Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the National Institutes of Health and the Fogarty International Center, the National Institute of Neurological Disorders and Stroke (ROINS058302), and Integra Life Sciences.	[Anonymous], 1996, J NEUROTRAUM, V13, P639; Association for the Advancement of Automotive Medicine, 2001, ABBR INJ SCAL AIS; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R, 1998, GUIDELINES MANAGEMEN; Carney N, 2012, J NEUROTRAUM, V29, P2022, DOI 10.1089/neu.2011.2019; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Gelabert-Gonzalez M, 2006, ACTA NEUROCHIR, V148, P435, DOI 10.1007/s00701-005-0683-3; Kerr M E, 2001, Neurosurg Focus, V11, pE1; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Meyer MJ, 2010, BRAIN INJURY, V24, P706, DOI 10.3109/02699051003692126; Morris GF, 1998, NEUROSURGERY, V43, P1369, DOI 10.1097/00006123-199812000-00063; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; SMITH HP, 1986, J NEUROSURG, V65, P820, DOI 10.3171/jns.1986.65.6.0820; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P457; VANELTEREN P, 1960, B INT STATIST INST, V37, P351	20	699	738	7	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2012	367	26					2471	2481		10.1056/NEJMoa1207363	http://dx.doi.org/10.1056/NEJMoa1207363			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	059OG	23234472	Green Accepted			2022-12-28	WOS:000312714200005
J	Mindell, JS; Reynolds, L; Cohen, DL; McKee, M				Mindell, Jennifer S.; Reynolds, Lucy; Cohen, David L.; McKee, Martin			CHRISTMAS 2012: THOUGHTS FOR TODAY All in this together: the corporate capture of public health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INDUSTRY; SCIENTISTS; NUTRITION; IMPACT		[Mindell, Jennifer S.] UCL, London WC1E 6BT, England; [McKee, Martin] Univ London London Sch Hyg & Trop Med, ECOHOST, London WC1E 7HT, England; [Cohen, David L.] Northwick Pk Hosp & Clin Res Ctr, Harrow HA1 3UJ, Middx, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Imperial College London	Mindell, JS (corresponding author), UCL, Mortimer St, London WC1E 6BT, England.	j.mindell@ucl.ac.uk	Reynolds, Dr L/CAG-7830-2022; Mindell, Jennifer S/G-2241-2011; McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	Mindell, Jennifer S/0000-0002-7604-6131; McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Cohen, David/0000-0001-7318-8567				Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Boffey D., 2011, OBSERVER; Bosanquet N, 2008, MAKING NHS BEST INSU; Brownell KD, 2011, NEW ENGL J MED, V364, P2373, DOI 10.1056/NEJMp1101033; Care Quality Commission, 2012, CQC PUBL REP OUT HOU; Cassidy J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2917; DAUBE M, 1993, TOB CONTROL, V2, P183, DOI DOI 10.1136/TC.2.3.183; Diethelm P, 2009, EUR J PUBLIC HEALTH, V19, P2, DOI 10.1093/eurpub/ckn139; Douglas MJ, 2011, J PUBLIC HEALTH-UK, V33, P160, DOI 10.1093/pubmed/fdr032; Drope J, 2004, TOB CONTROL, V13, P41, DOI 10.1136/tc.2003.004101; Dwyer Hogg C., 2011, INDEPENDENT; Eckel RH, 2007, CIRCULATION, V115, P2231, DOI 10.1161/CIRCULATIONAHA.106.181947; Goldacre Ben, 2012, BAD PHARM; Gruning T, 2006, AM J PUBLIC HEALTH, V96, P20, DOI 10.2105/AJPH.2004.061507; Hastings G, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5124; Health Action International. Europe/Corporate Europe Observatory. Divide and conquer: a look behind the scenes of the European Union (EU), 2012, DIV CONQ LOOK SCEN E; House of Commons Public Administration Committee, 2012, 3 HOUS COMM PUBL ADM; Jarman H, 2010, SOC POLICY ADMIN, V44, P172, DOI 10.1111/j.1467-9515.2009.00707.x; Jenkin GL, 2011, OBES REV, V12, P1022, DOI 10.1111/j.1467-789X.2011.00918.x; Kahn J, 2007, NY TIMES; Landman A, 2002, AM J PUBLIC HEALTH, V92, P917, DOI 10.2105/AJPH.92.6.917; Lang T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5466; Leatherhead Food International, 2006, EV IMP BUS CHANG NUT; Letwin O., 1988, PRIVATISING WORLD ST; Leys C., 2011, PLOT NHS; Love J., 2011, PHARM CO REGISTERED; MacFarlane J., 2012, DAILY MAIL; McKee S., 2009, BLOOMBERG BUSINESS W; Mindell J, 2001, J PUBLIC HEALTH MED, V23, P91, DOI 10.1093/pubmed/23.2.91; O'Connor RJ, 2006, TOB CONTROL, V15, P45, DOI 10.1136/tc.2005.013532; Quinn C, 2011, TOB CONTROL, V20, P151, DOI 10.1136/tc.2010.039602; Regulatory Affairs Associates, 2009, FDA CORR SPECT REG C; Rogers W, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2910; Rose D., 2012, MAIL SUNDAY     0212, P8; Royal College of Physicians, 1962, SMOK HLTH; Scollo M, 2003, TOB CONTROL, V12, P13, DOI 10.1136/tc.12.1.13; Sims M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2161; Smith KE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000202; Stender S, 2006, ATHEROSCLEROSIS SUPP, V7, P47, DOI 10.1016/j.atherosclerosissup.2006.04.011; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001242, 10.1371/journal.pmed.1001235]; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; WHO, 2012, TRAD FOR POL DIPL HL	43	41	41	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 17	2012	345								e8082	10.1136/bmj.e8082	http://dx.doi.org/10.1136/bmj.e8082			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IU	23247988	Green Submitted			2022-12-28	WOS:000312698700024
J	Godlee, F				Godlee, Fiona			Withdraw approval for Tamiflu until NICE has full data	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEURAMINIDASE INHIBITORS; METAANALYSIS; INFLUENZA					fgodlee@bmj.com						Burch J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13580; Cohen D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4848; Cohen D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5387; Doshi P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5164; Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; Godlee F., 2009, BMJ-BRIT MED J, V338, pb463; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Smith J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5374; Turner David, 2003, HEALTH TECHNOL ASSES, V7, P1, DOI DOI 10.3310/HTA7350	9	5	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 12	2012	345								e8415	10.1136/bmj.e8415	http://dx.doi.org/10.1136/bmj.e8415			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056MU	23236047				2022-12-28	WOS:000312495100017
J	Fryatt, R; Matsoso, P				Fryatt, Robert; Matsoso, Precious			The UK and South Africa health partnership	LANCET			English	Editorial Material									[Fryatt, Robert; Matsoso, Precious] Govt S Africa, Natl Dept Hlth, ZA-0001 Pretoria, South Africa		Fryatt, R (corresponding author), Govt S Africa, Natl Dept Hlth, ZA-0001 Pretoria, South Africa.	FryatB@health.gov.za						Department for International Development South Africa/HSRC/Coffey, 2012, S AFR HSRC COFF IMP; Foreign and Commonwealth Office, 2011, FOR SECR HOSTS UK S; Matsoso MP, 2012, S AFRICAS MOVE UNIVE; McIntyre D, 2012, SAMJ S AFR MED J, V102, P489, DOI 10.7196/SAMJ.5611; National Department of Health Government of South Africa, 2012, HLTH DAT ADV COORD C; National Department of Health Government of South Africa, 2012, KEY STRAT ISS HLTH S, P19; National Department of Health Government of South Africa, 2011, AID EFF FRAM HLTH S; National Department of Health Government of South Africa, 2011, NAT HLTH INS C LESS; Session on Climate Change and Health COP 17, 2011, HLTH DURB CLIM CHANG	9	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 8	2012	380	9858					1970	1971		10.1016/S0140-6736(12)61968-0	http://dx.doi.org/10.1016/S0140-6736(12)61968-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051KI	23201211				2022-12-28	WOS:000312124900005
J	Mayosi, BM; Lawn, JE; van Niekerk, A; Bradshaw, D; Karim, SSA; Coovadia, HM				Mayosi, Bongani M.; Lawn, Joy E.; van Niekerk, Ashley; Bradshaw, Debbie; Karim, Salim S. Abdool; Coovadia, Hoosen M.		Lancet South Africa Team	Health in South Africa: changes and challenges since 2009	LANCET			English	Review							NONCOMMUNICABLE DISEASES; ANTIRETROVIRAL TREATMENT; HIV; CARE; TUBERCULOSIS; VIOLENCE; IMPACT; MORTALITY; INFECTION; DELIVERY	Since the 2009 Lancet Health in South Africa Series, important changes have occurred in the country, resulting in an increase in life expectancy to 60 years. Historical injustices together with the disastrous health policies of the previous administration are being transformed. The change in leadership of the Ministry of Health has been key, but new momentum is inhibited by stasis within the health management bureaucracy. Specific policy and programme changes are evident for all four of the so-called colliding epidemics: HIV and tuberculosis; chronic illness and mental health; injury and violence; and maternal, neonatal, and child health. South Africa now has the world's largest programme of antiretroviral therapy, and some advances have been made in implementation of new tuberculosis diagnostics and treatment scale-up and integration. HIV prevention has received increased attention. Child mortality has benefited from progress in addressing HIV. However, more attention to postnatal feeding support is needed. Many risk factors for non-communicable diseases have increased substantially during the past two decades, but an ambitious government policy to address lifestyle risks such as consumption of salt and alcohol provide real potential for change. Although mortality due to injuries seems to be decreasing, high levels of interpersonal violence and accidents persist. An integrated strategic framework for prevention of injury and violence is in progress but its successful implementation will need high-level commitment, support for evidence-led prevention interventions, investment in surveillance systems and research, and improved human-resources and management capacities. A radical system of national health insurance and re-engineering of primary health care will be phased in for 14 years to enable universal, equitable, and affordable health-care coverage. Finally, national consensus has been reached about seven priorities for health research with a commitment to increase the health research budget to 2.0% of national health spending. However, large racial differentials exist in social determinants of health, especially housing and sanitation for the poor and inequity between the sexes, although progress has been made in access to basic education, electricity, piped water, and social protection. Integration of the private and public sectors and of services for HIV, tuberculosis, and non-communicable diseases needs to improve, as do surveillance and information systems. Additionally, successful interventions need to be delivered widely. Transformation of the health system into a national institution that is based on equity and merit and is built on an effective human-resources system could still place South Africa on track to achieve Millennium Development Goals 4, 5, and 6 and would enhance the lives of its citizens.	[Mayosi, Bongani M.] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa; [Mayosi, Bongani M.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Lawn, Joy E.] Save Children, Saving Newborn Lives, Cape Town, South Africa; [van Niekerk, Ashley] MRC, Safety & Peace Promot Res Unit, Cape Town, South Africa; [Bradshaw, Debbie] MRC, Burden Dis Res Unit, Cape Town, South Africa; [van Niekerk, Ashley] Univ S Africa, Inst Social & Hlth Sci, ZA-0001 Pretoria, South Africa; [Karim, Salim S. Abdool] Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, Durban, South Africa; [Coovadia, Hoosen M.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Paediat & Child Hlth, Durban, South Africa; [Karim, Salim S. Abdool] Columbia Univ, Dept Epidemiol, New York, NY USA; [Coovadia, Hoosen M.] Univ Witwatersrand, Maternal Adolescent & Child Hlth, Johannesburg, South Africa	University of Cape Town; University of Cape Town; Save the Children; University of South Africa; University of Kwazulu Natal; University of Kwazulu Natal; Columbia University; University of Witwatersrand	Coovadia, HM (corresponding author), Maternal Adolescent & Child Hlth, 155 Juniper Rd, ZA-4091 Durban, South Africa.	hcoovadia@match.org.za	Karim, Salim Abdool/P-3117-2019; Karim, Salim Safurdeen Abdool/N-5947-2013; Karim, Salim Abdool/AAE-7118-2019; Lawn, Joy/ABE-6382-2020	Karim, Salim Abdool/0000-0002-4986-2133; Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Lawn, Joy/0000-0002-4573-1443; van Niekerk, Ashley/0000-0003-2900-8519; Mayosi, Bongani/0000-0001-6641-8950; Tollman, Stephen/0000-0003-0744-7588	Lily and Hausmann Research Trust; South African Medical Research Council; National Research Foundation of South Africa	Lily and Hausmann Research Trust; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation of South Africa(National Research Foundation - South Africa)	Bongani Mayosi is partly funded by the Lily and Hausmann Research Trust, the South African Medical Research Council, and the National Research Foundation of South Africa. We thank Kate Kerber for help with data for figure 1 and Ria Laubscher for assisting with data for figures 1 and 3.	Abrahams N, 2009, VIOLENCE VICTIMS, V24, P546, DOI 10.1891/0886-6708.24.4.546; Adam MA, 2009, SAMJ S AFR MED J, V99, P661; Altbeker A, 2008, CRIME VIOLENCE INJUR, P122; Amnesty International USA, HIDD VIEW HIV WOM RU; [Anonymous], 2012, S. Afr. j. sci., V108, P1; [Anonymous], 2012, LANCET, V379, P1365, DOI 10.1016/S0140-6736(12)60578-9; [Anonymous], 2008, LANCET, V372, P1855, DOI 10.1016/S0140-6736(08)61789-4; [Anonymous], 2011, GLOB TUB CONTR 2011; [Anonymous], 2009, MAIL GUARDIAN; [Anonymous], 1994, INDEPENDENT; Auvert B., 2011, 6 INT AIDS SOC C HIV; Bateman C, 2010, SAMJ S AFR MED J, V100, P791, DOI 10.7196/SAMJ.4631; Bateman C, 2010, SAMJ S AFR MED J, V100, P17; Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Becquet R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007397; Bertram MY, 2012, SAMJ S AFR MED J, V102, P743, DOI [10.7196/samj.5832, 10.7196/SAMJ.5832]; Bornman S, 2012, STATE NATION GOVT PR; Bowen S, 2005, PLOS MED, V2, P600, DOI 10.1371/journal.pmed.0020166; Bradshaw D, SURVEILLANCE RES PRE; Bradshaw D, 2012, RAPID MORTALITY SURV; Burger EH, 2012, J CLIN EPIDEMIOL, V65, P309, DOI 10.1016/j.jclinepi.2011.08.007; Chersich MF, 2010, INT J STD AIDS, V21, P2, DOI 10.1258/ijsa.2000.009432; Chopra M, 2009, LANCET, V374, P1023, DOI 10.1016/S0140-6736(09)61122-3; Chopra M, 2009, LANCET, V374, P835, DOI 10.1016/S0140-6736(09)61123-5; Chweneyagae D, 2012, SAJOG-S AFR J OBSTET, V18, P70, DOI 10.7196/SAJOG.581; Coltart C, 2011, LANCET, V378, P1215, DOI 10.1016/S0140-6736(11)61461-X; Coovadia H, 2008, ADV EXP MED BIOL, V609, P16, DOI 10.1007/978-0-387-73960-1_2; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; Council for Medical Schemes, 2009, COUNC MED SCHEM ANN; Creswell J, 2011, EUR RESPIR J, V37, P1269, DOI 10.1183/09031936.00084310; Daire J, 2011, S AFRICAN HLTH REV, P69; Day C, 2012, HLTH RELATED INDICAT; Department of Health, 2011, 2010 NAT ANT SENT HI; Department of Health, 2011, DEP HLTH ANN REP 201; Department of Health, 2012, MAL EL MON EV PLAN 2; Department of Health, 2011, S AFR DECL PREV CONT; Department of Health, 2011, 1 DEP HLTH; Department of Health, 2012, HRH STRAT HLTH SECT; Department of Health, 2012, SAV MOTH 2008 2010 5; Doherty J, 2011, S AFRICAN HLTH MANAG; English R, 2012, S AFRICAN HLTH REV 2, P81; Esterhuizen TM, 2001, S AFR MED J, V91, P502; Gevers W, 2009, LANCET, V374, P760, DOI 10.1016/S0140-6736(09)61119-3; Gevisser M., 2007, THABO MBEKI DREAM DE; Goga A, 2012, EVALUATION EFFECTIVE; GunFree South Africa, 2009, 8000 MISS FIR; Harris B, 2011, J PUBLIC HEALTH POL, V32, pS102, DOI 10.1057/jphp.2011.35; Hartley W, 2012, MOTSOALEDI TAKES AIM; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Health Data Advisory Committee, 2012, HLTH DAT ADV COMM HD; Health Systems Trust, 2011, PROJ HLTH INF SYST D; Health Systems Trust, DISTR HLTH BAR; health-e, 2012, NHI PIL DISTR PROF; Human Sciences Research Council, 2012, S AFR NAT HLTH NUTR; Independent Complaints Directorate, 2011, IND COMPL DIR ANN RE; Jewkes R., 2009, UNDERSTANDING MENS H; Jewkes Rachel, 2011, PLoS One, V6, pe29590, DOI 10.1371/journal.pone.0029590; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Johnson LF, 2012, S AFR J HIV MED, P22; Kahn K, 2011, J PUBLIC HEALTH POL, V32, pS30, DOI 10.1057/jphp.2011.27; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kerber K, 2012, LANCET, V379, P1193, DOI 10.1016/S0140-6736(12)60502-9; Kleinert S, 2009, LANCET, V374, P759, DOI 10.1016/S0140-6736(09)61306-4; KPMG, 2011, FUND NHI SPOONF SUG; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Levitt NS, 2011, AM J CLIN NUTR, V94, p1690S, DOI 10.3945/ajcn.111.019075; Makgoba MW, 2000, SCIENCE, V288, P1171, DOI 10.1126/science.288.5469.1171; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Mayosi BM, 2012, STRENGTHENING RES HL; Mayosi BM, 2009, CONSENSUS REPORT REV; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Mills A, 2012, LANCET, V380, P126, DOI 10.1016/S0140-6736(12)60357-2; National Department of Health (NDoH), 2011, GOVT GAZETTE; National Health Laboratory Service, 2012, XPERT MTB RIF DIAGN; National Perinatal Mortality and Morbidity Committee, 2011, NAT PER MORT MORB CO; National Planning Commission, 2011, BUILD CAP STAT NAT D; National Planning Commission, 2011, DIAGN OV; Newham G, 2011, ARRESTING FEW POLICE; Nordling L, 2012, S AFRICA INVESTS RES; Norman R, 2007, B WORLD HEALTH ORGAN, V85, P695, DOI 10.2471/BLT.06.037184; Ntusi NBA, 2011, CARDIOVASC J AFR, V22, P172; Parks, 2007, ANN REP 2006 07; Peer N, 2009, SAMJ S AFR MED J, V99, P744; Petersen I, 2011, SAMJ S AFR MED J, V101, P751; PHILLIPS HT, 1993, AM J PUBLIC HEALTH, V83, P1037, DOI 10.2105/AJPH.83.7.1037; Pillay Y, 2012, SAMJ S AFR MED J, V102, P77, DOI 10.7196/SAMJ.5284; Pillay-van Wyk V, 2011, SAMJ S AFR MED J, V101, P626; Ratele K., 2011, NATL INT PERSPECTIVE, P44; Republic of South Africa, 2011, HUM COND DIAGN; Republic of South Africa, 2012, 2012 BUDG SPEECH MIN; Republic of South Africa, 2010, COUNTRY PROGR REPORT; Safety and Peace Promotion Research Unit, 2012, PROF FAT INJ GAUT 20; Safety and Peace Promotion Research Unit, 2012, PROF FAT INJ MPUM 20; Schaay N, 1998, S AFRICAN HLTH REV 1, P93; Seedat M, 2009, LANCET, V374, P1011, DOI 10.1016/S0140-6736(09)60948-X; Shisana O, 2009, S AFRICAN NATL HIV P; Singh E, 2011, NEW REGULATIONS CANC; Sorsdahl K, 2012, AFR J PSYCHIATRY, V15, P168, DOI [10.4314/ajpsy.v15i3.21, http://dx.doi.org/10.4314/ajpsy.v15i3.21]; South African Government, 2010, OUTC APPR; South African Government, 2012, LAUNCH CAMP ACC RED; South African Government, 2010, OUTL NAT HIV COUNS T; South African National AIDS Council, 2011, NAT STRAT PLAN HIV S; South African Police Service, 2011, CRIM REP 2010 2011; Statistics South Africa, 2011, LIV COND HOUS SA 200; Statistics South Africa, 2011, TOUR SAT ACC S AFR F; Statistics South Africa, 2011, MID POP EST; Statistics South Africa, 2011, STAT REL P0211 Q LAB; Statistics South Africa, 2011, MORT CAUS DEATH S AF; Statistics South Africa, 2009, STAT REL P0210 LAB F; Sukhai A, 2011, ACCIDENT ANAL PREV, V43, P421, DOI 10.1016/j.aap.2010.09.012; Sydney Ports Corporation, 2011, SYDN PORTS CORP ANN; The SARRAH Programme, 2009, S AFR HLTH IMPR PLAN; Tollman SM, 2008, LANCET, V372, P893, DOI 10.1016/S0140-6736(08)61399-9; UNICEF, 2012, COUNTD 2015 MAT NEWB; van den Heever A, 2011, EVALUATION GREEN PAP; Van Niekerk A., 2012, CRIME VIOLENCE INJUR; Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0; Ward CL, 2012, SAMJ S AFR MED J, V102, P215; WHO, 2006, ANT DRUGS TREAT PREG; WHO, 2011, S AFR TUB PROF; Word Health Organization, GLOB TUB REP 2012; World Health Assembly, 2011, SUST HLTH FIN STRUCT; World Health Organization, 2010, GLOB STRAT RED HARMF; World Health Organization, PROGR REP 2011 GLOB; World Health Organization, 2002, WORLD REPORT VIOLENC; Yudkin PL, 2009, AIDS, V23, P1600, DOI 10.1097/QAD.0b013e32832d4719	129	315	333	7	199	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	2012	380	9858					2029	2043		10.1016/S0140-6736(12)61814-5	http://dx.doi.org/10.1016/S0140-6736(12)61814-5			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051KI	23201214	Green Submitted			2022-12-28	WOS:000312124900034
J	Fang, WW; Wang, X; Bracht, JR; Nowacki, M; Landweber, LF				Fang, Wenwen; Wang, Xing; Bracht, John R.; Nowacki, Mariusz; Landweber, Laura F.			Piwi-Interacting RNAs Protect DNA against Loss during Oxytricha Genome Rearrangement	CELL			English	Article							PARAMECIUM-TETRAURELIA; TETRAHYMENA-THERMOPHILA; C. ELEGANS; LYSINE-9 METHYLATION; EPIGENETIC MEMORY; 3' TERMINI; PIRNAS; GERMLINE; ELIMINATION; GENE	Genome duality in ciliated protozoa offers a unique system to showcase their epigenome as a model of inheritance. In Oxytricha, the somatic genome is responsible for vegetative growth, whereas the germline contributes DNA to the next sexual generation. Somatic nuclear development removes all transposons and other so-called "junk'' DNA, which comprise similar to 95% of the germline. We demonstrate that Piwi-interacting small RNAs (piRNAs) from the maternal nucleus can specify genomic regions for retention in this process. Oxytricha piRNAs map primarily to the somatic genome, representing the similar to 5% of the germline that is retained. Furthermore, injection of synthetic piRNAs corresponding to normally deleted regions leads to their retention in later generations. Our findings highlight small RNAs as powerful transgenerational carriers of epigenetic information for genome programming.	[Wang, Xing; Bracht, John R.; Landweber, Laura F.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Fang, Wenwen] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Nowacki, Mariusz] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland	Princeton University; Princeton University; University of Bern	Landweber, LF (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	lfl@princeton.edu	Wang, Xing/B-3682-2018; Fang, Wenwen/B-8422-2016; Nowacki, Mariusz/E-4485-2011	Wang, Xing/0000-0001-9930-3287; Nowacki, Mariusz/0000-0003-4894-2905	NIH [GM59708]; NSF [0923810, 0900544]; DOD [W81XWH-10-1-0122]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059708, F32GM099462] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); DOD(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Perlman, B. Zee, and B. Garcia for mass spectrometry validation of the Otiwi1 antibody; J. Buckles, W. Wang, D. Storton, and L. Parsons for Illumina sequencing; L. Li and A. D. Goldman for assistance with phylogenetic analysis; X. Chen for searching the micronuclear genome assembly for junction-spanning piRNAs; A. Chen, K. Mochizuki, and M. Couvillion for sharing RNA IP protocols; E. Swart, J. Bloom, and P. Jiang for advice on computational analysis of deep-sequencing results; J. Postberg and J. Goodhouse for immunofluorescence advice; P. Andolfatto, J. Swan, J. Khurana, P. Schedl, and L. Beh for discussion or comments on the manuscript; and J. Wang for help with Oxytricha cell culture. We also thank three anonymous referees for valuable suggestions. This study was supported by NIH grant GM59708 and NSF grants 0923810 and 0900544 (to L.F.L.) and a DOD predoctoral fellowship W81XWH-10-1-0122 (to W.F.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Arnaiz O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002984; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bouhouche K, 2011, NUCLEIC ACIDS RES, V39, P4249, DOI 10.1093/nar/gkq1283; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chalker DL, 1996, MOL CELL BIOL, V16, P3658; Couvillion MT, 2009, GENE DEV, V23, P2016, DOI 10.1101/gad.1821209; Coyne RS, 2012, METHOD CELL BIOL, V109, P53, DOI 10.1016/B978-0-12-385967-9.00004-9; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; DUHARCOURT S, 1995, GENE DEV, V9, P2065, DOI 10.1101/gad.9.16.2065; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gan HY, 2011, RNA, V17, P1191, DOI 10.1261/rna.2648411; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; Kurth HM, 2009, RNA, V15, P675, DOI 10.1261/rna.1455509; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lee SR, 2006, GENE DEV, V20, P28, DOI 10.1101/gad.1377006; Lepere G, 2008, GENE DEV, V22, P1501, DOI 10.1101/gad.473008; Lepere G, 2009, NUCLEIC ACIDS RES, V37, P903, DOI 10.1093/nar/gkn1018; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Liu YF, 2004, P NATL ACAD SCI USA, V101, P1679, DOI 10.1073/pnas.0305421101; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mollenbeck M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002330; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; Nowacki M, 2009, SCIENCE, V324, P935, DOI 10.1126/science.1170023; Ohara T, 2007, NAT STRUCT MOL BIOL, V14, P349, DOI 10.1038/nsmb1220; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Patzel V, 1999, NUCLEIC ACIDS RES, V27, P4328, DOI 10.1093/nar/27.22.4328; Prescott DM, 2000, NAT REV GENET, V1, P191, DOI 10.1038/35042057; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Schoeberl UE, 2012, GENE DEV, V26, P1729, DOI 10.1101/gad.196493.112; Seto AG, 2007, MOL CELL, V26, P603, DOI 10.1016/j.molcel.2007.05.021; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Storici F, 2008, CURR OPIN MOL THER, V10, P224; Tian YA, 2011, P NATL ACAD SCI USA, V108, P903, DOI 10.1073/pnas.1017762108; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Witherspoon DJ, 1997, MOL BIOL EVOL, V14, P696, DOI 10.1093/oxfordjournals.molbev.a025809; Yao MC, 2003, SCIENCE, V300, P1581, DOI 10.1126/science.1084737; Zahler AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042371; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang HB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000219	71	99	100	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1243	1255		10.1016/j.cell.2012.10.045	http://dx.doi.org/10.1016/j.cell.2012.10.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217708	Green Accepted, Bronze			2022-12-28	WOS:000311999900014
J	Kumar, S				Kumar, Subrat			Extinction need not be forever	NATURE			English	Editorial Material									KIIT Univ, Sch Biotechnol, Bhubaneswar, India	Kalinga Institute of Industrial Technology (KIIT)	Kumar, S (corresponding author), KIIT Univ, Sch Biotechnol, Bhubaneswar, India.	subrat_kumar@yahoo.com	Kumar, Subrat/P-4225-2014	Kumar, Subrat/0000-0002-0659-6381					0	13	13	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 6	2012	492	7427					9	9		10.1038/492009a	http://dx.doi.org/10.1038/492009a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23222570	Bronze			2022-12-28	WOS:000311893400014
J	Veronesi, G; Maisonneuve, P; Bellomi, M; Rampinelli, C; Durli, I; Bertolotti, R; Spaggiari, L				Veronesi, Giulia; Maisonneuve, Patrick; Bellomi, Massimo; Rampinelli, Cristiano; Durli, Iara; Bertolotti, Raffaella; Spaggiari, Lorenzo			Estimating Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							HIGH-RISK INDIVIDUALS; NATURAL-HISTORY; GROWTH-RATES; CT; STAGE; TRIAL; CARCINOMA; NODULES; DESIGN; MODEL	Background: Lung cancer screening may detect cancer that will never become symptomatic (overdiagnosis), leading to overtreatment. Changes in size on sequential low-dose computed tomography (LDCT) screening, expressed as volume-doubling time (VDT), may help to distinguish aggressive cancer from cases that are unlikely to become symptomatic. Objective: To assess VDT for screening-detected lung cancer as an indicator of overdiagnosis. Design: Retrospective estimation of the VDT of cancer detected in a prospective LDCT screening cohort. Setting: Nonrandomized, single-center screening study involving persons at high risk for lung cancer enrolled between 2004 and 2005 who received LDCT annually for 5 years. Patients: 175 study patients diagnosed with primary lung cancer. Measurements: VDT was measured on LDCT and classified as fast-growing (<400 days), slow-growing (between 400 and 599 days), or indolent (>= 600 days). Results: Fifty-five cases of cancer were diagnosed at baseline, and 120 were diagnosed subsequently. Of the latter group, 19 cases (15.8%) were new (not visible on previous scans) and fast-growing (median VDT, 52 days); 101 (84.2%) were progressive, including 70 (58.3%) fast-growing and 31 (25.8%) slow-growing (15.0%) or indolent (10.8%) cases. Lung cancer-specific mortality was significantly higher (9.2% per year) in patients with new compared with slow-growing or indolent (0.9% per year) cancer. Sixty percent of fast-growing progressive cancer and 45% of new cancer were stage I, for which survival was good. Limitations: This is a retrospective study. Volume-doubling time can only indicate overdiagnosis and was estimated for new cancer from 1 measurement (a diameter of 2 mm assumed the previous year). Conclusion: Slow-growing or indolent cancer comprised approximately 25% of incident cases, many of which may have been overdiagnosed. To limit overtreatment in these cases, minimally invasive limited resection and nonsurgical treatments should be investigated.	[Veronesi, Giulia] European Inst Oncol, Div Thorac Surg, I-20141 Milan, Italy; Univ Milan, Sch Med, Milan, Italy	IRCCS European Institute of Oncology (IEO); University of Milan	Veronesi, G (corresponding author), European Inst Oncol, Div Thorac Surg, Via Ripamonti 435, I-20141 Milan, Italy.	giulia.veronesi@ieo.it	Maisonneuve, Patrick/U-9789-2018; Veronesi, Giulia/AAA-6327-2021; Spaggiari, Lorenzo/G-7915-2012; Bellomi, Massimo/AAM-4352-2020; Bertolotti, Raffaella/AAO-4674-2020	Maisonneuve, Patrick/0000-0002-5309-4704; Veronesi, Giulia/0000-0001-9032-1278; Spaggiari, Lorenzo/0000-0002-1068-3541	Italian Association for Cancer Research	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	By the Italian Association for Cancer Research.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Altorki N, 2010, J CLIN ONCOL, V28, P3131, DOI 10.1200/JCO.2009.23.9749; Bach PB, 2008, LANCET ONCOL, V9, P693, DOI 10.1016/S1470-2045(08)70176-1; Baldwin DR, 2011, THORAX, V66, P308, DOI 10.1136/thx.2010.152066; Beadsmoore CJ, 2003, EUR J RADIOL, V45, P8, DOI 10.1016/S0720-048X(02)00287-5; Berland Lincoln L, 2009, J Am Coll Radiol, V6, P14, DOI 10.1016/j.jacr.2008.06.018; Bianchi F, 2011, EMBO MOL MED, V3, P495, DOI 10.1002/emmm.201100154; Carpagnano GE, 2008, AM J RESP CRIT CARE, V177, P337, DOI 10.1164/rccm.200707-1136OC; Detterbeck FC, 2008, J THORAC ONCOL, V3, P781, DOI 10.1097/JTO.0b013e31817c9230; Diederich S, 2004, EUR RADIOL, V14, P691, DOI 10.1007/s00330-003-2200-5; Fan J, 2012, ANN SURG ONCOL, V19, P661, DOI 10.1245/s10434-011-1931-9; Field JK, 2012, J THORAC ONCOL, V7, P10, DOI 10.1097/JTO.0b013e31823c58ab; FONTANA RS, 1991, CANCER-AM CANCER SOC, V67, P1155, DOI 10.1002/1097-0142(19910215)67:4+<1155::AID-CNCR2820671509>3.0.CO;2-0; Friberg S, 1997, J SURG ONCOL, V65, P284, DOI 10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2; GEDDES DM, 1979, BRIT J DIS CHEST, V73, P1, DOI 10.1016/0007-0971(79)90002-0; HARACH HR, 1985, CANCER, V56, P531, DOI DOI 10.1002/1097-0142(19850801)56:3!; Hasegawa M, 2000, BRIT J RADIOL, V73, P1252, DOI 10.1259/bjr.73.876.11205667; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Henschke CI, 2011, LUNG CANCER, V71, P328, DOI 10.1016/j.lungcan.2010.10.025; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Leo F, 1999, THORAC CARDIOV SURG, V47, P53, DOI 10.1055/s-2007-1013110; Lindell RM, 2009, CHEST, V136, P1586, DOI 10.1378/chest.09-0915; Maisonneuve P, 2011, CANCER PREV RES, V4, P1778, DOI 10.1158/1940-6207.CAPR-11-0026; McMahon PM, 2008, RADIOLOGY, V248, P278, DOI 10.1148/radiol.2481071446; Mulshine JL, 2005, NEW ENGL J MED, V352, P2714, DOI 10.1056/NEJMcp042630; Nakamura K, 2010, JPN J CLIN ONCOL, V40, P271, DOI 10.1093/jjco/hyp156; Pedersen Jesper H, 2009, J Thorac Oncol, V4, P608, DOI 10.1097/JTO.0b013e3181a0d98f; Raz DJ, 2007, CHEST, V132, P193, DOI 10.1378/chest.06-3096; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sone S, 2000, BRIT J RADIOL, V73, P137, DOI 10.1259/bjr.73.866.10884725; Swensen SJ, 2003, RADIOLOGY, V226, P756, DOI 10.1148/radiol.2263020036; USUDA K, 1994, CANCER, V74, P2239, DOI 10.1002/1097-0142(19941015)74:8<2239::AID-CNCR2820740806>3.0.CO;2-P; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; Veronesi G, 2010, ECANCERMEDICALSCIENC, V4, DOI 10.3332/ecancer.2010.186; Veronesi G, 2008, LUNG CANCER, V61, P340, DOI 10.1016/j.lungcan.2008.01.001; Veronesi G, 2008, J THORAC CARDIOV SUR, V136, P611, DOI 10.1016/j.jtcvs.2008.02.082; Veronesi G, 2011, J THORAC ONCOL, V6, P525, DOI 10.1097/JTO.0b013e318206dbcc; Veronesi G, 2011, CANCER PREV RES, V4, P34, DOI 10.1158/1940-6207.CAPR-10-0182; Veronesi G, 2010, J THORAC CARDIOV SUR, V140, P19, DOI 10.1016/j.jtcvs.2009.10.025; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Whitson BA, 2008, ANN THORAC SURG, V86, P2008, DOI 10.1016/j.athoracsur.2008.07.009; Yankelevitz DF, 2000, RADIOLOGY, V217, P251, DOI 10.1148/radiology.217.1.r00oc33251; Yankelevitz DF, 2003, CANCER, V97, P1271, DOI 10.1002/cncr.11185; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C; Zhong L, 2005, AM J RESP CRIT CARE, V172, P1308, DOI 10.1164/rccm.200505-830OC	45	128	135	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 4	2012	157	11					776	+		10.7326/0003-4819-157-11-201212040-00005	http://dx.doi.org/10.7326/0003-4819-157-11-201212040-00005			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	049RC	23208167				2022-12-28	WOS:000312000100003
J	Aviezer, H; Trope, Y; Todorov, A				Aviezer, Hillel; Trope, Yaacov; Todorov, Alexander			A Mutation in EGF Repeat-8 of Notch Discriminates Between Serrate/Jagged and Delta Family Ligands	SCIENCE			English	Article							FACIAL EXPRESSIONS; EMOTION; RECOGNITION; PERCEPTION; AMYGDALA; INNATE; AGONY; FACES	Notch signaling affects many developmental and cellular processes and has been implicated in congenital disorders, stroke, and numerous cancers. The Notch receptor binds its ligands Delta and Serrate and is able to discriminate between them in different contexts. However, the specific domains in Notch responsible for this selectivity are poorly defined. Through genetic screens in Drosophila, we isolated a mutation, Notch(jigsaw), that affects Serrate-but not Delta-dependent signaling. Notch(jigsaw) carries a missense mutation in epidermal growth factor repeat-8 (EGFr-8) and is defective in Serrate binding. A homologous point mutation in mammalian Notch2 also exhibits defects in signaling of a mammalian Serrate homolog, Jagged1. Hence, an evolutionarily conserved valine in EGFr-8 is essential for ligand selectivity and provides a molecular handle to study numerous Notch-dependent signaling events.	[Aviezer, Hillel; Todorov, Alexander] Princeton Univ, Dept Psychol, Princeton, NJ 08540 USA; [Trope, Yaacov] NYU, Dept Psychol, New York, NY 10003 USA; [Todorov, Alexander] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Princeton University; New York University; Radboud University Nijmegen	Aviezer, H (corresponding author), Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel.	haviezer@mail.huji.ac.il		Aviezer, Hillel/0000-0001-5581-208X	NSF [0823749]	NSF(National Science Foundation (NSF))	We thank V. Falvello for assistance in collecting the data. We thank R. Hassin and A. Maril for helpful discussions. This study was partly supported by NSF grant 0823749 (to A.T.). All original and manipulated stimuli used in these studies are available for research purposes upon request by contacting H.A. at haviezer@mail.huji.ac.il.	ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Aviezer H, 2008, PSYCHOL SCI, V19, P724, DOI 10.1111/j.1467-9280.2008.02148.x; Aviezer H, 2012, J PERS SOC PSYCHOL, V103, P20, DOI 10.1037/a0027411; Barrett LF, 2007, TRENDS COGN SCI, V11, P327, DOI 10.1016/j.tics.2007.06.003; Barrett LF, 2010, PSYCHOL SCI, V21, P595, DOI 10.1177/0956797610363547; Calder AJ, 2000, COGNITION, V76, P105, DOI 10.1016/S0010-0277(00)00074-3; Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749; Carroll JM, 1996, J PERS SOC PSYCHOL, V70, P205, DOI 10.1037/0022-3514.70.2.205; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; Fernandez-Dols J. M., 1997, PSYCHOL FACIAL EXPRE, V2, P255; Fernandez-Dols JM, 2011, J NONVERBAL BEHAV, V35, P63, DOI 10.1007/s10919-010-0097-7; Gao XQ, 2009, J EXP CHILD PSYCHOL, V102, P503, DOI 10.1016/j.jecp.2008.11.002; Halberstadt J, 2009, PSYCHOL SCI, V20, P1254, DOI 10.1111/j.1467-9280.2009.02432.x; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; Hess U, 1997, J NONVERBAL BEHAV, V21, P241, DOI 10.1023/A:1024952730333; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Hughes S.M., 2008, J SOC EVOL CULT PSYC, V2, P289, DOI [10.1037/h0099338, DOI 10.1037/H0099338]; IZARD CE, 1994, PSYCHOL BULL, V115, P288, DOI 10.1037/0033-2909.115.2.288; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Matsumoto D, 2006, J PERS SOC PSYCHOL, V91, P568, DOI 10.1037/0022-3514.91.3.568; Meeren HKM, 2005, P NATL ACAD SCI USA, V102, P16518, DOI 10.1073/pnas.0507650102; Messinger D, 2007, ADV CHILD DEV BEHAV, V35, P327; Motley M. T., 1988, J COMMUN, V52, P1; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Said CP, 2009, J COGNITIVE NEUROSCI, V21, P519, DOI 10.1162/jocn.2009.21041; SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513; Seymour B, 2007, J NEUROSCI, V27, P4826, DOI 10.1523/JNEUROSCI.0400-07.2007; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; Tamir M, 2008, PSYCHOL SCI, V19, P324, DOI 10.1111/j.1467-9280.2008.02088.x; Tracy JL, 2008, P NATL ACAD SCI USA, V105, P11655, DOI 10.1073/pnas.0802686105; TROPE Y, 1986, PSYCHOL REV, V93, P239, DOI 10.1037/0033-295X.93.3.239; Young AW, 1997, COGNITION, V63, P271, DOI 10.1016/S0010-0277(97)00003-6; Zubieta JK, 2005, J NEUROSCI, V25, P7754, DOI 10.1523/JNEUROSCI.0439-05.2005	37	384	396	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	2012	338	6111					1225	1229		10.1126/science.1224313	http://dx.doi.org/10.1126/science.1224313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045AL	23197536				2022-12-28	WOS:000311666200050
J	Aziz, I; Hadjivassiliou, M; Sanders, DS				Aziz, Imran; Hadjivassiliou, Marios; Sanders, David S.			Does gluten sensitivity in the absence of coeliac disease exist?	BRITISH MEDICAL JOURNAL			English	Editorial Material							IRRITABLE-BOWEL-SYNDROME; INTOLERANCE; EXPRESSION; SYMPTOMS; CEREALS; CARE		[Aziz, Imran; Sanders, David S.] Royal Hallamshire Hosp, Dept Gastroenterol, Sheffield S10 2JF, S Yorkshire, England; [Hadjivassiliou, Marios] Royal Hallamshire Hosp, Dept Neurol, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield; University of Sheffield	Aziz, I (corresponding author), Royal Hallamshire Hosp, Dept Gastroenterol, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.	imran.aziz@sth.nhs.uk		Aziz, Imran/0000-0003-4313-0553				Barrett JS, 2012, THER ADV GASTROENTER, V5, P261, DOI 10.1177/1756283X11436241; Biesiekierski JR, 2011, J HUM NUTR DIET, V24, P154, DOI 10.1111/j.1365-277X.2010.01139.x; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; Carroccio A, AM J GASTRO IN PRESS; Di Sabatino A, 2012, ANN INTERN MED, V156, P309, DOI 10.7326/0003-4819-156-4-201202210-00010; Ferch Courtney C, 2012, Gastroenterology, V142, P664, DOI 10.1053/j.gastro.2012.01.020; Hopper AD, 2007, BRIT MED J, V335, P558, DOI 10.1136/bmj.39316.442338.AD; Hopper AD, 2007, BMJ-BRIT MED J, V334, P729, DOI 10.1136/bmj.39133.668681.BE; Kaukinen K, 2000, SCAND J GASTROENTERO, V35, P942, DOI 10.1080/003655200750022995; Painter K, 2008, US TODAY; Pimentel M, 2011, GASTROENTEROL CLIN N, V40, P69, DOI 10.1016/j.gtc.2010.12.010; Rubio-Tapia A, 2012, AM J GASTROENTEROL, V107, P1538, DOI 10.1038/ajg.2012.219; Sanders DS, 2003, EUR J GASTROEN HEPAT, V15, P407, DOI 10.1097/00042737-200304000-00012; Sanders DS, 2001, LANCET, V358, P1504, DOI 10.1016/S0140-6736(01)06581-3; Sapone A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-13; Sapone A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-23; Sapone A, 2010, INT ARCH ALLERGY IMM, V152, P75, DOI 10.1159/000260087; Shepherd SJ, 2008, CLIN GASTROENTEROL H, V6, P765, DOI 10.1016/j.cgh.2008.02.058; Tanpowpong P, 2012, ARCH DIS CHILD, V97, P12, DOI 10.1136/archdischild-2011-300248; Verdu EF, 2009, AM J GASTROENTEROL, V104, P1587, DOI 10.1038/ajg.2009.188; Volta U, 2012, J CLIN GASTROENTEROL, V46, P680, DOI 10.1097/MCG.0b013e3182372541; Volta U, 2012, NAT REV GASTRO HEPAT, V9, P295, DOI 10.1038/nrgastro.2012.15	22	16	16	0	41	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 30	2012	345								e7907	10.1136/bmj.e7907	http://dx.doi.org/10.1136/bmj.e7907			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048FS	23204002				2022-12-28	WOS:000311896500005
J	Sohi, SP				Sohi, Saran P.			Carbon Storage with Benefits	SCIENCE			English	Editorial Material							BIOCHAR; SOIL; CHARCOAL; UK		Univ Edinburgh, Sch Geosci, UK Biochar Res Ctr, Edinburgh EH9 3JN, Midlothian, Scotland	University of Edinburgh	Sohi, SP (corresponding author), Univ Edinburgh, Sch Geosci, UK Biochar Res Ctr, Edinburgh EH9 3JN, Midlothian, Scotland.	saran.sohi@ed.ac.uk	Sohi, Saran/K-1220-2019	Sohi, Saran/0000-0003-3207-8665				Bird MI, 2008, J ARCHAEOL SCI, V35, P2698, DOI 10.1016/j.jas.2008.04.018; Brewer CE, 2011, BIOENERG RES, V4, P312, DOI 10.1007/s12155-011-9133-7; Cross A, 2011, SOIL BIOL BIOCHEM, V43, P2127, DOI 10.1016/j.soilbio.2011.06.016; Dias BO, 2010, BIORESOURCE TECHNOL, V101, P1239, DOI 10.1016/j.biortech.2009.09.024; Elad Y, 2011, PHYTOPATHOL MEDITERR, V50, P335; Hale SE, 2011, ENVIRON SCI TECHNOL, V45, P10445, DOI 10.1021/es202970x; Hammond J, 2011, ENERG POLICY, V39, P2646, DOI 10.1016/j.enpol.2011.02.033; Jeffery S, 2011, AGR ECOSYST ENVIRON, V144, P175, DOI 10.1016/j.agee.2011.08.015; Prendergast-Miller MT, 2011, SOIL BIOL BIOCHEM, V43, P2243, DOI 10.1016/j.soilbio.2011.07.019; Quilliam RS, 2012, AGR ECOSYST ENVIRON, V158, P192, DOI 10.1016/j.agee.2012.06.011; Running SW, 2012, SCIENCE, V337, P1458, DOI 10.1126/science.1227620; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Scott AC, 2010, PALAEOGEOGR PALAEOCL, V291, P1, DOI 10.1016/j.palaeo.2010.03.044; Shackley S, 2011, CARBON MANAG, V2, P335, DOI 10.4155/CMT.11.22; Sohi SP, 2010, ADV AGRON, V105, P47, DOI 10.1016/S0065-2113(10)05002-9; Spokas KA, 2010, CARBON MANAG, V1, P289, DOI 10.4155/CMT.10.32; Spokas KA, 2010, PLANT SOIL, V333, P443, DOI 10.1007/s11104-010-0359-5; Steiner C, 2007, PLANT SOIL, V291, P275, DOI 10.1007/s11104-007-9193-9; Woolf D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1053	19	284	309	21	452	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2012	338	6110					1034	1035		10.1126/science.1225987	http://dx.doi.org/10.1126/science.1225987			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	041HJ	23180849				2022-12-28	WOS:000311390600028
J	Hallal, PC; Lee, IM				Hallal, Pedro C.; Lee, I-Min			Prescription of physical activity: an undervalued intervention	LANCET			English	Editorial Material							INACTIVITY		[Hallal, Pedro C.] Univ Fed Pelotas, BR-96020220 Pelotas, RS, Brazil; [Lee, I-Min] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med, Boston, MA 02115 USA	Universidade Federal de Pelotas; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Hallal, PC (corresponding author), Univ Fed Pelotas, BR-96020220 Pelotas, RS, Brazil.	prchallal@terra.com.br	Hallal, Pedro C/A-3249-2011; Lee, I-Min/ABD-5409-2021	Hallal, Pedro C/0000-0003-1470-6461; 				Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Heath GW, 2012, LANCET, V380, P272, DOI 10.1016/S0140-6736(12)60816-2; Kohl Harold W 3rd, 2012, Lancet, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Kokkinos PF, 2013, LANCET, V381, P394, DOI 10.1016/S0140-6736(12)61426-3; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Pratt M, 2012, LANCET, V380, P282, DOI 10.1016/S0140-6736(12)60736-3; Siqueira FV, 2009, CAD SAUDE PUBLICA, V25, P203, DOI 10.1590/S0102-311X2009000100022; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Willis BL, 2011, MED SCI SPORT EXER, V43, P2134, DOI 10.1249/MSS.0b013e31821c00a7	10	20	21	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 2	2013	381	9864					356	357		10.1016/S0140-6736(12)61804-2	http://dx.doi.org/10.1016/S0140-6736(12)61804-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	084ZA	23199848				2022-12-28	WOS:000314578900011
J	Maddocks, ODK; Berkers, CR; Mason, SM; Zheng, L; Blyth, K; Gottlieb, E; Vousden, KH				Maddocks, Oliver D. K.; Berkers, Celia R.; Mason, Susan M.; Zheng, Liang; Blyth, Karen; Gottlieb, Eyal; Vousden, Karen H.			Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells	NATURE			English	Article							PYRUVATE-KINASE M2; P53-INDUCIBLE REGULATOR; RETINOBLASTOMA PROTEIN; CYCLE ARREST; DNA-DAMAGE; P53; APOPTOSIS; GLYCINE; TUMORS; MICE	Cancer cells acquire distinct metabolic adaptations to survive stress associated with tumour growth and to satisfy the anabolic demands of proliferation. The tumour suppressor protein p53 (also known as TP53) influences a range of cellular metabolic processes, including glycolysis(1,2), oxidative phosphorylation(3), glutaminolysis(4,5) and anti-oxidant response(6). In contrast to its role in promoting apoptosis during DNA-damaging stress, p53 can promote cell survival during metabolic stress(7), a function that may contribute not only to tumour suppression but also to non-cancer-associated functions of p53(8). Here we show that human cancer cells rapidly use exogenous serine and that serine deprivation triggered activation of the serine synthesis pathway and rapidly suppressed aerobic glycolysis, resulting in an increased flux to the tricarboxylic acid cycle. Transient p53-p21 (also known as CDKN1A) activation and cell-cycle arrest promoted cell survival by efficiently channelling depleted serine stores to glutathione synthesis, thus preserving cellular anti-oxidant capacity. Cells lacking p53 failed to complete the response to serine depletion, resulting in oxidative stress, reduced viability and severely impaired proliferation. The role of p53 in supporting cancer cell proliferation under serine starvation was translated to an in vivo model, indicating that serine depletion has a potential role in the treatment of p53-deficient tumours.	[Maddocks, Oliver D. K.; Berkers, Celia R.; Mason, Susan M.; Zheng, Liang; Blyth, Karen; Gottlieb, Eyal; Vousden, Karen H.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute	Vousden, KH (corresponding author), Beatson Inst Canc Res, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	k.vousden@beatson.gla.ac.uk	Maddocks, Oliver/K-5410-2012; Berkers, Celia/I-3848-2016; Gottlieb, Eyal/G-6450-2010	Maddocks, Oliver/0000-0002-5551-9091; Gottlieb, Eyal/0000-0002-9770-0956; Berkers, Celia/0000-0003-0746-8565; Zheng, Liang/0000-0002-5346-4111; Blyth, Karen/0000-0002-9304-439X; Mason, Susan/0000-0002-3327-7693	Cancer Research UK; Netherlands Organisation for Scientific Research	Cancer Research UK(Cancer Research UK); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was funded by Cancer Research UK. C. R. B. is a recipient of a Rubicon Fellowship from the Netherlands Organisation for Scientific Research. The authors thank A. Vigneron, B. Chaneton, M. O'Prey, E. Cheung, D. Athineos, G. Kalna, G. Mackay and B. Ludwig for advice and technical assistance.	ALMASAN A, 1995, P NATL ACAD SCI USA, V92, P5436, DOI 10.1073/pnas.92.12.5436; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dimri GP, 1996, MOL CELL BIOL, V16, P2987; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Gruning NM, 2011, NATURE, V480, P190, DOI 10.1038/480190a; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kalhan SC, 2012, J BIOL CHEM, V287, P19786, DOI 10.1074/jbc.R112.357194; Kondoh H, 2005, CANCER RES, V65, P177; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Locasale JW, 2011, CELL CYCLE, V10, P3812, DOI 10.4161/cc.10.22.18224; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Messina E, 2004, INT J CANCER, V108, P812, DOI 10.1002/ijc.11642; Okamura S, 1999, ONCOL RES, V11, P281; Pollari S, 2011, BREAST CANCER RES TR, V125, P421, DOI 10.1007/s10549-010-0848-5; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Rose ML, 1999, CARCINOGENESIS, V20, P2075, DOI 10.1093/carcin/20.11.2075; Rose ML, 1999, CARCINOGENESIS, V20, P793, DOI 10.1093/carcin/20.5.793; SNELL K, 1986, TRENDS BIOCHEM SCI, V11, P241, DOI 10.1016/0968-0004(86)90184-2; SNELL K, 1990, ADV ENZYME REGUL, V30, P13; Stambolsky P, 2006, CELL DEATH DIFFER, V13, P2140, DOI 10.1038/sj.cdd.4401965; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Vigneron AM, 2010, GENE DEV, V24, P2430, DOI 10.1101/gad.1954310; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109	33	587	607	8	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2013	493	7433					542	+		10.1038/nature11743	http://dx.doi.org/10.1038/nature11743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23242140	Green Accepted			2022-12-28	WOS:000313871400040
J	Morgan, JLW; Strumillo, J; Zimmer, J				Morgan, Jacob L. W.; Strumillo, Joanna; Zimmer, Jochen			Crystallographic snapshot of cellulose synthesis and membrane translocation	NATURE			English	Article							C-DI-GMP; ACETOBACTER-XYLINUM; STRUCTURAL BASIS; IN-VITRO; BIOSYNTHESIS; SYNTHASES; BINDING; SYSTEM; GLYCOSYLTRANSFERASES; MICROFIBRILS	Cellulose, the most abundant biological macromolecule, is an extracellular, linear polymer of glucose molecules. It represents an essential component of plant cell walls but is also found in algae and bacteria. In bacteria, cellulose production frequently correlates with the formation of biofilms, a sessile, multicellular growth form. Cellulose synthesis and transport across the inner bacterial membrane is mediated by a complex of the membrane-integrated catalytic BcsA subunit and the membrane-anchored, periplasmic BcsB protein. Here we present the crystal structure of a complex of BcsA and BcsB from Rhodobacter sphaeroides containing a translocating polysaccharide. The structure of the BcsA-BcsB translocation intermediate reveals the architecture of the cellulose synthase, demonstrates how BcsA forms a cellulose-conducting channel, and suggests a model for the coupling of cellulose synthesis and translocation in which the nascent polysaccharide is extended by one glucose molecule at a time.	[Morgan, Jacob L. W.; Strumillo, Joanna; Zimmer, Jochen] Univ Virginia, Dept Mol Physiol & Biol Phys, Ctr Membrane Biol, Charlottesville, VA 22908 USA; [Strumillo, Joanna] Univ Lodz, Fac Biol & Environm Protect, PL-90231 Lodz, Poland	University of Virginia; University of Lodz	Zimmer, J (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Ctr Membrane Biol, Charlottesville, VA 22908 USA.	jochen_zimmer@virginia.edu		Strumillo, Joanna/0000-0001-5478-2595; Zimmer, Jochen/0000-0002-8423-2882	US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357, W-31-109-Eng-38]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; Department of Energy [DE-FG02-09ER-20097]; NIH [1R01GM101001]; University of Virginia; University of Virginia School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101001] Funding Source: NIH RePORTER	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Virginia; University of Virginia School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to G. Murshudov for advice on Refmac refinement and U. and Z. Derewenda for discussions. We thank L. Tamm, M. Wiener, A. Walling and T. Rapoport for critical comments on the manuscript. X-ray diffraction data were collected at GM/CA- and Southeast Regional-Collaborative Access Team beamlines at the Advanced Photon Source (APS), Argonne National Laboratory. Use of the APS was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, contract no. DE-AC02-06CH11357 and W-31-109-Eng-38. GM/CA at APS has been funded in whole or in part with funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Sciences (Y1-GM-1104). The University of Georgia CCRC is supported by the Department of Energy funded Center for Plant and Microbial Complex Carbohydrates (DE-FG02-09ER-20097). J.L.W.M. is partially supported by a Peach Fellowship, University of Virginia. J.Z. is support by NIH grant 1R01GM101001 and start-up funds from the University of Virginia School of Medicine.	ALONI Y, 1982, P NATL ACAD SCI-BIOL, V79, P6448, DOI 10.1073/pnas.79.21.6448; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Brown RM, 2004, J POLYM SCI POL CHEM, V42, P487, DOI 10.1002/pola.10877; BUREAU TE, 1987, P NATL ACAD SCI USA, V84, P6985, DOI 10.1073/pnas.84.20.6985; Burton B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000406; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carpita NC, 2011, PLANT PHYSIOL, V155, P171, DOI 10.1104/pp.110.163360; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Daras G, 2009, NEW PHYTOL, V184, P114, DOI 10.1111/j.1469-8137.2009.02960.x; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; DOWD MK, 1992, CARBOHYD RES, V233, P15, DOI 10.1016/S0008-6215(00)90917-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grimson MJ, 1996, J CELL SCI, V109, P3079; Harris DM, 2012, P NATL ACAD SCI USA, V109, P4098, DOI 10.1073/pnas.1200352109; Hu SQ, 2010, P NATL ACAD SCI USA, V107, P17957, DOI 10.1073/pnas.1000601107; Hubbard C, 2012, J MOL BIOL, V418, P21, DOI 10.1016/j.jmb.2012.01.053; Jahn CE, 2011, MICROBIOL-SGM, V157, P2733, DOI 10.1099/mic.0.051003-0; Kimura S, 1996, PROTOPLASMA, V194, P151, DOI 10.1007/BF01882023; Koyama M, 1997, P NATL ACAD SCI USA, V94, P9091, DOI 10.1073/pnas.94.17.9091; Kozmon S, 2006, J AM CHEM SOC, V128, P16921, DOI 10.1021/ja065944o; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; Lai-Kee-Him J, 2002, J BIOL CHEM, V277, P36931, DOI 10.1074/jbc.M203530200; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; MATTHYSSE AG, 1995, J BACTERIOL, V177, P1076, DOI 10.1128/jb.177.4.1076-1081.1995; Merzendorfer H, 2006, J COMP PHYSIOL B, V176, P1, DOI 10.1007/s00360-005-0005-3; Momany FA, 2011, CARBOHYD RES, V346, P619, DOI 10.1016/j.carres.2011.01.004; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PyMol, 2000, PYMOL MOL GRAPHICS S; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rapoport TA, 2008, FEBS J, V275, P4471, DOI 10.1111/j.1742-4658.2008.06588.x; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2002, RES MICROBIOL, V153, P205, DOI 10.1016/S0923-2508(02)01316-5; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; SAXENA IM, 1994, J BACTERIOL, V176, P5735, DOI 10.1128/JB.176.18.5735-5752.1994; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; STANDAL R, 1994, J BACTERIOL, V176, P665, DOI 10.1128/jb.176.3.665-672.1994; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545	50	363	371	29	416	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					181	U192		10.1038/nature11744	http://dx.doi.org/10.1038/nature11744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23222542	Green Accepted			2022-12-28	WOS:000313259600031
J	Adrian, C				Adrian, Chris			The Question	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Columbia Univ Coll Phys & Surg, Program Narrat Med, New York, NY 10032 USA	Columbia University	Adrian, C (corresponding author), Columbia Univ Coll Phys & Surg, Program Narrat Med, 630 W 168th St, New York, NY 10032 USA.								0	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2012	367	25					2371	2373		10.1056/NEJMp1212347	http://dx.doi.org/10.1056/NEJMp1212347			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056ZP	23252524				2022-12-28	WOS:000312531600004
J	Hawkes, N				Hawkes, Nigel			BODY POLITIC You can't mandate compassion	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 18	2012	345								e8509	10.1136/bmj.e8509	http://dx.doi.org/10.1136/bmj.e8509			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IW	23249671				2022-12-28	WOS:000312698900007
J	Isbister, WH				Isbister, William H.			CHRISTMAS 2012: YESTERDAY'S WORLD Surgical thimbles	BRITISH MEDICAL JOURNAL			English	Editorial Material											Isbister, WH (corresponding author), Hangstr 4, D-90537 Feucht Moosbach, Germany.	wisbister@t-online.de						Atkins SE., 1909, BRIT MED J, V1, P356; Coulson TE., 1938, BRIT MED J, V2, P789; Cresswell Baber E., 1906, BRIT MED J, V2, P432; De C Wheeler WI., 1921, BRIT MED J, V1, P197; GLENN WWL, 1957, ANN SURG, V145, P557, DOI 10.1097/00000658-195704000-00013; Gordon D., 1875, BRIT MED J, V1, P231; Harrison E, 1916, BRIT MED J, V1916, P645, DOI 10.1136/bmj.1.2888.645; Kilvington B., 1933, BRIT MED J, V1, P41; Taylor GN, 1943, BRIT MED J, V1943, P724; Velpau AALM., 1842, BRIT MED J, V1, P483; Wheeler WID, 1931, BRIT MED J, V1931, P975, DOI 10.1136/bmj.1.3674.975	11	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 17	2012	345								e8447	10.1136/bmj.e8447	http://dx.doi.org/10.1136/bmj.e8447			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059IU	23247995				2022-12-28	WOS:000312698700022
J	Lim, SS; Vos, T; Flaxman, AD; Danaei, G; Shibuya, K; Adair-Rohani, H; Amann, M; Anderson, HR; Andrews, KG; Aryee, M; Atkinson, C; Bacchus, LJ; Bahalim, AN; Balakrishnan, K; Balmes, J; Barker-Collo, S; Baxter, A; Bell, ML; Blore, JD; Blyth, F; Bonner, C; Borges, G; Bourne, R; Boussinesq, M; Brauer, M; Brooks, P; Bruce, NG; Brunekreef, B; Bryan-Hancock, C; Bucello, C; Buchbinder, R; Bull, F; Burnett, RT; Byers, TE; Calabria, B; Carapetis, J; Carnahan, E; Chafe, Z; Charlson, F; Chen, HL; Chen, JS; Cheng, ATA; Child, JC; Cohen, A; Colson, KE; Cowie, BC; Darby, S; Darling, S; Davis, A; Degenhardt, L; Dentener, F; Des Jarlais, DC; Devries, K; Dherani, M; Ding, EL; Dorsey, ER; Driscoll, T; Edmond, K; Ali, SE; Engell, RE; Erwin, PJ; Fahimi, S; Falder, G; Farzadfar, F; Ferrari, A; Finucane, MM; Flaxman, S; Fowkes, FGR; Freedman, G; Freeman, MK; Gakidou, E; Ghosh, S; Giovannucci, E; Gmel, G; Graham, K; Grainger, R; Grant, B; Gunnell, D; Gutierrez, HR; Hall, W; Hoek, HW; Hogan, A; Hosgood, HD; Hoy, D; Hu, H; Hubbell, BJ; Hutchings, SJ; Ibeanusi, SE; Jacklyn, GL; Jasrasaria, R; Jonas, JB; Kan, HD; Kanis, JA; Kassebaum, N; Kawakami, N; Khang, YH; Khatibzadeh, S; Khoo, JP; Kok, C; Laden, F; Lalloo, R; Lan, Q; Lathlean, T; Leasher, JL; Leigh, J; Li, Y; Lin, JK; Lipshultz, SE; London, S; Lozano, R; Lu, Y; Mak, J; Malekzadeh, R; Mallinger, L; Marcenes, W; March, L; Marks, R; Martin, R; McGale, P; McGrath, J; Mehta, S; Mensah, GA; Merriman, TR; Micha, R; Michaud, C; Mishra, V; Hanafiah, KM; Mokdad, AA; Morawska, L; Mozaffarian, D; Murphy, T; Naghavi, M; Neal, B; Nelson, PK; Nolla, JM; Norman, R; Olives, C; Omer, SB; Orchard, J; Osborne, R; Ostro, B; Page, A; Pandey, KD; Parry, CDH; Passmore, E; Patra, J; Pearce, N; Pelizzari, PM; Petzold, M; Phillips, MR; Pope, D; Pope, CA; Powles, J; Rao, M; Razavi, H; Rehfuess, EA; Rehm, JT; Ritz, B; Rivara, FP; Roberts, T; Robinson, C; Rodriguez-Portales, JA; Romieu, I; Room, R; Rosenfeld, LC; Roy, A; Rushton, L; Salomon, JA; Sampson, U; Sanchez-Riera, L; Sanman, E; Sapkota, A; Seedat, S; Shi, PL; Shield, K; Shivakoti, R; Singh, GM; Sleet, DA; Smith, E; Smith, KR; Stapelberg, NJC; Steenland, K; Stockl, H; Stovner, LJ; Straif, K; Straney, L; Thurston, GD; Tran, JH; Van Dingenen, R; van Donkelaar, A; Veerman, JL; Vijayakumar, L; Weintraub, R; Weissman, MM; White, RA; Whiteford, H; Wiersma, ST; Wilkinson, JD; Williams, HC; Williams, W; Wilson, N; Woolf, AD; Yip, P; Zielinski, JM; Lopez, AD; Murray, CJL; Ezzati, M				Lim, Stephen S.; Vos, Theo; Flaxman, Abraham D.; Danaei, Goodarz; Shibuya, Kenji; Adair-Rohani, Heather; Amann, Markus; Anderson, H. Ross; Andrews, Kathryn G.; Aryee, Martin; Atkinson, Charles; Bacchus, Loraine J.; Bahalim, Adil N.; Balakrishnan, Kalpana; Balmes, John; Barker-Collo, Suzanne; Baxter, Amanda; Bell, Michelle L.; Blore, Jed D.; Blyth, Fiona; Bonner, Carissa; Borges, Guilherme; Bourne, Rupert; Boussinesq, Michel; Brauer, Michael; Brooks, Peter; Bruce, Nigel G.; Brunekreef, Bert; Bryan-Hancock, Claire; Bucello, Chiara; Buchbinder, Rachelle; Bull, Fiona; Burnett, Richard T.; Byers, Tim E.; Calabria, Bianca; Carapetis, Jonathan; Carnahan, Emily; Chafe, Zoe; Charlson, Fiona; Chen, Honglei; Chen, Jian Shen; Cheng, Andrew Tai-Ann; Child, Jennifer Christine; Cohen, Aaron; Colson, K. Ellicott; Cowie, Benjamin C.; Darby, Sarah; Darling, Susan; Davis, Adrian; Degenhardt, Louisa; Dentener, Frank; Des Jarlais, Don C.; Devries, Karen; Dherani, Mukesh; Ding, Eric L.; Dorsey, E. Ray; Driscoll, Tim; Edmond, Karen; Ali, Suad Eltahir; Engell, Rebecca E.; Erwin, Patricia J.; Fahimi, Saman; Falder, Gail; Farzadfar, Farshad; Ferrari, Alize; Finucane, Mariel M.; Flaxman, Seth; Fowkes, Francis Gerry R.; Freedman, Greg; Freeman, Michael K.; Gakidou, Emmanuela; Ghosh, Santu; Giovannucci, Edward; Gmel, Gerhard; Graham, Kathryn; Grainger, Rebecca; Grant, Bridget; Gunnell, David; Gutierrez, Hialy R.; Hall, Wayne; Hoek, Hans W.; Hogan, Anthony; Hosgood, H. Dean, III; Hoy, Damian; Hu, Howard; Hubbell, Bryan J.; Hutchings, Sally J.; Ibeanusi, Sydney E.; Jacklyn, Gemma L.; Jasrasaria, Rashmi; Jonas, Jost B.; Kan, Haidong; Kanis, John A.; Kassebaum, Nicholas; Kawakami, Norito; Khang, Young-Ho; Khatibzadeh, Shahab; Khoo, Jon-Paul; Kok, Cindy; Laden, Francine; Lalloo, Ratilal; Lan, Qing; Lathlean, Tim; Leasher, Janet L.; Leigh, James; Li, Yang; Lin, John Kent; Lipshultz, Steven E.; London, Stephanie; Lozano, Rafael; Lu, Yuan; Mak, Joelle; Malekzadeh, Reza; Mallinger, Leslie; Marcenes, Wagner; March, Lyn; Marks, Robin; Martin, Randall; McGale, Paul; McGrath, John; Mehta, Sumi; Mensah, George A.; Merriman, Tony R.; Micha, Renata; Michaud, Catherine; Mishra, Vinod; Hanafiah, Khayriyyah Mohd; Mokdad, Ali A.; Morawska, Lidia; Mozaffarian, Dariush; Murphy, Tasha; Naghavi, Mohsen; Neal, Bruce; Nelson, Paul K.; Miquel Nolla, Joan; Norman, Rosana; Olives, Casey; Omer, Saad B.; Orchard, Jessica; Osborne, Richard; Ostro, Bart; Page, Andrew; Pandey, Kiran D.; Parry, Charles D. H.; Passmore, Erin; Patra, Jayadeep; Pearce, Neil; Pelizzari, Pamela M.; Petzold, Max; Phillips, Michael R.; Pope, Dan; Pope, C. Arden, III; Powles, John; Rao, Mayuree; Razavi, Homie; Rehfuess, Eva A.; Rehm, Juergen T.; Ritz, Beate; Rivara, Frederick P.; Roberts, Thomas; Robinson, Carolyn; Rodriguez-Portales, Jose A.; Romieu, Isabelle; Room, Robin; Rosenfeld, Lisa C.; Roy, Ananya; Rushton, Lesley; Salomon, Joshua A.; Sampson, Uchechukwu; Sanchez-Riera, Lidia; Sanman, Ella; Sapkota, Amir; Seedat, Soraya; Shi, Peilin; Shield, Kevin; Shivakoti, Rupak; Singh, Gitanjali M.; Sleet, David A.; Smith, Emma; Smith, Kirk R.; Stapelberg, Nicolas J. C.; Steenland, Kyle; Stoeckl, Heidi; Stovner, Lars Jacob; Straif, Kurt; Straney, Lahn; Thurston, George D.; Tran, Jimmy H.; Van Dingenen, Rita; van Donkelaar, Aaron; Veerman, J. Lennert; Vijayakumar, Lakshmi; Weintraub, Robert; Weissman, Myrna M.; White, Richard A.; Whiteford, Harvey; Wiersma, Steven T.; Wilkinson, James D.; Williams, Hywel C.; Williams, Warwick; Wilson, Nicholas; Woolf, Anthony D.; Yip, Paul; Zielinski, Jan M.; Lopez, Alan D.; Murray, Christopher J. L.; Ezzati, Majid			A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010	LANCET			English	Article							CORONARY-HEART-DISEASE; LUNG-CANCER RISK; FINE PARTICULATE MATTER; LONG-TERM EXPOSURE; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; AIR-POLLUTION; ALCOHOL-CONSUMPTION; BLOOD-PRESSURE; OCCUPATIONAL-EXPOSURE	Background Quantification of the disease burden caused by different risks informs prevention by providing an account of health loss different to that provided by a disease-by-disease analysis. No complete revision of global disease burden caused by risk factors has been done since a comparative risk assessment in 2000, and no previous analysis has assessed changes in burden attributable to risk factors over time. Methods We estimated deaths and disability-adjusted life years (DALYs; sum of years lived with disability [YLD] and years of life lost [YLL]) attributable to the independent effects of 67 risk factors and clusters of risk factors for 21 regions in 1990 and 2010. We estimated exposure distributions for each year, region, sex, and age group, and relative risks per unit of exposure by systematically reviewing and synthesising published and unpublished data. We used these estimates, together with estimates of cause-specific deaths and DALYs from the Global Burden of Disease Study 2010, to calculate the burden attributable to each risk factor exposure compared with the theoretical-minimum-risk exposure. We incorporated uncertainty in disease burden, relative risks, and exposures into our estimates of attributable burden. Findings In 2010, the three leading risk factors for global disease burden were high blood pressure (7.0% [95% uncertainty interval 6.2-7.7] of global DALYs), tobacco smoking including second-hand smoke (6.3% [5.5-7.0]), and alcohol use (5.5% [5.0-5.9]). In 1990, the leading risks were childhood underweight (7.9% [6.8-9.4]), household air pollution from solid fuels (HAP; 7.0% [5.6-8.3]), and tobacco smoking including second-hand smoke (6.1% [5.4-6.8]). Dietary risk factors and physical inactivity collectively accounted for 10.0% (95% UI 9.2-10.8) of global DALYs in 2010, with the most prominent dietary risks being diets low in fruits and those high in sodium. Several risks that primarily affect childhood communicable diseases, including unimproved water and sanitation and childhood micronutrient deficiencies, fell in rank between 1990 and 2010, with unimproved water and sanitation accounting for 0.9% (0.4-1.6) of global DALYs in 2010. However, in most of sub-Saharan Africa childhood underweight, HAP, and non-exclusive and discontinued breastfeeding were the leading risks in 2010, while HAP was the leading risk in south Asia. The leading risk factor in Eastern Europe, most of Latin America, and southern sub-Saharan Africa in 2010 was alcohol use; in most of Asia, North Africa and Middle East, and central Europe it was high blood pressure. Despite declines, tobacco smoking including second-hand smoke remained the leading risk in high-income north America and western Europe. High body-mass index has increased globally and it is the leading risk in Australasia and southern Latin America, and also ranks high in other high-income regions, North Africa and Middle East, and Oceania. Interpretation Worldwide, the contribution of different risk factors to disease burden has changed substantially, with a shift away from risks for communicable diseases in children towards those for non-communicable diseases in adults. These changes are related to the ageing population, decreased mortality among children younger than 5 years, changes in cause-of-death composition, and changes in risk factor exposures. New evidence has led to changes in the magnitude of key risks including unimproved water and sanitation, vitamin A and zinc deficiencies, and ambient particulate matter pollution. The extent to which the epidemiological shift has occurred and what the leading risks currently are varies greatly across regions. In much of sub-Saharan Africa, the leading risks are still those associated with poverty and those that affect children.	[Lim, Stephen S.; Flaxman, Abraham D.; Andrews, Kathryn G.; Atkinson, Charles; Carnahan, Emily; Colson, K. Ellicott; Engell, Rebecca E.; Freedman, Greg; Freeman, Michael K.; Gakidou, Emmanuela; Jasrasaria, Rashmi; Lozano, Rafael; Mallinger, Leslie; Mokdad, Ali A.; Murphy, Tasha; Naghavi, Mohsen; Roberts, Thomas; Rosenfeld, Lisa C.; Sanman, Ella; Straney, Lahn; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Kassebaum, Nicholas] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98121 USA; [Baxter, Amanda; Ferrari, Alize; Khoo, Jon-Paul; Whiteford, Harvey] Univ Queensland, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Vos, Theo; Blore, Jed D.; Charlson, Fiona; Norman, Rosana; Page, Andrew; Lopez, Alan D.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [McGrath, John] Univ Queensland, Inst Brain, Brisbane, Qld, Australia; [Finucane, Mariel M.] Harvard Univ, Dept Biostat, Boston, MA 02115 USA; [Khatibzadeh, Shahab] Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA; [Danaei, Goodarz; Ding, Eric L.; Giovannucci, Edward; Laden, Francine; Lin, John Kent; Micha, Renata; Mozaffarian, Dariush; Rao, Mayuree; Salomon, Joshua A.; Singh, Gitanjali M.; White, Richard A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Mozaffarian, Dariush] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [Balmes, John] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Amann, Markus] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Anderson, H. Ross] Univ London, London, England; [Hanafiah, Khayriyyah Mohd] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Aryee, Martin] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Bacchus, Loraine J.; Child, Jennifer Christine; Devries, Karen; Edmond, Karen; Falder, Gail; Mak, Joelle; Pearce, Neil; Stoeckl, Heidi] London Sch Hyg & Trop Med, London WC1, England; [Balakrishnan, Kalpana; Ghosh, Santu] Sri Ramachandra Univ, Chennai, Tamil Nadu, India; [Barker-Collo, Suzanne] Univ Auckland, Auckland 1, New Zealand; [Bell, Michelle L.] Yale Univ, New Haven, CT USA; [Leigh, James] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Smith, Emma] Univ Sydney, No Clin Sch, Dept Rheumatol, Sydney, NSW 2006, Australia; [Chen, Jian Shen; March, Lyn; Sanchez-Riera, Lidia; Wilson, Nicholas] Univ Sydney, Inst Bone & Joint Res, Sydney, NSW 2006, Australia; [Borges, Guilherme] Natl Inst Psychiat, Mexico City, DF, Mexico; [Borges, Guilherme] Univ Nacl Autonoma Mexico, Mexico City 04510, DF, Mexico; [Bourne, Rupert] Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, England; [Brauer, Michael] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Weintraub, Robert] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Degenhardt, Louisa] Univ Melbourne, Ctr Hlth Policy Programs & Econ, Melbourne, Vic, Australia; [Room, Robin] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic, Australia; [Bruce, Nigel G.; Dherani, Mukesh; Pope, Dan] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Brunekreef, Bert] Univ Utrecht, Insititute Risk Assessment Sci, Utrecht, Netherlands; [Bryan-Hancock, Claire; Lathlean, Tim] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [Calabria, Bianca; Degenhardt, Louisa; Nelson, Paul K.] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Buchbinder, Rachelle] Cabrini Inst, Malvern, Vic, Australia; [Buchbinder, Rachelle; Hoy, Damian] Monash Univ, Melbourne, Vic 3004, Australia; [Carapetis, Jonathan] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Burnett, Richard T.; Zielinski, Jan M.] Hlth Canada, Ottawa, ON K1A 0L2, Canada; [Byers, Tim E.] Colorado Sch Publ Hlth, Aurora, CO USA; [Chen, Honglei; London, Stephanie] NIEHS, Res Triangle Pk, NC 27709 USA; [Cheng, Andrew Tai-Ann] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Cohen, Aaron] Hlth Effects Inst, Boston, MA USA; [Cowie, Benjamin C.] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [McGale, Paul] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Davis, Adrian] MRC Hearing & Commun Grp, Manchester, Lancs, England; [Dentener, Frank; Van Dingenen, Rita] Commiss European Communities, Joint Res Ctr, B-1049 Brussels, Belgium; [Des Jarlais, Don C.] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; [Ali, Suad Eltahir] Fed Minist Hlth, Khartoum, Sudan; [Erwin, Patricia J.] Mayo Clin, Rochester, MN USA; [Powles, John] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Fahimi, Saman] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Malekzadeh, Reza] Univ Tehran Med Sci, Digest Dis Res Ctr, Tehran, Iran; [Flaxman, Seth] Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; [Fowkes, Francis Gerry R.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Gmel, Gerhard] Addict Info Switzerland, Lausanne, Switzerland; [Graham, Kathryn; Rehm, Juergen T.; Shield, Kevin] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Grainger, Rebecca; Merriman, Tony R.] Univ Otago, Dunedin, New Zealand; [Lan, Qing] NCI, Occupat & Environm Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Gunnell, David] Univ Bristol, Bristol, Avon, England; [Weissman, Myrna M.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Gutierrez, Hialy R.; Weissman, Myrna M.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Hoek, Hans W.] Parnassia Psychiat Inst, The Hague, Netherlands; [Hogan, Anthony] Australian Natl Univ, Canberra, ACT, Australia; [Hosgood, H. Dean, III] Yeshiva Univ, Albert Einstein Coll Med, New York, NY 10033 USA; [Hu, Howard] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Hubbell, Bryan J.] US EPA, Washington, DC 20460 USA; [Hutchings, Sally J.; Rushton, Lesley; Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England; [Ibeanusi, Sydney E.] Univ Port Harcourt, Port Harcourt, Nigeria; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Heidelberg, Germany; [Kan, Haidong] Fudan Univ, Shanghai 200433, Peoples R China; [Kanis, John A.] Univ Sheffield, Sheffield, S Yorkshire, England; [Khang, Young-Ho] Univ Ulsan, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kok, Cindy] Spinal Cord Injury Network, Glebe, New Zealand; [Lalloo, Ratilal] Griffith Univ, Sch Dent & Oral Hlth, Brisbane, Qld 4111, Australia; [Lalloo, Ratilal] Griffith Univ, Populat & Social Hlth Res Program, Brisbane, Qld 4111, Australia; [Leasher, Janet L.] Nova SE Univ, Ft Lauderdale, FL 33314 USA; [Li, Yang] George Inst Global Hlth, Crit Care & Trauma Div, Sydney, NSW, Australia; [Lipshultz, Steven E.; Wilkinson, James D.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Marcenes, Wagner] Queen Mary Univ London, London, England; [Martin, Randall; van Donkelaar, Aaron] Dalhousie Univ, Halifax, NS, Canada; [Mehta, Sumi] Global Alliance Clean Cookstoves, Washington, DC USA; [Mensah, George A.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Micha, Renata] Agr Univ Athens, Athens, Greece; [Michaud, Catherine] China Med Board, Boston, MA USA; [Mishra, Vinod] United Nations Populat Div, New York, NY USA; [Morawska, Lidia] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Miquel Nolla, Joan] Hosp Univ Bellvitge, Inst Invest Biomed Bellvitge, Dept Rheumatol, Barcelona, Spain; [Omer, Saad B.; Steenland, Kyle] Emory Univ, Sch Publ Hlth, Atlanta, GA USA; [Omer, Saad B.] Emory Univ, Sch Med, Atlanta, GA USA; [Osborne, Richard] Deakin Univ, Melbourne, Vic, Australia; [Ostro, Bart] Calif Environm Protect Agcy, Sacramento, CA USA; [Pandey, Kiran D.] World Bank, Washington, DC 20433 USA; [Parry, Charles D. H.] S African MRC, Cape Town, South Africa; [Patra, Jayadeep] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Pelizzari, Pamela M.] Ctr Medicare & Medicaid Serv, Baltimore, MD USA; [Petzold, Max] Univ Gothenburg, Sahlgrenska Acad, Ctr Appl Biostat, Gothenburg, Sweden; [Phillips, Michael R.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Pope, C. Arden, III] Brigham Young Univ, Provo, UT 84602 USA; [Razavi, Homie] Ctr Dis Anal, Louisville, CO USA; [Rehfuess, Eva A.] Univ Munich, Munich, Germany; [Ritz, Beate] Univ Calif Los Angeles, Los Angeles, CA USA; [Robinson, Carolyn] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Rodriguez-Portales, Jose A.] Pontificia Univ Catolica Chile, Santiago, Chile; [Romieu, Isabelle; Straif, Kurt] Int Agcy Res Canc, F-69372 Lyon, France; [Room, Robin] Turning Point Alcohol & Drug Ctr, Ctr Alcohol Policy Res, Fitzroy, SA, Australia; [Roy, Ananya] Univ Med & Dent New Jersey, Newark, NJ 07103 USA; [Sampson, Uchechukwu] Vanderbilt Univ, Nashville, TN USA; [Sapkota, Amir] Univ Maryland, Sch Publ Hlth, Baltimore, MD 21201 USA; [Seedat, Soraya] Univ Stellenbosch, ZA-7600 Stellenbosch, South Africa; [Sleet, David A.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Baltimore, MD USA; [Stovner, Lars Jacob] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Thurston, George D.] NYU, New York, NY USA; [Vijayakumar, Lakshmi] Voluntary Hlth Serv, Chennai, Tamil Nadu, India; [Weintraub, Robert] Royal Childrens Hosp, Melbourne, Vic, Australia; [Weintraub, Robert] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Williams, Hywel C.] Univ Nottingham, Nottingham NG7 2RD, England; [Williams, Warwick] Natl Acoust Labs, Sydney, NSW, Australia; [Woolf, Anthony D.] Royal Cornwall Hosp, Truro, England; [Yip, Paul] Univ Hong Kong, Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Queensland Centre for Mental Health Research; University of Queensland; University of Queensland; University of Queensland; Harvard University; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; University of Tokyo; University of California System; University of California Berkeley; International Institute for Applied Systems Analysis (IIASA); University of London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of London; London School of Hygiene & Tropical Medicine; Sri Ramachandra Institute of Higher Education & Research; University of Auckland; Yale University; University of Sydney; University of Sydney; University of Sydney; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Universidad Nacional Autonoma de Mexico; Anglia Ruskin University; University of British Columbia; University of Melbourne; University of Melbourne; University of Melbourne; University of Liverpool; Utrecht University; Flinders University South Australia; University of New South Wales Sydney; Cabrini Health; Monash University; Telethon Kids Institute; University of Western Australia; Health Canada; Colorado School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Academia Sinica - Taiwan; Health Effects Institute (HEI); Victorian Infectious Diseases Reference Laboratory; University of Oxford; European Commission Joint Research Centre; Harvard University; Beth Israel Deaconess Medical Center; Mayo Clinic; University of Cambridge; University of Cambridge; Tehran University of Medical Sciences; Carnegie Mellon University; University of Edinburgh; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Otago; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Bristol; Columbia University; Columbia University; Parnassia Psychiatric Institute; Australian National University; Yeshiva University; University of Toronto; United States Environmental Protection Agency; Imperial College London; University of Port Harcourt; Ruprecht Karls University Heidelberg; Fudan University; University of Sheffield; University of Ulsan; Griffith University; Griffith University; Nova Southeastern University; George Institute for Global Health; University of Sydney; University of Miami; University of London; Queen Mary University London; Dalhousie University; University of Cape Town; Agricultural University of Athens; Queensland University of Technology (QUT); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Emory University; Emory University; Deakin University; California Environmental Protection Agency; The World Bank; South African Medical Research Council; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Centers for Medicare & Medicaid Services; University of Gothenburg; Shanghai Jiao Tong University; Brigham Young University; University of Munich; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; Pontificia Universidad Catolica de Chile; World Health Organization; International Agency for Research on Cancer (IARC); Turning Point Alcohol & Drug Centre - Australia; Rutgers State University New Brunswick; Rutgers State University Medical Center; Vanderbilt University; University System of Maryland; University of Maryland Baltimore; Stellenbosch University; Centers for Disease Control & Prevention - USA; Norwegian University of Science & Technology (NTNU); New York University; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Nottingham; National Acoustic Laboratories; Royal Cornwall Hospital; University of Hong Kong	Lim, SS (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	stevelim@uw.edu	Malekzadeh, Reza/U-1382-2017; Cowie, Benjamin/HFZ-9941-2022; Boussinesq, Michel/J-7256-2016; Ferrari, Alize J/G-1746-2011; London, Stephanie/C-3734-2019; Hall, Wayne D/A-3283-2008; Kan, Haidong/AGU-0328-2022; Adair-Rohani, Heather/GXN-2766-2022; Gunnell, David/ABE-6653-2020; Degenhardt, Louisa J/D-4515-2012; Lalloo, Ratilal/O-5624-2014; Aryee, Martin/AAC-8113-2020; Davis, Adrian C/E-6022-2015; Balakrishnan, Kalpana/B-6653-2015; Bell, Michelle/Y-4608-2018; Pope, Daniel P/C-3054-2014; Lathlean, Tim/K-3653-2013; Ghosh, Santu/GQQ-0168-2022; Phillips, Michael Robert/AAE-7585-2021; Brauer, Michael/Y-2810-2019; Baxter, Amanda/E-5449-2011; Osborne, Richard H/A-9447-2010; Salomon, Joshua A/D-3898-2009; McGrath, John Joseph/G-5493-2010; bagheri, zeinab/AAH-2691-2021; Shield, Kevin/AAR-8220-2020; Carapetis, Jonathan R/H-8933-2014; Van Dingenen, Rita/AAI-3197-2021; Room, Robin/ABH-8505-2020; Parry, Charles/A-2906-2009; Room, Robin/ABF-7460-2021; Lopez, Alan/AAA-2734-2022; Reid, David W/B-3263-2011; Ritz, Beate R/E-3043-2015; Charlson, Fiona J/F-5290-2011; Lozano, Rafael/T-5352-2018; Stovner, Lars Jacob/D-5025-2014; Orchard, Jessica/O-4350-2019; Bacchus, Loraine/J-9996-2016; Rao, Rahul/P-7158-2014; Cheng, Andrew/O-1159-2018; van Donkelaar, Aaron/AAF-8355-2021; Pope, C. Arden/ABD-5522-2021; Ding, Eric L./K-1118-2019; Anderson, Hugh R/A-7417-2016; Hu, Howard/AAV-5360-2021; Lopez, Alan D/F-1487-2010; PACELLA, ROSANA E./F-2774-2010; Buchbinder, Rachelle/G-2952-2011; Martin, Randall/C-1205-2014; Salomon, Joshua/S-1929-2019; Sapkota, Amir/A-5968-2011; Charlson, Fiona/R-8963-2019; Stockwell, Tim/B-6662-2012; Bull, Fiona C/G-4148-2012; Rehfuess, Eva Annette/ABD-8167-2021; Veerman, Lennert/A-9973-2011; Whiteford, Harvey A/A-4840-2009; Hubbell, Bryan/AAA-2511-2020; Thurston, George/ABB-1359-2021; Balmes, John/L-6281-2019; Mokdad, Ali H./AAD-1232-2022; Grainger, Rebecca/I-1866-2012; Orchard, Jessica/E-2078-2013; Blore, Jed/K-6331-2012; Lu, Yuan/D-4941-2015; Devries, Karen/K-1083-2016; Morawska, Lidia/B-4140-2011; Shivakoti, Rupak/HIU-0448-2022; Leasher, Janet/B-8889-2016	Malekzadeh, Reza/0000-0002-9820-6335; Cowie, Benjamin/0000-0002-7087-5895; Boussinesq, Michel/0000-0001-6312-0681; Ferrari, Alize J/0000-0002-7863-9117; London, Stephanie/0000-0003-4911-5290; Hall, Wayne D/0000-0003-1984-0096; Gunnell, David/0000-0002-0829-6470; Degenhardt, Louisa J/0000-0002-8513-2218; Lalloo, Ratilal/0000-0001-5822-1269; Davis, Adrian C/0000-0001-7134-7528; Balakrishnan, Kalpana/0000-0002-5905-1801; Bell, Michelle/0000-0002-3965-1359; Ghosh, Santu/0000-0002-9373-9570; Phillips, Michael Robert/0000-0002-5973-2439; Brauer, Michael/0000-0002-9103-9343; Baxter, Amanda/0000-0001-8198-9022; Osborne, Richard H/0000-0002-9081-2699; Salomon, Joshua A/0000-0003-3929-5515; McGrath, John Joseph/0000-0002-4792-6068; Carapetis, Jonathan R/0000-0002-1182-9792; Van Dingenen, Rita/0000-0003-2521-4972; Parry, Charles/0000-0001-9787-2785; Room, Robin/0000-0002-5618-385X; Charlson, Fiona J/0000-0003-2876-5040; Lozano, Rafael/0000-0002-7356-8823; Orchard, Jessica/0000-0002-5702-7277; Bacchus, Loraine/0000-0002-9966-8208; Cheng, Andrew/0000-0002-2698-0516; Ding, Eric L./0000-0002-5881-8097; Lopez, Alan D/0000-0001-5818-6512; PACELLA, ROSANA E./0000-0002-9742-1957; Buchbinder, Rachelle/0000-0002-0597-0933; Martin, Randall/0000-0003-2632-8402; Salomon, Joshua/0000-0003-3929-5515; Charlson, Fiona/0000-0003-2876-5040; Veerman, Lennert/0000-0002-3206-8232; Whiteford, Harvey A/0000-0003-4667-6623; Hubbell, Bryan/0000-0002-7963-3438; Mokdad, Ali H./0000-0002-4994-3339; Grainger, Rebecca/0000-0001-9201-8678; Orchard, Jessica/0000-0002-5702-7277; Hoek, Hans/0000-0001-6353-5465; Smith, Emma/0000-0001-6510-2583; Child, Jennifer/0000-0001-5115-8164; Razavi, Homie/0000-0002-2658-6930; brunekreef, bert/0000-0001-9908-0060; Woolf, Anthony/0000-0001-8482-8056; Weissman, Myrna/0000-0003-3490-3075; Stockl, Heidi/0000-0002-0907-8483; Chen, Honglei/0000-0003-3446-7779; Straney, Lahn/0000-0002-2615-2366; Blore, Jed/0000-0002-3649-8686; Merriman, Tony/0000-0003-0844-8726; Dherani, Mukesh/0000-0002-3055-9636; Shield, Kevin/0000-0003-1871-8849; Chafe, Zoe/0000-0001-6670-6979; Hu, Howard/0000-0002-3676-2707; Lu, Yuan/0000-0001-5264-2169; Powles, John/0000-0002-0766-7989; WILKINSON, JAMES/0000-0003-1945-5622; Lin, John/0000-0003-2490-4453; Jacklyn, Gemma/0000-0002-4814-3241; Hogan, Anthony/0000-0002-8557-9589; Pope, Daniel/0000-0003-2694-5478; Devries, Karen/0000-0001-8935-2181; Seedat, Soraya/0000-0002-5118-786X; Farzadfar, Farshad/0000-0001-8288-4046; williams, hywel/0000-0002-5646-3093; Pelizzari, Pamela/0000-0002-6992-9462; O'donnell, Colm/0000-0002-8004-450X; Morawska, Lidia/0000-0002-0594-9683; Khang, Young-Ho/0000-0002-9585-8266; Shibuya, Kenji/0000-0003-2528-7530; Bonner, Carissa/0000-0002-4797-6460; Sanchez Riera, Lidia/0000-0003-0774-2480; Mensah, George/0000-0002-0387-5326; Gmel, Gerhard/0000-0001-9403-9405; Shivakoti, Rupak/0000-0002-2773-9310; White, Richard Aubrey/0000-0002-6747-1726; Pearce, Neil/0000-0002-9938-7852; Ghosh, Santu/0000-0003-1358-3471; Malekzadeh, Reza/0000-0003-1043-3814; Leasher, Janet/0000-0002-8779-5162; Neal, Bruce/0000-0002-0490-7465; Lathlean, Timothy/0000-0001-7340-1567; Calabria, Bianca/0000-0001-6444-4696; Borges, Guilherme/0000-0002-3269-0507	Lundbeck; Prana Biotechnology; Abbott; Amgen; AstraZeneca; George Clinical; GlaxoSmithKline; Novartis; PepsiCo; Pfizer; Pharmacy Guild of Australia; Roche; Sanofi-Aventis; Seervier; Tanabe; Australian Food and Grocery Council; Bupa Australia; Johnson and Johnson; Merck Schering-Plough; Servier; United Healthcare Group; Imperial College London (as PI) from the European Chemical Industry Council; CONCAWE; USEPA; Shell Foundation; Fight for Sight; Australian National Health and Medical Research Council; Monash University; Cabrini Health; Health Effects Institute; William and Flora Hewlett Foundation; Cancer Research UK; Safework Australia; Johns Hopkins Vaccine Initiative Scholarship; WHO; Parnassia Psychiatric Institute, The Hague, Netherlands; Department of Psychiatry, University Medical Center Groningen, University of Groningen, Netherlands; World Mental Health Japan; Grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Japan Ministry of Health, Labour, and Welfare [H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013]; Intramural Research Program of the NIH (National Cancer Institute); Division of Intramural Research, National Institute of Environmental Health Sciences, USA; Australian Research Council Future Fellowship; National Health and Medical Research Council of Australia Senior Research Fellowship; Munich Centre of Health Sciences; Foundation for Alcohol Research and Education; Victorian Department of Health; Burke Global Health Fellowship; Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; Spanish Society of Rheumatology; South African Research Chairs Initiative; National Research Foundation; National Institute of Environmental Health Sciences [ES00260]; UK Medical Research Council (MRC); National Institute for Health Research Comprehensive Biomedical research Centre at Imperial College Healthcare NHS Trust; Nutrition Impact Model Study (NIMS); Bill & Melinda Gates Foundation; Spanish Rheumatology Association; Institute of Bone and Joint Research; University of Sydney; Medical Research Council [MC_U137686857, G0801056B] Funding Source: researchfish; MRC [MC_U137686857] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [ZIACP010121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES043012, P30ES000260, ZIAES101986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC1AG035616] Funding Source: NIH RePORTER	Lundbeck(Lundbeck Corporation); Prana Biotechnology; Abbott(Abbott Laboratories); Amgen(Amgen); AstraZeneca(AstraZeneca); George Clinical; GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); PepsiCo; Pfizer(Pfizer); Pharmacy Guild of Australia; Roche(Roche Holding); Sanofi-Aventis(Sanofi-Aventis); Seervier; Tanabe; Australian Food and Grocery Council; Bupa Australia; Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Merck Schering-Plough(Merck & CompanySchering Plough Corporation); Servier(Servier); United Healthcare Group; Imperial College London (as PI) from the European Chemical Industry Council; CONCAWE; USEPA(United States Environmental Protection Agency); Shell Foundation; Fight for Sight; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University); Cabrini Health; Health Effects Institute; William and Flora Hewlett Foundation; Cancer Research UK(Cancer Research UK); Safework Australia; Johns Hopkins Vaccine Initiative Scholarship; WHO(World Health Organization); Parnassia Psychiatric Institute, The Hague, Netherlands; Department of Psychiatry, University Medical Center Groningen, University of Groningen, Netherlands; World Mental Health Japan; Grant for Research on Psychiatric and Neurological Diseases and Mental Health from the Japan Ministry of Health, Labour, and Welfare; Intramural Research Program of the NIH (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Division of Intramural Research, National Institute of Environmental Health Sciences, USA; Australian Research Council Future Fellowship(Australian Research Council); National Health and Medical Research Council of Australia Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Munich Centre of Health Sciences; Foundation for Alcohol Research and Education; Victorian Department of Health; Burke Global Health Fellowship; Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; Vanderbilt Clinical and Translational Scholars Award; Spanish Society of Rheumatology; South African Research Chairs Initiative; National Research Foundation; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Comprehensive Biomedical research Centre at Imperial College Healthcare NHS Trust; Nutrition Impact Model Study (NIMS); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Spanish Rheumatology Association; Institute of Bone and Joint Research; University of Sydney(University of Sydney); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	A Davis is employed by the NHS on works for the UK Dept of Health as lead adviser on audiology. E R Dorsey has been a consultant for Medtronic and Lundbeck and has received grant support from Lundbeck and Prana Biotechnology. M Ezzati chaired a session and gave a talk at the World Cardiology Congress (WCC), with travel cost reimbursed by the World Heart Federation. At the WCC, he also gave a talk at a session organised by Pepsico with no financial remuneration. G A Mensah is a former employee of PepsiCo. D Mozaffarian has received: ad hoc travel reimbursement and/or honoraria for one-time specific presentations on diet and cardiometabolic diseases from Nutrition Impact (9/10), the International Life Sciences Institute (12/10), Bunge (11/11), Pollock Institute (3/12), and Quaker Oats (4/12; modest); and Unilever's North America Scientific Advisory Board (modest). B Neal is the Chair of the Australian Division of World Action on Salt and Health. He has consulted to Roche and Takeda. He has received lecture fees, travel fees, or reimbursements from Abbott, Amgen, AstraZeneca, George Clinical, GlaxoSmithKline, Novartis, PepsiCo, Pfizer, Pharmacy Guild of Australia, Roche, Sanofi-Aventis, Seervier, and Tanabe. He holds research support from the Australian Food and Grocery Council, Bupa Australia, Johnson and Johnson, Merck Schering-Plough, Roche, Servier, and United Healthcare Group. He is not employed by a commercial entity and has no equity ownership or stock options, patents or royalties, or any other financial or non-financial support that might be viewed as a conflict of interest. L Rushton received honorarium for board membership of the European Centre for Ecotoxicology and Toxicology of Chemicals and research grants to Imperial College London (as PI) from the European Chemical Industry Council and CONCAWE.; We thank the countless individuals who have contributed to the Global Burden of Disease Study 2010 in various capacities. We specifically acknowledge the important contribution to this work from multiple staff members of the World Health Organization. We also thank the following organisations that hosted consultations during the final stages of the analytical process, providing valuable feedback about the results and the data to improve the study's findings overall: Pan American Health Organization; Eastern Mediterranean Regional Office of WHO; UNAIDS; Ministry of Health, Brazil; China Centers for Disease Control; and the University of Zambia. We thank Regina Guthold, Jordis Ott, Annette Pruss-Ustun, and Gretchen A Stevens for their collaboration and input into the analyses and estimates. Finally, we acknowledge the extensive support from all staff members at the Institute for Health Metrics and Evaluation and specifically thank: James Bullard, Andrew Ernst, and Serkan Yalcin for their tireless support of the computational infrastructure required to produce the results; Linda A Ettinger for her expert administrative support to facilitate communication and coordination amongst the authors; Peter Speyer, Abigail McLain, Katherine Leach-Kemon, and Eden Stork for their persistent and valuable work to gain access to and catalogue as much data as possible to inform the estimates; and Erin C Mullany for her systematic efforts in organising drafts of papers, formatting correspondence with expert groups, and preparing the final manuscript. J Balmes, Z Chafe, and K R Smith acknowledge that their aspects of the research were also supported by USEPA and the Shell Foundation, neither of which had any role in design, data collection, analysis, interpretation, or decisions related to publication. R Bourne acknowledges Institutional Support: Vision & Eye Research Unit, Postgraduate Medical Institute, Anglia Ruskin University, Cambridge, UK. Funding support: Fight for Sight (Dr Hans and Mrs Gertrude Hirsch award). R Buchbinder was partially supported by an Australian National Health and Medical Research Council Practitioner Fellowship, Monash University, and Cabrini Health. A J Cohen received support from the Health Effects Institute and The William and Flora Hewlett Foundation. S Darby was supported by Cancer Research UK. L Degenhardt was supported by an Australian National Health and Medical Research Council Senior Research Fellowship. T Driscoll was supported in part by funding from the National Occupational Health and Safety Commission (now Safework Australia). K M Hanafiah's work for the GBD hepatitis C prevalence study was funded partly by Johns Hopkins Vaccine Initiative Scholarship and partly by WHO. H W Hoek acknowledges the support of: the Parnassia Psychiatric Institute, The Hague, Netherlands; the Department of Psychiatry, University Medical Center Groningen, University of Groningen, Netherlands; and the Department of Epidemiology, Columbia University, New York, USA. D Hoy was supported by the Bill & Melinda Gates Foundation and the Australian National Health and Medical Research Council. N Kawakami notes that data used in the study was collected through support from the following grants: The World Mental Health Japan is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013) from the Japan Ministry of Health, Labour, and Welfare. He thanks staff members, filed coordinators, and interviewers of the WMH Japan 2002-2004 Survey.; Q Lan was supported in part by the Intramural Research Program of the NIH (National Cancer Institute). S London is supported by the Division of Intramural Research, National Institute of Environmental Health Sciences, USA. T R Merriman acknowledges the Health Research Council of New Zealand. B Neal was supported in his contribution to this work by an Australian Research Council Future Fellowship and a National Health and Medical Research Council of Australia Senior Research Fellowship. C Olives was supported in his contribution to this work by an Australian Research Council Future Fellowship and a National Health and Medical Research Council of Australia Senior Research Fellowship. E A Rehfuess acknowledges financial support from the Munich Centre of Health Sciences. R Room's position at the University of Melbourne and Turning Point Alcohol and Drug Centre is funded by the Foundation for Alcohol Research and Education and the Victorian Department of Health. J A Salomon received support from the Burke Global Health Fellowship while working on this study. U Sampson was supported in part by: The Harold Amos Medical Faculty Development Award of the Robert Wood Johnson Foundation; The Vanderbilt Clinical and Translational Scholars Award. L Sanchez-Riera acknowledges the Spanish Society of Rheumatology for their funds. S Seedat is supported by the South African Research Chairs Initiative, hosted by the Department of Science and Technology and the National Research Foundation. G D Thurston was supported in part by grant ES00260 from the National Institute of Environmental Health Sciences. J M Zielinski acknowledges institutional support from: Health Canada, University of Ottawa, and WHO (International Radon Project). M Ezzati's research is supported by a Strategic Award from the UK Medical Research Council (MRC) and by the National Institute for Health Research Comprehensive Biomedical research Centre at Imperial College Healthcare NHS Trust. Work on micronutrient deficiencies was supported by the Nutrition Impact Model Study (NIMS) funded by the Bill & Melinda Gates Foundation. The GBD Osteoporosis Expert Group was supported by the Spanish Rheumatology Association, Institute of Bone and Joint Research, University of Sydney. The GBD Osteoporosis Expert Group also acknowledges the contributions made by Professor Philip Sambrook who passed away in April, 2012.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Amiraslani F, 2011, J ENVIRON MANAGE, V92, P1, DOI 10.1016/j.jenvman.2010.08.012; [Anonymous], 2007, EUR J EPIDEMIOL, V22, P839, DOI 10.1007/s10654-007-9165-7; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Armstrong B, 2004, ENVIRON HEALTH PERSP, V112, P970, DOI 10.1289/ehp.6895; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Baan R, 2007, LANCET ONCOL, V8, P292, DOI 10.1016/S1470-2045(07)70099-2; Bailis R, 2005, SCIENCE, V308, P98, DOI 10.1126/science.1106881; Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; Balkau B, 2000, DIABETES METAB, V26, P282; Baumgartner J, 2011, ENVIRON HEALTH PERSP, V119, P1390, DOI 10.1289/ehp.1003371; Begg SJ, 2008, MED J AUSTRALIA, V188, P36, DOI 10.5694/j.1326-5377.2008.tb01503.x; Beydoun HA, 2012, SOC SCI MED, V75, P959, DOI 10.1016/j.socscimed.2012.04.025; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Brauer M, 2012, ENVIRON SCI TECHNOL, V46, P652, DOI 10.1021/es2025752; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Burnett RT, UNIFIED RIS IN PRESS; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; Camargo MC, 2011, ENVIRON HEALTH PERSP, V119, P1211, DOI 10.1289/ehp.1003283; Centers for Disease Control and Prevention, 2020, CHILDH LEAD POIS; Cho E, 2004, JNCI-J NATL CANCER I, V96, P1015, DOI 10.1093/jnci/djh185; Clasen TF, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007180.pub2; Cogswell ME, 2003, AM J CLIN NUTR, V78, P773, DOI 10.1093/ajcn/78.4.773; Collins JJ, 2004, REGUL TOXICOL PHARM, V40, P81, DOI 10.1016/j.yrtph.2004.04.006; Committee on the Medical Effects of Air Pollutants (COMEAP), 2009, LONG TERM EXP AIR PO; Cooke RM, 2007, ENVIRON SCI TECHNOL, V41, P6598, DOI 10.1021/es0714078; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Darby S, 2005, BMJ-BRIT MED J, V330, P223, DOI 10.1136/bmj.38308.477650.63; Das P, 2012, LANCET, V380, P189, DOI 10.1016/S0140-6736(12)61024-1; de Munter JSL, 2007, PLOS MED, V4, P1385, DOI 10.1371/journal.pmed.0040261; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; Dionisio KL, 2010, ENVIRON HEALTH PERSP, V118, P607, DOI 10.1289/ehp.0901365; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2005, CIRCULATION, V112, P489, DOI 10.1161/CIRCULATIONAHA.104.521708; Ezzati M, 2005, INT J CANCER, V116, P963, DOI 10.1002/ijc.21100; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Ezzati M., 2004, COMP QUANTIFICATION; Farzadfar F, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-55; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Fink G, 2011, INT J EPIDEMIOL, V40, P1196, DOI 10.1093/ije/dyr102; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fiore AM, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010816; Foote C, EFFECT BLOOD P UNPUB; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; Foti DJ, 2010, AM J PSYCHIAT, V167, P987, DOI 10.1176/appi.ajp.2010.09020189; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857; Goodman M, 1999, CANCER CAUSE CONTROL, V10, P453, DOI 10.1023/A:1008980927434; Grimsrud TK, 2006, OCCUP ENVIRON MED, V63, P365, DOI 10.1136/oem.2005.026336; Grimsrud TK, 2005, EPIDEMIOLOGY, V16, P146, DOI 10.1097/01.ede.0000152902.48916.d7; Hauptmann M, 2004, AM J EPIDEMIOL, V159, P1117, DOI 10.1093/aje/kwh174; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; He FJ, 2007, J HUM HYPERTENS, V21, P717, DOI 10.1038/sj.jhh.1002212; He K, 2004, CIRCULATION, V109, P2705, DOI 10.1161/01.CIR.0000132503.19410.6B; He K, 2004, STROKE, V35, P1538, DOI 10.1161/01.STR.0000130856.31468.47; Health Effects Institute, 2010, PROD HEI WORKSH FURT; HEI Accountability Working Group, 2003, ASS HLTH IMP AIR QUA; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P655, DOI 10.1001/jama.295.6.655; Hu FB, 2000, AM J CLIN NUTR, V72, P912; Hu FB, 2012, ARCH INTERN MED, V172, P694, DOI 10.1001/archinternmed.2012.463; Huijnen V, 2010, GEOSCI MODEL DEV, V3, P445, DOI 10.5194/gmd-3-445-2010; Hutchings S, 2011, AM J EPIDEMIOL, V173, P1069, DOI 10.1093/aje/kwq434; Hutchings SJ, 2012, BRIT J CANCER, V107, pS8, DOI 10.1038/bjc.2012.113; Ikeda N, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001160; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S20; Imdad A, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008524.pub2, 10.1002/14651858.CD008524.pub4]; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Irving HM, 2009, J PANCREAS, V10, P387; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Johnston FH, 2012, ENVIRON HEALTH PERSP, V120, P695, DOI 10.1289/ehp.1104422; Jones LL, 2012, ARCH PEDIAT ADOL MED, V166, P18, DOI 10.1001/archpediatrics.2011.158; Jones LL, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-5; Karjalainen A, 2002, SCAND J WORK ENV HEA, V28, P49, DOI 10.5271/sjweh.646; Karjalainen A, 2001, AM J RESP CRIT CARE, V164, P565, DOI 10.1164/ajrccm.164.4.2012146; Kelly JH, 2006, BRIT J NUTR, V96, pS61, DOI 10.1017/BJN20061865; Khalade A, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-31; KING G, 2000, AM J POLIT SCI, V0044; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kogevinas M, 1999, LANCET, V353, P1750, DOI 10.1016/S0140-6736(98)07397-8; Krewski Daniel, 2009, Res Rep Health Eff Inst, P5; Kurihara N, 2004, IND HEALTH, V42, P303, DOI 10.2486/indhealth.42.303; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lawes CMM, 2004, DIABETES CARE, V27, P2836; Lawes CMM, 2003, J HYPERTENS, V21, P707, DOI 10.1097/01.hjh.0000052492.18130.07; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; LEEFELDSTEIN A, 1986, J OCCUP ENVIRON MED, V28, P296; Lepeule J, 2012, ENVIRON HEALTH PERSP, V120, P965, DOI 10.1289/ehp.1104660; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lipsett M, 1999, AM J PUBLIC HEALTH, V89, P1009, DOI 10.2105/AJPH.89.7.1009; Lipsett MJ, 2011, AM J RESP CRIT CARE, V184, P828, DOI 10.1164/rccm.201012-2082OC; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lukacik M, 2008, PEDIATRICS, V121, P326, DOI 10.1542/peds.2007-0921; Martinez-Gonzalez MA, 2011, NUTR METAB CARDIOVAS, V21, P237, DOI 10.1016/j.numecd.2009.10.005; Mellen PB, 2008, NUTR METAB CARDIOVAS, V18, P283, DOI 10.1016/j.numecd.2006.12.008; Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mozaffarian D, 2009, EUR J CLIN NUTR, V63, pS22, DOI 10.1038/sj.ejcn.1602976; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Murray C.J.L., 2004, COMP QUANTIFICATION, V1, P257, DOI DOI 10.1007/S12263-011-0248-4; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 1999, EPIDEMIOLOGY, V10, P594, DOI 10.1097/00001648-199909000-00029; Murray CJL, 1996, GLOBAL BURDEN DIS CO; Navas-Acien A, 2008, EPIDEMIOLOGY, V19, P496, DOI 10.1097/EDE.0b013e31816a2400; Nelson DI, 2005, AM J IND MED, V48, P400, DOI 10.1002/ajim.20211; Norman R, 2007, SAMJ S AFR MED J, V97, P637; Normile D, 2007, SCIENCE, V317, P314, DOI 10.1126/science.317.5836.314; Oono IP, 2011, J PUBLIC HEALTH-UK, V33, P496, DOI 10.1093/pubmed/fdr025; Oza S, 2011, PREV MED, V52, P428, DOI 10.1016/j.ypmed.2011.04.007; Paciorek P, 2003, NONSTATIONARY GAUSSI; Pan A, 2011, AM J CLIN NUTR, V94, P1088, DOI 10.3945/ajcn.111.018978; Patra J, 2011, BJOG-INT J OBSTET GY, V118, P1411, DOI 10.1111/j.1471-0528.2011.03050.x; Patra J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-258; Pereira MA, 2004, ARCH INTERN MED, V164, P370, DOI 10.1001/archinte.164.4.370; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Pope CA, 2011, ENVIRON HEALTH PERSP, V119, P1616, DOI 10.1289/ehp.1103639; Pope CA, 2011, AIR QUAL ATMOS HLTH, V4, P5, DOI 10.1007/s11869-010-0082-7; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Pope CA, 2009, NEW ENGL J MED, V360, P376, DOI 10.1056/NEJMsa0805646; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; PRESTON SH, 1978, POP STUD-J DEMOG, V32, P275, DOI 10.2307/2173562; Puett RC, 2009, ENVIRON HEALTH PERSP, V117, P1697, DOI 10.1289/ehp.0900572; Rake C, 2009, BRIT J CANCER, V100, P1175, DOI 10.1038/sj.bjc.6604879; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Roerecke M, 2011, ALCOHOL CONSUMPTION; Roerecke M, 2010, AM J EPIDEMIOL, V171, P633, DOI 10.1093/aje/kwp451; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Rosenman KD, 1996, AM J IND MED, V29, P491, DOI 10.1002/(SICI)1097-0274(199605)29:5<491::AID-AJIM7>3.0.CO;2-P; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V104, P587, DOI 10.1093/oxfordjournals.aje.a112335; Samokhvalov AV, 2010, EPIDEMIOL INFECT, V138, P1789, DOI 10.1017/S0950268810000774; Samokhvalov AV, 2010, EUR J CARDIOV PREV R, V17, P706, DOI 10.1097/HJR.0b013e32833a1947; Samokhvalov AV, 2010, EPILEPSIA, V51, P1177, DOI 10.1111/j.1528-1167.2009.02426.x; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sazawal S, 2007, LANCET, V369, P927, DOI 10.1016/S0140-6736(07)60452-8; Schubauer-Berigan MK, 2011, OCCUP ENVIRON MED, V68, P354, DOI 10.1136/oem.2010.056515; Shield K., 2011, SUCHT, V57, P99, DOI DOI 10.1024/0939-5911.a000100; SLATTERY ML, 1988, AM J CLIN NUTR, V47, P1060, DOI 10.1093/ajcn/47.6.1060; Smith KR, 2011, LANCET, V378, P1717, DOI 10.1016/S0140-6736(11)60921-5; SOSKOLNE CL, 1992, SCAND J WORK ENV HEA, V18, P225, DOI 10.5271/sjweh.1585; Stayner L, 2007, AM J PUBLIC HEALTH, V97, P545, DOI 10.2105/AJPH.2004.061275; Stevens G, 2008, PLOS MED, V5, P900, DOI 10.1371/journal.pmed.0050125; Stevenson DS, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006338; Stoltzfus RJ., 2004, COMP QUANTIFICATION, pp. 163; Taylor B, 2010, DRUG ALCOHOL DEPEN, V110, P108, DOI 10.1016/j.drugalcdep.2010.02.011; THOMPSON PD, 1956, TELLUS, V8, P384, DOI 10.1111/j.2153-3490.1956.tb01236.x; Thun M, 2012, TOB CONTROL, V21, P96, DOI 10.1136/tobaccocontrol-2011-050294; Thun MJ, 2008, PLOS MED, V5, P1357, DOI 10.1371/journal.pmed.0050185; Trichopoulou A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2337; U.S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; van Donkelaar A, 2010, ENVIRON HEALTH PERSP, V118, P847, DOI 10.1289/ehp.0901623; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Waddington H., 2009, WATER SANITATION HYG; Wang XM, 2010, J ARID ENVIRON, V74, P13, DOI 10.1016/j.jaridenv.2009.08.001; Wang X, 2010, AM J TROP MED HYG, V83, P582, DOI 10.4269/ajtmh.2010.10-0215; Wang XM, 2004, J ARID ENVIRON, V58, P559, DOI 10.1016/j.jaridenv.2003.11.009; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050568; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO, 2002, RED RISKS PROM HLTH; Wiener N., 1964, EXTRAPOLATION INTERP; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2009, GLOB HLTH RISKS MOR; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Yakoob MY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S23; Zaridze D, 2009, INT J EPIDEMIOL, V38, P143, DOI 10.1093/ije/dyn160; Zeng LX, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2001; Zhang X, 2003, INT J EPIDEMIOL, V32, P563, DOI 10.1093/ije/dyg106; Zhou Z, 2011, P NATL ACAD SCI USA, V108, P11028, DOI 10.1073/pnas.1019183108	192	7120	7512	151	3534	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2012	380	9859					2224	2260		10.1016/S0140-6736(12)61766-8	http://dx.doi.org/10.1016/S0140-6736(12)61766-8			37	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23245609	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000312387000017
J	Clarke, PM; Walter, SJ; Hayen, A; Mallon, WJ; Heijmans, J; Studdert, DM				Clarke, Philip M.; Walter, Simon J.; Hayen, Andrew; Mallon, William J.; Heijmans, Jeroen; Studdert, David M.			Survival of the fittest: retrospective cohort study of the longevity of Olympic medallists in the modern era	BRITISH MEDICAL JOURNAL			English	Editorial Material							LEAGUE BASEBALL PLAYERS; PHYSICAL-ACTIVITY; LIFE EXPECTANCY; FOLLOW-UP; MORTALITY; HEALTH; EXPERIENCE; ACTORS	Objective To determine whether Olympic medallists live longer than the general population. Design Retrospective cohort study, with passive follow-up and conditional survival analysis to account for unidentified loss to follow-up. Setting and participants 15 174 Olympic athletes from nine country groups (United States, Germany, Nordic countries, Russia, United Kingdom, France, Italy, Canada, and Australia and New Zealand) who won medals in the Olympic Games held in 1896-2010. Medallists were compared with matched cohorts in the general population (by country, age, sex, and year of birth). Main outcome measures Relative conditional survival. Results More medallists than matched controls in the general population were alive 30 years after winning (relative conditional survival 1.08, 95% confidence interval 1.07 to 1.10). Medallists lived an average of 2.8 years longer than controls. Medallists in eight of the nine country groups had a significant survival advantage compared with controls. Gold, silver, and bronze medallists each enjoyed similar sized survival advantages. Medallists in endurance sports and mixed sports had a larger survival advantage over controls at 30 years (1.13, 1.09 to 1.17; 1.11, 1.09 to 1.13) than that of medallists in power sports (1.05, 1.01 to 1.08). Conclusions Olympic medallists live longer than the general population, irrespective of country, medal, or sport. This study was not designed to explain this effect, but possible explanations include genetic factors, physical activity, healthy lifestyle, and the wealth and status that come with international sporting glory.	[Clarke, Philip M.; Walter, Simon J.; Studdert, David M.] Univ Melbourne, Melbourne Sch Populat Hlth, Parkville, Vic 3052, Australia; [Hayen, Andrew] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Mallon, William J.] Triangle Orthopaed Associates, Durham, NC USA; [Heijmans, Jeroen] Software Improvement Grp SIG, NL-3134 EB Vlaardingen, Netherlands	University of Melbourne; University of New South Wales Sydney	Studdert, DM (corresponding author), Univ Melbourne, Melbourne Sch Populat Hlth, Parkville, Vic 3052, Australia.	d.studdert@unimelb.edu.au	Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537; Hayen, Andrew/0000-0003-4046-8030; Clarke, Philip/0000-0002-7555-5348				Alaranta A, 2006, INT J SPORTS MED, V27, P581, DOI 10.1055/s-2005-865826; Backmand H, 2003, INT J SPORTS MED, V24, P609; BEAGLEHOLE R, 1983, NEW ZEAL MED J, V96, P513; Coate D, 2012, SCAND J MED SCI SPOR, DOI [10.1111/j.1600-0838.2012.01449, DOI 10.1111/J.1600-0838.2012.01449]; Cutler D, 2006, J ECON PERSPECT, V20, P97, DOI 10.1257/jep.20.3.97; FIELLER EC, 1954, J ROY STAT SOC B, V16, P175; Gajewski AK, 2008, EUR J EPIDEMIOL, V23, P335, DOI 10.1007/s10654-008-9237-3; HAKULINEN T, 1982, BIOMETRICS, V38, P933, DOI 10.2307/2529873; Homer, 1998, ILIAD; Kamper E., 1992, GOLDEN BOOK OLYMPIC; Kujala UM, 2001, JAMA-J AM MED ASSOC, V285, P44, DOI 10.1001/jama.285.1.44; Kujala UM, 1996, JAMA-J AM MED ASSOC, V276, P216, DOI 10.1001/jama.276.3.216; Kuss O, 2010, SCAND J MED SCI SPOR, V13, P410; Mallon B, 2011, HIST DICT OLYMPIC MO; Mallon B, 2001, TOTAL OLYMPICS COMPL; Marmot M., 2005, PUBLIC HEALTH; MENOTTI A, 1990, EUR J EPIDEMIOL, V6, P257, DOI 10.1007/BF00150429; Redelmeier DA, 2001, ANN INTERN MED, V134, P955, DOI 10.7326/0003-4819-134-10-200105150-00009; Saint Onge JM, 2008, SOC SCI QUART, V89, P817; Sarna S, 1997, AGING-CLIN EXP RES, V9, P35, DOI 10.1007/BF03340126; SARNA S, 1993, MED SCI SPORT EXER, V25, P237; SCHNOHR P, 1971, LANCET, V2, P1364; Smith JP, 1999, J ECON PERSPECT, V13, P145, DOI 10.1257/jep.13.2.145; SR Olympic Sports, 2012, OL STAT HIST; Sylvestre MP, 2006, ANN INTERN MED, V145, P361, DOI 10.7326/0003-4819-145-5-200609050-00009; TALLIS GM, 1988, STAT MED, V7, P483, DOI 10.1002/sim.4780070405; Teramoto M, 2010, J SCI MED SPORT, V13, P410, DOI 10.1016/j.jsams.2009.04.010; U.S. Department of Health and Human Services, 2008, PHYS ACT GUID ADV CO; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; WATERBOR J, 1988, NEW ENGL J MED, V318, P1278, DOI 10.1056/NEJM198805123181917; YAMAJI K, 1977, Journal of Human Ergology, V6, P15	31	58	58	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 13	2012	345								e8308	10.1136/bmj.e8308	http://dx.doi.org/10.1136/bmj.e8308			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056MZ	23241272	Green Submitted			2022-12-28	WOS:000312495700007
J	Wang, YS; Rattner, A; Zhou, YL; Williams, J; Smallwood, PM; Nathans, J				Wang, Yanshu; Rattner, Amir; Zhou, Yulian; Williams, John; Smallwood, Philip M.; Nathans, Jeremy			Norrin/Frizzled4 Signaling in Retinal Vascular Development and Blood Brain Barrier Plasticity	CELL			English	Article							ENDOTHELIAL GROWTH-FACTOR; REDUNDANT ROLES; ANGIOGENESIS; MICE; FRIZZLED-4; DISEASE; NORRIN; VEGF; PERICYTES; SOX18	Norrin/Frizzled4 (Fz4) signaling activates the canonical Wnt pathway to control retinal vascular development. Using genetically engineered mice, we show that precocious Norrin production leads to premature retinal vascular invasion and delayed Norrin production leads to characteristic defects in intraretinal vascular architecture. In genetic mosaics, wildtype endothelial cells (ECs) instruct neighboring Fz4(-/-) ECs to produce an architecturally normal mosaic vasculature, a cell nonautonomous effect. However, over the ensuing weeks, Fz4(-/-) ECs are selectively eliminated from the mosaic vasculature, implying the existence of a quality control program that targets defective ECs. In the adult retina and cerebellum, gain or loss of Norrin/Fz4 signaling results in a cell-autonomous gain or loss, respectively, of blood retina barrier and blood brain barrier function, indicating an ongoing requirement for Frizzled signaling in barrier maintenance and substantial plasticity in mature CNS vascular structure.	[Wang, Yanshu; Rattner, Amir; Zhou, Yulian; Williams, John; Smallwood, Philip M.; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Wang, Yanshu; Williams, John; Smallwood, Philip M.; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Nathans, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	jnathans@jhmi.edu		Rattner, Amir/0000-0001-9542-6212; Nathans, Jeremy/0000-0001-8106-5460	National Eye Institute (NIH); HHMI; Johns Hopkins Brain Sciences Institute; Foundation Fighting Blindness; Ellison Medical Foundation; NATIONAL EYE INSTITUTE [R01EY018637] Funding Source: NIH RePORTER	National Eye Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); HHMI(Howard Hughes Medical Institute); Johns Hopkins Brain Sciences Institute; Foundation Fighting Blindness(European Commission); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Hugh Cahill, Hao Chang, Alex Kolodkin, Se-Jin Lee, Max Tischfield, and Xin Ye for advice and/or helpful comments on the manuscript. This work was supported by the National Eye Institute (NIH), HHMI, the Johns Hopkins Brain Sciences Institute, the Foundation Fighting Blindness, and the Ellison Medical Foundation.	Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Truong A, 2011, J MOL MED, V89, P343, DOI 10.1007/s00109-010-0709-z; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Cahill H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002055; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; de Boer AG, 2007, ANNU REV PHARMACOL, V47, P323, DOI 10.1146/annurev.pharmtox.47.120505.105237; Eichler AF, 2011, NAT REV CLIN ONCOL, V8, P344, DOI 10.1038/nrclinonc.2011.58; Fantin A, 2011, DEVELOPMENT, V138, P4185, DOI 10.1242/dev.070037; Fukushima Y, 2011, J CLIN INVEST, V121, P1974, DOI 10.1172/JCI44900; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Geretti E, 2008, ANGIOGENESIS, V11, P31, DOI 10.1007/s10456-008-9097-1; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Kim J, 2011, GENE DEV, V25, P1399, DOI 10.1101/gad.2042011; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Luhmann UFO, 2008, EUR J NEUROSCI, V27, P2619, DOI 10.1111/j.1460-9568.2008.06237.x; Makinen T, 1999, J BIOL CHEM, V274, P21217, DOI 10.1074/jbc.274.30.21217; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Paes KT, 2011, INVEST OPHTH VIS SCI, V52, P6452, DOI 10.1167/iovs.10-7146; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Pendeville H, 2008, DEV BIOL, V317, P405, DOI 10.1016/j.ydbio.2008.01.028; Richter M, 1998, INVEST OPHTH VIS SCI, V39, P2450; ROBERTS WG, 1995, J CELL SCI, V108, P2369; Sakamoto Y, 2007, BIOCHEM BIOPH RES CO, V360, P539, DOI 10.1016/j.bbrc.2007.06.093; Smallwood PM, 2007, J BIOL CHEM, V282, P4057, DOI 10.1074/jbc.M609618200; Stan RV, 1999, P NATL ACAD SCI USA, V96, P13203, DOI 10.1073/pnas.96.23.13203; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Strickland LA, 2005, J PATHOL, V206, P466, DOI 10.1002/path.1805; Walcott BP, 2012, NEUROTHERAPEUTICS, V9, P65, DOI 10.1007/s13311-011-0087-4; Wang YS, 2001, J NEUROSCI, V21, P4761, DOI 10.1523/JNEUROSCI.21-13-04761.2001; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Ye X, 2011, GENE EXPR PATTERNS, V11, P151, DOI 10.1016/j.gep.2010.10.007; Ye X, 2010, TRENDS MOL MED, V16, P417, DOI 10.1016/j.molmed.2010.07.003; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047	40	226	236	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 7	2012	151	6					1332	1344		10.1016/j.cell.2012.10.042	http://dx.doi.org/10.1016/j.cell.2012.10.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	049RA	23217714	Green Accepted, Bronze			2022-12-28	WOS:000311999900021
J	Heurlin, M; Magnusson, MH; Lindgren, D; Ek, M; Wallenberg, LR; Deppert, K; Samuelson, L				Heurlin, Magnus; Magnusson, Martin H.; Lindgren, David; Ek, Martin; Wallenberg, L. Reine; Deppert, Knut; Samuelson, Lars			Continuous gas-phase synthesis of nanowires with tunable properties	NATURE			English	Article							GROWTH; NANOPARTICLES	Semiconductor nanowires are key building blocks for the next generation of light-emitting diodes(1), solar cells(2) and batteries(3). To fabricate functional nanowire-based devices on an industrial scale requires an efficient methodology that enables the mass production of nanowires with perfect crystallinity, reproducible and controlled dimensions and material composition, and low cost. So far there have been no reports of reliable methods that can satisfy all of these requirements. Here we show how aerotaxy, an aerosol-based growth method(4), can be used to grow nanowires continuously with controlled nanoscale dimensions, a high degree of crystallinity and at a remarkable growth rate. In our aerotaxy approach, catalytic size-selected Au aerosol particles induce nucleation and growth of GaAs nanowires with a growth rate of about 1 micrometre per second, which is 20 to 1,000 times higher than previously reported for traditional, substrate-based growth of nanowires made of group III-V materials(5-7). We demonstrate that the method allows sensitive and reproducible control of the nanowire dimensions and shape-and, thus, controlled optical and electronic properties-through the variation of growth temperature, time and Au particle size. Photoluminescence measurements reveal that even as-grown nanowires have good optical properties and excellent spectral uniformity. Detailed transmission electron microscopy investigations show that our aerotaxy-grown nanowires form along one of the four equivalent < 111 > B crystallographic directions in the zincblende unit cell, which is also the preferred growth direction for III-V nanowires seeded by Au particles on a single-crystal substrate. The reported continuous and potentially high-throughput method can be expected substantially to reduce the cost of producing high-quality nanowires and may enable the low-cost fabrication of nanowire-based devices on an industrial scale.	[Heurlin, Magnus; Lindgren, David; Deppert, Knut; Samuelson, Lars] Lund Univ, Div Solid State Phys, S-22100 Lund, Sweden; [Magnusson, Martin H.] Sol Volta AB, S-22370 Lund, Sweden; [Ek, Martin; Wallenberg, L. Reine] Lund Univ, Div Polymer & Mat Chem, S-22100 Lund, Sweden	Lund University; Lund University	Samuelson, L (corresponding author), Lund Univ, Div Solid State Phys, S-22100 Lund, Sweden.	lars.samuelson@ftf.lth.se	Ek, Martin/G-9477-2011; Magnusson, Martin H/B-2518-2013; Deppert, Knut/A-6719-2008; Lindgren, David/I-2820-2014; Wallenberg, Reine/H-5405-2011; Magnusson, Martin/AAH-9688-2020; Heurlin, Magnus/B-5154-2011; Samuelson, Lars/A-2171-2010	Ek, Martin/0000-0002-5705-8495; Magnusson, Martin H/0000-0002-8049-2142; Deppert, Knut/0000-0002-0471-951X; Wallenberg, Reine/0000-0002-0850-0398; Magnusson, Martin/0000-0002-8049-2142; Samuelson, Lars/0000-0003-1971-9894	Swedish Research Council; Swedish Foundation for Strategic Research; Knut and Alice Wallenberg Foundation; VINNOVA	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); VINNOVA(Vinnova)	We thank M. Borgstrom for discussions on the nanowire growth, B. Meuller for technical assistance with the growth setup, D. Csontos for reviewing our manuscript before submission and B. Pedersen for supporting this project by making the infrastructure of Sol Voltaics AB available. We acknowledge G. Alcott and E. Nilsson for sharing their preliminary results on doping. This project is performed within the Nanometer Structure Consortium at Lund University (nmC@LU) and with financial support from the Swedish Research Council, the Swedish Foundation for Strategic Research, the Knut and Alice Wallenberg Foundation and VINNOVA.	Bjork MT, 2002, NANO LETT, V2, P87, DOI 10.1021/nl010099n; BOGARDUS EH, 1968, PHYS REV, V176, P993, DOI 10.1103/PhysRev.176.993; Borgstrom M, 2004, J CRYST GROWTH, V260, P18, DOI 10.1016/j.jcrysgro.2003.08.009; Borgstrom MT, 2007, NAT NANOTECHNOL, V2, P541, DOI 10.1038/nnano.2007.263; Borgstrom MT, 2011, IEEE J SEL TOP QUANT, V17, P1050, DOI 10.1109/JSTQE.2010.2073681; Boukai AI, 2008, NATURE, V451, P168, DOI 10.1038/nature06458; Caroff P, 2011, IEEE J SEL TOP QUANT, V17, P829, DOI 10.1109/JSTQE.2010.2070790; Chan CK, 2008, NAT NANOTECHNOL, V3, P31, DOI 10.1038/nnano.2007.411; Deppert K, 1996, APPL PHYS LETT, V68, P1409, DOI 10.1063/1.116096; Dong A, 2008, J AM CHEM SOC, V130, P5954, DOI 10.1021/ja711408t; Dresselhaus MS, 2007, ADV MATER, V19, P1043, DOI 10.1002/adma.200600527; Duan XF, 2000, APPL PHYS LETT, V76, P1116, DOI 10.1063/1.125956; Duan XF, 2000, ADV MATER, V12, P298, DOI 10.1002/(SICI)1521-4095(200002)12:4<298::AID-ADMA298>3.0.CO;2-Y; Morral AFI, 2011, IEEE J SEL TOP QUANT, V17, P819, DOI 10.1109/JSTQE.2010.2091259; Ford AC, 2009, NANO LETT, V9, P360, DOI 10.1021/nl803154m; Freer EM, 2010, NAT NANOTECHNOL, V5, P525, DOI [10.1038/nnano.2010.106, 10.1038/NNANO.2010.106]; Gudiksen MS, 2002, J PHYS CHEM B, V106, P4036, DOI 10.1021/jp014392n; HARAGUCHI K, 1994, J APPL PHYS, V75, P4220, DOI 10.1063/1.356009; Heiss M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.045303; Holmes JD, 2000, SCIENCE, V287, P1471, DOI 10.1126/science.287.5457.1471; Huang Y, 2001, SCIENCE, V291, P630, DOI 10.1126/science.291.5504.630; Joyce HJ, 2009, NANO LETT, V9, P695, DOI 10.1021/nl803182c; Karlsson LS, 2006, J NANOPART RES, V8, P971, DOI 10.1007/s11051-006-9094-5; Kim SH, 2007, MATER LETT, V61, P2079, DOI 10.1016/j.matlet.2006.08.031; Magnusson MH, 1999, NANOSTRUCT MATER, V12, P45, DOI 10.1016/S0965-9773(99)00063-X; Moewe M, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2949315; Qian F, 2005, NANO LETT, V5, P2287, DOI 10.1021/nl051689e; Ramdani MR, 2010, NANO LETT, V10, P1836, DOI 10.1021/nl100557d; Soci C, 2008, NANO LETT, V8, P4275, DOI 10.1021/nl801986r; TAFTO J, 1982, J APPL CRYSTALLOGR, V15, P60, DOI 10.1107/S0021889882011352; Wacaser BA, 2009, ADV MATER, V21, P153, DOI 10.1002/adma.200800440; Wang FD, 2006, INORG CHEM, V45, P7511, DOI 10.1021/ic060498r; YAZAWA M, 1992, APPL PHYS LETT, V61, P2051, DOI 10.1063/1.108329	33	135	137	2	372	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					90	+		10.1038/nature11652	http://dx.doi.org/10.1038/nature11652			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23201685				2022-12-28	WOS:000311893400051
J	Zaraa, I; Cogrel, O				Zaraa, Ines; Cogrel, Olivier			Subungual Tumor of the Thumb	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zaraa, Ines] La Rabta Hosp, Tunis, Tunisia; [Cogrel, Olivier] Haut Leveque Hosp, Bordeaux, France	Universite de Tunis-El-Manar; Hopital La Rabta; CHU Bordeaux	Zaraa, I (corresponding author), La Rabta Hosp, Tunis, Tunisia.	olivier.cogrel@chu-bordeaux.fr							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 6	2012	367	23					2240	2240		10.1056/NEJMicm1104277	http://dx.doi.org/10.1056/NEJMicm1104277			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048DO	23215560				2022-12-28	WOS:000311890600011
J	Christopher-Stine, L; Robinson, DR; Wu, CC; Mark, EJ				Christopher-Stine, Lisa; Robinson, Dwight R.; Wu, Carol C.; Mark, Eugene J.			Case 37-2012: A 21-Year-Old Man with Fevers, Arthralgias, and Pulmonary Infiltrates	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERSTITIAL LUNG-DISEASE; TRANSFER-RNA-SYNTHETASE; ADULT STILLS-DISEASE; IDIOPATHIC INFLAMMATORY MYOPATHIES; RHEUMATOID-ARTHRITIS; ANTISYNTHETASE SYNDROME; CLINICAL-COURSE; DERMATOMYOSITIS; AUTOANTIBODIES; ANTIBODIES		[Christopher-Stine, Lisa] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Christopher-Stine, Lisa] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Robinson, Dwight R.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; [Wu, Carol C.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Mark, Eugene J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Robinson, Dwight R.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Wu, Carol C.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Mark, Eugene J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Christopher-Stine, L (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.				Biogen Idec; Medimmune; Novartis; Questcor; URL	Biogen Idec(Biogen); Medimmune(AstraZenecaMedimmune); Novartis(Novartis); Questcor; URL	Dr. Christopher-Stine reports receiving consulting fees from Biogen Idec, Medimmune, Novartis, Questcor, and URL; providing expert testimony on behalf of patients and providers in cases of myositis; submitting a patent application together with her institution for anti-HMG-CoA reductase autoantibody enzymelinked immunosorbent assay and immunoprecipitation; receiving travel expenses from Crescent Health Care; and receiving payment for manuscript preparation from Year Book of Medicine. Dr. Mark reports providing expert testimony on behalf of patients who believe they have been harmed by exposure to asbestos. No other potential conflict of interest relevant to this article was reported.	Amato AA, 2011, ANN NEUROL, V70, P427, DOI 10.1002/ana.22477; [Anonymous], 2008, CURR RHEUMATOL REP, V10, P333; Betteridge ZE, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3275; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Cain HC, 1998, CLIN CHEST MED, V19, P687, DOI 10.1016/S0272-5231(05)70110-6; Cassidy EA, 2010, ARTHRITIS RHEUM S, V62, P929; Connors GR, 2010, CHEST, V138, P1464, DOI 10.1378/chest.10-0180; de Leon F C, 1995, Curr Opin Pulm Med, V1, P223; EISENBERG H, 1973, ANN INTERN MED, V79, P37, DOI 10.7326/0003-4819-79-1-37; Fiorentino D, 2011, J AM ACAD DERMATOL, V65, P25, DOI 10.1016/j.jaad.2010.09.016; Fischer A, 2009, RESP MED, V103, P1719, DOI 10.1016/j.rmed.2009.05.001; GRIECO MH, 1985, AM REV RESPIR DIS, V131, P952; Gunawardena H, 2009, RHEUMATOLOGY, V48, P607, DOI 10.1093/rheumatology/kep078; Handa T, 2005, INTERNAL MED, V44, P319, DOI 10.2169/internalmedicine.44.319; Hervier B, 2010, RHEUMATOLOGY, V49, P972, DOI 10.1093/rheumatology/kep455; Hirakata M, 1999, J IMMUNOL, V162, P2315; HOAGLAND MB, 1958, J BIOL CHEM, V231, P241; Kalluri M, 2009, CHEST, V135, P1550, DOI 10.1378/chest.08-2233; Koduri G, 2010, RHEUMATOLOGY, V49, P1483, DOI 10.1093/rheumatology/keq035; KOH WH, 1995, ANN RHEUM DIS, V54, P269, DOI 10.1136/ard.54.4.269; La Corte R, 2006, AUTOIMMUNITY, V39, P249, DOI 10.1080/08916930600623791; Mammen AL, 2011, ARTHRITIS RHEUM-US, V63, P713, DOI 10.1002/art.30156; MARGUERIE C, 1990, Q J MED, V77, P1019, DOI 10.1093/qjmed/77.1.1019; Marie I, 1998, J RHEUMATOL, V25, P1336; Masson C, 1996, J RHEUMATOL, V23, P495; Mehta P, 2010, J TRANSL MED, V8, P8; Mimori T, 2007, CURR OPIN RHEUMATOL, V19, P523, DOI 10.1097/BOR.0b013e3282f01a8c; OHTA A, 1990, J RHEUMATOL, V17, P1058; Satoh S, 1996, Ryumachi, V36, P862; Shapira Y, 1996, CLIN RHEUMATOL, V15, P335, DOI 10.1007/BF02230354; Targoff Ira N, 2006, Curr Rheumatol Rep, V8, P196, DOI 10.1007/s11926-996-0025-3; Vega P, 2011, J RHEUMATOL, V38, P394, DOI 10.3899/jrheum.100608; Watanabe K, 2011, RESP MED, V105, P1238, DOI 10.1016/j.rmed.2011.03.022; Yahaba Misuzu, 2008, Nihon Kokyuki Gakkai Zasshi, V46, P547; YAMAGUCHI M, 1992, J RHEUMATOL, V19, P424; Yoshifuji H, 2006, AUTOIMMUNITY, V39, P233, DOI 10.1080/08916930600622884; Young A, 2007, BEST PRACT RES CL RH, V21, P907, DOI 10.1016/j.berh.2007.05.007; Zimmermann C, 1998, ARTHRITIS RHEUM, V41, P1938, DOI 10.1002/1529-0131(199811)41:11<1938::AID-ART7>3.3.CO;2-O	38	6	6	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2012	367	22					2134	2146		10.1056/NEJMcpc1208147	http://dx.doi.org/10.1056/NEJMcpc1208147			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044MS	23190225				2022-12-28	WOS:000311624400013
J	Kuipers, AF; Bartels, LW				Kuipers, Albertus F.; Bartels, L. Wilbert			Sleep Apnea	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kuipers, Albertus F.] Isala Klin, Zwolle, Netherlands; [Bartels, L. Wilbert] Univ Med Ctr Utrecht, Utrecht, Netherlands	Isala Clinics; Utrecht University; Utrecht University Medical Center	Kuipers, AF (corresponding author), Isala Klin, Zwolle, Netherlands.	a.f.kuipers@isala.nl							0	2	2	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2012	367	22					E33	E33		10.1056/NEJMicm1212352	http://dx.doi.org/10.1056/NEJMicm1212352			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044MS	23190244				2022-12-28	WOS:000311624400012
J	VanLare, JM; Blum, JD; Conway, PH				VanLare, Jordan M.; Blum, Jonathan D.; Conway, Patrick H.			Linking Performance With Payment Implementing the Physician Value-Based Payment Modifier	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[VanLare, Jordan M.; Blum, Jonathan D.; Conway, Patrick H.] US Dept HHS, Ctr Medicare Serv, Woodlawn, MD 21244 USA; [VanLare, Jordan M.; Blum, Jonathan D.; Conway, Patrick H.] US Dept HHS, Ctr Medicaid Serv, Woodlawn, MD 21244 USA; [VanLare, Jordan M.] Columbia Univ, Columbia Coll Phys & Surg, New York, NY USA; [Conway, Patrick H.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; Columbia University; Cincinnati Children's Hospital Medical Center	VanLare, JM (corresponding author), US Dept HHS, Ctr Medicare Serv, 7500 Secur Blvd, Woodlawn, MD 21244 USA.	jordan.vanlare@cms.hhs.gov						[Anonymous], 2011, C NATL STRAT QUAL IM; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P2595, DOI 10.1001/jama.2012.6382; Chernew ME, 2011, HEALTH AFFAIR, V30, P51, DOI 10.1377/hlthaff.2010.0980; US Centers for Medicare & Medicaid Services, FIN RUL; VanLare JM, 2012, NEW ENGL J MED, V367, P292, DOI 10.1056/NEJMp1204939; Wharam J Frank, 2011, Qual Manag Health Care, V20, P234, DOI 10.1097/QMH.0b013e318222c398	6	44	44	1	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 28	2012	308	20					2089	2090		10.1001/jama.2012.14834	http://dx.doi.org/10.1001/jama.2012.14834			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043IV	23198298				2022-12-28	WOS:000311537200020
J	Liaropoulos, L				Liaropoulos, Lycourgos			Greek economic crisis: not a tragedy for health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Athens, Athens 15127, Greece	National & Kapodistrian University of Athens	Liaropoulos, L (corresponding author), Univ Athens, Athens 15127, Greece.	lliaropo@nurs.uoa.gr						[Anonymous], 2010, LIAROPOULOSS BLOG; Chrysoloras N, GREECES EC DESPAIR G; Forelle C, 2011, WALL STREET J; Hadjimatheou C, 2012, BBC NEWS; Kaitelidou D, 2012, PHP95 ISPOR 15 ANN E; Kentikelenis A, 2011, LANCET, V378, P1457, DOI 10.1016/S0140-6736(11)61556-0; Kirschbaum E, 2012, HUFFINGTON POST; Liaropoulos L, 2011, REORGANISATION HOSP; Liaropoulos L, 2008, HEALTH POLICY, V87, P72, DOI 10.1016/j.healthpol.2007.12.005; OECD, 2011, HLTH GLANC; Pagoulatos G, 2012, REINVENTION EUROPE S; Zarocostas J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d200	12	25	25	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2012	345								e7988	10.1136/bmj.e7988	http://dx.doi.org/10.1136/bmj.e7988			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048FM	23187095				2022-12-28	WOS:000311895700004
J	Nankivell, BJ				Nankivell, Brian J.			Antibody-mediated vascular rejection: relation to causation	LANCET			English	Editorial Material							RENAL-ALLOGRAFTS; TRANSPLANTATION		Univ Sydney, Dept Renal Med, Westmead Hosp, Sydney, NSW 2145, Australia	University of Sydney	Nankivell, BJ (corresponding author), Univ Sydney, Dept Renal Med, Westmead Hosp, Sydney, NSW 2145, Australia.	brian_nankivell@wsahs.nsw.gov.au						Colvin RB, 2007, J AM SOC NEPHROL, V18, P1046, DOI 10.1681/ASN.2007010073; Haas M, 2011, AM J TRANSPLANT, V11, P2123, DOI 10.1111/j.1600-6143.2011.03647.x; Lefaucheur C., 2012, LANCET; Mauiyyedi S, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133779; McDonald S, 2007, AM J TRANSPLANT, V7, P1201, DOI 10.1111/j.1600-6143.2007.01759.x; Mengel M, 2012, AM J TRANSPLANT, V12, P563, DOI 10.1111/j.1600-6143.2011.03926.x; Middleton J, 2002, BLOOD, V100, P3853, DOI 10.1182/blood.V100.12.3853; Shimizu T, 2010, CLIN TRANSPLANT, V24, P22, DOI 10.1111/j.1399-0012.2010.01277.x; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Sis B, 2009, AM J TRANSPLANT, V9, P2312, DOI 10.1111/j.1600-6143.2009.02761.x; Stegall MD, 2010, CURR OPIN ORGAN TRAN, V15, P8, DOI 10.1097/MOT.0b013e3283342712; Sun HJ, 2011, TRANSPL IMMUNOL, V25, P42, DOI 10.1016/j.trim.2011.04.002	12	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 26	2013	381	9863					275	277		10.1016/S0140-6736(12)61577-3	http://dx.doi.org/10.1016/S0140-6736(12)61577-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077IT	23182297				2022-12-28	WOS:000314021800010
J	Hackett, JA; Sengupta, R; Zylicz, JJ; Murakami, K; Lee, C; Down, TA; Surani, MA				Hackett, Jamie A.; Sengupta, Roopsha; Zylicz, Jan J.; Murakami, Kazuhiro; Lee, Caroline; Down, Thomas A.; Surani, M. Azim			Germline DNA Demethylation Dynamics and Imprint Erasure Through 5-Hydroxymethylcytosine	SCIENCE			English	Article							TET PROTEINS; MOUSE; METHYLATION; GENOME; CELL; 5-METHYLCYTOSINE; SPECIFICATION; MECHANISMS; CONVERSION; GENES	Mouse primordial germ cells (PGCs) undergo sequential epigenetic changes and genome-wide DNA demethylation to reset the epigenome for totipotency. Here, we demonstrate that erasure of CpG methylation (5mC) in PGCs occurs via conversion to 5-hydroxymethylcytosine (5hmC), driven by high levels of TET1 and TET2. Global conversion to 5hmC initiates asynchronously among PGCs at embryonic day (E) 9.5 to E10.5 and accounts for the unique process of imprint erasure. Mechanistically, 5hmC enrichment is followed by its protracted decline thereafter at a rate consistent with replication-coupled dilution. The conversion to 5hmC is an important component of parallel redundant systems that drive comprehensive reprogramming in PGCs. Nonetheless, we identify rare regulatory elements that escape systematic DNA demethylation in PGCs, providing a potential mechanistic basis for transgenerational epigenetic inheritance.	[Hackett, Jamie A.; Sengupta, Roopsha; Zylicz, Jan J.; Murakami, Kazuhiro; Lee, Caroline; Down, Thomas A.; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Hackett, Jamie A.; Sengupta, Roopsha; Zylicz, Jan J.; Murakami, Kazuhiro; Lee, Caroline; Surani, M. Azim] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge CB2 1QN, England; [Zylicz, Jan J.; Surani, M. Azim] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge; University of Cambridge	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England.	a.surani@gurdon.cam.ac.uk	Murakami, Kazuhiro/AAC-4569-2019	Zylicz, Jan/0000-0001-9622-5658; Hackett, Jamie/0000-0002-6237-3684; Surani, Azim/0000-0002-8640-4318; Murakami, Kazuhiro/0000-0003-1759-9542	Wellcome Trust [RG49135, RG44593, 083563]; Human Frontier Science Program	Wellcome Trust(Wellcome TrustEuropean Commission); Human Frontier Science Program(Human Frontier Science Program)	We thank N. Miller for fluorescence-activated cell sorting analysis, F. Tang and W. Tang for experimental support, and G-L. Xu for reagents. This work was funded by the Wellcome Trust (RG49135, RG44593, and 083563) and the Human Frontier Science Program. Sequencing data have been deposited in the Sequence Read Archive (SRA060914).	Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guibert S, 2012, GENOME RES, V22, P633, DOI 10.1101/gr.130997.111; Hackett JA, 2012, DEVELOPMENT, V139, P3623, DOI 10.1242/dev.081661; Hackett JA, 2012, TRENDS GENET, V28, P164, DOI 10.1016/j.tig.2012.01.005; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Qin CH, 2010, MOL CARCINOGEN, V49, P54, DOI 10.1002/mc.20576; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240	25	530	549	1	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2013	339	6118					448	452		10.1126/science.1229277	http://dx.doi.org/10.1126/science.1229277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23223451	Green Accepted			2022-12-28	WOS:000313960700044
J	Milstein, A				Milstein, Arnold			Code Red and Blue - Safely Limiting Health Care's GDP Footprint	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Sch Med, Clin Excellence Res Ctr, Stanford, CA 94305 USA	Stanford University	Milstein, A (corresponding author), Stanford Univ, Sch Med, Clin Excellence Res Ctr, Stanford, CA 94305 USA.							[Anonymous], 2005, BUILDING A BETTER DE; Farrell D, 2008, ACCOUNTING FOR THE C; Hillestad R, 2005, HEALTH AFFAIR, V24, P1103, DOI 10.1377/hlthaff.24.5.1103; Institute of Medicine, 2012, BEST CARE AT LOWER C; Sood N, 2009, HEALTH SERV RES, V44, P1449, DOI 10.1111/j.1475-6773.2009.00985.x	5	14	14	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2013	368	1					1	3		10.1056/NEJMp1211374	http://dx.doi.org/10.1056/NEJMp1211374			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	062PA	23234473				2022-12-28	WOS:000312930600013
J	Murray, CJL; Ezzati, M; Flaxman, AD; Lim, S; Lozano, R; Michaud, C; Naghavi, M; Salomon, JA; Shibuya, K; Vos, T; Lopez, AD				Murray, Christopher J. L.; Ezzati, Majid; Flaxman, Abraham D.; Lim, Stephen; Lozano, Rafael; Michaud, Catherine; Naghavi, Mohsen; Salomon, Joshua A.; Shibuya, Kenji; Vos, Theo; Lopez, Alan D.			GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology	LANCET			English	Editorial Material							SYSTEMATIC ANALYSIS; 187 COUNTRIES; BURDEN; DISEASE; MORTALITY; DEATH		[Murray, Christopher J. L.; Flaxman, Abraham D.; Lim, Stephen; Lozano, Rafael; Naghavi, Mohsen] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England; [Michaud, Catherine] China Med Board, Boston, MA USA; [Salomon, Joshua A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Vos, Theo; Lopez, Alan D.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health; University of Queensland; University of Tokyo	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	cjlm@uw.edu	Salomon, Joshua A/D-3898-2009; Lopez, Alan/AAA-2734-2022; Salomon, Joshua/S-1929-2019; Lozano, Rafael/T-5352-2018; Lopez, Alan D/F-1487-2010	Salomon, Joshua A/0000-0003-3929-5515; Salomon, Joshua/0000-0003-3929-5515; Lozano, Rafael/0000-0002-7356-8823; Lopez, Alan D/0000-0001-5818-6512; Shibuya, Kenji/0000-0003-2528-7530	Medical Research Council [G0801056B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		[Anonymous], 1996, GLOBAL BURDEN DIS CO; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Murray CJL, 2007, LANCET, V370, P109, DOI 10.1016/S0140-6736(07)61064-2; Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000262; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; Obermeyer Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000260; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rajaratnam JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000253; Shield KD, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-9; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X	14	80	84	0	62	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2012	380	9859					2055	2058		10.1016/S0140-6736(12)62134-5	http://dx.doi.org/10.1016/S0140-6736(12)62134-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23245598				2022-12-28	WOS:000312387000005
J	Shakur, H; Roberts, I; Piot, P; Horton, R; Krug, E; Mersch, J				Shakur, Haleema; Roberts, Ian; Piot, Peter; Horton, Richard; Krug, Etienne; Mersch, Jeannot			A promise to save 100 000 trauma patients	LANCET			English	Editorial Material									[Shakur, Haleema; Roberts, Ian; Piot, Peter] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Horton, Richard] The Lancet, London NW1 7BY, England; [Krug, Etienne] WHO, CH-1211 Geneva, Switzerland; [Mersch, Jeannot] European Federat Rd Traff Victims, Luxembourg, Luxembourg	University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Roberts, I (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	ian.roberts@lshtm.ac.uk		Shakur-Still, Haleema/0000-0002-6511-109X				Aeron-Thomas A, 2004, INVOLVEMENT IMPACT R; Guerriero C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018987; Ker K, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-3; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Peden M., 2004, WORLD REPORT ROAD TR; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Roberts I, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004896.pub3; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5	9	13	15	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	2012	380	9859					2062	2063		10.1016/S0140-6736(12)62037-6	http://dx.doi.org/10.1016/S0140-6736(12)62037-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23245601				2022-12-28	WOS:000312387000008
J	Hashmi, ASK				Hashmi, A. Stephen K.			Sub-Nanosized Gold Catalysts	SCIENCE			English	Editorial Material							HYDRATION		Heidelberg Univ, Inst Organ Chem, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Hashmi, ASK (corresponding author), Heidelberg Univ, Inst Organ Chem, D-69120 Heidelberg, Germany.	hashmi@hashmi.de	Hashmi, A. S. K./B-5188-2013	Hashmi, A. S. K./0000-0002-6720-8602				Bouhrara M, 2011, DALTON T, V40, P2995, DOI 10.1039/c0dt00932f; Chretien S, 2007, CURR OPIN SOLID ST M, V11, P62, DOI 10.1016/j.cossms.2008.07.003; Comotti M, 2004, ANGEW CHEM INT EDIT, V43, P5812, DOI 10.1002/anie.200460446; Haruta M, 2005, NATURE, V437, P1098, DOI 10.1038/4371098a; Hashmi ASK, 2010, ADV SYNTH CATAL, V352, P1315, DOI 10.1002/adsc.201000126; Hashmi ASK, 2000, ANGEW CHEM INT EDIT, V39, P2285, DOI 10.1002/1521-3773(20000703)39:13<2285::AID-ANIE2285>3.0.CO;2-F; Hashmi ASK, 2000, J AM CHEM SOC, V122, P11553, DOI 10.1021/ja005570d; Hutchings GJ, 2005, CATAL TODAY, V100, P55, DOI 10.1016/j.cattod.2004.12.016; Lu J., 2012, ANGEW CHEM INT EDIT, V51, P1; Marion N, 2009, J AM CHEM SOC, V131, P448, DOI 10.1021/ja809403e; Mizushima E, 2002, ANGEW CHEM INT EDIT, V41, P4563, DOI 10.1002/1521-3773(20021202)41:23<4563::AID-ANIE4563>3.0.CO;2-U; Oliver-Meseguer J, 2012, SCIENCE, V338, P1452, DOI 10.1126/science.1227813; Schmidbaur H., 1995, NATURWISS RUNDSCH, V48, P443; Teles JH, 1998, ANGEW CHEM INT EDIT, V37, P1415, DOI 10.1002/(SICI)1521-3773(19980605)37:10<1415::AID-ANIE1415>3.0.CO;2-N; Zhou CY, 2006, ORG LETT, V8, P325, DOI 10.1021/ol052696c	15	70	70	1	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 14	2012	338	6113					1434	1434		10.1126/science.1231901	http://dx.doi.org/10.1126/science.1231901			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053DN	23239727				2022-12-28	WOS:000312250800038
J	Rawlins, M				Rawlins, Michael			We are asking more questions about NICE appraisal of Tamiflu	BRITISH MEDICAL JOURNAL			English	Editorial Material																		Burch J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13580; NICE, 2011, TECHN APPR PROC GUID; NICE, 2002, SYST REV EFF COST EF	3	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 12	2012	345								e8420	10.1136/bmj.e8420	http://dx.doi.org/10.1136/bmj.e8420			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	056MU	23236048				2022-12-28	WOS:000312495100018
J	Motsoaledi, A				Motsoaledi, Aaron			Progress and changes in the South African health sector	LANCET			English	Editorial Material									Dept Hlth, ZA-0001 Pretoria, Gauteng, South Africa		Motsoaledi, A (corresponding author), Dept Hlth, ZA-0001 Pretoria, Gauteng, South Africa.	minister@health.gov.za						Bradshaw D, 2012, RAPID MORTALITY SURV; Day C, 2011, DISTRICT HLTH BAROME; Mayosi BM, 2012, LANCET; Statistics South Africa, 2012, STAT REL P0301 4 CEN	4	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 8	2012	380	9858					1969	1970		10.1016/S0140-6736(12)61997-7	http://dx.doi.org/10.1016/S0140-6736(12)61997-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051KI	23201212				2022-12-28	WOS:000312124900004
J	Liu, Y; Rutlin, M; Huang, SY; Barrick, CA; Wang, F; Jones, KR; Tessarollo, L; Ginty, DD				Liu, Yin; Rutlin, Michael; Huang, Siyi; Barrick, Colleen A.; Wang, Fan; Jones, Kevin R.; Tessarollo, Lino; Ginty, David D.			Sexually Dimorphic BDNF Signaling Directs Sensory Innervation of the Mammary Gland	SCIENCE			English	Article							CELL-DEATH; NERVOUS-SYSTEM; IN-VIVO; TRKB; RECEPTOR; NEURONS; MOUSE; DIFFERENTIATION; ORGANIZATION; GENE	How neural circuits associated with sexually dimorphic organs are differentially assembled during development is unclear. Here, we report a sexually dimorphic pattern of mouse mammary gland sensory innervation and the mechanism of its formation. Brain-derived neurotrophic factor (BDNF), emanating from mammary mesenchyme and signaling through its receptor TrkB on sensory axons, is required for establishing mammary gland sensory innervation of both sexes at early developmental stages. Subsequently, in males, androgens promote mammary mesenchymal expression of a truncated form of TrkB, which prevents BDNF-TrkB signaling in sensory axons and leads to a rapid loss of mammary gland innervation independent of neuronal apoptosis. Thus, sex hormone regulation of a neurotrophic factor signal directs sexually dimorphic axonal growth and maintenance, resulting in generation of a sex-specific neural circuit.	[Liu, Yin; Rutlin, Michael; Huang, Siyi; Ginty, David D.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Barrick, Colleen A.; Tessarollo, Lino] NCI, Mouse Canc Genet Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Wang, Fan] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Jones, Kevin R.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Howard Hughes Medical Institute; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Duke University; University of Colorado System; University of Colorado Boulder	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu		Liu, Yin/0000-0002-2377-2703; JONES, KEVIN/0000-0002-3802-7562	NIH [NS34814, EY014998, DE019440]; NATIONAL CANCER INSTITUTE [ZIABC010391, ZIABC010390] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034814, P30NS050274, R37NS034814, R29NS034814] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Ginty laboratory for assistance and discussions throughout the course of this project, and A. Kolodkin and R. Kuruvilla for comments on the manuscript. This work was supported by NIH grants NS34814 (D. D. G.), EY014998 (K.R.J.), and DE019440 (F. W.). D. D. G. is an investigator of the Howard Hughes Medical Institute. BDNFlox mice are covered under U. S. patent no. 4,959,317, which is licensed to Bristol-Myer Squibb Company, with the right to grant sublicenses. The mice are available for noncommercial biomedical research under a Material Transfer Agreement with the University of Colorado.	Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; BIFFO S, 1995, DEVELOPMENT, V121, P2461; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; da Silva S, 2011, P NATL ACAD SCI USA, V108, P3395, DOI 10.1073/pnas.1014411108; Dorsey SG, 2006, NEURON, V51, P21, DOI 10.1016/j.neuron.2006.06.009; Dunbar ME, 1999, DEVELOPMENT, V126, P3485; Forger NG, 2006, NEUROSCIENCE, V138, P929, DOI 10.1016/j.neuroscience.2005.07.006; Fryer RH, 1997, EXP NEUROL, V148, P616, DOI 10.1006/exnr.1997.6699; Gorski JA, 2003, J NEUROSCI, V23, P6856; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Low LK, 2006, PHILOS T R SOC B, V361, P1531, DOI 10.1098/rstb.2006.1883; LYON MF, 1970, NATURE, V227, P1217, DOI 10.1038/2271217a0; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; NORDEEN EJ, 1985, SCIENCE, V229, P671, DOI 10.1126/science.4023706; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Robinson GW, 2007, NAT REV GENET, V8, P963, DOI 10.1038/nrg2227; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; WRIGHT LL, 1987, INT J DEV NEUROSCI, V5, P305, DOI 10.1016/0736-5748(87)90005-0	21	47	47	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1357	1360		10.1126/science.1228258	http://dx.doi.org/10.1126/science.1228258			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	049NZ	23224557	Green Accepted			2022-12-28	WOS:000311991200071
J	Sipp, D; Turner, L				Sipp, Douglas; Turner, Leigh			US Regulation of Stem Cells as Medical Products	SCIENCE			English	Editorial Material							FDA REGULATION; ENCEPHALOMYELITIS; RULES; TEXAS		[Sipp, Douglas] RIKEN, Ctr Dev Biol, Kobe, Hyogo 12345, Japan; [Turner, Leigh] Univ Minnesota, Ctr Bioeth, Minneapolis, MN 55455 USA; [Turner, Leigh] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN 55455 USA; [Turner, Leigh] Univ Minnesota, Coll Pharm, Minneapolis, MN 55455 USA	RIKEN; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sipp, D (corresponding author), RIKEN, Ctr Dev Biol, Kobe, Hyogo 12345, Japan.	sipp@cdb.riken.jp	Sipp, Doug/C-9218-2017	Sipp, Doug/0000-0002-5979-0938; Turner, Leigh/0000-0001-7283-6809				Alderazi YJ, 2012, J CHILD NEUROL, V27, P632, DOI 10.1177/0883073811422831; Carpenter D, 2010, PRINC STUD AM POLIT, P73; Cyranoski D, 2012, NATURE, V484, P149, DOI 10.1038/484149a; Cyranoski D, 2011, NATURE, V477, P377; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Fink DW, 2009, SCIENCE, V324, P1662, DOI 10.1126/science.1173712; Giannakopoulou A, 2011, EXP NEUROL, V230, P16, DOI 10.1016/j.expneurol.2010.04.011; Gottlieb S., 2012, WALL STREET J, pA13; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; Ikegaya H, 2012, NATURE, V489, P33, DOI 10.1038/489033c; Johnson L., 2012, HOUSTON PUBLIC  1026; Kaiser J, 2012, SCIENCE, V336, P284, DOI 10.1126/science.336.6079.284; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Levine AD, 2012, REGEN MED, V7, P451, DOI [10.2217/RME.12.43, 10.2217/rme.12.43]; Patra P.K., 2010, LAW TECHNOL SCI, V7, P295; Pera MF, 2012, SUBMISSION NHMRC PUB; Prockop DJ, 2010, CYTOTHERAPY, V12, P576, DOI 10.3109/14653249.2010.507330; Steeves JD, 2011, YONSEI MED J, V52, P701, DOI 10.3349/ymj.2011.52.5.701; Thirabanjasak D, 2010, J AM SOC NEPHROL, V21, P1218, DOI 10.1681/ASN.2009111156; von Eschenbach Andrew, 2012, WALL STREET J, pA19	20	37	38	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 7	2012	338	6112					1296	1297		10.1126/science.1229918	http://dx.doi.org/10.1126/science.1229918			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	049NZ	23224541				2022-12-28	WOS:000311991200048
J	West, CP; Dupras, DM				West, Colin P.; Dupras, Denise M.			General Medicine vs Subspecialty Career Plans Among Internal Medicine Residents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DECISIONS; TRAINEES	Context Current medical training models in the United States are unlikely to produce sufficient numbers of general internists and primary care physicians. Differences in general internal medicine (GIM) career plans between internal medicine residency program types and across resident demographics are not well understood. Objective To evaluate the general medicine career plans of internal medicine residents and how career plans evolve during training. Design, Setting, and Participants A study of US internal medicine residents using an annual survey linked to the Internal Medicine In-Training Examination taken in October of 2009-2011 to evaluate career plans by training program, sex, and medical school location. Of 67 207 US eligible categorical and primary care internal medicine residents, 57 087 (84.9%) completed and returned the survey. Demographic data provided by the National Board of Medical Examiners were available for 52 035 (77.4%) of these residents, of whom 51 390 (76.5%) responded to all survey items and an additional 645 (1.0%) responded to at least 1 survey item. Data were analyzed from the 16 781 third-year residents (32.2%) in this sample. Main Outcome Measures Self-reported ultimate career plans of internal medicine residents. Results A GIM career plan was reported by 3605 graduating residents (21.5%). A total of 562 primary care program (39.6%) and 3043 categorical (19.9%) residents reported GIM as their ultimate career plan (adjusted odds ratio [AOR], 2.76; 99% CI, 2.35-3.23; P<.001). Conversely, 10 008 categorical (65.3%) and 745 primary care program (52.5%) residents reported a subspecialty career plan (AOR, 1.90; 99% CI, 1.62-2.23; P<.001). GIM career plans were reported more frequently by women than men (26.7% vs 17.3%, respectively; AOR, 1.69; 99% CI, 1.53-1.87; P<.001). US medical graduates were slightly more likely to report GIM career plans than international medical graduates (22.0% vs 21.1%, respectively; AOR, 1.76; 99% CI, 1.50-2.06; P<.001). Within primary care programs, US medical graduates were much more likely to report GIM career plans than international medical graduates (57.3% vs 27.3%, respectively; AOR, 3.48; 99% CI, 2.58-4.70; P<.001). Compared with their counterparts, maintaining a first-year GIM career plan over the course of their training was more likely among primary care program residents (68.2% vs 52.3%; AOR, 1.81; 99% CI, 1.25-2.64; P<.001), women (62.4% vs 47.2%; AOR, 1.75; 99% CI, 1.34-2.29; P<.001), and US medical graduates (60.9% vs 49.2%; AOR, 1.48; 99% CI, 1.13-1.93; P<.001). Conclusion Reported GIM career plans were markedly less common than subspecialty career plans among internal medicine residents, including those in primary care training programs, and differed according to resident sex, medical school location, and program type. JAMA. 2012;308(21):2241-2247 www.jama.com	[West, Colin P.] Mayo Clin, Dept Med, Div Gen Internal Med, Rochester, MN 55905 USA; [West, Colin P.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Dupras, Denise M.] Mayo Clin, Dept Med, Div Primary Care Internal Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	West, CP (corresponding author), Mayo Clin, Dept Med, Div Gen Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	west.colin@mayo.edu						American Board of Internal Medicine, NUMB PROGR RES; American College of Physicians, SOL CHALL FAC PRIM C; American College of Physicians, IS SHORT PRIM CAR PH; [Anonymous], CREAT NEW NAT WORKF; [Anonymous], STAND DEF FIN DISP C; Association of American Medical Colleges, 2018, COMPL PHYS SUPPL DEM; Brotherton SE, 2011, JAMA-J AM MED ASSOC, V306, P1015, DOI 10.1001/jama.2011.1236; Collwill JM, 2008, HEALTH AFFAIR, V27, pW232, DOI 10.1377/hlthaff.27.3.w232; Council on Graduate Medical Education, ADV PRIM CAR; Garibaldi RA, 2005, ACAD MED, V80, P507, DOI 10.1097/00001888-200505000-00021; GARIBALDI RA, 1994, ANN INTERN MED, V121, P117, DOI 10.7326/0003-4819-121-2-199407150-00008; Institute of Medicine, RET AG AM BUILD HEAL; Landon BE, 2006, MED CARE, V44, P234, DOI 10.1097/01.mlr.0000199848.17133.9b; Lipkin M, 2008, ACAD MED, V83, P1064, DOI 10.1097/ACM.0b013e31818928ab; Lipner RS, 2006, ANN INTERN MED, V144, P29, DOI 10.7326/0003-4819-144-1-200601030-00007; MCPHEE SJ, 1987, JAMA-J AM MED ASSOC, V258, P1491, DOI 10.1001/jama.258.11.1491; NOBLE J, 1992, ANN INTERN MED, V116, P482, DOI 10.7326/0003-4819-116-6-482; Schwartz MD, 2011, ARCH INTERN MED, V171, P744, DOI 10.1001/archinternmed.2011.139; West CP, 2006, ANN INTERN MED, V145, P774, DOI 10.7326/0003-4819-145-10-200611210-00010; West CP, 2009, J GEN INTERN MED, V24, P946, DOI 10.1007/s11606-009-1039-0; WITZBURG RA, 1988, J GEN INTERN MED, V3, P48, DOI 10.1007/BF02595756	21	84	85	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 5	2012	308	21					2241	2247		10.1001/jama.2012.47535	http://dx.doi.org/10.1001/jama.2012.47535			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047HI	23212502	Bronze			2022-12-28	WOS:000311829500016
J	Achan, J; Kakuru, A; Ikilezi, G; Ruel, T; Clark, TD; Nsanzabana, C; Charlebois, E; Aweeka, F; Dorsey, G; Rosenthal, PJ; Havlir, D; Kamya, MR				Achan, Jane; Kakuru, Abel; Ikilezi, Gloria; Ruel, Theodore; Clark, Tamara D.; Nsanzabana, Christian; Charlebois, Edwin; Aweeka, Francesca; Dorsey, Grant; Rosenthal, Philip J.; Havlir, Diane; Kamya, Moses R.			Antiretroviral Agents and Prevention of Malaria in HIV-Infected Ugandan Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYPE-1 PROTEASE INHIBITORS; PLASMODIUM-FALCIPARUM; IN-VITRO; ARTEMETHER-LUMEFANTRINE; ANTIMALARIAL ACTIVITY; THERAPY; DRUGS; EXPOSURE	BACKGROUND Human immunodeficiency virus (HIV) protease inhibitors show activity against Plasmodium falciparum in vitro. We hypothesized that the incidence of malaria in HIV-infected children would be lower among children receiving lopinavir-ritonavirbased antiretroviral therapy (ART) than among those receiving nonnucleoside reverse-transcriptase inhibitor (NNRTI)-based ART. METHODS We conducted an open-label trial in which HIV-infected children 2 months to 5 years of age who were eligible for ART or were currently receiving NNRTI-based ART were randomly assigned to either lopinavir-ritonavir-based ART or NNRTI-based ART and were followed for 6 months to 2 years. Cases of uncomplicated malaria were treated with artemether-lumefantrine. The primary end point was the incidence of malaria. RESULTS We enrolled 176 children, of whom 170 received the study regimen: 86 received NNRTI-based ART, and 84 lopinavir-ritonavir-based ART. The incidence of malaria was lower among children receiving the lopinavir-ritonavir-based regimen than among those receiving the NNRTI-based regimen (1.32 vs. 2.25 episodes per person-year; incidence-rate ratio, 0.59; 95% confidence interval [CI], 0.36 to 0.97; P=0.04), as was the risk of a recurrence of malaria after treatment with artemether-lumefantrine (28.1% vs. 54.2%; hazard ratio, 0.41; 95% CI, 0.22 to 0.76; P=0.004). The median lumefantrine level on day 7 after treatment for malaria was significantly higher in the lopinavir-ritonavir group than in the NNRTI group. In the lopinavir-ritonavir group, lumefantrine levels exceeding 300 ng per milliliter on day 7 were associated with a reduction of more than 85% in the 63-day risk of recurrent malaria. A greater number of serious adverse events occurred in the lopinavir-ritonavir group than in the NNRTI group (5.6% vs. 2.3%, P=0.16). Pruritus occurred significantly more frequently in the lopinavir-ritonavir group, and elevated alanine aminotransferase levels significantly more frequently in the NNRTI group. CONCLUSIONS Lopinavir-ritonavir-based ART as compared with NNRTI-based ART reduced the incidence of malaria by 41%, with the lower incidence attributable largely to a significant reduction in the recurrence of malaria after treatment with artemether-lumefantrine. Lopinavir-ritonavir-based ART was accompanied by an increase in serious adverse events. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development; ClinicalTrials.gov number, NCT00978068.)	[Achan, Jane] Makerere Univ, Coll Hlth Sci, Dept Pediat & Child Hlth, Kampala, Uganda; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Achan, Jane; Kakuru, Abel; Ikilezi, Gloria; Kamya, Moses R.] Infect Dis Res Collaborat, Kampala, Uganda; [Ruel, Theodore] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Clark, Tamara D.; Nsanzabana, Christian; Charlebois, Edwin; Dorsey, Grant; Rosenthal, Philip J.; Havlir, Diane] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Aweeka, Francesca] Univ Calif San Francisco, Dept Clin Pharm, Drug Res Unit, San Francisco, CA 94143 USA	Makerere University; Makerere University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Achan, J (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Pediat & Child Hlth, POB 7475, Kampala, Uganda.	achanj@yahoo.co.uk	Nsanzabana, Christian/ABE-8253-2021	Nsanzabana, Christian/0000-0002-6944-3892; Kakuru, Abel/0000-0001-9941-1309	Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD060459, P01HD059454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development; Supported by a grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Andrews KT, 2006, ANTIMICROB AGENTS CH, V50, P639, DOI 10.1128/AAC.50.2.639-648.2006; Ashley EA, 2007, TROP MED INT HEALTH, V12, P201, DOI 10.1111/j.1365-3156.2006.01785.x; Dokomajilar C, 2006, ANTIMICROB AGENTS CH, V50, P1893, DOI 10.1128/AAC.50.5.1893-1895.2006; Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210; FRANCOIS G, 1994, ANN SOC BELG MED TR, V74, P177; German P, 2009, JAIDS-J ACQ IMM DEF, V51, P424, DOI 10.1097/QAI.0b013e3181acb4ff; Huang LS, 2012, BIOANALYSIS, V4, P157, DOI [10.4155/BIO.11.303, 10.4155/bio.11.303]; Kamya MR, 2007, AIDS, V21, P2059, DOI 10.1097/QAD.0b013e3282ef6da1; Lek-Uthai U, 2008, ANTIMICROB AGENTS CH, V52, P2435, DOI 10.1128/AAC.00169-08; Mwesigwa J, 2010, ANTIMICROB AGENTS CH, V54, P52, DOI 10.1128/AAC.00679-09; *NAT I ALL INF DIS, 2004, TABL GRAD SEV AD PED; Nathoo S, 2003, LANCET, V362, P1039, DOI 10.1016/S0140-6736(03)14414-5; Nsanzabana C, 2011, ANTIMICROB AGENTS CH, V55, P5073, DOI 10.1128/AAC.05130-11; Nsobya SL, 2010, ANTIMICROB AGENTS CH, V54, P1200, DOI 10.1128/AAC.01412-09; Okello PE, 2006, AM J TROP MED HYG, V75, P219, DOI 10.4269/ajtmh.2006.75.219; Palumbo P, 2011, 18 C RETR OPP INF BO; Palumbo P, 2010, NEW ENGL J MED, V363, P1510, DOI 10.1056/NEJMoa1000931; Parikh S, 2005, ANTIMICROB AGENTS CH, V49, P2983, DOI 10.1128/AAC.49.7.2983-2985.2005; Redmond AM, 2007, AIDS, V21, P763, DOI 10.1097/QAD.0b013e328031f41a; Skinner-Adams TS, 2004, J INFECT DIS, V190, P1998, DOI 10.1086/425584; van Vugt M, 1999, AM J TROP MED HYG, V61, P964, DOI 10.4269/ajtmh.1999.61.964; WHO, 2005, SUSC PLASM FALC ANT; Zeldin RK, 2004, J ANTIMICROB CHEMOTH, V53, P4, DOI 10.1093/jac/dkh029	23	82	83	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 29	2012	367	22					2110	2118		10.1056/NEJMoa1200501	http://dx.doi.org/10.1056/NEJMoa1200501			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044MS	23190222	Green Accepted, Green Published			2022-12-28	WOS:000311624400008
J	Gornall, J				Gornall, Jonathan			PUBLIC HEALTH How the new guardians of public health are investing heavily in tobacco companies	BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						Department of Health (DoH), 2011, HLTH LIV HLTH PEOPL; Head of finance and head of pensions Norfolk County Council Hymans Robertson LLP, 2012, CONS INV ISS INCL FI; World Health Organization, 2003, WHO FRAM CONV TOB CO	3	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	NOV 28	2012	345								e8023	10.1136/bmj.e8023	http://dx.doi.org/10.1136/bmj.e8023			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	048FO	23190906				2022-12-28	WOS:000311895900007
J	Selmer, C; Olesen, JB; Hansen, ML; Lindhardsen, J; Olsen, AMS; Madsen, JC; Faber, J; Hansen, PR; Pedersen, OD; Torp-Pedersen, C; Gislason, GH				Selmer, Christian; Olesen, Jonas Bjerring; Hansen, Morten Lock; Lindhardsen, Jesper; Olsen, Anne-Marie Schjerning; Madsen, Jesper Clausager; Faber, Jens; Hansen, Peter Riis; Pedersen, Ole Dyg; Torp-Pedersen, Christian; Gislason, Gunnar Hilmar			The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ENDOGENOUS SUBCLINICAL HYPERTHYROIDISM; SERUM TSH; FOLLOW-UP; MORTALITY; HORMONE; COMORBIDITY; DYSFUNCTION; REGISTER; VALIDITY; THERAPY	Objectives To examine the risk of atrial fibrillation in relation to the whole spectrum of thyroid function in a large cohort of patients. Design Population based cohort study of general practice patients identified by linkage of nationwide registries at the individual level. Setting Primary care patients in the city of Copenhagen. Subjects Registry data for 586 460 adults who had their thyroid function evaluated for the first time by their general practitioner during 2000-10 and who were without previously recorded thyroid disease or atrial fibrillation. Main outcome measure Poisson regression models used to estimate risk of atrial fibrillation by thyroid function. Results Of the 586 460 individuals in the study population (mean (SD) age 50.2 (16.9) years, 39% men), 562 461 (96.0%) were euthyroid, 1670 (0.3%) had overt hypothyroidism, 12 087 (2.0%) had subclinical hypothyroidism, 3966 (0.7%) had overt hyperthyroidism, and 6276 (1.0%) had subclinical hyperthyroidism. Compared with the euthyroid individuals, the risk of atrial fibrillation increased with decreasing levels of thyroid stimulating hormone (TSH) from high normal euthyroidism (incidence rate ratio 1.12 (95% CI 1.03 to 1.21)) to subclinical hyperthyroidism with reduced TSH (1.16 (0.99 to 1.36)) and subclinical hyperthyroidism with supressed TSH (1.41 (1.25 to 1.59)). Both overt and subclinical hypothyroidism were associated with a lower risk of atrial fibrillation. Conclusion The risk of atrial fibrillation was closely associated with thyroid activity, with a low risk in overt hypothyroidism, high risk in hyperthyroidism, and a TSH level dependent association with risk of atrial fibrillation across the spectrum of subclinical thyroid disease.	[Selmer, Christian; Olesen, Jonas Bjerring; Hansen, Morten Lock; Lindhardsen, Jesper; Olsen, Anne-Marie Schjerning; Hansen, Peter Riis; Torp-Pedersen, Christian; Gislason, Gunnar Hilmar] Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark; [Madsen, Jesper Clausager] Copenhagen Gen Practitioners Lab, Copenhagen, Denmark; [Faber, Jens] Herlev Univ Hosp, Dept Endocrinol, DK-2730 Herlev, Denmark; [Faber, Jens; Torp-Pedersen, Christian] Univ Copenhagen, Fac Hlth Sci, DK-1168 Copenhagen, Denmark; [Pedersen, Ole Dyg] Roskilde Univ Hosp, Dept Cardiol, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Selmer, C (corresponding author), Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark.	cselmer@gmail.com	Torp-Pedersen, Christian/E-5931-2013; Gislason, Gunnar/B-7561-2009; Hansen, Peter Riis/AAR-7659-2020; Selmer, Christian/H-3314-2019	Gislason, Gunnar/0000-0002-0548-402X; Selmer, Christian/0000-0002-0534-3163; Hansen, Peter Riis/0000-0002-9056-535X	Danish Heart Foundation [11-04-R84-A3483-22669]; Danish Thyroid Association; Agnes and Knut Mork Foundation; FUKAP Foundation, Gentofte University Hospital, Denmark; START Foundation, Gentofte University Hospital, Denmark	Danish Heart Foundation; Danish Thyroid Association; Agnes and Knut Mork Foundation; FUKAP Foundation, Gentofte University Hospital, Denmark; START Foundation, Gentofte University Hospital, Denmark	The study was partly funded by unrestricted grants from the Danish Heart Foundation (No 11-04-R84-A3483-22669), Danish Thyroid Association, Agnes and Knut Mork Foundation, and FUKAP and START Foundations, Gentofte University Hospital, Denmark.	Asvold BO, 2012, J CLIN ENDOCR METAB, V97, P93, DOI 10.1210/jc.2011-1724; Atzmon G, 2009, J CLIN ENDOCR METAB, V94, P1251, DOI 10.1210/jc.2008-2325; Baadsgaard M, 2011, SCAND J PUBLIC HEALT, V39, P103, DOI 10.1177/1403494811405098; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Biondi B, 2002, ANN INTERN MED, V137, P904, DOI 10.7326/0003-4819-137-11-200212030-00011; Biondi B, 2000, J CLIN ENDOCR METAB, V85, P4701, DOI 10.1210/jc.85.12.4701; Biondi B, 2010, NAT REV ENDOCRINOL, V6, P431, DOI 10.1038/nrendo.2010.105; Buffenstein R, 2009, MOL CELL ENDOCRINOL, V299, P101, DOI 10.1016/j.mce.2008.04.021; Cappola AR, 2006, JAMA-J AM MED ASSOC, V295, P1033, DOI 10.1001/jama.295.9.1033; Collet TH, 2012, ARCH INTERN MED, V172, P799, DOI 10.1001/archinternmed.2012.402; Cooper DS, 2001, NEW ENGL J MED, V345, P260, DOI 10.1056/NEJM200107263450406; Faber J, 2001, EUR J ENDOCRINOL, V145, P391, DOI 10.1530/eje.0.1450391; FAZIO S, 1995, J CLIN ENDOCR METAB, V80, P2222, DOI 10.1210/jc.80.7.2222; Fine JP, 1999, J AM STAT ASS; Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993; Frost L, 2007, AM J MED, V120, P47, DOI 10.1016/j.amjmed.2005.12.027; Gammage MD, 2007, ARCH INTERN MED, V167, P928, DOI 10.1001/archinte.167.9.928; Goichot B, 2009, CLIN CHEM, V55, P420, DOI 10.1373/clinchem.2008.110627; Heeringa J, 2008, ARCH INTERN MED, V168, P2219, DOI 10.1001/archinte.168.20.2219; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Jensen MT, 2012, EUR J PREV CARDIOL, V19, P102, DOI 10.1177/1741826710394274; Kahaly GJ, 2000, THYROID, V10, P665, DOI 10.1089/10507250050137743; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Ladenson PW, 2010, NEW ENGL J MED, V362, P906, DOI 10.1056/NEJMoa0905633; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Mukamal KJ, 2005, CIRCULATION, V112, P1736, DOI 10.1161/CIRCULATIONAHA.105.547844; Nuttall M, 2006, J CLIN EPIDEMIOL, V59, P265, DOI 10.1016/j.jclinepi.2005.07.015; PARLE JV, 1991, CLIN ENDOCRINOL, V34, P77; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; Sgarbi JA, 2003, J CLIN ENDOCR METAB, V88, P1672, DOI 10.1210/jc.2002-021046; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; WHO Collaborating Centre for Drug Statistics Methodology, 2012, GUID ATC CLASS DDD A; Zhou ZH, 2011, INTERNAL MED, V50, P2947, DOI 10.2169/internalmedicine.50.6135	39	172	180	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 27	2012	345								e7895	10.1136/bmj.e7895	http://dx.doi.org/10.1136/bmj.e7895			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048FM	23186910	hybrid, Green Published			2022-12-28	WOS:000311895700003
J	Wu, D; Hu, Q; Yan, Z; Chen, W; Yan, CY; Huang, X; Zhang, J; Yang, PY; Deng, HT; Wang, JW; Deng, XW; Shi, YG				Wu, Di; Hu, Qi; Yan, Zhen; Chen, Wen; Yan, Chuangye; Huang, Xi; Zhang, Jing; Yang, Panyu; Deng, Haiteng; Wang, Jiawei; Deng, XingWang; Shi, Yigong			Structural basis of ultraviolet-B perception by UVR8	NATURE			English	Article							CATION-PI INTERACTIONS; PLANT PHOTORECEPTOR DOMAIN; BLUE; CRYPTOCHROMES; PHYTOCHROME; REGULATOR; SOFTWARE; REVEALS	The Arabidopsis thaliana protein UVR8 is a photoreceptor for ultraviolet-B. Upon ultraviolet-B irradiation, UVR8 undergoes an immediate switch from homodimer to monomer, which triggers a signalling pathway for ultraviolet protection. The mechanism by which UVR8 senses ultraviolet-B remains largely unknown. Here we report the crystal structure of UVR8 at 1.8 angstrom resolution, revealing a symmetric homodimer of seven-bladed beta-propeller that is devoid of any external cofactor as the chromophore. Arginine residues that stabilize the homodimeric interface, principally Arg 286 and Arg 338, make elaborate intramolecular cation-pi interactions with surrounding tryptophan amino acids. Two of these tryptophans, Trp 285 and Trp 233, collectively serve as the ultraviolet-B chromophore. Our structural and biochemical analyses identify the molecular mechanism for UVR8-mediated ultraviolet-B perception, in which ultraviolet-B radiation results in destabilization of the intramolecular cation-pi interactions, causing disruption of the critical intermolecular hydrogen bonds mediated by Arg 286 and Arg 338 and subsequent dissociation of the UVR8 homodimer.	[Wu, Di; Hu, Qi; Yan, Zhen; Zhang, Jing; Deng, Haiteng; Shi, Yigong] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Wu, Di; Hu, Qi; Yan, Zhen; Yan, Chuangye; Zhang, Jing; Deng, Haiteng; Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Chen, Wen; Huang, Xi; Yang, Panyu; Deng, XingWang] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Yan, Chuangye; Wang, Jiawei] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Huang, Xi; Yang, Panyu; Deng, XingWang] Peking Univ, Peking Yale Joint Ctr Plant Mol Genet & Agrobiote, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China	Tsinghua University; Tsinghua University; Peking University; Tsinghua University; Peking University	Shi, YG (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010; Deng, Xing Wang/ABF-4107-2020; Yan, Chuangye/AAJ-5832-2021	Wang, Jiawei/0000-0001-9893-8539; Shi, Yigong/0000-0003-2030-168X; Yan, Zhen/0000-0002-1999-8451; Jan, Yuh Nung/0000-0003-1367-6299; Yan, Chuangye/0000-0001-9338-8048; Jan, Lily/0000-0003-3938-8498; Deng, Haiteng/0000-0001-9496-1280; Yan, Zhiqiang/0000-0003-4714-2076; He, Ye/0000-0002-3936-4958	Ministry of Science and Technology [2009CB918801, 2012CB910900]; National Natural Science Foundation; Beijing Municipal Commission of Education; Beijing Municipal Commission of Science; Beijing Municipal Commission of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047850] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); Beijing Municipal Commission of Science; Beijing Municipal Commission of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. He and S. Huang at SSRF, and K. Hasegawa and T. Kumasaka at the SPring-8 beamline BL41XU, for assistance. This work was supported by funds from the Ministry of Science and Technology (grant no. 2009CB918801 to Y.S., and 2012CB910900 to X.W.D.), the National Natural Science Foundation, and the Beijing Municipal Commissions of Education and Science and Technology.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Brown BA, 2005, P NATL ACAD SCI USA, V102, P18225, DOI 10.1073/pnas.0507187102; Brown BA, 2008, PLANT PHYSIOL, V146, P576, DOI 10.1104/pp.107.108456; Brudler R, 2003, MOL CELL, V11, P59, DOI 10.1016/S1097-2765(03)00008-X; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2012, SCIENCE, V335, P1492, DOI 10.1126/science.1218091; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; DeLano W.L, PYMOL MOL GRAPHICS S; Dougherty DA, 2007, J NUTR, V137, p1504S, DOI 10.1093/jn/137.6.1504S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falciatore A, 2005, CURR TOP DEV BIOL, V68, P317, DOI 10.1016/S0070-2153(05)68011-8; Fogle KJ, 2011, SCIENCE, V331, P1409, DOI 10.1126/science.1199702; Gallivan JP, 2000, J AM CHEM SOC, V122, P870, DOI 10.1021/ja991755c; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Kaiserli E, 2007, PLANT CELL, V19, P2662, DOI 10.1105/tpc.107.053330; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Kliebenstein DJ, 2002, PLANT PHYSIOL, V130, P234, DOI 10.1104/pp.005041; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sinnokrot MO, 2002, J AM CHEM SOC, V124, P10887, DOI 10.1021/ja025896h; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; van der Linden AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000503; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; YU HT, 1992, J AM CHEM SOC, V114, P8449, DOI 10.1021/ja00048a015	40	321	369	10	242	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					214	U96		10.1038/nature10931	http://dx.doi.org/10.1038/nature10931			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22388820				2022-12-28	WOS:000303149900029
J	Deweerdt, S				Deweerdt, Sarah			COMPARATIVE BIOLOGY Looking for a master switch	NATURE			English	Editorial Material							FIBROBLASTS; RESISTANT											Austad SN, 2010, J COMP PATHOL, V141, pS10, DOI 10.1016/j.jcpa.2009.10.024; Edrey YH, 2012, AGING CELL, V11, P213, DOI 10.1111/j.1474-9726.2011.00772.x; Harper JM, 2007, AGING CELL, V6, P1, DOI 10.1111/j.1474-9726.2006.00255.x; Harper JM, 2011, J EXP BIOL, V214, P1902, DOI 10.1242/jeb.054643; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Soltow QA, 2010, INTEGR COMP BIOL, V50, P844, DOI 10.1093/icb/icq094	6	18	19	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 6	2012	492	7427					S10	S11		10.1038/492S10a	http://dx.doi.org/10.1038/492S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048EQ	23222666	Bronze			2022-12-28	WOS:000311893400006
J	Schiermeier, Q				Schiermeier, Quirin			Go West, young Russian	NATURE			English	News Item																		2012, NATURE, V483, P253	1	10	10	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					295	295		10.1038/485295a	http://dx.doi.org/10.1038/485295a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	23243677	Bronze			2022-12-28	WOS:000304099100010
